Cluster,Size,Density,Internal weight,External weight,Quality,P-value,Members,Top GO Terms,Top GO Term p-values,Top GO FDRs,Top GO Term Fold Enrichments
1,14,0.5014,45.62,10880.0,0.004164,0.9999969999999999,A1BG ACR ANHX MZF1 PGBD2 RABL2B SLC27A5 ZBTB45 ZNF132 ZNF324 ZNF324B ZNF497 ZNF891 ZSCAN22,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",8.655e-06|9.608e-05|9.63e-05|9.743e-05|0.0001775,0.1365|0.7578|0.5064|0.3842|0.56,5.12|3.822|3.821|3.815|3.542
2,47,0.3075,332.4,37330.0,0.008806,1.0,A1CF AGAP5 AGAP6 AGAP9 ANK3 ANXA8L1 CALHM3 CFAP70 COMTD1 CXCL12 CYP2C19 CYP2C8 CYP2C9 DKK1 DUPD1 DUSP13 FAM25A GDF2 GPRIN2 HKDC1 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPJ LRRC18 NUTM2A NUTM2B PTPN20 RET SAMD8 SFTPA1 SFTPA2 SHLD2 SORCS1 SYNPO2L SYT15 TMEM72 UNC5B WASHC2C ZNF22 ZNF239 ZNF32 ZNF33B ZNF37A ZNF485,omega-hydroxylase P450 pathway|epoxygenase P450 pathway|cellular response to type I interferon|exogenous drug catabolic process|response to type I interferon,2.399e-06|1.898e-05|2.288e-05|2.773e-05|3.127e-05,0.03784|0.1497|0.1203|0.1093|0.09866,146.1|65.73|25.4|57.16|23.37
3,15,0.5026,52.77,11700.0,0.004477,0.999999,A2M CLEC12B CLEC2B CLEC4D CLEC6A GALNT8 GYS2 KCNA6 KLRC1 PKP2 SLCO1B1 SLCO1B3 SLCO1B7 SLCO1C1 TAS2R20,sodium-independent organic anion transport|bile acid and bile salt transport|regulation of innate immune response|organic hydroxy compound transport|monocarboxylic acid transport,8.739e-10|1.321e-08|2.207e-06|3.938e-06|4.04e-06,1.379e-05|0.0001042|0.01161|0.01553|0.01275,343.2|161.5|22|36.37|36.13
4,9,0.5168,18.6,6111.0,0.0030269999999999997,0.9998530000000001,CTU2 DUS2 METTL1 NR2C2AP NSUN2 PUS3 THUMPD1 TRMT1 XPOT,tRNA modification|tRNA processing|RNA modification|tRNA metabolic process|ncRNA processing,5.127e-20|1.38e-18|1.246e-17|2.155e-17|4.601e-14,8.087e-16|1.089e-14|6.553e-14|8.5e-14|1.452e-10,187.2|127.7|99.12|93.1|39.01
5,5,0.512,5.12,3794.0,0.001344,0.996692,A3GALT2 DIS3L2 HBS1L NYAP1 TUT7,polyuridylation-dependent mRNA catabolic process|nuclear-transcribed mRNA catabolic process|mRNA catabolic process|miRNA metabolic process|RNA catabolic process,4.712e-07|8.754e-06|1.167e-05|1.19e-05|1.714e-05,0.007432|0.06905|0.06135|0.04693|0.05407,2746|63.05|57.21|392.3|50.23
6,85,0.3195,1141.0,65140.0,0.017169999999999998,1.0,ADORA2A AIFM3 APOBEC3A APOBEC3B APOBEC3C APOBEC3D APOBEC3F APOBEC3G APOL1 APOL2 APOL5 ARHGAP8 BCL2L13 C22orf15 C22orf23 CACNA1I CBY1 CCDC116 CCDC157 COMT CRYBA4 CRYBB1 CRYBB2 CRYBB3 CYTH4 DGCR6 DGCR6L DMC1 DRICH1 EMID1 FOXRED2 GAL3ST1 GGT1 GGTLC2 GSTT2B GUCD1 HIC2 HMOX1 HORMAD2 HPS1 IGLL1 IGLL5 LRRC75B MGAT3 MICALL1 MIF MMP11 MPPE1 MPST MTFP1 NIPSNAP1 RAC2 RASD2 RFPL2 RFPL3 RGL4 RIMBP3 RNF215 SDF2L1 SEC14L2 SEC14L3 SEC14L4 SEC14L6 SEPT5 SGSM1 SIRPA SLC5A1 SLC5A4 SPECC1L SUSD2 SYNGR1 TBC1D10A TCN2 TOP3B TPST2 TRIOBP TSSK2 TST TUBA8 UPB1 USP18 VPREB1 YPEL1 ZDHHC8 ZNF74,pyrimidine nucleoside catabolic process|DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination,3.43e-11|3.6e-11|8.289e-11|8.289e-11|8.289e-11,5.41e-07|2.839e-07|4.358e-07|3.269e-07|2.615e-07,72.05|142|118.4|118.4|118.4
7,4,0.5279,3.167,3187.0,0.0009904999999999998,0.9929309999999999,A4GNT CASR IFT80 KATNAL2,negative regulation of epithelial cell proliferation|connective tissue development|articular cartilage development|ossification|osteoblast proliferation,0.0002462|0.000578|0.0007766|0.0009653|0.001165,1|1|1|1|1,78.61|50.98|1716|39.3|1030
8,19,0.5355,91.57,12560.0,0.007215000000000001,1.0,AAAS AHCTF1 CDCA3 CLCC1 KPNA2 NDC1 NUP133 NUP153 NUP160 NUP188 NUP35 NUP37 NUP43 NUP50 NUP98 POM121 POM121C SENP2 TMEM201,intracellular transport of virus|tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus|transport of virus|multi-organism localization,4.954e-32|1.948e-31|1.948e-31|2.25e-31|3.37e-31,7.815e-28|1.536e-27|1.024e-27|8.874e-28|1.063e-27,281|414.5|414.5|248.8|240.9
9,5,0.5686,5.686,4194.0,0.001351,0.996692,AACS ADAMTS3 DISP1 GNG4 TRAFD1,response to oleic acid|positive regulation of vascular endothelial growth factor signaling pathway|regulation of protein secretion|vascular endothelial growth factor production|cellular response to testosterone stimulus,0.001698|0.001698|0.001868|0.00194|0.002183,1|1|1|1|1,686.5|686.5|29.01|588.4|514.9
10,11,0.5294,29.12,8847.0,0.003273,0.999969,AADAC ARHGEF26 CPA3 CPB1 GPR87 P2RY14 PLSCR1 PLSCR2 TFDP2 TM4SF18 TM4SF4,G protein-coupled purinergic nucleotide receptor signaling pathway|plasma membrane phospholipid scrambling|phospholipid translocation|purinergic nucleotide receptor signaling pathway|lipid translocation,3.713e-05|7.135e-05|0.0003455|0.0003601|0.0003901,0.5858|0.5627|1|1|1,245.2|171.6|74.62|73.03|70.05
11,5,0.5016,5.016,3956.0,0.001263,0.996692,AADACL2 ARGFX C6orf48 SAYSD1 TAP2,"antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent",8.046e-06|9.879e-06|1.777e-05|0.0002404|0.0004854,0.1269|0.07792|0.09344|0.9481|1,484.6|433.6|316.8|82.38|4119
12,4,0.5463,3.278,3178.0,0.0010279999999999998,0.9929309999999999,AADACL3 C11orf52 C1QB WDTC1,synapse pruning|cell junction disassembly|negative regulation of fatty acid biosynthetic process|negative regulation of fatty acid metabolic process|regulation of fatty acid biosynthetic process,0.002328|0.002522|0.003104|0.007166|0.009289,1|1|1|1|1,468.1|429.1|343.2|143|109.5
13,26,0.6754,219.5,17550.0,0.012320000000000001,1.0,ACTR2 ACTR3 ARPC2 ARPC3 ARPC4 CCDC93 COMMD10 COMMD2 COMMD3 COMMD4 COMMD5 COMMD6 COMMD7 COMMD8 COMMD9 LZIC RAB21 RAB7A SNX17 VPS26C VPS29 VPS35 VPS35L WASHC3 WASHC4 WASHC5,"retrograde transport, endosome to plasma membrane|vesicle-mediated transport|endosomal transport|vesicle-mediated transport to the plasma membrane|Arp2/3 complex-mediated actin nucleation",1.376e-14|6.052e-12|9.556e-12|1.583e-11|1.106e-10,2.171e-10|4.773e-08|5.024e-08|6.243e-08|3.49e-07,198|6.877|30.6|66.01|198
14,12,0.5154,34.02,9445.0,0.0035789999999999997,0.999986,AAED1 C9orf3 C9orf47 FBP1 FBP2 GNA14 MUSK NUTM2G TXNDC8 ZNF484 ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.864e-06|3.106e-06|6.518e-06|1.705e-05|2.416e-05,0.0294|0.02449|0.03427|0.06723|0.07622,1716|1144|686.5|381.4|312
15,19,0.5231,89.45,12340.0,0.0071730000000000006,1.0,AAGAB AGFG1 AP2A1 AP2A2 AP2B1 AP2M1 AP2S1 C10orf88 CCDC32 CLTC DNM2 FCHO2 ITSN2 PICALM PPP6C RAB5C RALGAPB SH3GL1 TFRC,clathrin-dependent endocytosis|receptor-mediated endocytosis|endocytosis|receptor metabolic process|low-density lipoprotein particle receptor catabolic process,5.509e-21|2.934e-17|4.086e-17|1.636e-16|1.389e-15,8.69e-17|2.314e-13|2.149e-13|6.452e-13|4.383e-12,343.2|50.75|26.47|98.07|686.5
16,5,0.5012,5.012,3670.0,0.0013599999999999999,0.996692,AAK1 EIF3D THOC5 TOMM20 TOMM22,protein targeting to mitochondrion|protein transmembrane transport|establishment of protein localization to mitochondrion|protein localization to mitochondrion|protein import,7.749e-05|8.861e-05|0.0001369|0.000163|0.0005758,1|0.6989|0.7199|0.6428|1,147.1|137.3|109.8|100.5|52.81
17,4,0.5322,3.193,3342.0,0.0009524,0.9929309999999999,AAMDC CCPG1 CFAP126 SGTB,regulation of Rho guanyl-nucleotide exchange factor activity|positive regulation of chaperone-mediated protein folding|positive regulation of protein folding|regulation of chaperone-mediated protein folding|regulation of guanyl-nucleotide exchange factor activity,0.0005825|0.0005825|0.0009706|0.001165|0.001941,1|1|1|1|1,2574|2574|1287|1030|572.1
18,5,0.5155,5.155,3392.0,0.001513,0.996692,AAMP CHMP7 LEMD2 PDE2A ZNF574,protein localization to chromatin|mitotic nuclear envelope reassembly|mitotic nuclear membrane organization|nuclear envelope reassembly|nuclear membrane organization,1.411e-05|6.463e-05|6.463e-05|7.22e-05|8.295e-05,0.2225|0.5097|0.3398|0.2847|0.2617,358.2|161.5|161.5|152.6|142
19,5,0.5033,5.033,4226.0,0.001187,0.996692,AANAT EBPL NT5C RHBDF2 SNED1,IMP catabolic process|dGMP catabolic process|dGMP metabolic process|melatonin biosynthetic process|melatonin metabolic process,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
20,7,0.5334,11.2,4516.0,0.002467,0.9992989999999999,AAR2 CD2BP2 DDX23 EAF1 ICE2 NCDN USPL1,RNA metabolic process|gene expression|spliceosomal tri-snRNP complex assembly|nucleic acid metabolic process|ribonucleoprotein complex assembly,1.448e-06|9.175e-06|1.037e-05|1.037e-05|2.756e-05,0.02284|0.07236|0.05452|0.0409|0.08694,11.04|8.075|452.6|7.909|46.45
21,20,0.4319,82.06,16880.0,0.0048270000000000006,1.0,AARD C8orf76 COL14A1 COLEC10 ENPP2 FAM83A FBXO32 GNPNAT1 GSDMC KLHL38 MTSS1 NETO2 NOV RGS22 RNF139 SLC22A4 SLC30A8 TRMT12 WDYHV1 ZHX2,chemotaxis|taxis|nephron tubule epithelial cell differentiation|smooth muscle cell proliferation|epithelial cell proliferation,0.0025|0.00255|0.003198|0.003198|0.004203,1|1|1|1|1,6.858|6.821|468.1|468.1|21.04
22,17,0.508,69.09,12060.0,0.005683,1.0,AARS CDT1 CENPT CFDP1 CIAPIN1 EXOSC6 GINS2 GINS3 KARS NIP7 NUP93 ORC6 SF3B3 SLC7A6OS TANGO6 UTP4 ZC3H18,DNA replication initiation|DNA-dependent DNA replication|DNA replication|nucleic acid metabolic process|DNA strand elongation involved in DNA replication,5.709e-06|1.374e-05|4.973e-05|0.0001106|0.0001176,0.09005|0.1083|0.2615|0.4363|0.3711,89.8|26.54|19|4.614|135.5
23,101,0.4645,2346.0,70210.0,0.03224,1.0,AARS2 DAP3 EARS2 FARS2 GADD45GIP1 GATB GATC GFM1 HARS2 KIAA0391 LARS2 LRPPRC MARS2 MRPL10 MRPL11 MRPL12 MRPL13 MRPL14 MRPL15 MRPL16 MRPL17 MRPL18 MRPL19 MRPL2 MRPL20 MRPL21 MRPL22 MRPL23 MRPL28 MRPL3 MRPL30 MRPL32 MRPL33 MRPL34 MRPL35 MRPL37 MRPL38 MRPL39 MRPL4 MRPL40 MRPL41 MRPL43 MRPL44 MRPL45 MRPL46 MRPL47 MRPL48 MRPL49 MRPL51 MRPL53 MRPL54 MRPL55 MRPL57 MRPS10 MRPS11 MRPS12 MRPS14 MRPS16 MRPS17 MRPS18A MRPS18B MRPS18C MRPS2 MRPS21 MRPS22 MRPS23 MRPS24 MRPS25 MRPS26 MRPS27 MRPS31 MRPS35 MRPS5 MRPS6 MRPS7 MRPS9 MTG2 MTPAP NARS2 NSUN4 PNPT1 POLG POLG2 POLRMT PTCD1 PTCD3 QRSL1 RARS2 RPUSD4 SARS2 SLC25A26 SSBP1 SUPV3L1 TARS2 TFAM TFB1M TFB2M TRMT10C TRUB2 TWNK VARS2,mitochondrial gene expression|mitochondrial translation|mitochondrial translational elongation|mitochondrial translational termination|translation,4.099e-155|4.669e-141|1.413e-124|5.986e-122|2.15e-121,6.465e-151|3.682e-137|7.432e-121|2.361e-118|6.782e-118,120.2|137.4|153|149.1|43.32
24,4,0.5275,3.165,2980.0,0.001058,0.9929309999999999,AARSD1 CALCA GLTPD2 IGSF22,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure|baroreceptor response to increased systemic arterial blood pressure|regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback|alanyl-tRNA aminoacylation|calcitonin gene-related peptide receptor signaling pathway,0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
25,4,0.5908,3.545,3217.0,0.001098,0.9929309999999999,AASDH CDK20 COBL TSPAN33,amino acid activation for nonribosomal peptide biosynthetic process|collateral sprouting in absence of injury|beta-alanine metabolic process|somite specification|collateral sprouting,0.0003883|0.0005825|0.0009706|0.001165|0.001553,1|1|1|1|1,5149|2574|1287|1030|735.5
26,9,0.5408,19.47,5873.0,0.0032939999999999996,0.9998530000000001,ACACA ACLY CHP1 FASN GPAT4 GPI SLC25A1 TMEM120B VKORC1L1,acyl-CoA metabolic process|thioester metabolic process|fatty-acyl-CoA biosynthetic process|purine ribonucleotide metabolic process|purine nucleoside bisphosphate metabolic process,6.653e-10|6.653e-10|1.454e-09|2.669e-09|3.073e-09,1.049e-05|5.247e-06|7.644e-06|1.052e-05|9.696e-06,106.2|106.2|265.7|39.35|77.42
27,14,0.5152,46.89,9615.0,0.004839,0.9999969999999999,AATF CDC6 DHX8 PSMB3 PSMD11 PSMD3 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 ZNF830,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,2.111e-13|2.967e-13|5.593e-13|7.098e-13|7.524e-13,3.33e-09|2.34e-09|2.941e-09|2.799e-09|2.374e-09,107.3|102|92.77|89.54|88.77
28,9,0.5008,18.03,7514.0,0.002388,0.9998530000000001,AATK BAIAP2 DCXR LRRC45 PYCR1 RAC3 RFNG SLC25A10 SLC38A10,"positive regulation of cell morphogenesis involved in differentiation|modification of synaptic structure, modulating synaptic transmission|regulation of cell morphogenesis involved in differentiation|glucose metabolic process|D-xylose metabolic process",0.0006729|0.0009704|0.0009829|0.001396|0.00194,1|1|1|1|1,52.14|2060|42.91|35.82|686.5
29,5,0.5095,5.095,3874.0,0.00131,0.996692,ABCA1 KIF12 PIP5KL1 SYT6 TOR1B,signal release|positive regulation of high-density lipoprotein particle assembly|regulation of high-density lipoprotein particle assembly|sphingolipid translocation|apolipoprotein A-I-mediated signaling pathway,0.0006583|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,49.33|2060|1373|1030|823.8
30,4,0.566,3.3960000000000004,3238.0,0.001045,0.9929309999999999,ABCA10 LAPTM5 NGFR ZNF609,activation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity|induction of programmed cell death|positive regulation of endopeptidase activity,0.0001203|0.0002727|0.0003385|0.0003883|0.0004604,1|1|1|1|1,113.2|74.62|66.87|5149|57.21
31,4,0.5039,3.023,3046.0,0.0009891,0.9929309999999999,ABCA12 CSRP2 JAG1 NRARP,tissue development|regulation of Notch signaling pathway|Notch signaling pathway|tube development|anatomical structure formation involved in morphogenesis,5.029e-05|0.0001623|0.0002004|0.0002658|0.0002939,0.7932|1|1|1|0.9271,11.89|97.15|87.27|18.37|17.75
32,4,0.561,3.366,3204.0,0.001047,0.9929309999999999,ABCA13 CAPN12 PI16 PRAM1,regulation of neutrophil degranulation|negative regulation of cell growth involved in cardiac muscle cell development|regulation of neutrophil activation|regulation of cell growth involved in cardiac muscle cell development|negative regulation of cardiac muscle tissue growth,0.001698|0.002667|0.00291|0.004604|0.006054,1|1|1|1|1,686.5|411.9|374.5|228.8|171.6
33,17,0.4533,61.65,13820.0,0.004432,1.0,ABCA2 AK8 ARRDC1 DPP7 ENTPD2 FAM69B GLT6D1 LCN10 LCN15 LCN6 LCN8 LHX3 NPDC1 PHPT1 RNF224 SARDH TUBB4B,negative regulation of ATP citrate synthase activity|regulation of ATP citrate synthase activity|peptidyl-histidine dephosphorylation|sarcosine catabolic process|negative regulation of cholesterol esterification,0.001649|0.001649|0.001649|0.001649|0.001649,1|1|1|1|1,1211|1211|1211|1211|1211
34,5,0.5428,5.428,3765.0,0.001436,0.996692,ABCA3 FLI1 FXYD6 KCNJ1 KCNJ5,potassium ion import across plasma membrane|transmembrane transport|regulation of ion transport|inorganic ion import across plasma membrane|inorganic cation import across plasma membrane,4.441e-05|7.408e-05|8.477e-05|0.0001669|0.0001669,0.7005|0.5842|0.4457|0.6582|0.5266,196.1|12.75|12.32|99.25|99.25
35,14,0.5119,46.58,9799.0,0.004718,0.9999969999999999,ALG14 ATP5PB BCAS2 CDC7 DDX20 DNTTIP2 HEATR3 PRPF38B RNPC3 RPAP2 RPF1 RPL5 SASS6 WDR3,RNA processing|nucleobase-containing compound metabolic process|heterocycle metabolic process|RNA metabolic process|cellular aromatic compound metabolic process,1.743e-06|2.592e-06|4.774e-06|5.252e-06|5.486e-06,0.0275|0.02045|0.0251|0.02071|0.01731,10.41|5.05|4.728|6.869|4.657
36,4,0.512,3.072,2952.0,0.001037,0.9929309999999999,ABCA6 NEIL3 OR4B1 PTPRJ,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|positive regulation of Fc receptor mediated stimulatory signaling pathway|regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|detection of cell density|contact inhibition,0.001165|0.001553|0.001553|0.001941|0.001941,1|1|1|1|1,1030|735.5|735.5|572.1|572.1
37,61,0.4072,745.1,47210.0,0.0155,1.0,CBR1 CBR3 CHODL CLDN14 CLDN17 CLDN8 COL6A1 COL6A2 CRYZL1 DNAJC28 FAM243A HUNK IFNAR2 IFNGR2 IL10RB ITSN1 KCNJ6 KRTAP10-11 KRTAP10-3 KRTAP10-6 KRTAP10-8 KRTAP10-9 KRTAP11-1 KRTAP12-1 KRTAP12-3 KRTAP12-4 KRTAP13-1 KRTAP13-2 KRTAP13-3 KRTAP13-4 KRTAP15-1 KRTAP19-1 KRTAP19-2 KRTAP19-3 KRTAP19-4 KRTAP19-5 KRTAP19-6 KRTAP19-7 KRTAP19-8 KRTAP20-1 KRTAP20-2 KRTAP21-1 KRTAP21-2 KRTAP22-1 KRTAP24-1 KRTAP27-1 KRTAP6-1 KRTAP6-2 KRTAP8-1 MRAP OLIG1 OLIG2 PCBP3 SIM2 SON TCP10L TIAM1 TMEM50B TMPRSS2 TMPRSS3 TRPM2,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,5.543e-45|8.717e-43|1.2e-40|3.893e-38|5.067e-37,8.744e-41|6.875e-39|6.31e-37|1.535e-34|1.599e-33,47.03|39.66|33.64|27.75|25.49
38,11,0.5007,27.54,8949.0,0.0030600000000000002,0.999969,ABCA8 CSH2 CSHL1 EPX GH2 LIMD2 METTL2B MIF4GD MYCBPAP PRR29 STRADA,growth hormone receptor signaling pathway|cellular response to growth hormone stimulus|response to growth hormone|positive regulation of receptor signaling pathway via JAK-STAT|positive regulation of receptor signaling pathway via STAT,1.993e-07|2.277e-07|9.45e-07|1.106e-06|1.481e-06,0.003143|0.001795|0.004969|0.004362|0.004672,280.8|267.5|160.5|151.8|137
39,4,0.5538,3.323,3210.0,0.001032,0.9929309999999999,ABCA9 ATP11A DLEC1 TMC3,aminophospholipid translocation|lipid transport|aminophospholipid transport|lipid localization|phospholipid translocation,0.001553|0.001845|0.001941|0.002199|0.009096,1|1|1|1|1,735.5|28.29|572.1|25.87|111.9
40,10,0.5137,23.12,7720.0,0.002978,0.999933,C6orf203 ENPP1 ENPP3 RAET1G RAET1L TAAR2 TAAR6 ULBP1 ULBP2 ULBP3,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity|cell killing|natural killer cell activation,5.695e-10|7.618e-10|3.42e-09|2.551e-07|2.505e-06,8.983e-06|6.009e-06|1.798e-05|0.001006|0.007901,343.3|316.8|211.2|68.65|112.3
41,10,0.5057,22.75,7377.0,0.0030670000000000003,0.999933,ABCB10 ARHGAP11B CHRFAM7A CHRNA7 DEXI GOLGA6L6 GOLGA8H GOLGA8M GOLGA8R WHAMM,"synaptic transmission, cholinergic|excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|regulation of postsynaptic membrane potential|Golgi organization",4.104e-07|5.321e-06|6.341e-06|1.944e-05|4.662e-05,0.006473|0.04197|0.03334|0.07666|0.1471,216|87.76|82.6|56.17|41.61
42,8,0.5263,14.74,6456.0,0.0022719999999999997,0.9996790000000001,ABCB11 BBS5 CASP10 CRYGA CRYGB CRYGC CRYGD CXCR2,visual perception|sensory perception of light stimulus|lens development in camera-type eye|camera-type eye development|eye development,1.651e-08|1.806e-08|2.616e-08|6.935e-06|1.201e-05,0.0002604|0.0001425|0.0001375|0.02735|0.03788,52.97|52.01|120.4|28.78|25.01
43,4,0.6088,3.653,3124.0,0.001165,0.9929309999999999,ABCB4 HOMER1 NOVA1 PIP,response to fenofibrate|phospholipase C-activating G protein-coupled glutamate receptor signaling pathway|tissue homeostasis|cellular response to bile acid|response to bile acid,0.0004854|0.000728|0.001214|0.001456|0.001456,1|1|1|1|1,4119|2060|36.13|823.8|823.8
44,37,0.4219,281.0,29760.0,0.00933,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 DBNL DPY19L1 FKBP9 GCK GHRHR GSDME HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MTURN MYO1G NIPSNAP2 NME8 NPC1L1 NPY NUPR2 PHKG1 PKD1L1 POU6F2 PSPH SEPT14 SUMF2 UBE2D4 URGCP VWC2 WIPF3 ZNF713 ZNRF2,embryonic skeletal system morphogenesis|embryonic skeletal system development|lung goblet cell differentiation|lobar bronchus epithelium development|skeletal system morphogenesis,1.162e-06|3.973e-06|3.469e-05|5.197e-05|6.822e-05,0.01832|0.03133|0.1824|0.2049|0.2152,28.09|21.64|352.1|264|11.79
45,49,0.3687,433.5,38860.0,0.011009999999999999,1.0,AKR7A3 AMIGO1 AMY2A AMY2B CASQ2 CD101 CHIA CYB561D1 DENND2C FAM19A3 FAM69A FNDC7 GBP1 GBP5 GNAI3 GNAT2 GPR61 GSTM1 GSTM2 GSTM3 GSTM4 GSTM5 HAO2 HENMT1 HSD3B1 HSD3B2 INKA2 KCNA10 KCNA2 KCNA3 MOV10 NGF NRBF2 OVGP1 PHTF1 PNRC2 PPM1J PSRC1 PTPN22 RAP1A REG4 RHOC SLC22A15 SLC25A24 SLC6A17 SYPL2 TMEM56 TRIM45 UBL4B,nitrobenzene metabolic process|glutathione derivative biosynthetic process|glutathione derivative metabolic process|xenobiotic catabolic process|benzene-containing compound metabolic process,1.788e-09|4.261e-09|4.261e-09|4.587e-08|5.855e-07,2.821e-05|3.361e-05|2.241e-05|0.0001809|0.001847,429.1|97.51|97.51|143|68.65
46,4,0.5443,3.266,3252.0,0.001001,0.9929309999999999,ABCB9 ARL6IP4 PITPNM2 TRAFD1,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|intermembrane lipid transfer|negative regulation of innate immune response,0.003491|0.003878|0.005233|0.009482|0.01256,1|1|1|1|1,302.9|271|198|107.3|80.45
47,68,0.3936,896.6,52370.0,0.01679,1.0,ABCC6 ACSM1 ACSM2B ACSM3 ACSM5 AHSP BCKDK BFAR C16orf45 C16orf92 CA5A CCDC189 CHP2 CLN3 CORO7 DCTPP1 DOC2A FAM57B GDPD3 HIRIP3 HS3ST2 HSD3B7 IL21R ITGAD ITGAL ITGAM ITGAX LAT MARF1 METTL22 MPV17L MYH11 NFATC2IP NOMO1 NOMO2 NPIPA5 NPIPB6 PDZD9 PHKG2 PKD1 PLA2G10 PYCARD PYDC1 SBK1 SCNN1B SCNN1G SEPT1 SEPT12 SH2B1 SLC5A2 STX1B SULT1A1 SULT1A2 SYT17 TBX6 TMC7 USP31 VKORC1 YPEL3 ZG16 ZNF500 ZNF688 ZNF689 ZNF747 ZNF764 ZNF771 ZNF785 ZNF843,integrin-mediated signaling pathway|purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process|nucleoside bisphosphate metabolic process|long-chain fatty acid metabolic process,1.195e-06|6.461e-06|6.461e-06|6.461e-06|5.745e-05,0.01884|0.05096|0.03397|0.02548|0.1813,18.54|13.66|13.66|13.66|12.62
48,7,0.5195,10.91,5605.0,0.0019379999999999998,0.9992989999999999,ABCC10 HLA-DPA1 HLA-DPB1 OR14J1 OR2J2 OR2J3 ZNF76,positive regulation of interferon-gamma production|interferon-gamma-mediated signaling pathway|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception,0.0002297|0.0002642|0.0003262|0.0003881|0.0004332,1|1|1|1|1,87.83|81.73|20.01|18.86|18.16
49,64,0.3497,705.1,51080.0,0.013580000000000002,1.0,ABCC11 ABCC12 ADGRG5 AGRP C16orf78 CA7 CALB2 CBLN1 CCDC102A CES1 CES2 CES3 CES4A CES5A CETP CHST5 CHST6 CKLF CLEC18A CLEC18B CLEC18C CMTM1 CPNE2 CTRB1 CTRB2 DRC7 DUS2 FUK GLG1 HP HSD11B2 HSF4 IRX5 IRX6 LCAT LDHD MMP15 MT1A MT1B MT1F MT1G MT1H MT1M MT1X MT2A MT4 MTSS1L NLRC5 NRN1L PARD6A PDP2 PDPR PDXDC1 PLA2G15 PLLP SHCBP1 TEPP TMED6 TMEM170A TPPP3 WWP2 ZDHHC1 ZNF19 ZNF23,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,2.871e-17|2.871e-17|6.556e-17|9.638e-17|7.214e-16,4.529e-13|2.265e-13|3.447e-13|3.801e-13|2.276e-12,181|181|160.9|152.4|115.8
50,4,0.5825,3.495,3378.0,0.001031,0.9929309999999999,ABCC2 AP4E1 GDF11 TMEM184A,spinal cord anterior/posterior patterning|benzylpenicillin metabolic process|beta-lactam antibiotic metabolic process|bilirubin transport|mercury ion transport,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
51,4,0.5586,3.352,3480.0,0.0009601000000000001,0.9929309999999999,ABCC3 ADPRHL1 BFSP1 PDZD3,glucuronoside transport|negative regulation of guanylate cyclase activity|canalicular bile acid transport|glycoside transport|protein de-ADP-ribosylation,0.0003883|0.0007766|0.0009706|0.001165|0.001359,1|1|1|1|1,5149|1716|1287|1030|858.1
52,5,0.5009,5.0089999999999995,4112.0,0.001214,0.996692,ABCC4 LAT LY6G6D PEAK1 SULT1A2,cAMP transport|platelet degranulation|regulated exocytosis|cyclic nucleotide transport|exocytosis,0.0005824|0.000583|0.0007114|0.0008735|0.001022,1|1|1|1|1,3432|53.63|14.86|1716|13.12
53,4,0.5362,3.217,3147.0,0.001019,0.9929309999999999,ABCC8 FAM92B HCN2 TLDC1,potassium ion transmembrane transport|positive regulation of uterine smooth muscle relaxation|regulation of uterine smooth muscle relaxation|positive regulation of relaxation of smooth muscle|negative regulation of neuroblast migration,0.0003561|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,65.17|5149|5149|5149|5149
54,5,0.5329,5.329,4168.0,0.001274,0.996692,ABCD2 ARL8B CPNE8 FOXI1 SLC8B1,calcium export from the mitochondrion|long-chain fatty acid import into peroxisome|very long-chain fatty acid catabolic process|regulation of cardiac muscle cell membrane potential|positive regulation of unsaturated fatty acid biosynthetic process,0.000728|0.001213|0.001698|0.00194|0.002425,1|1|1|1|1,2060|1030|686.5|588.4|457.7
55,15,0.532,55.86,10230.0,0.005413,0.999999,CCDC12 CCDC130 CFAP20 CLASRP CRIPT CWF19L1 CWF19L2 DHX35 ESS2 FRA10AC1 GPATCH1 ISY1 LENG1 PPIE WDR83,"RNA splicing|mRNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",2.835e-14|1.051e-11|1.406e-11|1.406e-11|1.519e-11,4.471e-10|8.288e-08|7.393e-08|5.545e-08|4.791e-08,33.73|25.53|36.37|36.37|36.01
56,38,0.412,289.6,22030.0,0.01293,1.0,ADSL ADSS AHCY ATIC CAD CTPS1 DHFR DHFR2 DHODH DTYMK FH FPGS GART GMPS IMPDH2 IPPK MTHFD1 MTR NAMPT PAICS PFAS PGM3 PPAT PPCDC PPCS RFK RPIA SDHA SDHB SDHC TFRC TKT TRPM7 TYMS UGP2 UMPS UXS1 YRDC,small molecule metabolic process|nucleobase-containing small molecule metabolic process|nucleotide biosynthetic process|nucleoside phosphate biosynthetic process|nucleoside monophosphate biosynthetic process,2.584e-31|1.228e-30|1.987e-29|2.571e-29|2.584e-26,4.076e-27|9.684e-27|1.045e-25|1.014e-25|8.151e-23,10.33|24.13|43.92|43.35|152.4
57,23,0.4635,117.3,16010.0,0.007252,1.0,ABCE1 CCT3 COPB2 EIF2S1 ETF1 ISY1 NEDD8 NUTF2 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 PSMB3 RPL17 SARS SMU1 SNRNP200 SNRPD1 SNU13 SRP54 VCP,proteasomal ubiquitin-independent protein catabolic process|protein-containing complex subunit organization|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly,1.693e-15|6.32e-13|1.549e-12|1.549e-12|1.549e-12,2.67e-11|4.985e-09|8.144e-09|6.108e-09|4.887e-09,273|8.684|92.41|92.41|92.41
58,17,0.4824,65.61,11880.0,0.005476,1.0,ABCF1 DHX16 EXOC2 FARS2 LYRM4 MRPS18B NOL7 NUP153 PAK1IP1 PPP1R10 PRPF4B PSMG4 RIOK1 RPP40 SNRNP48 TUBB4B WDR46,gene expression|RNA processing|maturation of SSU-rRNA|ribosomal small subunit biogenesis|cellular component biogenesis,1.772e-06|4.863e-06|1.064e-05|3.412e-05|0.0001039,0.02795|0.03835|0.05595|0.1346|0.3276,5.542|9.188|72.69|48.46|4.037
59,6,0.5507,8.261000000000001,4427.0,0.001857,0.998474,ABCF2 DRG1 HSPA14 MPG TRMT2A ZC3H15,cytoplasmic translation|'de novo' cotranslational protein folding|peripheral nervous system myelin maintenance|DNA dealkylation involved in DNA repair|depurination,0.0003804|0.001164|0.00349|0.004264|0.005038,1|1|1|1|1,68.65|1287|321.8|257.4|214.5
60,6,0.6926,10.39,4443.0,0.002327,0.998474,ABCF3 NFIA NFIB NFIC NFIX PTGES3,DNA replication|cellular macromolecule biosynthetic process|macromolecule biosynthetic process|positive regulation of macromolecule biosynthetic process|positive regulation of nucleobase-containing compound metabolic process,4.563e-07|1.891e-05|2.133e-05|3.296e-05|3.641e-05,0.007198|0.1492|0.1122|0.13|0.1149,50.66|10.37|10.12|9.262|9.076
61,18,0.4628,70.8,12280.0,0.005715,1.0,ABCG1 BUB3 CNIH4 DUX4 HSPE1 NEDD1 OR2A25 RPL11 RPL12 RPL13 RPL17 RPL23 RPL37 RPL4 RPL9 RPLP2 RPS13 RPS28,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,3.171e-21|5.361e-21|1.429e-20|2.065e-20|2.26e-20,5.002e-17|4.229e-17|7.511e-17|8.144e-17|7.131e-17,124.2|118.1|107.4|103.7|102.8
62,4,0.5731,3.438,3378.0,0.0010140000000000001,0.9929309999999999,ABCG2 CPA1 PAX4 RAB11FIP5,urate salt excretion|biotin transport|negative regulation of adiponectin secretion|xenobiotic transport across blood-brain barrier|riboflavin transport,0.0003883|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,5149|1716|1287|1030|1030
63,17,0.4295,58.42,12870.0,0.0045049999999999995,1.0,CCDC73 CYBC1 DDC DEF8 FDX1 KCNK13 MAFB NAT8L RPH3A SELE SERPINC1 SLC5A12 TAL2 TNFRSF19 TRAK1 UCKL1 WNT8A,rhombomere 6 development|polarity specification of proximal/distal axis|abducens nerve formation|abducens nerve morphogenesis|abducens nerve development,0.001649|0.002472|0.002472|0.002472|0.002472,1|1|1|1|1,1211|605.7|605.7|605.7|605.7
64,4,0.5607,3.364,3243.0,0.001034,0.9929309999999999,ABCG8 MMP17 SERPINB5 ST8SIA3,negative regulation of intestinal cholesterol absorption|negative regulation of intestinal lipid absorption|negative regulation of intestinal phytosterol absorption|negative regulation of intestinal absorption|protein sialylation,0.0005825|0.0005825|0.0005825|0.0007766|0.001165,1|1|1|1|1,2574|2574|2574|1716|1030
65,20,0.427,81.12,15110.0,0.005327,1.0,ANO1 BBS1 CABP2 CABP4 CCDC36 CREM CTTN FADD FGF19 FGF3 FGF4 FOLR2 GSTP1 KRTAP5-9 MRGPRD MRGPRF MYEOV P2RY6 POLD4 TBX10,cellular response to endogenous stimulus|fibroblast growth factor receptor signaling pathway|cell differentiation|negative regulation of extrinsic apoptotic signaling pathway|cellular developmental process,6.842e-05|7.077e-05|0.0001306|0.0001494|0.0001502,1|0.5581|0.6866|0.5891|0.4738,6.29|38.14|3.228|29.42|3.18
66,6,0.5427,8.14,4875.0,0.001663,0.998474,DBNDD1 GAS8 NRG4 PTH SPG7 VPS9D1,positive regulation of osteoclast proliferation|regulation of osteoclast proliferation|negative regulation of bone mineralization involved in bone maturation|hormone-mediated apoptotic signaling pathway|negative regulation of apoptotic process in bone marrow cell,0.001019|0.001698|0.001698|0.001698|0.002037,1|1|1|1|1,1471|735.5|735.5|735.5|588.4
67,34,0.408,228.9,26200.0,0.008638,1.0,ABHD11 ASL CASTOR3 CLDN3 CLIP2 CYP3A43 CYP3A5 CYP3A7 GNAT3 GUSB KCTD7 PILRB PMS2 PON1 SEMA3E SPDYE1 TBL2 TMEM248 TPST1 TRIM40 TRIM50 TRIM73 TYW1 VKORC1L1 ZKSCAN1 ZNF107 ZNF138 ZNF273 ZNF479 ZNF679 ZNF727 ZNF736 ZNF92 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|steroid metabolic process|retinoic acid metabolic process,6.738e-06|9.991e-05|0.0002171|0.001033|0.001606,0.1063|0.788|1|1|1,92.91|168.1|26.75|8.984|35.66
68,27,0.4707,165.2,21100.0,0.007751000000000001,1.0,ABHD12 ACSS1 APMAP BANF2 BFSP1 CST1 CST11 CST2 CST3 CST4 CST5 CST7 CST8 CST9 CST9L CSTL1 FOXA2 GGTLC1 GZF1 NANP NAPB NINL PCSK2 PLCB4 THBD ZNF133 ZNF337,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|regulation of endopeptidase activity|regulation of peptidase activity,9.52e-15|1.453e-14|3.437e-13|3.123e-12|6.125e-12,1.502e-10|1.146e-10|1.807e-09|1.232e-08|1.932e-08,34.25|32.9|24.39|19.79|18.56
69,4,0.5675,3.405,2960.0,0.001146,0.9929309999999999,ABHD12B DNAL1 PSMC6 SIX6,phosphatidylserine catabolic process|positive regulation of inclusion body assembly|monoacylglycerol catabolic process|positive regulation of RNA polymerase II transcription preinitiation complex assembly|regulation of RNA polymerase II transcription preinitiation complex assembly,0.001213|0.001698|0.00194|0.002667|0.003394,1|1|1|1|1,1030|686.5|588.4|411.9|316.8
70,32,0.3862,191.6,25240.0,0.007515999999999999,1.0,ABHD14A ABHD14B APEH CACNA2D2 CAMP CCR2 CCR3 CCR5 CCR8 CCR9 DNAH1 GLYCTK GNAT1 HYAL1 HYAL3 IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 KLHDC8B KRBOX1 MUSTN1 MYL3 NISCH NT5DC2 PFKFB4 SEMA3G TLR9 XCR1 ZNF502,hyaluronan metabolic process|chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|inflammatory response,4.318e-09|5.016e-09|9.851e-09|9.851e-09|8.945e-08,6.811e-05|3.956e-05|5.18e-05|3.885e-05|0.0002822,91.78|46.01|40.84|40.84|10.99
71,13,0.4667,36.4,9933.0,0.0036409999999999997,0.999993,AIF1 C6orf48 HLA-DMB HSPA1L LY6G6F MICB MSH5 NCR3 NUDT3 STK19 TAP1 TAP2 TNXB,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|cytosol to endoplasmic reticulum transport,2.222e-07|2.999e-07|7.098e-07|5.414e-06|5.502e-06,0.003505|0.002365|0.003732|0.02135|0.01736,279.6|250.1|182.8|32.83|792.1
72,5,0.5298,5.297999999999999,4153.0,0.001271,0.996692,ABHD16B CCR4 SLC1A6 SMIM14 TCIRG1,"RNA phosphodiester bond hydrolysis, exonucleolytic|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|response to silver ion|dentin mineralization|regulation of osteoblast differentiation",9.729e-05|0.0001914|0.0006794|0.0006794|0.0007163,1|1|1|1|1,136.8|96.46|2942|2942|49.04
73,9,0.5177,18.64,6443.0,0.002876,0.9998530000000001,CDC20 EBNA1BP2 GNL2 PABPC1 PSMB2 SF3A3 SNIP1 TRAPPC3 UTP11,"cellular component biogenesis|RNA processing|ribonucleoprotein complex biogenesis|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",1.899e-05|1.986e-05|3.05e-05|0.0002525|0.0002525,0.2995|0.1566|0.1604|0.9959|0.7967,5.931|12.4|19.68|22.73|22.73
74,28,0.3867,146.2,21530.0,0.006725,1.0,BICDL2 C16orf89 C16orf90 CASKIN1 CDIP1 CLDN6 CLDN9 CLUAP1 CORO7 GLIS2 HAGH HCFC1R1 HMOX2 KREMEN2 NMRAL1 OR1F1 OR2C1 PAQR4 PRSS21 PRSS27 PRSS33 SEPT12 TNFRSF12A TPSAB1 ZNF174 ZNF213 ZNF500 ZSCAN10,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|cellular macromolecule metabolic process|regulation of transcription from RNA polymerase II promoter involved in kidney development|cellular metabolic process|bicellular tight junction assembly,0.0004419|0.000625|0.002714|0.00293|0.002997,1|1|1|1|1,70.05|0|735.5|0.2915|25.36
75,4,0.5016,3.01,3120.0,0.0009613,0.9929309999999999,ABHD17C LRRC4C NTNG1 SALL3,synaptic membrane adhesion|cell-cell adhesion via plasma-membrane adhesion molecules|synapse organization|negative regulation of protein localization to microtubule|regulation of protein localization to microtubule,8.472e-06|0.0009436|0.001139|0.001165|0.001165,0.1336|1|1|1|1,447.7|39.76|36.13|1030|1030
76,4,0.5665,3.3989999999999996,3273.0,0.001035,0.9929309999999999,ABHD18 AGBL2 APOA4 RUFY2,negative regulation of plasma lipoprotein oxidation|regulation of plasma lipoprotein oxidation|response to lipid hydroperoxide|protein side chain deglutamylation|response to stilbenoid,0.0005825|0.0005825|0.0007766|0.001165|0.001359,1|1|1|1|1,2574|2574|1716|1030|858.1
77,4,0.5413,3.248,3141.0,0.00103,0.9929309999999999,ABHD2 DCBLD2 GJA5 RAB38,regulation of Purkinje myocyte action potential|vasomotion|Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling|bundle of His cell to Purkinje myocyte communication by electrical coupling|atrial cardiac muscle cell to AV node cell communication by electrical coupling,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
78,28,0.3947,149.2,22680.0,0.006520000000000001,1.0,ABHD3 ANKRD29 B4GALT6 C18orf32 CABLES1 CDH20 CDH7 CELF4 CHST9 CTIF DSC1 DSC3 DSG1 DSG2 DSG3 DSG4 HRH4 KIAA1328 MAPRE2 RNF138 SERPINB5 SERPINB7 SYT4 TPGS2 ZBTB7C ZNF24 ZNF396 ZNF397,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cornification|cell-cell adhesion|keratinization,4.344e-14|2.878e-12|3.446e-10|1.958e-09|3.501e-08,6.852e-10|2.27e-08|1.812e-06|7.72e-06|0.0001105,41.11|26.51|42.53|13.36|21.26
79,5,0.5172,5.172000000000001,3933.0,0.00131,0.996692,ABHD4 ACADVL CSF2 FBXL15 OR10Q1,response to silicon dioxide|positive regulation of interleukin-23 production|neutrophil differentiation|histamine secretion|lipid catabolic process,0.0009706|0.001456|0.001456|0.00194|0.002135,1|1|1|1|1,1373|823.8|823.8|588.4|27.1
80,6,0.502,7.53,4586.0,0.0016350000000000002,0.998474,ABHD5 BLCAP HS3ST4 MARCH6 MEF2C TMX1,sinoatrial valve morphogenesis|sinoatrial valve development|nephron tubule epithelial cell differentiation|muscle cell fate determination|regulation of synaptic activity,0.0005824|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|3432|1716|1716|1144
81,4,0.5547,3.3280000000000003,3581.0,0.0009266,0.9929309999999999,ABHD6 ENO2 HNRNPLL SHISA4,"lysobisphosphatidic acid metabolic process|regulation of endocannabinoid signaling pathway|regulation of vacuole fusion, non-autophagic|monoacylglycerol catabolic process|alditol phosphate metabolic process",0.0005825|0.0007766|0.0009706|0.001553|0.002522,1|1|1|1|1,2574|1716|1287|735.5|429.1
82,4,0.5734,3.44,3228.0,0.001062,0.9929309999999999,ABHD8 MAN2B1 RGS7BP TNPO2,mannose metabolic process|oligosaccharide catabolic process|protein deglycosylation|phosphatidic acid biosynthetic process|phosphatidic acid metabolic process,0.001941|0.002716|0.006393|0.009675|0.01025,1|1|1|1|1,572.1|396.1|160.9|105.1|99.01
83,5,0.5248,5.247999999999999,4257.0,0.0012289999999999998,0.996692,ABI2 MTSS1 PPP1R27 SLC45A4 TMEM86B,nephron tubule epithelial cell differentiation|zonula adherens assembly|epithelial cell proliferation involved in renal tubule morphogenesis|oligosaccharide transport|sucrose transport,0.000728|0.000728|0.001213|0.001213|0.001213,1|1|1|1|1,2060|2060|1030|1030|1030
84,4,0.5384,3.23,3242.0,0.0009931,0.9929309999999999,ABI3BP ATOH8 NFKBID VSTM2B,myoblast proliferation|positive regulation of T-helper 17 cell differentiation|positive regulation of T-helper 17 type immune response|positive regulation of endothelial cell differentiation|positive regulation of cell adhesion,0.0009706|0.001553|0.001941|0.002328|0.002619,1|1|1|1|1,1287|735.5|572.1|468.1|23.67
85,9,0.5328,19.18,6009.0,0.003172,0.9998530000000001,ABL1 BCR GAB2 LMO2 MYB PTPN1 PTPN11 QRFP SOS1,platelet-derived growth factor receptor signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|regulation of hematopoietic progenitor cell differentiation|enzyme linked receptor protein signaling pathway|epidermal growth factor receptor signaling pathway,1.371e-09|2.094e-08|5.03e-08|1.51e-07|1.335e-06,2.163e-05|0.0001651|0.0002645|0.0005956|0.004213,261.5|26.45|101.7|18.91|137.3
86,15,0.518,54.39,11330.0,0.004763,0.999999,ANO1 BBS1 CCDC36 CPT1A CTTN FGF19 FGF4 FOLR2 GAL IGHMBP2 MRGPRD MRGPRF MYEOV POLD4 ZNF20,regulation of hormone secretion|fibroblast growth factor receptor signaling pathway|feeding behavior|positive regulation of large conductance calcium-activated potassium channel activity|positive regulation of timing of catagen,0.00145|0.002095|0.002145|0.002472|0.002472,1|1|1|1|1,13.17|29.91|29.55|605.7|605.7
87,16,0.474,56.88,12650.0,0.0044659999999999995,0.999999,AAED1 AKAP2 C9orf3 FBP1 FBP2 GNA14 KIF12 NUTM2G OR1J4 OR1L1 OR1N2 PALM2 TXNDC8 ZNF484 ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",3.387e-06|5.642e-06|1.184e-05|3.095e-05|4.385e-05,0.05342|0.0445|0.06224|0.122|0.1383,1287|858.1|514.9|286|234
88,4,0.5969,3.5810000000000004,3106.0,0.001149,0.9929309999999999,ABLIM2 MIOX QDPR RBBP8NL,polyol metabolic process|inositol catabolic process|dihydrobiopterin metabolic process|response to aluminum ion|alcohol metabolic process,0.0002174|0.0003883|0.0005825|0.001165|0.001539,1|1|1|1|1,83.72|5149|2574|1030|31.02
89,60,0.3474,614.9,46470.0,0.013019999999999999,1.0,AIPL1 ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ARHGEF15 ASGR1 ASGR2 C17orf107 CCDC144A CCDC144NL CDRT1 CDRT15 CDRT15L2 CFAP52 CHRNB1 CLEC10A DNAH2 DNAH9 DYNLT1 FBXO39 GID4 GP1BA INCA1 KCTD11 KRT16 MFAP4 MFSD6L MYH1 MYH10 MYH2 MYH3 MYH4 MYH8 OR1A1 OR1A2 OR1D5 OR1G1 OR3A1 OR3A3 P2RX1 P2RX5 RCVRN SAT2 SHBG SLC16A11 SLC16A13 SLC2A4 SPNS3 STX8 TBC1D28 TMEM107 TMEM256 TNFRSF13B TNFSF12 TNFSF13 VAMP2 ZNF287 ZNF624,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|system process,4.824e-08|4.824e-08|3.218e-07|8.311e-07|4.213e-06,0.0007609|0.0003804|0.001692|0.003277|0.01329,150.1|150.1|84.41|64.31|3.145
90,4,0.5336,3.201,3089.0,0.001033,0.9929309999999999,ABRACL BRSK2 KIR2DL3 PRSS16,"microtubule cytoskeleton organization involved in establishment of planar polarity|regulation of synaptic vesicle clustering|regulation of retrograde protein transport, ER to cytosol|establishment of tissue polarity|establishment of planar polarity",0.0005825|0.001553|0.002716|0.004846|0.004846,1|1|1|1|1,2574|735.5|396.1|214.5|214.5
91,12,0.5259,34.71,8775.0,0.003929,0.999986,ABRAXAS2 ARRDC4 CCDC96 CYS1 DNAL4 IER5 ITPKA PTRH1 SALL3 TCOF1 TMEM82 TSPAN17,"positive regulation of cellular response to heat|positive regulation of ATP-dependent microtubule motor activity, plus-end-directed|regulation of ATP-dependent microtubule motor activity, plus-end-directed|nucleolar large rRNA transcription by RNA polymerase I|positive regulation of microtubule motor activity",0.001164|0.002327|0.002327|0.002327|0.002909,1|1|1|1|1,1716|572.1|572.1|572.1|429.1
92,6,0.5126,7.688,4881.0,0.0015689999999999999,0.998474,ABTB1 CFAP97D1 GALK1 NME1 ST3GAL6 UNC119,nucleoside diphosphate phosphorylation|nucleotide phosphorylation|nucleoside diphosphate metabolic process|galactitol metabolic process|glycolytic process from galactose,0.0001326|0.000137|0.0002556|0.0005824|0.0005824,1|1|1|1|1,114.4|112.5|81.73|3432|3432
93,16,0.9543,114.5,10220.0,0.01105,0.999999,ACBD5 ACOX1 HSD17B4 PEX1 PEX10 PEX12 PEX13 PEX16 PEX19 PEX2 PEX26 PEX3 PEX5 PEX6 PEX7 SCP2,protein targeting to peroxisome|establishment of protein localization to peroxisome|protein localization to peroxisome|peroxisomal transport|peroxisome organization,1.993e-36|1.993e-36|1.993e-36|2.386e-36|7.979e-36,3.143e-32|1.572e-32|1.048e-32|9.409e-33|2.517e-32,228.8|228.8|228.8|226|208
94,4,0.5442,3.265,3299.0,0.0009864,0.9929309999999999,ACAA2 ADGRG3 KIAA1143 KIF9,negative regulation of mitochondrial membrane permeability involved in apoptotic process|negative regulation of CREB transcription factor activity|negative regulation of mitochondrial membrane permeability|negative regulation of membrane permeability|negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,0.0009706|0.001165|0.001359|0.001747|0.001941,1|1|1|1|1,1287|1030|858.1|643.6|572.1
95,5,0.5429,5.428999999999999,4391.0,0.001232,0.996692,ACACB HHIPL1 NPR2 SLC9A3 ZNRF1,purine ribonucleotide biosynthetic process|purine nucleotide biosynthetic process|ribonucleotide biosynthetic process|ribose phosphate biosynthetic process|purine-containing compound biosynthetic process,0.0005331|0.0006126|0.0006353|0.0006897|0.0006976,1|1|1|1|1,54.92|51.17|50.23|48.18|47.9
96,5,0.5232,5.232,4282.0,0.001218,0.996692,ACAD10 ATP2B4 SEMA4G SMPDL3B SWT1,negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process|negative regulation of the force of heart contraction,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
97,4,0.5021,3.012,3086.0,0.0009726000000000001,0.9929309999999999,ACAD11 ACVR1C UCK2 ZNF639,trophectodermal cell proliferation|negative regulation of chorionic trophoblast cell proliferation|CTP salvage|pyrimidine ribonucleotide salvage|regulation of chorionic trophoblast cell proliferation,0.0005825|0.0005825|0.0007766|0.001165|0.001165,1|1|1|1|1,2574|2574|1716|1030|1030
98,4,0.5431,3.258,3158.0,0.0010279999999999998,0.9929309999999999,ACAD8 C1QTNF5 MADCAM1 TEKT4,valine catabolic process|valine metabolic process|leukocyte tethering or rolling|leukocyte adhesion to vascular endothelial cell|branched-chain amino acid catabolic process,0.0009706|0.001553|0.004072|0.004266|0.004266,1|1|1|1|1,1287|735.5|257.4|245.2|245.2
99,79,0.4795,1477.0,53090.0,0.027,1.0,ACAD9 BCS1L COA5 COA6 COA7 COQ2 COQ4 COQ7 COX10 COX11 COX16 COX19 COX4I1 COX5B COX6B1 COX6C COX7C CYC1 CYCS DMAC1 ECSIT FASTKD5 FOXRED1 GLRX5 GRSF1 IBA57 ISCA2 MTO1 NDUFA10 NDUFA11 NDUFA2 NDUFA3 NDUFA5 NDUFA6 NDUFA8 NDUFA9 NDUFAF1 NDUFAF3 NDUFAF4 NDUFAF6 NDUFAF7 NDUFAF8 NDUFB10 NDUFB2 NDUFB3 NDUFB4 NDUFB5 NDUFB6 NDUFB7 NDUFB8 NDUFB9 NDUFC1 NDUFC2 NDUFS1 NDUFS2 NDUFS3 NDUFS5 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NFU1 NUBPL PDSS1 PDSS2 PET100 PET117 PYURF RTN4IP1 SCO1 SCO2 TIMMDC1 UQCR10 UQCRB UQCRC1 UQCRC2 UQCRFS1 UQCRQ YBEY,mitochondrial respiratory chain complex assembly|ATP synthesis coupled electron transport|respiratory electron transport chain|mitochondrial ATP synthesis coupled electron transport|NADH dehydrogenase complex assembly,2.332e-85|9.756e-76|3.729e-75|1.196e-73|2.513e-73,3.679e-81|7.695e-72|1.961e-71|4.718e-70|7.929e-70,123.9|124.6|106.2|123|158
100,4,0.5593,3.3560000000000003,3375.0,0.000991,0.9929309999999999,ACADL C20orf194 SNCAIP TRIM59,"carnitine catabolic process|carnitine metabolic process, CoA-linked|amino-acid betaine catabolic process|long-chain fatty acid catabolic process|fatty acid beta-oxidation using acyl-CoA dehydrogenase",0.0003883|0.0007766|0.0007766|0.001165|0.002134,1|1|1|1|1,5149|1716|1716|1030|514.9
101,13,0.5014,39.11,10510.0,0.003699,0.999993,AGO1 AGO3 AGO4 BSDC1 C1QB GJA4 GJB3 GJB4 GJB5 TSSK3 ZFP69 ZFP69B ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",2.347e-08|3.226e-08|4.3e-08|1.093e-07|1.093e-07,0.0003702|0.0002545|0.0002261|0.000431|0.0003448,679|594.1|528.1|365.6|365.6
102,25,0.4832,144.9,19800.0,0.0072510000000000005,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 GHRHR HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MINDY4 MTURN NME8 NPY PHKG1 RBAK RSPH10B RSPH10B2 SUMF2 URGCP ZNF12 ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|lung goblet cell differentiation|lobar bronchus epithelium development,1.134e-07|3.941e-07|7.167e-06|1.408e-05|2.111e-05,0.001789|0.003108|0.03769|0.05553|0.06658,43.82|33.76|18.39|549.2|411.9
103,4,0.5022,3.013,2937.0,0.0010220000000000001,0.9929309999999999,ACADSB DAZAP1 HNRNPL S1PR4,"regulation of mRNA splicing, via spliceosome|regulation of mRNA processing|regulation of RNA splicing|isoleucine catabolic process|isoleucine metabolic process",0.0001505|0.0002845|0.0003172|0.0009706|0.001553,1|1|1|1|1,101|73.03|69.11|1287|735.5
104,31,0.5,232.5,23920.0,0.009602,1.0,ACAP1 ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ASGR1 ASGR2 CCDC144A CLEC10A KCTD11 MFSD6L MYH1 MYH2 MYH4 MYH8 OR1A1 OR1A2 OR1D5 OR1E2 OR1G1 OR3A1 OVCA2 P2RX1 SHBG SLC16A13 SPNS3 TMEM256 TNFSF12 TNFSF13 VAMP2,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,2.956e-09|2.956e-09|1.988e-08|5.165e-08|2.663e-07,4.663e-05|2.331e-05|0.0001046|0.0002037|0.00084,295.3|295.3|166.1|126.5|80.53
105,9,0.5283,19.02,5936.0,0.003184,0.9998530000000001,ACAP2 ARF6 RAB10 RAB35 RAB8A RABIF RALGAPB SBF1 SBF2,endosomal transport|endocytic recycling|cellular response to nerve growth factor stimulus|response to nerve growth factor|protein localization to endosome,2.393e-08|7.564e-07|1.579e-06|1.757e-06|1.539e-05,0.0003774|0.005966|0.008303|0.006928|0.04856,49.11|167.4|129.5|124.8|381.4
106,4,0.5723,3.4339999999999997,3424.0,0.0009995,0.9929309999999999,ACAT1 APBB3 E2F5 TMEM74B,cholesterol esterification|sterol esterification|steroid esterification|metanephric proximal convoluted tubule development|proximal convoluted tubule development,7.067e-07|7.067e-07|7.067e-07|0.0004854|0.0004854,0.01115|0.005574|0.003716|1|1,2060|2060|2060|4119|4119
107,11,0.5176,28.47,7339.0,0.003853,0.999969,ACAT2 FDFT1 FDPS HSD17B7 LSS MSMO1 MVD SC5D SQLE SREBF2 UBIAD1,cholesterol metabolic process|secondary alcohol metabolic process|sterol metabolic process|secondary alcohol biosynthetic process|cholesterol biosynthetic process,6.9e-24|1.569e-23|2.497e-23|2.439e-22|2.439e-22,1.088e-19|1.237e-19|1.313e-19|9.619e-19|7.695e-19,153.5|141.9|135.8|386.2|386.2
108,5,0.5256,5.256,3705.0,0.001413,0.996692,ACBD3 DDHD2 FLT3 TFCP2 ZFP64,pro-B cell differentiation|myeloid progenitor cell differentiation|common myeloid progenitor cell proliferation|mRNA transcription by RNA polymerase II|lymphoid progenitor cell differentiation,0.001213|0.001698|0.00194|0.00291|0.003152,1|1|1|1|1,1030|686.5|588.4|374.5|343.3
109,4,0.5373,3.2239999999999998,3220.0,0.0009977,0.9929309999999999,ACBD4 CELF5 NCF2 SEC22C,superoxide anion generation|respiratory burst|mRNA splice site selection|superoxide metabolic process|cell redox homeostasis,0.003297|0.004266|0.006393|0.007745|0.008903,1|1|1|1|1,321.8|245.2|160.9|132|114.4
110,5,0.5228,5.228,4092.0,0.001273,0.996692,ACBD6 C1orf105 DNM3 PRG4 SELP,positive regulation of platelet activation|negative regulation of dendritic spine morphogenesis|synaptic vesicle budding from presynaptic endocytic zone membrane|positive regulation of leukocyte tethering or rolling|dynamin family protein polymerization involved in mitochondrial fission,0.001213|0.001698|0.00194|0.002183|0.002183,1|1|1|1|1,1030|686.5|588.4|514.9|514.9
111,23,0.4373,110.6,15780.0,0.006940999999999999,1.0,AFDN ARHGAP29 CDC42 CDH1 CDH2 CRB3 CTNNA1 CTNND1 F11R HNF1B IRF6 MPP5 PARD3 PARD6B PATJ PAX8 PRKCI RASSF7 RASSF8 RIPK4 TAX1BP3 TJP1 TP53BP2,cell-cell junction organization|cell-cell junction assembly|cell junction assembly|cell junction organization|apical junction assembly,7.416e-23|1.369e-20|1.818e-20|4.819e-17|9.62e-17,1.17e-18|1.08e-16|9.559e-17|1.9e-13|3.035e-13,64.59|81.08|42.91|23.98|115.3
112,31,0.3761,174.9,22610.0,0.0076549999999999995,1.0,ACCS ACCSL ALX4 ANO3 BDNF CAT CHRM4 COMMD9 CRY2 EHF ELF5 LIN7C MAPK8IP1 MRGPRX1 MRGPRX3 MYBPC3 OR4A47 OR4A5 OR4B1 OR4C12 OR4C13 OR4C3 OR4C46 OR4S1 OR4X1 PAMR1 RAPSN SAA1 SLC1A2 TP53I11 TRIM49B,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|G protein-coupled receptor signaling pathway|detection of chemical stimulus,2.504e-08|4.129e-08|5.669e-08|5.927e-08|1.031e-07,0.0003949|0.0003257|0.0002981|0.0002337|0.0003254,12.74|12|11.56|6.105|10.76
113,27,0.3871,135.9,21300.0,0.006324000000000001,1.0,ACE ACSF2 ADAM11 BCAS3 C17orf47 C17orf67 CRHR1 CSH2 CSHL1 EPX HOXB5 HOXB9 KCNJ2 LPO MKS1 MPO MTMR4 MYCBPAP NME1 NME2 OR4D1 OR4D2 PLEKHM1 RSAD1 SCPEP1 SEPT4 SGCA,hydrogen peroxide catabolic process|response to growth hormone|hydrogen peroxide metabolic process|UTP biosynthetic process|GTP biosynthetic process,9.679e-06|1.638e-05|2.558e-05|0.0001081|0.0001276,0.1527|0.1292|0.1345|0.4262|0.4026,78.91|65.38|55.81|152.6|138.7
114,4,0.5773,3.464,3264.0,0.001057,0.9929309999999999,ACER1 KCNJ11 PAX6 WDR17,pancreatic A cell development|forebrain-midbrain boundary formation|glucose homeostasis|carbohydrate homeostasis|epithalamus development,0.0003883|0.0003883|0.0005069|0.0005122|0.0007766,1|1|1|1|1,5149|5149|54.48|54.2|1716
115,5,0.5032,5.032,4437.0,0.0011300000000000001,0.996692,ACER2 AEBP1 CAMK1D TMEM88B ZNF341,negative regulation of protein glycosylation in Golgi|negative regulation of protein glycosylation|regulation of protein glycosylation in Golgi|regulation of collagen fibril organization|positive regulation of respiratory burst,0.000728|0.0009706|0.0009706|0.001698|0.002425,1|1|1|1|1,2060|1373|1373|686.5|457.7
116,14,0.4797,43.65,10730.0,0.0040409999999999995,0.9999969999999999,ACER3 CAPN5 FCHSD2 FOLR1 FOLR2 GDPD4 KCTD21 KRTAP5-9 OMP P2RY2 P2RY6 PLEKHB1 THRSP UCP3,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|folic acid transport|response to folic acid,2.964e-06|1.036e-05|1.381e-05|2.217e-05|3.839e-05,0.04675|0.08172|0.07261|0.08744|0.1211,1373|549.2|457.7|343.2|249.6
117,4,0.5562,3.3369999999999997,3256.0,0.001021,0.9929309999999999,ACHE HYKK SLC7A2 TPM2,"synaptic transmission, cholinergic|negative regulation of synaptic transmission, cholinergic|acetylcholine catabolic process|acetylcholine catabolic process in synaptic cleft|muscle contraction",1.777e-05|0.0004854|0.000728|0.000728|0.001376,0.2803|1|1|1|1,316.8|4119|2060|2060|33.9
118,8,0.5176,14.49,5179.0,0.002782,0.9996790000000001,ACIN1 BCAS2 CCNL1 CDK11A CTNNBL1 PPP1R8 PRPF19 WBP11,RNA splicing|RNA processing|mRNA processing|mRNA metabolic process|nucleic acid metabolic process,4.995e-09|1.241e-08|1.387e-08|1.159e-07|1.57e-07,7.878e-05|9.791e-05|7.295e-05|0.0004569|0.0004952,33.73|17.35|28.37|19.78|8.202
119,4,0.5535,3.321,3270.0,0.0010119999999999999,0.9929309999999999,ACKR1 C15orf65 DENND6B GIN1,DNA integration|chemokine-mediated signaling pathway|regulation of chemokine production|cellular response to chemokine|response to chemokine,0.003685|0.01545|0.01698|0.01736|0.01736,1|1|1|1|1,286|65.17|59.18|57.85|57.85
120,4,0.5254,3.1519999999999997,3218.0,0.0009762000000000001,0.9929309999999999,ACKR4 ANGPTL7 SCCPDH VTI1B,platelet degranulation|negative regulation of vasculature development involved in avascular cornea development in camera-type eye|avascular cornea development in camera-type eye|vesicle fusion with Golgi apparatus|cornea development in camera-type eye,0.0002352|0.0003883|0.0003883|0.001747|0.002328,1|1|1|1|1,80.45|5149|5149|643.6|468.1
121,4,0.5698,3.4189999999999996,3202.0,0.001064,0.9929309999999999,ACO1 LPCAT3 MAMDC4 SERPINA6,positive regulation of acylglycerol transport|regulation of acylglycerol transport|positive regulation of triglyceride transport|regulation of triglyceride transport|positive regulation of sterol regulatory element binding protein cleavage,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
122,4,0.5666,3.4,3162.0,0.0010710000000000001,0.9929309999999999,ACOD1 PITPNC1 SWSAP1 ZSWIM7,double-strand break repair via homologous recombination|recombinational repair|protein stabilization|double-strand break repair|tolerance induction to lipopolysaccharide,0.0001476|0.0001534|0.0005446|0.000578|0.0005825,1|1|1|1|1,102|99.98|52.54|50.98|2574
123,5,0.5269,5.269,4153.0,0.0012640000000000001,0.996692,ACOT1 C10orf113 KLRG1 MGST3 ZNF586,sulfur compound metabolic process|organic heteropentacyclic compound metabolic process|mycotoxin metabolic process|aflatoxin metabolic process|leukotriene biosynthetic process,0.003121|0.00412|0.00412|0.00412|0.005329,1|1|1|1|1,22.33|257.4|257.4|257.4|196.1
124,6,0.5477,8.216000000000001,4287.0,0.001907,0.998474,ASCL1 DYNC1I2 FOXA2 NKX2-1 SOX1 TOX3,cell fate commitment|forebrain neuron differentiation|forebrain generation of neurons|neuron fate commitment|regionalization,2.691e-07|3.017e-07|4.909e-07|6.238e-07|8.574e-07,0.004244|0.00238|0.002581|0.00246|0.002705,57.93|210.2|177.5|163.5|43.18
125,10,0.5067,22.8,7947.0,0.0028539999999999998,0.999933,BSND C1orf123 CYP4X1 FAM69A GBP5 GPX7 IFI44 PCSK9 PLA2G12A ZYG11B,interleukin-18 production|negative regulation of low-density lipoprotein particle receptor binding|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport,0.0008734|0.0008734|0.00131|0.00131|0.00131,1|1|1|1|1,2288|2288|1144|1144|1144
126,4,0.5608,3.365,3002.0,0.001117,0.9929309999999999,ACOT2 OR10J1 SLC4A4 TNN,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|negative regulation of osteoblast proliferation|negative regulation of neuron migration|sodium ion export across plasma membrane,0.0003883|0.0003883|0.002134|0.002328|0.00291,1|1|1|1|1,5149|5149|514.9|468.1|367.8
127,21,0.7671,161.1,14920.0,0.01065,1.0,CD46 CD55 DPM1 DPM3 GPAA1 PGAP2 PIGC PIGH PIGK PIGL PIGM PIGN PIGO PIGP PIGQ PIGS PIGT PIGU PIGV PIGW PIGY,GPI anchor biosynthetic process|GPI anchor metabolic process|glycolipid biosynthetic process|protein lipidation|lipoprotein biosynthetic process,1.334e-49|2.102e-49|1.498e-44|6.729e-43|1.489e-42,2.104e-45|1.658e-45|7.878e-41|2.654e-39|4.696e-39,582.3|564.7|278.1|221.8|211.7
128,4,0.501,3.0060000000000002,3012.0,0.0009943999999999999,0.9929309999999999,ACOT7 GRSF1 PRR3 ZNF311,long-chain fatty-acyl-CoA catabolic process|palmitic acid biosynthetic process|palmitic acid metabolic process|medium-chain fatty-acyl-CoA catabolic process|positive regulation of mitochondrial RNA catabolic process,0.0004854|0.000728|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|2060|2060|2060|1373
129,24,0.4525,124.9,16050.0,0.007696,1.0,CHCHD3 CLPB CLUH CRLS1 DNAJC11 FAM136A GHITM HAX1 HTRA2 IMMP2L IMMT MFN2 MTCH2 MTX1 MTX2 OCIAD1 PARL ROMO1 SAMM50 TIMM13 TIMM17A TIMM23 TMEM11 YME1L1,mitochondrion organization|inner mitochondrial membrane organization|mitochondrial membrane organization|protein localization to mitochondrion|protein targeting to mitochondrion,3.143e-23|5.347e-20|5.164e-18|6.657e-14|5.856e-13,4.957e-19|4.217e-16|2.715e-14|2.625e-10|1.847e-09,31.92|165|67.42|83.72|107.3
130,4,0.552,3.312,3398.0,0.0009712999999999999,0.9929309999999999,ACOX3 CEACAM1 KAZALD1 PINLYP,granulocyte colony-stimulating factor signaling pathway|insulin receptor internalization|negative regulation of cytotoxic T cell degranulation|regulation of cytotoxic T cell degranulation|negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
131,4,0.5633,3.38,3336.0,0.00101,0.9929309999999999,ACOXL ANKRD44 ARL6IP6 TSGA10,fatty acid beta-oxidation using acyl-CoA oxidase|fatty acid beta-oxidation|fatty acid oxidation|lipid oxidation|fatty acid catabolic process,0.003104|0.0116|0.0164|0.01717|0.01756,1|1|1|1|1,343.2|87.27|61.29|58.51|57.21
132,4,0.5318,3.1910000000000003,3283.0,0.0009687999999999999,0.9929309999999999,ACP2 INSC LHFPL2 SFTPD,regulation of adhesion of symbiont to host epithelial cell|regulation of asymmetric cell division|negative regulation by host of symbiont molecular function|positive regulation of fertilization|induction of bacterial agglutination,0.0003883|0.0009706|0.001165|0.001165|0.001165,1|1|1|1|1,5149|1287|1030|1030|1030
133,4,0.5153,3.092,3201.0,0.0009627,0.9929309999999999,ACP5 BIRC7 SEZ6L2 SPACA9,regulation of natural killer cell apoptotic process|riboflavin metabolic process|flavin-containing compound metabolic process|synapse maturation|regulation of protein kinase C signaling,0.0003883|0.001553|0.001747|0.002522|0.003685,1|1|1|1|1,5149|735.5|643.6|429.1|286
134,23,0.5039,127.5,17360.0,0.007272,1.0,ACP6 CIART CTSK CTSS FLG2 GBA GOLPH3L HIST2H2AB HIST2H2BE HRNR LCE3E LCE5A PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A6 S100A8 S100A9 SELENBP1 SLAMF7 TNFAIP8L2,leukocyte activation|toll-like receptor signaling pathway|regulation of water loss via skin|immune system process|neutrophil aggregation,2.223e-06|3.557e-06|3.633e-06|4.321e-06|5.922e-06,0.03507|0.02805|0.0191|0.01704|0.01868,8.391|38.84|109|4.131|980.7
135,4,0.5538,3.323,3260.0,0.001016,0.9929309999999999,ACP7 APOPT1 CEP72 EXOC3L4,cellular protein-containing complex localization|protein-containing complex localization|gamma-tubulin complex localization|exocyst localization|regulation of protein localization to centrosome,3.576e-06|0.0004686|0.0005825|0.0008737|0.001601,0.0564|1|1|1|1,653.8|53.42|2288|1373|686.5
136,4,0.522,3.1319999999999997,3186.0,0.0009797,0.9929309999999999,ACRBP ACSM1 FASTKD3 WDR27,benzoate metabolic process|butyrate metabolic process|regulation of mitochondrial mRNA stability|acrosome assembly|positive regulation of mitochondrial translation,0.0003883|0.0005825|0.001553|0.003297|0.003491,1|1|1|1|1,5149|2574|735.5|321.8|302.9
137,5,0.5054,5.053999999999999,4212.0,0.001196,0.996692,ACRV1 DEFB129 DPCD LCP1 MC4R,third ventricle development|regulation of grooming behavior|positive regulation of podosome assembly|negative regulation of feeding behavior|diet induced thermogenesis,0.001213|0.001456|0.002425|0.002425|0.00291,1|1|1|1|1,1030|823.8|457.7|457.7|374.5
138,4,0.5095,3.057,3322.0,0.000917,0.9929309999999999,ACSBG1 FGD5 FZD6 MBLAC2,embryonic nail plate morphogenesis|establishment of body hair planar orientation|establishment of body hair or bristle planar orientation|midbrain morphogenesis|cell proliferation in midbrain,0.0005825|0.0007766|0.0007766|0.0007766|0.001359,1|1|1|1|1,2574|1716|1716|1716|858.1
139,5,0.5504,5.504,3980.0,0.001377,0.996692,ACSBG2 CD300LG DDRGK1 F2RL2 WASF1,dendritic transport of mitochondrion|positive regulation of protein localization to endoplasmic reticulum|regulation of protein localization to endoplasmic reticulum|modification of postsynaptic actin cytoskeleton|positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,0.000728|0.000728|0.000728|0.001213|0.001213,1|1|1|1|1,2060|2060|2060|1030|1030
140,5,0.5113,5.113,4111.0,0.001239,0.996692,ACSF3 DPPA4 PSKH1 PSTPIP2 XAF1,malonate catabolic process|dicarboxylic acid catabolic process|long-chain fatty-acyl-CoA biosynthetic process|long-chain fatty-acyl-CoA metabolic process|fatty-acyl-CoA biosynthetic process,0.0004854|0.004362|0.004845|0.006295|0.007744,1|1|1|1|1,4119|242.3|216.8|164.8|132.9
141,19,0.5029,86.0,14970.0,0.005697,1.0,CSH2 CSHL1 EPX GH2 HOXB5 HOXB9 LIMD2 LPO METTL2B MKS1 MPO MYCBPAP NME1 NME2 OR4D1 OR4D2 PLEKHM1 RSAD1 SEPT4,response to growth hormone|growth hormone receptor signaling pathway|cellular response to growth hormone stimulus|hydrogen peroxide catabolic process|positive regulation of receptor signaling pathway via JAK-STAT,4.153e-08|1.162e-06|1.327e-06|3.237e-06|6.419e-06,0.0006551|0.009165|0.006979|0.01277|0.02025,123.9|162.6|154.8|112.1|87.89
142,11,0.653,35.91,6845.0,0.005202,0.999969,ACSL3 AGPAT2 AMFR C12orf49 CYB5B LPIN1 MBTPS1 SCAP SCD SREBF1 TMEM41A,regulation of cholesterol biosynthetic process|regulation of sterol biosynthetic process|regulation of cholesterol metabolic process|regulation of lipid biosynthetic process|regulation of alcohol biosynthetic process,8.448e-09|8.448e-09|2.413e-08|3.794e-08|5.528e-08,0.0001333|6.663e-05|0.0001269|0.0001496|0.0001744,170.2|170.2|129.1|47.52|104
143,5,0.5199,5.199,4117.0,0.001258,0.996692,ACSL6 EMILIN1 FDXACB1 RPS6KC1 SHISA4,negative regulation of collagen fibril organization|regulation of collagen fibril organization|negative regulation of macrophage migration|positive regulation of extracellular matrix assembly|negative regulation of extracellular matrix organization,0.000728|0.001698|0.002425|0.002667|0.00291,1|1|1|1|1,2060|686.5|457.7|411.9|374.5
144,5,0.5223,5.223,4215.0,0.001235,0.996692,ACSM4 C4orf17 GCKR NGEF PURA,dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|negative regulation of glucokinase activity|negative regulation of hexokinase activity|negative regulation of dendritic spine morphogenesis,0.0009706|0.0009706|0.001456|0.001456|0.001698,1|1|1|1|1,1373|1373|823.8|823.8|686.5
145,16,0.5174,62.09,11050.0,0.005571,0.999999,COX6C EIF3E EIF3H EMC2 INTS8 MRPL13 MRPS28 MTBP MTERF3 NBN POP1 RPL30 RPL7 UQCRB UTP23 VIRMA,gene expression|translation|peptide biosynthetic process|ribonucleoprotein complex biogenesis|amide biosynthetic process,5.173e-08|3.013e-07|4.339e-07|9.095e-07|1.888e-06,0.0008159|0.002376|0.002281|0.003587|0.005956,6.477|20.11|18.88|16.61|14.63
146,4,0.515,3.09,3109.0,0.0009904,0.9929309999999999,ACSS2 BIN2 CPTP GBX2,acetyl-CoA biosynthetic process from acetate|acetate biosynthetic process|rhombomere 2 development|acetate metabolic process|propionate biosynthetic process,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
147,4,0.5897,3.5380000000000003,3192.0,0.001105,0.9929309999999999,ACTA1 C1orf198 FBXO28 GRID2IP,skeletal muscle fiber adaptation|mesenchyme migration|skeletal muscle thin filament assembly|skeletal myofibril assembly|skeletal muscle adaptation,0.0009706|0.001165|0.001359|0.001747|0.002716,1|1|1|1|1,1287|1030|858.1|643.6|396.1
148,19,0.5015,85.76,15360.0,0.005538,1.0,ACTA2 CALHM3 DUPD1 DUSP13 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPJ LIPM NUTM2A NUTM2B OPN4 PNLIPRP1 PTPN20 SAMD8 SFTPA1 SFTPA2,cellular response to type I interferon|response to type I interferon|response to virus|type I interferon signaling pathway|defense response to symbiont,5.388e-07|7.411e-07|7.632e-06|3.647e-05|4.016e-05,0.008499|0.005845|0.04013|0.1438|0.1267,62.84|57.81|17.6|47.82|20.45
149,5,0.5038,5.038,3739.0,0.001342,0.996692,ACTBL2 FST HTT PLK2 RASSF4,learning or memory|cognition|negative regulation of synaptic transmission|positive regulation of endothelial cell migration|negative regulation of cell communication,6.323e-05|9.945e-05|0.0001914|0.000583|0.0005904,0.9973|0.7843|1|1|1,35.03|30.02|96.46|54.48|8.571
150,6,0.5472,8.207,3716.0,0.0021969999999999997,0.998474,ACTG1 CAP1 CFL1 CORO1C IQGAP1 WDR1,actin cytoskeleton organization|actin filament-based process|regulation of focal adhesion assembly|regulation of cell-substrate junction assembly|actin filament fragmentation,5.753e-07|1.1e-06|1.819e-06|1.819e-06|1.977e-06,0.009075|0.008672|0.009566|0.007175|0.006238,24.56|21.52|120.7|120.7|1287
151,5,0.533,5.33,4013.0,0.001323,0.996692,ACTG2 ADORA2B BACH1 REPIN1 ZNF843,spermatogonial cell division|regulation of transcription involved in G2/M transition of mitotic cell cycle|meiotic DNA double-strand break processing involved in reciprocal meiotic recombination|cellular response to hypoxia|cellular response to decreased oxygen levels,0.0008735|0.0008735|0.0008735|0.001265|0.001385,1|1|1|1|1,1716|1716|1716|36.13|34.5
152,5,0.5216,5.216,3987.0,0.001303,0.996692,ACTL10 MT1B MT1E SLC38A8 ZNF507,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,7.2e-06|7.2e-06|8.939e-06|9.879e-06|1.65e-05,0.1136|0.05679|0.047|0.03896|0.05206,514.9|514.9|457.7|433.6|329.5
153,11,0.5042,27.73,8641.0,0.003191,0.999969,ACTL7A AKAP2 C9orf84 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 PLPP7 TXNDC8 ZNF483,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,4.065e-05|5.117e-05|5.92e-05|7.802e-05|9.018e-05,0.6413|0.4035|0.3113|0.3077|0.2845,18.68|17.6|16.95|15.78|15.2
154,13,0.6006,46.84,10040.0,0.004633,0.999993,AGAP6 ALOX5 BCL11B C10orf53 C10orf71 CHAT DRGX ERCC6 FAM170B SLC18A3 TMEM273 VSTM4 WASHC2A,olfactory bulb axon guidance|leukotriene A4 biosynthetic process|neurotransmitter secretion|signal release from synapse|leukotriene production involved in inflammatory response,0.001261|0.001261|0.001587|0.001587|0.001891,1|1|1|1|1,1584|1584|34.07|34.07|792.1
155,8,0.5013,14.04,6657.0,0.0020989999999999997,0.9996790000000001,ACTL8 AGO3 AZIN2 BSDC1 C1QA C1QB PLA2G2D TSSK3,synapse pruning|cell junction disassembly|trans-Golgi network membrane organization|regulation of complement activation|positive regulation of polyamine transmembrane transport,1.027e-05|1.198e-05|0.0007765|0.0009055|0.001164,0.162|0.09447|1|1|1,468.1|429.1|2574|44.01|1287
156,4,0.5011,3.0069999999999997,2963.0,0.001011,0.9929309999999999,ACTN1 NRSN2 RPS21 TP53RK,"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|rRNA 3'-end processing|actin filament network formation|ncRNA processing",0.0003883|0.001941|0.002134|0.002522|0.002584,1|1|1|1|1,5149|572.1|514.9|429.1|23.84
157,13,0.4898,38.2,8828.0,0.004297,0.999993,ACTR10 ATP6V1D EIF2S1 ERH EXOC5 LIN52 LRR1 POLE2 PSMA3 PSMC6 SNAPC1 TIMM9 TRMT5,antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen|antigen processing and presentation of peptide antigen|DNA-dependent DNA replication|cellular macromolecule biosynthetic process,0.0001786|0.0002029|0.0002259|0.0002293|0.0002838,1|1|1|0.9042|0.8954,26.7|25.55|24.63|24.5|5.743
158,8,0.5303,14.85,5127.0,0.002879,0.9996790000000001,ACTR1A DYNC1LI1 DYNC1LI2 DYNLRB1 NDE1 PAFAH1B1 SGO1 ZWINT,mitotic prometaphase|biological phase|mitotic cell cycle phase|cell cycle phase|anaphase,2.156e-14|4.146e-13|4.146e-13|4.146e-13|6.179e-12,3.401e-10|3.27e-09|2.18e-09|1.635e-09|1.949e-08,107.9|70.12|70.12|70.12|98.38
159,4,0.5713,3.428,3090.0,0.001105,0.9929309999999999,ACTR1B ALAD CYB5A MGAT4A,response to cadmium ion|response to vitamin B1|cellular response to lead ion|response to platinum ion|response to aluminum ion,6.606e-05|0.0007766|0.0007766|0.0007766|0.001165,1|1|1|1|1,153.7|1716|1716|1716|1030
160,37,0.3868,257.6,28000.0,0.009093,1.0,ACTR3B AGBL3 AKR1D1 CLEC5A CPA1 CPA2 CPA5 EPHB6 FAM71F2 HYAL4 KEL KIAA1147 MGAM OR2A12 OR2A2 OR2A5 OR2F2 OR6B1 OR6V1 OR9A2 OR9A4 PRSS1 PRSS37 PRSS58 RAB19 RNF148 SPAM1 STRA8 TAS2R3 TAS2R39 TAS2R41 TAS2R60 TRPV5 TRPV6 ZNF398 ZNF783 ZNF786,sensory perception of chemical stimulus|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|detection of stimulus involved in sensory perception|detection of stimulus,1.788e-10|9.488e-10|1.974e-09|3.627e-09|5.001e-08,2.82e-06|7.483e-06|1.038e-05|1.43e-05|0.0001578,12|12.27|11.42|10.76|8.303
161,14,0.5087,46.3,11060.0,0.004158,0.9999969999999999,ABCA2 DPP7 ENTPD2 ENTR1 FAM69B GLT6D1 LCN10 LCN15 LCN6 LCN8 NPDC1 PHPT1 TUBB4B UAP1L1,negative regulation of ATP citrate synthase activity|regulation of ATP citrate synthase activity|peptidyl-histidine dephosphorylation|negative regulation of cholesterol esterification|negative regulation of intracellular cholesterol transport,0.001358|0.001358|0.001358|0.001358|0.002037,1|1|1|1|1,1471|1471|1471|1471|735.5
162,4,0.5793,3.4760000000000004,3429.0,0.00101,0.9929309999999999,ACTRT2 ADCYAP1 IDUA ZNF765,heparin catabolic process|dermatan sulfate catabolic process|negative regulation of acute inflammatory response to non-antigenic stimulus|positive regulation of somatostatin secretion|regulation of somatostatin secretion,0.0003883|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,5149|5149|5149|2574|1716
163,18,0.4899,74.95,12830.0,0.005790999999999999,1.0,ACVR1 ACVR2A BAMBI BMPR1A BMPR2 FKBP1A IPO8 LEMD3 LRIG1 LRIG3 MIB1 NEO1 RGMB SMAD1 SMAD6 SMAD7 SMURF2 UBAC1,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of BMP signaling pathway|negative regulation of BMP signaling pathway|transmembrane receptor protein serine/threonine kinase signaling pathway|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,2.51e-19|6.273e-19|2.184e-18|2.532e-18|1.279e-17,3.96e-15|4.947e-15|1.148e-14|9.985e-15|4.035e-14,54.7|112.2|163.5|63.89|81.73
164,16,0.5146,61.75,10980.0,0.005576,0.999999,ACVR1 ACVR2A BAMBI BMPR1A CNEP1R1 CTDNEP1 FKBP1A IPO8 LEMD3 LRIG1 LRIG3 MIB1 NEO1 RGMB SMAD1 SMAD7,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|transmembrane receptor protein serine/threonine kinase signaling pathway|regulation of BMP signaling pathway|negative regulation of BMP signaling pathway|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,7.46e-14|1.004e-12|1.047e-12|8.789e-12|8.813e-12,1.177e-09|7.918e-09|5.503e-09|3.466e-08|2.78e-08,46.15|52.27|88.34|122.6|64.36
165,5,0.5002,5.002,4096.0,0.001217,0.996692,ACVR2B BCHE MOSPD3 PLEKHA6 RNF222,cocaine metabolic process|tropane alkaloid metabolic process|neuroblast differentiation|endoplasmic reticulum membrane organization|endoplasmic reticulum-plasma membrane tethering,0.0004854|0.0004854|0.001456|0.001698|0.001698,1|1|1|1|1,4119|4119|823.8|686.5|686.5
166,71,0.3148,782.3,52750.0,0.014580000000000001,1.0,ACVRL1 ANKRD33 AQP2 AQP5 AQP6 ARF3 ASIC1 ATF7 DNAJC14 FAM19A2 GLIPR1L1 GRASP HOXC10 HOXC11 HOXC12 HOXC4 HOXC5 HOXC6 HOXC8 IKZF4 INHBE KIF5A KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT7 KRT71 KRT72 KRT73 KRT74 KRT75 KRT76 KRT77 KRT78 KRT79 KRT80 KRT82 KRT83 KRT84 KRT85 KRT86 LACRT MARCH9 METTL7B NDUFA4L2 OR10A7 OR10AD1 OR10P1 OR2AP1 OR6C1 OR6C2 OR6C3 OR6C4 OR6C6 OR6C65 OR6C75 OR6C76 OR8S1 OR9K2 OS9 POU6F1 PPP1R1A RDH16 RDH5 SDR9C7 SLC38A4 VDR,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,1.305e-33|2.819e-27|1.082e-25|3.71e-24|2.302e-22,2.058e-29|2.223e-23|5.69e-22|1.463e-20|7.263e-19,59.88|29.94|25.25|21.41|17.67
167,5,0.5097,5.0969999999999995,3720.0,0.0013650000000000001,0.996692,ACY1 AP3S2 BTG1 CNOT2 CNOT8,"nuclear-transcribed mRNA poly(A) tail shortening|negative regulation of mitotic cell cycle|RNA phosphodiester bond hydrolysis, exonucleolytic|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint",1.411e-05|2.904e-05|4.647e-05|8.295e-05|8.576e-05,0.2225|0.229|0.2443|0.3271|0.2706,358.2|42.03|191.6|142|139.6
168,4,0.5238,3.1430000000000002,3055.0,0.001025,0.9929309999999999,ACY3 RAB3GAP2 SLC13A1 TNFAIP8L2,establishment of protein localization to endoplasmic reticulum membrane|positive regulation of protein lipidation|positive regulation of endoplasmic reticulum tubular network organization|positive regulation of lipoprotein metabolic process|regulation of endoplasmic reticulum tubular network organization,0.0007766|0.0009706|0.0009706|0.001165|0.001359,1|1|1|1|1,1716|1287|1287|1030|858.1
169,5,0.5188,5.188,4192.0,0.001233,0.996692,ACYP1 DDX58 DIRAS2 GALNT16 RDH12,regulation of type III interferon production|detection of virus|RIG-I signaling pathway|positive regulation of myeloid dendritic cell cytokine production|regulation of myeloid dendritic cell cytokine production,0.001213|0.001698|0.001698|0.001698|0.001698,1|1|1|1|1,1030|686.5|686.5|686.5|686.5
170,28,0.4165,157.4,22110.0,0.007051999999999999,1.0,ADAP2 ALDOC C17orf50 C17orf75 CCL11 CCL13 CCL14 CCL2 CCL5 CCL7 CORO6 CRYBA1 DHRS11 EVI2A GAS2L2 GSDMB KRT40 KRTAP4-8 LGALS9 LYRM9 RDM1 SLC13A2 SLFN12 SLFN12L SLFN13 SLFN14 SPAG5 UNC119,monocyte chemotaxis|eosinophil chemotaxis|lymphocyte chemotaxis|eosinophil migration|lymphocyte migration,4.592e-11|9.898e-11|1.23e-10|1.263e-10|1.245e-09,7.243e-07|7.806e-07|6.469e-07|4.982e-07|3.928e-06,103.9|208.9|86.96|197.3|57.58
171,29,0.4195,170.3,23550.0,0.007162999999999999,1.0,ADA BPIFB4 CDH22 CNBD2 CPNE1 DEFB116 DUSP15 FAM209A FAM209B FAM83C FOXS1 GGT7 GHRH HCK LBP MAP1LC3A MYH7B MYLK2 R3HDML SDC4 SPINT4 TLDC2 TM9SF4 WFDC11 WFDC3 WFDC6 WISP2 XKR7 ZNF341,"regulation of circadian sleep/wake cycle, sleep|response to bacterium|negative regulation of peptidase activity|regulation of circadian sleep/wake cycle|positive regulation of multicellular organism growth",0.0002997|0.0003565|0.0003925|0.0004419|0.001029,1|1|1|1|1,86.53|6.147|11.54|70.05|44.58
172,5,0.5003,5.003,4438.0,0.001123,0.996692,ADAD1 AKAP12 CAPN7 MSH4 RAET1E,positive regulation of hepatic stellate cell migration|positive regulation of oligodendrocyte apoptotic process|hepatic stellate cell activation|regulation of hepatic stellate cell migration|regulation of oligodendrocyte apoptotic process,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
173,6,0.5212,7.818,4680.0,0.001663,0.998474,ADAD2 HRASLS5 MACROD1 MAP4K2 NUDT22 TMEM179B,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|adenosine to inosine editing|N-acylphosphatidylethanolamine metabolic process|activation of MAPKKK activity,0.001165|0.002037|0.002619|0.002909|0.004071,1|1|1|1|1,1144|572.1|429.1|381.4|264
174,29,0.3775,153.3,22440.0,0.0067659999999999994,1.0,ADAL APBA2 ARHGAP11B BMF C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8M HCN2 MYO5A MYO5C NIPA1 NIPA2 OCA2 PLA2G4D PLA2G4E PLA2G4F RASGRP1 RPUSD2 SNURF TGM5 TMCO5A TPM1 TYRO3,"phosphatidylinositol acyl-chain remodeling|phosphatidylserine acyl-chain remodeling|synaptic transmission, cholinergic|phosphatidylethanolamine acyl-chain remodeling|glycerophospholipid catabolic process",3.629e-06|6.25e-06|9.891e-06|9.891e-06|1.339e-05,0.05724|0.0493|0.05201|0.039|0.04223,114.4|93.61|79.21|79.21|71.02
175,13,0.4892,38.16,9991.0,0.003795,0.999993,ADAM10 GXYLT1 HES1 JAG1 METRNL NCSTN NOTCH1 NOTCH3 POFUT1 POGLUT1 PSENEN RFNG TSPAN14,"regulation of Notch signaling pathway|Notch signaling pathway|positive regulation of Notch signaling pathway|Notch receptor processing, ligand-dependent|amyloid-beta formation",2.676e-18|1.956e-15|8.82e-13|2.347e-08|5.588e-08,4.222e-14|1.542e-11|4.638e-09|9.256e-05|0.0001763,134.5|107.4|172.8|679|475.3
176,4,0.5861,3.516,3182.0,0.001101,0.9929309999999999,ADAM11 CCDC62 MAN2C1 RCHY1,mannose metabolic process|oligosaccharide catabolic process|error-free translesion synthesis|blastocyst hatching|organism emergence from protective structure,0.001941|0.002716|0.004459|0.005233|0.005233,1|1|1|1|1,572.1|396.1|234|198|198
177,48,0.3692,416.5,35750.0,0.011479999999999999,1.0,APOA2 AQP10 ATP1A2 CD1B CD1C CD1E CD5L CLK2 CTSK EFNA4 FCGR2B FCGR3A FCRL1 FCRL2 FCRL3 FLG2 FMO2 FMO3 FMO4 GBA HRNR ITLN1 ITLN2 KCNJ10 LCE3E LCE5A MNDA OR10J3 OR10J5 OR10T2 OR6K2 OR6K6 OR6N1 OR6N2 OR6Y1 PGLYRP3 RXRG S100A12 S100A2 S100A4 S100A7A S100A8 S100A9 SLAMF7 SPRR1A SPRR2G XCL1 YY1AP1,"regulation of T cell mediated cytotoxicity|response to stimulus|regulation of cell killing|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|positive regulation of cell killing",5.494e-08|2.924e-07|3.691e-07|6.979e-07|1.061e-06,0.0008665|0.002306|0.001941|0.002752|0.003349,55.3|1.88|22.32|252.2|29.19
178,5,0.5121,5.121,3967.0,0.001286,0.996692,ADAM17 OMD SOCS1 SPN UBLCP1,positive regulation of T cell migration|positive regulation of lymphocyte migration|regulation of T cell migration|regulation of lymphocyte migration|positive regulation of mononuclear cell migration,2.331e-05|3.48e-05|4.647e-05|9.445e-05|0.0001036,0.3677|0.2745|0.2443|0.3725|0.3267,274.6|222.6|191.6|132.9|126.7
179,40,0.4015,313.2,32590.0,0.009496,1.0,ADAM18 ADAM2 ADAM28 ADAM32 ADAM7 ADGRA2 ADRB3 ANK1 AP3M2 C8orf58 CHRNA6 CHRNB3 DDHD2 DKK4 ERLIN2 FUT10 GOT1L1 HGSNAT HOOK3 HTRA4 KCNU1 LETM2 LSM1 NKX6-3 PEBP4 PLPP5 POMK RNF170 RNF5 SARAF SLC20A2 STAR STC1 STMN4 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D VDAC3 ZMAT4,TRAIL-activated apoptotic signaling pathway|sperm-egg recognition|cell-cell recognition|fertilization|extrinsic apoptotic signaling pathway via death domain receptors,6.064e-07|8.316e-06|2.2e-05|3.686e-05|4.558e-05,0.009566|0.06559|0.1157|0.1453|0.1438,251.2|32.94|25.43|13.5|47.09
180,4,0.5632,3.3789999999999996,3256.0,0.001034,0.9929309999999999,ADAM19 DMAC2 FAM81A PLD3,positive regulation of cell-cell adhesion mediated by cadherin|amyloid precursor protein catabolic process|membrane protein ectodomain proteolysis|regulation of cell-cell adhesion mediated by cadherin|amyloid precursor protein metabolic process,0.002328|0.003297|0.004072|0.004266|0.004653,1|1|1|1|1,468.1|321.8|257.4|245.2|223.9
181,7,0.5008,10.52,5776.0,0.001813,0.9992989999999999,ADAM20 ADAM21 FBXO34 JKAMP RDH11 RDH12 TMEM229B,cellular detoxification of aldehyde|cellular response to aldehyde|binding of sperm to zona pellucida|retinol metabolic process|sperm-egg recognition,4.447e-06|8.988e-06|0.0001017|0.0001203|0.0001914,0.07015|0.07089|0.5347|0.4743|0.6037,735.5|490.4|133.7|122.6|96.46
182,12,0.5183,34.21,9674.0,0.003515,0.999986,ARHGEF26 CPA3 CPB1 GPR87 P2RY14 PLSCR1 PLSCR2 SERPINI1 SERPINI2 TFDP2 TM4SF18 TM4SF4,G protein-coupled purinergic nucleotide receptor signaling pathway|plasma membrane phospholipid scrambling|phospholipid translocation|purinergic nucleotide receptor signaling pathway|lipid translocation,4.386e-05|8.425e-05|0.0004076|0.0004248|0.0004603,0.6919|0.6645|1|1|1,226.3|158.4|68.88|67.41|64.66
183,4,0.5823,3.4939999999999998,3274.0,0.0010630000000000001,0.9929309999999999,ACBD4 ADAM23 ATP7B MPLKIP,copper ion export|sequestering of calcium ion|copper ion transmembrane transport|copper ion import|cellular copper ion homeostasis,0.0009706|0.001456|0.001698|0.001698|0.003636,1|1|1|1|1,1373|823.8|686.5|686.5|294.2
184,4,0.5075,3.045,3227.0,0.0009402000000000001,0.9929309999999999,ADAM29 GPR22 NKG7 TRAM1L1,"SRP-dependent cotranslational protein targeting to membrane, translocation|protein insertion into ER membrane|intracellular protein transmembrane transport|protein transmembrane transport|protein insertion into membrane",0.001747|0.00678|0.01006|0.01179|0.01333,1|1|1|1|1,643.6|151.4|101|85.81|75.72
185,4,0.5642,3.385,3106.0,0.001086,0.9929309999999999,ADAM30 CNGA1 COCH TAF15,"transcription initiation from RNA polymerase II promoter|regulation of signal transduction by p53 class mediator|DNA-templated transcription, initiation|rhodopsin mediated signaling pathway|transcription by RNA polymerase II",0.0007796|0.0009018|0.001172|0.003152|0.003761,1|1|1|1|1,45.26|42.03|36.78|343.3|20.29
186,4,0.5084,3.05,3212.0,0.0009464,0.9929309999999999,ADAM8 CSNK1G1 NGF SLFN13,negative regulation of neuron apoptotic process|positive regulation of fibronectin-dependent thymocyte migration|regulation of fibronectin-dependent thymocyte migration|positive regulation of tumor necrosis factor (ligand) superfamily member 11 production|tRNA catabolic process,0.0002966|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,71.51|5149|5149|2574|2574
187,4,0.5464,3.279,3274.0,0.0009979,0.9929309999999999,ADAM9 BROX GPANK1 TMEM14C,regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|regulation of tetrapyrrole metabolic process|positive regulation of macrophage fusion|regulation of macrophage fusion,0.0007766|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,1716|1716|1287|1030|1030
188,5,0.5097,5.0969999999999995,3458.0,0.001468,0.996692,ADAMDEC1 CDK5RAP2 CEP192 CEP85 KIF18B,centriole replication|centriole assembly|chromosome segregation|centrosome duplication|microtubule polymerization or depolymerization,1.411e-05|2.185e-05|2.676e-05|3.128e-05|6.711e-05,0.2225|0.1724|0.1407|0.1234|0.2117,358.2|284.1|43.21|235.4|158.4
189,5,0.5042,5.042,4109.0,0.0012230000000000001,0.996692,ADAMTS10 NOX4 PRSS12 SLC36A4 TYR,response to cAMP|response to organophosphorus|response to purine-containing compound|melanin biosynthetic process from tyrosine|proline import across plasma membrane,0.0002311|0.0004461|0.0005471|0.000728|0.000728,1|1|1|1|1,84.06|60.13|54.2|2060|2060
190,4,0.5865,3.5189999999999997,3271.0,0.001072,0.9929309999999999,ADAMTS12 C9 LMBRD2 PGM2L1,negative regulation of cellular response to hepatocyte growth factor stimulus|negative regulation of hepatocyte growth factor receptor signaling pathway|regulation of cellular response to hepatocyte growth factor stimulus|regulation of hepatocyte growth factor receptor signaling pathway|proteoglycan catabolic process,0.0003883|0.0003883|0.0005825|0.0009706|0.0009706,1|1|1|1|1,5149|5149|2574|1287|1287
191,4,0.5151,3.09,3217.0,0.0009573,0.9929309999999999,ADAMTS13 C17orf78 MICAL2 TRAF1,sulfur oxidation|cellular response to tumor necrosis factor|positive regulation of transcription via serum response element binding|response to tumor necrosis factor|actin filament depolymerization,0.0005825|0.0008662|0.0009706|0.00107|0.002522,1|1|1|1|1,2574|41.52|1287|37.31|429.1
192,4,0.5169,3.1010000000000004,3248.0,0.0009517000000000001,0.9929309999999999,ADAMTS14 CHRM1 SELP TEDDM1,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway|positive regulation of platelet activation|saliva secretion|positive regulation of leukocyte tethering or rolling|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,0.0007766|0.0009706|0.001165|0.001747|0.001747,1|1|1|1|1,1716|1287|1030|643.6|643.6
193,11,0.5022,27.62,8405.0,0.0032670000000000004,0.999969,ADAMTS15 ADAMTS8 CCDC153 FXYD6 KCNJ1 NTM NXPE4 OR10G9 OR4D5 OR6M1 TMEM136,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.001441|0.001708|0.001901|0.002329|0.002591,1|1|1|1|1,12.74|12|11.56|10.76|10.36
194,5,0.5173,5.172999999999999,4278.0,0.0012050000000000001,0.996692,ADAMTS16 FAM167A PKHD1 SLC30A3 ZNF429,branching morphogenesis of an epithelial tube|morphogenesis of a branching epithelium|morphogenesis of a branching structure|zinc ion import into synaptic vesicle|zinc ion import into organelle,0.0003903|0.0005758|0.0006429|0.000728|0.000728,1|1|1|1|1,64.36|52.81|49.93|2060|2060
195,23,0.4388,111.0,18740.0,0.005874,1.0,AP5S1 AVP C20orf194 C20orf202 CDC25B CST1 HSPA12B LZTS3 OXT PLCB1 PLCB4 PRND PROKR2 RASSF2 RSPO4 SIRPA SIRPB1 SIRPG SMOX SPEF1 TGM3 TGM6 ZNF343,maternal aggressive behavior|aggressive behavior|female mating behavior|hyperosmotic salinity response|regulation of female receptivity,1.188e-05|4.265e-05|5.328e-05|5.328e-05|5.328e-05,0.1874|0.3364|0.2801|0.2101|0.1681,597|255.8|223.9|223.9|223.9
196,15,0.4527,47.53,11130.0,0.004242,0.999999,ARRDC4 C1QL1 CCDC96 CTSO CYS1 DNAL4 IER5 ITPKA MDK PTRH1 SALL3 TAC3 TCOF1 TMEM82 TSPAN17,cellular component maintenance|regulation of cartilage development|positive regulation of cellular response to heat|positive regulation of cell morphogenesis involved in differentiation|glial cell projection elongation,0.0008795|0.001399|0.001552|0.001766|0.002327,1|1|1|1|1,46.81|36.78|1287|32.59|643.6
197,4,0.5324,3.194,3186.0,0.0009988999999999998,0.9929309999999999,ADAMTS19 NRXN1 OR5B12 RBM20,protein-containing complex assembly involved in synapse maturation|positive regulation of presynapse assembly|positive regulation of presynaptic active zone assembly|regulation of presynaptic active zone assembly|guanylate kinase-associated protein clustering,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
198,4,0.548,3.2880000000000003,3041.0,0.001077,0.9929309999999999,ADAMTS2 NBEAL2 NKIRAS2 RALGAPB,platelet formation|platelet morphogenesis|collagen catabolic process|collagen metabolic process|I-kappaB kinase/NF-kappaB signaling,0.003685|0.003878|0.008517|0.01199|0.01372,1|1|1|1|1,286|271|119.7|84.41|73.55
199,49,0.4348,511.3,35430.0,0.014190000000000001,1.0,ACAD9 ATPAF2 C12orf65 CARS2 COA7 COQ7 DARS2 DDX28 FOXRED1 GFM2 GRSF1 GTPBP10 GTPBP8 MALSU1 MCAT METTL17 MRM2 MRM3 MRPL1 MRPL18 MRPL41 MRPL44 MRPL50 MRPL58 MRPL9 MRRF MTERF3 MTERF4 MTFMT MTG1 MTG2 MTIF2 MTIF3 MTO1 NDUFAF1 NGRN NOA1 NSUN3 NSUN4 NUBPL PREPL PTCD1 RMND1 RPUSD3 RPUSD4 SSBP1 TFB1M TRUB2 YBEY,mitochondrial gene expression|translation|mitochondrial translation|gene expression|peptide biosynthetic process,2.03e-22|1.133e-18|2.043e-18|2.93e-18|3.308e-18,3.201e-18|8.935e-15|1.074e-14|1.155e-14|1.044e-14,47.07|19.31|48.24|5.841|18.13
200,4,0.5218,3.1310000000000002,3124.0,0.0009986,0.9929309999999999,ADAMTS4 CABS1 TACC2 TRPM4,positive regulation of atrial cardiac muscle cell action potential|positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization|membrane depolarization during bundle of His cell action potential|membrane depolarization during Purkinje myocyte cell action potential|Purkinje myocyte action potential,0.0003883|0.0003883|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|5149|1716|1716|1716
201,7,0.8653,18.17,4680.0,0.003856,0.9992989999999999,AVEN DIS3L FOCAD HBS1L PELO SKIV2L TTC37,RNA catabolic process|nucleobase-containing compound catabolic process|heterocycle catabolic process|cellular nitrogen compound catabolic process|aromatic compound catabolic process,5.311e-09|4.237e-08|7.236e-08|7.762e-08|9.317e-08,8.377e-05|0.0003342|0.0003804|0.0003061|0.0002939,59.8|39.23|35.19|34.7|33.43
202,5,0.5047,5.047,4086.0,0.001231,0.996692,ADAMTS6 CYP26C1 IFIT2 IFIT3 NUCKS1,cellular response to interferon-alpha|response to interferon-alpha|type I interferon signaling pathway|cellular response to type I interferon|response to type I interferon,4.943e-06|1.528e-05|0.0001131|0.0001163|0.0001369,0.07796|0.1205|0.5945|0.4588|0.4319,633.7|343.3|121.1|119.4|109.8
203,11,0.4678,25.73,8802.0,0.002907,0.999969,ADAMTS7 CHRNB4 CSPG4 GOLGA6B MAP2K5 PLEKHO2 PPIB RAB8B SCAMP2 SLC24A1 UBE2Q2L,negative regulation of chemokine (C-X-C motif) ligand 2 production|ERK5 cascade|macrophage apoptotic process|synaptic transmission involved in micturition|Golgi vesicle fusion to target membrane,0.001601|0.001601|0.002134|0.002134|0.002667,1|1|1|1|1,936.1|936.1|624.1|624.1|468.1
204,8,0.5138,14.39,6424.0,0.002229,0.9996790000000001,ADAMTS9 CTSZ FAM209A FAM209B OPRL1 PRICKLE2 SNTN STX16,endothelial cell-matrix adhesion|positive regulation of gastric acid secretion|conditioned place preference|regulation of locomotor rhythm|regulation of blood pressure,0.0007765|0.001164|0.001552|0.001552|0.002213,1|1|1|1|1,2574|1287|858.1|858.1|27.83
205,4,0.5253,3.1519999999999997,2963.0,0.00106,0.9929309999999999,ADAMTSL1 METTL15 MTRNR2L1 TIPARP,"response to 2,3,7,8-tetrachlorodibenzodioxine|rRNA base methylation|protein auto-ADP-ribosylation|protein mono-ADP-ribosylation|smooth muscle tissue development",0.0009706|0.002328|0.002328|0.002522|0.003878,1|1|1|1|1,1287|468.1|468.1|429.1|271
206,45,0.417,412.8,35330.0,0.01152,1.0,PCDHA1 PCDHA10 PCDHA11 PCDHA12 PCDHA13 PCDHA2 PCDHA3 PCDHA4 PCDHA5 PCDHA6 PCDHA7 PCDHA8 PCDHA9 PCDHAC2 PCDHB10 PCDHB11 PCDHB12 PCDHB13 PCDHB14 PCDHB15 PCDHB16 PCDHB3 PCDHB4 PCDHB5 PCDHB6 PCDHB7 PCDHB8 PCDHGA10 PCDHGA11 PCDHGA12 PCDHGA2 PCDHGA3 PCDHGA4 PCDHGA5 PCDHGA6 PCDHGA7 PCDHGA8 PCDHGB1 PCDHGB2 PCDHGB3 PCDHGB4 PCDHGC3 PCDHGC4 PCDHGC5 SLC22A5,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cell adhesion|biological adhesion,9.867e-89|3.785e-81|8.145e-69|1.954e-57|2.56e-57,1.556e-84|2.985e-77|4.283e-65|7.707e-54|8.077e-54,120.6|77.75|39.18|21.17|21.04
207,4,0.5516,3.31,3167.0,0.001041,0.9929309999999999,ADAMTSL3 EVC SLC10A2 UTRN,muscle organ development|response to denervation involved in regulation of muscle adaptation|response to muscle inactivity involved in regulation of muscle adaptation|response to muscle inactivity|muscle structure development,0.0011|0.002328|0.002328|0.002522|0.002923,1|1|1|1|1,36.78|468.1|468.1|429.1|22.39
208,52,0.3518,466.5,39030.0,0.01178,1.0,ADAMTSL4 CD1B CD1C CD1E CIART CLK2 CTSK CTSS ECM1 EFNA1 EFNA3 EFNA4 FCRL3 FLG2 GABPB2 GBA HIST2H2AB HIST2H2BE HRNR ITLN1 ITLN2 KCNJ10 LCE2A LCE3A LCE3E LCE5A LCE6A MINDY1 OR10J5 OR6K6 PGLYRP3 PIAS3 PRR9 PRUNE1 S100A12 S100A13 S100A2 S100A3 S100A4 S100A5 S100A6 S100A7 S100A7A S100A8 S100A9 SELENBP1 SLAMF7 SPRR1A SPRR2G SPRR4 YY1AP1 ZNF687,skin development|keratinocyte differentiation|keratinization|epidermis development|epidermal cell differentiation,1.65e-10|1.31e-09|5.524e-09|6.042e-09|6.046e-09,2.603e-06|1.033e-05|2.904e-05|2.383e-05|1.907e-05,12.65|15.07|16.08|10.65|12.78
209,18,0.4129,63.18,13820.0,0.00454,1.0,ADAMTSL5 BCL2L15 CYBC1 DDC DEF8 EIF2D FDX1 GGACT KCNK13 MAFB NAT8L PSKH1 RDH10 RPH3A SLC5A12 TNFRSF19 UCKL1 WNT8A,primary lung bud formation|rhombomere 6 development|positive regulation of retinoic acid biosynthetic process|positive regulation of isoprenoid metabolic process|canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,0.001746|0.001746|0.001746|0.001746|0.002618,1|1|1|1|1,1144|1144|1144|1144|572.1
210,23,0.5079,128.5,18530.0,0.006872,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 CYP2W1 GHRHR HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MINDY4 MTURN NME8 NPY RBAK RSPH10B RSPH10B2 SCIN ZNF12,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|regulation of myeloid cell differentiation|lung goblet cell differentiation,7.242e-08|2.522e-07|4.624e-06|5.931e-06|1.188e-05,0.001142|0.001989|0.02432|0.02339|0.03748,47.63|36.7|19.99|18.97|597
211,11,0.8248,45.36,7322.0,0.006139,0.999969,ADAR EIF2AK2 IFNAR1 IFNAR2 IRF9 ISG15 JAK1 STAT1 STAT2 TYK2 USP18,type I interferon signaling pathway|cellular response to type I interferon|response to type I interferon|innate immune response|response to virus,4.787e-21|5.411e-21|1.092e-20|1.436e-13|4.44e-13,7.551e-17|4.267e-17|5.74e-17|5.662e-10|1.401e-09,247.8|244.2|224.7|22.29|48.63
212,5,0.5198,5.1979999999999995,4042.0,0.001281,0.996692,ADARB1 BST2 COL18A1 EXTL2 PITPNM3,regulation of viral genome replication|hypoglossal nerve morphogenesis|hypoglossal nerve development|negative regulation of plasmacytoid dendritic cell cytokine production|regulation of plasmacytoid dendritic cell cytokine production,0.0001709|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,98.07|4119|4119|4119|4119
213,5,0.5085,5.085,4245.0,0.001194,0.996692,ADARB2 ARHGAP44 CNPY1 PDZRN3 TNFSF13,"modification of dendritic spine|regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane|negative regulation of Rac protein signal transduction|negative regulation of filopodium assembly|regulation of endosome to plasma membrane protein transport",0.000728|0.0009706|0.0009706|0.001456|0.001456,1|1|1|1|1,2060|1373|1373|823.8|823.8
214,4,0.5107,3.0639999999999996,3132.0,0.0009748,0.9929309999999999,ADAT1 MARC2 REXO4 SULT1C3,xenobiotic metabolic process|cellular response to xenobiotic stimulus|response to xenobiotic stimulus|cellular nitrogen compound metabolic process|nitrate metabolic process,0.0002209|0.0002388|0.000265|0.0007508|0.0009706,1|1|1|1|1,83.04|79.83|75.72|6.045|1287
215,12,0.5053,33.35,7981.0,0.004149,0.999986,AASDHPPT ADAT2 ADAT3 CDIPT DNLZ DOLK FDXR MRE11 RTCB RTRAF TRMT6 TRMT61A,tRNA processing|tRNA metabolic process|ncRNA processing|tRNA modification|ncRNA metabolic process,7.227e-11|4.551e-10|7.389e-08|1.954e-07|2.108e-07,1.14e-06|3.589e-06|0.0003885|0.0007706|0.0006649,78.01|56.89|23.84|76.28|19.92
216,6,0.5017,7.526,4700.0,0.0015949999999999998,0.998474,ABHD16A ADCK1 HSPA1L LY6G6F MSH5 STK19,prostaglandin catabolic process|prostanoid catabolic process|positive regulation of cristae formation|phosphatidylserine catabolic process|regulation of cristae formation,0.0008735|0.0008735|0.001165|0.001456|0.001456,1|1|1|1|1,1716|1716|1144|858.1|858.1
217,11,0.5113,28.12,7576.0,0.0036880000000000003,0.999969,ARGLU1 BORA CDC16 DIS3 GTF3A MRPS31 MZT1 PCID2 RBM27 TUBGCP3 ZC3H13,regulation of mitotic nuclear division|regulation of nuclear division|microtubule nucleation|microtubule polymerization|biological phase,2.566e-05|4.764e-05|8.361e-05|0.0001708|0.000304,0.4048|0.3757|0.4396|0.6735|0.9591,51.06|41.3|156|107|21.86
218,4,0.5034,3.0210000000000004,3146.0,0.0009568,0.9929309999999999,ADCK5 CCDC88B MRPL13 TMEM135,response to food|defense response to protozoan|response to protozoan|regulation of mitochondrial fission|response to cold,0.004459|0.004846|0.00504|0.005426|0.009482,1|1|1|1|1,234|214.5|205.9|190.7|107.3
219,6,0.5012,7.518,5022.0,0.001491,0.998474,ADCY1 GHRHR KIAA0895 SCG5 STEAP1 STK17A,cAMP-mediated signaling|activation of adenylate cyclase activity|cyclic-nucleotide-mediated signaling|water homeostasis|regulation of secretion by cell,3.718e-05|6.35e-05|0.0001005|0.0002381|0.000421,0.5864|0.5008|0.5283|0.9388|1,221.5|167.4|132|84.75|17.78
220,5,0.5375,5.375,3934.0,0.001361,0.996692,ADCY10 HIST1H2BA HIST3H2A METTL13 TMEM184C,cAMP biosynthetic process|cAMP metabolic process|cyclic purine nucleotide metabolic process|cyclic nucleotide biosynthetic process|epithelial cilium movement involved in extracellular fluid movement,0.001068|0.002232|0.002329|0.002329|0.003396,1|1|1|1|1,1030|468.1|447.7|447.7|302.9
221,4,0.5537,3.322,3280.0,0.001009,0.9929309999999999,ADCY2 IL10RB OR1E1 PIP4P1,proton-transporting V-type ATPase complex assembly|cAMP biosynthetic process|cellular response to forskolin|response to forskolin|response to sterol depletion,0.001747|0.002134|0.002134|0.002134|0.002522,1|1|1|1|1,643.6|514.9|514.9|514.9|429.1
222,6,0.513,7.695,4875.0,0.001572,0.998474,ADCY4 CEBPE HECA LTB4R2 MMP14 PDZD7,respiratory tube development|response to odorant|multicellular organismal process|response to mechanical stimulus|keratinocyte migration,0.001017|0.001165|0.001428|0.001626|0.001746,1|1|1|1|1,40.38|1144|2.981|31.78|686.5
223,4,0.54,3.24,3199.0,0.001009,0.9929309999999999,ADCY5 DCAF11 EPN2 HSD11B1,adenylate cyclase-inhibiting dopamine receptor signaling pathway|G protein-coupled adenosine receptor signaling pathway|G protein-coupled purinergic receptor signaling pathway|adenylate cyclase-activating dopamine receptor signaling pathway|cAMP biosynthetic process,0.001165|0.001941|0.001941|0.002134|0.002134,1|1|1|1|1,1030|572.1|572.1|514.9|514.9
224,6,0.5037,7.556,4479.0,0.00168,0.998474,ADCY6 ANKMY2 CMIP GPR3 PTGES3 RIC8B,adenylate cyclase-activating G protein-coupled receptor signaling pathway|cellular response to vasopressin|response to vasopressin|telomerase holoenzyme complex assembly|adenylate cyclase-modulating G protein-coupled receptor signaling pathway,0.0006378|0.001165|0.001165|0.001456|0.001685,1|1|1|1|1,51.23|1144|1144|858.1|31.2
225,4,0.546,3.2760000000000002,3321.0,0.000983,0.9929309999999999,ADCY7 B4GALT2 LYZL6 SLC28A1,cytidine transport|purine nucleobase transmembrane transport|pyrimidine nucleoside transport|uridine transport|pyrimidine nucleobase transport,0.0003883|0.0009706|0.001165|0.001165|0.001165,1|1|1|1|1,5149|1287|1030|1030|1030
226,32,0.4027,199.7,24510.0,0.008062,1.0,ADCY8 C8orf33 C8orf82 DENND3 FAM135B FOXH1 GLI4 GML GSDMC GSDMD KCNQ3 LRRC24 LY6E LY6K LYPD2 MAPK15 MROH6 NAPRT PLEC PPP1R16A RHPN1 SLURP2 TSNARE1 WISP1 ZFP41 ZNF16 ZNF250 ZNF34 ZNF517 ZNF623 ZNF696 ZNF707,pyroptosis|macromolecule metabolic process|NAD salvage|cellular response to sodium dodecyl sulfate|positive regulation of meiotic chromosome separation,0.0004353|0.001684|0.0031|0.0031|0.0031,1|1|1|1|1,71.51|0.2078|643.6|643.6|643.6
227,10,0.512,23.04,6554.0,0.0034920000000000003,0.999933,CNOT1 CNOT10 CNOT11 EIF3K EIF3L EIF4E2 FAM193A GGNBP2 GIGYF2 GPBP1,gene silencing|regulation of translation|regulation of cellular amide metabolic process|mitotic G1 DNA damage checkpoint|mitotic G1/S transition checkpoint,5.519e-09|6.786e-09|1.742e-08|2.525e-08|2.675e-08,8.706e-05|5.352e-05|9.161e-05|9.958e-05|8.44e-05,68.65|33.58|28.6|124.8|123
228,5,0.5019,5.019,4336.0,0.0011539999999999999,0.996692,ACSS1 ADD2 HCN3 QRFP TMEM87B,acetyl-CoA biosynthetic process from acetate|acetate biosynthetic process|acetate metabolic process|propionate biosynthetic process|short-chain fatty acid biosynthetic process,0.000728|0.000728|0.000728|0.000728|0.001213,1|1|1|1|1,2060|2060|2060|2060|1030
229,14,0.5248,47.76,9823.0,0.004825,0.9999969999999999,ARHGAP21 ARHGEF12 BTBD9 GNA13 GRK2 LPAR2 LUZP1 MYO9A MYO9B RHOA RHOC RIC8A ROCK1 ROCK2,Rho protein signal transduction|positive regulation of hydrolase activity|regulation of hydrolase activity|small GTPase mediated signal transduction|regulation of small GTPase mediated signal transduction,2.762e-12|5.433e-12|2.158e-11|1.895e-10|8.587e-10,4.356e-08|4.285e-08|1.135e-07|7.474e-07|2.709e-06,144.7|18.93|12.37|39.3|31.49
230,4,0.5465,3.279,3198.0,0.0010220000000000001,0.9929309999999999,ADGRA1 KRTAP10-3 LRRC3 TLX1,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,0.04336|0.05122|0.06015|0.07251|0.07874,1|1|1|1|1,22.78|19.21|16.29|13.44|12.35
231,36,0.504,317.5,27230.0,0.0115,1.0,AIFM3 APOBEC3A APOBEC3D APOBEC3G APOL1 CRYBA4 CRYBB1 DGCR6 DGCR6L FOXRED2 GSTT2B HIC2 KLHL22 LRRC75B LZTR1 MIF MPPE1 P2RX6 RFPL2 RFPL3 RIMBP3 SDF2L1 SEC14L3 SEC14L4 SEC14L6 SEPT5 SLC5A1 SLC5A4 SLC7A4 SUSD2 TBC1D10A THAP7 USP18 VPREB1 YPEL1 ZNF74,DNA cytosine deamination|cytidine metabolic process|cytidine catabolic process|cytidine deamination|cytidine to uridine editing,1.5e-06|2.38e-06|2.38e-06|2.38e-06|2.38e-06,0.02366|0.01877|0.01251|0.009386|0.007508,167|139.2|139.2|139.2|139.2
232,5,0.538,5.38,4191.0,0.001279,0.996692,ADGRB2 HNRNPUL2 KCNE3 SIX5 WFDC5,negative regulation of membrane repolarization during cardiac muscle cell action potential|negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential|regulation of membrane repolarization during ventricular cardiac muscle cell action potential|negative regulation of potassium ion export across plasma membrane|negative regulation of skeletal muscle satellite cell proliferation,0.0004854|0.0004854|0.0009706|0.0009706|0.001213,1|1|1|1|1,4119|4119|1373|1373|1030
233,5,0.5028,5.0280000000000005,4024.0,0.001245,0.996692,ADGRB3 ANPEP B4GALNT4 CRYGN DENND6A,motor learning|positive regulation of cell-cell adhesion mediated by cadherin|neuron remodeling|maintenance of synapse structure|regulation of cell-cell adhesion mediated by cadherin,0.001698|0.00291|0.003152|0.004845|0.005329,1|1|1|1|1,686.5|374.5|343.3|216.8|196.1
234,4,0.5163,3.0980000000000003,3183.0,0.0009699999999999999,0.9929309999999999,ADGRD1 ALKAL2 NID1 RHOD,cell-matrix adhesion|cell-substrate adhesion|positive regulation of ERK5 cascade|regulation of ERK5 cascade|glomerular basement membrane development,0.000228|0.000486|0.0005825|0.0005825|0.002328,1|1|1|1|1,81.73|55.66|2574|2574|468.1
235,4,0.5282,3.1689999999999996,3197.0,0.0009881,0.9929309999999999,ADGRE1 ARNTL CD37 PPFIA3,oxidative stress-induced premature senescence|positive regulation of skeletal muscle cell differentiation|negative regulation of glucocorticoid receptor signaling pathway|regulation of glucocorticoid receptor signaling pathway|stress-induced premature senescence,0.0009706|0.001359|0.001359|0.001747|0.001747,1|1|1|1|1,1287|858.1|858.1|643.6|643.6
236,4,0.5188,3.113,2787.0,0.001112,0.9929309999999999,ADGRE2 PRPF3 RPL28 SF3B4,"mRNA metabolic process|RNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",0.0001504|0.0003501|0.001277|0.001277|0.001302,1|1|1|1|1,22.26|16.73|34.1|34.1|33.76
237,14,0.5051,45.97,11240.0,0.004063000000000001,0.9999969999999999,C1orf123 C1orf50 CCDC30 CFAP57 ERMAP EXO5 FAM183A KLF17 PPT1 TMEM53 ZFP69 ZFP69B ZNF684 ZNF691,cellular process|positive regulation of pinocytosis|lysosomal lumen acidification|protein depalmitoylation|pinocytosis,0.0009339|0.005036|0.006919|0.006919|0.007546,1|1|1|1|1,0.4092|226.3|158.4|158.4|144
238,11,0.517,28.43,8731.0,0.0032380000000000004,0.999969,ATP12A C1QTNF9 C1QTNF9B GJB2 GJB6 RCBTB2 RNF6 SIAH3 SLC25A30 SOHLH2 SPATA13,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|cell-cell junction assembly,7.241e-06|9.308e-06|1.163e-05|5.95e-05|0.002061,0.1142|0.07341|0.06116|0.2346|1,624.1|534.9|468.1|187.2|29.48
239,23,0.4238,107.2,18060.0,0.005887,1.0,ADGRF1 CRISP1 CRISP2 ENPP4 ENPP5 FBXO9 GLYATL3 GSTA1 GSTA2 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP MUT OPN5 PAQR8 PKHD1 RAB23 SPATS1 TFAP2B TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|glutathione metabolic process|xenobiotic metabolic process|cellular response to xenobiotic stimulus,1.431e-08|1.431e-08|8.029e-07|9.508e-06|1.106e-05,0.0002257|0.0001129|0.004222|0.03749|0.0349,170.2|170.2|57.61|30.2|29.03
240,4,0.5667,3.4,3105.0,0.001091,0.9929309999999999,ADGRF3 CASD1 GNPDA1 WDR27,glucosamine catabolic process|N-acetylglucosamine catabolic process|glucosamine metabolic process|N-acetylneuraminate catabolic process|glucosamine-containing compound catabolic process,0.0005825|0.0007766|0.0009706|0.001359|0.001941,1|1|1|1|1,2574|1716|1287|858.1|572.1
241,11,0.4857,26.71,8255.0,0.0032170000000000002,0.999969,ASCL1 GATA3 HAND2 IGF2BP1 INSM2 ISL1 LIN28B PDK1 PHOX2B SOX11 TFAP2B,sympathetic nervous system development|autonomic nervous system development|noradrenergic neuron differentiation|cardiac ventricle morphogenesis|regulation of neuron apoptotic process,2.56e-15|1.973e-13|2.17e-11|7.02e-08|8.019e-08,4.038e-11|1.556e-09|1.141e-07|0.0002769|0.000253,490.4|219.1|980.7|99.49|41.66
242,10,0.5038,22.67,8039.0,0.002805,0.999933,ADGRF5 C6orf226 GUCA1A IL17A IL17F NCR2 PGC TFAP2D TMEM217 YIPF3,positive regulation of antimicrobial peptide production|regulation of antimicrobial peptide production|positive regulation of antimicrobial humoral response|regulation of antimicrobial humoral response|positive regulation of humoral immune response,9.489e-09|1.355e-08|1.355e-08|3.227e-08|1.993e-07,0.0001497|0.0001069|7.126e-05|0.0001273|0.0006286,936.1|802.4|802.4|561.7|280.8
243,4,0.5385,3.2310000000000003,3200.0,0.001006,0.9929309999999999,ADGRG1 CORIN LUC7L3 PDE5A,regulation of systemic arterial blood pressure by atrial natriuretic peptide|cGMP catabolic process|cerebral cortex regionalization|vascular endothelial growth factor production|negative regulation of neuron migration,0.0005825|0.001165|0.001359|0.001553|0.002328,1|1|1|1|1,2574|1030|858.1|735.5|468.1
244,24,0.4155,114.7,17900.0,0.0063479999999999995,1.0,ADGRG7 ALCAM ARL13B CD200R1 CD200R1L CDV3 CLDND1 IFT57 IMPG2 MTRNR2L8 NXPE3 OR5AC2 OR5H1 OR5H14 OR5H15 OR5H2 OR5H6 OR5K1 OR5K3 OR5K4 PROS1 SLC9C1 ST3GAL6 STX19,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.014e-09|1.691e-09|2.338e-09|4.316e-09|5.954e-09,1.6e-05|1.334e-05|1.229e-05|1.702e-05|1.878e-05,17.51|16.5|15.89|14.8|14.25
245,44,0.4144,392.0,32200.0,0.01199,1.0,ADCY4 ANG BCL2L2 CEBPE CHMP4A CMA1 CMTM5 CTSG DHRS2 DHRS4 EDDM3A EDDM3B FITM1 GZMB GZMH LTB4R LTB4R2 MYH6 MYH7 OR10G2 OR10G3 OR11G2 OR11H4 OR11H6 OR4E2 OR4K13 OR4M2 OR4N4 OR5AU1 OR6S1 RBM23 REC8 RNASE1 RNASE13 RNASE3 RNASE4 RNASE6 RNASE7 RNASE8 RNF212B SLC7A7 SLC7A8 TM9SF1 TSSK4,detection of chemical stimulus involved in sensory perception of smell|RNA phosphodiester bond hydrolysis|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,1.97e-09|2.839e-09|3.607e-09|5.291e-09|1.09e-08,3.107e-05|2.239e-05|1.896e-05|2.086e-05|3.44e-05,11.68|22.69|11|10.59|9.864
246,27,0.5108,179.3,17620.0,0.01004,1.0,ARL8B BLOC1S1 FNIP1 GDAP2 GNPTAB LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 NPC1 NPC2 PSAP RAB7A RRAGA RRAGC SNAPIN SPG21 TBC1D5 TMEM251 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41,lysosomal transport|vacuolar transport|macromolecule localization|cellular localization|cellular protein localization,3.2e-18|9.536e-17|2.108e-15|2.915e-15|4.903e-15,5.048e-14|7.521e-13|1.108e-11|1.15e-11|1.547e-11,74.23|53.58|6.346|5.633|8.527
247,32,0.395,195.9,24980.0,0.007761,1.0,ADH1A ADH4 AFM AFP ALB AMBN CFAP299 CXCL1 CXCL2 CXCL3 CXCL5 FAM47E HNRNPDL HSD17B11 HTN3 ODAPH PF4 PF4V1 PPBP SULT1B1 SULT1E1 THEGL TMPRSS11B TMPRSS11D TMPRSS11E UGT2A1 UGT2A3 UGT2B11 UGT2B15 UGT2B28 UGT2B4 UGT2B7,cellular glucuronidation|uronic acid metabolic process|glucuronate metabolic process|hormone metabolic process|cellular hormone metabolic process,1.099e-14|4.367e-14|4.367e-14|7.644e-13|9.378e-13,1.733e-10|3.444e-10|2.296e-10|3.014e-09|2.959e-09,223.2|176.7|176.7|31.22|42.26
248,4,0.5588,3.353,3124.0,0.0010689999999999999,0.9929309999999999,ADGRL4 HEPHL1 NLGN1 STRA6,positive regulation of behavior|regulation of behavior|vitamin A import|vitamin A transport|cytoskeletal matrix organization at active zone,1.146e-05|6.8e-05|0.0003883|0.0003883|0.0003883,0.1808|0.5363|1|1|1,381.4|151.4|5149|5149|5149
249,6,0.5004,7.506,5061.0,0.001477,0.998474,ACAP1 ADGRV1 CDH12 FER RAB3C ZNF33A,cell-cell adhesion|Kit signaling pathway|cellular response to stem cell factor stimulus|response to stem cell factor|insulin receptor signaling pathway via phosphatidylinositol 3-kinase,0.000297|0.0008735|0.0008735|0.0008735|0.001456,1|1|1|1|1,20.03|1716|1716|1716|858.1
250,6,0.5243,7.864,4879.0,0.001605,0.998474,ADH7 CSH2 LIMD2 METTL2B PLEKHM1 RNFT1,fatty acid omega-oxidation|ethanol oxidation|ethanol catabolic process|positive regulation of ERAD pathway|positive regulation of ruffle assembly,0.001746|0.003781|0.003781|0.004361|0.004651,1|1|1|1|1,686.5|286|286|245.2|228.8
251,4,0.5689,3.4130000000000003,3404.0,0.0009994,0.9929309999999999,ADIG CFAP58 DYDC1 TMPRSS11E,chromatin silencing at telomere|white fat cell differentiation|brown fat cell differentiation|histone H3-K4 methylation|chromatin silencing,0.001941|0.002716|0.005426|0.006586|0.01064,1|1|1|1|1,572.1|396.1|190.7|156|95.35
252,5,0.5623,5.622999999999999,3997.0,0.001401,0.996692,ADIPOQ BARX1 C18orf63 SPAG1 ZNF670,negative regulation of metanephros development|negative regulation of metanephric mesenchymal cell migration|positive regulation of renal albumin absorption|positive regulation of metanephric glomerular visceral epithelial cell development|regulation of metanephric glomerular visceral epithelial cell development,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
253,5,0.5134,5.1339999999999995,3832.0,0.001334,0.996692,ADIPOR1 DNAJC5 MET MFAP3 SIM2,negative regulation of thrombin-activated receptor signaling pathway|regulation of thrombin-activated receptor signaling pathway|regulation of epithelial cell migration|negative regulation of hydrogen peroxide-mediated programmed cell death|negative regulation of guanyl-nucleotide exchange factor activity,0.0009706|0.0009706|0.001246|0.001456|0.001698,1|1|1|1|1,1373|1373|35.66|823.8|686.5
254,18,0.4308,65.91,12730.0,0.005136,1.0,ADIPOR2 BCL6 CD81 CEPT1 CYB561A3 DMXL1 EBF1 EPS15L1 IRF8 ITSN2 MEF2B PAX5 PIK3CD POU2AF1 POU2F2 SH3GL1 SLC38A1 TTC7A,hemopoiesis|leukocyte differentiation|hematopoietic or lymphoid organ development|immune system development|mononuclear cell differentiation,3.235e-07|4.164e-07|5.478e-07|8.06e-07|4.06e-06,0.005103|0.003284|0.00288|0.003178|0.01281,14|19.45|12.94|12.21|19.93
255,14,0.5129,46.68,9158.0,0.005055,0.9999969999999999,AMOTL2 DLG5 KIRREL1 LATS2 MAP4K4 NF2 NRP1 PDCD10 PKN2 PLXNA1 PTPN14 RNF146 SAV1 TAOK1,anatomical structure morphogenesis|regulation of cell motility|regulation of locomotion|regulation of cellular component movement|regulation of cell migration,1.396e-08|9.934e-08|1.396e-07|1.834e-07|1.318e-06,0.0002203|0.0007835|0.000734|0.0007234|0.004158,7.074|11.6|11.09|10.71|10.86
256,5,0.5235,5.235,3945.0,0.001322,0.996692,ADM2 ANKRD61 LMF2 PARVB RFPL3,establishment or maintenance of cell polarity regulating cell shape|lamellipodium assembly|lamellipodium organization|negative regulation of blood pressure|substrate adhesion-dependent cell spreading,0.000728|0.008949|0.01064|0.01088|0.01376,1|1|1|1|1,2060|114.4|95.79|93.61|73.55
257,4,0.5616,3.37,3256.0,0.001031,0.9929309999999999,ADM5 EDAR SNCB SPHKAP,salivary gland cavitation|tube lumen cavitation|salivary gland morphogenesis|salivary gland development|dopamine metabolic process,0.001165|0.001165|0.005426|0.005813|0.006007,1|1|1|1|1,1030|1030|190.7|177.5|171.6
258,5,0.5131,5.131,3756.0,0.001361,0.996692,ADNP CEBPB PABPC1L POFUT2 SERINC3,memory|negative regulation of neuron apoptotic process|granuloma formation|nitric oxide homeostasis|positive regulation of sodium-dependent phosphate transport,0.0003163|0.000492|0.000728|0.0009706|0.0009706,1|1|1|1|1,71.63|57.21|2060|1373|1373
259,4,0.5015,3.009,3193.0,0.0009390000000000001,0.9929309999999999,ADNP2 CIDEA CLEC11A STARD6,response to stilbenoid|positive regulation of sequestering of triglyceride|cellular response to cold|lipid localization|regulation of apoptotic DNA fragmentation,0.001359|0.001941|0.002134|0.002199|0.002328,1|1|1|1|1,858.1|572.1|514.9|25.87|468.1
260,9,0.5465,19.67,6039.0,0.003237,0.9998530000000001,ADPGK DERL1 GSR NFE2L2 RPE SLC33A1 SLC35B4 SUCO TAPT1,cell redox homeostasis|monosaccharide catabolic process|carbohydrate derivative transport|generation of precursor metabolites and energy|acetyl-CoA transport,0.0001815|0.0002865|0.0004753|0.0005798|0.0008734,1|1|1|1|1,101.7|80.29|61.85|17.08|2288
261,4,0.5104,3.062,3172.0,0.0009619,0.9929309999999999,ADPRH B4GALT6 MYL9 PLEKHF2,lactosylceramide biosynthetic process|lactosylceramide metabolic process|ganglioside biosynthetic process via lactosylceramide|protein de-ADP-ribosylation|ganglioside biosynthetic process,0.0003883|0.0003883|0.001165|0.001359|0.003297,1|1|1|1|1,5149|5149|1030|858.1|321.8
262,8,0.5034,14.1,6584.0,0.002131,0.9996790000000001,ADPRHL2 AGO4 DCDC2B GJA4 GJB3 TMEM39B TSSK3 ZSCAN20,peptidyl-serine ADP-deribosylation|male gamete generation|gamete generation|protein de-ADP-ribosylation|negative regulation of autophagosome maturation,0.0007765|0.001063|0.001901|0.002715|0.002715,1|1|1|1|1,2574|13.62|11.13|429.1|429.1
263,4,0.5406,3.2439999999999998,3123.0,0.001035,0.9929309999999999,ADPRM CYP4F22 NGB OR52K2,oxygen transport|gas transport|nucleobase-containing small molecule catabolic process|ceramide biosynthetic process|ceramide metabolic process,0.00291|0.003878|0.009675|0.01064|0.01813,1|1|1|1|1,367.8|271|105.1|95.35|55.36
264,4,0.5112,3.0669999999999997,3130.0,0.0009763999999999999,0.9929309999999999,ADRA1A KRTAP10-1 RFPL4AL1 SYT3,neuron-glial cell signaling|positive regulation of heart rate by epinephrine-norepinephrine|positive regulation of blood pressure by epinephrine-norepinephrine|regulation of systemic arterial blood pressure by norepinephrine-epinephrine|adenylate cyclase-activating adrenergic receptor signaling pathway,9.893e-07|1.319e-06|1.696e-06|2.59e-06|1.19e-05,0.01561|0.0104|0.008915|0.01021|0.03754,1648|1373|1177|915.3|392.3
265,4,0.5949,3.569,3484.0,0.001021,0.9929309999999999,ADRA1B C8orf48 CSF1 NR2C2,positive regulation of macrophage colony-stimulating factor signaling pathway|mammary gland fat development|positive regulation of odontogenesis of dentin-containing tooth|regulation of macrophage colony-stimulating factor signaling pathway|macrophage colony-stimulating factor signaling pathway,0.0003883|0.0003883|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|5149|2574|1716|1287
266,17,0.5027,68.37,13870.0,0.004893,1.0,CNBD2 EPPIN FAM209B GGT7 GHRH HCK LBP MAP1LC3A MATN4 MYLK2 PKIG RBPJL SLC13A3 TMEM189 WFDC11 WFDC6 WISP2,"response to bacterium|lipopolysaccharide-mediated signaling pathway|positive regulation of circadian sleep/wake cycle, REM sleep|positive regulation of cytolysis|response to external stimulus",0.0001658|0.0003505|0.001552|0.001552|0.001674,1|1|1|1|1,8.964|75.72|1287|1287|3.593
267,26,0.4102,133.3,18840.0,0.0070090000000000005,1.0,B4GALT1 BEST3 CPM CPSF6 FAM3C FAM49A FGF8 FGFR4 FRS2 LFNG LRRC10 LYZ MDM2 MEGF10 MYCN MYOG NUP107 PAX3 PDK1 PTPRG RAB3IP RAP1B SLC35E3 SOX8 ST3GAL4 ZBTB18,tissue development|epithelial cell development|developmental induction|anatomical structure development|positive regulation of animal organ morphogenesis,6.722e-07|5.274e-06|7.149e-06|8.665e-06|1.166e-05,0.0106|0.0416|0.03759|0.03417|0.03678,5.285|19.76|88.01|2.607|73.82
268,5,0.5286,5.2860000000000005,4300.0,0.001225,0.996692,ADRA2C GRXCR2 MRPS10 MTX3 SLC12A5,thermosensory behavior|negative regulation of uterine smooth muscle contraction|negative regulation of epinephrine secretion|receptor transactivation|regulation of epinephrine secretion,0.0004854|0.0004854|0.001213|0.001456|0.001698,1|1|1|1|1,4119|4119|1030|823.8|686.5
269,11,0.5057,27.81,9333.0,0.002964,0.999969,ADRB1 CALHM3 CYP17A1 CYP2C9 GSTO2 IFIT5 MORN4 SEMA4G SFXN2 SORCS1 SORCS3,negative regulation of developmental growth|olefinic compound metabolic process|neuropeptide signaling pathway|positive regulation of the force of heart contraction by epinephrine-norepinephrine|xenobiotic metabolic process,0.001373|0.001505|0.001532|0.001601|0.001968,1|1|1|1|1,36.35|34.67|34.35|936.1|30.2
270,4,0.605,3.63,3042.0,0.001189,0.9929309999999999,ABLIM2 ADSSL1 BOC CDC42BPB,actin cytoskeleton organization|actin filament-based process|positive regulation of myoblast differentiation|lamellipodium assembly|lamellipodium organization,0.00192|0.002492|0.003346|0.005379|0.006395,1|1|1|1|1,26.2|22.96|312|190.7|159.7
271,14,0.5024,45.72,9640.0,0.004707,0.9999969999999999,ARHGAP21 ARHGAP29 ARHGEF12 BTBD9 GNA13 KCTD10 LPAR2 LUZP1 MYO9A MYO9B RHOA RHOC RIC8A ROCK1,regulation of small GTPase mediated signal transduction|Rho protein signal transduction|positive regulation of hydrolase activity|regulation of hydrolase activity|small GTPase mediated signal transduction,1.363e-13|2.762e-12|5.433e-12|2.158e-11|1.895e-10,2.15e-09|2.178e-08|2.857e-08|8.51e-08|5.979e-07,40.49|144.7|18.93|12.37|39.3
272,4,0.5119,3.071,3052.0,0.001003,0.9929309999999999,AEN HMGCLL1 LRFN5 SLC38A6,leucine catabolic process|glutamine transport|leucine metabolic process|ketone body biosynthetic process|cellular ketone body metabolic process,0.001359|0.001747|0.001747|0.001941|0.002328,1|1|1|1|1,858.1|643.6|643.6|572.1|468.1
273,11,0.5294,29.12,8423.0,0.003436,0.999969,AES CELF5 MUM1 PLIN3 SGTA TNFSF14 UQCR11 ZNF554 ZNF555 ZNF556 ZNF77,negative regulation of transcription by RNA polymerase II|negative regulation of nitrogen compound metabolic process|negative regulation of cellular metabolic process|negative regulation of macromolecule metabolic process|regulation of nitrogen compound metabolic process,6.047e-05|6.158e-05|0.0001014|0.000198|0.0002921,0.9538|0.4857|0.5331|0.7806|0.9215,10.38|5.484|5.08|4.581|2.962
274,18,0.5013,76.69,14560.0,0.005228,1.0,AFAP1L2 CALHM3 DUPD1 DUSP13 GOLGA7B IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPJ LIPK LIPM NUTM2A NUTM2B PNLIP SFTPA1 SFTPA2,cellular response to type I interferon|response to type I interferon|lipid catabolic process|type I interferon signaling pathway|defense response to symbiont,4.266e-07|5.869e-07|5.35e-06|3.079e-05|3.198e-05,0.006729|0.004629|0.02813|0.1214|0.1009,66.33|61.02|18.82|50.48|21.59
275,5,0.5202,5.202000000000001,3918.0,0.001323,0.996692,AFG1L CHIT1 IGFN1 PEF1 TMEM81,positive regulation of protein monoubiquitination|mitochondrial protein catabolic process|regulation of protein monoubiquitination|chitin catabolic process|chitin metabolic process,0.001456|0.001456|0.001698|0.001698|0.001698,1|1|1|1|1,823.8|823.8|686.5|686.5|686.5
276,11,0.5872,32.29,7255.0,0.004418,0.999969,AFG3L2 CEP192 FAM210A NDC80 NDUFV2 PRELID3B SEH1L THOC1 TRIM37 TXNDC2 ZBTB14,attachment of mitotic spindle microtubules to kinetochore|attachment of spindle microtubules to kinetochore|mitotic spindle organization|mitotic prometaphase|microtubule cytoskeleton organization involved in mitosis,2.349e-05|7.72e-05|8.224e-05|8.671e-05|0.0001169,0.3706|0.6089|0.4324|0.3419|0.3686,312|162.8|34.25|33.63|30.36
277,4,0.5544,3.327,3309.0,0.0010019999999999999,0.9929309999999999,ABRAXAS2 AFMID EFCAB3 LRRC37A3,tryptophan catabolic process to kynurenine|'de novo' NAD biosynthetic process from tryptophan|'de novo' NAD biosynthetic process|tryptophan catabolic process|indole-containing compound catabolic process,0.001165|0.001359|0.001553|0.002134|0.002134,1|1|1|1|1,1030|858.1|735.5|514.9|514.9
278,13,0.5071,39.55,9823.0,0.004,0.999993,AAGAB AFTPH AP1B1 AP1G1 AP1M1 AP1M2 AP1S1 HEATR5B RAB11A SCYL2 SYNRG TBCK VIPAS39,intracellular transport|regulation of defense response to virus by virus|protein transport|peptide transport|protein localization,2.811e-13|1.146e-11|1.651e-11|2.041e-11|2.123e-11,4.434e-09|9.038e-08|8.678e-08|8.048e-08|6.699e-08,12.68|273.1|11.91|11.68|8.809
279,4,0.5055,3.033,3145.0,0.0009611000000000001,0.9929309999999999,AGAP1 ATP1B2 PHACTR3 SLC51B,neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration|positive regulation of sodium ion export across plasma membrane|regulation of sodium ion export across plasma membrane|third ventricle development|regulation of hydrolase activity,0.0003883|0.0009706|0.0009706|0.0009706|0.0009799,1|1|1|1|1,5149|1287|1287|1287|11.81
280,5,0.5478,5.478,4185.0,0.0013039999999999998,0.996692,AGAP2 DDX60 FAM163B PLEKHF1 VPS13C,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization|regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization|positive regulation of 1-phosphatidylinositol-3-kinase activity|regulation of 1-phosphatidylinositol-3-kinase activity|positive regulation of intracellular signal transduction,0.0004854|0.0004854|0.0009706|0.0009706|0.001116,1|1|1|1|1,4119|4119|1373|1373|12.17
281,4,0.516,3.096,3082.0,0.001001,0.9929309999999999,AGAP3 CD302 GMPPB SLC46A2,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway|regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway|GDP-mannose biosynthetic process|positive regulation of nucleotide-binding oligomerization domain containing signaling pathway|GDP-mannose metabolic process,0.0007766|0.0009706|0.001165|0.001359|0.001747,1|1|1|1|1,1716|1287|1030|858.1|643.6
282,14,0.734,66.8,11270.0,0.005878,0.9999969999999999,ATOH1 C7orf33 CHRM2 CTLA4 IK IL33 KIAA0319 KIAA0586 LLCFC1 MLF2 MMP27 PRR9 SLC44A5 TBC1D1,positive regulation of inner ear receptor cell differentiation|regulation of CD86 production|positive regulation of CD86 production|regulation of CD80 production|auditory receptor cell fate specification,0.001358|0.001358|0.001358|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|1471|1471
283,6,0.5179,7.768,4638.0,0.001668,0.998474,AGBL4 C6orf203 ENPP1 ENPP3 SPACA7 TAAR6,nucleoside triphosphate catabolic process|nucleoside phosphate catabolic process|nucleoside triphosphate metabolic process|nucleobase-containing small molecule biosynthetic process|negative regulation of hh target transcription factor activity,8.468e-06|0.0002497|0.0002989|0.0004726|0.0005824,0.1336|1|1|1|1,490.4|82.71|75.44|59.7|3432
284,5,0.5011,5.011,4112.0,0.001214,0.996692,AGBL5 FAM177B PBK SLC25A15 ZNF214,protein branching point deglutamylation|mitochondrial L-ornithine transmembrane transport|L-ornithine transmembrane transport|ornithine transport|protein deglutamylation,0.0004854|0.0009706|0.001698|0.00194|0.002183,1|1|1|1|1,4119|1373|686.5|588.4|514.9
285,7,0.523,10.98,5406.0,0.002022,0.9992989999999999,AGER BTN2A2 HLA-A MCCD1 NAAA NEU1 OR2J3,regulation of T cell proliferation|regulation of lymphocyte proliferation|regulation of mononuclear cell proliferation|regulation of leukocyte proliferation|regulation of T cell mediated cytotoxicity,3.269e-05|7.283e-05|7.474e-05|9.228e-05|0.0001021,0.5157|0.5744|0.393|0.3639|0.3223,44.9|34.17|33.87|31.52|135.5
286,4,0.5113,3.068,3140.0,0.0009737,0.9929309999999999,AGFG2 APLNR SOHLH2 SOX1,positive regulation of inhibitory G protein-coupled receptor phosphorylation|regulation of inhibitory G protein-coupled receptor phosphorylation|apelin receptor signaling pathway|ventral spinal cord interneuron specification|cell fate specification involved in pattern specification,0.0003883|0.0003883|0.0007766|0.001553|0.001553,1|1|1|1|1,5149|5149|1716|735.5|735.5
287,15,0.5187,54.47,11020.0,0.0049039999999999995,0.999999,C1orf131 COG2 DTL EPRS GUK1 HEATR1 INTS7 NUP133 NVL RRP15 SDE2 SRP9 TBCE URB2 UTP25,ncRNA metabolic process|gene expression|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,1.694e-05|2.709e-05|6.105e-05|0.0001671|0.0002211,0.2673|0.2136|0.321|0.6591|0.6975,14.23|5.384|17.72|13.62|12.65
288,11,0.5019,27.61,7449.0,0.0036810000000000002,0.999969,AGK FDX2 LYRM4 SLC25A28 SLC25A37 STARD7 STOML2 TIMM10 TIMM22 TIMM29 TIMM9,mitochondrial transport|protein insertion into mitochondrial inner membrane|protein insertion into mitochondrial membrane|establishment of protein localization to mitochondrial membrane|inner mitochondrial membrane organization,4.358e-14|6.504e-14|1.763e-12|4.125e-12|6.173e-11,6.875e-10|5.13e-10|9.268e-09|1.627e-08|1.947e-07,65.41|851|390.1|322.8|180
289,4,0.5611,3.367,3307.0,0.001015,0.9929309999999999,AGL CAPZA3 NYAP2 RNF222,cytoplasm organization|glycogen catabolic process|glucan catabolic process|cellular polysaccharide catabolic process|glycogen biosynthetic process,0.002328|0.003685|0.003878|0.004072|0.004459,1|1|1|1|1,468.1|286|271|257.4|234
290,4,0.522,3.1319999999999997,3083.0,0.0010119999999999999,0.9929309999999999,AGMO OR2B11 SERINC3 UGT8,membrane lipid metabolic process|sphingolipid metabolic process|cellular lipid metabolic process|protein localization to paranode region of axon|lipid metabolic process,4.328e-06|0.0003741|0.0004117|0.0007766|0.000802,0.06826|1|1|1|1,73.55|63.56|15.84|1716|12.64
291,8,0.7664,21.46,5659.0,0.0037670000000000004,0.9996790000000001,AGO2 ANKRD52 DGCR8 DICER1 DROSHA TARBP2 TNRC6A XPO5,gene silencing by miRNA|post-transcriptional gene silencing by RNA|posttranscriptional gene silencing|miRNA metabolic process|gene silencing by RNA,5.187e-18|1.779e-17|3.062e-17|7.794e-17|2.612e-16,8.182e-14|1.403e-13|1.61e-13|3.074e-13|8.24e-13,375.4|310.7|286|735.5|207.1
292,23,0.5084,128.6,14860.0,0.008553,1.0,CLEC16A COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 EIPR1 GET4 PTAR1 RAB1A RAB1B RAB2A SLC10A7 SLC39A9 TRAPPC13 UNC50 VPS51 VPS52 VPS54 YKT6,Golgi vesicle transport|endoplasmic reticulum to Golgi vesicle-mediated transport|establishment of protein localization|protein transport|peptide transport,1.026e-20|9.73e-17|1.683e-16|2.179e-15|3.011e-15,1.618e-16|7.674e-13|8.849e-13|8.594e-12|9.498e-12,33.92|50.25|10.35|10.4|10.2
293,4,0.526,3.156,3154.0,0.0009972000000000002,0.9929309999999999,AGPAT3 ASIP PAQR9 PTTG1IP,"regulation of molecular function, epigenetic|positive regulation of secondary metabolite biosynthetic process|positive regulation of melanin biosynthetic process|adult feeding behavior|regulation of secondary metabolic process",0.0005825|0.001553|0.001553|0.002134|0.002522,1|1|1|1|1,2574|735.5|735.5|514.9|429.1
294,9,0.5235,18.84,6726.0,0.002787,0.9998530000000001,AGPAT5 CFAP53 ISL2 LHX3 MAN1A2 MGAT1 NEUROD1 OTP OTX2,spinal cord motor neuron cell fate specification|multicellular organism development|forebrain development|endocrine system development|pattern specification process,1.396e-05|1.855e-05|2.282e-05|2.597e-05|3.459e-05,0.2201|0.1463|0.12|0.1024|0.1091,411.9|3.801|21.68|50.23|19.48
295,4,0.575,3.45,3230.0,0.001064,0.9929309999999999,AGRN CTAGE15 DCLRE1C HES4,positive regulation of synaptic growth at neuromuscular junction|positive regulation of neuromuscular junction development|regulation of synaptic growth at neuromuscular junction|clustering of voltage-gated sodium channels|protection from non-homologous end joining at telomere,0.0003883|0.0005825|0.001165|0.001359|0.001553,1|1|1|1|1,5149|2574|1030|858.1|735.5
296,5,0.506,5.06,3926.0,0.001284,0.996692,AGT CCDC71 FAM71A TDRD10 TRANK1,"positive regulation of membrane hyperpolarization|glycine biosynthetic process, by transamination of glyoxylate|G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger|renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure|maintenance of blood vessel diameter homeostasis by renin-angiotensin",0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
297,6,0.5146,7.718999999999999,4147.0,0.001853,0.998474,CFDP1 H2AFZ METTL1 TRMT10A WDR4 ZNHIT1,tRNA methylation|tRNA (guanine-N7)-methylation|RNA methylation|tRNA modification|RNA (guanine-N7)-methylation,9.064e-08|2.827e-07|7.747e-07|8.85e-07|1.696e-06,0.00143|0.00223|0.004073|0.00349|0.005349,301.4|4119|143.7|137.3|1177
298,9,0.5088,18.32,5898.0,0.0030859999999999998,0.9998530000000001,AHCYL1 FAM13B KIDINS220 MAPK6 MAPKAPK5 SLC20A1 SLC4A2 SLC4A7 XPR1,inorganic anion transport|phosphate ion transmembrane transport|anion transmembrane transport|phosphate ion transport|bicarbonate transport,4.5e-07|2.299e-05|2.875e-05|3.9e-05|0.0001589,0.007098|0.1813|0.1512|0.1538|0.5014,57.93|305.1|19.99|228.8|109
299,7,0.9996,20.99,4168.0,0.004994,0.999333,GID8 MAEA RANBP9 RMND5A UBE2H WDR26 YPEL5,proteasome-mediated ubiquitin-dependent protein catabolic process|proteasomal protein catabolic process|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process,4.147e-06|5.369e-06|2.939e-05|3.093e-05|3.345e-05,0.06542|0.04235|0.1545|0.122|0.1055,31.88|29.85|19.32|19.07|18.69
300,26,0.4345,141.2,16540.0,0.008436,1.0,BCAR1 BCAR3 CRK CRKL DOCK5 ELMO2 FERMT2 ILK ITGA3 ITGAV ITGB1 ITGB5 LIMS1 MYO10 NCKAP1 PTK2 PXN RAC1 RAPGEF1 RAPH1 RSU1 SRC TLN1 TNS3 VCL YES1,regulation of cell-substrate adhesion|integrin-mediated signaling pathway|vascular endothelial growth factor receptor signaling pathway|cell-matrix adhesion|enzyme linked receptor protein signaling pathway,2.218e-17|5.02e-17|3.706e-16|5.402e-16|1.001e-15,3.498e-13|3.959e-13|1.949e-12|2.13e-12|3.158e-12,43.8|80.83|100.4|62.87|16.37
301,59,0.3988,682.3,45570.0,0.014709999999999999,1.0,AOC2 AOC3 ARL5C CCR7 EPOP FKBP10 GSDMA GSDMB HAP1 HEXIM2 HSPB9 KRT10 KRT12 KRT13 KRT15 KRT16 KRT19 KRT20 KRT222 KRT23 KRT24 KRT25 KRT26 KRT27 KRT28 KRT31 KRT32 KRT33A KRT33B KRT35 KRT36 KRT37 KRT39 KRT40 KRT9 KRTAP1-1 KRTAP1-3 KRTAP1-4 KRTAP1-5 KRTAP3-1 KRTAP3-2 KRTAP3-3 KRTAP4-11 KRTAP4-2 KRTAP4-3 KRTAP4-4 KRTAP4-6 KRTAP4-8 KRTAP4-9 KRTAP9-1 KRTAP9-3 KRTAP9-8 KRTAP9-9 LRRC3C P3H4 RDM1 STAT5A TMUB2 TUBG2,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,7.619e-64|4.637e-61|2.433e-58|3.893e-55|1.037e-53,1.202e-59|3.657e-57|1.279e-54|1.535e-51|3.273e-50,61.25|51.65|43.81|36.14|33.2
302,7,0.5103,10.72,4628.0,0.002303,0.9992989999999999,AHR ANKMY2 ARNT HSPA4 PTGES3 STIP1 TIPARP,"response to 2,3,7,8-tetrachlorodibenzodioxine|xenobiotic metabolic process|cellular response to xenobiotic stimulus|response to xenobiotic stimulus|chaperone-mediated protein complex assembly",1.483e-06|7.864e-06|8.831e-06|1.031e-05|2.495e-05,0.0234|0.06202|0.04643|0.04067|0.07872,1471|71.18|68.42|64.9|280.2
303,4,0.5188,3.113,3236.0,0.0009586,0.9929309999999999,AHRR FZD10 KCTD3 STATH,non-canonical Wnt signaling pathway via JNK cascade|saliva secretion|non-canonical Wnt signaling pathway via MAPK cascade|secretion by tissue|negative regulation of bone mineralization,0.001165|0.001165|0.001359|0.003491|0.003878,1|1|1|1|1,1030|1030|858.1|302.9|271
304,7,0.522,10.96,4560.0,0.002391,0.9992989999999999,AHR AHSA1 ARNT HSF1 HSPA4 STIP1 TIPARP,"response to 2,3,7,8-tetrachlorodibenzodioxine|positive regulation of catabolic process|cellular response to organic cyclic compound|response to chemical|regulation of transcription from RNA polymerase II promoter in response to stress",1.483e-06|0.000369|0.0004706|0.0005238|0.0006259,0.0234|1|1|1|1,1471|19.19|17.65|4.04|52.54
305,5,0.5043,5.043,4106.0,0.001224,0.996692,AHSG FTCD MYOM3 PLXNA2 TMEM238,cerebellar granule cell precursor tangential migration|hindbrain tangential cell migration|formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide,0.000728|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,2060|1373|1030|1030|1030
306,11,0.5167,28.42,7478.0,0.003775,0.999969,CAB39 CCM2 FRYL ITGB1BP1 KRIT1 MAP3K2 PDCD10 RALGAPB STK24 TAOK1 TLNRD1,intracellular signal transduction|negative regulation of endothelial cell migration|positive regulation of protein kinase activity|negative regulation of epithelial cell migration|negative regulation of cell migration,1.595e-07|3.089e-06|4.874e-06|6.896e-06|8.979e-06,0.002515|0.02436|0.02563|0.0272|0.02833,9.51|106|17.53|80.24|28.05
307,5,0.5302,5.3020000000000005,3995.0,0.001322,0.996692,AIF1L FAM78A LAMC3 PCID2 SH3GLB2,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery|nuclear retention of pre-mRNA at the site of transcription|transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery|positive regulation of mitotic cell cycle spindle assembly checkpoint|positive regulation of spindle checkpoint,0.000728|0.001456|0.001698|0.00194|0.00194,1|1|1|1|1,2060|823.8|686.5|588.4|588.4
308,5,0.5304,5.303999999999999,3936.0,0.001342,0.996692,AIG1 CNTNAP2 FUCA2 PHACTR2 TAAR2,superior temporal gyrus development|clustering of voltage-gated potassium channels|protein localization to juxtaparanode region of axon|long-chain fatty acid catabolic process|observational learning,0.000728|0.0009706|0.001213|0.001456|0.001698,1|1|1|1|1,2060|1373|1030|823.8|686.5
309,5,0.507,5.07,3726.0,0.001355,0.996692,AIMP1 ATXN10 NUDT17 SAMM50 THOC5,NADP catabolic process|positive regulation of glucagon secretion|NAD catabolic process|pyridine nucleotide catabolic process|outer mitochondrial membrane organization,0.0009706|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,1373|1373|1373|1030|1030
310,11,0.5444,29.94,6932.0,0.004287,0.999969,ATM CDKN1A CHEK2 DCLRE1B MDM2 MDM4 PPM1D PPM1G TP53 UBE2D3 USP28,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|cell cycle checkpoint|signal transduction in response to DNA damage|cellular response to DNA damage stimulus",2.535e-16|5.595e-15|9.742e-15|3.091e-14|7.534e-14,3.998e-12|4.413e-11|5.122e-11|1.219e-10|2.377e-10,126.9|165.9|79.25|128.5|23.79
311,4,0.5512,3.307,3296.0,0.001,0.9929309999999999,AJM1 GPR149 IL32 PGC,negative regulation of ovulation|positive regulation of type III interferon production|regulation of ovulation|preantral ovarian follicle growth|multi-layer follicle stage,0.0003883|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|2574|1716|1716|1716
312,5,0.5392,5.392,4272.0,0.001258,0.996692,AK1 IFI6 KLHL26 RIPOR1 TYMP,nucleoside monophosphate metabolic process|negative regulation of Rho guanyl-nucleotide exchange factor activity|dTMP catabolic process|dTMP metabolic process|ADP biosynthetic process,0.0001441|0.000728|0.0009706|0.001456|0.001456,1|1|1|1|1,107|2060|1373|823.8|823.8
313,23,0.4855,122.8,18120.0,0.006717,1.0,ADAP2 ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EPOP EVI2A GAS2L2 GSDMB HAP1 KRT28 KRTAP4-8 LYRM9 MMP28 RDM1 SLC13A2 SLFN12 SLFN14 SPAG5 UNC119,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|lymphocyte chemotaxis|regulation of natural killer cell chemotaxis,1.77e-06|2.064e-06|2.018e-05|3.345e-05|6.313e-05,0.02793|0.01628|0.1061|0.1319|0.1992,145.4|137.3|60.28|50.44|205.9
314,4,0.5362,3.217,3385.0,0.0009474,0.9929309999999999,AK5 DCLK2 MB UVSSA,dADP biosynthetic process|slow-twitch skeletal muscle fiber contraction|purine deoxyribonucleoside diphosphate biosynthetic process|voluntary skeletal muscle contraction|dADP metabolic process,0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
315,13,0.5008,39.06,9025.0,0.004297,0.999993,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 IMP3 NEPRO NOP9 POP4 POP5 WDR43 WDR75,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,3.573e-16|5.16e-16|3.875e-15|5.077e-14|1.043e-13,5.636e-12|4.07e-12|2.037e-11|2.002e-10|3.29e-10,52.81|50.85|41.36|31.78|29.53
316,6,0.5138,7.707000000000001,4745.0,0.0016179999999999999,0.998474,AK7 APOPT1 BAG5 CRIP1 MOK PPP1R13B,intrinsic apoptotic signaling pathway|prostate gland stromal morphogenesis|negative regulation of protein refolding|regulation of protein refolding|cell death,0.0005123|0.000728|0.001213|0.001213|0.001334,1|1|1|1|1,56.04|2060|1030|1030|11.45
317,4,0.5571,3.343,3243.0,0.001027,0.9929309999999999,AK9 PCSK1 RIPOR2 TSPOAP1,AMP phosphorylation|dGDP phosphorylation|dADP phosphorylation|negative regulation of protein localization to cell leading edge|regulation of protein localization to cell leading edge,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
318,20,0.4918,93.44,12810.0,0.007219,1.0,AP3B1 AP3D1 ARFGEF2 ARFRP1 EIPR1 HTT RAB14 RAB6A RGP1 RIC1 SYS1 UNC50 VIPAS39 VPS26A VPS33B VPS50 VPS51 VPS52 VPS53 VPS54,"endosomal transport|cytosolic transport|intracellular transport|retrograde transport, endosome to Golgi|nitrogen compound transport",2.544e-22|1.898e-20|3.331e-19|2.797e-18|1.019e-17,4.013e-18|1.497e-16|1.751e-15|1.103e-14|3.216e-14,56.25|75.9|11.87|104|9.876
319,4,0.5333,3.2,3275.0,0.0009736,0.9929309999999999,AKAP11 IFT88 RYR3 SMIM2,cellular response to gibberellin stimulus|gibberellic acid mediated signaling pathway|response to gibberellin|gibberellin mediated signaling pathway|cellular response to magnesium ion,0.0003883|0.0003883|0.0003883|0.0003883|0.001553,1|1|1|1|1,5149|5149|5149|5149|735.5
320,4,0.5618,3.3710000000000004,3351.0,0.001003,0.9929309999999999,AKAP13 PEX11G SOSTDC1 XPA,negative regulation of determination of dorsal identity|nucleotide-excision repair involved in interstrand cross-link repair|regulation of peroxisome size|mammary gland bud morphogenesis|regulation of determination of dorsal identity,0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
321,4,0.5317,3.19,3176.0,0.001001,0.9929309999999999,AKAP3 BAG2 CCDC113 KIAA1024L,negative regulation of ubiquitin protein ligase activity|negative regulation of ubiquitin-protein transferase activity|acrosome reaction|regulation of ubiquitin protein ligase activity|positive regulation of protein processing,0.001601|0.002619|0.003492|0.003782|0.003782,1|1|1|1|1,686.5|403.8|298.5|274.6|274.6
322,5,0.5215,5.215,3886.0,0.0013369999999999999,0.996692,AKAP6 CEBPG KIF13A TRIM25 ZNFX1,heterochromatin assembly by small RNA|positive regulation of delayed rectifier potassium channel activity|positive regulation of DNA-binding transcription factor activity|plus-end-directed vesicle transport along microtubule|enucleate erythrocyte differentiation,0.001213|0.001456|0.001692|0.001698|0.001698,1|1|1|1|1,1030|823.8|30.51|686.5|686.5
323,4,0.5602,3.361,3161.0,0.00106,0.9929309999999999,AKAP7 RPS6KA1 SLC9A1 SMPD2,intracellular signal transduction|positive regulation of ion transmembrane transporter activity|positive regulation of transporter activity|positive regulation of cell growth|positive regulation of cation transmembrane transport,3.44e-05|0.0001653|0.0001938|0.0003832|0.0003972,0.5427|1|1|1|1,13.08|96.24|88.77|62.79|61.66
324,4,0.5651,3.391,3099.0,0.00109,0.9929309999999999,AKAP8 CALR3 DMRT3 GCDH,ventral spinal cord interneuron specification|cell fate specification involved in pattern specification|fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of odontogenesis of dentin-containing tooth|cell fate commitment involved in pattern specification,0.001553|0.001553|0.002134|0.002134|0.002328,1|1|1|1|1,735.5|735.5|514.9|514.9|468.1
325,19,0.5086,86.97,13310.0,0.006475,1.0,AKIP1 CCDC77 CEP120 CEP135 CEP295 CEP41 CEP44 HYLS1 MIIP PCM1 POC1A POC1B POC5 PPP1R35 RTTN SPICE1 TBC1D31 TUBE1 WRAP73,centrosome cycle|microtubule organizing center organization|microtubule cytoskeleton organization|centriole replication|centriole assembly,1.19e-14|3.142e-14|1.978e-11|3.638e-11|1.027e-10,1.877e-10|2.478e-10|1.04e-07|1.435e-07|3.239e-07,98.54|86.72|19.15|235.6|186.9
326,8,0.5473,15.32,5438.0,0.002802,0.9996790000000001,AKIRIN1 DDI2 INAFM1 NFE2L1 NGLY1 PLAA RAD23B USP15,proteolysis involved in cellular protein catabolic process|cellular protein catabolic process|protein catabolic process|cellular macromolecule catabolic process|macromolecule catabolic process,1.082e-06|1.409e-06|2.108e-06|8.648e-06|1.684e-05,0.01706|0.01111|0.01108|0.0341|0.05313,21.6|20.46|18.85|14.11|12.31
327,5,0.5249,5.249,4031.0,0.001297,0.996692,AKNA INKA2 NGF SPINK7 TLR9,negative regulation of molecular function|neuroblast delamination|regulation of protein kinase activity|negative regulation of catalytic activity|negative regulation of cellular process,5.027e-05|0.0004854|0.0005502|0.0005854|0.0007712,0.793|1|1|1|1,14.07|4119|15.5|15.18|4.195
328,4,0.5306,3.1830000000000003,3169.0,0.001001,0.9929309999999999,AKR1B10 BCAR3 CCDC150 STPG1,farnesol catabolic process|farnesol metabolic process|sesquiterpenoid catabolic process|sesquiterpenoid metabolic process|polyprenol catabolic process,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
329,9,0.5138,18.5,6911.0,0.0026620000000000003,0.9998530000000001,AKR1C1 AKR1C3 AKR1C4 AKR1E2 CALML3 CALML5 FAM208B ITIH2 NET1,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,3.956e-09|3.956e-09|2.483e-08|2.483e-08|2.483e-08,6.241e-05|3.12e-05|0.0001306|9.792e-05|7.834e-05,1404|1404|624.1|624.1|624.1
330,9,0.5247,18.89,6594.0,0.002849,0.9998530000000001,ATP6V0A2 HMGCL KCNK5 MSI2 NOTCH1 PSEN1 SLC25A19 SUCLA2 SUCLG1,regulation of resting membrane potential|organic cation transport|cation transmembrane transport|tricarboxylic acid cycle|astrocyte differentiation,9.31e-06|8.356e-05|0.0001032|0.000106|0.0002399,0.1468|0.659|0.5427|0.4181|0.7567,508.5|152.6|14.37|134.6|88.01
331,20,0.5038,95.73,12260.0,0.007726,1.0,AKT1 FNIP1 LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MAPKAP1 MIOS MLST8 MTOR PDPK1 PIK3CA PIK3CB RICTOR RRAGA RRAGC SEH1L VPS41 WDR24 WDR59,positive regulation of TOR signaling|regulation of TOR signaling|cellular response to starvation|cellular response to amino acid starvation|response to amino acid starvation,1.031e-32|3.619e-28|2.328e-24|3.623e-24|5.451e-24,1.626e-28|2.854e-24|1.224e-20|1.429e-20|1.72e-20,335.3|145.6|75.09|154.5|148.9
332,19,0.4258,72.8,12220.0,0.005905,1.0,BMT2 C12orf66 DEPDC5 ITFG2 KPTN LAMTOR3 MIOS MLST8 NPRL2 PTEN SEH1L SESN2 SZT2 TBC1D5 TBC1D7 TSC1 TSC2 WDR24 WDR59,regulation of TOR signaling|cellular response to amino acid starvation|response to amino acid starvation|response to starvation|cellular response to nutrient levels,2.83e-37|6.965e-30|1.117e-29|3.88e-26|5.955e-26,4.464e-33|5.493e-26|5.873e-26|1.53e-22|1.879e-22,186.1|189.7|182.8|69.78|67.75
333,4,0.5568,3.341,3167.0,0.001051,0.9929309999999999,AKTIP C6 MEIOB SMAGP,female meiosis I|resolution of meiotic recombination intermediates|meiotic chromosome separation|male meiosis I|early endosome to late endosome transport,0.001941|0.003685|0.004266|0.004653|0.004653,1|1|1|1|1,572.1|286|245.2|223.9|223.9
334,61,0.3599,658.6,47600.0,0.013609999999999999,1.0,BCKDHA CCDC61 CEACAM1 CEACAM3 CEACAM4 CEACAM5 CEACAM6 CEACAM7 CLC CXCL17 CYP2A13 CYP2A7 CYP2B6 CYP2F1 CYP2S1 DMRTC2 EML2 FFAR2 FFAR3 IFNL1 IGFL1 ITPKC KCNN4 KIR2DL1 KIR2DL3 LAIR2 LGALS13 LGALS14 LHB LIPE PSG1 PSG11 PSG2 PSG3 PSG4 PSG5 PSG6 PSG8 PSG9 PVR ZFAND5 ZNF112 ZNF155 ZNF222 ZNF225 ZNF226 ZNF230 ZNF233 ZNF235 ZNF284 ZNF285 ZNF296 ZNF302 ZNF45 ZNF546 ZNF569 ZNF571 ZNF577 ZNF585B ZNF599 ZNF780B,epoxygenase P450 pathway|exogenous drug catabolic process|drug catabolic process|female pregnancy|multi-multicellular organism process,1.441e-08|2.647e-08|3.819e-08|1.422e-07|4.278e-07,0.0002274|0.0002087|0.0002008|0.0005607|0.001349,78.01|67.84|62.41|13.95|12
335,12,0.4671,30.83,7512.0,0.004074,0.999986,ALDH18A1 ASNS ATF4 EIF2AK4 GCN1 NADK2 NARS2 SLC38A2 SLC3A2 SLC7A1 SLC7A5 TRPM7,L-amino acid transport|cellular response to starvation|aromatic amino acid transport|cellular response to amino acid starvation|response to amino acid starvation,4.11e-08|5.692e-08|8.413e-08|1.24e-07|1.429e-07,0.0006483|0.000449|0.0004423|0.0004891|0.000451,114.4|44.69|396.1|85.81|82.71
336,10,0.511,22.99,7909.0,0.002891,0.999933,AKAP2 ALDH1A1 C9orf16 OR1N2 PALM2 PTBP3 RABEPK TXNDC8 UCK1 ZBTB6,CTP salvage|pyrimidine ribonucleotide salvage|fructose catabolic process|pyrimidine nucleotide salvage|UMP salvage,0.00194|0.002909|0.002909|0.002909|0.002909,1|1|1|1|1,686.5|411.9|411.9|411.9|411.9
337,4,0.5397,3.238,3249.0,0.0009932,0.9929309999999999,ALDH1A3 CSN1S1 GRM4 PGF,nucleus accumbens development|response to 11-deoxycorticosterone|response to dehydroepiandrosterone|olfactory pit development|Harderian gland development,0.0003883|0.0003883|0.0003883|0.0007766|0.0009706,1|1|1|1|1,5149|5149|5149|1716|1287
338,4,0.5554,3.333,3197.0,0.001039,0.9929309999999999,ALDH1L1 IGSF10 PLSCR2 SLC12A8,10-formyltetrahydrofolate catabolic process|folic acid-containing compound catabolic process|pteridine-containing compound catabolic process|10-formyltetrahydrofolate metabolic process|monovalent inorganic anion homeostasis,0.0005825|0.0007766|0.0007766|0.001165|0.003297,1|1|1|1|1,2574|1716|1716|1030|321.8
339,5,0.5212,5.212000000000001,4369.0,0.001189,0.996692,ALDH1L2 ANO4 CHST11 NOX3 TMC6,detection of gravity|polysaccharide localization|10-formyltetrahydrofolate catabolic process|folic acid-containing compound catabolic process|pteridine-containing compound catabolic process,0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
340,4,0.5349,3.21,3052.0,0.001048,0.9929309999999999,ALDH3B2 BTN2A2 HLA-DQA2 TMEM221,T cell receptor signaling pathway|antigen receptor-mediated signaling pathway|ethanol catabolic process|immune response-activating cell surface receptor signaling pathway|immune response-activating signal transduction,0.0004604|0.001252|0.002522|0.002848|0.002848,1|1|1|1|1,57.21|34.44|429.1|22.68|22.68
341,5,0.5018,5.018,4184.0,0.0011949999999999999,0.996692,ALDH4A1 GNA14 HLA-DOB TMEM42 TRPM6,negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|proline catabolic process to glutamate|4-hydroxyproline metabolic process|4-hydroxyproline catabolic process,0.000728|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,2060|1373|1373|1030|1030
342,5,0.5459,5.459,4232.0,0.001285,0.996692,ALDH5A1 BBS9 FAM78A PTPRA VSTM2A,positive regulation of white fat cell proliferation|gamma-aminobutyric acid catabolic process|regulation of white fat cell proliferation|positive regulation of fat cell proliferation|gamma-aminobutyric acid metabolic process,0.000728|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|2060|1373|1030|823.8
343,12,0.5071,33.47,9653.0,0.0034460000000000003,0.999986,AGO4 C1orf123 CFAP57 ERMAP EXO5 HPCAL4 ZBTB8A ZBTB8B ZFP69 ZFP69B ZNF684 ZNF691,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of gene expression",0.0001029|0.0006703|0.0006716|0.0006777|0.0008028,1|1|1|1|1,5.068|3.783|3.782|3.777|3.074
344,12,0.5269,34.78,7473.0,0.0046170000000000004,0.999986,ALDOA BSG GAPDH GPI PGAM1 PGD PGP PKM RPE RPIA TKT TPI1,monosaccharide metabolic process|carbohydrate metabolic process|carbohydrate catabolic process|monosaccharide biosynthetic process|generation of precursor metabolites and energy,9.761e-19|8.201e-17|1.715e-15|2.09e-15|2.482e-15,1.54e-14|6.468e-13|9.017e-12|8.241e-12|7.83e-12,88.01|36.76|109.3|209.2|39.41
345,4,0.5025,3.015,3072.0,0.000978,0.9929309999999999,ALDOB HPS5 PILRB TMEM270,NADH oxidation|fructose catabolic process|fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate|vacuolar proton-transporting V-type ATPase complex assembly|proton-transporting V-type ATPase complex assembly,0.001165|0.001165|0.001165|0.001359|0.001747,1|1|1|1|1,1030|1030|1030|858.1|643.6
346,11,0.5085,27.97,7215.0,0.00385,0.999969,ALG1 ALG2 BUD13 DOLK DPAGT1 HYOU1 RFT1 SLC35B1 SLC39A7 TMEM258 ZPR1,dolichol-linked oligosaccharide biosynthetic process|oligosaccharide-lipid intermediate biosynthetic process|protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation,2.56e-15|3.258e-15|9.474e-15|2.601e-11|2.601e-11,4.038e-11|2.569e-11|4.982e-11|1.026e-07|8.204e-08,490.4|468.1|160.2|49.64|49.64
347,10,0.5037,22.67,7621.0,0.002957,0.999933,C6orf48 CYP21A2 HLA-DMB HLA-DPB1 MICB MSH5 PSMB8 TAP1 TAP2 TNXB,antigen processing and presentation of peptide antigen|antigen processing and presentation|antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen|antigen processing and presentation of endogenous peptide antigen via MHC class I,1.53e-10|3.571e-10|1.272e-08|1.576e-08|9.343e-08,2.414e-06|2.817e-06|6.687e-05|6.216e-05|0.0002948,64.03|55.41|57.85|55.36|363.4
348,14,0.4757,43.29,9319.0,0.00461,0.9999969999999999,ALG11 CENPJ COG3 DIS3 EXOSC8 GTF3A MRPS31 MZT1 NUP58 POMP RFC3 SKA3 USPL1 ZC3H13,microtubule nucleation by microtubule organizing center|rRNA catabolic process|microtubule nucleation|ncRNA catabolic process|cellular macromolecule metabolic process,8.982e-06|8.933e-05|0.000138|0.0002236|0.0002485,0.1417|0.7045|0.7255|0.8816|0.784,588.4|154.8|122.6|94.91|2.964
349,31,0.4371,203.3,19740.0,0.010159999999999999,1.0,ALG12 ALG3 ALG5 ALG6 ALG8 ALG9 AUP1 DERL2 DNAJB11 DNAJC3 DOLPP1 DPM1 DPM2 DPM3 FAF2 HERPUD1 MANF MPDU1 MPI OST4 PMM2 SEC62 SEC63 SEL1L SLC33A1 SURF4 SYVN1 TMEM41B UBE2G2 UBE2J1 UGP2,protein N-linked glycosylation|glycoprotein metabolic process|protein glycosylation|macromolecule glycosylation|glycosylation,1.174e-25|2.388e-23|8.408e-21|8.408e-21|1.781e-20,1.852e-21|1.884e-19|4.421e-17|3.316e-17|5.618e-17,120.1|31.14|39.89|39.89|37.86
350,4,0.5567,3.34,3161.0,0.001053,0.9929309999999999,ALG1L C1QTNF12 SCNN1D TNFRSF4,negative regulation of gluconeogenesis|positive regulation of insulin receptor signaling pathway|positive regulation of cellular response to insulin stimulus|positive regulation of insulin secretion involved in cellular response to glucose stimulus|mannosylation,0.003685|0.004653|0.005233|0.007166|0.007166,1|1|1|1|1,286|223.9|198|143|143
351,11,0.5009,27.55,8425.0,0.003251,0.999969,ALK ASCL1 GATA3 HAND2 INSM2 ISL1 LIN28B MYT1 PDK1 PHOX2B SOX11,sympathetic nervous system development|noradrenergic neuron differentiation|autonomic nervous system development|neuron differentiation|regulation of nitrogen compound metabolic process,2.716e-12|3.133e-11|1.064e-10|4.079e-08|5.503e-08,4.284e-08|2.471e-07|5.595e-07|0.0001609|0.0001736,377.2|905.3|168.5|12.33|3.621
352,4,0.5297,3.178,3184.0,0.0009948000000000001,0.9929309999999999,ADM2 ALKAL1 FAM181B GATM,creatine biosynthetic process|positive regulation of ERK5 cascade|regulation of ERK5 cascade|creatine metabolic process|muscle atrophy,0.0005825|0.0005825|0.0005825|0.001553|0.002134,1|1|1|1|1,2574|2574|2574|735.5|514.9
353,49,0.3902,458.8,38320.0,0.0118,1.0,ALKBH4 ARPC1A ARPC1B ASL C7orf43 C7orf61 CASTOR3 CLDN15 CNPY4 CYP3A4 CYP3A43 CYP3A5 CYP3A7 DLX6 FBXO24 GJC3 GNAT3 GNG11 GRM3 IFT22 LRCH4 MBLAC1 MOGAT3 MUC12 NAPEPLD NYAP1 PCOLCE PILRA PILRB PON1 PON2 PON3 PVRIG RNF148 SEMA3E SLC12A9 SLC26A3 SLC26A4 SLC26A5 TECPR1 THAP5 TRIM50 WNT2 ZKSCAN1 ZNF394 ZNF789 ZNF804B ZSCAN21 ZSCAN25,oxidative demethylation|demethylation|lipid hydroxylation|oxalate transport|lipoxygenase pathway,2.509e-09|7.07e-07|1.49e-06|3.534e-06|1.186e-05,3.958e-05|0.005576|0.007837|0.01394|0.0374,110.6|31.84|180.1|126.1|78.81
354,4,0.536,3.216,3024.0,0.001059,0.9929309999999999,ALKBH7 IPCEF1 SDSL UBXN7,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death|isoleucine biosynthetic process|threonine catabolic process|branched-chain amino acid biosynthetic process|L-threonine catabolic process to glycine,0.0007766|0.0007766|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1716|1030|1030|1030
355,11,0.8778,48.28,7035.0,0.006795000000000001,0.999969,ALKBH8 CTU1 CTU2 DPH3 ELP5 ELP6 MOCS3 NR2C2AP PUS3 RNF25 URM1,tRNA wobble uridine modification|tRNA wobble base modification|tRNA modification|tRNA processing|RNA modification,3.194e-22|8.773e-22|5.127e-20|1.38e-18|1.246e-17,5.039e-18|6.919e-18|2.696e-16|5.443e-15|3.932e-14,832.1|713.2|187.2|127.7|99.12
356,5,0.5221,5.221,4208.0,0.001236,0.996692,ALLC GFRA2 HTR6 ODF3L1 TNFSF13B,allantoin catabolic process|positive regulation of germinal center formation|allantoin metabolic process|cellular amide catabolic process|B cell costimulation,0.0004854|0.000728|0.0009706|0.001213|0.001213,1|1|1|1|1,4119|2060|1373|1030|1030
357,4,0.5148,3.089,3016.0,0.0010199999999999999,0.9929309999999999,ALOX12 APBB1IP OR6C68 SLC45A3,lipoxin B4 biosynthetic process|lipoxin B4 metabolic process|leukotriene A4 metabolic process|positive regulation of endothelial tube morphogenesis|lipoxin A4 biosynthetic process,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
358,4,0.5343,3.2060000000000004,3310.0,0.0009652999999999999,0.9929309999999999,ALOX5AP ELMOD2 L1TD1 TPP2,"leukotriene production involved in inflammatory response|arachidonic acid metabolite production involved in inflammatory response|transposition, RNA-mediated|lipoxin biosynthetic process|transposition",0.0005825|0.0005825|0.0009706|0.001553|0.001553,1|1|1|1|1,2574|2574|1287|735.5|735.5
359,19,0.5024,85.9,15820.0,0.005386,1.0,ADA BPIFA1 BPIFA3 CNBD2 CPNE1 DEFB115 DEFB116 DUSP15 GGT7 GHRH HCK KIAA1755 LBP MAP1LC3A MYH7B MYLK2 WFDC11 WFDC6 ZNF341,response to bacterium|defense response to bacterium|response to external stimulus|innate immune response|response to other organism,1.467e-06|9.798e-06|1.252e-05|5.702e-05|0.0001201,0.02314|0.07727|0.06581|0.2249|0.3787,11.15|16.58|4.562|8.173|5.648
360,6,0.5267,7.901,4910.0,0.001603,0.998474,ALPI CHRND CHRNG NEU2 PDE6D TRAK2,"excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|regulation of postsynaptic membrane potential|anterograde dendritic transport of mitochondrion|cellular oligosaccharide catabolic process",0.0002101|0.0002364|0.0005015|0.0006794|0.001019,1|1|1|1|1,91.94|86.53|58.84|2942|1471
361,25,0.4419,132.6,19960.0,0.006581,1.0,COX6B2 FCAR GPR32 KIR2DL1 KIR2DL3 KIR2DL4 KIR3DL1 KIR3DL2 KLK11 LAIR1 LAIR2 LILRA1 LILRA4 LILRB2 LILRB4 LILRB5 NLRP11 NLRP4 NLRP9 RFPL4A SHISA7 ZNF28 ZNF524 ZNF581 ZSCAN5B,regulation of immune response|regulation of immune system process|immune response-inhibiting cell surface receptor signaling pathway|defense response|immune response-inhibiting signal transduction,2.281e-10|3.206e-08|2.916e-07|4.911e-07|5.046e-07,3.599e-06|0.0002528|0.001533|0.001937|0.001592,9.121|6.054|297|6.153|237.6
362,7,0.5074,10.66,5716.0,0.0018559999999999998,0.9992989999999999,ALPK2 CDH7 CGNL1 FAM69C SERPINB3 SERPINB7 SERPINB8,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|regulation of endopeptidase activity|regulation of peptidase activity,5.82e-05|6.546e-05|0.0001577|0.0002908|0.0003506,0.9181|0.5163|0.829|1|1,36.03|34.61|25.66|20.82|19.53
363,4,0.5888,3.533,3216.0,0.0010949999999999998,0.9929309999999999,ALPK3 KLHL18 LARP6 TOM1L2,positive regulation of mRNA binding|positive regulation of RNA binding|regulation of mRNA binding|regulation of RNA binding|regulation of mitotic cell cycle,0.001553|0.001747|0.001941|0.002328|0.004729,1|1|1|1|1,735.5|643.6|572.1|468.1|17.51
364,5,0.5394,5.394,4364.0,0.001232,0.996692,ALPL GUCA2B HTR6 TEKT2 ZNF683,cellular response to organic cyclic compound|cementum mineralization|regulation of extrathymic T cell differentiation|response to organic cyclic compound|regulation of natural killer cell differentiation involved in immune response,0.0001395|0.000728|0.000728|0.0007503|0.0009706,1|1|1|1|1,24.71|2060|2060|13.95|1373
365,5,0.5301,5.301,4171.0,0.001266,0.996692,ALS2 CCDC14 COL20A1 KRTAP20-3 RPH3AL,regulation of endosome size|positive regulation of Rac protein signal transduction|regulation of vesicle size|regulation of Rac protein signal transduction|protein localization to centrosome,0.001456|0.00194|0.00291|0.005087|0.005812,1|1|1|1|1,823.8|588.4|374.5|205.9|179.1
366,4,0.5432,3.259,3263.0,0.0009954,0.9929309999999999,ALS2CL LIPF PRKCD TMIE,positive regulation of glucosylceramide catabolic process|regulation of glucosylceramide catabolic process|positive regulation of phospholipid scramblase activity|regulation of phospholipid scramblase activity|positive regulation of lipid transporter activity,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
367,4,0.5472,3.283,3205.0,0.001021,0.9929309999999999,ALX3 CROCC RAX TDRP,limb development|appendage development|skeletal system morphogenesis|ciliary basal body organization|positive regulation of protein localization to cilium,0.0007217|0.0007217|0.001172|0.001213|0.001456,1|1|1|1|1,47.07|47.07|36.78|1030|823.8
368,7,0.5045,10.59,4138.0,0.002545,0.9992989999999999,AMBRA1 CCND3 CDK4 CDK6 CDKN1B CDKN2C DYRK1A,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|mitotic cell cycle phase transition|cell cycle phase transition|regulation of cyclin-dependent protein serine/threonine kinase activity,5.001e-10|9.161e-10|1.096e-08|1.256e-08|2.038e-08,7.889e-06|7.225e-06|5.762e-05|4.953e-05|6.431e-05,96.78|85.53|51.62|50.21|118.9
369,6,0.5162,7.742999999999999,4653.0,0.001657,0.998474,ACSL1 AMDHD1 CSH2 CSHL1 GH2 METTL2B,growth hormone receptor signaling pathway|cellular response to growth hormone stimulus|response to growth hormone|positive regulation of receptor signaling pathway via JAK-STAT|positive regulation of receptor signaling pathway via STAT,2.426e-08|2.772e-08|1.154e-07|1.351e-07|1.81e-07,0.0003826|0.0002186|0.0006066|0.0005327|0.000571,514.9|490.4|294.2|278.3|251.2
370,4,0.5426,3.2560000000000002,3168.0,0.001024,0.9929309999999999,AMDHD2 ATP6V0D2 BAX MPEG1,release of matrix enzymes from mitochondria|T cell homeostatic proliferation|B cell receptor apoptotic signaling pathway|B cell homeostatic proliferation|B cell negative selection,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
371,4,0.5686,3.411,3245.0,0.001048,0.9929309999999999,AMER3 CLEC4E COL27A1 ZP1,growth plate cartilage chondrocyte development|chondrocyte development involved in endochondral bone morphogenesis|growth plate cartilage chondrocyte differentiation|chondrocyte differentiation involved in endochondral bone morphogenesis|growth plate cartilage development,0.001165|0.001747|0.001941|0.003104|0.003491,1|1|1|1|1,1030|643.6|572.1|343.2|302.9
372,4,0.5481,3.2880000000000003,3193.0,0.001026,0.9929309999999999,AMH DNAJC6 LRRN3 MAN2A1,negative regulation of ovarian follicle development|preantral ovarian follicle growth|multi-layer follicle stage|Mullerian duct regression|synaptic vesicle uncoating,0.0005825|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1716|1287|1287
373,4,0.5368,3.221,3298.0,0.0009732000000000001,0.9929309999999999,AMHR2 FBRSL1 GPR27 PLXNB1,anti-Mullerian hormone signaling pathway|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|Mullerian duct regression|positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,0.0003883|0.0005825|0.0009706|0.0009706|0.001165,1|1|1|1|1,5149|2574|1287|1287|1030
374,5,0.5112,5.112,4211.0,0.00121,0.996692,AMIGO3 CABP7 HOOK3 MFSD8 VDAC3,lysosome organization|lytic vacuole organization|vacuole organization|adenine transport|interkinetic nuclear migration,0.0001163|0.0001163|0.0004525|0.001213|0.001456,1|0.9176|1|1|1,119.4|119.4|59.7|1030|823.8
375,5,0.5083,5.083,4543.0,0.001115,0.996692,ACBD4 AMMECR1L CSNK1G2 HIGD1B VWA3B,mitochondrial respirasome assembly|UNCLASSIFIED|biological_process|sphingolipid biosynthetic process|membrane lipid biosynthetic process,0.002667|0.01923|0.01923|0.02404|0.03329,1|1|1|1|1,411.9|4.502|0.4615|41.61|29.85
376,4,0.5193,3.116,3171.0,0.0009793,0.9929309999999999,AMN RAB28 SORD TRMO,hexitol catabolic process|sorbitol catabolic process|L-xylitol metabolic process|L-xylitol catabolic process|pentitol catabolic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
377,13,0.4759,37.12,10510.0,0.003511,0.999993,ALG10 AMN1 BICD1 ERGIC2 ETFBKMT IL17RE KIAA1551 KLHL42 MANSC4 SYT10 TM7SF3 TMTC1 TSPAN11,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity|regulation of proteinase activated receptor activity,0.001261|0.001261|0.001261|0.001261|0.001261,1|1|1|1|1,1584|1584|1584|1584|1584
378,11,0.6944,38.19,7698.0,0.004922999999999999,0.999969,C16orf72 CAND1 COPS2 COPS3 COPS4 COPS6 COPS7A COPS7B COPS8 DDA1 GPS1,"protein deneddylation|nucleotide-excision repair, DNA damage recognition|transcription-coupled nucleotide-excision repair|post-translational protein modification|nucleotide-excision repair",8.957e-24|1.612e-21|6.53e-18|3.436e-17|9.615e-17,1.413e-19|1.271e-17|3.433e-14|1.355e-13|3.033e-13,1498|651.2|205.2|51.86|144
379,4,0.5725,3.435,3348.0,0.0010220000000000001,0.9929309999999999,AMPD2 FAM200B GJD2 SPINK6,IMP salvage|negative regulation of serine-type peptidase activity|purine nucleotide salvage|negative regulation of serine-type endopeptidase activity|regulation of serine-type peptidase activity,0.0009706|0.001553|0.001553|0.001553|0.001941,1|1|1|1|1,1287|735.5|735.5|735.5|572.1
380,4,0.5107,3.0639999999999996,3061.0,0.0009975,0.9929309999999999,AMPD3 ARVCF INSYN1 PPIF,"regulation of proton-transporting ATPase activity, rotational mechanism|negative regulation of oxidative phosphorylation uncoupler activity|AMP catabolic process|regulation of mitochondrial membrane permeability involved in programmed necrotic cell death|regulation of oxidative phosphorylation uncoupler activity",0.0003883|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|2574|2574|1716|1287
381,36,0.4328,272.7,29560.0,0.009118000000000001,1.0,ADAM18 ADAM2 ADAM32 ADRB3 ANK1 AP3M2 BIN3 C8orf58 CHRNA6 CHRNB3 DEFA4 DEFA5 DKK4 DMTN ERLIN2 HGSNAT LETM2 NAT1 NAT2 NKX6-3 PEBP4 PLPP5 RNF170 RNF5 SARAF SCARA3 SGCZ SLC20A2 SORBS3 STC1 STMN4 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D VDAC3,TRAIL-activated apoptotic signaling pathway|glutamine transport|sodium ion transport|transmembrane transport|extrinsic apoptotic signaling pathway via death domain receptors,6.064e-07|1.188e-06|2.702e-05|3.313e-05|4.558e-05,0.009566|0.009369|0.1421|0.1306|0.1438,251.2|188.4|14.43|4.277|47.09
382,4,0.5595,3.3569999999999998,3403.0,0.0009832,0.9929309999999999,ALDH1A2 AMTN DLL4 IGSF9B,regulation of endothelial cell proliferation|cardiac muscle tissue development|animal organ morphogenesis|retinoic acid receptor signaling pathway involved in somitogenesis|blood vessel lumenization,0.0002574|0.000313|0.0003753|0.0003883|0.0005825,1|1|1|1|1,76.85|69.58|16.35|5149|2574
383,24,0.5005,138.1,19340.0,0.007075,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 AMZ1 GCK GHRHR HOXA1 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MINDY4 MTURN NME8 NPY PHKG1 SUMF2 VWC2 WIPF3 ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|lung goblet cell differentiation|lobar bronchus epithelium development,1.134e-07|3.941e-07|7.167e-06|1.408e-05|2.111e-05,0.001789|0.003108|0.03769|0.05553|0.06658,43.82|33.76|18.39|549.2|411.9
384,4,0.5061,3.037,3203.0,0.0009448000000000001,0.9929309999999999,AMZ2 ESR2 MADD SIK3,positive regulation of TORC2 signaling|regulation of TORC2 signaling|regulation of Rab protein signal transduction|positive regulation of TORC1 signaling|intracellular estrogen receptor signaling pathway,0.0005825|0.0005825|0.001553|0.003491|0.003878,1|1|1|1|1,2574|2574|735.5|302.9|271
385,10,0.5174,23.28,7165.0,0.00323,0.999933,ANAPC1 DARS DDX18 IMP4 MCM6 NIFK ORC4 RANBP2 WDR33 ZC3H8,nucleic acid metabolic process|nucleobase-containing compound metabolic process|heterocycle metabolic process|cellular aromatic compound metabolic process|gene expression,2.349e-06|1.059e-05|1.743e-05|1.953e-05|3.43e-05,0.03705|0.08351|0.09166|0.07702|0.1082,6.711|5.509|5.158|5.081|5.995
386,21,0.4963,104.2,14620.0,0.007056000000000001,1.0,ABCE1 COPB2 CSE1L EIF2S1 NBEAL1 NEDD8 NUTF2 PSMA1 PSMA2 PSMA3 PSMA4 PSMA5 PSMA6 RPL17 RPL18 RPL18A SMU1 SNRPD1 SNU13 SRP54 VCP,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,2.599e-13|9.601e-11|9.601e-11|9.601e-11|9.601e-11,4.1e-09|7.572e-07|5.048e-07|3.786e-07|3.029e-07,255.3|86.41|86.41|86.41|86.41
387,15,0.5018,52.69,10560.0,0.00495,0.999999,ANAPC11 CHMP6 EIF4A3 FTSJ3 GPS1 HGS NPLOC4 NUP85 PSMC5 PSMD12 RPL38 SAP30BP SRP68 TBCD USP36,cellular catabolic process|cellular macromolecule catabolic process|protein modification by small protein removal|catabolic process|protein modification by small protein conjugation or removal,9.176e-07|1.61e-06|1.684e-06|3.197e-06|3.63e-06,0.01447|0.0127|0.008855|0.01261|0.01145,6.876|10.54|23.27|5.929|9.322
388,13,0.5097,39.76,8599.0,0.004589,0.999993,ANAPC13 ANAPC15 ANAPC5 CCNF CDC16 CDC27 PRPF39 SGO2 SKA3 SPAG5 TRNAU1AP UBE2C UBE2S,cell division|protein K11-linked ubiquitination|regulation of exit from mitosis|anaphase|mitotic anaphase,1.228e-16|2.598e-14|2.229e-13|2.93e-12|2.93e-12,1.936e-12|2.049e-10|1.172e-09|1.155e-08|9.243e-09,35.42|327.8|221.1|70.63|70.63
389,4,0.5408,3.245,3139.0,0.00103,0.9929309999999999,ANAPC16 FKBP14 LPCAT2 PRG2,platelet activating factor biosynthetic process|platelet activating factor metabolic process|basement membrane assembly|ether lipid biosynthetic process|cellular lipid biosynthetic process,0.001213|0.002183|0.002667|0.00291|0.00291,1|1|1|1|1,1030|514.9|411.9|374.5|374.5
390,14,0.502,45.68,9990.0,0.004539,0.9999969999999999,ANAPC2 CDC26 EXOSC2 GLE1 IARS NDOR1 NOL8 NUP214 PRPF4 RPL35 SEC16A SPOUT1 SURF6 TXN,gene expression|cellular macromolecule localization|ribosome biogenesis|metabolic process|protein localization to organelle,2.709e-05|4.353e-05|6.105e-05|6.848e-05|0.000127,0.4273|0.3433|0.321|0.2701|0.4007,5.384|6.26|17.72|2.295|9.299
391,8,0.5062,14.17,5624.0,0.002506,0.9996790000000001,ANAPC4 DHX15 GRPEL1 HAUS3 LETM1 NOP14 STX18 TACC3,regulation of mitotic sister chromatid separation|regulation of sister chromatid segregation|regulation of chromosome separation|regulation of chromosome segregation|cell division,0.000288|0.0003514|0.0003514|0.000531|0.0007055,1|1|1|1|1,79.21|71.51|71.51|57.85|15.7
392,7,0.5814,12.21,5331.0,0.0022789999999999998,0.9992989999999999,ANAPC7 C17orf58 DND1 LRRC37A LRRC37A2 LRRC37A3 LRRC37B,UNCLASSIFIED|biological_process|metaphase/anaphase transition of mitotic cell cycle|metaphase/anaphase transition of cell cycle|positive regulation of mitotic sister chromatid separation,0.0007013|0.0007013|0.002715|0.002715|0.005086,1|1|1|1|1,5.359|0.3297|420.3|420.3|210.2
393,5,0.5001,5.001,4163.0,0.0011970000000000001,0.996692,ANGEL1 BBOF1 DNAAF3 FPR1 STOM,motile cilium assembly|regulation of acid-sensing ion channel activity|positive regulation by host of viral genome replication|cilium assembly|complement receptor mediated signaling pathway,1.65e-05|0.0004854|0.002183|0.003271|0.003394,0.2603|1|1|1|1,329.5|4119|514.9|21.79|316.8
394,4,0.5903,3.542,3142.0,0.001123,0.9929309999999999,ANGEL2 EFHB FBXL14 ZNF8,"regulation of store-operated calcium entry|3'-UTR-mediated mRNA stabilization|regulation of calcineurin-NFAT signaling cascade|regulation of calcineurin-mediated signaling|RNA phosphodiester bond hydrolysis, exonucleolytic",0.002716|0.004072|0.00678|0.006973|0.008517,1|1|1|1|1,396.1|257.4|151.4|147.1|119.7
395,4,0.5721,3.4330000000000003,3276.0,0.001044,0.9929309999999999,ANGPT1 ERI2 IGFBP3 KCNIP2,regulation of macrophage migration inhibitory factor signaling pathway|clustering of voltage-gated potassium channels|positive regulation of potassium ion export across plasma membrane|Tie signaling pathway|positive regulation of blood-brain barrier permeability,0.0007766|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,1716|1716|1716|1287|1030
396,4,0.5921,3.553,3313.0,0.001068,0.9929309999999999,ANGPT2 NKIRAS2 OPCML THEGL,negative regulation of positive chemotaxis|Tie signaling pathway|glomerulus vasculature development|kidney vasculature development|renal system vasculature development,0.0003883|0.0009706|0.003685|0.003878|0.003878,1|1|1|1|1,5149|1287|286|271|271
397,4,0.5292,3.175,3181.0,0.0009949,0.9929309999999999,ANGPT4 DDX49 IRX2 ST14,tube morphogenesis|embryonic epithelial tube formation|epithelial tube formation|tube development|anatomical structure formation involved in morphogenesis,0.0001211|0.0002174|0.0002462|0.0002658|0.0002939,1|1|1|1|0.9271,23.95|83.72|78.61|18.37|17.75
398,5,0.5315,5.315,4108.0,0.001289,0.996692,ANGPTL2 CCDC178 PCYOX1 TPGS1 VNN1,prenylcysteine metabolic process|prenylcysteine catabolic process|prenylated protein catabolic process|pantothenate metabolic process|positive regulation of T cell differentiation in thymus,0.000728|0.000728|0.0009706|0.00194|0.002667,1|1|1|1|1,2060|2060|1373|588.4|411.9
399,4,0.5677,3.406,3140.0,0.0010810000000000001,0.9929309999999999,ANGPTL3 ECHDC3 EREG SPATA46,primary follicle stage|luteinizing hormone signaling pathway|ovarian cumulus expansion|fused antrum stage|antral ovarian follicle growth,0.0003883|0.0005825|0.0007766|0.0007766|0.001359,1|1|1|1|1,5149|2574|1716|1716|858.1
400,4,0.5125,3.075,3147.0,0.0009737999999999999,0.9929309999999999,ANGPTL5 DPP3 PLA2G2D PRLHR,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|regulatory T cell differentiation|regulation of acute inflammatory response to antigenic stimulus|phosphatidylinositol acyl-chain remodeling|phosphatidylglycerol acyl-chain remodeling",0.0009706|0.001359|0.00291|0.003685|0.003685,1|1|1|1|1,1287|858.1|367.8|286|286
401,29,0.3878,157.5,21050.0,0.007405,1.0,C19orf66 CALR CNN1 DAND5 OR7C2 P2RY11 STX10 SYCE2 TMEM205 ZNF20 ZNF433 ZNF439 ZNF441 ZNF442 ZNF443 ZNF490 ZNF563 ZNF564 ZNF625 ZNF627 ZNF682 ZNF69 ZNF700 ZNF709 ZNF763 ZNF791 ZNF799 ZNF844 ZNF878,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of cellular macromolecule biosynthetic process|regulation of RNA biosynthetic process",2.773e-16|2.15e-13|2.164e-13|2.171e-13|2.236e-13,4.374e-12|1.696e-09|1.138e-09|8.561e-10|7.053e-10,6.166|4.603|4.602|4.245|4.595
402,4,0.5894,3.536,3203.0,0.0011,0.9929309999999999,ANK2 BTC CBR4 PI4K2A,protein localization to T-tubule|protein localization to M-band|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|membrane depolarization during SA node cell action potential,0.0005825|0.0005825|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|2574|1716|1287|1030
403,5,0.5269,5.269,4194.0,0.0012519999999999999,0.996692,ANKAR CD37 CYP26B1 TMEM38A VSX2,positive regulation of tongue muscle cell differentiation|regulation of tongue muscle cell differentiation|positive regulation of skeletal muscle fiber differentiation|regulation of skeletal muscle fiber differentiation|diterpenoid catabolic process,0.000728|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|2060|1373|1030|823.8
404,6,0.5,7.5,4299.0,0.001737,0.998474,ANKDD1A CARS FBXW8 GGPS1 RABGGTB YARS,tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|geranylgeranyl diphosphate biosynthetic process|geranylgeranyl diphosphate metabolic process,7.927e-05|8.956e-05|9.313e-05|0.0005824|0.0005824,1|0.7064|0.4897|1|1,149.2|140.1|137.3|3432|3432
405,4,0.5493,3.2960000000000003,3093.0,0.0010609999999999999,0.9929309999999999,ACADSB ANKDD1B C8G TP53INP2,"isoleucine catabolic process|isoleucine metabolic process|complement activation, alternative pathway|branched-chain amino acid catabolic process|branched-chain amino acid metabolic process",0.0009706|0.001553|0.003104|0.004266|0.004846,1|1|1|1|1,1287|735.5|343.2|245.2|214.5
406,11,0.6734,37.04,7727.0,0.004757,0.999969,ATP6V1E1 CDC45 CRK DGCR8 ESS2 GNB1L MRPL40 PI4KA PPIL2 TFIP11 UFD1,cellular response to endothelin|negative regulation of DNA ligation|negative regulation of DNA ligase activity|viral replication complex formation and maintenance|mitotic DNA replication preinitiation complex assembly,0.001067|0.001067|0.001067|0.001067|0.001067,1|1|1|1|1,1872|1872|1872|1872|1872
407,4,0.5297,3.178,3167.0,0.001,0.9929309999999999,ANKFN1 GIMAP5 IK MCF2L,"equilibrioception|locomotor rhythm|protein localization to kinetochore|protein localization to chromosome, centromeric region|circadian behavior",0.001747|0.002716|0.003104|0.004266|0.004846,1|1|1|1|1,643.6|396.1|343.2|245.2|214.5
408,18,0.5052,77.3,11100.0,0.006895,1.0,ANKFY1 LAMTOR1 LAMTOR2 LAMTOR3 RAB5C RAB7A RABGEF1 RBSN TGFBRAP1 VPS16 VPS18 VPS29 VPS33A VPS35 VPS39 VPS41 VPS45 VPS8,vesicle-mediated transport|lysosomal transport|vacuolar transport|protein localization|establishment of localization in cell,4.356e-19|1.176e-18|2.641e-17|3.82e-16|1.783e-15,6.872e-15|9.278e-15|1.389e-13|1.506e-12|5.624e-12,10.52|105|75.77|9.013|8.224
409,17,0.4846,65.9,11180.0,0.005843999999999999,1.0,ANKFY1 C12orf4 PPP1R21 RAB5C RAB7A RABGEF1 RBSN TBCK TGFBRAP1 VPS16 VPS18 VPS29 VPS33A VPS39 VPS41 VPS45 VPS8,lysosomal transport|vacuolar transport|endosome to lysosome transport|protein transport|peptide transport,1.132e-16|1.88e-15|2.344e-14|4.919e-14|6.439e-14,1.786e-12|1.482e-11|1.232e-10|1.94e-10|2.031e-10,100|72.21|160|11.59|11.37
410,14,0.507,46.14,9957.0,0.0046,0.9999969999999999,ALG2 CDC26 EXOSC2 GLE1 IARS NOL8 NUP214 PRPF4 RPL35 RPL7A SEC16A SPOUT1 SURF6 TXN,ribosome biogenesis|gene expression|cellular macromolecule localization|protein localization to organelle|ribonucleoprotein complex biogenesis,2.013e-06|2.109e-06|3.259e-06|7.553e-06|1.02e-05,0.03175|0.01663|0.01714|0.02978|0.03218,22.15|6.057|7.154|11.16|15.82
411,6,0.5129,7.693,4318.0,0.0017739999999999998,0.998474,ANKLE2 NUP50 POLE SFSWAP SNRNP35 USP14,DNA replication proofreading|negative regulation of ER-associated ubiquitin-dependent protein catabolic process|leading strand elongation|mRNA 5'-splice site recognition|negative regulation of ERAD pathway,0.0008735|0.001165|0.001456|0.002037|0.002037,1|1|1|1|1,1716|1144|858.1|572.1|572.1
412,4,0.5913,3.548,3310.0,0.001068,0.9929309999999999,ABCB8 ANKMY1 EMX2 KLK8,cerebral cortex regionalization|ureter morphogenesis|negative regulation of myelination|keratinocyte proliferation|telencephalon regionalization,0.001359|0.001553|0.001747|0.002328|0.002522,1|1|1|1|1,858.1|735.5|643.6|468.1|429.1
413,15,0.4683,49.17,10820.0,0.0045119999999999995,0.999999,DCTN4 DDX41 DDX46 GEMIN5 IK LARS NHP2 RACK1 RBM22 RPS14 SLU7 SPDL1 THOC3 TTC1 ZMAT2,RNA processing|RNA splicing|mRNA metabolic process|mRNA processing|RNA metabolic process,8.419e-11|1.437e-10|2.475e-10|5.537e-10|6.509e-10,1.328e-06|1.134e-06|1.301e-06|2.184e-06|2.053e-06,14.88|26.99|17.81|22.69|9.445
414,9,0.515,18.54,5888.0,0.003129,0.9998530000000001,EIF3D EIF3E EIF3F EIF3G EIF3H EIF3M EIF4G2 PRRC2A PRRC2C,formation of cytoplasmic translation initiation complex|cytoplasmic translational initiation|translational initiation|cytoplasmic translation|translation,5.891e-17|1.535e-15|3.348e-14|2.543e-13|2.928e-11,9.292e-13|1.211e-11|1.76e-10|1.003e-09|9.237e-08,858.1|457.7|112|183.1|41.71
415,4,0.5687,3.412,3230.0,0.001053,0.9929309999999999,ANKRD12 IL20 MSR1 PNMA2,positive regulation of cholesterol storage|lipoprotein transport|lipoprotein localization|regulation of cholesterol storage|positive regulation of keratinocyte differentiation,0.00194|0.003394|0.003636|0.00412|0.004604,1|1|1|1|1,588.4|316.8|294.2|257.4|228.8
416,5,0.5552,5.5520000000000005,3850.0,0.001436,0.996692,ANKRD13B CHRDL2 EGFLAM RHOG SIAE,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|negative regulation of receptor internalization|engulfment of apoptotic cell|Rac protein signal transduction|negative regulation of receptor-mediated endocytosis,0.001698|0.003394|0.00412|0.005329|0.00702,1|1|1|1|1,686.5|316.8|257.4|196.1|147.1
417,4,0.5676,3.406,3199.0,0.0010609999999999999,0.9929309999999999,ANKRD13C OR2T33 ST3GAL3 TUBB1,ganglioside biosynthetic process via lactosylceramide|protein retention in ER lumen|maintenance of protein localization in endoplasmic reticulum|ganglioside biosynthetic process|sialylation,0.001165|0.001941|0.00291|0.003297|0.004072,1|1|1|1|1,1030|572.1|367.8|321.8|257.4
418,4,0.5402,3.241,3227.0,0.001001,0.9929309999999999,ANKRD13D SLC8A3 THAP8 VSTM2B,calcium ion export across plasma membrane|calcium ion export|regulation of postsynaptic cytosolic calcium ion concentration|negative regulation of receptor internalization|regulation of skeletal muscle contraction,0.001165|0.001941|0.002328|0.002716|0.003104,1|1|1|1|1,1030|572.1|468.1|396.1|343.2
419,8,0.5269,14.75,6188.0,0.002372,0.9996790000000001,AKR1C1 AKR1C3 AKR1E2 ANKRD16 CALML3 CALML5 FAM208B NET1,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,3.177e-06|3.177e-06|1.163e-05|1.163e-05|1.163e-05,0.05011|0.02505|0.06116|0.04587|0.0367,1030|1030|457.7|457.7|457.7
420,7,0.5154,10.82,4477.0,0.002405,0.9992989999999999,ANKRD17 CAPRIN1 CNOT4 G3BP1 SERBP1 SRRD USP10,"DNA damage response, signal transduction by p53 class mediator|signal transduction in response to DNA damage|ubiquitin-dependent protein catabolic process|signal transduction by p53 class mediator|modification-dependent protein catabolic process",0.0004209|0.0006928|0.0008894|0.0009206|0.0009235,1|1|1|1|1,65.17|50.48|14.49|43.63|14.3
421,4,0.5107,3.0639999999999996,2989.0,0.001021,0.9929309999999999,AGAP1 ANKRD18A PAX8 SOX17,animal organ formation|metanephros development|regulation of thyroid-stimulating hormone secretion|cardiogenic plate morphogenesis|gall bladder development,2.091e-05|8.892e-05|0.0003883|0.0003883|0.0005825,0.3298|0.7013|1|1|0.3995,278.3|132|5149|5149|2574
422,4,0.5013,3.008,3197.0,0.0009375,0.9929309999999999,ACSL6 ANKRD2 FDXACB1 HSPG2,rRNA base methylation|regulation of transcription from RNA polymerase II promoter in response to oxidative stress|negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|long-chain fatty-acyl-CoA biosynthetic process,0.002328|0.002328|0.002522|0.003104|0.003878,1|1|1|1|1,468.1|468.1|429.1|343.2|271
423,22,0.5058,116.8,17720.0,0.006534999999999999,1.0,ANKRD22 CALHM3 CYP2C9 DUPD1 DUSP13 GPRIN2 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPF LIPJ LIPK LIPM NUTM2A NUTM2B OPN4 PTPN20 SFTPA1 SFTPA2 ZNF239,cellular response to type I interferon|response to type I interferon|lipid catabolic process|type I interferon signaling pathway|defense response to symbiont,1.008e-06|1.386e-06|1.564e-05|5.75e-05|7.391e-05,0.0159|0.01093|0.08223|0.2268|0.2332,54.27|49.93|15.4|41.3|17.66
424,11,0.5128,28.2,8759.0,0.0032020000000000004,0.999969,ANKRD23 CFC1 FAHD2A IL1F10 IL1RN IL36G LYG1 POTEI RNF149 SCTR TUBA3D,inflammatory response to antigenic stimulus|cell wall macromolecule catabolic process|inflammatory response|cell wall organization or biogenesis|cell wall macromolecule metabolic process,9.45e-07|0.001601|0.002015|0.002134|0.002134,0.01491|1|1|1|1,160.5|936.1|11.32|624.1|624.1
425,4,0.5249,3.1489999999999996,3378.0,0.0009292,0.9929309999999999,ANKRD24 CCDC88A MEP1A TYMP,maintenance of protein location in plasma membrane|maintenance of protein location in membrane|dTMP catabolic process|dTMP metabolic process|regulation of gastric motility,0.0005825|0.0005825|0.0007766|0.001165|0.001165,1|1|1|1|1,2574|2574|1716|1030|1030
426,16,0.4889,58.67,11970.0,0.004866,0.999999,ANKRD26 BID C2CD3 CASP2 CCSAP CEP120 CEP76 CEP83 CNTROB CRADD FOPNL KIAA0753 PCM1 PIBF1 PIDD1 SCLT1,protein localization to centrosome|protein localization to microtubule organizing center|protein localization to microtubule cytoskeleton|protein localization to cytoskeleton|cell cycle,1.372e-11|1.657e-11|1.334e-10|2.123e-10|4.381e-10,2.163e-07|1.306e-07|7.016e-07|8.37e-07|1.382e-06,279.8|268.2|169.4|153.2|10.19
427,86,0.355,1297.0,67660.0,0.01877,1.0,ACP7 APLP1 ARHGAP33 C19orf12 CATSPERG CEACAM21 CEACAM4 CLC CYP2A13 CYP2A6 CYP2B6 CYP2S1 EID2 EID2B ETV2 FAM187B FAM98C FBXO27 FFAR2 FFAR3 FXYD3 GAPDHS GMFG HKR1 IFNL1 IFNL2 IFNL3 IGFLR1 LGALS13 LGALS14 LGALS16 LGALS7B LGI4 MAG MSRB1 NCCRP1 PLEKHF1 PLEKHG2 PVR RAB4B RASGRP4 RYR1 SBSN SCGB2B2 SERTAD3 SLC7A9 UPK1A WDR87 WDR88 ZFP14 ZFP30 ZFP82 ZNF155 ZNF181 ZNF222 ZNF230 ZNF285 ZNF30 ZNF302 ZNF345 ZNF382 ZNF383 ZNF45 ZNF461 ZNF527 ZNF529 ZNF536 ZNF540 ZNF546 ZNF566 ZNF567 ZNF568 ZNF569 ZNF570 ZNF571 ZNF573 ZNF585A ZNF585B ZNF599 ZNF607 ZNF780B ZNF790 ZNF792 ZNF793 ZNF829 ZNF850,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of nucleobase-containing compound metabolic process",1.375e-13|2.941e-12|2.971e-12|3.12e-12|2.093e-11,2.17e-09|2.32e-08|1.562e-08|1.231e-08|6.603e-08,3.57|2.939|2.938|2.933|2.658
428,10,0.5316,23.92,6387.0,0.00372,0.999933,BRAF DUSP4 DUSP6 ELAVL1 MAP2K1 MAP2K2 MAPK1 PEA15 SOX10 SOX9,MAPK cascade|ERK1 and ERK2 cascade|regulation of MAP kinase activity|regulation of Golgi inheritance|activation of protein kinase activity,1.481e-10|1.288e-09|2.428e-09|2.878e-09|3.388e-09,2.336e-06|1.016e-05|1.277e-05|1.135e-05|1.069e-05,35.25|274.6|39.99|1545|37.79
429,12,0.5025,33.16,9086.0,0.0036270000000000004,0.999986,ANKRD30A CREM HSD17B7 KIN MCM10 MTRNR2L7 PRPF18 RPP38 ZNF248 ZNF25 ZNF33A ZNF37A,nuclear retention of unspliced pre-mRNA at the site of transcription|nuclear mRNA surveillance of spliceosomal pre-mRNA splicing|generation of catalytic spliceosome for second transesterification step|nuclear retention of pre-mRNA at the site of transcription|spliceosomal conformational changes to generate catalytic conformation,0.001746|0.001746|0.001746|0.003489|0.00407,1|1|1|1|1,858.1|858.1|858.1|343.2|286
430,19,0.513,87.73,12020.0,0.007222,1.0,ARMH3 COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 COL4A3BP GET4 PI4KB PTAR1 SPTLC2 SPTSSA TM9SF2 TRAPPC13 UNC50 VPS54,intra-Golgi vesicle-mediated transport|endoplasmic reticulum to Golgi vesicle-mediated transport|Golgi vesicle transport|protein localization|macromolecule localization,7.704e-13|3.224e-12|1.661e-11|9.765e-10|7.698e-09,1.215e-08|2.542e-08|8.733e-08|3.851e-06|2.429e-05,196.1|46.7|26|6.893|5.833
431,4,0.5016,3.01,3045.0,0.0009847999999999999,0.9929309999999999,ANKRD31 METTL2A MRI1 ZNF646,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination|positive regulation of meiotic DNA double-strand break formation|regulation of meiotic DNA double-strand break formation|L-methionine salvage from S-adenosylmethionine|L-methionine salvage from methylthioadenosine,0.0003883|0.0003883|0.0003883|0.0007766|0.001165,1|1|1|1|1,5149|5149|5149|1716|1030
432,13,0.5083,39.65,10650.0,0.003699,0.999993,ANKRD33B C1QTNF3 CDH10 CDH12 CDH6 DNAH5 FAM173B OTULINL PRLR ROPN1L SLC1A3 SLC45A2 UGT3A1,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,2.112e-06|6.457e-06|5.177e-05|0.0001149|0.0001572,0.03331|0.05093|0.2722|0.4531|0.4959,122.6|83.04|40.54|30.83|27.68
433,21,0.4842,101.7,16920.0,0.005958,1.0,APBB2 CHRNA9 CNGA1 CORIN CWH43 FRYL GABRA2 GABRA4 GABRB1 GABRG1 NIPAL1 OCIAD1 OCIAD2 SLC10A4 TEC TLR1 TLR10 TLR6 TXK WDR19 ZAR1,"gamma-aminobutyric acid signaling pathway|regulation of postsynaptic membrane potential|synaptic transmission, GABAergic|chloride transmembrane transport|chloride transport",3.001e-08|7.651e-08|8.516e-07|3.708e-06|4.667e-06,0.0004734|0.0006034|0.004478|0.01462|0.01472,138.7|46.81|187.2|38.6|36.35
434,5,0.5089,5.0889999999999995,4256.0,0.001192,0.996692,ANKRD34B CTDSPL EMP2 LHX5 PAFAH2,positive regulation of integrin-mediated signaling pathway|cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation|bleb assembly|positive regulation of cerebellar granule cell precursor proliferation|membrane raft assembly,0.00194|0.00194|0.002425|0.002425|0.002667,1|1|1|1|1,588.4|588.4|457.7|457.7|411.9
435,4,0.5313,3.188,3230.0,0.0009836,0.9929309999999999,ANKRD34C HLA-DOA MYRIP SPTBN5,negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide antigen|regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,0.0005825|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1716|1287|1287|1030
436,11,0.5128,28.2,8260.0,0.003394,0.999969,ANKRD36B CCDC74B CFC1 CFC1B FAHD2A IL1F10 MRPL30 MZT2A POTEI TRIM43 TUBA3D,nodal signaling pathway|activin receptor signaling pathway|determination of left/right symmetry|determination of bilateral symmetry|specification of symmetry,2.349e-05|0.0001044|0.001907|0.002061|0.002093,0.3706|0.8231|1|1|1,312|138.7|30.69|29.48|29.25
437,5,0.5125,5.125,4070.0,0.001254,0.996692,ANKRD37 INSL4 RFPL3 SEC14L6 SLC35G5,positive regulation of chorionic trophoblast cell proliferation|regulation of chorionic trophoblast cell proliferation|UNCLASSIFIED|biological_process|cellular process,0.0004854|0.001456|0.01923|0.01923|0.1015,1|1|1|1|1,4119|823.8|4.502|0.4615|0.5319
438,4,0.5126,3.075,3088.0,0.0009924,0.9929309999999999,ABLIM3 ANKRD40 CCT6B RCSD1,cellular hyperosmotic response|hyperosmotic response|skeletal muscle contraction|positive regulation of protein targeting to mitochondrion|cellular response to osmotic stress,0.002328|0.004653|0.006393|0.006393|0.006586,1|1|1|1|1,468.1|223.9|160.9|160.9|156
439,4,0.5307,3.1839999999999997,3067.0,0.001035,0.9929309999999999,ANKRD42 C11orf16 GLTPD2 IRX4,establishment of animal organ orientation|establishment of anatomical structure orientation|ceramide 1-phosphate transport|ceramide transport|positive regulation of cytokine production involved in inflammatory response,0.0005825|0.0007766|0.001747|0.00291|0.004266,1|1|1|1|1,2574|1716|643.6|367.8|245.2
440,4,0.5856,3.514,3206.0,0.001092,0.9929309999999999,ANKRD46 CCL26 FETUB MAP3K19,T cell chemotaxis|eosinophil chemotaxis|eosinophil migration|T cell migration|monocyte chemotaxis,0.00291|0.003491|0.003685|0.006007|0.008131,1|1|1|1|1,367.8|302.9|286|171.6|125.6
441,6,0.5398,8.097000000000001,3876.0,0.002079,0.998474,ANKRD49 CSNK1A1 CSNK1D FKBPL MRE11 VEZT,positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of proteasomal protein catabolic process|mitochondrial double-strand break repair via homologous recombination|mitochondrial double-strand break repair,0.0002925|0.0004104|0.0004488|0.0005824|0.0005824,1|1|1|1|1,76.28|64.16|61.29|3432|3432
442,5,0.5527,5.527,4303.0,0.00128,0.996692,ANKRD50 FBXO34 NPAS3 SIPA1L1 VSTM2L,"dendrite self-avoidance|retrograde transport, endosome to plasma membrane|regulation of dendritic spine morphogenesis|neuron recognition|regulation of dendrite morphogenesis",0.004362|0.00702|0.01112|0.0116|0.0164,1|1|1|1|1,242.3|147.1|91.53|87.64|61.48
443,10,0.5053,22.74,8399.0,0.002693,0.999933,ADGRV1 ANKRD55 BHMT CDH12 DMGDH F2R F2RL2 GZMK ITGA1 ITGA2,amino-acid betaine catabolic process|choline catabolic process|thrombin-activated receptor signaling pathway|choline metabolic process|amino-acid betaine metabolic process,2.118e-06|5.927e-06|1.163e-05|1.163e-05|4.009e-05,0.03341|0.04674|0.06116|0.04587|0.1265,1373|686.5|457.7|457.7|228.8
444,5,0.5149,5.149,4049.0,0.001267,0.996692,ANKRD6 PHLPP1 PKDREJ USP46 WDR20,regulation of JNK cascade|regulation of stress-activated MAPK cascade|regulation of stress-activated protein kinase signaling cascade|protein deubiquitination|regulation of T cell anergy,0.0003963|0.0007463|0.0007712|0.001792|0.00194,1|1|1|1|1,63.86|46.28|45.51|29.63|588.4
445,5,0.5258,5.257999999999999,4157.0,0.00126,0.996692,ANKRD62 CYP26B1 HRH4 IRGC SLC35G3,positive regulation of tongue muscle cell differentiation|regulation of tongue muscle cell differentiation|positive regulation of skeletal muscle fiber differentiation|regulation of skeletal muscle fiber differentiation|diterpenoid catabolic process,0.000728|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|2060|1373|1030|823.8
446,4,0.5494,3.2969999999999997,3097.0,0.00106,0.9929309999999999,ANKRD65 BTNL9 IRX4 TMEM240,establishment of animal organ orientation|establishment of anatomical structure orientation|axis specification|T cell receptor signaling pathway|antigen receptor-mediated signaling pathway,0.0005825|0.0007766|0.01698|0.03469|0.057,1|1|1|1|1,2574|1716|59.18|28.6|17.22
447,5,0.5296,5.296,3888.0,0.0013570000000000001,0.996692,ANKRD7 GIMAP6 KRBOX1 PILRB WNT2,lung induction|canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation|positive regulation of epithelial cell proliferation involved in lung morphogenesis|cell proliferation in midbrain|atrial cardiac muscle tissue morphogenesis,0.0009706|0.001213|0.001456|0.001698|0.001698,1|1|1|1|1,1373|1030|823.8|686.5|686.5
448,5,0.5017,5.0169999999999995,4192.0,0.001192,0.996692,ANKRD9 DNAAF3 MEDAG STX11 TJP2,positive regulation of blood-brain barrier permeability|regulation of blood-brain barrier permeability|GDP metabolic process|establishment of endothelial intestinal barrier|vesicle fusion to plasma membrane,0.001456|0.002183|0.00291|0.003152|0.003394,1|1|1|1|1,823.8|514.9|374.5|343.3|316.8
449,4,0.5333,3.2,3249.0,0.0009816,0.9929309999999999,ANKS1A NHLH2 SCLT1 THOP1,neuron maturation|cell maturation|anatomical structure maturation|regulation of ephrin receptor signaling pathway|developmental maturation,1.984e-05|0.0003214|0.0005176|0.0005825|0.0007402,0.3129|1|1|1|1,286|68.65|53.91|2574|44.97
450,4,0.5235,3.141,3160.0,0.0009904,0.9929309999999999,ANKS3 BCL7C NEK7 PLD1,regulation of microvillus assembly|regulation of synaptic vesicle cycle|regulation of microvillus organization|positive regulation of telomere capping|regulation of telomere capping,0.001359|0.001747|0.002716|0.003491|0.005233,1|1|1|1|1,858.1|643.6|396.1|302.9|198
451,4,0.5181,3.109,3230.0,0.0009593,0.9929309999999999,ANKS4B ETNK2 SERPINF1 WDFY4,protein localization to microvillus|cellular response to cobalt ion|brush border assembly|negative regulation of epithelial cell proliferation involved in prostate gland development|response to cobalt ion,0.0005825|0.0009706|0.001165|0.001359|0.002134,1|1|1|1|1,2574|1287|1030|858.1|514.9
452,7,0.5151,10.82,5604.0,0.0019219999999999999,0.9992989999999999,ANKZF1 ATXN7L3B KIAA1257 LRRN1 MYO16 PCDHA4 PCDHB12,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|nervous system development|phosphatidylinositol 3-kinase signaling|cell-cell adhesion,0.001813|0.004257|0.006296|0.01505|0.01586,1|1|1|1|1,30.83|19.88|4.704|67.75|10.02
453,7,0.5018,10.54,4582.0,0.002288,0.9992989999999999,ANLN DIAPH3 ECT2 FLII KIF20A PRC1 RACGAP1,mitotic cytokinesis|regulation of cytokinesis|cytoskeleton-dependent cytokinesis|cytokinesis|cell division,4.76e-09|1.348e-08|1.809e-08|2.86e-08|1.616e-07,7.509e-05|0.0001063|9.509e-05|0.0001128|0.0005098,173.1|132.2|122.6|109|29.9
454,11,0.5076,27.92,8541.0,0.00325,0.999969,ADCY10 ANO2 ATXN7L3B CCNB1IP1 INIP MCOLN3 PCDHGA9 RNF114 TMEM100 ZNF286A ZNF512B,spermatogenesis|male gamete generation|chiasma assembly|arterial endothelial cell differentiation|blood vessel endothelial cell differentiation,0.002673|0.002943|0.003731|0.003731|0.004795,1|1|1|1|1,10.25|9.906|312|312|234
455,4,0.5617,3.37,3179.0,0.001057,0.9929309999999999,ANO7 CLDN5 JAG1 JAG2,inner ear auditory receptor cell differentiation|regulation of endothelial cell differentiation|hair cell differentiation|positive regulation of Notch signaling pathway|inner ear receptor cell differentiation,1.4e-05|1.984e-05|2.429e-05|4.498e-05|4.987e-05,0.2208|0.1564|0.1277|0.1774|0.1573,343.2|286|257.4|187.2|177.5
456,4,0.5263,3.158,3156.0,0.0009971000000000001,0.9929309999999999,ALMS1 ANO9 CXCL14 TMEFF2,regulation of stress fiber assembly|regulation of actomyosin structure organization|regulation of actin filament bundle assembly|negative regulation of intracellular calcium activated chloride channel activity|negative regulation of integrin biosynthetic process,0.0001151|0.0001363|0.0001476|0.0003883|0.0005825,1|1|0.7761|1|1,115.7|106.2|102|5149|2574
457,4,0.5336,3.202,3087.0,0.001034,0.9929309999999999,ANP32A IKZF2 IRAK2 PPP1R3D,"regulation of glycogen catabolic process|regulation of cellular carbohydrate catabolic process|toll-like receptor 9 signaling pathway|nucleotide-binding oligomerization domain containing signaling pathway|nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",0.001553|0.002522|0.003297|0.005813|0.006007,1|1|1|1|1,735.5|429.1|321.8|177.5|171.6
458,4,0.5034,3.0210000000000004,3034.0,0.0009919,0.9929309999999999,ANP32D FOPNL PIBF1 ZC3H12A,"negative regulation of lymphocyte activation|negative regulation of leukocyte activation|negative regulation of cell activation|nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay|negative regulation of prostaglandin biosynthetic process",0.0003299|0.0004554|0.0005667|0.0005825|0.0005825,1|1|1|1|1,67.75|57.53|51.49|2574|2574
459,5,0.5002,5.002,4043.0,0.001233,0.996692,ACVR1C ANTXR1 GKN1 KRT71 TEX35,negative regulation of extracellular matrix assembly|trophectodermal cell proliferation|negative regulation of chorionic trophoblast cell proliferation|positive regulation of peptidase activity|regulation of chorionic trophoblast cell proliferation,0.0004854|0.000728|0.000728|0.0009109|0.001456,1|1|1|1|1,4119|2060|2060|41.82|823.8
460,5,0.5453,5.452999999999999,4112.0,0.0013210000000000001,0.996692,ANTXR2 ETV3L KCNN2 RMND5B TCP10,atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell signaling|atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell communication,0.001456|0.001456|0.003636|0.003636|0.003878,1|1|1|1|1,823.8|823.8|294.2|294.2|274.6
461,4,0.5988,3.593,3147.0,0.001137,0.9929309999999999,ANTXRL KIAA0408 PDIA5 PPFIA1,negative regulation of protein localization to plasma membrane|negative regulation of protein localization to cell periphery|negative regulation of stress fiber assembly|glutamate secretion|negative regulation of actin filament bundle assembly,0.004846|0.005233|0.005426|0.005813|0.006007,1|1|1|1|1,214.5|198|190.7|177.5|171.6
462,5,0.5107,5.107,3970.0,0.001282,0.996692,ANXA1 C3orf18 MAN1C1 MARCH7 SLC9A3R1,negative regulation of T cell activation|negative regulation of leukocyte cell-cell adhesion|renal phosphate ion absorption|negative regulation of lymphocyte activation|monocarboxylic acid transport,0.0003327|0.0003963|0.0004854|0.0005471|0.0005471,1|1|1|1|1,69.81|63.86|4119|54.2|54.2
463,5,0.53,5.3,4131.0,0.0012779999999999998,0.996692,ANXA11 COL22A1 COTL1 KLHL38 MYADML2,endothelial cell morphogenesis|epithelial cell morphogenesis|cytokinetic process|defense response to fungus|endothelial cell development,0.003394|0.007985|0.008708|0.01064|0.01304,1|1|1|1|1,316.8|128.7|117.7|95.79|77.72
464,47,0.3974,429.6,36590.0,0.01158,1.0,APTX AQP7 BAG1 CCL19 CCL21 CD274 CNTFR CREB3 DNAI1 DNAJB5 FAM205A FAM219A FRMPD1 GALT GBA2 GLIPR2 IFNA1 IFNA10 IFNA14 IFNA16 IFNA17 IFNA2 IFNA21 IFNA4 IFNA5 IFNA6 IFNA7 IFNA8 IFNB1 IFNE IFNK IFNW1 IL11RA KIF24 MTAP NPR2 OR13J1 OR2S2 PDCD1LG2 PRSS3 RCL1 SIGMAR1 SPAG8 TESK1 TMEM8B TOMM5 UBAP2,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,2.068e-34|1.063e-33|1.063e-33|1.591e-30|1.76e-29,3.263e-30|8.383e-30|5.588e-30|6.273e-27|5.554e-26,350.6|304.8|304.8|171|143.1
465,23,0.4394,111.2,17910.0,0.0061530000000000005,1.0,ANXA2R C1QTNF3 C7 CCL28 CDH10 CDH12 CDH6 EXOC3 FBXO4 FGF10 HCN1 ICE1 NIM1K NNT OXCT1 PDZD2 PLCXD3 PRLR SLC1A3 SLC45A2 TMEM267 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|cytolysis|homophilic cell adhesion via plasma membrane adhesion molecules,1.669e-05|5.063e-05|0.0003955|0.0006926|0.0008639,0.2632|0.3993|1|1|1,63.96|43.33|21.15|54.27|16.09
466,4,0.5019,3.012,3179.0,0.0009441000000000001,0.9929309999999999,ANXA3 LRRC32 NPSR1 RXRB,regulation of transforming growth factor beta3 activation|regulation of transforming growth factor beta3 production|response to steroid hormone|response to endogenous stimulus|regulation of transforming growth factor beta activation,0.0003883|0.0009706|0.001108|0.001238|0.001941,1|1|1|1|1,5149|1287|36.65|10.91|572.1
467,5,0.5011,5.011,4023.0,0.001241,0.996692,ANXA4 FOSL2 MESD PLB1 TMIE,positive regulation of skeletal muscle acetylcholine-gated channel clustering|regulation of skeletal muscle acetylcholine-gated channel clustering|positive regulation of receptor clustering|keratinocyte development|positive regulation of acrosome reaction,0.0009706|0.001456|0.00194|0.002667|0.003152,1|1|1|1|1,1373|823.8|588.4|411.9|343.3
468,4,0.5881,3.528,3306.0,0.001064,0.9929309999999999,ANXA5 BTN3A2 DNASE1 TDGF1,regulation of neutrophil mediated cytotoxicity|interferon-gamma production|nodal signaling pathway|immune response|cellular response to hepatocyte growth factor stimulus,0.001359|0.001941|0.002522|0.003268|0.003297,1|1|1|1|1,858.1|572.1|429.1|7.833|321.8
469,33,0.4584,242.0,26740.0,0.008948000000000001,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 EGR3 FKBP9 GCK GHRHR GPCPD1 INHBA INMT KIAA0895 MTURN MYL7 MYO1G NIPSNAP2 NME8 NPC1L1 NPY NUPR2 PHKG1 PKD1L1 POM121L12 PSPH RNASET2 SEPT14 SUMF2 UBE2D4 URGCP VWC2 WIPF3 ZNF713,positive regulation of hormone secretion|regulation of hormone secretion|cellular glucose homeostasis|regulation of peptide hormone secretion|positive regulation of peptide hormone secretion,8.544e-05|0.0001051|0.0005394|0.0005625|0.0007868,1|0.8289|1|1|1,17.57|10.66|19.4|10.6|16.97
470,7,0.5016,10.53,5810.0,0.0018059999999999999,0.9992989999999999,ANXA7 MYOZ1 NODAL PLA2G12B PPP3CB RPL26L1 SYNPO2L,sarcomere organization|anatomical structure formation involved in morphogenesis|myofibril assembly|striated muscle cell development|cellular component assembly involved in morphogenesis,5.857e-05|0.0001016|0.0001511|0.0004172|0.0004261,0.9238|0.8013|0.7943|1|1,178.3|13.53|109|64.66|63.96
471,4,0.5356,3.214,3376.0,0.0009488,0.9929309999999999,AOAH CTRL SFI1 ZNF70,lipopolysaccharide catabolic process|lipopolysaccharide metabolic process|cellular polysaccharide catabolic process|polysaccharide catabolic process|cellular carbohydrate catabolic process,0.0003883|0.0003883|0.004072|0.004459|0.007745,1|1|1|1|1,5149|5149|257.4|234|132
472,19,0.609,104.1,13260.0,0.007768000000000001,1.0,ATG10 ATG101 ATG12 ATG13 ATG14 ATG16L1 ATG3 ATG4B ATG5 ATG7 ATG9A BECN1 EPG5 GABARAP PIK3C3 PIK3R4 RB1CC1 ULK1 WIPI2,macroautophagy|autophagy|process utilizing autophagic mechanism|autophagosome assembly|autophagosome organization,6.81e-39|3.368e-35|3.368e-35|3.37e-31|6.046e-31,1.074e-34|2.656e-31|1.771e-31|1.329e-27|1.908e-27,107.3|67.3|67.3|240.9|229.9
473,5,0.529,5.29,4098.0,0.001286,0.996692,AP1AR ATP2C2 PARP16 PDGFB WASF1,regulation of Arp2/3 complex-mediated actin nucleation|positive regulation of calcium ion import|regulation of actin nucleation|regulation of calcium ion import|positive regulation of calcium ion transport,1.19e-05|1.298e-05|2.331e-05|4.441e-05|0.0003667,0.1877|0.1024|0.1226|0.1751|1,392.3|374.5|274.6|196.1|66.44
474,12,0.5026,33.17,10090.0,0.003268,0.999986,AP3B2 BNIP2 CELF6 FBXL22 GOLGA6B PLEKHO2 PPIB SCAMP2 SCAMP5 SLC24A1 SNX22 THAP10,macrophage apoptotic process|polyphosphate catabolic process|polyphosphate metabolic process|myeloid cell apoptotic process|inflammatory cell apoptotic process,0.002327|0.003489|0.00407|0.00407|0.00465,1|1|1|1|1,572.1|343.2|286|286|245.2
475,9,0.509,18.32,7043.0,0.002588,0.9998530000000001,AP3S1 CCNB1IP1 KIF26B LYRM1 NIPSNAP3B PCDH10 PCDHB12 PCDHGA9 PROC,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|ureteric bud invasion|metanephric renal vesicle formation,4.469e-05|0.0001613|0.001179|0.001746|0.002182,0.705|1|1|1|1,41.11|26.51|13.36|762.8|572.1
476,16,0.5072,60.86,12400.0,0.004873,0.999999,ADCY10 AP5M1 ATXN7L3B CARNS1 CCNB1IP1 KIF26B MAP3K7CL MCOLN3 NIPSNAP3B PCDHB12 PCDHB13 PCDHGA9 RNF114 SDR39U1 TMEM100 ZNF286A,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|carnosine biosynthetic process|carnosine metabolic process|ureteric bud invasion,0.0002853|0.001006|0.001552|0.002327|0.003102,1|1|1|1|1,23.12|14.91|1287|643.6|429.1
477,4,0.5527,3.3160000000000003,3167.0,0.0010429999999999999,0.9929309999999999,AP5Z1 NADK NMRK1 SNAP25,pyridine nucleotide biosynthetic process|nicotinamide nucleotide biosynthetic process|pyridine nucleotide metabolic process|nicotinamide nucleotide metabolic process|pyridine-containing compound biosynthetic process,1.49e-05|1.49e-05|1.778e-05|1.778e-05|1.879e-05,0.2351|0.1175|0.09348|0.07011|0.05929,332.2|332.2|302.9|302.9|294.2
478,7,0.5016,10.53,5744.0,0.0018260000000000001,0.9992989999999999,APBA1 FAM189A2 FBP2 FOXB2 PIP5K1B PRKACG ZNF782,gamma-aminobutyric acid secretion|sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|gamma-aminobutyric acid transport,0.001164|0.001164|0.001552|0.002328|0.003877,1|1|1|1|1,1287|1287|858.1|514.9|286
479,4,0.5284,3.17,3134.0,0.001008,0.9929309999999999,APBA3 C19orf38 GPR27 TBC1D26,positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|positive regulation of G protein-coupled receptor signaling pathway|positive regulation of insulin secretion involved in cellular response to glucose stimulus|regulation of insulin secretion involved in cellular response to glucose stimulus,0.0009706|0.001165|0.005426|0.007166|0.01199,1|1|1|1|1,1287|1030|190.7|143|84.41
480,5,0.7577,7.577000000000001,3329.0,0.002264,0.996692,APC AXIN1 CSNK1A1 CTNNBIP1 ZNRF3,negative regulation of Wnt signaling pathway|beta-catenin destruction complex assembly|cell-cell signaling by wnt|Wnt signaling pathway|regulation of Wnt signaling pathway,1.298e-10|3.843e-10|1.457e-09|1.457e-09|1.845e-09,2.047e-06|3.031e-06|7.663e-06|5.747e-06|5.821e-06,96.24|2471|59.01|59.01|56.27
481,4,0.546,3.2760000000000002,3288.0,0.0009931,0.9929309999999999,APCDD1L CCNY GPR135 PTGER2,cellular response to prostaglandin E stimulus|cellular response to prostaglandin stimulus|response to prostaglandin E|response to prostaglandin|cellular response to alcohol,7.2e-06|1.19e-05|1.528e-05|2.481e-05|0.0001789,0.1136|0.09386|0.08035|0.09784|0.5645,514.9|392.3|343.3|265.7|95.79
482,4,0.5633,3.38,3244.0,0.001038,0.9929309999999999,APCS CCDC150 KCNT2 MFNG,negative regulation of exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|modulation by host of viral glycoprotein metabolic process|negative regulation by host of viral exo-alpha-sialidase activity|modulation by host of viral catalytic activity,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
483,12,0.5189,34.25,7911.0,0.004298,0.999986,APH1A CNEP1R1 CTDNEP1 IPO8 LEMD3 NCSTN PSEN1 PSENEN RNF111 TGFBR1 TGFBR2 TGFBR3,"Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing|amyloid precursor protein catabolic process|membrane protein ectodomain proteolysis",2.17e-11|6.576e-11|6.576e-11|3.177e-10|6.959e-10,3.423e-07|5.187e-07|3.458e-07|1.253e-06|2.195e-06,980.7|686.5|686.5|429.1|343.2
484,4,0.5296,3.177,3200.0,0.0009894,0.9929309999999999,APH1B LMO7 PGBD4 TMEM87A,"Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing|amyloid precursor protein catabolic process|amyloid-beta metabolic process",0.001553|0.002134|0.002134|0.003297|0.004072,1|1|1|1|1,735.5|514.9|514.9|321.8|257.4
485,8,0.5154,14.43,5446.0,0.002635,0.9996790000000001,API5 CHTOP DDX39B POLDIP3 RBM33 SARNP THOC6 ZC3HC1,mRNA 3'-end processing|mRNA export from nucleus|mRNA-containing ribonucleoprotein complex export from nucleus|ribonucleoprotein complex export from nucleus|ribonucleoprotein complex localization,9.312e-11|2.866e-10|2.866e-10|5.516e-10|5.731e-10,1.469e-06|2.26e-06|1.507e-06|2.175e-06|1.808e-06,146.3|116|116|101.4|100.6
486,6,0.5433,8.149,4900.0,0.001656,0.998474,APLF DDRGK1 F2RL2 LBH PSKH1 WASF1,regulation of intracellular estrogen receptor signaling pathway|regulation of intracellular steroid hormone receptor signaling pathway|positive regulation of mammary stem cell proliferation|regulation of mammary stem cell proliferation|positive regulation of somatic stem cell division,6.96e-05|0.0002737|0.0005824|0.0005824|0.0005824,1|1|1|1|1,159.7|78.91|3432|3432|3432
487,5,0.5287,5.287000000000001,3919.0,0.001344,0.996692,APLP2 LAMA5 SH2D3A SRMS UCKL1,CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage|UMP salvage|UMP biosynthetic process,0.0009706|0.001456|0.001456|0.001456|0.00291,1|1|1|1|1,1373|823.8|823.8|823.8|374.5
488,4,0.5732,3.4389999999999996,3192.0,0.001074,0.9929309999999999,APOA1 RGMA SDS VAT1,negative regulation of cellular component organization|organic hydroxy compound transport|regulation of anatomical structure morphogenesis|isoleucine biosynthetic process|L-serine catabolic process,0.000405|0.0005401|0.0009343|0.0009706|0.001213,1|1|1|1|1,17.21|54.56|12.94|1373|1030
489,4,0.5301,3.181,3146.0,0.001008,0.9929309999999999,APOA5 CAPN12 PI16 TMEM136,positive regulation of very-low-density lipoprotein particle remodeling|regulation of very-low-density lipoprotein particle remodeling|positive regulation of lipoprotein lipase activity|regulation of intestinal lipid absorption|positive regulation of triglyceride catabolic process,0.0005825|0.001359|0.001941|0.001941|0.001941,1|1|1|1|1,2574|858.1|572.1|572.1|572.1
490,4,0.5606,3.364,3331.0,0.001006,0.9929309999999999,APOBEC2 CALHM4 LARGE1 RIPPLY2,somite rostral/caudal axis specification|cytidine metabolic process|cytidine catabolic process|cytidine deamination|cytidine to uridine editing,0.002328|0.002522|0.002522|0.002522|0.002522,1|1|1|1|1,468.1|429.1|429.1|429.1|429.1
491,5,0.5017,5.0169999999999995,3989.0,0.001253,0.996692,APOBEC3H GGT5 PI4KA RCN3 RPTN,viral replication complex formation and maintenance|organonitrogen compound catabolic process|collagen biosynthetic process|leukotriene D4 biosynthetic process|leukotriene D4 metabolic process,0.0004854|0.001338|0.002425|0.002667|0.002667,1|1|1|1|1,4119|11.44|457.7|411.9|411.9
492,37,0.3767,250.9,29750.0,0.008341,1.0,ERVV-1 ERVV-2 FPR1 FPR2 FPR3 KIR2DL1 KIR2DL3 LILRB5 NLRP12 SIGLEC11 SIGLEC12 SIGLEC5 SIGLEC9 VN1R4 ZFP28 ZNF175 ZNF28 ZNF320 ZNF347 ZNF415 ZNF432 ZNF528 ZNF534 ZNF571 ZNF578 ZNF610 ZNF613 ZNF614 ZNF615 ZNF665 ZNF677 ZNF701 ZNF765 ZNF808 ZNF813 ZNF841 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",4.605e-12|2.298e-10|2.312e-10|2.384e-10|1.146e-09,7.265e-08|1.812e-06|1.216e-06|9.4e-07|3.616e-06,4.82|3.755|3.754|3.749|3.48
493,6,0.5092,7.638999999999999,4796.0,0.001586,0.998474,APOC2 CD96 COL4A1 FXR1 FXR2 KY,"regulation of filopodium assembly|regulation of alternative mRNA splicing, via spliceosome|regulation of mRNA splicing, via spliceosome|positive regulation of response to DNA damage stimulus|positive regulation of translation",8.263e-05|0.0001242|0.0003737|0.0004332|0.0006566,1|0.9795|1|1|1,146.1|118.4|67.3|62.41|50.48
494,4,0.5249,3.1489999999999996,3355.0,0.0009356,0.9929309999999999,APOC3 RAB11B TMCO4 TTC12,negative regulation of high-density lipoprotein particle clearance|negative regulation of sterol import|negative regulation of cholesterol import|regulation of high-density lipoprotein particle clearance|regulation of sterol import,0.0003883|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|2574|2574|1716|1287
495,19,0.5089,87.03,15640.0,0.005520000000000001,1.0,APOC2 APOC4 C5AR1 CBLC CCDC61 CEACAM19 CEACAM8 CYP2A13 EML2 IFNL1 IGFL1 IGFL2 IGFL3 IGFL4 PGLYRP1 PVR SCGB2B2 ZNF285 ZNF599,plasma lipoprotein particle assembly|protein-lipid complex assembly|triglyceride homeostasis|acylglycerol homeostasis|plasma lipoprotein particle clearance,0.0003448|0.0004437|0.0005547|0.0005547|0.000646,1|1|1|1|1,77.42|67.75|60.22|60.22|55.59
496,4,0.5346,3.208,3238.0,0.0009872,0.9929309999999999,APOE COL23A1 PLCB1 TNNC1,skeletal muscle contraction|actin-myosin filament sliding|muscle filament sliding|musculoskeletal movement|multicellular organismal movement,2.636e-05|3.663e-05|3.663e-05|4.857e-05|4.857e-05,0.4158|0.2889|0.1926|0.1916|0.1532,257.4|216.8|216.8|187.2|187.2
497,4,0.5295,3.177,3163.0,0.001001,0.9929309999999999,AMDHD2 APOF PRDX5 RIN1,regulation of apoptosis involved in tissue homeostasis|N-acetylglucosamine catabolic process|negative regulation of transcription by RNA polymerase III|N-acetylneuraminate catabolic process|NADPH oxidation,0.0003883|0.0007766|0.0007766|0.001359|0.001359,1|1|1|1|1,5149|1716|1716|858.1|858.1
498,4,0.5253,3.1519999999999997,3368.0,0.0009327,0.9929309999999999,APOL6 ATP8B4 CAMTA2 CDA,cytosine metabolic process|lipid transport|lipid localization|pyrimidine nucleoside salvage|pyrimidine-containing compound salvage,0.0005825|0.001845|0.002199|0.002328|0.002328,1|1|1|1|1,2574|28.29|25.87|468.1|468.1
499,9,0.5049,18.17,7149.0,0.002529,0.9998530000000001,APOLD1 CLEC12A CLEC12B CLEC4D GABARAPL1 KCNA1 KLRC1 PZP STYK1,natural killer cell inhibitory signaling pathway|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|negative regulation of natural killer cell mediated cytotoxicity|negative regulation of natural killer cell mediated immunity,1.695e-06|7.619e-06|1.117e-05|3.209e-05|3.547e-05,0.02674|0.06009|0.05873|0.1266|0.1119,1526|572.1|457.7|254.3|240.9
500,4,0.5678,3.407,3019.0,0.001124,0.9929309999999999,APP KCNK5 NPEPPS SLC12A7,potassium ion transmembrane transport|regulation of response to calcium ion|positive regulation of cellular response to tunicamycin|positive regulation of cellular response to thapsigargin|potassium ion transport,0.0003561|0.0003883|0.0003883|0.0003883|0.0004019,1|1|1|1|1,65.17|5149|5149|5149|61.29
501,4,0.5237,3.142,3254.0,0.0009621,0.9929309999999999,AQP12B C2orf50 LRRC7 SSMEM1,regulation of NMDA receptor activity|receptor localization to synapse|establishment or maintenance of epithelial cell apical/basal polarity|receptor clustering|establishment or maintenance of apical/basal cell polarity,0.007938|0.007938|0.00871|0.008903|0.009675,1|1|1|1|1,128.7|128.7|117|114.4|105.1
502,4,0.5304,3.182,3184.0,0.0009958999999999999,0.9929309999999999,AQP4 EPPIN LRP5L PRLH,negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement|reduction of food intake in response to dietary excess|retinal blood vessel morphogenesis,0.0009706|0.0009706|0.0009706|0.001165|0.001359,1|1|1|1|1,1287|1287|1287|1030|858.1
503,4,0.5529,3.318,3389.0,0.0009757999999999999,0.9929309999999999,ADCYAP1 AQP8 CLUL1 TMEM255B,negative regulation of acute inflammatory response to non-antigenic stimulus|positive regulation of somatostatin secretion|regulation of somatostatin secretion|regulation of acute inflammatory response to non-antigenic stimulus|negative regulation of acute inflammatory response to antigenic stimulus,0.0003883|0.0005825|0.0007766|0.0007766|0.001165,1|1|1|1|1,5149|2574|1716|1716|1030
504,16,0.5042,60.51,12690.0,0.004733,0.999999,AQP9 BNIP2 C15orf53 DUOXA1 DUOXA2 EPB42 MYO5C NIPA2 PIGH PLA2G4D PLA2G4E PLEKHO2 PPIB SCAMP2 SNURF SNX22,positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process|phosphatidylinositol acyl-chain remodeling,1.184e-05|1.578e-05|2.027e-05|2.533e-05|0.0001065,0.1867|0.1244|0.1066|0.0999|0.3359,514.9|429.1|367.8|321.8|143
505,13,0.6657,51.92,8358.0,0.006155,0.999993,CHMP5 CHMP6 CLTC HGS PTPN23 SNF8 STAMBP TFG UBAP1 USP8 VPS25 VPS36 VPS37A,endosomal transport|multivesicular body assembly|multivesicular body organization|endosome organization|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,1.197e-17|5.604e-17|6.867e-17|7.56e-17|7.616e-15,1.888e-13|4.42e-13|3.611e-13|2.981e-13|2.403e-11,67.99|369.7|357.7|164.6|413.3
506,10,0.5166,23.25,6322.0,0.0036520000000000003,0.999933,ARCN1 COPB1 COPB2 COPZ1 IER3IP1 SCYL1 TBC1D20 TMEM167A UNC50 YIPF5,"Golgi vesicle transport|endoplasmic reticulum to Golgi vesicle-mediated transport|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|vesicle-mediated transport|transport",1.186e-10|1.675e-10|3.519e-10|5.922e-09|2.51e-07,1.871e-06|1.321e-06|1.85e-06|2.335e-05|0.0007917,36.41|63.05|121.1|9.467|4.576
507,5,0.5029,5.029,4060.0,0.001234,0.996692,AREG BSPRY DEFB135 LRTM2 ZNF646,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis|epithelial cell proliferation involved in mammary gland duct elongation|thelarche|branch elongation involved in mammary gland duct branching|mammary gland branching involved in thelarche,0.0004854|0.001213|0.001456|0.001456|0.001456,1|1|1|1|1,4119|1030|823.8|823.8|823.8
508,6,0.516,7.74,3889.0,0.0019809999999999997,0.998474,ARF1 CLINT1 MON2 OSBPL11 OSBPL9 VPS54,post-Golgi vesicle-mediated transport|Golgi vesicle transport|organic substance transport|anion transport|transport,2.862e-08|2.037e-06|7.15e-05|9.245e-05|0.0001094,0.0004514|0.01606|0.3759|0.3646|0.345,102.5|34.67|7.909|7.504|4.576
509,4,0.5174,3.1039999999999996,2350.0,0.001315,0.9929309999999999,ARF1 ARF4 COPG1 MON2,Golgi vesicle transport|protein transport|peptide transport|intracellular transport|amide transport,1.401e-07|2.563e-05|2.772e-05|2.824e-05|3.033e-05,0.00221|0.2021|0.1457|0.1114|0.09567,52.01|14.08|13.8|13.74|13.5
510,4,0.5505,3.303,3223.0,0.001021,0.9929309999999999,ARFGAP2 FBXL15 HECTD2 TRIM42,COPI-coated vesicle budding|COPI coating of Golgi vesicle|Golgi transport vesicle coating|protein polyubiquitination|Golgi vesicle budding,0.001359|0.001359|0.001359|0.001449|0.002134,1|1|1|1|1,858.1|858.1|858.1|31.98|514.9
511,5,0.5118,5.118,3801.0,0.001341,0.996692,ARFGAP3 GRK3 UBE2D1 UBE2D2 UBE2D3,TRIF-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|protein K48-linked ubiquitination|protein targeting to peroxisome|establishment of protein localization to peroxisome,3.737e-08|4.89e-08|2.339e-07|6.271e-07|6.271e-07,0.0005895|0.0003856|0.00123|0.002473|0.001978,411.9|374.5|216.8|154.5|154.5
512,4,0.5405,3.2430000000000003,3012.0,0.001073,0.9929309999999999,ARFGEF1 ARL5A GYPE RAB2A,Golgi organization|positive regulation of protein glycosylation in Golgi|protein localization to Golgi membrane|regulation of protein glycosylation in Golgi|protein transport,0.0002612|0.0003883|0.0007766|0.0007766|0.001362,1|1|1|1|1,76.28|5149|1716|1716|10.56
513,4,0.5985,3.591,3349.0,0.0010689999999999999,0.9929309999999999,ARFGEF3 HGF MAP2 TIMP4,negative regulation of hydrolase activity|negative regulation of catalytic activity|negative regulation of molecular function|regulation of hydrolase activity|negative regulation of microtubule motor activity,1.195e-06|1.195e-05|5.027e-05|7.776e-05|0.0004854,0.01885|0.09428|0.2643|0.3066|1,36.21|20.24|14.07|12.6|4119
514,4,0.5354,3.2119999999999997,3219.0,0.0009945,0.9929309999999999,ARFIP1 CHRNE SLC30A4 SNCAIP,"negative regulation of retrograde transport, endosome to Golgi|negative regulation of cytoplasmic transport|regulation of sequestering of zinc ion|regulation of retrograde transport, endosome to Golgi|regulation of biological quality",0.0003883|0.0007766|0.001165|0.001359|0.001436,1|1|1|1|1,5149|1716|1030|858.1|5.14
515,4,0.5156,3.093,3186.0,0.0009675,0.9929309999999999,ARG1 CCDC186 IL12RB2 NXPH3,regulation of L-arginine import|positive regulation of neutrophil mediated killing of fungus|regulation of neutrophil mediated killing of fungus|arginine catabolic process to ornithine|positive regulation of neutrophil mediated killing of symbiont cell,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
516,5,0.5237,5.237,4057.0,0.001286,0.996692,ADAM21 ARG2 ECI2 NICN1 WSCD2,"negative regulation of chemokine (C-C motif) ligand 4 production|regulation of chemokine (C-C motif) ligand 4 production|negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process|arginine catabolic process to ornithine|negative regulation of macrophage inflammatory protein 1 alpha production",0.0004854|0.0004854|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|4119|2060|2060|1373
517,5,0.5009,5.0089999999999995,4363.0,0.001144,0.996692,ARHGAP10 ERGIC1 IL5RA TACR3 TMC5,interleukin-5-mediated signaling pathway|maintenance of Golgi location|positive regulation of uterine smooth muscle contraction|tachykinin receptor signaling pathway|establishment of Golgi localization,0.0008735|0.001165|0.002328|0.002619|0.002619,1|1|1|1|1,1716|1144|490.4|429.1|429.1
518,16,0.5008,60.09,11830.0,0.0050420000000000005,0.999999,ARHGAP11A ARHGAP11B C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 GABRA5 GOLGA8M GOLGA8R NIPA2 PLA2G4D PLA2G4E SNURF UBE2Q2L WHAMM,"regulation of postsynaptic membrane potential|synaptic transmission, cholinergic|excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|phosphatidylinositol acyl-chain remodeling",1.384e-06|1.68e-06|2.161e-05|2.573e-05|0.0001206,0.02183|0.01325|0.1136|0.1014|0.3804,48.46|139.8|56.79|53.45|134.6
519,11,0.5088,27.98,8416.0,0.0033049999999999998,0.999969,ANKRD30A ARHGAP12 CREM MTRNR2L7 NRP1 PRPF18 ZNF248 ZNF25 ZNF33A ZNF33B ZNF37A,endothelial cell chemotaxis|vascular endothelial growth factor signaling pathway|semaphorin-plexin signaling pathway|cellular response to vascular endothelial growth factor stimulus|endothelial cell migration,2.416e-05|9.257e-05|0.0002395|0.0003172|0.0007344,0.3811|0.7301|1|1|1,312|149.2|90.33|78.01|50.48
520,4,0.5911,3.5469999999999997,3266.0,0.001082,0.9929309999999999,ARHGAP15 NAGLU OTX1 TACC2,metencephalon development|brain development|ear morphogenesis|head development|hindbrain development,0.0001777|0.0001856|0.0001971|0.0002192|0.000313,1|1|1|0.8644|0.9876,92.77|20.73|88.01|19.6|69.58
521,4,0.5759,3.455,3165.0,0.001088,0.9929309999999999,ARHGAP18 GNS MAP3K5 STXBP5,positive regulation of hydrolase activity|regulation of hydrolase activity|positive regulation of catalytic activity|p38MAPK cascade|regulation of synaptic vesicle priming,0.0002102|0.0009799|0.001235|0.001747|0.001747,1|1|1|1|1,19.88|11.81|10.92|643.6|643.6
522,4,0.5148,3.089,3251.0,0.0009467000000000001,0.9929309999999999,ARHGAP19 LRRN4 TRIM62 ZNF865,negative regulation of viral transcription|regulation of viral release from host cell|long-term memory|negative regulation of epithelial to mesenchymal transition|regulation of viral transcription,0.00412|0.007502|0.008467|0.008708|0.01064,1|1|1|1|1,257.4|137.3|121.1|117.7|95.79
523,4,0.519,3.114,3187.0,0.0009735,0.9929309999999999,ARHGAP22 ASCL5 MX2 PDE4A,regulation of synapse structure or activity|synaptic vesicle budding from presynaptic endocytic zone membrane|dynamin family protein polymerization involved in mitochondrial fission|dynamin family protein polymerization involved in membrane fission|postsynaptic endocytosis,0.0006778|0.001553|0.001747|0.001747|0.001941,1|1|1|1|1,47.02|735.5|643.6|643.6|572.1
524,4,0.5232,3.139,3269.0,0.0009568999999999999,0.9929309999999999,ARHGAP23 SOCS7 SYNJ2BP TMEM150B,phosphatidylinositol phosphorylation|regulation of phosphatidylinositol 3-kinase activity|regulation of lipid kinase activity|lipid phosphorylation|phosphatidylinositol metabolic process,8.02e-05|8.295e-05|0.0001197|0.0001264|0.0007712,1|0.6543|0.6291|0.4985|1,144.5|142|117.7|114.4|45.51
525,4,0.577,3.4619999999999997,3129.0,0.001102,0.9929309999999999,ARHGAP24 LPO SLC24A4 ZNF277,"thiocyanate metabolic process|negative regulation of Rac protein signal transduction|negative regulation of ruffle assembly|wound healing, spreading of epidermal cells|response to oxidative stress",0.0003883|0.0007766|0.001359|0.002134|0.002177,1|1|1|1|1,5149|1716|858.1|514.9|26
526,5,0.5327,5.327000000000001,4184.0,0.001268,0.996692,ADAMTSL2 ARHGAP25 HTR3C NOTO TRABD2A,positive regulation of protein oxidation|regulation of protein oxidation|lobar bronchus epithelium development|lobar bronchus development|negative regulation of signal transduction,0.000728|0.000728|0.001213|0.001456|0.002172,1|1|1|1|1,2060|2060|1030|823.8|9.684
527,18,0.5059,77.4,14550.0,0.005279,1.0,GP6 KIR2DL1 KLK11 LAIR1 LAIR2 LILRB4 LILRB5 NLRP4 SHISA7 ZNF160 ZNF211 ZNF460 ZNF581 ZNF587 ZNF772 ZNF773 ZSCAN5A ZSCAN5B,"regulation of transcription by RNA polymerase II|immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|cellular process|regulation of transcription, DNA-templated",3.083e-05|3.606e-05|5.283e-05|7.712e-05|0.0003834,0.4864|0.2844|0.2778|0.3041|1,4.192|271|216.8|0.4199|3.129
528,4,0.5938,3.563,3160.0,0.001123,0.9929309999999999,ARHGAP27 GPR157 RPS12 SYNGR1,synaptic vesicle membrane organization|protein targeting|radial glial cell differentiation|regulation of short-term neuronal synaptic plasticity|regulation of long-term neuronal synaptic plasticity,0.0009706|0.001895|0.002328|0.002716|0.004459,1|1|1|1|1,1287|27.91|468.1|396.1|234
529,4,0.5499,3.3,3146.0,0.001045,0.9929309999999999,ARHGAP28 C12orf57 LRRC30 SIGLEC6,negative regulation of GTP binding|third ventricle development|psychomotor behavior|corpus callosum morphogenesis|motor behavior,0.0007766|0.0009706|0.0009706|0.001165|0.002522,1|1|1|1|1,1716|1287|1287|1030|429.1
530,6,0.5361,8.042,4464.0,0.001794,0.998474,ARHGAP32 FLI1 FXYD6 KCNJ1 KCNJ5 TMEM136,potassium ion import across plasma membrane|inorganic ion import across plasma membrane|inorganic cation import across plasma membrane|regulation of ion transmembrane transport|regulation of transmembrane transport,6.651e-05|0.0002497|0.0002497|0.0004231|0.0004338,1|1|1|1|1,163.5|82.71|82.71|17.75|17.6
531,5,0.5296,5.296,4162.0,0.001268,0.996692,ARHGAP39 C10orf113 KLRG1 MGST3 RBM43,organic heteropentacyclic compound metabolic process|mycotoxin metabolic process|aflatoxin metabolic process|leukotriene biosynthetic process|glutathione derivative biosynthetic process,0.00412|0.00412|0.00412|0.005329|0.005571,1|1|1|1|1,257.4|257.4|257.4|196.1|187.2
532,20,0.5104,96.97,12670.0,0.007575,1.0,BCAR1 CRK CRKL DOCK5 ELMO2 FERMT2 ILK ITGAV LIMS1 NCKAP1 PTK2 PTPN12 PXN RAC1 RAPGEF1 RAPH1 RHOG RSU1 TLN1 TRIO,regulation of substrate adhesion-dependent cell spreading|vascular endothelial growth factor receptor signaling pathway|enzyme linked receptor protein signaling pathway|positive regulation of substrate adhesion-dependent cell spreading|regulation of cell morphogenesis involved in differentiation,8.69e-16|3.921e-15|8.951e-15|2.075e-14|3.821e-14,1.371e-11|3.092e-11|4.706e-11|8.181e-11|1.205e-10,142|116|18.44|171.6|85.81
533,4,0.5004,3.002,3085.0,0.0009697000000000001,0.9929309999999999,ARHGDIB C1orf54 LGI3 POLB,"immunoglobulin heavy chain V-D-J recombination|base-excision repair, base-free sugar-phosphate removal|DNA dephosphorylation|base-excision repair, DNA ligation|cellular response to redox state",0.0005825|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,2574|2574|2574|1716|1287
534,5,0.5139,5.138999999999999,4123.0,0.001242,0.996692,ARHGDIG CD300A CD7 PTPN6 RPL22,leukocyte activation|negative regulation of antigen receptor-mediated signaling pathway|negative regulation of cell adhesion|cell activation|regulation of T cell receptor signaling pathway,2.067e-05|2.331e-05|2.54e-05|3.707e-05|4.239e-05,0.3261|0.1838|0.1336|0.1462|0.1337,17.62|274.6|43.98|15.2|200.9
535,4,0.5393,3.236,2746.0,0.001173,0.9929309999999999,ARHGEF1 ILF2 ILF3 ZFR,negative regulation of viral genome replication|Rho protein signal transduction|immune effector process|regulation of viral genome replication|negative regulation of viral process,0.01064|0.01199|0.01582|0.0164|0.01813,1|1|1|1|1,95.35|84.41|9.404|61.29|55.36
536,7,0.5111,10.73,5146.0,0.002076,0.9992989999999999,ARHGEF10L ARMC1 CCM2 KRIT1 PDCD10 STARD5 TLNRD1,negative regulation of endothelial cell proliferation|negative regulation of endothelial cell migration|negative regulation of epithelial cell migration|blood vessel morphogenesis|blood vessel development,9.729e-05|0.0001457|0.0002501|0.0002562|0.0004411,1|1|1|1|1,136.8|111|84.06|21.74|18.05
537,4,0.5075,3.045,3201.0,0.0009478999999999999,0.9929309999999999,ARHGEF11 GBP7 HAL SCOC,formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide|formate metabolic process|histidine catabolic process,0.0009706|0.0009706|0.0009706|0.001359|0.001747,1|1|1|1|1,1287|1287|1287|858.1|643.6
538,4,0.5714,3.428,3340.0,0.001023,0.9929309999999999,ARHGEF16 HSD11B2 KCNG4 PTS,regulation of blood volume by renal aldosterone|tetrahydrobiopterin biosynthetic process|glucocorticoid biosynthetic process|tetrahydrobiopterin metabolic process|pteridine-containing compound biosynthetic process,0.0005825|0.001553|0.002328|0.002716|0.00291,1|1|1|1|1,2574|735.5|468.1|396.1|367.8
539,5,0.547,5.47,4451.0,0.001225,0.996692,ARHGEF17 CD248 DNAJC5G GPR4 MDFI,glomerular mesangial cell development|mesangial cell development|glomerular mesangial cell differentiation|mesangial cell differentiation|glomerular mesangium development,0.001456|0.001698|0.001698|0.00194|0.002183,1|1|1|1|1,823.8|686.5|686.5|588.4|514.9
540,4,0.5291,3.175,3202.0,0.0009881,0.9929309999999999,ARHGEF19 DAGLA GUF1 NID2,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|diacylglycerol catabolic process|trans-synaptic signaling by endocannabinoid,0.0007766|0.0007766|0.0007766|0.0007766|0.001165,1|1|1|1|1,1716|1716|1716|1716|1030
541,4,0.5359,3.215,3211.0,0.0009978,0.9929309999999999,ARHGEF2 DPEP1 HPS1 LRIT1,cellular lactam catabolic process|antibiotic metabolic process|cellular lactam metabolic process|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|cellular amide catabolic process,0.0003883|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|2574|1716|1287|1287
542,4,0.5318,3.1910000000000003,3197.0,0.0009945,0.9929309999999999,ARHGEF25 FA2H HSD17B8 PRSS33,fatty acid biosynthetic process|monocarboxylic acid biosynthetic process|sebaceous gland cell differentiation|glucosylceramide biosynthetic process|central nervous system myelin maintenance,0.0002209|0.0004258|0.0005825|0.0005825|0.0009706,1|1|1|1|1,83.04|59.52|2574|2574|1287
543,6,0.5041,7.562,4706.0,0.0016,0.998474,ARHGEF28 FSHR LHCGR OXER1 POMK STON1,cellular response to gonadotropin stimulus|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|response to gonadotropin|activation of adenylate cyclase activity|ovulation cycle process,1.206e-05|2.443e-05|2.663e-05|6.35e-05|6.35e-05,0.1903|0.1927|0.14|0.2504|0.2003,403.8|46.81|264|167.4|167.4
544,23,0.5052,127.8,17230.0,0.0073420000000000004,1.0,AGBL3 ARHGEF35 ARHGEF5 CPA1 CTAGE15 CTAGE9 EPHB6 FAM71F2 MGAM OR2A2 OR2A5 OR2A7 OR6V1 OR9A2 OR9A4 PRSS1 PRSS37 PRSS58 RNF148 TAS2R39 TAS2R60 TRPV5 TRPV6,sensory perception of chemical stimulus|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|detection of stimulus involved in sensory perception|detection of chemical stimulus involved in sensory perception of smell,5.954e-09|5.385e-08|9.252e-08|1.45e-07|5.483e-07,9.392e-05|0.0004247|0.0004865|0.000572|0.00173,14.25|14.13|13.15|12.39|13.62
545,5,0.5382,5.382000000000001,4200.0,0.001277,0.996692,ACSBG2 ARHGEF37 CPB2 RAB17 TFF1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|positive regulation of extracellular matrix constituent secretion|negative regulation of hepatocyte proliferation|negative regulation of plasminogen activation,0.000728|0.0009706|0.0009706|0.001213|0.001698,1|1|1|1|1,2060|1373|1373|1030|686.5
546,4,0.5684,3.41,3443.0,0.0009871,0.9929309999999999,ARHGEF38 BTG4 CACHD1 SLC37A1,glucose-6-phosphate transport|hexose phosphate transport|phosphate ion transmembrane transport|phosphate ion transport|inorganic ion transmembrane transport,0.001359|0.001359|0.003104|0.004072|0.005997,1|1|1|1|1,858.1|858.1|343.2|257.4|15.51
547,4,0.547,3.282,3162.0,0.001034,0.9929309999999999,ARHGEF39 PHETA2 SNCAIP TMEM167B,constitutive secretory pathway|receptor recycling|regulation of inclusion body assembly|dopamine metabolic process|catecholamine metabolic process,0.001165|0.002134|0.003685|0.006007|0.009096,1|1|1|1|1,1030|514.9|286|171.6|111.9
548,19,0.4437,75.87,15370.0,0.004899000000000001,1.0,ADAMTSL1 CCDC54 CD274 CDC37L1 CNTLN DDX58 IFNA16 INSL6 MPL PDCD1LG2 PLPP6 PUM3 RLN1 RLN2 SAXO1 SPATA6L TPD52L3 TYRP1 ZDHHC21,negative regulation of activated T cell proliferation|negative regulation of interleukin-10 production|positive regulation of lymphocyte proliferation|positive regulation of mononuclear cell proliferation|positive regulation of leukocyte proliferation,9.584e-05|0.0001673|0.0002801|0.000286|0.000356,1|1|1|1|1,154.8|114.1|23.56|23.39|21.68
549,12,0.5029,33.19,8134.0,0.004052,0.999986,CASP8 CFLAR CHMP5 KHDRBS1 NCOA5 RIPK1 RNF31 TAB2 TNFRSF10A TNFRSF10B TRAF2 ZNF638,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|regulation of I-kappaB kinase/NF-kappaB signaling|regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of peptidase activity,1.3e-13|5.29e-13|1.079e-12|8.938e-12|1.371e-11,2.05e-09|4.172e-09|5.672e-09|3.525e-08|4.325e-08,243.7|52.16|166.8|59.94|56.29
550,20,0.5026,95.49,12310.0,0.007670000000000001,1.0,ARHGEF7 BCAR1 CD151 CRKL ELMO2 FERMT2 ILK ITGA3 ITGAV ITGB1 ITGB5 LIMS1 NCKAP1 PTK2 PXN RAC1 RSU1 SNX17 TLN1 VCL,cell-matrix adhesion|cell adhesion|biological adhesion|integrin-mediated signaling pathway|cell-substrate adhesion,1.949e-17|1.291e-16|1.416e-16|3.105e-16|7.737e-16,3.074e-13|1.019e-12|7.446e-13|1.225e-12|2.441e-12,81.73|16.24|16.14|94.57|55.66
551,6,0.5531,8.296,3577.0,0.002306,0.998474,ARIH1 CAND1 CUL3 KCTD10 KEAP1 UBE2M,protein modification by small protein conjugation|protein modification by small protein conjugation or removal|protein ubiquitination|post-translational protein modification|ubiquitin-dependent protein catabolic process,4.113e-09|1.605e-08|3.577e-07|1.414e-06|6.57e-06,6.487e-05|0.0001266|0.001881|0.005576|0.02073,25.09|19.98|23.16|38.03|25.76
552,11,0.5309,29.2,7434.0,0.003901,0.999969,ARIH2 ARIH2OS CUL5 DCUN1D1 DCUN1D3 NAE1 RNF7 SENP8 SOCS6 UBE2F UBE2R2,protein modification by small protein conjugation or removal|protein neddylation|protein modification by small protein conjugation|post-translational protein modification|cellular protein modification process,6.016e-14|2.184e-13|6.617e-13|4.559e-12|7.104e-09,9.49e-10|1.723e-09|3.479e-09|1.798e-08|2.241e-05,18.31|660.1|20.9|38.03|6.253
553,25,0.4864,145.9,15640.0,0.009212,1.0,ARFRP1 ARL1 COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 EIPR1 GPR107 PTAR1 RAB1B RAB6A RGP1 RIC1 SYS1 TRAPPC13 UNC50 VPS51 VPS52 VPS53 VPS54 YKT6,Golgi vesicle transport|intracellular transport|protein transport|peptide transport|amide transport,2.564e-23|1.202e-21|4.055e-20|6.061e-20|9.614e-20,4.045e-19|9.481e-18|2.132e-16|2.39e-16|3.033e-16,34|11.63|11.37|11.15|10.9
554,15,0.4603,48.34,11340.0,0.004235,0.999999,ALDOC ARL10 BPNT1 CCDC102A DVL3 GML OR5AU1 OR8I2 PLEKHG4 PM20D1 PSD4 RTN3 VASH1 WFDC11 WRN,positive regulation of strand invasion|regulation of strand invasion|negative regulation of lymphangiogenesis|endoplasmic reticulum tubular network formation|regulation of oxidative phosphorylation uncoupler activity,0.001455|0.001455|0.002908|0.003634|0.003634,1|1|1|1|1,1373|1373|457.7|343.2|343.2
555,23,0.5039,127.5,17190.0,0.007343000000000001,1.0,CTSK GBA HRNR LCE1A LCE1B LCE1E LCE2A LCE3A LCE3B LCE3C LCE3D LCE3E LCE5A PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A8 S100A9 SPRR1A SPRR2F SPRR2G,keratinization|keratinocyte differentiation|skin development|epidermal cell differentiation|epidermis development,4.263e-22|4.247e-21|6.312e-21|3.946e-20|1.699e-18,6.724e-18|3.35e-17|3.319e-17|1.556e-16|5.361e-15,55.47|46.78|35.07|39.67|30.06
556,4,0.5514,3.3080000000000003,3075.0,0.001072,0.9929309999999999,ARL14 ERP27 TCAF1 ZNF189,positive regulation of anion channel activity|regulation of anion channel activity|positive regulation of protein targeting to membrane|regulation of protein targeting to membrane|positive regulation of anion transmembrane transport,0.0009706|0.002134|0.0062|0.007359|0.01199,1|1|1|1|1,1287|514.9|166.1|139.2|84.41
557,5,0.5079,5.079,3997.0,0.001266,0.996692,ARL14EP CDCA7L NME8 SENP7 SUGCT,protein desumoylation|sperm motility|flagellated sperm motility|cilium movement involved in cell motility|cilium-dependent cell motility,0.002183|0.0219|0.0219|0.0238|0.02689,1|1|1|1|1,514.9|45.77|45.77|42.03|37.11
558,5,0.5338,5.337999999999999,3996.0,0.0013310000000000002,0.996692,ACVR1C ARL14EPL KRT71 MAFA TEX35,response to glucose|response to hexose|response to monosaccharide|trophectodermal cell proliferation|negative regulation of chorionic trophoblast cell proliferation,0.0006756|0.0007344|0.0007956|0.0008735|0.0008735,1|1|1|1|1,49.75|47.67|45.77|1716|1716
559,5,0.5771,5.771,3468.0,0.001656,0.996692,ARL15 CCDC107 PTP4A1 PTP4A2 TRPM7,peptidyl-tyrosine dephosphorylation|calcium-dependent cell-matrix adhesion|protein dephosphorylation|cellular magnesium ion homeostasis|dephosphorylation,0.0002695|0.000728|0.001092|0.001213|0.002361,1|1|1|1|1,77.72|2060|38.14|1030|25.74
560,7,0.541,11.36,4807.0,0.0023510000000000002,0.9992989999999999,ARL2 PFDN1 PFDN6 TBCB TBCC TBCD TBCE,tubulin complex assembly|post-chaperonin tubulin folding pathway|protein folding|cellular protein-containing complex assembly|regulation of supramolecular fiber organization,3.331e-12|1.344e-09|3.655e-09|2.51e-06|3.777e-06,5.255e-08|1.06e-05|1.922e-05|0.009899|0.01191,1308|1765|64.52|17.13|31.38
561,5,0.513,5.13,4059.0,0.001259,0.996692,ARL4A AXL CD28 PRR13 ZNF780B,positive regulation of viral process|regulation of viral life cycle|regulation of lymphocyte differentiation|positive regulation of protein kinase B signaling|regulation of viral process,0.0002042|0.0005261|0.0007299|0.0007712|0.0008396,1|1|1|1|1,89.54|55.29|46.81|45.51|43.59
562,5,0.5112,5.112,4035.0,0.0012619999999999999,0.996692,ARL4C CHST15 COL5A3 HRG OSTF1,positive regulation of blood vessel remodeling|negative regulation of lamellipodium assembly|negative regulation of endothelial cell chemotaxis|negative regulation of lamellipodium organization|regulation of blood vessel remodeling,0.000728|0.0009706|0.001213|0.001456|0.001698,1|1|1|1|1,2060|1373|1030|823.8|686.5
563,4,0.5513,3.3080000000000003,3234.0,0.001019,0.9929309999999999,ARL4D ITGA6 ITGB4 ZSCAN18,nail development|skin morphogenesis|hemidesmosome assembly|cell-substrate junction assembly|cell-substrate junction organization,1.555e-06|2.204e-06|2.572e-06|2.919e-05|3.048e-05,0.02452|0.01739|0.01352|0.1151|0.09617,1144|936.1|858.1|234|228.8
564,5,0.5336,5.336,3855.0,0.001379,0.996692,ARL6IP1 CIB2 REEP3 REEP4 RETREG3,endoplasmic reticulum tubular network organization|endoplasmic reticulum organization|mitotic nuclear envelope reassembly|mitotic nuclear membrane organization|nuclear envelope reassembly,5.595e-09|1.205e-06|6.463e-05|6.463e-05|7.22e-05,8.826e-05|0.009505|0.3398|0.2549|0.2278,823.8|123.6|161.5|161.5|152.6
565,4,0.5016,3.01,3169.0,0.0009464,0.9929309999999999,ARL6IP5 MARCH3 MKRN2OS NEURL1,negative regulation of response to drug|negative regulation of L-glutamate import across plasma membrane|regulation of response to drug|neuron death in response to oxidative stress|positive regulation of long-term neuronal synaptic plasticity,0.0003883|0.0003883|0.0009706|0.0009706|0.001165,1|1|1|1|1,5149|5149|1287|1287|1030
566,6,0.5401,8.102,4723.0,0.0017079999999999999,0.998474,ARL8A DVL1 FZD5 LRP5 SCMH1 WLS,canonical Wnt signaling pathway|cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|anterior/posterior pattern specification,1.077e-08|2.973e-08|2.973e-08|7.321e-08|3.654e-07,0.0001699|0.0002345|0.0001563|0.0002887|0.001153,140.1|42.15|42.15|35.11|56.85
567,5,0.5298,5.297999999999999,3738.0,0.0014119999999999998,0.996692,ARMC12 RAPGEF1 RRAS2 S100A5 TRIO,Ras protein signal transduction|positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|small GTPase mediated signal transduction|transmembrane receptor protein tyrosine phosphatase signaling pathway|positive regulation of Fc receptor mediated stimulatory signaling pathway,0.0007299|0.001456|0.001595|0.001698|0.00194,1|1|1|1|1,46.81|823.8|31.44|686.5|588.4
568,13,0.5037,39.29,8395.0,0.004644,0.999993,CKAP5 CLTC DLGAP5 GAK GTSE1 KIF15 KNTC1 MAD2L1BP MAPRE1 MKI67 MYBL2 TACC3 TRIP13,cell cycle|mitotic cell cycle|regulation of cell cycle process|regulation of cell cycle|regulation of chromosome segregation,1.147e-13|1.311e-12|1.509e-12|1.863e-12|1.367e-11,1.809e-09|1.034e-08|7.936e-09|7.348e-09|4.312e-08,13.68|20.82|20.52|14.57|106.8
569,5,0.5824,5.824,3407.0,0.0017010000000000003,0.996692,ARMC3 IPMK IPPK ITPK1 KCNMB2,inositol phosphorylation|inositol phosphate metabolic process|inositol trisphosphate metabolic process|polyol metabolic process|inositol metabolic process,4.24e-07|5.158e-07|1.978e-06|4.408e-06|5.506e-06,0.006689|0.004068|0.0104|0.01738|0.01737,3432|174.5|1144|83.72|624.1
570,4,0.5522,3.313,3167.0,0.001042,0.9929309999999999,ARMC4 ENO3 KCNJ10 MTHFSD,"central nervous system development|glutamate reuptake|regulation of vacuole fusion, non-autophagic|amino acid neurotransmitter reuptake|regulation of resting membrane potential",0.000432|0.0005825|0.0009706|0.001359|0.001941,1|1|1|1|1,15.59|2574|1287|858.1|572.1
571,8,0.5351,14.98,4955.0,0.003005,0.9996790000000001,ARMC5 CD2BP2 EAF1 GEMIN4 ICE2 PHAX TOE1 USPL1,RNA metabolic process|gene expression|nucleic acid metabolic process|snRNA transcription|nucleobase-containing compound metabolic process,1.288e-07|1.114e-06|1.285e-06|2.459e-06|4.989e-06,0.002032|0.008784|0.006759|0.009696|0.01574,11.27|8.244|8.074|108.8|6.628
572,4,0.5253,3.1519999999999997,3149.0,0.0009972999999999998,0.9929309999999999,ARMC6 TF THEM6 TRPM2,hemopoiesis|hematopoietic or lymphoid organ development|immune system development|transition metal ion transport|activation of plasma proteins involved in acute inflammatory response,0.0002075|0.0002618|0.0003106|0.0003552|0.0004854,1|1|1|1|1,21.6|19.96|18.84|67.52|4119
573,12,0.474,31.29,8020.0,0.0038740000000000003,0.999986,ARMC7 CCDC84 DDX59 DHX9 PDCD7 PPIH RBM48 RNPC3 SCNM1 SNRNP25 TXNL4B ZMAT5,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",1.126e-12|1.126e-12|1.217e-12|1.167e-11|4.543e-11,1.777e-08|8.883e-09|6.398e-09|4.604e-08|1.433e-07,45.46|45.46|45.02|33.73|28.37
574,49,0.397,466.9,38650.0,0.0119,1.0,AIPL1 ALDH3A1 ALOX15 ALOX15B ALOXE3 ASGR1 ASGR2 C17orf51 CCDC144A CCDC144NL CLEC10A DRC3 FOXO3 GID4 HS3ST3A1 HS3ST3B1 KCTD11 KRT16 KRT17 LLGL1 MFAP4 MFSD6L MIEF2 MYH1 MYH10 MYH2 MYH4 MYH8 MYO15A OR1G1 PRPSAP2 RCVRN SHBG SLC16A13 SLC2A4 SLC47A1 SLC47A2 SMCR8 TBC1D28 TMEM256 TNFRSF13B TNFSF12 TNFSF13 TRPV2 ULK2 VAMP2 ZNF287 ZNF624 ZSWIM7,hepoxilin biosynthetic process|hepoxilin metabolic process|actin filament-based movement|lipoxygenase pathway|linoleic acid metabolic process,2.723e-06|2.723e-06|1.113e-05|1.186e-05|2.456e-05,0.04296|0.02148|0.05851|0.04675|0.07747,140.1|140.1|17.66|78.81|60.04
575,4,0.5159,3.095,3241.0,0.0009517000000000001,0.9929309999999999,ARMC9 ATP8B4 MLN WEE2,negative regulation of calcium ion import into sarcoplasmic reticulum|female pronucleus assembly|negative regulation of calcium ion binding|regulation of calcium ion binding|negative regulation of oocyte maturation,0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
576,4,0.5419,3.2510000000000003,3373.0,0.0009607999999999998,0.9929309999999999,ARMH1 IL4 KNOP1 TPPP3,"positive regulation of eosinophil chemotaxis|regulation of eosinophil chemotaxis|T-helper 2 cell cytokine production|T cell cytokine production|CD4-positive, alpha-beta T cell cytokine production",0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
577,5,0.5118,5.118,3926.0,0.001299,0.996692,ABCC12 ARMH2 FKBP14 LPCAT2 PRG2,platelet activating factor biosynthetic process|platelet activating factor metabolic process|basement membrane assembly|ether lipid biosynthetic process|cellular lipid biosynthetic process,0.001456|0.002619|0.0032|0.00349|0.00349,1|1|1|1|1,858.1|429.1|343.2|312|312
578,4,0.5614,3.3680000000000003,3268.0,0.001027,0.9929309999999999,ARMS2 CX3CL1 SLC22A14 SLC30A3,positive regulation of calcium-independent cell-cell adhesion|negative regulation of glutamate receptor signaling pathway|negative regulation of hippocampal neuron apoptotic process|negative regulation of interleukin-1 alpha production|leukocyte adhesive activation,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
579,4,0.5534,3.32,3178.0,0.001041,0.9929309999999999,ARMT1 IL31 PPP1R3A ZNF681,regulation of glycogen biosynthetic process|regulation of glucan biosynthetic process|regulation of glycogen metabolic process|regulation of polysaccharide biosynthetic process|regulation of polysaccharide metabolic process,0.0062|0.0062|0.007552|0.007745|0.009096,1|1|1|1|1,166.1|166.1|135.5|132|111.9
580,16,0.4766,57.19,11110.0,0.005104999999999999,0.999999,CFLAR IKBKB IL1R1 IL1RAP IRAK4 MYD88 NCOA5 RBCK1 RELA RIPK1 RNF31 TAB2 TRADD TRAF2 TRAF6 ZNF638,regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of NF-kappaB transcription factor activity|positive regulation of I-kappaB kinase/NF-kappaB signaling|I-kappaB kinase/NF-kappaB signaling|positive regulation of DNA-binding transcription factor activity,2.806e-22|5.709e-22|2.458e-21|8.233e-21|1.982e-19,4.426e-18|4.502e-18|1.292e-17|3.247e-17|6.251e-16,64.81|89.19|78.58|173.1|53.84
581,16,0.4825,57.9,10710.0,0.005362,0.999999,AMOTL2 FAM49B FRMD6 FRYL KIRREL1 LATS2 MAP4K4 NF2 NRP1 PDCD10 PLXNA1 PTPN14 RAP2B RNF146 SAV1 TAOK1,anatomical structure morphogenesis|regulation of cell migration|regulation of cell motility|regulation of locomotion|regulation of cellular component movement,1.037e-07|2.064e-07|3.451e-07|4.831e-07|6.327e-07,0.001635|0.001628|0.001815|0.001905|0.001996,6.242|10.95|10.23|9.79|9.446
582,4,0.5384,3.23,3207.0,0.001004,0.9929309999999999,AK3 ARPC5L HCLS1 PLXND1,ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|ribonucleoside diphosphate biosynthetic process|purine nucleoside diphosphate biosynthetic process|nucleoside diphosphate biosynthetic process,9.893e-07|9.893e-07|1.319e-06|1.319e-06|3.108e-06,0.01561|0.007803|0.006935|0.005201|0.009804,1648|1648|1373|1373|823.8
583,4,0.5309,3.185,3213.0,0.0009878999999999999,0.9929309999999999,ARPIN ITGB7 NLRP6 RNF19A,"negative regulation of lamellipodium morphogenesis|cell-matrix adhesion involved in ameboidal cell migration|directional locomotion|regulation of protein catabolic process at postsynapse, modulating synaptic transmission|negative regulation of lamellipodium organization",0.0005825|0.0005825|0.0007766|0.0007766|0.001165,1|1|1|1|1,2574|2574|1716|1716|1030
584,4,0.5097,3.0580000000000003,2935.0,0.001038,0.9929309999999999,ARPP19 MRFAP1 TPH1 ZCCHC4,serotonin biosynthetic process|primary amino compound biosynthetic process|indole-containing compound biosynthetic process|indolalkylamine biosynthetic process|serotonin metabolic process,0.0007766|0.001165|0.001165|0.001165|0.002134,1|1|1|1|1,1716|1030|1030|1030|514.9
585,9,0.5249,18.9,5978.0,0.0031420000000000003,0.9998530000000001,ATXN2L CNOT10 CNOT11 CNOT4 CNOT9 G3BP2 LSM12 NUFIP2 PUM1,"nuclear-transcribed mRNA poly(A) tail shortening|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint|signal transduction involved in mitotic DNA integrity checkpoint|signal transduction involved in mitotic DNA damage checkpoint",2.933e-10|9.258e-09|9.884e-09|9.884e-09|9.884e-09,4.626e-06|7.302e-05|5.197e-05|3.898e-05|3.118e-05,398|157.8|155.1|155.1|155.1
586,5,0.5235,5.235,3385.0,0.0015400000000000001,0.996692,ARHGEF7 ARRB2 GIT2 ITGB1 PAK2,regulation of hydrolase activity|regulation of GTPase activity|positive regulation of apoptotic process|positive regulation of programmed cell death|positive regulation of cell death,1.044e-06|1.603e-06|2.514e-06|2.798e-06|4.255e-06,0.01648|0.01264|0.01322|0.01103|0.01342,15.75|33.62|30.01|29.21|26.28
587,4,0.5941,3.565,3340.0,0.0010630000000000001,0.9929309999999999,ARRDC2 EGR4 MATN1 WDPCP,chondrocyte morphogenesis|growth plate cartilage chondrocyte morphogenesis|chondrocyte morphogenesis involved in endochondral bone morphogenesis|growth plate cartilage morphogenesis|regulation of embryonic cell shape,0.0003883|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,5149|5149|5149|2574|1716
588,4,0.5545,3.327,3004.0,0.001103,0.9929309999999999,ARRDC5 DDX19A DDX19B VPS37D,poly(A)+ mRNA export from nucleus|protein transport|peptide transport|amide transport|establishment of protein localization,7.795e-06|2.563e-05|2.772e-05|3.033e-05|3.295e-05,0.123|0.2021|0.1457|0.1196|0.1039,468.1|14.08|13.8|13.5|13.22
589,4,0.5407,3.2439999999999998,3161.0,0.001023,0.9929309999999999,ARSA OR51V1 TARSL2 TEF,threonyl-tRNA aminoacylation|response to methylmercury|binding of sperm to zona pellucida|response to pH|tRNA aminoacylation for protein translation,0.0007766|0.001359|0.00871|0.00871|0.009096,1|1|1|1|1,1716|858.1|117|117|111.9
590,7,0.5109,10.73,5899.0,0.001811,0.9992989999999999,ARSB BHMT CD180 DDR1 F2RL2 FST ITGA2,collagen-activated signaling pathway|wound healing|cell population proliferation|regulation of body fluid levels|tissue morphogenesis,1.343e-05|0.0003328|0.0004102|0.0004543|0.0005638,0.2118|1|1|1|1,392.3|19.88|18.5|17.87|16.59
591,4,0.5336,3.201,3292.0,0.0009691000000000001,0.9929309999999999,ARSG DLX4 SLC4A9 ZNF45,"bicarbonate transport|regulation of transcription initiation from RNA polymerase II promoter|regulation of DNA-templated transcription, initiation|regulation of intracellular pH|regulation of cellular pH",0.008324|0.01545|0.01698|0.01717|0.01851,1|1|1|1|1,122.6|65.17|59.18|58.51|54.2
592,5,0.5058,5.058,4275.0,0.001179,0.996692,ARSI CNNM2 IAPP RHBDL3 TECTB,positive regulation of calcium ion import across plasma membrane|regulation of calcium ion import across plasma membrane|amylin receptor signaling pathway|calcitonin family receptor signaling pathway|magnesium ion homeostasis,0.0009706|0.001456|0.00194|0.002183|0.00291,1|1|1|1|1,1373|823.8|588.4|514.9|374.5
593,4,0.5358,3.215,3336.0,0.0009603,0.9929309999999999,ARSJ C2CD2 DSPP ST6GAL2,odontoblast differentiation|regulation of odontoblast differentiation|dentinogenesis|neuroepithelial cell differentiation|sialylation,0.0007766|0.0009706|0.001359|0.003491|0.004072,1|1|1|1|1,1716|1287|858.1|302.9|257.4
594,4,0.52,3.12,3037.0,0.001024,0.9929309999999999,ART1 ART5 FGD3 PTPDC1,peptidyl-arginine ADP-ribosylation|peptidyl-arginine modification|protein ADP-ribosylation|plasma membrane bounded cell projection assembly|cell projection assembly,4.241e-07|1.146e-05|1.313e-05|0.003036|0.003243,0.00669|0.0904|0.06902|1|1,2574|381.4|355.1|21.96|21.23
595,10,0.9681,43.56,6029.0,0.00715,0.999933,CDK5RAP3 DDRGK1 DNAJC21 EFL1 ODR4 UBA5 UFC1 UFL1 UFM1 UFSP2,protein ufmylation|protein K69-linked ufmylation|protein polyufmylation|reticulophagy|regulation of intracellular estrogen receptor signaling pathway,1.825e-18|2.051e-15|2.051e-15|5.028e-14|1.383e-11,2.879e-14|1.617e-11|1.078e-11|1.983e-10|4.362e-08,2060|2060|2060|858.1|239.5
596,4,0.5396,3.237,3258.0,0.0009902,0.9929309999999999,ART4 EPB41L4B FZD7 STX11,protein ADP-ribosylation|negative regulation of ectodermal cell fate specification|regulation of ectodermal cell fate specification|peptidyl-arginine ADP-ribosylation|skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,2.185e-05|0.0004854|0.0004854|0.001213|0.001213,0.3447|1|1|1|1,284.1|4119|4119|1030|1030
597,4,0.5334,3.2,3168.0,0.001007,0.9929309999999999,ACRBP ARV1 QRFPR SRD5A1,"steroid biosynthetic process|regulation of plasma membrane sterol distribution|circadian sleep/wake cycle, REM sleep|circadian sleep/wake cycle, sleep|steroid metabolic process",0.000228|0.0003883|0.0005825|0.0007766|0.0009653,1|1|1|1|1,81.73|5149|2574|1716|39.3
598,4,0.5434,3.261,3221.0,0.001009,0.9929309999999999,ASAH1 IFNGR1 SMIM12 XKR6,phosphatidylserine exposure on apoptotic cell surface|negative regulation of amyloid-beta clearance|sphingoid biosynthetic process|sphingosine biosynthetic process|engulfment of apoptotic cell,0.001747|0.001941|0.00291|0.00291|0.003297,1|1|1|1|1,643.6|572.1|367.8|367.8|321.8
599,5,0.5149,5.149,4268.0,0.001202,0.996692,AK3 ASAH2 HPN PRX SSC5D,ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|ribonucleoside diphosphate biosynthetic process|purine nucleoside diphosphate biosynthetic process|nucleoside diphosphate biosynthetic process,1.484e-06|1.484e-06|1.978e-06|1.978e-06|4.66e-06,0.0234|0.0117|0.0104|0.0078|0.0147,1373|1373|1144|1144|686.5
600,5,0.5187,5.187,4046.0,0.001277,0.996692,ASAP2 NPFFR2 POMT1 SEZ6L2 SUN5,positive regulation of protein O-linked glycosylation|regulation of protein O-linked glycosylation|positive regulation of protein glycosylation|synapse maturation|regulation of protein glycosylation,0.0009706|0.0009706|0.002425|0.003152|0.003878,1|1|1|1|1,1373|1373|457.7|343.3|274.6
601,5,0.5136,5.136,3950.0,0.001295,0.996692,ASAP3 CLCNKA FAM131C L3HYPDH MTFR1L,mitochondrial fission|excretion|aerobic respiration|regulation of stress fiber assembly|regulation of actomyosin structure organization,0.005329|0.009913|0.01879|0.02166|0.02356,1|1|1|1|1,196.1|103|53.49|46.28|42.46
602,4,0.538,3.228,3034.0,0.00106,0.9929309999999999,ASB1 GAMT RPS6KB1 TRAPPC9,developmental process involved in reproduction|creatine biosynthetic process|muscle contraction|response to electrical stimulus involved in regulation of muscle adaptation|muscle system process,0.0003884|0.0005825|0.0008321|0.0009706|0.001171,1|1|1|1|1,16.16|2574|42.38|1287|35.63
603,4,0.5228,3.137,3160.0,0.0009892000000000002,0.9929309999999999,ASB10 CAPN11 LELP1 SLC38A8,amino acid transmembrane transport|amino acid transport|carboxylic acid transmembrane transport|organic acid transmembrane transport|sodium ion transport,0.01756|0.02558|0.02748|0.02767|0.03355,1|1|1|1|1,57.21|39.01|36.26|36.01|29.59
604,20,0.5062,96.17,14640.0,0.006509999999999999,1.0,ACCSL CAT CHRM4 COMMD9 CRY2 EHF ELF5 FBXO3 MAPK8IP1 MRGPRX3 MYBPC3 OR4A47 OR4B1 OR4C12 OR4C13 OR4C3 OR4X1 PAMR1 SLC1A2 TP53I11,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,5.581e-06|7.807e-06|9.657e-06|1.443e-05|1.781e-05,0.08803|0.06157|0.05077|0.05689|0.05619,12.74|12|11.56|10.76|10.36
605,4,0.513,3.0780000000000003,3193.0,0.0009607000000000001,0.9929309999999999,ASB14 ECHS1 EXOG MECR,fatty acid beta-oxidation|fatty acid oxidation|lipid oxidation|fatty acid catabolic process|monocarboxylic acid catabolic process,5.156e-05|0.0001028|0.0001126|0.0001177|0.0001905,0.8133|0.8109|0.5922|0.4641|0.601,174.5|122.6|117|114.4|89.54
606,13,0.4938,38.52,8733.0,0.004378,0.999993,FLII GNA13 LRRFIP2 LUZP1 MYH9 MYL12A MYL12B MYL6 ROCK1 ROCK2 SIAH1 TMOD3 UNC45A,muscle contraction|actomyosin structure organization|muscle system process|actin filament-based process|regulation of angiotensin-activated signaling pathway,4.684e-09|4.696e-09|1.29e-08|8.903e-07|2.203e-06,7.388e-05|3.703e-05|6.783e-05|0.003511|0.006948,39.12|76.16|32.89|15.9|1584
607,4,0.5741,3.445,2896.0,0.001185,0.9929309999999999,ASB3 DCAF15 SLC2A10 TFAP2C,negative regulation of proteoglycan biosynthetic process|negative regulation of connective tissue growth factor production|protein localization to T-tubule|galactose transmembrane transport|negative regulation of integrin-mediated signaling pathway,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
608,4,0.5671,3.403,3223.0,0.001052,0.9929309999999999,ASB4 BCL2L13 DUOX2 TMEM252,adenohypophysis morphogenesis|hypophysis morphogenesis|diencephalon morphogenesis|cuticle development|hydrogen peroxide biosynthetic process,0.0003883|0.0005825|0.0007766|0.0007766|0.001941,1|1|1|1|1,5149|2574|1716|1716|572.1
609,12,0.512,33.79,9825.0,0.0034189999999999997,0.999986,AK8 ASB6 CERCAM DPP7 ENTPD2 LCN10 LCN15 LCN6 LCN8 NTMT1 PHPT1 ZNF79,nucleoside diphosphate metabolic process|N-terminal peptidyl-serine methylation|N-terminal peptidyl-serine dimethylation|N-terminal peptidyl-serine trimethylation|peptidyl-histidine dephosphorylation,0.001106|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,40.86|1716|1716|1716|1716
610,5,0.5735,5.735,3644.0,0.001567,0.996692,ASB7 FAM208A MORC2 PPHLN1 ZNF638,positive regulation of DNA methylation-dependent heterochromatin assembly|positive regulation of heterochromatin organization|positive regulation of heterochromatin assembly|positive regulation of chromatin assembly or disassembly|regulation of DNA methylation-dependent heterochromatin assembly,2.204e-06|2.967e-06|2.967e-06|3.391e-06|3.843e-06,0.03477|0.0234|0.0156|0.01337|0.01212,936.1|792.1|792.1|735.5|686.5
611,5,0.5203,5.202999999999999,3998.0,0.001296,0.996692,ASCC1 C9 GCM1 IPP PLLP,astrocyte fate commitment|regulation of cell differentiation involved in embryonic placenta development|DNA dealkylation involved in DNA repair|branching involved in labyrinthine layer morphogenesis|glial cell fate commitment,0.001456|0.001456|0.0032|0.003781|0.004071,1|1|1|1|1,858.1|858.1|343.2|286|264
612,4,0.5171,3.102,2832.0,0.001091,0.9929309999999999,ASCC2 ASCC3 ATP2A2 PAX3,DNA dealkylation involved in DNA repair|DNA dealkylation|DNA modification|calcium ion transport from cytosol to endoplasmic reticulum|regulation of calcium ion-dependent exocytosis of neurotransmitter,1.865e-06|1.067e-05|0.0001534|0.0005825|0.0007766,0.02942|0.08417|0.8065|1|1,1030|396.1|99.98|2574|1716
613,13,0.4851,37.84,9673.0,0.003886,0.999993,FCHSD2 FOLR1 FOLR2 GDPD5 KCTD21 KRTAP5-1 KRTAP5-10 KRTAP5-7 KRTAP5-9 P2RY2 P2RY6 PLEKHB1 UCP3,keratinization|keratinocyte differentiation|epidermal cell differentiation|cellular response to folic acid|skin development,3.124e-07|7.139e-07|1.585e-06|2.569e-06|4.012e-06,0.004927|0.005631|0.008336|0.01013|0.01266,32.55|27.45|23.28|1471|19.2
614,4,0.5244,3.1460000000000004,3195.0,0.0009812000000000002,0.9929309999999999,ASIC3 PI4K2B SEMA3E TBL2,enterobactin transport|detection of chemical stimulus involved in sensory perception of pain|siderophore transport|sensory perception of sour taste|iron coordination entity transport,0.0003883|0.0007766|0.0007766|0.001165|0.00291,1|1|1|1|1,5149|1716|1716|1030|367.8
615,5,0.5288,5.287999999999999,4157.0,0.001267,0.996692,ASIC4 COL5A1 EPPIN FNDC11 RNF114,integrin biosynthetic process|negative regulation of endodermal cell differentiation|negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement,0.0004854|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,4119|1373|1030|1030|1030
616,4,0.5419,3.252,3325.0,0.0009746,0.9929309999999999,ASIC5 MCFD2 MYO1G STAP1,sodium ion transmembrane transport|cell gliding|T cell meandering migration|negative regulation of microglial cell migration|sodium ion transport,0.0003438|0.0004854|0.0004854|0.0004854|0.0007136,1|1|1|1|1,68.65|4119|4119|4119|47.34
617,21,0.5104,107.2,13250.0,0.007997,1.0,ASNA1 CAMLG COG1 COG2 COG3 COG4 COG5 COG6 COG7 COG8 GET4 PTAR1 RAB1B TM9SF3 TRAPPC13 UNC50 VPS51 VPS52 VPS54 WRB YKT6,Golgi vesicle transport|endoplasmic reticulum to Golgi vesicle-mediated transport|establishment of protein localization|protein localization|protein transport,1.489e-18|6.812e-16|4.702e-14|1.582e-13|7.325e-13,2.348e-14|5.372e-12|2.472e-10|6.238e-10|2.311e-09,35.58|55.3|10.44|8.037|10.37
618,4,0.5154,3.092,3142.0,0.0009808999999999998,0.9929309999999999,ASNSD1 DUS1L F13B RIT1,olfactory bulb axon guidance|asparagine biosynthetic process|lymphoid lineage cell migration into thymus|lymphoid lineage cell migration|striatal medium spiny neuron differentiation,0.0004854|0.000728|0.000728|0.000728|0.001213,1|1|1|1|1,4119|2060|2060|2060|1030
619,4,0.5455,3.273,3151.0,0.001035,0.9929309999999999,ASPDH CCDC85C NDUFA4 RIIAD1,"mitochondrial electron transport, cytochrome c to oxygen|aerobic electron transport chain|NAD biosynthetic process|pyridine nucleotide biosynthetic process|nicotinamide nucleotide biosynthetic process",0.004072|0.004072|0.00562|0.0062|0.0062,1|1|1|1|1,257.4|257.4|183.9|166.1|166.1
620,4,0.5558,3.335,3433.0,0.0009682,0.9929309999999999,ASPG CBLN1 CCDC105 LYSMD4,negative regulation of inhibitory synapse assembly|regulation of inhibitory synapse assembly|negative regulation of synapse assembly|positive regulation of long-term synaptic depression|cellular amino acid metabolic process,0.0004854|0.001213|0.001698|0.001698|0.001804,1|1|1|1|1,4119|1030|686.5|686.5|29.53
621,8,0.5037,14.1,4970.0,0.002821,0.9996790000000001,ASPM PFDN1 PFDN4 TBCA TUBA1B TUBA1C TUBB TUBB4B,microtubule cytoskeleton organization|microtubule-based process|negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|cell division,8.397e-07|4.65e-06|1.198e-05|1.789e-05|2.151e-05,0.01325|0.03667|0.06298|0.07055|0.06787,22.74|16.03|429.1|343.2|20.93
622,4,0.5119,3.072,3188.0,0.0009601000000000001,0.9929309999999999,ASRGL1 FAM163A ITGA4 SWT1,asparagine catabolic process via L-aspartate|asparagine catabolic process|clathrin-dependent extracellular exosome endocytosis|negative regulation of protein homodimerization activity|cell-cell adhesion in response to extracellular stimulus,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
623,4,0.5232,3.139,3145.0,0.0009946,0.9929309999999999,ASS1 DCANP1 F2R PCDHB2,negative regulation of secretion|argininosuccinate metabolic process|negative regulation of renin secretion into blood stream|cellular response to amine stimulus|establishment of synaptic specificity at neuromuscular junction,0.0003741|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,63.56|5149|5149|2574|2574
624,4,0.5308,3.185,3194.0,0.0009937000000000001,0.9929309999999999,ASTE1 C22orf39 LRRC73 PHOSPHO1,bone mineralization involved in bone maturation|phosphatidylethanolamine biosynthetic process|ossification involved in bone maturation|bone maturation|animal organ maturation,0.001553|0.003104|0.003104|0.003685|0.004459,1|1|1|1|1,735.5|343.2|343.2|286|234
625,13,0.505,39.39,10510.0,0.0037229999999999997,0.999993,ASTL CFC1 CNNM4 FAHD2A FAM178B IL1F10 IL1RN IL36G LYG1 POTEI SCTR SLC9A2 TUBA3D,inflammatory response to antigenic stimulus|prevention of polyspermy|negative regulation of fertilization|cell wall macromolecule catabolic process|cell wall organization or biogenesis,1.633e-06|0.001891|0.001891|0.001891|0.002521,0.02576|1|1|1|1,135.8|792.1|792.1|792.1|528.1
626,5,0.5522,5.522,4148.0,0.001326,0.996692,ASTN2 GDF6 IMPACT MTMR11 SORCS3,response to benomyl|cellular response to benomyl|GCN2-mediated signaling|positive regulation of translational initiation in response to starvation|regulation of translational initiation in response to starvation,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
627,4,0.5307,3.1839999999999997,3215.0,0.0009871,0.9929309999999999,ATAD1 CLRN1 MAN2A2 MEP1B,"equilibrioception|mannose metabolic process|negative regulation of synaptic transmission, glutamatergic|regulation of postsynaptic neurotransmitter receptor internalization|auditory receptor cell stereocilium organization",0.001747|0.001941|0.002134|0.002522|0.003297,1|1|1|1|1,643.6|572.1|514.9|429.1|321.8
628,20,0.5065,96.24,13140.0,0.007247,1.0,CHCHD3 CLPB CRLS1 DNAJC11 FAM136A HAX1 HTRA2 IMMP2L IMMT MFN2 MTCH2 MTX1 MTX2 OPA1 PARL ROMO1 TIMM13 TIMM17A TIMM44 YME1L1,mitochondrion organization|inner mitochondrial membrane organization|mitochondrial membrane organization|protein localization to mitochondrion|protein targeting to mitochondrion,2.984e-19|3.883e-16|6.618e-15|1.628e-12|2.165e-11,4.707e-15|3.063e-12|3.48e-11|6.418e-09|6.83e-08,31.55|158.4|66.2|87.91|110.3
629,6,0.5276,7.914,4640.0,0.001698,0.998474,ATAD3B ATAD3C CLCNKA FAM131C MMP23B SLC35E2B,mitochondrion organization|blastocyst hatching|organism emergence from protective structure|hatching|excretion,0.007002|0.007839|0.007839|0.007839|0.01188,1|1|1|1|1,15.02|132|132|132|85.81
630,11,0.5288,29.08,7495.0,0.003854,0.999969,ATAD5 CRNKL1 DDRGK1 ESF1 NAA20 NOP56 SHLD1 SIVA1 TRMT6 VPS16 XRN2,ncRNA processing|RNA processing|ribonucleoprotein complex biogenesis|ncRNA metabolic process|rRNA processing,5.798e-05|6.746e-05|7.7e-05|0.0001157|0.0003144,0.9146|0.5321|0.4049|0.4564|0.9919,17.34|10.14|16.11|14.49|21.6
631,10,0.5059,22.77,7765.0,0.002916,0.999933,ATAT1 C6orf48 CLIC1 HLA-DMB MICB MSH5 NEU1 OR2J3 PSORS1C2 TNXB,positive regulation of hindgut contraction|response to retinoic acid|alpha-tubulin acetylation|regulation of hindgut contraction|positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,0.0009704|0.001236|0.001455|0.001455|0.00194,1|1|1|1|1,2060|38.14|1030|1030|686.5
632,9,0.5142,18.51,6662.0,0.002764,0.9998530000000001,ATCAY FUT3 FUT5 FUT6 GNA15 PLIN3 UQCR11 ZNF556 ZNF77,fucosylation|oligosaccharide biosynthetic process|oligosaccharide metabolic process|ceramide metabolic process|fucose catabolic process,6.545e-08|3.124e-07|2.722e-06|8.068e-06|9.31e-06,0.001032|0.002464|0.01431|0.03182|0.02937,403.8|228.8|107.3|73.82|508.5
633,4,0.505,3.03,3146.0,0.0009597000000000002,0.9929309999999999,ATF5 DVL2 MAP4 NAA80,regulation of cellular component organization|N-terminal peptidyl-aspartic acid acetylation|convergent extension involved in neural plate elongation|neural plate elongation|microtubule sliding,0.0001731|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,8.727|5149|2574|2574|2574
634,4,0.5279,3.167,3053.0,0.001033,0.9929309999999999,AKAP2 ATF6B C9orf43 PTBP3,negative regulation of ATF6-mediated unfolded protein response|regulation of ATF6-mediated unfolded protein response|ATF6-mediated unfolded protein response|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|erythrocyte maturation,0.0005825|0.0009706|0.001941|0.002522|0.00291,1|1|1|1|1,2574|1287|572.1|429.1|367.8
635,4,0.5308,3.185,2945.0,0.001077,0.9929309999999999,ATG16L2 OR10R2 S100A14 S100A16,negative stranded viral RNA replication|viral RNA genome replication|toll-like receptor 4 signaling pathway|positive regulation of monocyte chemotaxis|positive regulation of granulocyte chemotaxis,0.0007766|0.002716|0.004266|0.004459|0.005426,1|1|1|1|1,1716|396.1|245.2|234|190.7
636,4,0.5424,3.2539999999999996,3463.0,0.0009368,0.9929309999999999,ATG2B LIPG LIPI SLC34A2,triglyceride metabolic process|acylglycerol metabolic process|neutral lipid metabolic process|triglyceride catabolic process|lipid catabolic process,5.824e-07|1.391e-06|1.43e-06|1.909e-05|3.206e-05,0.009186|0.01097|0.007519|0.07526|0.1011,158.4|117.7|116.6|305.1|40.65
637,9,0.5064,18.23,7207.0,0.002517,0.9998530000000001,ATG4C BSND C1orf123 CYP4X1 GPX7 PCSK9 PLA2G12A ZNF684 ZYG11B,negative regulation of low-density lipoprotein particle receptor binding|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport|negative regulation of receptor-mediated endocytosis involved in cholesterol transport,0.0007765|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,2574|1287|1287|1287|1287
638,7,0.5031,10.56,4654.0,0.002258,0.9992989999999999,ANLN BIRC5 ECT2 KIF23 PRC1 RACGAP1 TOP2A,cell division|mitotic cytokinesis|cytoskeleton-dependent cytokinesis|cytokinesis|cell cycle process,4.693e-12|1.015e-11|5.339e-11|9.452e-11|1.047e-09,7.402e-08|8.003e-08|2.807e-07|3.727e-07|3.304e-06,41.86|216.3|153.2|136.2|19.25
639,19,0.5162,88.27,12070.0,0.007238,1.0,ATL2 BNIP1 C19orf25 FITM2 GOLT1B INPP5K NAPG NBAS RAB18 RAB3GAP1 RAB3GAP2 RINT1 SCFD1 SCFD2 STX18 TBC1D20 USE1 YIPF5 ZW10,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|regulation of ER to Golgi vesicle-mediated transport|Golgi vesicle transport|establishment of protein localization|macromolecule localization",3.087e-12|1.007e-11|9.518e-11|3.174e-10|6.624e-10,4.869e-08|7.944e-08|5.004e-07|1.252e-06|2.09e-06,80.76|326.9|22.29|8.183|5.769
640,4,0.5376,3.2260000000000004,3181.0,0.00101,0.9929309999999999,ATL3 CTF1 NEK4 UBFD1,positive regulation of endoplasmic reticulum tubular network organization|regulation of endoplasmic reticulum tubular network organization|leukemia inhibitory factor signaling pathway|regulation of cellular senescence|regulation of cell aging,0.001213|0.001698|0.002425|0.01064|0.01232,1|1|1|1|1,1030|686.5|457.7|95.79|82.38
641,6,0.5236,7.854,4130.0,0.0018920000000000002,0.998474,ATOX1 NAIF1 SLC30A1 SLC39A10 SLC39A6 UBE3D,cellular transition metal ion homeostasis|transition metal ion transport|transition metal ion homeostasis|zinc ion transmembrane transport|zinc ion transport,1.469e-08|1.982e-08|2.946e-08|4.005e-08|6.151e-08,0.0002318|0.0001563|0.0001549|0.0001579|0.0001941,121.5|112.5|101.7|429.1|367.8
642,4,0.5882,3.529,3197.0,0.0011,0.9929309999999999,ATP10A ODF2L PTDSS2 RWDD3,positive regulation of hypoxia-inducible factor-1alpha signaling pathway|regulation of hypoxia-inducible factor-1alpha signaling pathway|phosphatidylserine biosynthetic process|positive regulation of membrane tubulation|regulation of membrane tubulation,0.0003883|0.0003883|0.0009706|0.001165|0.001553,1|1|1|1|1,5149|5149|1287|1030|735.5
643,4,0.509,3.054,3224.0,0.000944,0.9929309999999999,ATP10D CRH IDNK STEAP2,"D-gluconate catabolic process|aldonic acid catabolic process|negative regulation of circadian sleep/wake cycle, REM sleep|D-gluconate metabolic process|aldonic acid metabolic process",0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
644,4,0.5144,3.0869999999999997,3039.0,0.0010119999999999999,0.9929309999999999,ADIPOR1 ATP11B DLG1 MET,negative regulation of intracellular signal transduction|positive regulation of protein polymerization|branching morphogenesis of an epithelial tube|morphogenesis of a branching epithelium|morphogenesis of a branching structure,5.419e-05|0.0002245|0.0002352|0.0003472|0.0003878,0.8548|1|1|1|1,31.39|82.38|80.45|66.01|62.41
645,12,0.4795,31.65,8017.0,0.00392,0.999986,ATP13A1 BAK1 BAX BCL2L1 BCL2L2 MARCH5 MCL1 PMAIP1 THAP3 UBE2J2 VDAC2 WSB2,signal transduction in absence of ligand|extrinsic apoptotic signaling pathway in absence of ligand|apoptotic signaling pathway|intrinsic apoptotic signaling pathway|apoptotic mitochondrial changes,8.237e-12|8.237e-12|6.39e-11|1.352e-10|1.769e-10,1.299e-07|6.496e-08|3.36e-07|5.332e-07|5.582e-07,286|286|43.53|70.05|148
646,10,0.5348,24.07,6474.0,0.003692,0.999933,CEP350 FGFR1OP FOSL1 JUN JUNB MAP2K4 MAP2K7 MAP3K1 PPP2R3C STK40,Fc-epsilon receptor signaling pathway|response to mechanical stimulus|Fc receptor signaling pathway|activation of protein kinase activity|cellular response to external stimulus,1.062e-06|2.525e-06|3.687e-06|1.272e-05|1.515e-05,0.01675|0.01992|0.01939|0.05018|0.04779,47.62|38.14|34.61|25.19|24.09
647,4,0.5448,3.2689999999999997,3227.0,0.001009,0.9929309999999999,ATP13A4 RDH5 RUSC2 THADA,negative regulation of ATPase-coupled calcium transmembrane transporter activity|negative regulation of endoplasmic reticulum calcium ion concentration|regulation of ATPase-coupled calcium transmembrane transporter activity|cellular calcium ion homeostasis|calcium ion homeostasis,0.0009706|0.001941|0.002328|0.002525|0.002679,1|1|1|1|1,1287|572.1|468.1|24.12|23.4
648,5,0.508,5.08,4193.0,0.001207,0.996692,ATP13A5 MTSS1 NMI SYBU USP46,positive regulation of protein K48-linked ubiquitination|nephron tubule epithelial cell differentiation|regulation of synaptic activity|epithelial cell proliferation involved in renal tubule morphogenesis|regulation of protein K48-linked ubiquitination,0.000728|0.000728|0.0009706|0.001213|0.001213,1|1|1|1|1,2060|2060|1373|1030|1030
649,4,0.5084,3.051,3216.0,0.0009452999999999999,0.9929309999999999,ATP2A3 FAM227B PKIB ZNF232,calcium ion transport from cytosol to endoplasmic reticulum|cytosol to endoplasmic reticulum transport|negative regulation of cAMP-dependent protein kinase activity|negative regulation of receptor binding|positive regulation of telomere capping,0.0005825|0.0009706|0.001941|0.00291|0.003491,1|1|1|1|1,2574|1287|572.1|367.8|302.9
650,8,0.5074,14.21,6366.0,0.002221,0.9996790000000001,ATP2B2 C9orf3 FAM120A FBP1 FBP2 TMEFF1 ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.271e-06|2.118e-06|4.446e-06|1.163e-05|1.649e-05,0.02005|0.01671|0.02338|0.04587|0.05202,2060|1373|823.8|457.7|374.5
651,17,0.5438,73.96,11030.0,0.006640999999999999,1.0,CCDC134 CNPY2 CPD FURIN HSP90B1 IGF1R INSR IRS1 IRS2 KBTBD2 OST4 OSTC PTEN SSR1 SSR2 SSR3 STT3A,response to endogenous stimulus|phosphatidylinositol-mediated signaling|cellular response to hormone stimulus|inositol lipid-mediated signaling|response to hormone,1.579e-08|1.658e-08|1.764e-08|2.087e-08|2.589e-08,0.0002491|0.0001307|9.273e-05|8.229e-05|8.168e-05,7.999|63.56|15.75|60.57|11.48
652,7,0.5181,10.88,6240.0,0.001737,0.9992989999999999,ATP4B BFAR PHOX2A TMC7 TNP2 ZDHHC14 ZKSCAN2,locus ceruleus development|trochlear nerve formation|trochlear nerve morphogenesis|oculomotor nerve formation|oculomotor nerve morphogenesis,0.0006794|0.0006794|0.0006794|0.001019|0.001019,1|1|1|1|1,2942|2942|2942|1471|1471
653,14,0.8961,81.54,9259.0,0.008704,0.9999969999999999,ATP5F1A ATP5F1B ATP5F1C ATP5F1D ATP5F1E ATP5ME ATP5MF ATP5MG ATP5MPL ATP5PB ATP5PD ATP5PF ATP5PO TMEM242,"mitochondrial ATP synthesis coupled proton transport|ATP synthesis coupled proton transport|energy coupled proton transport, down electrochemical gradient|cristae formation|ATP biosynthetic process",1.049e-33|9.303e-33|9.303e-33|1.139e-31|5.173e-31,1.655e-29|7.338e-29|4.892e-29|4.493e-28|1.632e-27,929.1|735.5|735.5|569.4|490.4
654,4,0.5234,3.14,3264.0,0.0009586999999999999,0.9929309999999999,ALDH4A1 ATP5IF1 PIN1 TMEM42,proline catabolic process to glutamate|4-hydroxyproline metabolic process|4-hydroxyproline catabolic process|proline catabolic process|mitochondrial depolarization,0.0007766|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1716|1287|1287|1287|1287
655,4,0.5057,3.034,3206.0,0.0009432,0.9929309999999999,ATP5MC2 CCL23 KRT14 XIRP2,negative regulation of C-C chemokine binding|regulation of C-C chemokine binding|intermediate filament bundle assembly|hemidesmosome assembly|cell junction organization,0.0003883|0.0003883|0.001553|0.002522|0.003456,1|1|1|1|1,5149|5149|735.5|429.1|20.55
656,14,0.5208,47.39,9759.0,0.0048189999999999995,0.9999969999999999,AATF CDC6 CWC25 DDX52 DHX8 NLE1 NSRP1 PSMB3 PSMD11 PSMD3 RPL19 RPL23 RPL27 ZNF830,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|negative regulation of mitotic cell cycle|negative regulation of cell cycle|RNA processing,5.198e-09|8.724e-09|2.464e-08|3.718e-08|3.967e-08,8.199e-05|6.881e-05|0.0001296|0.0001466|0.0001251,75.83|68.11|30.02|18.1|12.75
657,4,0.5017,3.01,2802.0,0.00107,0.9929309999999999,ATP5MGL EIF2B4 PIK3R3 PPP1R15B,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|negative regulation of PERK-mediated unfolded protein response|response to oxygen-containing compound|regulation of translation|response to peptide hormone,0.001165|0.001359|0.001721|0.001885|0.002221,1|1|1|1|1,1030|858.1|9.751|27.98|25.74
658,5,0.5236,5.236000000000001,3934.0,0.001326,0.996692,ATP6AP1L CD36 CYP3A5 GNAT3 PIK3CG,blood coagulation|coagulation|hemostasis|wound healing|sensory perception of taste,3.022e-05|3.083e-05|3.144e-05|9.825e-05|0.0001131,0.4767|0.2431|0.1653|0.3874|0.3567,41.47|41.19|40.92|27.83|121.1
659,19,0.5164,88.3,12360.0,0.00707,1.0,AAGAB AGFG1 AP2A1 AP2A2 AP2B1 AP2M1 AP2S1 C10orf88 CCDC32 CLTC DNM2 FCHO2 PICALM RAB5C SH3GL1 SLC11A2 STEAP3 TFRC WDR7,clathrin-dependent endocytosis|receptor metabolic process|low-density lipoprotein particle receptor catabolic process|low-density lipoprotein receptor particle metabolic process|endocytosis,2.617e-18|1.636e-16|1.389e-15|1.389e-15|3.095e-15,4.128e-14|1.29e-12|7.305e-12|5.479e-12|9.763e-12,305.1|98.07|686.5|686.5|24.43
660,19,0.5187,88.7,11610.0,0.007556,1.0,AP2M1 AP2S1 ATP6V0B ATP6V0C ATP6V0D1 ATP6V1A ATP6V1B2 ATP6V1C1 ATP6V1D ATP6V1E1 ATP6V1F ATP6V1G1 ATP6V1H CCDC115 EMC3 EMC7 TFRC TMEM199 WDR7,intracellular pH reduction|pH reduction|transferrin transport|regulation of intracellular pH|phagosome acidification,9.057e-30|1.81e-29|2.833e-28|1.113e-26|1.758e-26,1.429e-25|1.428e-25|1.49e-24|4.391e-23|5.545e-23,293.6|276.3|361.3|160.1|425.8
661,4,0.5609,3.365,3200.0,0.001048,0.9929309999999999,ALDH1L1 ATP6V0E2 B3GALT1 ZC2HC1C,10-formyltetrahydrofolate catabolic process|folic acid-containing compound catabolic process|pteridine-containing compound catabolic process|10-formyltetrahydrofolate metabolic process|galactolipid biosynthetic process,0.0005825|0.0007766|0.0007766|0.001165|0.001359,1|1|1|1|1,2574|1716|1716|1030|858.1
662,5,0.5128,5.127999999999999,3402.0,0.001501,0.996692,ATP6V1B1 LZTR1 PLCG1 RASA2 SHOC2,regulation of Ras protein signal transduction|regulation of small GTPase mediated signal transduction|negative regulation of Ras protein signal transduction|negative regulation of small GTPase mediated signal transduction|transmembrane receptor protein tyrosine kinase signaling pathway,9.021e-06|3.978e-05|6.219e-05|8.295e-05|0.0001557,0.1423|0.3137|0.327|0.3271|0.4913,62.41|37.79|164.8|142|23.81
663,5,0.5244,5.244,4025.0,0.0012980000000000001,0.996692,ATP6V1C2 CDKN2D DGKQ MOK TIGD6,regulation of progesterone biosynthetic process|autophagic cell death|regulation of cortisol biosynthetic process|regulation of glucocorticoid biosynthetic process|thrombin-activated receptor signaling pathway,0.001213|0.001698|0.00194|0.002183|0.002425,1|1|1|1|1,1030|686.5|588.4|514.9|457.7
664,5,0.5057,5.0569999999999995,4082.0,0.001234,0.996692,ADGRF5 ATP6V1E2 C22orf42 C6orf226 PPP3R1,pharyngeal arch artery morphogenesis|positive regulation of phospholipid biosynthetic process|calcineurin-NFAT signaling cascade|surfactant homeostasis|glomerular filtration,0.002183|0.00291|0.003152|0.003152|0.003636,1|1|1|1|1,514.9|374.5|343.3|343.3|294.2
665,5,0.5093,5.093,4159.0,0.00122,0.996692,ATP8B1 BFSP1 MSANTD3 SIRPD SLC35B3,organophosphate ester transport|3'-phospho-5'-adenylyl sulfate transmembrane transport|3'-phosphoadenosine 5'-phosphosulfate transport|vestibulocochlear nerve formation|vestibulocochlear nerve morphogenesis,0.0004146|0.000728|0.000728|0.001456|0.001698,1|1|1|1|1,62.41|2060|2060|823.8|686.5
666,14,0.5015,45.64,9586.0,0.004724,0.9999969999999999,CCND2 HERPUD1 IKBKB IKZF3 IRF4 MAF MEF2C NFKB1 POU2AF1 PRDM1 RELA RELB SMAD7 TCF3,regulation of transcription by RNA polymerase II|positive regulation of macromolecule metabolic process|positive regulation of metabolic process|positive regulation of transcription by RNA polymerase II|regulation of nitrogen compound metabolic process,1.628e-10|1.647e-10|5e-10|1.128e-09|4.213e-09,2.568e-06|1.299e-06|2.629e-06|4.448e-06|1.329e-05,6.902|5.602|5.169|11.38|3.621
667,18,0.4148,63.47,14310.0,0.004403,1.0,ATP9A BMP7 CASS4 CTSZ EEF1A2 FAM209A FAM209B GNAS MTRNR2L3 NPBWR2 OPRL1 PCK1 PPDPF RBM38 SLC2A4RG STX16 TFAP2C ZGPAT,opioid receptor signaling pathway|cellular response to glucagon stimulus|response to glucagon|positive regulation of osteoblast differentiation|negative regulation of signaling receptor activity,4.729e-05|0.0003088|0.0005788|0.001406|0.001586,0.7459|1|1|1|1,228.8|81.73|58.68|36.91|34.67
668,4,0.5161,3.097,3161.0,0.0009761000000000001,0.9929309999999999,ATP9B C12orf50 FICD ST8SIA3,protein deadenylylation|protein denucleotidylation|protein nucleotidylation|protein adenylylation|protein sialylation,0.0003883|0.0003883|0.0005825|0.0005825|0.001165,1|1|1|1|1,5149|5149|2574|2574|1030
669,4,0.538,3.228,3112.0,0.001034,0.9929309999999999,ATPAF1 OPTN RBAK USP32,negative regulation of receptor recycling|parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization|mitochondrial proton-transporting ATP synthase complex assembly|proton-transporting ATP synthase complex assembly|positive regulation of xenophagy,0.0009706|0.0009706|0.001359|0.001553|0.001553,1|1|1|1|1,1287|1287|858.1|735.5|735.5
670,10,0.5078,22.85,6978.0,0.003254,0.999933,ATR COPB2 ISY1 PIK3R4 RPN1 SEC61A1 SRPRB TOPBP1 U2SURP XAB2,spliceosomal conformational changes to generate catalytic conformation|establishment of protein localization to organelle|DNA repair|cellular response to stress|toxin transport,8.687e-06|9.916e-05|0.000187|0.000227|0.0002901,0.137|0.7821|0.9834|0.8951|0.9152,572.1|15.29|12.95|5.868|81.73
671,13,0.5003,39.02,8426.0,0.004596,0.999993,ATR ATRIP CIP2A H2AFX HUS1 MAD2L2 NBN RAD1 RAD17 RAD9A RFC5 RHNO1 TOPBP1,cell cycle checkpoint|regulation of signal transduction by p53 class mediator|DNA damage checkpoint|DNA integrity checkpoint|DNA replication,1.615e-17|2.297e-17|1.915e-16|3.11e-16|5.35e-16,2.548e-13|1.812e-13|1.007e-12|1.226e-12|1.688e-12,72.65|70.05|88.9|84.06|50.66
672,13,0.4845,37.79,10210.0,0.0036780000000000003,0.999993,C6orf203 COL19A1 DDX43 DPPA5 ENPP3 FAM135A GABRR1 KHDC1 KHDC1L KHDC3L LGSN SMAP1 TCF21,muscle organ development|activation of cysteine-type endopeptidase activity involved in apoptotic process|basophil activation involved in immune response|glutamine biosynthetic process|branchiomeric skeletal muscle development,0.0008336|0.00177|0.002037|0.002037|0.002715,1|1|1|1|1,15.76|32.33|735.5|735.5|490.4
673,4,0.5325,3.195,3078.0,0.001034,0.9929309999999999,ATXN1L BTG4 CIC STK32C,biological process involved in intraspecies interaction between organisms|social behavior|memory|learning|learning or memory,3.738e-05|3.738e-05|0.0001905|0.0002885|0.000894,0.5896|0.2948|1|1|1,205.9|205.9|89.54|72.52|40.86
674,12,0.4273,28.2,8354.0,0.003355,0.999986,ATXN2 ATXN2L CCNI CNOT2 CNOT9 G3BP2 LARP1 LARP4 LARP4B LSM12 NUFIP2 PUM1,regulation of translation|regulation of cellular amide metabolic process|posttranscriptional regulation of gene expression|regulation of cytoplasmic mRNA processing body assembly|stress granule assembly,4.577e-10|1.372e-09|6.888e-09|4.301e-08|2.654e-07,7.22e-06|1.082e-05|3.622e-05|0.0001696|0.0008374,32.65|27.81|21.96|514.9|257.4
675,4,0.5753,3.452,3163.0,0.0010869999999999999,0.9929309999999999,ATXN3 GJD4 MCUR1 SLIRP,negative regulation of mitochondrial RNA catabolic process|protein localization to cytosolic proteasome complex involved in ERAD pathway|protein localization to cytosolic proteasome complex|regulation of mitochondrial RNA catabolic process|monoubiquitinated protein deubiquitination,0.0005825|0.0005825|0.0005825|0.001165|0.001941,1|1|1|1|1,2574|2574|2574|1030|572.1
676,4,0.5226,3.136,3326.0,0.0009394999999999999,0.9929309999999999,AUH C2CD4B GREB1L LTBP1,"putrescine biosynthetic process from arginine, using agmatinase|putrescine biosynthetic process from arginine|agmatine biosynthetic process|spermidine biosynthetic process|regulation of vascular permeability involved in acute inflammatory response",0.0004854|0.0004854|0.000728|0.0009706|0.001213,1|1|1|1|1,4119|4119|2060|1373|1030
677,10,0.6653,29.94,6236.0,0.004763,0.999933,CYB5R4 LCMT1 PPME1 PPP4C PPP4R3A PPP4R3B PPP6C PPP6R3 PTPA TIPRL,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|protein dephosphorylation|regulation of dephosphorylation,4.254e-07|8.33e-07|1.976e-06|3.934e-06|3.934e-06,0.006711|0.00657|0.01039|0.01551|0.01241,61.39|51.65|41.38|34.67|34.67
678,4,0.502,3.012,3135.0,0.0009574999999999999,0.9929309999999999,ARMT1 AVL9 RNF151 TMEM116,protein methylation|protein alkylation|regulation of response to DNA damage stimulus|macromolecule methylation|methylation,0.02444|0.02444|0.04298|0.04786|0.05867,1|1|1|1|1,40.86|40.86|22.99|20.59|16.72
679,5,0.5237,5.237,3919.0,0.0013310000000000002,0.996692,AXDND1 CYP11A1 RUBCNL ZNF563 ZNF564,autophagosome-endosome fusion|cortisol metabolic process|autophagosome-lysosome fusion|glucocorticoid biosynthetic process|tertiary alcohol metabolic process,0.0004854|0.001213|0.001456|0.00291|0.003394,1|1|1|1|1,4119|1030|823.8|374.5|316.8
680,4,0.53,3.18,3193.0,0.0009926,0.9929309999999999,AZI2 GALNTL6 NDUFV1 TMEM63C,dendritic cell proliferation|protein O-linked glycosylation via threonine|glomerular filtration|renal filtration|dendritic cell differentiation,0.0005825|0.001941|0.00291|0.003104|0.007166,1|1|1|1|1,2574|572.1|367.8|343.2|143
681,5,0.5003,5.003,4043.0,0.001233,0.996692,AZU1 BPIFB4 FAM184B MPZL1 SLA2,fractalkine production|neutrophil-mediated killing of bacterium|neutrophil-mediated killing of symbiont cell|neutrophil mediated cytotoxicity|chemokine production,0.0004854|0.001456|0.001456|0.001456|0.002183,1|1|1|1|1,4119|823.8|823.8|823.8|514.9
682,5,0.504,5.04,4229.0,0.001188,0.996692,B3GALNT2 CFC1 LYG1 SCN1A VWA3B,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,0.000728|0.0009706|0.0009706|0.001698|0.001698,1|1|1|1|1,2060|1373|1373|686.5|686.5
683,4,0.5356,3.214,3118.0,0.001027,0.9929309999999999,B3GALT2 LIMA1 NR4A1 ZNF385A,"platelet alpha granule organization|mRNA localization resulting in posttranscriptional regulation of gene expression|positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|cellular response to corticotropin-releasing hormone stimulus",0.0005825|0.0005825|0.0007766|0.0007766|0.001165,1|1|1|1|1,2574|2574|1716|1716|1030
684,5,0.504,5.04,4270.0,0.001176,0.996692,B3GALT4 IFI6 MDM1 QSOX1 SCYL3,negative regulation of mitochondrial depolarization|negative regulation of membrane depolarization|negative regulation of centriole replication|negative regulation of centrosome duplication|negative regulation of centrosome cycle,0.001698|0.00194|0.00194|0.003152|0.003152,1|1|1|1|1,686.5|588.4|588.4|343.3|343.3
685,5,0.5777,5.777,4011.0,0.0014349999999999999,0.996692,B3GALT5 BATF2 FAM107B SCGB2A2 SNX32,poly-N-acetyllactosamine biosynthetic process|poly-N-acetyllactosamine metabolic process|androgen receptor signaling pathway|myeloid dendritic cell differentiation|defense response to protozoan,0.003152|0.003394|0.004604|0.005329|0.006054,1|1|1|1|1,343.3|316.8|228.8|196.1|171.6
686,21,0.6732,141.4,13450.0,0.01037,1.0,B3GALT6 B3GAT3 B4GALT7 C3orf58 EXT1 EXT2 EXTL3 FAM20B FGFR1 FRS2 GLCE GRB2 HS2ST1 NDST1 PTPN11 SLC35B2 SLC39A9 TM9SF3 TMEM165 UGDH XYLT2,proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|proteoglycan metabolic process|heparan sulfate proteoglycan metabolic process|glycoprotein biosynthetic process,3.593e-25|5.903e-24|1.65e-23|4.313e-23|3.241e-19,5.668e-21|4.656e-20|8.678e-20|1.701e-19|1.022e-15,196.1|445.8|138.5|350.3|42.5
687,11,0.5007,27.54,8666.0,0.00316,0.999969,B3GAT2 CGAS COL19A1 DDX43 DPPA5 GABRR1 GJB7 KHDC1 KHDC1L KHDC3L LGSN,regulation of double-strand break repair|activation of cysteine-type endopeptidase activity involved in apoptotic process|glutamine biosynthetic process|regulation of DNA repair|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.0009672|0.001079|0.001601|0.002189|0.002421,1|1|1|1|1,43.54|41.15|936.1|28.58|27.13
688,5,0.5113,5.113,4130.0,0.001234,0.996692,ACACB B3GLCT DCT EDNRB RCBTB2,developmental pigmentation|pigmentation|enteric smooth muscle cell differentiation|posterior midgut development|malonyl-CoA biosynthetic process,3.663e-05|0.0001872|0.0004854|0.000728|0.000728,0.5778|1|1|1|1,216.8|93.61|4119|2060|2060
689,13,0.5063,39.49,9040.0,0.004337,0.999993,ALG8 B3GNT2 B3GNT5 B4GALT3 B4GALT5 GALE SLC35A3 SPPL3 TM9SF2 TMEM165 UGCG UGP2 UXS1,carbohydrate derivative biosynthetic process|carbohydrate derivative metabolic process|protein glycosylation|macromolecule glycosylation|glycosylation,1.106e-11|2.03e-11|4.572e-09|4.572e-09|6.208e-09,1.745e-07|1.601e-07|2.404e-05|1.803e-05|1.958e-05,23.61|15.75|39.28|39.28|37.28
690,12,0.4749,31.34,9221.0,0.003379,0.999986,C11orf53 CLDN25 CRYAB FXYD6 HTR3A HTR3B NXPE1 NXPE2 NXPE4 POU2F3 TENM4 TMEM136,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cardiac cell fate specification|cellular response to catecholamine stimulus,0.0002517|0.00103|0.001055|0.001164|0.001461,1|1|1|1|1,88.01|42.38|41.86|1716|35.39
691,5,0.5209,5.209,4058.0,0.001279,0.996692,ABCG4 B3GNT6 CEP126 FDXACB1 ZNF570,"protein O-linked glycosylation|aminoglycan biosynthetic process|O-glycan processing, core 3|aminoglycan metabolic process|protein glycosylation",0.0003881|0.0004104|0.0005824|0.0009705|0.002031,1|1|1|1|1,66.01|64.16|3432|41.36|28.37
692,5,0.5404,5.404,4064.0,0.001325,0.996692,B3GNT7 ETV2 PPOX SPTA1 TCHHL1,porphyrin-containing compound biosynthetic process|tetrapyrrole biosynthetic process|porphyrin-containing compound metabolic process|tetrapyrrole metabolic process|BMP signaling pathway involved in mesodermal cell fate specification,3.718e-05|3.718e-05|9.313e-05|0.0001791|0.0005824,0.5864|0.2932|0.4897|0.7061|1,221.5|221.5|137.3|98.07|3432
693,4,0.5367,3.22,3317.0,0.0009675,0.9929309999999999,B3GNT9 CYP7A1 NLRP2 SULT1C3,cholesterol metabolic process|secondary alcohol metabolic process|sterol metabolic process|steroid metabolic process|alcohol metabolic process,0.0002174|0.0002536|0.0002766|0.0009653|0.001539,1|1|1|1|1,83.72|77.42|74.08|39.3|31.02
694,4,0.5272,3.1630000000000003,3304.0,0.0009539999999999999,0.9929309999999999,B3GNTL1 BCL7C PLD1 TUBA3C,regulation of microvillus assembly|regulation of synaptic vesicle cycle|regulation of microvillus organization|phosphatidic acid biosynthetic process|phosphatidic acid metabolic process,0.001359|0.001747|0.002716|0.009675|0.01025,1|1|1|1|1,858.1|643.6|396.1|105.1|99.01
695,4,0.5612,3.367,3168.0,0.001059,0.9929309999999999,B4GALNT1 GPR182 STMN2 ZNF254,positive regulation of microtubule depolymerization|lipid glycosylation|negative regulation of microtubule polymerization|ganglioside biosynthetic process|microtubule depolymerization,0.0009706|0.002522|0.002716|0.003297|0.003491,1|1|1|1|1,1287|429.1|396.1|321.8|302.9
696,4,0.5501,3.3,3234.0,0.001017,0.9929309999999999,B4GALNT2 CCDC70 DHRS12 PTTG2,UDP-N-acetylgalactosamine metabolic process|lipid glycosylation|UDP-N-acetylglucosamine metabolic process|negative regulation of mitotic sister chromatid separation|negative regulation of mitotic sister chromatid segregation,0.0007766|0.002522|0.003297|0.006007|0.006007,1|1|1|1|1,1716|429.1|321.8|171.6|171.6
697,5,0.5124,5.124,4069.0,0.001255,0.996692,B4GALT4 BPIFB1 ELF1 TTYH3 ZNF266,negative regulation of toll-like receptor 4 signaling pathway|regulation of toll-like receptor 4 signaling pathway|innate immune response in mucosa|regulation of B cell receptor signaling pathway|keratan sulfate biosynthetic process,0.002667|0.005571|0.005812|0.006295|0.00702,1|1|1|1|1,411.9|187.2|179.1|164.8|147.1
698,4,0.5029,3.0180000000000002,3179.0,0.0009460000000000001,0.9929309999999999,B9D1 KATNBL1 NEMP1 STMP1,positive regulation of NLRP3 inflammasome complex assembly|regulation of NLRP3 inflammasome complex assembly|neuroepithelial cell differentiation|positive regulation of interleukin-1 beta production|embryonic digit morphogenesis,0.001941|0.003104|0.003491|0.01064|0.01122,1|1|1|1|1,572.1|343.2|302.9|95.35|90.33
699,5,0.508,5.08,4077.0,0.001241,0.996692,AARD BAALC FKBP5 FOXL1 NECAB1,visceral mesoderm-endoderm interaction involved in midgut development|Peyer's patch morphogenesis|Peyer's patch development|mucosa-associated lymphoid tissue development|midgut development,0.0004854|0.0009706|0.002183|0.002183|0.003394,1|1|1|1|1,4119|1373|514.9|514.9|316.8
700,9,0.5092,18.33,6729.0,0.00271,0.9998530000000001,BACE1 FXYD6 HTR3A HTR3B KCNJ1 NXPE2 NXPE4 RNF214 TMEM136,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|ion transmembrane transport|cellular response to catecholamine stimulus,0.0001379|0.0005667|0.0005804|0.0006999|0.0008049,1|1|1|1|1,117.4|56.5|55.81|8.709|47.18
701,4,0.5211,3.127,3229.0,0.000965,0.9929309999999999,BACE2 CNPY3 CSGALNACT2 PRCP,"dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|glucose homeostasis|carbohydrate homeostasis|chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|plasma kallikrein-kinin cascade",0.0003883|0.0005069|0.0005122|0.0005825|0.0007766,1|1|1|1|1,5149|54.48|54.2|2574|1716
702,4,0.5426,3.255,3350.0,0.0009686,0.9929309999999999,BACH2 BANK1 FAT4 GPR135,primary adaptive immune response involving T cells and B cells|primary adaptive immune response|condensed mesenchymal cell proliferation|regulation of metanephric nephron tubule epithelial cell differentiation|regulation of nephron tubule epithelial cell differentiation,0.0003883|0.0003883|0.0009706|0.001553|0.002716,1|1|1|1|1,5149|5149|1287|735.5|396.1
703,5,0.5316,5.316,4220.0,0.001255,0.996692,BAG3 LCA5 SEMA7A TENM4 WNT11,developmental growth|growth|protein transport along microtubule|microtubule-based protein transport|cellular response to mechanical stimulus,5.03e-05|5.157e-05|0.0001131|0.0001131|0.0001515,0.7934|0.4067|0.5945|0.4459|0.4781,34.91|34.61|121.1|121.1|104.3
704,5,0.522,5.22,3866.0,0.0013449999999999998,0.996692,BAIAP2L1 CD1B DPEP2 EPS8 OR6K2,actin crosslink formation|actin filament bundle assembly|actin filament bundle organization|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization,5.648e-06|8.295e-05|9.15e-05|0.0007056|0.0008396,0.08909|0.6543|0.4811|1|1,588.4|142|135|47.62|43.59
705,19,0.4899,83.77,14800.0,0.005612,1.0,C17orf47 CSHL1 EPX HOXB5 HOXB6 HOXB7 HOXB8 HOXB9 LPO MKS1 MPO NME1 NME2 OR4D1 OR4D2 PLEKHM1 RSAD1 SEPT4 WNT9B,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|embryonic organ morphogenesis|anterior/posterior pattern specification,2.886e-10|1.293e-09|4.344e-08|1.932e-07|1.135e-06,4.553e-06|1.02e-05|0.0002284|0.0007619|0.00358,69.19|53.31|29.03|22.43|26.18
706,4,0.5621,3.373,3221.0,0.0010429999999999999,0.9929309999999999,BAIAP3 FUT2 MISP PPP1R16B,regulation of endothelial cell proliferation|regulation of dense core granule exocytosis|negative regulation of peptidyl-serine dephosphorylation|dense core granule maturation|secretory granule maturation,0.0002574|0.0003883|0.0007766|0.0007766|0.0009706,1|1|1|1|1,76.85|5149|1716|1716|1287
707,12,0.5256,34.69,7770.0,0.004431,0.999986,ATRIP CIP2A H2AFX HUS1 MAD2L2 PALB2 RAD1 RAD17 RAD9A RFC5 RHNO1 TOPBP1,DNA repair|cell cycle checkpoint|regulation of signal transduction by p53 class mediator|DNA metabolic process|cellular response to DNA damage stimulus,8.858e-15|2.898e-14|3.846e-14|4.044e-13|4.361e-13,1.397e-10|2.285e-10|2.022e-10|1.595e-09|1.376e-09,32.38|72.65|70.05|21.98|21.81
708,10,0.5123,23.06,7777.0,0.002948,0.999933,BARHL1 C9orf84 OR13C3 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 RALGAPA1 TXNDC8,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|sensory perception|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,5.451e-07|7.29e-07|8.416e-07|8.768e-07|1.243e-06,0.008598|0.00575|0.004425|0.003458|0.003922,25.94|24.45|14.11|23.54|21.92
709,4,0.5662,3.397,3152.0,0.001074,0.9929309999999999,BARHL2 CACNG8 SERPINE2 TRIM58,"regulation of synaptic transmission, glutamatergic|positive regulation of synaptic transmission|mating plug formation|seminal vesicle epithelium development|seminal vesicle development",7.196e-05|0.0002425|0.0003883|0.0003883|0.0005825,1|1|1|1|1,147.1|79.21|5149|5149|2574
710,4,0.5276,3.1660000000000004,3378.0,0.0009341000000000001,0.9929309999999999,AGL BARX2 CD276 FBLN5,regulation of removal of superoxide radicals|elastic fiber assembly|glycogen catabolic process|glucan catabolic process|cellular polysaccharide catabolic process,0.001359|0.002328|0.003685|0.003878|0.004072,1|1|1|1|1,858.1|468.1|286|271|257.4
711,8,0.5508,15.42,5372.0,0.0028539999999999998,0.9996790000000001,BATF3 IKZF1 IRF4 JUNB PTPN1 RORC SBNO2 STAT3,leukocyte differentiation|hemopoiesis|hematopoietic or lymphoid organ development|immune system development|myeloid cell differentiation,3.699e-12|1.043e-10|1.802e-10|2.695e-10|9.046e-09,5.835e-08|8.226e-07|9.477e-07|1.063e-06|2.854e-05,51.05|31.5|29.11|27.47|57.21
712,5,0.5036,5.0360000000000005,4273.0,0.001175,0.996692,BBIP1 GSTA1 KLHL31 KRTAP24-1 LIM2,receptor localization to non-motile cilium|protein localization to non-motile cilium|protein localization to ciliary membrane|pigment catabolic process|porphyrin-containing compound catabolic process,0.001456|0.002667|0.002667|0.00412|0.00412,1|1|1|1|1,823.8|411.9|411.9|257.4|257.4
713,4,0.5632,3.3789999999999996,3099.0,0.001086,0.9929309999999999,BBS10 SLC43A1 SRGAP1 ST8SIA6,negative regulation of leucine import|regulation of leucine import|negative regulation of leucine import across plasma membrane|regulation of leucine import across plasma membrane|regulation of amino acid import across plasma membrane,0.0005825|0.0005825|0.0005825|0.0005825|0.002522,1|1|1|1|1,2574|2574|2574|2574|429.1
714,4,0.5086,3.052,3097.0,0.0009818,0.9929309999999999,BBS12 MRGPRX3 OR5P2 TMEM45A,chaperone-mediated protein complex assembly|eating behavior|photoreceptor cell maintenance|negative regulation of fat cell differentiation|intraciliary transport,0.004266|0.005813|0.008903|0.009289|0.01045,1|1|1|1|1,245.2|177.5|114.4|109.5|97.15
715,5,0.5572,5.572,4035.0,0.001376,0.996692,ANO8 BBS2 KRT40 PSMB10 ZNF423,negative regulation of appetite by leptin-mediated signaling pathway|smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation|regulation of cilium beat frequency involved in ciliary motility|cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation|cerebellar granule cell precursor proliferation,0.001213|0.001456|0.00194|0.00194|0.00194,1|1|1|1|1,1030|823.8|588.4|588.4|588.4
716,14,0.5094,46.36,9073.0,0.005068,0.9999969999999999,AMOTL2 CAB39 FRYL KIRREL1 LATS2 MAP4K4 NF2 PDCD10 PTPN14 RALGAPB RNF146 SAV1 STK24 TAOK1,hippo signaling|intracellular signal transduction|regulation of protein kinase activity|regulation of kinase activity|anatomical structure morphogenesis,1.109e-06|2.349e-06|7.885e-06|1.654e-05|2.276e-05,0.0175|0.01853|0.04146|0.06524|0.07181,157.6|7.472|11.07|9.721|5.512
717,15,0.5072,53.25,11730.0,0.004508,0.999999,ADCY10 ATXN7L3B BBS7 CARNS1 CCNB1IP1 FEZF2 KIF26B MAP3K7CL NIPSNAP3B PCDHB12 PCDHB13 PCDHGA9 RNF114 SDR39U1 ZNF286A,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|carnosine biosynthetic process|pigment granule aggregation in cell center|carnosine metabolic process,0.0002332|0.0008252|0.001455|0.002182|0.002182,1|1|1|1|1,24.66|15.9|1373|686.5|686.5
718,4,0.5659,3.395,3342.0,0.0010119999999999999,0.9929309999999999,BCAN ERGIC1 RASGRF1 TMC5,synapse maturation|dermatan sulfate biosynthetic process|dermatan sulfate metabolic process|chondroitin sulfate catabolic process|dermatan sulfate proteoglycan biosynthetic process,0.002522|0.002522|0.002716|0.00291|0.003104,1|1|1|1|1,429.1|429.1|396.1|367.8|343.2
719,4,0.5792,3.475,3287.0,0.0010539999999999998,0.9929309999999999,ALDH16A1 BCAP29 CGNL1 KLK3,zymogen activation|protein processing|Factor XII activation|antibacterial peptide production|antimicrobial peptide production,5.517e-05|0.0007217|0.000728|0.000728|0.000728,0.8703|1|1|1|1,175.3|47.07|2060|2060|2060
720,4,0.5789,3.4730000000000003,3209.0,0.001078,0.9929309999999999,ADAMTS13 BCAS1 TRAF1 USP30,protein K6-linked deubiquitination|cellular response to tumor necrosis factor|response to tumor necrosis factor|negative regulation of mitophagy|negative regulation of autophagy of mitochondrion,0.0007766|0.0008662|0.00107|0.001165|0.001553,1|1|1|1|1,1716|41.52|37.31|1030|735.5
721,4,0.5484,3.2910000000000004,3002.0,0.001092,0.9929309999999999,BCDIN3D SWSAP1 ZNF69 ZSWIM7,double-strand break repair via homologous recombination|recombinational repair|miRNA 2'-O-methylation|protein stabilization|double-strand break repair,0.0001476|0.0001534|0.0003883|0.0005446|0.000578,1|1|1|1|1,102|99.98|5149|52.54|50.98
722,4,0.6032,3.6189999999999998,3255.0,0.001108,0.9929309999999999,BCKDHB GNPDA2 IFT52 KCNB1,glucosamine catabolic process|N-acetylglucosamine catabolic process|intraciliary anterograde transport|organic acid catabolic process|glucosamine metabolic process,0.0005825|0.0007766|0.0007766|0.000812|0.0009706,1|1|1|1|1,2574|1716|1716|42.91|1287
723,14,0.4878,44.39,9666.0,0.0045579999999999996,0.9999969999999999,BCL10 CYLD IKBKB N4BP1 NFKB2 NFKBIA NFKBIB NFKBIE SPATA2 STUB1 TNFAIP3 TNIP1 TRAF2 TRAF3,pattern recognition receptor signaling pathway|regulation of DNA-binding transcription factor activity|toll-like receptor signaling pathway|regulation of I-kappaB kinase/NF-kappaB signaling|protein deubiquitination,1.701e-14|5.193e-14|8.187e-11|2.105e-10|5.259e-10,2.683e-10|4.096e-10|4.305e-07|8.3e-07|1.659e-06,86.49|31.71|81.56|39.55|34.57
724,4,0.5763,3.458,2953.0,0.001167,0.9929309999999999,ACBD3 BCL11A FLT3 ZFP64,negative regulation of branching morphogenesis of a nerve|negative regulation of protein homooligomerization|negative regulation of protein oligomerization|negative regulation of neuron remodeling|regulation of neuron remodeling,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
725,4,0.5281,3.168,3138.0,0.001006,0.9929309999999999,BCL2A1 GLRX2 GPR87 SELENOT,cell redox homeostasis|aging|DNA protection|translational readthrough|selenocysteine incorporation,3.048e-05|0.00107|0.001165|0.001747|0.001747,0.4809|1|1|1|1,228.8|37.31|1030|643.6|643.6
726,19,0.5117,87.5,15440.0,0.005621,1.0,AP5S1 AVP CDC25B HSPA12B LZTS3 MAVS OXT PLCB1 PLCB4 PRND RASSF2 RSPO4 SIRPA SIRPB1 SIRPG SPEF1 TGM3 TGM6 TMEM239,maternal aggressive behavior|aggressive behavior|positive regulation of phagocytosis|female mating behavior|hyperosmotic salinity response,8.035e-06|2.886e-05|3.064e-05|3.606e-05|3.606e-05,0.1267|0.2276|0.1611|0.1422|0.1138,722.6|309.7|50.81|271|271
727,5,0.5153,5.153,4223.0,0.001216,0.996692,BCL2L11 BLOC1S2 GMPR NEIL2 SPINT3,mitochondrial outer membrane permeabilization|positive regulation of mitochondrial membrane permeability involved in apoptotic process|mitochondrial outer membrane permeabilization involved in programmed cell death|positive regulation of mitochondrial membrane permeability|regulation of mitochondrial membrane permeability involved in apoptotic process,7.2e-06|8.939e-06|1.087e-05|1.411e-05|1.65e-05,0.1136|0.07051|0.05714|0.05564|0.05206,514.9|457.7|411.9|358.2|329.5
728,4,0.5769,3.4619999999999997,3156.0,0.001093,0.9929309999999999,BCL2L12 FCRLB IFT80 PMAIP1,regulation of extrinsic apoptotic signaling pathway|regulation of intrinsic apoptotic signaling pathway|regulation of signal transduction by p53 class mediator|inhibition of cysteine-type endopeptidase activity involved in apoptotic process|regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.0003472|0.0003561|0.0005446|0.0005825|0.0006358,1|1|1|1|1,66.01|65.17|52.54|2574|48.57
729,4,0.5703,3.4219999999999997,3140.0,0.001086,0.9929309999999999,BCL2L14 DPPA4 KIRREL2 RMDN2,positive regulation of extrinsic apoptotic signaling pathway|somatic stem cell population maintenance|positive regulation of apoptotic signaling pathway|stem cell population maintenance|maintenance of cell number,0.009482|0.01276|0.02367|0.02444|0.02482,1|1|1|1|1,107.3|79.21|42.2|40.86|40.22
730,11,0.5267,28.97,7256.0,0.003965,0.999969,BLM FANCM NFATC2IP NSMCE1 NSMCE3 NSMCE4A RMI1 RMI2 SMC6 TOP3A TRAIP,DNA metabolic process|DNA repair|DNA recombination|cellular response to DNA damage stimulus|double-strand break repair via homologous recombination,6.984e-14|2.818e-13|6.454e-12|9.404e-12|1.476e-09,1.102e-09|2.223e-09|3.393e-08|3.708e-08|4.658e-06,23.97|31.79|58.51|21.41|92.69
731,4,0.5463,3.278,3343.0,0.000977,0.9929309999999999,BCL9 CAMKK1 MDGA1 MEIOB,regulation of synaptic membrane adhesion|myotube differentiation involved in skeletal muscle regeneration|female meiosis I|spinal cord association neuron differentiation|resolution of meiotic recombination intermediates,0.0009706|0.001747|0.001941|0.002522|0.003685,1|1|1|1|1,1287|643.6|572.1|429.1|286
732,12,0.5022,33.15,8437.0,0.0039020000000000005,0.999986,BCL9L BMPR1A FOXA2 HNF1A HNF4A IPO8 LRIG3 RGMB SMAD1 SMAD7 TCF7L2 UBAC1,"transmembrane receptor protein serine/threonine kinase signaling pathway|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|positive regulation of RNA metabolic process",7.465e-10|2.108e-08|2.108e-08|2.119e-08|3.484e-08,1.178e-05|0.0001662|0.0001108|8.357e-05|0.0001099,52.27|9.523|9.523|9.517|8.991
733,4,0.5567,3.34,2980.0,0.001117,0.9929309999999999,BDH2 BRAP SNX14 USP47,siderophore biosynthetic process|siderophore metabolic process|positive regulation of histone deacetylase activity|regulation of histone deacetylase activity|positive regulation of deacetylase activity,0.0004854|0.0004854|0.001698|0.002425|0.002425,1|1|1|1|1,4119|4119|686.5|457.7|457.7
734,5,0.5234,5.234,4306.0,0.0012109999999999998,0.996692,ARMH1 AZIN2 BDKRB1 GKN2 ZBTB8A,trans-Golgi network membrane organization|positive regulation of polyamine transmembrane transport|agmatine biosynthetic process|putrescine biosynthetic process from ornithine|positive regulation of ion transmembrane transport,0.0004854|0.000728|0.000728|0.0009706|0.001267,1|1|1|1|1,4119|2060|2060|1373|35.36
735,5,0.5111,5.111000000000001,4283.0,0.001189,0.996692,BDKRB2 COX7A1 PIK3C2G PROK2 SLC10A6,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|sodium-dependent organic anion transport|monocarboxylic acid transport|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.0004854|0.0004854|0.0004854|0.0005471|0.001213,1|1|1|1|1,4119|4119|4119|54.2|1030
736,6,0.5004,7.506,4903.0,0.001525,0.998474,BEAN1 CELF6 GOLGA6B GOLGA6D PARP6 SCAMP2,Golgi organization|protein auto-ADP-ribosylation|protein mono-ADP-ribosylation|endomembrane system organization|protein ADP-ribosylation,0.0006471|0.00349|0.003781|0.007948|0.008707,1|1|1|1|1,50.85|312|286|14.07|118.4
737,4,0.5607,3.364,3105.0,0.00108,0.9929309999999999,ANTXRL BEGAIN KIAA0408 OR1M1,regulation of postsynaptic neurotransmitter receptor activity|toxin transport|regulation of neurotransmitter receptor activity|regulation of nervous system process|regulation of signaling receptor activity,0.003878|0.008324|0.01698|0.02786|0.03733,1|1|1|1|1,271|122.6|59.18|35.76|26.54
738,6,0.5078,7.617000000000001,4792.0,0.001583,0.998474,BEND3 LRRTM3 MORN4 PAPSS2 SFTPA2 SFXN2,sulfate assimilation|serine import into mitochondrion|histone H3-K27 trimethylation|histone H3-K9 trimethylation|histone H4-K20 trimethylation,0.0008735|0.001165|0.001456|0.001456|0.001746,1|1|1|1|1,1716|1144|858.1|858.1|686.5
739,7,0.5183,10.88,5218.0,0.002076,0.9992989999999999,ADIPOR2 BCL2 BEND4 IRF8 MEF2D SIK3 ZFP64,"plasmacytoid dendritic cell differentiation|negative regulation of cellular pH reduction|negative regulation of hepatic stellate cell migration|CD8-positive, alpha-beta T cell lineage commitment|regulation of hepatic stellate cell migration",0.0006794|0.0006794|0.0006794|0.001019|0.001019,1|1|1|1|1,2942|2942|2942|1471|1471
740,5,0.5434,5.434,3863.0,0.001401,0.996692,BEND5 CD3G CLCN6 DHRS4L2 GRP,neuropeptide signaling pathway|positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|psychomotor behavior|regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of SMAD protein signal transduction,0.0007886|0.00194|0.00194|0.002328|0.003103,1|1|1|1|1,47.24|643.6|643.6|514.9|367.8
741,5,0.5088,5.088,4075.0,0.0012439999999999999,0.996692,BEND6 BSPH1 OR2T35 RETREG2 ZC3H14,negative regulation of mRNA polyadenylation|negative regulation of mRNA 3'-end processing|regulation of mRNA polyadenylation|sperm capacitation|regulation of mRNA 3'-end processing,0.002183|0.002425|0.004362|0.006537|0.00702,1|1|1|1|1,514.9|457.7|242.3|158.4|147.1
742,23,0.4622,116.9,17910.0,0.006468000000000001,1.0,C3AR1 CLEC12A CLEC12B CLEC2A CLEC2B CLEC4C CLEC4D CLEC6A GALNT8 KCNA1 KCNA6 KLRC1 PKP2 PRB4 PRH2 PZP RERGL SLCO1C1 TAS2R13 TAS2R20 TAS2R30 TAS2R7 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|natural killer cell inhibitory signaling pathway,7.915e-10|1.443e-09|1.613e-09|1.55e-08|1.188e-05,1.249e-05|1.138e-05|8.482e-06|6.112e-05|0.03748,124.4|109.2|106.6|65.84|597
743,16,0.5067,60.8,13010.0,0.00464,0.999999,AGO1 AGO3 AGO4 BEST4 C1orf123 C1orf50 CFAP57 CYP4Z1 ERMAP LURAP1 MFSD2A PPT1 ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",3.731e-08|5.128e-08|6.835e-08|1.737e-07|1.737e-07,0.0005886|0.0004045|0.0003594|0.0006848|0.0005479,588.4|514.9|457.7|316.8|316.8
744,23,0.4846,122.6,15690.0,0.007732999999999999,1.0,BET1 BUD31 COPS6 CPSF4 CRCP EXOC4 LAMTOR4 LSM8 MCM7 MEPCE NOM1 NUP205 ORC5 PMPCB POP7 PSMC2 RBM28 RBM48 RINT1 SEM1 SRRT TNPO3 ZNHIT1,nucleic acid metabolic process|nucleobase-containing compound metabolic process|heterocycle metabolic process|cellular aromatic compound metabolic process|organic cyclic compound metabolic process,1.146e-06|9.312e-06|1.847e-05|2.157e-05|4.841e-05,0.01808|0.07344|0.09711|0.08508|0.1527,4.814|3.952|3.7|3.645|3.368
745,4,0.5676,3.405,3251.0,0.001044,0.9929309999999999,ACRBP BET1L EGFLAM TTC23L,"regulation of retrograde vesicle-mediated transport, Golgi to ER|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|acrosome assembly|secretory granule organization|chondroitin sulfate metabolic process",0.0005825|0.001359|0.003297|0.006973|0.007552,1|1|1|1|1,2574|858.1|321.8|147.1|135.5
746,4,0.5151,3.091,3188.0,0.0009663,0.9929309999999999,BFSP2 FBXL14 SLC5A9 TMEM61,lens fiber cell development|intermediate filament organization|lens fiber cell differentiation|glucose transmembrane transport|hexose transmembrane transport,0.002716|0.004846|0.00504|0.006586|0.007359,1|1|1|1|1,396.1|214.5|205.9|156|139.2
747,4,0.5815,3.489,2943.0,0.001181,0.9929309999999999,ARHGAP29 BGLAP BTBD9 RTN1,"circadian sleep/wake cycle, non-REM sleep|circadian sleep/wake cycle, sleep|response to hydroxyisoflavone|response to vitamin K|circadian sleep/wake cycle process",0.0003883|0.0007766|0.0009706|0.0009706|0.0009706,1|1|1|1|1,5149|1716|1287|1287|1287
748,4,0.5607,3.364,3300.0,0.001016,0.9929309999999999,BHLHA9 GAS2L1 RAB15 RAPGEF4,protein secretion|establishment of protein localization to extracellular region|protein localization to extracellular region|peptide secretion|regulation of exocytosis,0.0001593|0.0001623|0.000184|0.0002174|0.000595,1|1|0.9677|0.8575|1,98.07|97.15|91.13|83.72|50.23
749,4,0.5045,3.0269999999999997,2977.0,0.001013,0.9929309999999999,BHLHE22 DNAJB1 RAB3A TSEN34,positive regulation of ATPase activity|regulation of ATPase activity|evoked neurotransmitter secretion|regulation of plasma membrane repair|tRNA-type intron splice site recognition and cleavage,4.987e-05|9.574e-05|0.0003883|0.0007766|0.0007766,0.7867|0.7551|1|1|1,177.5|127.1|5149|1716|1716
750,4,0.543,3.258,3104.0,0.001046,0.9929309999999999,AVPR1A BHLHE23 PRX PTPRO,regulation of renal system process|cell differentiation|cellular developmental process|regulation of systemic arterial blood pressure|peptidyl-tyrosine dephosphorylation,2.96e-05|0.0001441|0.0001553|0.0002265|0.0002695,0.4668|1|0.8166|0.8932|0.8503,242.3|5.869|5.782|84.93|77.72
751,8,0.6003,16.81,5622.0,0.002972,0.9996790000000001,IL6R IL6ST JAK1 LIFR SBNO2 SLC39A1 SOCS3 STAT3,cellular response to interleukin-6|response to interleukin-6|interleukin-6-mediated signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|cellular response to cytokine stimulus,1.38e-15|2.462e-15|6.081e-14|2.15e-09|5.251e-09,2.176e-11|1.942e-11|3.197e-10|8.478e-06|1.657e-05,429.1|386.2|715.1|1545|17.9
752,17,0.4618,62.8,12550.0,0.004966,1.0,AQP7 CBWD1 CBWD2 CBWD5 CNN2 CNTNAP3 CNTNAP3B FOXD4 FOXD4L4 FOXD4L5 IL11RA OR2S2 PGM5 SPATA31A6 SPATA31A7 ST3GAL1 ZNF658,"memory B cell differentiation|immunological memory formation process|immunological memory process|negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process|interleukin-11-mediated signaling pathway",0.001649|0.002472|0.002472|0.002472|0.003295,1|1|1|1|1,1211|605.7|605.7|605.7|403.8
753,4,0.5156,3.094,3158.0,0.0009761000000000001,0.9929309999999999,ARGFX BHMT2 LZTS2 THOC5,S-methylmethionine metabolic process|primary ureteric bud growth|nuclear export|nucleocytoplasmic transport|nuclear transport,0.0003883|0.0003883|0.0003925|0.0009436|0.0009653,1|1|1|1|1,5149|5149|62.03|39.76|39.3
754,19,0.4928,84.27,13610.0,0.006137,1.0,GMIP MEF2B SSBP4 ZNF100 ZNF101 ZNF124 ZNF14 ZNF195 ZNF253 ZNF43 ZNF443 ZNF486 ZNF492 ZNF682 ZNF714 ZNF737 ZNF91 ZNF98 ZNF99,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.067e-15|1.93e-13|1.94e-13|1.99e-13|7.455e-13,1.683e-11|1.522e-09|1.02e-09|7.847e-10|2.352e-09,7.545|5.633|5.631|5.623|5.22
755,4,0.5444,3.266,3389.0,0.0009606,0.9929309999999999,BICDL1 FTCD PLXNA2 TLL2,negative regulation of skeletal muscle tissue growth|Golgi to secretory granule transport|cerebellar granule cell precursor tangential migration|hindbrain tangential cell migration|formamide metabolic process,0.0005825|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,2574|2574|2574|1716|1287
756,4,0.5511,3.307,3003.0,0.001097,0.9929309999999999,BICRA BICRAL RASD2 ZXDC,positive regulation of nitrogen compound metabolic process|positive regulation of cellular metabolic process|positive regulation of macromolecule metabolic process|positive regulation of metabolic process|positive regulation of nucleic acid-templated transcription,0.0004874|0.0006126|0.0007721|0.001066|0.001845,1|1|1|1|1,6.735|6.36|6.003|5.538|9.523
757,4,0.5569,3.341,3245.0,0.001026,0.9929309999999999,BIK RABL2B TEX9 VAV2,plasma membrane bounded cell projection assembly|cell projection assembly|positive regulation of release of cytochrome c from mitochondria|positive regulation of phosphatidylinositol 3-kinase activity|lamellipodium assembly,0.003036|0.003243|0.00562|0.006973|0.007166,1|1|1|1|1,21.96|21.23|183.9|147.1|143
758,4,0.575,3.45,3206.0,0.001072,0.9929309999999999,BIN1 MAP3K19 MTRNR2L4 SCYL2,endosome to lysosome transport|lysosomal transport|vacuolar transport|negative regulation of cardiac muscle cell contraction|negative regulation of ventricular cardiac muscle cell action potential,4.185e-05|0.0001714|0.0003257|0.0003883|0.0003883,0.6602|1|1|1|1,194.3|94.47|68.2|5149|5149
759,11,0.5305,29.18,7328.0,0.003954,0.999969,BIRC6 DNAJA1 DNAJC7 EIF2AK1 EIF2B4 HECTD1 KCMF1 PPP1R15B UBA6 UBR4 USP19,protein modification by small protein conjugation or removal|cellular protein metabolic process|regulation of cellular response to stress|cellular protein modification process|protein modification process,5.948e-06|6.656e-06|1.621e-05|2.337e-05|2.337e-05,0.09382|0.0525|0.08522|0.09217|0.07373,10.9|4.625|13.67|4.961|4.961
760,6,0.5249,7.874,4723.0,0.0016600000000000002,0.998474,BIVM COL4A1 COL4A2 F7 KDELC1 PLA2G4A,collagen-activated tyrosine kinase receptor signaling pathway|collagen-activated signaling pathway|collagen fibril organization|response to amino acid|response to acid chemical,4.284e-06|6.401e-06|0.0002548|0.0002951|0.0004024,0.06758|0.05048|1|1|1,686.5|549.2|79.98|74.22|63.37
761,17,0.482,65.55,13020.0,0.004998,1.0,BIRC3 C11orf88 CARD16 CEP126 CFAP300 FAM76B FOLR2 MMP1 MMP10 MMP13 MMP20 MMP27 MMP3 MMP7 MMP8 P2RY6 SYT9,collagen catabolic process|collagen metabolic process|extracellular matrix disassembly|extracellular matrix organization|extracellular structure organization,9.516e-20|1.67e-18|1.604e-13|1.213e-11|1.241e-11,1.501e-15|1.317e-14|8.435e-10|4.784e-08|3.915e-08,239.5|168.8|121.4|26.96|26.89
762,4,0.5288,3.173,3341.0,0.0009465,0.9929309999999999,BLMH FAM171B HS3ST6 PREX2,homocysteine catabolic process|homocysteine metabolic process|sulfur amino acid catabolic process|blastocyst hatching|organism emergence from protective structure,0.0007766|0.002716|0.002716|0.005233|0.005233,1|1|1|1|1,1716|396.1|396.1|198|198
763,5,0.5351,5.351,4206.0,0.001267,0.996692,ADAM23 BAG4 BLNK HRH4 IMPACT,"negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity|regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity|response to benomyl|negative regulation of mRNA modification|cellular response to benomyl",0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
764,4,0.5784,3.47,3170.0,0.001091,0.9929309999999999,BLOC1S4 CTAGE15 DCLRE1C UNC80,protection from non-homologous end joining at telomere|telomere maintenance in response to DNA damage|Golgi vesicle transport|V(D)J recombination|synaptic vesicle transport along microtubule,0.001553|0.002134|0.002177|0.003297|0.003297,1|1|1|1|1,735.5|514.9|26|321.8|321.8
765,6,0.5226,7.8389999999999995,4942.0,0.00158,0.998474,LAMP3 SCN7A STYXL1 TGFBR3 TMEM222 UBXN11,negative regulation of stress granule assembly|definitive erythrocyte differentiation|transforming growth factor beta receptor complex assembly|epicardium-derived cardiac fibroblast cell development|epicardium-derived cardiac fibroblast cell differentiation,0.0005824|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,3432|1144|1144|1144|1144
766,28,0.5039,190.5,17830.0,0.01054,1.0,AP3B1 AP3D1 ARL8B BLOC1S1 FNIP1 GDAP2 HTT LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MIOS MTMR9 RAB7A RRAGA RRAGC SNAPIN SPG21 TBC1D5 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41 WDR24,positive regulation of TOR signaling|endosomal transport|lysosomal transport|cellular localization|cellular protein localization,1.911e-17|2.617e-16|5.08e-16|5.163e-16|5.707e-16,3.014e-13|2.064e-12|2.671e-12|2.036e-12|1.801e-12,148.6|36.58|65.15|5.676|8.666
767,5,0.5133,5.132999999999999,4250.0,0.0012029999999999999,0.996692,BLVRA GOLGA3 HYAL4 NXN SPAM1,hyaluronan catabolic process|hyaluronan metabolic process|glycosaminoglycan catabolic process|aminoglycan catabolic process|mucopolysaccharide metabolic process,8.939e-06|2.795e-05|9.445e-05|0.0001131|0.0002847,0.141|0.2205|0.4966|0.4459|0.8982,457.7|249.6|132.9|121.1|75.58
768,4,0.569,3.4139999999999997,3147.0,0.0010810000000000001,0.9929309999999999,ACOT1 BLZF1 MMP16 RDH11,cellular detoxification of aldehyde|chondrocyte proliferation|cellular response to aldehyde|retinal metabolic process|craniofacial suture morphogenesis,0.001747|0.002328|0.002522|0.003104|0.003878,1|1|1|1|1,643.6|468.1|429.1|343.2|271
769,4,0.5431,3.259,3344.0,0.0009711,0.9929309999999999,BMP1 INTU TP53I3 XIRP2,animal organ morphogenesis|tongue morphogenesis|tissue development|negative regulation of keratinocyte proliferation|high-density lipoprotein particle assembly,0.0003753|0.002134|0.002236|0.002716|0.002716,1|1|1|1|1,16.35|514.9|8.918|396.1|396.1
770,4,0.5196,3.1180000000000003,3212.0,0.0009673,0.9929309999999999,BMP10 PLD4 PYCARD SLC12A1,regulation of cytokine production involved in inflammatory response|positive regulation of supramolecular fiber organization|positive regulation of antigen processing and presentation of peptide antigen via MHC class II|positive regulation of antigen processing and presentation of peptide antigen|positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,3.454e-05|0.0005501|0.0005825|0.0005825|0.0005825,0.5448|1|1|1|1,214.5|52.27|2574|2574|2574
771,5,0.5071,5.071000000000001,4271.0,0.001183,0.996692,ADRB3 B3GLCT BMP2 EDNRB TEX15,vasodilation|regulation of response to stress|blood vessel diameter maintenance|regulation of tube diameter|regulation of tube size,3.128e-05|0.0001501|0.0003784|0.0003784|0.0003843,0.4935|1|1|1|1,235.4|10.66|65.38|65.38|64.87
772,7,0.5099,10.71,4658.0,0.002287,0.9992989999999999,ARPC4 ETFRF1 FGFR1OP2 MOB4 RAC1 SLMAP STRIP1,actin filament polymerization|cortical cytoskeleton organization|actin polymerization or depolymerization|ephrin receptor signaling pathway|protein polymerization,6.2e-05|0.0001735|0.0001853|0.0003736|0.0004631,0.978|1|0.9744|1|1,173.1|101.5|98.07|68.42|61.29
773,5,0.5076,5.0760000000000005,4096.0,0.001235,0.996692,BMP3 FRZB LRRC66 SEPT10 SNTG1,negative regulation of hepatocyte differentiation|regulation of hepatocyte differentiation|convergent extension involved in organogenesis|convergent extension|skeletal system development,0.0004854|0.000728|0.001456|0.003394|0.005025,1|1|1|1|1,4119|2060|823.8|316.8|17.49
774,4,0.5223,3.134,3173.0,0.0009841000000000001,0.9929309999999999,BMP5 DRD2 HS6ST3 PLCH2,endocrine system development|allantois development|orbitofrontal cortex development|neural fold elevation formation|negative regulation of dopamine receptor signaling pathway,0.0002174|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,83.72|2574|1716|1716|1716
775,5,0.5002,5.002,3954.0,0.00126,0.996692,ALDH1L1 BMP6 GPR87 NPHP3 PLSCR2,pancreas development|determination of stomach left/right asymmetry|determination of intestine left/right asymmetry|regulation of planar cell polarity pathway involved in neural tube closure|positive regulation of aldosterone secretion,0.000123|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,116|4119|4119|4119|2060
776,4,0.506,3.036,2943.0,0.0010279999999999998,0.9929309999999999,BCHE BMP8B OR2T12 REG4,cocaine metabolic process|tropane alkaloid metabolic process|neuroblast differentiation|alkaloid metabolic process|choline metabolic process,0.0003883|0.0003883|0.001165|0.001553|0.001941,1|1|1|1|1,5149|5149|1030|735.5|572.1
777,5,0.538,5.38,4133.0,0.001297,0.996692,BMPR1B CASP10 CXCR2 GPBAR1 SPARC,regulation of cell population proliferation|cell surface bile acid receptor signaling pathway|interleukin-8-mediated signaling pathway|positive regulation of cholangiocyte proliferation|fused antrum stage,0.0005316|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,8.372|3432|1716|1716|1144
778,8,0.5023,14.06,5673.0,0.002466,0.9996790000000001,BMS1 DDX21 HNRNPH1 NOC3L PDCD11 RRP12 SUPV3L1 TIMM23,RNA processing|rRNA processing|rRNA metabolic process|ribosome biogenesis|nucleic acid metabolic process,1.241e-08|4.095e-08|4.926e-08|1.357e-07|1.57e-07,0.0001958|0.0003229|0.000259|0.0005351|0.0004952,17.35|44.01|42.38|34.46|8.202
779,4,0.5594,3.3560000000000003,3092.0,0.001082,0.9929309999999999,BNC2 ECHDC2 GNRH1 HAND1,embryonic heart tube formation|cardiac left ventricle formation|mesenchyme development|response to prolactin|cardiac right ventricle formation,0.0003883|0.0005825|0.0006717|0.0007766|0.0009706,1|1|1|1|1,5149|2574|47.24|1716|1287
780,5,0.5199,5.199,4127.0,0.001255,0.996692,ANTXR2 BNIP3L CHRNA6 CYP2E1 FUT4,4-nitrophenol metabolic process|benzene metabolic process|carbon tetrachloride metabolic process|halogenated hydrocarbon metabolic process|response to ozone,0.0004854|0.0004854|0.0004854|0.000728|0.001213,1|1|1|1|1,4119|4119|4119|2060|1030
781,4,0.5522,3.313,3159.0,0.001045,0.9929309999999999,BOD1 C6orf201 FAM217A RNF133,"mitotic sister chromatid biorientation|mitotic sister chromatid cohesion, centromeric|sister chromatid biorientation|centromeric sister chromatid cohesion|attachment of mitotic spindle microtubules to kinetochore",0.0003883|0.0007766|0.0007766|0.001553|0.002522,1|1|1|1|1,5149|1716|1716|735.5|429.1
782,4,0.5034,3.02,3021.0,0.0009962,0.9929309999999999,BOD1L1 CPN2 DDX42 NUB1,replication fork processing|DNA-dependent DNA replication maintenance of fidelity|negative regulation of phosphoprotein phosphatase activity|negative regulation of protein dephosphorylation|positive regulation of proteasomal ubiquitin-dependent protein catabolic process,0.007745|0.009482|0.01237|0.01333|0.01756,1|1|1|1|1,132|107.3|81.73|75.72|57.21
783,4,0.5836,3.502,3125.0,0.001117,0.9929309999999999,BOD1L2 FARP2 H1FNT TOB1,"spermatid nucleus elongation|negative regulation of nuclear-transcribed mRNA poly(A) tail shortening|negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|podosome assembly|neuron remodeling",0.0007766|0.0007766|0.0007766|0.0009706|0.002522,1|1|1|1|1,1716|1716|1716|1287|429.1
784,4,0.5248,3.1489999999999996,3184.0,0.0009855,0.9929309999999999,BOK FAM107A SPAG16 TRIM3,regulation of granulosa cell apoptotic process|positive regulation of PERK-mediated unfolded protein response|regulation of chorionic trophoblast cell proliferation|mucociliary clearance|negative regulation of mitochondrial depolarization,0.0005825|0.0009706|0.001165|0.001165|0.001359,1|1|1|1|1,2574|1287|1030|1030|858.1
785,4,0.5229,3.138,3208.0,0.0009747,0.9929309999999999,BOLA1 MINK1 PRM1 SIGIRR,negative regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of multi-organism process|negative regulation of chemokine production|regulation of lipopolysaccharide-mediated signaling pathway|regulation of AMPA receptor activity,0.003394|0.005087|0.005812|0.006295|0.006778,1|1|1|1|1,316.8|205.9|179.1|164.8|152.6
786,4,0.5656,3.3939999999999997,3109.0,0.001088,0.9929309999999999,BOLL C10orf120 HS3ST5 SEMA3C,glycosaminoglycan biosynthetic process|aminoglycan biosynthetic process|cardiac endothelial to mesenchymal transition|pulmonary myocardium development|glycosaminoglycan metabolic process,0.0002404|0.0002745|0.0004854|0.0004854|0.0005471,1|1|1|1|1,82.38|76.99|4119|4119|54.2
787,15,0.507,53.23,10390.0,0.005084,0.999999,BOP1 COX6C CYC1 EIF3E EIF3H EXOSC4 INTS8 MRPL13 MTBP POP1 PUF60 RPL30 RPL8 UTP23 VPS28,ribonucleoprotein complex biogenesis|ncRNA processing|gene expression|ncRNA metabolic process|RNA processing,4.055e-10|1.053e-08|1.791e-08|3.558e-08|8.159e-08,6.396e-06|8.307e-05|9.417e-05|0.0001403|0.0002574,23.62|22.25|6.909|18.59|11.9
788,31,0.4529,210.6,21020.0,0.009891,1.0,AP3B1 AP3D1 ARL8B BLOC1S1 BLOC1S2 BORCS5 BORCS6 BORCS7 BORCS8 DNAJC13 FNIP1 HTT KXD1 LAMTOR3 LAMTOR4 MTMR6 MTMR9 NPC1 RAB7A SNAPIN SPG21 TBC1D5 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41 WDR91,vesicle-mediated transport|lysosomal transport|cellular localization|vacuolar transport|endosomal transport,1.655e-18|1.882e-17|7.275e-17|5.566e-16|1.101e-15,2.611e-14|1.484e-13|3.825e-13|2.195e-12|3.474e-12,7.889|64.95|5.572|46.88|33.15
789,4,0.5254,3.1519999999999997,3026.0,0.001038,0.9929309999999999,AGK BPGM SLC25A13 SLC37A3,glucose metabolic process|organophosphate metabolic process|hexose metabolic process|monosaccharide metabolic process|ATP metabolic process,0.0001905|0.0003228|0.0003472|0.0004604|0.0006008,1|1|1|1|1,89.54|17.2|66.01|57.21|49.99
790,4,0.5642,3.385,3164.0,0.001066,0.9929309999999999,BPHL FOXF2 SLC6A12 WFIKKN1,roof of mouth development|establishment of planar polarity of embryonic epithelium|gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|gamma-aminobutyric acid transport,0.0001126|0.0007766|0.0009706|0.001359|0.001941,1|1|1|1|1,117|1716|1287|858.1|572.1
791,4,0.5086,3.052,3136.0,0.0009697000000000001,0.9929309999999999,ADAMTS8 BPI EML6 OR8B2,phosphate ion transmembrane transport|negative regulation of macrophage activation|negative regulation of interleukin-8 production|phosphate ion transport|lipopolysaccharide-mediated signaling pathway,0.003104|0.003685|0.003878|0.004072|0.00678,1|1|1|1|1,343.2|286|271|257.4|151.4
792,16,0.5008,60.1,13060.0,0.00457,0.999999,BPIFA1 BPIFA2 BPIFB1 CNBD2 DEFB115 DEFB116 FAM83C FOXS1 GGT7 GHRH HCK MAP1LC3A MMP24 MYH7B MYLK2 XKR7,response to external stimulus|response to bacterium|response to other organism|response to external biotic stimulus|response to biotic stimulus,2.894e-06|1.09e-05|4.883e-05|4.928e-05|5.759e-05,0.04565|0.08595|0.2568|0.1943|0.1817,5.132|10.76|6.354|6.345|6.193
793,16,0.506,60.72,13530.0,0.004456,0.999999,BPI BPIFB2 CNBD2 CPNE1 DLGAP4 FAM83C GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 NNAT SPAG4 VSTM2L ZNF341,"lipopolysaccharide-mediated signaling pathway|positive regulation of circadian sleep/wake cycle, REM sleep|response to external stimulus|response to lipopolysaccharide|response to molecule of bacterial origin",0.0003505|0.001552|0.001674|0.001787|0.002071,1|1|1|1|1,75.72|1287|3.593|12.18|11.56
794,19,0.5058,86.49,15830.0,0.0054210000000000005,1.0,BPIFB3 BPIFB4 CCM2L CNBD2 CPNE1 DLGAP4 DUSP15 FAM83C FOXS1 GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 TM9SF4 VSTM2L XKR7 ZNF341,"positive regulation of multicellular organism growth|regulation of multicellular organism growth|positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response|phagocytosis",0.0004703|0.001717|0.001843|0.002763|0.003229,1|1|1|1|1,65.69|33.35|1084|542|9.975
795,4,0.5616,3.37,3180.0,0.001056,0.9929309999999999,BPIFB6 CFC1B COPS7B ERRFI1,lung vasculature development|COP9 signalosome assembly|negative regulation of cardiac muscle hypertrophy in response to stress|negative regulation of cardiac muscle adaptation|regulation of cardiac muscle hypertrophy in response to stress,0.001165|0.001165|0.001359|0.001359|0.001941,1|1|1|1|1,1030|1030|858.1|858.1|572.1
796,10,0.5078,22.85,6783.0,0.0033469999999999997,0.999933,BRAT1 BRF2 DCTN6 FNTA INTS9 MAK16 PPP2CA PPP2CB TTI2 WDR73,positive regulation of microtubule binding|regulation of microtubule binding|peptidyl-serine dephosphorylation|peptidyl-threonine dephosphorylation|response to lead ion,7.241e-06|1.705e-05|3.096e-05|7.105e-05|7.72e-05,0.1142|0.1345|0.1628|0.2802|0.2436,624.1|374.5|267.5|170.2|162.8
797,31,0.4571,212.5,19730.0,0.010620000000000001,1.0,AP3B1 ARL8B BLOC1S1 FNIP1 GDAP2 LAMTOR1 LAMTOR2 LAMTOR3 LAMTOR4 MIOS MLST8 MTOR NPC1 RAB7A RRAGA RRAGC SEH1L SNAPIN SPG21 SPNS1 TBC1D5 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41 WDR24 WDR59,positive regulation of TOR signaling|response to starvation|cellular response to amino acid starvation|response to amino acid starvation|cellular response to starvation,4.838e-24|2.625e-21|3.876e-21|5.825e-21|1.436e-20,7.631e-20|2.07e-17|2.038e-17|2.297e-17|4.53e-17,185.4|42.77|99.65|96.05|48.44
798,5,0.5193,5.193,4226.0,0.001224,0.996692,BMP7 BRICD5 GCH1 PCK1 PSMB10,regulation of removal of superoxide radicals|cellular response to hypoxia|cellular response to decreased oxygen levels|cellular response to oxygen levels|regulation of response to reactive oxygen species,1.319e-06|7.986e-06|9.156e-06|1.167e-05|2.185e-05,0.0208|0.06298|0.04814|0.04601|0.06895,1373|65.04|62.1|57.21|284.1
799,15,0.5055,53.08,11670.0,0.004517,0.999999,ATXN7L3B BRINP2 CARNS1 CCNB1IP1 KIF26B LYRM1 MAP3K7CL NECAP2 NIPSNAP3B PCDHGA9 RNF114 SDR39U1 TXNDC16 ZNF286A ZNF512B,carnosine biosynthetic process|carnosine metabolic process|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation,0.001455|0.002182|0.002908|0.003634|0.004359,1|1|1|1|1,1373|686.5|457.7|343.2|274.6
800,5,0.5517,5.517,4228.0,0.0013,0.996692,BRINP3 CRB1 CSMD3 S100A13 SYNE1,interleukin-1 alpha production|establishment of bipolar cell polarity|establishment of bipolar cell polarity involved in cell morphogenesis|post-embryonic retina morphogenesis in camera-type eye|nuclear matrix anchoring at nuclear membrane,0.0004854|0.0004854|0.0004854|0.000728|0.0009706,1|1|1|1|1,4119|4119|4119|2060|1373
801,19,0.737,126.0,12440.0,0.009999,1.0,BRIP1 CENPS CENPX FAAP100 FAAP20 FAAP24 FANCA FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM RFWD3 SLX4 UBE2T XRCC2,interstrand cross-link repair|DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|cellular response to stress,3.264e-40|1.736e-29|2.423e-26|2.796e-26|9.696e-20,5.149e-36|1.369e-25|1.274e-22|1.103e-22|3.059e-16,312.6|36.92|25.05|24.86|11.15
802,15,0.5798,60.88,10200.0,0.005915,0.999999,BRIX1 CCT5 DROSHA EXOC3 ICE1 MRPL36 MRPS30 NUP155 RAD1 RPL37 TARS WDR70 ZFR ZNF131 ZNF622,ribosome biogenesis|ribonucleoprotein complex biogenesis|translation|peptide biosynthetic process|amide biosynthetic process,4.273e-06|2.142e-05|0.0001881|0.0002389|0.0006239,0.0674|0.1689|0.989|0.942|1,19.39|13.84|13.41|12.59|9.751
803,14,0.482,43.86,8863.0,0.004909,0.9999969999999999,DENND4C EXOC1 EXOC2 EXOC3 EXOC4 EXOC5 EXOC7 EXOC8 RAB10 RABIF RALGAPB SNAP23 STX4 STXBP3,post-Golgi vesicle-mediated transport|protein transport|peptide transport|amide transport|establishment of protein localization,5.616e-17|1.624e-14|2.09e-14|2.793e-14|3.648e-14,8.859e-13|1.281e-10|1.099e-10|1.102e-10|1.151e-10,98.8|13.07|12.82|12.53|12.27
804,5,0.5556,5.556,4172.0,0.001327,0.996692,BRMS1L CARMIL3 FBXO34 SYNE2 TTLL5,nuclear migration along microfilament|nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration|nuclear migration along microtubule|modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration|cell motility involved in cerebral cortex radial glia guided migration,0.000728|0.0009706|0.001213|0.001456|0.00194,1|1|1|1|1,2060|1373|1030|823.8|588.4
805,4,0.529,3.174,3439.0,0.0009199999999999999,0.9929309999999999,BRSK1 PCK2 PMP22 WNT9A,microtubule cytoskeleton organization involved in establishment of planar polarity|glycerol biosynthetic process from pyruvate|propionate catabolic process|propionate metabolic process|response to starvation,0.000728|0.000728|0.000728|0.001213|0.001267,1|1|1|1|1,2060|2060|2060|1030|35.36
806,6,0.507,7.605,4711.0,0.0016079999999999998,0.998474,BSCL2 CCER1 ISLR2 KIR3DL3 TNFSF8 TOP3B,"CD8-positive, alpha-beta T cell differentiation|DNA topological change|lipid droplet formation|CD8-positive, alpha-beta T cell activation|negative regulation of lipid catabolic process",0.002619|0.002909|0.00349|0.003781|0.00755,1|1|1|1|1,429.1|381.4|312|286|137.3
807,4,0.5074,3.0439999999999996,3155.0,0.0009615,0.9929309999999999,BSN CCDC62 LEPROTL1 MANBAL,presynapse to nucleus signaling pathway|presynaptic signal transduction|presynaptic active zone assembly|maintenance of presynaptic active zone structure|presynaptic active zone organization,0.0005825|0.0005825|0.0007766|0.001359|0.001747,1|1|1|1|1,2574|2574|1716|858.1|643.6
808,4,0.5472,3.283,3187.0,0.001026,0.9929309999999999,BST1 DYDC1 POLD3 WDR72,DNA synthesis involved in UV-damage excision repair|chromatin silencing at telomere|enamel mineralization|UV-damage excision repair|regulation of integrin-mediated signaling pathway,0.0005825|0.001941|0.002522|0.002716|0.003104,1|1|1|1|1,2574|572.1|429.1|396.1|343.2
809,4,0.6237,3.742,2706.0,0.001377,0.9929309999999999,BTAF1 DRAP1 GTF2H5 WRAP53,telomerase RNA localization|telomerase RNA localization to Cajal body|telomere formation via telomerase|protein localization to Cajal body|protein localization to nuclear body,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
810,5,0.5137,5.1370000000000005,4106.0,0.001247,0.996692,BTBD10 EPHA5 FOXA3 LAMB1 PLA2G2D,"pallium development|neuronal-glial interaction involved in cerebral cortex radial glia guided migration|CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|telencephalon development|regulatory T cell differentiation",0.0006739|0.000728|0.001213|0.001478|0.001698,1|1|1|1|1,48.75|2060|1030|32.69|686.5
811,4,0.5962,3.577,3278.0,0.0010869999999999999,0.9929309999999999,BTBD16 FGF5 GCNT1 MAB21L1,cell adhesion molecule production|signal transduction involved in regulation of gene expression|leukocyte tethering or rolling|anatomical structure morphogenesis|leukocyte adhesion to vascular endothelial cell,0.0007766|0.003878|0.004072|0.00412|0.004266,1|1|1|1|1,1716|271|257.4|7.235|245.2
812,4,0.5183,3.11,3233.0,0.0009586,0.9929309999999999,BTBD17 CARMIL2 DCAF12 OR2M5,negative regulation of barbed-end actin filament capping|regulation of barbed-end actin filament capping|positive regulation of extracellular matrix disassembly|actin filament network formation|positive regulation of actin filament depolymerization,0.0009706|0.001359|0.001747|0.002522|0.002716,1|1|1|1|1,1287|858.1|643.6|429.1|396.1
813,5,0.5293,5.292999999999999,3837.0,0.001374,0.996692,ANKLE2 BTBD18 POLE SFSWAP SNRNP35,nucleic acid metabolic process|DNA replication proofreading|leading strand elongation|cell cycle process|nucleobase-containing compound metabolic process,0.0006324|0.000728|0.001213|0.001302|0.001363,1|1|1|1|1,7.382|2060|1030|11.55|6.06
814,5,0.5352,5.352,3921.0,0.0013599999999999999,0.996692,BTBD3 C4orf46 CNN2 TBC1D3B UQCRH,"mitochondrial electron transport, ubiquinol to cytochrome c|negative regulation of phagocytosis|interleukin-12-mediated signaling pathway|cellular response to interleukin-12|response to interleukin-12",0.003636|0.005812|0.01136|0.01184|0.01208,1|1|1|1|1,294.2|179.1|89.54|85.81|84.06
815,4,0.5036,3.022,3129.0,0.0009624000000000001,0.9929309999999999,BTBD6 FICD LMBR1 TMEM150A,protein deadenylylation|protein denucleotidylation|protein nucleotidylation|protein adenylylation|regulation of IRE1-mediated unfolded protein response,0.0003883|0.0003883|0.0005825|0.0005825|0.003104,1|1|1|1|1,5149|5149|2574|2574|343.2
816,4,0.5241,3.145,3077.0,0.001018,0.9929309999999999,BTBD7 KLHL20 LRRC14B MAST4,protein K33-linked ubiquitination|regulation of branching involved in salivary gland morphogenesis|Golgi to endosome transport|response to interferon-alpha|regulation of morphogenesis of a branching structure,0.0003883|0.001553|0.003491|0.004846|0.009867,1|1|1|1|1,5149|735.5|302.9|214.5|103
817,4,0.5282,3.1689999999999996,3210.0,0.0009839,0.9929309999999999,BTBD8 FUT4 KIF1B NEUROD6,response to rotenone|clathrin-dependent synaptic vesicle endocytosis|retrograde neuronal dense core vesicle transport|anterograde neuronal dense core vesicle transport|neuron-neuron synaptic transmission,0.0003883|0.0009706|0.001165|0.001165|0.001359,1|1|1|1|1,5149|1287|1030|1030|858.1
818,13,0.5115,39.89,8988.0,0.004406,0.999993,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 NEPRO NOP9 PARN POP4 POP5 RPP38 WDR43,ncRNA processing|rRNA processing|rRNA metabolic process|ncRNA metabolic process|ribosome biogenesis,1.726e-14|1.819e-14|2.534e-14|1.004e-13|1.558e-13,2.723e-10|1.435e-10|1.332e-10|3.957e-10|4.915e-10,34.05|50.92|49.04|28.45|39.88
819,5,0.5226,5.226,4343.0,0.001199,0.996692,BTG2 FAM69C MATN2 RASGRF2 SUN2,pallium development|nuclear migration along microfilament|nuclear matrix anchoring at nuclear membrane|nuclear matrix organization|nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,0.0006739|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,48.75|2060|1373|1373|1373
820,5,0.533,5.33,3634.0,0.00146,0.996692,BTG3 CNOT2 CNOT6 CNOT6L CNOT7,"nuclear-transcribed mRNA poly(A) tail shortening|RNA phosphodiester bond hydrolysis, exonucleolytic|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint|signal transduction involved in mitotic DNA integrity checkpoint",1.169e-11|1.187e-10|3.71e-10|3.961e-10|3.961e-10,1.844e-07|9.361e-07|1.951e-06|1.562e-06|1.25e-06,716.3|383.2|284.1|279.3|279.3
821,4,0.5103,3.062,3135.0,0.0009732000000000001,0.9929309999999999,BTN1A1 BTN2A1 DRC1 METTL27,axonemal dynein complex assembly|axoneme assembly|microtubule bundle formation|T cell receptor signaling pathway|antigen receptor-mediated signaling pathway,3.302e-05|0.0001478|0.0002847|0.0007628|0.002067,0.5208|1|1|1|1,228.8|105.6|75.58|45.77|27.55
822,4,0.5635,3.3810000000000002,3112.0,0.001083,0.9929309999999999,BTNL3 BTNL8 DCAF17 RALB,regulation of exocyst assembly|regulation of exocyst localization|T cell receptor signaling pathway|regulation of vesicle docking|antigen receptor-mediated signaling pathway,0.0003883|0.0003883|0.0004604|0.0005825|0.001252,1|1|1|1|1,5149|5149|57.21|2574|34.44
823,10,0.5111,23.0,8176.0,0.002798,0.999933,AK8 CERCAM ENTPD2 LCN6 LCN8 NTMT1 OR1J4 PIP5KL1 RALGPS1 TOR1B,nucleoside diphosphate metabolic process|peptidyl-alanine modification|N-terminal peptidyl-proline dimethylation|N-terminal peptidyl-glycine methylation|N-terminal peptidyl-alanine trimethylation,0.0007582|0.0009704|0.0009704|0.0009704|0.0009704,1|1|1|1|1,49.04|2060|2060|2060|2060
824,11,0.5002,27.51,7024.0,0.003889,0.999969,BUB1B BUB3 CLTC DLGAP5 GTSE1 KIF15 KNTC1 MAD2L1BP MAPRE1 TACC3 TRIP13,regulation of mitotic sister chromatid separation|regulation of sister chromatid segregation|regulation of chromosome separation|regulation of chromosome segregation|mitotic cell cycle,1.538e-15|3.022e-15|3.022e-15|1.239e-14|5.403e-14,2.426e-11|2.384e-11|1.589e-11|4.886e-11|1.705e-10,201.6|182|182|147.3|24.6
825,5,0.5049,5.0489999999999995,3344.0,0.001503,0.996692,C19orf53 C1D CBWD2 METAP1 METAP2,protein initiator methionine removal|peptidyl-methionine modification|regulation of rhodopsin mediated signaling pathway|N-terminal protein amino acid modification|regulation of G protein-coupled receptor signaling pathway,4.712e-07|4.943e-06|1.777e-05|1.909e-05|0.0005055,0.007432|0.03898|0.09344|0.07526|1,2746|633.7|316.8|305.1|56.42
826,6,0.5596,8.395,4063.0,0.0020559999999999997,0.998474,BYSL PFDN1 PFDN6 RPL7L1 TBCC TUBB4B,negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|protein folding|blastocyst formation|cellular component biogenesis,6.423e-06|9.595e-06|2.715e-05|5.213e-05|0.0002083,0.1013|0.07568|0.1427|0.2056|0.6571,572.1|457.7|45.16|185.5|6.354
827,4,0.5554,3.332,2957.0,0.001123,0.9929309999999999,BZW1 KDELR1 KDELR2 WIPF1,"protein retention in ER lumen|maintenance of protein localization in endoplasmic reticulum|maintenance of protein localization in organelle|maintenance of protein location in cell|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",1.555e-06|3.391e-06|2.792e-05|6.415e-05|0.0001052,0.02452|0.02674|0.1468|0.253|0.332,1144|735.5|239.5|156|121.1
828,22,0.5027,116.1,17500.0,0.0065769999999999995,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 BZW2 GHRHR GSDME HOXA1 HOXA11 HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MTURN NME8 NPY PHKG1 WIPF3 ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|embryonic organ morphogenesis|multicellular organism development,7.838e-10|3.5e-09|1.16e-07|5.119e-07|1.642e-06,1.236e-05|2.76e-05|0.0006102|0.002019|0.005179,59.75|46.04|25.08|19.37|3.071
829,6,0.5179,7.768,5080.0,0.001523,0.998474,C10orf55 LIPA LIPM METTL9 MYOZ1 NUTM2B,negative regulation of skeletal muscle tissue regeneration|skeletal muscle fiber adaptation|regulation of skeletal muscle tissue regeneration|lipid catabolic process|skeletal muscle adaptation,0.0005824|0.001456|0.002328|0.003171|0.004071,1|1|1|1|1,3432|858.1|490.4|22.58|264
830,5,0.5169,5.169,4141.0,0.0012439999999999999,0.996692,ACYP2 C10orf62 HOOK2 SERPINE2 USP13,mating plug formation|seminal vesicle epithelium development|seminal vesicle development|protein K6-linked deubiquitination|maintenance of unfolded protein,0.0004854|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|4119|2060|1373|1373
831,5,0.5713,5.712999999999999,4134.0,0.001377,0.996692,C10orf67 C4orf51 CLCA2 KCTD19 SIAE,regulation of cellular process|chloride transmembrane transport|chloride transport|inorganic anion transmembrane transport|inorganic anion transport,0.01872|0.02356|0.02499|0.02832|0.038,1|1|1|1|1,0|42.46|39.99|35.21|26.07
832,5,0.516,5.16,4143.0,0.001241,0.996692,C10orf82 MATN4 OR51B6 PKIG RBPJL,negative regulation of cAMP-dependent protein kinase activity|negative regulation of protein import|negative regulation of protein import into nucleus|regulation of cAMP-dependent protein kinase activity|negative regulation of nucleocytoplasmic transport,0.002425|0.003152|0.003152|0.005087|0.005087,1|1|1|1|1,457.7|343.3|343.3|205.9|205.9
833,4,0.5171,3.103,2980.0,0.001037,0.9929309999999999,C10orf99 CCDC73 CFAP161 ZNF14,cellular process|UNCLASSIFIED|biological_process|response to stimulus|metabolic process,0.01527|0.0486|0.0486|0.273|0.2773,1|1|1|1|1,0|5.002|0.3846|0|0
834,5,0.51,5.1,3923.0,0.001295,0.996692,ASTN1 C11orf21 OR9A4 PRR9 SPAM1,neuron cell-cell adhesion|hyaluronan catabolic process|fusion of sperm to egg plasma membrane involved in single fertilization|plasma membrane fusion|hyaluronan metabolic process,0.004362|0.004604|0.005329|0.006295|0.008226,1|1|1|1|1,242.3|228.8|196.1|164.8|124.8
835,4,0.5267,3.16,3187.0,0.0009883,0.9929309999999999,C11orf24 CBWD6 LONRF1 SERPINB3,paracrine signaling|autocrine signaling|negative regulation of JUN kinase activity|negative regulation of JNK cascade|negative regulation of stress-activated MAPK cascade,0.001553|0.001747|0.00291|0.007166|0.009096,1|1|1|1|1,735.5|643.6|367.8|143|111.9
836,44,0.4568,432.2,30640.0,0.013869999999999999,1.0,H2AFX HIST1H1A HIST1H1B HIST1H1C HIST1H1D HIST1H1E HIST1H2AA HIST1H2AC HIST1H2AD HIST1H2AE HIST1H2AG HIST1H2AI HIST1H2AJ HIST1H2BA HIST1H2BB HIST1H2BC HIST1H2BD HIST1H2BE HIST1H2BF HIST1H2BG HIST1H2BH HIST1H2BI HIST1H2BJ HIST1H2BK HIST1H2BL HIST1H2BM HIST1H2BN HIST1H2BO HIST1H3A HIST1H3B HIST1H3C HIST1H3D HIST1H3F HIST1H3G HIST1H3H HIST1H3I HIST1H3J HIST1H4A HIST1H4E HIST1H4I HIST1H4L HIST2H2AC HIST2H2BE HIST2H2BF,"regulation of gene expression, epigenetic|chromatin organization|chromosome organization|chromatin organization involved in negative regulation of transcription|negative regulation of gene expression, epigenetic",2.5e-08|4.533e-08|3.678e-07|5.608e-07|5.824e-07,0.0003943|0.0003575|0.001934|0.002212|0.001837,96.35|29.55|19.41|160.5|158.4
837,10,0.5046,22.71,6013.0,0.00375,0.999933,BRAF DUSP4 ELAVL1 MAP2K1 MAPK1 PEA15 PTPN11 SHOC2 SOX10 SOX9,face development|astrocyte differentiation|glial cell differentiation|MAPK cascade|Bergmann glial cell differentiation,6.913e-09|1.015e-08|1.046e-08|1.263e-08|1.355e-08,0.000109|8.004e-05|5.498e-05|4.981e-05|4.276e-05,175.3|158.4|60.22|30.21|772.3
838,5,0.5329,5.329,4064.0,0.001306,0.996692,C11orf45 OIT3 STEAP1B TMEM161A TMEM211,urate homeostasis|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|regulation of intrinsic apoptotic signaling pathway in response to DNA damage|cellular process|positive regulation of DNA repair,0.0004854|0.007502|0.00919|0.01519|0.01855,1|1|1|1|1,4119|137.3|111.3|0.266|54.2
839,4,0.5422,3.253,3183.0,0.001019,0.9929309999999999,APBB3 C11orf49 CYB561 TCERG1L,positive regulation of protein secretion|positive regulation of peptide secretion|electron transport chain|cellular process|regulation of protein secretion,0.02634|0.0309|0.0328|0.04971|0.05421,1|1|1|1|1,37.86|32.18|30.29|0.3325|18.13
840,4,0.5026,3.015,3287.0,0.0009144,0.9929309999999999,C11orf54 FAM71B LRIT3 PRR35,cellular process|regulation of fibroblast growth factor receptor signaling pathway|UNCLASSIFIED|biological_process|visual perception,0.00379|0.0062|0.008539|0.008539|0.04148,1|1|1|1|1,0|166.1|5.627|0.2884|23.84
841,4,0.523,3.138,3087.0,0.001013,0.9929309999999999,C11orf68 CPA6 OR2D3 SLC26A5,response to salicylic acid|fructose transmembrane transport|oxalate transport|positive regulation of cell size|response to potassium ion,0.0003883|0.001165|0.002134|0.002522|0.003104,1|1|1|1|1,5149|1030|514.9|429.1|343.2
842,4,0.5804,3.4819999999999998,3244.0,0.00107,0.9929309999999999,ANTXRL C11orf71 FAM222A SLC30A7,sequestering of zinc ion|sequestering of metal ion|zinc ion transport|cellular zinc ion homeostasis|zinc ion homeostasis,0.0009706|0.002522|0.00562|0.006973|0.007552,1|1|1|1|1,1287|429.1|183.9|147.1|135.5
843,4,0.569,3.4139999999999997,3099.0,0.001098,0.9929309999999999,ARG2 C11orf86 P2RX3 TSPAN13,"negative regulation of chemokine (C-C motif) ligand 4 production|regulation of chemokine (C-C motif) ligand 4 production|negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process|behavioral response to formalin induced pain|behavioral response to chemical pain",0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
844,5,0.5171,5.171,3951.0,0.0013039999999999998,0.996692,C11orf87 EBF2 INPP5J NTM TCF24,negative regulation of microtubule polymerization|positive regulation of chromatin binding|inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation,0.003394|0.003636|0.004362|0.004845|0.004845,1|1|1|1|1,316.8|294.2|242.3|216.8|216.8
845,4,0.5401,3.24,3171.0,0.001018,0.9929309999999999,C11orf94 TTC3 UBASH3A ZNF839,negative regulation of T cell receptor signaling pathway|negative regulation of antigen receptor-mediated signaling pathway|regulation of T cell receptor signaling pathway|protein K48-linked ubiquitination|regulation of antigen receptor-mediated signaling pathway,0.004653|0.006007|0.008131|0.01122|0.01256,1|1|1|1|1,223.9|171.6|125.6|90.33|80.45
846,4,0.5162,3.097,3111.0,0.0009922000000000002,0.9929309999999999,C12orf10 GABRA5 LRP1B PLEKHB2,"locomotory exploration behavior|synaptic transmission, GABAergic|behavior|innervation|exploration behavior",0.00291|0.003104|0.00412|0.004653|0.004653,1|1|1|1|1,367.8|343.2|18.79|223.9|223.9
847,4,0.5806,3.484,3218.0,0.0010789999999999999,0.9929309999999999,C12orf29 GOLGA3 NKIRAS1 PYCR3,proline biosynthetic process|L-proline biosynthetic process|proline metabolic process|glutamine family amino acid biosynthetic process|intra-Golgi vesicle-mediated transport,0.001359|0.001359|0.002134|0.003491|0.006973,1|1|1|1|1,858.1|858.1|514.9|302.9|147.1
848,5,0.5431,5.431,4172.0,0.001297,0.996692,ABCD2 C12orf40 CPNE8 FOXI1 SLC8B1,calcium export from the mitochondrion|long-chain fatty acid import into peroxisome|very long-chain fatty acid catabolic process|regulation of cardiac muscle cell membrane potential|positive regulation of unsaturated fatty acid biosynthetic process,0.000728|0.001213|0.001698|0.00194|0.002425,1|1|1|1|1,2060|1030|686.5|588.4|457.7
849,4,0.537,3.222,3160.0,0.001016,0.9929309999999999,C12orf42 CHFR DPYSL5 SNX31,meiotic spindle checkpoint|negative regulation of metaphase/anaphase transition of meiotic cell cycle|negative regulation of meiotic chromosome separation|negative regulation of meiotic cell cycle phase transition|regulation of metaphase/anaphase transition of meiotic cell cycle,0.0005825|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1716|1287|1287
850,4,0.5051,3.03,3185.0,0.0009482000000000001,0.9929309999999999,C12orf43 REC114 RGMA UPK2,Spemann organizer formation|negative regulation of collateral sprouting|negative regulation of axon regeneration|negative regulation of receptor binding|negative regulation of neuron projection regeneration,0.0009706|0.001941|0.00291|0.00291|0.003297,1|1|1|1|1,1287|572.1|367.8|367.8|321.8
851,7,0.5246,11.02,4688.0,0.002337,0.9992989999999999,AK6 C12orf45 CCDC59 NOP9 PWP1 RBM19 UTP20,"rRNA 5'-end processing|endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|nucleoside monophosphate phosphorylation",2.768e-06|2.768e-06|4.743e-06|7.244e-06|1.382e-05,0.04366|0.02183|0.02494|0.02856|0.04359,1030|1030|735.5|572.1|396.1
852,4,0.5188,3.113,3228.0,0.0009611000000000001,0.9929309999999999,BTG4 C12orf54 FMNL3 MAB21L2,embryonic body morphogenesis|cortical actin cytoskeleton organization|body morphogenesis|cortical cytoskeleton organization|cell cycle arrest,0.001359|0.007552|0.00871|0.01141|0.02786,1|1|1|1|1,858.1|135.5|117|88.77|35.76
853,4,0.5916,3.549,3135.0,0.0011279999999999999,0.9929309999999999,C12orf60 KDELC1 TTLL3 ZNF865,protein polyglycylation|peptidyl-glutamic acid modification|axoneme assembly|microtubule bundle formation|protein phosphopantetheinylation,0.0005825|0.004654|0.01146|0.01594|0.04829,1|1|1|1|1,2288|221.5|88.01|62.98|20.43
854,10,0.5016,22.57,7768.0,0.0028899999999999998,0.999933,C12orf71 PRB1 PRB2 PRB4 PRH2 RERG TAS2R13 TAS2R19 TAS2R20 TAS2R30,sensory perception of taste|detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|regulation of cell division,6.638e-08|1.363e-06|1.971e-06|2.112e-06|0.0001252,0.001047|0.01075|0.01037|0.008327|0.3949,101|143|125.6|122.6|29.93
855,4,0.5097,3.0580000000000003,3197.0,0.0009531,0.9929309999999999,ANGPTL6 C12orf74 CCDC169 SYNJ2,inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation|polyol catabolic process|phosphatidylinositol dephosphorylation,0.003491|0.003878|0.003878|0.00562|0.0062,1|1|1|1|1,302.9|271|271|183.9|166.1
856,4,0.5775,3.465,3266.0,0.001057,0.9929309999999999,BAG5 C12orf76 MTNR1B SLC16A10,"thyroid-stimulating hormone secretion|positive regulation of circadian sleep/wake cycle, non-REM sleep|negative regulation of protein refolding|regulation of protein refolding|regulation of neuronal action potential",0.0003883|0.0009706|0.0009706|0.0009706|0.001165,1|1|1|1|1,5149|1287|1287|1287|1030
857,6,0.5026,7.539,5005.0,0.0015,0.998474,C14orf119 DNAH14 EXOSC9 IGIP PCDHGB7 ZIK1,U5 snRNA 3'-end processing|U1 snRNA 3'-end processing|polyadenylation-dependent mRNA catabolic process|nuclear polyadenylation-dependent mRNA catabolic process|tRNA surveillance,0.001165|0.001165|0.001456|0.001456|0.002037,1|1|1|1|1,1144|1144|858.1|858.1|572.1
858,4,0.5325,3.195,3191.0,0.0009977,0.9929309999999999,C14orf177 DRD1 NEURL1B PRKAR1B,negative regulation of inflammatory response to antigenic stimulus|regulation of inflammatory response to antigenic stimulus|ubiquitin-dependent endocytosis|learning or memory|cognition,0.0006123|0.0006963|0.0007766|0.000894|0.001211,1|1|1|1|1,49.51|46.39|1716|40.86|35.03
859,4,0.5388,3.233,3102.0,0.001038,0.9929309999999999,C14orf28 EPO RNASE11 TRIM41,response to bacterium|negative regulation of erythrocyte apoptotic process|regulation of erythrocyte apoptotic process|defense response to nematode|erythropoietin-mediated signaling pathway,0.000405|0.0004854|0.0004854|0.000728|0.001213,1|1|1|1|1,17.21|4119|4119|2060|1030
860,4,0.5269,3.162,3227.0,0.0009763,0.9929309999999999,C15orf39 GRAMD2A IGHMBP2 TMEM151A,endoplasmic reticulum-plasma membrane tethering|endoplasmic reticulum localization|regulation of store-operated calcium entry|endoplasmic reticulum organization|DNA duplex unwinding,0.001359|0.002134|0.002716|0.01947|0.02062,1|1|1|1|1,858.1|514.9|396.1|51.49|48.57
861,4,0.5651,3.39,3097.0,0.001091,0.9929309999999999,ANKK1 C15orf40 CARD18 GUCY1A2,positive regulation of nitric oxide mediated signal transduction|inhibition of cysteine-type endopeptidase activity|zymogen inhibition|regulation of nitric oxide mediated signal transduction|cGMP biosynthetic process,0.001165|0.001553|0.001747|0.001941|0.002522,1|1|1|1|1,1030|735.5|643.6|572.1|429.1
862,7,0.506,10.63,4283.0,0.002467,0.9992989999999999,C15orf41 DNAJC9 RNASEH2A RNASEH2B RNASEH2C TIMELESS TIPIN,replication fork arrest|replication fork protection|negative regulation of DNA-dependent DNA replication|DNA replication checkpoint|RNA catabolic process,1.483e-06|5.435e-06|1.688e-05|1.688e-05|5.89e-05,0.0234|0.04286|0.08873|0.06655|0.1858,1471|653.8|346.1|346.1|35.88
863,4,0.5268,3.161,3224.0,0.000977,0.9929309999999999,C15orf61 CAV3 CBWD2 FAM200A,negative regulation of sarcomere organization|regulation of signal transduction by receptor internalization|negative regulation of membrane depolarization during cardiac muscle cell action potential|regulation of nerve growth factor receptor activity|positive regulation of caveolin-mediated endocytosis,0.0003883|0.0003883|0.0003883|0.0003883|0.0009706,1|1|1|1|1,5149|5149|5149|5149|1287
864,4,0.572,3.432,3390.0,0.001009,0.9929309999999999,C15orf62 DENND1A LGALS4 SH3TC2,regulation of Rab protein signal transduction|peripheral nervous system myelin maintenance|positive regulation of pseudopodium assembly|regulation of pseudopodium assembly|myelin maintenance,0.001553|0.001747|0.002716|0.00291|0.003297,1|1|1|1|1,735.5|643.6|396.1|367.8|321.8
865,4,0.5403,3.242,3115.0,0.001037,0.9929309999999999,C16orf58 C9orf85 GFRA4 HERC1,glial cell-derived neurotrophic factor receptor signaling pathway|cerebellar Purkinje cell differentiation|cerebellar Purkinje cell layer formation|cerebellar Purkinje cell layer morphogenesis|cell differentiation in hindbrain,0.001941|0.002328|0.002716|0.003491|0.004459,1|1|1|1|1,572.1|468.1|396.1|302.9|234
866,5,0.5162,5.162000000000001,3901.0,0.001318,0.996692,C16orf70 GRASP KIAA1958 NPFF R3HDM2,"somatostatin secretion|vasopressin secretion|regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane|regulation of endosome to plasma membrane protein transport|acute inflammatory response to antigenic stimulus",0.000728|0.000728|0.0009706|0.001456|0.002667,1|1|1|1|1,2060|2060|1373|823.8|411.9
867,7,0.5043,10.59,5698.0,0.00185,0.9992989999999999,C16orf71 CYP2W1 DIXDC1 GPER1 GPR146 RBAK RNF216,"protein catabolic process at synapse|protein catabolic process, modulating synaptic transmission|nuclear fragmentation involved in apoptotic nuclear change|positive regulation of cardiac vascular smooth muscle cell differentiation|regulation of cardiac vascular smooth muscle cell differentiation",0.0006794|0.0006794|0.0006794|0.001019|0.001358,1|1|1|1|1,2942|2942|2942|1471|980.7
868,4,0.5382,3.2289999999999996,3245.0,0.0009916999999999999,0.9929309999999999,C16orf74 GPR84 IGSF21 SLC2A7,synapse maturation|hexose transmembrane transport|monosaccharide transmembrane transport|carbohydrate transmembrane transport|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,0.002522|0.007359|0.007745|0.008131|0.009482,1|1|1|1|1,429.1|139.2|132|125.6|107.3
869,5,0.5258,5.257999999999999,4182.0,0.001253,0.996692,ARSI C16orf87 COLEC12 NKD1 SLCO2A1,negative regulation of convergent extension involved in axis elongation|regulation of convergent extension involved in axis elongation|positive regulation of non-canonical Wnt signaling pathway via JNK cascade|regulation of non-canonical Wnt signaling pathway via JNK cascade|regulation of cell migration involved in somitogenic axis elongation,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
870,4,0.5463,3.278,3100.0,0.001053,0.9929309999999999,C16orf91 CERCAM ERICH4 SEMA5A,signal clustering|blood vessel endothelial cell proliferation involved in sprouting angiogenesis|positive regulation of axon extension involved in axon guidance|positive regulation of actin filament depolymerization|positive regulation of endothelial cell chemotaxis,0.0003883|0.001553|0.001553|0.002716|0.003104,1|1|1|1|1,5149|735.5|735.5|396.1|343.2
871,5,0.5233,5.233,4285.0,0.001217,0.996692,C16orf95 C17orf97 KIAA0556 MAPK9 RAB2B,protein localization to tricellular tight junction|positive regulation of transcription factor catabolic process|regulation of transcription factor catabolic process|JUN phosphorylation|positive regulation of podosome assembly,0.0005825|0.0007766|0.0007766|0.0009706|0.001941,1|1|1|1|1,2574|1716|1716|1287|572.1
872,27,0.5135,180.3,17510.0,0.010159999999999999,1.0,BRIP1 CENPS CENPX FAAP100 FAAP20 FAAP24 FANCA FANCC FANCD2 FANCE FANCF FANCG FANCI FANCL FANCM MCM8 MCM9 RAD51 RAD51B RAD51C RAD51D RFWD3 SFR1 SLX4 UBE2T XRCC2 XRCC3,interstrand cross-link repair|DNA repair|DNA metabolic process|cellular response to DNA damage stimulus|cellular response to stress,7.253e-50|6.548e-42|1.821e-37|2.23e-37|4.153e-28,1.144e-45|5.164e-38|9.573e-34|8.793e-34|1.31e-24,289|37.47|25.43|25.23|11.32
873,4,0.5306,3.1839999999999997,3335.0,0.0009513999999999999,0.9929309999999999,ACAD10 ATP2B4 C17orf80 SMPDL3B,negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process|negative regulation of the force of heart contraction,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
874,4,0.5609,3.365,3344.0,0.001003,0.9929309999999999,ANGPTL7 C17orf98 CFAP97D1 LYSMD3,negative regulation of vasculature development involved in avascular cornea development in camera-type eye|avascular cornea development in camera-type eye|cornea development in camera-type eye|sperm axoneme assembly|regulation of extracellular matrix organization,0.0003883|0.0003883|0.002328|0.004459|0.008903,1|1|1|1|1,5149|5149|468.1|234|114.4
875,4,0.5474,3.285,3171.0,0.001032,0.9929309999999999,C17orf99 C8orf34 KCNV1 OPRK1,positive regulation of immunoglobulin production in mucosal tissue|regulation of immunoglobulin production in mucosal tissue|adenylate cyclase-inhibiting opioid receptor signaling pathway|response to acrylamide|negative regulation of luteinizing hormone secretion,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
876,31,0.4515,209.9,24550.0,0.008457,1.0,ADCYAP1R1 AEBP1 AGR2 AGR3 CALM1 EGR3 FKBP9 GCK GHRHR KIAA0895 LANCL2 MTURN MYL7 NIPSNAP2 NPC1L1 NUPR2 PHKG1 PKD1L1 POM121L12 PSPH RNASET2 SEPT14 SLC29A4 SUMF2 VWC2 WIPF3 ZNF479 ZNF679 ZNF713 ZNF716 ZNF736,carbohydrate catabolic process|cellular carbohydrate metabolic process|negative regulation of ryanodine-sensitive calcium-release channel activity|negative regulation of release of sequestered calcium ion into cytosol|regulation of high voltage-gated calcium channel activity,3.912e-05|0.0001883|0.0001915|0.0002572|0.0002937,0.617|1|1|1|0.9265,21.52|14.18|113.5|96.01|89.16
877,4,0.6141,3.685,3221.0,0.00114,0.9929309999999999,C18orf54 IGDCC4 MC4R RTP5,regulation of grooming behavior|negative regulation of feeding behavior|diet induced thermogenesis|negative regulation of behavior|adaptive thermogenesis,0.001165|0.001941|0.002328|0.003297|0.003685,1|1|1|1|1,1030|572.1|468.1|321.8|286
878,5,0.5018,5.018,4077.0,0.0012259999999999999,0.996692,C18orf32 C19orf33 CDH7 FAM69C ORMDL2,cellular sphingolipid homeostasis|negative regulation of ceramide biosynthetic process|negative regulation of sphingolipid biosynthetic process|regulation of ceramide biosynthetic process|regulation of sphingolipid biosynthetic process,0.001456|0.001456|0.001698|0.004604|0.004845,1|1|1|1|1,823.8|823.8|686.5|228.8|216.8
879,4,0.5042,3.025,2977.0,0.0010119999999999999,0.9929309999999999,C19orf47 DRG1 DUSP1 MPG,negative regulation of monocyte chemotaxis|negative regulation of p38MAPK cascade|peripheral nervous system myelin maintenance|DNA dealkylation involved in DNA repair|depurination,0.001698|0.001698|0.002183|0.002667|0.003152,1|1|1|1|1,686.5|686.5|514.9|411.9|343.3
880,5,0.5006,5.006,3947.0,0.001263,0.996692,ALDH1A2 C19orf57 CD1C CTSK EPHA5,regulation of hormone levels|retinoic acid receptor signaling pathway involved in somitogenesis|hormone metabolic process|9-cis-retinoic acid metabolic process|9-cis-retinoic acid biosynthetic process,0.0001675|0.0004854|0.0008838|0.001213|0.001213,1|1|1|1|1,23.23|4119|42.46|1030|1030
881,4,0.5515,3.3089999999999997,3413.0,0.0009664,0.9929309999999999,C19orf67 DSCAM DST LACTB2,post-embryonic retina morphogenesis in camera-type eye|cell junction assembly|positive regulation of axon extension involved in axon guidance|netrin-activated signaling pathway|hemidesmosome assembly,0.0005825|0.0011|0.001553|0.002134|0.002522,1|1|1|1|1,2574|36.78|735.5|514.9|429.1
882,16,0.5005,60.05,13170.0,0.004529999999999999,0.999999,C19orf73 C5AR1 C5AR2 CABP5 CRX EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IGFL1 IGFL2 KPTN SULT2A1 SULT2B1,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,2.136e-07|3.387e-06|3.095e-05|3.095e-05|3.095e-05,0.003369|0.02671|0.1627|0.122|0.09763,297|1287|286|286|286
883,4,0.5767,3.46,3184.0,0.001083,0.9929309999999999,C19orf81 NMRAL1 PHKB SFN,regulation of epidermal cell division|keratinocyte development|urea cycle|nitrogen cycle metabolic process|negative regulation of keratinocyte proliferation,0.0009706|0.002667|0.003152|0.003394|0.003394,1|1|1|1|1,1373|411.9|343.3|316.8|316.8
884,4,0.5578,3.347,3010.0,0.001108,0.9929309999999999,C19orf84 FARP2 GLI1 PCMTD1,notochord regression|ventral midline development|podosome assembly|smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation|cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,0.0005825|0.0009706|0.0009706|0.001165|0.001553,1|1|1|1|1,2574|1287|1287|1030|735.5
885,12,0.4747,31.33,8473.0,0.003674,0.999986,C1GALT1 CMAS GNE MAN1A2 MAN2A1 MGAT1 MGAT2 MGAT5 NANS SLC35A1 SLC39A9 TM9SF1,glycosylation|carbohydrate metabolic process|carbohydrate derivative biosynthetic process|carbohydrate derivative metabolic process|protein glycosylation,1.576e-10|2.243e-10|1.482e-09|2.636e-09|7.918e-09,2.486e-06|1.769e-06|7.795e-06|1.039e-05|2.498e-05,40.38|24.83|19.48|13.16|36.47
886,6,0.5333,7.999,5247.0,0.001519,0.998474,C1QB C1QC CTRC NCALD SLC2A5 TAS1R2,synapse pruning|cell junction disassembly|regulation of systemic arterial blood pressure|regulation of complement activation|fructose import across plasma membrane,5.506e-06|6.423e-06|0.0003386|0.0004889|0.0005824,0.08685|0.05066|1|1|1,624.1|572.1|70.77|58.68|3432
887,4,0.5015,3.009,3190.0,0.0009400000000000001,0.9929309999999999,ACOX2 C1QL2 TTLL1 ZNF300,immune response in nasopharyngeal-associated lymphoid tissue|immune response in gut-associated lymphoid tissue|regulation of blastocyst development|mucociliary clearance|positive regulation of response to oxidative stress,0.0005825|0.0005825|0.0009706|0.001165|0.001553,1|1|1|1|1,2574|2574|1287|1030|735.5
888,4,0.5234,3.14,3208.0,0.0009754,0.9929309999999999,C1QL3 CRYZ GCH1 PIGR,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|dihydrobiopterin metabolic process|immunoglobulin transcytosis in epithelial cells|regulation of lung blood pressure",0.0003883|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|2574|2574|1716|1287
889,4,0.5369,3.222,3119.0,0.001029,0.9929309999999999,C1QL4 IQCD OXCT1 SPACA7,ketone body catabolic process|cellular ketone body metabolic process|ketone body metabolic process|ketone catabolic process|fatty acid derivative catabolic process,0.0009706|0.002328|0.002522|0.00291|0.003104,1|1|1|1|1,1287|468.1|429.1|367.8|343.2
890,4,0.5424,3.2539999999999996,3177.0,0.001021,0.9929309999999999,C1QTNF1 CACNA1C MPP6 TINAGL1,positive regulation of aldosterone secretion|positive regulation of mineralocorticoid secretion|membrane depolarization during atrial cardiac muscle cell action potential|calcium ion transmembrane transport via high voltage-gated calcium channel|calcium-mediated signaling using extracellular calcium source,0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
891,4,0.5621,3.373,3161.0,0.0010630000000000001,0.9929309999999999,C1QTNF8 FAM173A SSTR5 UBE2Q2,somatostatin signaling pathway|somatostatin receptor signaling pathway|positive regulation of cytokinesis|protein K48-linked ubiquitination|cellular response to glucocorticoid stimulus,0.0008737|0.0008737|0.005815|0.008424|0.008424,1|1|1|1|1,1373|1373|176|120.4|120.4
892,5,0.5419,5.419,4319.0,0.00125,0.996692,C1RL C2CD4A ITGBL1 MMP9 PEAK1,cell-matrix adhesion|cell-substrate adhesion|cell migration|regulation of vascular permeability involved in acute inflammatory response|localization of cell,0.0003784|0.000805|0.0009632|0.001213|0.001422,1|1|1|1|1,65.38|44.53|12.81|1030|11.2
893,4,0.532,3.1919999999999997,3233.0,0.0009839,0.9929309999999999,C1orf100 DUS4L PSEN2 SLC22A15,"regulation of calcium import into the mitochondrion|mitochondrion-endoplasmic reticulum membrane tethering|tRNA dihydrouridine synthesis|Notch receptor processing, ligand-dependent|amyloid-beta formation",0.0005825|0.0009706|0.001165|0.001553|0.002134,1|1|1|1|1,2574|1287|1030|735.5|514.9
894,14,0.51,46.41,9221.0,0.004992,0.9999969999999999,BUB3 C1orf109 DAD1 DHX33 DPAGT1 FARSB MYBBP1A OSGEP POP5 RPP21 SPATA5L1 TRMT112 UTP4 WDR18,ncRNA metabolic process|tRNA metabolic process|ncRNA processing|tRNA processing|ribosome biogenesis,1.941e-08|1.063e-07|2.315e-07|1.725e-06|2.013e-06,0.0003062|0.0008387|0.001217|0.006804|0.00635,19.92|40.64|20.43|44.58|22.15
895,4,0.5698,3.4189999999999996,3030.0,0.001124,0.9929309999999999,C1orf112 FER1L6 FIGNL1 MEGF6,osteoblast proliferation|microtubule severing|male meiotic nuclear division|regulation of double-strand break repair via homologous recombination|cytoplasmic microtubule organization,0.001165|0.002522|0.009096|0.009289|0.01237,1|1|1|1|1,1030|429.1|111.9|109.5|81.73
896,4,0.5699,3.42,3343.0,0.001019,0.9929309999999999,C1orf115 GRM6 LCT RNLS,polysaccharide digestion|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|negative regulation of heart rate|NAD biosynthesis via nicotinamide riboside salvage pathway|G protein-coupled glutamate receptor signaling pathway,0.001359|0.001553|0.002328|0.00291|0.003104,1|1|1|1|1,858.1|735.5|468.1|367.8|343.2
897,4,0.5247,3.148,3233.0,0.0009705,0.9929309999999999,ARPIN C1orf116 PSKH1 STPG4,DNA demethylation of male pronucleus|negative regulation of lamellipodium morphogenesis|chromatin reprogramming in the zygote|directional locomotion|C-5 methylation of cytosine,0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
898,4,0.5092,3.055,3143.0,0.0009687999999999999,0.9929309999999999,BCAS3 C1orf127 OR4D2 PGLYRP2,negative regulation of natural killer cell differentiation involved in immune response|negative regulation of natural killer cell differentiation|peptide amidation|regulation of natural killer cell differentiation involved in immune response|peptide modification,0.0005825|0.0005825|0.0005825|0.0007766|0.001165,1|1|1|1|1,2574|2574|2574|1716|1030
899,4,0.5106,3.063,3103.0,0.0009837,0.9929309999999999,C1orf159 DVL3 HRG PLEKHF2,positive regulation of blood vessel remodeling|negative regulation of lamellipodium assembly|negative regulation of endothelial cell chemotaxis|negative regulation of lamellipodium organization|non-canonical Wnt signaling pathway via JNK cascade,0.0005825|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,2574|1716|1287|1030|1030
900,4,0.507,3.042,3062.0,0.00099,0.9929309999999999,C1orf174 FCN2 UCK1 ZBTB6,CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage|UMP salvage|recognition of apoptotic cell,0.0007766|0.001165|0.001165|0.001165|0.001553,1|1|1|1|1,1716|1030|1030|1030|735.5
901,6,0.5034,7.551,5130.0,0.001466,0.998474,C1orf185 CEP57L1 ODF1 REN TMEM81 ZNF76,renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of blood volume by renin-angiotensin|response to cGMP,0.001698|0.002376|0.002376|0.002715|0.002715,1|1|1|1|1,735.5|490.4|490.4|420.3|420.3
902,5,0.5361,5.361000000000001,4286.0,0.0012460000000000001,0.996692,C1orf189 IFT172 NCMAP PLA2G2E ZNF683,regulation of extrathymic T cell differentiation|regulation of natural killer cell differentiation involved in immune response|peripheral nervous system myelin formation|cellular response to ionomycin|response to ionomycin,0.000728|0.0009706|0.0009706|0.001456|0.001456,1|1|1|1|1,2060|1373|1373|823.8|823.8
903,4,0.5294,3.176,3183.0,0.0009946,0.9929309999999999,C1orf194 FOXN1 HIST1H4C NT5M,thymus epithelium morphogenesis|lymphoid lineage cell migration into thymus|lymphoid lineage cell migration|regulation of positive thymic T cell selection|heme export,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
904,5,0.5263,5.263,3633.0,0.001442,0.996692,C1orf21 EVPLL FGFR3 PRDM1 REEP4,fibroblast growth factor receptor apoptotic signaling pathway|sebum secreting cell proliferation|regulation of extrathymic T cell differentiation|regulation of NK T cell differentiation|regulation of natural killer cell differentiation,0.0004854|0.0004854|0.000728|0.001698|0.00291,1|1|1|1|1,4119|4119|2060|686.5|374.5
905,5,0.5037,5.037,3977.0,0.0012619999999999999,0.996692,C1orf210 FOXF1 KLHL40 RTP5 ZNF197,right lung morphogenesis|embryonic ectodermal digestive tract morphogenesis|ectodermal digestive tract morphogenesis|lateral mesodermal cell differentiation|detection of wounding,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
906,4,0.5538,3.323,3289.0,0.001007,0.9929309999999999,C1orf216 KCNH8 TMEM218 TMTC3,protein O-linked mannosylation|protein mannosylation|mannosylation|protein O-linked glycosylation|positive regulation of proteasomal protein catabolic process,0.003685|0.004653|0.007166|0.02024|0.02176,1|1|1|1|1,286|223.9|143|49.51|45.97
907,4,0.5054,3.033,2953.0,0.001023,0.9929309999999999,C1orf226 EMP2 PYHIN1 RPF2,"regulation of signal transduction by p53 class mediator|positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|protein localization to nucleolus|positive regulation of integrin-mediated signaling pathway",0.0005446|0.0007766|0.0007766|0.001553|0.001553,1|1|1|1|1,52.54|1716|1716|735.5|735.5
908,7,0.5153,10.82,4510.0,0.002386,0.9992989999999999,CDC6 CWC25 NSRP1 PPIL1 SNRNP40 SNRPB2 ZNF830,RNA splicing|mRNA processing|mRNA metabolic process|RNA processing|nucleic acid metabolic process,4.309e-10|1.205e-09|1.024e-08|5.572e-08|1.776e-07,6.797e-06|9.503e-06|5.387e-05|0.0002197|0.0005602,43.37|36.47|25.44|19.13|9.227
909,5,0.5672,5.672000000000001,3745.0,0.001508,0.996692,C1orf43 C2CD2L KIAA0100 KIAA1109 VAPA,positive regulation by host of viral release from host cell|modulation by host of viral release from host cell|positive regulation by host of viral genome replication|negative regulation by host of viral genome replication|phagocytosis,0.001456|0.001456|0.002183|0.002183|0.002449,1|1|1|1|1,823.8|823.8|514.9|514.9|25.27
910,14,0.5088,46.3,11370.0,0.004047,0.9999969999999999,AGO1 AGO3 AGO4 C1QA C1QB C1orf123 ERMAP GJB4 LURAP1 MFSD2A ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",2.347e-08|3.226e-08|4.3e-08|1.093e-07|1.093e-07,0.0003702|0.0002545|0.0002261|0.000431|0.0003448,679|594.1|528.1|365.6|365.6
911,4,0.5158,3.095,3162.0,0.0009754,0.9929309999999999,C1orf56 PPEF2 TAS1R3 UBE2E2,detection of chemical stimulus involved in sensory perception of sweet taste|sensory perception of umami taste|sensory perception of sweet taste|ISG15-protein conjugation|negative regulation of peptidyl-threonine phosphorylation,0.0005825|0.001359|0.001359|0.001359|0.003878,1|1|1|1|1,2574|858.1|858.1|858.1|271
912,4,0.5374,3.225,2914.0,0.001102,0.9929309999999999,C1orf61 GOLGA1 MATN3 VPS54,neurofilament cytoskeleton organization|Golgi to vacuole transport|homeostasis of number of cells within a tissue|musculoskeletal movement|multicellular organismal movement,0.00131|0.00291|0.004218|0.00654|0.00654,1|1|1|1|1,858.1|361.3|245.2|156|156
913,4,0.5036,3.022,3000.0,0.001004,0.9929309999999999,C1orf68 HES6 NIPSNAP3A RALGAPA1,activation of GTPase activity|negative regulation of DNA-binding transcription factor activity|anterior/posterior pattern specification|cellular process|regionalization,0.02253|0.03204|0.03979|0.04971|0.06052,1|1|1|1|1,44.39|31.02|24.87|0.3325|16.19
914,4,0.5102,3.0610000000000004,3134.0,0.0009734,0.9929309999999999,APAF1 C1orf74 PELI1 ST3GAL2,response to G1 DNA damage checkpoint signaling|response to mitotic cell cycle checkpoint signaling|globoside biosynthetic process via lactosylceramide|globoside biosynthetic process|globoside metabolic process,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
915,5,0.5258,5.257999999999999,4041.0,0.001296,0.996692,C1orf87 MYF5 PAX7 RRAS2 SEMA4C,muscle structure development|muscle cell differentiation|ossification|muscle organ development|positive regulation of skeletal muscle fiber development,0.0001091|0.001288|0.001595|0.001817|0.002425,1|1|1|1|1,26.86|35.06|31.44|29.42|457.7
916,12,0.4684,30.91,7909.0,0.003882,0.999986,CEP55 CHMP1B CIT ECT2 IST1 KIF14 KIF1BP PDCD6IP UEVLD VPS4A VPS4B VTA1,cytoskeleton-dependent cytokinesis|cytokinesis|mitotic cytokinesis|multivesicular body assembly|multivesicular body organization,5.214e-17|1.284e-16|2.071e-15|8.417e-15|1.004e-14,8.224e-13|1.013e-12|1.089e-11|3.319e-11|3.169e-11,156|138.7|192.7|374.5|362.4
917,4,0.5499,3.3,3176.0,0.001035,0.9929309999999999,C2 DPEP2 IL17F IL18,regulation of granulocyte macrophage colony-stimulating factor production|regulation of immune effector process|cytokine production|adaptive immune response|positive regulation of production of molecular mediator of immune response,3.843e-06|4.821e-05|0.0001151|0.0001233|0.0001534,0.06061|0.3802|0.6055|0.4862|0.4839,686.5|32.66|115.7|23.8|99.98
918,4,0.5582,3.3489999999999998,3264.0,0.001023,0.9929309999999999,C20orf144 CLN8 ITGB7 MPPED1,glutamate reuptake|age-dependent response to oxidative stress|cell-matrix adhesion involved in ameboidal cell migration|age-dependent general metabolic decline|somatic motor neuron differentiation,0.0005825|0.0005825|0.0005825|0.0005825|0.001165,1|1|1|1|1,2574|2574|2574|2574|1030
919,4,0.521,3.1260000000000003,3331.0,0.0009353,0.9929309999999999,ADARB1 C20orf27 COL18A1 PITPNM3,hypoglossal nerve morphogenesis|hypoglossal nerve development|spinal cord ventral commissure morphogenesis|motor neuron apoptotic process|response to hydrostatic pressure,0.0003883|0.0003883|0.0007766|0.0009706|0.001359,1|1|1|1|1,5149|5149|1716|1287|858.1
920,5,0.5286,5.2860000000000005,4204.0,0.001253,0.996692,ANKRD55 C20orf85 DDX4 HECW2 SPATA18,mitophagy by induced vacuole formation|piRNA biosynthetic process|mitochondrial protein catabolic process|negative regulation of sodium ion transmembrane transporter activity|negative regulation of sodium ion transmembrane transport,0.0004854|0.001456|0.001456|0.003394|0.003636,1|1|1|1|1,4119|823.8|823.8|316.8|294.2
921,12,0.529,34.91,8170.0,0.004243,0.999986,C21orf2 CCP110 CEP135 CEP44 CEP97 CFAP97 CNTROB KATNB1 KIF2A NEK1 PCM1 POC1A,organelle assembly|centrosome cycle|centriole replication|microtubule organizing center organization|centriole assembly,6.647e-10|7.595e-10|7.664e-10|1.407e-09|1.784e-09,1.049e-05|5.99e-06|4.03e-06|5.549e-06|5.628e-06,19.18|106.4|325.6|93.61|258.2
922,5,0.5229,5.229,4113.0,0.001267,0.996692,AVP C21orf58 ITPRIP PRKAR1B TMEM74B,renal water homeostasis|multicellular organismal water homeostasis|water homeostasis|renal system process|negative regulation of catalytic activity,3.663e-05|0.0001299|0.0001591|0.0003109|0.0005854,0.5778|1|0.8367|1|1,216.8|112.8|101.7|72.26|15.18
923,4,0.5406,3.2439999999999998,3173.0,0.001019,0.9929309999999999,AUNIP C21orf62 CELA3B KDELR2,negative regulation of double-strand break repair via nonhomologous end joining|protein retention in ER lumen|maintenance of protein localization in endoplasmic reticulum|regulation of double-strand break repair via nonhomologous end joining|negative regulation of double-strand break repair,0.001553|0.001941|0.00291|0.006007|0.006586,1|1|1|1|1,735.5|572.1|367.8|171.6|156
924,8,0.5219,14.61,6490.0,0.002241,0.9996790000000001,ARHGAP8 C22orf46 CSDC2 MEI1 PNPLA5 SEPT3 SULT4A1 TTC38,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|triglyceride catabolic process|acylglycerol catabolic process,0.009668|0.01005|0.01005|0.01082|0.01466,1|1|1|1|1,107.3|103|103|95.35|69.58
925,4,0.523,3.138,3007.0,0.0010400000000000001,0.9929309999999999,C2CD4C DNAJA3 GFER XAF1,activation-induced cell death of T cells|skeletal muscle acetylcholine-gated channel clustering|negative regulation of interferon-gamma-mediated signaling pathway|negative regulation of response to interferon-gamma|mitochondrial DNA replication,0.001359|0.001553|0.001747|0.001747|0.001941,1|1|1|1|1,858.1|735.5|643.6|643.6|572.1
926,4,0.5398,3.239,3262.0,0.0009897,0.9929309999999999,C2CD4D MYOM3 TMEM235 TUBB3,dorsal root ganglion development|netrin-activated signaling pathway|ganglion development|muscle contraction|cellular process,0.001359|0.002134|0.003297|0.04655|0.04971,1|1|1|1|1,858.1|514.9|321.8|21.19|0.3325
927,7,0.5071,10.65,5046.0,0.0021,0.9992989999999999,ARL15 C2CD5 CDK5 FIBP PTP4A1 RCE1 TMEM94,positive regulation of protein targeting to membrane|regulation of protein targeting to membrane|regulation of protein targeting|positive regulation of protein localization to membrane|positive regulation of glial cell apoptotic process,5.199e-05|7.289e-05|0.0003486|0.0008378|0.001019,0.8201|0.5749|1|1|1,189.8|159|70.9|45.26|1471
928,4,0.5712,3.427,3318.0,0.001029,0.9929309999999999,C2orf15 DNAJC27 SFXN5 ZNF583,regulation of MAPK export from nucleus|tricarboxylic acid transport|citrate transport|regulation of protein export from nucleus|mitochondrial transmembrane transport,0.0003883|0.001165|0.001165|0.00678|0.02043,1|1|1|1|1,5149|1030|1030|151.4|49.04
929,5,0.534,5.34,4128.0,0.001289,0.996692,ACOX2 C1QL2 C2orf16 HEPACAM USP25,negative regulation of ERAD pathway|positive regulation of response to oxidative stress|fatty acid beta-oxidation using acyl-CoA oxidase|regulation of ERAD pathway|bile acid biosynthetic process,0.001698|0.00194|0.003878|0.005087|0.007261,1|1|1|1|1,686.5|588.4|274.6|205.9|142
930,23,0.5018,126.9,18270.0,0.006883,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 DBNL GHRHR HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MTURN NME8 NPY NUPR2 PDE1C PHKG1 PSPH SUMF2 WIPF3 ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|lung goblet cell differentiation|lobar bronchus epithelium development|lobar bronchus development,3.965e-06|1.076e-05|1.188e-05|1.781e-05|2.491e-05,0.06254|0.08487|0.06246|0.07022|0.07859,38.1|29.36|597|447.7|358.2
931,11,0.5018,27.6,7179.0,0.0038179999999999998,0.999969,ADAT2 ADAT3 CDIPT DOLK FAM98B MRE11 PYROXD1 RTCB RTRAF TRMT6 TRMT61A,"tRNA processing|tRNA metabolic process|ncRNA processing|ncRNA metabolic process|tRNA splicing, via endonucleolytic cleavage and ligation",1.761e-13|1.505e-12|5.824e-10|1.997e-09|9.194e-08,2.777e-09|1.187e-08|3.062e-06|7.873e-06|0.0002901,99.29|72.41|30.34|25.35|374.5
932,4,0.5327,3.196,3088.0,0.001031,0.9929309999999999,C2orf54 CARD17 CCDC159 YPEL4,negative regulation of interleukin-1 beta production|negative regulation of interleukin-1 production|regulation of interleukin-1 beta production|regulation of interleukin-1 production|cellular response to lipopolysaccharide,0.004218|0.005089|0.01276|0.01493|0.02628,1|1|1|1|1,245.2|201.9|78.91|67.3|37.93
933,7,0.5033,10.57,5692.0,0.001849,0.9992989999999999,ARHGAP25 C2orf68 REEP1 SFTPB THNSL2 TRABD2A WBP1,2-oxobutyrate biosynthetic process|positive regulation of protein oxidation|regulation of protein oxidation|2-oxobutyrate metabolic process|short-chain fatty acid biosynthetic process,0.0006794|0.001019|0.001019|0.001019|0.001698,1|1|1|1|1,2942|1471|1471|1471|735.5
934,7,0.5196,10.91,4755.0,0.002283,0.9992989999999999,C2orf69 EIF2AK4 GCN1 GLUL QARS SLC1A5 SLC7A11,cellular response to leucine starvation|regulation of cellular amide metabolic process|peptide metabolic process|import into cell|lipid import into cell,8.691e-06|1.294e-05|3.026e-05|3.922e-05|4.268e-05,0.1371|0.1021|0.1591|0.1546|0.1346,514.9|23.84|19.18|42.2|214.5
935,5,0.5026,5.026,4185.0,0.0011970000000000001,0.996692,C2orf70 CCDC88A TACR1 TGOLN2 TRIM54,maintenance of protein location in plasma membrane|maintenance of protein location in membrane|regulation of microtubule-based process|positive regulation of protein localization to cilium|tachykinin receptor signaling pathway,0.000728|0.000728|0.001288|0.001456|0.002183,1|1|1|1|1,2060|2060|35.06|823.8|514.9
936,13,0.5067,39.52,10130.0,0.0038770000000000002,0.999993,ADCY10 ATXN7L3B CARNS1 CCNB1IP1 GPRC5D KIF26B MAP3K7CL NECAP2 NIPSNAP3B PCDHGA9 RNF114 SDR39U1 TMEM184C,carnosine biosynthetic process|carnosine metabolic process|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation,0.001261|0.001891|0.002521|0.00315|0.003779,1|1|1|1|1,1584|792.1|528.1|396.1|316.8
937,4,0.5235,3.141,2914.0,0.001074,0.9929309999999999,C2orf73 MARCH3 MYOG VPS4A,actomyosin contractile ring contraction|contractile ring contraction|cellular response to magnetism|positive regulation of muscle atrophy|late endosomal microautophagy,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
938,8,0.5166,14.46,5183.0,0.002775,0.9996790000000001,DDX47 GAPDH NOP2 PHB2 TIMM13 USP5 WBP11 YME1L1,mitochondrial calcium ion transmembrane transport|rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing,4.608e-05|0.0001098|0.0001227|0.0002246|0.0004837,0.7269|0.8662|0.645|0.8855|1,205.9|29.7|28.6|23.26|17.88
939,5,0.5542,5.542000000000001,4335.0,0.001274,0.996692,ATP2B2 AVPI1 C2orf91 CNPY1 GRIK1,regulation of cardiac conduction|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process,0.000116|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,122.6|3432|3432|3432|3432
940,4,0.5364,3.218,3238.0,0.0009904,0.9929309999999999,ADARB1 BST2 C3AR1 PITPNM3,regulation of viral genome replication|regulation of cell migration|regulation of viral life cycle|regulation of cell motility|hypoglossal nerve morphogenesis,0.0001028|0.0003091|0.0003172|0.0003777|0.0003883,1|1|1|1|1,122.6|17.45|69.11|16.31|5149
941,4,0.5043,3.0260000000000002,2978.0,0.0010119999999999999,0.9929309999999999,C3orf14 MLX PGLS TXNIP,"cellular response to tumor cell|pentose-phosphate shunt, oxidative branch|pentose-phosphate shunt|response to tumor cell|NADPH regeneration",0.0005825|0.0009706|0.002716|0.00291|0.003104,1|1|1|1|1,2574|1287|396.1|367.8|343.2
942,9,0.5036,18.13,7416.0,0.002433,0.9998530000000001,C3orf20 C9orf3 FBP1 FBP2 FOXB2 FRRS1L GNA14 ZNF510 ZNF782,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.271e-06|2.118e-06|4.446e-06|1.163e-05|1.649e-05,0.02005|0.01671|0.02338|0.04587|0.05202,2060|1373|823.8|457.7|374.5
943,4,0.5697,3.418,3093.0,0.001101,0.9929309999999999,C3orf22 KCNMB4 PLCL1 POU4F1,negative regulation of transcription elongation by RNA polymerase I|regulation of transcription elongation from RNA polymerase I promoter|proprioception involved in equilibrioception|positive regulation of binding|epithalamus development,0.0003883|0.0003883|0.0003883|0.0004405|0.0007766,1|1|1|1|1,5149|5149|5149|58.51|1716
944,5,0.5132,5.132000000000001,4095.0,0.0012490000000000001,0.996692,ABHD16B AHSA1 C3orf30 FFAR1 LCN15,phosphatidylserine catabolic process|monoacylglycerol catabolic process|macromolecule depalmitoylation|monoacylglycerol metabolic process|negative regulation of interleukin-1 beta production,0.001213|0.00194|0.003636|0.003636|0.00702,1|1|1|1|1,1030|588.4|294.2|294.2|147.1
945,5,0.5129,5.129,4107.0,0.0012439999999999999,0.996692,C3orf33 COL6A6 EPDR1 NOL3 SVBP,myofibroblast contraction|response to injury involved in regulation of muscle adaptation|inhibition of cysteine-type endopeptidase activity involved in apoptotic process|negative regulation of muscle atrophy|negative regulation of mitochondrial membrane permeability involved in apoptotic process,0.0004854|0.0004854|0.000728|0.000728|0.001213,1|1|1|1|1,4119|4119|2060|2060|1030
946,11,0.5317,29.24,7574.0,0.0038350000000000003,0.999969,CIAO1 CIAO2B CIAPIN1 GLRX3 LYRM4 NDOR1 NUBP1 NUBP2 SOD1 TIMM10 TIMM9,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|protein maturation by iron-sulfur cluster transfer|cellular component organization,1.612e-21|1.612e-21|1.14e-14|9.194e-08|8.497e-07,2.543e-17|1.271e-17|5.993e-11|0.0003626|0.002681,651.2|651.2|45.67|374.5|3.566
947,5,0.5139,5.138999999999999,3984.0,0.001285,0.996692,C3orf62 FAM174B GREB1L TM4SF19 TRIM71,"negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation|regulation of translation, ncRNA-mediated|3'-UTR-mediated mRNA destabilization|miRNA metabolic process",0.003394|0.003394|0.003394|0.004604|0.005329,1|1|1|1|1,316.8|316.8|316.8|228.8|196.1
948,4,0.5085,3.051,3047.0,0.0009977,0.9929309999999999,C3orf67 PREB TTC27 ZNF80,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis|regulation of COPII vesicle coating|regulation of ER to Golgi vesicle-mediated transport|protein exit from endoplasmic reticulum|IRE1-mediated unfolded protein response,0.0009706|0.0009706|0.003104|0.004846|0.01083,1|1|1|1|1,1287|1287|343.2|214.5|93.61
949,4,0.5039,3.023,3197.0,0.0009423999999999999,0.9929309999999999,APOB C3orf70 LPAR6 NPHP3,cilium movement|determination of stomach left/right asymmetry|determination of intestine left/right asymmetry|regulation of planar cell polarity pathway involved in neural tube closure|embryo development,0.0002966|0.0003883|0.0003883|0.0003883|0.0004067,1|1|1|1|1,71.51|5149|5149|5149|15.91
950,5,0.5193,5.193,4158.0,0.0012439999999999999,0.996692,C3orf80 DGLUCY GHSR GLIPR1L1 PRR23C,negative regulation of locomotion involved in locomotory behavior|positive regulation of small intestinal transit|regulation of small intestinal transit|ghrelin secretion|regulation of hindgut contraction,0.000728|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,2060|2060|2060|2060|2060
951,5,0.5217,5.2170000000000005,4451.0,0.001168,0.996692,ABCG5 C3orf84 DOK2 MSRA PTCD2,negative regulation of intestinal cholesterol absorption|negative regulation of intestinal lipid absorption|negative regulation of intestinal phytosterol absorption|negative regulation of intestinal absorption|protein repair,0.000728|0.000728|0.000728|0.0009706|0.00194,1|1|1|1|1,2060|2060|2060|1373|588.4
952,22,0.501,115.7,17480.0,0.006559000000000001,1.0,ADAP2 ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 CRYBA1 DHRS11 EVI2A GAS2L2 LGALS9 LYRM9 PIPOX RDM1 SEBOX SLC13A2 SLFN12 SLFN14 SPAG5 TIAF1 UNC119,eosinophil chemotaxis|eosinophil migration|regulation of ERK1 and ERK2 cascade|monocyte chemotaxis|lymphocyte chemotaxis,1.188e-06|1.385e-06|1.271e-05|1.358e-05|2.253e-05,0.01874|0.01092|0.06683|0.05354|0.07107,165.2|156|16.08|68.5|57.31
953,7,0.5239,11.0,5721.0,0.0019149999999999998,0.9992989999999999,C4orf3 HERC3 HERC5 MYOZ2 TMPRSS11B UGT2B4 USP53,skeletal muscle fiber adaptation|ISG15-protein conjugation|protein modification by small protein conjugation or removal|skeletal muscle adaptation|protein phosphopantetheinylation,0.001698|0.002376|0.003789|0.004748|0.005337,1|1|1|1|1,735.5|490.4|8.561|226.3|17.51
954,5,0.5145,5.145,3911.0,0.00131,0.996692,C4orf33 FAM131C MMP23B PRPF40B SLC35E2B,"mRNA cis splicing, via spliceosome|blastocyst hatching|organism emergence from protective structure|hatching|biological regulation",0.005329|0.006537|0.006537|0.006537|0.008988,1|1|1|1|1,196.1|158.4|158.4|158.4|0
955,7,0.5384,11.31,4656.0,0.002415,0.9992989999999999,ANLN DIAPH3 ECT2 FLII KIF20A SEPT11 SEPT2,cytoskeleton-dependent cytokinesis|cytokinesis|cell division|mitotic cytokinesis|cell cycle process,5.339e-11|9.452e-11|1.616e-07|1.359e-06|7.37e-06,8.422e-07|7.455e-07|0.0008497|0.00536|0.02325,153.2|136.2|29.9|129.8|13.75
956,4,0.5543,3.326,3230.0,0.001026,0.9929309999999999,C4orf45 GDF3 LMBR1L ZNF26,negative regulation of epidermis development|negative regulation of epidermal cell differentiation|hematopoietic stem cell differentiation|T cell apoptotic process|lymphocyte apoptotic process,0.002716|0.002716|0.003104|0.003491|0.004266,1|1|1|1|1,396.1|396.1|343.2|302.9|245.2
957,4,0.5802,3.4810000000000003,3191.0,0.0010869999999999999,0.9929309999999999,C4orf47 GSTZ1 PYROXD2 TRHDE,tyrosine catabolic process|regulation of acetyl-CoA biosynthetic process from pyruvate|regulation of acyl-CoA biosynthetic process|L-phenylalanine catabolic process|L-phenylalanine metabolic process,0.001165|0.001747|0.001941|0.002328|0.002328,1|1|1|1|1,1030|643.6|572.1|468.1|468.1
958,4,0.5419,3.252,3292.0,0.0009843999999999999,0.9929309999999999,C4orf48 NAB1 TMEM182 TMEM45B,endochondral ossification|replacement ossification|Schwann cell differentiation|UNCLASSIFIED|biological_process,0.006007|0.006007|0.007359|0.008539|0.008539,1|1|1|1|1,171.6|171.6|139.2|5.627|0.2884
959,5,0.5382,5.382000000000001,4010.0,0.0013369999999999999,0.996692,C5 CFAP36 GNLY STON1 TLX2,"negative regulation of macrophage chemotaxis|negative regulation of macrophage migration|negative regulation of dendrite morphogenesis|humoral immune response|complement activation, alternative pathway",0.001698|0.002425|0.002425|0.003408|0.003878,1|1|1|1|1,686.5|457.7|457.7|21.34|274.6
960,4,0.5404,3.242,3316.0,0.0009743,0.9929309999999999,C5orf24 SPHKAP TOX2 TSHZ2,"cellular process|regulation of transcription by RNA polymerase II|UNCLASSIFIED|biological_process|regulation of transcription, DNA-templated",0.00379|0.07957|0.08866|0.08866|0.1341,1|1|1|1|1,0|3.982|3.751|0.5769|2.973
961,5,0.5252,5.252000000000001,4334.0,0.001208,0.996692,C5orf30 CHST15 DGAT2 KIAA1217 PROKR1,cellular response to oleic acid|fat pad development|response to oleic acid|monoacylglycerol biosynthetic process|cellular triglyceride homeostasis,0.0009706|0.001456|0.001698|0.00194|0.00194,1|1|1|1|1,1373|823.8|686.5|588.4|588.4
962,25,0.5455,163.7,16980.0,0.00952,1.0,CCDC77 CCP110 CENPJ CEP120 CEP135 CEP152 CEP295 CEP41 CEP44 MIIP PCM1 PCNT PLK4 POC1A PPP1R35 RTTN SASS6 SPICE1 STIL TBC1D31 TEDC1 TEDC2 TUBD1 TUBE1 WRAP73,centrosome cycle|microtubule organizing center organization|centrosome duplication|microtubule cytoskeleton organization|centriole replication,2.076e-24|9.703e-24|2.667e-21|3.287e-21|3.042e-20,3.275e-20|7.653e-20|1.402e-17|1.296e-17|9.596e-17,121.7|107.1|235.4|24.74|322.4
963,4,0.567,3.4019999999999997,3320.0,0.001021,0.9929309999999999,C5orf47 NKD1 OR2V1 SLC2A4,amylopectin metabolic process|amylopectin biosynthetic process|negative regulation of convergent extension involved in axis elongation|regulation of convergent extension involved in axis elongation|positive regulation of non-canonical Wnt signaling pathway via JNK cascade,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
964,4,0.5095,3.057,3193.0,0.0009542,0.9929309999999999,C5orf49 NOL4 TEKT5 TTC39C,otolith morphogenesis|otolith development|cilium assembly|cilium organization|plasma membrane bounded cell projection assembly,0.0009706|0.001747|0.001987|0.002243|0.003036,1|1|1|1|1,1287|643.6|27.24|25.62|21.96
965,16,0.5081,60.97,12640.0,0.004789,0.999999,ADAMTS12 ANXA2R C1QTNF3 C5orf51 C7 CDH6 FBXO4 HCN1 NIM1K NNT OXCT1 PLCXD3 SLC45A2 TMEM267 UGT3A1 UGT3A2,negative regulation of cellular response to hepatocyte growth factor stimulus|negative regulation of hepatocyte growth factor receptor signaling pathway|cellular response to hydroxyisoflavone|cellular response to genistein|cellular response to phenylpropanoid,0.001552|0.001552|0.001552|0.001552|0.001552,1|1|1|1|1,1287|1287|1287|1287|1287
966,5,0.5079,5.079,4200.0,0.0012050000000000001,0.996692,C5orf52 DCDC1 FZD3 OR10G7 TMPPE,positive regulation of neural precursor cell proliferation|neural precursor cell proliferation|canonical Wnt signaling pathway|regulation of neural precursor cell proliferation|negative regulation of receptor clustering,0.0001005|0.0001692|0.0002556|0.0002737|0.0005824,1|1|1|1|1,132|101|81.73|78.91|3432
967,4,0.5183,3.11,3218.0,0.0009631,0.9929309999999999,C5orf63 CDCP1 CTGF LRMP,vesicle fusion|organelle membrane fusion|vesicle targeting|organelle fusion|nucleus organization,0.0119|0.01276|0.01348|0.01565|0.02111,1|1|1|1|1,84.75|78.91|74.62|64.16|47.34
968,4,0.5624,3.3739999999999997,3508.0,0.0009587999999999999,0.9929309999999999,BEAN1 C6orf10 TRIM63 TYROBP,positive regulation of hippocampal neuron apoptotic process|stimulatory killer cell immunoglobulin-like receptor signaling pathway|positive regulation of microglial cell mediated cytotoxicity|regulation of microglial cell mediated cytotoxicity|positive regulation of receptor localization to synapse,0.0004369|0.0004369|0.0005825|0.0005825|0.0007281,1|1|1|1|1,3432|3432|2288|2288|1716
969,10,0.5089,22.9,7777.0,0.002928,0.999933,ATAT1 C6orf106 C6orf48 CLIC1 EGFL8 HLA-DMB MSH5 NUDT3 STK19 TNXB,diphosphoinositol polyphosphate catabolic process|alpha-tubulin acetylation|positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell|peptide antigen assembly with MHC class II protein complex|MHC class II protein complex assembly,0.0007765|0.001164|0.001552|0.00194|0.00194,1|1|1|1|1,2574|1287|858.1|643.6|643.6
970,4,0.5301,3.18,3207.0,0.0009883,0.9929309999999999,ANO7 C6orf120 RFTN1 TNFRSF8,positive regulation of TRAIL production|regulation of TRAIL production|T cell antigen processing and presentation|dsRNA transport|positive regulation of growth rate,0.0005825|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|2574|1716|1716|1716
971,4,0.5855,3.513,3005.0,0.001164,0.9929309999999999,C6orf141 OR8S1 TESMIN TUBA1A,blastocyst hatching|organism emergence from protective structure|hatching|ciliary basal body-plasma membrane docking|blastocyst development,0.005233|0.005233|0.005233|0.01851|0.0189,1|1|1|1|1,198|198|198|54.2|53.08
972,5,0.527,5.27,3743.0,0.001402,0.996692,C6orf15 GPSM3 HLA-A MCCD1 OR2J3,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent|positive regulation of memory T cell activation|regulation of memory T cell activation|T cell mediated immune response to tumor cell|T cell mediated cytotoxicity directed against tumor cell target",0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
973,4,0.5165,3.0989999999999998,3104.0,0.0009949,0.9929309999999999,C6orf163 CMPK2 EVI5 PBX1,dUDP metabolic process|dTDP metabolic process|dTDP biosynthetic process|dUDP biosynthetic process|pyrimidine deoxyribonucleoside diphosphate biosynthetic process,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
974,10,0.5114,23.01,7733.0,0.00296,0.999933,C6orf222 C6orf48 HLA-DMB HSPA1L MSH5 NUDT3 STK19 TAP1 TAP2 TNXB,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation,9.343e-08|1.262e-07|2.988e-07|1.627e-06|2.86e-06,0.001474|0.000995|0.001571|0.006417|0.009023,363.4|325.2|237.6|42.68|36.94
975,4,0.5058,3.035,3193.0,0.000947,0.9929309999999999,C6orf223 CD14 RBKS TBATA,D-ribose catabolic process|cellular response to triacyl bacterial lipopeptide|response to triacyl bacterial lipopeptide|D-ribose metabolic process|cellular response to diacyl bacterial lipopeptide,0.0005825|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|1716|1716|1716|1287
976,5,0.5223,5.223,3827.0,0.001359,0.996692,ARL6IP1 C6orf47 REEP4 RETREG3 SCGB3A2,endoplasmic reticulum tubular network organization|endoplasmic reticulum organization|positive regulation of L-glutamate import across plasma membrane|endoplasmic reticulum tubular network formation|endoplasmic reticulum tubular network membrane organization,6.401e-06|0.0002404|0.0009706|0.001213|0.001213,0.101|1|1|1|1,549.2|82.38|1373|1030|1030
977,4,0.5249,3.1489999999999996,3159.0,0.0009935,0.9929309999999999,C6orf58 UBXN6 YIPF2 ZNF429,endosome to lysosome transport via multivesicular body sorting pathway|endosome transport via multivesicular body sorting pathway|multivesicular body sorting pathway|endosome to lysosome transport|ERAD pathway,0.001165|0.004654|0.005525|0.007845|0.0132,1|1|1|1|1,980.7|221.5|185.5|129.5|76.28
978,6,0.535,8.025,4281.0,0.001866,0.998474,NFIA PLAT POLQ UBE3A VPS36 ZER1,cellular macromolecule metabolic process|proteolysis|proteolysis involved in cellular protein catabolic process|cellular protein catabolic process|positive regulation of Golgi lumen acidification,0.0001965|0.0002092|0.0004581|0.0005363|0.0005824,1|1|1|1|1,4.15|10.65|17.28|16.37|3432
979,6,0.5061,7.591,4642.0,0.001628,0.998474,ATG2B C7orf25 CDH2 GTPBP1 GTPBP2 WDR12,translational elongation|mesenchymal cell migration|positive regulation of synaptic vesicle clustering|neuroligin clustering involved in postsynaptic membrane assembly|regulation of postsynaptic density protein 95 clustering,0.0005565|0.0008735|0.001165|0.001165|0.001165,1|1|1|1|1,54.92|1716|1144|1144|1144
980,9,0.51,18.36,5394.0,0.0033810000000000003,0.9998530000000001,BRAT1 C7orf26 INTS10 INTS13 INTS14 INTS9 SNRPB2 TTI2 WDR73,snRNA transcription by RNA polymerase II|snRNA transcription|ncRNA transcription|snRNA processing|snRNA metabolic process,1.905e-08|2.012e-08|5.953e-08|5.225e-07|1.118e-06,0.0003005|0.0001587|0.000313|0.002061|0.003527,130.8|128.9|97.38|190.7|146.1
981,4,0.5429,3.258,3425.0,0.0009481,0.9929309999999999,ANGPT2 C7orf31 GPR88 NCR3,negative regulation of positive chemotaxis|Tie signaling pathway|motor learning|response to radiation|glomerulus vasculature development,0.0003883|0.0009706|0.001359|0.002739|0.003685,1|1|1|1|1,5149|1287|858.1|23.14|286
982,13,0.481,37.51,9307.0,0.004004,0.999993,C7orf50 CNIH4 DUX4 EIF2S1 FOXD4 GJA3 NBEAL1 NUTF2 POGZ RPL17 SNU13 ST20 TSPYL5,cellular response to radiation|cellular response to abiotic stimulus|cellular response to environmental stimulus|cellular response to UV|negative regulation of vascular endothelial growth factor production,0.0001757|0.0009281|0.0009281|0.001489|0.001891,1|1|1|1|1,26.85|15.09|15.09|35.21|792.1
983,4,0.5242,3.145,3065.0,0.0010220000000000001,0.9929309999999999,C7orf57 TIRAP TMEM71 TPM2,positive regulation of interleukin-15 production|regulation of interleukin-15 production|TIRAP-dependent toll-like receptor 4 signaling pathway|TIRAP-dependent toll-like receptor signaling pathway|positive regulation of chemokine (C-X-C motif) ligand 1 production,0.0003883|0.0003883|0.0003883|0.0003883|0.0009706,1|1|1|1|1,5149|5149|5149|5149|1287
984,4,0.5011,3.0069999999999997,3009.0,0.0009956,0.9929309999999999,C8A HNRNPCL1 PRAMEF2 TXLNB,"complement activation, alternative pathway|cytolysis|regulation of complement activation|regulation of humoral immune response|complement activation, classical pathway",0.003104|0.006586|0.02272|0.0271|0.03109,1|1|1|1|1,343.2|156|44.01|36.78|31.98
985,4,0.5956,3.574,3288.0,0.001083,0.9929309999999999,C8B CST5 EPHB2 LGALS2,"neuron projection retraction|inactivation of MAPKK activity|negative regulation of NMDA glutamate receptor activity|trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission|optic nerve morphogenesis",0.0003883|0.0005825|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|2574|2574|1716|1030
986,14,0.5129,46.67,10630.0,0.004358,0.9999969999999999,A1BG ACR ANHX C8orf33 CHAMP1 MZF1 PARD6G PGBD2 RABL2B SLC27A5 ZBTB45 ZNF132 ZNF324 ZNF672,acrosome matrix dispersal|sister chromatid biorientation|triglyceride mobilization|long-chain fatty acid import across plasma membrane|regulation of transcription by RNA polymerase II,0.001358|0.002715|0.003392|0.003392|0.004799,1|1|1|1|1,1471|490.4|367.8|367.8|3.413
987,18,0.4605,70.45,14980.0,0.0046700000000000005,1.0,C8orf44 CA1 CA13 CA2 CA3 CA8 CNGB3 CPA6 CYP7A1 FABP12 FABP4 GDAP1 MCMDC2 MTFR1 PMP2 SGK3 TRIM55 UBE2W,one-carbon metabolic process|bicarbonate transport|organic anion transport|mitochondrial fission|triglyceride catabolic process,2.941e-10|6.49e-08|9.138e-06|0.0001802|0.0002883,4.639e-06|0.0005119|0.04805|0.7108|0.9097,146.7|109|16.83|109|84.75
988,4,0.5142,3.085,3143.0,0.0009782999999999999,0.9929309999999999,C8orf74 CSMD2 ID2 MS4A2,endodermal digestive tract morphogenesis|positive regulation of transcription involved in G1/S transition of mitotic cell cycle|epithelial cell differentiation involved in mammary gland alveolus development|mammary gland epithelial cell proliferation|locomotor rhythm,0.0005825|0.0007766|0.0009706|0.002522|0.002716,1|1|1|1|1,2574|1716|1287|429.1|396.1
989,4,0.5584,3.35,3086.0,0.001082,0.9929309999999999,C9orf131 CARD11 FAM107A PRSS3,TORC1 signaling|GDP metabolic process|negative regulation of long-term synaptic potentiation|positive regulation of T cell receptor signaling pathway|GMP metabolic process,0.001941|0.002328|0.002522|0.00291|0.003104,1|1|1|1|1,572.1|468.1|429.1|367.8|343.2
990,5,0.5062,5.062,4152.0,0.001215,0.996692,C9orf135 CXCL8 ENTPD6 MYH13 SPINT3,negative regulation of cell adhesion molecule production|regulation of entry of bacterium into host cell|regulation of cell adhesion molecule production|nucleoside diphosphate catabolic process|PERK-mediated unfolded protein response,0.001456|0.00194|0.002667|0.003152|0.003394,1|1|1|1|1,823.8|588.4|411.9|343.3|316.8
991,5,0.5017,5.0169999999999995,3990.0,0.001253,0.996692,ALDH1A1 C9orf152 GRIN3A PTBP3 ZBTB6,fructose catabolic process|fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate|glyceraldehyde-3-phosphate metabolic process|prepulse inhibition|ethanol oxidation,0.001456|0.001456|0.002183|0.003152|0.003152,1|1|1|1|1,823.8|823.8|514.9|343.3|343.3
992,12,0.5253,34.67,8202.0,0.004197,0.999986,ATM CDKN1A CHEK2 DDX31 HDDC2 MDM2 MDM4 PPM1D RPS27L TP53 USP28 WDR89,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|signal transduction in response to DNA damage|DNA damage checkpoint|mitotic G1 DNA damage checkpoint",2.083e-18|3.543e-17|2.474e-16|2.673e-15|4.068e-15,3.285e-14|2.794e-13|1.301e-12|1.054e-11|1.283e-11,130.9|173.8|134.6|98.78|182
993,26,0.502,163.2,21800.0,0.007412,1.0,ADAM2 ADAM32 ADRB3 AP3M2 C8orf58 CHRNA6 CHRNB3 DKK4 DMTN DOK2 LETM2 NAT1 PEBP4 RNF170 RNF5 SARAF SCARA3 SMIM18 STC1 STMN4 TEX15 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D ZDHHC2,TRAIL-activated apoptotic signaling pathway|extrinsic apoptotic signaling pathway via death domain receptors|glutamine transport|extrinsic apoptotic signaling pathway|activation of NF-kappaB-inducing kinase activity,2.088e-07|1.587e-05|8.531e-05|0.0003074|0.0003571,0.003293|0.1252|0.4486|1|1,355.1|66.58|177.5|23.41|78.91
994,4,0.5195,3.117,3127.0,0.0009932,0.9929309999999999,C9orf57 CCDC62 MANBAL METTL25,blastocyst hatching|organism emergence from protective structure|hatching|cellular response to estradiol stimulus|blastocyst development,0.005233|0.005233|0.005233|0.007166|0.0189,1|1|1|1|1,198|198|198|143|53.08
995,4,0.5385,3.2310000000000003,3132.0,0.0010279999999999998,0.9929309999999999,ACVR1 ANKRD9 C9orf66 TRPC3,endocardial cushion cell fate commitment|endocardial cell fate commitment|positive regulation of cardiac muscle hypertrophy in response to stress|positive regulation of determination of dorsal identity|endocardial cushion cell differentiation,0.0002913|0.0002913|0.0004369|0.0004369|0.0004369,1|1|1|1|1,6865|6865|3432|3432|3432
996,4,0.5381,3.2289999999999996,3262.0,0.0009862999999999999,0.9929309999999999,CA10 GEM IL13 PEAK3,regulation of calcium ion transmembrane transport|positive regulation of pancreatic stellate cell proliferation|positive regulation of lung goblet cell differentiation|regulation of lung goblet cell differentiation|negative regulation of lung ciliated cell differentiation,0.0003299|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,67.75|5149|5149|5149|5149
997,17,0.5026,68.35,13960.0,0.00486,1.0,C5AR1 C5AR2 CA11 CABP5 CRX EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IGFL1 IGFL2 IGFL3 SULT2A1 SULT2B1 ZNF45,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,3.109e-07|4.317e-06|3.943e-05|3.943e-05|3.943e-05,0.004904|0.03405|0.2073|0.1555|0.1244,264|1144|254.3|254.3|254.3
998,4,0.5968,3.5810000000000004,3240.0,0.001101,0.9929309999999999,CA12 CLVS2 PIK3CD SLC30A7,mast cell differentiation|natural killer cell chemotaxis|sequestering of zinc ion|mast cell chemotaxis|positive regulation of neutrophil apoptotic process,0.0007766|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,1716|1716|1287|1030|1030
999,14,0.5091,46.33,11670.0,0.003945000000000001,0.9999969999999999,C8orf76 CA1 CA13 CA2 CA3 CYP7A1 MCMDC2 MTSS1 PKIA PMP2 SGK3 SNX16 TMEM67 TMEM69,one-carbon metabolic process|bicarbonate transport|organic anion transport|cellular response to fluid shear stress|response to fluid shear stress,2.204e-08|2.911e-08|3.34e-06|9.323e-05|0.0002737,0.0003477|0.0002296|0.01756|0.3676|0.8633,140.8|130.8|20.19|152.6|85.81
1000,4,0.5289,3.173,3359.0,0.0009416,0.9929309999999999,ATG16L1 CA14 FAM167A TAS2R4,negative stranded viral RNA replication|xenophagy|protein lipidation involved in autophagosome assembly|C-terminal protein lipidation|viral RNA genome replication,0.0007766|0.0009706|0.0009706|0.001553|0.002716,1|1|1|1|1,1716|1287|1287|735.5|396.1
1001,4,0.5782,3.469,3372.0,0.001025,0.9929309999999999,C3orf14 CA6 KCNG4 ZFPL1,detection of chemical stimulus involved in sensory perception of bitter taste|one-carbon metabolic process|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|bicarbonate transport,0.007166|0.007745|0.008131|0.008324|0.008324,1|1|1|1|1,143|132|125.6|122.6|122.6
1002,4,0.573,3.438,3430.0,0.000999,0.9929309999999999,CA9 GREM1 MYO1C RNF222,vesicle transport along actin filament|actin filament-based transport|epithelial cell differentiation involved in kidney development|cell differentiation involved in kidney development|vesicle cytoskeletal trafficking,9.879e-06|1.19e-05|2.96e-05|5.073e-05|0.0001131,0.1558|0.09386|0.1556|0.2|0.3567,433.6|392.3|242.3|183.1|121.1
1003,5,0.5361,5.361000000000001,3983.0,0.001341,0.996692,CAAP1 CALY FADS6 SLURP2 STK32C,positive regulation of retrograde axon cargo transport|regulation of retrograde axon cargo transport|positive regulation of clathrin coat assembly|regulation of clathrin coat assembly|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,0.0004854|0.0004854|0.000728|0.000728|0.001698,1|1|1|1|1,4119|4119|2060|2060|686.5
1004,8,0.5094,14.26,6831.0,0.002079,0.9996790000000001,CAB39L DDAH1 DNAI1 ERCC6L2 FAM205A GALT NPR2 TMEM215,UDP-glucose catabolic process|nucleotide-sugar catabolic process|galactose catabolic process via UDP-galactose|negative regulation of oocyte maturation|UDP-glucose metabolic process,0.0007765|0.001164|0.001552|0.001552|0.00194,1|1|1|1|1,2574|1287|858.1|858.1|643.6
1005,25,0.5039,151.2,15840.0,0.009423,1.0,ALG12 ALG3 ALG5 ALG6 ALG8 ALG9 DNAJB11 DNAJC3 DOLPP1 DPM1 DPM2 DPM3 GANAB MANF MPDU1 MPI OST4 PMM2 PRKCSH SEC63 SLC33A1 STT3A SYVN1 UBE2G2 UGP2,protein N-linked glycosylation|glycoprotein metabolic process|protein glycosylation|macromolecule glycosylation|glycosylation,2.465e-27|8.823e-26|1.232e-22|1.232e-22|2.62e-22,3.888e-23|6.959e-22|6.48e-19|4.86e-19|8.264e-19,147.9|38.33|49.1|49.1|46.6
1006,5,0.5127,5.127000000000001,4243.0,0.001204,0.996692,CABP1 MYL9 PRPH2 PTCH1 ZNF512,response to chlorate|neural plate axis specification|epidermal cell fate specification|visual perception|sensory perception of light stimulus,0.000728|0.000728|0.0009706|0.001092|0.001132,1|1|1|1|1,2060|2060|1373|38.14|37.45
1007,6,0.5076,7.614,4880.0,0.0015539999999999998,0.998474,ARRDC1 C9orf16 CACFD1 PGK2 UCK1 ZBTB6,CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage|UMP salvage|extracellular vesicle biogenesis,0.001165|0.001746|0.001746|0.001746|0.002619,1|1|1|1|1,1144|686.5|686.5|686.5|429.1
1008,4,0.5207,3.1239999999999997,3219.0,0.0009672000000000001,0.9929309999999999,CACNA1A CD22 NLRP2 ZNF132,negative regulation of B cell receptor signaling pathway|negative regulation of immunoglobulin production|negative regulation of calcium-mediated signaling|regulation of B cell receptor signaling pathway|negative regulation of antigen receptor-mediated signaling pathway,0.001553|0.00291|0.003878|0.00504|0.006007,1|1|1|1|1,735.5|367.8|271|205.9|171.6
1009,4,0.5131,3.0789999999999997,2901.0,0.001057,0.9929309999999999,CACNA1B OTOP1 PDE4DIP PPIAL4A,positive regulation of microtubule nucleation|negative regulation of interferon-gamma-mediated signaling pathway|negative regulation of response to interferon-gamma|regulation of microtubule nucleation|astral microtubule organization,0.001359|0.001747|0.001747|0.001747|0.002328,1|1|1|1|1,858.1|643.6|643.6|643.6|468.1
1010,4,0.5614,3.3680000000000003,3293.0,0.001019,0.9929309999999999,BPIFB1 CACNA1D MEIOB SGCD,heart contraction|heart process|membrane depolarization during SA node cell action potential|regulation of atrial cardiac muscle cell membrane repolarization|SA node cell to atrial cardiac muscle cell signaling,0.0001151|0.0001505|0.001165|0.001553|0.001553,1|1|1|1|1,115.7|101|1030|735.5|735.5
1011,4,0.5352,3.2110000000000003,3065.0,0.001044,0.9929309999999999,ANGPTL4 C10orf82 CACNA1E HOOK2,protein unfolding|negative regulation of lipoprotein lipase activity|negative regulation of lipase activity|regulation of lipoprotein lipase activity|early endosome to late endosome transport,0.0007766|0.001359|0.003491|0.004459|0.004653,1|1|1|1|1,1716|858.1|302.9|234|223.9
1012,5,0.5063,5.063,4216.0,0.0011970000000000001,0.996692,ACO1 CACNA1G HUS1B KRT32 LGALS2,response to nickel cation|meiotic DNA integrity checkpoint|response to iron(II) ion|citrate metabolic process|membrane depolarization during SA node cell action potential,0.0004854|0.000728|0.001456|0.001456|0.001456,1|1|1|1|1,4119|2060|823.8|823.8|823.8
1013,4,0.5337,3.202,3238.0,0.0009853,0.9929309999999999,CACNA1S OR5T1 PEX11A RGL1,regulation of peroxisome size|peroxisome membrane biogenesis|cellular response to caffeine|peroxisome fission|regulation of lipid metabolic process,0.0007766|0.0009706|0.002134|0.002134|0.002254,1|1|1|1|1,1716|1287|514.9|514.9|25.55
1014,8,0.5035,14.1,4784.0,0.0029289999999999997,0.9996790000000001,CCNE2 CDK4 CDK6 CKS1B E2F3 SKP2 SOX4 UBE2Q1,G1 phase|mitotic G1 phase|mitotic interphase|interphase|mitotic cell cycle phase transition,1.188e-13|1.188e-13|5.538e-11|5.538e-11|2.062e-10,1.874e-09|9.372e-10|2.912e-07|2.184e-07|6.506e-07,612.9|612.9|162.9|162.9|54.2
1015,4,0.5536,3.321,3240.0,0.0010220000000000001,0.9929309999999999,ASTL CACNA2D3 CCDC138 PCIF1,prevention of polyspermy|negative regulation of fertilization|negative regulation of binding of sperm to zona pellucida|egg activation|regulation of binding of sperm to zona pellucida,0.0005825|0.0005825|0.0009706|0.001165|0.001165,1|1|1|1|1,2574|2574|1287|1030|1030
1016,4,0.5369,3.221,3096.0,0.001037,0.9929309999999999,CACNB3 CSF3 HEMGN TNFRSF6B,negative regulation of detection of mechanical stimulus involved in sensory perception of touch|regulation of detection of mechanical stimulus involved in sensory perception of touch|calcium ion transmembrane transport via high voltage-gated calcium channel|regulation of membrane hyperpolarization|positive regulation of high voltage-gated calcium channel activity,0.0003883|0.0003883|0.0007766|0.001165|0.001165,1|1|1|1|1,5149|5149|1716|1030|1030
1017,4,0.558,3.3480000000000003,3326.0,0.001003,0.9929309999999999,CACNB4 DENND4C PHYHIPL SLC5A6,pantothenate transmembrane transport|biotin import across plasma membrane|biotin transport|regulation of Rab protein signal transduction|pantothenate metabolic process,0.0003883|0.0005825|0.0007766|0.001553|0.001553,1|1|1|1|1,5149|2574|1716|735.5|735.5
1018,17,0.5059,68.8,13490.0,0.005062,1.0,C17orf47 CACNG1 CACNG4 CACNG5 EPX HOXB5 HOXB9 LPO MKS1 MPO NME1 NME2 OR4D1 OR4D2 PLEKHM1 RSAD1 SEPT4,"hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|neurotransmitter receptor transport, postsynaptic endosome to lysosome|neurotransmitter receptor diffusion trapping|postsynaptic neurotransmitter receptor diffusion trapping",2.277e-06|6.044e-06|2.297e-05|3.506e-05|3.506e-05,0.03592|0.04767|0.1208|0.1383|0.1106,125.3|88.64|346.1|269.2|269.2
1019,7,0.5015,10.53,5547.0,0.0018899999999999998,0.9992989999999999,CACNG6 FPR2 LHX3 NEUROD1 OTP OTX2 PKDREJ,forebrain development|endocrine system development|central nervous system development|calcium ion transmembrane transport|neurogenesis,7.838e-06|1.223e-05|1.295e-05|4.378e-05|6.186e-05,0.1236|0.09646|0.06812|0.1727|0.1952,27.1|62.79|12.99|40.65|9.402
1020,4,0.5025,3.015,3103.0,0.0009683,0.9929309999999999,CACNG7 HCRTR2 RPL26 ZNF99,"positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|regulation of translation involved in cellular response to UV|positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|regulation of circadian sleep/wake cycle, wakefulness",0.0003883|0.0003883|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|5149|1716|1716|1287
1021,11,0.5917,32.54,7643.0,0.004228,0.999969,ATP5F1C CDC123 GTPBP4 KIN MCM10 PDSS1 PRPF18 RBM17 RPP38 UPF2 ZNF33A,nucleobase-containing compound metabolic process|heterocycle metabolic process|cellular aromatic compound metabolic process|organic cyclic compound metabolic process|nucleic acid metabolic process,1.059e-05|1.743e-05|1.953e-05|3.538e-05|3.933e-05,0.167|0.1375|0.1027|0.1395|0.1241,5.509|5.158|5.081|4.695|5.872
1022,5,0.5123,5.122999999999999,4134.0,0.001235,0.996692,ACSF2 CACUL1 FMNL1 OR4D2 SOST,cellular response to parathyroid hormone stimulus|response to parathyroid hormone|actin filament severing|cortical actin cytoskeleton organization|negative regulation of ossification,0.002425|0.003394|0.003878|0.009431|0.009431,1|1|1|1|1,457.7|316.8|274.6|108.4|108.4
1023,4,0.5397,3.238,3170.0,0.001018,0.9929309999999999,CADM1 MFSD10 NECTIN1 PARM1,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|tetracycline transmembrane transport|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,3.454e-05|5.679e-05|0.0003883|0.0003972|0.0004912,0.5448|0.4479|1|1|1,214.5|166.1|5149|61.66|55.36
1024,4,0.5033,3.02,3015.0,0.0009979,0.9929309999999999,CADM2 MTHFSD NOP16 RRP1,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,4.16e-05|0.0001126|0.001571|0.001692|0.004246,0.6563|0.8882|1|1|1,37.22|26.57|31.68|30.51|19.07
1025,4,0.5106,3.0639999999999996,3143.0,0.0009714000000000001,0.9929309999999999,C8B CADM3 SGSM3 SLC39A2,"regulation of Rab protein signal transduction|plasma membrane to endosome transport|Rap protein signal transduction|complement activation, alternative pathway|zinc ion transmembrane transport",0.001553|0.001747|0.002328|0.003104|0.004846,1|1|1|1|1,735.5|643.6|468.1|343.2|214.5
1026,10,0.5081,22.87,8082.0,0.002814,0.999933,AGO4 BSND C1orf123 CADM4 CYP4X1 FAAH GJB3 PCSK9 RAB3B ZNF684,negative regulation of low-density lipoprotein particle receptor binding|acylglycerol metabolic process|neutral lipid metabolic process|sebaceous gland cell differentiation|glucosylceramide biosynthetic process,0.0009704|0.00117|0.001192|0.001455|0.001455,1|1|1|1|1,2060|39.23|38.86|1030|1030
1027,5,0.5126,5.126,4002.0,0.001276,0.996692,C3orf62 CADPS FAM174B LMX1A TUT4,"polyuridylation-dependent mRNA catabolic process|negative regulation of transposition, RNA-mediated|regulation of transposition, RNA-mediated|RNA 3' uridylation|dense core granule exocytosis",0.0009706|0.0009706|0.0009706|0.001456|0.00194,1|1|1|1|1,1373|1373|1373|823.8|588.4
1028,4,0.546,3.2760000000000002,3159.0,0.001033,0.9929309999999999,BAX CADPS2 CERS1 NIPAL1,cellular response to UV|cellular response to light stimulus|response to UV|sphingolipid metabolic process|release of matrix enzymes from mitochondria,0.0001177|0.0002004|0.0003257|0.0003741|0.0003883,1|1|1|1|1,114.4|87.27|68.2|63.56|5149
1029,4,0.568,3.408,3502.0,0.0009701,0.9929309999999999,CAGE1 CCDC146 COL4A1 NNAT,protein lipoylation|retinal blood vessel morphogenesis|retina vasculature morphogenesis in camera-type eye|collagen-activated tyrosine kinase receptor signaling pathway|collagen-activated signaling pathway,0.001359|0.001359|0.002328|0.002522|0.003104,1|1|1|1|1,858.1|858.1|468.1|429.1|343.2
1030,5,0.532,5.32,3705.0,0.00143,0.996692,ARMC3 CALB1 IRF3 TBK1 TMEM173,positive regulation of type I interferon-mediated signaling pathway|positive regulation of interferon-alpha production|regulation of interferon-alpha production|TRIF-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway,2.967e-06|9.177e-06|1.4e-05|1.4e-05|1.679e-05,0.0468|0.07238|0.07362|0.05521|0.05297,792.1|429.1|343.2|343.2|312
1031,4,0.5163,3.0980000000000003,3231.0,0.0009552999999999999,0.9929309999999999,CALCB RASL10B SLC24A3 SNX9,regulation of systemic arterial blood pressure by atrial natriuretic peptide|lipid tube assembly|regulation of biological quality|cleavage furrow formation|cellular calcium ion homeostasis,0.0005825|0.0009706|0.001436|0.001553|0.002525,1|1|1|1|1,2574|1287|5.14|735.5|24.12
1032,4,0.5665,3.3989999999999996,3355.0,0.00101,0.9929309999999999,CALCRL DLGAP1 STEAP4 TMEM200C,cellular response to sucrose stimulus|cellular response to disaccharide stimulus|calcitonin gene-related peptide receptor signaling pathway|adrenomedullin receptor signaling pathway|copper ion import,0.0003883|0.0003883|0.0007766|0.0009706|0.001359,1|1|1|1|1,5149|5149|1716|1287|858.1
1033,4,0.5795,3.477,3189.0,0.001086,0.9929309999999999,CALD1 MIEF1 MSANTD2 WDR31,positive regulation of mitochondrial fission|positive regulation of mitochondrial translation|mitochondrial fission|regulation of mitochondrial translation|regulation of mitochondrial fission,0.003491|0.003491|0.004266|0.005233|0.005426,1|1|1|1|1,302.9|302.9|245.2|198|190.7
1034,4,0.5525,3.315,3554.0,0.0009297000000000001,0.9929309999999999,C5AR2 CALHM2 KLHDC9 MYOZ3,complement component C5a signaling pathway|negative regulation of granulocyte chemotaxis|negative regulation of neutrophil chemotaxis|negative regulation of neutrophil migration|complement receptor mediated signaling pathway,0.0005825|0.0007766|0.0007766|0.0009706|0.002716,1|1|1|1|1,2574|1716|1716|1287|396.1
1035,4,0.5496,3.2969999999999997,3284.0,0.001001,0.9929309999999999,CALHM5 LGALSL METTL26 TM7SF2,secondary alcohol biosynthetic process|cholesterol biosynthetic process|regulation of cholesterol biosynthetic process|regulation of sterol biosynthetic process|sterol biosynthetic process,0.007938|0.007938|0.00871|0.00871|0.009096,1|1|1|1|1,128.7|128.7|117|117|111.9
1036,4,0.5344,3.2060000000000004,3224.0,0.0009912,0.9929309999999999,CALHM6 PLEKHG5 POR TRIM72,cellular organofluorine metabolic process|cellular organohalogen metabolic process|nitrate catabolic process|regulation of growth plate cartilage chondrocyte proliferation|nitric oxide catabolic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1037,7,0.5122,10.76,4418.0,0.002421,0.9992989999999999,ASPM CALM2 DYNLRB1 NDE1 PAFAH1B1 PFDN1 TUBB4B,G2/M transition of mitotic cell cycle|cell cycle G2/M phase transition|spindle localization|mitotic cell cycle phase transition|cell cycle phase transition,7.882e-08|8.332e-08|7.352e-07|1.284e-06|1.432e-06,0.001243|0.0006572|0.003866|0.005064|0.004517,84.06|82.88|160.5|41.29|40.17
1038,10,0.5089,22.9,8071.0,0.002823,0.999933,BNIP2 CALML4 CELF6 GOLGA6B MAP2K5 PLEKHO2 PPIB SCAMP2 SCAMP5 SLC24A1,negative regulation of chemokine (C-X-C motif) ligand 2 production|ERK5 cascade|macrophage apoptotic process|polyphosphate catabolic process|polyphosphate metabolic process,0.001455|0.001455|0.00194|0.002909|0.003393,1|1|1|1|1,1030|1030|686.5|411.9|343.3
1039,4,0.5828,3.497,3271.0,0.001065,0.9929309999999999,CALN1 CDHR3 IRX2 WNT7A,asymmetric protein localization involved in cell fate determination|proximal/distal pattern formation involved in metanephric nephron development|positive regulation of protein localization to presynapse|regulation of protein localization to presynapse|positive regulation of excitatory synapse assembly,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
1040,17,0.5005,68.07,11370.0,0.005934,1.0,CNIH1 COG1 GOSR2 RAB18 RAB1A RAB1B SAR1A SCFD1 SEC23IP SLC39A9 SURF4 TM9SF3 TMED7 TRAPPC12 TRAPPC13 TRAPPC2L UNC50,endoplasmic reticulum to Golgi vesicle-mediated transport|Golgi vesicle transport|COPII-coated vesicle budding|vesicle budding from membrane|COPII vesicle coating,9.416e-19|1.744e-17|6.874e-16|1.278e-14|7.245e-14,1.485e-14|1.376e-13|3.614e-12|5.039e-11|2.286e-10,67.99|36.71|138.5|94.09|134.6
1041,7,0.5003,10.51,5796.0,0.001805,0.9992989999999999,ATP2B2 CAMK1G CCR2 CCR3 SCN10A SCN11A TOPAZ1,ion homeostasis|regulation of cytosolic calcium ion concentration|cellular calcium ion homeostasis|calcium ion homeostasis|cellular divalent inorganic cation homeostasis,3.646e-06|4.097e-06|1.237e-05|1.391e-05|1.683e-05,0.05752|0.03232|0.06504|0.05484|0.05309,16.85|31.98|24.12|23.4|22.29
1042,4,0.5575,3.345,3378.0,0.0009871,0.9929309999999999,ARV1 CAMK2A NEDD4 RUFY2,regulation of transport|regulation of localization|development involved in symbiotic interaction|negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage|regulation of plasma membrane sterol distribution,5.337e-05|0.0003115|0.0003883|0.0003883|0.0003883,0.8418|1|1|1|1,11.72|7.533|5149|5149|5149
1043,5,0.5546,5.546,4272.0,0.001294,0.996692,CAMK2B CD52 FAM114A2 MEGF9 TSPAN19,regulation of synapse structural plasticity|positive regulation of synapse maturation|regulation of skeletal muscle adaptation|regulation of synapse maturation|positive regulation of dendritic spine morphogenesis,0.002425|0.002425|0.003394|0.003636|0.004845,1|1|1|1|1,457.7|457.7|316.8|294.2|216.8
1044,5,0.5446,5.446000000000001,4303.0,0.001261,0.996692,CAMK2G FHOD3 MCCC2 PRR14 SH3BP5,cortical actin cytoskeleton organization|cortical cytoskeleton organization|leucine catabolic process|leucine metabolic process|biotin metabolic process,5.487e-05|0.0001242|0.002037|0.002619|0.002909,0.8655|0.9795|1|1|1,180.7|118.4|572.1|429.1|381.4
1045,4,0.5066,3.04,3104.0,0.0009759,0.9929309999999999,CAMK2N1 CDCA7 STX10 ZNF69,positive regulation of systemic arterial blood pressure|negative regulation of cyclin-dependent protein kinase activity|positive regulation of insulin secretion involved in cellular response to glucose stimulus|positive regulation of blood pressure|regulation of protein localization,0.003104|0.006007|0.007166|0.007552|0.01081,1|1|1|1|1,343.2|171.6|143|135.5|11.45
1046,5,0.5079,5.079,4161.0,0.001216,0.996692,CAMK2N2 CASP10 CXCR2 GPBAR1 TEX44,cell surface bile acid receptor signaling pathway|interleukin-8-mediated signaling pathway|positive regulation of cholangiocyte proliferation|cellular response to interleukin-8|response to interleukin-8,0.0005824|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,3432|1716|1716|1144|1144
1047,4,0.5729,3.437,3329.0,0.001029,0.9929309999999999,AMY2B ARHGEF17 CAMKK2 SLC1A7,CAMKK-AMPK signaling cascade|calmodulin dependent kinase signaling pathway|positive regulation of autophagy of mitochondrion|neurotransmitter reuptake|L-glutamate transmembrane transport,0.0009706|0.001165|0.001941|0.004459|0.004459,1|1|1|1|1,1287|1030|572.1|234|234
1048,4,0.5423,3.2539999999999996,3204.0,0.0010119999999999999,0.9929309999999999,APOLD1 CAMSAP1 GABARAPL1 STYK1,endothelial cell activation|cellular response to nitrogen starvation|cellular response to nitrogen levels|negative regulation of microtubule depolymerization|autophagosome maturation,0.002328|0.002716|0.002716|0.005426|0.005813,1|1|1|1|1,468.1|396.1|396.1|190.7|177.5
1049,4,0.5202,3.1210000000000004,2975.0,0.001045,0.9929309999999999,ABCF3 CAMSAP2 DYM TM9SF3,regulation of Golgi organization|negative regulation of microtubule depolymerization|regulation of microtubule depolymerization|negative regulation of microtubule polymerization or depolymerization|regulation of microtubule polymerization,0.003491|0.005426|0.0062|0.007745|0.01045,1|1|1|1|1,302.9|190.7|166.1|132|97.15
1050,15,0.4974,52.23,11850.0,0.004376,0.999999,AKAP2 FAM206A FBP1 FBP2 KIF12 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8 ZBTB6 ZNF484,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,4.268e-07|6.017e-07|7.482e-07|1.13e-06|1.403e-06,0.006732|0.004746|0.003934|0.004455|0.004426,18.68|17.6|16.95|15.78|15.2
1051,23,0.501,126.7,17810.0,0.007047,1.0,ACTR3B CPA1 EPHB6 GIMAP2 GIMAP4 GIMAP6 OR2A5 OR9A2 OR9A4 PDIA4 PRSS37 PRSS58 RNF148 TAS2R39 TAS2R60 TRPV5 TRPV6 ZNF212 ZNF282 ZNF398 ZNF425 ZNF783 ZNF786,calcium ion import across plasma membrane|calcium ion import into cytosol|sensory perception of chemical stimulus|sensory perception of bitter taste|calcium ion import,0.0001802|0.0002012|0.0002922|0.001045|0.001468,1|1|1|1|1,111.9|105.3|8.26|43.68|36.55
1052,4,0.5305,3.1830000000000003,3088.0,0.001027,0.9929309999999999,CANT1 FSD1 GABRR1 ICK,intraciliary anterograde transport|regulation of presynaptic membrane potential|intraciliary retrograde transport|gamma-aminobutyric acid signaling pathway|regulation of mitotic spindle organization,0.0007766|0.001165|0.00291|0.005426|0.007166,1|1|1|1|1,1716|1030|367.8|190.7|143
1053,4,0.5348,3.2089999999999996,3283.0,0.000974,0.9929309999999999,BDKRB2 CANX COX7A1 PIK3C2G,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress|regulation of cellular response to osmotic stress,0.0003883|0.0003883|0.0009706|0.001165|0.002134,1|1|1|1|1,5149|5149|1287|1030|514.9
1054,4,0.6019,3.611,3363.0,0.00107,0.9929309999999999,CAP2 CATSPER3 NKIRAS2 SRRM5,epithelial cell-cell adhesion|sperm capacitation|cAMP-mediated signaling|regulation of adenylate cyclase activity|activation of adenylate cyclase activity,0.004604|0.006537|0.007744|0.008226|0.01015,1|1|1|1|1,228.8|158.4|132.9|124.8|100.5
1055,6,0.5012,7.518,5038.0,0.001486,0.998474,CAPG GNLY STON1 TLX2 TRABD2A TRIM56,positive regulation of protein oxidation|regulation of protein oxidation|interferon-beta production|type I interferon production|negative regulation of dendrite morphogenesis,0.001019|0.001019|0.001358|0.002037|0.003393,1|1|1|1|1,1471|1471|980.7|588.4|326.9
1056,4,0.5068,3.0410000000000004,3311.0,0.0009152999999999999,0.9929309999999999,CAPN10 DUSP2 PCDHGB7 TNK1,type B pancreatic cell apoptotic process|positive regulation of type B pancreatic cell apoptotic process|tRNA dihydrouridine synthesis|regulation of type B pancreatic cell apoptotic process|peptidyl-threonine dephosphorylation,0.0005825|0.0007766|0.001165|0.001941|0.004459,1|1|1|1|1,2574|1716|1030|572.1|234
1057,8,0.5111,14.31,6329.0,0.00225,0.9996790000000001,ABCG5 CAPN13 FSHR LHCGR OXER1 SIX3 STON1 TEX261,cellular response to gonadotropin stimulus|response to gonadotropin|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|activation of adenylate cyclase activity|ovulation cycle process,2.249e-05|4.962e-05|6.731e-05|0.0001182|0.0001182,0.3547|0.3913|0.3539|0.4661|0.3729,302.9|198|35.11|125.6|125.6
1058,4,0.5289,3.173,3428.0,0.0009227,0.9929309999999999,AANAT AARD CAPN14 FAM167B,melatonin biosynthetic process|melatonin metabolic process|indole-containing compound biosynthetic process|indolalkylamine biosynthetic process|N-terminal protein amino acid acetylation,0.0005825|0.0005825|0.001165|0.001165|0.003297,1|1|1|1|1,2574|2574|1030|1030|321.8
1059,6,0.5122,7.683,4176.0,0.001831,0.998474,BMPR1A CAPN15 GATA6 HNF4A TCF7L2 UBE2Z,pancreas development|endocrine system development|type B pancreatic cell differentiation|enteroendocrine cell differentiation|positive regulation of cardiac muscle cell proliferation,8.83e-07|4.408e-06|1.784e-05|2.114e-05|2.29e-05,0.01393|0.03477|0.09378|0.08338|0.07226,145|83.72|326.9|298.5|286
1060,4,0.5756,3.4539999999999997,3117.0,0.001104,0.9929309999999999,CAPN2 HIST3H3 LAX1 TFAP2B,positive regulation of neuron death|cellular urea homeostasis|cellular creatinine homeostasis|cellular ammonium homeostasis|urea homeostasis,6.564e-05|0.0002913|0.0002913|0.0002913|0.0004369,1|1|1|1|1,144.5|6865|6865|6865|3432
1061,4,0.5252,3.1510000000000002,3194.0,0.0009832,0.9929309999999999,CAPN3 FAM111B MTMR10 TSNAXIP1,calcium-dependent self proteolysis|positive regulation of satellite cell activation involved in skeletal muscle regeneration|regulation of satellite cell activation involved in skeletal muscle regeneration|G1 to G0 transition involved in cell differentiation|positive regulation of skeletal muscle tissue regeneration,0.0003883|0.0005825|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|2574|2574|1716|1030
1062,4,0.5111,3.0669999999999997,3363.0,0.0009089,0.9929309999999999,CAPS2 CD96 FAS TMPRSS7,Fas signaling pathway|negative regulation of natural killer cell cytokine production|motor neuron apoptotic process|neutrophil differentiation|activation-induced cell death of T cells,0.0008735|0.0008735|0.001456|0.001746|0.002037,1|1|1|1|1,1716|1716|858.1|686.5|572.1
1063,17,0.5098,69.34,13570.0,0.00507,1.0,C1QTNF3 C7 CAPSL CCL28 CDH10 CDH12 CDH6 FBXO4 HCN1 NIM1K OXCT1 PLCXD3 PRLR SLC45A2 UBE2QL1 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cytolysis,6.472e-06|1.972e-05|0.0001563|0.0003443|0.0003749,0.1021|0.1555|0.8216|1|1,86.53|58.62|28.62|21.76|73.42
1064,4,0.5037,3.022,3113.0,0.0009673,0.9929309999999999,CAPZA1 MYLPF SLAMF9 ZNF541,barbed-end actin filament capping|actin filament capping|negative regulation of actin filament depolymerization|interleukin-12-mediated signaling pathway|cellular response to interleukin-12,0.004459|0.007359|0.008131|0.009096|0.009482,1|1|1|1|1,234|139.2|125.6|111.9|107.3
1065,6,0.5794,8.691,3725.0,0.00232,0.998474,CAP1 CAPZB CFL1 CORO1C SSH2 WDR1,actin cytoskeleton organization|actin filament-based process|cytoskeleton organization|actin polymerization or depolymerization|actin filament fragmentation,7.552e-09|1.65e-08|1.025e-06|1.509e-06|1.977e-06,0.0001191|0.0001301|0.005388|0.005952|0.006238,29.48|25.83|12.83|128.7|1287
1066,14,0.5006,45.55,9709.0,0.004657,0.9999969999999999,BCL10 CARD10 CYLD IKBKB MALT1 N4BP1 NFKB2 NFKBIA NFKBIB SPATA2 TNFAIP3 TNIP1 TRAF2 TRAF3,pattern recognition receptor signaling pathway|regulation of DNA-binding transcription factor activity|regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of NF-kappaB transcription factor activity|toll-like receptor signaling pathway,1.701e-14|5.193e-14|2.588e-12|1.397e-11|8.187e-11,2.683e-10|4.096e-10|1.361e-08|5.508e-08|2.583e-07,86.49|31.71|45.2|58.96|81.56
1067,4,0.5575,3.345,3131.0,0.001065,0.9929309999999999,ABCA7 CARD14 KIF14 STX11,cerebellar granular layer structural organization|cerebellar cortex structural organization|cerebellar Purkinje cell layer structural organization|positive regulation of engulfment of apoptotic cell|negative regulation of integrin activation,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
1068,4,0.5221,3.133,3099.0,0.001007,0.9929309999999999,CARD19 CEACAM6 MYBPC1 STUM,positive regulation of endothelial cell-matrix adhesion via fibronectin|regulation of endothelial cell-matrix adhesion via fibronectin|positive regulation of heterotypic cell-cell adhesion|negative regulation of anoikis|regulation of heterotypic cell-cell adhesion,0.001165|0.001359|0.003297|0.003685|0.00504,1|1|1|1|1,1030|858.1|321.8|286|205.9
1069,4,0.5018,3.011,3031.0,0.0009899,0.9929309999999999,APOBEC3D ARL6 CARD9 PMPCA,defense response to symbiont|defense response to virus|protein processing involved in protein targeting to mitochondrion|response to virus|protein targeting,0.0006358|0.0006358|0.001165|0.001328|0.001895,1|1|1|1|1,48.57|48.57|1030|33.43|27.91
1070,12,0.5019,33.12,9814.0,0.003356,0.999986,ADAMTS7 BNIP2 CSPG4 GOLGA6B MAP2K5 MYO5C PLEKHO2 PPIB RAB8B SCAMP2 SLC24A1 SNX22,negative regulation of chemokine (C-X-C motif) ligand 2 production|ERK5 cascade|macrophage apoptotic process|Golgi vesicle fusion to target membrane|polyphosphate catabolic process,0.001746|0.001746|0.002327|0.002909|0.003489,1|1|1|1|1,858.1|858.1|572.1|429.1|343.2
1071,4,0.5251,3.15,3225.0,0.0009736,0.9929309999999999,CARMIL1 GRK6 HSF2BP PSD2,barbed-end actin filament uncapping|actin filament uncapping|negative regulation of barbed-end actin filament capping|regulation of barbed-end actin filament capping|double-strand break repair involved in meiotic recombination,0.0003883|0.0005825|0.0009706|0.001359|0.001359,1|1|1|1|1,5149|2574|1287|858.1|858.1
1072,4,0.5405,3.2430000000000003,3214.0,0.001006,0.9929309999999999,CALD1 CARTPT FRAT1 OR6Q1,positive regulation of epinephrine secretion|somatostatin secretion|negative regulation of glucagon secretion|positive regulation of transmission of nerve impulse|regulation of epinephrine secretion,0.0005825|0.0005825|0.0009706|0.001359|0.001359,1|1|1|1|1,2574|2574|1287|858.1|858.1
1073,5,0.5268,5.268,3269.0,0.001604,0.996692,CASC1 KRAS LRMP SHOC2 SOX5,positive regulation of Ras protein signal transduction|positive regulation of small GTPase mediated signal transduction|endocrine signaling|forebrain astrocyte development|forebrain astrocyte differentiation,0.0001441|0.0001709|0.0004854|0.000728|0.000728,1|1|1|1|1,107|98.07|4119|2060|2060
1074,5,0.5351,5.351,4032.0,0.001322,0.996692,CASC10 MSRB2 MTRNR2L3 PTF1A SPAG6,regulation of neural retina development|amacrine cell differentiation|exocrine pancreas development|protein repair|retinoic acid receptor signaling pathway,0.0007766|0.001165|0.001165|0.001553|0.003878,1|1|1|1|1,1716|1030|1030|735.5|271
1075,8,0.5151,14.42,6665.0,0.002154,0.9996790000000001,BNIP2 CASC4 CDC42EP5 GNB5 PLA2G4D PLEKHO2 PPIB SNX22,macrophage apoptotic process|polyphosphate catabolic process|polyphosphate metabolic process|myeloid cell apoptotic process|inflammatory cell apoptotic process,0.001552|0.002328|0.002715|0.002715|0.003103,1|1|1|1|1,858.1|514.9|429.1|429.1|367.8
1076,8,0.5178,14.5,5215.0,0.002764,0.9996790000000001,ACTR1A DYNC1LI1 DYNC1LI2 DYNLRB1 NDE1 PAFAH1B1 PAFAH1B2 ZWINT,mitotic prometaphase|biological phase|mitotic cell cycle phase|cell cycle phase|anaphase,8.873e-12|1.12e-10|1.12e-10|1.12e-10|1.552e-09,1.4e-07|8.836e-07|5.891e-07|4.418e-07|4.897e-06,92.49|60.1|60.1|60.1|81.99
1077,8,0.5148,14.41,6199.0,0.002314,0.9996790000000001,C11orf53 CASP1 CASP4 CRYAB HTR3A KDELC2 POU2F3 TMEM136,positive regulation of tumor necrosis factor-mediated signaling pathway|pyroptosis|protein autoprocessing|positive regulation of cytokine-mediated signaling pathway|positive regulation of response to cytokine stimulus,7.705e-06|1.875e-05|3.204e-05|0.0001252|0.0001621,0.1215|0.1479|0.1684|0.4936|0.5114,534.9|326.9|245.2|120.1|105.1
1078,4,0.5087,3.052,3216.0,0.0009459,0.9929309999999999,CASP3 MARCH7 SLC41A3 VPS13C,negative regulation of T cell proliferation|negative regulation of lymphocyte proliferation|negative regulation of mononuclear cell proliferation|negative regulation of leukocyte proliferation|negative regulation of T cell activation,6.997e-05|0.0001028|0.0001052|0.0001203|0.0002004,1|0.8109|0.5533|0.4743|0.6322,149.2|122.6|121.1|113.2|87.27
1079,5,0.5091,5.091,3809.0,0.0013310000000000002,0.996692,CARD16 CARD18 CASP5 DDI1 P2RY6,inhibition of cysteine-type endopeptidase activity|zymogen inhibition|negative regulation of interleukin-1 beta production|negative regulation of protein processing|negative regulation of protein maturation,1.696e-06|2.119e-06|2.045e-05|2.185e-05|2.185e-05,0.02675|0.01671|0.1075|0.08618|0.06895,1177|1030|294.2|284.1|284.1
1080,4,0.559,3.3539999999999996,3303.0,0.0010119999999999999,0.9929309999999999,BPIFA3 CASP6 LYPD6B ZKSCAN5,cellular response to staurosporine|response to staurosporine|cellular response to alkaloid|execution phase of apoptosis|regulation of neurotransmitter receptor activity,0.001165|0.001165|0.007166|0.0116|0.01698,1|1|1|1|1,1030|1030|143|87.27|59.18
1081,4,0.5741,3.445,3217.0,0.001067,0.9929309999999999,ASCL2 CASP7 ETFDH FAT1,establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis|spongiotrophoblast layer development|cellular response to staurosporine|response to staurosporine|negative regulation of Schwann cell proliferation,0.0003883|0.0003883|0.001165|0.001165|0.001359,1|1|1|1|1,5149|5149|1030|1030|858.1
1082,9,0.526,18.94,6175.0,0.003048,0.9998530000000001,ABL1 BCR GAB2 LMO2 MYB PTPN1 QRFP SOS1 WT1,regulation of hematopoietic progenitor cell differentiation|platelet-derived growth factor receptor signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|regulation of hematopoietic stem cell differentiation|enzyme linked receptor protein signaling pathway,5.03e-08|4.825e-07|1.209e-06|4.313e-06|6.205e-06,0.0007934|0.003805|0.006356|0.01701|0.01958,101.7|196.1|22.05|91.53|15.76
1083,5,0.5257,5.257000000000001,4087.0,0.001281,0.996692,ARHGEF28 CAST PHYHIP POMK STON1,negative regulation of type B pancreatic cell apoptotic process|inhibition of cysteine-type endopeptidase activity|presynaptic active zone organization|zymogen inhibition|regulation of type B pancreatic cell apoptotic process,0.001698|0.00194|0.002183|0.002183|0.002425,1|1|1|1|1,686.5|588.4|514.9|514.9|457.7
1084,6,0.5093,7.638999999999999,4669.0,0.001629,0.998474,CASTOR1 CEBPB PABPC1L PCIF1 RBPJL YWHAB,cellular response to amino acid stimulus|cellular response to acid chemical|cellular response to amino acid starvation|response to amino acid starvation|posttranscriptional regulation of gene expression,0.0001597|0.0001943|0.0002323|0.0002497|0.0003564,1|1|1|0.9846|1,104|94.04|85.81|82.71|18.83
1085,4,0.5765,3.4589999999999996,3123.0,0.001104,0.9929309999999999,CASTOR2 CASTOR3 DHX34 TFF1,cellular response to L-arginine|response to L-arginine|negative regulation of TORC1 signaling|regulation of TORC1 signaling|negative regulation of TOR signaling,2.828e-07|5.937e-07|4.831e-06|2.313e-05|2.792e-05,0.00446|0.004683|0.0254|0.09122|0.08809,3432|2060|605.7|264|239.5
1086,6,0.5147,7.72,4369.0,0.001759,0.998474,ATP5PB CASZ1 CHDH DDX20 PSMA5 SARS,glycine betaine biosynthetic process from choline|seryl-tRNA aminoacylation|glycine betaine biosynthetic process|glycine betaine metabolic process|negative regulation of vascular endothelial growth factor production,0.0008735|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,1716|1716|1716|1716|1716
1087,4,0.5022,3.013,3193.0,0.0009402999999999998,0.9929309999999999,CATSPER1 ZNF251 ZNF414 ZNF431,regulation of cilium beat frequency involved in ciliary motility|regulation of cilium beat frequency|regulation of cilium movement involved in cell motility|regulation of cilium-dependent cell motility|regulation of transcription by RNA polymerase II,0.001553|0.00291|0.005426|0.005426|0.007187,1|1|1|1|1,735.5|367.8|190.7|190.7|5.973
1088,5,0.5303,5.303,4481.0,0.001179,0.996692,AGTRAP CATSPER4 FAM76A IFI6 UBXN1,negative regulation of protein K48-linked deubiquitination|negative regulation of ubiquitin-specific protease activity|regulation of protein K48-linked deubiquitination|negative regulation of protein deubiquitination|regulation of ubiquitin-specific protease activity,0.000728|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|2060|1373|1030|823.8
1089,4,0.5084,3.051,3077.0,0.0009878,0.9929309999999999,CALU CATSPERB GREM2 RNF41,regulation of cytokine activity|negative regulation of mitophagy|embryonic body morphogenesis|negative regulation of autophagy of mitochondrion|sequestering of BMP from receptor via BMP binding,0.0009706|0.001165|0.001359|0.001553|0.001747,1|1|1|1|1,1287|1030|858.1|735.5|643.6
1090,20,0.4843,92.02,14580.0,0.006254,1.0,C19orf66 CNN1 ICAM1 ICAM3 P2RY11 ZNF121 ZNF433 ZNF441 ZNF442 ZNF443 ZNF490 ZNF563 ZNF564 ZNF625 ZNF627 ZNF69 ZNF700 ZNF709 ZNF763 ZNF878,"regulation of transcription by RNA polymerase II|regulation of cellular macromolecule biosynthetic process|regulation of macromolecule biosynthetic process|regulation of cellular biosynthetic process|regulation of transcription, DNA-templated",2.617e-10|3.555e-10|4.043e-10|7.756e-10|1.028e-09,4.128e-06|2.804e-06|2.126e-06|3.059e-06|3.244e-06,5.973|4.474|4.439|4.264|4.756
1091,4,0.5048,3.029,3063.0,0.0009851,0.9929309999999999,AARS CAVIN3 HEXDC HSPG2,negative regulation of fermentation|regulation of fermentation|negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|cortical actin cytoskeleton organization,0.0004855|0.0005825|0.001262|0.001553|0.003783,1|1|1|1|1,2574|2060|858.1|686.5|271
1092,5,0.536,5.36,4327.0,0.001234,0.996692,C20orf173 CAVIN4 CSN3 EFCAB1 F2RL2,regulation of Rho protein signal transduction|regulation of Ras protein signal transduction|thrombin-activated receptor signaling pathway|protein deneddylation|regulation of small GTPase mediated signal transduction,0.0002676|0.001371|0.002909|0.0032|0.003656,1|1|1|1|1,79.83|34.67|381.4|343.2|20.99
1093,6,0.5097,7.645,3736.0,0.0020350000000000004,0.998474,CBFB LMO2 MYB RUNX1 RUNX2 SOS1,regulation of hematopoietic progenitor cell differentiation|regulation of hematopoietic stem cell differentiation|regulation of stem cell differentiation|regulation of T cell differentiation|regulation of lymphocyte differentiation,1.121e-11|2.986e-09|1.469e-08|4.224e-08|8.341e-08,1.768e-07|2.355e-05|7.725e-05|0.0001666|0.0002631,190.7|183.1|121.5|92.77|78.01
1094,11,0.505,27.77,7107.0,0.0038799999999999998,0.999969,CBL DUSP6 LZTR1 MAPK1 NF1 RAF1 RASA2 SHOC2 SOS1 SPRED1 SPRED2,regulation of intracellular signal transduction|MAPK cascade|response to growth factor|fibroblast growth factor receptor signaling pathway|regulation of signal transduction,1.931e-12|4.118e-12|3.254e-11|5.098e-10|7.572e-10,3.045e-08|3.248e-08|1.711e-07|2.01e-06|2.389e-06,11.65|36.62|28.15|115.6|6.759
1095,14,0.5095,46.37,11350.0,0.00406,0.9999969999999999,AK4 BICD1 CBLB ETFBKMT IL17RE KIAA1551 KLHL42 LMNTD1 MANSC4 RASSF8 SYT10 TM7SF3 TMTC1 TSPAN11,regulation of microtubule-based process|negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity,0.0005039|0.001358|0.001358|0.001358|0.001358,1|1|1|1|1,18.78|1471|1471|1471|1471
1096,8,0.9254,25.91,5129.0,0.005011,0.9996790000000001,CBLL1 METTL14 METTL3 RBM15 VIRMA WTAP YTHDF2 ZC3H13,mRNA methylation|mRNA modification|RNA methylation|RNA modification|macromolecule methylation,1.965e-17|1.563e-16|2.418e-16|2.435e-14|3.429e-13,3.1e-13|1.233e-12|1.271e-12|9.603e-11|1.082e-09,965.4|643.6|209.5|106|72.08
1097,4,0.5058,3.035,3080.0,0.0009818,0.9929309999999999,CBLN3 LAMB2 LDHAL6A TNFAIP8,substrate adhesion-dependent cell spreading|metanephric glomerular basement membrane development|sprouting of injured axon|axon extension involved in regeneration|metanephric glomerular epithelial cell development,7.749e-05|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,147.1|4119|4119|4119|2060
1098,5,0.5697,5.697,3796.0,0.001495,0.996692,CBS GAS2 HOXB13 OR8B3 SAA4,initiation of primordial ovarian follicle growth|cysteine biosynthetic process from serine|cysteine biosynthetic process via cystathionine|homocysteine catabolic process|epithelial cell maturation involved in prostate gland development,0.0004854|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|2060|1373|1373|1373
1099,7,0.5077,10.66,5675.0,0.001871,0.9992989999999999,BTNL8 CBY3 EIF4E1B NSG2 RUFY1 ZNF454 ZNF879,clathrin coat assembly|dopamine receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus,0.006439|0.01082|0.02753|0.02787|0.03283,1|1|1|1|1,163.5|94.91|36.32|35.88|30.33
1100,4,0.5508,3.305,3172.0,0.001038,0.9929309999999999,CC2D1B KIR3DL3 OMA1 ZNF526,HRI-mediated signaling|regulation of cristae formation|negative regulation of mitochondrial fusion|diet induced thermogenesis|mitochondrial protein processing,0.0009706|0.0009706|0.001941|0.002328|0.002328,1|1|1|1|1,1287|1287|572.1|468.1|468.1
1101,4,0.5413,3.248,3383.0,0.0009567,0.9929309999999999,ANKS1A CC2D2A DEFA4 TOMM34,regulation of ephrin receptor signaling pathway|protein localization to ciliary transition zone|membrane disruption in other organism|antifungal humoral response|embryonic brain development,0.0005825|0.001747|0.002134|0.002328|0.002522,1|1|1|1|1,2574|643.6|514.9|468.1|429.1
1102,4,0.5787,3.472,3166.0,0.001093,0.9929309999999999,C2orf73 CC2D2B DMBT1 TAS2R31,induction of bacterial agglutination|detection of bacterial lipoprotein|response to bacterial lipoprotein|detection of molecule of bacterial origin|detection of bacterium,0.001165|0.001165|0.001747|0.002522|0.003491,1|1|1|1|1,1030|1030|643.6|429.1|302.9
1103,5,0.5657,5.657,3961.0,0.001423,0.996692,CCBE1 FZD1 NAGK SDHAF3 SLC4A10,positive regulation of lymphangiogenesis|canonical Wnt signaling pathway involved in osteoblast differentiation|N-acetylmannosamine metabolic process|mannosamine metabolic process|central nervous system neuron differentiation,0.000728|0.000728|0.000728|0.000728|0.0007712,1|1|1|1|1,2060|2060|2060|2060|45.51
1104,4,0.5623,3.3739999999999997,3249.0,0.001035,0.9929309999999999,CCDC102B CD86 CDHR2 LRGUK,negative regulation of cell growth involved in contact inhibition|intermicrovillar adhesion|positive regulation of lymphotoxin A production|regulation of lymphotoxin A production|activation of protein kinase C activity,0.0003883|0.0005825|0.0005825|0.0005825|0.001165,1|1|1|1|1,5149|2574|2574|2574|1030
1105,4,0.5233,3.14,3155.0,0.0009916999999999999,0.9929309999999999,CCDC103 MALL OR5A2 ZNF320,determination of digestive tract left/right asymmetry|epithelial cilium movement involved in determination of left/right asymmetry|inner dynein arm assembly|outer dynein arm assembly|epithelial cilium movement involved in extracellular fluid movement,0.001553|0.002328|0.003297|0.004266|0.00678,1|1|1|1|1,735.5|468.1|321.8|245.2|151.4
1106,12,0.4945,32.64,9077.0,0.0035740000000000004,0.999986,AES CELF5 FUT5 FUT6 MUM1 PLIN3 SGTA SLC25A23 UQCR11 ZNF555 ZNF556 ZNF77,fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|fucose metabolic process|fucosylation,1.705e-05|1.705e-05|1.705e-05|4.732e-05|5.287e-05,0.2689|0.1345|0.08964|0.1866|0.1668,381.4|381.4|381.4|214.5|201.9
1107,4,0.5074,3.0439999999999996,2871.0,0.001056,0.9929309999999999,CCDC110 GOLGA1 PTBP3 VPS54,homeostasis of number of cells|neurofilament cytoskeleton organization|erythrocyte maturation|Golgi to vacuole transport|negative regulation of RNA splicing,0.0006536|0.001747|0.00291|0.003878|0.005233,1|1|1|1|1,47.9|643.6|367.8|271|198
1108,4,0.5276,3.1660000000000004,3181.0,0.0009918,0.9929309999999999,CCDC112 CCDC69 MAP2K4 TCTN1,central nervous system interneuron axonogenesis|cellular response to sorbitol|negative regulation of motor neuron apoptotic process|somatic motor neuron differentiation|regulation of motor neuron apoptotic process,0.0003883|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,5149|1716|1287|1030|1030
1109,5,0.5616,5.6160000000000005,4219.0,0.001326,0.996692,CCDC117 FGA IBTK NT5DC3 SMTNL2,positive regulation of vasoconstriction|regulation of vasoconstriction|blood vessel diameter maintenance|regulation of tube diameter|regulation of tube size,2.481e-05|9.15e-05|0.0003784|0.0003784|0.0003843,0.3914|0.7217|1|1|1,265.7|135|65.38|65.38|64.87
1110,4,0.5168,3.1010000000000004,3003.0,0.001029,0.9929309999999999,CCDC124 RSPH1 SLTM TMED3,"axoneme assembly|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|microtubule bundle formation|cell cycle|Golgi organization",0.01525|0.0166|0.02119|0.02498|0.02615,1|1|1|1|1,66.01|60.57|47.24|7.408|38.14
1111,4,0.5199,3.12,3249.0,0.0009568,0.9929309999999999,CCDC125 PMS2 SEPT3 SMDT1,calcium import into the mitochondrion|somatic hypermutation of immunoglobulin genes|somatic diversification of immune receptors via somatic mutation|negative regulation of Rho protein signal transduction|mitochondrial calcium ion transmembrane transport,0.002328|0.003104|0.003297|0.004459|0.00504,1|1|1|1|1,468.1|343.2|321.8|234|205.9
1112,5,0.5108,5.1080000000000005,4149.0,0.001227,0.996692,CCDC126 NWD2 POU5F2 TMSB10 ZNF175,sequestering of actin monomers|negative regulation of actin filament polymerization|cellular process|maintenance of protein location in cell|negative regulation of protein polymerization,0.00291|0.01472|0.01519|0.01616|0.01807,1|1|1|1|1,374.5|68.65|0.266|62.41|55.66
1113,6,0.5035,7.553,4720.0,0.001594,0.998474,CCDC127 CDH18 FAM173B PLEKHG4B SLC6A18 UBTD2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|regulation of biological process|adherens junction organization|regulation of cellular process|amino acid transmembrane transport,0.01039|0.01377|0.0152|0.01872|0.0219,1|1|1|1|1,98.07|0|66.44|0|45.77
1114,4,0.5548,3.3289999999999997,3154.0,0.001052,0.9929309999999999,CCDC13 KRT3 MUC15 TTC21A,cilium organization|intraciliary retrograde transport|microtubule-based process|non-motile cilium assembly|intermediate filament cytoskeleton organization,0.002243|0.00291|0.008684|0.008903|0.01006,1|1|1|1|1,25.62|367.8|12.82|114.4|101
1115,13,0.4518,35.24,9044.0,0.00387,0.999993,AK6 C18orf21 C1D DIS3 EXOSC1 EXOSC10 EXOSC7 EXOSC8 EXOSC9 MPHOSPH6 RBM7 TENT4B ZCCHC7,ncRNA catabolic process|rRNA processing|rRNA metabolic process|polyadenylation-dependent ncRNA catabolic process|polyadenylation-dependent RNA catabolic process,1.371e-16|1.819e-14|2.534e-14|5.107e-14|8.296e-14,2.163e-12|1.435e-10|1.332e-10|2.014e-10|2.617e-10,332.2|50.92|49.04|1051|919.4
1116,4,0.5564,3.339,3335.0,0.0009976000000000002,0.9929309999999999,CCDC148 GCHFR MYO1C ZBTB1,vesicle transport along actin filament|actin filament-based transport|vesicle cytoskeletal trafficking|actin filament-based movement|positive regulation of pro-T cell differentiation,9.879e-06|1.19e-05|0.0001131|0.0003382|0.0004854,0.1558|0.09386|0.5945|1|1,433.6|392.3|121.1|69.23|4119
1117,5,0.513,5.13,4265.0,0.001198,0.996692,CCDC149 CPLX3 GRM7 TRIM60 ZNF106,negative regulation of glutamate secretion|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|regulation of synaptic vesicle fusion to presynaptic active zone membrane|negative regulation of amino acid transport|G protein-coupled glutamate receptor signaling pathway,0.001456|0.00194|0.002183|0.003394|0.003878,1|1|1|1|1,823.8|588.4|514.9|316.8|274.6
1118,5,0.501,5.01,4088.0,0.001221,0.996692,CCDC151 FAM183A GCC2 NUDT19 SLC35F6,recycling endosome to Golgi transport|late endosome to Golgi transport|negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|protein targeting|Golgi ribbon formation,0.000728|0.001456|0.002425|0.003121|0.003394,1|1|1|1|1,2060|823.8|457.7|22.33|316.8
1119,17,0.5062,68.84,13280.0,0.005143,1.0,ANXA2R C1QTNF3 C7 CCDC152 CCL28 CDH10 CDH6 EXOC3 FBXO4 HCN1 NIM1K OXCT1 PLCXD3 SLC45A2 TMEM267 UGT3A1 UGT3A2,cytolysis|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cellular response to hydroxyisoflavone|cellular response to genistein,0.0003749|0.0005935|0.001253|0.001649|0.001649,1|1|1|1|1,73.42|57.69|39.08|1211|1211
1120,4,0.5622,3.373,3131.0,0.001073,0.9929309999999999,CCDC155 PHETA1 SPIC TAOK3,microtubule cytoskeleton organization involved in homologous chromosome segregation|receptor recycling|chromosome localization to nuclear envelope involved in homologous chromosome segregation|telomere localization|DNA repair,0.0003883|0.002134|0.002134|0.002134|0.003859,1|1|1|1|1,5149|514.9|514.9|514.9|19.43
1121,4,0.5158,3.095,3044.0,0.001013,0.9929309999999999,CCDC158 GC ME2 MTRNR2L4,protein carboxylation|peptidyl-glutamic acid carboxylation|regulation of NADP metabolic process|malate metabolic process|vitamin D metabolic process,0.0009706|0.0009706|0.001456|0.002183|0.00412,1|1|1|1|1,1373|1373|823.8|514.9|257.4
1122,5,0.5531,5.531000000000001,4143.0,0.00133,0.996692,CALM3 CCDC166 CLDN24 IFIH1 MYO9A,MDA-5 signaling pathway|regulation of type III interferon production|negative regulation of high voltage-gated calcium channel activity|positive regulation of cyclic-nucleotide phosphodiesterase activity|detection of virus,0.0009706|0.001213|0.001456|0.001456|0.001698,1|1|1|1|1,1373|1030|823.8|823.8|686.5
1123,4,0.568,3.408,3154.0,0.001077,0.9929309999999999,CCDC17 CCDC74A PTH2 SPATA31A7,positive regulation of anoikis|negative regulation of anoikis|regulation of anoikis|neuropeptide signaling pathway|negative regulation of inflammatory response to antigenic stimulus,0.00194|0.004604|0.006295|0.02642|0.04971,1|1|1|1|1,588.4|228.8|164.8|37.79|19.8
1124,4,0.5825,3.495,3233.0,0.001077,0.9929309999999999,CCDC170 FGF12 KCNJ15 PKIG,regulation of ion transport|regulation of neuronal action potential|negative regulation of ion transport|regulation of voltage-gated sodium channel activity|regulation of cation transmembrane transport,0.001045|0.001165|0.001319|0.001553|0.001926,1|1|1|1|1,11.55|1030|33.54|735.5|27.68
1125,9,0.7105,25.58,6243.0,0.004069,0.9998530000000001,CCDC174 CHCHD4 LSM3 RPL32 SEC13 SGO1 TAMM41 TRNT1 TSEN2,gene expression|RNA processing|ncRNA processing|establishment of protein localization to organelle|tRNA 3'-terminal CCA addition,9.098e-05|0.0004277|0.0007141|0.0007983|0.0008734,1|1|1|1|1,6.281|9.917|15.89|15.29|2288
1126,4,0.5967,3.58,3282.0,0.0010869999999999999,0.9929309999999999,CCDC177 CDC25C CPA3 LRRC25,positive regulation of G2/MI transition of meiotic cell cycle|regulation of G2/MI transition of meiotic cell cycle|positive regulation of meiotic cell cycle phase transition|regulation of meiotic cell cycle phase transition|angiotensin maturation,0.0009706|0.0009706|0.001456|0.002425|0.003152,1|1|1|1|1,1373|1373|823.8|457.7|343.3
1127,20,0.5058,96.1,12660.0,0.007509999999999999,1.0,AP3B1 ARFRP1 ARL1 COG6 COG7 EIPR1 HTT RAB14 RAB6A RGP1 RIC1 SYS1 UNC50 VIPAS39 VPS33B VPS50 VPS51 VPS52 VPS53 VPS54,"intracellular transport|cytosolic transport|endosomal transport|establishment of localization in cell|retrograde transport, endosome to Golgi",3.957e-21|1.898e-20|3.268e-20|3.894e-19|2.797e-18,6.241e-17|1.497e-16|1.718e-16|1.536e-15|8.824e-15,12.49|75.9|52.23|8.312|104
1128,4,0.5604,3.362,3156.0,0.001062,0.9929309999999999,CCDC181 FCAMR MSMB PTGES3,telomerase holoenzyme complex assembly|glucocorticoid receptor signaling pathway|corticosteroid receptor signaling pathway|lung saccule development|cyclooxygenase pathway,0.0009706|0.001359|0.001553|0.001941|0.002328,1|1|1|1|1,1287|858.1|735.5|572.1|468.1
1129,6,0.5016,7.523,4929.0,0.0015199999999999999,0.998474,ANKRD29 CCDC182 HRH4 NUDT16L1 OR2A14 ZNF396,negative regulation of double-strand break repair via nonhomologous end joining|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway|G protein-coupled acetylcholine receptor signaling pathway|G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception of smell,0.002715|0.003054|0.006777|0.007749|0.009019,1|1|1|1|1,420.3|367.8|154.8|6.641|13.34
1130,4,0.5547,3.3280000000000003,3151.0,0.001052,0.9929309999999999,CCDC183 MT1B PPP1R1C ZER1,detoxification of copper ion|stress response to copper ion|detoxification of inorganic compound|stress response to metal ion|cellular response to zinc ion,0.003297|0.003297|0.003685|0.003878|0.00504,1|1|1|1|1,321.8|321.8|286|271|205.9
1131,4,0.5605,3.363,3119.0,0.001074,0.9929309999999999,CCDC184 KCNH3 LRRK2 TPH2,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation|Wnt signalosome assembly|cellular response to metal ion|negative regulation of protein processing involved in protein targeting to mitochondrion|regulation of protein processing involved in protein targeting to mitochondrion,0.0003883|0.0003883|0.0005283|0.0005825|0.0005825,1|1|1|1|1,5149|5149|53.35|2574|2574
1132,4,0.5074,3.0439999999999996,3233.0,0.0009384,0.9929309999999999,CCDC185 CFHR4 PDLIM3 SH3RF1,"regulation of CD8-positive, alpha-beta T cell proliferation|regulation of CD8-positive, alpha-beta T cell activation|regulation of alpha-beta T cell proliferation|regulation of CD4-positive, alpha-beta T cell differentiation|regulation of CD4-positive, alpha-beta T cell activation",0.001747|0.003878|0.00678|0.009867|0.01295,1|1|1|1|1,643.6|271|151.4|103|78.01
1133,4,0.5144,3.0869999999999997,3083.0,0.0009976000000000002,0.9929309999999999,CCDC190 IP6K3 SRL ZNF699,inositol phosphate biosynthetic process|polyol biosynthetic process|phosphatidylinositol phosphorylation|inositol phosphate metabolic process|lipid phosphorylation,0.00291|0.009675|0.01122|0.0116|0.0141,1|1|1|1|1,367.8|105.1|90.33|87.27|71.51
1134,4,0.5212,3.127,3292.0,0.0009467000000000001,0.9929309999999999,ARHGDIA CCDC191 IQUB TOMM20L,tRNA import into mitochondrion|cellular response to redox state|RNA import into mitochondrion|response to redox state|protein import into mitochondrial matrix,0.0005825|0.0009706|0.001165|0.003104|0.004072,1|1|1|1|1,2574|1287|1030|343.2|257.4
1135,4,0.5774,3.464,3274.0,0.0010550000000000002,0.9929309999999999,CCDC198 NID2 TMEM182 TMEM45B,basement membrane organization|UNCLASSIFIED|biological_process|biological regulation|cell-matrix adhesion,0.005426|0.008539|0.008539|0.02306|0.02444,1|1|1|1|1,190.7|5.627|0.2884|0|40.86
1136,4,0.5275,3.165,3279.0,0.000962,0.9929309999999999,ABCD2 ARHGAP10 CCDC24 HIBADH,maintenance of Golgi location|carboxylic acid catabolic process|valine catabolic process|long-chain fatty acid import into peroxisome|organic acid catabolic process,0.0009706|0.001172|0.001213|0.001213|0.001343,1|1|1|1|1,1373|36.78|1030|1030|34.33
1137,15,0.5008,52.58,11850.0,0.004406,0.999999,ATXN7L3B CCDC25 CCNB1IP1 CTDSP1 KIAA1257 KIF26B LYRM1 MAP3K7CL NECAP2 NIPSNAP3B RAB22A SDR39U1 SLC25A36 TXNDC16 ZNF286A,response to stimulus|pyrimidine nucleotide transport|pyrimidine nucleotide import into mitochondrion|ureteric bud invasion|metanephric renal vesicle formation,0.0003816|0.002182|0.002182|0.002908|0.003634,1|1|1|1|1,0|686.5|686.5|457.7|343.2
1138,7,0.5418,11.38,5349.0,0.002117,0.9992989999999999,CCDC28B CLCNKA PRAMEF11 PRAMEF12 PRAMEF14 PRAMEF18 PRAMEF20,negative regulation of cell differentiation|negative regulation of developmental process|negative regulation of apoptotic process|negative regulation of programmed cell death|positive regulation of cell population proliferation,5.814e-07|2.672e-06|2.955e-06|3.278e-06|3.746e-06,0.009171|0.02107|0.01554|0.01293|0.01182,23.06|16.91|16.57|16.22|15.78
1139,6,0.5388,8.082,4955.0,0.001625,0.998474,CCDC3 HOXD10 HOXD11 HOXD12 HOXD8 HOXD9,pattern specification process|regionalization|embryonic limb morphogenesis|embryonic appendage morphogenesis|skeletal system development,2.231e-08|8.574e-07|3.902e-06|3.902e-06|4.036e-06,0.0003519|0.006762|0.02052|0.01539|0.01273,40.57|43.18|87.27|87.27|29.15
1140,4,0.5178,3.1069999999999998,3179.0,0.0009737999999999999,0.9929309999999999,CCDC38 MYF5 OAS2 OASL,regulation of ribonuclease activity|regulation of nuclease activity|negative regulation of viral genome replication|type I interferon signaling pathway|cellular response to type I interferon,1.555e-06|7.795e-06|4.34e-05|6.8e-05|6.997e-05,0.02452|0.06148|0.2282|0.2682|0.2207,1144|468.1|190.7|151.4|149.2
1141,4,0.5006,3.0039999999999996,3216.0,0.0009308,0.9929309999999999,CCDC39 CLN6 PCDH10 STARD5,establishment of left/right asymmetry|locomotion involved in locomotory behavior|determination of pancreatic left/right asymmetry|determination of liver left/right asymmetry|cholesterol import,0.0007766|0.001165|0.001165|0.001359|0.001359,1|1|1|1|1,1716|1030|1030|858.1|858.1
1142,5,0.5168,5.167999999999999,4175.0,0.001233,0.996692,CCDC42 KRTAP8-1 PAFAH2 TRIM59 TSPYL1,negative regulation of I-kappaB kinase/NF-kappaB signaling|nucleosome assembly|chromatin assembly|spermatid development|nucleosome organization,0.01112|0.02832|0.03588|0.0373|0.03753,1|1|1|1|1,91.53|35.21|27.64|26.57|26.4
1143,4,0.5693,3.4160000000000004,3330.0,0.0010220000000000001,0.9929309999999999,CCDC43 DAPK2 MAN1A1 SLC5A6,pantothenate transmembrane transport|positive regulation of eosinophil chemotaxis|regulation of eosinophil chemotaxis|biotin import across plasma membrane|biotin transport,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
1144,15,0.5115,53.71,9754.0,0.0054600000000000004,0.999999,CCDC115 CCDC47 EMC1 EMC2 EMC3 EMC4 EMC6 EMC7 EMC8 LPAR2 NCLN PDCL RAB5IF RIC8A TMEM147,protein insertion into ER membrane by stop-transfer membrane-anchor sequence|tail-anchored membrane protein insertion into ER membrane|protein insertion into ER membrane|endoplasmic reticulum organization|protein insertion into membrane,3.984e-19|5.011e-18|4.568e-16|2.726e-15|3.986e-14,6.284e-15|3.952e-14|2.402e-12|1.075e-11|1.258e-10,961.1|600.7|282.7|109.8|141.3
1145,7,0.5086,10.68,5111.0,0.0020800000000000003,0.9992989999999999,CCDC51 DNM1L KLHL12 MFF MIEF1 SLC25A46 STARD7,mitochondrial fission|positive regulation of mitochondrial fission|regulation of mitochondrial fission|mitochondrial membrane fission|regulation of peroxisome organization,5.886e-11|2.731e-08|9.713e-08|5.936e-07|1.483e-06,9.284e-07|0.0002154|0.0005107|0.002341|0.00468,560.4|519.2|326.9|2942|1471
1146,4,0.5003,3.002,3123.0,0.0009579,0.9929309999999999,CCDC58 CLEC4F PNPLA8 WDR5B,phosphatidylethanolamine catabolic process|phosphatidylcholine catabolic process|prostaglandin biosynthetic process|prostanoid biosynthetic process|linoleic acid metabolic process,0.0007766|0.002522|0.004072|0.004072|0.004266,1|1|1|1|1,1716|429.1|257.4|257.4|245.2
1147,12,0.5042,33.28,6957.0,0.004744,0.999986,CCDC6 CYB5R4 FBXO42 LCMT1 PPME1 PPP2CA PPP2R1A PPP2R2A PPP6C PPP6R3 PTPA TIPRL,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|regulation of dephosphorylation|mitotic cell cycle process,8.448e-11|2.304e-10|8.385e-10|2.354e-09|6.72e-08,1.333e-06|1.817e-06|4.409e-06|9.281e-06|0.000212,77.91|65.55|52.52|44.01|16.19
1148,4,0.5341,3.205,3250.0,0.0009827,0.9929309999999999,CCDC63 DEPDC4 KCNN2 TMEM26,atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell signaling|atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell communication,0.001165|0.001165|0.00291|0.00291|0.003104,1|1|1|1|1,1030|1030|367.8|367.8|343.2
1149,74,0.4827,1304.0,50150.0,0.025269999999999997,1.0,ACAD9 ATPAF2 CARS2 COA6 COA7 COQ7 COX18 COX4I1 CYC1 DARS2 DMAC1 ECSIT FASTKD5 FOXRED1 GFM2 GLRX5 GRSF1 GTPBP10 GTPBP8 IBA57 ISCA2 MCAT METTL17 MRM2 MRM3 MTFMT MTG1 MTIF2 MTIF3 MTO1 MTRF1L NDUFA10 NDUFA11 NDUFA2 NDUFA3 NDUFA5 NDUFA6 NDUFA8 NDUFA9 NDUFAF1 NDUFAF3 NDUFAF4 NDUFAF6 NDUFAF7 NDUFAF8 NDUFB10 NDUFB2 NDUFB3 NDUFB4 NDUFB5 NDUFB6 NDUFB7 NDUFB8 NDUFB9 NDUFC1 NDUFC2 NDUFS1 NDUFS2 NDUFS3 NDUFS5 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NFU1 NOA1 NSUN4 NUBPL PET117 RTN4IP1 TFB1M TIMMDC1 UQCRC2 YBEY,NADH dehydrogenase complex assembly|mitochondrial respiratory chain complex I assembly|mitochondrial respiratory chain complex assembly|ATP synthesis coupled electron transport|mitochondrial ATP synthesis coupled electron transport,3.027e-72|3.027e-72|7.478e-71|7.182e-53|6.559e-51,4.775e-68|2.387e-68|3.932e-67|2.832e-49|2.069e-47,162.3|162.3|111.5|97.64|95.65
1150,8,0.5389,15.09,5599.0,0.00268,0.9996790000000001,ANAPC10 HSPA13 LSM6 NAF1 NOP10 SPCS3 TMA16 TRAPPC11,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|positive regulation of telomerase RNA localization to Cajal body|pseudouridine synthesis|regulation of telomerase RNA localization to Cajal body,1.319e-06|8.691e-06|1.789e-05|2.498e-05|2.498e-05,0.0208|0.06854|0.09407|0.09851|0.07881,1716|514.9|343.2|286|286
1151,5,0.5204,5.204,3966.0,0.001307,0.996692,BEND4 CCDC78 EHBP1 ERC1 EXOC8,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation|de novo centriole assembly|maintenance of presynaptic active zone structure|presynaptic active zone organization|multi-ciliated epithelial cell differentiation,0.001456|0.001456|0.001698|0.002183|0.002425,1|1|1|1|1,823.8|823.8|686.5|514.9|457.7
1152,4,0.5254,3.153,3107.0,0.001011,0.9929309999999999,CCDC8 HDHD5 MEFV OR13D1,negative regulation of macrophage inflammatory protein 1 alpha production|regulation of macrophage inflammatory protein 1 alpha production|negative regulation of NLRP3 inflammasome complex assembly|regulation of NLRP3 inflammasome complex assembly|negative regulation of interleukin-12 production,0.0007766|0.001165|0.001165|0.003104|0.003491,1|1|1|1|1,1716|1030|1030|343.2|302.9
1153,4,0.5693,3.4160000000000004,3176.0,0.001072,0.9929309999999999,CCDC81 METTL2B MMP3 TRABD,negative regulation of hydrogen peroxide metabolic process|cellular response to UV-A|response to UV-A|cellular response to nitric oxide|positive regulation of oxidative stress-induced cell death,0.001359|0.002328|0.00291|0.003104|0.003491,1|1|1|1|1,858.1|468.1|367.8|343.2|302.9
1154,4,0.5262,3.157,2983.0,0.0010539999999999998,0.9929309999999999,CCDC82 DUSP11 RBM34 ZNF337,polynucleotide 5' dephosphorylation|peptidyl-tyrosine dephosphorylation|protein dephosphorylation|cellular process|dephosphorylation,0.0005825|0.02062|0.04148|0.04971|0.0609,1|1|1|1|1,2574|48.57|23.84|0.3325|16.09
1155,4,0.5711,3.426,3024.0,0.001129,0.9929309999999999,CCDC83 CDC42EP1 DAD1 HCFC1R1,positive regulation of pseudopodium assembly|regulation of pseudopodium assembly|protein N-linked glycosylation via asparagine|peptidyl-asparagine modification|viral protein processing,0.002716|0.00291|0.006007|0.0062|0.007745,1|1|1|1|1,396.1|367.8|171.6|166.1|132
1156,4,0.5024,3.014,2834.0,0.001059,0.9929309999999999,CCDC85B CDK5RAP2 FAM50B PCNT,ciliary basal body-plasma membrane docking|G2/M transition of mitotic cell cycle|cell cycle G2/M phase transition|mitotic prometaphase|organelle localization by membrane tethering,0.0001309|0.0002806|0.0002885|0.0003972|0.0004161,1|1|1|1|1,108.4|73.55|72.52|61.66|60.22
1157,7,0.5201,10.92,5073.0,0.002143,0.9992989999999999,CCDC86 EEF1G INTS5 NXF1 OSBP TMEM258 WDR74,biological regulation|regulation of biological process|gene expression|regulation of cellular process|intracellular cholesterol transport,0.001366|0.002481|0.00342|0.003815|0.006777,1|1|1|1|1,0|0|5.384|0|154.8
1158,4,0.5091,3.055,2888.0,0.0010539999999999998,0.9929309999999999,AMOTL1 CCDC87 DLG5 PKN2,apical junction assembly|cell-cell junction assembly|regulation of cell motility|regulation of locomotion|ameboidal-type cell migration,6.606e-05|0.0002316|0.0003777|0.0004307|0.0004604,1|1|1|1|1,153.7|81.08|16.31|15.6|57.21
1159,5,0.5362,5.362,4148.0,0.001288,0.996692,ANKRD31 C7 CCDC88C CPT1B ZNF646,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination|positive regulation of meiotic DNA double-strand break formation|regulation of meiotic DNA double-strand break formation|apical constriction|response to blue light,0.0004854|0.0004854|0.0004854|0.000728|0.001698,1|1|1|1|1,4119|4119|4119|2060|686.5
1160,11,0.5182,28.5,8419.0,0.0033659999999999996,0.999969,CCDC89 CREBZF FCHSD2 FOLR1 FOLR2 KCTD21 KRTAP5-9 P2RY2 P2RY6 PLEKHB1 UCP3,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|folic acid transport|response to folic acid,1.864e-06|6.518e-06|8.687e-06|1.395e-05|2.416e-05,0.0294|0.0514|0.04568|0.05502|0.07622,1716|686.5|572.1|429.1|312
1161,17,0.5099,69.34,14120.0,0.004877,1.0,C5AR1 C5AR2 CCDC61 CCDC9 CRX EML2 FLT3LG FUT1 IGFL1 IGFL2 IGFL3 IGFL4 SPACA4 SULT2A1 SULT2B1 TPRX1 ZNF45,complement component C5a signaling pathway|complement receptor mediated signaling pathway|sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process,3.838e-06|6.68e-05|0.0002057|0.000222|0.000222,0.06054|0.5269|1|0.8755|0.7004,1211|186.4|101|96.92|96.92
1162,5,0.5297,5.297000000000001,4269.0,0.001236,0.996692,CCDC90B MAP1B MFSD6 PRSS38 RIMS3,induction of synaptic plasticity by chemical substance|positive regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity|peripheral nervous system axon regeneration,0.0004854|0.0004854|0.0004854|0.000788|0.001698,1|1|1|1|1,4119|4119|4119|45.02|686.5
1163,4,0.5082,3.049,3181.0,0.0009552999999999999,0.9929309999999999,AZIN2 CCDC91 CHL1 PLA2G2D,nucleolar chromatin organization|trans-Golgi network membrane organization|positive regulation of polyamine transmembrane transport|cellular response to bleomycin|response to bleomycin,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
1164,4,0.5106,3.0639999999999996,3211.0,0.0009507999999999999,0.9929309999999999,C17orf78 CCDC92 HMGCLL1 TACR3,leucine catabolic process|positive regulation of uterine smooth muscle contraction|tachykinin receptor signaling pathway|leucine metabolic process|hyperosmotic salinity response,0.001359|0.001553|0.001747|0.001747|0.001747,1|1|1|1|1,858.1|735.5|643.6|643.6|643.6
1165,18,0.5071,77.59,13560.0,0.005676,1.0,ARHGAP11A ARHGAP11B C15orf53 CHRFAM7A CHRNA7 DEXI DUOXA1 EPB42 GABRA5 GOLGA8M GOLGA8R NIPA2 PLA2G4D PLA2G4E SNURF TGM5 TMCO5A WHAMM,"regulation of postsynaptic membrane potential|synaptic transmission, cholinergic|excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|phosphatidylinositol acyl-chain remodeling",2.235e-06|2.389e-06|3.064e-05|3.647e-05|0.0001514,0.03526|0.01884|0.1611|0.1438|0.4777,43.36|125.1|50.81|47.82|120.4
1166,5,0.508,5.08,4287.0,0.001181,0.996692,BRINP3 CACNG6 CCDC89 CCK GPR12,cardiac conduction|regulation of system process|negative regulation of behavioral fear response|negative regulation of fear response|multicellular organismal signaling,0.0003251|0.0004295|0.0005824|0.0005824|0.0006378,1|1|1|1|1,72.26|17.66|3432|3432|51.23
1167,4,0.553,3.318,3282.0,0.001008,0.9929309999999999,ACTR1B CCKAR RFX2 TTC36,cholecystokinin signaling pathway|plasma membrane bounded cell projection organization|cell projection organization|cell development|cilium assembly,0.0005825|0.0006983|0.0007828|0.001821|0.001987,1|1|1|1|1,2574|13.25|12.74|9.564|27.24
1168,4,0.5042,3.025,3028.0,0.0009957,0.9929309999999999,CALR CCKBR ENPP1 TAAR6,cellular ion homeostasis|inorganic ion homeostasis|cellular chemical homeostasis|ion homeostasis|cellular homeostasis,0.0001239|0.000165|0.0001886|0.0002|0.0003122,1|1|0.9916|0.7887|0.985,23.76|21.57|20.62|20.22|17.39
1169,18,0.5001,76.52,14240.0,0.005331,1.0,CCL1 CSHL1 EPX HOXB5 HOXB9 LPO MKS1 MPO NME1 NME2 OR4D1 OR4D2 PLEKHM1 RSAD1 SCPEP1 SEPT4 SGCA TBKBP1,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|UTP biosynthetic process|GTP biosynthetic process|UTP metabolic process,2.73e-06|7.241e-06|4.729e-05|5.586e-05|6.513e-05,0.04306|0.05711|0.2486|0.2203|0.2055,118.4|83.72|228.8|208|190.7
1170,6,0.5095,7.642,5307.0,0.0014349999999999999,0.998474,ATP2B2 CCL17 DYTN KCTD6 NME3 PDPR,regulation of cardiac conduction|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process,0.0001621|0.0006794|0.0006794|0.0006794|0.0006794,1|1|1|1|1,105.1|2942|2942|2942|2942
1171,4,0.5808,3.485,3318.0,0.001047,0.9929309999999999,CCL18 LRRC47 LRRN2 PDCD4,epithelial to mesenchymal transition involved in cardiac fibroblast development|epicardium-derived cardiac fibroblast cell development|epicardium-derived cardiac fibroblast cell differentiation|cardiac fibroblast cell development|cardiac fibroblast cell differentiation,0.000728|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|1373|1373|1373|1373
1172,14,0.5031,45.78,11350.0,0.004006,0.9999969999999999,ARHGEF26 CPA3 CPB1 GPR171 P2RY12 P2RY13 P2RY14 PLSCR1 PLSCR2 SCHIP1 SERPINI1 SERPINI2 TFDP2 TM4SF4,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|plasma membrane phospholipid scrambling|phospholipid translocation|lipid translocation,5.524e-10|4.448e-08|0.0001133|0.000547|0.0006175,8.714e-06|0.0003508|0.5955|1|1,392.3|116.9|137.3|59.7|56.04
1173,33,0.459,242.3,25530.0,0.009381,1.0,ABHD11 ARPC1B ASL C7orf43 CASTOR3 CLDN3 CLDN4 CYP3A43 CYP3A5 CYP3A7 CYP51A1 FBXO24 GNAT3 IFT22 MOGAT3 MUC12 PILRA PILRB PON1 PON3 PVRIG SEMA3A SEMA3E SPDYE1 TBL2 TECPR1 TRIM50 TYW1 ZKSCAN1 ZNF394 ZNF92 ZSCAN21 ZSCAN25,demethylation|oxidative demethylation|steroid metabolic process|positive regulation of metallopeptidase activity|lipid hydroxylation,4.619e-06|5.626e-06|6.174e-05|6.907e-05|8.872e-05,0.07285|0.04438|0.3246|0.2724|0.2799,37.82|98.54|11.91|208|178.3
1174,28,0.4937,186.6,20970.0,0.008795,1.0,CTSK EFNA1 EFNA4 FLG2 GBA HIST2H2AB HRNR ITLN2 LCE1A LCE1B LCE1E LCE2A LCE3A LCE3D LCE3E LCE5A PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A6 S100A8 S100A9 SLAMF7 SPRR1A SPRR2F SPRR2G,skin development|keratinization|keratinocyte differentiation|epidermis development|epidermal cell differentiation,1.222e-17|6.307e-17|4.498e-16|1.811e-15|3.012e-15,1.928e-13|4.974e-13|2.365e-12|7.141e-12|9.501e-12,27.88|40.5|34.15|23.78|28.97
1175,4,0.5532,3.319,3105.0,0.001065,0.9929309999999999,CCL3 CCL4 RIPOR2 TSPOAP1,regulation of lymphocyte migration|cellular response to chemokine|response to chemokine|positive regulation of leukocyte chemotaxis|regulation of mononuclear cell migration,1.197e-07|3.438e-07|3.438e-07|3.911e-07|6.753e-07,0.001888|0.002711|0.001807|0.001542|0.00213,249.1|173.6|173.6|166.1|137.9
1176,4,0.5365,3.219,3125.0,0.001026,0.9929309999999999,CCL8 GBP2 MEIOC NDFIP2,cellular response to interferon-gamma|cellular response to interleukin-1|response to interferon-gamma|response to interleukin-1|cell cycle switching,0.0003561|0.0004355|0.0004655|0.0005723|0.0007766,1|1|1|1|1,65.17|58.84|56.89|51.23|1716
1177,5,0.5126,5.126,4069.0,0.001255,0.996692,CCNA1 PIK3C2A SPATA4 WASL WIPF2,actin filament-based movement|immune response-regulating cell surface receptor signaling pathway involved in phagocytosis|Fc-gamma receptor signaling pathway involved in phagocytosis|Fc-gamma receptor signaling pathway|Fc receptor mediated stimulatory signaling pathway,0.0003382|0.0004334|0.0004334|0.0004461|0.0004525,1|1|1|1|1,69.23|61.02|61.02|60.13|59.7
1178,9,0.5357,19.29,5861.0,0.0032700000000000003,0.9998530000000001,CCNA2 CCNB1 CDC25B DBF4 FBXO5 FOXM1 LIN37 LIN54 PKMYT1,mitotic cell cycle phase transition|cell cycle phase transition|regulation of cell cycle|mitotic cell cycle process|G2/M transition of mitotic cell cycle,3.756e-12|4.544e-12|7.782e-12|1.588e-09|1.984e-09,5.925e-08|3.584e-08|4.092e-08|6.264e-06|6.259e-06,56.2|54.67|17.22|23.38|81.73
1179,16,0.4543,54.51,11300.0,0.004788000000000001,0.999999,CLASRP CLNS1A EXOSC5 GEMIN7 HNRNPL POP4 PSMC4 RBM42 RPS11 RPS16 RPS19 SAE1 SNRPD2 SYMPK TBCB UBA2,mRNA metabolic process|RNA processing|RNA metabolic process|ribonucleoprotein complex biogenesis|gene expression,1.35e-11|2.153e-10|1.934e-09|3.023e-08|5.173e-08,2.129e-07|1.698e-06|1.017e-05|0.0001192|0.0001632,18.55|13.95|8.855|19.38|6.477
1180,4,0.5066,3.0389999999999997,3228.0,0.0009384,0.9929309999999999,CACNG3 CCNDBP1 FGFRL1 SERPINB13,"negative regulation of keratinocyte apoptotic process|regulation of keratinocyte apoptotic process|neurotransmitter receptor transport, postsynaptic endosome to lysosome|positive regulation of AMPA receptor activity|neurotransmitter receptor diffusion trapping",0.0003883|0.001359|0.001553|0.001747|0.001941,1|1|1|1|1,5149|858.1|735.5|643.6|572.1
1181,11,0.5146,28.3,7754.0,0.0036270000000000004,0.999969,LARP7 LSM2 LSM3 LSM4 LSM5 LSM6 LSM7 LSM8 TMCO6 USB1 ZNF511,"exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|RNA splicing|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|mRNA processing",1.409e-14|1.941e-14|2.714e-14|4.285e-13|1.547e-11,2.223e-10|1.531e-10|1.427e-10|1.69e-09|4.881e-08,340.4|321|41.4|184.2|30.95
1182,4,0.558,3.3480000000000003,3335.0,0.001,0.9929309999999999,CCNJL HLA-DOA NCKIPSD PDE1B,negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide antigen|regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,0.0005825|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1716|1287|1287|1030
1183,14,0.5108,46.49,9493.0,0.0048590000000000005,0.9999969999999999,ATP6V1D CCNK CINP DDX24 DICER1 DYNC1H1 EIF2S1 EIF5 LRR1 NRDE2 PSMC1 PSMC6 WARS WDR25,posttranscriptional regulation of gene expression|NIK/NF-kappaB signaling|cellular macromolecule biosynthetic process|RNA interference|macromolecule biosynthetic process,9.083e-07|2.302e-05|4.526e-05|5.114e-05|5.301e-05,0.01433|0.1815|0.238|0.2017|0.1672,16.14|54.48|6.222|210.2|6.072
1184,4,0.5688,3.4130000000000003,3370.0,0.001009,0.9929309999999999,C11orf24 CCNYL1 LOXL3 NPEPL1,fibronectin fibril organization|negative regulation of T-helper 17 cell lineage commitment|peptidyl-lysine oxidation|positive regulation of integrin-mediated signaling pathway|regulation of T-helper 17 cell lineage commitment,0.0003883|0.0007766|0.001165|0.001553|0.001553,1|1|1|1|1,5149|1716|1030|735.5|735.5
1185,4,0.8411,5.046,2919.0,0.001721,0.9929309999999999,HLA-DQA1 HLA-DQB1 HLA-DRB1 HLA-DRB5,interferon-gamma-mediated signaling pathway|antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|cellular response to interferon-gamma,6.394e-13|2.976e-12|3.28e-12|3.441e-12|2.917e-11,1.009e-08|2.347e-08|1.724e-08|1.357e-08|9.202e-08,286|208|203.9|201.9|130.3
1186,4,0.5021,3.013,3338.0,0.0008996000000000001,0.9929309999999999,CAB39L CCR10 KIF27 NFAT5,calcium-mediated signaling|second-messenger-mediated signaling|chemokine-mediated signaling pathway|intracellular signal transduction|cellular response to chemokine,3.596e-06|1.199e-05|0.0001515|0.0001615|0.0001913,0.05672|0.09456|0.7968|0.6368|0.6036,85.22|56.68|104.3|10.46|92.56
1187,5,0.5861,5.861000000000001,3996.0,0.0014609999999999998,0.996692,CCR6 GPR31 LPA TBXT ZBTB43,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|isotype switching to IgA isotypes|DN3 thymocyte differentiation,0.0002267|0.0002862|0.0002862|0.0005824|0.0005824,1|1|1|1|1,86.9|77.13|77.13|3432|3432
1188,18,0.5002,76.54,14270.0,0.0053219999999999995,1.0,CCR2 CCR3 CCR5 CCR8 CCR9 FAM198A GNAT1 IQCF2 IQCF5 ITIH3 ITIH4 MUSTN1 SCN10A SCN11A SLC22A14 TLR9 VIPR1 XCR1,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,4.905e-11|9.702e-11|9.702e-11|1.62e-09|1.108e-08,7.737e-07|7.652e-07|5.101e-07|6.388e-06|3.497e-05,92.01|81.67|81.67|50.13|35.98
1189,14,0.5075,46.18,11090.0,0.004136,0.9999969999999999,CCR2 CCR3 CCR5 CCR8 CCR9 CCRL2 FAM198A IQCF5 ITIH4 SCN10A SCN11A SLC22A14 VIPR1 XCR1,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,2.888e-14|6.39e-14|6.39e-14|1.709e-12|1.626e-11,4.556e-10|5.04e-10|3.36e-10|6.738e-09|5.131e-08,140.4|124.6|124.6|76.48|54.9
1190,4,0.5629,3.377,3380.0,0.0009958,0.9929309999999999,CCSER1 GCKR INPP4B SCUBE2,negative regulation of glucokinase activity|negative regulation of hexokinase activity|positive regulation of chondrocyte proliferation|response to fructose|regulation of glucokinase activity,0.001165|0.001165|0.001359|0.001941|0.002134,1|1|1|1|1,1030|1030|858.1|572.1|514.9
1191,5,0.5024,5.024,3988.0,0.001255,0.996692,C1QL1 CCSER2 KIF19 LXN TTYH2,axonemal microtubule depolymerization|plus-end specific microtubule depolymerization|cytoplasmic microtubule depolymerization|cilium disassembly|motor learning,0.0004854|0.0004854|0.0004854|0.0004854|0.001698,1|1|1|1|1,4119|4119|4119|4119|686.5
1192,12,0.4746,31.32,7840.0,0.003967,0.999986,CCT4 CCT5 MSTO1 PDCD5 PFDN1 PFDN4 TBCA TCP1 TUBA1B TUBA1C TUBB TXNDC9,protein folding|positive regulation of establishment of protein localization to telomere|regulation of establishment of protein localization to telomere|positive regulation of protein localization to Cajal body|regulation of protein localization to Cajal body,1.755e-09|4.301e-08|5.472e-08|5.472e-08|5.472e-08,2.769e-05|0.0003392|0.0002877|0.0002158|0.0001726,45.16|514.9|468.1|468.1|468.1
1193,4,0.5473,3.284,2820.0,0.00116,0.9929309999999999,CCT7 CD46 CR1L GLB1L2,regulation of complement activation|regulation of humoral immune response|single fertilization|fertilization|interleukin-10 production,0.0001971|0.0002806|0.0003257|0.0004912|0.0009706,1|1|1|1|1,88.01|73.55|68.2|55.36|1287
1194,10,0.518,23.31,6587.0,0.0035159999999999996,0.999933,CCT8 PDCD5 PFDN1 PFDN4 TBCA TCP1 TUBA1B TUBA1C TUBB TXNDC9,protein folding|tubulin complex assembly|positive regulation of establishment of protein localization to telomere|regulation of establishment of protein localization to telomere|positive regulation of protein localization to Cajal body,4.262e-08|1.163e-05|1.396e-05|1.649e-05|1.649e-05,0.0006724|0.09174|0.07338|0.06502|0.05202,45.16|457.7|411.9|374.5|374.5
1195,19,0.4564,78.04,14290.0,0.005416,1.0,CD19 CD79A CD79B CD81 CLBA1 DOCK2 EBF1 ELMO1 GNAI2 KLHL6 LDLRAP1 LRP10 ODC1 PAX5 RAC2 RHOH RNF121 SYK TOX,leukocyte differentiation|positive regulation of immune system process|endocytosis|lymphocyte activation|lymphocyte differentiation,1.365e-09|1.439e-09|1.968e-09|2.997e-09|4.092e-09,2.153e-05|1.135e-05|1.035e-05|1.182e-05|1.291e-05,22.23|10.24|15.71|20.07|27.68
1196,4,0.5435,3.261,3240.0,0.001003,0.9929309999999999,C1orf116 CD200 FKRP GMPR,positive regulation of arginase activity|regulation of arginase activity|negative regulation of matrix metallopeptidase secretion|positive regulation of protein-glutamine gamma-glutamyltransferase activity|regulation of protein-glutamine gamma-glutamyltransferase activity,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
1197,4,0.5115,3.069,3166.0,0.0009658999999999999,0.9929309999999999,CA11 CD226 JAM2 SLC39A8,leukocyte adhesion to vascular endothelial cell|leukocyte cell-cell adhesion|mitochondrial manganese ion transmembrane transport|leukocyte adhesion to arterial endothelial cell|plasma membrane selenite transport,1.19e-05|7.482e-05|0.0004854|0.0004854|0.0004854,0.1877|0.5901|1|1|1,392.3|149.8|4119|4119|4119
1198,7,0.5091,10.69,5671.0,0.001877,0.9992989999999999,C1orf105 CD244 KNSTRN OR10Z1 SLC36A1 SPRR4 SWT1,positive regulation of granzyme B production|regulation of granzyme B production|alkanesulfonate transport|taurine transport|proline transmembrane transport,0.001358|0.001358|0.002376|0.002376|0.003054,1|1|1|1|1,980.7|980.7|490.4|490.4|367.8
1199,8,0.5146,14.41,6629.0,0.002164,0.9996790000000001,BSND C1orf123 CD247 GPX7 GUCA2B PCSK9 PLA2G12A TMEM53,negative regulation of low-density lipoprotein particle receptor binding|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport|negative regulation of intracellular lipid transport|negative regulation of receptor-mediated endocytosis involved in cholesterol transport,0.0006794|0.001019|0.001019|0.001019|0.001019,1|1|1|1|1,2942|1471|1471|1471|1471
1200,4,0.5568,3.341,3379.0,0.0009855,0.9929309999999999,CD27 FHIT ICOS TTC26,diadenosine triphosphate catabolic process|diadenosine triphosphate metabolic process|T cell tolerance induction|positive regulation of T cell activation|intraciliary anterograde transport,0.0003883|0.0003883|0.0005825|0.0006657|0.0007766,1|1|1|1|1,5149|5149|2574|47.45|1716
1201,4,0.5911,3.5469999999999997,3108.0,0.001137,0.9929309999999999,AGA CD300E P2RY14 VNN2,pantothenate metabolic process|G protein-coupled purinergic nucleotide receptor signaling pathway|protein deglycosylation|carboxylic acid metabolic process|purinergic nucleotide receptor signaling pathway,0.001553|0.00291|0.006393|0.009216|0.009289,1|1|1|1|1,735.5|367.8|160.9|12.44|109.5
1202,4,0.5555,3.333,3123.0,0.001064,0.9929309999999999,CD300LD LRRC46 RPS6KB1 USP24,response to electrical stimulus involved in regulation of muscle adaptation|positive regulation of skeletal muscle tissue growth|regulation of skeletal muscle tissue growth|skeletal muscle atrophy|striated muscle atrophy,0.0009706|0.001359|0.001747|0.001747|0.001941,1|1|1|1|1,1287|858.1|643.6|643.6|572.1
1203,17,0.5077,69.04,13230.0,0.005179,1.0,CD300LF CSH2 CSHL1 EPX HOXB5 HOXB9 LPO MIF4GD MKS1 MPO NME1 NME2 OR4D1 OR4D2 PLEKHM1 RSAD1 SEPT4,hydrogen peroxide catabolic process|response to growth hormone|hydrogen peroxide metabolic process|UTP biosynthetic process|GTP biosynthetic process,2.277e-06|3.861e-06|6.044e-06|4.205e-05|4.967e-05,0.03592|0.03046|0.03178|0.1658|0.1567,125.3|103.8|88.64|242.3|220.3
1204,4,0.5526,3.3160000000000003,3124.0,0.001058,0.9929309999999999,CD320 GREB1L TPRG1L TRIM71,"B cell costimulation|cobalamin transport|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation|regulation of translation, ncRNA-mediated",0.0009706|0.001747|0.002716|0.002716|0.002716,1|1|1|1|1,1287|643.6|396.1|396.1|396.1
1205,4,0.555,3.33,3051.0,0.0010869999999999999,0.9929309999999999,BACE1 CD33 GLB1L3 THYN1,negative regulation of monocyte activation|positive regulation of protein tyrosine phosphatase activity|regulation of protein tyrosine phosphatase activity|amyloid-beta formation|immune response-inhibiting signal transduction,0.0005825|0.0007766|0.001359|0.002134|0.002134,1|1|1|1|1,2574|1716|858.1|514.9|514.9
1206,4,0.5238,3.1430000000000002,3073.0,0.001019,0.9929309999999999,CD34 DEGS2 IFFO2 ZNF619,extracellular exosome assembly|negative regulation of cellular response to heat|metanephric glomerular mesangial cell differentiation|metanephric mesangial cell differentiation|sphinganine metabolic process,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
1207,5,0.5089,5.0889999999999995,4043.0,0.001254,0.996692,ANXA10 CD38 IFNK MBOAT1 RECK,female pregnancy|regulation of establishment of blood-brain barrier|multi-multicellular organism process|negative regulation of metalloendopeptidase activity|regulation of metalloendopeptidase activity,0.0007545|0.0009706|0.001014|0.001213|0.001698,1|1|1|1|1,46.02|1373|39.61|1030|686.5
1208,21,0.5046,106.0,16750.0,0.006273,1.0,ADAP2 C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EFCAB5 EPOP EVI2A GAS2L2 GSDMB HAP1 KRT26 KRT28 KRTAP4-8 LYRM9 RDM1 SLFN12 SLFN5 UNC119,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|lymphocyte chemotaxis|regulation of natural killer cell chemotaxis,1.559e-06|1.818e-06|1.778e-05|2.95e-05|5.81e-05,0.02459|0.01434|0.09351|0.1163|0.1833,151.4|143|62.79|52.54|214.5
1209,5,0.5612,5.612,3811.0,0.001467,0.996692,AMOTL1 CD47 DLG5 KLHL7 TSPAN13,zonula adherens assembly|negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|establishment or maintenance of cell polarity|ATP export|establishment of cell polarity involved in ameboidal cell migration,0.000728|0.000728|0.0008928|0.0009706|0.0009706,1|1|1|1|1,2060|2060|42.25|1373|1373
1210,7,0.5127,10.77,5534.0,0.0019370000000000001,0.9992989999999999,APOA2 CD48 FMO3 NECTIN4 NMNAT2 PRELP SLAMF7,negative regulation of lipid transporter activity|negative regulation of cholesterol transporter activity|negative regulation of sterol import|regulation of cholesterol transporter activity|negative regulation of cholesterol import,0.0006794|0.0006794|0.001019|0.001019|0.001019,1|1|1|1|1,2942|2942|1471|1471|1471
1211,4,0.5198,3.1189999999999998,2785.0,0.001116,0.9929309999999999,CD5 PRKCE SECISBP2L SHOC2,positive regulation of cellular glucuronidation|TRAM-dependent toll-like receptor 4 signaling pathway|TRAM-dependent toll-like receptor signaling pathway|positive regulation of mucus secretion|translational readthrough,0.0003883|0.0007766|0.0007766|0.001165|0.001747,1|1|1|1|1,5149|1716|1716|1030|643.6
1212,4,0.5468,3.281,3098.0,0.0010550000000000002,0.9929309999999999,CD53 FAM174B LIN28B TRIM71,miRNA metabolic process|production of miRNAs involved in gene silencing by miRNA|production of small RNA involved in gene silencing by RNA|dsRNA processing|RNA destabilization,7.146e-06|1.4e-05|1.778e-05|1.778e-05|2.091e-05,0.1127|0.1104|0.09348|0.07011|0.06596,490.4|343.2|302.9|302.9|278.3
1213,4,0.5362,3.217,3112.0,0.00103,0.9929309999999999,CD6 EOGT OIT3 TMF1,urate homeostasis|protein O-GlcNAcylation via threonine|positive regulation of testosterone secretion|regulation of testosterone secretion|luteinizing hormone secretion,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
1214,4,0.5398,3.239,3159.0,0.0010220000000000001,0.9929309999999999,C6orf48 CD63 KLK6 LY6G6C,positive regulation of integrin-mediated signaling pathway|pigment granule maturation|endosome to pigment granule transport|endosome to melanosome transport|cellular pigment accumulation,0.001165|0.001601|0.001601|0.001601|0.001892,1|1|1|1|1,980.7|686.5|686.5|686.5|572.1
1215,4,0.5706,3.423,3308.0,0.001031,0.9929309999999999,CD69 CRELD1 LRRC7 SPINK1,negative regulation of nitric oxide mediated signal transduction|negative regulation of serine-type peptidase activity|negative regulation of serine-type endopeptidase activity|regulation of serine-type peptidase activity|negative regulation of calcium ion import,0.0007766|0.001553|0.001553|0.001941|0.001941,1|1|1|1|1,1716|735.5|735.5|572.1|572.1
1216,4,0.5459,3.275,3232.0,0.00101,0.9929309999999999,CD70 EEF1D NEIL1 SCG3,protein localization to secretory granule|negative regulation of nuclease activity|depyrimidination|mRNA transcription|pyrimidine deoxyribonucleotide catabolic process,0.0007766|0.001553|0.001747|0.003491|0.003685,1|1|1|1|1,1716|735.5|643.6|302.9|286
1217,4,0.5032,3.0189999999999997,3090.0,0.0009736,0.9929309999999999,CD72 DISC1 OR6C74 SLC17A9,guanine nucleotide transport|guanine nucleotide transmembrane transport|ATP export|pyramidal neuron migration|ADP transport,0.0005825|0.0005825|0.0007766|0.0007766|0.001747,1|1|1|1|1,2574|2574|1716|1716|643.6
1218,4,0.5149,3.089,3091.0,0.0009958,0.9929309999999999,CD74 EFCAB7 TH YWHAB,regulation of peptide transport|positive regulation of protein localization to membrane|regulation of anion transport|dopamine biosynthetic process from tyrosine|macrophage migration inhibitory factor signaling pathway,9.767e-05|0.0002425|0.000284|0.0003883|0.0003883,1|1|1|1|1,25.74|79.21|17.96|5149|5149
1219,5,0.5801,5.801,4165.0,0.0013880000000000001,0.996692,C9orf47 CD80 CHST12 GEM PEAR1,negative regulation of high voltage-gated calcium channel activity|positive regulation of T-helper 1 cell differentiation|recognition of apoptotic cell|regulation of T-helper 1 cell differentiation|dermatan sulfate biosynthetic process,0.001456|0.001698|0.00194|0.002667|0.003152,1|1|1|1|1,823.8|686.5|588.4|411.9|343.3
1220,4,0.5577,3.346,3310.0,0.001008,0.9929309999999999,CACNG6 CD83 KRTAP26-1 SPINK2,cardiac conduction|multicellular organismal signaling|calcium ion transmembrane transport|regulation of heart contraction|calcium ion transport,0.0002174|0.0004271|0.0008484|0.001332|0.001387,1|1|1|1|1,86.72|61.48|43.36|34.47|33.76
1221,21,0.471,98.91,17360.0,0.005651,1.0,C5AR1 C5AR2 CABP5 CRX EML2 FFAR3 FGF21 FLT3LG FUT1 FUT2 GPR32 KLK11 KLK3 KLK6 SIGLEC5 SPHK2 SULT2A1 SULT2B1 VN1R4 ZNF665 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,5.853e-07|6.513e-06|5.944e-05|5.944e-05|5.944e-05,0.009232|0.05137|0.3125|0.2344|0.1875,216|936.1|208|208|208
1222,4,0.5355,3.213,3236.0,0.0009896,0.9929309999999999,ARHGAP39 CD8A OTOA SCGN,cytotoxic T cell differentiation|regulation of presynaptic cytosolic calcium ion concentration|T cell mediated immunity|neuron cellular homeostasis|regulation of long-term synaptic potentiation,0.0003883|0.003297|0.006007|0.006586|0.008903,1|1|1|1|1,5149|321.8|171.6|156|114.4
1223,4,0.5494,3.2960000000000003,3355.0,0.0009789999999999998,0.9929309999999999,CD93 GNLY PLEKHO2 RAB8B,exocytosis|immune system process|secretion by cell|export from cell|secretion,0.0002167|0.0003673|0.0003789|0.0004385|0.0005285,1|1|1|1|1,19.68|7.229|16.29|15.51|14.56
1224,13,0.5053,39.41,9791.0,0.003999,0.999993,ACR ANHX C8orf33 CHAMP1 MZF1 PARD6G PGBD2 RABL2B SH3BP5L SLC27A5 ZBTB45 ZNF132 ZNF672,acrosome matrix dispersal|sister chromatid biorientation|triglyceride mobilization|long-chain fatty acid import across plasma membrane|penetration of zona pellucida,0.001261|0.002521|0.00315|0.00315|0.006292,1|1|1|1|1,1584|528.1|396.1|396.1|176
1225,7,0.5003,10.51,5780.0,0.0018100000000000002,0.9992989999999999,CDC20B DBH ENTR1 GYPE LCN6 LCN8 SARDH,amine catabolic process|cellular biogenic amine catabolic process|cellular biogenic amine metabolic process|cellular amine metabolic process|amine metabolic process,5.523e-05|5.523e-05|0.0004918|0.0005015|0.0005517,0.8712|0.4356|1|1|1,183.9|183.9|59.44|58.84|56.04
1226,4,0.5185,3.111,2771.0,0.001118,0.9929309999999999,CDC37 CHORDC1 ERBB2 LSM4,ERBB2 signaling pathway|regulation of protein serine/threonine kinase activity|ERBB signaling pathway|regulation of protein kinase activity|regulation of kinase activity,1.583e-05|5.354e-05|7.196e-05|0.0002267|0.0003335,0.2498|0.4223|0.3784|0.894|1,321.8|31.52|147.1|19.38|17.01
1227,4,0.5874,3.525,3228.0,0.001088,0.9929309999999999,CDC42BPA METTL7B PKP3 TPD52L1,desmosome assembly|desmosome organization|negative regulation of mRNA catabolic process|actin cytoskeleton reorganization|negative regulation of RNA catabolic process,0.0009706|0.002134|0.01141|0.01314|0.01352,1|1|1|1|1,1287|514.9|88.77|76.85|74.62
1228,4,0.5191,3.114,3274.0,0.0009478999999999999,0.9929309999999999,CDC42EP3 DCDC2 PDE5A TMEM144,regulation of plasma membrane bounded cell projection assembly|regulation of cell projection assembly|cGMP catabolic process|positive regulation of pseudopodium assembly|regulation of pseudopodium assembly,0.000486|0.0004964|0.001165|0.002716|0.00291,1|1|1|1|1,55.66|55.07|1030|396.1|367.8
1229,4,0.5635,3.3810000000000002,3103.0,0.001086,0.9929309999999999,ARPIN CDC42EP4 HCAR2 MFSD4B,regulation of actin filament polymerization|regulation of actin polymerization or depolymerization|regulation of actin filament length|neutrophil apoptotic process|negative regulation of lamellipodium morphogenesis,0.0004258|0.0005069|0.0005122|0.0005825|0.0005825,1|1|1|1|1,59.52|54.48|54.2|2574|2574
1230,4,0.551,3.306,2537.0,0.0012980000000000001,0.9929309999999999,CCDC6 CDCA4 FAM122A FBXO42,"chromatin-mediated maintenance of transcription|mitotic G2/M transition checkpoint|positive regulation of gene expression, epigenetic|negative regulation of phosphoprotein phosphatase activity|negative regulation of protein dephosphorylation",0.002522|0.006973|0.0116|0.01237|0.01333,1|1|1|1|1,429.1|147.1|87.27|81.73|75.72
1231,4,0.5396,3.238,3247.0,0.0009935,0.9929309999999999,CDH11 MMP19 SEZ6L ZIC4,corticospinal tract morphogenesis|luteolysis|ovulation from ovarian follicle|ovulation|central nervous system projection neuron axonogenesis,0.001359|0.001553|0.001553|0.00291|0.005426,1|1|1|1|1,858.1|735.5|735.5|367.8|190.7
1232,4,0.5329,3.197,3402.0,0.0009369,0.9929309999999999,CDH17 SPTAN1 SPTBN1 TMEM170B,actin filament capping|negative regulation of actin filament depolymerization|regulation of protein-containing complex assembly|regulation of actin filament depolymerization|negative regulation of actin filament polymerization,2.091e-05|2.547e-05|4.268e-05|4.658e-05|5.327e-05,0.3298|0.2009|0.2244|0.1837|0.1681,278.3|251.2|34.02|183.9|171.6
1233,4,0.5211,3.1260000000000003,3207.0,0.0009714000000000001,0.9929309999999999,CDH19 GADL1 RD3L ZNF354B,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,4.441e-05|9.445e-05|0.0003843|0.0006583|0.0008136,0.7005|0.7449|1|1|1,196.1|132.9|64.87|49.33|44.29
1234,23,0.4428,112.0,18470.0,0.006013,1.0,C18orf32 CDH20 CDH7 CHST9 CTIF DSC1 DSEL DSG1 DSG2 DSG3 DSG4 HRH4 MAPRE2 PQLC1 SERPINB10 SERPINB12 SERPINB2 SERPINB5 SERPINB7 SERPINB8 ZBTB7C ZNF396 ZNF397,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cornification|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,1.009e-11|2.952e-10|2.418e-09|1.747e-07|1.861e-07,1.591e-07|2.328e-06|1.271e-05|0.000689|0.0005871,42.9|27.66|15.68|39.62|85.28
1235,4,0.5767,3.46,3146.0,0.0010960000000000002,0.9929309999999999,CDH26 CRACR2B CTSB UGGT2,UDP-glucosylation|UDP-glucose metabolic process|store-operated calcium entry|ER-associated misfolded protein catabolic process|regulation of store-operated calcium entry,0.0005825|0.0009706|0.001747|0.002522|0.002716,1|1|1|1|1,2574|1287|643.6|429.1|396.1
1236,4,0.5022,3.013,3140.0,0.0009562999999999999,0.9929309999999999,CDH8 PNMA1 QTRT2 ZNF805,"tRNA-guanine transglycosylation|synaptic transmission, glutamatergic|inflammatory response to antigenic stimulus|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|response to cold",0.0007766|0.005426|0.006973|0.008324|0.009482,1|1|1|1|1,1716|190.7|147.1|122.6|107.3
1237,18,0.5025,76.89,14150.0,0.005392,1.0,C1QTNF3 C7 CDH10 CDH12 CDH18 CDH6 CDH9 FAM173B FBXO4 HCN1 NIM1K NNT OXCT1 PLCXD3 PRLR SLC45A2 UGT3A1 UGT3A2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,3.001e-10|1.871e-09|5.807e-08|2.178e-07|3.665e-07,4.734e-06|1.476e-05|0.0003053|0.0008589|0.001156,144.2|97.7|47.7|36.27|32.57
1238,20,0.4811,91.4,11680.0,0.007737000000000001,1.0,ADSL AHCY CMPK1 COASY DHFR DTYMK GMPPB GMPS HMGCR HMGCS1 MAT2A MVD MVK PGD PMVK PPAT RPIA TFRC UBIAD1 YRDC,small molecule metabolic process|nucleobase-containing small molecule metabolic process|carbohydrate derivative metabolic process|ribose phosphate metabolic process|nucleotide metabolic process,1.591e-17|3.049e-16|9.82e-16|9.615e-15|1.131e-13,2.51e-13|2.405e-12|5.163e-12|3.792e-11|3.568e-10,10.88|24.71|14.62|31.54|25.03
1239,4,0.5391,3.235,3160.0,0.0010199999999999999,0.9929309999999999,CDK15 SPATA20 TEC ZNF530,protein phosphorylation|positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway|pyruvate oxidation|regeneration|Fc-epsilon receptor signaling pathway,0.0003512|0.0004854|0.0004854|0.0006126|0.0007056,1|1|1|1|1,18.07|4119|4119|51.17|47.62
1240,5,0.5337,5.337000000000001,4021.0,0.001322,0.996692,ANKRD30A CCNY CDK17 CREM FZD8,mitotic cell cycle phase transition|cell cycle phase transition|cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling,0.001881|0.001986|0.002798|0.002798|0.004,1|1|1|1|1,28.91|28.12|23.6|23.6|19.66
1241,7,0.5405,11.35,5432.0,0.0020800000000000003,0.9992989999999999,CDK18 CHIT1 RGS13 RGS18 RGS2 RGS21 TROVE2,regulation of G protein-coupled receptor signaling pathway|negative regulation of G protein-coupled receptor signaling pathway|negative regulation of signal transduction|G protein-coupled receptor signaling pathway|negative regulation of cell communication,7.299e-06|8.606e-05|0.0002011|0.0002355|0.0002673,0.1151|0.6788|1|0.9288|0.8432,70.53|143|10.76|10.33|10
1242,4,0.5328,3.197,3066.0,0.001039,0.9929309999999999,AGBL2 CD320 CDK5R1 STAC,positive regulation of protein localization to membrane|regulation of protein localization to membrane|superior olivary nucleus maturation|superior olivary nucleus development|pons maturation,0.0002425|0.0005612|0.0005825|0.0005825|0.0005825,1|1|1|1|1,79.21|51.75|2574|2574|2574
1243,4,0.5516,3.3089999999999997,3289.0,0.001003,0.9929309999999999,CDK5R2 HOXD11 NECTIN4 SLCO6A1,superior olivary nucleus maturation|superior olivary nucleus development|pons maturation|hindbrain maturation|central nervous system maturation,0.0005825|0.0005825|0.0005825|0.001165|0.001553,1|1|1|1|1,2574|2574|2574|1030|735.5
1244,5,0.5135,5.135,4349.0,0.0011769999999999999,0.996692,ASPSCR1 CAMKK2 CDK5RAP1 NGFR SLPI,regulation of cellular protein metabolic process|regulation of protein metabolic process|positive regulation of cellular protein metabolic process|positive regulation of protein metabolic process|negative regulation of catalytic activity,2.333e-05|3.192e-05|0.0001186|0.0001471|0.0005854,0.3679|0.2518|0.6234|0.58|1,8.451|7.936|11.32|10.71|15.18
1245,19,0.4957,84.77,14090.0,0.005965,1.0,BTN2A2 CDKAL1 GPX6 HIST1H1E HIST1H1T HIST1H2AC HIST1H2AD HIST1H2BD OR14J1 OR2B6 OR2J3 SLC17A2 SLC17A4 TRIM10 ZKSCAN4 ZNF165 ZNF184 ZSCAN16 ZSCAN31,sialic acid transport|cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance|detoxification,1.184e-05|5.581e-05|8.089e-05|9.701e-05|0.0001478,0.1867|0.4402|0.4253|0.3826|0.4662,514.9|40.65|35.76|33.58|29.03
1246,4,0.5602,3.361,3152.0,0.001062,0.9929309999999999,C20orf96 CBR4 CDKL2 KLRG1,doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process|aminoglycoside antibiotic metabolic process|tertiary alcohol metabolic process,0.001941|0.001941|0.001941|0.002134|0.002716,1|1|1|1|1,572.1|572.1|572.1|514.9|396.1
1247,5,0.5025,5.025,3726.0,0.001343,0.996692,CDKL4 GNA13 ROCK1 S1PR2 SLC1A4,regulation of establishment of endothelial barrier|regulation of endothelial cell development|regulation of endothelial cell differentiation|Rho protein signal transduction|adenylate cyclase-activating G protein-coupled receptor signaling pathway,8.046e-06|8.046e-06|3.302e-05|9.15e-05|0.0004271,0.1269|0.06346|0.1736|0.3608|1,484.6|484.6|228.8|135|61.48
1248,19,0.5071,86.71,13830.0,0.006215,1.0,ACCSL CAT CHRM4 COMMD9 EHF ELF5 KCNC1 MRGPRX3 MYBPC3 OR4A47 OR4B1 OR4C12 OR4C13 OR4C3 OR4C46 OR4X1 PAMR1 SLC1A2 TP53I11,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.951e-07|2.899e-07|3.727e-07|5.99e-07|7.684e-07,0.003078|0.002287|0.00196|0.002362|0.002424,15.57|14.67|14.13|13.15|12.67
1249,4,0.5732,3.4389999999999996,3294.0,0.0010400000000000001,0.9929309999999999,CDNF DSG4 FAM169A TMEM168,dopaminergic neuron differentiation|hair follicle development|skin epidermis development|hair cycle process|molting cycle process,0.0062|0.01449|0.01525|0.01525|0.01525,1|1|1|1|1,166.1|69.58|66.01|66.01|66.01
1250,4,0.5763,3.458,3175.0,0.001085,0.9929309999999999,CDON LRRC8E ORMDL1 USP2,skeletal muscle satellite cell differentiation|muscle organ development|cellular sphingolipid homeostasis|negative regulation of ceramide biosynthetic process|embryonic body morphogenesis,0.0009706|0.0011|0.001165|0.001165|0.001359,1|1|1|1|1,1287|36.78|1030|1030|858.1
1251,17,0.4718,64.17,10860.0,0.005853,1.0,CKAP5 CLTC DHX9 GAK GTSE1 HAUS1 HAUS2 HAUS3 HAUS4 HAUS5 HAUS6 HAUS8 KIF15 KIF18A TACC3 TUBGCP4 TUBGCP5,spindle organization|mitotic cell cycle|mitotic prometaphase|cell cycle|microtubule-based process,2.374e-20|4.81e-20|1.725e-19|3.229e-18|1.291e-17,3.745e-16|3.793e-16|9.068e-16|1.273e-14|4.073e-14,64.61|23.88|79.8|13.94|21.12
1252,5,0.5068,5.0680000000000005,4237.0,0.001192,0.996692,CDR2 FKBP5 NANOS1 POPDC3 RASGRF1,"cerebellar neuron development|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|regulation of Rac protein signal transduction|long-term memory",0.0009706|0.00412|0.004604|0.005087|0.008467,1|1|1|1|1,1373|257.4|228.8|205.9|121.1
1253,12,0.5126,33.83,8233.0,0.004079999999999999,0.999986,CRNKL1 DDRGK1 ESF1 FASTKD5 GINS1 MRPS26 NAA20 NOP56 SIVA1 TRMT6 VPS16 XRN2,gene expression|RNA processing|nucleic acid metabolic process|ncRNA processing|ribonucleoprotein complex biogenesis,5.441e-06|6.041e-06|8.547e-05|8.551e-05|0.0001134,0.08582|0.04765|0.4494|0.3372|0.3578,6.281|11.16|5.383|15.89|14.76
1254,4,0.519,3.114,3119.0,0.0009949,0.9929309999999999,ARMC2 CDSN LTN1 NEMF,ribosome-associated ubiquitin-dependent protein catabolic process|rescue of stalled ribosome|translational elongation|negative regulation of cornification|regulation of cornification,1.697e-07|4.241e-07|0.0002245|0.0003883|0.0003883,0.002676|0.003345|1|1|1,5149|2574|82.38|5149|5149
1255,4,0.5342,3.205,3274.0,0.0009756,0.9929309999999999,CDX1 GJA5 LRRC3B PDE1A,regulation of Purkinje myocyte action potential|vasomotion|Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling|bundle of His cell to Purkinje myocyte communication by electrical coupling|atrial cardiac muscle cell to AV node cell communication by electrical coupling,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1256,4,0.5555,3.333,3145.0,0.001056,0.9929309999999999,CDX2 SRRM4 TPRA1 UNC119B,embryonic cleavage|regulation of somitogenesis|lipoprotein transport|lipoprotein localization|multicellular organism development,0.001359|0.001359|0.002716|0.00291|0.00315,1|1|1|1|1,858.1|858.1|396.1|367.8|4.223
1257,4,0.5297,3.178,3318.0,0.0009548,0.9929309999999999,CEACAM16 FHL3 KNCN SLC31A2,regulation of copper ion transmembrane transport|copper ion transmembrane transport|cellular copper ion homeostasis|copper ion transport|copper ion homeostasis,0.0003883|0.001359|0.00291|0.003297|0.003491,1|1|1|1|1,5149|858.1|367.8|321.8|302.9
1258,6,0.5261,7.892,4386.0,0.001791,0.998474,ADIPOR2 BCL2 CEBPA IRF8 MEF2D ZFP64,positive regulation of nitrogen compound metabolic process|positive regulation of cellular metabolic process|cytokine-mediated signaling pathway|positive regulation of macromolecule metabolic process|positive regulation of metabolic process,1.078e-05|1.519e-05|1.733e-05|2.149e-05|3.483e-05,0.17|0.1198|0.09113|0.08473|0.1099,6.735|6.36|20.13|6.003|5.538
1259,4,0.5049,3.03,2855.0,0.001057,0.9929309999999999,CEBPB CEBPD PARN PDCD2L,ncRNA deadenylation|granuloma formation|box H/ACA RNA 3'-end processing|box H/ACA RNA processing|positive regulation of sodium-dependent phosphate transport,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
1260,4,0.5046,3.0269999999999997,3242.0,0.0009307,0.9929309999999999,CELA2A HOXA9 LRRC49 NMNAT3,insulin catabolic process|insulin metabolic process|endothelial cell activation|definitive hemopoiesis|uterus development,0.0007766|0.001165|0.002328|0.003491|0.003878,1|1|1|1|1,1716|1030|468.1|302.9|271
1261,9,0.5315,19.14,6321.0,0.003009,0.9998530000000001,CLNS1A INTS4 NUMA1 POLA2 POLD3 RPS3 SPCS2 THAP12 UVRAG,cell cycle process|positive regulation of microtubule polymerization|cellular nitrogen compound metabolic process|nucleic acid metabolic process|spindle organization,4.047e-05|8.893e-05|8.988e-05|0.0001024|0.0001069,0.6383|0.7014|0.4726|0.4039|0.3374,10.69|147.6|4.702|6.151|30.51
1262,4,0.5875,3.525,3305.0,0.0010630000000000001,0.9929309999999999,CELF2 LTBR TCAIM TSHZ2,myeloid dendritic cell differentiation|myeloid dendritic cell activation|mRNA splice site selection|dendritic cell differentiation|positive regulation of extrinsic apoptotic signaling pathway,0.004266|0.00504|0.006393|0.007166|0.009482,1|1|1|1|1,245.2|205.9|160.9|143|107.3
1263,4,0.5544,3.326,3280.0,0.001011,0.9929309999999999,CELF3 DUSP13 ELFN1 TTYH3,"nuclear body organization|spermatogenesis|male gamete generation|positive regulation of mRNA splicing, via spliceosome|mRNA splice site selection",0.003297|0.00412|0.004404|0.004653|0.006393,1|1|1|1|1,321.8|18.79|18.16|223.9|160.9
1264,7,0.511,10.73,5996.0,0.001782,0.9992989999999999,BPI CELSR1 DLGAP4 GHRH NNAT TLDC2 ZDHHC2,positive regulation of anion transport|positive regulation of peptide hormone secretion|lateral sprouting involved in lung morphogenesis|planar dichotomous subdivision of terminal units involved in lung branching morphogenesis|orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,0.0004761|0.0005415|0.0006794|0.0006794|0.0006794,1|1|1|1|1,17.58|56.58|2942|2942|2942
1265,5,0.5405,5.405,3991.0,0.001349,0.996692,APC2 C12orf40 CELSR2 PLPPR3 TMEM222,cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|organophosphate ester transport|positive regulation of very-low-density lipoprotein particle remodeling,0.0002598|0.0002598|0.0004426|0.001146|0.001164,1|1|1|1|1,22.13|22.13|18.43|39.01|1287
1266,4,0.5198,3.1189999999999998,3071.0,0.0010119999999999999,0.9929309999999999,CELSR3 FIGLA HOXC8 RAB5B,plasma membrane to endosome transport|oocyte development|oocyte differentiation|endosome organization|oogenesis,0.001747|0.007359|0.008131|0.01506|0.01525,1|1|1|1|1,643.6|139.2|125.6|66.87|66.01
1267,4,0.5104,3.062,3147.0,0.0009697000000000001,0.9929309999999999,CEMP1 MUC7 SIGLEC5 ZAP70,T cell aggregation|beta selection|lymphocyte aggregation|negative thymic T cell selection|positive thymic T cell selection,0.0005825|0.0005825|0.001165|0.002328|0.002328,1|1|1|1|1,2574|2574|1030|468.1|468.1
1268,4,0.5144,3.0860000000000003,3072.0,0.001001,0.9929309999999999,CEND1 DLX4 DNAJB1 DTX4,cerebellar granular layer maturation|radial glia guided migration of cerebellar granule cell|negative regulation of cerebellar granule cell precursor proliferation|cerebellar cortex maturation|cerebellum maturation,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
1269,7,0.5173,10.86,5126.0,0.002109,0.9992989999999999,CENPE GAR1 NAF1 RPL34 SPATA5 SPCS3 TMA16,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|pseudouridine synthesis|rRNA processing|rRNA metabolic process,9.891e-07|6.521e-06|1.875e-05|6.931e-05|7.744e-05,0.0156|0.05143|0.09857|0.2733|0.2443,1961|588.4|326.9|33.95|32.69
1270,8,0.5365,15.02,5298.0,0.0028190000000000003,0.9996790000000001,ACTR1A CENPF DCTN6 DYNC1LI1 DYNC1LI2 DYNLRB1 NDE1 PAFAH1B1,mitotic spindle organization|mitotic prometaphase|microtubule cytoskeleton organization involved in mitosis|spindle organization|biological phase,7.978e-12|8.873e-12|1.618e-11|5.116e-11|1.12e-10,1.258e-07|6.998e-08|8.507e-08|2.018e-07|3.534e-07,94.18|92.49|83.49|68.65|60.1
1271,10,0.501,22.54,7931.0,0.002827,0.999933,C9orf3 CKS2 FBP1 FBP2 GNA14 TRPM3 TRPM6 TXNDC8 ZNF484 ZNF510,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.554e-06|2.588e-06|5.433e-06|1.421e-05|2.014e-05,0.02451|0.02042|0.02856|0.05604|0.06355,1872|1248|748.9|416.1|340.4
1272,4,0.5633,3.38,3178.0,0.00106,0.9929309999999999,CEP128 MYO1F TMEM132D ZGLP1,vesicle transport along actin filament|actin filament-based transport|oocyte development|oocyte differentiation|vesicle cytoskeletal trafficking,0.003878|0.004266|0.007359|0.008131|0.01333,1|1|1|1|1,271|245.2|139.2|125.6|75.72
1273,14,0.5028,45.75,9722.0,0.004671,0.9999969999999999,CNIH4 DUX4 EIF2S1 HSPE1 NBEAL1 NUTF2 OR2A25 POGZ RPL17 RPL37 RPS13 SNU13 ST20 TSPYL5,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,3.19e-06|4.691e-05|5.434e-05|7.145e-05|7.917e-05,0.05032|0.37|0.2857|0.2817|0.2498,38.41|42.91|40.78|37.11|35.82
1274,4,0.5406,3.2439999999999998,3192.0,0.001013,0.9929309999999999,CEP162 DGCR6 PROK2 SMO,ventral midline determination|mesenchymal to epithelial transition involved in metanephric renal vesicle formation|mesenchymal to epithelial transition involved in renal vesicle formation|positive regulation of hh target transcription factor activity|signal transduction downstream of smoothened,0.0003883|0.0003883|0.0003883|0.0007766|0.0007766,1|1|1|1|1,5149|5149|5149|1716|1716
1275,4,0.5613,3.3680000000000003,3236.0,0.001037,0.9929309999999999,CEP290 FAM171B SLF1 TAS2R42,positive regulation of maintenance of mitotic sister chromatid cohesion|positive regulation of maintenance of sister chromatid cohesion|protein localization to site of double-strand break|regulation of maintenance of mitotic sister chromatid cohesion|regulation of maintenance of sister chromatid cohesion,0.001165|0.001165|0.001165|0.001747|0.001747,1|1|1|1|1,1030|1030|1030|643.6|643.6
1276,17,0.4737,64.42,13690.0,0.004672,1.0,AGO1 C1orf123 C1orf50 CCDC30 CFAP57 CYP4A22 CYP4Z1 ERMAP EXO5 LURAP1 MFSD2A PPT1 ZFP69 ZFP69B ZNF606 ZNF684 ZNF691,lysophospholipid translocation|regulation of phosphatidylserine metabolic process|regulation of phosphatidylethanolamine metabolic process|lysophospholipid transport|lauric acid metabolic process,0.001552|0.001552|0.001552|0.002327|0.002327,1|1|1|1|1,1287|1287|1287|643.6|643.6
1277,19,0.706,120.7,12770.0,0.009335,1.0,CCP110 CENPJ CEP120 CEP135 CEP152 CEP295 CEP44 PCNT PLK4 PPP1R35 RTTN SASS6 SPICE1 STIL TEDC1 TEDC2 TUBD1 TUBE1 WRAP73,centrosome cycle|microtubule organizing center organization|centrosome duplication|microtubule cytoskeleton organization|centriole replication,4.202e-24|1.76e-23|7.628e-23|1.193e-22|1.387e-21,6.628e-20|1.388e-19|4.011e-19|4.703e-19|4.377e-18,147.8|130.1|309.7|30.64|424.2
1278,4,0.5114,3.068,3081.0,0.0009925000000000001,0.9929309999999999,CEP70 KIF22 PURG TMEM135,response to food|organelle localization|regulation of mitochondrial fission|mitotic cell cycle process|mitotic cell cycle,0.004459|0.005179|0.005426|0.006373|0.007822,1|1|1|1|1,234|16.72|190.7|15.03|13.53
1279,5,0.5158,5.1579999999999995,3990.0,0.001288,0.996692,AEN CEP85L ENPP3 FABP7 TAAR6,basophil activation involved in immune response|basophil activation|negative regulation of mast cell proliferation|regulation of mast cell proliferation|nucleic acid phosphodiester bond hydrolysis,0.000728|0.0009706|0.0009706|0.001213|0.002121,1|1|1|1|1,2060|1373|1373|1030|27.19
1280,4,0.5246,3.148,3374.0,0.0009298,0.9929309999999999,BLMH C16orf74 CER1 LCA5L,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry|negative regulation of nodal signaling pathway involved in determination of left/right asymmetry|growth plate cartilage chondrocyte proliferation|negative regulation of mesoderm development|homocysteine catabolic process,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
1281,4,0.529,3.174,3230.0,0.0009794,0.9929309999999999,CERK GJA8 RHO SCGB1A1,absorption of visible light|light absorption|thermotaxis|response to silicon dioxide|response to ozone,0.0003883|0.0003883|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|5149|2574|1716|1287
1282,4,0.5797,3.478,3213.0,0.0010789999999999999,0.9929309999999999,CERKL GLI2 PCDHA3 PCDHGA12,floor plate formation|homophilic cell adhesion via plasma membrane adhesion molecules|floor plate morphogenesis|notochord regression|smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,0.0003883|0.0003972|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|61.66|2574|2574|1716
1283,12,0.5116,33.76,8114.0,0.004132,0.999986,ARMH3 CERS2 COL4A3BP ELOVL1 KDSR PI4KB SGMS1 SPTLC1 SPTLC2 SPTSSA TM9SF2 TMEM189,sphingolipid biosynthetic process|ceramide biosynthetic process|membrane lipid biosynthetic process|sphingolipid metabolic process|lipid biosynthetic process,2.529e-14|2.153e-13|2.38e-13|7.072e-13|8.222e-13,3.989e-10|1.698e-09|1.251e-09|2.789e-09|2.594e-09,132.4|208|94.97|80.9|28.18
1284,4,0.5516,3.3089999999999997,3171.0,0.0010400000000000001,0.9929309999999999,CERS3 EDN3 LEP MTNR1B,regulation of hormone secretion|negative regulation of peptide hormone secretion|peptide hormone secretion|regulation of vasoconstriction|negative regulation of hormone secretion,9.735e-06|2.919e-05|4.821e-05|5.502e-05|6.227e-05,0.1536|0.2302|0.2535|0.217|0.1964,55.96|234|180.7|168.8|158.4
1285,4,0.555,3.33,3195.0,0.001039,0.9929309999999999,ARL6 CERS4 COTL1 SPIRE1,protein polymerization|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization|regulation of actin filament length|regulation of protein polymerization,0.0001336|0.0004258|0.0005069|0.0005122|0.0007595,1|1|1|1|1,107.3|59.52|54.48|54.2|44.39
1286,4,0.5581,3.3489999999999998,3189.0,0.001046,0.9929309999999999,CERS5 PFN4 THTPA TMEM116,thiamine diphosphate metabolic process|thiamine metabolic process|thiamine-containing compound metabolic process|sequestering of actin monomers|ceramide biosynthetic process,0.0005825|0.0009706|0.001553|0.002328|0.01064,1|1|1|1|1,2574|1287|735.5|468.1|95.35
1287,10,0.521,23.44,6592.0,0.0035329999999999997,0.999933,CERS2 CERS6 COL4A3BP ELOVL1 FASN PI4KB SPTLC2 SPTSSA TECR TMEM189,lipid biosynthetic process|cellular lipid metabolic process|lipid metabolic process|ceramide biosynthetic process|sphingolipid metabolic process,1.578e-14|1.248e-12|9.436e-12|2.022e-11|2.212e-11,2.489e-10|9.843e-09|4.961e-08|7.973e-08|6.977e-08,34.44|21.12|16.85|211.9|84.75
1288,4,0.5828,3.497,3251.0,0.001072,0.9929309999999999,ACSL6 CETN1 EMILIN1 FDXACB1,negative regulation of collagen fibril organization|regulation of collagen fibril organization|negative regulation of macrophage migration|positive regulation of extracellular matrix assembly|negative regulation of extracellular matrix organization,0.0005825|0.001359|0.001941|0.002134|0.002328,1|1|1|1|1,2574|858.1|572.1|514.9|468.1
1289,4,0.5639,3.383,3195.0,0.0010550000000000002,0.9929309999999999,CCL22 CFAP206 PCOLCE2 TREML2,regulation of cilium beat frequency|regulation of flagellated sperm motility|sperm axoneme assembly|regulation of cilium movement involved in cell motility|regulation of cilium-dependent cell motility,0.00291|0.004072|0.004459|0.005426|0.005426,1|1|1|1|1,367.8|257.4|234|190.7|190.7
1290,5,0.5101,5.101,4081.0,0.001245,0.996692,CFAP221 FMNL1 OR4D2 SP6 WNT9B,mesonephric duct formation|establishment of planar polarity involved in nephron morphogenesis|mesenchymal stem cell maintenance involved in nephron morphogenesis|non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation|regulation of animal organ morphogenesis,0.0004854|0.0004854|0.000728|0.000728|0.0007712,1|1|1|1|1,4119|4119|2060|2060|45.51
1291,8,0.5047,14.13,5727.0,0.002455,0.9996790000000001,CCT8 CFAP298 DONSON MCM3AP PAXBP1 PWP2 SOD1 URB1,response to antipsychotic drug|response to carbon monoxide|positive regulation of chromosome organization|negative regulation of cholesterol biosynthetic process|negative regulation of cholesterol metabolic process,0.001164|0.00194|0.001964|0.002328|0.002328,1|1|1|1|1,1287|643.6|29.59|514.9|514.9
1292,4,0.5281,3.1689999999999996,3377.0,0.0009353,0.9929309999999999,CFAP43 LINGO1 NQO2 RMND5B,mucociliary clearance|cerebrospinal fluid circulation|regulation of cilium beat frequency|respiratory system process|sperm axoneme assembly,0.001165|0.002134|0.00291|0.004266|0.004459,1|1|1|1|1,1030|514.9|367.8|245.2|234
1293,5,0.5287,5.287000000000001,3984.0,0.001322,0.996692,ARL6 CFAP44 LRBA SH2D3A TLR10,toll-like receptor 10 signaling pathway|cilium assembly|cilium organization|plasma membrane bounded cell projection assembly|cell projection assembly,0.0004854|0.003271|0.003689|0.004983|0.00532,1|1|1|1|1,4119|21.79|20.49|17.57|16.99
1294,4,0.5166,3.1,3133.0,0.0009857999999999998,0.9929309999999999,ARHGAP1 CFAP45 RAB11FIP5 TMEM14C,negative regulation of endocytic recycling|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|regulation of tetrapyrrole metabolic process|negative regulation of adiponectin secretion,0.0003883|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|1716|1716|1287|1287
1295,4,0.538,3.228,3036.0,0.001059,0.9929309999999999,CFAP46 FEM1C PGM5 PIK3IP1,negative regulation of phosphatidylinositol 3-kinase activity|negative regulation of lipid kinase activity|negative regulation of phosphatidylinositol 3-kinase signaling|organelle assembly|myofibril assembly,0.0009706|0.001747|0.002716|0.008227|0.01064,1|1|1|1|1,1287|643.6|396.1|13.19|95.35
1296,5,0.5082,5.082,4076.0,0.001242,0.996692,BDNF CFAP61 GKN1 HPSE LIN7C,positive regulation of brain-derived neurotrophic factor receptor signaling pathway|regulation of brain-derived neurotrophic factor receptor signaling pathway|heparan sulfate proteoglycan catabolic process|brain-derived neurotrophic factor receptor signaling pathway|proteoglycan catabolic process,0.000728|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,2060|1373|1373|1030|1030
1297,4,0.5647,3.388,3392.0,0.0009954,0.9929309999999999,CFAP65 CHCHD6 CNMD GRIA1,cellular response to ammonium ion|response to ammonium ion|regulation of postsynaptic cytosolic calcium ion concentration|endothelial cell morphogenesis|negative regulation of vascular endothelial growth factor receptor signaling pathway,0.001165|0.001359|0.002328|0.002716|0.00291,1|1|1|1|1,1030|858.1|468.1|396.1|367.8
1298,4,0.5398,3.239,3265.0,0.0009883,0.9929309999999999,CFAP73 FHOD3 TSPO2 ZMPSTE24,cortical actin cytoskeleton organization|cardiac muscle cell development|cortical cytoskeleton organization|cardiac cell development|cardiac muscle cell differentiation,3.663e-05|6.963e-05|8.295e-05|8.295e-05|0.0001405,0.5778|0.5492|0.4362|0.3271|0.4432,216.8|155.4|142|142|108.4
1299,4,0.5382,3.2289999999999996,3438.0,0.0009361,0.9929309999999999,CFAP77 FRMD4B OAS1 RNF5,regulation of ribonuclease activity|ER-associated misfolded protein catabolic process|cellular response to interferon-alpha|endoplasmic reticulum mannose trimming|cellular response to misfolded protein,0.001941|0.002522|0.002716|0.004072|0.004459,1|1|1|1|1,572.1|429.1|396.1|257.4|234
1300,4,0.5661,3.3960000000000004,3200.0,0.001058,0.9929309999999999,CFB MPIG6B SGPL1 ZNF567,"luteinization|Leydig cell differentiation|fibroblast migration|skeletal system development|complement activation, alternative pathway",0.001747|0.002134|0.002522|0.003062|0.003104,1|1|1|1|1,643.6|514.9|429.1|21.86|343.2
1301,4,0.5412,3.247,3198.0,0.0010119999999999999,0.9929309999999999,ANXA3 CFD OMD THAP6,"keratan sulfate catabolic process|complement activation, alternative pathway|neutrophil degranulation|neutrophil activation involved in immune response|neutrophil mediated immunity",0.002522|0.003104|0.003204|0.003256|0.003349,1|1|1|1|1,429.1|343.2|21.36|21.19|20.89
1302,4,0.5232,3.139,3212.0,0.0009737999999999999,0.9929309999999999,CFH COL5A2 DCAF5 TM7SF2,"negative regulation of endodermal cell differentiation|regulation of endodermal cell differentiation|regulation of complement-dependent cytotoxicity|complement activation, alternative pathway|secondary alcohol biosynthetic process",0.0007766|0.001165|0.001747|0.003104|0.007938,1|1|1|1|1,1716|1030|643.6|343.2|128.7
1303,4,0.5967,3.58,3147.0,0.0011330000000000001,0.9929309999999999,CFHR1 CFHR3 KCND2 PDLIM7,cytolysis by host of symbiont cells|cytolysis in other organism involved in symbiotic interaction|locomotor rhythm|cytolysis in other organism|killing by host of symbiont cells,0.002522|0.002522|0.002716|0.002716|0.004459,1|1|1|1|1,429.1|429.1|396.1|396.1|234
1304,29,0.4822,195.8,21700.0,0.008919,1.0,CD1C CLK2 CTSK EFNA4 FCRL3 GBA HRNR ITLN2 LCE1A LCE1B LCE1E LCE2A LCE3A LCE3D LCE3E LCE5A OR10J5 PGLYRP3 PRR9 S100A12 S100A2 S100A4 S100A5 S100A8 S100A9 SLAMF7 SPRR1A SPRR2F SPRR2G,keratinization|keratinocyte differentiation|skin development|epidermal cell differentiation|epidermis development,1.843e-16|1.309e-15|2.038e-15|8.728e-15|2.123e-13,2.907e-12|1.033e-11|1.071e-11|3.442e-11|6.699e-10,37.71|31.8|24.11|26.97|20.44
1305,20,0.4738,90.02,15480.0,0.005768,1.0,CLEC12A CLEC12B CLEC2A CLEC2B CLEC4C CLEC4D CLEC6A CLEC9A KLRC1 KLRC4 PRB4 PRH2 PZP RERG SLCO1C1 TAS2R13 TAS2R20 TAS2R30 TAS2R7 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|natural killer cell inhibitory signaling pathway,3.666e-10|6.685e-10|7.476e-10|7.206e-09|8.926e-06,5.782e-06|5.272e-06|3.931e-06|2.842e-05|0.02816,143|125.6|122.6|75.72|686.5
1306,5,0.5011,5.011,4111.0,0.001215,0.996692,AGT CFL2 MIEF2 TRMT2A WDR19,"protein-containing complex subunit organization|positive regulation of membrane hyperpolarization|glycine biosynthetic process, by transamination of glyoxylate|G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger|ciliary receptor clustering involved in smoothened signaling pathway",0.0004615|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,8.684|3432|1716|1716|1716
1307,4,0.5461,3.2769999999999997,3217.0,0.001015,0.9929309999999999,CFTR FKBP15 PDE7B SERPINB3,positive regulation of cyclic nucleotide-gated ion channel activity|regulation of cyclic nucleotide-gated ion channel activity|positive regulation of voltage-gated chloride channel activity|regulation of voltage-gated chloride channel activity|transepithelial water transport,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
1308,4,0.5592,3.355,3333.0,0.001003,0.9929309999999999,CGA MFSD6L SMKR1 TCN1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|positive regulation of dense core granule biogenesis|positive regulation of relaxation of cardiac muscle|mast cell cytokine production|regulation of dense core granule biogenesis,0.0004854|0.000728|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|2060|2060|2060|1373
1309,8,0.5178,14.5,6310.0,0.002286,0.9996790000000001,CGGBP1 EPHA3 FAM19A4 HTR1F LMOD3 POU1F1 VGLL3 ZNF654,fasciculation of motor neuron axon|fasciculation of sensory neuron axon|dsDNA loop formation|skeletal muscle thin filament assembly|adenylate cyclase-inhibiting serotonin receptor signaling pathway,0.001019|0.001358|0.002037|0.002376|0.002715,1|1|1|1|1,1471|980.7|588.4|490.4|420.3
1310,4,0.5114,3.068,3128.0,0.0009775,0.9929309999999999,CGREF1 HLF IGF2R RPH3AL,response to tetrachloromethane|myoblast fate commitment|regulation of protein neddylation|regulation of transcription from RNA polymerase II promoter in response to oxidative stress|surfactant homeostasis,0.001213|0.001456|0.00291|0.00291|0.003152,1|1|1|1|1,1030|823.8|374.5|374.5|343.3
1311,6,0.5049,7.574,5074.0,0.0014869999999999998,0.998474,ABCB5 AGR3 CH25H DYSF EHD4 KCNQ4,monocyte activation involved in immune response|B cell chemotaxis|T-tubule organization|monocyte activation|pinocytosis,0.0008735|0.002037|0.002909|0.0032|0.00349,1|1|1|1|1,1716|572.1|381.4|343.2|312
1312,8,0.5229,14.64,6184.0,0.002356,0.9996790000000001,AKR1C1 AKR1C3 AKR1E2 CALML3 CALML5 CHAC1 FAM208B NET1,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,3.177e-06|3.177e-06|1.163e-05|1.163e-05|1.163e-05,0.05011|0.02505|0.06116|0.04587|0.0367,1030|1030|457.7|457.7|457.7
1313,4,0.5051,3.03,3332.0,0.0009065,0.9929309999999999,ADAMDEC1 CHAC2 OSTN ZMYND12,negative regulation of dendrite extension|glutathione catabolic process|negative regulation of glucose import|glutathione biosynthetic process|negative regulation of glucose transmembrane transport,0.0007766|0.002328|0.002328|0.003104|0.003297,1|1|1|1|1,1716|468.1|468.1|343.2|321.8
1314,5,0.5194,5.194,4092.0,0.0012640000000000001,0.996692,CHAD DGKZ GAST GUCY2D TMEM88,positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|negative regulation of bone trabecula formation|regulation of bone trabecula formation|regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|receptor guanylyl cyclase signaling pathway,0.0004854|0.000728|0.000728|0.001213|0.002667,1|1|1|1|1,4119|2060|2060|1030|411.9
1315,4,0.5655,3.3930000000000002,3215.0,0.001052,0.9929309999999999,CHCHD10 MAP7D1 NINL NKX3-2,mitochondrial nucleoid organization|nucleoid organization|positive regulation of mitochondrial transcription|mitochondria-nucleus signaling pathway|positive regulation of cristae formation,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
1316,4,0.5152,3.091,3142.0,0.0009803,0.9929309999999999,ARHGAP33 CHCHD5 GPR45 GRAMD1A,cellular response to cholesterol|cellular response to sterol|response to cholesterol|response to sterol|regulation of dendritic spine morphogenesis,0.003491|0.004459|0.005426|0.006393|0.008903,1|1|1|1|1,302.9|234|190.7|160.9|114.4
1317,16,0.5068,60.81,13310.0,0.004539,0.999999,C8orf44 CA1 CA13 CA2 CA3 CHCHD7 CHMP4C CNGB3 CPA6 CYP7A1 MCMDC2 NSMAF PMP2 SGK3 SNX16 TRIM55,one-carbon metabolic process|bicarbonate transport|organic anion transport|ion transport|organic substance transport,2.934e-08|3.874e-08|4.791e-06|9.289e-05|0.000701,0.0004628|0.0003056|0.02519|0.3663|1,132|122.6|18.93|4.021|4.152
1318,6,0.5132,7.6979999999999995,4885.0,0.00157,0.998474,CEP170B CHGA GPR68 MTRF1 SERPINA4 TFR2,regulation of peptide hormone secretion|regulation of hormone secretion|regulation of peptide secretion|regulation of hormone levels|positive regulation of peptide hormone secretion,2.51e-05|4.769e-05|7.04e-05|0.0003285|0.0003881,0.3959|0.3761|0.3702|1|1,46.39|37.31|32.69|19.36|66.01
1319,5,0.5018,5.018,3866.0,0.0012929999999999999,0.996692,CHI3L1 FAM129A ITLN1 SIGLEC8 TNFSF4,cytokine production|positive regulation of interleukin-4-dependent isotype switching to IgE isotypes|regulation of interleukin-4-dependent isotype switching to IgE isotypes|response to nitrogen dioxide|T-helper 2 cell activation,0.0001913|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,92.56|4119|4119|4119|4119
1320,13,0.5239,40.87,8985.0,0.004515,0.999993,HERPUD1 IKBKB IKZF3 IRF4 MEF2C NFKB1 POU2AF1 PRDM1 RELA RELB SMAD7 TCF3 ZNF296,"regulation of transcription by RNA polymerase II|positive regulation of transcription by RNA polymerase II|positive regulation of macromolecule metabolic process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription",2.458e-11|3.973e-10|9.205e-10|1.04e-09|1.044e-09,3.878e-07|3.133e-06|4.84e-06|4.103e-06|3.294e-06,7.395|12.2|5.574|5.521|5.519
1321,26,0.5012,162.9,19380.0,0.008315000000000001,1.0,CD1B CD1E CTSK EFNA4 FAM189B FCGR2B FCGR3A FCRL3 FMO2 GBA ITLN1 ITLN2 KCNJ10 LCE3E OR10J5 OR6K6 OR6N1 OR6N2 PGLYRP3 S100A12 S100A2 S100A9 SLAMF7 TNN XCL1 YY1AP1,regulation of T cell mediated cytotoxicity|antimicrobial humoral response|regulation of T cell mediated immunity|regulation of leukocyte mediated cytotoxicity|positive regulation of T cell mediated cytotoxicity,2.521e-07|1.915e-06|3.801e-06|3.989e-06|9.679e-06,0.003976|0.0151|0.01998|0.01573|0.03054,80.29|24.45|39.12|38.62|78.91
1322,5,0.5088,5.088,4047.0,0.001253,0.996692,C12orf40 CHKB CPNE8 PAK5 PLPPR3,memory|stress-activated protein kinase signaling cascade|learning|phosphate-containing compound metabolic process|phosphorus metabolic process,0.0004726|0.0005478|0.0007146|0.0009479|0.001,1|1|1|1|1,59.7|55.36|48.35|7.204|7.103
1323,5,0.51,5.1,4161.0,0.001221,0.996692,CHML KLK3 NCKAP5L TECTB TERB2,zymogen activation|Factor XII activation|antibacterial peptide production|antimicrobial peptide production|protein processing,8.263e-05|0.0008735|0.0008735|0.0008735|0.001076,1|1|1|1|1,146.1|1716|1716|1716|39.23
1324,11,0.5066,27.86,6934.0,0.00399,0.999969,CHMP1B CHMP3 CHMP4B CHMP5 IST1 STAMBP USP8 VPS36 VPS4A VPS4B VTA1,multivesicular body assembly|multivesicular body organization|endosome organization|cytoskeleton-dependent cytokinesis|cytokinesis,6.309e-24|8.14e-24|1.156e-23|8.895e-20|2.442e-19,9.952e-20|6.42e-20|6.076e-20|3.508e-16|7.704e-16,561.7|543.6|243.2|175.5|156
1325,5,0.5026,5.026,4143.0,0.001209,0.996692,CHN1 CHRM1 MYO1A OPA3 RMDN3,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway|saliva secretion|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway|nervous system process|microvillus assembly,0.0009706|0.001456|0.002183|0.002724|0.00291,1|1|1|1|1,1373|823.8|514.9|8.954|374.5
1326,5,0.5046,5.046,3989.0,0.00126,0.996692,CHPF ETV3 HOXC6 OR1N2 UBXN2A,response to granulocyte macrophage colony-stimulating factor|cellular response to granulocyte macrophage colony-stimulating factor stimulus|chondroitin sulfate biosynthetic process|chondroitin sulfate proteoglycan biosynthetic process|chondroitin sulfate metabolic process,0.00291|0.00291|0.006295|0.007502|0.009431,1|1|1|1|1,374.5|374.5|164.8|137.3|108.4
1327,4,0.5114,3.068,2885.0,0.00106,0.9929309999999999,CCT4 CHPF2 RANBP3 XPO1,protein export from nucleus|nuclear export|RNA localization|nucleocytoplasmic transport|nuclear transport,0.0003299|0.0003925|0.0006963|0.0009436|0.0009653,1|1|1|1|1,67.75|62.03|46.39|39.76|39.3
1328,5,0.5193,5.193,3733.0,0.001385,0.996692,CHRD HCLS1 SERPINI1 WIZ ZNF644,BMP signaling pathway involved in spinal cord dorsal/ventral patterning|positive regulation of nuclear cell cycle DNA replication|positive regulation of granulocyte differentiation|floor plate development|positive regulation of DNA-dependent DNA replication,0.0004854|0.001698|0.002183|0.002425|0.003152,1|1|1|1|1,4119|686.5|514.9|457.7|343.3
1329,6,0.5072,7.608,4758.0,0.001593,0.998474,BTNL8 CHRM3 NSG2 RUFY1 ZNF454 ZNF879,cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus|response to catecholamine,0.0002381|0.0002438|0.0003386|0.0003386|0.0003665,1|1|1|1|1,84.75|83.72|70.77|70.77|67.97
1330,4,0.5188,3.113,3253.0,0.0009537,0.9929309999999999,CHRM5 KRTAP1-4 PIK3CG PLAG1,natural killer cell chemotaxis|negative regulation of cardiac muscle contraction|negative regulation of triglyceride catabolic process|regulation of phosphatidylinositol dephosphorylation|neutrophil extravasation,0.0007766|0.0009706|0.001165|0.001359|0.001359,1|1|1|1|1,1716|1287|1030|858.1|858.1
1331,4,0.5786,3.472,3219.0,0.001075,0.9929309999999999,CHRNA1 GALNT5 KLHDC9 RAB17,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|skeletal muscle tissue growth|filopodium assembly|transcytosis,0.0005825|0.0007766|0.0007766|0.004072|0.004266,1|1|1|1|1,2574|1716|1716|257.4|245.2
1332,4,0.5302,3.181,3043.0,0.001041,0.9929309999999999,CDH26 CHRNA10 GPR21 PLA2G5,positive regulation of phagosome maturation|positive regulation of antifungal innate immune response|positive regulation of opsonization|positive regulation of immune complex clearance by monocytes and macrophages|regulation of antifungal innate immune response,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
1333,4,0.5217,3.13,3193.0,0.0009771,0.9929309999999999,CHRNA3 OR4K5 RABL2A TTC26,"synaptic transmission involved in micturition|regulation of acetylcholine secretion, neurotransmission|intraciliary anterograde transport|manchette assembly|micturition",0.0007766|0.0007766|0.0007766|0.0009706|0.001359,1|1|1|1|1,1716|1716|1716|1287|858.1
1334,4,0.5475,3.285,3226.0,0.001015,0.9929309999999999,CHRNA4 ELFN1 FSCN1 FSCN3,actin filament bundle assembly|actin filament bundle organization|establishment or maintenance of cell polarity|microspike assembly|actin filament organization,4.987e-05|5.502e-05|0.0005391|0.0009706|0.001024,0.7867|0.4339|1|1|1,177.5|168.8|52.81|1287|38.14
1335,4,0.5736,3.4419999999999997,3180.0,0.001078,0.9929309999999999,CHRNA5 EBNA1BP2 HLA-DOA RPF1,ribosomal large subunit biogenesis|ganglion mother cell fate determination|negative regulation of antigen processing and presentation of peptide antigen via MHC class II|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|regulation of antigen processing and presentation of peptide antigen via MHC class II,0.0001264|0.000728|0.000728|0.0009706|0.001213,1|1|1|1|1,114.4|2060|2060|1373|1030
1336,4,0.5562,3.3369999999999997,3134.0,0.0010609999999999999,0.9929309999999999,CHRNB2 FCER1A RXFP4 TNN,regulation of behavior|lateral geniculate nucleus development|negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|synaptic transmission involved in micturition,6.8e-05|0.0003883|0.0003883|0.0003883|0.0007766,1|1|1|1|1,151.4|5149|5149|5149|1716
1337,5,0.5229,5.229,4118.0,0.001265,0.996692,ACSM6 CHRNB4 CIB2 NRG2 RAB32,synaptic transmission involved in micturition|melanosome assembly|micturition|pigment granule maturation|endosome to pigment granule transport,0.0009706|0.001456|0.001698|0.002667|0.002667,1|1|1|1|1,1373|823.8|686.5|411.9|411.9
1338,5,0.5517,5.517,4227.0,0.0013,0.996692,CHST1 FOXH1 GRINA HCK IFI27L2,mesoderm development|leukocyte migration involved in immune response|respiratory burst after phagocytosis|nodal signaling pathway involved in determination of left/right asymmetry|nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,0.0003438|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,68.65|2060|1373|1373|1373
1339,5,0.5255,5.255,4103.0,0.001276,0.996692,CHST10 GPRC5C PLEK2 STK39 ZACN,negative regulation of creatine transmembrane transporter activity|regulation of creatine transmembrane transporter activity|negative regulation of pancreatic juice secretion|chemokine (C-X-C motif) ligand 12 signaling pathway|maintenance of lens transparency,0.000728|0.000728|0.0009706|0.001213|0.001213,1|1|1|1|1,2060|2060|1373|1030|1030
1340,4,0.5769,3.4610000000000003,3081.0,0.001119,0.9929309999999999,CHST13 FAM162B PRPF38B RET,posterior midgut development|positive regulation of metanephric glomerulus development|regulation of metanephric glomerulus development|positive regulation of metanephros development|positive regulation of glomerulus development,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
1341,4,0.5453,3.272,3177.0,0.001026,0.9929309999999999,AMOTL1 CHST4 LYPD6 PRSS23,establishment of cell polarity involved in ameboidal cell migration|protein sulfation|N-acetylglucosamine metabolic process|sulfation|glucosamine-containing compound metabolic process,0.0007766|0.001747|0.003878|0.004846|0.005233,1|1|1|1|1,1716|643.6|271|214.5|198
1342,5,0.5527,5.527,4159.0,0.001324,0.996692,CHST8 HOXD10 HOXD11 HOXD8 HOXD9,regionalization|pattern specification process|peripheral nervous system neuron development|peripheral nervous system neuron differentiation|anterior/posterior pattern specification,2.894e-07|8.954e-07|4.284e-06|4.284e-06|1.029e-05,0.004565|0.007062|0.02253|0.01689|0.03246,51.81|38.95|686.5|686.5|59.7
1343,12,0.5159,34.05,9725.0,0.003481,0.999986,C1orf123 CLCA4 FAM69A GBP5 GBP6 GNAT2 IFI44 IFI44L KCNA10 TMEM56 TYW3 ZNF326,interleukin-18 production|cellular response to interferon-gamma|protein homooligomerization|response to interferon-gamma|interleukin-1 beta production,0.001067|0.003147|0.004049|0.004093|0.004263,1|1|1|1|1,1872|23.7|20.8|20.69|267.5
1344,12,0.5073,33.48,8217.0,0.004046,0.999986,CIAO1 CIAO2B CIAO3 CIAPIN1 FXN LYRM4 NDOR1 NFS1 NUBP2 SOD1 TIMM10 TIMM9,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|cellular component organization|cellular component organization or biogenesis,3.337e-24|3.337e-24|2.515e-16|2.386e-07|3.765e-07,5.265e-20|2.632e-20|1.322e-12|0.000941|0.001188,671.6|671.6|46.51|3.566|3.433
1345,5,0.5065,5.065,3938.0,0.001281,0.996692,BAIAP2 CIB4 MAFG PYCR1 SLC25A10,"modification of synaptic structure, modulating synaptic transmission|oxaloacetate(2-) transmembrane transport|malate transmembrane transport|malate transport|oxaloacetate transport",0.0004854|0.001213|0.001213|0.001213|0.001213,1|1|1|1|1,4119|1030|1030|1030|1030
1346,4,0.5662,3.397,3468.0,0.0009765,0.9929309999999999,C3orf20 CAMKV CIDEC ELF2,regulation of modification of postsynaptic structure|regulation of modification of synaptic structure|regulation of B cell receptor signaling pathway|lipid droplet organization|execution phase of apoptosis,0.001941|0.002716|0.00504|0.005426|0.0116,1|1|1|1|1,572.1|396.1|205.9|190.7|87.27
1347,4,0.5238,3.1430000000000002,3121.0,0.001003,0.9929309999999999,CIPC CYP4F22 NGB OR52K2,oxygen transport|negative regulation of circadian rhythm|gas transport|ceramide biosynthetic process|ceramide metabolic process,0.00291|0.003104|0.003878|0.01064|0.01813,1|1|1|1|1,367.8|343.2|271|95.35|55.36
1348,4,0.5459,3.275,3160.0,0.001033,0.9929309999999999,C1orf226 CIRBP MUM1 SELENOK,protein acylation|positive regulation of gene expression|respiratory burst after phagocytosis|regulation of T cell activation|respiratory burst involved in defense response,0.0004454|0.0005449|0.0007766|0.001539|0.001553,1|1|1|1|1,58.18|14.41|1716|31.02|735.5
1349,4,0.5696,3.418,3516.0,0.0009689,0.9929309999999999,BAALC CISD1 FLRT3 PENK,"general adaptation syndrome, behavioral process|proepicardium cell migration involved in pericardium morphogenesis|general adaptation syndrome|synaptic signaling via neuropeptide|positive regulation of behavioral fear response",0.0003883|0.0003883|0.0005825|0.0005825|0.001553,1|1|1|1|1,5149|5149|2574|2574|735.5
1350,4,0.5365,3.219,3276.0,0.0009793,0.9929309999999999,CISD2 MTMR7 SIX4 SLC35G3,skeletal muscle fiber differentiation|olfactory placode morphogenesis|olfactory placode development|regulation of branch elongation involved in ureteric bud branching|olfactory placode formation,0.0005825|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|1716|1716|1716|1716
1351,4,0.5843,3.5060000000000002,3179.0,0.001099,0.9929309999999999,CIZ1 GPR35 LMAN1 MLYCD,malonyl-CoA catabolic process|negative regulation of neuronal action potential|positive regulation of DNA-dependent DNA replication initiation|malonyl-CoA metabolic process|regulation of neuronal action potential,0.0003883|0.0003883|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|5149|2574|1716|1030
1352,4,0.5633,3.38,3014.0,0.001117,0.9929309999999999,CKAP2 MADD NUSAP1 SLC18B1,mitotic cytokinesis|cytoskeleton-dependent cytokinesis|cytokinesis|regulation of Rab protein signal transduction|cell division,6.8e-05|0.0001336|0.0001684|0.001553|0.003335,1|1|0.8853|1|1,151.4|107.3|95.35|735.5|20.93
1353,8,0.5439,15.23,5397.0,0.002806,0.9996790000000001,ASPM CDK5RAP2 CKAP2L HMMR KIFC1 NDE1 PCNT TUBB4B,regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|microtubule cytoskeleton organization|organelle localization|ciliary basal body-plasma membrane docking,5.461e-09|7.923e-09|1.192e-08|1.966e-08|3.459e-08,8.615e-05|6.249e-05|6.266e-05|7.753e-05|0.0001091,63.41|58.78|27.29|25.08|108.4
1354,4,0.595,3.57,3384.0,0.001051,0.9929309999999999,CKAP4 SLC16A8 SLC30A2 ZBTB8B,positive regulation of sequestering of zinc ion|regulation of sequestering of zinc ion|lactate transmembrane transport|lactate transport|zinc ion transmembrane transport,0.0003883|0.001165|0.001553|0.001553|0.004846,1|1|1|1|1,5149|1030|735.5|735.5|214.5
1355,5,0.524,5.24,4088.0,0.001277,0.996692,CKB HTR3E IGFBP6 RETREG1 UCHL1,sensory perception of pain|axon target recognition|phosphocreatine metabolic process|phosphagen metabolic process|phosphagen biosynthetic process,0.0001995|0.001165|0.001456|0.001456|0.001456,1|1|1|1|1,92.77|1144|858.1|858.1|858.1
1356,4,0.5371,3.222,3166.0,0.0010140000000000001,0.9929309999999999,CKMT2 NAB1 OR10G8 OR10S1,phosphocreatine metabolic process|phosphagen metabolic process|phosphagen biosynthetic process|phosphocreatine biosynthetic process|creatine metabolic process,0.0009706|0.0009706|0.0009706|0.0009706|0.001553,1|1|1|1|1,1287|1287|1287|1287|735.5
1357,30,0.4854,211.1,23750.0,0.008789,1.0,AKR7A3 AMY2A CASQ2 CD101 CLCA4 CYB561D1 FAM19A3 FAM69A GBP5 GBP6 GNAI3 GNAT2 GPR61 GSTM2 GSTM3 GSTM4 GSTM5 HAO2 HSD3B1 HSD3B2 IFI44 INKA2 KCNA10 MCOLN3 MOV10 PPM1J RHOC SLC22A15 TMEM56 UBL4B,glutathione derivative biosynthetic process|glutathione derivative metabolic process|nitrobenzene metabolic process|xenobiotic catabolic process|glutathione metabolic process,4.612e-08|4.612e-08|8.715e-08|1.124e-06|2.558e-06,0.0007275|0.0003638|0.0004583|0.004434|0.00807,129.1|129.1|532.6|177.5|43.7
1358,16,0.5105,61.25,12480.0,0.004873,0.999999,A2M C3AR1 CLEC2B CLEC4D CLEC6A GALNT8 GYS2 KCNA1 KCNA5 KCNA6 KLRC1 PKP2 PRB4 SLCO1B3 SLCO1C1 TAS2R20,action potential|bundle of His cell to Purkinje myocyte communication|regulation of innate immune response|sodium-independent organic anion transport|cell communication by electrical coupling,5.086e-05|5.897e-05|8.53e-05|8.582e-05|0.0001293,0.8023|0.4651|0.4485|0.3384|0.408,41.97|198|16.5|160.9|128.7
1359,5,0.533,5.33,3989.0,0.0013310000000000002,0.996692,CELA2B CLCNKB CYP4A22 CYP4Z1 HTR6,lauric acid metabolic process|lipid hydroxylation|medium-chain fatty acid metabolic process|linoleic acid metabolic process|G protein-coupled serotonin receptor signaling pathway,0.000728|0.00194|0.003636|0.005329|0.008467,1|1|1|1|1,2060|588.4|294.2|196.1|121.1
1360,9,0.5339,19.22,5891.0,0.003242,0.9998530000000001,CERS2 CERS6 ELOVL1 FASN HSD17B12 SPTLC2 SPTSSA TECR TMEM189,lipid biosynthetic process|cellular lipid metabolic process|amide biosynthetic process|lipid metabolic process|ceramide biosynthetic process,1.578e-14|1.248e-12|1.753e-12|9.436e-12|2.022e-11,2.489e-10|9.843e-09|9.216e-09|3.721e-08|6.378e-08,34.44|21.12|34.67|16.85|211.9
1361,11,0.5066,27.86,6961.0,0.003975,0.999969,BSG GPI HK2 PFKP PGAM1 PGD PGP PKM SLC2A1 TPI1 VDAC1,pyruvate metabolic process|NADH regeneration|glucose catabolic process to pyruvate|canonical glycolysis|glycolytic process through glucose-6-phosphate,1.278e-17|9.565e-15|9.565e-15|9.565e-15|1.161e-14,2.016e-13|7.544e-11|5.029e-11|3.772e-11|3.663e-11,199|381.4|381.4|381.4|367.8
1362,4,0.541,3.2460000000000004,3197.0,0.0010119999999999999,0.9929309999999999,CLDN11 COX7B2 NUGGC SMR3B,regulation of nuclear cell cycle DNA replication|calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|regulation of sensory perception of pain|regulation of sensory perception|regulation of DNA-dependent DNA replication,0.00291|0.004266|0.007938|0.008131|0.009675,1|1|1|1|1,367.8|245.2|128.7|125.6|105.1
1363,5,0.5072,5.072,3962.0,0.001275,0.996692,CLDN16 NMUR1 PACS1 RAB40C WDR37,protein localization to plasma membrane|protein localization to cell periphery|metal ion transport|magnesium ion transmembrane transport|magnesium ion transport,0.0008928|0.001278|0.002419|0.00412|0.004362,1|1|1|1|1,42.25|35.21|25.43|257.4|242.3
1364,4,0.5019,3.011,3144.0,0.0009544,0.9929309999999999,CLDN18 KLK2 PSKH2 ZNF93,negative regulation of transposon integration|regulation of transposon integration|TNFSF11-mediated signaling pathway|negative regulation of osteoclast development|regulation of osteoclast development,0.0005825|0.0005825|0.0009706|0.001165|0.002522,1|1|1|1|1,2574|2574|1287|1030|429.1
1365,4,0.5348,3.2089999999999996,3251.0,0.0009837,0.9929309999999999,CLDN19 GABRA4 GNRHR VEPH1,regulation of transepithelial transport|neuronal action potential propagation|action potential propagation|cellular response to gonadotropin-releasing hormone|negative regulation of SMAD protein signal transduction,0.0009706|0.001359|0.001359|0.001359|0.001553,1|1|1|1|1,1287|858.1|858.1|858.1|735.5
1366,5,0.5092,5.092,4134.0,0.001227,0.996692,CLDN20 HEXA SLC9C2 TNFSF18 TUBB4A,negative regulation of T-helper 17 cell lineage commitment|T cell proliferation involved in immune response|ganglioside catabolic process|regulation of T-helper 17 cell lineage commitment|regulation of dendritic cell chemotaxis,0.0009706|0.001456|0.00194|0.00194|0.002667,1|1|1|1|1,1373|823.8|588.4|588.4|411.9
1367,8,0.5095,14.27,6544.0,0.00217,0.9996790000000001,BTN2A2 CDKAL1 CLDN22 GABBR1 HIST1H1T INTU OR2B6 TXNDC5,maintenance of translational fidelity|tRNA methylthiolation|neuron-glial cell signaling|tongue morphogenesis|negative regulation of keratinocyte proliferation,0.001019|0.001019|0.002037|0.003732|0.004748,1|1|1|1|1,1471|1471|588.4|294.2|226.3
1368,4,0.518,3.108,3124.0,0.0009912,0.9929309999999999,APBA3 CLDN23 IPCEF1 SLC10A5,oxygen transport|gas transport|calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules|bile acid and bile salt transport|bicellular tight junction assembly,0.00291|0.003878|0.004266|0.00678|0.01141,1|1|1|1|1,367.8|271|245.2|151.4|88.77
1369,4,0.5305,3.1830000000000003,3113.0,0.001019,0.9929309999999999,CLDND2 FGB IL26 NAGLU,positive regulation of ERK1 and ERK2 cascade|induction of bacterial agglutination|regulation of ERK1 and ERK2 cascade|retinal rod cell development|plasminogen activation,0.000595|0.001165|0.001187|0.002134|0.002328,1|1|1|1|1,50.23|1030|35.39|514.9|468.1
1370,4,0.5247,3.148,2945.0,0.001065,0.9929309999999999,CDCA4 CLEC1A FAM122A HIST4H4,"chromatin organization involved in regulation of transcription|regulation of gene expression, epigenetic|negative regulation of megakaryocyte differentiation|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization",0.0001151|0.0004161|0.001165|0.002134|0.002134,1|1|1|1|1,115.7|60.22|1030|514.9|514.9
1371,18,0.502,76.8,14060.0,0.005418,1.0,C3AR1 CLEC12A CLEC1B CLEC2B CLEC4C CLEC4D CLEC6A GALNT8 KCNA1 KCNA6 KLRC1 PRB4 PRH2 PZP TAS2R10 TAS2R13 TAS2R20 TAS2R7,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|immune response-regulating cell surface receptor signaling pathway,3.647e-08|5.929e-08|6.49e-08|4.034e-07|5.226e-05,0.0005752|0.0004676|0.0003413|0.001591|0.1649,127.1|111.6|109|67.3|11.65
1372,16,0.5054,60.65,11000.0,0.005468,0.999999,HSPE1 RPL10A RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL31 RPL35 RPL37 RPL4 RPL9 RPLP2 RPS13 RPS20,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,5.531e-34|1.12e-33|4.184e-33|6.873e-33|7.761e-33,8.725e-30|8.831e-30|2.2e-29|2.71e-29|2.448e-29,201.1|191.2|173.9|167.9|166.4
1373,4,0.5018,3.011,3188.0,0.0009410999999999999,0.9929309999999999,B4GALT2 CLEC3B LYZL6 VWCE,positive regulation of plasminogen activation|regulation of plasminogen activation|fusion of sperm to egg plasma membrane involved in single fertilization|plasma membrane fusion|positive regulation of protein processing,0.001359|0.002716|0.004266|0.00504|0.00504,1|1|1|1|1,858.1|396.1|245.2|205.9|205.9
1374,11,0.5092,28.0,8637.0,0.0032240000000000003,0.999969,A2M C3AR1 CLEC2B CLEC4A CLEC4D CLEC6A GALNT8 KCNA1 KCNA6 KLRC1 KLRD1,regulation of innate immune response|regulation of immune response|regulation of response to biotic stimulus|immune response-regulating cell surface receptor signaling pathway|immune response-regulating signaling pathway,5.579e-09|1.192e-08|3.235e-08|7.965e-08|8.254e-08,8.801e-05|9.405e-05|0.0001701|0.0003141|0.0002604,36.01|13.27|26.68|22.88|22.74
1375,4,0.5494,3.2960000000000003,3085.0,0.001065,0.9929309999999999,ACADVL CLEC4G CSF2 SYPL1,response to silicon dioxide|positive regulation of interleukin-23 production|neutrophil differentiation|histamine secretion|regulation of interleukin-23 production,0.0007766|0.001165|0.001165|0.001553|0.001747,1|1|1|1|1,1716|1030|1030|735.5|643.6
1376,4,0.5167,3.1,3097.0,0.0009972999999999998,0.9929309999999999,ANTXRL CLEC4M FAM222A STXBP2,peptide antigen transport|virion attachment to host cell|adhesion of symbiont to host cell|adhesion of symbiont to host|viral genome replication,0.0007766|0.002134|0.002328|0.002522|0.005426,1|1|1|1|1,1716|514.9|468.1|429.1|190.7
1377,18,0.5072,77.61,14070.0,0.005472,1.0,CLEC12A CLEC12B CLEC2A CLEC2B CLEC4C CLEC4D CLEC6A CLEC7A KLRC1 PRB4 PRH2 PZP TAS2R13 TAS2R19 TAS2R20 TAS2R30 TAS2R7 TAS2R9,sensory perception of taste|detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|detection of chemical stimulus,3.122e-11|2.033e-10|3.708e-10|4.147e-10|3.921e-06,4.925e-07|1.603e-06|1.95e-06|1.636e-06|0.01237,101|158.9|139.5|136.2|13.15
1378,4,0.5771,3.463,3344.0,0.001032,0.9929309999999999,CLGN DBNDD1 LNX1 MBOAT2,phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling|phosphatidylcholine acyl-chain remodeling|phosphatidylserine metabolic process|binding of sperm to zona pellucida,0.004459|0.005233|0.006007|0.007166|0.00871,1|1|1|1|1,234|198|171.6|143|117
1379,4,0.5573,3.344,3134.0,0.0010630000000000001,0.9929309999999999,CLHC1 IQGAP2 LSAMP PECR,fatty alcohol metabolic process|phytol metabolic process|fatty acid alpha-oxidation|thrombin-activated receptor signaling pathway|Arp2/3 complex-mediated actin nucleation,0.0005825|0.0005825|0.001941|0.001941|0.004072,1|1|1|1|1,2574|2574|572.1|572.1|257.4
1380,6,0.5022,7.5329999999999995,4649.0,0.001614,0.998474,CLIC4 EZR PPP1R18 RASA2 SLK STK10,endothelial cell development|leukocyte cell-cell adhesion|cytoplasmic microtubule organization|endothelial cell differentiation|endothelium development,0.0001457|0.0001565|0.0002037|0.0003486|0.0004631,1|1|1|1|1,111|107|93.4|70.9|61.29
1381,4,0.5088,3.053,3163.0,0.0009619,0.9929309999999999,CD1E CLIC6 FCRL3 LRMDA,"positive regulation of protein serine/threonine phosphatase activity|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|negative regulation of B cell receptor signaling pathway|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib",0.0005825|0.001165|0.001553|0.001553|0.001553,1|1|1|1|1,2574|1030|735.5|735.5|735.5
1382,5,0.5066,5.066,4068.0,0.001241,0.996692,C16orf71 CLIP1 GPER1 GPR146 SLC38A10,nuclear fragmentation involved in apoptotic nuclear change|positive regulation of cardiac vascular smooth muscle cell differentiation|regulation of cardiac vascular smooth muscle cell differentiation|positive regulation of inositol trisphosphate biosynthetic process|apoptotic chromosome condensation,0.0004854|0.000728|0.0009706|0.001456|0.001456,1|1|1|1|1,4119|2060|1373|823.8|823.8
1383,5,0.5425,5.425,3985.0,0.001356,0.996692,CLK1 CLK4 ELOVL3 NR1H4 PLEKHG7,positive regulation of ammonia assimilation cycle|regulation of ammonia assimilation cycle|intracellular bile acid receptor signaling pathway|positive regulation of glutamate metabolic process|nitrogen catabolite activation of transcription,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
1384,4,0.5412,3.247,3103.0,0.0010429999999999999,0.9929309999999999,CLLU1OS RPS8 S100Z UGT3A1,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|maturation of SSU-rRNA|ribosomal small subunit biogenesis|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane",0.005525|0.00741|0.01103|0.01406|0.01478,1|1|1|1|1,185.5|137.3|91.53|71.51|67.97
1385,6,0.5044,7.565,4580.0,0.001645,0.998474,CFAP300 CLMP GJC1 MMP7 NPTX1 TJP1,gap junction assembly|cell-cell junction assembly|cell communication by electrical coupling involved in cardiac conduction|cell communication by electrical coupling|cell-cell junction organization,4.447e-06|8.435e-06|1.343e-05|2.279e-05|2.589e-05,0.07015|0.06653|0.07059|0.08985|0.08167,735.5|69.5|392.3|294.2|47.45
1386,4,0.5103,3.062,2966.0,0.0010279999999999998,0.9929309999999999,ASNA1 CLNK MICA NAGK,negative regulation of natural killer cell activation|regulation of natural killer cell activation|regulation of natural killer cell mediated immunity|negative regulation of lymphocyte activation|regulation of lymphocyte mediated immunity,7.776e-07|9.931e-06|1.661e-05|0.0001658|0.0001767,0.01227|0.07832|0.08732|0.6538|0.5576,1526|381.4|292.1|90.33|87.45
1387,4,0.5486,3.2910000000000004,3169.0,0.001035,0.9929309999999999,ARNTL CLOCK SLC39A6 TMCO2,negative regulation of glucocorticoid receptor signaling pathway|regulation of glucocorticoid receptor signaling pathway|regulation of type B pancreatic cell development|response to redox state|regulation of hair cycle,7.916e-07|1.272e-06|1.865e-06|3.843e-06|1.067e-05,0.01249|0.01003|0.009808|0.01515|0.03367,1716|1287|1030|686.5|396.1
1388,38,0.4844,340.5,27170.0,0.01234,1.0,C12orf65 CLPP CLPX DDX28 FASTKD2 FOXRED1 GRSF1 GTPBP10 GTPBP8 MALSU1 MCAT METTL17 MPV17L2 MRM2 MRM3 MRPL1 MRPL44 MRPL50 MRPL58 MRPL9 MTERF3 MTERF4 MTFMT MTG1 MTIF2 NGRN NOA1 NSUN4 PDE12 PTCD1 REXO2 RMND1 RPUSD3 RPUSD4 SLC30A9 TFB1M TRUB2 YBEY,ribosome biogenesis|regulation of mitochondrial translation|regulation of mitochondrial gene expression|ribonucleoprotein complex biogenesis|positive regulation of mitochondrial translation,8.061e-19|7.753e-18|2.315e-17|1.368e-16|1.648e-14,1.271e-14|6.115e-14|1.217e-13|5.396e-13|5.199e-11,25.45|182.8|158.4|18.17|217.4
1389,4,0.5168,3.1010000000000004,3097.0,0.0009976000000000002,0.9929309999999999,CLPS FAM45A FBLIM1 FBXL20,"regulation of protein catabolic process at presynapse, modulating synaptic transmission|presynaptic modulation of chemical synaptic transmission|lipid digestion|regulation of integrin activation|response to food",0.0004369|0.001601|0.002329|0.002619|0.003346,1|1|1|1|1,3432|686.5|457.7|403.8|312
1390,4,0.5058,3.035,3288.0,0.0009198,0.9929309999999999,CLPSL2 MPZ NMB RAB4A,cell-cell signaling|Rab protein signal transduction|cell aggregation|response to food|arachidonic acid secretion,0.001506|0.003636|0.005571|0.005571|0.006054,1|1|1|1|1,10.98|294.2|187.2|187.2|171.6
1391,5,0.5014,5.013999999999999,4263.0,0.001172,0.996692,ATP2B2 CCR2 CLPTM1L SERPINF1 TOPAZ1,negative regulation of angiogenesis|negative regulation of blood vessel morphogenesis|negative regulation of vasculature development|cellular chemical homeostasis|regulation of angiogenesis,2.545e-06|2.619e-06|2.694e-06|2.505e-05|4.82e-05,0.04014|0.02065|0.01416|0.09877|0.1521,101|99.98|99.01|18.33|37.18
1392,4,0.5462,3.2769999999999997,3191.0,0.001023,0.9929309999999999,CLRN2 CNBD2 OR7C2 ZNF564,cellular process|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.04971|0.08311|0.08802|0.09127|0.09776,1|1|1|1|1,0.3325|11.68|11|10.59|9.864
1393,4,0.5651,3.391,2979.0,0.001134,0.9929309999999999,CLRN3 EIF3M PCDHA4 ZNF555,formation of cytoplasmic translation initiation complex|cytoplasmic translational initiation|cytoplasmic translation|translational initiation|homophilic cell adhesion via plasma membrane adhesion molecules,0.003297|0.006007|0.01468|0.02767|0.03223,1|1|1|1|1,321.8|171.6|68.65|36.01|30.83
1394,10,0.5296,23.83,7049.0,0.00336,0.999933,CLSPN EIF3I GNL2 PABPC1 PSMB2 SF3A3 SNIP1 TRAPPC3 UTP11 YARS,"ribonucleoprotein complex biogenesis|gene expression|nucleic acid metabolic process|cellular nitrogen compound metabolic process|mRNA splicing, via spliceosome",4.991e-05|0.0002068|0.0002324|0.0002564|0.0003568,0.7873|1|1|1|1,17.72|5.653|5.536|4.231|20.46
1395,5,0.5288,5.287999999999999,4361.0,0.001208,0.996692,CCDC28B CD9 CLSTN1 MTHFR SMIM1,response to acid chemical|response to vitamin B2|heterochromatin maintenance|heterochromatin organization involved in chromatin silencing|myoblast fusion involved in skeletal muscle regeneration,0.0004024|0.0004854|0.001213|0.001456|0.001456,1|1|1|1|1,63.37|4119|1030|823.8|823.8
1396,19,0.4943,84.53,14880.0,0.005634,1.0,CLEC12A CLEC2B CLEC4C CLEC4D CLEC6A GALNT8 KLRC1 PRB4 PRH2 PZP SLC2A3 SLCO1C1 TAS2R13 TAS2R20 TAS2R30 TAS2R50 TAS2R7 TAS2R8 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of taste|detection of chemical stimulus involved in sensory perception,5.085e-15|1.159e-14|1.351e-14|3.081e-13|1.685e-07,8.021e-11|9.14e-11|7.105e-11|1.215e-09|0.0005314,210.8|185.1|180.7|111.6|15.61
1397,4,0.5139,3.0839999999999996,3004.0,0.001023,0.9929309999999999,CDC42 CLTB KCTD3 RAX,submandibular salivary gland formation|actin filament branching|neuropilin signaling pathway|positive regulation of synapse structural plasticity|positive regulation of epithelial cell proliferation involved in lung morphogenesis,0.000728|0.0009706|0.001213|0.001213|0.001456,1|1|1|1|1,2060|1373|1030|1030|823.8
1398,4,0.5464,3.279,3184.0,0.001026,0.9929309999999999,CLVS1 LRRC29 MAB21L3 VEGFC,positive regulation of lymphangiogenesis|positive regulation of mesenchymal stem cell proliferation|regulation of mesenchymal stem cell proliferation|regulation of lymphangiogenesis|positive regulation of mast cell chemotaxis,0.0005825|0.001165|0.001165|0.001165|0.001359,1|1|1|1|1,2574|1030|1030|1030|858.1
1399,8,0.5034,14.1,6297.0,0.002228,0.9996790000000001,BIVM CLYBL DLEU7 GAS6 GPR183 SLITRK5 ZIC2 ZIC5,lymphocyte chemotaxis|lymphocyte migration|mononuclear cell migration|negative regulation of renal albumin absorption|positive regulation of cobalamin metabolic process,0.0001666|0.0003706|0.0007331|0.0007765|0.0007765,1|1|1|1|1,105.1|69.58|49.04|2574|2574
1400,12,0.5148,33.98,9661.0,0.003496,0.999986,CDH12 CDH18 CMBL DNAH5 FAM173B OTULIN OTULINL PRLR ROPN1L SLC6A18 SLC6A19 UGT3A1,epithelial cilium movement involved in extracellular fluid movement|extracellular transport|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|sperm motility,0.0001616|0.0001899|0.0002421|0.0005129|0.001056,1|1|1|1|1,110.1|101.2|89.16|60.4|41.61
1401,6,0.5368,8.052,4727.0,0.001696,0.998474,CMC1 CRYGA CRYGB CRYGC CRYGD MYBPHL,lens development in camera-type eye|visual perception|sensory perception of light stimulus|camera-type eye development|eye development,7.312e-09|4.319e-07|4.642e-07|1.975e-06|3.433e-06,0.0001153|0.003406|0.002441|0.00779|0.01083,154.8|54.48|53.49|37.01|32.15
1402,4,0.5068,3.0410000000000004,3182.0,0.0009523,0.9929309999999999,CHAC1 CMC2 CPNE7 PLEKHG6,response to calcium ion|malate-aspartate shuttle|aspartate transmembrane transport|glutathione catabolic process|L-aspartate transmembrane transport,0.0005401|0.001213|0.002425|0.00291|0.00291,1|1|1|1|1,54.56|1030|457.7|374.5|374.5
1403,4,0.5038,3.023,2951.0,0.001021,0.9929309999999999,CLNS1A CMKLR1 SNRPD2 TSEN15,spliceosomal snRNP assembly|RNA splicing|mRNA processing|mRNA metabolic process|RNA processing,2.313e-05|3.085e-05|5.161e-05|0.0001504|0.0003501,0.3649|0.2433|0.2714|0.5932|1,264|37.95|31.91|22.26|16.73
1404,4,0.5667,3.4,3347.0,0.0010119999999999999,0.9929309999999999,CMSS1 KNCN LCLAT1 PACRG,cardiolipin acyl-chain remodeling|CDP-diacylglycerol biosynthetic process|CDP-diacylglycerol metabolic process|cardiolipin metabolic process|phosphatidylinositol acyl-chain remodeling,0.001747|0.002716|0.00291|0.003297|0.003685,1|1|1|1|1,643.6|396.1|367.8|321.8|286
1405,5,0.5237,5.237,4064.0,0.001284,0.996692,C12orf29 CD22 CMTM4 NAPSA TGM2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine|isopeptide cross-linking|peptidyl-glutamine modification|salivary gland cavitation|tube lumen cavitation,0.000728|0.0009706|0.001213|0.001456|0.001456,1|1|1|1|1,2060|1373|1030|823.8|823.8
1406,5,0.5367,5.367000000000001,3973.0,0.0013460000000000002,0.996692,CMTM8 GOLM1 KCNK3 RGMB TMEM229A,negative regulation of cytosolic calcium ion concentration|stabilization of membrane potential|cellular response to zinc ion|cochlea development|response to zinc ion,0.003636|0.004362|0.006295|0.01208|0.01448,1|1|1|1|1,294.2|242.3|164.8|84.06|69.81
1407,21,0.4782,100.4,15360.0,0.006476999999999999,1.0,BOP1 C8orf33 CYC1 EXOSC4 FOXH1 GLI4 LYPD2 MAPK15 MROH6 NAPRT PPP1R16A PUF60 RHPN1 RPL8 TSNARE1 VPS28 ZFP41 ZNF16 ZNF250 ZNF696 ZNF707,maturation of 5.8S rRNA|ribonucleoprotein complex biogenesis|NAD salvage|cellular response to sodium dodecyl sulfate|positive regulation of meiotic chromosome separation,0.0006442|0.001164|0.002036|0.002036|0.002036,1|1|1|1|1,56.04|8.436|980.7|980.7|980.7
1408,5,0.5223,5.223,4334.0,0.001201,0.996692,AATK CMYA5 EVI5 RAB37 ZNF620,"peptidyl-tyrosine autophosphorylation|retrograde transport, endosome to Golgi|activation of GTPase activity|peptidyl-tyrosine phosphorylation|cytosolic transport",0.00412|0.0219|0.02808|0.03541|0.03565,1|1|1|1|1,257.4|45.77|35.51|28.02|27.83
1409,5,0.5089,5.0889999999999995,3073.0,0.001648,0.996692,CCND2 CCND3 CDK6 CNBP MSI2,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|positive regulation of cyclin-dependent protein serine/threonine kinase activity|mitotic cell cycle phase transition|cell cycle phase transition,4.132e-06|5.952e-06|2.636e-05|2.649e-05|2.875e-05,0.06518|0.04694|0.1386|0.1045|0.09069,81.3|71.84|257.4|43.36|42.17
1410,6,0.5198,7.797999999999999,4820.0,0.001611,0.998474,BNIP2 CNDP2 FAM71F1 PIGH PPIB SNX22,polyphosphate catabolic process|polyphosphate metabolic process|positive regulation by host of viral genome replication|response to oxygen-glucose deprivation|glutathione biosynthetic process,0.001746|0.002037|0.002619|0.0032|0.004651,1|1|1|1|1,686.5|572.1|429.1|343.2|228.8
1411,4,0.5207,3.1239999999999997,3169.0,0.0009823,0.9929309999999999,CNFN GSTA3 SLC39A2 ST8SIA4,ganglioside biosynthetic process|N-glycan processing|sialylation|glutathione derivative biosynthetic process|glutathione derivative metabolic process,0.003297|0.003878|0.004072|0.004459|0.004459,1|1|1|1|1,321.8|271|257.4|234|234
1412,4,0.5622,3.373,3243.0,0.001036,0.9929309999999999,CNGA3 EIF3I PHLDB3 SYN3,"synaptic vesicle clustering|formation of cytoplasmic translation initiation complex|response to magnesium ion|cytoplasmic translational initiation|regulation of synaptic transmission, GABAergic",0.001941|0.003297|0.003878|0.006007|0.006393,1|1|1|1|1,572.1|321.8|271|171.6|160.9
1413,4,0.5465,3.279,3233.0,0.001011,0.9929309999999999,CNGA4 PCSK1 TEX2 TNRC6C,"negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation|regulation of translation, ncRNA-mediated|positive regulation of nuclear-transcribed mRNA poly(A) tail shortening|regulation of nuclear-transcribed mRNA poly(A) tail shortening",0.002716|0.002716|0.002716|0.00291|0.003297,1|1|1|1|1,396.1|396.1|396.1|367.8|321.8
1414,4,0.604,3.6239999999999997,3134.0,0.001152,0.9929309999999999,CNIH2 MAP3K11 SNX17 TMEM179B,negative regulation of receptor localization to synapse|negative regulation of vesicle transport along microtubule|negative regulation of anterograde synaptic vesicle transport|negative regulation of synaptic vesicle transport|regulation of anterograde synaptic vesicle transport,0.0003883|0.0003883|0.0003883|0.0003883|0.0007766,1|1|1|1|1,5149|5149|5149|5149|1716
1415,4,0.5344,3.207,3275.0,0.0009756999999999999,0.9929309999999999,ATP12A CNKSR1 CNTN5 NEUROG2,establishment or maintenance of transmembrane electrochemical gradient|sodium ion export across plasma membrane|cellular potassium ion homeostasis|cellular sodium ion homeostasis|presynapse assembly,0.002716|0.00291|0.00291|0.003878|0.004653,1|1|1|1|1,396.1|367.8|367.8|271|223.9
1416,4,0.5165,3.0989999999999998,3143.0,0.0009824,0.9929309999999999,CLEC2A CNKSR3 FXR1 ZMYM1,natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|positive regulation of gene silencing by miRNA|negative regulation of peptidyl-serine phosphorylation|positive regulation of posttranscriptional gene silencing,0.004846|0.005233|0.005813|0.005813|0.006007,1|1|1|1|1,214.5|198|177.5|177.5|171.6
1417,5,0.5555,5.555,4271.0,0.001296,0.996692,CNN3 LRP2 MEGF8 RAB27B SLC5A9,coronary vasculature development|epiboly involved in gastrulation with mouth forming second|positive regulation of oligodendrocyte progenitor proliferation|positive regulation of lysosomal protein catabolic process|fasciculation of sensory neuron axon,4.647e-05|0.0004854|0.0009706|0.0009706|0.0009706,0.733|1|1|1|1,191.6|4119|1373|1373|1373
1418,4,0.5887,3.532,3202.0,0.001099,0.9929309999999999,AKR1B10 CNNM1 NSUN6 ZNF746,farnesol catabolic process|farnesol metabolic process|sesquiterpenoid catabolic process|tRNA C5-cytosine methylation|sesquiterpenoid metabolic process,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
1419,12,0.503,33.2,9478.0,0.003482,0.999986,ASTL C2orf49 CNNM3 CNNM4 FAHD2A FAM178B IL1F10 LYG1 MGAT4A MRPL30 POTEI TUBA3D,prevention of polyspermy|negative regulation of fertilization|cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process,0.001746|0.001746|0.001746|0.002327|0.002327,1|1|1|1|1,858.1|858.1|858.1|572.1|572.1
1420,7,0.5402,11.34,4707.0,0.002397,0.9992989999999999,ANKRD17 BTG1 CNOT2 CNOT3 CNOT6 CNOT7 CNOT8,"nuclear-transcribed mRNA poly(A) tail shortening|regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|signal transduction involved in mitotic G1 DNA damage checkpoint",6.664e-14|1.287e-12|2.657e-12|4.752e-12|5.155e-12,1.051e-09|1.015e-08|1.397e-08|1.874e-08|1.626e-08,639.6|116.1|102.6|253.6|249.3
1421,4,0.5122,3.073,3207.0,0.0009549,0.9929309999999999,CALU CNPPD1 KCNB1 TMEM9B,positive regulation of norepinephrine secretion|regulation of motor neuron apoptotic process|positive regulation of long-term synaptic depression|positive regulation of catecholamine secretion|regulation of long-term synaptic depression,0.0009706|0.001165|0.001359|0.00291|0.00291,1|1|1|1|1,1287|1030|858.1|367.8|367.8
1422,4,0.5669,3.4010000000000002,3515.0,0.0009645,0.9929309999999999,BBIP1 CNR1 EFCAB12 TMCO2,"induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration|trans-synaptic signaling by endocannabinoid, modulating synaptic transmission|trans-synaptic signaling by lipid, modulating synaptic transmission|positive regulation of presynaptic cytosolic calcium concentration|retrograde trans-synaptic signaling by endocannabinoid",0.0007766|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,1716|1716|1716|1716|1716
1423,6,0.5135,7.702999999999999,5005.0,0.001533,0.998474,CA2 CA3 CNR2 CYP7A1 FAM71F1 PTPRR,one-carbon metabolic process|bicarbonate transport|organic anion transport|response to oxygen-containing compound|response to ethanol,5.767e-05|6.651e-05|8.816e-05|0.0004649|0.0006853,0.9098|0.5246|0.4636|1|1,176|163.5|30.29|8.668|49.39
1424,4,0.5278,3.167,3210.0,0.000983,0.9929309999999999,BRMS1L CNRIP1 OC90 RASSF3,otolith mineralization|otolith development|arachidonic acid secretion|arachidonate transport|icosanoid secretion,0.0005825|0.001747|0.004846|0.004846|0.005426,1|1|1|1|1,2574|643.6|214.5|214.5|190.7
1425,4,0.5591,3.3539999999999996,3262.0,0.001025,0.9929309999999999,CNST FOXI2 GRM6 HIST1H4F,negative regulation of megakaryocyte differentiation|positive regulation of Golgi to plasma membrane protein transport|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|DNA replication-dependent nucleosome assembly|regulation of Golgi to plasma membrane protein transport,0.001165|0.001165|0.001553|0.002134|0.002134,1|1|1|1|1,1030|1030|735.5|514.9|514.9
1426,4,0.5857,3.514,3274.0,0.00107,0.9929309999999999,CIB3 CNTD1 GMIP PALMD,negative regulation of GTPase activity|reciprocal meiotic recombination|reciprocal homologous recombination|homologous recombination|activation of GTPase activity,0.009096|0.01102|0.01102|0.01141|0.02253,1|1|1|1|1,111.9|91.94|91.94|88.77|44.39
1427,4,0.5765,3.4589999999999996,3233.0,0.001066,0.9929309999999999,CNTF HOMER3 MBP TBC1D9,positive regulation of metalloendopeptidase activity|regulation of retinal cell programmed cell death|ciliary neurotrophic factor-mediated signaling pathway|regulation of metalloendopeptidase activity|positive regulation of metallopeptidase activity,0.000728|0.0009706|0.001456|0.001698|0.001698,1|1|1|1|1,2060|1373|823.8|686.5|686.5
1428,5,0.5114,5.114,3978.0,0.001281,0.996692,CDK18 CNTN2 RGS18 SNX3 TMEM81,establishment of protein localization to juxtaparanode region of axon|regulation of G protein-coupled receptor signaling pathway|negative regulation of early endosome to late endosome transport|intralumenal vesicle formation|positive regulation of adenosine receptor signaling pathway,0.0004854|0.0005055|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|56.42|2060|2060|1373
1429,4,0.512,3.072,3003.0,0.001019,0.9929309999999999,ABCC1 CNTN3 NOMO2 UGT1A5,sphingolipid translocation|glutathione transmembrane transport|tripeptide transmembrane transport|glutathione transport|leukotriene transport,0.0009706|0.001165|0.001359|0.001359|0.001553,1|1|1|1|1,1287|1030|858.1|858.1|735.5
1430,4,0.5783,3.47,3336.0,0.001037,0.9929309999999999,B3GALT4 CNTN4 GPR31 ZFPL1,ganglioside biosynthetic process|neuron cell-cell adhesion|dendrite self-avoidance|axonal fasciculation|neuron projection fasciculation,0.003297|0.003491|0.003491|0.004072|0.004072,1|1|1|1|1,321.8|302.9|302.9|257.4|257.4
1431,4,0.5121,3.073,3033.0,0.001009,0.9929309999999999,CNTN6 MUC16 PRDX2 ZNF69,respiratory burst involved in inflammatory response|respiratory burst involved in defense response|regulation of response to biotic stimulus|removal of superoxide radicals|negative regulation of lipopolysaccharide-mediated signaling pathway,0.0003883|0.001553|0.002456|0.002716|0.002716,1|1|1|1|1,5149|735.5|24.46|396.1|396.1
1432,4,0.5335,3.201,3145.0,0.0010140000000000001,0.9929309999999999,CMTM2 CNTNAP4 SMIM22 TRIP10,"regulation of grooming behavior|regulation of synaptic transmission, dopaminergic|lipid droplet formation|lipid droplet organization|regulation of synaptic transmission, GABAergic",0.001165|0.001553|0.002328|0.005426|0.006393,1|1|1|1|1,1030|735.5|468.1|190.7|160.9
1433,4,0.5799,3.4789999999999996,3271.0,0.00106,0.9929309999999999,CALN1 CNTNAP5 IRX2 WNT7A,asymmetric protein localization involved in cell fate determination|proximal/distal pattern formation involved in metanephric nephron development|positive regulation of protein localization to presynapse|regulation of protein localization to presynapse|positive regulation of excitatory synapse assembly,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
1434,8,0.5169,14.47,4929.0,0.002918,0.9996790000000001,AMBRA1 CCND3 CDK4 CDK6 DYRK1A FAM117B FAM53C GLCCI1,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|G1 phase|mitotic G1 phase|mitotic cell cycle phase transition,2.275e-05|3.269e-05|3.324e-05|3.324e-05|0.0001437,0.3588|0.2579|0.1748|0.1311|0.4534,50.81|44.9|245.2|245.2|27.1
1435,4,0.5498,3.299,3218.0,0.001021,0.9929309999999999,ACOX2 AXDND1 COA1 PROK2,positive regulation of response to oxidative stress|fatty acid beta-oxidation using acyl-CoA oxidase|mitochondrial cytochrome c oxidase assembly|endothelial cell proliferation|respiratory chain complex IV assembly,0.001553|0.003104|0.004459|0.004846|0.005233,1|1|1|1|1,735.5|343.2|234|214.5|198
1436,9,0.5134,18.48,6015.0,0.003054,0.9998530000000001,C12orf45 C16orf72 DDX21 HSPA14 NCL NOLC1 PINX1 ZNHIT3 ZNHIT6,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,1.469e-07|1.766e-07|4.84e-07|1.744e-06|2.493e-06,0.002318|0.001393|0.002545|0.006876|0.007864,36.01|34.67|28.2|21.67|20.13
1437,4,0.516,3.096,3193.0,0.0009663,0.9929309999999999,COL10A1 RFPL1 SRPK2 UBXN11,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|nuclear speck organization|regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|R-loop disassembly|negative regulation of cell division,0.0005825|0.0009706|0.001165|0.001165|0.003297,1|1|1|1|1,2574|1287|1030|1030|321.8
1438,4,0.5017,3.01,3058.0,0.0009808999999999998,0.9929309999999999,COL11A2 LRRC57 OR11L1 SEMA4D,positive regulation of inhibitory synapse assembly|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|negative regulation of alkaline phosphatase activity|ossification|regulation of inhibitory synapse assembly,0.0005825|0.0005825|0.0007766|0.0009653|0.0009706,1|1|1|1|1,2574|2574|1716|39.3|1287
1439,4,0.578,3.468,3384.0,0.001021,0.9929309999999999,ANXA4 C17orf47 COL15A1 KCNA2,endothelial cell morphogenesis|negative regulation of interleukin-8 production|neuronal action potential|epithelial cell differentiation|epithelial cell morphogenesis,0.002716|0.003878|0.00562|0.006174|0.006393,1|1|1|1|1,396.1|271|183.9|15.28|160.9
1440,5,0.5032,5.032,4142.0,0.00121,0.996692,BMPR1A COL17A1 DDHD1 EIF4EBP2 TCTN3,regulation of lateral mesodermal cell fate specification|paraxial mesoderm structural organization|mesoderm structural organization|fibrous ring of heart morphogenesis|positive regulation of cardiac ventricle development,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
1441,4,0.5325,3.195,3260.0,0.0009767,0.9929309999999999,APLNR COL1A1 DNAJB13 SAMD14,cellular response to fluoride|positive regulation of inhibitory G protein-coupled receptor phosphorylation|regulation of inhibitory G protein-coupled receptor phosphorylation|cellular response to vitamin E|apelin receptor signaling pathway,0.0003883|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,5149|5149|5149|2574|1716
1442,4,0.5594,3.3560000000000003,3290.0,0.001017,0.9929309999999999,BMP1 CIZ1 COL1A2 SLC37A2,collagen fibril organization|protein heterotrimerization|positive regulation of DNA-dependent DNA replication initiation|ossification|glucose-6-phosphate transport,0.0001534|0.0003883|0.0005825|0.0009653|0.001359,1|1|1|1|1,99.98|5149|2574|39.3|858.1
1443,4,0.571,3.426,3255.0,0.001049,0.9929309999999999,COL2A1 DYDC1 EHD3 PLEK,regulation of cell diameter|phospholipase C-inhibiting G protein-coupled receptor signaling pathway|positive regulation of inositol-polyphosphate 5-phosphatase activity|regulation of inositol-polyphosphate 5-phosphatase activity|negative regulation of inositol phosphate biosynthetic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1444,8,0.5256,14.72,6466.0,0.0022649999999999997,0.9996790000000001,COL4A3 COL4A4 CRYGA CRYGB CRYGC CRYGD PRLH SNORC,lens development in camera-type eye|visual perception|sensory perception of light stimulus|system development|camera-type eye development,1.458e-08|8.564e-07|9.202e-07|3.496e-06|3.902e-06,0.0002299|0.006754|0.004839|0.01379|0.01231,135.5|47.67|46.81|4.813|32.38
1445,4,0.5948,3.569,3269.0,0.001088,0.9929309999999999,COL6A3 FDCSP PPFIBP2 SPSB1,neuromuscular junction development|collagen fibril organization|negative regulation of endopeptidase activity|negative regulation of peptidase activity|muscle organ development,0.008324|0.02004|0.04692|0.0488|0.05346,1|1|1|1|1,122.6|49.99|21.02|20.19|18.39
1446,5,0.502,5.02,3861.0,0.001295,0.996692,COL7A1 DNASE2 HOXA11 KLHDC8B ZNF749,formation of primary germ layer|gastrulation|mesodermal cell fate specification|embryonic skeletal joint morphogenesis|mesodermal cell fate commitment,0.0002951|0.0005685|0.00194|0.00291|0.003394,1|1|1|1|1,74.22|53.15|588.4|374.5|316.8
1447,10,0.5231,23.54,6373.0,0.003668,0.999933,BRAF DUSP4 ELAVL1 MAFF MAP2K1 MAPK1 MITF PEA15 SOX10 SOX9,trachea development|thyroid gland development|endocrine system development|positive regulation of nitrogen compound metabolic process|ERK1 and ERK2 cascade,1.262e-07|2.393e-07|2.809e-07|3.076e-07|4.457e-07,0.00199|0.001887|0.001477|0.001213|0.001406,325.2|257.4|66.98|6.061|205.9
1448,5,0.5507,5.507000000000001,4335.0,0.001266,0.996692,COL8A2 ELOVL3 HTR6 PLAU SLC44A3,"regulation of smooth muscle cell-matrix adhesion|fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid|fatty acid elongation, polyunsaturated fatty acid|fatty acid elongation, monounsaturated fatty acid",0.001213|0.00194|0.00194|0.00194|0.00194,1|1|1|1|1,1030|588.4|588.4|588.4|588.4
1449,15,0.5056,53.09,12050.0,0.004375,0.999999,C1orf50 CCDC30 CFAP57 COL9A2 CYP4A22 CYP4Z1 ERMAP EXO5 MFSD2A MPL PPT1 ZFP69 ZFP69B ZNF684 ZNF691,basophil homeostasis|eosinophil homeostasis|lysophospholipid translocation|regulation of phosphatidylserine metabolic process|regulation of phosphatidylethanolamine metabolic process,0.001455|0.001455|0.001455|0.001455|0.001455,1|1|1|1|1,1373|1373|1373|1373|1373
1450,8,0.5028,14.08,5987.0,0.00234,0.9996790000000001,C11orf53 COLCA2 IDE POU2F3 SOX4 STAM2 TFAP2B TP73,sympathetic nervous system development|aorta morphogenesis|kidney development|renal system development|autonomic nervous system development,3.324e-05|6.1e-05|0.000135|0.0001482|0.0001537,0.5244|0.4811|0.71|0.5843|0.485,245.2|177.5|27.68|26.82|109.5
1451,16,0.5144,61.73,13690.0,0.00448,0.999999,AARD C8orf76 COL14A1 COLEC10 DCDC2 ENPP2 FBXO32 KLHL38 MTSS1 NETO2 NOV RNF139 SLC22A4 SLC30A8 TNFRSF11B TRMT12,chemotaxis|taxis|negative regulation of animal organ morphogenesis|nephron tubule epithelial cell differentiation|smooth muscle cell proliferation,0.001139|0.001162|0.002618|0.002618|0.002618,1|1|1|1|1,8.382|8.336|572.1|572.1|572.1
1452,4,0.5895,3.537,3192.0,0.001104,0.9929309999999999,C2orf73 CC2D2B COLGALT1 TAS2R31,positive regulation of collagen fibril organization|regulation of collagen fibril organization|positive regulation of extracellular matrix organization|detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste,0.0007766|0.001359|0.004653|0.007166|0.008131,1|1|1|1|1,1716|858.1|223.9|143|125.6
1453,4,0.5293,3.176,3122.0,0.0010140000000000001,0.9929309999999999,COLGALT2 PAX2 TBCEL TBX5,cell fate specification|optic nerve structural organization|positive regulation of optic nerve formation|regulation of optic nerve formation|regulation of metanephros size,9.574e-05|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,127.1|5149|5149|5149|5149
1454,4,0.5174,3.1039999999999996,3342.0,0.0009259,0.9929309999999999,COLQ EPN3 EPS15 INPP4A,acetylcholine catabolic process|acetylcholine catabolic process in synaptic cleft|acetate ester metabolic process|regulation of synaptic growth at neuromuscular junction|acetylcholine metabolic process,0.0005825|0.0005825|0.001165|0.001165|0.001165,1|1|1|1|1,2574|2574|1030|1030|1030
1455,5,0.5081,5.081,3916.0,0.0012929999999999999,0.996692,COMMD1 DUSP23 NAT8 PCDHB8 PCDHGA8,homophilic cell adhesion via plasma membrane adhesion molecules|peptidyl-lysine N6-acetylation|cell-cell adhesion via plasma-membrane adhesion molecules|plasma membrane to endosome transport|negative regulation of protein localization to cell surface,0.0006583|0.000728|0.001559|0.002183|0.003394,1|1|1|1|1,49.33|2060|31.81|514.9|316.8
1456,9,0.5354,19.27,5560.0,0.0034439999999999996,0.9998530000000001,COP1 DDA1 DET1 DUSP4 DUSP5 FOSL1 JUNB STK40 TRIB1,positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of proteasomal protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|regulation of proteasomal ubiquitin-dependent protein catabolic process,8.352e-08|1.634e-07|1.951e-07|3.59e-07|3.92e-07,0.001317|0.001289|0.001026|0.001416|0.001237,91.53|76.99|73.55|62.89|61.48
1457,18,0.5094,77.94,14210.0,0.005442,1.0,CCL13 CCL2 CCL7 CORO6 CRYBA1 EVI2A GAS2L2 LGALS9 LYRM9 NOS2 PIPOX SLC13A2 SLFN12 SPAG5 TIAF1 TMEM97 UNC119 VTN,cellular response to interferon-gamma|response to interferon-gamma|eosinophil chemotaxis|eosinophil migration|regulation of ERK1 and ERK2 cascade,3.09e-07|5.947e-07|7.493e-07|8.737e-07|5.818e-06,0.004875|0.004691|0.00394|0.003445|0.01836,34.3|29.94|191.3|180.7|18.62
1458,18,0.4804,73.5,14080.0,0.005178,1.0,CCM2L COX4I2 CPNE1 DEFB115 DEFB116 DUSP15 FAM83C FOXS1 HCK KIF3B MYH7B MYLK2 NOL4L PLAGL2 POFUT1 TM9SF4 WFDC11 XKR7,leukocyte migration involved in immune response|phagocytosis|response to bacterium|defense response to bacterium|respiratory burst after phagocytosis,0.002618|0.002752|0.003085|0.003225|0.003489,1|1|1|1|1,572.1|10.53|6.374|9.949|381.4
1459,73,0.5013,1318.0,48990.0,0.02611,1.0,ACAD9 BCS1L CARS2 COA6 COA7 COQ2 COQ4 COQ7 COX18 COX4I1 COX5B COX6C COX7C CYC1 DARS2 DMAC1 ECSIT FASTKD5 FOXRED1 GLRX5 GRSF1 GTPBP10 IBA57 ISCA2 METTL17 MRM2 MRM3 MTFMT MTO1 NDUFA10 NDUFA11 NDUFA2 NDUFA3 NDUFA5 NDUFA6 NDUFA8 NDUFA9 NDUFAF1 NDUFAF3 NDUFAF4 NDUFAF6 NDUFAF7 NDUFAF8 NDUFB10 NDUFB2 NDUFB3 NDUFB4 NDUFB5 NDUFB6 NDUFB7 NDUFB8 NDUFB9 NDUFC1 NDUFC2 NDUFS1 NDUFS2 NDUFS3 NDUFS5 NDUFS7 NDUFS8 NDUFV1 NDUFV2 NFU1 NUBPL PET117 PYURF RTN4IP1 TIMMDC1 UQCR10 UQCRB UQCRC1 UQCRC2 YBEY,NADH dehydrogenase complex assembly|mitochondrial respiratory chain complex I assembly|mitochondrial respiratory chain complex assembly|ATP synthesis coupled electron transport|mitochondrial ATP synthesis coupled electron transport,3.041e-75|3.041e-75|8.133e-74|1.997e-66|2.402e-64,4.797e-71|2.399e-71|4.276e-70|7.876e-63|7.578e-61,171|171|117.3|119.1|117.3
1460,4,0.572,3.432,3339.0,0.001024,0.9929309999999999,COX6B2 GRB14 HAPLN1 ZNF414,negative regulation of insulin receptor signaling pathway|negative regulation of cellular response to insulin stimulus|regulation of cellular response to insulin stimulus|regulation of insulin receptor signaling pathway|insulin receptor signaling pathway,0.007166|0.007552|0.01295|0.01333|0.0166,1|1|1|1|1,143|135.5|78.01|75.72|60.57
1461,6,0.5109,7.662999999999999,5021.0,0.0015199999999999999,0.998474,CNMD COX8C DCUN1D2 F10 F7 ZIC5,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",1.483e-06|1.483e-06|1.483e-06|6.521e-06|7.705e-06,0.0234|0.0117|0.0078|0.02571|0.02431,1471|1471|1471|588.4|534.9
1462,5,0.5281,5.281000000000001,4197.0,0.001254,0.996692,CDS1 CPE GLDN IGFL3 SQOR,"sulfide oxidation|sulfide oxidation, using sulfide:quinone oxidoreductase|clustering of voltage-gated sodium channels|hydrogen sulfide metabolic process|CDP-choline pathway",0.001456|0.001456|0.001698|0.001698|0.00194,1|1|1|1|1,823.8|823.8|686.5|686.5|588.4
1463,5,0.5033,5.033,3965.0,0.001265,0.996692,CPEB2 HSD11B2 ISOC1 PLLP RP9,regulation of blood volume by renal aldosterone|negative regulation of cytoplasmic translational elongation|response to insulin|negative regulation of translational elongation|negative regulation of cytoplasmic translation,0.000728|0.000728|0.00131|0.001456|0.002183,1|1|1|1|1,2060|2060|34.76|823.8|514.9
1464,5,0.5611,5.611000000000001,3990.0,0.001401,0.996692,B4GALNT3 CPEB3 ERC1 SLC6A12 WNT5B,negative regulation of cytoplasmic translational elongation|positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|regulation of synaptic plasticity|gamma-aminobutyric acid reuptake,0.000728|0.000728|0.000728|0.000788|0.001213,1|1|1|1|1,2060|2060|2060|45.02|1030
1465,14,0.5014,45.63,9067.0,0.004991,0.9999969999999999,AKT1 GNB1 GNB2 GNG5 MAPKAP1 MIOS MLST8 PDCL PDPK1 PIK3CA PIK3CB RICTOR WDR24 WDR59,positive regulation of TOR signaling|activation of protein kinase B activity|regulation of TOR signaling|activation of protein kinase activity|positive regulation of signal transduction,3.893e-13|3.206e-11|4.397e-11|8.587e-10|4.563e-09,6.141e-09|2.529e-07|2.312e-07|3.386e-06|1.439e-05,205.3|222.9|89.16|31.49|9.485
1466,4,0.5379,3.228,3270.0,0.0009836,0.9929309999999999,CPED1 GRM8 LTK PPP1R3C,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|positive regulation of cardiac muscle cell apoptotic process|positive regulation of striated muscle cell apoptotic process|G protein-coupled glutamate receptor signaling pathway|glycogen biosynthetic process,0.001553|0.002134|0.002134|0.003104|0.004459,1|1|1|1|1,735.5|514.9|514.9|343.2|234
1467,5,0.5587,5.587000000000001,4359.0,0.001277,0.996692,CLN5 CPLX1 KTN1 NIPAL1 TTPA,intracellular pH reduction|pH reduction|regulation of intracellular pH|regulation of cellular pH|regulation of pH,5.747e-05|6.463e-05|0.0001872|0.0002174|0.0002548,0.9065|0.5097|0.9841|0.8574|0.8038,171.6|161.5|93.61|86.72|79.98
1468,4,0.5135,3.0810000000000004,3142.0,0.0009769,0.9929309999999999,CPLX2 ITGA6 NKX2-5 ZBTB5,atrial cardiac muscle cell development|atrial cardiac muscle cell differentiation|septum secundum development|right ventricular cardiac muscle tissue morphogenesis|positive regulation of transcription via serum response element binding,0.0007766|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,1716|1716|1716|1716|1287
1469,4,0.5588,3.353,3251.0,0.0010279999999999998,0.9929309999999999,CASC10 CPN1 MOS PTF1A,establishment of meiotic spindle orientation|negative regulation of metaphase/anaphase transition of meiotic cell cycle|negative regulation of meiotic chromosome separation|regulation of neural retina development|negative regulation of meiotic cell cycle phase transition,0.0003883|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|1716|1716|1716|1287
1470,30,0.4531,197.1,23980.0,0.008133,1.0,KIR2DL1 NLRP11 NLRP13 NLRP4 SMIM17 VN1R1 VN1R4 ZFP28 ZNF135 ZNF211 ZNF264 ZNF304 ZNF324B ZNF416 ZNF460 ZNF548 ZNF550 ZNF581 ZNF586 ZNF587 ZNF610 ZNF665 ZNF667 ZNF701 ZNF772 ZNF773 ZNF805 ZNF880 ZSCAN22 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|cellular process",5.788e-15|3.205e-12|3.225e-12|3.326e-12|8.216e-12,9.13e-11|2.528e-08|1.696e-08|1.312e-08|2.592e-08,5.909|4.411|4.41|4.404|0.2145
1471,4,0.5827,3.4960000000000004,3270.0,0.001066,0.9929309999999999,CPNE5 PPP4C SCUBE3 SRCIN1,positive regulation of dendrite extension|regulation of dendrite extension|negative regulation of protein tyrosine kinase activity|regulation of dendritic spine morphogenesis|regulation of double-strand break repair via homologous recombination,0.004846|0.005426|0.006007|0.008903|0.009289,1|1|1|1|1,214.5|190.7|171.6|114.4|109.5
1472,6,0.5078,7.6160000000000005,5223.0,0.0014529999999999999,0.998474,ATP2B2 CAMK1G CPNE9 LHFPL4 SLC6A1 SLC6A11,gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|gamma-aminobutyric acid transport|inorganic cation transmembrane transport|import into cell,1.483e-06|2.768e-06|5.435e-06|1.979e-05|2.468e-05,0.0234|0.02183|0.02858|0.07805|0.07785,1471|980.7|653.8|20.57|48.23
1473,5,0.5269,5.269,3999.0,0.001312,0.996692,ATP5S CPO CRYGA RSPH10B RSPH10B2,protoporphyrinogen IX biosynthetic process|protoporphyrinogen IX metabolic process|biological regulation|mitochondrial ATP synthesis coupled proton transport|regulation of biological process,0.002909|0.00349|0.003503|0.005812|0.005845,1|1|1|1|1,381.4|312|0|180.7|0
1474,5,0.5003,5.003,4056.0,0.0012289999999999998,0.996692,CPPED1 DPYSL3 GPC2 PARVB SLC8A3,positive regulation of neuron projection development|establishment or maintenance of cell polarity regulating cell shape|calcium ion export across plasma membrane|calcium ion export|neurogenesis,0.0005831|0.000728|0.001456|0.002425|0.002662,1|1|1|1|1,52.47|2060|823.8|457.7|9.026
1475,5,0.5237,5.237,4132.0,0.001263,0.996692,CD8B CPS1 CRB2 CYP17A1 LVRN,carbamoyl phosphate biosynthetic process|carbamoyl phosphate metabolic process|ingression involved in gastrulation with mouth forming second|cellular response to oleic acid|citrulline biosynthetic process,0.0004854|0.0004854|0.0004854|0.0009706|0.001213,1|1|1|1|1,4119|4119|4119|1373|1030
1476,4,0.5308,3.185,3266.0,0.0009718,0.9929309999999999,CPT2 RHOU SLC2A8 ZNF620,fructose transmembrane transport|dehydroascorbic acid transport|Cdc42 protein signal transduction|carnitine shuttle|anion transmembrane transport,0.001165|0.001553|0.001553|0.002328|0.002898,1|1|1|1|1,1030|735.5|735.5|468.1|22.48
1477,4,0.5169,3.1010000000000004,3192.0,0.0009681000000000001,0.9929309999999999,AAED1 C9orf47 CPXM1 GPR139,phospholipase C-activating G protein-coupled receptor signaling pathway|neuropeptide signaling pathway|protein processing|protein maturation|peptide metabolic process,0.01449|0.01594|0.02542|0.03498|0.07633,1|1|1|1|1,69.34|62.98|39.23|28.37|12.78
1478,4,0.5682,3.409,2799.0,0.001213,0.9929309999999999,CD46 CR1 CR1L PDZK1,regulation of complement activation|regulation of humoral immune response|positive regulation of regulatory T cell differentiation|regulation of regulatory T cell differentiation|regulation of immune effector process,7.68e-07|1.304e-06|4.831e-06|1.583e-05|4.821e-05,0.01211|0.01028|0.0254|0.06244|0.1521,132|110.3|605.7|321.8|32.66
1479,5,0.5066,5.066,4083.0,0.001236,0.996692,BCL2L10 CRABP1 CYP1B1 DGKQ HSPA1B,regulation of hormone levels|retinoid metabolic process|diterpenoid metabolic process|terpenoid metabolic process|cellular hormone metabolic process,0.0001675|0.0002796|0.0003109|0.0003667|0.0003963,1|1|1|1|1,23.23|76.28|72.26|66.44|63.86
1480,4,0.5354,3.213,3210.0,0.0009972999999999998,0.9929309999999999,CACNG8 CRABP2 NLRP3 RIMS3,"positive regulation of synaptic transmission|positive regulation of T-helper 2 cell differentiation|positive regulation of T-helper 2 cell cytokine production|neurotransmitter receptor transport, postsynaptic endosome to lysosome|neurotransmitter receptor diffusion trapping",0.0002425|0.001553|0.001553|0.001553|0.001941,1|1|1|1|1,79.21|735.5|735.5|735.5|572.1
1481,4,0.5067,3.04,3203.0,0.0009459,0.9929309999999999,BVES CRBN PGPEP1L SLC22A23,negative regulation of large conductance calcium-activated potassium channel activity|regulation of large conductance calcium-activated potassium channel activity|sinoatrial node cell development|cardiac pacemaker cell development|sinoatrial node cell differentiation,0.0003883|0.0007766|0.001165|0.001359|0.001359,1|1|1|1|1,5149|1716|1030|858.1|858.1
1482,5,0.5344,5.343999999999999,3319.0,0.001603,0.996692,MAPK1 WIZ ZBTB2 ZNF592 ZNF644,cytosine metabolic process|diadenosine tetraphosphate biosynthetic process|diadenosine tetraphosphate metabolic process|diadenosine polyphosphate biosynthetic process|regulation of Golgi inheritance,0.000728|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,2060|1373|1373|1373|1030
1483,5,0.5324,5.324,4054.0,0.001308,0.996692,CFAP97D1 CREB3L1 HEXIM2 MPP3 PLGRKT,extracellular matrix constituent secretion|positive regulation of plasminogen activation|negative regulation of sprouting angiogenesis|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|regulation of plasminogen activation,0.001213|0.001698|0.00291|0.003152|0.003394,1|1|1|1|1,1030|686.5|374.5|343.3|316.8
1484,4,0.5325,3.195,3168.0,0.001005,0.9929309999999999,CREB5 F3 INF2 NOXRED1,"activation of plasma proteins involved in acute inflammatory response|activation of blood coagulation via clotting cascade|negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway",0.0003883|0.0005825|0.0009706|0.0009706|0.0009706,1|1|1|1|1,5149|2574|1287|1287|1287
1485,4,0.5262,3.157,3261.0,0.0009648999999999999,0.9929309999999999,CRHBP SEC22C SLC15A2 SVEP1,negative regulation of corticotropin secretion|negative regulation of corticotropin-releasing hormone receptor activity|regulation of corticotropin-releasing hormone receptor activity|lymph circulation|peptidoglycan transport,0.0003883|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,5149|5149|5149|2574|1716
1486,4,0.5937,3.562,3094.0,0.001147,0.9929309999999999,CRHR2 HMSD MMD2 PRR4,cellular response to corticotropin-releasing hormone stimulus|response to corticotropin-releasing hormone|cytolysis|long-term synaptic potentiation|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,0.001456|0.001456|0.008226|0.01136|0.01184,1|1|1|1|1,823.8|823.8|124.8|89.54|85.81
1487,4,0.5339,3.2039999999999997,3090.0,0.001033,0.9929309999999999,CRIM1 KLRC2 REG1B SPSB2,cell wall disruption in other organism|positive regulation of natural killer cell degranulation|regulation of natural killer cell degranulation|insulin-like growth factor receptor signaling pathway|biological process involved in interspecies interaction between organisms,0.0009706|0.001165|0.001165|0.002716|0.004025,1|1|1|1|1,1287|1030|1030|396.1|7.293
1488,5,0.5102,5.102,3759.0,0.001352,0.996692,CRIP2 NFIA PLAT RIPK4 VPS36,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|smooth muscle cell migration|plasminogen activation|synapse maturation|ureter development,0.001456|0.002667|0.00291|0.003152|0.004362,1|1|1|1|1,823.8|411.9|374.5|343.3|242.3
1489,4,0.5963,3.5780000000000003,3372.0,0.001057,0.9929309999999999,CRIP3 ITGB1BP1 MYMK PPIL3,positive regulation of skeletal muscle hypertrophy|negative regulation of cell adhesion involved in substrate-bound cell migration|regulation of skeletal muscle hypertrophy|myoblast fusion involved in skeletal muscle regeneration|negative regulation of protein targeting to membrane,0.0005825|0.0007766|0.0007766|0.001165|0.001359,1|1|1|1|1,2574|1716|1716|1030|858.1
1490,5,0.5138,5.138,3954.0,0.001294,0.996692,CNTN5 COL6A6 CRIPAK KLHDC10 TUFT1,negative regulation of intracellular estrogen receptor signaling pathway|presynapse assembly|presynapse organization|negative regulation of intracellular steroid hormone receptor signaling pathway|regulation of intracellular estrogen receptor signaling pathway,0.00412|0.005812|0.006537|0.00919|0.01064,1|1|1|1|1,257.4|179.1|158.4|111.3|95.79
1491,4,0.5023,3.014,3073.0,0.0009773,0.9929309999999999,CRISP3 HSPA1L MSH5 PPP2R2B,meiotic mismatch repair|peptidyl-serine dephosphorylation|protein refolding|positive regulation of protein targeting to mitochondrion|mismatch repair,0.001165|0.00291|0.003878|0.006393|0.00678,1|1|1|1|1,1030|367.8|271|160.9|151.4
1492,4,0.5062,3.037,3200.0,0.0009459,0.9929309999999999,ATP9B CRISPLD1 OXTR PPP1R36,response to anoxia|positive regulation of norepinephrine secretion|positive regulation of penile erection|regulation of systemic arterial blood pressure by vasopressin|maternal process involved in parturition,0.0007766|0.0009706|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1287|1030|1030|1030
1493,4,0.5375,3.225,3348.0,0.0009601000000000001,0.9929309999999999,CRLF1 GNAZ PEX11G TSN,regulation of peroxisome size|negative regulation of motor neuron apoptotic process|regulation of motor neuron apoptotic process|peroxisome fission|production of siRNA involved in RNA interference,0.0007766|0.0009706|0.001165|0.002134|0.002134,1|1|1|1|1,1716|1287|1030|514.9|514.9
1494,4,0.526,3.156,3179.0,0.0009891,0.9929309999999999,AP3B1 BLOC1S6 CRLF3 SLC17A5,synaptic vesicle transport along microtubule|synaptic vesicle cytoskeletal transport|anterograde synaptic vesicle transport|melanosome organization|pigment granule organization,4.323e-06|4.323e-06|4.323e-06|1.067e-05|1.146e-05,0.06819|0.03409|0.02273|0.04209|0.03616,643.6|643.6|643.6|396.1|381.4
1495,5,0.5129,5.129,3948.0,0.001294,0.996692,CRMP1 HS6ST3 KCNH5 NOVA1 SLC35E1,"negative regulation of actin binding|negative regulation of actin filament binding|regulation of actin filament binding|regulation of actin binding|heparan sulfate proteoglycan biosynthetic process, enzymatic modification",0.0004854|0.0004854|0.000728|0.0009706|0.001698,1|1|1|1|1,4119|4119|2060|1373|686.5
1496,9,0.5042,18.15,6487.0,0.002783,0.9998530000000001,ARHGAP45 ECHS1 JAK3 LDLR LDLRAP1 LRP8 MCEMP1 PYCR2 REEP4,receptor-mediated endocytosis involved in cholesterol transport|intracellular cholesterol transport|intracellular sterol transport|low-density lipoprotein particle clearance|plasma lipoprotein particle clearance,1.695e-06|3.547e-05|3.9e-05|5.482e-05|0.0001379,0.02674|0.2797|0.2051|0.2162|0.4349,1526|240.9|228.8|190.7|117.4
1497,4,0.6183,3.71,3242.0,0.00114,0.9929309999999999,CROT DIO3 GNAI1 SPO11,cellular modified amino acid metabolic process|negative regulation of eye photoreceptor cell development|regulation of eye photoreceptor cell development|thyroid hormone catabolic process|retinal cone cell apoptotic process,0.0005283|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,53.35|2574|2574|2574|2574
1498,4,0.5176,3.1060000000000003,3205.0,0.0009658,0.9929309999999999,CRP HJV SRI SV2A,cellular iron ion homeostasis|iron ion homeostasis|cellular metal ion homeostasis|metal ion homeostasis|regulation of biological quality,0.0001099|0.0001669|0.0001908|0.0002655|0.0002796,1|1|1|1|0.8822,123|99.25|22.22|19.87|5.14
1499,4,0.5282,3.1689999999999996,3265.0,0.0009673,0.9929309999999999,ATP2A1 CRTAP LILRB1 ZNF780B,positive regulation of actin filament-based movement|positive regulation of gamma-delta T cell activation involved in immune response|regulation of gamma-delta T cell activation involved in immune response|peptidyl-proline hydroxylation to 3-hydroxy-L-proline|positive regulation of cardiac muscle cell contraction,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1500,8,0.5003,14.01,5383.0,0.002588,0.9996790000000001,CRTC2 CRTC3 DUSP4 MAFF MITF SOX10 TFAP2A ZEB2,"positive regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|positive regulation of RNA metabolic process",1.831e-08|1.422e-07|1.422e-07|1.428e-07|2.115e-07,0.0002888|0.001121|0.0007476|0.0005631|0.0006673,14.94|11.11|11.11|11.1|10.49
1501,4,0.5764,3.4589999999999996,3279.0,0.001051,0.9929309999999999,ABTB1 CRY1 FADS6 GALK1,hexose metabolic process|galactitol metabolic process|glycolytic process from galactose|monosaccharide metabolic process|cellular response to blue light,0.0003472|0.0003883|0.0003883|0.0004604|0.0005825,1|1|1|1|1,66.01|5149|5149|57.21|2574
1502,4,0.5846,3.5069999999999997,3447.0,0.0010140000000000001,0.9929309999999999,CRYBA2 LGALS9 SARDH SSPN,"sarcosine catabolic process|positive regulation of activated T cell autonomous cell death|regulation of activated T cell autonomous cell death|positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response|regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
1503,4,0.543,3.258,3166.0,0.001025,0.9929309999999999,ARMH4 CRYBB2 KIAA1671 SLC35E4,lens development in camera-type eye|biological regulation|regulation of biological process|regulation of cellular process|visual perception,0.01487|0.02306|0.03244|0.04148|0.04148,1|1|1|1|1,67.75|0|0|0|23.84
1504,4,0.5614,3.3689999999999998,3114.0,0.001078,0.9929309999999999,CRYL1 FAM162B RET TUB,retina development in camera-type eye|posterior midgut development|positive regulation of metanephric glomerulus development|regulation of metanephric glomerulus development|positive regulation of metanephros development,0.0003214|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,68.65|2574|2574|2574|2574
1505,9,0.838,30.17,5891.0,0.0050799999999999994,0.9998530000000001,CS DLAT LIPT1 MDH2 MPC1 MPC2 PDHB PDHX SLC25A1,acetyl-CoA biosynthetic process from pyruvate|acyl-CoA biosynthetic process|thioester biosynthetic process|purine nucleoside bisphosphate biosynthetic process|ribonucleoside bisphosphate biosynthetic process,5.531e-12|8.569e-12|8.569e-12|3.332e-11|3.332e-11,8.725e-08|6.758e-08|4.505e-08|1.314e-07|1.051e-07,1308|254.3|254.3|190.7|190.7
1506,4,0.5402,3.241,3267.0,0.0009888,0.9929309999999999,BNIPL CSAD GPR26 SLITRK6,L-cysteine catabolic process to taurine|L-cysteine catabolic process to hypotaurine|linear vestibuloocular reflex|taurine biosynthetic process|alkanesulfonate biosynthetic process,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
1507,6,0.5545,8.317,3479.0,0.0023769999999999998,0.998474,CSDE1 DHX29 EIF4A1 EIF4G2 STRAP XRN1,regulation of translational initiation|cellular nitrogen compound metabolic process|regulation of translation|regulation of cellular amide metabolic process|translational initiation,2.344e-06|3.414e-06|3.507e-06|6.584e-06|1.195e-05,0.03698|0.02693|0.01844|0.02596|0.0377,107.6|6.045|31.98|27.24|61.72
1508,5,0.5389,5.388999999999999,4052.0,0.001325,0.996692,BTLA CSF1R HOXC6 LRRC27 SLC2A2,macrophage colony-stimulating factor signaling pathway|positive regulation of macrophage proliferation|fructose transmembrane transport|intestinal hexose absorption|regulation of macrophage proliferation,0.001213|0.001456|0.001456|0.001698|0.001698,1|1|1|1|1,1030|823.8|823.8|686.5|686.5
1509,7,0.5122,10.76,4843.0,0.00221,0.9992989999999999,CSF2RB ETV6 GSE1 LMO2 MYB RUNX1 SOS1,regulation of hematopoietic progenitor cell differentiation|vitellogenesis|regulation of hematopoietic stem cell differentiation|regulation of stem cell differentiation|cytoplasm organization,1.407e-08|1.483e-06|1.807e-06|5.988e-06|7.705e-06,0.000222|0.0117|0.009503|0.02361|0.02431,130.8|1471|117.7|78.11|534.9
1510,13,0.5033,39.26,10480.0,0.003722,0.999993,AGO1 AGO3 AGO4 BEST4 CSF3R ERMAP GJB4 LURAP1 MFSD2A ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",2.347e-08|3.226e-08|4.3e-08|1.093e-07|1.093e-07,0.0003702|0.0002545|0.0002261|0.000431|0.0003448,679|594.1|528.1|365.6|365.6
1511,5,0.5357,5.357,3606.0,0.0014789999999999998,0.996692,C1orf43 CSK KIAA0100 KIAA1109 VAPA,positive regulation by host of viral release from host cell|modulation by host of viral release from host cell|negative regulation of Golgi to plasma membrane protein transport|negative regulation of low-density lipoprotein particle clearance|positive regulation by host of viral genome replication,0.001456|0.001456|0.001698|0.00194|0.002183,1|1|1|1|1,823.8|823.8|686.5|588.4|514.9
1512,5,0.5094,5.093999999999999,3827.0,0.001326,0.996692,B4GAT1 CSKMT LRRC10B MACROD1 TMEM179B,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|peptidyl-lysine monomethylation|protein O-linked mannosylation|peptidyl-lysine dimethylation,0.0009706|0.001698|0.002667|0.004604|0.004845,1|1|1|1|1,1373|686.5|411.9|228.8|216.8
1513,4,0.5459,3.275,3211.0,0.001016,0.9929309999999999,CSMD1 GJD4 MT1HL1 SPOCK3,conditioned place preference|oviduct epithelium development|oviduct development|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|mammary gland branching involved in pregnancy,0.0007766|0.0007766|0.001165|0.001359|0.001553,1|1|1|1|1,1716|1716|1030|858.1|735.5
1514,4,0.5029,3.0180000000000002,3179.0,0.0009461000000000001,0.9929309999999999,CSN2 HOXB1 HOXB4 TMEM132E,animal organ development|embryonic skeletal system morphogenesis|chordate embryonic development|embryo development ending in birth or egg hatching|embryonic skeletal system development,8.909e-05|0.000213|0.00024|0.000263|0.0003552,1|1|1|1|1,6.462|87.64|20.56|19.93|67.52
1515,4,0.5986,3.592,3266.0,0.0010960000000000002,0.9929309999999999,CSNK1G3 GFY OCM2 SLFN11,replication fork arrest|negative regulation of DNA-dependent DNA replication|negative regulation of DNA replication|DNA-dependent DNA replication maintenance of fidelity|regulation of DNA-dependent DNA replication,0.0009706|0.003491|0.00678|0.009482|0.009675,1|1|1|1|1,1287|302.9|151.4|107.3|105.1
1516,5,0.5215,5.215,3929.0,0.001322,0.996692,ATP6V0A2 CSRNP1 KCNK5 NOTCH1 XKR6,apoptotic process involved in development|positive regulation of aorta morphogenesis|regulation of aorta morphogenesis|venous endothelial cell differentiation|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,2.045e-05|0.0004854|0.0004854|0.0004854|0.0004854,0.3225|1|1|1|1,294.2|4119|4119|4119|4119
1517,4,0.5643,3.386,3257.0,0.001036,0.9929309999999999,CSRNP3 GPR176 PDK2 TTN,striated muscle myosin thick filament assembly|sarcomerogenesis|skeletal muscle myosin thick filament assembly|myosin filament assembly|myosin filament organization,0.0007766|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1716|1287|1287
1518,4,0.5707,3.424,3329.0,0.001025,0.9929309999999999,BATF CD8B CSRP1 DFFA,cell activation|negative regulation of deoxyribonuclease activity|negative regulation of apoptotic DNA fragmentation|T cell activation|T-helper 2 cell differentiation,0.0005631|0.0005825|0.0007766|0.0008254|0.0009706,1|1|1|1|1,14.25|2574|1716|42.55|1287
1519,5,0.5419,5.419,4066.0,0.001328,0.996692,CST6 GAL3ST3 HRASLS2 PRSS8 ZRANB3,DNA rewinding|negative regulation of endopeptidase activity|negative regulation of peptidase activity|DNA strand renaturation|replication fork protection,0.0005824|0.00208|0.00225|0.002619|0.002909,1|1|1|1|1,3432|28.02|26.92|429.1|381.4
1520,5,0.535,5.35,3675.0,0.00145,0.996692,C2orf69 CSTF2T GLUL QARS WSB1,cellular amino acid metabolic process|tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|cellular macromolecule biosynthetic process,4.923e-05|7.927e-05|8.956e-05|9.313e-05|0.0005506,0.7766|0.6252|0.4709|0.3673|1,36.91|149.2|140.1|137.3|8.296
1521,4,0.5439,3.264,3275.0,0.0009932,0.9929309999999999,C19orf33 CT62 FAM69C PLIN1,intracellular receptor signaling pathway|cellular process|lipid catabolic process|UNCLASSIFIED|biological_process,0.03771|0.04971|0.05793|0.08866|0.08866,1|1|1|1|1,26.27|0.3325|16.94|3.751|0.5769
1522,8,0.506,14.17,6302.0,0.0022370000000000003,0.9996790000000001,ATP12A C1QTNF9 CTAGE1 KCNRG POSTN RNF6 SIAH3 SOHLH2,cellular response to vitamin K|response to vitamin K|bone regeneration|negative regulation of cell development|protein K27-linked ubiquitination,0.001164|0.00194|0.00194|0.002008|0.002328,1|1|1|1|1,1287|643.6|643.6|29.25|514.9
1523,7,0.5203,10.93,4548.0,0.002389,0.9992989999999999,C8orf33 CHAMP1 CTC1 DCLRE1B RABL2B STN1 TEN1,telomere capping|telomere maintenance|telomere organization|negative regulation of telomere maintenance via telomerase|negative regulation of telomere maintenance via telomere lengthening,1.481e-10|8.49e-08|9.492e-08|1.161e-07|2.575e-07,2.336e-06|0.0006696|0.0004991|0.0004579|0.0008122,481.8|88.87|86.35|326.9|245.2
1524,4,0.5726,3.4360000000000004,3047.0,0.001124,0.9929309999999999,CTDSP2 DAP LGR5 OR2T5,adenylate cyclase-activating G protein-coupled receptor signaling pathway|positive regulation of calcium ion import across plasma membrane|epithelial cell proliferation involved in renal tubule morphogenesis|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|regulation of calcium ion import across plasma membrane,0.0006378|0.001165|0.001456|0.001685|0.001746,1|1|1|1|1,51.23|1144|858.1|31.2|686.5
1525,4,0.551,3.306,2823.0,0.001166,0.9929309999999999,CTDSPL2 DMTF1 STK35 USP42,positive regulation of protein export from nucleus|regulation of protein export from nucleus|cellular protein modification process|protein modification process|negative regulation of BMP signaling pathway,0.004266|0.00678|0.01123|0.01123|0.01237,1|1|1|1|1,245.2|151.4|5.116|5.116|81.73
1526,9,0.5173,18.62,7369.0,0.002515,0.9998530000000001,ATG4C BSND C1orf123 CTH CYP4X1 FAAH PCSK9 RAB3B TMEM53,protein sulfhydration|protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine|negative regulation of low-density lipoprotein particle receptor binding|acylglycerol metabolic process|neutral lipid metabolic process,0.0009704|0.0009704|0.0009704|0.00117|0.001192,1|1|1|1|1,2060|2060|2060|39.23|38.86
1527,4,0.581,3.486,3319.0,0.001047,0.9929309999999999,CTHRC1 DNAJC5B OGN SLC39A14,establishment of planar polarity involved in neural tube closure|manganese ion homeostasis|establishment of planar polarity of embryonic epithelium|ossification involved in bone remodeling|cadmium ion transmembrane transport,0.0003883|0.0007766|0.0007766|0.001165|0.001165,1|1|1|1|1,5149|1716|1716|1030|1030
1528,8,0.5175,14.49,6269.0,0.0023,0.9996790000000001,NAT8 REG3G SFTPB SIX3 STON1 TEX261 TRABD2A WBP1,neuroblast migration|peptidyl-lysine N6-acetylation|positive regulation of protein oxidation|regulation of protein oxidation|optic vesicle morphogenesis,0.0007765|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,2574|1287|1287|1287|1287
1529,4,0.5308,3.185,3224.0,0.0009845000000000001,0.9929309999999999,B3GALT1 CTNNA3 TCAF2 UPB1,beta-alanine biosynthetic process via 3-ureidopropionate|beta-alanine biosynthetic process|beta-alanine metabolic process|negative regulation of anion channel activity|dUMP catabolic process,0.0003883|0.0005825|0.0009706|0.0009706|0.001165,1|1|1|1|1,5149|2574|1287|1287|1030
1530,4,0.5675,3.405,3426.0,0.0009904999999999998,0.9929309999999999,CALY CTNNAL1 MAB21L1 RETN,positive regulation of progesterone secretion|positive regulation of retrograde axon cargo transport|regulation of retrograde axon cargo transport|positive regulation of female gonad development|regulation of progesterone secretion,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
1531,13,0.5015,39.11,10710.0,0.0036299999999999995,0.999993,CA13 CA2 CA3 CHCHD7 CHMP4C CPA6 CYP7A1 NSMAF PMP2 SGK3 SNX16 TRIM55 ZFAND1,one-carbon metabolic process|bicarbonate transport|organic anion transport|ion transport|organic substance transport,2.219e-06|2.74e-06|4.843e-05|0.0008311|0.001224,0.03501|0.02161|0.2546|1|1,121.9|113.2|18.64|3.849|4.38
1532,4,0.5428,3.2569999999999997,3170.0,0.001024,0.9929309999999999,BTD CTSC NOL11 NPY,positive regulation of response to nutrient levels|positive regulation of response to extracellular stimulus|positive regulation of appetite|positive regulation of response to food|negative regulation of myelination,0.0009706|0.0009706|0.0009706|0.0009706|0.001747,1|1|1|1|1,1287|1287|1287|1287|643.6
1533,4,0.5439,3.263,3208.0,0.0010140000000000001,0.9929309999999999,CSGALNACT2 CTSD PDGFC STAR,intermembrane lipid transfer|sterol transport|cholesterol metabolic process|steroid biosynthetic process|secondary alcohol metabolic process,5.747e-05|0.0001405|0.0003609|0.0003784|0.0004208,0.9065|1|1|1|1,171.6|108.4|66.98|65.38|61.94
1534,5,0.5168,5.167999999999999,4020.0,0.001281,0.996692,CTSE IL19 IL20 REN SLC26A9,protein processing|renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of blood volume by renin-angiotensin,0.001498|0.001698|0.002376|0.002376|0.002715,1|1|1|1|1,33.62|735.5|490.4|490.4|420.3
1535,4,0.5016,3.01,3200.0,0.0009372,0.9929309999999999,CTSF IGF2BP3 PPP2R5B ZNF2,positive regulation of neurotrophin TRK receptor signaling pathway|regulation of neurotrophin TRK receptor signaling pathway|negative regulation of G0 to G1 transition|regulation of G0 to G1 transition|negative regulation of protein kinase B signaling,0.001359|0.002522|0.007745|0.00871|0.009289,1|1|1|1|1,858.1|429.1|132|117|109.5
1536,4,0.5321,3.1919999999999997,3202.0,0.0009934,0.9929309999999999,CTSH NAT14 POMT1 ZBTB20,positive regulation of nitrogen compound metabolic process|dichotomous subdivision of terminal units involved in lung branching|neuropeptide catabolic process|positive regulation of cellular metabolic process|positive regulation of protein O-linked glycosylation,0.0004874|0.0005825|0.0005825|0.0006126|0.0007766,1|1|1|1|1,6.735|2574|2574|6.36|1716
1537,4,0.565,3.39,3274.0,0.001032,0.9929309999999999,CTSV DEFB131A ENO3 KIAA1328,"regulation of vacuole fusion, non-autophagic|cellular response to lipoteichoic acid|response to lipoteichoic acid|positive regulation of monocyte chemotaxis|NADH regeneration",0.0009706|0.002328|0.002328|0.004459|0.005426,1|1|1|1|1,1287|468.1|468.1|234|190.7
1538,4,0.535,3.21,3208.0,0.0009971000000000001,0.9929309999999999,CTSW GAL3ST3 KBTBD3 KDELC2,poly-N-acetyllactosamine metabolic process|proteoglycan biosynthetic process|oligosaccharide metabolic process|glycolipid biosynthetic process|cellular polysaccharide metabolic process,0.002038|0.008859|0.009438|0.009872|0.01204,1|1|1|1|1,528.1|114.4|107.3|102.5|83.72
1539,20,0.5048,95.91,16250.0,0.005854,1.0,AFAP1L2 CALHM3 DUPD1 DUSP13 GPRIN2 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPJ LIPK LIPM MYOZ1 NUTM2A NUTM2B PTPN20 SFTPA1 SFTPA2 ZNF239,cellular response to type I interferon|response to type I interferon|type I interferon signaling pathway|defense response to symbiont|defense response to virus,6.715e-07|9.236e-07|4.279e-05|4.978e-05|4.978e-05,0.01059|0.007284|0.225|0.1963|0.1571,59.7|54.92|45.43|19.43|19.43
1540,4,0.512,3.072,3272.0,0.0009357000000000001,0.9929309999999999,CTTNBP2NL DSP KRTAP22-2 ZDHHC3,lipoprotein localization to membrane|odontoblast differentiation|positive regulation of receptor localization to synapse|regulation of odontoblast differentiation|TRAIL-activated apoptotic signaling pathway,0.0004854|0.0009706|0.001213|0.001213|0.001698,1|1|1|1|1,4119|1373|1030|1030|686.5
1541,4,0.5724,3.4339999999999997,3266.0,0.001048,0.9929309999999999,AIPL1 ANKRD24 CTXN2 SPOCD1,"protein farnesylation|protein prenylation|prenylation|phototransduction, visible light|negative regulation of transposition",0.0007766|0.002134|0.002134|0.003685|0.005233,1|1|1|1|1,1716|514.9|514.9|286|198
1542,9,0.5096,18.34,6922.0,0.002636,0.9998530000000001,ABCC9 AKR1C1 AKR1C3 AKR1C4 CALML3 CALML5 FAM208B ITIH2 NET1,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,3.956e-09|3.956e-09|2.483e-08|2.483e-08|2.483e-08,6.241e-05|3.12e-05|0.0001306|9.792e-05|7.834e-05,1404|1404|624.1|624.1|624.1
1543,4,0.5227,3.136,2963.0,0.0010550000000000002,0.9929309999999999,C16orf96 CUEDC1 HMGCLL1 OR4Q3,leucine catabolic process|leucine metabolic process|ketone body biosynthetic process|cellular ketone body metabolic process|ketone body metabolic process,0.001359|0.001747|0.001941|0.002328|0.002522,1|1|1|1|1,858.1|643.6|572.1|468.1|429.1
1544,4,0.5097,3.0580000000000003,3088.0,0.0009869,0.9929309999999999,ATP5MD CUEDC2 DDX52 TEFM,transcription elongation from mitochondrial promoter|negative regulation of macrophage cytokine production|mitochondrial transcription|regulation of macrophage cytokine production|negative regulation of cytokine production involved in inflammatory response,0.0003883|0.001165|0.002716|0.003104|0.003878,1|1|1|1|1,5149|1030|396.1|343.2|271
1545,6,0.5001,7.501,3822.0,0.001952,0.998474,CCT4 CUL2 MSTO1 PDCD5 TCP1 VHL,RNA localization to nucleus|RNA localization to Cajal body|scaRNA localization to Cajal body|positive regulation of establishment of protein localization to telomere|regulation of establishment of protein localization to telomere,1.484e-06|1.484e-06|1.484e-06|4.66e-06|5.506e-06,0.0234|0.0117|0.007801|0.01838|0.01737,1373|1373|1373|686.5|624.1
1546,4,0.6396,3.838,2781.0,0.001374,0.9929309999999999,CUL4A GLMN RBX1 UBE2G1,"nucleotide-excision repair, DNA incision, 3'-to lesion|nucleotide-excision repair, preincision complex stabilization|nucleotide-excision repair, DNA duplex unwinding|nucleotide-excision repair, DNA damage recognition|global genome nucleotide-excision repair",7.146e-06|7.146e-06|7.795e-06|8.472e-06|1.067e-05,0.1127|0.05636|0.04098|0.03341|0.03367,490.4|490.4|468.1|447.7|396.1
1547,10,0.5126,23.07,7060.0,0.003247,0.999933,AK6 CCDC59 DDX49 IMP3 IMP4 KRR1 NOP9 RBM19 UTP4 WDR43,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,9.098e-11|1.177e-10|4.831e-10|2.916e-09|4.819e-09,1.435e-06|9.284e-07|2.54e-06|1.15e-05|1.52e-05,42.65|41.07|33.4|25.67|23.85
1548,11,0.5222,28.72,7437.0,0.003836,0.999969,FBXO5 LTV1 MRPL18 NUP43 PDCD5 PPIL4 PSMB1 RPS12 SF3B5 TCP1 WTAP,RNA localization|RNA transport|nucleic acid transport|establishment of RNA localization|nucleobase-containing compound transport,4.377e-06|0.0001488|0.0001488|0.0001531|0.0002905,0.06905|1|0.7823|0.6039|0.9164,33.73|27.94|27.94|27.67|22.2
1549,4,0.5277,3.1660000000000004,3377.0,0.0009346000000000001,0.9929309999999999,CUTC EMX2 PAFAH1B3 WFS1,negative regulation of ATF6-mediated unfolded protein response|regulation of ATF6-mediated unfolded protein response|renal system development|cerebral cortex regionalization|negative regulation of type B pancreatic cell apoptotic process,0.0005825|0.0009706|0.001163|0.001359|0.001359,1|1|1|1|1,2574|1287|35.76|858.1|858.1
1550,4,0.5526,3.3160000000000003,3311.0,0.0009979,0.9929309999999999,CUX2 FAM89B KHK PIP4K2A,"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process|1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process|negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity|vesicle-mediated cholesterol transport|regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity",0.0007766|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,1716|1716|1716|1716|1287
1551,11,0.5015,27.58,7631.0,0.0035909999999999996,0.999969,COPB2 CWC22 ISY1 PSMA2 PSMA6 SF3A1 SF3B1 SF3B3 SMU1 SNRNP200 XAB2,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",3.805e-13|3.805e-13|4.112e-13|3.962e-12|1.547e-11,6.002e-09|3.001e-09|2.162e-09|1.563e-08|4.881e-08,49.6|49.6|49.11|36.8|30.95
1552,5,0.5236,5.236000000000001,4101.0,0.0012720000000000001,0.996692,CX3CR1 GNAT2 NKAIN4 SLC25A52 TSHB,"multiple spine synapse organization, single dendrite|multiple spine synapse organization|negative regulation of hippocampal neuron apoptotic process|mitochondrial NAD transmembrane transport|NAD transport",0.0004854|0.0004854|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|4119|2060|2060|1373
1553,16,0.477,57.24,11440.0,0.004966,0.999999,ANG EDDM3B OR11G2 OR11H4 OR4K1 OR4K13 OR4K15 OR4K2 OR4K5 OR4M1 OR4M2 OR4N4 OR4Q3 OR5AU1 OR6S1 RNF145,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.279e-19|2.727e-19|4.411e-19|1.097e-18|1.773e-18,2.017e-15|2.15e-15|2.319e-15|4.327e-15|5.592e-15,37.94|35.76|34.43|32.06|30.87
1554,5,0.5087,5.087,4364.0,0.0011619999999999998,0.996692,CXCL11 GLT6D1 GOLGA7B KDR LITAF,cellular response to hydrogen sulfide|cellular response to lipopolysaccharide|cellular response to molecule of bacterial origin|response to hydrogen sulfide|cellular response to biotic stimulus,0.000728|0.0007712|0.0008572|0.0009706|0.001082,1|1|1|1|1,2060|45.51|43.13|1373|38.32
1555,4,0.5014,3.008,2881.0,0.0010400000000000001,0.9929309999999999,AHCYL1 CPEB4 CXCL13 SLC4A2,lymphocyte chemotaxis across high endothelial venule|negative regulation of endothelial cell chemotaxis to fibroblast growth factor|negative regulation of cell chemotaxis to fibroblast growth factor|endothelial cell chemotaxis to fibroblast growth factor|cell chemotaxis to fibroblast growth factor,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1556,4,0.523,3.138,3196.0,0.0009784,0.9929309999999999,APOA4 CXCL16 DOCK8 LRCH3,mononuclear cell migration|memory T cell proliferation|positive regulation of establishment of T cell polarity|negative regulation of plasma lipoprotein oxidation|regulation of plasma lipoprotein oxidation,0.0001593|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,98.07|5149|2574|2574|2574
1557,22,0.5026,116.1,17260.0,0.006664,1.0,AFM AFP ALB CXCL1 CXCL2 CXCL3 CXCL5 CXCL6 FAM47E HNRNPDL PF4 PF4V1 SLC9B2 SULT1B1 TMPRSS11B TMPRSS11E UGT2A1 UGT2A3 UGT2B11 UGT2B15 UGT2B4 UGT2B7,cellular glucuronidation|uronic acid metabolic process|glucuronate metabolic process|neutrophil chemotaxis|chemokine-mediated signaling pathway,2.204e-13|7.36e-13|7.36e-13|4.721e-12|5.593e-12,3.476e-09|5.805e-09|3.87e-09|1.862e-08|1.764e-08,271|214.5|214.5|78.01|76.04
1558,4,0.5223,3.134,3148.0,0.000992,0.9929309999999999,CXCL9 DGUOK SREBF2 WDFY2,guanosine metabolic process|purine deoxyribonucleoside metabolic process|dAMP biosynthetic process|purine deoxyribonucleoside monophosphate biosynthetic process|dAMP metabolic process,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
1559,4,0.5039,3.023,3212.0,0.0009381,0.9929309999999999,CPAMD8 CPLANE2 CXXC4 IL27RA,negative regulation of T cell extravasation|zygotic specification of dorsal/ventral axis|regulation of T cell extravasation|negative regulation of T cell migration|negative regulation of cellular extravasation,0.0003883|0.0007766|0.001165|0.001359|0.001553,1|1|1|1|1,5149|1716|1030|858.1|735.5
1560,5,0.552,5.52,4482.0,0.001227,0.996692,CASKIN2 CXXC5 FAR2 LRRC27 MANSC4,wax metabolic process|wax biosynthetic process|long-chain fatty-acyl-CoA metabolic process|fatty-acyl-CoA metabolic process|cellular process,0.001213|0.001213|0.006295|0.01039|0.01519,1|1|1|1|1,1030|1030|164.8|98.07|0.266
1561,8,0.7613,21.32,5538.0,0.003824,0.9996790000000001,FOXK1 FOXK2 GSK3A GSK3B GSKIP RANBP3 UBALD1 UBALD2,regulation of glucose metabolic process|regulation of cellular carbohydrate metabolic process|negative regulation of type B pancreatic cell development|regulation of carbohydrate metabolic process|negative regulation of glycogen (starch) synthase activity,8.043e-08|2.162e-07|7.913e-07|8.257e-07|1.319e-06,0.001269|0.001705|0.004161|0.003256|0.00416,87.27|67.75|2574|48.12|1716
1562,4,0.571,3.426,3390.0,0.001007,0.9929309999999999,COPS7B CYB5D2 FERMT3 TMEM63B,"COP9 signalosome assembly|integrin activation|protein deneddylation|regulation of cell-cell adhesion mediated by integrin|nucleotide-excision repair, DNA damage recognition",0.001165|0.001941|0.002134|0.002328|0.004653,1|1|1|1|1,1030|572.1|514.9|468.1|223.9
1563,4,0.5372,3.2230000000000003,3225.0,0.0009961,0.9929309999999999,AIMP2 CYB5R2 DNAH7 TMPRSS5,positive regulation of aminoacyl-tRNA ligase activity|regulation of aminoacyl-tRNA ligase activity|type II pneumocyte differentiation|lung secretory cell differentiation|positive regulation of ligase activity,0.0003883|0.0005825|0.001165|0.001941|0.002134,1|1|1|1|1,5149|2574|1030|572.1|514.9
1564,11,0.5028,27.66,7495.0,0.0036659999999999996,0.999969,ARIH2 CUL5 CYB5A CYB5R3 DCUN1D1 NAE1 RNF7 SENP8 SOCS6 UBE2F UBE2R2,protein modification by small protein conjugation or removal|protein modification by small protein conjugation|protein neddylation|post-translational protein modification|cellular protein modification process,6.246e-12|5.276e-11|1.562e-10|4.014e-10|2.305e-07,9.852e-08|4.161e-07|8.213e-07|1.583e-06|0.0007273,16.65|18.81|528.1|33.28|5.685
1565,5,0.7955,7.955,3102.0,0.00255,0.996692,CAB39 NRBP1 OXSR1 TSC22D2 WNK1,response to osmotic stress|chemokine (C-C motif) ligand 21 signaling pathway|regulation of potassium ion transmembrane transport|regulation of potassium ion transport|cellular hypotonic response,5.194e-07|7.067e-07|1.391e-06|2.059e-06|2.119e-06,0.008193|0.005574|0.007313|0.008121|0.006686,164.8|2060|117.7|103|1030
1566,4,0.5634,3.3810000000000002,3304.0,0.0010199999999999999,0.9929309999999999,CYBA ETV2 JAKMIP3 RBM24,negative regulation of renal output by angiotensin|BMP signaling pathway involved in mesodermal cell fate specification|smooth muscle hypertrophy|negative regulation of glomerular filtration by angiotensin|positive regulation of mesoderm development,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
1567,5,0.5156,5.156000000000001,3806.0,0.001349,0.996692,CBWD1 CNTNAP3 CYHR1 FOXD4 TPD52L1,positive regulation of JNK cascade|positive regulation of stress-activated MAPK cascade|positive regulation of stress-activated protein kinase signaling cascade|positive regulation of apoptotic signaling pathway|regulation of JNK cascade,0.0207|0.02784|0.02832|0.0295|0.03116,1|1|1|1|1,48.46|35.82|35.21|33.76|31.93
1568,6,0.5037,7.556,5029.0,0.001497,0.998474,CYLC2 DOK2 PDE1A STC1 TNFRSF10D ZDHHC2,growth plate cartilage axis specification|negative regulation of renal phosphate excretion|regulation of renal phosphate excretion|positive regulation of postsynaptic membrane organization|positive regulation of endosome to plasma membrane protein transport,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
1569,9,0.5466,19.68,5712.0,0.0034219999999999997,0.9998530000000001,COP1 DDA1 DET1 DUSP4 DUSP5 JUNB STK40 TRIB1 TRIB2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of ubiquitin-dependent protein catabolic process|positive regulation of proteasomal protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|regulation of proteasomal ubiquitin-dependent protein catabolic process,4.634e-10|1.069e-09|1.334e-09|2.855e-09|3.187e-09,7.31e-06|8.434e-06|7.015e-06|1.126e-05|1.006e-05,114.4|96.24|91.94|78.61|76.85
1570,4,0.5885,3.531,3370.0,0.001044,0.9929309999999999,CAMKV CYP1A2 PSME2 ZBTB8A,toxin biosynthetic process|dibenzo-p-dioxin metabolic process|monoterpenoid metabolic process|alkaloid metabolic process|regulation of modification of postsynaptic structure,0.0003883|0.0007766|0.001359|0.001553|0.001941,1|1|1|1|1,5149|1716|858.1|735.5|572.1
1571,4,0.5401,3.241,3281.0,0.0009842,0.9929309999999999,CYP20A1 EDN1 EPHA5 ZNF311,phospholipase D-activating G protein-coupled receptor signaling pathway|rhythmic excitation|protein kinase C deactivation|response to prostaglandin F|second-messenger-mediated signaling,0.0003883|0.0003883|0.0003883|0.0005825|0.0006717,1|1|1|1|1,5149|5149|5149|2574|47.24
1572,12,0.5153,34.01,9612.0,0.003517,0.999986,ATP9A BCAS1 CASS4 CTSZ CYP24A1 FAM209A FAM209B MTRNR2L3 RBM38 STX16 TFAP2C ZGPAT,negative regulation of signaling receptor activity|regulation of protein tyrosine kinase activity|vitamin D receptor signaling pathway|vitamin D catabolic process|fatty acid omega-oxidation,0.0006932|0.001375|0.002327|0.002327|0.003489,1|1|1|1|1,52.01|36.52|572.1|572.1|343.2
1573,8,0.5131,14.37,6578.0,0.0021739999999999997,0.9996790000000001,CALHM3 CYP26A1 GSTO2 LDB3 MORN4 OPN4 SEMA4G SNCG,vitamin metabolic process|xenobiotic metabolic process|cellular response to xenobiotic stimulus|thermotaxis|optokinetic behavior,0.0009825|0.001014|0.001096|0.001164|0.001164,1|1|1|1|1,42.2|41.52|39.91|1287|1287
1574,5,0.5003,5.003,4368.0,0.001141,0.996692,ANGPTL2 CYP27A1 MYO7B NLRC4 PLPPR1,cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process|brush border assembly,0.001213|0.001213|0.001213|0.001213|0.001456,1|1|1|1|1,1030|1030|1030|1030|823.8
1575,4,0.5307,3.1839999999999997,3237.0,0.0009801999999999999,0.9929309999999999,CYP27C1 EPPIN IQSEC3 RBPJL,negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement|negative regulation of calcium ion import|retinal metabolic process,0.0009706|0.0009706|0.0009706|0.001941|0.003104,1|1|1|1|1,1287|1287|1287|572.1|343.2
1576,4,0.5642,3.385,3060.0,0.001102,0.9929309999999999,CHCHD2 CYP2C18 HIST1H2AA OR10C1,positive regulation of mitochondrial ATP synthesis coupled electron transport|regulation of mitochondrial ATP synthesis coupled electron transport|regulation of cellular response to hypoxia|epoxygenase P450 pathway|exogenous drug catabolic process,0.0007281|0.001019|0.001892|0.003056|0.003492,1|1|1|1|1,1716|1144|572.1|343.2|298.5
1577,4,0.5934,3.5610000000000004,3136.0,0.001131,0.9929309999999999,CYP2J2 GDPD3 LRRC42 RSBN1L,N-acylethanolamine metabolic process|ethanolamine-containing compound metabolic process|phosphatidylcholine catabolic process|epoxygenase P450 pathway|linoleic acid metabolic process,0.001165|0.001941|0.002522|0.004072|0.004266,1|1|1|1|1,1030|572.1|429.1|257.4|245.2
1578,5,0.5198,5.1979999999999995,3911.0,0.001324,0.996692,CTSH CYP2R1 HSBP1L1 NAT14 OTX2,response to cesium ion|dichotomous subdivision of terminal units involved in lung branching|neuropeptide catabolic process|cellular alcohol biosynthetic process|cellular alcohol metabolic process,0.0004854|0.000728|0.000728|0.001213|0.001213,1|1|1|1|1,4119|2060|2060|1030|1030
1579,4,0.5039,3.023,3130.0,0.0009625,0.9929309999999999,CYP2U1 NHLH2 OSMR PHLDA3,male mating behavior|oncostatin-M-mediated signaling pathway|leukemia inhibitory factor signaling pathway|omega-hydroxylase P450 pathway|cell migration in hindbrain,0.001553|0.001553|0.001941|0.001941|0.003104,1|1|1|1|1,735.5|735.5|572.1|572.1|343.2
1580,5,0.5047,5.047,4205.0,0.001196,0.996692,CEACAM8 CYP46A1 GABRG1 TEC ZMYM5,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway|pyruvate oxidation|positive regulation of mast cell cytokine production|regeneration|Fc-epsilon receptor signaling pathway,0.0005824|0.0005824|0.0008735|0.0009141|0.001052,1|1|1|1|1,3432|3432|1716|42.64|39.68
1581,14,0.5002,45.51,11130.0,0.004061,0.9999969999999999,BSND C1orf123 CFAP57 CYP4A11 CYP4X1 ERMAP EXO5 PCSK9 PPT1 ZFP69 ZFP69B ZNF684 ZNF691 ZYG11B,positive regulation of receptor-mediated endocytosis|fatty acid derivative metabolic process|negative regulation of low-density lipoprotein particle receptor binding|negative regulation of intracellular cholesterol transport|negative regulation of intracellular sterol transport,0.0005749|0.001244|0.001261|0.001891|0.001891,1|1|1|1|1,57.61|38.64|1584|792.1|792.1
1582,4,0.5127,3.076,3043.0,0.001007,0.9929309999999999,AXDND1 CYP11A1 CYP4B1 ZNF563,biphenyl metabolic process|cortisol metabolic process|glucocorticoid biosynthetic process|tertiary alcohol metabolic process|glucocorticoid metabolic process,0.0007766|0.0009706|0.002328|0.002716|0.003104,1|1|1|1|1,1716|1287|468.1|396.1|343.2
1583,18,0.5008,76.62,12830.0,0.005918,1.0,CYP4F11 CYP4F12 CYP4F2 MEF2B OR10H2 OR7C1 OR7C2 ZNF195 ZNF253 ZNF43 ZNF486 ZNF492 ZNF682 ZNF714 ZNF737 ZNF91 ZNF98 ZNF99,vitamin K catabolic process|menaquinone catabolic process|quinone catabolic process|leukotriene B4 catabolic process|leukotriene catabolic process,1.953e-08|1.953e-08|3.122e-08|3.122e-08|3.122e-08,0.000308|0.000154|0.0001642|0.0001231|9.85e-05,858.1|858.1|686.5|686.5|686.5
1584,4,0.5477,3.286,2858.0,0.001145,0.9929309999999999,CYP4F22 CYP4F3 OR7A5 WIZ,icosanoid metabolic process|vitamin K catabolic process|menaquinone catabolic process|quinone catabolic process|leukotriene B4 catabolic process,0.000184|0.0009706|0.0009706|0.001165|0.001165,1|1|1|1|1,91.13|1287|1287|1030|1030
1585,4,0.5106,3.0639999999999996,3080.0,0.0009912,0.9929309999999999,CYP4V2 ESYT2 GOLGA8N SWI5,fatty acid omega-oxidation|endoplasmic reticulum-plasma membrane tethering|endoplasmic reticulum localization|endomembrane system organization|cellular lipid metabolic process,0.001165|0.001359|0.002134|0.003282|0.01265,1|1|1|1|1,1030|858.1|514.9|21.1|10.56
1586,4,0.54,3.24,3324.0,0.0009715,0.9929309999999999,AUH CYP7B1 FBXL22 USP29,"putrescine biosynthetic process from arginine, using agmatinase|putrescine biosynthetic process from arginine|carboxylic acid metabolic process|oxoacid metabolic process|agmatine biosynthetic process",0.0004854|0.0004854|0.0006154|0.00069|0.000728,1|1|1|1|1,4119|4119|14.92|14.35|2060
1587,4,0.591,3.5460000000000003,3124.0,0.001131,0.9929309999999999,CYP8B1 LTF NMU VILL,regulation of digestive system process|siderophore-dependent iron import into cell|negative regulation of tumor necrosis factor (ligand) superfamily member 11 production|positive regulation of stomach fundus smooth muscle contraction|regulation of stomach fundus smooth muscle contraction,2.547e-05|0.0003883|0.0003883|0.0003883|0.0003883,0.4018|1|1|1|1,251.2|5149|5149|5149|5149
1588,4,0.5252,3.1510000000000002,3225.0,0.0009736,0.9929309999999999,ABHD10 CYR61 NRG4 PTX3,positive regulation of cell proliferation in midbrain|negative regulation of exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|modulation by host of viral glycoprotein metabolic process|negative regulation by host of viral exo-alpha-sialidase activity,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
1589,4,0.5509,3.305,3168.0,0.0010400000000000001,0.9929309999999999,BCL7C CELA2A CGREF1 CYSRT1,insulin catabolic process|insulin metabolic process|regulation of platelet aggregation|regulation of homotypic cell-cell adhesion|regulation of platelet activation,0.0007766|0.001165|0.004266|0.005813|0.007166,1|1|1|1|1,1716|1030|245.2|177.5|143
1590,5,0.5236,5.236000000000001,4373.0,0.001193,0.996692,CLCN6 CYSTM1 FCGRT ITGB7 ZNF664,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor|cell-matrix adhesion involved in ameboidal cell migration|immunoglobulin transcytosis in epithelial cells|leukocyte tethering or rolling|transcytosis,0.0004854|0.000728|0.0009706|0.005087|0.005329,1|1|1|1|1,4119|2060|1373|205.9|196.1
1591,4,0.5623,3.3739999999999997,3240.0,0.001037,0.9929309999999999,CYTH1 IL1RN LGALS3BP PKP3,desmosome assembly|negative regulation of interleukin-1-mediated signaling pathway|regulation of interleukin-1-mediated signaling pathway|negative regulation of heterotypic cell-cell adhesion|regulation of cell-cell adhesion involved in gastrulation,0.0009706|0.001165|0.001747|0.002134|0.002134,1|1|1|1|1,1287|1030|643.6|514.9|514.9
1592,6,0.5219,7.829,4368.0,0.001784,0.998474,CYTH3 DIS3 ISLR MRPS31 MZT1 ZC3H13,microtubule nucleation by interphase microtubule organizing center|gamma-tubulin complex localization|CUT metabolic process|CUT catabolic process|microtubule nucleation by microtubule organizing center,0.0005824|0.001165|0.001456|0.001456|0.001746,1|1|1|1|1,3432|1144|858.1|858.1|686.5
1593,4,0.5292,3.175,3116.0,0.001016,0.9929309999999999,CYTIP ERC2 MMP8 TMEM121,maintenance of presynaptic active zone structure|presynaptic active zone organization|positive regulation of microglial cell activation|positive regulation of neuroinflammatory response|synaptic vesicle priming,0.001359|0.001747|0.001747|0.00291|0.00291,1|1|1|1|1,858.1|643.6|643.6|367.8|367.8
1594,4,0.5484,3.29,3258.0,0.001006,0.9929309999999999,CYTL1 MOV10 NOTCH3 SP6,"regulation of transcription by RNA polymerase II|mRNA cleavage involved in gene silencing|mRNA cleavage involved in gene silencing by miRNA|cartilage homeostasis|negative regulation of transposition, RNA-mediated",0.0002494|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,7.964|2574|2574|1716|1716
1595,5,0.5005,5.005,4118.0,0.0012109999999999998,0.996692,D2HGDH HSPH1 IL20RA SMAD9 VLDLR,response to chemical|glycoprotein transport|receptor-mediated endocytosis|positive regulation of MHC class I biosynthetic process|very-low-density lipoprotein particle clearance,0.0004308|0.0009706|0.001432|0.001698|0.001698,1|1|1|1|1,4.714|1373|33.22|686.5|686.5
1596,6,0.5041,7.561,4834.0,0.001558,0.998474,BBS9 CRYZ CUL4A DAAM1 S100A11 SPATA18,mitophagy by induced vacuole formation|regulation of nucleotide-excision repair|visual perception|sensory perception of light stimulus|mitochondrial protein catabolic process,0.0005824|0.001456|0.001626|0.001685|0.001746,1|1|1|1|1,3432|858.1|31.78|31.2|686.5
1597,4,0.5244,3.1460000000000004,3141.0,0.0009982,0.9929309999999999,ANKRD13B DAAM2 SIAE TEX19,negative regulation of oligodendrocyte differentiation|negative regulation of receptor internalization|dorsal spinal cord development|negative regulation of glial cell differentiation|regulation of non-canonical Wnt signaling pathway,0.002328|0.002716|0.004072|0.004459|0.00504,1|1|1|1|1,468.1|396.1|257.4|234|205.9
1598,4,0.5528,3.3169999999999997,3189.0,0.001037,0.9929309999999999,CHRNA10 DAB1 SLC9A3R1 TMED5,Golgi localization|negative regulation of ERK1 and ERK2 cascade|inner ear morphogenesis|ear morphogenesis|sensory perception of sound,3.391e-06|7.603e-05|0.0001391|0.0001971|0.0003299,0.05349|0.5997|0.7314|0.7771|1,735.5|143|105.1|88.01|67.75
1599,4,0.5827,3.4960000000000004,3478.0,0.0010019999999999999,0.9929309999999999,DAB2 IDNK NUAK2 PMEPA1,regulation of pathway-restricted SMAD protein phosphorylation|regulation of transforming growth factor beta receptor signaling pathway|regulation of cellular response to transforming growth factor beta stimulus|leading edge cell differentiation|D-gluconate catabolic process,5.679e-05|0.0002105|0.0002209|0.0003883|0.0005825,0.8958|1|1|1|1,166.1|85.1|83.04|5149|2574
1600,4,0.536,3.216,3285.0,0.0009755000000000001,0.9929309999999999,CPO DACT2 LMAN2L OSTM1,inner medullary collecting duct development|negative regulation of nodal signaling pathway|regulation of nodal signaling pathway|protoporphyrinogen IX biosynthetic process|negative regulation of activin receptor signaling pathway,0.0009706|0.001213|0.002183|0.002425|0.00291,1|1|1|1|1,1373|1030|514.9|457.7|374.5
1601,4,0.5188,3.113,2902.0,0.0010689999999999999,0.9929309999999999,DAGLB INS RPS21 TP53RK,"regulation of lipid catabolic process|positive regulation of lipid metabolic process|endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|negative regulation of glycogen catabolic process|endocannabinoid signaling pathway",5.327e-05|0.0003385|0.0003883|0.0003883|0.0007766,0.8403|1|1|1|1,171.6|66.87|5149|5149|1716
1602,4,0.544,3.264,3296.0,0.0009868000000000001,0.9929309999999999,C4orf51 CLCA2 DALRD3 SLC22A3,epinephrine uptake|arginyl-tRNA aminoacylation|histamine uptake|epinephrine transport|imidazole-containing compound metabolic process,0.0005825|0.0007766|0.0007766|0.0009706|0.001359,1|1|1|1|1,2574|1716|1716|1287|858.1
1603,15,0.5048,53.01,11730.0,0.004487,0.999999,A2M CLEC2B CLEC4D CLEC6A GALNT8 GYS2 IAPP KCNA1 KCNA6 KLRC1 PKP2 SLCO1B1 SLCO1B3 SLCO1C1 TAS2R20,sodium-independent organic anion transport|bile acid and bile salt transport|regulation of innate immune response|pigment catabolic process|porphyrin-containing compound catabolic process,3.001e-07|2.388e-06|6.476e-05|7.514e-05|7.514e-05,0.004734|0.01883|0.3405|0.2963|0.237,257.4|121.1|17.6|171.6|171.6
1604,4,0.5407,3.2439999999999998,3201.0,0.00101,0.9929309999999999,ABCA7 DAOA EPHA7 MFSD10,organic hydroxy compound transport|negative regulation of D-amino-acid oxidase activity|regulation of D-amino-acid oxidase activity|tetracycline transmembrane transport|positive regulation of engulfment of apoptotic cell,0.0003257|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,68.2|5149|5149|5149|2574
1605,5,0.5493,5.492999999999999,3768.0,0.001452,0.996692,ADCY6 ANKMY2 DAPP1 PTGES3 RIC8B,cellular response to vasopressin|response to vasopressin|telomerase holoenzyme complex assembly|negative regulation of urine volume|glucocorticoid receptor signaling pathway,0.0009706|0.0009706|0.001213|0.001456|0.001698,1|1|1|1|1,1373|1373|1030|823.8|686.5
1606,4,0.5501,3.301,3305.0,0.0009954,0.9929309999999999,DAW1 EFHC1 KLHL5 ZBTB20,cerebrospinal fluid circulation|outer dynein arm assembly|microtubule cytoskeleton organization|positive regulation of glycolytic process|epithelial cilium movement involved in extracellular fluid movement,0.002134|0.004266|0.004389|0.004846|0.00678,1|1|1|1|1,514.9|245.2|18.19|214.5|151.4
1607,4,0.5465,3.279,3064.0,0.001066,0.9929309999999999,C1orf158 DAZL OR10H1 OR10H2,"G protein-coupled serotonin receptor signaling pathway|serotonin receptor signaling pathway|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|cellular response to dopamine|response to dopamine",1.778e-05|2.313e-05|6.606e-05|9.574e-05|9.807e-05,0.2804|0.1824|0.3474|0.3775|0.3094,302.9|264|153.7|127.1|125.6
1608,4,0.5332,3.199,3184.0,0.001001,0.9929309999999999,DBN1 IVD PRR30 RECQL5,cell communication by chemical coupling|positive regulation of receptor localization to synapse|cellular response to camptothecin|response to camptothecin|leucine catabolic process,0.0005825|0.0009706|0.0009706|0.001165|0.001359,1|1|1|1|1,2574|1287|1287|1030|858.1
1609,4,0.5581,3.3480000000000003,3162.0,0.0010550000000000002,0.9929309999999999,DBNDD2 FAM3D ITPKB ZFYVE1,negative regulation of neutrophil apoptotic process|negative regulation of glucagon secretion|inositol trisphosphate metabolic process|regulation of neutrophil apoptotic process|common myeloid progenitor cell proliferation,0.0003883|0.0009706|0.001359|0.001553|0.001553,1|1|1|1|1,5149|1287|858.1|735.5|735.5
1610,4,0.5248,3.1489999999999996,3217.0,0.0009755000000000001,0.9929309999999999,DBP IBSP PP2D1 UBASH3A,vitamin D metabolic process|vitamin transmembrane transport|negative regulation of T cell receptor signaling pathway|negative regulation of antigen receptor-mediated signaling pathway|fat-soluble vitamin metabolic process,0.00412|0.004362|0.005812|0.007502|0.009913,1|1|1|1|1,257.4|242.3|179.1|137.3|103
1611,13,0.5094,39.74,8516.0,0.00463,0.999993,BUB3 C1orf109 DAD1 DBR1 DHX33 DPAGT1 FARSB OSGEP POP5 RPN1 RPP21 SPATA5L1 WDR18,"tRNA metabolic process|ncRNA metabolic process|protein N-linked glycosylation|RNA phosphodiester bond hydrolysis, endonucleolytic|tRNA 5'-leader removal",4.22e-06|1.113e-05|1.452e-05|2.384e-05|3.839e-05,0.06656|0.08775|0.07633|0.09401|0.1211,35.01|15.32|63.37|53.4|243.7
1612,4,0.5547,3.3280000000000003,3217.0,0.001031,0.9929309999999999,DBT RARB STPG1 TMEM51,ventricular cardiac muscle cell differentiation|growth plate cartilage development|striatum development|positive regulation of mitochondrial membrane permeability involved in apoptotic process|retinoic acid receptor signaling pathway,0.003104|0.003491|0.003685|0.003685|0.003878,1|1|1|1|1,343.2|302.9|286|286|271
1613,4,0.5437,3.262,3220.0,0.00101,0.9929309999999999,AFM ATF7 C18orf54 DBX2,protein transport within extracellular region|cellular process|vitamin transport|establishment of protein localization to extracellular region|protein localization to extracellular region,0.0003883|0.00379|0.008131|0.02062|0.02196,1|1|1|1|1,5149|0|125.6|48.57|45.56
1614,6,0.5319,7.979,4478.0,0.0017739999999999998,0.998474,DCAF16 MRFAP1L1 TRMT44 USP17L10 USP17L13 USP17L5,protein deubiquitination|protein modification by small protein removal|protein phosphopantetheinylation|protein modification by small protein conjugation or removal|ubiquitin-dependent protein catabolic process,4.871e-05|5.803e-05|8.514e-05|8.759e-05|0.0003304,0.7684|0.4577|0.4477|0.3454|1,37.04|34.91|30.65|13.32|19.32
1615,4,0.5591,3.3539999999999996,3102.0,0.001077,0.9929309999999999,DCAF4L1 LRIT2 SHLD2 ZNF696,positive regulation of double-strand break repair via nonhomologous end joining|negative regulation of double-strand break repair via homologous recombination|positive regulation of isotype switching|regulation of double-strand break repair via nonhomologous end joining|negative regulation of double-strand break repair,0.003491|0.003878|0.005426|0.006007|0.006586,1|1|1|1|1,302.9|271|190.7|171.6|156
1616,4,0.5025,3.015,3060.0,0.0009818,0.9929309999999999,DCC NPPA PDLIM1 POMGNT2,neuron migration|negative regulation of collecting lymphatic vessel constriction|regulation of collecting lymphatic vessel constriction|cell migration|negative regulation of cell growth,0.0001938|0.0003883|0.0003883|0.0003993|0.0004964,1|1|1|1|1,88.77|5149|5149|16.01|55.07
1617,5,0.5247,5.247000000000001,4053.0,0.0012900000000000001,0.996692,CCL21 DCD HSD17B1 RAB3C RADIL,killing of cells of other organism|antimicrobial humoral immune response mediated by antimicrobial peptide|cell killing|negative regulation of dendritic cell dendrite assembly|positive regulation of myeloid dendritic cell chemotaxis,0.0001709|0.0002548|0.0003438|0.0004854|0.0004854,1|1|1|1|1,98.07|79.98|68.65|4119|4119
1618,4,0.5471,3.283,3205.0,0.001021,0.9929309999999999,DCHS1 KIAA1522 NGF SLFN13,tRNA catabolic process|mitral valve formation|condensed mesenchymal cell proliferation|nerve growth factor processing|cell migration involved in endocardial cushion formation,0.0005825|0.0007766|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1287|1287|1287
1619,4,0.5392,3.235,3460.0,0.0009320999999999999,0.9929309999999999,DCHS2 DDO RGS22 TCF15,D-amino acid catabolic process|D-amino acid metabolic process|condensed mesenchymal cell proliferation|aspartate catabolic process|aspartate metabolic process,0.0005825|0.0007766|0.0009706|0.0009706|0.001747,1|1|1|1|1,2574|1716|1287|1287|643.6
1620,4,0.5413,3.248,3381.0,0.0009573,0.9929309999999999,CPPED1 DCK EFCAB13 FAM118A,dAMP biosynthetic process|purine deoxyribonucleoside monophosphate biosynthetic process|dAMP metabolic process|purine deoxyribonucleoside monophosphate metabolic process|purine deoxyribonucleotide biosynthetic process,0.0005825|0.0005825|0.0007766|0.001165|0.001165,1|1|1|1|1,2574|2574|1716|1030|1030
1621,4,0.5221,3.1319999999999997,3050.0,0.001023,0.9929309999999999,CKAP2 DCLK1 NUSAP1 SOHLH2,mitotic cytokinesis|cytoskeleton-dependent cytokinesis|cytokinesis|cell division|central nervous system projection neuron axonogenesis,6.8e-05|0.0001336|0.0001684|0.003335|0.005426,1|1|0.8853|1|1,151.4|107.3|95.35|20.93|190.7
1622,4,0.5024,3.014,3065.0,0.0009799,0.9929309999999999,DCLK3 OR2T35 PCDHB15 ZC3H14,negative regulation of mRNA polyadenylation|negative regulation of mRNA 3'-end processing|regulation of mRNA polyadenylation|regulation of mRNA 3'-end processing|negative regulation of mRNA processing,0.001747|0.001941|0.003491|0.00562|0.006007,1|1|1|1|1,643.6|572.1|302.9|183.9|171.6
1623,5,0.5453,5.452999999999999,4001.0,0.001358,0.996692,B4GALNT3 DCP1B ERC1 SLC6A12 WNT5B,positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|gamma-aminobutyric acid reuptake|deadenylation-independent decapping of nuclear-transcribed mRNA|amino acid neurotransmitter reuptake,0.000728|0.000728|0.001213|0.001456|0.001698,1|1|1|1|1,2060|2060|1030|823.8|686.5
1624,10,0.5296,23.83,6961.0,0.003403,0.999933,DCP2 DDX6 EDC3 EDC4 EIF4E2 EIF4ENIF1 GIGYF2 LSM14A PNRC2 XRN1,negative regulation of gene expression|negative regulation of translation|negative regulation of cellular amide metabolic process|methylguanosine-cap decapping|RNA decapping,5.329e-14|2.064e-11|4.922e-11|5.076e-11|8.53e-11,8.407e-10|1.628e-07|2.588e-07|2.002e-07|2.691e-07,21.36|90.2|77.72|686.5|588.4
1625,4,0.565,3.39,3245.0,0.001041,0.9929309999999999,B3GNT7 DCSTAMP PAX9 UPK3A,urinary bladder development|positive regulation of macrophage fusion|regulation of macrophage fusion|osteoclast fusion|cellular response to macrophage colony-stimulating factor stimulus,0.0009706|0.001165|0.001165|0.001359|0.001747,1|1|1|1|1,1287|1030|1030|858.1|643.6
1626,9,0.5232,18.84,6373.0,0.002939,0.9998530000000001,ACTR10 ACTR1A DCTN1 DCTN2 DCTN3 DCTN4 DCTN5 DCTN6 VEZT,antigen processing and presentation of exogenous peptide antigen via MHC class II|antigen processing and presentation of peptide antigen via MHC class II|antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen,3.631e-18|4.232e-18|4.563e-18|3.386e-16|4.771e-16,5.728e-14|3.338e-14|2.399e-14|1.335e-12|1.505e-12,184.9|181.3|179.5|102.8|98.42
1627,21,0.5078,106.6,16860.0,0.006268,1.0,CALHM3 CYP2C9 DUSP13 GPRIN2 IDE IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPF LIPJ LIPK NUTM2A NUTM2B PTPN20 SFTPA1 SFTPA2 SYT15 ZNF239 ZNF33B,cellular response to type I interferon|response to type I interferon|type I interferon signaling pathway|defense response to symbiont|defense response to virus,8.272e-07|1.137e-06|4.979e-05|6.098e-05|6.098e-05,0.01305|0.00897|0.2618|0.2405|0.1924,56.85|52.3|43.27|18.5|18.5
1628,4,0.564,3.384,3097.0,0.0010890000000000001,0.9929309999999999,DDAH2 ENPP4 PRR3 WNT9B,mesonephric duct formation|establishment of planar polarity involved in nephron morphogenesis|mesenchymal stem cell maintenance involved in nephron morphogenesis|non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation|mesonephric duct morphogenesis,0.0004854|0.0004854|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|4119|2060|2060|1373
1629,6,0.5176,7.763999999999999,4118.0,0.001876,0.998474,DDOST DHDDS GPN2 NUDC RPA2 SYF2,protein N-linked glycosylation|mitotic DNA damage checkpoint|mitotic DNA integrity checkpoint|DNA damage checkpoint|nucleologenesis,0.0002861|0.0005213|0.000562|0.000955|0.001019,1|1|1|1|1,78.46|57.69|55.51|42.33|1471
1630,16,0.5863,70.36,10610.0,0.006567,0.999999,ARCN1 BUD13 CCDC84 CHORDC1 CWF19L2 DDX10 DPAGT1 HYOU1 NKAPD1 PPP2R1A RPS25 SRFBP1 SRPRA TRAPPC4 ZPR1 ZW10,RNA processing|endoplasmic reticulum to Golgi vesicle-mediated transport|RNA metabolic process|mRNA metabolic process|Golgi vesicle transport,2.977e-06|1.429e-05|0.000105|0.0001415|0.0002114,0.04696|0.1127|0.552|0.5579|0.6668,9.762|26.27|5.635|9.274|13
1631,7,0.5181,10.88,4504.0,0.002403,0.9992989999999999,ACTR1A DDX11 DYNC1LI2 ESCO2 SGO1 SRSF10 ZWINT,biological phase|mitotic cell cycle phase|cell cycle phase|sister chromatid segregation|cell cycle process,6.586e-09|6.586e-09|6.586e-09|1.006e-07|1.34e-07,0.0001039|5.195e-05|3.463e-05|0.0003967|0.0004226,57.24|57.24|57.24|78.98|16.5
1632,4,0.5845,3.5069999999999997,3248.0,0.001076,0.9929309999999999,DDX25 PCMTD2 PPP2R1B TTC39B,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|negative regulation of cholesterol storage|apoptotic process involved in morphogenesis|regulation of cholesterol storage|negative regulation of lipid storage,0.001941|0.001941|0.003104|0.003297|0.004266,1|1|1|1|1,572.1|572.1|343.2|321.8|245.2
1633,7,0.5059,10.62,4789.0,0.002207,0.9992989999999999,DDX39A DDX39B RBM33 THOC5 THOC6 THOC7 XPO4,protein export from nucleus|nuclear export|viral mRNA export from host cell nucleus|translocation of molecules into host|nucleocytoplasmic transport,1.287e-12|2.157e-12|2.307e-12|3.331e-12|2.965e-11,2.029e-08|1.701e-08|1.213e-08|1.314e-08|9.353e-08,116.1|106.3|1471|1308|68.16
1634,7,0.5106,10.72,5204.0,0.0020510000000000003,0.9992989999999999,C1orf131 DDX51 NOC4L SDE2 URB1 URB2 UTP25,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,1.016e-06|3.837e-06|3.999e-05|4.47e-05|0.0001783,0.01603|0.03026|0.2103|0.1763|0.5626,41.36|29.53|39.61|38.14|23.84
1635,11,0.5043,27.74,7533.0,0.003658,0.999969,C1orf109 DDX55 DHX33 MAK16 PAK1IP1 POP5 RPP21 RPP40 RRP12 UTP4 WDR18,ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis|rRNA processing|ncRNA metabolic process,9.564e-11|5.824e-10|9.65e-10|1.914e-09|1.997e-09,1.509e-06|4.593e-06|5.074e-06|7.549e-06|6.299e-06,39.48|30.34|28.18|43.21|25.35
1636,17,0.5075,69.02,12360.0,0.005539,1.0,ANLN CCT6A DDX56 EIF3B HUS1 LSM5 MRPL32 MRPS24 NUDCD3 POLD2 PSMA2 RPA3 SEC61G TRA2B TWISTNB YAE1 YKT6,cellular macromolecule biosynthetic process|macromolecule biosynthetic process|mitochondrial translational elongation|mitochondrial translational termination|DNA replication,2.212e-05|2.644e-05|5.413e-05|5.592e-05|6.434e-05,0.349|0.2085|0.2846|0.2205|0.203,5.856|5.714|41.3|40.84|17.88
1637,4,0.5389,3.233,3172.0,0.001016,0.9929309999999999,DDX60L FBXL3 FYB1 MPPED2,entrainment of circadian clock by photoperiod|photoperiodism|entrainment of circadian clock|protein destabilization|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,0.005813|0.006586|0.00678|0.009482|0.01813,1|1|1|1|1,177.5|156|151.4|107.3|55.36
1638,4,0.5578,3.347,3345.0,0.0009971000000000001,0.9929309999999999,DECR1 EMX2 FAM166B TRAM1,receptor transactivation|cerebral cortex regionalization|cell dedifferentiation|dedifferentiation|ureter morphogenesis,0.001456|0.001698|0.001698|0.001698|0.00194,1|1|1|1|1,823.8|686.5|686.5|686.5|588.4
1639,4,0.5622,3.373,3172.0,0.00106,0.9929309999999999,DECR2 FBXL16 MYO3A RNASE3,induction of bacterial agglutination|organic substance catabolic process|cellular catabolic process|fatty acid beta-oxidation using acyl-CoA oxidase|catabolic process,0.001165|0.002347|0.002491|0.003104|0.003839,1|1|1|1|1,1030|8.771|8.596|343.2|7.412
1640,12,0.5094,33.62,9648.0,0.003464,0.999986,BIN3 C8orf58 DEFA5 DEFB108B DEFB4A DEFB4B PRSS55 SORBS3 SOX7 TNFRSF10D ZNF705A ZNF705B,defense response to bacterium|killing of cells of other organism|defense response to Gram-negative bacterium|cell septum assembly|division septum assembly,0.0007125|0.000924|0.001034|0.001067|0.001067,1|1|1|1|1,16.28|44.58|42.07|1872|1872
1641,4,0.5944,3.5660000000000003,3209.0,0.0011070000000000001,0.9929309999999999,BRSK1 CRISP1 DCUN1D4 DEFB112,microtubule cytoskeleton organization involved in establishment of planar polarity|positive regulation of protein neddylation|regulation of synaptic vesicle clustering|regulation of protein neddylation|protein neddylation,0.0005825|0.001165|0.001553|0.002328|0.002716,1|1|1|1|1,2574|1030|735.5|468.1|396.1
1642,4,0.5148,3.089,3160.0,0.0009741,0.9929309999999999,DEFB113 GRM5 SEC31B TYR,"phospholipase C-activating G protein-coupled glutamate receptor signaling pathway|melanin biosynthetic process from tyrosine|eye pigment biosynthetic process|trans-synaptic signaling by endocannabinoid, modulating synaptic transmission|trans-synaptic signaling by lipid, modulating synaptic transmission",0.0005825|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|2574|1716|1716|1716
1643,4,0.5801,3.48,3297.0,0.001052,0.9929309999999999,CTGF DEFB114 SLC39A3 ZNF480,antifungal innate immune response|negative regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of multi-organism process|zinc ion transmembrane transport|regulation of lipopolysaccharide-mediated signaling pathway,0.0008737|0.002038|0.003056|0.003637|0.003782,1|1|1|1|1,1373|528.1|343.2|286|274.6
1644,15,0.5063,53.16,11520.0,0.00458,0.999999,CCM2L COX4I2 DEFB115 DEFB116 DEFB118 DEFB121 DUSP15 FOXS1 HCK HM13 MYLK2 NOL4L REM1 TM9SF4 XKR7,defense response to bacterium|response to bacterium|innate immune response|defense response to other organism|phagocytosis,9.517e-05|0.0001174|0.0002438|0.000628|0.00159,1|0.9257|1|1|1,15.92|9.561|8.173|6.652|12.63
1645,12,0.5006,33.04,9233.0,0.003556,0.999986,COX4I2 DEFB115 DEFB116 DEFB118 DEFB119 DEFB121 DEFB123 DEFB124 FOXS1 HCK MYLK2 REM1,defense response to bacterium|response to bacterium|innate immune response|defense response to other organism|defense response,2.943e-10|9.98e-10|3.402e-09|1.693e-08|1.964e-07,4.642e-06|7.871e-06|1.789e-05|6.675e-05|0.0006197,34.82|19.12|16.35|13.3|9.696
1646,5,0.5141,5.141,4292.0,0.001194,0.996692,ACAD10 C10orf113 DEFB125 NTRK2 SLC17A8,acidic amino acid transport|neural retina development|dicarboxylic acid transport|fatty acid transport|amino acid transport,6.963e-05|0.0001163|0.0001553|0.0003109|0.0004146,1|0.9176|0.8166|1|1,155.4|119.4|103|72.26|62.41
1647,4,0.5223,3.134,3139.0,0.0009948000000000001,0.9929309999999999,C12orf57 DEFB126 GRXCR2 RNF157,sensory organ morphogenesis|third ventricle development|psychomotor behavior|corpus callosum morphogenesis|motor behavior,0.0009364|0.0009706|0.0009706|0.001165|0.002522,1|1|1|1|1,39.91|1287|1287|1030|429.1
1648,5,0.509,5.09,3711.0,0.001366,0.996692,DEFB127 HLA-A HLA-B HLA-C LRRIQ4,"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway|antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent|antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen",1.132e-09|1.132e-09|1.509e-09|7.816e-09|1.056e-08,1.786e-05|8.928e-06|7.935e-06|3.082e-05|3.33e-05,1545|1545|1373|726.9|650.4
1649,4,0.5026,3.015,3181.0,0.0009445,0.9929309999999999,DCUN1D5 DEFB134 TACR3 UBE2R2,positive regulation of protein neddylation|positive regulation of uterine smooth muscle contraction|tachykinin receptor signaling pathway|hyperosmotic salinity response|regulation of uterine smooth muscle contraction,0.001165|0.001553|0.001747|0.001747|0.002134,1|1|1|1|1,1030|735.5|643.6|643.6|514.9
1650,6,0.545,8.175,4606.0,0.0017670000000000001,0.998474,BIRC6 DELE1 EIF2AK1 OMA1 OPA3 TDGF1,HRI-mediated signaling|integrated stress response signaling|negative regulation of hemoglobin biosynthetic process|negative regulation of translational initiation by iron|protein phosphorylation,4.802e-10|1.822e-08|0.0005824|0.0005824|0.0006849,7.575e-06|0.0001437|1|1|1,2574|572.1|3432|3432|15.05
1651,4,0.5413,3.248,3336.0,0.0009701,0.9929309999999999,CEP131 DENND1B RHOJ ZNF480,"intramanchette transport|T-helper 2 cell cytokine production|T cell cytokine production|CD4-positive, alpha-beta T cell cytokine production|manchette assembly",0.0003883|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|2574|1716|1716|1287
1652,4,0.5226,3.136,3032.0,0.00103,0.9929309999999999,C14orf28 DENND2D EPO TRIM41,response to bacterium|negative regulation of erythrocyte apoptotic process|regulation of erythrocyte apoptotic process|defense response to nematode|erythropoietin-mediated signaling pathway,0.000405|0.0004854|0.0004854|0.000728|0.001213,1|1|1|1|1,17.21|4119|4119|2060|1030
1653,4,0.5477,3.286,3171.0,0.001033,0.9929309999999999,B4GALT2 CTBS DENND4B NCKAP5L,aminoglycan metabolic process|chitin catabolic process|chitin metabolic process|regulation of Rab protein signal transduction|glucosamine-containing compound catabolic process,0.0003925|0.001359|0.001359|0.001553|0.001941,1|1|1|1|1,62.03|858.1|858.1|735.5|572.1
1654,4,0.5023,3.014,3024.0,0.0009927999999999998,0.9929309999999999,CCNO CYB561A3 DENND5A LPCAT1,negative regulation of phosphatidylcholine biosynthetic process|negative regulation of phosphatidylcholine metabolic process|regulation of phosphatidylcholine biosynthetic process|negative regulation of phospholipid biosynthetic process|negative regulation of phospholipid metabolic process,0.0003883|0.0005825|0.001165|0.001165|0.001359,1|1|1|1|1,5149|2574|1030|1030|858.1
1655,4,0.5039,3.023,3229.0,0.000933,0.9929309999999999,AGMAT COL12A1 DEPDC1B INTU,"putrescine biosynthetic process from arginine, using agmatinase|putrescine biosynthetic process from arginine|agmatine biosynthetic process|spermidine biosynthetic process|primary amino compound biosynthetic process",0.0003883|0.0003883|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|5149|2574|1716|1030
1656,4,0.5868,3.5210000000000004,3399.0,0.001032,0.9929309999999999,DEPP1 PLPP4 SLC30A3 STOX2,zinc ion import into synaptic vesicle|zinc ion import into organelle|regulation of sequestering of zinc ion|zinc ion transmembrane transport|blastocyst hatching,0.0005825|0.0005825|0.001165|0.004846|0.005233,1|1|1|1|1,2574|2574|1030|214.5|198
1657,4,0.5255,3.153,3181.0,0.0009876,0.9929309999999999,DEPTOR HRCT1 IFRD2 SLC2A10,negative regulation of proteoglycan biosynthetic process|negative regulation of connective tissue growth factor production|galactose transmembrane transport|negative regulation of integrin-mediated signaling pathway|regulation of connective tissue growth factor production,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
1658,4,0.5183,3.11,3096.0,0.001001,0.9929309999999999,DERA LINS1 METTL23 RTP4,deoxyribonucleoside catabolic process|nervous system process|cognition|deoxyribonucleoside metabolic process|pentose-phosphate shunt,0.0007766|0.001147|0.001211|0.001747|0.002716,1|1|1|1|1,1716|11.19|35.03|643.6|396.1
1659,4,0.5426,3.255,3395.0,0.0009556000000000001,0.9929309999999999,DES EPS8L2 FBXL20 ORMDL3,"negative regulation of serine C-palmitoyltransferase activity|regulation of protein catabolic process at presynapse, modulating synaptic transmission|cellular sphingolipid homeostasis|negative regulation of ceramide biosynthetic process|regulation of serine C-palmitoyltransferase activity",0.0003883|0.0005825|0.001165|0.001165|0.001165,1|1|1|1|1,5149|2574|1030|1030|1030
1660,8,0.5075,14.21,6386.0,0.002215,0.9996790000000001,C22orf46 DESI1 MEI1 PARVB PMM1 SEPT3 SMDT1 TTLL12,establishment or maintenance of cell polarity regulating cell shape|GDP-mannose biosynthetic process|protein desumoylation|GDP-mannose metabolic process|mannose metabolic process,0.001164|0.002328|0.00349|0.00349|0.003877,1|1|1|1|1,1287|514.9|321.8|321.8|286
1661,4,0.5326,3.195,3218.0,0.0009894,0.9929309999999999,DESI2 FAM20C NEU4 ZDHHC18,odontoblast differentiation|ganglioside catabolic process|protein phosphopantetheinylation|protein metabolic process|enamel mineralization,0.0007766|0.001553|0.001576|0.001763|0.002522,1|1|1|1|1,1716|735.5|30.65|4.883|429.1
1662,4,0.5271,3.162,3247.0,0.0009706,0.9929309999999999,DEUP1 FAM81B PROB1 TOPORS,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation|de novo centriole assembly|multi-ciliated epithelial cell differentiation|retinal rod cell development|retinal cone cell differentiation,0.001165|0.001165|0.001941|0.002134|0.002328,1|1|1|1|1,1030|1030|572.1|514.9|468.1
1663,4,0.5371,3.2230000000000003,2848.0,0.001127,0.9929309999999999,DFFB ECHS1 LDHB MECR,fatty acid beta-oxidation|monocarboxylic acid metabolic process|fatty acid oxidation|lipid oxidation|fatty acid catabolic process,5.156e-05|6.171e-05|0.0001028|0.0001126|0.0001177,0.8133|0.4867|0.5406|0.4441|0.3713,174.5|30.05|122.6|117|114.4
1664,13,0.5021,39.16,10930.0,0.0035619999999999996,0.999993,C8orf76 CA1 CA13 CA2 CA3 CYP7A1 DGAT1 FABP4 MTSS1 NOV PKIA PMP2 SGK3,one-carbon metabolic process|bicarbonate transport|organic anion transport|cellular response to fluid shear stress|lipid homeostasis,2.204e-08|2.911e-08|3.34e-06|9.323e-05|0.0001677,0.0003477|0.0002296|0.01756|0.3676|0.529,140.8|130.8|20.19|152.6|27.64
1665,4,0.5445,3.267,3391.0,0.0009602,0.9929309999999999,DGCR2 DLL3 FAM200A NSG2,compartment pattern specification|paraxial mesoderm development|clathrin coat assembly|dopamine receptor signaling pathway|somitogenesis,0.0009706|0.003685|0.003685|0.0062|0.01218,1|1|1|1|1,1287|286|286|166.1|83.04
1666,4,0.5352,3.2110000000000003,3179.0,0.001007,0.9929309999999999,DGKA IFT172 MCEMP1 ZBTB39,hindgut development|left/right axis specification|left/right pattern formation|diacylglycerol metabolic process|embryonic camera-type eye morphogenesis,0.001553|0.002522|0.003878|0.004846|0.005233,1|1|1|1|1,735.5|429.1|271|214.5|198
1667,21,0.5015,105.3,17100.0,0.006106,1.0,FFAR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 LAIR1 LAIR2 LILRA1 LILRA4 LILRB2 LILRB4 LILRB5 NLRP9 SHISA7 SIGLEC12 SPIB SULT2B1 VN1R4 ZNF665 ZNF880,immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|regulation of immune response|immune response|regulation of immune system process,1.989e-07|3.443e-07|1.862e-06|2.866e-06|6.301e-06,0.003138|0.002715|0.00979|0.0113|0.01988,335.8|268.6|7.138|4.995|5.264
1668,5,0.5048,5.048,4185.0,0.001202,0.996692,ACOD1 DDO DGKH KATNAL1 PDX1,organophosphate biosynthetic process|small molecule metabolic process|D-amino acid catabolic process|response to chlorate|tolerance induction to lipopolysaccharide,0.0003214|0.0005107|0.0008735|0.0008735|0.0008735,1|1|1|1|1,19.5|8.46|1716|1716|1716
1669,5,0.5402,5.402,4080.0,0.0013189999999999999,0.996692,DGKI LRRC73 NT5E PGC YIPF3,adenosine biosynthetic process|AMP catabolic process|habituation|positive regulation of antibacterial peptide production|purine ribonucleoside monophosphate catabolic process,0.0004854|0.000728|0.001213|0.001213|0.001456,1|1|1|1|1,4119|2060|1030|1030|823.8
1670,4,0.5288,3.173,3336.0,0.0009480000000000001,0.9929309999999999,DHCR24 GJD2 PCDHAC2 RXFP2,male sex differentiation|cholesterol biosynthetic process via lathosterol|cholesterol biosynthetic process via desmosterol|sex differentiation|reproductive structure development,0.0003385|0.0009706|0.0009706|0.0009798|0.002309,1|1|1|1|1,66.87|1287|1287|39.01|25.24
1671,13,0.5183,40.43,9664.0,0.004155,0.999993,CTTN FGF19 FOLR1 FOLR2 KRTAP5-1 KRTAP5-10 KRTAP5-11 KRTAP5-9 MRGPRD MRGPRF P2RY6 PLEKHB1 POLD4,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,8.77e-09|2.366e-08|6.171e-08|1.885e-07|3.087e-07,0.0001383|0.0001866|0.0003245|0.0007435|0.0009738,36.45|30.74|26.07|21.51|19.76
1672,4,0.5382,3.2289999999999996,3036.0,0.00106,0.9929309999999999,CCDC51 CDC42BPB DHH SLC25A46,mitochondrial membrane fission|Leydig cell differentiation|male sex determination|membrane fission|sex determination,0.0005825|0.002134|0.002134|0.003104|0.003491,1|1|1|1|1,2574|514.9|514.9|343.2|302.9
1673,7,0.5013,10.53,4751.0,0.002205,0.9992989999999999,DHPS DOHH EIF5A EIF5AL1 RTCB RTRAF TTC4,peptidyl-lysine modification to peptidyl-hypusine|positive regulation of translational termination|positive regulation of translational elongation|regulation of translational termination|gene expression,5.936e-07|1.483e-06|2.076e-06|7.705e-06|9.175e-06,0.009363|0.0117|0.01092|0.03038|0.02895,2942|1471|1177|534.9|8.075
1674,5,0.5237,5.237,3933.0,0.001326,0.996692,ALPK1 DHRS3 RARG RPTN RXRA,intracellular receptor signaling pathway|retinoic acid receptor signaling pathway|bone morphogenesis|response to retinoic acid|hormone-mediated signaling pathway,8.754e-06|9.879e-06|0.0002357|0.0002796|0.0004085,0.1381|0.07792|1|1|1,63.05|433.6|83.21|76.28|62.89
1675,5,0.5184,5.184,4109.0,0.001257,0.996692,DHRS7 LYPD5 MCTP2 MPZ WNT16,optic cup formation involved in camera-type eye development|oxidative stress-induced premature senescence|optic cup morphogenesis involved in camera-type eye development|stress-induced premature senescence|keratinocyte proliferation,0.000728|0.001213|0.00194|0.002183|0.00291,1|1|1|1|1,2060|1030|588.4|514.9|374.5
1676,15,0.5071,53.24,11670.0,0.004531,0.999999,ATXN7L3B CCNB1IP1 DHX32 KIAA1257 KIF26B LYRM1 MAP3K7CL NECAP2 NIPSNAP3B PCDHGA9 RNF114 SDR39U1 SLC25A36 ZNF286A ZNF512B,response to stimulus|regulation of cellular process|UNCLASSIFIED|biological_process|pyrimidine nucleotide transport,0.0003816|0.001269|0.001809|0.001809|0.002182,1|1|1|1|1,0|0.243|3.501|0.6154|686.5
1677,5,0.5018,5.018,3755.0,0.0013310000000000002,0.996692,CLDN7 DHX37 KCNIP2 RSRC2 SBNO1,clustering of voltage-gated potassium channels|positive regulation of potassium ion export across plasma membrane|regulation of potassium ion export across plasma membrane|positive regulation of male gonad development|positive regulation of gonad development,0.0009706|0.0009706|0.00194|0.002425|0.002667,1|1|1|1|1,1373|1373|588.4|457.7|411.9
1678,19,0.4786,81.84,15310.0,0.005303,1.0,EPX HOXB9 LPO LRRC46 MKS1 MPO MYCBPAP NFE2L3 NME1 NME2 OR4D1 OR4D2 OSBPL7 PLEKHM1 RSAD1 SCRN2 SEPT4 TBKBP1 TBX21,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|UTP biosynthetic process|GTP biosynthetic process|UTP metabolic process,3.237e-06|8.584e-06|5.283e-05|6.24e-05|7.276e-05,0.05107|0.0677|0.2778|0.2461|0.2295,112.1|79.31|216.8|197.1|180.7
1679,4,0.571,3.426,3341.0,0.0010220000000000001,0.9929309999999999,ASAP2 DHX58 DYSF HEPACAM2,monocyte activation involved in immune response|positive regulation of MDA-5 signaling pathway|negative regulation of MDA-5 signaling pathway|regulation of MDA-5 signaling pathway|negative regulation of RIG-I signaling pathway,0.0005825|0.0009706|0.0009706|0.001553|0.001747,1|1|1|1|1,2574|1287|1287|735.5|643.6
1680,7,0.5493,11.54,4746.0,0.0024170000000000003,0.9992989999999999,NAE1 NEDD8 PSMD6 SHQ1 THOC7 UBA3 UBE2M,protein neddylation|post-translational protein modification|protein modification by small protein conjugation|protein modification by small protein conjugation or removal|protein phosphopantetheinylation,1.108e-11|3.512e-08|2.01e-06|6.145e-06|0.0001472,1.748e-07|0.000277|0.01057|0.02423|0.4643,905.3|40.75|17.92|14.27|26.27
1681,12,0.5029,33.19,8083.0,0.004078,0.999986,DIAPH1 DIAPH3 FLII LRRFIP2 LUZP1 MYH9 MYL12B MYL6 PFN1 ROCK1 ROCK2 TMOD3,actin filament-based process|actin cytoskeleton organization|actomyosin structure organization|regulation of actin filament-based process|cytoskeleton organization,3.202e-12|8.466e-11|2.903e-09|4.443e-08|5.603e-08,5.05e-08|6.677e-07|1.526e-05|0.0001752|0.0001768,25.83|26.2|82.51|26|11.4
1682,8,0.501,14.03,5778.0,0.002415,0.9996790000000001,C1D DIMT1 EXOSC1 MTREX PPWD1 RPS23 UTP15 ZCCHC9,rRNA processing|rRNA metabolic process|ribosome biogenesis|RNA metabolic process|RNA processing,1.84e-08|2.214e-08|6.114e-08|1.288e-07|2.143e-07,0.0002902|0.0001746|0.0003215|0.000508|0.000676,49.51|47.67|38.77|11.27|16.73
1683,4,0.5631,3.3789999999999996,3263.0,0.001032,0.9929309999999999,ALPG C2orf40 DIO1 WFDC1,vasopressin secretion|positive regulation of corticosterone secretion|positive regulation of corticotropin-releasing hormone secretion|regulation of corticotropin-releasing hormone secretion|regulation of corticosterone secretion,0.0005825|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|1716|1716|1287|1030
1684,13,0.5142,40.1,8425.0,0.004723,0.999993,AMOTL2 DIP2B KIRREL1 LATS2 MAP4K4 MOB4 NF2 NRP1 PDCD10 PLXNA1 PTPN14 RNF146 TAOK1,anatomical structure morphogenesis|semaphorin-plexin signaling pathway|generation of neurons|anatomical structure formation involved in morphogenesis|neurogenesis,1.727e-06|2.62e-06|7.211e-06|1.298e-05|1.317e-05,0.02724|0.02066|0.03791|0.0512|0.04156,6.201|116.1|8.245|10.15|7.522
1685,13,0.5143,40.12,9684.0,0.0041140000000000005,0.999993,AAGAB AFTPH AP1B1 AP1G1 AP1M1 AP1S1 HEATR5B RAB11A RAB14 SCYL2 TBC1D14 TBCK VIPAS39,intracellular transport|protein transport|peptide transport|protein localization|amide transport,2.811e-13|1.651e-11|2.041e-11|2.123e-11|2.604e-11,4.434e-09|1.302e-07|1.073e-07|8.373e-08|8.215e-08,12.68|11.91|11.68|8.809|11.42
1686,4,0.5366,3.219,3359.0,0.0009552999999999999,0.9929309999999999,ACTG2 DIRAS1 GPX8 PLSCR5,mesenchyme migration|plasma membrane phospholipid scrambling|phospholipid translocation|lipid translocation|mesenchyme morphogenesis,0.001165|0.004072|0.009096|0.009675|0.009675,1|1|1|1|1,1030|257.4|111.9|105.1|105.1
1687,4,0.5284,3.17,3220.0,0.0009812999999999998,0.9929309999999999,DIRC1 IYD NOTUM SLC15A3,protein depalmitoleylation|peptidoglycan transport|dipeptide import across plasma membrane|oligopeptide import across plasma membrane|positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,0.0003883|0.0007766|0.001165|0.001165|0.001165,1|1|1|1|1,5149|1716|1030|1030|1030
1688,4,0.5482,3.2889999999999997,3281.0,0.000999,0.9929309999999999,DKK3 DNASE1L2 DZIP1 TCAP,negative regulation of anti-Mullerian hormone signaling pathway|regulation of anti-Mullerian hormone signaling pathway|corneocyte development|striated muscle myosin thick filament assembly|sarcomerogenesis,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
1689,17,0.5026,68.35,14310.0,0.0047409999999999996,1.0,C5AR1 C5AR2 CABP5 CCDC61 CRX DKKL1 EML2 FLT3LG FUT1 FUT2 IGFL1 IGFL2 IGFL4 SPACA4 SULT2A1 SULT2B1 TPRX1,complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|complement receptor mediated signaling pathway,3.838e-06|3.506e-05|3.506e-05|3.506e-05|6.68e-05,0.06054|0.2765|0.1843|0.1383|0.2108,1211|269.2|269.2|269.2|186.4
1690,4,0.517,3.102,3199.0,0.0009662000000000001,0.9929309999999999,DLG4 LMO1 NXPH2 PNKD,neuromuscular process|regulation of T cell homeostatic proliferation|methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione|methylglyoxal catabolic process|methylglyoxal catabolic process to lactate,0.0002452|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,81.56|1373|1373|1030|1030
1691,4,0.5541,3.325,3143.0,0.0010539999999999998,0.9929309999999999,CIZ1 DLK1 GPR35 MLYCD,malonyl-CoA catabolic process|negative regulation of neuronal action potential|positive regulation of DNA-dependent DNA replication initiation|malonyl-CoA metabolic process|regulation of neuronal action potential,0.0003883|0.0003883|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|5149|2574|1716|1030
1692,18,0.505,77.27,14160.0,0.005415,1.0,CRISP1 CRISP2 DLK2 ENPP4 ENPP5 FBXO9 GFRAL GLYATL3 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP MUT SPATS1 TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|positive regulation of antimicrobial peptide production,1.06e-06|1.06e-06|9.585e-06|1.341e-05|1.787e-05,0.01672|0.008359|0.0504|0.05289|0.05639,165.2|165.2|605.7|484.6|403.8
1693,4,0.54,3.24,3383.0,0.0009547000000000001,0.9929309999999999,DLX1 RTP4 SYNGR3 VWA3A,cerebral cortex GABAergic interneuron fate commitment|positive regulation of amacrine cell differentiation|negative regulation of cellular response to transforming growth factor beta stimulus|regulation of amacrine cell differentiation|negative regulation of photoreceptor cell differentiation,0.0005825|0.0005825|0.0007766|0.0007766|0.001359,1|1|1|1|1,2574|2574|1716|1716|858.1
1694,4,0.5284,3.1710000000000003,3245.0,0.0009738999999999999,0.9929309999999999,DLX2 HOXB4 SNX11 TBKBP1,embryonic skeletal system morphogenesis|embryonic skeletal system development|cerebral cortex GABAergic interneuron fate commitment|positive regulation of amacrine cell differentiation|skeletal system morphogenesis,0.0001282|0.000214|0.0005825|0.0005825|0.0007087,1|1|1|1|1,109.5|84.41|2574|2574|45.97
1695,10,0.5642,25.39,6926.0,0.0036420000000000003,0.999933,ESR1 FOXA1 GATA3 GRHL2 LMX1B SPDEF TFAP2A TFAP2C TRPS1 ZNF652,"regulation of transcription by RNA polymerase II|positive regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",9.925e-10|5.745e-09|1.836e-08|1.841e-08|1.868e-08,1.566e-05|4.531e-05|9.654e-05|7.261e-05|5.893e-05,7.964|13.66|5.945|5.944|5.935
1696,5,0.5262,5.2620000000000005,4039.0,0.0012980000000000001,0.996692,ABCC10 DEFB1 DMBX1 MMP20 SPATA25,collagen catabolic process|collagen metabolic process|positive regulation of flagellated sperm motility involved in capacitation|regulation of enamel mineralization|leukotriene transport,6.96e-05|0.000137|0.001165|0.001746|0.002328,1|1|1|1|1,159.7|112.5|1144|686.5|490.4
1697,5,0.5268,5.268,4163.0,0.001261,0.996692,DMKN FNDC8 GPR179 LYRM9 TMPRSS5,cornified envelope assembly|membrane assembly|membrane biogenesis|plasma membrane organization|visual perception,0.001213|0.008467|0.009913|0.0238|0.05158,1|1|1|1|1,1030|121.1|103|42.03|19.07
1698,4,0.5002,3.0010000000000003,3209.0,0.0009318999999999999,0.9929309999999999,CAPN12 DMPK RILP SALL4,neural tube closure|tube closure|primary neural tube formation|neural tube formation|embryonic epithelial tube formation,0.0001956|0.0001999|0.0002219|0.0002597|0.0003609,1|1|1|1|1,91.53|90.53|85.81|79.21|66.98
1699,4,0.5766,3.46,3160.0,0.001091,0.9929309999999999,AATF DMRT2 GGACT WDR60,embryonic skeletal system development|regulation of myotome development|positive regulation of myotome development|embryo development|negative regulation of superoxide anion generation,0.000214|0.0003883|0.0003883|0.0004067|0.0005825,1|1|1|1|1,84.41|5149|5149|15.91|2574
1700,5,0.5275,5.275,4194.0,0.001253,0.996692,CD300LG DMRTA2 HEXIM2 MPP3 RIIAD1,cerebral cortex regionalization|telencephalon regionalization|positive regulation of neuroblast proliferation|forebrain regionalization|negative regulation of cyclin-dependent protein serine/threonine kinase activity,0.001698|0.003152|0.005571|0.005571|0.007261,1|1|1|1|1,686.5|343.3|187.2|187.2|142
1701,5,0.5147,5.147,4264.0,0.0012029999999999999,0.996692,C1orf216 CCDC28B DMRTB1 ZBTB8A ZBTB8B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",0.01628|0.03643|0.03646|0.0366|0.04474,1|1|1|1|1,4.778|3.567|3.566|3.561|3.306
1702,4,0.5152,3.091,3088.0,0.0009974,0.9929309999999999,DMWD FOXP4 INSIG1 LRRC32,roof of mouth development|regulation of transforming growth factor beta3 activation|negative regulation of cargo loading into COPII-coated vesicle|regulation of cargo loading into COPII-coated vesicle|SREBP-SCAP complex retention in endoplasmic reticulum,0.0001126|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,117|5149|5149|2574|2574
1703,18,0.5148,78.77,14080.0,0.00555,1.0,C15orf53 CHRNA7 DEXI DMXL2 DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8M MYO5A MYO5C NIPA2 PLA2G4D PLA2G4E SNURF SQOR TGM5 TMCO5A,positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process|regulation of postsynaptic membrane potential,1.686e-05|2.246e-05|2.886e-05|3.606e-05|0.0001108,0.2659|0.1772|0.1518|0.1422|0.3494,433.6|361.3|309.7|271|32.52
1704,4,0.538,3.228,3225.0,0.0009974,0.9929309999999999,DNAAF1 MOBP SLC41A3 VPS13C,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization|regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization|protein retention in Golgi apparatus|central nervous system myelin formation|determination of pancreatic left/right asymmetry,0.0003883|0.0003883|0.001165|0.001165|0.001165,1|1|1|1|1,5149|5149|1030|1030|1030
1705,4,0.5107,3.0639999999999996,3128.0,0.0009761000000000001,0.9929309999999999,CXCL14 DNAAF2 GATM HKDC1,creatine biosynthetic process|establishment of left/right asymmetry|positive regulation of natural killer cell chemotaxis|creatine metabolic process|regulation of natural killer cell chemotaxis,0.0005825|0.0007766|0.001359|0.001553|0.001747,1|1|1|1|1,2574|1716|858.1|735.5|643.6
1706,4,0.5377,3.2260000000000004,3178.0,0.001011,0.9929309999999999,DNAAF4 REXO1 YIF1A ZNF555,inner dynein arm assembly|outer dynein arm assembly|epithelial cilium movement involved in extracellular fluid movement|axonemal dynein complex assembly|extracellular transport,0.003297|0.004266|0.00678|0.007166|0.007359,1|1|1|1|1,321.8|245.2|151.4|143|139.2
1707,7,0.5175,10.87,4779.0,0.002262,0.9992989999999999,DNAAF5 ICE2 PIH1D1 POLR2M RPAP3 WDCP ZNHIT3,snoRNA localization|box C/D snoRNP assembly|small nucleolar ribonucleoprotein complex assembly|protein-containing complex assembly|RNA biosynthetic process,2.076e-06|4.447e-06|6.521e-06|0.0005334|0.0006751,0.03275|0.03508|0.03429|1|1,1177|735.5|588.4|8.802|15.59
1708,4,0.5131,3.0789999999999997,2996.0,0.001024,0.9929309999999999,DNAH10 HCAR2 HCAR3 P2RX4,neutrophil apoptotic process|positive regulation of adiponectin secretion|microglial cell migration|sensory perception of touch|positive regulation of secretion by cell,0.0005825|0.0005825|0.0005825|0.0009706|0.001132,1|1|1|1|1,2574|2574|2574|1287|36.26
1709,5,0.5074,5.074,4144.0,0.00122,0.996692,CAMK2A CROCC DNAH11 PCDHGA2 SERINC1,peptidyl-threonine autophosphorylation|determination of left/right asymmetry in nervous system|regulation of endocannabinoid signaling pathway|positive regulation of serine C-palmitoyltransferase activity|positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,0.000728|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|2060|1373|1373|1373
1710,4,0.5115,3.069,3072.0,0.0009956,0.9929309999999999,ANP32A DNAH12 HIVEP1 MORN3,BMP signaling pathway|cellular response to BMP stimulus|response to BMP|regulation of mRNA stability|transmembrane receptor protein serine/threonine kinase signaling pathway,0.01698|0.01985|0.01985|0.03696|0.0379,1|1|1|1|1,59.18|50.48|50.48|26.82|26.14
1711,4,0.5432,3.259,3225.0,0.001007,0.9929309999999999,DNAH6 DOK3 MKNK1 ZDHHC18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine|peptidyl-L-cysteine S-palmitoylation|protein palmitoylation|peptidyl-cysteine modification|peptidyl-amino acid modification,0.004846|0.004846|0.006393|0.007552|0.01026,1|1|1|1|1,214.5|214.5|160.9|135.5|11.77
1712,6,0.549,8.235,3781.0,0.002167,0.998474,AHR ARNT DNAJA1 DNAJA2 STIP1 TIPARP,"response to 2,3,7,8-tetrachlorodibenzodioxine|intracellular receptor signaling pathway|positive regulation of ATPase activity|regulation of ATPase activity|cellular response to organic cyclic compound",1.06e-06|1.738e-05|0.0001242|0.0002381|0.0002739,0.01672|0.1371|0.653|0.9388|0.8642,1716|52.54|118.4|84.75|20.59
1713,4,0.5455,3.273,2933.0,0.001112,0.9929309999999999,DNAJA4 PUS7L SLC38A2 WSB1,glycine betaine transport|cellular response to arsenite(3-)|response to arsenite(3-)|cellular response to arsenite ion|response to arsenite ion,0.0003883|0.0003883|0.0003883|0.0009706|0.0009706,1|1|1|1|1,5149|5149|5149|1287|1287
1714,4,0.5464,3.279,3499.0,0.0009339000000000001,0.9929309999999999,DNAJB14 GPR1 GUCY2C TMEM150C,proprioception|receptor guanylyl cyclase signaling pathway|cGMP biosynthetic process|neuromuscular process controlling posture|cGMP metabolic process,0.001165|0.002134|0.002522|0.003297|0.003685,1|1|1|1|1,1030|514.9|429.1|321.8|286
1715,4,0.5953,3.572,3210.0,0.001109,0.9929309999999999,CYB5D1 DHX34 DNAJB2 TSSK4,"peptidyl-threonine autophosphorylation|negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|negative regulation of protein deubiquitination|regulation of chaperone-mediated protein folding",0.0005825|0.0009706|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1287|1287|1287|1030
1716,4,0.5753,3.452,3344.0,0.001029,0.9929309999999999,DNAJB4 GADD45A LNPK LRRC58,endoplasmic reticulum tubular network maintenance|negative regulation of peptidyl-serine phosphorylation of STAT protein|positive regulation of endoplasmic reticulum tubular network organization|regulation of endoplasmic reticulum tubular network organization|activation of MAPKKK activity,0.0003883|0.0007766|0.0009706|0.001359|0.002716,1|1|1|1|1,5149|1716|1287|858.1|396.1
1717,6,0.5246,7.869,4205.0,0.0018629999999999999,0.998474,COLCA2 DNAJB6 POU2F3 SOX4 TFAP2B TP73,sympathetic nervous system development|aorta morphogenesis|kidney development|regulation of protein localization|renal system development,1.784e-05|3.275e-05|4.923e-05|5.125e-05|5.406e-05,0.2814|0.2583|0.2589|0.2021|0.1706,326.9|236.7|36.91|15.27|35.76
1718,4,0.5376,3.225,3222.0,0.0009976000000000002,0.9929309999999999,DNAJB7 HK3 NEU4 UNC5A,carbohydrate catabolic process|anterior/posterior axon guidance|ganglioside catabolic process|netrin-activated signaling pathway|fructose 6-phosphate metabolic process,0.0001938|0.001553|0.001553|0.002134|0.002328,1|1|1|1|1,88.77|735.5|735.5|514.9|468.1
1719,4,0.5322,3.193,3350.0,0.00095,0.9929309999999999,DNAJB8 EVI2B KLHL33 RXFP4,positive regulation of neutrophil differentiation|regulation of neutrophil differentiation|positive regulation of granulocyte differentiation|positive regulation of feeding behavior|regulation of stem cell division,0.0003883|0.0007766|0.001747|0.002134|0.002134,1|1|1|1|1,5149|1716|643.6|514.9|514.9
1720,8,0.5015,14.04,6263.0,0.002231,0.9996790000000001,DNAJB9 GNAI1 GNAT3 GRM3 IFRD1 SEMA3E SLC26A3 THAP5,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|myoblast fate determination|platelet activation|myoblast fate commitment,4.011e-06|6.731e-05|0.001164|0.001303|0.002328,0.06327|0.5309|1|1|1,91.94|35.11|1287|36.52|514.9
1721,4,0.5565,3.339,3100.0,0.001073,0.9929309999999999,ACAN DNAJC10 GNG13 MTRNR2L5,negative regulation of mitochondrial membrane permeability involved in apoptotic process|cellular response to staurosporine|response to staurosporine|negative regulation of mitochondrial membrane permeability|negative regulation of membrane permeability,0.0009706|0.001165|0.001165|0.001359|0.001747,1|1|1|1|1,1287|1030|1030|858.1|643.6
1722,4,0.5761,3.4560000000000004,3027.0,0.001137,0.9929309999999999,DNAJC12 FETUB KCNRG PRDX6,"negative regulation of delayed rectifier potassium channel activity|negative regulation of voltage-gated potassium channel activity|regulation of delayed rectifier potassium channel activity|negative regulation of potassium ion transmembrane transporter activity|positive regulation of mRNA splicing, via spliceosome",0.002522|0.002716|0.004266|0.004459|0.004653,1|1|1|1|1,429.1|396.1|245.2|234|223.9
1723,10,0.527,23.72,6789.0,0.003471,0.999933,AQR BUB1B DNAJC17 HAUS2 MFAP1 RPAP1 RTF1 TUBGCP4 TUBGCP5 USP8,mitotic prometaphase|spindle organization|biological phase|mitotic cell cycle phase|cell cycle phase,9.25e-07|2.961e-06|4.976e-06|4.976e-06|4.976e-06,0.01459|0.02336|0.02616|0.01962|0.0157,49.33|36.61|32.05|32.05|32.05
1724,4,0.5605,3.363,3232.0,0.001037,0.9929309999999999,CCL18 DNAJC18 IGDCC4 RASSF3,cellular response to misfolded protein|response to misfolded protein|chaperone cofactor-dependent protein refolding|'de novo' posttranslational protein folding|monocyte chemotaxis,0.004459|0.004846|0.00678|0.007745|0.008131,1|1|1|1|1,234|214.5|151.4|132|125.6
1725,11,0.5255,28.9,7335.0,0.003913000000000001,0.999969,DNAJC24 DOHH DPH1 DPH2 DPH3 DPH5 DPH6 DPH7 N6AMT1 TPT1 TTC4,peptidyl-diphthamide biosynthetic process from peptidyl-histidine|peptidyl-diphthamide metabolic process|regulation of cytoplasmic translational elongation|peptidyl-histidine modification|regulation of translational elongation,6.782e-21|6.782e-21|3.353e-20|8.164e-20|1.245e-18,1.07e-16|5.349e-17|1.763e-16|3.219e-16|3.928e-15,1638|1638|1191|1008|624.1
1726,12,0.5093,33.61,9595.0,0.003482,0.999986,BICD1 ETFBKMT IAPP ITPR2 KIAA1551 KLHL42 MANSC4 PTHLH RASSF8 SLCO1B3 SLCO1C1 TM7SF3,sodium-independent organic anion transport|bile acid and bile salt transport|regulation of microtubule-based process|negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase,4.732e-05|0.0001937|0.0003099|0.001164|0.001164,0.7464|1|1|1|1,214.5|101|21.91|1716|1716
1727,14,0.5159,46.95,9286.0,0.0050149999999999995,0.9999969999999999,ANAPC13 ANAPC15 ANAPC5 CDC16 MAD2L1BP PRPF39 SGO1 SGO2 SKA1 SKA3 SPAG5 TRNAU1AP UBE2C UBE2S,cell division|anaphase|mitotic anaphase|M phase|mitotic M phase,5.6e-16|4.102e-14|4.102e-14|4.749e-14|4.749e-14,8.834e-12|3.235e-10|2.157e-10|1.873e-10|1.498e-10,32.89|74.96|74.96|73.55|73.55
1728,4,0.5047,3.028,3110.0,0.0009701,0.9929309999999999,DERL3 DNALI1 MMD TTC33,"negative regulation of retrograde protein transport, ER to cytosol|negative regulation of protein exit from endoplasmic reticulum|regulation of retrograde protein transport, ER to cytosol|regulation of protein exit from endoplasmic reticulum|protein N-linked glycosylation via asparagine",0.001941|0.002134|0.002716|0.005233|0.006007,1|1|1|1|1,572.1|514.9|396.1|198|171.6
1729,5,0.5189,5.189,4202.0,0.001231,0.996692,CXCR6 DNASE1L3 LYPD3 TNS4 TOGARAM1,"regulation of neutrophil mediated cytotoxicity|programmed cell death involved in cell development|apoptotic DNA fragmentation|DNA catabolic process, endonucleolytic|apoptotic nuclear changes",0.001698|0.002425|0.00412|0.005812|0.006295,1|1|1|1|1,686.5|457.7|257.4|179.1|164.8
1730,6,0.5008,7.5120000000000005,5002.0,0.0014960000000000002,0.998474,DNER IL1F10 IL1RN IL36G PXYLP1 RNF149,inflammatory response to antigenic stimulus|inflammatory response|cytokine-mediated signaling pathway|cellular response to lipopolysaccharide|positive regulation of heparan sulfate proteoglycan biosynthetic process,1.154e-07|0.0002675|0.000679|0.00115|0.001165,0.00182|1|1|1|1,294.2|20.76|15.1|37.93|1144
1731,4,0.5543,3.326,3117.0,0.0010630000000000001,0.9929309999999999,CARF DNMBP MC1R USP48,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus|cellular response to calcium ion|response to calcium ion|cellular response to metal ion,2.827e-07|1.411e-05|0.0001749|0.0005401|0.0008749,0.00446|0.1113|0.9195|1|1,4119|358.2|96.92|54.56|42.68
1732,9,0.5245,18.88,6217.0,0.003019,0.9998530000000001,ARMC7 CCDC84 DDX59 LINS1 METTL23 NOSIP PPIH RBM48 SCNM1,negative regulation of nitric-oxide synthase activity|negative regulation of monooxygenase activity|negative regulation of centrosome duplication|negative regulation of centrosome cycle|cognition,0.003925|0.005665|0.005665|0.005665|0.006927,1|1|1|1|1,286|190.7|190.7|190.7|15.57
1733,4,0.5377,3.2260000000000004,2898.0,0.001109,0.9929309999999999,DNTTIP1 ELMSAN1 NAT2 TEAD4,trophectodermal cell fate commitment|female pregnancy|multi-multicellular organism process|N-terminal peptidyl-methionine acetylation|glutamine transport,0.0004854|0.0007545|0.001014|0.00194|0.002183,1|1|1|1|1,4119|46.02|39.61|588.4|514.9
1734,5,0.5086,5.086,3771.0,0.001343,0.996692,ACBD3 DOCK10 FLT3 SPN ZFP64,lymphocyte differentiation|mononuclear cell differentiation|leukocyte differentiation|lymphocyte activation|leukocyte homeostasis,1.755e-05|2.704e-05|4.988e-05|6.748e-05|0.0001163,0.2769|0.2133|0.2623|0.2661|0.367,49.83|43.06|35.01|31.6|119.4
1735,4,0.5416,3.25,3233.0,0.0010019999999999999,0.9929309999999999,CISH DOCK3 GDF3 WDR6,regulation of phosphorylation|positive regulation of non-membrane spanning protein tyrosine kinase activity|regulation of non-membrane spanning protein tyrosine kinase activity|regulation of phosphate metabolic process|regulation of phosphorus metabolic process,0.001197|0.001553|0.001747|0.001808|0.001808,1|1|1|1|1,11.03|735.5|643.6|9.588|9.588
1736,4,0.5001,3.0010000000000003,3102.0,0.000964,0.9929309999999999,DOCK4 MMP16 SSH3 ZMYM6,negative regulation of vascular associated smooth muscle contraction|negative regulation of vasoconstriction|regulation of vascular associated smooth muscle contraction|chondrocyte proliferation|negative regulation of smooth muscle contraction,0.0007766|0.001553|0.001747|0.002328|0.002716,1|1|1|1|1,1716|735.5|643.6|468.1|396.1
1737,4,0.5035,3.0210000000000004,3165.0,0.000951,0.9929309999999999,DOCK6 HTR3D MNX1 TCTEX1D2,regulation of intraciliary retrograde transport|spinal cord motor neuron cell fate specification|intraciliary retrograde transport|neuron fate specification|spinal cord motor neuron differentiation,0.0005825|0.002134|0.00291|0.005813|0.006007,1|1|1|1|1,2574|514.9|367.8|177.5|171.6
1738,6,0.5496,8.244,4560.0,0.0018,0.998474,DOCK7 ITPRIPL2 LRCH1 MOB1A STK4 TAOK2,hippo signaling|intracellular signal transduction|regulation of protein autophosphorylation|positive regulation of phosphorylation|positive regulation of phosphorus metabolic process,1.075e-07|4.856e-05|0.0001203|0.0001225|0.000167,0.001696|0.383|0.6325|0.4832|0.5269,315.2|9.34|122.6|12.89|11.9
1739,5,0.5142,5.142,4157.0,0.001232,0.996692,AP3M2 DOK1 FA2H HGSNAT MAP3K20,positive regulation of mitotic DNA damage checkpoint|sebaceous gland cell differentiation|glucosylceramide biosynthetic process|positive regulation of DNA damage checkpoint|regulation of mitotic DNA damage checkpoint,0.0005824|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,3432|1716|1716|1716|1716
1740,5,0.5029,5.029,4058.0,0.001235,0.996692,APOM C1QTNF12 DOK4 PDP2 TPPP3,positive regulation of pyruvate dehydrogenase activity|negative regulation of plasma lipoprotein oxidation|regulation of plasma lipoprotein oxidation|regulation of pyruvate dehydrogenase activity|regulation of acetyl-CoA biosynthetic process from pyruvate,0.000728|0.000728|0.000728|0.0009706|0.002183,1|1|1|1|1,2060|2060|2060|1373|514.9
1741,4,0.558,3.3480000000000003,3314.0,0.001007,0.9929309999999999,DOK5 KCNQ2 MCCC1 TKTL2,leucine catabolic process|leucine metabolic process|biotin metabolic process|regulation of neurotrophin TRK receptor signaling pathway|branched-chain amino acid catabolic process,0.001359|0.001747|0.001941|0.002522|0.004266,1|1|1|1|1,858.1|643.6|572.1|429.1|245.2
1742,4,0.5035,3.0210000000000004,3101.0,0.0009707000000000001,0.9929309999999999,ANAPC1 ANAPC10 DOK7 PIWIL1,protein K11-linked ubiquitination|regulation of exit from mitosis|anaphase-promoting complex-dependent catabolic process|anaphase|mitotic anaphase,1.313e-05|2.792e-05|0.0001101|0.0003516|0.0003516,0.2071|0.2202|0.5791|1|1,355.1|239.5|118.4|65.59|65.59
1743,5,0.5201,5.2010000000000005,3892.0,0.0013310000000000002,0.996692,BTN2A2 DOPEY1 GPX5 HLA-DMB TXNDC5,regulation of T cell proliferation|regulation of lymphocyte proliferation|regulation of mononuclear cell proliferation|positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell|regulation of leukocyte proliferation,0.0004209|0.0007212|0.0007339|0.0007766|0.0008457,1|1|1|1|1,59.87|45.56|45.16|1716|42.03
1744,4,0.5184,3.11,3140.0,0.0009871,0.9929309999999999,DOPEY2 HEPACAM IFT80 PEAR1,articular cartilage development|osteoblast proliferation|receptor localization to non-motile cilium|negative regulation of non-canonical Wnt signaling pathway|recognition of apoptotic cell,0.0005825|0.0008737|0.0008737|0.001019|0.001165,1|1|1|1|1,2288|1373|1373|1144|980.7
1745,4,0.5754,3.452,3182.0,0.0010810000000000001,0.9929309999999999,DPEP3 ENPP4 KSR2 SPATS1,purine ribonucleoside catabolic process|purine nucleoside catabolic process|positive regulation of hemostasis|positive regulation of blood coagulation|positive regulation of coagulation,0.002667|0.002667|0.005812|0.005812|0.006054,1|1|1|1|1,411.9|411.9|179.1|179.1|171.6
1746,4,0.5046,3.028,3107.0,0.0009712,0.9929309999999999,CD5 DPP4 RASSF3 ULK4,T cell costimulation|lymphocyte costimulation|positive regulation of T cell activation|negative regulation of granulocyte chemotaxis|negative regulation of neutrophil chemotaxis,4.185e-05|4.498e-05|0.0006657|0.0007766|0.0007766,0.6602|0.3547|1|1|1,194.3|187.2|47.45|1716|1716
1747,6,0.542,8.13,4712.0,0.001718,0.998474,BIVM CLYBL DPP8 GAS6 GPR183 SLITRK5,lymphocyte chemotaxis|lymphocyte migration|mononuclear cell migration|negative regulation of renal albumin absorption|positive regulation of cobalamin metabolic process,8.956e-05|0.0001995|0.0003955|0.0005824|0.0005824,1|1|1|1|1,140.1|92.77|65.38|3432|3432
1748,5,0.5313,5.313,4187.0,0.0012640000000000001,0.996692,DPP9 GPR141 OARD1 PEPD SMIM29,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|collagen catabolic process|collagen metabolic process|purine nucleoside metabolic process,0.0009706|0.001698|0.01064|0.01496|0.0152,1|1|1|1|1,1373|686.5|95.79|67.52|66.44
1749,4,0.5483,3.29,3165.0,0.001036,0.9929309999999999,CFAP299 DPRX NAAA NPFFR2,N-acylethanolamine metabolic process|N-acylphosphatidylethanolamine metabolic process|ethanolamine-containing compound metabolic process|sphingosine metabolic process|regulation of cAMP-dependent protein kinase activity,0.001165|0.001941|0.001941|0.004072|0.004072,1|1|1|1|1,1030|572.1|572.1|257.4|257.4
1750,4,0.5514,3.3089999999999997,3302.0,0.0009984,0.9929309999999999,DPT LTB PACRGL VAMP4,synaptic vesicle to endosome fusion|synaptic vesicle endosomal processing|SNARE complex assembly|Golgi ribbon formation|regulation of synaptic vesicle endocytosis,0.0007766|0.002134|0.002134|0.002716|0.003491,1|1|1|1|1,1716|514.9|514.9|396.1|302.9
1751,18,0.5063,77.47,13350.0,0.005753,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1C HIST1H1E HIST1H1T HIST1H2AC HIST1H2AD HIST1H2BD HIST1H4C OR14J1 OR2B6 OR2J2 OR2J3 SLC17A2 SLC17A4 ZKSCAN4 ZSCAN16,sialic acid transport|cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance|detoxification,8.982e-06|3.654e-05|5.301e-05|6.361e-05|9.701e-05,0.1417|0.2882|0.2787|0.2508|0.3061,588.4|46.45|40.86|38.38|33.18
1752,4,0.5172,3.103,3256.0,0.0009496999999999999,0.9929309999999999,CD6 DPYS HSD17B8 MYLIP,uracil catabolic process|thymine catabolic process|pyrimidine nucleobase catabolic process|uracil metabolic process|thymine metabolic process,0.0005825|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|1716|1716|1716|1716
1753,4,0.5196,3.117,3217.0,0.0009658,0.9929309999999999,C14orf119 CUZD1 DPYSL4 NXPH4,trypsinogen activation|zymogen activation|neuron death|neuropeptide signaling pathway|protein processing,0.0003883|0.009289|0.01199|0.02119|0.03374,1|1|1|1|1,5149|109.5|84.41|47.24|29.42
1754,7,0.5297,11.12,5211.0,0.002125,0.9992989999999999,CLCNKA GPR153 PRAMEF11 PRAMEF12 PRAMEF14 PRAMEF18 PRAMEF20,negative regulation of cell differentiation|negative regulation of developmental process|negative regulation of apoptotic process|negative regulation of programmed cell death|positive regulation of cell population proliferation,5.814e-07|2.672e-06|2.955e-06|3.278e-06|3.746e-06,0.009171|0.02107|0.01554|0.01293|0.01182,23.06|16.91|16.57|16.22|15.78
1755,7,0.5016,10.53,5508.0,0.0019039999999999999,0.9992989999999999,DRD3 LNP1 MAATS1 MTRNR2L8 OR5K3 PROS1 TMPRSS7,"negative regulation of sodium:proton antiporter activity|musculoskeletal movement, spinal reflex action|gastric emptying|gastric motility|regulation of locomotion involved in locomotory behavior",0.0008735|0.0008735|0.001165|0.001165|0.001456,1|1|1|1|1,1716|1716|1144|1144|858.1
1756,4,0.5269,3.161,3191.0,0.0009873,0.9929309999999999,CAPN11 DRD4 PATE2 TBC1D24,positive regulation of catecholamine uptake involved in synaptic transmission|positive regulation of dopamine uptake involved in synaptic transmission|positive regulation of sodium:proton antiporter activity|neuron death in response to oxidative stress|adenylate cyclase-inhibiting dopamine receptor signaling pathway,0.0007766|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,1716|1716|1287|1287|1030
1757,11,0.5131,28.22,7915.0,0.003543,0.999969,DDX41 DDX46 GEMIN5 IK ISY1 LARS RBM22 RPS14 SLU7 TTC1 U2SURP,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|mRNA metabolic process|RNA splicing",3.805e-13|3.805e-13|4.112e-13|3.081e-12|3.962e-12,6.002e-09|3.001e-09|2.162e-09|1.215e-08|1.25e-08,49.6|49.6|49.11|24.28|36.8
1758,6,0.503,7.546,4097.0,0.0018329999999999998,0.998474,CCND2 DRG2 IRF4 PRDM1 RWDD1 SMAD7,regulation of alpha-beta T cell differentiation|regulation of alpha-beta T cell activation|regulation of T cell differentiation|regulation of lymphocyte differentiation|regulation of leukocyte differentiation,7.14e-07|2.472e-06|7.597e-06|1.266e-05|5.081e-05,0.01126|0.0195|0.03995|0.04991|0.1603,156|102|69.58|58.51|36.52
1759,9,0.528,19.01,6230.0,0.0030329999999999997,0.9998530000000001,CDT1 MRE11 ORC1 ORC2 ORC3 ORC4 ORC5 ORC6 PNKP,DNA-dependent DNA replication|DNA replication initiation|DNA replication|pre-replicative complex assembly|G1/S transition of mitotic cell cycle,7.321e-19|1.147e-17|1.391e-17|1.688e-16|1.343e-14,1.155e-14|9.043e-14|7.312e-14|6.656e-13|4.238e-11,106.2|372.5|76|246.4|128.1
1760,24,0.5052,139.4,18760.0,0.007359,1.0,APTX AQP7 BAG1 CCL19 CCL21 CREB3 DNAJA1 DNAJB5 FAM205A FAM219A GALT GBA2 IFNK IL11RA KIF24 NPR2 OR13J1 OR2S2 SIGMAR1 SPAG8 SPINK4 TESK1 TOMM5 UBAP2,regulation of dendritic cell dendrite assembly|positive regulation of dendritic cell antigen processing and presentation|negative regulation of dendritic cell apoptotic process|establishment of T cell polarity|establishment of lymphocyte polarity,1.296e-05|4.651e-05|4.651e-05|5.81e-05|7.096e-05,0.2044|0.3668|0.2446|0.2291|0.2239,572.1|245.2|245.2|214.5|190.7
1761,9,0.5369,19.33,5923.0,0.003243,0.9998530000000001,BUB1B DLGAP5 DSN1 KNTC1 MAD1L1 MAPRE1 TRIP13 ZWILCH ZWINT,mitotic spindle organization|microtubule cytoskeleton organization involved in mitosis|spindle organization|mitotic cell cycle process|anaphase,1.789e-16|4.575e-16|2.114e-15|5.307e-14|6.321e-14,2.822e-12|3.608e-12|1.111e-11|2.093e-10|1.994e-10,111.6|98.95|81.36|30.07|102
1762,4,0.533,3.198,3118.0,0.0010220000000000001,0.9929309999999999,DSTN FBXW9 IPP TMCO4,actin filament fragmentation|actin filament depolymerization|positive regulation of actin filament depolymerization|actin filament severing|inositol phosphate dephosphorylation,0.001213|0.003152|0.003394|0.003878|0.004362,1|1|1|1|1,1030|343.3|316.8|274.6|242.3
1763,5,0.5497,5.497000000000001,4244.0,0.001291,0.996692,C19orf73 DSTYK GRM7 LAIR2 ZNF765,negative regulation of glutamate secretion|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|positive regulation of fibroblast growth factor receptor signaling pathway|response to pheromone|negative regulation of amino acid transport,0.001456|0.00194|0.002183|0.002667|0.003394,1|1|1|1|1,823.8|588.4|514.9|411.9|316.8
1764,5,0.5466,5.466,4044.0,0.0013460000000000002,0.996692,BBS5 DTD2 G6PC2 SCN2A SCN7A,neuronal action potential|membrane depolarization during action potential|transmission of nerve impulse|membrane depolarization|action potential,2.045e-05|2.331e-05|6.711e-05|6.711e-05|0.0002042,0.3225|0.1838|0.3528|0.2646|0.6441,294.2|274.6|158.4|158.4|89.54
1765,5,0.5315,5.315,3858.0,0.001372,0.996692,DTHD1 FUT6 S100A10 UQCR11 ZNF77,N-glycan fucosylation|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|membrane raft assembly,0.000728|0.002425|0.002425|0.002425|0.002667,1|1|1|1|1,2060|457.7|457.7|457.7|411.9
1766,4,0.5369,3.222,3199.0,0.001004,0.9929309999999999,DTNA FAM3D GALNT11 PPARD,regulation of insulin secretion|regulation of peptide hormone secretion|negative regulation of glucagon secretion|regulation of hormone secretion|regulation of protein secretion,0.0005069|0.0006963|0.0009706|0.00107|0.001132,1|1|1|1|1,54.48|46.39|1287|37.31|36.26
1767,14,0.5113,46.53,10930.0,0.004229,0.9999969999999999,ATXN7L3B CCDC25 CCNB1IP1 DTWD1 KIAA1257 KIF26B LYRM1 MAP3K7CL NIPSNAP3B PCDHGA9 SDR39U1 SLC25A36 ZNF286A ZNF512B,response to stimulus|UNCLASSIFIED|biological_process|pyrimidine nucleotide transport|pyrimidine nucleotide import into mitochondrion,0.0006707|0.00109|0.00109|0.002037|0.002037,1|1|1|1|1,0|3.751|0.5769|735.5|735.5
1768,5,0.5117,5.117,4277.0,0.001192,0.996692,ACTRT2 CBY3 DTWD2 HMHB1 TBC1D19,positive regulation of interferon-gamma production|regulation of cellular process|tRNA modification|regulation of interferon-gamma production|tRNA processing,0.0164|0.01872|0.0219|0.02618|0.03187,1|1|1|1|1,61.48|0|45.77|38.14|31.2
1769,5,0.5073,5.073,4242.0,0.001192,0.996692,ASIC4 DUS3L HDHD3 HOXD8 SSFA2,"tRNA dihydrouridine synthesis|tripartite regional subdivision|anterior/posterior axis specification, embryo|blastoderm segmentation|behavioral fear response",0.001165|0.003491|0.003491|0.004072|0.005426,1|1|1|1|1,1030|302.9|302.9|257.4|190.7
1770,4,0.5405,3.2430000000000003,3170.0,0.001019,0.9929309999999999,ANKIB1 DUSP14 HOXA9 NECTIN3,fertilization|endothelial cell activation|definitive hemopoiesis|uterus development|spermatogenesis,0.0004912|0.002328|0.003491|0.003878|0.00412,1|1|1|1|1,55.36|468.1|302.9|271|18.79
1771,4,0.5136,3.0810000000000004,3155.0,0.0009731,0.9929309999999999,DUSP16 RNF220 TNFRSF11A TREM2,osteoclast differentiation|regulation of MAPK cascade|myeloid leukocyte differentiation|positive regulation of inflammatory response|positive regulation of CAMKK-AMPK signaling cascade,2.429e-05|0.0001504|0.0002105|0.0002316|0.0003883,0.3831|1|1|0.9132|0.5569,257.4|22.26|85.1|81.08|5149
1772,4,0.5228,3.137,3199.0,0.0009772000000000001,0.9929309999999999,C22orf15 DENND6B DUSP19 SEMA4F,negative regulation of JUN kinase activity|retinal ganglion cell axon guidance|negative regulation of axon extension involved in axon guidance|regulation of axon extension involved in axon guidance|negative regulation of JNK cascade,0.00291|0.003491|0.005233|0.006393|0.007166,1|1|1|1|1,367.8|302.9|198|160.9|143
1773,4,0.5383,3.23,3162.0,0.001018,0.9929309999999999,DUSP26 GABARAPL2 MC2R MEDAG,positive regulation of peptidyl-serine dephosphorylation|regulation of peptidyl-serine dephosphorylation|negative regulation of protein kinase activity by regulation of protein phosphorylation|cellular response to nitrogen starvation|cellular response to nitrogen levels,0.0005825|0.001165|0.001747|0.002716|0.002716,1|1|1|1|1,2574|1030|643.6|396.1|396.1
1774,4,0.5948,3.569,3363.0,0.001058,0.9929309999999999,APOF DUSP27 HAL LSR,tricellular tight junction assembly|protein localization to tricellular tight junction|formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide,0.0003883|0.0005825|0.0009706|0.0009706|0.0009706,1|1|1|1|1,5149|2574|1287|1287|1287
1775,14,0.51,46.41,9395.0,0.004901,0.9999969999999999,C1orf109 DHX33 MYBBP1A NOL9 PAK1IP1 POP5 RPP21 RPP30 RPP40 SPATA5L1 TIMM10 TRMT112 UTP4 WDR18,ribosome biogenesis|ribonucleoprotein complex biogenesis|ncRNA processing|rRNA processing|rRNA metabolic process,1.558e-13|3.02e-12|1.088e-10|1.799e-10|2.327e-10,2.457e-09|2.382e-08|5.719e-07|7.094e-07|7.34e-07,39.88|28.47|27.24|39.61|38.14
1776,4,0.5361,3.217,3155.0,0.001016,0.9929309999999999,DUSP3 FAP HDGFL3 OR4L1,negative regulation of T cell activation|negative regulation of leukocyte cell-cell adhesion|melanocyte apoptotic process|negative regulation of lymphocyte activation|negative regulation of leukocyte activation,0.0003327|0.0003963|0.0004854|0.0005471|0.0007545,1|1|1|1|1,69.81|63.86|4119|54.2|46.02
1777,10,0.5152,23.18,5947.0,0.003871,0.999933,GRB2 LZTR1 NF1 NRAS PTPN11 RAF1 SHOC2 SOS1 SPRED1 SPRED2,MAPK cascade|fibroblast growth factor receptor signaling pathway|neurotrophin TRK receptor signaling pathway|cellular response to growth factor stimulus|transmembrane receptor protein tyrosine kinase signaling pathway,1.481e-10|2.791e-10|2.958e-10|6.148e-10|7.626e-10,2.336e-06|2.201e-06|1.555e-06|2.424e-06|2.406e-06,35.25|127.1|411.9|28.66|27.78
1778,15,0.4807,50.47,11810.0,0.0042450000000000005,0.999999,AP5M1 ATXN7L3B CCNB1IP1 KIF26B LYRM1 MAP3K7CL NECAP2 NIPSNAP3B PCBP4 RAB22A RNF114 SDR39U1 SLC25A40 TXNDC16 ZNF286A,ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation|renal vesicle formation|chiasma assembly,0.002908|0.003634|0.004359|0.005084|0.005084,1|1|1|1|1,457.7|343.2|274.6|228.8|228.8
1779,4,0.562,3.372,3234.0,0.001039,0.9929309999999999,DYDC2 GSTZ1 SLC50A1 SPRN,glucoside transport|tyrosine catabolic process|glycoside transport|regulation of acetyl-CoA biosynthetic process from pyruvate|chromatin silencing at telomere,0.0009706|0.001456|0.001456|0.002183|0.002425,1|1|1|1|1,1373|823.8|823.8|514.9|457.7
1780,4,0.526,3.156,3026.0,0.001039,0.9929309999999999,DDAH2 DYNC1I1 ENPP4 PRR3,citrulline metabolic process|arginine catabolic process|purine ribonucleoside catabolic process|purine nucleoside catabolic process|small molecule catabolic process,0.00194|0.002425|0.002667|0.002667|0.003816,1|1|1|1|1,588.4|457.7|411.9|411.9|20.14
1781,16,0.5176,62.12,12440.0,0.004958,0.999999,BIRC3 CARD16 CCDC81 CEP126 CFAP300 DYNC2H1 FAM76B MMP1 MMP10 MMP13 MMP20 MMP27 MMP3 MMP7 MMP8 SYT9,collagen catabolic process|collagen metabolic process|extracellular matrix disassembly|extracellular matrix organization|extracellular structure organization,4.769e-20|8.377e-19|9.834e-14|6.171e-12|6.313e-12,7.523e-16|6.607e-15|5.171e-10|2.433e-08|1.992e-08,253.6|178.7|128.5|28.54|28.47
1782,5,0.5022,5.022,4159.0,0.0012029999999999999,0.996692,CAMKK1 DYNC2LI1 FBLN2 FBXO41 RBP7,intraciliary retrograde transport|intraciliary transport involved in cilium assembly|intraciliary transport|regulation of cilium assembly|protein transport along microtubule,0.003636|0.009913|0.01304|0.01448|0.01664,1|1|1|1|1,294.2|103|77.72|69.81|60.57
1783,4,0.5667,3.4,3359.0,0.001009,0.9929309999999999,CELA2A DYNLL2 HOXA9 OPN3,"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed|regulation of ATP-dependent microtubule motor activity, plus-end-directed|insulin catabolic process|positive regulation of microtubule motor activity|keratinocyte differentiation",0.0007766|0.0007766|0.0007766|0.0009706|0.001009,1|1|1|1|1,1716|1716|1716|1287|38.42
1784,4,0.5578,3.347,3329.0,0.0010019999999999999,0.9929309999999999,CLDN10 DYRK3 IL22RA1 SFN,regulation of epidermal cell division|nuclear speck organization|stress granule disassembly|ribonucleoprotein complex disassembly|positive regulation of cell cycle process,0.0009706|0.001213|0.001456|0.00194|0.002026,1|1|1|1|1,1373|1030|823.8|588.4|27.83
1785,18,0.5008,76.62,14020.0,0.005423,1.0,A2M C3AR1 CLEC2B CLEC4C CLEC4D CLEC6A GALNT8 KCNA5 KCNA6 KLRC1 PKP2 PRB4 PRH2 SLC2A3 SLCO1C1 TAS2R20 TAS2R7 TAS2R9,detection of chemical stimulus involved in sensory perception of bitter taste|regulation of innate immune response|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|regulation of response to biotic stimulus,5.01e-06|6.059e-06|7.241e-06|7.754e-06|2.527e-05,0.07903|0.04778|0.03807|0.03058|0.07971,95.35|18.34|83.72|81.73|13.59
1786,15,0.5032,52.84,10960.0,0.004786,0.999999,HIST1H2AC HIST1H2AD HIST1H2BD HIST1H2BG HIST1H2BN HIST1H3D HIST1H3J HLA-F OR14J1 OR2B6 OR2J3 PSORS1C2 TRIM10 TRIM26 ZKSCAN4,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|innate immune response,4.658e-05|6.374e-05|0.0001663|0.0002224|0.0002986,0.7347|0.5027|0.8743|0.8769|0.9422,208|176|106.4|91.53|10.9
1787,4,0.5006,3.0039999999999996,3220.0,0.0009297000000000001,0.9929309999999999,E2F2 FOXQ1 STOM TMEM143,regulation of acid-sensing ion channel activity|lens fiber cell apoptotic process|positive regulation by host of viral genome replication|negative regulation of sprouting angiogenesis|positive regulation by host of viral process,0.0003883|0.0009706|0.001747|0.002328|0.003104,1|1|1|1|1,5149|1287|643.6|468.1|343.2
1788,4,0.5514,3.3089999999999997,3044.0,0.001083,0.9929309999999999,CABP5 E2F4 PTDSS1 ZNF628,phosphatidylserine biosynthetic process|multi-ciliated epithelial cell differentiation|motile cilium assembly|centriole assembly|cell volume homeostasis,0.0009706|0.001941|0.00504|0.005813|0.006007,1|1|1|1|1,1287|572.1|205.9|177.5|171.6
1789,5,0.5079,5.079,4123.0,0.001227,0.996692,EAF2 HAVCR2 PLPP7 ZDHHC12 ZNF189,negative regulation of granulocyte colony-stimulating factor production|negative regulation of interleukin-3 production|negative regulation of macrophage colony-stimulating factor production|negative regulation of immunological synapse formation|regulation of interleukin-3 production,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
1790,14,0.5068,46.12,10770.0,0.004254,0.9999969999999999,ADCY10 ARMC1 ATXN7L3B CCNB1IP1 EAPP KIF26B LYRM1 MAP3K7CL NIPSNAP3B PCDHB12 PCDHB13 PCDHGA9 SDR39U1 ZNF286A,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation,0.0001877|0.0006665|0.002715|0.003392|0.004069,1|1|1|1|1,26.43|17.04|490.4|367.8|294.2
1791,4,0.5333,3.2,3150.0,0.0010119999999999999,0.9929309999999999,DIRAS3 EBAG9 MMP13 SLC28A2,inosine transport|adenosine transport|purine nucleobase transmembrane transport|purine nucleoside transmembrane transport|pyrimidine nucleoside transport,0.0003883|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,5149|1716|1287|1287|1030
1792,4,0.548,3.2880000000000003,3113.0,0.001052,0.9929309999999999,EBF3 NLK OTX2 TBR1,"regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated",0.0001351|0.0001353|0.0001363|0.0001812|0.0001812,1|1|0.7165|0.7147|0.5718,5.945|5.944|5.935|10.16|10.16
1793,4,0.5354,3.2119999999999997,3132.0,0.0010220000000000001,0.9929309999999999,EBI3 IPP MGST2 TMCO4,leptin-mediated signaling pathway|interleukin-35-mediated signaling pathway|interleukin-27-mediated signaling pathway|glutathione biosynthetic process|organic heteropentacyclic compound metabolic process,0.00291|0.00291|0.00291|0.003878|0.00412,1|1|1|1|1,374.5|374.5|374.5|274.6|257.4
1794,6,0.5003,7.505,5506.0,0.001358,0.998474,EBLN2 IL4 TGM4 TMEM104 TTC39B ZFAND4,"positive regulation of eosinophil chemotaxis|regulation of eosinophil chemotaxis|T-helper 2 cell cytokine production|T cell cytokine production|CD4-positive, alpha-beta T cell cytokine production",0.0008735|0.0008735|0.0008735|0.001165|0.001165,1|1|1|1|1,1716|1716|1716|1144|1144
1795,4,0.5105,3.063,3175.0,0.0009615,0.9929309999999999,B3GAT1 ECEL1 ENTPD4 OBSL1,UDP catabolic process|pyrimidine ribonucleoside diphosphate catabolic process|pyrimidine nucleoside diphosphate catabolic process|GDP catabolic process|UDP metabolic process,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
1796,4,0.5607,3.364,3019.0,0.0011099999999999999,0.9929309999999999,ECH1 LGALS7 LGALS7B LYPD4,"negative regulation of CD4-positive, alpha-beta T cell proliferation|regulation of CD4-positive, alpha-beta T cell proliferation|negative regulation of alpha-beta T cell proliferation|negative regulation of CD4-positive, alpha-beta T cell activation|regulation of alpha-beta T cell proliferation",0.001456|0.001892|0.001892|0.004799|0.005089,1|1|1|1|1,762.8|572.1|572.1|214.5|201.9
1797,4,0.5634,3.38,3162.0,0.001065,0.9929309999999999,ECM2 LSS MSR1 RALBP1,organic hydroxy compound transport|doxorubicin transport|triterpenoid biosynthetic process|triterpenoid metabolic process|glycoside transport,0.0003257|0.0003883|0.0003883|0.0005825|0.001165,1|1|1|1|1,68.2|5149|5149|2574|1030
1798,12,0.5004,33.03,9253.0,0.003547,0.999986,AKAP2 ASB6 C9orf84 ECPAS FAM129B OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.071e-06|1.43e-06|1.719e-06|2.434e-06|2.922e-06,0.01689|0.01128|0.009037|0.009597|0.009218,23.35|22|21.19|19.73|19
1799,4,0.5551,3.3310000000000004,3276.0,0.001013,0.9929309999999999,EDARADD GPM6A HS3ST1 NID2,basement membrane organization|positive regulation of filopodium assembly|regulation of filopodium assembly|positive regulation of NIK/NF-kappaB signaling|neural retina development,0.005426|0.006007|0.009289|0.01314|0.01352,1|1|1|1|1,190.7|171.6|109.5|76.85|74.62
1800,4,0.5041,3.025,3212.0,0.0009385,0.9929309999999999,EDIL3 HOGA1 NDFIP1 PLIN5,oxalate metabolic process|negative regulation of isotype switching to IgE isotypes|glyoxylate catabolic process|negative regulation of peroxisome proliferator activated receptor signaling pathway|4-hydroxyproline metabolic process,0.0003883|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|1716|1716|1716|1287
1801,5,0.5092,5.092,4152.0,0.001222,0.996692,EDNRA METTL22 MUC16 RFNG RNF150,endothelin receptor signaling pathway|artery smooth muscle contraction|tonic smooth muscle contraction|enteric nervous system development|vascular associated smooth muscle contraction,0.00194|0.002425|0.002667|0.003878|0.00412,1|1|1|1|1,588.4|457.7|411.9|274.6|257.4
1802,7,0.5194,10.91,4831.0,0.002246,0.9992989999999999,CCT3 COPA EEF1A1 PSMB4 PSMD4 RPL23A SF3B4,regulation of mRNA metabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,0.0001524|0.0002165|0.0002165|0.0002165|0.0002165,1|1|1|0.8538|0.683,25.96|90.53|90.53|90.53|90.53
1803,4,0.5506,3.304,3360.0,0.00098,0.9929309999999999,DCDC2B EEF1AKMT1 LIX1 ZNF660,autophagosome maturation|peptidyl-lysine methylation|protein methylation|protein alkylation|macroautophagy,0.005813|0.0164|0.02444|0.02444|0.03696,1|1|1|1|1,177.5|61.29|40.86|40.86|26.82
1804,5,0.5077,5.077,3876.0,0.0013050000000000002,0.996692,EEF1AKMT2 REEP4 SMIM2 SNX18 TMEFF1,cleavage furrow formation|peptidyl-lysine monomethylation|endoplasmic reticulum tubular network organization|peptidyl-lysine dimethylation|cell division,0.00194|0.002667|0.003878|0.004845|0.00547,1|1|1|1|1,588.4|411.9|274.6|216.8|16.74
1805,5,0.5286,5.2860000000000005,4004.0,0.001315,0.996692,B3GALT5 EEF1AKMT3 FAM107B SCGB2A2 SYCP2,male anatomical structure morphogenesis|male genitalia morphogenesis|poly-N-acetyllactosamine biosynthetic process|poly-N-acetyllactosamine metabolic process|genitalia morphogenesis,0.001213|0.001213|0.003152|0.003394|0.003394,1|1|1|1|1,1030|1030|343.3|316.8|316.8
1806,12,0.5035,33.23,8481.0,0.003892,0.999986,ANAPC11 CHMP6 EIF4A3 FTSJ3 GOSR2 GPS1 HGS NPLOC4 NSF SAP30BP TBCD USP36,vesicle organization|vesicle budding from membrane|post-Golgi vesicle-mediated transport|protein transport|vacuolar transport,2.377e-05|2.814e-05|6.053e-05|8.251e-05|8.57e-05,0.375|0.2219|0.3182|0.3254|0.2704,22.15|49.99|38.42|7.039|34.1
1807,6,0.5011,7.516,4195.0,0.0017829999999999999,0.998474,EEF2 EIF3G PPAN PWP2 SF3A2 WDR18,ribonucleoprotein complex biogenesis|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|cellular protein-containing complex assembly|gene expression,3.564e-08|1.127e-07|1.299e-07|4.288e-05|7.412e-05,0.0005621|0.0008889|0.0006832|0.1691|0.2338,36.91|72.26|69.7|15.98|7.851
1808,15,0.5092,53.47,10300.0,0.005149,0.999999,CNIH4 DUX4 EIF2S1 HSPE1 NBEAL1 NUTF2 OR2A25 RPL12 RPL17 RPL37 RPL4 RPLP2 RPS13 SNU13 ST20,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,1.017e-11|9.737e-11|1.304e-10|2.247e-10|2.757e-10,1.604e-07|7.68e-07|6.857e-07|8.863e-07|8.698e-07,63.01|80.45|76.47|69.58|67.16
1809,7,0.8885,18.66,3795.0,0.004875,0.9992989999999999,EEFSEC GPX4 PSTK SECISBP2 SEPHS2 SEPSECS TXNRD1,translational readthrough|selenocysteine incorporation|translational elongation|peptide metabolic process|selenocysteinyl-tRNA(Sec) biosynthetic process,2.307e-12|2.307e-12|5.06e-08|2.488e-07|1.483e-06,3.638e-08|1.819e-08|0.0002661|0.000981|0.00468,1471|1471|94.15|27.39|1471
1810,4,0.5103,3.062,3100.0,0.0009841000000000001,0.9929309999999999,CDCA4 CLEC1A EEPD1 HIST4H4,"chromatin organization involved in regulation of transcription|regulation of gene expression, epigenetic|negative regulation of megakaryocyte differentiation|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization",0.0001151|0.0004161|0.001165|0.002134|0.002134,1|1|1|1|1,115.7|60.22|1030|514.9|514.9
1811,4,0.5412,3.247,3207.0,0.001009,0.9929309999999999,ABCG5 EFCAB6 PITPNC1 RAPGEF5,intermembrane lipid transfer|negative regulation of intestinal cholesterol absorption|negative regulation of intestinal lipid absorption|negative regulation of intestinal phytosterol absorption|negative regulation of intestinal absorption,3.454e-05|0.0005825|0.0005825|0.0005825|0.0007766,0.5448|1|1|1|1,214.5|2574|2574|2574|1716
1812,5,0.5371,5.371,3800.0,0.001408,0.996692,EFCAB9 HAGHL HBM HBQ1 HBZ,oxygen transport|gas transport|hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification,4.663e-09|1.056e-08|3.398e-08|9.064e-08|1.037e-06,7.356e-05|8.326e-05|0.0001786|0.0003575|0.003271,882.6|650.4|426.1|301.4|130.1
1813,4,0.5114,3.068,3118.0,0.0009806,0.9929309999999999,BSPRY EFCC1 LRRC66 ZNF79,cellular response to leukemia inhibitory factor|response to leukemia inhibitory factor|calcium ion transport|cellular process|metal ion transport,0.01717|0.01736|0.04674|0.04971|0.06164,1|1|1|1|1,58.51|57.85|21.1|0.3325|15.89
1814,5,0.5604,5.604,4343.0,0.001286,0.996692,CNTNAP1 EFEMP1 PHTF1 PRB4 RAB31,protein localization to paranode region of axon|protein localization to juxtaparanode region of axon|neuronal action potential propagation|action potential propagation|paranodal junction assembly,0.0009706|0.001213|0.001698|0.001698|0.001698,1|1|1|1|1,1373|1030|686.5|686.5|686.5
1815,4,0.5694,3.4160000000000004,3009.0,0.001131,0.9929309999999999,AP1G2 CHST2 CLEC4E EFEMP2,positive regulation of smooth muscle cell-matrix adhesion|positive regulation of aortic smooth muscle cell differentiation|regulation of aortic smooth muscle cell differentiation|aorta smooth muscle tissue morphogenesis|positive regulation of collagen fibril organization,0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
1816,4,0.5454,3.273,3263.0,0.0009996,0.9929309999999999,C2orf16 EFHD1 GINM1 ST6GALNAC3,regulation of response to salt stress|regulation of cellular hyperosmotic salinity response|regulation of cellular response to osmotic stress|regulation of response to osmotic stress|glycosylceramide metabolic process,0.0009706|0.0009706|0.002134|0.002522|0.003104,1|1|1|1|1,1287|1287|514.9|429.1|343.2
1817,4,0.5291,3.174,3155.0,0.001003,0.9929309999999999,CD37 DSTYK EFNA2 GON7,positive regulation of fibroblast growth factor receptor signaling pathway|olfactory bulb development|regulation of fibroblast growth factor receptor signaling pathway|olfactory lobe development|osteoclast differentiation,0.001747|0.006007|0.0062|0.006393|0.007938,1|1|1|1|1,643.6|171.6|166.1|160.9|128.7
1818,31,0.5024,233.6,24090.0,0.009581000000000001,1.0,APTX AQP7 BAG1 CD274 FAM205A GALT IFNA1 IFNA10 IFNA14 IFNA16 IFNA17 IFNA2 IFNA21 IFNA4 IFNA5 IFNA6 IFNA7 IFNA8 IFNB1 IFNE IFNK IFNW1 INSL6 OR2S2 PDCD1LG2 RLN1 RLN2 SIGMAR1 SPAG8 TOMM5 TYRP1,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,4.249e-38|2.188e-37|2.188e-37|3.318e-34|3.693e-33,6.702e-34|1.726e-33|1.15e-33|1.309e-30|1.165e-29,531.5|462.2|462.2|259.3|216.9
1819,5,0.5299,5.2989999999999995,4025.0,0.0013109999999999999,0.996692,CFAP97D1 EFNB3 GRIN2D NME1 NPTN,"trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission|trans-synaptic signaling, modulating synaptic transmission|trans-synaptic signaling by trans-synaptic complex|long-term synaptic potentiation|neuron recognition",4.712e-07|3.108e-06|3.108e-06|5.293e-05|5.517e-05,0.007432|0.02451|0.01634|0.2087|0.1741,2746|823.8|823.8|179.1|175.3
1820,16,0.5059,60.71,10900.0,0.005521,0.999999,COPB2 EFTUD2 EIF4A3 KPNB1 PSMA1 PSMA2 PSMA3 PSMA5 PSMA6 PSMB3 SF3A1 SMU1 SNRNP200 SNRPD1 SNU13 VCP,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,4.337e-14|1.616e-11|1.616e-11|1.616e-11|1.616e-11,6.841e-10|1.275e-07|8.5e-08|6.375e-08|5.1e-08,330.4|111.8|111.8|111.8|111.8
1821,5,0.5299,5.2989999999999995,4220.0,0.001251,0.996692,CCDC159 EGF FAT4 HOGA1 MARK4,branching morphogenesis of an epithelial tube|oxalate metabolic process|epidermal growth factor receptor signaling pathway via MAPK cascade|morphogenesis of a branching epithelium|morphogenesis of a branching structure,0.0003903|0.0004854|0.0004854|0.0005758|0.0006429,1|1|1|1|1,64.36|4119|4119|52.81|49.93
1822,9,0.5009,18.03,5773.0,0.003104,0.9998530000000001,ASPM CDK5RAP2 DYNLRB1 HMMR KIFC1 NDE1 PCNT PFDN1 TUBB4B,microtubule-based process|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|microtubule cytoskeleton organization|organelle localization,4.754e-09|1.218e-08|1.766e-08|3.49e-08|5.745e-08,7.499e-05|9.609e-05|9.288e-05|0.0001376|0.0001813,19.95|56.36|52.25|24.26|22.29
1823,5,0.5071,5.071000000000001,3485.0,0.001449,0.996692,DUSP5 EGR1 MIDN STK40 TRIB1,regulation of kinase activity|negative regulation of kinase activity|regulation of transferase activity|negative regulation of transferase activity|negative regulation of phosphorylation,1.841e-05|2.042e-05|2.972e-05|3.113e-05|6.954e-05,0.2905|0.161|0.1563|0.1228|0.2194,18.15|47.34|16.07|41.05|31.28
1824,4,0.5044,3.0260000000000002,3189.0,0.0009459,0.9929309999999999,ANKRD27 EGR2 GCFC2 TCF25,rhombomere 5 formation|rhombomere 5 structural organization|rhombomere 5 morphogenesis|rhombomere 3 formation|rhombomere 3 structural organization,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
1825,5,0.5484,5.484,4069.0,0.001343,0.996692,EHHADH MAIP1 PCDH15 SLC2A13 TIMD4,protein insertion into mitochondrial inner membrane from matrix|protein insertion into membrane from inner side|myo-inositol transport|equilibrioception|calcium import into the mitochondrion,0.001213|0.001213|0.001213|0.002183|0.00291,1|1|1|1|1,1030|1030|1030|514.9|374.5
1826,4,0.5082,3.049,3147.0,0.0009656,0.9929309999999999,CCDC191 EID3 IQUB WASHC5,endosome fission|polar body extrusion after meiotic divisions|meiotic cytokinesis|spindle assembly involved in meiosis|regulation of vesicle size,0.0007766|0.0009706|0.001553|0.001553|0.002328,1|1|1|1|1,1716|1287|735.5|735.5|468.1
1827,15,0.6,63.0,9453.0,0.0066,0.999999,ALKBH8 CTU1 CTU2 DPH3 EIF1 EIF2AK4 ELP5 ELP6 MOCS3 NR2C2AP PDAP1 PPP1R15B PUS3 RNF25 URM1,tRNA wobble uridine modification|tRNA wobble base modification|tRNA modification|tRNA processing|RNA modification,1.24e-20|3.404e-20|4.584e-18|1.225e-16|1.099e-15,1.956e-16|2.685e-16|2.41e-14|4.831e-13|3.467e-12,610.2|523|137.3|93.61|72.69
1828,4,0.5576,3.346,3186.0,0.001046,0.9929309999999999,DOK1 EIF2AK3 PURG TM2D2,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|eiF2alpha phosphorylation in response to endoplasmic reticulum stress|response to manganese-induced endoplasmic reticulum stress|regulation of translation initiation in response to endoplasmic reticulum stress|macrophage colony-stimulating factor signaling pathway,0.0004854|0.000728|0.0009706|0.0009706|0.001213,1|1|1|1|1,4119|2060|1373|1373|1030
1829,14,0.5069,46.13,9566.0,0.004785,0.9999969999999999,ACTR10 ATP6V1D CCNK CINP DDX24 DICER1 DYNC1H1 EIF2B2 EIF2S1 EIF5 NRDE2 PSMC1 WARS WDR25,posttranscriptional regulation of gene expression|regulation of translational initiation|cellular macromolecule biosynthetic process|RNA interference|macromolecule biosynthetic process,9.083e-07|2.385e-05|4.526e-05|5.114e-05|5.301e-05,0.01433|0.1881|0.238|0.2017|0.1672,16.14|53.82|6.222|210.2|6.072
1830,9,0.5405,19.46,6341.0,0.00305,0.9998530000000001,EIF2B5 LSG1 NMD3 OPA1 PDCD6 PSMD2 RFC4 RPL35A TRA2A,establishment of organelle localization|ribosome localization|ribosomal subunit export from nucleus|rRNA-containing ribonucleoprotein complex export from nucleus|organelle localization,1.648e-05|1.776e-05|1.776e-05|2.029e-05|9.069e-05,0.26|0.14|0.09336|0.08001|0.2861,23.06|352.1|352.1|326.9|14.86
1831,9,0.5219,18.79,5939.0,0.003144,0.9998530000000001,EIF3A EIF3D EIF3E EIF3F EIF3G EIF3H EIF3I EIF3M EIF4G2,formation of cytoplasmic translation initiation complex|translational initiation|cytoplasmic translational initiation|cytoplasmic translation|translation,4.107e-23|3.782e-22|2.727e-21|2.191e-18|5.837e-18,6.478e-19|2.983e-18|1.434e-17|8.641e-15|1.841e-14,1030|144|549.2|219.7|53.63
1832,19,0.5025,85.93,13250.0,0.006423999999999999,1.0,ABCE1 COPB2 EIF2S1 EIF3CL NARS NEDD8 NUTF2 PSMA1 PSMA2 PSMA4 PSMA5 PSMA6 RPL17 SMU1 SNRPD1 SNU13 SRP54 VCP YARS,proteasomal ubiquitin-independent protein catabolic process|cellular macromolecule biosynthetic process|positive regulation of canonical Wnt signaling pathway|regulation of cellular amino acid metabolic process|S phase,3.983e-11|5.131e-09|5.387e-09|5.817e-09|5.817e-09,6.282e-07|4.047e-05|2.833e-05|2.294e-05|1.835e-05,234|7.466|42.03|79.21|79.21
1833,12,0.5142,33.93,8513.0,0.003959000000000001,0.999986,CNIH4 DUX4 EIF2S1 NBEAL1 NEDD8 NUTF2 POGZ RPL17 SNU13 ST20 TSPYL5 UQCRH,cellular response to radiation|cellular response to abiotic stimulus|cellular response to environmental stimulus|cellular response to UV|negative regulation of vascular endothelial growth factor production,0.0001361|0.0007222|0.0007222|0.001264|0.001746,1|1|1|1|1,29.09|16.35|16.35|38.14|858.1
1834,4,0.5442,3.265,2710.0,0.0012,0.9929309999999999,EIF4A1 EIF4B EIF4E EIF4G1,translational initiation|cytoplasmic translational initiation|translation|peptide biosynthetic process|cytoplasmic translation,2.49e-09|1.497e-08|1.24e-07|1.593e-07|2.084e-07,3.927e-05|0.000118|0.0006519|0.0006282|0.0006573,144|514.9|53.63|50.35|205.9
1835,5,0.5167,5.167000000000001,3763.0,0.001367,0.996692,CEP290 EIF4G3 IRF3 TBK1 TMEM173,positive regulation of type I interferon-mediated signaling pathway|positive regulation of interferon-alpha production|regulation of interferon-alpha production|TRIF-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway,2.967e-06|9.177e-06|1.4e-05|1.4e-05|1.679e-05,0.0468|0.07238|0.07362|0.05521|0.05297,792.1|429.1|343.2|343.2|312
1836,4,0.5457,3.2739999999999996,3113.0,0.001048,0.9929309999999999,EIF4H OR51I1 OR52D1 PDCD4,epithelial to mesenchymal transition involved in cardiac fibroblast development|eukaryotic translation initiation factor 4F complex assembly|epicardium-derived cardiac fibroblast cell development|epicardium-derived cardiac fibroblast cell differentiation|cardiac fibroblast cell development,0.0005825|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|2574|1716|1716|1716
1837,4,0.5476,3.286,3392.0,0.0009654999999999999,0.9929309999999999,C4orf17 EIF5A2 ORMDL1 TMEM101,polyamine homeostasis|positive regulation of translational termination|cellular sphingolipid homeostasis|negative regulation of ceramide biosynthetic process|positive regulation of translational elongation,0.0003883|0.0009706|0.001165|0.001165|0.001165,1|1|1|1|1,5149|1287|1030|1030|1030
1838,17,0.5003,68.04,11520.0,0.005856,1.0,DUX4 EIF6 HSPE1 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL23A RPL27A RPL37 RPL4 RPL9 RPLP2 RPS13 RPS6,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum,1.26e-30|4.321e-30|8.367e-30|2.875e-29|4.577e-29,1.987e-26|3.408e-26|4.4e-26|1.134e-25|1.444e-25,127.1|176.7|167.9|152.8|147.5
1839,5,0.518,5.18,3846.0,0.001341,0.996692,ELAC1 MYCT1 PRB1 PRB2 PRB4,"regulation of lipid kinase activity|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of cell cycle G1/S phase transition|tRNA 3'-trailer cleavage, endonucleolytic|regulation of G1/S transition of mitotic cell cycle",0.0002501|0.0005725|0.0006043|0.001019|0.001137,1|1|1|1|1,84.06|54.99|53.49|1471|38.71
1840,4,0.5686,3.412,3216.0,0.001057,0.9929309999999999,ELAVL2 TCAIM ZNF620 ZNF90,"regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process|regulation of cellular macromolecule biosynthetic process",0.01665|0.01667|0.01674|0.02068|0.02355,1|1|1|1|1,4.459|4.458|4.451|4.132|3.947
1841,15,0.5067,53.21,11010.0,0.004797,0.999999,C19orf66 ELAVL3 ICAM1 ICAM3 P2RY11 QTRT1 TMED1 ZNF433 ZNF441 ZNF443 ZNF490 ZNF625 ZNF627 ZNF69 ZNF700,regulation of cellular macromolecule biosynthetic process|regulation of macromolecule biosynthetic process|regulation of cellular biosynthetic process|regulation of biosynthetic process|regulation of transcription by RNA polymerase II,7.225e-05|7.754e-05|0.0001108|0.0001326|0.0001761,1|0.6116|0.5825|0.5229|0.5555,3.509|3.481|3.345|3.278|4.247
1842,5,0.5023,5.023,3797.0,0.001318,0.996692,DCD ELAVL4 OR1M1 OR7D4 OR7G1,nervous system process|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,9.602e-05|9.63e-05|0.0001148|0.0001283|0.0001584,1|0.7595|0.6035|0.5059|0.4998,11.94|28.02|26.4|25.43|23.67
1843,11,0.5013,27.57,7292.0,0.0037560000000000002,0.999969,AMFR C12orf49 CYB5B LDLR LDLRAP1 MYLIP NPC1 NR1H2 SCD SREBF1 TMEM41A,cholesterol homeostasis|sterol homeostasis|lipid homeostasis|regulation of cholesterol metabolic process|positive regulation of triglyceride biosynthetic process,3.138e-10|3.324e-10|5.343e-09|1.539e-08|4.594e-08,4.95e-06|2.622e-06|2.809e-05|6.07e-05|0.0001449,124.1|122.6|69.11|142|475.3
1844,5,0.5018,5.018,3960.0,0.0012619999999999999,0.996692,ELFN2 KLHL5 SLC25A17 WFDC2 ZNF562,"adenosine 3',5'-bisphosphate transmembrane transport|FAD transport|coenzyme A transport|FAD transmembrane transport|coenzyme A transmembrane transport",0.000728|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,2060|2060|2060|2060|2060
1845,4,0.5481,3.2889999999999997,3195.0,0.001026,0.9929309999999999,CARD17 ELK3 GSDME MX2,synaptic vesicle budding from presynaptic endocytic zone membrane|granzyme-mediated programmed cell death signaling pathway|dynamin family protein polymerization involved in mitochondrial fission|dynamin family protein polymerization involved in membrane fission|response to virus,0.00194|0.002183|0.002183|0.002183|0.002191,1|1|1|1|1,588.4|514.9|514.9|514.9|26.75
1846,4,0.5531,3.318,2981.0,0.001109,0.9929309999999999,DUSP5 EGR1 ELK4 MIDN,negative regulation of cellular metabolic process|regulation of kinase activity|positive regulation of glomerular metanephric mesangial cell proliferation|regulation of transferase activity|negative regulation of metabolic process,0.0002471|0.0003335|0.0003883|0.0004773|0.0005174,1|1|1|1|1,7.983|17.01|5149|15.07|6.635
1847,4,0.535,3.21,3310.0,0.0009664,0.9929309999999999,CXCL8 DTHD1 ELMOD1 S100A10,negative regulation of cell adhesion molecule production|regulation of entry of bacterium into host cell|regulation of cell adhesion molecule production|membrane raft assembly|positive regulation of GTPase activity,0.001165|0.001553|0.002134|0.002134|0.002365,1|1|1|1|1,1030|735.5|514.9|514.9|24.93
1848,4,0.5441,3.265,3167.0,0.001027,0.9929309999999999,ELOVL4 FOXF1 MSRB3 MYOM2,detection of external stimulus|right lung morphogenesis|embryonic ectodermal digestive tract morphogenesis|ectodermal digestive tract morphogenesis|lateral mesodermal cell differentiation,0.0002574|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,76.85|5149|5149|5149|5149
1849,4,0.5453,3.272,3198.0,0.001019,0.9929309999999999,ELOVL5 HCN3 MX1 ZNF668,"fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid|synaptic vesicle budding from presynaptic endocytic zone membrane|fatty acid elongation, polyunsaturated fatty acid|fatty acid elongation, monounsaturated fatty acid",0.001553|0.001553|0.001553|0.001553|0.001553,1|1|1|1|1,735.5|735.5|735.5|735.5|735.5
1850,4,0.5519,3.312,3264.0,0.001011,0.9929309999999999,ELOVL7 LARGE2 SPSB4 ZNF648,"fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid|fatty acid elongation, polyunsaturated fatty acid|fatty acid elongation, monounsaturated fatty acid|very long-chain fatty acid biosynthetic process",0.001553|0.001553|0.001553|0.001553|0.002716,1|1|1|1|1,735.5|735.5|735.5|735.5|396.1
1851,4,0.5232,3.139,3205.0,0.0009763,0.9929309999999999,DLX1 ELSPBP1 THEMIS2 TRIM23,cerebral cortex GABAergic interneuron fate commitment|positive regulation of amacrine cell differentiation|negative regulation of cellular response to transforming growth factor beta stimulus|regulation of amacrine cell differentiation|negative regulation of photoreceptor cell differentiation,0.0005825|0.0005825|0.0007766|0.0007766|0.001359,1|1|1|1|1,2574|2574|1716|1716|858.1
1852,13,0.5107,39.84,9681.0,0.0040869999999999995,0.999993,HIST1H2AC HIST1H2AD HIST1H2BD HIST1H3J HLA-F OR14J1 OR2B6 OR2J3 PSORS1C2 TCF19 TRIM10 TRIM26 ZKSCAN4,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway,4.658e-05|6.374e-05|0.0001663|0.0002224|0.0004507,0.7347|0.5027|0.8743|0.8769|1,208|176|106.4|91.53|63.56
1853,4,0.5241,3.1439999999999997,3050.0,0.001027,0.9929309999999999,EMCN KRT81 SLC35B4 ZNF93,UDP-xylose transmembrane transport|negative regulation of transposon integration|regulation of transposon integration|UDP-N-acetylglucosamine transmembrane transport|pyrimidine nucleotide-sugar transmembrane transport,0.0003883|0.0005825|0.0005825|0.001165|0.002328,1|1|1|1|1,5149|2574|2574|1030|468.1
1854,4,0.568,3.408,3258.0,0.001042,0.9929309999999999,ABCG4 EML1 OR8D1 SMIM6,cholesterol efflux|neuroblast proliferation|cholesterol transport|neural precursor cell proliferation|sterol transport,0.00504|0.005426|0.01179|0.01333|0.01487,1|1|1|1|1,205.9|190.7|85.81|75.72|67.75
1855,4,0.554,3.324,3154.0,0.00105,0.9929309999999999,DYNC2LI1 EML4 KLKB1 WDR54,"Factor XII activation|plasma kallikrein-kinin cascade|kinin cascade|positive regulation of fibrinolysis|negative regulation of blood coagulation, intrinsic pathway",0.0005825|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|1716|1716|1287|1030
1856,5,0.5237,5.237,4174.0,0.00125,0.996692,DRC7 EML5 LHFPL4 RAB3IL1 TEPP,regulation of inhibitory synapse assembly|gamma-aminobutyric acid receptor clustering|neurotransmitter-gated ion channel clustering|postsynaptic membrane organization|receptor clustering,0.001213|0.001456|0.002667|0.00702|0.01112,1|1|1|1|1,1030|823.8|411.9|147.1|91.53
1857,5,0.5096,5.096,3907.0,0.0013,0.996692,ANKRD45 EMX1 FMO2 ITLN1 TBX19,drug metabolic process|response to nematode|oxygen metabolic process|cerebral cortex regionalization|NADPH oxidation,7.927e-05|0.001165|0.001165|0.002037|0.002037,1|1|1|1|1,149.2|1144|1144|572.1|572.1
1858,4,0.5547,3.3280000000000003,3333.0,0.0009953,0.9929309999999999,B3GNT9 ENAH TBXA2R UPP1,thromboxane A2 signaling pathway|uridine metabolic process|uridine catabolic process|dTMP catabolic process|pyrimidine ribonucleotide salvage,0.0003883|0.0005825|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|2574|2574|1716|1030
1859,6,0.5038,7.556,4691.0,0.001604,0.998474,ENAM FAM208A LIG4 MORC2 PPHLN1 XRCC4,immunoglobulin V(D)J recombination|DNA ligation involved in DNA repair|establishment of integrated proviral latency|establishment of viral latency|DNA ligation,1.319e-06|1.696e-06|2.119e-06|3.108e-06|3.672e-06,0.0208|0.01337|0.01114|0.01226|0.01159,1373|1177|1030|823.8|748.9
1860,6,0.5001,7.501,4495.0,0.001661,0.998474,ATP2C1 CLK2 ENC1 FAT1 S100A12 S100A8,defense response to fungus|response to fungus|neutrophil chemotaxis|granulocyte chemotaxis|neutrophil migration,6.96e-05|0.0001201|0.0002156|0.0002497|0.0002737,1|0.9469|1|0.9846|0.8635,159.7|120.4|89.16|82.71|78.91
1861,5,0.5019,5.019,4137.0,0.001209,0.996692,ENDOD1 ERBB4 GPR22 LBHD1 NAPEPLD,central nervous system morphogenesis|host-mediated regulation of intestinal microbiota composition|negative regulation of eating behavior|cardiac muscle tissue regeneration|N-acylethanolamine metabolic process,0.000728|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|2060|1373|1030|823.8
1862,4,0.5163,3.0980000000000003,3266.0,0.0009452999999999999,0.9929309999999999,ENDOU JPT2 MANBA SLC30A3,zinc ion import into synaptic vesicle|zinc ion import into organelle|regulation of sequestering of zinc ion|oligosaccharide catabolic process|zinc ion transmembrane transport,0.0005825|0.0005825|0.001165|0.002716|0.004846,1|1|1|1|1,2574|2574|1030|396.1|214.5
1863,5,0.5011,5.011,4143.0,0.0012050000000000001,0.996692,CA2 CNGB3 ENG FABP4 OR51B5,positive regulation of dipeptide transport|positive regulation of oligopeptide transport|positive regulation of dipeptide transmembrane transport|regulation of dipeptide transmembrane transport|regulation of dipeptide transport,0.000728|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,2060|2060|2060|2060|2060
1864,5,0.5196,5.196000000000001,4164.0,0.001243,0.996692,ENGASE IFT88 RASL11A ZMYM2 ZMYM5,cellular response to gibberellin stimulus|gibberellic acid mediated signaling pathway|response to gibberellin|gibberellin mediated signaling pathway|positive regulation of transcription by RNA polymerase I,0.0004854|0.0004854|0.0004854|0.0004854|0.005812,1|1|1|1|1,4119|4119|4119|4119|179.1
1865,4,0.521,3.1260000000000003,3129.0,0.0009954,0.9929309999999999,BMP8A ENKUR HSPG2 MAPK8IP3,establishment of left/right asymmetry|microtubule-based movement|anterograde axonal protein transport|protein localization to presynapse|diet induced thermogenesis,0.0007766|0.001708|0.001941|0.001941|0.002328,1|1|1|1|1,1716|29.42|572.1|572.1|468.1
1866,4,0.5133,3.08,2928.0,0.001048,0.9929309999999999,ARL15 ENOPH1 PTP4A1 XBP1,positive regulation of lactation|positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response|L-methionine salvage from S-adenosylmethionine|response to insulin-like growth factor stimulus|positive regulation of plasma cell differentiation,0.0005825|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|1716|1716|1716|1716
1867,4,0.5767,3.46,3456.0,0.0009978,0.9929309999999999,ENOSF1 FAM78B RD3L SPATA31A1,cellular carbohydrate catabolic process|cellular amino acid catabolic process|carbohydrate catabolic process|biological regulation|regulation of biological process,0.007745|0.02004|0.02253|0.02306|0.03244,1|1|1|1|1,132|49.99|44.39|0|0
1868,10,0.5027,22.62,7920.0,0.002841,0.999933,C1QTNF9 C1QTNF9B ENOX1 GJB2 GJB6 POSTN RNF6 SOHLH2 SPATA13 ZAR1L,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|cellular response to vitamin K,5.927e-06|7.618e-06|9.52e-06|4.872e-05|0.001455,0.09349|0.06008|0.05006|0.1921|1,686.5|588.4|514.9|205.9|1030
1869,4,0.544,3.264,3107.0,0.001047,0.9929309999999999,ENPEP PIFO SFRP2 SLCO4C1,tube development|circulatory system development|negative regulation of dermatome development|negative regulation of planar cell polarity pathway involved in axis elongation|regulation of planar cell polarity pathway involved in axis elongation,0.0002658|0.0002772|0.0003883|0.0005825|0.0005825,1|1|1|1|1,18.37|18.11|5149|2574|2574
1870,11,0.5026,27.65,6657.0,0.004122,0.999969,CCDC6 CYB5R4 FBXO42 LCMT1 PPME1 PPP2CA PPP2CB PPP2R1A PPP2R2A PTPA TIPRL,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|protein dephosphorylation|regulation of dephosphorylation,6.284e-09|1.453e-08|4.271e-08|1.01e-07|1.01e-07,9.912e-05|0.0001146|0.0002246|0.0003983|0.0003187,70.34|59.18|47.41|39.73|39.73
1871,4,0.5803,3.4819999999999998,3440.0,0.001009,0.9929309999999999,ENTHD1 EXOC6 NIPAL2 RPL7L1,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|magnesium ion transmembrane transport|magnesium ion transport|maturation of LSU-rRNA|blastocyst formation",0.003104|0.003297|0.003491|0.00562|0.007359,1|1|1|1|1,343.2|321.8|302.9|183.9|139.2
1872,4,0.5453,3.272,3307.0,0.0009859,0.9929309999999999,C10orf67 ENTPD1 INHA TRMT44,negative regulation of follicle-stimulating hormone secretion|negative regulation of B cell differentiation|positive regulation of gonadotropin secretion|positive regulation of follicle-stimulating hormone secretion|regulation of follicle-stimulating hormone secretion,0.0007766|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1030|1030|1030|1030
1873,4,0.5048,3.029,3159.0,0.0009556000000000001,0.9929309999999999,ATG4B ENTPD3 RLF UBQLN4,protein delipidation|negative regulation of autophagosome maturation|autophagy|process utilizing autophagic mechanism|histone H3-K4 monomethylation,0.0004854|0.001698|0.002163|0.002163|0.002183,1|1|1|1|1,4119|686.5|26.92|26.92|514.9
1874,4,0.6018,3.611,3128.0,0.00115,0.9929309999999999,C17orf67 ENTPD5 KATNBL1 NEMP1,nucleoside diphosphate catabolic process|positive regulation of glycolytic process|'de novo' posttranslational protein folding|positive regulation of ATP metabolic process|'de novo' protein folding,0.002522|0.004846|0.007745|0.007938|0.008517,1|1|1|1|1,429.1|214.5|132|128.7|119.7
1875,4,0.5428,3.2569999999999997,3150.0,0.00103,0.9929309999999999,ENTPD7 KCNMB4 MKKS TOMM40,blood vessel diameter maintenance|regulation of tube diameter|regulation of tube size|UTP catabolic process|CTP catabolic process,0.0003784|0.0003784|0.0003843|0.0004854|0.0004854,1|1|1|1|1,65.38|65.38|64.87|4119|4119
1876,4,0.5288,3.173,3141.0,0.001006,0.9929309999999999,CASC10 COPS9 EOMES SCN3B,"CD8-positive, alpha-beta T cell differentiation involved in immune response|mesodermal to mesenchymal transition involved in gastrulation|regulation of ventricular cardiac muscle cell membrane depolarization|endodermal cell fate specification|negative regulation of protein neddylation",0.0002913|0.0005825|0.0008737|0.0008737|0.0008737,1|1|1|1|1,6865|2288|1373|1373|1373
1877,5,0.5435,5.435,3237.0,0.0016710000000000002,0.996692,ARNT EPAS1 HIF1A TNFSF10 VHL,regulation of transcription from RNA polymerase II promoter in response to hypoxia|regulation of transcription from RNA polymerase II promoter in response to oxidative stress|regulation of transcription from RNA polymerase II promoter in response to stress|regulation of DNA-templated transcription in response to stress|cellular response to hypoxia,1.162e-09|2.497e-09|4.752e-09|5.828e-09|3.785e-08,1.833e-05|1.969e-05|2.499e-05|2.298e-05|0.0001194,211.2|1123|147.1|139.6|86.72
1878,5,0.5098,5.098,4178.0,0.001216,0.996692,EPB41L1 FAM209A RAB28 TLDC2 ZNF831,biological regulation|cortical actin cytoskeleton organization|toxin transport|regulation of biological process|cortical cytoskeleton organization,0.008988|0.009431|0.01039|0.01377|0.01424,1|1|1|1|1,0|108.4|98.07|0|71.02
1879,10,0.5076,22.84,8419.0,0.002699,0.999933,C8orf76 CA13 CA2 CA3 CYP7A1 EPB41L5 ESRP1 MTSS1 PKIA PMP2,one-carbon metabolic process|bicarbonate transport|organic anion transport|cellular response to fluid shear stress|response to fluid shear stress,1.284e-06|1.586e-06|2.296e-05|4.897e-05|0.000144,0.02026|0.01251|0.1207|0.1931|0.4543,144|133.7|22.03|208|117
1880,5,0.5055,5.055,4167.0,0.001209,0.996692,ANKRD28 CCL20 DENND2D EPGN SAPCD1,thymocyte migration|positive regulation of epidermal growth factor-activated receptor activity|calcium-mediated signaling using intracellular calcium source|positive regulation of MAPK cascade|telomere maintenance via telomerase,0.000728|0.003394|0.005812|0.006092|0.007261,1|1|1|1|1,2060|316.8|179.1|15.84|142
1881,4,0.515,3.09,3140.0,0.0009806,0.9929309999999999,EPHA1 FGD4 PPP3R1 ZNF280A,regulation of hydrolase activity|calcineurin-NFAT signaling cascade|calcineurin-mediated signaling|regulation of GTPase activity|filopodium assembly,0.0009799|0.002522|0.003104|0.003309|0.004072,1|1|1|1|1,11.81|429.1|343.2|21.02|257.4
1882,4,0.5401,3.24,3249.0,0.0009937000000000001,0.9929309999999999,CCDC14 COL20A1 EPHA10 SLC9A3R2,protein localization to centrosome|protein localization to microtubule organizing center|protein localization to microtubule cytoskeleton|protein localization to cytoskeleton|substantia nigra development,0.004653|0.004846|0.007552|0.008324|0.009096,1|1|1|1|1,223.9|214.5|135.5|122.6|111.9
1883,9,0.513,18.47,5740.0,0.0031969999999999998,0.9998530000000001,EGFR EPHA2 ERRFI1 GAB1 GRB2 PTPN11 RASA1 SHB SOS1,transmembrane receptor protein tyrosine kinase signaling pathway|epidermal growth factor receptor signaling pathway|enzyme linked receptor protein signaling pathway|ERBB signaling pathway|response to growth factor,1.53e-12|1.406e-11|2.179e-11|6.952e-11|2.776e-10,2.413e-08|1.109e-07|1.146e-07|2.741e-07|8.757e-07,35.27|228.8|25.22|163.5|30.11
1884,4,0.5222,3.133,3073.0,0.001016,0.9929309999999999,EPHA6 EVI2B PTH SERINC1,positive regulation of neutrophil differentiation|positive regulation of osteoclast proliferation|regulation of neutrophil differentiation|positive regulation of serine C-palmitoyltransferase activity|positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,0.0004854|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|2060|1373|1373|1373
1885,4,0.5795,3.477,3150.0,0.0011,0.9929309999999999,CTSO EPHA8 TRAPPC6B UBB,proteolysis involved in cellular protein catabolic process|toll-like receptor signaling pathway|cellular protein catabolic process|protein catabolic process|pattern recognition receptor signaling pathway,0.0002342|0.0002452|0.0002744|0.0003497|0.0003843,1|1|1|1|1,20.73|81.56|19.65|18.09|64.87
1886,4,0.5417,3.25,3186.0,0.001016,0.9929309999999999,ARL5C EPHB4 FAHD2B GRID1,"protein localization to Golgi membrane|cell migration involved in sprouting angiogenesis|synaptic transmission, glutamatergic|ionotropic glutamate receptor signaling pathway|protein localization to Golgi apparatus",0.0007766|0.004072|0.005426|0.005426|0.005813,1|1|1|1|1,1716|257.4|190.7|190.7|177.5
1887,4,0.5181,3.109,3174.0,0.0009761000000000001,0.9929309999999999,ATP11A DLEC1 EPHX3 HLA-DQB2,B cell affinity maturation|peripheral B cell selection|B cell selection|epoxide metabolic process|aminophospholipid translocation,0.0005825|0.0005825|0.0009706|0.001165|0.001553,1|1|1|1|1,2574|2574|1287|1030|735.5
1888,5,0.504,5.04,4089.0,0.001228,0.996692,BTBD2 CYBC1 EPHX4 FRZB NCK2,negative regulation of hepatocyte differentiation|regulation of hepatocyte differentiation|respiratory burst after phagocytosis|negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|convergent extension involved in organogenesis,0.0004854|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,4119|2060|1373|1030|823.8
1889,5,0.5141,5.141,4157.0,0.001232,0.996692,CAPG EPN1 GNLY STON1 TLX2,negative regulation of dendrite morphogenesis|negative regulation of sprouting angiogenesis|enteric nervous system development|actin filament severing|barbed-end actin filament capping,0.002909|0.00349|0.004651|0.004651|0.006681,1|1|1|1|1,381.4|312|228.8|228.8|156
1890,5,0.5038,5.038,3832.0,0.00131,0.996692,EPS8L1 PTPN3 RRM1 RRM2 WEE1,deoxyribonucleotide biosynthetic process|phosphate-containing compound metabolic process|phosphorus metabolic process|nucleobase-containing small molecule interconversion|deoxyribonucleotide metabolic process,6.401e-06|6.838e-06|7.335e-06|1.909e-05|4.042e-05,0.101|0.05393|0.03857|0.07526|0.1275,549.2|10.81|10.65|305.1|205.9
1891,4,0.544,3.264,3096.0,0.001051,0.9929309999999999,ARL6IP4 EPSTI1 P2RX4 PITPNM2,microglial cell migration|sensory perception of touch|positive regulation of microglial cell migration|regulation of microglial cell migration|positive regulation of prostaglandin secretion,0.0005825|0.0009706|0.001553|0.001747|0.002328,1|1|1|1|1,2574|1287|735.5|643.6|468.1
1892,4,0.5466,3.28,3189.0,0.001025,0.9929309999999999,EPYC TTC9 WNT5A ZNF280B,cartilage development|non-canonical Wnt signaling pathway involved in heart development|planar cell polarity pathway involved in heart morphogenesis|planar cell polarity pathway involved in ventricular septum morphogenesis|planar cell polarity pathway involved in cardiac right atrium morphogenesis,0.0003385|0.0003883|0.0003883|0.0003883|0.0003883,1|0.5569|0.6126|0.7657|0.8751,66.87|5149|5149|5149|5149
1893,4,0.6069,3.641,3143.0,0.0011539999999999999,0.9929309999999999,ERAP1 MAGI2 SYNC TNIK,asparaginyl-tRNA aminoacylation|planar cell polarity pathway involved in axis elongation|activation of JNKK activity|cell-cell signaling by wnt|Wnt signaling pathway,0.0009706|0.0009706|0.002667|0.002798|0.002798,1|1|1|1|1,1373|1373|411.9|23.6|23.6
1894,4,0.5033,3.02,3409.0,0.0008829,0.9929309999999999,C15orf39 ERAP2 GEM IL13,regulation of calcium ion transmembrane transport|positive regulation of pancreatic stellate cell proliferation|positive regulation of lung goblet cell differentiation|regulation of lung goblet cell differentiation|negative regulation of lung ciliated cell differentiation,0.0003299|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,67.75|5149|5149|5149|5149
1895,5,0.511,5.11,4201.0,0.001212,0.996692,ERBIN HPCAL4 TEKT2 TMEM171 TRIM23,basal protein localization|negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway|negative regulation of nucleotide-binding oligomerization domain containing signaling pathway|negative regulation of monocyte chemotactic protein-1 production|regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,0.0004854|0.0009706|0.0009706|0.001698|0.002183,1|1|1|1|1,4119|1373|1373|686.5|514.9
1896,4,0.5107,3.0639999999999996,3183.0,0.0009593,0.9929309999999999,BEST2 ERF IRGC PDE6A,"rhodopsin mediated signaling pathway|phototransduction, visible light|cellular response to interferon-beta|regulation of rhodopsin mediated signaling pathway|response to interferon-beta",0.002522|0.003685|0.004459|0.005233|0.006393,1|1|1|1|1,429.1|286|234|198|160.9
1897,4,0.5107,3.0639999999999996,3163.0,0.0009652999999999999,0.9929309999999999,ERG28 KCNA7 MIIP MYCL,regulation of inner ear receptor cell differentiation|regulation of mechanoreceptor differentiation|regulation of inner ear auditory receptor cell differentiation|sterol biosynthetic process|regulation of epidermal cell differentiation,0.001747|0.001747|0.001747|0.009096|0.01199,1|1|1|1|1,643.6|643.6|643.6|111.9|84.41
1898,4,0.5273,3.1639999999999997,2701.0,0.001167,0.9929309999999999,ERI1 MARK2 SIK2 STK11,protein autophosphorylation|protein phosphorylation|establishment of cell polarity|regulation of axonogenesis|phosphorylation,2.925e-06|0.0001441|0.0002037|0.0003561|0.0004732,0.04615|1|1|1|1,83.95|22.58|86.53|65.17|15.11
1899,4,0.5155,3.093,2997.0,0.0010279999999999998,0.9929309999999999,ERI3 KIRREL1 RAD51AP2 TULP4,"DNA catabolic process, exonucleolytic|exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|exonucleolytic trimming involved in rRNA processing|rRNA 3'-end processing|maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",0.001747|0.001941|0.001941|0.002134|0.004846,1|1|1|1|1,643.6|572.1|572.1|514.9|214.5
1900,5,0.5128,5.127999999999999,4256.0,0.001201,0.996692,ERICH3 LYSMD4 PGPEP1L RYR3 TTC23,cellular response to magnesium ion|cellular response to caffeine|cellular response to purine-containing compound|negative regulation of cytosolic calcium ion concentration|cellular response to ATP,0.00194|0.002667|0.003394|0.003636|0.004362,1|1|1|1|1,588.4|411.9|316.8|294.2|242.3
1901,4,0.5872,3.523,3318.0,0.001058,0.9929309999999999,EBPL ERICH6B IQUB SLC2A8,fructose transmembrane transport|dehydroascorbic acid transport|male meiosis I|glucose transmembrane transport|hexose transmembrane transport,0.001165|0.001553|0.004653|0.006586|0.007359,1|1|1|1|1,1030|735.5|223.9|156|139.2
1902,4,0.5486,3.292,3271.0,0.001003,0.9929309999999999,BLNK ERLIN1 LRRC29 LRRC8E,negative regulation of cholesterol biosynthetic process|negative regulation of cholesterol metabolic process|negative regulation of sterol biosynthetic process|SREBP signaling pathway|aspartate transmembrane transport,0.001165|0.001165|0.001165|0.001941|0.001941,1|1|1|1|1,1030|1030|1030|572.1|572.1
1903,4,0.5042,3.025,3278.0,0.0009199,0.9929309999999999,APBA1 ERMN HIPK4 PRKACG,gamma-aminobutyric acid secretion|gamma-aminobutyric acid transport|chemical synaptic transmission|anterograde trans-synaptic signaling|trans-synaptic signaling,0.0005825|0.001941|0.002445|0.002445|0.002643,1|1|1|1|1,2574|572.1|24.52|24.52|23.56
1904,4,0.5361,3.217,3145.0,0.001019,0.9929309999999999,ERMP1 NOL11 PLA1A SPATA6L,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I|regulation of transcription of nucleolar large rRNA by RNA polymerase I|phosphatidylserine acyl-chain remodeling|positive regulation of transcription by RNA polymerase I|regulation of transcription by RNA polymerase I,0.002134|0.003104|0.004459|0.004653|0.00678,1|1|1|1|1,514.9|343.2|234|223.9|151.4
1905,4,0.5472,3.283,3273.0,0.0009998,0.9929309999999999,CDKN2D ERN2 LYZL6 SLC28A1,cell cycle arrest|cytidine transport|purine nucleobase transmembrane transport|pyrimidine nucleoside transport|uridine transport,0.0002966|0.0003883|0.0009706|0.001165|0.001165,1|1|1|1|1,71.51|5149|1287|1030|1030
1906,5,0.5159,5.159,4215.0,0.00122,0.996692,ANPEP ERO1B LITAF OTUD1 ZNF438,protein phosphopantetheinylation|protein folding in endoplasmic reticulum|negative regulation of NIK/NF-kappaB signaling|peptide catabolic process|protein K63-linked deubiquitination,0.002598|0.00291|0.006537|0.007744|0.008226,1|1|1|1|1,24.52|374.5|158.4|132.9|124.8
1907,4,0.5069,3.0410000000000004,3093.0,0.0009796,0.9929309999999999,ERP29 KIRREL1 MYBPHL TULP4,protein unfolding|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|negative regulation of protein secretion|negative regulation of peptide secretion|regulation of response to endoplasmic reticulum stress,0.0007766|0.006586|0.01276|0.0141|0.0166,1|1|1|1|1,1716|156|79.21|71.51|60.57
1908,14,0.5004,45.54,10040.0,0.004502,0.9999969999999999,ANG CXADR OR11G2 OR11H4 OR4K1 OR4K2 OR4K5 OR4M1 OR4M2 OR4N4 OR4Q3 OR6S1 RNF145 ZNF519,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.113e-14|3.782e-14|5.474e-14|1.103e-13|1.594e-13,3.332e-10|2.983e-10|2.878e-10|4.349e-10|5.029e-10,33.36|31.43|30.27|28.18|27.14
1909,5,0.5146,5.146,3725.0,0.001376,0.996692,ERN1 ERVFRD-1 HERPUD1 SLC35F2 XBP1,positive regulation of response to endoplasmic reticulum stress|regulation of response to endoplasmic reticulum stress|endoplasmic reticulum unfolded protein response|positive regulation of ER-associated ubiquitin-dependent protein catabolic process|cellular response to unfolded protein,6.764e-08|7.486e-07|1.391e-06|2.119e-06|2.606e-06,0.001067|0.005904|0.007313|0.008357|0.008223,334|145.4|117.7|1030|95.05
1910,7,0.5211,10.94,5317.0,0.002049,0.9992989999999999,CNN2 DUX4 EIF4B ERVW-1 NBEAL1 TBC1D3B UQCRH,"eukaryotic translation initiation factor 4F complex assembly|formation of translation preinitiation complex|mitochondrial electron transport, ubiquinol to cytochrome c|negative regulation of phagocytosis|myoblast fusion",0.001019|0.004071|0.005086|0.008127|0.008802,1|1|1|1|1,1471|267.5|210.2|127.9|117.7
1911,4,0.546,3.2760000000000002,3113.0,0.001048,0.9929309999999999,ESAM REC114 REM2 TM4SF5,maintenance of blood-brain barrier|regulation of actin cytoskeleton reorganization|bicellular tight junction assembly|tight junction assembly|tight junction organization,0.00678|0.007745|0.01141|0.01179|0.01218,1|1|1|1|1,151.4|132|88.77|85.81|83.04
1912,4,0.5465,3.279,3314.0,0.0009862,0.9929309999999999,C20orf194 CATIP ESCO1 MGAT4D,negative regulation of protein glycosylation|post-translational protein acetylation|negative regulation of glycoprotein biosynthetic process|regulation of protein glycosylation|negative regulation of glycoprotein metabolic process,0.0007766|0.0007766|0.00291|0.003104|0.003491,1|1|1|1|1,1716|1716|367.8|343.2|302.9
1913,4,0.5726,3.4360000000000004,3395.0,0.001008,0.9929309999999999,ADAL ESD GPR176 KLHL23,inosine biosynthetic process|adenosine catabolic process|formaldehyde catabolic process|inosine metabolic process|formaldehyde metabolic process,0.0007766|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1716|1287|1287
1914,4,0.5568,3.341,3154.0,0.0010550000000000002,0.9929309999999999,ESM1 OR5T3 PCLO TH,chemical synaptic transmission|anterograde trans-synaptic signaling|trans-synaptic signaling|synaptic signaling|synaptic vesicle cycle,3.387e-05|3.387e-05|3.811e-05|4.641e-05|0.0002004,0.5343|0.2671|0.2004|0.183|0.6322,36.78|36.78|35.35|33.08|87.27
1915,4,0.5638,3.383,3119.0,0.0010810000000000001,0.9929309999999999,CLCNKB ESPN MST1 WDR38,positive regulation of mammary gland epithelial cell proliferation|regulation of mammary gland epithelial cell proliferation|regulation of macrophage chemotaxis|regulation of macrophage migration|regulation of leukocyte chemotaxis,3.108e-06|9.879e-06|2.045e-05|4.239e-05|0.0003495,0.04902|0.07792|0.1075|0.1672|1,823.8|433.6|294.2|200.9|68.08
1916,4,0.5768,3.4610000000000003,3372.0,0.001023,0.9929309999999999,ANKRD46 DLG1 ERICH5 ESRRB,positive regulation of transcription involved in G2/M transition of mitotic cell cycle|regulation of transcription involved in G2/M transition of mitotic cell cycle|positive regulation of transcription involved in G1/S transition of mitotic cell cycle|cortical microtubule organization|regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,0.0003883|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|2574|1716|1716|1716
1917,4,0.5374,3.225,3296.0,0.0009749,0.9929309999999999,AMIGO3 CABP7 ESRRG VDAC3,adenine transport|purine nucleobase transport|nucleobase transport|retinoic acid receptor signaling pathway|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,0.0009706|0.001747|0.001941|0.003878|0.009482,1|1|1|1|1,1287|643.6|572.1|271|107.3
1918,5,0.531,5.31,4269.0,0.001239,0.996692,COL4A2 ESYT3 FMN2 PLXND1 PROZ,homologous chromosome movement towards spindle pole in meiosis I anaphase|formin-nucleated actin cable organization|formin-nucleated actin cable assembly|meiotic chromosome movement towards spindle pole|polar body extrusion after meiotic divisions,0.0004854|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,4119|1373|1373|1373|1030
1919,6,0.5188,7.782,4829.0,0.001605,0.998474,ETFA ETFB ETFDH GBP7 KCNK7 PRKCD,fatty acid beta-oxidation using acyl-CoA dehydrogenase|fatty acid beta-oxidation|fatty acid oxidation|lipid oxidation|fatty acid catabolic process,3.922e-09|5.158e-07|1.442e-06|1.652e-06|1.764e-06,6.186e-05|0.004068|0.00758|0.006513|0.005565,1030|174.5|122.6|117|114.4
1920,4,0.5255,3.153,3174.0,0.0009897999999999999,0.9929309999999999,DCAKD ETNPPL TUBA1B UBQLN4,negative regulation of autophagosome maturation|coenzyme A biosynthetic process|regulation of autophagosome maturation|phosphatidylethanolamine biosynthetic process|coenzyme A metabolic process,0.001359|0.002328|0.00291|0.003104|0.003297,1|1|1|1|1,858.1|468.1|367.8|343.2|321.8
1921,6,0.5065,7.597,3977.0,0.0019010000000000001,0.998474,ETS2 FOSL1 HIVEP1 JUN MIDN STK40,"positive regulation of DNA-templated transcription, initiation|positive regulation of pri-miRNA transcription by RNA polymerase II|regulation of pri-miRNA transcription by RNA polymerase II|positive regulation of transcription by RNA polymerase II|negative regulation of cellular process",5.213e-05|6.35e-05|0.0001043|0.0001614|0.000184,0.8223|0.5008|0.5482|0.6367|0.5805,185.5|167.4|129.5|11.38|4.195
1922,4,0.5649,3.389,3352.0,0.001008,0.9929309999999999,ARRDC2 ENPEP ETV1 RIPOR1,negative regulation of Rho guanyl-nucleotide exchange factor activity|negative regulation of guanyl-nucleotide exchange factor activity|establishment of Golgi localization|regulation of guanyl-nucleotide exchange factor activity|angiotensin maturation,0.0005825|0.001359|0.001747|0.001941|0.002522,1|1|1|1|1,2574|858.1|643.6|572.1|429.1
1923,4,0.5812,3.487,2914.0,0.001192,0.9929309999999999,ETV4 ETV5 ITPA KLHL11,ITP catabolic process|purine ribonucleoside triphosphate catabolic process|ITP metabolic process|ribonucleoside triphosphate catabolic process|germline stem cell asymmetric division,0.0003883|0.0003883|0.0005825|0.0005825|0.0009706,1|1|1|1|1,5149|5149|2574|2574|1287
1924,4,0.5194,3.116,3347.0,0.0009279999999999999,0.9929309999999999,BTBD6 ETV7 H6PD LMBR1,"pentose-phosphate shunt, oxidative branch|regulation of cortisol biosynthetic process|regulation of glucocorticoid biosynthetic process|regulation of glucocorticoid metabolic process|regulation of steroid hormone biosynthetic process",0.0009706|0.001553|0.001747|0.002134|0.002328,1|1|1|1|1,1287|735.5|643.6|514.9|468.1
1925,7,0.5165,10.85,5571.0,0.001939,0.9992989999999999,ARHGEF10L ARMC1 CCNB1IP1 EVA1B RNF114 TMEM39A TMEM39B,negative regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|positive regulation of viral genome replication|negative regulation of macroautophagy,2.768e-06|1.185e-05|1.51e-05|5.199e-05|6.916e-05,0.04366|0.09345|0.0794|0.205|0.2182,980.7|420.3|367.8|189.8|163.5
1926,5,0.5261,5.261,3865.0,0.001356,0.996692,CACNA1H EVC2 TSEN2 TSEN34 TSEN54,"tRNA-type intron splice site recognition and cleavage|tRNA splicing, via endonucleolytic cleavage and ligation|RNA splicing, via endonucleolytic cleavage and ligation|tRNA processing|tRNA metabolic process",1.373e-10|5.595e-09|6.644e-09|2.726e-06|6.919e-06,2.165e-06|4.413e-05|3.493e-05|0.01075|0.02183,4119|823.8|772.3|93.61|68.27
1927,4,0.5192,3.115,3030.0,0.001024,0.9929309999999999,EVI5L IL22 MTHFSD SHOX2,regulation of branching morphogenesis of a nerve|sinoatrial node cell development|cardiac pacemaker cell development|sinoatrial node cell differentiation|sinoatrial node development,0.001165|0.001165|0.001359|0.001359|0.001359,1|1|1|1|1,1030|1030|858.1|858.1|858.1
1928,4,0.5564,3.338,3262.0,0.0010199999999999999,0.9929309999999999,EVL PRPS1L1 SV2B TULP2,5-phosphoribose 1-diphosphate biosynthetic process|negative regulation of ruffle assembly|5-phosphoribose 1-diphosphate metabolic process|regulation of ruffle assembly|negative regulation of plasma membrane bounded cell projection assembly,0.001359|0.001359|0.001359|0.005813|0.006007,1|1|1|1|1,858.1|858.1|858.1|177.5|171.6
1929,4,0.5127,3.076,3209.0,0.0009552999999999999,0.9929309999999999,ANKRD9 EVPL LPCAT1 OSMR,negative regulation of phosphatidylcholine biosynthetic process|negative regulation of phosphatidylcholine metabolic process|regulation of phosphatidylcholine biosynthetic process|negative regulation of phospholipid biosynthetic process|negative regulation of phospholipid metabolic process,0.0003883|0.0005825|0.001165|0.001165|0.001359,1|1|1|1|1,5149|2574|1030|1030|858.1
1930,4,0.5091,3.054,3126.0,0.0009737,0.9929309999999999,APC2 EXD1 GAA TMBIM4,vacuolar sequestering|organophosphate ester transport|diaphragm contraction|positive regulation of very-low-density lipoprotein particle remodeling|urea homeostasis,0.0006794|0.0008632|0.001019|0.001019|0.001019,1|1|1|1|1,2942|44.58|1471|1471|1471
1931,5,0.5354,5.354,3164.0,0.001684,0.996692,ARNT CUL2 EPAS1 HIF1A VHL,regulation of transcription from RNA polymerase II promoter in response to hypoxia|regulation of transcription from RNA polymerase II promoter in response to stress|regulation of DNA-templated transcription in response to stress|cellular response to hypoxia|cellular response to decreased oxygen levels,9.397e-13|5.423e-12|6.993e-12|7.221e-11|9.069e-11,1.482e-08|4.277e-08|3.677e-08|2.848e-07|2.861e-07,264|183.9|174.5|108.4|103.5
1932,5,0.5082,5.082,3956.0,0.00128,0.996692,ATP7B EXOC3L1 FGF23 MYO9A SYTL2,copper ion export|positive regulation of vitamin D 24-hydroxylase activity|regulation of vitamin D 24-hydroxylase activity|response to sodium phosphate|vitamin D catabolic process,0.0009706|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1373|1373|1373|1373|1373
1933,4,0.5291,3.175,3282.0,0.000964,0.9929309999999999,C1orf115 EXOC3L2 LCT RNLS,exocyst localization|polysaccharide digestion|negative regulation of heart rate|NAD biosynthesis via nicotinamide riboside salvage pathway|response to epinephrine,0.001165|0.001359|0.002328|0.00291|0.003297,1|1|1|1|1,1030|858.1|468.1|367.8|321.8
1934,10,0.5153,23.19,7000.0,0.0032920000000000002,0.999933,AQP7 CCL19 DMAC1 EXOSC3 FAM205A HAUS6 OR2S2 RCL1 RPS6 SNAPC3,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|cleavage involved in rRNA processing|maturation of 5.8S rRNA|rRNA processing|rRNA metabolic process",6.847e-05|8.547e-05|0.0001399|0.0002309|0.0002577,1|0.6741|0.7357|0.9104|0.8129,171.6|152.6|117.7|23.76|22.88
1935,4,0.5176,3.1060000000000003,3064.0,0.00101,0.9929309999999999,BTBD7 EXTL1 KLHL20 LRRC14B,protein K33-linked ubiquitination|regulation of branching involved in salivary gland morphogenesis|Golgi to endosome transport|response to interferon-alpha|regulation of morphogenesis of a branching structure,0.0003883|0.001553|0.003491|0.004846|0.009867,1|1|1|1|1,5149|735.5|302.9|214.5|103
1936,4,0.5586,3.3510000000000004,3288.0,0.001016,0.9929309999999999,CBLC F13A1 LIM2 SIGLEC10,"negative regulation of inflammatory response to wounding|regulation of inflammatory response to wounding|protein phosphopantetheinylation|negative regulation of epidermal growth factor-activated receptor activity|blood coagulation, fibrin clot formation",0.0007766|0.001165|0.001576|0.00291|0.005426,1|1|1|1|1,1716|1030|30.65|367.8|190.7
1937,21,0.5071,106.5,15290.0,0.006895999999999999,1.0,ACCS ACCSL ANO3 CHRM4 COMMD9 CRY2 EHF ELF5 F2 FBXO3 MAPK8IP1 MRGPRX3 OR4A47 OR4B1 OR4C12 OR4C13 OR4C3 OR4X1 PAMR1 SLC1A2 TP53I11,G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception of smell|detection of stimulus|sensory perception of smell|detection of chemical stimulus involved in sensory perception,4.566e-06|5.581e-06|6.942e-06|7.807e-06|9.657e-06,0.07202|0.04402|0.0365|0.03079|0.03046,6.34|12.74|9.127|12|11.56
1938,4,0.5551,3.33,3094.0,0.001073,0.9929309999999999,F5 MGAT4C REPS1 TNN,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|negative regulation of osteoblast proliferation|negative regulation of neuron migration|dendrite self-avoidance,0.0003883|0.0003883|0.002134|0.002328|0.003491,1|1|1|1|1,5149|5149|514.9|468.1|302.9
1939,4,0.5458,3.275,3280.0,0.0009952,0.9929309999999999,FABP1 SLC16A8 SLC30A2 TRAT1,positive regulation of sequestering of zinc ion|negative regulation of receptor recycling|organic acid transport|regulation of sequestering of zinc ion|lactate transmembrane transport,0.0003883|0.0009706|0.001108|0.001165|0.001553,1|1|1|1|1,5149|1287|36.65|1030|735.5
1940,5,0.5748,5.747999999999999,4492.0,0.001275,0.996692,CD180 CPT1C FABP2 SMCO1 ZNF202,cellular lipid catabolic process|B cell proliferation involved in immune response|lipid metabolic process|lipid catabolic process|positive regulation of lipopolysaccharide-mediated signaling pathway,0.0009384|0.001698|0.001916|0.002135|0.002183,1|1|1|1|1,41.19|686.5|10.11|27.1|514.9
1941,8,0.5131,14.37,7085.0,0.002019,0.9996790000000001,BSDC1 C1QB C1QC CTRC FABP3 KIAA0319L SCMH1 TSSK3,synapse pruning|cell junction disassembly|regulation of complement activation|regulation of humoral immune response|positive regulation of long-chain fatty acid import into cell,1.027e-05|1.198e-05|0.0009055|0.001285|0.001552,0.162|0.09447|1|1|1,468.1|429.1|44.01|36.78|858.1
1942,4,0.5574,3.344,2776.0,0.0012,0.9929309999999999,CCNK CDK10 FABP5 TTC14,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues|regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues|positive regulation of phosphorylation of RNA polymerase II C-terminal domain|regulation of retrograde trans-synaptic signaling by endocanabinoid|regulation of phosphorylation of RNA polymerase II C-terminal domain,0.0003883|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,5149|5149|5149|2574|1716
1943,5,0.5094,5.093999999999999,4271.0,0.001189,0.996692,CPLANE1 DYNLL2 FABP6 JCHAIN SLC45A2,"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed|regulation of ATP-dependent microtubule motor activity, plus-end-directed|positive regulation of microtubule motor activity|oligosaccharide transport|sucrose transport",0.0009706|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,1373|1373|1030|1030|1030
1944,14,0.5153,46.89,10530.0,0.004423,0.9999969999999999,CHRM1 HRASLS2 HRASLS5 NUDT22 PLA2G16 RARRES3 RASGRP2 SCGB1D1 SCGB1D2 SCGB1D4 SCGB2A1 SCGB2A2 SLC22A10 SLC22A9,N-acylphosphatidylethanolamine metabolic process|phosphatidylethanolamine metabolic process|androgen receptor signaling pathway|phosphatidylethanolamine acyl-chain remodeling|intracellular steroid hormone receptor signaling pathway,4.3e-08|1.16e-06|6.935e-05|0.0001376|0.0004971,0.0006783|0.009151|0.3646|0.5425|1,528.1|153.3|176|121.9|62.13
1945,5,0.5781,5.781000000000001,4142.0,0.00139,0.996692,FADS3 FAM81B IL17B MAP4K2 PCK1,pyruvate metabolic process|monocarboxylic acid metabolic process|cellular glucose homeostasis|glucose metabolic process|hexose metabolic process,0.0001163|0.0001514|0.0001999|0.0003163|0.0005758,1|1|1|1|1,119.4|24.04|90.53|71.63|52.81
1946,4,0.519,3.114,3191.0,0.0009724,0.9929309999999999,FAH LAMA2 SGPP1 SYT1,positive regulation of synaptic transmission|positive regulation of calcium ion-dependent exocytosis of neurotransmitter|synchronous neurotransmitter secretion|homogentisate metabolic process|homogentisate catabolic process,0.0002425|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,79.21|5149|5149|5149|5149
1947,4,0.5225,3.135,3179.0,0.0009827,0.9929309999999999,FAHD1 LOXL4 RUSC2 SF3A3,U2-type prespliceosome assembly|peptidyl-lysine oxidation|mRNA 3'-splice site recognition|protein oxidation|mRNA splice site selection,0.0007766|0.001165|0.001359|0.002522|0.006393,1|1|1|1|1,1716|1030|858.1|429.1|160.9
1948,10,0.5008,22.54,7801.0,0.002873,0.999933,CARNS1 CCNB1IP1 FAIM KIF26B KLK10 LRRC40 NIPSNAP3B RNF114 SDR39U1 TEX12,homologous chromosome pairing at meiosis|homologous chromosome segregation|chromosome organization involved in meiotic cell cycle|meiotic chromosome segregation|carnosine biosynthetic process,0.0002883|0.0004206|0.000503|0.0008483|0.0009704,1|1|1|1|1,80.76|66.44|60.57|46.28|2060
1949,5,0.5593,5.593,3698.0,0.001506,0.996692,C1orf43 FAM102A KIAA0100 KIAA1109 VAPA,positive regulation by host of viral release from host cell|modulation by host of viral release from host cell|positive regulation by host of viral genome replication|negative regulation by host of viral genome replication|phagocytosis,0.001456|0.001456|0.002183|0.002183|0.002449,1|1|1|1|1,823.8|823.8|514.9|514.9|25.27
1950,4,0.5759,3.455,3231.0,0.001066,0.9929309999999999,DRICH1 FAM110A KCNG3 PDE4D,regulation of ion transmembrane transport|regulation of transmembrane transport|adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate|adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate|potassium ion transmembrane transport,0.0002161|0.0002217|0.0004854|0.0004854|0.0005904,1|1|1|1|1,21.31|21.12|4119|4119|52.14
1951,5,0.5059,5.059,3709.0,0.001358,0.996692,CHMP1B CHMP3 FAM110B PLCXD3 RNF11,midbody abscission|viral budding via host ESCRT complex|mitotic cytokinetic process|late endosome to vacuole transport|viral budding,8.046e-06|1.087e-05|1.19e-05|1.65e-05|1.65e-05,0.1269|0.0857|0.06257|0.06508|0.05206,484.6|411.9|392.3|329.5|329.5
1952,4,0.5262,3.157,3034.0,0.001037,0.9929309999999999,FAM114A1 FAM162A OR10H5 WDR5B,positive regulation of release of cytochrome c from mitochondria|histone H3-K4 methylation|G protein-coupled serotonin receptor signaling pathway|serotonin receptor signaling pathway|regulation of release of cytochrome c from mitochondria,0.00562|0.006586|0.00678|0.007745|0.009096,1|1|1|1|1,183.9|156|151.4|132|111.9
1953,4,0.5496,3.298,3137.0,0.001047,0.9929309999999999,DSCAML1 FAM118B OR6X1 PDZD3,negative regulation of guanylate cyclase activity|Cajal body organization|negative regulation of purine nucleotide biosynthetic process|negative regulation of nucleotide biosynthetic process|negative regulation of cGMP-mediated signaling,0.0007766|0.0009706|0.001359|0.001359|0.001359,1|1|1|1|1,1716|1287|858.1|858.1|858.1
1954,4,0.5781,3.469,3150.0,0.001097,0.9929309999999999,ERBB4 FAM120B HSDL1 NDUFAF1,central nervous system morphogenesis|cardiac muscle tissue regeneration|peroxisome proliferator activated receptor signaling pathway|mitochondrial fragmentation involved in apoptotic process|negative regulation of neuron migration,0.0005825|0.0009706|0.001553|0.001941|0.002328,1|1|1|1|1,2574|1287|735.5|572.1|468.1
1955,5,0.5093,5.093,4215.0,0.001204,0.996692,ANKRD46 FAM124B PLB1 SLC35F3 STMN2,positive regulation of microtubule depolymerization|thiamine transport|positive regulation of acrosome reaction|negative regulation of microtubule polymerization|regulation of acrosome reaction,0.001213|0.001213|0.003152|0.003394|0.003878,1|1|1|1|1,1030|1030|343.3|316.8|274.6
1956,4,0.5238,3.1430000000000002,3266.0,0.0009587999999999999,0.9929309999999999,APOF FAM126A LRRC26 MTNR1B,"regulation of potassium ion transmembrane transporter activity|regulation of potassium ion transmembrane transport|regulation of potassium ion transport|regulation of cation channel activity|positive regulation of circadian sleep/wake cycle, non-REM sleep",5.502e-05|0.0001593|0.0002071|0.000486|0.0009706,0.8678|1|1|1|1,168.8|98.07|85.81|55.66|1287
1957,6,0.5197,7.795,3841.0,0.002019,0.998474,FAM126B FERMT1 FERMT2 ILK TCF7L2 TTC7A,"positive regulation of cell-matrix adhesion|positive regulation of wound healing, spreading of epidermal cells|integrin-mediated signaling pathway|regulation of wound healing, spreading of epidermal cells|regulation of cell-matrix adhesion",4.435e-07|1.06e-06|2.263e-06|3.178e-06|4.408e-06,0.006996|0.008359|0.0119|0.01253|0.01391,183.9|1716|105.1|858.1|83.72
1958,4,0.5593,3.3560000000000003,3093.0,0.0010810000000000001,0.9929309999999999,FAM129C PRX TM6SF2 ZNF140,peripheral nervous system myelin maintenance|myelin maintenance|myelination in peripheral nervous system|peripheral nervous system axon ensheathment|Schwann cell development,0.001747|0.003297|0.00562|0.00562|0.0062,1|1|1|1|1,643.6|321.8|183.9|183.9|166.1
1959,9,0.5254,18.92,7203.0,0.002613,0.9998530000000001,FAM131A HRASLS HTR3D MUC4 PDCD6 SERPINI1 SLC51A TCTEX1D2 TM4SF19,regulation of intraciliary retrograde transport|positive regulation of protein monoubiquitination|vascular endothelial growth factor receptor-2 signaling pathway|regulation of protein monoubiquitination|bile acid secretion,0.00131|0.002618|0.002618|0.003054|0.003054,1|1|1|1|1,1144|457.7|457.7|381.4|381.4
1960,4,0.5071,3.043,3326.0,0.0009117000000000001,0.9929309999999999,AP5S1 DISC1 FAM131B LRFN1,regulation of synapse organization|regulation of synapse structure or activity|pyramidal neuron migration|regulation of postsynaptic density assembly|pyramidal neuron development,0.0006123|0.0006778|0.0007766|0.002328|0.002328,1|1|1|1|1,49.51|47.02|1716|468.1|468.1
1961,5,0.5235,5.235,4135.0,0.001261,0.996692,CTSK ECM1 FAM133B ITSN1 LIX1L,positive regulation of caveolin-mediated endocytosis|clathrin-dependent synaptic vesicle endocytosis|ossification|regulation of modification of postsynaptic actin cytoskeleton|regulation of caveolin-mediated endocytosis,0.001213|0.001213|0.001595|0.001698|0.00194,1|1|1|1|1,1030|1030|31.44|686.5|588.4
1962,4,0.5581,3.3480000000000003,3290.0,0.0010140000000000001,0.9929309999999999,FAM13A HOXC13 LONP2 RXYLT1,nail development|tongue morphogenesis|protein import into peroxisome matrix|protein O-linked mannosylation|regulation of fatty acid beta-oxidation,0.001941|0.002134|0.002716|0.003685|0.004072,1|1|1|1|1,572.1|514.9|396.1|286|257.4
1963,5,0.5034,5.034,3789.0,0.001323,0.996692,FAM13C LVRN OR56B1 RALGPS1 TRIM34,regulation of Ral protein signal transduction|peptide catabolic process|regulation of viral entry into host cell|modulation by symbiont of entry into host|signal transduction,0.0009706|0.007744|0.01064|0.01232|0.01552,1|1|1|1|1,1373|132.9|95.79|82.38|3.207
1964,4,0.5142,3.085,3293.0,0.0009339000000000001,0.9929309999999999,ATP10B FAM149A FAM198B IL7,lysosomal membrane organization|positive regulation of B cell differentiation|interleukin-7-mediated signaling pathway|T cell lineage commitment|bone resorption,0.001165|0.003104|0.003878|0.004459|0.004846,1|1|1|1|1,1030|343.2|271|234|214.5
1965,5,0.5585,5.585,4118.0,0.001351,0.996692,ACOT12 ADGRV1 ANKRD31 FAM151B FAM169A,meiotic DNA double-strand break formation involved in reciprocal meiotic recombination|positive regulation of meiotic DNA double-strand break formation|regulation of meiotic DNA double-strand break formation|maintenance of animal organ identity|meiotic DNA double-strand break formation,0.0004854|0.0004854|0.0004854|0.001456|0.00194,1|1|1|1|1,4119|4119|4119|823.8|588.4
1966,4,0.5213,3.128,3299.0,0.0009448000000000001,0.9929309999999999,EPS8L1 FAM160A1 PTPN3 RNF13,regulation of membrane depolarization during action potential|negative regulation of membrane protein ectodomain proteolysis|positive regulation of ruffle assembly|regulation of membrane protein ectodomain proteolysis|regulation of ruffle assembly,0.001165|0.001747|0.003104|0.00504|0.005813,1|1|1|1|1,1030|643.6|343.2|205.9|177.5
1967,4,0.5569,3.342,3229.0,0.001031,0.9929309999999999,FAM160B2 FBXO25 MFGE8 TSGA10,apoptotic cell clearance|sexual reproduction|positive regulation of phagocytosis|amyloid fibril formation|multi-organism reproductive process,0.00871|0.009521|0.01256|0.01256|0.01326,1|1|1|1|1,117|12.23|80.45|80.45|10.31
1968,4,0.5413,3.248,3071.0,0.0010539999999999998,0.9929309999999999,FAM161A MRPS31 SCN1B TMEM247,corticospinal neuron axon guidance|membrane depolarization during Purkinje myocyte cell action potential|Purkinje myocyte action potential|response to pyrethroid|Purkinje myocyte to ventricular cardiac muscle cell signaling,0.0005825|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|1716|1716|1287|1030
1969,5,0.5511,5.511,4102.0,0.001338,0.996692,ACBD3 FAM161B HTR3D HTR3E SERP1,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus,3.85e-05|0.0001591|0.000163|0.0002265|0.0002265,0.6073|1|0.857|0.8932|0.7145,211.2|101.7|100.5|84.93|84.93
1970,4,0.5233,3.14,3110.0,0.001006,0.9929309999999999,BNC2 FAM166A GNRH1 HAND1,embryonic heart tube formation|cardiac left ventricle formation|mesenchyme development|response to prolactin|cardiac right ventricle formation,0.0003883|0.0005825|0.0006717|0.0007766|0.0009706,1|1|1|1|1,5149|2574|47.24|1716|1287
1971,4,0.5268,3.161,3236.0,0.0009732999999999999,0.9929309999999999,FAM168B FBXO40 STK39 TACC1,negative regulation of creatine transmembrane transporter activity|regulation of creatine transmembrane transporter activity|negative regulation of pancreatic juice secretion|chemokine (C-X-C motif) ligand 12 signaling pathway|maintenance of lens transparency,0.0005825|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|2574|1716|1287|1287
1972,4,0.5861,3.517,3207.0,0.001093,0.9929309999999999,ADGRF4 FAM169B GRB14 TBX5,cell migration involved in coronary vasculogenesis|cardiac left ventricle formation|bundle of His development|His-Purkinje system development|positive regulation of secondary heart field cardioblast proliferation,0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
1973,4,0.5149,3.09,2984.0,0.001031,0.9929309999999999,ACAA2 EIF3M FAM170A LARP4,organic substance biosynthetic process|biosynthetic process|negative regulation of mitochondrial membrane permeability involved in apoptotic process|negative regulation of mitochondrial membrane permeability|cellular nitrogen compound biosynthetic process,0.0003447|0.0003735|0.0009706|0.001359|0.001692,1|1|1|1|1,7.345|7.199|1287|858.1|9.807
1974,5,0.5013,5.013,3989.0,0.0012519999999999999,0.996692,AKR1C1 AKR1C3 FAM171A1 PDGFD PRTFDC1,cellular response to jasmonic acid stimulus|response to jasmonic acid|doxorubicin metabolic process|daunorubicin metabolic process|polyketide metabolic process,7.067e-07|7.067e-07|2.59e-06|2.59e-06|2.59e-06,0.01115|0.005574|0.01362|0.01021|0.008171,2060|2060|915.3|915.3|915.3
1975,5,0.5422,5.422000000000001,4381.0,0.001233,0.996692,C14orf39 FAM172A MFAP3L MFSD6 ZBTB25,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination|meiotic DNA double-strand break processing|heterochromatin assembly by small RNA|DNA double-strand break processing|heterochromatin assembly,0.000728|0.001213|0.001213|0.005571|0.00702,1|1|1|1|1,2060|1030|1030|187.2|147.1
1976,4,0.535,3.21,3268.0,0.0009787,0.9929309999999999,BAIAP2L2 FAM181A MGAT3 PIH1D2,negative regulation of lysosomal protein catabolic process|negative regulation of protein catabolic process in the vacuole|box C/D snoRNP assembly|regulation of lysosomal protein catabolic process|positive regulation of protein localization to early endosome,0.0007766|0.0007766|0.001747|0.001747|0.001941,1|1|1|1|1,1716|1716|643.6|643.6|572.1
1977,4,0.5466,3.28,3246.0,0.001007,0.9929309999999999,CLDN25 FAM184A LBH SLC17A6,positive regulation of mammary stem cell proliferation|regulation of mammary stem cell proliferation|positive regulation of somatic stem cell division|regulation of somatic stem cell division|positive regulation of somatic stem cell population maintenance,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
1978,13,0.5119,39.93,10140.0,0.00391,0.999993,CLEC2B KLRC1 KLRC4 PRB1 PRB2 PRB4 PRH2 RERG TAS2R13 TAS2R19 TAS2R20 TAS2R30 TAS2R7,sensory perception of taste|detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste|sensory perception of chemical stimulus,1.417e-09|1.634e-08|2.659e-08|2.911e-08|3.114e-05,2.235e-05|0.0001289|0.0001398|0.0001148|0.09825,101|152.6|134|130.8|12.67
1979,4,0.5011,3.0060000000000002,3022.0,0.0009914,0.9929309999999999,FAM186B FCN1 PXK SNX1,"cell surface pattern recognition receptor signaling pathway|lamellipodium morphogenesis|recognition of apoptotic cell|early endosome to Golgi transport|complement activation, lectin pathway",0.0005825|0.001165|0.001553|0.001941|0.002134,1|1|1|1|1,2574|1030|735.5|572.1|514.9
1980,4,0.5136,3.0810000000000004,3423.0,0.0008972000000000001,0.9929309999999999,AMIGO3 ERICH6B FAM189A1 TRAFD1,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|positive regulation of synapse assembly|negative regulation of innate immune response|positive regulation of cell junction assembly|regulation of synapse assembly,0.009482|0.0116|0.01256|0.0189|0.01909,1|1|1|1|1,107.3|87.27|80.45|53.08|52.54
1981,5,0.5013,5.013,3998.0,0.0012490000000000001,0.996692,CFAP44 FAM192A LRBA SH2D3A TLR10,toll-like receptor 10 signaling pathway|sperm axoneme assembly|MyD88-dependent toll-like receptor signaling pathway|negative regulation of proteasomal protein catabolic process|negative regulation of proteolysis involved in cellular protein catabolic process,0.0004854|0.005571|0.007744|0.01184|0.01568,1|1|1|1|1,4119|187.2|132.9|85.81|64.36
1982,31,0.5015,233.2,23340.0,0.009867,1.0,ACVRL1 AQP5 FAM19A2 GLIPR1L1 HOXC5 HOXC6 HOXC8 INHBE KRT1 KRT5 KRT6B KRT74 KRT75 KRT77 KRT78 KRT79 KRT82 KRT83 KRT84 KRT85 KRT86 OR10P1 OR2AP1 OR6C1 OR6C3 OR6C4 OR6C65 POU6F1 PPP1R1A RDH16 SDR9C7,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development,9.589e-22|4.922e-18|4.111e-17|3.208e-16|3.532e-15,1.513e-17|3.882e-14|2.162e-13|1.265e-12|1.114e-11,78.98|39.49|33.3|28.24|23.3
1983,14,0.5001,45.51,10060.0,0.004493,0.9999969999999999,ANAPC11 EIF4A3 FTSJ3 INTS2 NPLOC4 NUP85 PSMC5 PSMD12 RPL38 SAP30BP SRP68 TSEN54 USP36 UTP18,ncRNA processing|ncRNA metabolic process|cellular macromolecule catabolic process|macromolecule catabolic process|anaphase,2.315e-07|6.556e-07|8.933e-07|2.229e-06|3.379e-06,0.003651|0.00517|0.004697|0.008789|0.01066,20.43|17.07|11.29|9.845|37.48
1984,10,0.5189,23.35,6724.0,0.0034509999999999996,0.999933,ARMC7 CCDC84 DDX59 DHX9 FAM204A PPIH RBM48 SCNM1 TXNL4B WDR25,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|alternative mRNA splicing, via spliceosome",9.334e-06|9.334e-06|9.701e-06|2.979e-05|5.334e-05,0.1472|0.07362|0.05101|0.1175|0.1683,27.28|27.28|27.01|20.24|196.1
1985,4,0.5075,3.045,3233.0,0.0009387999999999999,0.9929309999999999,FAM210B ISLR2 MSANTD4 PATL2,negative regulation of cytoplasmic mRNA processing body assembly|deadenylation-dependent decapping of nuclear-transcribed mRNA|regulation of cytoplasmic mRNA processing body assembly|methylguanosine-cap decapping|RNA decapping,0.0005825|0.001941|0.002134|0.002522|0.00291,1|1|1|1|1,2574|572.1|514.9|429.1|367.8
1986,4,0.5332,3.199,3318.0,0.0009609999999999999,0.9929309999999999,FAM214A MOB1B PPP1R14D TEX26,negative regulation of protein serine/threonine phosphatase activity|positive regulation of protein serine/threonine phosphatase activity|positive regulation of phosphoprotein phosphatase activity|hippo signaling|positive regulation of phosphatase activity,0.0003883|0.0005825|0.004266|0.00562|0.00678,1|1|1|1|1,5149|2574|245.2|183.9|151.4
1987,17,0.5096,69.3,11560.0,0.005940999999999999,1.0,DUX4 HSPE1 OR2A25 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL23A RPL37 RPL4 RPL9 RPLP0 RPLP2 RPS13 RPS6,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,1.935e-29|3.745e-29|1.287e-28|2.047e-28|2.294e-28,3.052e-25|2.954e-25|6.765e-25|8.074e-25|7.237e-25,166.9|158.6|144.3|139.3|138.1
1988,4,0.5392,3.235,3086.0,0.001044,0.9929309999999999,AIG1 FAM216B GBE1 IL22,long-chain fatty acid catabolic process|glycogen biosynthetic process|glucan biosynthetic process|acute-phase response|cellular polysaccharide biosynthetic process,0.001165|0.004459|0.004459|0.008131|0.009289,1|1|1|1|1,1030|234|234|125.6|109.5
1989,4,0.5121,3.072,3319.0,0.0009226000000000001,0.9929309999999999,CRYZ FAM219B PANK3 TMEM91,coenzyme A biosynthetic process|xenobiotic catabolic process|coenzyme A metabolic process|protein homotetramerization|purine nucleoside bisphosphate biosynthetic process,0.002328|0.002522|0.003297|0.01102|0.01179,1|1|1|1|1,468.1|429.1|321.8|91.94|85.81
1990,23,0.5083,128.6,18280.0,0.006967,1.0,ABCB5 ADCYAP1R1 AEBP1 AGR2 AGR3 GHRHR GSDME HOXA5 HOXA6 HOXA7 HOXA9 INMT KIAA0895 MTURN NME8 NPY PHKG1 PRR15 RBAK RSPH10B2 WIPF3 ZNF12 ZNF713,embryonic skeletal system morphogenesis|embryonic skeletal system development|lung goblet cell differentiation|lobar bronchus epithelium development|lobar bronchus development,3.965e-06|1.076e-05|1.188e-05|1.781e-05|2.491e-05,0.06254|0.08487|0.06246|0.07022|0.07859,38.1|29.36|597|447.7|358.2
1991,6,0.5068,7.602,5056.0,0.001498,0.998474,FAM221A FFAR4 GJD2 GLDN PCDHAC2 SGPP2,negative regulation of somatostatin secretion|ghrelin secretion|regulation of somatostatin secretion|positive regulation of glucagon secretion|clustering of voltage-gated sodium channels,0.0005824|0.0008735|0.001165|0.001165|0.002037,1|1|1|1|1,3432|1716|1144|1144|572.1
1992,4,0.5517,3.31,3228.0,0.0010220000000000001,0.9929309999999999,ANGPTL4 FAM222B RWDD2A SYNGR2,protein unfolding|synaptic vesicle membrane organization|negative regulation of lipoprotein lipase activity|negative regulation of lipase activity|regulation of lipoprotein lipase activity,0.0007766|0.0009706|0.001359|0.003491|0.004459,1|1|1|1|1,1716|1287|858.1|302.9|234
1993,4,0.5468,3.281,3228.0,0.001013,0.9929309999999999,FAM228A ITGA2 NDUFS4 TTC38,positive regulation of collagen binding|regulation of collagen binding|response to L-ascorbic acid|positive regulation of transmission of nerve impulse|positive regulation of alkaline phosphatase activity,0.0003883|0.0005825|0.001359|0.001359|0.001359,1|1|1|1|1,5149|2574|858.1|858.1|858.1
1994,4,0.5411,3.247,3274.0,0.0009884,0.9929309999999999,ACKR3 FAM229A PNPLA7 SYNE2,nuclear migration along microfilament|positive regulation of mesenchymal stem cell migration|regulation of mesenchymal stem cell migration|nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration|nuclear migration along microtubule,0.0005825|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|1716|1716|1716|1287
1995,13,0.4383,34.19,10340.0,0.0032869999999999996,0.999993,C6orf203 ENPP1 ENPP3 GABRR1 NKAIN2 PTPRK TAAR2 TAAR6 TAAR8 TCF21 ULBP3 VNN2 WISP3,nucleoside triphosphate catabolic process|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process|negative regulation of hh target transcription factor activity|nucleoside triphosphate metabolic process,3.713e-05|0.00108|0.00108|0.001164|0.001291,0.5858|1|1|1|1,245.2|41.36|41.36|1716|37.72
1996,5,0.5039,5.039,4115.0,0.00122,0.996692,AFAP1L1 ARHGDIG FAM234A GRIN1 RHBDD1,ionotropic glutamate receptor signaling pathway|glutamate receptor signaling pathway|propylene metabolic process|response to glycine|cellular alkene metabolic process,2.86e-05|8.263e-05|0.0005824|0.0008735|0.0008735,0.4511|0.6517|1|1|1,254.3|146.1|3432|1716|1716
1997,15,0.5007,52.58,10260.0,0.0050810000000000004,0.999999,ANKFY1 ANKH ATP6V0A1 C12orf4 PPP1R21 RAB5C RABGEF1 RBSN TBCK TGFBRAP1 VPS16 VPS18 VPS33A VPS45 VPS8,lysosomal transport|protein transport|peptide transport|amide transport|establishment of protein localization,1.271e-10|2.522e-10|3.11e-10|3.955e-10|4.935e-10,2.005e-06|1.989e-06|1.635e-06|1.56e-06|1.557e-06,75.58|10.32|10.12|9.897|9.694
1998,5,0.5049,5.0489999999999995,4206.0,0.001196,0.996692,ASPSCR1 FAM241B FBLN1 NDUFA12 ZP1,"negative regulation of transformation of host cell by virus|regulation of transformation of host cell by virus|positive regulation of substrate-dependent cell migration, cell attachment to substrate|regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of stem cell proliferation",0.0004854|0.0004854|0.0009706|0.0009706|0.001456,1|1|1|1|1,4119|4119|1373|1373|823.8
1999,4,0.5355,3.213,3200.0,0.001,0.9929309999999999,FAM24A FAM49B NOTCH3 PANK4,positive regulation of memory T cell activation|regulation of memory T cell activation|coenzyme A biosynthetic process|coenzyme A metabolic process|positive regulation of transcription of Notch receptor target,0.0005825|0.0005825|0.002328|0.003297|0.003685,1|1|1|1|1,2574|2574|468.1|321.8|286
2000,4,0.5509,3.305,3348.0,0.0009838,0.9929309999999999,EMX2 FAM24B GH1 LRRC70,cerebral cortex regionalization|ureter morphogenesis|positive regulation of activation of Janus kinase activity|regulation of activation of Janus kinase activity|telencephalon regionalization,0.001359|0.001553|0.001553|0.001941|0.002522,1|1|1|1|1,858.1|735.5|735.5|572.1|429.1
2001,8,0.5191,14.53,5563.0,0.002598,0.9996790000000001,CHERP DDX39B FAM32A HAUS8 LSM4 RPL18A SUGP1 UBA52,"mRNA metabolic process|RNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",3.978e-08|2.143e-07|3.187e-06|3.187e-06|3.313e-06,0.0006275|0.00169|0.01676|0.01257|0.01045,22.26|16.73|34.1|34.1|33.76
2002,4,0.5171,3.103,3227.0,0.0009582000000000001,0.9929309999999999,FAM43A KIF3B NXPE1 SPTBN1,plus-end-directed vesicle transport along microtubule|common-partner SMAD protein phosphorylation|mitotic centrosome separation|plus-end-directed organelle transport along microtubule|centrosome separation,0.001359|0.001359|0.001359|0.001553|0.001747,1|1|1|1|1,858.1|858.1|858.1|735.5|643.6
2003,5,0.517,5.17,4051.0,0.001271,0.996692,ALPK2 CGNL1 FAM43B SERPINB3 SERPINB8,epicardium morphogenesis|negative regulation of endopeptidase activity|negative regulation of peptidase activity|paracrine signaling|negative regulation of Wnt signaling pathway involved in heart development,0.000728|0.001398|0.001512|0.00194|0.00194,1|1|1|1|1,2060|33.62|32.31|588.4|588.4
2004,4,0.5705,3.423,3055.0,0.001117,0.9929309999999999,BHLHA9 FAM53A KLB NR5A2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway|pancreas morphogenesis|calcineurin-mediated signaling|positive regulation of viral genome replication|bile acid metabolic process,0.0009706|0.0009706|0.003104|0.0062|0.008131,1|1|1|1|1,1287|1287|343.2|166.1|125.6
2005,4,0.5487,3.292,3176.0,0.001033,0.9929309999999999,BCAM FAM53B MYBPC1 TPST1,peptidyl-tyrosine sulfation|protein sulfation|sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process,0.0005825|0.001747|0.004846|0.00504|0.00504,1|1|1|1|1,2574|643.6|214.5|205.9|205.9
2006,4,0.5596,3.358,3318.0,0.001009,0.9929309999999999,C1orf105 FAM71D MIA2 TEX43,protein localization to endoplasmic reticulum exit site|lipoprotein transport|lipoprotein localization|protein exit from endoplasmic reticulum|vesicle cargo loading,0.001747|0.002716|0.00291|0.004846|0.005426,1|1|1|1|1,643.6|396.1|367.8|214.5|190.7
2007,4,0.5506,3.304,3170.0,0.001039,0.9929309999999999,ETFDH FAM71E1 FAT1 OC90,establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis|otolith mineralization|lipid catabolic process|otolith development|fatty acid beta-oxidation using acyl-CoA dehydrogenase,0.0003883|0.0005825|0.001294|0.001747|0.002134,1|1|1|1|1,5149|2574|33.87|643.6|514.9
2008,5,0.5031,5.031000000000001,3994.0,0.001255,0.996692,FAM83B HIP1 SMIM21 STATH STXBP5,positive regulation of platelet-derived growth factor receptor-beta signaling pathway|positive regulation of platelet-derived growth factor receptor signaling pathway|saliva secretion|regulation of platelet-derived growth factor receptor-beta signaling pathway|regulation of synaptic vesicle priming,0.0009706|0.001456|0.001456|0.002183|0.002183,1|1|1|1|1,1373|823.8|823.8|514.9|514.9
2009,4,0.5329,3.198,2736.0,0.001164,0.9929309999999999,FAM83D FAM83H HMMR TUBB4B,protein localization to cytoskeleton|regulation of cell cycle phase transition|regulation of cell cycle process|protein localization to mitotic spindle|regulation of G2/M transition of mitotic cell cycle,2.668e-05|4.495e-05|0.0002063|0.0003883|0.0005836,0.4209|0.3546|1|1|1,245.2|33.43|20.01|5149|50.73
2010,27,0.503,176.6,22400.0,0.007802,1.0,ADAM2 ADAM32 ADRB3 AP3M2 C8orf58 CHRNA6 CHRNB3 DKK4 DOK2 ERLIN2 LETM2 NKX6-3 PEBP4 PLPP5 RNF170 RNF5 SARAF SLC20A2 SMIM18 STC1 STMN4 TEX15 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D ZDHHC2,"TRAIL-activated apoptotic signaling pathway|extrinsic apoptotic signaling pathway via death domain receptors|extrinsic apoptotic signaling pathway|activation of NF-kappaB-inducing kinase activity|synaptic transmission, cholinergic",1.672e-07|1.274e-05|0.0002478|0.0003091|0.000611,0.002638|0.1005|1|1|1,381.4|71.51|25.15|84.75|58.68
2011,4,0.575,3.45,3041.0,0.0011300000000000001,0.9929309999999999,ARHGAP28 ATP1B1 FAM8A1 SIGLEC6,protein transport into plasma membrane raft|positive regulation of calcium:sodium antiporter activity|regulation of calcium:sodium antiporter activity|protein localization to plasma membrane raft|negative regulation of GTP binding,0.0003883|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|2574|1716|1716|1716
2012,6,0.5271,7.906000000000001,3910.0,0.002012,0.998474,CLINT1 MON2 OSBPL11 OSBPL9 SCYL1 VPS54,Golgi vesicle transport|post-Golgi vesicle-mediated transport|transport|establishment of localization|macromolecule localization,2.037e-06|5.671e-06|0.0001094|0.0001335|0.0001574,0.03213|0.04473|0.575|0.5263|0.4964,34.67|76.85|4.576|4.426|6.73
2013,4,0.5362,3.217,3221.0,0.0009954,0.9929309999999999,FAM92A GDF9 OR4D11 SCRN1,regulation of progesterone secretion|oocyte growth|regulation of female gonad development|regulation of gonad development|regulation of steroid hormone secretion,0.0005825|0.0005825|0.001359|0.002716|0.004072,1|1|1|1|1,2574|2574|858.1|396.1|257.4
2014,4,0.5367,3.22,3210.0,0.0009998,0.9929309999999999,ATRAID FAM98A SLC37A3 SLC43A1,negative regulation of leucine import|regulation of leucine import|negative regulation of leucine import across plasma membrane|regulation of leucine import across plasma membrane|negative regulation of osteoblast proliferation,0.0005825|0.0005825|0.0005825|0.0005825|0.002134,1|1|1|1|1,2574|2574|2574|2574|514.9
2015,4,0.5633,3.38,3275.0,0.001029,0.9929309999999999,CBARP FAN1 IFT46 THAP9,"transposition, DNA-mediated|DNA recombination|microspike assembly|regulation of microvillus assembly|transposition",0.0009706|0.001172|0.001213|0.001698|0.00194,1|1|1|1|1,1373|36.78|1030|686.5|588.4
2016,5,0.5158,5.1579999999999995,4057.0,0.001267,0.996692,ABCA9 CALY FANK1 OR10Z1 TSN,positive regulation of retrograde axon cargo transport|regulation of retrograde axon cargo transport|positive regulation of clathrin coat assembly|regulation of clathrin coat assembly|postsynaptic endocytosis,0.0004854|0.0004854|0.000728|0.000728|0.002425,1|1|1|1|1,4119|4119|2060|2060|457.7
2017,4,0.5922,3.553,3175.0,0.001115,0.9929309999999999,CAMTA2 FASLG OR1J2 OR56B4,positive regulation of phosphatidylserine exposure on apoptotic cell surface|regulation of phosphatidylserine exposure on apoptotic cell surface|retinal cell programmed cell death|endosomal lumen acidification|positive regulation of phospholipid translocation,0.0003883|0.0003883|0.0005825|0.0009706|0.001165,1|1|1|1|1,5149|5149|2574|1287|1030
2018,4,0.5697,3.418,3260.0,0.001045,0.9929309999999999,CACNG3 FASTK KIAA1841 RPL15,"regulation of mitochondrial mRNA stability|neurotransmitter receptor transport, postsynaptic endosome to lysosome|positive regulation of AMPA receptor activity|protein targeting|neurotransmitter receptor diffusion trapping",0.001553|0.001553|0.001747|0.001895|0.001941,1|1|1|1|1,735.5|735.5|643.6|27.91|572.1
2019,8,0.5058,14.16,5165.0,0.002726,0.9996790000000001,BRAT1 GNB1L INTS9 PPP2CA TELO2 TTI1 TTI2 WDR73,regulation of TOR signaling|positive regulation of TORC2 signaling|regulation of TORC2 signaling|nucleus organization|positive regulation of microtubule binding,0.0006536|0.001164|0.001164|0.001376|0.002715,1|1|1|1|1,52.01|1287|1287|35.51|429.1
2020,16,0.5054,60.65,10860.0,0.005539,0.999999,EIF3F FAU HSPE1 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL23A RPL27A RPL37 RPL4 RPL9 RPLP2 RPS13,translational initiation|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|viral gene expression|protein targeting to ER,1.493e-31|7.664e-31|1.484e-30|2.083e-30|5.103e-30,2.355e-27|6.045e-27|7.805e-27|8.213e-27|1.61e-26,135|187.7|178.4|112.3|162.3
2021,5,0.5082,5.082,4119.0,0.0012289999999999998,0.996692,FAXC GRHL1 NHSL1 RETNLB TSEN2,"tRNA-type intron splice site recognition and cleavage|desmosome organization|tRNA splicing, via endonucleolytic cleavage and ligation|RNA splicing, via endonucleolytic cleavage and ligation|establishment of skin barrier",0.0009706|0.002667|0.003878|0.00412|0.006295,1|1|1|1|1,1373|411.9|274.6|257.4|164.8
2022,5,0.5325,5.325,4483.0,0.001184,0.996692,CPLANE1 DYNLL2 FAXDC2 FRMD5 SLC45A2,"organic hydroxy compound biosynthetic process|positive regulation of ATP-dependent microtubule motor activity, plus-end-directed|regulation of ATP-dependent microtubule motor activity, plus-end-directed|positive regulation of microtubule motor activity|oligosaccharide transport",0.0007136|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,47.34|1373|1373|1030|1030
2023,4,0.5638,3.383,3368.0,0.001001,0.9929309999999999,COL1A1 FBF1 SAMD14 UBE2O,cellular response to fluoride|cellular response to vitamin E|response to fluoride|bone trabecula formation|intramembranous ossification,0.0003883|0.0005825|0.0009706|0.001553|0.001553,1|1|1|1|1,5149|2574|1287|735.5|735.5
2024,4,0.5372,3.2230000000000003,3340.0,0.0009618000000000001,0.9929309999999999,ELFN1 FBH1 OLIG2 WFDC13,negative regulation of nitrogen compound metabolic process|negative regulation of cellular metabolic process|negative regulation of macromolecule metabolic process|negative regulation of metabolic process|negative regulation of molecular function,0.000182|0.0002471|0.0003735|0.0005174|0.0007072,1|1|1|1|1,8.617|7.983|7.199|6.635|13.19
2025,4,0.5026,3.016,3084.0,0.0009743,0.9929309999999999,ARHGAP30 FAM184A FBN2 PGLYRP4,sequestering of TGFbeta in extracellular matrix|peptidoglycan metabolic process|peptidoglycan catabolic process|bone trabecula formation|maintenance of protein location in extracellular region,0.0009706|0.001359|0.001359|0.001553|0.001553,1|1|1|1|1,1287|858.1|858.1|735.5|735.5
2026,7,0.5231,10.99,5181.0,0.0021100000000000003,0.9992989999999999,FBN3 OR1M1 OR7G1 OR7G3 P2RY11 ZNF121 ZNF266,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|G protein-coupled receptor signaling pathway|detection of chemical stimulus,0.0003262|0.0003881|0.0004332|0.0005212|0.0005335,1|1|1|1|1,20.01|18.86|18.16|8.855|16.91
2027,4,0.5006,3.0039999999999996,2872.0,0.001042,0.9929309999999999,FBXL12 ISL1 LRRC41 TFAP2B,negative regulation of neuron apoptotic process|cellular urea homeostasis|cellular creatinine homeostasis|cellular ammonium homeostasis|regulation of insulin secretion,0.0002966|0.0003883|0.0003883|0.0003883|0.0005069,1|1|1|1|1,71.51|5149|5149|5149|54.48
2028,4,0.5153,3.092,3203.0,0.0009618000000000001,0.9929309999999999,FBXL17 RTP4 SYNGR3 ZNF772,protein quality control for misfolded or incompletely synthesized proteins|entrainment of circadian clock by photoperiod|photoperiodism|entrainment of circadian clock|detection of chemical stimulus involved in sensory perception of bitter taste,0.00562|0.005813|0.006586|0.00678|0.007166,1|1|1|1|1,183.9|177.5|156|151.4|143
2029,8,0.5222,14.62,5869.0,0.002478,0.9996790000000001,FBXL18 IKZF3 NFKB1 OR10G2 PKP2 POU2AF1 TCF3 TRAF5,B cell activation|positive regulation of DNA-binding transcription factor activity|regulation of B cell proliferation|leukocyte activation|lymphocyte activation,4.238e-05|0.0001822|0.0003478|0.0004493|0.000535,0.6686|1|1|1|1,41.86|25.43|72.65|9.79|17.56
2030,5,0.5323,5.3229999999999995,3837.0,0.001382,0.996692,ANKRD13B CHRDL2 EGFLAM FBXL2 SIAE,modulation by host of viral RNA genome replication|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|negative regulation of receptor internalization|modulation by host of viral genome replication|negative regulation of receptor-mediated endocytosis,0.001213|0.001698|0.003394|0.004604|0.00702,1|1|1|1|1,1030|686.5|316.8|228.8|147.1
2031,13,0.4868,37.97,10310.0,0.0036609999999999998,0.999993,CEP72 DNAH5 FAM173B FBXL7 NKD2 OTULIN OTULINL SLC6A18 SLC6A19 SLC6A3 TPPP TRIO ZDHHC11,sodium ion transmembrane transport|sodium ion transport|amino acid transmembrane transport|microtubule bundle formation|central nervous system development,4.389e-05|0.0001295|0.001264|0.001832|0.001958,0.6924|1|1|1|1,42.91|29.59|38.14|31.49|6.927
2032,4,0.5484,3.29,3416.0,0.0009601000000000001,0.9929309999999999,FBXL8 NPY2R SEC24D SLC1A7,"regulation of circadian rhythm|positive regulation of circadian sleep/wake cycle, non-REM sleep|regulation of circadian sleep/wake cycle, non-REM sleep|positive regulation of circadian sleep/wake cycle, sleep|positive regulation of dopamine secretion",0.0002037|0.0009706|0.001359|0.001359|0.001553,1|1|1|1|1,86.53|1287|858.1|858.1|735.5
2033,24,0.5035,139.0,18900.0,0.007281,1.0,APTX AQP7 BAG1 CNTFR CREB3 DNAJB5 FAM205A FBXO10 GALT GBA2 GRHPR IFNA1 IFNA16 IFNA21 IFNA4 IFNW1 IL11RA NPR2 OR13J1 OR2S2 SIGMAR1 SPAG8 TESK1 TOMM5,positive regulation of peptidyl-serine phosphorylation of STAT protein|natural killer cell activation involved in immune response|regulation of peptidyl-serine phosphorylation of STAT protein|B cell proliferation|response to exogenous dsRNA,7.164e-11|1.322e-10|1.322e-10|1.819e-09|4.17e-09,1.13e-06|1.043e-06|6.952e-07|7.172e-06|1.316e-05,214.5|186.5|186.5|104.6|87.56
2034,4,0.5061,3.036,3182.0,0.0009507999999999999,0.9929309999999999,F13B FBXO16 RIT1 RSPO4,olfactory bulb axon guidance|lymphoid lineage cell migration into thymus|lymphoid lineage cell migration|striatal medium spiny neuron differentiation|somatic diversification of T cell receptor genes,0.0004854|0.000728|0.000728|0.001213|0.001456,1|1|1|1|1,4119|2060|2060|1030|823.8
2035,4,0.5093,3.056,3219.0,0.0009463,0.9929309999999999,FBXO17 METTL9 NAALADL1 ZNF843,glycoprotein catabolic process|peptide catabolic process|ubiquitin-dependent ERAD pathway|organonitrogen compound catabolic process|ERAD pathway,0.005233|0.0062|0.01468|0.01541|0.01756,1|1|1|1|1,198|166.1|68.65|9.535|57.21
2036,5,0.5063,5.063,3679.0,0.00137,0.996692,FBXO22 KIF13B SP1 SP3 WBP4,sequestering of nodal from receptor via nodal binding|positive regulation of hydrogen sulfide biosynthetic process|regulation of hydrogen sulfide biosynthetic process|positive regulation of sulfur metabolic process|negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
2037,4,0.5562,3.3369999999999997,3287.0,0.0010119999999999999,0.9929309999999999,DUSP2 FBXO30 ZNF740 ZP2,prevention of polyspermy|negative regulation of fertilization|egg activation|tRNA dihydrouridine synthesis|regulation of fertilization,0.0005825|0.0005825|0.001165|0.001165|0.002522,1|1|1|1|1,2574|2574|1030|1030|429.1
2038,4,0.5051,3.03,3320.0,0.0009097999999999999,0.9929309999999999,FBXO31 PAFAH1B3 TAS1R1 WFS1,negative regulation of ATF6-mediated unfolded protein response|regulation of ATF6-mediated unfolded protein response|negative regulation of type B pancreatic cell apoptotic process|sensory perception of umami taste|proteasome-mediated ubiquitin-dependent protein catabolic process,0.0005825|0.0009706|0.001359|0.001359|0.001458,1|1|1|1|1,2574|1287|858.1|858.1|31.88
2039,4,0.5061,3.036,3296.0,0.0009182000000000001,0.9929309999999999,FBXO33 SLC9A3R2 SPHK2 XDH,small molecule biosynthetic process|polyol metabolic process|pentitol metabolic process|pentitol catabolic process|xanthine catabolic process,0.0001928|0.0003609|0.0004854|0.0004854|0.0004854,1|1|0.638|0.696|0.7657,22.15|66.98|4119|4119|4119
2040,4,0.5289,3.174,3119.0,0.0010140000000000001,0.9929309999999999,EPS8L2 FBXO36 KISS1 TMEM230,positive regulation of ruffle assembly|regulation of ruffle assembly|synaptic vesicle transport|synaptic vesicle localization|Rho protein signal transduction,0.003104|0.005813|0.007745|0.008903|0.01199,1|1|1|1|1,343.2|177.5|132|114.4|84.41
2041,4,0.5114,3.068,2985.0,0.001024,0.9929309999999999,BCL11B DEDD FBXO38 STAG1,olfactory bulb axon guidance|lymphoid lineage cell migration into thymus|lymphoid lineage cell migration|striatal medium spiny neuron differentiation|negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,0.0004854|0.000728|0.000728|0.001213|0.001213,1|1|1|1|1,4119|2060|2060|1030|1030
2042,7,0.5013,10.53,6022.0,0.001741,0.9992989999999999,FBXO43 GSDMC KCNQ3 MATN2 PGM2 RGS22 WISP1,galactose catabolic process|negative regulation of meiotic nuclear division|membrane hyperpolarization|pentose-phosphate shunt|galactose metabolic process,0.003054|0.003393|0.003732|0.004748|0.004748,1|1|1|1|1,367.8|326.9|294.2|226.3|226.3
2043,5,0.5021,5.021,4355.0,0.001149,0.996692,C16orf95 C17orf97 FBXO44 KIAA0556 POU4F3,vestibulocochlear nerve development|cerebrospinal fluid circulation|retinal ganglion cell axon guidance|glycoprotein catabolic process|inner ear auditory receptor cell differentiation,0.001941|0.002134|0.003491|0.005233|0.006007,1|1|1|1|1,572.1|514.9|302.9|198|171.6
2044,4,0.5129,3.077,3239.0,0.0009469,0.9929309999999999,ANO4 FBXO45 OPN1SW WNT9A,synapse assembly involved in innervation|calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling|calcium activated phosphatidylcholine scrambling|calcium activated phospholipid scrambling,0.0003883|0.0009706|0.0009706|0.001165|0.001359,1|1|1|1|1,5149|1287|1287|1030|858.1
2045,4,0.5172,3.103,3097.0,0.0009983,0.9929309999999999,AADACL3 C11orf52 C1orf127 FBXO6,glycoprotein catabolic process|ubiquitin-dependent ERAD pathway|ERAD pathway|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process|DNA damage checkpoint,0.005233|0.01468|0.01756|0.01813|0.02691,1|1|1|1|1,198|68.65|57.21|55.36|37.04
2046,6,0.6573,9.86,3989.0,0.0024579999999999997,0.998474,HNRNPF PCBP1 PRPF40A PSMF1 SON SRRM2,"RNA splicing|mRNA processing|mRNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",1.843e-08|4.345e-08|2.586e-07|6.994e-07|6.994e-07,0.0002908|0.0003427|0.00136|0.002758|0.002207,42.17|35.46|24.73|45.46|45.46
2047,6,0.5138,7.707000000000001,4522.0,0.001697,0.998474,AIFM2 FBXO8 GCLC GCLM GSS OSGIN1,glutathione biosynthetic process|nonribosomal peptide biosynthetic process|cellular modified amino acid biosynthetic process|cellular response to L-phenylalanine derivative|cellular response to thyroxine stimulus,1.118e-08|1.562e-08|2.074e-07|4.24e-07|4.24e-07,0.0001764|0.0001232|0.001091|0.001672|0.001338,686.5|605.7|239.5|3432|3432
2048,8,0.5189,14.53,5349.0,0.0027010000000000003,0.9996790000000001,CUL1 DCUN1D1 DCUN1D5 FBXW11 NAE1 SENP8 UBE2Q1 UBE2R2,protein modification by small protein conjugation or removal|protein modification by small protein conjugation|protein neddylation|post-translational protein modification|cellular protein modification process,4.077e-11|1.276e-09|2.147e-08|9.227e-08|2.154e-07,6.431e-07|1.006e-05|0.0001129|0.0003639|0.0006795,19.98|21.95|594.1|35.66|6.822
2049,6,0.5011,7.516,4958.0,0.00151,0.998474,CNBD2 FBXW12 LST1 MAP1LC3A MUCL1 MYH7B,response to iron(II) ion|cellular response to nitrogen starvation|cellular response to nitrogen levels|pigment catabolic process|porphyrin-containing compound catabolic process,0.002037|0.004748|0.004748|0.005763|0.005763,1|1|1|1|1,588.4|226.3|226.3|183.9|183.9
2050,4,0.5382,3.2289999999999996,3313.0,0.0009712999999999999,0.9929309999999999,FBXW2 JPH2 MIEF1 SETX,"positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled|positive regulation of termination of RNA polymerase II transcription|positive regulation of DNA-templated transcription, termination|regulation of termination of RNA polymerase II transcription, poly(A)-coupled|regulation of termination of RNA polymerase II transcription",0.0003883|0.0003883|0.0003883|0.0007766|0.0007766,1|1|1|1|1,5149|5149|5149|1716|1716
2051,5,0.503,5.03,4001.0,0.0012519999999999999,0.996692,CEACAM5 CYP2F1 FBXW5 MICAL3 ZNF780A,trichloroethylene metabolic process|chlorinated hydrocarbon metabolic process|naphthalene metabolic process|naphthalene-containing compound metabolic process|halogenated hydrocarbon metabolic process,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
2052,4,0.5712,3.427,3338.0,0.001023,0.9929309999999999,FCER2 MCOLN1 PLPP1 RNPEP,positive regulation of humoral immune response mediated by circulating immunoglobulin|positive regulation of killing of cells of other organism|iron ion transmembrane transport|regulation of humoral immune response mediated by circulating immunoglobulin|positive regulation of nitric-oxide synthase biosynthetic process,0.001359|0.002328|0.002716|0.002716|0.003297,1|1|1|1|1,858.1|468.1|396.1|396.1|321.8
2053,4,0.5004,3.002,3127.0,0.0009567,0.9929309999999999,C4orf17 DMP1 FCGR3B PURA,dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|regulation of enamel mineralization|dendritic transport|regulation of tooth mineralization,0.0009706|0.0009706|0.001456|0.002667|0.002667,1|1|1|1|1,1373|1373|823.8|411.9|411.9
2054,4,0.5456,3.2739999999999996,3188.0,0.001023,0.9929309999999999,FCHSD1 IQGAP2 LRRC8D VTN,positive regulation of actin filament polymerization|positive regulation of protein polymerization|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization|regulation of actin filament length,0.0001126|0.0002245|0.0004258|0.0005069|0.0005122,1|1|1|1|1,117|82.38|59.52|54.48|54.2
2055,21,0.5005,105.1,15800.0,0.006591,1.0,APOA2 CD1B CD1E CHIT1 FCGR2B FCGR3A FCRL3 FMO2 FMO4 GBA ITLN1 ITLN2 KCNJ10 METTL13 OR10J5 OR6K6 OR6N1 OR6N2 S100A2 SLAMF7 YY1AP1,"regulation of T cell mediated cytotoxicity|negative regulation of production of molecular mediator of immune response|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|negative regulation of B cell receptor signaling pathway|antigen processing and presentation, exogenous lipid antigen via MHC class Ib",8.13e-06|8.75e-06|1.872e-05|3.206e-05|3.206e-05,0.1282|0.06901|0.09845|0.1264|0.1011,81.3|79.21|411.9|294.2|294.2
2056,4,0.5501,3.301,3299.0,0.000997,0.9929309999999999,ADAM15 FCN3 INHBB TMCO4,negative regulation of hepatocyte growth factor production|regulation of hepatocyte growth factor production|positive regulation of ovulation|gonad development|development of primary sexual characteristics,0.0003883|0.0003883|0.0005825|0.0006181|0.0006536,1|1|1|1|1,5149|5149|2574|49.27|47.9
2057,20,0.5052,95.99,14920.0,0.006374,1.0,AQP10 CD1C CD1E CTSK EFNA4 FAM189B FCGR2B FCGR3A FCRL3 FCRL5 GBA HSPA6 ITLN2 LCE3E S100A12 S100A2 SLAMF7 TMCO1 XCL1 YY1AP1,regulation of T cell mediated cytotoxicity|regulation of T cell mediated immunity|regulation of leukocyte mediated cytotoxicity|positive regulation of T cell mediated cytotoxicity|regulation of cell killing,7.04e-08|1.073e-06|1.127e-06|3.804e-06|4.451e-06,0.001111|0.008464|0.005924|0.015|0.01404,108.4|52.81|52.14|106.5|36.45
2058,6,0.5102,7.653,5018.0,0.001519,0.998474,DOC2A FEM1A LIPC RBM11 SAMSN1 TRIM69,intermediate-density lipoprotein particle remodeling|spontaneous neurotransmitter secretion|triglyceride-rich lipoprotein particle clearance|spontaneous synaptic transmission|chylomicron remnant clearance,0.0005824|0.001746|0.002328|0.002328|0.002328,1|1|1|1|1,3432|686.5|490.4|490.4|490.4
2059,4,0.529,3.174,3181.0,0.0009943,0.9929309999999999,BVES FERD3L KCTD20 PTPRN2,sinoatrial node cell development|cardiac pacemaker cell development|sinoatrial node cell differentiation|sinoatrial node development|cardiac pacemaker cell differentiation,0.001165|0.001359|0.001359|0.001359|0.001553,1|1|1|1|1,1030|858.1|858.1|858.1|735.5
2060,4,0.6055,3.633,3184.0,0.001137,0.9929309999999999,FES OR5B12 PCARE RGL2,regulation of Ral protein signal transduction|protein localization to photoreceptor outer segment|protein localization to non-motile cilium|positive regulation of monocyte differentiation|photoreceptor cell outer segment organization,0.0007766|0.001359|0.002134|0.002328|0.002716,1|1|1|1|1,1716|858.1|514.9|468.1|396.1
2061,4,0.5636,3.3819999999999997,3024.0,0.001114,0.9929309999999999,ARL6 EPHA6 FEV LRRC14,melanosome transport|pigment granule transport|establishment of melanosome localization|establishment of pigment granule localization|melanosome localization,0.004266|0.004459|0.004459|0.004653|0.004846,1|1|1|1|1,245.2|234|234|223.9|214.5
2062,4,0.5125,3.075,3029.0,0.001011,0.9929309999999999,AZU1 FEZ2 NECAP2 SPINT2,fractalkine production|epithelial cell morphogenesis involved in placental branching|epithelial cell differentiation involved in embryonic placenta development|neutrophil-mediated killing of bacterium|neutrophil-mediated killing of symbiont cell,0.0003883|0.0007766|0.0007766|0.001165|0.001165,1|1|1|1|1,5149|1716|1716|1030|1030
2063,4,0.5946,3.568,3112.0,0.001142,0.9929309999999999,FEZF1 MIOX PTF1A TMCO4,inositol catabolic process|forebrain anterior/posterior pattern specification|regulation of neural retina development|amacrine cell differentiation|exocrine pancreas development,0.0003883|0.0007766|0.0007766|0.001165|0.001165,1|1|1|1|1,5149|1716|1716|1030|1030
2064,4,0.5232,3.139,3095.0,0.001011,0.9929309999999999,FGD2 IDI1 MBOAT4 OR8D1,peptidyl-serine octanoylation|protein octanoylation|dimethylallyl diphosphate metabolic process|dimethylallyl diphosphate biosynthetic process|isopentenyl diphosphate biosynthetic process,0.0003883|0.0003883|0.0005825|0.0005825|0.001165,1|1|1|1|1,5149|5149|2574|2574|1030
2065,5,0.5546,5.546,3892.0,0.001419,0.996692,FGD6 HAO1 MACO1 TMEM131 TMEM39A,glycolate catabolic process|glycolate metabolic process|negative regulation of autophagosome maturation|neuronal signal transduction|fatty acid alpha-oxidation,0.0004854|0.0009706|0.001698|0.00194|0.002425,1|1|1|1|1,4119|1373|686.5|588.4|457.7
2066,23,0.5014,126.9,18130.0,0.0069299999999999995,1.0,ADAP2 C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EPOP EVI2A GAS2L2 GSDMB HAP1 KRT25 KRT26 KRT28 KRT40 KRTAP4-11 KRTAP4-2 KRTAP4-8 LYRM9 RDM1 SLFN12 UNC119,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,8.689e-09|2.722e-08|8.182e-08|2.94e-07|5.163e-07,0.0001371|0.0002147|0.0004302|0.001159|0.001629,25.52|21.52|18.25|15.06|13.83
2067,4,0.5338,3.2030000000000003,3219.0,0.0009915,0.9929309999999999,ACOT7 FGF14 PPP6R2 RELN,positive regulation of cation channel activity|positive regulation of ion transmembrane transporter activity|positive regulation of transporter activity|positive regulation of lateral motor column neuron migration|regulation of lateral motor column neuron migration,8.022e-05|0.0001653|0.0001938|0.0003883|0.0003883,1|1|1|1|1,139.2|96.24|88.77|5149|5149
2068,4,0.5643,3.386,3177.0,0.001062,0.9929309999999999,FGF22 MIDN RAPGEF5 RNF126,cytoplasm protein quality control by the ubiquitin-proteasome system|cytoplasm protein quality control|negative regulation of glucokinase activity|negative regulation of hexokinase activity|regulation of glucokinase activity,0.0003883|0.0003883|0.001165|0.001165|0.002134,1|1|1|1|1,5149|5149|1030|1030|514.9
2069,4,0.5028,3.017,3177.0,0.0009464,0.9929309999999999,FGF6 PNPLA6 SHH SRR,myoblast differentiation|positive regulation of cell division|positive regulation of kidney smooth muscle cell differentiation|negative regulation of kidney smooth muscle cell differentiation|regulation of kidney smooth muscle cell differentiation,1.879e-05|0.0001101|0.0003883|0.0003883|0.0003883,0.2964|0.8686|1|1|1,294.2|118.4|5149|5149|5149
2070,4,0.5406,3.2439999999999998,3164.0,0.0010220000000000001,0.9929309999999999,FGF7 OR5AK2 SOCS4 ZNF382,phosphatidylinositol phosphorylation|regulation of phosphatidylinositol 3-kinase activity|regulation of lipid kinase activity|lipid phosphorylation|phosphatidylinositol metabolic process,8.02e-05|8.295e-05|0.0001197|0.0001264|0.0007712,1|0.6543|0.6291|0.4985|1,144.5|142|117.7|114.4|45.51
2071,4,0.5626,3.3760000000000003,3221.0,0.001044,0.9929309999999999,COX6A2 FGF9 TRIM55 UBE2G1,negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching|negative regulation of cell differentiation involved in phenotypic switching|negative regulation of phenotypic switching|regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching|regulation of cell differentiation involved in phenotypic switching,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
2072,4,0.5487,3.292,3336.0,0.0009837,0.9929309999999999,CMSS1 FGFBP1 HHIPL1 TRIML2,positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|positive regulation of cell migration involved in sprouting angiogenesis|regulation of fibroblast growth factor receptor signaling pathway,0.001747|0.001941|0.003297|0.004072|0.0062,1|1|1|1|1,643.6|572.1|321.8|257.4|166.1
2073,15,0.5113,53.68,11180.0,0.004765,0.999999,BTN2A2 HIST1H1T HLA-G OR14J1 OR2B2 OR2B6 OR2J2 OR2J3 TRIM10 TRIM26 ZKSCAN4 ZNF165 ZNF184 ZSCAN16 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,7.908e-06|1.052e-05|1.26e-05|1.774e-05|2.123e-05,0.1247|0.08296|0.06627|0.06996|0.06698,16.68|15.72|15.13|14.09|13.57
2074,5,0.5349,5.349,4341.0,0.001228,0.996692,CEP290 FGG KBTBD3 S100A10 ZFYVE27,positive regulation of cell development|positive regulation of substrate adhesion-dependent cell spreading|regulation of substrate adhesion-dependent cell spreading|regulation of cell development|positive regulation of cell morphogenesis involved in differentiation,2.904e-05|4.441e-05|8.295e-05|0.0001314|0.0001515,0.4581|0.3502|0.4362|0.5183|0.4781,42.03|196.1|142|25.22|104.3
2075,28,0.5011,189.4,21970.0,0.008526,1.0,ABHD11 ARPC1B ASL C7orf43 CASTOR3 CLDN3 CYP3A43 CYP3A5 CYP3A7 FGL2 GNAT3 MOGAT3 PILRA PILRB PON1 RNF148 SEMA3E SPDYE1 TBL2 TRIM50 TYW1 VPS50 WNT2 ZKSCAN1 ZNF394 ZNF92 ZSCAN21 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|steroid metabolic process|retinoic acid metabolic process,3.392e-06|6.362e-05|0.0001106|0.0004341|0.001029,0.05351|0.5018|0.5815|1|1,116.1|210.2|33.43|11.23|44.58
2076,5,0.5158,5.1579999999999995,4024.0,0.001277,0.996692,CDH19 FGR KCNK7 PACS1 SSSCA1,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,4.441e-05|9.445e-05|0.0003843|0.0006583|0.0008136,0.7005|0.7449|1|1|1,196.1|132.9|64.87|49.33|44.29
2077,5,0.5047,5.047,3781.0,0.00133,0.996692,FHDC1 ORMDL3 PSMD7 SARS SNRNP200,spliceosome conformational change to release U4 (or U4atac) and U1 (or U11)|negative regulation of serine C-palmitoyltransferase activity|seryl-tRNA aminoacylation|cis assembly of pre-catalytic spliceosome|negative regulation of vascular endothelial growth factor production,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
2078,4,0.5417,3.25,3265.0,0.0009918,0.9929309999999999,B4GALNT1 FHL5 PCSK1 SIRPD,lipid glycosylation|ganglioside biosynthetic process|amide biosynthetic process|ganglioside metabolic process|glycosphingolipid biosynthetic process,0.002522|0.003297|0.00383|0.005233|0.00562,1|1|1|1|1,429.1|321.8|19.5|198|183.9
2079,4,0.5187,3.112,3179.0,0.0009756999999999999,0.9929309999999999,C18orf63 FIBIN SPAG1 ZNF670,protein kinase C signaling|response to manganese ion|axonemal dynein complex assembly|response to dexamethasone|axoneme assembly,0.003104|0.003878|0.007166|0.007938|0.01525,1|1|1|1|1,343.2|271|143|128.7|66.01
2080,4,0.561,3.366,3215.0,0.0010429999999999999,0.9929309999999999,FIGN SYNPO TNS2 VCAN,spine apparatus assembly|modification of dendritic spine|modification of postsynaptic structure|modification of synaptic structure|microtubule severing,0.0003883|0.0005825|0.001553|0.002522|0.002522,1|1|1|1|1,5149|2574|735.5|429.1|429.1
2081,5,0.5433,5.433,4030.0,0.001343,0.996692,CHRND FILIP1 MMP25 NEU2 TRAK2,collagen catabolic process|collagen metabolic process|anterograde dendritic transport of mitochondrion|cellular oligosaccharide catabolic process|cellular oligosaccharide metabolic process,9.729e-05|0.0001914|0.0006794|0.001019|0.001019,1|1|1|1|1,136.8|96.46|2942|1471|1471
2082,4,0.5182,3.109,3227.0,0.0009603,0.9929309999999999,FILIP1L OR7C2 RNF10 WBP2NL,male pronucleus assembly|female pronucleus assembly|egg activation|negative regulation of Schwann cell proliferation|regulation of Schwann cell proliferation,0.0005825|0.0005825|0.001165|0.001359|0.001553,1|1|1|1|1,2574|2574|1030|858.1|735.5
2083,4,0.5516,3.3089999999999997,3304.0,0.0009982,0.9929309999999999,AXL C5orf52 CD28 FJX1,positive regulation of viral process|regulation of viral life cycle|regulation of lymphocyte differentiation|positive regulation of protein kinase B signaling|regulation of viral process,0.0001229|0.0003172|0.0004405|0.0004655|0.0005069,1|1|1|1|1,111.9|69.11|58.51|56.89|54.48
2084,5,0.5065,5.065,4148.0,0.001217,0.996692,FKBP1B KCTD6 RNF24 UBXN7 ZNF766,neuronal action potential propagation|action potential propagation|cellular protein modification process|protein modification process|protein maturation by protein folding,0.001698|0.001698|0.002043|0.002043|0.002183,1|1|1|1|1,686.5|686.5|5.457|5.457|514.9
2085,4,0.5844,3.5060000000000002,3122.0,0.001119,0.9929309999999999,FKBP3 GDNF KCNMB4 ZDHHC4,regulation of neurotransmitter transport|postganglionic parasympathetic fiber development|regulation of neurotransmitter levels|regulation of semaphorin-plexin signaling pathway|positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,0.0001593|0.0005825|0.0007087|0.0007766|0.0009706,1|1|1|1|1,98.07|2574|45.97|1716|1287
2086,4,0.528,3.168,3284.0,0.0009615,0.9929309999999999,CAPG FKBP4 PROSER2 RBMXL1,negative regulation of protein polymerization|negative regulation of protein-containing complex assembly|negative regulation of cytoskeleton organization|negative regulation of supramolecular fiber organization|regulation of protein polymerization,0.0001334|0.0004525|0.0005471|0.0005614|0.001256,1|1|1|1|1,111.3|59.7|54.2|53.49|35.51
2087,4,0.5284,3.17,3060.0,0.001032,0.9929309999999999,CNTNAP2 FKBP7 PHACTR2 TAAR2,superior temporal gyrus development|clustering of voltage-gated potassium channels|protein localization to juxtaparanode region of axon|observational learning|imitative learning,0.0005825|0.0007766|0.0009706|0.001359|0.001359,1|1|1|1|1,2574|1716|1287|858.1|858.1
2088,4,0.5053,3.032,3279.0,0.0009214000000000001,0.9929309999999999,FAS FKTN SH3TC2 SLC29A4,epinephrine uptake|Fas signaling pathway|regulation of stress-activated MAPK cascade|regulation of stress-activated protein kinase signaling cascade|histamine uptake,0.000728|0.000728|0.0007463|0.0007712|0.0009706,1|1|1|1|1,2060|2060|46.28|45.51|1373
2089,5,0.5046,5.046,3981.0,0.001263,0.996692,CNTN2 FLG REN TMEM81 ZNF76,establishment of protein localization to juxtaparanode region of axon|cell maturation|positive regulation of adenosine receptor signaling pathway|clustering of voltage-gated potassium channels|anatomical structure maturation,0.0005824|0.0007956|0.001165|0.001165|0.001278,1|1|1|1|1,3432|45.77|1144|1144|35.94
2090,5,0.5042,5.042,4079.0,0.001232,0.996692,ACBD4 FLNB LBX2 SCUBE3 SMCO3,positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|positive regulation of non-canonical Wnt signaling pathway|muscle structure development|regulation of non-canonical Wnt signaling pathway,0.000728|0.000728|0.003878|0.004799|0.006295,1|1|1|1|1,2060|2060|274.6|17.91|164.8
2091,5,0.53,5.3,4194.0,0.001259,0.996692,DAGLA FBXO36 FLRT1 GRK4 SH3BP2,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|diacylglycerol catabolic process|trans-synaptic signaling by endocannabinoid,0.001165|0.001165|0.001165|0.001165|0.001746,1|1|1|1|1,1144|1144|1144|1144|686.5
2092,4,0.541,3.2460000000000004,3265.0,0.0009907,0.9929309999999999,EMILIN2 FLRT2 PIP4K2A SPIRE1,"positive regulation of cellular component biogenesis|regulation of cellular component biogenesis|positive regulation of cellular component organization|1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process|1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process",6.646e-05|0.0004018|0.000645|0.0007766|0.0007766,1|1|1|1|1,29.31|15.97|13.61|1716|1716
2093,4,0.5027,3.016,3007.0,0.0009993,0.9929309999999999,FLT4 GHITM KCTD16 XRCC6,cellular hyperosmotic salinity response|positive regulation of mitochondrial ATP synthesis coupled electron transport|regulation of blood vessel remodeling|regulation of mitochondrial ATP synthesis coupled electron transport|double-strand break repair via classical nonhomologous end joining,0.0007766|0.0009706|0.001359|0.001359|0.001359,1|1|1|1|1,1716|1287|858.1|858.1|858.1
2094,4,0.539,3.234,3227.0,0.0009988999999999998,0.9929309999999999,FLVCR2 GAS6 KCNIP1 SLC2A10,cation transport|transmembrane transport|inorganic cation transmembrane transport|cation transmembrane transport|inorganic ion transmembrane transport,2.618e-06|1.56e-05|8.476e-05|0.0001167|0.0001319,0.04129|0.123|0.4457|0.46|0.4162,24.93|15.94|27|24.25|23.26
2095,4,0.5059,3.035,3111.0,0.0009721,0.9929309999999999,DLK2 FLYWCH1 GFRAL YIPF2,reduction of food intake in response to dietary excess|glial cell-derived neurotrophic factor receptor signaling pathway|response to dietary excess|eating behavior|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,0.001165|0.001941|0.004846|0.005813|0.006973,1|1|1|1|1,1030|572.1|214.5|177.5|147.1
2096,5,0.5155,5.155,3792.0,0.001354,0.996692,BICDL2 CASKIN1 FLYWCH2 OR52I2 PRSS21,Golgi to secretory granule transport|vesicle transport along microtubule|vesicle cytoskeletal trafficking|organelle transport along microtubule|transport along microtubule,0.000728|0.01088|0.01664|0.01927|0.03753,1|1|1|1|1,2060|93.61|60.57|52.14|26.4
2097,4,0.5329,3.197,3247.0,0.0009814000000000001,0.9929309999999999,FAM129A FMN1 IGFN1 TBC1D15,ureteric bud invasion|metanephric renal vesicle formation|ureteric bud elongation|renal vesicle formation|metanephric renal vesicle morphogenesis,0.0007766|0.0009706|0.001165|0.001359|0.002328,1|1|1|1|1,1716|1287|1030|858.1|468.1
2098,4,0.5473,3.284,3202.0,0.0010220000000000001,0.9929309999999999,FBXW4 FMNL2 MYBPC1 PIP4P2,positive regulation of mesenchymal cell proliferation|negative regulation of phagocytosis|actin filament-based process|regulation of mesenchymal cell proliferation|phosphatidylinositol dephosphorylation,0.004653|0.004653|0.004888|0.005813|0.0062,1|1|1|1|1,223.9|223.9|17.22|177.5|166.1
2099,8,0.5353,14.99,6069.0,0.002457,0.9996790000000001,FSHR LHCGR NAT8 OXER1 REG3G SIX3 STON1 TEX261,cellular response to gonadotropin stimulus|response to gonadotropin|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|activation of adenylate cyclase activity|ovulation cycle process,2.249e-05|4.962e-05|6.731e-05|0.0001182|0.0001182,0.3547|0.3913|0.3539|0.4661|0.3729,302.9|198|35.11|125.6|125.6
2100,7,0.5139,10.79,5595.0,0.0019199999999999998,0.9992989999999999,CDK18 CHI3L1 FMO3 FMOD NMNAT2 PRELP RGS18,aminoglycan catabolic process|keratan sulfate catabolic process|aminoglycan metabolic process|carbohydrate derivative catabolic process|keratan sulfate biosynthetic process,1.359e-06|8.988e-06|1.853e-05|3.02e-05|4.285e-05,0.02144|0.07089|0.09741|0.1191|0.1352,129.8|490.4|53.17|45.03|210.2
2101,4,0.5096,3.0580000000000003,3111.0,0.0009794,0.9929309999999999,FLG FN1 REN TMEM81,"peptide cross-linking|positive regulation of substrate-dependent cell migration, cell attachment to substrate|regulation of substrate-dependent cell migration, cell attachment to substrate|calcium-independent cell-matrix adhesion|renin-angiotensin regulation of aldosterone production",0.0002499|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,80.76|1373|1373|1030|1030
2102,4,0.5311,3.1860000000000004,3225.0,0.0009845000000000001,0.9929309999999999,CLDN5 FN3K MARCH1 TLL2,establishment of blood-retinal barrier|fructoselysine metabolic process|negative regulation of skeletal muscle tissue growth|protein deglycation|fructosamine metabolic process,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
2103,4,0.5295,3.177,3013.0,0.001051,0.9929309999999999,CYB561D1 FN3KRP ROBO2 TNNT1,negative regulation of negative chemotaxis|slow-twitch skeletal muscle fiber contraction|voluntary skeletal muscle contraction|apoptotic process involved in luteolysis|twitch skeletal muscle contraction,0.0005825|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|2574|1716|1716|1716
2104,4,0.535,3.21,3365.0,0.0009509000000000001,0.9929309999999999,ABTB1 CAPN7 FNBP1 GPR158,self proteolysis|translational elongation|positive regulation of epithelial cell migration|protein localization to plasma membrane|regulation of epithelial cell migration,0.001747|0.02425|0.029|0.03752|0.0443,1|1|1|1|1,643.6|41.19|34.33|26.4|22.29
2105,6,0.5429,8.144,4200.0,0.00193,0.998474,ARGLU1 CFAP20 DAZAP1 FNBP4 NKTR SFSWAP,"regulation of mRNA splicing, via spliceosome|regulation of mRNA processing|regulation of RNA splicing|mRNA 5'-splice site recognition|regulation of cilium beat frequency involved in ciliary motility",0.0003737|0.0007047|0.0007853|0.002037|0.002328,1|1|1|1|1,67.3|48.69|46.07|572.1|490.4
2106,5,0.5829,5.829,3930.0,0.001477,0.996692,FNDC1 LPA OPRM1 PHACTR2 TPD52L1,negative regulation of Wnt protein secretion|adenylate cyclase-inhibiting opioid receptor signaling pathway|regulation of Wnt protein secretion|positive regulation of response to nutrient levels|positive regulation of response to extracellular stimulus,0.0004854|0.000728|0.0009706|0.001213|0.001213,1|1|1|1|1,4119|2060|1373|1030|1030
2107,6,0.541,8.115,5047.0,0.0016010000000000002,0.998474,AZIN2 FNDC5 HPCA KNCN ZBTB8A ZBTB8B,response to ketamine|trans-Golgi network membrane organization|response to Aroclor 1254|cellular response to monosodium glutamate|positive regulation of polyamine transmembrane transport,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
2108,4,0.5476,3.286,3185.0,0.0010279999999999998,0.9929309999999999,FNIP2 MMP16 TOR3A VCPKMT,chondrocyte proliferation|negative regulation of ATPase activity|craniofacial suture morphogenesis|endochondral ossification|replacement ossification,0.002328|0.003685|0.003878|0.006007|0.006007,1|1|1|1|1,468.1|286|271|171.6|171.6
2109,7,0.5073,10.65,4898.0,0.002164,0.9992989999999999,BRF2 DCTN6 FNTA FNTB GINS4 MAK16 TTI2,protein farnesylation|protein prenylation|prenylation|regulation of rhodopsin mediated signaling pathway|MAPK cascade,1.319e-06|8.691e-06|8.691e-06|4.962e-05|0.0004125,0.0208|0.06854|0.0457|0.1957|1,1716|514.9|514.9|198|18.88
2110,13,0.4811,37.53,9728.0,0.003833,0.999993,CTTN FCHSD2 FOLH1 FOLR1 FOLR2 GDPD4 KCTD21 KRTAP5-9 P2RY2 P2RY6 PLEKHB1 POLD4 UCP3,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|folic acid transport|response to folic acid,2.569e-06|8.982e-06|1.197e-05|1.922e-05|3.328e-05,0.04053|0.07084|0.06294|0.07581|0.105,1471|588.4|490.4|367.8|267.5
2111,6,0.5574,8.361,4340.0,0.001918,0.998474,OR13C3 OR13C4 OR13C8 OR13D1 OR2K2 RALGAPA1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.742e-08|3.679e-08|4.434e-08|6.316e-08|7.608e-08,0.0004325|0.0002902|0.0002332|0.0002491|0.00024,38.92|36.67|35.31|32.88|31.67
2112,4,0.515,3.09,3117.0,0.0009878999999999999,0.9929309999999999,C1QTNF5 FAP FOXC2 TEKT4,blood vessel morphogenesis|blood vessel development|vasculature development|tube morphogenesis|regulation of wound healing,7.542e-05|0.0001306|0.0001496|0.0002955|0.0004085,1|1|0.7867|1|1,30.44|25.27|24.13|19.16|62.89
2113,6,0.5287,7.931,4514.0,0.001749,0.998474,FOXD2 KDELR1 PIK3R5 PTPN6 SPAST ULK3,cell activation|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of phosphatidylinositol 3-kinase signaling|platelet activation|cellular developmental process,0.0001065|0.0002989|0.0005653|0.0007047|0.0007973,1|1|1|1|1,12.67|75.44|54.48|48.69|4.818
2114,4,0.5824,3.495,2895.0,0.001202,0.9929309999999999,CD46 CR1L FOXE1 GLB1L2,regulation of complement activation|regulation of humoral immune response|pharynx development|interleukin-10 production|soft palate development,0.0001971|0.0002806|0.0007766|0.0009706|0.001165,1|1|1|1|1,88.01|73.55|1716|1287|1030
2115,4,0.556,3.3360000000000003,3415.0,0.0009737,0.9929309999999999,ABHD17A FOXE3 GAS1 TMCC3,positive regulation of lens epithelial cell proliferation|regulation of lens epithelial cell proliferation|trabecular meshwork development|ciliary body morphogenesis|negative regulation of protein localization to microtubule,0.0005825|0.0005825|0.0005825|0.0009706|0.001165,1|1|1|1|1,2574|2574|2574|1287|1030
2116,4,0.5301,3.181,3253.0,0.0009744999999999999,0.9929309999999999,COLEC12 FOXJ1 SPOCK2 TAS2R5,positive regulation of central tolerance induction|regulation of central tolerance induction|glomerular parietal epithelial cell development|positive regulation of lung ciliated cell differentiation|positive regulation of central B cell tolerance induction,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2117,4,0.5337,3.202,3028.0,0.0010539999999999998,0.9929309999999999,FOXJ3 NEK6 NEK9 SOX5,mitotic nuclear envelope disassembly|nuclear envelope disassembly|membrane disassembly|cell division|nuclear envelope organization,2.572e-06|3.843e-06|3.843e-06|5.419e-05|0.0001004,0.04057|0.03031|0.0202|0.2137|0.3168,858.1|686.5|686.5|31.39|124.1
2118,4,0.5325,3.195,3066.0,0.001038,0.9929309999999999,FOXL2 HMX1 PHOX2B TCF7L1,skeletal muscle tissue development|skeletal muscle organ development|regulation of transcription by RNA polymerase II|medullary reticular formation development|efferent axon development in a lateral line nerve,0.0002105|0.0002462|0.0002494|0.0003883|0.0003883,1|1|1|1|1,85.1|78.61|7.964|5149|5149
2119,5,0.5329,5.329,4190.0,0.001267,0.996692,CFAP57 FOXN3 OARD1 PDF RNF150,negative regulation of growth hormone receptor signaling pathway|peptidyl-glutamate ADP-deribosylation|co-translational protein modification|reduction of food intake in response to dietary excess|regulation of growth hormone receptor signaling pathway,0.0008735|0.001165|0.001165|0.001746|0.002037,1|1|1|1|1,1716|1144|1144|686.5|572.1
2120,4,0.5273,3.1639999999999997,3238.0,0.0009737,0.9929309999999999,FOXN4 RHCE WDR60 ZNF83,amacrine cell differentiation|embryonic organ morphogenesis|atrioventricular canal development|ammonium transmembrane transport|ammonium transport,0.001165|0.001179|0.001941|0.002134|0.002134,1|1|1|1|1,1030|35.51|572.1|514.9|514.9
2121,10,0.5238,23.57,7122.0,0.0032890000000000003,0.999933,B4GALT1 DLL1 FOXO1 MYCN MYOG PAX3 SOX8 TCF12 TFAP2B ZBTB18,"positive regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|muscle organ development",7.939e-11|1.111e-09|1.111e-09|1.117e-09|1.36e-09,1.252e-06|8.759e-06|5.84e-06|4.404e-06|4.291e-06,15.37|11.43|11.43|11.42|44.13
2122,4,0.5262,3.157,3202.0,0.0009824999999999999,0.9929309999999999,ANO7 DNAH2 FOXP1 SEMA6A,negative regulation of cell adhesion involved in sprouting angiogenesis|regulation of cell adhesion involved in sprouting angiogenesis|interleukin-21 production|calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling,0.0003883|0.0003883|0.0005825|0.0009706|0.0009706,1|1|1|1|1,5149|5149|2574|1287|1287
2123,4,0.5419,3.252,3293.0,0.000984,0.9929309999999999,ANGPTL5 CATSPER4 FOXP2 LRRC59,putamen development|caudate nucleus development|innate vocalization behavior|response to ketone|striatum development,0.0003883|0.0003883|0.0003883|0.0005612|0.003685,1|1|1|1|1,5149|5149|5149|51.75|286
2124,5,0.5661,5.6610000000000005,3707.0,0.001521,0.996692,FOXR1 NDE1 PAFAH1B2 RPL22 RPP25,"regulation of translation at presynapse|regulation of translation at presynapse, modulating synaptic transmission|rRNA processing|rRNA metabolic process|mitotic centrosome separation",0.0004854|0.0004854|0.001571|0.001692|0.001698,1|1|1|1|1,4119|4119|31.68|30.51|686.5
2125,5,0.5136,5.136,4114.0,0.0012439999999999999,0.996692,ABCC12 CD276 FPGT LEPROT MT1F,negative regulation of growth hormone receptor signaling pathway|regulation of growth hormone receptor signaling pathway|negative regulation of protein localization to cell surface|detoxification of copper ion|fucose metabolic process,0.000728|0.001698|0.003394|0.00412|0.00412,1|1|1|1|1,2060|686.5|316.8|257.4|257.4
2126,5,0.5059,5.059,4289.0,0.001175,0.996692,FRAS1 GPAT3 GPR135 REG1B UBE2L6,cell wall disruption in other organism|ISG15-protein conjugation|glycerol-3-phosphate metabolic process|alditol phosphate metabolic process|CDP-diacylglycerol biosynthetic process,0.001213|0.001698|0.002667|0.003152|0.003394,1|1|1|1|1,1030|686.5|411.9|343.3|316.8
2127,4,0.5359,3.216,2972.0,0.001078,0.9929309999999999,ACTL7A FRAT2 MFSD14B TRPM5,beta-catenin destruction complex disassembly|sensory perception of taste|canonical Wnt signaling pathway|transmembrane transport|sodium ion transmembrane transport,0.004266|0.01333|0.0164|0.02173|0.02329,1|1|1|1|1,245.2|75.72|61.29|7.97|42.91
2128,4,0.5031,3.0189999999999997,3096.0,0.0009715,0.9929309999999999,FREM1 IGSF9 RNF130 SUMO4,dendrite self-avoidance|craniofacial suture morphogenesis|protein modification by small protein conjugation|neuron recognition|negative regulation of DNA binding,0.003491|0.003878|0.009066|0.009289|0.01083,1|1|1|1|1,302.9|271|12.54|109.5|93.61
2129,4,0.5587,3.352,3071.0,0.0010869999999999999,0.9929309999999999,FRG1 GRXCR2 PPIG SAMD11,RNA splicing|auditory receptor cell stereocilium organization|auditory receptor cell morphogenesis|auditory receptor cell development|inner ear auditory receptor cell differentiation,0.002298|0.003297|0.003685|0.004266|0.006007,1|1|1|1|1,25.3|321.8|286|245.2|171.6
2130,5,0.518,5.18,3888.0,0.001327,0.996692,FRG2B HHIP ICAM5 SOD1 USP25,response to antipsychotic drug|response to carbon monoxide|negative regulation of cholesterol biosynthetic process|negative regulation of cholesterol metabolic process|negative regulation of sterol biosynthetic process,0.000728|0.001213|0.001456|0.001456|0.001456,1|1|1|1|1,2060|1030|823.8|823.8|823.8
2131,4,0.5668,3.4010000000000002,3339.0,0.001015,0.9929309999999999,CC2D2A FRMD3 IQSEC1 TMEM80,non-motile cilium assembly|plasma membrane bounded cell projection organization|cytoskeleton organization|cell projection organization|organelle organization,3.048e-05|0.0006983|0.0007676|0.0007828|0.000909,0.4809|1|1|1|1,228.8|13.25|12.83|12.74|5.762
2132,5,0.5212,5.212000000000001,4220.0,0.001231,0.996692,FRMD8 PRSS35 PUS10 RIMS1 TRAPPC3L,tRNA pseudouridine synthesis|acrosomal vesicle exocytosis|modulation of inhibitory postsynaptic potential|positive regulation of inhibitory postsynaptic potential|primary miRNA processing,0.001456|0.001698|0.001698|0.001698|0.00291,1|1|1|1|1,823.8|686.5|686.5|686.5|374.5
2133,4,0.5432,3.259,3172.0,0.001024,0.9929309999999999,FRMPD2 PARP6 PCDHAC2 TRDN,positive regulation of cell communication by electrical coupling involved in cardiac conduction|positive regulation of cell communication by electrical coupling|endoplasmic reticulum membrane organization|regulation of cardiac muscle cell membrane potential|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,0.0003883|0.0005825|0.001359|0.001553|0.001747,1|1|1|1|1,5149|2574|858.1|735.5|643.6
2134,18,0.5043,77.16,14190.0,0.005393,1.0,CRISP1 CRISP2 ENPP4 ENPP5 FBXO9 FRS3 GLYATL3 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP MUT PRPH2 SPATS1 TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|positive regulation of antimicrobial peptide production,1.06e-06|1.06e-06|9.585e-06|1.341e-05|1.787e-05,0.01672|0.008359|0.0504|0.05289|0.05639,165.2|165.2|605.7|484.6|403.8
2135,6,0.542,8.13,4945.0,0.001637,0.998474,FRY GPC5 HEPN1 PAEP RAB17 ZNF584,negative regulation of sperm capacitation|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|regulation of sperm capacitation|regulation of binding of sperm to zona pellucida,0.0005824|0.0008735|0.001165|0.001456|0.001746,1|1|1|1|1,3432|1716|1144|858.1|686.5
2136,4,0.575,3.45,3129.0,0.001099,0.9929309999999999,FSCN2 HACE1 PHLDA3 TOR3A,Rac protein signal transduction|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|eye photoreceptor cell development|eye photoreceptor cell differentiation|negative regulation of protein kinase B signaling,0.004266|0.005813|0.00678|0.009289|0.009289,1|1|1|1|1,245.2|177.5|151.4|109.5|109.5
2137,4,0.5358,3.215,3234.0,0.0009904999999999998,0.9929309999999999,BSPH1 BTBD6 FSD2 PNPLA2,negative regulation of sequestering of triglyceride|diacylglycerol biosynthetic process|acylglycerol acyl-chain remodeling|post-translational protein modification|positive regulation of triglyceride catabolic process,0.001165|0.001747|0.001747|0.001815|0.001941,1|1|1|1|1,1030|643.6|643.6|28.52|572.1
2138,16,0.509,61.08,13260.0,0.004574,0.999999,C5AR1 C5AR2 CABP5 CCDC9 CRX EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IGFL1 SPACA4 SULT2A1 SULT2B1 TPRX1,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,2.136e-07|3.387e-06|3.095e-05|3.095e-05|3.095e-05,0.003369|0.02671|0.1627|0.122|0.09763,297|1287|286|286|286
2139,13,0.4987,38.9,10020.0,0.003857,0.999993,CCDC74B CFC1 CFC1B FAHD2A IL1F10 LYG1 LYG2 MGAT4A MRPL30 MZT2A POTEI TRIM43 TUBA3D,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,2.203e-06|3.67e-06|3.67e-06|1.026e-05|1.026e-05,0.03474|0.02894|0.01929|0.04047|0.03238,1584|1056|1056|528.1|528.1
2140,4,0.5112,3.0669999999999997,3125.0,0.0009782,0.9929309999999999,CDKN1B ENTPD3 FSTL1 TEX264,negative regulation of cardiac muscle tissue regeneration|regulation of cardiac muscle tissue regeneration|protein-DNA covalent cross-linking repair|autophagic cell death|negative regulation of epithelial cell proliferation involved in prostate gland development,0.0005825|0.0005825|0.001359|0.001359|0.001359,1|1|1|1|1,2574|2574|858.1|858.1|858.1
2141,14,0.4779,43.49,9735.0,0.0044340000000000004,0.9999969999999999,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 NEPRO NOL6 NOP9 PARN PDCD11 POP4 WDR43 WDR75,rRNA processing|ncRNA processing|rRNA metabolic process|ncRNA metabolic process|ribosome biogenesis,3.573e-16|5.056e-16|5.16e-16|3.503e-15|3.875e-15,5.636e-12|3.988e-12|2.713e-12|1.381e-11|1.222e-11,52.81|34.96|50.85|29.21|41.36
2142,5,0.505,5.05,4220.0,0.001192,0.996692,DUS4L FSTL5 SH2D1B TTC23L ZNF860,tRNA dihydrouridine synthesis|positive regulation of natural killer cell mediated immunity|regulation of natural killer cell mediated immunity|tRNA modification|positive regulation of lymphocyte mediated immunity,0.001456|0.007502|0.0116|0.0219|0.02618,1|1|1|1|1,823.8|137.3|87.64|45.77|38.14
2143,4,0.5096,3.057,3249.0,0.0009378,0.9929309999999999,COL4A1 FTH1 GPD2 TNFSF11,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling|positive regulation of fever generation by positive regulation of prostaglandin secretion|glycerophosphate shuttle|positive regulation of corticotropin-releasing hormone secretion|regulation of actin binding,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
2144,5,0.5197,5.197,4009.0,0.001291,0.996692,FTL HIGD1A NNAT PERP TGM2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine|isopeptide cross-linking|peptidyl-glutamine modification|protein maturation|salivary gland cavitation,0.000728|0.0009706|0.001213|0.001365|0.001456,1|1|1|1|1,2060|1373|1030|34.04|823.8
2145,4,0.5054,3.033,3082.0,0.0009804,0.9929309999999999,FTMT NCALD PDE4DIP PPIAL4A,positive regulation of succinate dehydrogenase activity|regulation of succinate dehydrogenase activity|positive regulation of aconitate hydratase activity|regulation of aconitate hydratase activity|intracellular sequestering of iron ion,0.0005825|0.0005825|0.0007766|0.0007766|0.001359,1|1|1|1|1,2574|2574|1716|1716|858.1
2146,5,0.5344,5.343999999999999,3299.0,0.0016129999999999999,0.996692,FUBP1 HNRNPD HNRNPUL1 KHSRP RBM5,"RNA splicing, via transesterification reactions|RNA splicing|mRNA processing|mRNA metabolic process|3'-UTR-mediated mRNA destabilization",2.454e-07|7.686e-07|1.527e-06|6.36e-06|8.939e-06,0.00387|0.006062|0.008027|0.02508|0.0282,54.02|40.48|34.04|23.74|457.7
2147,26,0.5104,165.9,17710.0,0.009254,1.0,ARL8B BLOC1S1 BLOC1S2 BORCS5 BORCS7 BORCS8 DNAJC13 FNIP1 KXD1 LAMTOR3 MTMR6 MTMR9 NPC1 RAB7A SNAPIN SPG21 TBC1D5 VPS16 VPS18 VPS26A VPS29 VPS33A VPS35 VPS39 VPS41 WDR91,vesicle-mediated transport|lysosomal transport|intracellular transport|endosomal transport|vacuolar transport,1.566e-17|1.389e-14|8.112e-14|1.932e-13|2.267e-13,2.47e-13|1.095e-10|4.265e-10|7.617e-10|7.153e-10,8.496|65.4|8.983|34|47.21
2148,4,0.5412,3.247,3186.0,0.001016,0.9929309999999999,ANTXRL FUCA1 GPR152 PPFIA1,glycoside catabolic process|glycolipid catabolic process|fucose metabolic process|glycoside metabolic process|negative regulation of protein localization to plasma membrane,0.002328|0.003104|0.003297|0.004459|0.004846,1|1|1|1|1,468.1|343.2|321.8|234|214.5
2149,4,0.5653,3.392,3174.0,0.001065,0.9929309999999999,CXCL12 DCBLD2 FLG FUOM,response to ultrasound|negative regulation of leukocyte tethering or rolling|chemokine (C-X-C motif) ligand 12 signaling pathway|negative regulation of leukocyte adhesion to vascular endothelial cell|positive regulation of dopamine secretion,0.0005825|0.0009706|0.0009706|0.001165|0.001553,1|1|1|1|1,2574|1287|1287|1030|735.5
2150,4,0.5156,3.093,3092.0,0.000997,0.9929309999999999,FLYWCH1 FUT9 OR5F1 TMEM179B,fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|regulation of leukocyte tethering or rolling|fucose metabolic process,0.001941|0.001941|0.001941|0.002716|0.003297,1|1|1|1|1,572.1|572.1|572.1|396.1|321.8
2151,4,0.5369,3.221,3160.0,0.001016,0.9929309999999999,ADM5 CSKMT FKBP2 FXYD4,peptidyl-lysine monomethylation|peptidyl-lysine dimethylation|peptidyl-lysine trimethylation|protein peptidyl-prolyl isomerization|peptidyl-amino acid modification,0.002134|0.003878|0.006586|0.009482|0.01026,1|1|1|1|1,514.9|271|156|107.3|11.77
2152,4,0.549,3.2939999999999996,3028.0,0.001084,0.9929309999999999,FYB2 HMGCLL1 UBLCP1 UBQLNL,leucine catabolic process|leucine metabolic process|ketone body biosynthetic process|cellular ketone body metabolic process|ketone body metabolic process,0.001359|0.001747|0.001941|0.002328|0.002522,1|1|1|1|1,858.1|643.6|572.1|468.1|429.1
2153,14,0.5092,46.34,10510.0,0.004379,0.9999969999999999,BBS1 CTTN FGF19 FOLR1 FOLR2 KRTAP5-10 KRTAP5-11 KRTAP5-9 MRGPRD MRGPRF MYEOV P2RY6 PLEKHB1 POLD4,keratinization|keratinocyte differentiation|epidermal cell differentiation|cellular response to folic acid|skin development,6.688e-07|1.523e-06|3.37e-06|3.387e-06|8.482e-06,0.01055|0.01202|0.01772|0.01336|0.02676,28.48|24.01|20.37|1287|16.8
2154,4,0.5573,3.344,3145.0,0.001059,0.9929309999999999,CACNA1C FAM19A2 FZD9 OR6C65,negative regulation of receptor clustering|negative regulation of skeletal muscle acetylcholine-gated channel clustering|membrane depolarization during atrial cardiac muscle cell action potential|calcium ion transmembrane transport via high voltage-gated calcium channel|bone regeneration,0.0002913|0.0002913|0.0005825|0.0005825|0.0007281,1|1|1|1|1,6865|6865|2288|2288|1716
2155,12,0.5013,33.09,7811.0,0.0042049999999999995,0.999986,ANAPC13 ANAPC15 ANAPC5 CCNF CDC16 CDC27 FZR1 PRPF39 SGO2 TRNAU1AP UBE2C UBE2S,protein K11-linked ubiquitination|cell division|anaphase-promoting complex-dependent catabolic process|regulation of exit from mitosis|anaphase,2.101e-17|4.257e-15|2.544e-14|1.203e-13|1.362e-12,3.314e-13|3.358e-11|1.338e-10|4.743e-10|4.296e-09,414.3|34.88|138.1|239.5|76.52
2156,5,0.5149,5.149,4188.0,0.001225,0.996692,G6PC3 HAS3 IFT140 PLCH2 TREML1,carbohydrate biosynthetic process|extracellular polysaccharide biosynthetic process|positive regulation of hyaluranon cable assembly|regulation of hyaluranon cable assembly|extracellular polysaccharide metabolic process,0.0004397|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,60.57|1373|1373|1373|1373
2157,19,0.4812,82.29,14120.0,0.0057810000000000005,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1T HIST1H2AD HIST1H2BD OR14J1 OR2B2 OR2B6 OR2J2 OR2J3 SLC17A2 SLC17A4 TRIM10 ZKSCAN4 ZNF165 ZNF184 ZSCAN16 ZSCAN31,sialic acid transport|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,1.509e-05|3.148e-05|4.168e-05|4.98e-05|6.969e-05,0.238|0.2483|0.2192|0.1964|0.2198,457.7|12.97|12.22|11.77|10.96
2158,4,0.5697,3.418,2758.0,0.001234,0.9929309999999999,GABPA GABPB1 H2AFZ RSL24D1,assembly of large subunit precursor of preribosome|negative regulation of megakaryocyte differentiation|mitochondrion organization|ribosomal large subunit assembly|organelle organization,0.0005825|0.0008737|0.001465|0.004218|0.005233,1|1|1|1|1,2288|1373|30.04|245.2|5.762
2159,4,0.5321,3.193,3333.0,0.0009548,0.9929309999999999,GAD2 SLC2A5 VGF ZNF117,secretion by cell|fructose import across plasma membrane|fructose import|signal release|export from cell,0.0003789|0.0003883|0.0003883|0.0003972|0.0004385,1|1|1|1|1,16.29|5149|5149|61.66|15.51
2160,5,0.5096,5.096,3576.0,0.001419,0.996692,CYB5R4 GADD45B MAP2K3 PPM1A PPM1B,N-terminal protein myristoylation|protein myristoylation|N-terminal protein lipidation|peptidyl-threonine dephosphorylation|negative regulation of NIK/NF-kappaB signaling,7.067e-07|7.067e-07|9.893e-07|1.298e-05|1.777e-05,0.01115|0.005574|0.005202|0.05119|0.05606,2060|2060|1648|374.5|316.8
2161,5,0.5553,5.553,4123.0,0.001342,0.996692,GADD45G MCTP2 RMDN1 SI TMEM129,"polysaccharide digestion|attachment of mitotic spindle microtubules to kinetochore|activation of MAPKKK activity|retrograde protein transport, ER to cytosol|endoplasmic reticulum to cytosol transport",0.001698|0.003152|0.003394|0.004362|0.004362,1|1|1|1|1,686.5|343.3|316.8|242.3|242.3
2162,4,0.5347,3.208,3285.0,0.0009734,0.9929309999999999,GAL3ST2 KLHL30 PCLO SLC25A47,presynapse to nucleus signaling pathway|presynaptic signal transduction|presynaptic active zone assembly|acyl carnitine transmembrane transport|acyl carnitine transport,0.0005825|0.0005825|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|2574|1716|1287|1030
2163,4,0.5537,3.322,3093.0,0.00107,0.9929309999999999,CPNE7 CYP2U1 GAL3ST4 PLEKHG6,cellular lipid metabolic process|lipid metabolic process|omega-hydroxylase P450 pathway|exogenous drug catabolic process|lipid biosynthetic process,0.0004117|0.000802|0.001941|0.004653|0.004888,1|1|1|1|1,15.84|12.64|572.1|223.9|17.22
2164,4,0.5313,3.188,3349.0,0.0009488,0.9929309999999999,ESD GALK2 HESX1 LZTFL1,negative regulation of protein localization to ciliary membrane|regulation of protein localization to ciliary membrane|negative regulation of protein localization to cilium|formaldehyde catabolic process|formaldehyde metabolic process,0.0003883|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|2574|2574|1716|1287
2165,5,0.5278,5.278,4268.0,0.001232,0.996692,ABCG5 CCDC80 CDC14A GALM THBS1,negative regulation of lipid transport|negative regulation of lipid localization|cell cycle arrest|regulation of lipid transport|negative regulation of intestinal cholesterol absorption,3.48e-05|7.22e-05|0.000492|0.0005192|0.000728,0.5489|0.5695|1|1|1,222.6|152.6|57.21|55.66|2060
2166,4,0.5812,3.487,3308.0,0.001051,0.9929309999999999,GALNS SARDH SUN2 TNNI1,actin filament-based movement|sarcosine catabolic process|sarcosine metabolic process|nuclear migration along microfilament|nuclear matrix anchoring at nuclear membrane,0.0002037|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,86.53|5149|2574|2574|1716
2167,18,0.5122,78.37,14490.0,0.005367,1.0,ABHD3 C18orf32 CABLES1 CHST9 CTIF DSC1 DSG1 DSG2 DSG3 DSG4 GALNT1 HRH4 KIAA1328 MAPRE2 SERPINB7 ZNF396 ZNF397 ZNF521,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,4.557e-08|2.995e-07|1.288e-06|2.48e-06|2.923e-06,0.0007188|0.002362|0.00677|0.009781|0.009221,50.63|34.26|25.31|22.09|21.35
2168,4,0.5364,3.218,3190.0,0.001005,0.9929309999999999,GALNT12 LRRN3 PANK1 TMPRSS4,negative regulation of growth rate|regulation of growth rate|coenzyme A biosynthetic process|positive regulation by symbiont of entry into host|positive regulation of viral entry into host cell,0.0007766|0.001747|0.002328|0.002522|0.002522,1|1|1|1|1,1716|643.6|468.1|429.1|429.1
2169,4,0.6111,3.6660000000000004,3349.0,0.001091,0.9929309999999999,GALNT18 KLHL30 MADD PVR,susceptibility to T cell mediated cytotoxicity|susceptibility to natural killer cell mediated cytotoxicity|positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target|regulation of Rab protein signal transduction|positive regulation of natural killer cell mediated immune response to tumor cell,0.0005825|0.0007766|0.001359|0.001553|0.001553,1|1|1|1|1,2574|1716|858.1|735.5|735.5
2170,4,0.5051,3.031,3174.0,0.0009513999999999999,0.9929309999999999,GALNT3 KCTD17 MMP7 RLBP1,vitamin A metabolic process|protein O-linked glycosylation via threonine|protein O-linked glycosylation via serine|estrous cycle|membrane protein ectodomain proteolysis,0.001941|0.001941|0.002134|0.003491|0.004072,1|1|1|1|1,572.1|572.1|514.9|302.9|257.4
2171,5,0.5063,5.063,4138.0,0.001219,0.996692,ADAM15 GALNT7 PPID RPS6KB2 SYNPO2,protein metabolic process|response to hypobaric hypoxia|organonitrogen compound metabolic process|regulation of Rho-dependent protein serine/threonine kinase activity|cellular response to phorbol 13-acetate 12-myristate,0.0003614|0.0009706|0.00108|0.001456|0.001456,1|1|1|1|1,4.883|1373|3.922|823.8|823.8
2172,4,0.5812,3.487,3172.0,0.0010949999999999998,0.9929309999999999,ABCB1 GALNTL5 QPCT ULBP3,"ceramide translocation|peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase|terpenoid transport|isoprenoid transport|positive regulation of anion channel activity",0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
2173,4,0.5492,3.295,2999.0,0.0010949999999999998,0.9929309999999999,GALP RND1 SLC6A13 TRMT61B,behavioral response to starvation|creatine transmembrane transport|gamma-aminobutyric acid import|gamma-aminobutyric acid reuptake|mitochondrial tRNA methylation,0.0005825|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1716|1287|1287|1030
2174,4,0.561,3.366,3313.0,0.001013,0.9929309999999999,GALR1 HIST1H3J NCK2 NCKIPSD,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|positive regulation of cortisol secretion|regulation of cortisol secretion|positive regulation of translation in response to endoplasmic reticulum stress|negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,0.0007281|0.0007281|0.0008737|0.0008737|0.0008737,1|1|1|1|1,1716|1716|1373|1373|1373
2175,5,0.5092,5.092,3379.0,0.0015,0.996692,ECT2 FLII GAN KIF20A SACS,"mitotic cytokinesis|regulation of cytokinesis|cytoskeleton-dependent cytokinesis|cytokinesis|regulation of cytokinesis, actomyosin contractile ring assembly",0.0001131|0.0001913|0.0002219|0.0002796|0.0004854,1|1|1|1|1,121.1|92.56|85.81|76.28|4119
2176,6,0.5191,7.7860000000000005,4662.0,0.001663,0.998474,ARPP21 GANC SLCO1B1 SLCO1B3 SLCO1B7 SLCO1C1,sodium-independent organic anion transport|bile acid and bile salt transport|organic hydroxy compound transport|monocarboxylic acid transport|carboxylic acid transport,9.675e-12|1.472e-10|4.57e-08|4.69e-08|3.269e-07,1.526e-07|1.161e-06|0.0002403|0.000185|0.001031,858.1|403.8|90.93|90.33|55.14
2177,10,0.5258,23.66,7604.0,0.003094,0.999933,ACR ANHX RABL2B ZNF10 ZNF132 ZNF140 ZNF26 ZNF605 ZNF84 ZNF891,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",2.22e-06|2.102e-05|2.107e-05|2.13e-05|3.756e-05,0.03502|0.1658|0.1108|0.084|0.1185,6.371|4.756|4.755|4.748|4.408
2178,9,0.5027,18.1,7281.0,0.0024739999999999996,0.9998530000000001,ATP12A C1QTNF9 CBLB GAREM1 GJB2 GJB6 RNF6 SIAH3 SPATA13,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|cell-cell junction assembly,4.743e-06|6.096e-06|7.619e-06|3.9e-05|0.001361,0.07481|0.04808|0.04006|0.1538|1,762.8|653.8|572.1|228.8|36.04
2179,5,0.518,5.18,4163.0,0.00124,0.996692,ENTHD1 GAS2L3 LRMDA SDSL SLC17A8,isoleucine biosynthetic process|threonine catabolic process|branched-chain amino acid biosynthetic process|L-threonine catabolic process to glycine|threonine metabolic process,0.0009706|0.001456|0.001456|0.001456|0.001698,1|1|1|1|1,1373|823.8|823.8|823.8|686.5
2180,4,0.5233,3.14,3242.0,0.0009652000000000002,0.9929309999999999,CPED1 GAS7 LTK PPP1R3C,positive regulation of cardiac muscle cell apoptotic process|positive regulation of striated muscle cell apoptotic process|glycogen biosynthetic process|glucan biosynthetic process|positive regulation of muscle cell apoptotic process,0.002134|0.002134|0.004459|0.004459|0.004846,1|1|1|1|1,514.9|514.9|234|234|214.5
2181,11,0.5056,27.81,8765.0,0.0031550000000000003,0.999969,CLCA4 FAM69A GBP3 GBP4 GBP5 GBP6 GBP7 GNAT2 IFI44 ST6GALNAC3 TMEM56,cellular response to interferon-gamma|response to interferon-gamma|defense response to protozoan|response to protozoan|defense response to Gram-positive bacterium,2.205e-08|4.271e-08|4.378e-07|4.902e-07|2.582e-05,0.0003478|0.0003369|0.002302|0.001933|0.08146,54.31|47.41|214.5|205.9|51.49
2182,17,0.5096,69.31,12700.0,0.005412,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1T OR14J1 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 SLC17A4 TRIM10 TRIM26 ZKSCAN4 ZNF184 ZSCAN16 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.496e-06|2.103e-06|2.609e-06|3.921e-06|4.857e-06,0.0236|0.01658|0.01372|0.01546|0.01532,15.57|14.67|14.13|13.15|12.67
2183,4,0.5301,3.181,3272.0,0.0009689,0.9929309999999999,GCAT SLC35E4 SMIM15 SNURF,regulation of kinetochore assembly|threonine catabolic process|regulation of centromere complex assembly|L-threonine catabolic process to glycine|threonine metabolic process,0.0009706|0.001456|0.001456|0.001456|0.001698,1|1|1|1|1,1373|823.8|823.8|823.8|686.5
2184,23,0.5065,128.1,18750.0,0.006770999999999999,1.0,C5AR1 ERVV-2 FFAR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 KLK6 SIGLEC12 SIGLEC5 SULT2B1 VN1R4 ZNF175 ZNF28 ZNF415 ZNF528 ZNF534 ZNF571 ZNF610 ZNF665 ZNF701 ZNF880,complement receptor mediated signaling pathway|regulation of transcription by RNA polymerase II|cellular process|protein processing|zymogen activation,0.0001468|0.0005315|0.0008485|0.001265|0.001603,1|1|1|1|1,126.7|3.186|0.5851|14.12|35.06
2185,6,0.5327,7.9910000000000005,4685.0,0.001698,0.998474,ATP6V0A2 GCGR KCNK5 NOTCH1 PIK3CD SUCLA2,cellular response to vascular endothelial growth factor stimulus|response to peptide|cellular response to hormone stimulus|coronary sinus valve development|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,7.275e-05|0.000243|0.0003125|0.0005824|0.0005824,1|1|1|0.9187|1,156|21.45|19.69|3432|3432
2186,4,0.5621,3.372,3253.0,0.001033,0.9929309999999999,GCM2 MYH11 TRAF3IP2 ZNF451,negative regulation of histone H3-K9 acetylation|striated muscle myosin thick filament assembly|skeletal muscle myosin thick filament assembly|myosin filament assembly|myosin filament organization,0.0003883|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|1716|1716|1287|1287
2187,4,0.5427,3.2560000000000002,3192.0,0.001016,0.9929309999999999,C12orf54 FBXO43 GCNT3 MAB21L2,embryonic body morphogenesis|negative regulation of meiotic nuclear division|negative regulation of meiotic cell cycle|regulation of meiotic nuclear division|intestinal absorption,0.001359|0.001941|0.003491|0.0062|0.006393,1|1|1|1|1,858.1|572.1|302.9|166.1|160.9
2188,4,0.5261,3.157,3117.0,0.001009,0.9929309999999999,C6orf48 CD63 GCSAM KIF5A,anterograde dendritic transport of neurotransmitter receptor complex|retrograde neuronal dense core vesicle transport|anterograde dendritic transport|positive regulation of integrin-mediated signaling pathway|dense core granule transport,0.0007281|0.0008737|0.001019|0.001165|0.001456,1|1|1|1|1,1716|1373|1144|980.7|762.8
2189,4,0.5218,3.1310000000000002,3113.0,0.0010019999999999999,0.9929309999999999,FAM219A GDA MAP3K9 OR5V1,guanine catabolic process|guanine metabolic process|purine nucleobase catabolic process|nucleobase catabolic process|purine nucleotide metabolic process,0.0004854|0.0009706|0.0009706|0.001456|0.002568,1|1|1|1|1,4119|1373|1373|823.8|24.66
2190,13,0.5079,39.61,10300.0,0.0038229999999999996,0.999993,BCAS4 CNBD2 FAM209A FAM209B GDAP1L1 GGT7 LBP R3HDML RALY RBPJL TFAP2C WFDC11 WISP2,glutathione metabolic process|positive regulation of cytolysis|positive regulation of respiratory burst involved in inflammatory response|lipopolysaccharide transport|regulation of cytolysis,0.0007936|0.001261|0.001891|0.001891|0.00315,1|1|1|1|1,48.75|1584|792.1|792.1|396.1
2191,4,0.5445,3.267,3256.0,0.0009997,0.9929309999999999,GDF10 PELI3 RHOBTB1 STOML1,regulation of Toll signaling pathway|Toll signaling pathway|engulfment of apoptotic cell|negative regulation of tumor necrosis factor-mediated signaling pathway|apoptotic cell clearance,0.0009706|0.001359|0.003297|0.004266|0.00871,1|1|1|1|1,1287|858.1|321.8|245.2|117
2192,4,0.5341,3.2039999999999997,3132.0,0.001019,0.9929309999999999,CEP164 GDF15 NBL1 TMEM81,negative regulation of growth hormone receptor signaling pathway|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|determination of dorsal identity|sequestering of BMP in extracellular matrix|reduction of food intake in response to dietary excess,0.0005825|0.000887|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|41.03|1287|1287|1030
2193,20,0.4911,93.31,16170.0,0.005721,1.0,BPIFB1 BPIFB4 CNBD2 CPNE1 DEFB116 DUSP15 FAM209B FAM83C FOXS1 GDF5 GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 OCSTAMP TM9SF4 WFDC11 XKR7,"regulation of multicellular organism growth|positive regulation of multicellular organism growth|response to external stimulus|positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response",3.759e-05|0.0005219|0.001574|0.001939|0.002908,0.593|1|1|1|1,47.53|62.41|3.285|1030|514.9
2194,4,0.5321,3.193,3244.0,0.000981,0.9929309999999999,CC2D1B GDF7 KIR3DL3 TRIM56,roof plate formation|positive regulation of tendon cell differentiation|regulation of tendon cell differentiation|interferon-beta production|type I interferon production,0.0003883|0.0003883|0.0003883|0.0007766|0.001165,1|1|1|1|1,5149|5149|5149|1716|1030
2195,4,0.557,3.342,3243.0,0.001027,0.9929309999999999,CHAC2 GDPD1 OARD1 SPATA33,peptidyl-glutamate ADP-deribosylation|N-acylethanolamine metabolic process|protein de-ADP-ribosylation|ethanolamine-containing compound metabolic process|glutathione catabolic process,0.0007766|0.001165|0.001359|0.001941|0.002328,1|1|1|1|1,1716|1030|858.1|572.1|468.1
2196,4,0.5044,3.0260000000000002,3190.0,0.0009455,0.9929309999999999,CCDC157 GAS1 GDPGP1 HMOX1,regulation of transcription from RNA polymerase II promoter in response to iron|heme oxidation|negative regulation of mast cell cytokine production|muscle hyperplasia|smooth muscle hyperplasia,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
2197,6,0.5546,8.318,4210.0,0.001966,0.998474,GEMIN2 GEMIN4 GEMIN6 GEMIN7 SNUPN TGS1,"spliceosomal snRNP assembly|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",7.677e-17|6.87e-13|8.503e-13|1.064e-11|1.064e-11,1.211e-12|5.419e-09|4.471e-09|4.197e-08|3.357e-08,528.1|108.4|104.5|68.2|68.2
2198,4,0.5559,3.335,3211.0,0.001035,0.9929309999999999,BLOC1S6 DNAJC5B GFAP TUBB3,neuron projection development|neuron development|positive regulation of Schwann cell proliferation|neuron differentiation|plasma membrane bounded cell projection organization,0.0001435|0.0002584|0.0003883|0.0004814|0.0006983,1|1|1|1|1,22.62|18.54|5149|15.03|13.25
2199,5,0.5328,5.327999999999999,4330.0,0.0012259999999999999,0.996692,AK1 GFOD2 IFI6 RIPOR1 URGCP,negative regulation of Rho guanyl-nucleotide exchange factor activity|ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|negative regulation of mitochondrial depolarization|negative regulation of guanyl-nucleotide exchange factor activity,0.000728|0.001456|0.001456|0.001698|0.001698,1|1|1|1|1,2060|823.8|823.8|686.5|686.5
2200,4,0.5423,3.2539999999999996,3227.0,0.001005,0.9929309999999999,ABCA7 ACADS DDIAS GFRA3,butyrate catabolic process|positive regulation of engulfment of apoptotic cell|butyrate metabolic process|regulation of engulfment of apoptotic cell|regulation of DNA stability,0.0003883|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|2574|2574|1716|1287
2201,4,0.5647,3.388,3182.0,0.0010609999999999999,0.9929309999999999,GGA3 MLXIPL RPL9 TMEM52,glucose mediated signaling pathway|sugar mediated signaling pathway|hexose mediated signaling|carbohydrate mediated signaling|establishment of protein localization to membrane,0.0007766|0.0007766|0.0007766|0.001165|0.001319,1|1|1|1|1,1716|1716|1716|1030|33.54
2202,4,0.5212,3.127,3221.0,0.0009674,0.9929309999999999,BST1 GGCT KCNA5 NUDT12,membrane repolarization during SA node cell action potential|membrane repolarization during bundle of His cell action potential|NAD-cap decapping|NADP catabolic process|NAD catabolic process,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
2203,5,0.5145,5.145,4048.0,0.001266,0.996692,FSHR GGCX MTHFD2 PUS10 TEX37,regulation of acetylcholine metabolic process|primary ovarian follicle growth|protein carboxylation|peptidyl-glutamic acid carboxylation|Sertoli cell proliferation,0.0004854|0.000728|0.0009706|0.0009706|0.001213,1|1|1|1|1,4119|2060|1373|1373|1030
2204,15,0.5058,53.11,12680.0,0.004161,0.999999,C8orf44 CA1 CA13 CA2 CA3 CA8 CNGB3 CPA6 CYP7A1 GGH MCMDC2 NSMAF PMP2 SGK3 TRIM55,one-carbon metabolic process|bicarbonate transport|organic anion transport|response to ethanol|small molecule metabolic process,1.036e-10|2.911e-08|3.34e-06|0.0001371|0.0006475,1.635e-06|0.0002296|0.01756|0.5407|1,176|130.8|20.19|29.63|5.076
2205,4,0.5763,3.458,3217.0,0.0010710000000000001,0.9929309999999999,GGT6 SLC12A5 SMCP TNF,response to osmotic stress|positive regulation of fractalkine production|regulation of fractalkine production|thermosensory behavior|positive regulation of interleukin-33 production,8.235e-05|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,137.3|5149|5149|5149|5149
2206,5,0.5182,5.182,4207.0,0.001227,0.996692,FASTKD1 GHDC NAV3 TBCK VSIG2,regulation of mitochondrial mRNA stability|negative regulation of microtubule depolymerization|negative regulation of interleukin-2 production|positive regulation of microtubule polymerization|regulation of microtubule depolymerization,0.00194|0.006778|0.00702|0.007744|0.007744,1|1|1|1|1,588.4|152.6|147.1|132.9|132.9
2207,5,0.5458,5.457999999999999,4414.0,0.001232,0.996692,CYP27A1 GHRL NIPAL3 SLC34A2 YWHAH,steroid catabolic process|response to estrogen|hormone-mediated signaling pathway|glucocorticoid catabolic process|cortisol secretion,1.777e-05|0.0001478|0.0004085|0.0004854|0.0004854,0.2803|1|1|1|1,316.8|105.6|62.89|4119|4119
2208,4,0.5489,3.2939999999999996,3195.0,0.001027,0.9929309999999999,GIMAP8 MC2R NFAM1 TMEM230,positive regulation of B cell receptor signaling pathway|positive regulation of antigen receptor-mediated signaling pathway|regulation of B cell receptor signaling pathway|regulation of B cell differentiation|regulation of T cell apoptotic process,0.001553|0.004266|0.00504|0.005813|0.007166,1|1|1|1|1,735.5|245.2|205.9|177.5|143
2209,7,0.53,11.13,5589.0,0.001982,0.9992989999999999,CD244 KCNK7 OR10Z1 SLC36A1 SPRR4 STMND1 SWT1,positive regulation of granzyme B production|regulation of granzyme B production|alkanesulfonate transport|taurine transport|proline transmembrane transport,0.001358|0.001358|0.002376|0.002376|0.003054,1|1|1|1|1,980.7|980.7|490.4|490.4|367.8
2210,4,0.563,3.378,3184.0,0.001057,0.9929309999999999,GIPC2 POPDC2 SLC30A2 UNCX,positive regulation of sequestering of zinc ion|regulation of sequestering of zinc ion|common myeloid progenitor cell proliferation|olfactory bulb interneuron differentiation|dorsal spinal cord development,0.0003883|0.001165|0.001553|0.002328|0.004072,1|1|1|1|1,5149|1030|735.5|468.1|257.4
2211,4,0.5632,3.3789999999999996,3045.0,0.001106,0.9929309999999999,ADIPOR1 DNAJC5 GIPC3 MFAP3,adiponectin-activated signaling pathway|regulation of synaptic vesicle cycle|leptin-mediated signaling pathway|cellular response to leptin stimulus|positive regulation of insulin receptor signaling pathway,0.001553|0.001747|0.002328|0.003878|0.004653,1|1|1|1|1,735.5|643.6|468.1|271|223.9
2212,4,0.5208,3.125,3120.0,0.0009979,0.9929309999999999,C6orf106 EGFL8 GIPR JAKMIP2,gastric inhibitory peptide signaling pathway|positive regulation of cAMP-mediated signaling|desensitization of G protein-coupled receptor signaling pathway|negative adaptation of signaling pathway|adaptation of signaling pathway,0.0002913|0.002619|0.002765|0.002765|0.00291,1|1|1|1|1,6865|403.8|381.4|381.4|361.3
2213,5,0.5744,5.744,3391.0,0.001686,0.996692,ARHGEF7 GIT1 GIT2 ITGB1 PAK2,positive regulation of GTPase activity|regulation of hydrolase activity|positive regulation of catalytic activity|regulation of GTPase activity|positive regulation of molecular function,8.145e-07|1.044e-06|1.546e-06|1.603e-06|4.672e-06,0.01285|0.008238|0.00813|0.006321|0.01474,39.89|15.75|14.55|33.62|11.66
2214,6,0.5387,8.081,5426.0,0.001484,0.998474,CGA GJA10 HTR1E IL2 ZKSCAN2 ZNF664,cell-cell signaling|adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation|G protein-coupled receptor signaling pathway|positive regulation of dense core granule biogenesis|positive regulation of relaxation of cardiac muscle,0.0005255|0.0007765|0.0009888|0.001164|0.001164,1|1|1|1|1,9.153|2574|7.748|1287|1287
2215,6,0.5056,7.584,5018.0,0.001506,0.998474,GLB1L GPR142 LGALS3BP MIF4GD SSTR2 TIMP2,regulation of Rap protein signal transduction|somatostatin signaling pathway|somatostatin receptor signaling pathway|negative regulation of metallopeptidase activity|negative regulation of membrane protein ectodomain proteolysis,0.001456|0.001746|0.001746|0.002328|0.002619,1|1|1|1|1,858.1|686.5|686.5|490.4|429.1
2216,4,0.5175,3.105,2958.0,0.001046,0.9929309999999999,ADAMTSL4 CNOT7 GLI3 TOB1,"positive regulation of nuclear-transcribed mRNA poly(A) tail shortening|regulation of nuclear-transcribed mRNA poly(A) tail shortening|positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|positive regulation of mRNA catabolic process",3.391e-06|4.323e-06|4.323e-06|5.367e-06|4.185e-05,0.05349|0.03409|0.02273|0.02117|0.132,735.5|643.6|643.6|572.1|194.3
2217,5,0.8969,8.969,3501.0,0.002548,0.996692,YWHAB YWHAE YWHAG YWHAQ YWHAZ,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway|positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|positive regulation of establishment of protein localization to mitochondrion,5.499e-15|5.499e-15|2.425e-14|7.602e-14|2.275e-13,8.674e-11|4.337e-11|1.275e-10|2.998e-10|7.176e-10,792.1|792.1|572.1|447.7|355.1
2218,4,0.505,3.03,3156.0,0.0009568,0.9929309999999999,FCHSD2 GLRB PITPNA TMEM86B,"membrane organization|visual perception|sensory perception of light stimulus|synaptic transmission, glycinergic|gamma-aminobutyric acid receptor clustering",0.0003884|0.0006596|0.0006839|0.001165|0.001165,1|1|1|1|1,16.16|47.67|46.81|1030|1030
2219,5,0.5035,5.035,4272.0,0.001175,0.996692,FBXL22 GLT1D1 INSYN1 LOXL1 MEGF11,protein deamination|peptidyl-lysine oxidation|inhibitory postsynaptic potential|protein oxidation|retina layer formation,0.0004854|0.001456|0.002183|0.003152|0.006537,1|1|1|1|1,4119|823.8|514.9|343.3|158.4
2220,4,0.5044,3.0260000000000002,3097.0,0.0009737999999999999,0.9929309999999999,GLT8D1 NUF2 OTOP1 TKTL2,negative regulation of interferon-gamma-mediated signaling pathway|negative regulation of response to interferon-gamma|attachment of mitotic spindle microtubules to kinetochore|kinetochore organization|attachment of spindle microtubules to kinetochore,0.001747|0.001747|0.002522|0.003878|0.004653,1|1|1|1|1,643.6|643.6|429.1|271|223.9
2221,5,0.5529,5.529,3885.0,0.001418,0.996692,GLT8D2 NPL PROK1 SAA4 SNX29,N-acetylneuraminate catabolic process|N-acetylneuraminate metabolic process|amino sugar catabolic process|acute-phase response|amino sugar metabolic process,0.001698|0.00291|0.003394|0.01015|0.01015,1|1|1|1|1,686.5|374.5|316.8|100.5|100.5
2222,18,0.5041,77.13,14300.0,0.005351,1.0,C17orf50 CCL13 CCL2 CCL7 CRYBA1 EVI2A GAS2L2 LGALS9 LYRM9 MYO18A PIPOX SEBOX SEZ6 SLFN12 SPAG5 TIAF1 UNC119 VTN,eosinophil chemotaxis|eosinophil migration|regulation of ERK1 and ERK2 cascade|monocyte chemotaxis|cellular response to interferon-gamma,6.315e-07|7.363e-07|4.339e-06|7.241e-06|1.032e-05,0.009961|0.005807|0.02281|0.02855|0.03257,201.9|190.7|19.66|83.72|28.97
2223,4,0.5755,3.4530000000000003,3114.0,0.001105,0.9929309999999999,CDX1 GMCL1 MVD TRPM8,"isopentenyl diphosphate biosynthetic process, mevalonate pathway|isopentenyl diphosphate biosynthetic process|isopentenyl diphosphate metabolic process|thermoception|regulation of somitogenesis",0.0007766|0.001165|0.001165|0.001359|0.001359,1|1|1|1|1,1716|1030|1030|858.1|858.1
2224,5,0.5409,5.409,3533.0,0.001524,0.996692,ERBB2 ERBB3 FUT8 GMDS SLC35C1,GDP-L-fucose metabolic process|fucosylation|ERBB2 signaling pathway|phosphatidylinositol 3-kinase signaling|nucleotide-sugar metabolic process,7.067e-07|8.046e-06|2.636e-05|3.663e-05|3.663e-05,0.01115|0.06346|0.1386|0.1444|0.1156,2060|484.6|257.4|216.8|216.8
2225,4,0.5566,3.34,3423.0,0.0009722999999999999,0.9929309999999999,FAS GMFB OLR1 TEX36,actin filament debranching|Fas signaling pathway|motor neuron apoptotic process|cell death|neutrophil differentiation,0.000728|0.000728|0.001213|0.001334|0.001456,1|1|1|1|1,2060|2060|1030|11.45|823.8
2226,4,0.5604,3.362,3142.0,0.001066,0.9929309999999999,CEP250 GMPPA MTMR4 TSPAN9,regulation of centriole-centriole cohesion|regulation of phosphatidylinositol dephosphorylation|positive regulation of protein localization to centrosome|regulation of protein localization to centrosome|response to denervation involved in regulation of muscle adaptation,0.0007766|0.001359|0.001553|0.002134|0.002328,1|1|1|1|1,1716|858.1|735.5|514.9|468.1
2227,14,0.5056,46.01,9787.0,0.004665,0.9999969999999999,ARHGAP21 ARHGEF12 BTBD9 GNA13 GRK2 LPAR1 LPAR2 MYO9A MYO9B PDCL PKN2 RHOA RHOC RIC8A,positive regulation of hydrolase activity|regulation of small GTPase mediated signal transduction|regulation of hydrolase activity|positive regulation of lipase activity|positive regulation of catalytic activity,5.433e-12|1.237e-11|8.748e-10|1.329e-09|1.876e-09,8.57e-08|9.758e-08|4.599e-06|5.241e-06|5.919e-06,18.93|35.99|11.25|100.8|10.4
2228,4,0.5813,3.488,3294.0,0.0010550000000000002,0.9929309999999999,GNA12 PPP2R5A SCUBE1 VSIG10L,blood coagulation|coagulation|hemostasis|negative regulation of lipid kinase activity|adult heart development,0.001244|0.001261|0.001277|0.001747|0.002716,1|1|1|1|1,34.56|34.33|34.1|643.6|396.1
2229,4,0.5581,3.3489999999999998,3408.0,0.0009793,0.9929309999999999,C1orf115 CXCL16 GNAL LCT,polysaccharide digestion|adenylate cyclase-activating dopamine receptor signaling pathway|T cell chemotaxis|T cell migration|dopamine receptor signaling pathway,0.001359|0.002134|0.00291|0.006007|0.0062,1|1|1|1|1,858.1|514.9|367.8|171.6|166.1
2230,4,0.5269,3.162,3187.0,0.0009886,0.9929309999999999,ELMOD2 GNAO1 NIPAL1 PPDPFL,positive regulation of GTPase activity|magnesium ion transmembrane transport|regulation of GTPase activity|magnesium ion transport|dopamine receptor signaling pathway,0.002365|0.003297|0.003309|0.003491|0.0062,1|1|1|1|1,24.93|321.8|21.02|302.9|166.1
2231,4,0.5348,3.2089999999999996,3123.0,0.001024,0.9929309999999999,GNAQ SHISAL1 SYT16 TMEM253,"phototransduction, visible light|G protein-coupled acetylcholine receptor signaling pathway|acetylcholine receptor signaling pathway|cellular response to acetylcholine|response to acetylcholine",0.003685|0.003878|0.005813|0.0062|0.0062,1|1|1|1|1,286|271|177.5|166.1|166.1
2232,5,0.5484,5.484,4463.0,0.001224,0.996692,CISD1 GNB3 HTR1D ITPRIPL1 TMEM138,intestine smooth muscle contraction|gastro-intestinal system smooth muscle contraction|adenylate cyclase-inhibiting serotonin receptor signaling pathway|blood circulation|phasic smooth muscle contraction,0.001213|0.001698|0.00194|0.003391|0.004845,1|1|1|1|1,1030|686.5|588.4|21.4|216.8
2233,5,0.5288,5.287999999999999,3501.0,0.001504,0.996692,CDC37L1 DNAJB6 HNRNPU HSF1 HSPA4,negative regulation of inclusion body assembly|regulation of inclusion body assembly|positive regulation of ATPase activity|regulation of cellular response to heat|regulation of ATPase activity,3.672e-06|8.939e-06|8.295e-05|0.0001515|0.0001591,0.05793|0.07051|0.4362|0.5976|0.502,748.9|457.7|142|104.3|101.7
2234,4,0.5883,3.53,3213.0,0.0010949999999999998,0.9929309999999999,GNG2 HEATR4 PROX2 RHOQ,positive regulation of ion transmembrane transport|positive regulation of transmembrane transport|adenylate cyclase-activating dopamine receptor signaling pathway|cellular response to prostaglandin E stimulus|cellular response to hormone stimulus,0.0007659|0.0007659|0.002134|0.003297|0.00376,1|1|1|1|1,44.2|44.2|514.9|321.8|19.69
2235,5,0.5139,5.138999999999999,4220.0,0.001213,0.996692,ACSM4 ACSM5 GCKR GNG8 PURA,acyl-CoA metabolic process|thioester metabolic process|long-chain fatty acid metabolic process|fatty acid biosynthetic process|cellular response to pheromone,0.0003386|0.0003386|0.0005137|0.0005478|0.0005824,1|1|1|1|1,70.77|70.77|57.21|55.36|3432
2236,4,0.5479,3.2880000000000003,3130.0,0.001047,0.9929309999999999,GNGT2 SFR1 STK19 SYDE1,regulation of small GTPase mediated signal transduction|positive regulation of trophoblast cell migration|regulation of trophoblast cell migration|cellular response to estrogen stimulus|phototransduction,0.001494|0.001553|0.002716|0.003491|0.00871,1|1|1|1|1,31.49|735.5|396.1|302.9|117
2237,13,0.4885,38.1,9339.0,0.004052,0.999993,DDX55 MAK16 NOL9 PAK1IP1 PPAN PWP2 RRP1 RRP12 RSL1D1 URB1 UTP4 WDR12 WDR18,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,8.928e-23|6.56e-21|5.832e-19|8.741e-19|1.375e-16,1.408e-18|5.174e-17|3.067e-15|3.447e-15|4.339e-13,57.6|41.13|62.24|59.93|37.46
2238,5,0.5258,5.257999999999999,3919.0,0.0013369999999999999,0.996692,GNMT KCNK16 KCNK17 MAPK13 TUBB4A,stabilization of membrane potential|cellular response to anisomycin|potassium ion transmembrane transport|potassium ion transport|sarcosine metabolic process,8.046e-06|0.0004854|0.0005904|0.0006661|0.000728,0.1269|1|1|1|1,484.6|4119|52.14|49.04|2060
2239,4,0.5079,3.048,3026.0,0.001003,0.9929309999999999,FBXL4 GNRH2 PPTC7 ZCCHC4,regulation of ubiquinone biosynthetic process|peptidyl-serine dephosphorylation|regulation of ketone biosynthetic process|rRNA methylation|rRNA modification,0.0005825|0.00291|0.003491|0.00562|0.007938,1|1|1|1|1,2574|367.8|302.9|183.9|128.7
2240,13,0.5033,39.26,10250.0,0.003807,0.999993,AKAP2 C9orf3 C9orf84 FAM206A FBP1 FBP2 GOLGA2 KIF12 OR1J4 OR1L8 OR1N2 PALM2 TXNDC8,"sucrose biosynthetic process|sucrose metabolic process|disaccharide biosynthetic process|fructose 1,6-bisphosphate metabolic process|disaccharide metabolic process",1.864e-06|3.106e-06|6.518e-06|1.705e-05|2.416e-05,0.0294|0.02449|0.03427|0.06723|0.07622,1716|1144|686.5|381.4|312
2241,13,0.507,39.55,8712.0,0.0045060000000000005,0.999993,BUB3 C1orf109 DHX33 EXOSC6 IMP3 NIP7 POP5 RPP21 SPATA5L1 TIMM10 TRMT112 UTP4 WDR18,ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process,9.523e-10|5.724e-09|9.445e-09|1.203e-08|1.5e-08,1.502e-05|4.515e-05|4.966e-05|4.745e-05|4.731e-05,31.02|23.84|22.15|33.95|32.69
2242,8,0.5431,15.21,4823.0,0.0031320000000000002,0.9996790000000001,GOLGA7 KRAS MAPK1 NRAS RAF1 RCE1 SHOC2 ZDHHC5,MAPK cascade|intracellular signal transduction|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction,1.023e-11|1.16e-07|1.004e-05|1.11e-05|1.138e-05,1.614e-07|0.0009152|0.05281|0.04378|0.03589,44.06|11.44|67.16|64.9|64.36
2243,4,0.5342,3.205,3293.0,0.0009701,0.9929309999999999,GOLIM4 RECQL5 SLC27A4 TMEM244,"negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity|regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity|medium-chain fatty acid transport|cellular response to camptothecin|response to camptothecin",0.0003883|0.0003883|0.0005825|0.0009706|0.001165,1|1|1|1|1,5149|5149|2574|1287|1030
2244,4,0.5371,3.2230000000000003,3303.0,0.0009725,0.9929309999999999,DOK4 GOLT1A RBPMS2 SPRR3,embryonic digestive tract morphogenesis|negative regulation of smooth muscle cell differentiation|embryonic digestive tract development|regulation of smooth muscle cell differentiation|digestive tract morphogenesis,0.003297|0.003491|0.0062|0.006393|0.00871,1|1|1|1|1,321.8|302.9|166.1|160.9|117
2245,5,0.5405,5.405,3511.0,0.001533,0.996692,GON4L PPP1R10 SS18L2 TOX4 ZC3H4,regulation of nucleobase-containing compound metabolic process|negative regulation of mitotic DNA damage checkpoint|regulation of mitotic DNA damage checkpoint|regulation of nitrogen compound metabolic process|negative regulation of DNA damage checkpoint,0.0002796|0.0004854|0.000728|0.00161|0.001698,1|1|1|1|1,5.14|4119|2060|3.621|686.5
2246,6,0.5,7.5,4344.0,0.001719,0.998474,ASNA1 CAMLG GOPC NAGK SNX33 WRB,negative regulation of protein localization to cell surface|regulation of protein localization to cell surface|negative regulation of cellular protein localization|regulation of Golgi to plasma membrane CFTR protein transport|cytoplasmic sequestering of CFTR protein,2.967e-06|2.201e-05|0.0001938|0.0003883|0.0003883,0.0468|0.1736|1|1|1,792.1|271|88.77|5149|5149
2247,4,0.5152,3.091,3225.0,0.0009551000000000001,0.9929309999999999,ADCK5 ANKRD46 GORAB NKAIN4,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning|hair follicle morphogenesis|epidermis morphogenesis|positive regulation of smoothened signaling pathway,0.0003883|0.001747|0.00562|0.006393|0.007359,1|1|1|1|1,5149|643.6|183.9|160.9|139.2
2248,17,0.5038,68.52,11160.0,0.006082,1.0,CNIH1 COG1 GET4 GOSR2 RAB18 RAB1A RAB1B SAR1A SCFD1 SEC23IP SEC31A SURF4 TM9SF3 TRAPPC12 TRAPPC13 TRAPPC2L UNC50,endoplasmic reticulum to Golgi vesicle-mediated transport|COPII-coated vesicle budding|Golgi vesicle transport|vesicle budding from membrane|COPII vesicle coating,9.416e-19|2.643e-18|1.744e-17|6.974e-17|3.128e-16,1.485e-14|2.084e-14|9.172e-14|2.75e-13|9.867e-13,67.99|155.8|36.71|105.9|153.8
2249,4,0.5076,3.045,3069.0,0.0009888,0.9929309999999999,GOSR1 HFE SLC17A4 ZNF184,"negative regulation of T cell antigen processing and presentation|cellular response to iron ion starvation|regulation of vesicle targeting, to, from or within Golgi|negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I|regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I",0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2250,4,0.5163,3.0980000000000003,3192.0,0.000967,0.9929309999999999,APOC2 GCNT1 GOT1L1 SAXO2,positive regulation of very-low-density lipoprotein particle remodeling|cell adhesion molecule production|aspartate biosynthetic process|positive regulation of phospholipid catabolic process|negative regulation of very-low-density lipoprotein particle clearance,0.0005825|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|1716|1716|1716|1287
2251,7,0.503,10.56,5771.0,0.001823,0.9992989999999999,BBS5 GP2 HOXD8 SCN1A SCN2A SCN3A SCN7A,neuronal action potential|membrane depolarization during action potential|transmission of nerve impulse|membrane depolarization|action potential,1.672e-10|2.155e-10|1.703e-09|1.703e-09|1.533e-08,2.637e-06|1.7e-06|8.953e-06|6.715e-06|4.836e-05,420.3|392.3|226.3|226.3|127.9
2252,5,0.5312,5.312,4300.0,0.001231,0.996692,CCPG1 CD7 GP5 SGTB SYCP2L,regulation of Rho guanyl-nucleotide exchange factor activity|positive regulation of chaperone-mediated protein folding|positive regulation of protein folding|regulation of chaperone-mediated protein folding|regulation of guanyl-nucleotide exchange factor activity,0.000728|0.000728|0.001213|0.001456|0.002425,1|1|1|1|1,2060|2060|1030|823.8|457.7
2253,4,0.538,3.228,3254.0,0.0009886,0.9929309999999999,CHRM1 GPA33 SELP TEDDM1,phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway|positive regulation of platelet activation|saliva secretion|positive regulation of leukocyte tethering or rolling|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,0.0007766|0.0009706|0.001165|0.001747|0.001747,1|1|1|1|1,1716|1287|1030|643.6|643.6
2254,4,0.5197,3.1180000000000003,3226.0,0.0009632999999999999,0.9929309999999999,COQ9 ERVW-1 GPALPP1 HPGDS,cyclooxygenase pathway|ubiquinone biosynthetic process|quinone biosynthetic process|ubiquinone metabolic process|prostaglandin biosynthetic process,0.002328|0.003297|0.003297|0.003491|0.004072,1|1|1|1|1,468.1|321.8|321.8|302.9|257.4
2255,4,0.56,3.36,3330.0,0.001006,0.9929309999999999,CDRT1 GPAM MYMK ZNF276,positive regulation of skeletal muscle hypertrophy|negative regulation of activation-induced cell death of T cells|regulation of skeletal muscle hypertrophy|regulation of activation-induced cell death of T cells|myoblast fusion involved in skeletal muscle regeneration,0.0005825|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|1716|1716|1287|1030
2256,4,0.504,3.0239999999999996,3221.0,0.0009356,0.9929309999999999,ARNTL2 GPATCH11 IKBKE MPDZ,I-kappaB phosphorylation|positive regulation of type I interferon-mediated signaling pathway|positive regulation of circadian rhythm|positive regulation of lipid storage|TRIF-dependent toll-like receptor signaling pathway,0.002522|0.002716|0.003491|0.00504|0.006007,1|1|1|1|1,429.1|396.1|302.9|205.9|171.6
2257,4,0.5284,3.17,3173.0,0.0009955,0.9929309999999999,GPATCH2L GPR182 HMOX1 HSPA1B,cellular response to heat|response to heat|negative regulation of extrinsic apoptotic signaling pathway|regulation of extrinsic apoptotic signaling pathway|regulation of transcription from RNA polymerase II promoter in response to iron,4.34e-05|0.0001336|0.0001593|0.0003472|0.0003883,0.6846|1|0.8376|1|1,190.7|107.3|98.07|66.01|5149
2258,4,0.5489,3.293,3134.0,0.001047,0.9929309999999999,APLNR GPC6 ITGA8 SOX1,gastrulation|positive regulation of inhibitory G protein-coupled receptor phosphorylation|regulation of inhibitory G protein-coupled receptor phosphorylation|apelin receptor signaling pathway|ventral spinal cord interneuron specification,0.0003429|0.0003883|0.0003883|0.0007766|0.001553,1|1|1|1|1,66.44|5149|5149|1716|735.5
2259,5,0.5157,5.157,3920.0,0.0013109999999999999,0.996692,CLDN25 GPD1 HTR3A HTR3B METTL7A,serotonin receptor signaling pathway|cellular response to organic cyclic compound|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus,3.85e-05|0.0001395|0.0001591|0.000163|0.0002265,0.6073|1|0.8367|0.6428|0.7145,211.2|24.71|101.7|100.5|84.93
2260,4,0.5831,3.498,3144.0,0.001109,0.9929309999999999,GPD1L LEMD1 RNGTT SCN10A,regulation of membrane depolarization|cardiac muscle cell action potential|action potential|regulation of heart rate|glycerol-3-phosphate catabolic process,2.792e-05|3.595e-05|0.0001229|0.0001363|0.0005825,0.4404|0.2835|0.6461|0.5376|1,239.5|210.2|111.9|106.2|2574
2261,4,0.5117,3.07,3226.0,0.0009482000000000001,0.9929309999999999,F2RL1 GPHA2 LHX1 MAPK1IP1L,positive regulation of neutrophil mediated killing of gram-negative bacterium|positive regulation of neutrophil mediated killing of bacterium|horizontal cell localization|nephric duct elongation|uterine epithelium development,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2262,4,0.5494,3.2969999999999997,3315.0,0.000991,0.9929309999999999,CHST4 GPLD1 PNMA1 SLC24A1,response to triglyceride|GPI anchor release|cellular response to triglyceride|positive regulation of high-density lipoprotein particle clearance|regulation of high-density lipoprotein particle clearance,0.0003883|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,5149|5149|5149|2574|1716
2263,11,0.519,28.55,7251.0,0.00391,0.999969,BUB3 C1orf109 DAD1 DHX33 DPAGT1 FARSB GPN3 HSPE1 POP5 SPATA5L1 TXNL4A,protein N-linked glycosylation|phenylalanyl-tRNA aminoacylation|dolichol metabolic process|tRNA metabolic process|dolichyl diphosphate biosynthetic process,0.0007417|0.002134|0.003199|0.004093|0.004263,1|1|1|1|1,49.93|624.1|374.5|20.69|267.5
2264,4,0.5143,3.0860000000000003,2994.0,0.001027,0.9929309999999999,ERO1B GPNMB TRMT112 WDR74,rRNA (guanine-N7)-methylation|rRNA processing|rRNA metabolic process|peptidyl-glutamine methylation|ribosome biogenesis,0.0005825|0.0009508|0.001024|0.001359|0.001539,1|1|1|1|1,2574|39.61|38.14|858.1|31.02
2265,4,0.5703,3.4219999999999997,3364.0,0.0010140000000000001,0.9929309999999999,GPR137 PEAK1 SLC9A2 THPO,regulation of myeloid cell differentiation|thrombopoietin-mediated signaling pathway|positive regulation of hematopoietic stem cell proliferation|regulation of hematopoietic stem cell proliferation|regulation of hemopoiesis,0.0007855|0.001165|0.001359|0.001941|0.002145,1|1|1|1|1,43.63|1030|858.1|572.1|26.2
2266,4,0.5002,3.0010000000000003,3084.0,0.0009698,0.9929309999999999,ACTR3B GPR151 OR1C1 PRSS37,positive regulation of fertilization|positive regulation of acrosome reaction|regulation of fertilization|regulation of acrosome reaction|positive regulation of multi-organism process,0.001165|0.002522|0.002522|0.003104|0.003878,1|1|1|1|1,1030|429.1|429.1|343.2|271
2267,5,0.514,5.14,3978.0,0.001287,0.996692,ELF2 GPR162 GPRC5A NCF1 SP5,regulation of epidermal growth factor-activated receptor activity|regulation of epidermal growth factor receptor signaling pathway|regulation of ERBB signaling pathway|regulation of protein tyrosine kinase activity|regulation of signaling receptor activity,3.493e-05|0.0002737|0.0003184|0.0003184|0.001317,0.5509|1|1|1|1,228.8|78.91|73.03|73.03|35.39
2268,4,0.5679,3.408,3267.0,0.001039,0.9929309999999999,GPR17 PLD3 STON2 TBC1D8,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway|positive regulation of Rho protein signal transduction|regulation of cytokine production involved in inflammatory response|presynaptic endocytosis|synaptic vesicle endocytosis,0.006586|0.00678|0.009482|0.009867|0.009867,1|1|1|1|1,156|151.4|107.3|103|103
2269,7,0.5152,10.82,4620.0,0.002329,0.9992989999999999,AHR AHSA1 ARNT HSF1 HSP90AA1 HSPA4 STIP1,outer mitochondrial membrane organization|protein insertion into mitochondrial outer membrane|response to unfolded protein|chaperone-mediated protein complex assembly|response to topologically incorrect protein,1.483e-06|1.483e-06|1.886e-05|2.495e-05|2.671e-05,0.0234|0.0117|0.09915|0.0984|0.08428,1471|1471|52.85|280.2|46.95
2270,5,0.5063,5.063,4103.0,0.0012289999999999998,0.996692,CPLX4 GPR176 GPR20 LGMN PDK2,vacuolar protein processing|negative regulation of inflammatory response to antigenic stimulus|regulation of inflammatory response to antigenic stimulus|signaling|cell communication,0.000728|0.001014|0.001152|0.001343|0.001452,1|1|1|1|1,2060|39.61|37.11|3.755|3.696
2271,4,0.5848,3.509,3201.0,0.001092,0.9929309999999999,FAM84A GPR37 LAMP3 LRCH3,septin cytoskeleton organization|locomotion involved in locomotory behavior|positive regulation of dopamine metabolic process|positive regulation of catecholamine metabolic process|positive regulation of cellular amine metabolic process,0.0009706|0.001165|0.001165|0.001165|0.001747,1|1|1|1|1,1287|1030|1030|1030|643.6
2272,4,0.5377,3.2260000000000004,3181.0,0.001011,0.9929309999999999,GPR37L1 GRM2 NECAP2 RCHY1,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|glutamate homeostasis|amino acid homeostasis|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,0.0001028|0.0006839|0.001165|0.001359|0.001553,1|1|1|1|1,122.6|46.81|1030|858.1|735.5
2273,4,0.5193,3.116,3308.0,0.0009387,0.9929309999999999,GPR39 S100P SCN9A TCEA3,behavioral response to pain|neuronal action potential|response to pain|membrane depolarization during action potential|transmission of nerve impulse,0.002716|0.00562|0.00562|0.006007|0.01025,1|1|1|1|1,396.1|183.9|183.9|171.6|99.01
2274,4,0.5964,3.5789999999999997,3482.0,0.001024,0.9929309999999999,CAMK2B DXO GPR55 TMEM181,pathogenesis|NAD-cap decapping|cannabinoid signaling pathway|regulation of synapse structural plasticity|positive regulation of synapse maturation,0.0003883|0.0005825|0.001359|0.001941|0.001941,1|1|1|1|1,5149|2574|858.1|572.1|572.1
2275,13,0.5139,40.08,9933.0,0.004007999999999999,0.999993,ANO1 CCDC36 CPT1A DIXDC1 FGF19 FGF4 GPR6 LTO1 MRGPRD MRGPRF MYEOV ZNF20 ZNF789,fibroblast growth factor receptor signaling pathway|cellular response to fibroblast growth factor stimulus|negative regulation of bile acid biosynthetic process|negative regulation of bile acid metabolic process|response to fibroblast growth factor,0.001413|0.002643|0.002715|0.002715|0.002923,1|1|1|1|1,36.32|26.27|490.4|490.4|24.93
2276,16,0.5005,60.06,12910.0,0.004618,0.999999,AGO1 AGO4 C1orf123 C1orf50 CCDC30 CFAP57 CYP4Z1 ERMAP EXO5 FAM183A MFSD2A PPT1 ZFP69 ZFP69B ZNF684 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",1.775e-05|2.217e-05|2.709e-05|5.163e-05|5.163e-05,0.2799|0.1749|0.1424|0.2036|0.1629,392.3|343.2|305.1|211.2|211.2
2277,4,0.507,3.042,3132.0,0.0009676999999999999,0.9929309999999999,GPR65 KCNK10 KRTAP26-1 TMEM141,stabilization of membrane potential|response to acidic pH|positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway|positive regulation of Rho protein signal transduction|response to pH,0.003491|0.00504|0.006586|0.00678|0.00871,1|1|1|1|1,302.9|205.9|156|151.4|117
2278,4,0.5305,3.1830000000000003,3240.0,0.0009791000000000001,0.9929309999999999,GPR78 LRRC63 NSG2 PLAG1,prostate gland growth|positive regulation of glial cell proliferation|clathrin coat assembly|dopamine receptor signaling pathway|regulation of glial cell proliferation,0.002134|0.003297|0.003685|0.0062|0.0062,1|1|1|1|1,514.9|321.8|286|166.1|166.1
2279,5,0.542,5.42,4388.0,0.001231,0.996692,CD248 COQ8B GPR4 GPR83 MDFI,anatomical structure morphogenesis|glomerular mesangial cell development|mesangial cell development|glomerular mesangial cell differentiation|mesangial cell differentiation,0.0005317|0.001456|0.001698|0.001698|0.00194,1|1|1|1|1,7.717|823.8|686.5|686.5|588.4
2280,5,0.5267,5.267,4123.0,0.001273,0.996692,DAB2 GPR85 NUAK2 TMEM168 TMEM229B,"leading edge cell differentiation|positive regulation of clathrin-dependent endocytosis|positive regulation of early endosome to late endosome transport|positive regulation of Wnt signaling pathway, planar cell polarity pathway|positive regulation of cytoplasmic transport",0.0004854|0.001456|0.002183|0.002425|0.003394,1|1|1|1|1,4119|823.8|514.9|457.7|316.8
2281,4,0.5428,3.2569999999999997,3244.0,0.001,0.9929309999999999,FAM186A GFOD1 GPSM1 LLGL1,negative regulation of guanyl-nucleotide exchange factor activity|regulation of guanyl-nucleotide exchange factor activity|regulation of GTP binding|regulation of GTPase activity|regulation of establishment or maintenance of cell polarity,0.001359|0.001941|0.003104|0.003309|0.005233,1|1|1|1|1,858.1|572.1|343.2|21.02|198
2282,5,0.5189,5.189,4058.0,0.001274,0.996692,GPSM2 KCND3 NMNAT2 NTNG1 ZNF319,maintenance of centrosome location|Ran protein signal transduction|positive regulation of spindle assembly|positive regulation of protein localization to cell cortex|regulation of protein localization to cell cortex,0.001213|0.001213|0.001456|0.001698|0.002425,1|1|1|1|1,1030|1030|823.8|686.5|457.7
2283,4,0.5732,3.4389999999999996,3285.0,0.0010429999999999999,0.9929309999999999,DOK1 FA2H GPX1 MAP3K20,response to gamma radiation|positive regulation of mitotic DNA damage checkpoint|response to ionizing radiation|carboxylic acid metabolic process|oxoacid metabolic process,7.482e-05|0.0004854|0.0005055|0.0006154|0.00069,1|1|1|1|1,149.8|4119|56.42|14.92|14.35
2284,4,0.555,3.33,3294.0,0.001007,0.9929309999999999,AMTN DERA GPX2 PRRC1,deoxyribonucleoside catabolic process|positive regulation of enamel mineralization|regulation of enamel mineralization|positive regulation of tooth mineralization|deoxyribonucleoside metabolic process,0.0007766|0.0007766|0.001165|0.001359|0.001747,1|1|1|1|1,1716|1716|1030|858.1|643.6
2285,4,0.5765,3.4589999999999996,3373.0,0.0010220000000000001,0.9929309999999999,FAM174B GPX3 GUCA1C TWF2,response to lipid hydroperoxide|regulation of microvillus length|positive regulation of guanylate cyclase activity|sequestering of actin monomers|regulation of cell projection size,0.0007766|0.001553|0.001941|0.002328|0.002522,1|1|1|1|1,1716|735.5|572.1|468.1|429.1
2286,4,0.5796,3.478,3174.0,0.001092,0.9929309999999999,GRAMD1B RFPL4AL1 TARSL2 UHRF1BP1L,threonyl-tRNA aminoacylation|cellular response to cholesterol|cellular response to sterol|response to cholesterol|response to sterol,0.0007766|0.003491|0.004459|0.005426|0.006393,1|1|1|1|1,1716|302.9|234|190.7|160.9
2287,5,0.5045,5.045,4207.0,0.0011949999999999999,0.996692,CHSY1 GRAMD1C TNFRSF14 TSGA10 UGT8,negative regulation of adaptive immune memory response|protein localization to paranode region of axon|regulation of adaptive immune memory response|galactolipid biosynthetic process|galactosylceramide biosynthetic process,0.000728|0.0009706|0.0009706|0.001698|0.001698,1|1|1|1|1,2060|1373|1373|686.5|686.5
2288,4,0.5289,3.174,3242.0,0.0009756999999999999,0.9929309999999999,GRAMD4 KREMEN1 OR5B2 PNPLA3,"triglyceride acyl-chain remodeling|cellular response to 3,3',5-triiodo-L-thyronine|response to 3,3',5-triiodo-L-thyronine|negative regulation of toll-like receptor 9 signaling pathway|response to sucrose",0.0003883|0.0005825|0.0007766|0.0009706|0.001747,1|1|1|1|1,5149|2574|1716|1287|643.6
2289,4,0.5759,3.455,3083.0,0.001117,0.9929309999999999,GRAP2 MRGPRD PVALB TJP3,positive regulation of blood-brain barrier permeability|regulation of blood-brain barrier permeability|establishment of endothelial intestinal barrier|positive regulation of vascular permeability|protein localization to cell-cell junction,0.001165|0.001747|0.002522|0.003104|0.003685,1|1|1|1|1,1030|643.6|429.1|343.2|286
2290,4,0.5228,3.137,3112.0,0.001005,0.9929309999999999,GRB7 IGSF11 OR5M9 PITHD1,penetration of cumulus oophorus|positive regulation of mini excitatory postsynaptic potential|regulation of mini excitatory postsynaptic potential|penetration of zona pellucida|positive regulation of megakaryocyte differentiation,0.0003883|0.0005825|0.0005825|0.001941|0.002328,1|1|1|1|1,5149|2574|2574|572.1|468.1
2291,5,0.5362,5.362,3626.0,0.0014730000000000001,0.996692,EIF5A EIF5AL1 GREB1 PTGDS RTCB,positive regulation of translational termination|positive regulation of translational elongation|regulation of translational termination|regulation of translational elongation|positive regulation of protein-containing complex disassembly,7.067e-07|9.893e-07|3.672e-06|1.19e-05|3.128e-05,0.01115|0.007803|0.01931|0.04693|0.09869,2060|1648|748.9|392.3|235.4
2292,5,0.5158,5.1579999999999995,4043.0,0.001271,0.996692,CCNA2 EXOSC9 GRIA2 MRPL24 SPATA5,cellular response to luteinizing hormone stimulus|U5 snRNA 3'-end processing|U1 snRNA 3'-end processing|cellular response to cocaine|polyadenylation-dependent mRNA catabolic process,0.0009706|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,1373|1373|1373|1030|1030
2293,4,0.5211,3.127,3020.0,0.001031,0.9929309999999999,CEP104 GRIA4 MFSD14A NPR3,osteoclast proliferation|pancreatic juice secretion|positive regulation of urine volume|secretion by tissue|negative regulation of adenylate cyclase activity,0.0009706|0.001553|0.00291|0.003491|0.004072,1|1|1|1|1,1287|735.5|367.8|302.9|257.4
2294,4,0.5776,3.465,3263.0,0.001058,0.9929309999999999,AKAP7 GRIK2 LALBA RANBP6,"synaptic transmission, glutamatergic|ionotropic glutamate receptor signaling pathway|receptor clustering|glutamate receptor signaling pathway|positive regulation of neuron apoptotic process",1.909e-05|1.909e-05|5.073e-05|5.517e-05|7.22e-05,0.3011|0.1505|0.2667|0.2176|0.2278,305.1|305.1|183.1|175.3|152.6
2295,4,0.5261,3.157,3184.0,0.0009880000000000002,0.9929309999999999,EFCAB6 EN2 GRIK4 RAPGEF5,"embryonic brain development|synaptic transmission, glutamatergic|ionotropic glutamate receptor signaling pathway|glutamate receptor signaling pathway|midbrain development",0.002522|0.005426|0.005426|0.009289|0.01679,1|1|1|1|1,429.1|190.7|190.7|109.5|59.87
2296,4,0.5116,3.069,2993.0,0.0010220000000000001,0.9929309999999999,GRIN2A KRT81 PRB1 RRP15,directional locomotion|excitatory chemical synaptic transmission|serotonin metabolic process|primary amino compound metabolic process|sleep,0.0009706|0.002425|0.002667|0.003636|0.003636,1|1|1|1|1,1373|457.7|411.9|294.2|294.2
2297,7,0.5083,10.67,5652.0,0.0018800000000000002,0.9992989999999999,A2M GRIN2B KCNC4 PKP2 SLCO1B1 SLCO1C1 TSPAN11,"sodium-independent organic anion transport|bile acid and bile salt transport|localization|transmembrane transport|negative regulation of complement activation, lectin pathway",1.51e-05|6.2e-05|0.0001422|0.0004678|0.001019,0.2382|0.489|0.7476|1|1,367.8|173.1|3.547|9.109|1471
2298,4,0.5408,3.245,3263.0,0.000991,0.9929309999999999,GRIN3B GTDC1 TBCCD1 TM7SF2,maintenance of Golgi location|maintenance of centrosome location|maintenance of organelle location|Golgi localization|ionotropic glutamate receptor signaling pathway,0.0007766|0.0009706|0.002134|0.00291|0.005426,1|1|1|1|1,1716|1287|514.9|367.8|190.7
2299,4,0.5347,3.208,3118.0,0.001025,0.9929309999999999,GP2 GRK5 OR8J1 TTN,striated muscle myosin thick filament assembly|sarcomerogenesis|skeletal muscle myosin thick filament assembly|myosin filament assembly|myosin filament organization,0.0007766|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1716|1287|1287
2300,5,0.5001,5.001,3890.0,0.001281,0.996692,C9orf16 GRK7 PTBP3 ZBTB6 ZNF8,negative regulation of RNA metabolic process|negative regulation of nucleobase-containing compound metabolic process|erythrocyte maturation|negative regulation of RNA splicing|regulation of rhodopsin mediated signaling pathway,0.002805|0.00356|0.003636|0.006537|0.006537,1|1|1|1|1,8.864|8.162|294.2|158.4|158.4
2301,6,0.5199,7.797999999999999,5016.0,0.0015480000000000001,0.998474,GRN HOXB5 HOXB9 OSBPL7 SLC25A47 WNT9B,embryonic skeletal system morphogenesis|embryonic skeletal system development|skeletal system morphogenesis|embryonic organ morphogenesis|embryonic organ development,2.003e-06|4.304e-06|2.577e-05|5.518e-05|0.0001723,0.0316|0.03395|0.1355|0.2176|0.5437,109.5|84.41|45.97|35.51|24.12
2302,4,0.5335,3.201,3132.0,0.001018,0.9929309999999999,G3BP2 GRPEL2 TBC1D24 TTC33,positive regulation of stress granule assembly|neuron death in response to oxidative stress|regulation of stress granule assembly|cytoplasmic sequestering of NF-kappaB|cytoplasmic sequestering of transcription factor,0.0005825|0.0009706|0.001165|0.001747|0.003297,1|1|1|1|1,2574|1287|1030|643.6|321.8
2303,5,0.5308,5.308,4326.0,0.0012230000000000001,0.996692,DLG2 GRTP1 HRH1 TSKU U2AF1L4,retrograde axonal protein transport|positive regulation of hair cycle|negative regulation of myofibroblast differentiation|ciliary body morphogenesis|organic substance transport,0.0008735|0.0008735|0.001456|0.001456|0.001557,1|1|1|1|1,1716|1716|858.1|858.1|6.327
2304,6,0.5303,7.954,4297.0,0.001843,0.998474,CCDC86 GRWD1 INTS5 OSBP TMEM258 WDR74,biological regulation|cellular biosynthetic process|organic substance biosynthetic process|biosynthetic process|nucleosome disassembly,0.003503|0.003607|0.004106|0.004428|0.005522,1|1|1|1|1,0|5.068|4.897|4.799|190.7
2305,4,0.5491,3.295,3080.0,0.001066,0.9929309999999999,COA1 GRXCR1 SCEL SPINK5,epidermal cell differentiation|hair cell differentiation|epidermis development|epithelial cell differentiation|negative regulation of antimicrobial humoral response,1.455e-05|2.429e-05|3.316e-05|0.0001379|0.0003883,0.2295|0.1916|0.1743|0.5439|1,48.88|257.4|37.04|22.92|5149
2306,4,0.5015,3.009,3099.0,0.0009676,0.9929309999999999,GSC2 KCTD17 MPP5 RLBP1,protein localization to myelin sheath abaxonal region|peripheral nervous system myelin maintenance|vitamin A metabolic process|myelin maintenance|myelin assembly,0.0003883|0.001747|0.001941|0.003297|0.004266,1|1|1|1|1,5149|643.6|572.1|321.8|245.2
2307,4,0.5746,3.448,3089.0,0.001112,0.9929309999999999,COX5A GSG1L TAP2 XYLT1,"antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent",8.046e-06|9.879e-06|1.777e-05|0.0002404|0.0004854,0.1269|0.07792|0.09344|0.9481|1,484.6|433.6|316.8|82.38|4119
2308,13,0.5147,40.15,10050.0,0.0039700000000000004,0.999993,AKAP2 C9orf16 FAM129B GSN OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 TXNDC8 ZBTB6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,8.335e-08|1.179e-07|1.47e-07|2.229e-07|2.775e-07,0.001315|0.00093|0.0007728|0.0008791|0.0008755,23.35|22|21.19|19.73|19
2309,15,0.5017,52.68,12470.0,0.004196,0.999999,CALHM3 CYP17A1 CYP2C9 GSTO1 GSTO2 IFIT1 IFIT1B IFIT5 LIPA LIPJ MORN4 NUTM2A SEMA4G SORCS1 SORCS3,cellular response to type I interferon|response to type I interferon|L-ascorbic acid metabolic process|xenobiotic metabolic process|cellular response to exogenous dsRNA,1.805e-05|2.296e-05|3.839e-05|9.849e-05|0.000103,0.2847|0.1811|0.2018|0.3884|0.3249,59.7|54.92|249.6|33.22|144.5
2310,6,0.5082,7.624,4607.0,0.001648,0.998474,GSX2 PDGFRA PNMA8A PRRX1 SCFD2 TWIST2,embryonic cranial skeleton morphogenesis|neuron fate commitment|cranial skeletal system development|roof of mouth development|embryonic skeletal system morphogenesis,8.263e-05|0.0001458|0.0001791|0.0002799|0.0003184,1|1|0.9415|1|1,146.1|109|98.07|78.01|73.03
2311,5,0.511,5.11,4228.0,0.001204,0.996692,CALHM2 GTF2I LMOD1 NT5C1A ZNF45,positive regulation of DNA repair by transcription from RNA polymerase II promoter|nucleobase-containing compound biosynthetic process|heterocycle biosynthetic process|aromatic compound biosynthetic process|organic cyclic compound biosynthetic process,0.000728|0.001078|0.001323|0.001359|0.001916,1|1|1|1|1,2060|12.32|11.48|11.38|10.11
2312,5,0.5171,5.171,4185.0,0.001231,0.996692,GTSF1L NTN3 PIPOX SLC43A1 SUN5,L-lysine catabolic process to acetyl-CoA via L-pipecolate|negative regulation of leucine import|regulation of leucine import|negative regulation of leucine import across plasma membrane|regulation of leucine import across plasma membrane,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
2313,4,0.5673,3.404,3346.0,0.0010140000000000001,0.9929309999999999,CDH24 GUCA1B RPS6KL1 SDCBP2,positive regulation of guanylate cyclase activity|receptor guanylyl cyclase signaling pathway|regulation of guanylate cyclase activity|positive regulation of purine nucleotide biosynthetic process|positive regulation of nucleotide biosynthetic process,0.001941|0.002134|0.002522|0.004266|0.004266,1|1|1|1|1,572.1|514.9|429.1|245.2|245.2
2314,4,0.5476,3.286,3250.0,0.001007,0.9929309999999999,CCDC169 DMAC2 DRICH1 GUCY1A1,"retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission|trans-synaptic signaling by nitric oxide, modulating synaptic transmission|trans-synaptic signaling by soluble gas, modulating synaptic transmission|retrograde trans-synaptic signaling by nitric oxide|retrograde trans-synaptic signaling by soluble gas",0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
2315,5,0.538,5.38,4035.0,0.001328,0.996692,BATF2 BOLL CD47 GULP1 PKIB,negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|ATP export|monocyte extravasation|regulation of Fc-gamma receptor signaling pathway involved in phagocytosis|negative regulation of cAMP-dependent protein kinase activity,0.000728|0.0009706|0.001456|0.00194|0.002425,1|1|1|1|1,2060|1373|823.8|588.4|457.7
2316,4,0.5224,3.135,2937.0,0.0010630000000000001,0.9929309999999999,GXYLT2 OR2W1 OR5V1 PDRG1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.00269|0.003023|0.003256|0.003746|0.004032,1|1|1|1|1,23.35|22|21.19|19.73|19
2317,19,0.5058,86.49,15610.0,0.005495,1.0,C5AR1 C5AR2 CABP5 FFAR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 PSG2 SIGLEC11 SIGLEC12 SIGLEC5 SPIB SULT2B1 VN1R4 ZNF610 ZNF665 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|inflammatory response|phospholipase C-activating G protein-coupled receptor signaling pathway|regulation of neutrophil chemotaxis,5.058e-07|5.922e-06|0.0001225|0.0001466|0.0005119,0.007978|0.04671|0.644|0.578|1,226.3|980.7|9.886|29.72|63.27
2318,4,0.5188,3.113,3121.0,0.0009939,0.9929309999999999,ELOA2 GZMA SPEF2 UGT3A1,negative regulation of endodeoxyribonuclease activity|cytotoxic T cell pyroptotic process|negative regulation of deoxyribonuclease activity|negative regulation of nuclease activity|granzyme-mediated programmed cell death signaling pathway,0.0003883|0.0005825|0.0005825|0.001553|0.001747,1|1|1|1|1,5149|2574|2574|735.5|643.6
2319,4,0.5618,3.3710000000000004,3235.0,0.001038,0.9929309999999999,COL23A1 HABP2 HSPA12A NR2E1,regulation of timing of neuron differentiation|amygdala development|anterior commissure morphogenesis|aggressive behavior|regulation of timing of cell differentiation,0.0007766|0.0009706|0.001359|0.001553|0.001553,1|1|1|1|1,1716|1287|858.1|735.5|735.5
2320,4,0.5006,3.003,3041.0,0.0009841000000000001,0.9929309999999999,HABP4 KANK2 SLC39A13 ZNF470,negative regulation of vitamin D receptor signaling pathway|glomerular visceral epithelial cell migration|regulation of vitamin D receptor signaling pathway|PML body organization|negative regulation of intracellular estrogen receptor signaling pathway,0.0005825|0.001359|0.001553|0.001553|0.003297,1|1|1|1|1,2574|858.1|735.5|735.5|321.8
2321,4,0.5356,3.214,3128.0,0.001024,0.9929309999999999,HACD1 NRM SPATA22 WDR31,cementum mineralization|meiotic DNA repair synthesis|very long-chain fatty acid biosynthetic process|fatty acid elongation|tooth mineralization,0.0005825|0.0007766|0.002716|0.002716|0.003297,1|1|1|1|1,2574|1716|396.1|396.1|321.8
2322,9,0.5291,19.05,6122.0,0.003092,0.9998530000000001,CERS2 CERS6 ELOVL1 HACD2 HSD17B12 SPTLC2 SPTSSA TECR TMEM189,lipid biosynthetic process|sphingolipid metabolic process|membrane lipid metabolic process|cellular lipid metabolic process|sphingolipid biosynthetic process,1.578e-14|7.827e-14|4.614e-13|1.248e-12|1.257e-12,2.489e-10|6.174e-10|2.426e-09|4.922e-09|3.967e-09,34.44|98.88|76.28|21.12|138.7
2323,4,0.5755,3.4530000000000003,3240.0,0.001062,0.9929309999999999,HACL1 KPNA5 TMEM79 VPS37D,establishment of protein localization to organelle|protein localization to organelle|phytanic acid metabolic process|intracellular protein transport|cuticle development,4.13e-05|0.0002217|0.0003883|0.0004092|0.0007766,0.6515|1|1|1|1,34.4|19.53|5149|15.87|1716
2324,9,0.5017,18.06,6279.0,0.00286,0.9998530000000001,C11orf53 CKS1B COMMD4 E2F3 IDE POU2F3 SKP2 SOX4 STAM2,G1 phase|mitotic G1 phase|mitotic interphase|interphase|mitotic cell cycle process,1.161e-07|1.161e-07|5.016e-06|5.016e-06|0.0001366,0.001831|0.0009157|0.02638|0.01978|0.4309,326.9|326.9|86.9|86.9|13.36
2325,4,0.5165,3.0989999999999998,3200.0,0.0009652000000000002,0.9929309999999999,C16orf58 C9orf85 GFRA4 HADHB,cardiolipin acyl-chain remodeling|glial cell-derived neurotrophic factor receptor signaling pathway|cardiolipin metabolic process|phosphatidylglycerol metabolic process|negative regulation of ossification,0.001747|0.001941|0.003297|0.006973|0.007552,1|1|1|1|1,643.6|572.1|321.8|147.1|135.5
2326,12,0.5132,33.87,8566.0,0.003927,0.999986,CHCHD1 CNIH4 DUX4 EIF2S1 FOXD4 HAMP NBEAL1 NUTF2 RPL17 SNU13 ST20 TSPYL5,cellular response to radiation|cellular response to abiotic stimulus|cellular response to environmental stimulus|response to radiation|cellular response to ionizing radiation,2.697e-06|2.529e-05|2.529e-05|9.581e-05|0.0007344,0.04255|0.1995|0.133|0.3778|1,38.79|21.79|21.79|15.43|50.48
2327,26,0.5068,164.7,19480.0,0.008362,1.0,CD1C CLK2 CTSK EFNA4 FCRL3 FLG2 GBA HAPLN2 HIST2H2AB HIST2H2BE HRNR ITLN2 LCE3E LCE5A PGLYRP3 S100A12 S100A2 S100A3 S100A4 S100A5 S100A6 S100A7A S100A8 S100A9 SLAMF7 THEM5,regulation of water loss via skin|leukocyte activation|neutrophil aggregation|sequestering of zinc ion|defense response to fungus,5.51e-06|7.1e-06|7.78e-06|1.942e-05|2.035e-05,0.08692|0.056|0.04091|0.07659|0.06421,95.35|7.342|858.1|429.1|59.87
2328,5,0.5127,5.127000000000001,4324.0,0.001182,0.996692,CDRT15 GHSR HAPLN3 LRRC29 WNT5A,regulation of protein localization to synapse|regulation of leukocyte apoptotic process|regulation of interleukin-1 beta production|regulation of postsynapse organization|positive regulation of endothelial cell proliferation,1.909e-05|0.000163|0.000183|0.0001913|0.0002042,0.3011|1|0.9623|0.7546|0.6441,305.1|100.5|94.69|92.56|89.54
2329,19,0.5093,87.08,13720.0,0.006291,1.0,ACCS ACCSL CHRM4 COMMD9 CRY2 EHF ELF5 HARBI1 MRGPRX3 OR4A47 OR4B1 OR4C12 OR4C13 OR4C3 OR4C46 OR4X1 PAMR1 PDHX TP53I11,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,8.785e-08|1.308e-07|1.685e-07|2.716e-07|3.49e-07,0.001386|0.001032|0.0008857|0.001071|0.001101,17.21|16.21|15.61|14.54|14
2330,12,0.5228,34.51,8797.0,0.003897,0.999986,DCTN4 DDX41 GEMIN5 HARS IK LARS RARS RBM22 RPS14 SLU7 SPDL1 TTC1,"RNA metabolic process|gene expression|nucleic acid metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",1.86e-08|2.833e-07|3.392e-07|5.164e-07|5.164e-07,0.0002934|0.002234|0.001784|0.002037|0.001629,9.66|7.066|6.92|28.41|28.41
2331,4,0.5518,3.3110000000000004,3042.0,0.001084,0.9929309999999999,DNM3 FAM129A FCGR2A HBB,nitric oxide transport|receptor-mediated endocytosis|negative regulation of dendritic spine morphogenesis|synaptic vesicle budding from presynaptic endocytic zone membrane|dynamin family protein polymerization involved in mitochondrial fission,0.0007766|0.0008662|0.001359|0.001553|0.001747,1|1|1|1|1,1716|41.52|858.1|735.5|643.6
2332,4,0.5071,3.043,3086.0,0.0009824,0.9929309999999999,CPED1 HBD PRSS53 ZNF471,oxygen transport|gas transport|hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification,0.00291|0.003878|0.005813|0.008131|0.01851,1|1|1|1|1,367.8|271|177.5|125.6|54.2
2333,7,0.5277,11.08,5271.0,0.002093,0.9992989999999999,HBE1 OR51B4 OR51I1 OR52B2 OR52M1 OR52W1 OR56A1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,6.936e-10|9.869e-10|1.235e-09|1.887e-09|2.359e-09,1.094e-05|7.784e-06|6.492e-06|7.443e-06|7.444e-06,40.03|37.72|36.32|33.82|32.57
2334,4,0.5779,3.467,3138.0,0.001101,0.9929309999999999,FAM71B HBEGF LDLRAD3 LRRC75A,"negative regulation of elastin biosynthetic process|regulation of elastin biosynthetic process|wound healing, spreading of epidermal cells|positive regulation of keratinocyte migration|positive regulation of epidermal growth factor-activated receptor activity",0.0003883|0.0003883|0.002134|0.002522|0.002716,1|1|1|1|1,5149|5149|514.9|429.1|396.1
2335,4,0.5321,3.1919999999999997,3121.0,0.001019,0.9929309999999999,FASLG HBG2 OR1J2 TMEM9,endosomal lumen acidification|intracellular pH reduction|pH reduction|endosome organization|regulation of intracellular pH,4.241e-07|3.454e-05|3.884e-05|8.67e-05|0.0001126,0.00669|0.2724|0.2042|0.3419|0.3553,2574|214.5|201.9|133.7|117
2336,5,0.5129,5.129,4416.0,0.001158,0.996692,ATP10B HCN4 TMEM204 TMEM74B ZNF35,membrane depolarization during SA node cell action potential|lysosomal membrane organization|cellular response to cGMP|response to cGMP|SA node cell to atrial cardiac muscle cell signaling,0.001456|0.001456|0.001698|0.00194|0.00194,1|1|1|1|1,823.8|823.8|686.5|588.4|588.4
2337,4,0.5061,3.037,3312.0,0.0009138,0.9929309999999999,CSTF2T HCRT LURAP1L PHYHIP,positive regulation of transmission of nerve impulse|negative regulation of transmission of nerve impulse|pre-mRNA cleavage required for polyadenylation|mRNA cleavage involved in mRNA processing|sleep,0.001359|0.001359|0.002716|0.00291|0.00291,1|1|1|1|1,858.1|858.1|396.1|367.8|367.8
2338,4,0.5109,3.065,3051.0,0.001001,0.9929309999999999,DDX55 HCRTR1 PSME2 RRP12,interleukin-12-mediated signaling pathway|cellular response to interleukin-12|response to interleukin-12|regulation of cellular amino acid metabolic process|S phase,0.009096|0.009482|0.009675|0.01276|0.01276,1|1|1|1|1,111.9|107.3|105.1|79.21|79.21
2339,4,0.5068,3.0410000000000004,3317.0,0.0009137,0.9929309999999999,APOL6 HCST JAK3 TNFSF15,negative regulation of FasL production|regulation of FasL production|negative regulation of dendritic cell cytokine production|negative regulation of T-helper 1 cell differentiation|interleukin-4-mediated signaling pathway,0.0003883|0.0003883|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|5149|2574|1716|1287
2340,5,0.5255,5.255,4003.0,0.001308,0.996692,HDC MMP2 ZFP2 ZNF684 ZNF691,catechol-containing compound biosynthetic process|catecholamine biosynthetic process|phenol-containing compound biosynthetic process|cellular biogenic amine biosynthetic process|amine biosynthetic process,2.279e-05|2.279e-05|6.2e-05|8.064e-05|8.465e-05,0.3594|0.1797|0.326|0.318|0.2671,294.2|294.2|173.1|150.9|147.1
2341,4,0.5371,3.2230000000000003,3220.0,0.0009972000000000002,0.9929309999999999,C12orf29 CD22 CMTM4 HDDC3,negative regulation of B cell receptor signaling pathway|negative regulation of immunoglobulin production|negative regulation of calcium-mediated signaling|regulation of B cell receptor signaling pathway|negative regulation of antigen receptor-mediated signaling pathway,0.001553|0.00291|0.003878|0.00504|0.006007,1|1|1|1|1,735.5|367.8|271|205.9|171.6
2342,4,0.5421,3.252,3283.0,0.0009872,0.9929309999999999,CDC20B HDHD2 LARP6 PLPP1,positive regulation of anaphase-promoting complex-dependent catabolic process|regulation of anaphase-promoting complex-dependent catabolic process|dephosphorylation|positive regulation of mRNA binding|positive regulation of RNA binding,0.0007766|0.0007766|0.001432|0.001553|0.001747,1|1|1|1|1,1716|1716|32.18|735.5|643.6
2343,5,0.7495,7.495,3361.0,0.002218,0.996692,MCPH1 PIAS4 RBM4 RBM4B SRBD1,entrainment of circadian clock by photoperiod|photoperiodism|entrainment of circadian clock|regulation of circadian rhythm|circadian rhythm,2.185e-05|2.795e-05|2.96e-05|0.0003382|0.0004655,0.3447|0.2205|0.1556|1|1,284.1|249.6|242.3|69.23|58.84
2344,4,0.5023,3.014,3047.0,0.0009855,0.9929309999999999,HEATR9 IMPACT RMC1 TNKS1BP1,regulation of protein autophosphorylation|response to benomyl|cellular response to benomyl|cellular response to radiation|GCN2-mediated signaling,3.454e-05|0.0003883|0.0003883|0.0004454|0.0005825,0.5448|1|1|1|1,214.5|5149|5149|58.18|2574
2345,7,0.5245,11.01,5678.0,0.0019309999999999998,0.9992989999999999,C22orf46 CSDC2 HEBP1 PNPLA5 SEPT3 SULT4A1 TTLL12,positive regulation of glutathione biosynthetic process|organic heteropentacyclic compound catabolic process|positive regulation of sulfur metabolic process|mycotoxin catabolic process|toxin catabolic process,0.0007765|0.001164|0.001164|0.001164|0.001164,1|1|1|1|1,2574|1287|1287|1287|1287
2346,4,0.5589,3.353,3253.0,0.001027,0.9929309999999999,ARHGEF26 HECTD3 JUND MEX3D,mRNA localization resulting in posttranscriptional regulation of gene expression|intracellular mRNA localization|endothelial cell morphogenesis|ruffle assembly|osteoblast development,0.0005825|0.001941|0.002716|0.00291|0.003685,1|1|1|1|1,2574|572.1|396.1|367.8|286
2347,4,0.5255,3.153,3241.0,0.0009693999999999999,0.9929309999999999,CORO7 FAM83F HECW1 OR11H6,negative regulation of sodium ion transmembrane transporter activity|negative regulation of sodium ion transmembrane transport|Golgi to endosome transport|negative regulation of sodium ion transport|actin filament polymerization,0.002716|0.00291|0.003491|0.003878|0.00678,1|1|1|1|1,396.1|367.8|302.9|271|151.4
2348,11,0.5011,27.56,9004.0,0.0030440000000000003,0.999969,ARHGEF26 CPB1 GPR171 HEG1 P2RY12 P2RY13 PLSCR2 SCHIP1 SERPINI1 SERPINI2 TM4SF4,G protein-coupled purinergic nucleotide receptor signaling pathway|purinergic nucleotide receptor signaling pathway|endothelial cell morphogenesis|epithelial cell morphogenesis|endothelial cell development,7.664e-08|2.188e-06|2.71e-05|0.000144|0.0003788,0.001209|0.01726|0.1425|0.5678|1,401.2|119.5|288|117|70.65
2349,4,0.5771,3.4619999999999997,3237.0,0.001066,0.9929309999999999,CD63 GCSAM HELB MAP4K1,"regulation of DNA double-strand break processing|cellular response to phorbol 13-acetate 12-myristate|response to phorbol 13-acetate 12-myristate|DNA replication, synthesis of RNA primer|positive regulation of integrin-mediated signaling pathway",0.0005825|0.001165|0.001165|0.001359|0.001553,1|1|1|1|1,2574|1030|1030|858.1|735.5
2350,4,0.5628,3.377,3237.0,0.0010400000000000001,0.9929309999999999,CFAP206 DCUN1D2 HERC6 TREML2,positive regulation of protein neddylation|regulation of protein neddylation|protein neddylation|regulation of cilium beat frequency|regulation of flagellated sperm motility,0.001165|0.002328|0.002716|0.00291|0.004072,1|1|1|1|1,1030|468.1|396.1|367.8|257.4
2351,7,0.5038,10.58,4710.0,0.002235,0.9992989999999999,BCAS2 CTNNBL1 HEXIM1 LARP7 MEPCE PNISR PPP1R8,positive regulation of snRNA transcription by RNA polymerase II|regulation of snRNA transcription by RNA polymerase II|snRNA modification|RNA splicing|positive regulation of protein localization to Cajal body,1.483e-06|2.076e-06|3.558e-06|5.21e-06|7.705e-06,0.0234|0.01638|0.01871|0.02054|0.02431,1471|1177|840.6|28.92|534.9
2352,14,0.5154,46.91,11740.0,0.0039689999999999994,0.9999969999999999,C8orf44 CA1 CA2 CA8 CNGB3 CPA6 FABP12 HEY1 MCMDC2 PMP2 SGK3 TMEM69 TRIM55 UBE2W,one-carbon metabolic process|bicarbonate transport|positive regulation of dipeptide transport|positive regulation of oligopeptide transport|positive regulation of dipeptide transmembrane transport,2.82e-06|0.0003988|0.002037|0.002037|0.002037,0.04449|1|1|1|1,113.2|70.05|735.5|735.5|735.5
2353,4,0.5014,3.008,2949.0,0.001016,0.9929309999999999,EHF HFM1 RBP7 USP17L13,resolution of meiotic recombination intermediates|meiotic chromosome separation|chromosome separation|reciprocal meiotic recombination|reciprocal homologous recombination,0.003685|0.004266|0.00562|0.01102|0.01102,1|1|1|1|1,286|245.2|183.9|91.94|91.94
2354,4,0.5689,3.4130000000000003,3425.0,0.0009932,0.9929309999999999,CYB561 HGFAC TCERG1L TNFRSF13C,B cell costimulation|positive regulation of B cell proliferation|zymogen activation|T cell costimulation|lymphocyte costimulation,0.0009706|0.008131|0.009289|0.01045|0.01083,1|1|1|1|1,1287|125.6|109.5|97.15|93.61
2355,4,0.5054,3.032,3114.0,0.0009704000000000001,0.9929309999999999,HGH1 JPT2 RHEBL1 SLC30A3,zinc ion import into synaptic vesicle|zinc ion import into organelle|regulation of sequestering of zinc ion|zinc ion transmembrane transport|zinc ion transport,0.0005825|0.0005825|0.001165|0.004846|0.00562,1|1|1|1|1,2574|2574|1030|214.5|183.9
2356,6,0.5001,7.501,4929.0,0.001516,0.998474,FAM198A GORASP2 HHATL SCN10A WNT3 XCR1,negative regulation of N-terminal protein palmitoylation|regulation of N-terminal protein palmitoylation|Spemann organizer formation at the anterior end of the primitive streak|canonical Wnt signaling pathway involved in stem cell proliferation|negative regulation of protein lipidation,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
2357,7,0.5292,11.11,5292.0,0.00209,0.9992989999999999,CFHR1 CHIT1 RGS13 RGS18 RGS2 RGS21 TROVE2,regulation of G protein-coupled receptor signaling pathway|negative regulation of G protein-coupled receptor signaling pathway|negative regulation of signal transduction|G protein-coupled receptor signaling pathway|negative regulation of cell communication,7.299e-06|8.606e-05|0.0002011|0.0002355|0.0002673,0.1151|0.6788|1|0.9288|0.8432,70.53|143|10.76|10.33|10
2358,4,0.5618,3.3710000000000004,3096.0,0.001085,0.9929309999999999,ARRDC4 HHLA2 PLEK SLC46A3,regulation of cell diameter|phospholipase C-inhibiting G protein-coupled receptor signaling pathway|positive regulation of inositol-polyphosphate 5-phosphatase activity|regulation of inositol-polyphosphate 5-phosphatase activity|negative regulation of inositol phosphate biosynthetic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2359,5,0.5106,5.106,4188.0,0.001215,0.996692,ASCL2 HHLA3 LSR NUCKS1 PIP5K1C,cell-cell junction assembly|modulation by host of viral RNA-binding transcription factor activity|modulation by host of RNA binding by virus|tricellular tight junction assembly|spongiotrophoblast layer development,0.0003843|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,64.87|4119|4119|4119|4119
2360,7,0.5722,12.02,5351.0,0.002235,0.9992989999999999,JAG2 LRP10 PREP RBM47 SUSD6 TMEM127 WWP2,odontogenesis of dentin-containing tooth|epithelial cell apoptotic process involved in palatal shelf morphogenesis|regulation of Notch signaling pathway|odontogenesis|positive regulation of presynaptic membrane organization,0.0005667|0.0008734|0.0009567|0.001179|0.00131,1|1|1|1|1,56.5|2288|43.18|38.79|1144
2361,5,0.5325,5.325,3894.0,0.001362,0.996692,DISP2 HIC1 OR1A1 OR1G1 SERPINF2,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure|maintenance of blood vessel diameter homeostasis by renin-angiotensin|negative regulation of plasminogen activation|negative regulation of fibrinolysis|positive regulation of cell-cell adhesion mediated by cadherin,0.0009706|0.0009706|0.001698|0.002667|0.00291,1|1|1|1|1,1373|1373|686.5|411.9|374.5
2362,4,0.5164,3.0980000000000003,3071.0,0.001005,0.9929309999999999,ANKRD13B ARL3 FBXL2 HILPDA,modulation by host of viral RNA genome replication|autocrine signaling|protein localization to ciliary membrane|negative regulation of receptor internalization|modulation by host of viral genome replication,0.0009706|0.001747|0.002134|0.002716|0.003685,1|1|1|1|1,1287|643.6|514.9|396.1|286
2363,4,0.5274,3.1639999999999997,3157.0,0.0009987,0.9929309999999999,HINT3 MRPL52 MRRF SMIM14,mitochondrial translational termination|translational termination|mitochondrial translation|cellular protein complex disassembly|mitochondrial gene expression,0.0001151|0.0001363|0.0001777|0.0002727|0.0002806,1|1|0.9343|1|0.8851,115.7|106.2|92.77|74.62|73.55
2364,4,0.5273,3.1639999999999997,3316.0,0.0009509000000000001,0.9929309999999999,ART3 ATF1 HIP1R TPH2,positive regulation of clathrin coat assembly|regulation of clathrin coat assembly|positive regulation of platelet-derived growth factor receptor-beta signaling pathway|serotonin biosynthetic process|peptidyl-arginine ADP-ribosylation,0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
2365,4,0.5724,3.4339999999999997,3210.0,0.001066,0.9929309999999999,HIPK3 MASP2 STAC3 YPEL2,"complement activation, lectin pathway|positive regulation of voltage-gated calcium channel activity|negative regulation of JUN kinase activity|mRNA transcription|neuromuscular synaptic transmission",0.002134|0.002522|0.00291|0.003491|0.004653,1|1|1|1|1,514.9|429.1|367.8|302.9|223.9
2366,5,0.5155,5.155,3703.0,0.0013859999999999999,0.996692,GSTA3 HIST1H2AH LY6G6F OR5B2 TRIM10,glutathione derivative biosynthetic process|glutathione derivative metabolic process|negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell,0.004459|0.004459|0.004459|0.005233|0.008517,1|1|1|1|1,234|234|234|198|119.7
2367,5,0.5034,5.034,3901.0,0.001285,0.996692,ATP13A2 HIST1H4H HLA-DMB OR7G2 PSORS1C2,peptidyl-aspartic acid autophosphorylation|polyamine transmembrane transport|peptidyl-aspartic acid phosphorylation|regulation of autophagosome size|spermine transmembrane transport,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2368,4,0.5506,3.304,3215.0,0.001024,0.9929309999999999,CDC42EP5 CDH19 HIVEP2 SOAT2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,4.441e-05|9.445e-05|0.0003843|0.0006583|0.0008136,0.7005|0.7449|1|1|1,196.1|132.9|64.87|49.33|44.29
2369,4,0.5563,3.338,3279.0,0.0010140000000000001,0.9929309999999999,GPR25 HIVEP3 PTX3 ZNF648,positive regulation of cell proliferation in midbrain|negative regulation of exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|modulation by host of viral glycoprotein metabolic process|negative regulation by host of viral exo-alpha-sialidase activity,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
2370,15,0.507,53.24,11100.0,0.00476,0.999999,BTN2A2 HIST1H1C HIST1H1E HIST1H1T HIST1H2AC HIST1H2AD HIST1H2BD HLA-F OR14J1 OR2B6 OR2J3 PSORS1C2 TRIM10 TRIM26 ZKSCAN4,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway,4.658e-05|6.374e-05|0.0001663|0.0002224|0.0004507,0.7347|0.5027|0.8743|0.8769|1,208|176|106.4|91.53|63.56
2371,9,0.5038,18.14,6888.0,0.0026190000000000002,0.9998530000000001,C2 C6orf48 HLA-DMB HLA-DQB2 HLA-E LY6G6F MSH5 NUDT3 STK19,antigen processing and presentation of exogenous peptide antigen|antigen processing and presentation of exogenous antigen|antigen processing and presentation of peptide antigen|adaptive immune response|positive regulation of T cell activation,3.615e-05|4.113e-05|4.584e-05|6.322e-05|6.465e-05,0.5703|0.3244|0.241|0.2493|0.204,43.39|41.52|40.02|15.87|35.59
2372,9,0.5037,18.13,6135.0,0.002938,0.9998530000000001,AQP7 DCTN3 EXOSC3 NOL6 RCL1 SMU1 TLN1 UBAP1 VCP,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|cleavage involved in rRNA processing|maturation of 5.8S rRNA|rRNA processing|rRNA metabolic process",5.482e-05|6.844e-05|0.0001121|0.0001632|0.0001822,0.8648|0.5398|0.5893|0.6435|0.5747,190.7|169.5|130.8|26.4|25.43
2373,4,0.5757,3.4539999999999997,3365.0,0.001023,0.9929309999999999,HMBOX1 KCNG1 NMRK2 SLC6A4,"positive regulation of serotonin secretion|negative regulation of synaptic transmission, dopaminergic|regulation of thalamus size|negative regulation of cerebellar granule cell precursor proliferation|sperm ejaculation",0.0003883|0.0003883|0.0003883|0.0005825|0.001165,1|1|1|1|1,5149|5149|5149|2574|1030
2374,4,0.5368,3.221,3109.0,0.001032,0.9929309999999999,CEBPG HMX2 HMX3 HNRNPA0,regulation of RNA metabolic process|inner ear morphogenesis|regulation of nucleobase-containing compound metabolic process|ear morphogenesis|regulation of gene expression,0.0001976|0.0002311|0.0002796|0.0003272|0.0007426,1|1|1|1|1,5.51|84.06|5.14|70.41|4.227
2375,4,0.5538,3.323,3341.0,0.0009912,0.9929309999999999,EBF2 HNMT MESP2 NEIL1,imidazole-containing compound catabolic process|histamine catabolic process|imidazole-containing compound metabolic process|histamine metabolic process|negative regulation of nuclease activity,0.0003883|0.0003883|0.001359|0.001359|0.001553,1|1|1|1|1,5149|5149|858.1|858.1|735.5
2376,4,0.5308,3.185,3066.0,0.001035,0.9929309999999999,HNRNPA1 HNRNPA3 MAN1A1 SBF1,Golgi apparatus mannose trimming|protein deglycosylation involved in glycoprotein catabolic process|cellular response to sodium arsenite|mannose trimming involved in glycoprotein ERAD pathway|ubiquitin-dependent glycoprotein ERAD pathway,0.0007766|0.001165|0.001165|0.001165|0.001165,1|1|1|1|1,1716|1030|1030|1030|1030
2377,4,0.5234,3.141,3117.0,0.001004,0.9929309999999999,CLIP1 HNRNPA1L2 PHOSPHO2 PHYKPL,lysine catabolic process|lysine metabolic process|aspartate family amino acid catabolic process|positive regulation of microtubule polymerization|positive regulation of microtubule polymerization or depolymerization,0.002522|0.002716|0.004653|0.0062|0.006973,1|1|1|1|1,429.1|396.1|223.9|166.1|147.1
2378,5,0.5568,5.568,3384.0,0.001638,0.996692,HNRNPAB HNRNPD HNRNPUL1 KHSRP RBM5,"RNA splicing, via transesterification reactions|RNA splicing|mRNA processing|mRNA metabolic process|3'-UTR-mediated mRNA destabilization",2.454e-07|7.686e-07|1.527e-06|6.36e-06|8.939e-06,0.00387|0.006062|0.008027|0.02508|0.0282,54.02|40.48|34.04|23.74|457.7
2379,6,0.512,7.68,4406.0,0.0017350000000000002,0.998474,C2orf69 GLUL HNRNPH3 QARS SLC1A5 SREK1,cellular amino acid metabolic process|tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|L-glutamine import across plasma membrane,8.527e-05|0.0001108|0.0001252|0.0001302|0.0006794,1|0.8739|0.6582|0.5133|1,31.64|127.9|120.1|117.7|2942
2380,6,0.5014,7.521,3923.0,0.001907,0.998474,KRAS MAP2K5 MAP3K2 MAPK7 RAF1 SYNCRIP,MAPK cascade|negative regulation of extrinsic apoptotic signaling pathway|cellular response to laminar fluid shear stress|regulation of protein metabolic process|negative regulation of heterotypic cell-cell adhesion,1.889e-08|2.77e-06|3.178e-06|4.03e-06|4.66e-06,0.0002979|0.02185|0.01671|0.01589|0.0147,41.96|98.07|858.1|7.936|686.5
2381,4,0.5553,3.332,3137.0,0.001058,0.9929309999999999,DGKD HOMER2 KLHL30 USP40,second-messenger-mediated signaling|negative regulation of protein kinase C signaling|positive regulation of clathrin-dependent endocytosis|regulation of store-operated calcium entry|chemical homeostasis within a tissue,0.0006717|0.0009706|0.001165|0.002716|0.00291,1|1|1|1|1,47.24|1287|1030|396.1|367.8
2382,4,0.5435,3.261,3201.0,0.001015,0.9929309999999999,HOXA2 PLAC8L1 PPIB TGM7,rhombomere 3 morphogenesis|rhombomere morphogenesis|rhombomere 2 development|rhombomere 3 development|brain segmentation,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
2383,4,0.5075,3.045,2969.0,0.0010220000000000001,0.9929309999999999,CTDSP2 HOXA3 LGR5 PMPCA,specification of animal organ position|glossopharyngeal nerve morphogenesis|epithelial cell proliferation involved in renal tubule morphogenesis|glossopharyngeal nerve development|protein processing involved in protein targeting to mitochondrion,0.0007766|0.0009706|0.0009706|0.001165|0.001165,1|1|1|1|1,1716|1287|1287|1030|1030
2384,4,0.5179,3.1069999999999998,2961.0,0.001045,0.9929309999999999,DALRD3 HIST1H2AE HOXB2 PITRM1,rhombomere 4 development|rhombomere 3 development|arginyl-tRNA aminoacylation|rhombomere development|facial nerve structural organization,0.0004369|0.0005825|0.0005825|0.001165|0.00131,1|1|1|1|1,3432|2288|2288|980.7|858.1
2385,5,0.543,5.43,4232.0,0.0012779999999999998,0.996692,CREM HOXC9 LASP1 LRRC23 PAAF1,retinoic acid receptor signaling pathway|proximal/distal pattern formation|embryonic skeletal system morphogenesis|glucose metabolic process|regulation of circadian rhythm,0.004845|0.008708|0.02285|0.02784|0.02879,1|1|1|1|1,216.8|117.7|43.82|35.82|34.61
2386,6,0.5351,8.027000000000001,3944.0,0.002025,0.998474,MON2 OSBPL11 OSBPL9 PTDSS1 VKORC1L1 VPS54,sterol transport|post-Golgi vesicle-mediated transport|cytosolic transport|organic hydroxy compound transport|protein carboxylation,0.0002102|0.0006378|0.000775|0.0008061|0.001165,1|1|1|1|1,90.33|51.23|46.39|45.46|1144
2387,5,0.5092,5.092,3978.0,0.001275,0.996692,EMID1 GUCD1 HOXD3 PXK RAB28,glossopharyngeal nerve morphogenesis|glossopharyngeal nerve development|negative regulation of ATPase activity|thyroid gland development|cranial nerve morphogenesis,0.001213|0.001456|0.004604|0.006054|0.007261,1|1|1|1|1,1030|823.8|228.8|171.6|142
2388,4,0.5458,3.275,3294.0,0.0009908,0.9929309999999999,GAD1 HOXD3 HOXD4 ZNF541,embryonic skeletal system morphogenesis|embryonic skeletal system development|glutamate decarboxylation to succinate|protein-pyridoxal-5-phosphate linkage|anterior/posterior pattern specification,0.0001282|0.000214|0.0005825|0.0005825|0.0006065,1|1|1|1|1,109.5|84.41|2574|2574|49.75
2389,5,0.5339,5.3389999999999995,4294.0,0.001239,0.996692,HPCA HPCAL1 LST1 NCR3 SPOCK2,response to ketamine|response to Aroclor 1254|cellular response to monosodium glutamate|response to monosodium glutamate|negative regulation of guanylate cyclase activity,0.0005824|0.0005824|0.0005824|0.0008735|0.001165,1|1|1|1|1,3432|3432|3432|1716|1144
2390,4,0.525,3.15,3200.0,0.0009811,0.9929309999999999,CEP290 FAM43A HPR LRRC28,pronephros development|otic vesicle formation|otic vesicle morphogenesis|otic vesicle development|eye photoreceptor cell development,0.001747|0.001747|0.001941|0.00291|0.00678,1|1|1|1|1,643.6|643.6|572.1|367.8|151.4
2391,5,0.5145,5.145,4044.0,0.001267,0.996692,ACTA1 C1orf198 FAM78A FBXO28 HPSE2,skeletal muscle fiber adaptation|mesenchyme migration|skeletal muscle thin filament assembly|skeletal myofibril assembly|skeletal muscle adaptation,0.001213|0.001456|0.001698|0.002183|0.003394,1|1|1|1|1,1030|823.8|686.5|514.9|316.8
2392,11,0.5025,27.64,8086.0,0.003397,0.999969,FOLR1 FOLR2 GJD4 KRTAP5-1 KRTAP5-10 KRTAP5-11 KRTAP5-3 KRTAP5-9 P2RY6 TRIM49D1 UCP3,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,8.416e-10|2.287e-09|6.013e-09|1.858e-08|3.059e-08,1.328e-05|1.804e-05|3.161e-05|7.326e-05|9.651e-05,49.71|41.92|35.55|29.33|26.94
2393,4,0.5362,3.217,3251.0,0.0009861000000000002,0.9929309999999999,CLPTM1L CTRL HRH2 MINDY3,gastric acid secretion|acid secretion|positive regulation of vasoconstriction|protein K48-linked deubiquitination|G protein-coupled serotonin receptor signaling pathway,0.001747|0.004266|0.0062|0.006586|0.00678,1|1|1|1|1,643.6|245.2|166.1|156|151.4
2394,4,0.5792,3.475,3427.0,0.001011,0.9929309999999999,ACSBG1 HRH3 SCGB3A1 TPRX1,negative regulation of serotonin secretion|negative regulation of glutamate secretion|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway|regulation of serotonin secretion|negative regulation of amino acid transport,0.001165|0.001165|0.001747|0.001747|0.002716,1|1|1|1|1,1030|1030|643.6|643.6|396.1
2395,4,0.5508,3.305,2899.0,0.0011359999999999999,0.9929309999999999,EIF4B EIF4E EIF4G1 HRK,translational initiation|behavioral fear response|behavioral defense response|cytoplasmic translational initiation|fear response,1.388e-06|1.146e-05|1.228e-05|1.4e-05|1.49e-05,0.02189|0.0904|0.06457|0.05521|0.04702,108|381.4|367.8|343.2|332.2
2396,7,0.5068,10.64,5859.0,0.001809,0.9992989999999999,CCDC121 FNDC4 HS1BP3 IFT172 LBH NDUFAF2 PEBP1,positive regulation of mammary stem cell proliferation|regulation of mammary stem cell proliferation|positive regulation of somatic stem cell division|regulation of somatic stem cell division|positive regulation of somatic stem cell population maintenance,0.0006794|0.0006794|0.0006794|0.0006794|0.001019,1|1|1|1|1,2942|2942|2942|2942|1471
2397,12,0.5004,33.03,8012.0,0.004093,0.999986,C1orf109 CIAO1 CIAO2B FXN HSCB LONP1 LYRM4 NFS1 SOD1 TIMM10 TIMM9 WDR18,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|protein maturation by iron-sulfur cluster transfer|iron incorporation into metallo-sulfur cluster,4.106e-15|4.106e-15|4.663e-10|1.225e-07|1.864e-06,6.477e-11|3.239e-11|2.452e-06|0.0004831|0.00588,447.7|447.7|32.56|343.2|1716
2398,4,0.5105,3.063,3034.0,0.001006,0.9929309999999999,ABHD14A GJA5 HSD11B1L SIRPB2,regulation of Purkinje myocyte action potential|vasomotion|Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling|bundle of His cell to Purkinje myocyte communication by electrical coupling|atrial cardiac muscle cell to AV node cell communication by electrical coupling,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2399,4,0.553,3.318,3171.0,0.001042,0.9929309999999999,DGCR2 HSD17B13 MGAT4B NEO1,N-glycan processing|lipid droplet organization|positive regulation of BMP signaling pathway|viral protein processing|cell adhesion,0.003878|0.005426|0.007552|0.007745|0.01205,1|1|1|1|1,271|190.7|135.5|132|10.83
2400,4,0.5517,3.31,3310.0,0.0009965,0.9929309999999999,CNGB1 HSD17B14 MXRA8 WDR88,establishment of glial blood-brain barrier|establishment of blood-brain barrier|rhodopsin mediated signaling pathway|estrogen biosynthetic process|photoreceptor cell outer segment organization,0.0005825|0.002134|0.002522|0.002716|0.002716,1|1|1|1|1,2574|514.9|429.1|396.1|396.1
2401,4,0.5751,3.451,3293.0,0.001044,0.9929309999999999,DMRT1 GPIHBP1 HSD17B2 TNIK,positive regulation of chylomicron remnant clearance|regulation of chylomicron remnant clearance|male germ cell proliferation|germ cell proliferation|positive regulation of meiosis I,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
2402,12,0.5128,33.85,10050.0,0.003348,0.999986,AK8 CERCAM DBH DPP7 ENTPD2 ENTR1 HSD17B3 LCN10 LCN6 LCN8 SARDH USP20,amine catabolic process|cellular biogenic amine catabolic process|nucleoside diphosphate metabolic process|sarcosine catabolic process|small molecule metabolic process,0.0001726|0.0001726|0.001106|0.001164|0.001511,1|1|1|1|1,107.3|107.3|40.86|1716|5.287
2403,4,0.5391,3.235,3146.0,0.001025,0.9929309999999999,CYP1B1 DGKQ HSPA1A HSPA1B,heat acclimation|positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway|cellular heat acclimation|positive regulation of microtubule nucleation|positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,5.937e-07|5.937e-07|5.937e-07|7.916e-07|7.916e-07,0.009365|0.004683|0.003122|0.003122|0.002497,2060|2060|2060|1716|1716
2404,16,0.5004,60.05,10890.0,0.00547,0.999999,DUX4 HSPA5 HSPE1 RPL11 RPL12 RPL13 RPL17 RPL18A RPL23 RPL35 RPL37 RPL4 RPL9 RPLP0 RPLP2 RPS13,protein targeting to ER|establishment of protein localization to endoplasmic reticulum|protein localization to endoplasmic reticulum|SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane,5.103e-30|8.124e-30|1.321e-28|6.669e-28|1.235e-27,8.05e-26|6.408e-26|6.945e-25|2.63e-24|3.897e-24,162.3|156.7|126.9|174.3|165.7
2405,21,0.4994,104.9,14440.0,0.007188,1.0,RPL11 RPL13A RPL14 RPL15 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL31 RPL37 RPL4 RPL6 RPL7 RPL9 RPLP0 RPLP2 RPS15A RPS6,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,1.02e-48|2.669e-48|1.616e-47|3.187e-47|3.764e-47,1.609e-44|2.105e-44|8.497e-44|1.257e-43|1.187e-43,214.5|203.9|185.5|179.1|177.5
2406,9,0.5063,18.23,6800.0,0.002666,0.9998530000000001,CRYAB HSPB2 HTR3A NXPE1 NXPE2 NXPE4 OR4D5 RAB39A TMEM136,tubulin complex assembly|phagosome-lysosome fusion|negative regulation of amyloid fibril formation|Rab protein signal transduction|phagolysosome assembly,0.00436|0.005231|0.005665|0.006534|0.006969,1|1|1|1|1,254.3|208|190.7|163.5|152.6
2407,6,0.5454,8.181000000000001,5116.0,0.001593,0.998474,CELF6 HSPB7 LINGO1 PAX7 SEMA7A SKOR1,negative regulation of axonogenesis|negative regulation of neuron projection development|negative regulation of neurogenesis|negative regulation of nervous system development|regulation of axonogenesis,0.0001692|0.0006471|0.0006661|0.0007146|0.000881,1|1|1|1|1,101|50.85|50.11|48.35|43.45
2408,4,0.5335,3.201,3176.0,0.001004,0.9929309999999999,HSPBP1 SMCO3 TSNAX UBL5,production of siRNA involved in RNA interference|RNA interference|positive regulation of protein targeting to mitochondrion|production of small RNA involved in gene silencing by RNA|dsRNA processing,0.002134|0.00291|0.006393|0.00678|0.00678,1|1|1|1|1,514.9|367.8|160.9|151.4|151.4
2409,6,0.5566,8.347999999999999,3946.0,0.002105,0.998474,DYNLRB1 HSPD1 HSPE1 NDE1 NEDD1 PAFAH1B1,cilium assembly|ciliary basal body-plasma membrane docking|cilium organization|plasma membrane bounded cell projection assembly|cell projection assembly,1.695e-06|2.066e-06|2.161e-06|3.968e-06|4.529e-06,0.02674|0.0163|0.01136|0.01565|0.01429,36.32|108.4|34.15|29.28|28.31
2410,4,0.5143,3.0860000000000003,3144.0,0.0009781,0.9929309999999999,HTN1 KLHDC1 LIPM MYO18B,cardiac muscle fiber development|tissue development|defense response to fungus|muscle fiber development|cardiac muscle cell development,0.001747|0.002236|0.008517|0.009096|0.01045,1|1|1|1|1,643.6|8.918|119.7|111.9|97.15
2411,15,0.5013,52.64,10680.0,0.00489,0.999999,CCDC137 DDX31 DNAJC21 EBNA1BP2 GNL1 GPATCH4 ODR4 PINX1 RBM34 RPF1 UFL1 UFM1 UFSP2 WDR89 ZNF622,regulation of intracellular estrogen receptor signaling pathway|protein K69-linked ufmylation|protein polyufmylation|protein ufmylation|ribosomal large subunit biogenesis,5.709e-06|1.184e-05|1.184e-05|1.578e-05|2.505e-05,0.09005|0.09336|0.06224|0.06221|0.07902,89.8|514.9|514.9|429.1|53.63
2412,4,0.5141,3.085,3066.0,0.001003,0.9929309999999999,CA1 HTR2B LRRCC1 OR6F1,phospholipase C-activating serotonin receptor signaling pathway|positive regulation of phosphatidylinositol biosynthetic process|intestine smooth muscle contraction|cellular response to temperature stimulus|regulation of phosphatidylinositol biosynthetic process,0.0007766|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,1716|1716|1287|1030|1030
2413,5,0.5326,5.3260000000000005,4113.0,0.0012900000000000001,0.996692,FADS3 FAM81B HTRA1 IL17B MAP4K2,chorionic trophoblast cell differentiation|chorion development|dentinogenesis|extraembryonic membrane development|activation of MAPKKK activity,0.001213|0.001456|0.001698|0.00194|0.003394,1|1|1|1|1,1030|823.8|686.5|588.4|316.8
2414,4,0.5355,3.213,3335.0,0.0009603,0.9929309999999999,CAPSL HTRA3 MPZL3 SNRNP70,negative regulation of chaperone-mediated autophagy|negative regulation of protein refolding|regulation of protein refolding|negative regulation of protein folding|regulation of chaperone-mediated autophagy,0.0007766|0.0009706|0.0009706|0.001359|0.001747,1|1|1|1|1,1716|1287|1287|858.1|643.6
2415,4,0.5798,3.4789999999999996,2977.0,0.001164,0.9929309999999999,AZIN1 HYAL2 OAZ1 RFX6,positive regulation of anion transport|regulation of polyamine transmembrane transport|positive regulation of ion transport|regulation of anion transport|polyamine biosynthetic process,3.599e-07|5.937e-07|1.424e-06|3.075e-06|3.391e-06,0.005677|0.004683|0.007486|0.01212|0.0107,41.03|2060|29.05|23.95|735.5
2416,6,0.5437,8.156,4238.0,0.0019149999999999998,0.998474,GEMIN4 GEMIN6 GEMIN7 HYPK SNUPN TGS1,"spliceosomal snRNP assembly|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",2.105e-13|4.298e-10|5.135e-10|4.218e-09|4.218e-09,3.32e-09|3.39e-06|2.7e-06|1.663e-05|1.331e-05,440.1|90.33|87.12|56.83|56.83
2417,7,0.5155,10.83,4522.0,0.002381,0.9992989999999999,HSPD1 HSPE1 IARS2 LETM1 LONP1 TAMM41 TRIAP1,chaperone-mediated protein complex assembly|regulation of cysteine-type endopeptidase activity involved in apoptotic process|regulation of cysteine-type endopeptidase activity|'de novo' protein folding|regulation of endopeptidase activity,2.495e-05|3.804e-05|5.279e-05|9.729e-05|0.0002908,0.3936|0.3|0.2776|0.3837|0.9175,280.2|41.63|37.24|136.8|20.82
2418,4,0.5141,3.0839999999999996,3118.0,0.0009857000000000002,0.9929309999999999,COL27A1 ICAM2 OR1A2 ZNF560,growth plate cartilage chondrocyte development|chondrocyte development involved in endochondral bone morphogenesis|growth plate cartilage chondrocyte differentiation|extracellular matrix organization|extracellular structure organization,0.001165|0.001747|0.001941|0.002029|0.002039,1|1|1|1|1,1030|643.6|572.1|26.96|26.89
2419,10,0.5103,22.96,5668.0,0.00402,0.999933,GRB2 KRAS MAPK1 NF1 NRAS PTPN11 RAF1 RCE1 SHOC2 SOS1,MAPK cascade|Ras protein signal transduction|neurotrophin TRK receptor signaling pathway|intracellular signal transduction|small GTPase mediated signal transduction,5.249e-15|8.917e-11|2.958e-10|8.55e-10|9.204e-10,8.28e-11|7.033e-07|1.555e-06|3.372e-06|2.904e-06,45.32|70.21|411.9|11.77|47.16
2420,12,0.5001,33.01,8165.0,0.004014,0.999986,ID2 IKZF3 IPO5 IRF4 NFKB1 POU2AF1 PRDM1 RC3H1 RELB SMAD7 TCF12 TCF3,regulation of transcription by RNA polymerase II|regulation of RNA metabolic process|regulation of cellular macromolecule biosynthetic process|regulation of macromolecule biosynthetic process|regulation of nucleobase-containing compound metabolic process,7.633e-09|1.406e-08|2.41e-08|2.644e-08|3.186e-08,0.0001204|0.0001109|0.0001267|0.0001043|0.0001005,6.739|5.086|4.858|4.82|4.744
2421,4,0.5086,3.051,3218.0,0.0009449,0.9929309999999999,ABHD14B IER3 SLC19A3 SSMEM1,thiamine transmembrane transport|thiamine transport|thiamine-containing compound metabolic process|sulfur compound metabolic process|azole transmembrane transport,0.0007766|0.0009706|0.001553|0.001895|0.002522,1|1|1|1|1,1716|1287|735.5|27.91|429.1
2422,4,0.5003,3.002,3060.0,0.0009773,0.9929309999999999,IER5L LEFTY2 TCHH TMEM18,intermediate filament organization|positive regulation of pathway-restricted SMAD protein phosphorylation|intermediate filament cytoskeleton organization|intermediate filament-based process|SMAD protein signal transduction,0.004846|0.009482|0.01006|0.01025|0.01218,1|1|1|1|1,214.5|107.3|101|99.01|83.04
2423,4,0.5292,3.175,3138.0,0.001008,0.9929309999999999,IFFO1 NCKAP5L NPAS2 PFKP,DNA double-strand break attachment to nuclear envelope|protein localization to site of double-strand break|positive regulation of behavioral fear response|chromosome attachment to the nuclear envelope|positive regulation of fear response,0.0005825|0.001165|0.001553|0.001553|0.001553,1|1|1|1|1,2574|1030|735.5|735.5|735.5
2424,5,0.5302,5.3020000000000005,4121.0,0.001282,0.996692,ANKRD55 FAM198A IFI27 SCN10A VIPR1,bundle of His cell action potential|bundle of His cell to Purkinje myocyte signaling|regulation of atrial cardiac muscle cell membrane depolarization|AV node cell to bundle of His cell signaling|AV node cell action potential,0.001165|0.001165|0.001553|0.001553|0.001553,1|1|1|1|1,1030|1030|735.5|735.5|735.5
2425,4,0.5889,3.534,3242.0,0.001086,0.9929309999999999,AKR7A3 IFI35 LAPTM5 UQCR10,positive regulation of NIK/NF-kappaB signaling|regulation of NIK/NF-kappaB signaling|induction of programmed cell death|electron transport chain|organic heteropentacyclic compound catabolic process,6.606e-05|0.0001391|0.0003883|0.0004114|0.0005825,1|1|1|1|1,153.7|105.1|5149|60.57|2574
2426,4,0.5307,3.1839999999999997,3137.0,0.001011,0.9929309999999999,GSTK1 IFITM1 PKIB UBD,response to interferon-gamma|aggresome assembly|inclusion body assembly|negative regulation of cAMP-dependent protein kinase activity|positive regulation of telomere capping,0.0004655|0.001359|0.001553|0.001941|0.003491,1|1|1|1|1,56.89|858.1|735.5|572.1|302.9
2427,4,0.5819,3.491,3180.0,0.001094,0.9929309999999999,CLDN19 CSN1S1 GABRA4 IFITM10,response to 11-deoxycorticosterone|response to dehydroepiandrosterone|regulation of transepithelial transport|neuronal action potential propagation|action potential propagation,0.0003883|0.0003883|0.0009706|0.001359|0.001359,1|1|1|1|1,5149|5149|1287|858.1|858.1
2428,5,0.5371,5.371,3779.0,0.001415,0.996692,IFITM5 NR5A2 SOX17 VGLL2 WT1,cardiac cell fate commitment|tissue development|animal organ morphogenesis|embryo development|positive regulation of transcription by RNA polymerase II,3.672e-06|4.24e-06|2.156e-05|2.4e-05|5.646e-05,0.05793|0.03344|0.1134|0.09466|0.1781,748.9|11.89|17.43|16.97|13.66
2429,4,0.5678,3.407,3061.0,0.001109,0.9929309999999999,CD63 HELB IFNG RESP18,"regulation of carbohydrate phosphatase activity|positive regulation of fructose 1,6-bisphosphate metabolic process|regulation of fructose 1,6-bisphosphate metabolic process|positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity|regulation of fructose 1,6-bisphosphate 1-phosphatase activity",0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2430,4,0.5135,3.0810000000000004,3094.0,0.0009924,0.9929309999999999,C11orf40 HIST1H2BA IFNLR1 SIGLEC11,response to type III interferon|mucosal immune response|organ or tissue specific immune response|regulation of defense response to virus by host|regulation of defense response to virus,0.0004369|0.004654|0.005234|0.00654|0.01045,1|1|1|1|1,3432|221.5|196.1|156|96.69
2431,4,0.5912,3.5469999999999997,3093.0,0.001143,0.9929309999999999,IFT43 PXMP4 ROBO3 TGM2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine|isopeptide cross-linking|peptidyl-glutamine modification|chemoattraction of axon|axon midline choice point recognition,0.0005825|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1716|1287|1287|1030
2432,4,0.5375,3.225,3148.0,0.001021,0.9929309999999999,IFT74 OTOP3 RRN3 SLC9A3R1,renal phosphate ion absorption|microtubule-based transport|epithelial cell development|negative regulation of sodium:proton antiporter activity|gamma-aminobutyric acid import,0.0003883|0.0005176|0.0005283|0.0005825|0.0009706,1|1|1|1|1,5149|53.91|53.35|2574|1287
2433,4,0.5865,3.5189999999999997,3348.0,0.001047,0.9929309999999999,IGDCC3 ST6GAL2 TENM3 TUBA3D,regulation of homophilic cell adhesion|sialylation|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|neuromuscular process controlling balance|oligosaccharide metabolic process,0.0007766|0.004072|0.009482|0.009867|0.01256,1|1|1|1|1,1716|257.4|107.3|103|80.45
2434,4,0.5181,3.109,3101.0,0.000999,0.9929309999999999,IGF2 KANK1 MS4A2 OR5A1,regulation of cellular response to insulin stimulus|regulation of insulin receptor signaling pathway|negative regulation of lamellipodium morphogenesis|insulin receptor signaling pathway via phosphatidylinositol 3-kinase|negative regulation of lamellipodium organization,6.415e-05|6.8e-05|0.0005825|0.0009706|0.001165,1|0.5363|1|1|1,156|151.4|2574|1287|1030
2435,5,0.5007,5.007,4156.0,0.0012,0.996692,ADPRM ATG16L2 C6orf52 IGF2BP2 PTPRH,negative stranded viral RNA replication|viral RNA genome replication|viral genome replication|nucleobase-containing small molecule catabolic process|autophagosome assembly,0.0009706|0.003394|0.006778|0.01208|0.01544,1|1|1|1|1,1373|316.8|152.6|84.06|65.38
2436,4,0.5082,3.049,2929.0,0.001037,0.9929309999999999,ANKRD11 IGFALS PRRC2A ZNF778,face morphogenesis|head morphogenesis|body morphogenesis|face development|odontogenesis of dentin-containing tooth,0.006007|0.007166|0.00871|0.009289|0.01583,1|1|1|1|1,171.6|143|117|109.5|63.56
2437,5,0.5433,5.433,4097.0,0.0013210000000000001,0.996692,IGFBP1 NINJ1 PPIA THADA WDR38,tissue regeneration|uncoating of virus|regeneration|negative regulation of protein K48-linked ubiquitination|cell adhesion molecule production,0.0001005|0.0004854|0.0006126|0.000728|0.0009706,1|1|1|1|1,128.7|4119|51.17|2060|1373
2438,4,0.5366,3.22,3180.0,0.001009,0.9929309999999999,CHN1 IGFBP2 PGM2L1 ZNF527,galactose catabolic process|galactose metabolic process|glycogen catabolic process|glucan catabolic process|cellular polysaccharide catabolic process,0.001747|0.002716|0.003685|0.003878|0.004072,1|1|1|1|1,643.6|396.1|286|271|257.4
2439,4,0.5734,3.44,3220.0,0.001065,0.9929309999999999,IGFBP5 LRRC74A RTN1 TCF4,negative regulation of cellular amide metabolic process|negative regulation of skeletal muscle hypertrophy|regulation of skeletal muscle hypertrophy|mammary gland involution|negative regulation of insulin-like growth factor receptor signaling pathway,0.0003605|0.0003883|0.0007766|0.001359|0.001359,1|1|1|1|1,64.76|5149|1716|858.1|858.1
2440,5,0.5478,5.478,4094.0,0.001333,0.996692,ASTL CCL27 GFRA2 IGFBPL1 SCN9A,prevention of polyspermy|negative regulation of fertilization|cellular response to tumor cell|negative regulation of binding of sperm to zona pellucida|egg activation,0.000728|0.000728|0.000728|0.001213|0.001456,1|1|1|1|1,2060|2060|2060|1030|823.8
2441,5,0.5443,5.443,3926.0,0.001381,0.996692,IGSF23 OR2L5 OR51A7 RELL2 VWA8,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.00442|0.004963|0.005341|0.006137|0.006602,1|1|1|1|1,18.68|17.6|16.95|15.78|15.2
2442,5,0.5372,5.372000000000001,4020.0,0.0013310000000000002,0.996692,IGSF5 NIPA2 SERINC4 TMEM62 WDR76,magnesium ion transmembrane transport|regulation of DNA damage checkpoint|magnesium ion transport|regulation of cell cycle checkpoint|regulation of response to DNA damage stimulus,0.00412|0.004362|0.004362|0.008226|0.05344,1|1|1|1|1,257.4|242.3|242.3|124.8|18.39
2443,4,0.526,3.156,3198.0,0.0009836,0.9929309999999999,CCDC184 IGSF6 KCNH3 TPH2,serotonin biosynthetic process|primary amino compound biosynthetic process|indole-containing compound biosynthetic process|indolalkylamine biosynthetic process|serotonin metabolic process,0.0007766|0.001165|0.001165|0.001165|0.002134,1|1|1|1|1,1716|1030|1030|1030|514.9
2444,22,0.5042,116.5,18200.0,0.006344,1.0,AP3M1 CALHM3 CYP17A1 CYP2C9 DUPD1 DUSP13 GPRIN2 IFIT1 IFIT1B IFIT5 NUTM2A NUTM2B PPP3CB PTPN20 SEMA4G SFTPA1 SFTPA2 SRGN SYT15 ZNF239 ZNF32 ZNF33B,cellular response to type I interferon|response to type I interferon|protein dephosphorylation|peptidyl-tyrosine dephosphorylation|cellular response to exogenous dsRNA,5.996e-05|7.617e-05|7.936e-05|0.0002057|0.0002255,0.9458|0.6008|0.4173|0.8113|0.7113,40.7|37.45|17.34|26.49|98.54
2445,4,0.503,3.0180000000000002,3119.0,0.0009641,0.9929309999999999,FLG HHAT IKBIP TMEM81,establishment of skin barrier|regulation of water loss via skin|response to X-ray|protein palmitoylation|smoothened signaling pathway,0.00504|0.005426|0.006007|0.006393|0.01372,1|1|1|1|1,205.9|190.7|171.6|160.9|73.55
2446,4,0.5154,3.093,3413.0,0.0009032,0.9929309999999999,ABHD8 IKZF5 OR13A1 RALGDS,phosphatidic acid biosynthetic process|phosphatidic acid metabolic process|lipid homeostasis|Ras protein signal transduction|glycerophospholipid biosynthetic process,0.009675|0.01025|0.02881|0.03393|0.04204,1|1|1|1|1,105.1|99.01|34.56|29.25|23.51
2447,4,0.5399,3.239,3226.0,0.001001,0.9929309999999999,IL10RA MS4A7 RPS6KB2 SMCO4,ubiquitin-dependent endocytosis|TOR signaling|positive regulation of translational initiation|positive regulation of receptor signaling pathway via JAK-STAT|protein kinase B signaling,0.0007766|0.006007|0.006007|0.007359|0.007938,1|1|1|1|1,1716|171.6|171.6|139.2|128.7
2448,4,0.5035,3.0210000000000004,3101.0,0.0009708000000000001,0.9929309999999999,C1orf159 IL11 MVB12B TNFRSF19,virus maturation|positive regulation of MAPK cascade|megakaryocyte differentiation|ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway|viral budding,0.0005825|0.003718|0.004459|0.004653|0.00504,1|1|1|1|1,2574|19.8|234|223.9|205.9
2449,4,0.5437,3.262,3325.0,0.0009779,0.9929309999999999,IL15RA NUCB1 TEKT2 TNFRSF1B,glial cell-neuron signaling|negative regulation of extracellular matrix constituent secretion|positive regulation of apoptotic process involved in morphogenesis|positive regulation of apoptotic process involved in development|regulation of extracellular matrix constituent secretion,0.0007766|0.0009706|0.001359|0.001359|0.001747,1|1|1|1|1,1716|1287|858.1|858.1|643.6
2450,4,0.5323,3.194,3308.0,0.0009622,0.9929309999999999,H1FOO IL17C PDE6C SLC16A4,interleukin-17-mediated signaling pathway|cellular response to interleukin-17|response to interleukin-17|retinal cone cell differentiation|retinal cone cell development,0.001456|0.001456|0.001456|0.001747|0.001747,1|1|1|1|1,762.8|762.8|762.8|624.1|624.1
2451,7,0.5061,10.63,4599.0,0.002299,0.9992989999999999,CEP192 CEP85 FAM210A IL17D KIF18B KIF2C TRIM37,microtubule polymerization or depolymerization|microtubule depolymerization|mitotic nuclear division|protein depolymerization|chromosome segregation,6.254e-07|1.688e-05|3.647e-05|6.916e-05|9.171e-05,0.009865|0.1331|0.1918|0.2727|0.2893,169.7|346.1|42.23|163.5|30.86
2452,4,0.5626,3.3760000000000003,3127.0,0.001076,0.9929309999999999,ATM DCLRE1C IL17RB SHLD1,V(D)J recombination|somatic diversification of immune receptors via germline recombination within a single locus|somatic cell DNA recombination|somatic diversification of immune receptors|double-strand break repair via nonhomologous end joining,4.323e-06|1.679e-05|1.679e-05|2.919e-05|5.859e-05,0.06819|0.1324|0.08829|0.1151|0.1848,643.6|312|312|234|163.5
2453,4,0.5514,3.3089999999999997,3127.0,0.0010539999999999998,0.9929309999999999,C1orf54 CTSK IL18R1 LDAH,positive regulation of T-helper 1 cell cytokine production|regulation of T-helper 1 cell cytokine production|intramembranous ossification|cellular response to interleukin-18|interleukin-18-mediated signaling pathway,0.001165|0.001165|0.001553|0.001553|0.001553,1|1|1|1|1,1030|1030|735.5|735.5|735.5
2454,4,0.5648,3.389,3239.0,0.0010429999999999999,0.9929309999999999,ALPK2 CGNL1 IL1R2 MEOX2,negative regulation of multicellular organismal process|negative regulation of interleukin-1 alpha production|epicardium morphogenesis|negative regulation of signal transduction|striated muscle tissue development,0.0004463|0.0005825|0.0005825|0.000911|0.0009872,1|1|1|1|1,15.42|2574|2574|12.11|38.86
2455,4,0.5619,3.3710000000000004,3298.0,0.001019,0.9929309999999999,ACAA1 IL1RL2 MAP1A ZNF280D,phenylacetate catabolic process|retrograde axonal protein transport|negative regulation of protein localization to microtubule|regulation of protein localization to microtubule|voluntary musculoskeletal movement,0.0005825|0.0005825|0.001165|0.001165|0.001359,1|1|1|1|1,2574|2574|1030|1030|858.1
2456,4,0.5481,3.2889999999999997,3189.0,0.0010279999999999998,0.9929309999999999,IL20RB KLF4 RCAN3 TSPAN2,negative regulation of leukocyte cell-cell adhesion|negative regulation of type IV hypersensitivity|negative regulation of leukocyte adhesion to arterial endothelial cell|negative regulation of cell-cell adhesion|negative regulation of chemokine (C-X-C motif) ligand 2 production,0.0002388|0.0003883|0.0003883|0.0004808|0.0005825,1|1|1|1|1,79.83|5149|5149|55.96|2574
2457,4,0.5289,3.173,3259.0,0.0009702999999999999,0.9929309999999999,IL21 SERTAD1 SPINT3 TMEM229A,germinal center B cell differentiation|T follicular helper cell differentiation|interleukin-21-mediated signaling pathway|cellular response to interleukin-21|response to interleukin-21,0.001359|0.001359|0.001747|0.001747|0.001747,1|1|1|1|1,858.1|858.1|643.6|643.6|643.6
2458,4,0.5597,3.358,3138.0,0.001066,0.9929309999999999,CC2D2B IL22RA2 NAA11 SH3D19,N-terminal peptidyl-serine acetylation|peptidyl-serine acetylation|N-terminal peptidyl-glutamic acid acetylation|N-terminal protein amino acid acetylation|positive regulation of membrane protein ectodomain proteolysis,0.0005825|0.0005825|0.0007766|0.003297|0.003491,1|1|1|1|1,2574|2574|1716|321.8|302.9
2459,4,0.5669,3.4010000000000002,3187.0,0.0010630000000000001,0.9929309999999999,IL23A LLPH MGST1 OTOP3,cellular response to lipid hydroperoxide|response to lipid hydroperoxide|positive regulation of T-helper 17 cell lineage commitment|positive regulation of NK T cell proliferation|regulation of NK T cell proliferation,0.0003883|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,5149|1716|1287|1287|1030
2460,4,0.5367,3.22,3163.0,0.0010140000000000001,0.9929309999999999,ADGRE3 DDX25 IL23R TTC39B,positive regulation of T-helper 17 cell lineage commitment|regulation of T-helper 17 cell lineage commitment|positive regulation of T-helper 17 cell differentiation|positive regulation of NK T cell activation|positive regulation of activation of Janus kinase activity,0.0009706|0.001553|0.001553|0.001553|0.001553,1|1|1|1|1,1287|735.5|735.5|735.5|735.5
2461,4,0.5119,3.071,3210.0,0.0009532999999999999,0.9929309999999999,IL36A LYG2 RSPO3 TEKT4,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,0.0005825|0.0007766|0.0007766|0.001359|0.001359,1|1|1|1|1,2574|1716|1716|858.1|858.1
2462,5,0.5297,5.297000000000001,4128.0,0.0012779999999999998,0.996692,CXCL11 IL36RN NANP UBOX5 UGT1A8,N-acetylneuraminate biosynthetic process|antimicrobial humoral response|N-acetylglucosamine biosynthetic process|glucosamine-containing compound biosynthetic process|cellular response to lipopolysaccharide,0.0004854|0.0005758|0.000728|0.000728|0.0007712,1|1|1|1|1,4119|52.81|2060|2060|45.51
2463,8,0.5042,14.12,6647.0,0.002114,0.9996790000000001,IL37 LYG1 LYG2 MGAT4A MRPL30 PIK3C2G SULT1C2 SULT1C4,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,7.913e-07|1.319e-06|1.319e-06|3.69e-06|3.69e-06,0.01248|0.0104|0.006933|0.01455|0.01164,2574|1716|1716|858.1|858.1
2464,4,0.5376,3.2260000000000004,3082.0,0.0010429999999999999,0.9929309999999999,IL5 PDE1B RPL27 RPS15,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,0.0001336|0.0001476|0.0001777|0.0001905|0.0001938,1|1|0.9343|0.7512|0.6113,107.3|102|92.77|89.54|88.77
2465,15,0.5022,52.73,11680.0,0.004484,0.999999,ARL9 CXCL2 HTN3 KDR KIT PDGFRA PF4 SULT1B1 TMPRSS11B UGT2A1 UGT2A3 UGT2B11 UGT2B15 UGT2B4 UGT2B7,cellular glucuronidation|uronic acid metabolic process|glucuronate metabolic process|estrogen metabolic process|steroid metabolic process,8.274e-15|2.769e-14|2.769e-14|9.19e-11|3.513e-10,1.305e-10|2.184e-10|1.456e-10|3.624e-07|1.108e-06,433.6|343.2|343.2|180.7|36.68
2466,4,0.5023,3.014,3160.0,0.0009502000000000001,0.9929309999999999,EIF4H IL9 MORN2 PLCB2,eukaryotic translation initiation factor 4F complex assembly|interleukin-9-mediated signaling pathway|cellular response to interleukin-9|positive regulation of interleukin-5 production|response to interleukin-9,0.0005825|0.001941|0.001941|0.002134|0.002134,1|1|1|1|1,2574|572.1|572.1|514.9|514.9
2467,4,0.5392,3.235,3204.0,0.001006,0.9929309999999999,ILDR1 SYNDIG1L TEKT5 TNFSF9,positive regulation of cytotoxic T cell differentiation|regulation of cytotoxic T cell differentiation|positive regulation of activated T cell proliferation|regulation of activated T cell proliferation|cellular response to cytokine stimulus,0.0005825|0.0007766|0.004846|0.007938|0.01346,1|1|1|1|1,2574|1716|214.5|128.7|10.23
2468,4,0.5289,3.174,3243.0,0.0009753,0.9929309999999999,CELF2 ILDR2 NTRK3 TNNI2,modulation by virus of host transcription|modulation of transcription in other organism involved in symbiotic interaction|modulation by symbiont of host transcription|modulation by virus of host gene expression|positive regulation of neurotrophin TRK receptor signaling pathway,0.0003883|0.0003883|0.0003883|0.0007766|0.001359,1|1|1|1|1,5149|5149|5149|1716|858.1
2469,8,0.5045,14.12,6455.0,0.0021780000000000002,0.9996790000000001,ABCB11 BBS5 CRYGA CRYGB CRYGC CRYGD ILKAP PRLH,visual perception|sensory perception of light stimulus|lens development in camera-type eye|camera-type eye development|eye development,7.404e-09|8.102e-09|1.458e-08|3.902e-06|6.767e-06,0.0001168|6.39e-05|7.665e-05|0.01539|0.02135,59.59|58.51|135.5|32.38|28.14
2470,4,0.5144,3.0869999999999997,3076.0,0.001,0.9929309999999999,AKAP2 ILVBL SHPK ZNF483,cellular response to interleukin-13|valine biosynthetic process|isoleucine biosynthetic process|response to interleukin-13|branched-chain amino acid biosynthetic process,0.0007766|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,1716|1716|1716|1287|1030
2471,5,0.5594,5.593999999999999,4136.0,0.001348,0.996692,IMMP1L LRSAM1 NAGA SRPK2 UBXN11,organonitrogen compound catabolic process|organonitrogen compound metabolic process|organic substance catabolic process|cellular catabolic process|N-acetylglucosamine catabolic process,0.000105|0.0002755|0.0006994|0.000756|0.001165,1|1|1|1|1,12.71|3.922|7.797|7.641|1144
2472,4,0.537,3.222,3242.0,0.0009904999999999998,0.9929309999999999,IMPA2 RNASEH1 SGSM2 WNT11,positive regulation of transforming growth factor beta2 production|mediolateral intercalation|negative regulation of fibroblast growth factor production|planar cell polarity pathway involved in gastrula mediolateral intercalation|cloacal septation,0.0005825|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,2574|2574|2574|2574|1716
2473,4,0.5108,3.065,3175.0,0.000962,0.9929309999999999,CNR2 IMPDH1 TNNT2 TRMT1L,regulation of muscle filament sliding speed|tRNA N2-guanine methylation|regulation of muscle filament sliding|GMP biosynthetic process|negative regulation of action potential,0.0005825|0.0005825|0.0009706|0.0009706|0.001359,1|1|1|1|1,2574|2574|1287|1287|858.1
2474,8,0.5053,14.15,5472.0,0.002572,0.9996790000000001,MMS22L NUS1 ORC3 PNISR REV3L RPF2 TTK ZWINT,mitotic spindle assembly checkpoint|mitotic spindle checkpoint|spindle assembly checkpoint|DNA-dependent DNA replication|spindle checkpoint,4.608e-05|4.608e-05|4.608e-05|4.654e-05|4.962e-05,0.7269|0.3635|0.2423|0.1835|0.1565,205.9|205.9|205.9|39.81|198
2475,9,0.5073,18.26,5875.0,0.00309,0.9998530000000001,POLE2 PSMA3 PSMC6 SNAPC1 SNAPC2 SNAPC3 SNAPC5 SNRPA1 SNRPB2,transcription by RNA polymerase III|snRNA transcription by RNA polymerase III|snRNA transcription by RNA polymerase II|snRNA transcription|ncRNA transcription,9.825e-10|9.492e-09|1.905e-08|2.012e-08|5.953e-08,1.55e-05|7.486e-05|0.0001002|7.935e-05|0.0001878,286|858.1|130.8|128.9|97.38
2476,4,0.5336,3.201,3170.0,0.001006,0.9929309999999999,BMP5 CISH INKA1 IQCF6,neural tube development|allantois development|neural fold elevation formation|negative regulation of cortisol biosynthetic process|negative regulation of aldosterone biosynthetic process,0.0003429|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,66.44|2574|1716|1287|1287
2477,4,0.5505,3.303,3222.0,0.001021,0.9929309999999999,INPP5B PRAP1 SLC10A5 TINAG,inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation|polyol catabolic process|phosphatidylinositol dephosphorylation,0.003491|0.003878|0.003878|0.00562|0.0062,1|1|1|1|1,302.9|271|271|183.9|166.1
2478,7,0.5028,10.56,5677.0,0.001852,0.9992989999999999,ATP12A C1QTNF9 DGKH HTR2A INPP5F RNF6 SIAH3,phosphatidylinositol-mediated signaling|inositol lipid-mediated signaling|phosphatidylinositol catabolic process|adult behavior|negative regulation of neuron projection development,0.0003324|0.0003651|0.0006794|0.0008504|0.000902,1|1|1|1|1,72.65|69.23|2942|44.92|43.59
2479,13,0.5038,39.29,8213.0,0.004746,0.999993,AKT1 INPPL1 KCTD5 MAPKAP1 MIOS MLST8 PDPK1 PIK3CA PIK3CB PIK3R1 RICTOR WDR24 WDR59,positive regulation of TOR signaling|activation of protein kinase B activity|regulation of TOR signaling|regulation of intracellular signal transduction|activation of protein kinase activity,2.229e-13|2.064e-11|2.524e-11|1.277e-10|4.355e-10,3.516e-09|1.628e-07|1.327e-07|5.036e-07|1.374e-06,221.1|240|96.01|9.857|33.91
2480,4,0.5588,3.353,2907.0,0.001149,0.9929309999999999,HSP90AA1 INSL3 ITM2B TMEM221,protein unfolding|outer mitochondrial membrane organization|protein insertion into mitochondrial outer membrane|telomerase holoenzyme complex assembly|negative regulation of amyloid precursor protein biosynthetic process,0.0007766|0.0009706|0.0009706|0.0009706|0.001553,1|1|1|1|1,1716|1287|1287|1287|735.5
2481,4,0.5741,3.444,3293.0,0.001042,0.9929309999999999,CLUL1 HIST1H2BE INSL5 SLC9A5,positive regulation of feeding behavior|sodium ion import across plasma membrane|innate immune response in mucosa|regulation of feeding behavior|positive regulation of behavior,0.002134|0.003878|0.004653|0.005233|0.005426,1|1|1|1|1,514.9|271|223.9|198|190.7
2482,4,0.5085,3.051,3236.0,0.0009398,0.9929309999999999,ANAPC7 INSYN2B OXLD1 RXFP1,lung connective tissue development|nipple morphogenesis|nipple development|metaphase/anaphase transition of mitotic cell cycle|metaphase/anaphase transition of cell cycle,0.0003883|0.0003883|0.0003883|0.001553|0.001553,1|1|1|1|1,5149|5149|5149|735.5|735.5
2483,9,0.5079,18.28,6521.0,0.002788,0.9998530000000001,EIF3I GNL2 INTS11 NOL9 PSMB2 SNIP1 TRAPPC3 UTP11 YARS,ribonucleoprotein complex biogenesis|ncRNA metabolic process|gene expression|RNA metabolic process|cellular component biogenesis,3.05e-05|4.603e-05|9.098e-05|0.0002744|0.000301,0.4811|0.3631|0.4784|1|0.9494,19.68|17.7|6.281|7.156|5.083
2484,9,0.5039,18.14,6187.0,0.002915,0.9998530000000001,CCT3 COPA INTS3 PRPF3 PSMA1 PSMB3 PSMB4 PSMD4 SF3B4,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|regulation of G2/M transition of mitotic cell cycle|regulation of cellular amino acid metabolic process|S phase,3.34e-10|5.619e-10|1.218e-08|1.433e-08|1.433e-08,5.269e-06|4.432e-06|6.406e-05|5.65e-05|4.52e-05,118|105.9|56.36|140.8|140.8
2485,8,0.5486,15.36,5329.0,0.002866,0.9996790000000001,C7orf26 INTS1 INTS10 INTS2 INTS5 INTS6 INTS7 INTS8,snRNA processing|snRNA metabolic process|snRNA transcription by RNA polymerase II|snRNA transcription|ncRNA transcription,8.241e-19|4.527e-18|6.141e-17|6.746e-17|4.388e-16,1.3e-14|3.57e-14|3.229e-13|2.66e-13|1.384e-12,500.6|383.4|257.4|253.8|191.7
2486,4,0.5351,3.2110000000000003,3113.0,0.0010279999999999998,0.9929309999999999,CNIH3 IP6K1 IP6K2 MOB1B,inositol phosphate biosynthetic process|polyol biosynthetic process|phosphatidylinositol phosphorylation|inositol phosphate metabolic process|lipid phosphorylation,3.391e-06|3.595e-05|4.821e-05|5.156e-05|7.603e-05,0.05349|0.2835|0.2535|0.2033|0.2399,735.5|210.2|180.7|174.5|143
2487,6,0.5153,7.73,4177.0,0.001842,0.998474,ATP6V0B CDC20 EBNA1BP2 IPO13 PABPC1 SNIP1,gene silencing by RNA|gene silencing|positive regulation of anaphase-promoting complex-dependent catabolic process|regulation of anaphase-promoting complex-dependent catabolic process|regulation of cellular catabolic process,0.0002737|0.0007956|0.001165|0.001165|0.00131,1|1|1|1|1,78.91|45.77|1144|1144|12.04
2488,9,0.5217,18.78,6033.0,0.003094,0.9998530000000001,EIF3D EIF3E EIF3F EIF3G EIF3H EIF3I EIF3M IPO7 RPL27A,formation of cytoplasmic translation initiation complex|cytoplasmic translational initiation|translational initiation|cytoplasmic translation|translation,2.821e-20|1.183e-18|6.172e-17|4.352e-16|1.416e-13,4.449e-16|9.332e-15|3.245e-13|1.716e-12|4.467e-10,1001|533.9|128|213.6|47.67
2489,4,0.5779,3.467,3046.0,0.001134,0.9929309999999999,CEP85L IQCB1 RWDD1 ZNF263,maintenance of animal organ identity|photoreceptor cell maintenance|cytoplasmic translation|retina homeostasis|ciliary basal body-plasma membrane docking,0.001165|0.008903|0.01468|0.01583|0.01851,1|1|1|1|1,1030|114.4|68.65|63.56|54.2
2490,4,0.5506,3.304,3165.0,0.0010400000000000001,0.9929309999999999,IQCC LRRC47 OBSL1 TMEM237,cardiac myofibril assembly|retina layer formation|protein localization to Golgi apparatus|positive regulation of dendrite morphogenesis|organelle assembly,0.003297|0.005233|0.005813|0.007166|0.008227,1|1|1|1|1,321.8|198|177.5|143|13.19
2491,9,0.5305,19.1,7131.0,0.002664,0.9998530000000001,HRASLS HTR3D IQCG MUC20 MUC4 PDCD6 SLC51A TCTEX1D2 TM4SF19,O-glycan processing|protein O-linked glycosylation|stimulatory C-type lectin receptor signaling pathway|innate immune response activating cell surface receptor signaling pathway|innate immune response-activating signal transduction,0.0003267|0.0009219|0.001121|0.001199|0.001218,1|1|1|1|1,75.03|44.01|39.8|38.46|38.14
2492,4,0.516,3.096,3104.0,0.0009939,0.9929309999999999,CLRN3 IQCH PCDHA4 ZNF555,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cellular process|cell-cell adhesion|response to stimulus,0.03223|0.04954|0.04971|0.09632|0.1481,1|1|1|1|1,30.83|19.88|0.3325|10.02|0
2493,4,0.5489,3.2939999999999996,3280.0,0.001001,0.9929309999999999,IQCJ RHOBTB1 STK16 STOML1,"engulfment of apoptotic cell|apoptotic cell clearance|cortical cytoskeleton organization|phagocytosis, engulfment|plasma membrane invagination",0.003297|0.00871|0.01141|0.02539|0.0271,1|1|1|1|1,321.8|117|88.77|39.3|36.78
2494,4,0.5837,3.502,3285.0,0.0010630000000000001,0.9929309999999999,ATP2A1 BCL2A1 IQCK SSH1,intrinsic apoptotic signaling pathway|positive regulation of actin filament-based movement|positive regulation of cardiac muscle cell contraction|positive regulation of postsynaptic membrane organization|positive regulation of calcium ion import into sarcoplasmic reticulum,0.0003089|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,70.05|5149|5149|2574|2574
2495,6,0.5112,7.669,3697.0,0.0020629999999999997,0.998474,ACO2 CIAO2B GLRX3 IREB2 SLC25A3 SOD2,citrate metabolic process|response to isolation stress|tricarboxylic acid metabolic process|protein maturation by iron-sulfur cluster transfer|metallo-sulfur cluster assembly,1.484e-06|3.178e-06|8.468e-06|9.595e-06|2.114e-05,0.0234|0.02506|0.04452|0.03784|0.06671,1373|858.1|490.4|457.7|298.5
2496,6,0.5056,7.585,4113.0,0.001835,0.998474,HIVEP1 IRF2BP1 IRF2BP2 IRF2BPL JUN VGLL4,"negative regulation of transcription, DNA-templated|negative regulation of nucleic acid-templated transcription|negative regulation of RNA biosynthetic process|negative regulation of RNA metabolic process|negative regulation of cellular macromolecule biosynthetic process",6.075e-08|6.132e-08|6.189e-08|9.752e-08|1.435e-07,0.0009583|0.0004836|0.0003254|0.0003846|0.0004528,15.99|15.97|15.94|14.77|13.85
2497,4,0.5281,3.168,3322.0,0.0009504,0.9929309999999999,IFNLR1 IRF7 SPTB ZNF707,interferon-alpha production|response to type III interferon|defense response to symbiont|defense response to virus|interferon-beta production,0.0003883|0.0005825|0.0006358|0.0006358|0.0007766,1|1|1|1|1,5149|2574|48.57|48.57|1716
2498,5,0.5034,5.034,4102.0,0.0012230000000000001,0.996692,BLZF1 IRGM MMP16 OC90 RDH11,otolith mineralization|CAMKK-AMPK signaling cascade|protein lipidation involved in autophagosome assembly|calmodulin dependent kinase signaling pathway|positive regulation of interferon-gamma-mediated signaling pathway,0.000728|0.001213|0.001213|0.001456|0.001698,1|1|1|1|1,2060|1030|1030|823.8|686.5
2499,11,0.5026,27.64,8082.0,0.003399,0.999969,ANXA2R CCL28 DROSHA EXOC3 HCN1 ICE1 IRX1 IRX2 NUP155 UGT3A1 ZFR,proximal/distal pattern formation involved in metanephric nephron development|pattern specification involved in metanephros development|specification of loop of Henle identity|specification of nephron tubule identity|proximal/distal pattern formation involved in nephron development,1.554e-06|3.882e-06|3.882e-06|5.433e-06|5.433e-06,0.02451|0.03061|0.02041|0.02142|0.01714,1872|936.1|936.1|748.9|748.9
2500,7,0.5029,10.56,5182.0,0.0020280000000000003,0.9992989999999999,CCT3 COPA ISG20L2 MRPL24 PRCC PSMB4 SMG5,regulation of telomere maintenance via telomerase|regulation of telomere maintenance via telomere lengthening|regulation of telomere maintenance|regulation of DNA biosynthetic process|pancreatic juice secretion,0.0001511|0.0001975|0.0003324|0.000615|0.002715,1|1|1|1|1,109|94.91|72.65|53.01|420.3
2501,4,0.5482,3.2889999999999997,3179.0,0.001031,0.9929309999999999,GGA3 ISM1 OR4F6 TMEM52,negative regulation of amyloid-beta formation|negative regulation of amyloid precursor protein catabolic process|protein targeting to lysosome|protein localization to cell surface|Golgi to plasma membrane protein transport,0.003685|0.004266|0.004846|0.005813|0.006007,1|1|1|1|1,286|245.2|214.5|177.5|171.6
2502,5,0.5126,5.126,4081.0,0.001251,0.996692,ITGA10 MTHFD1L RIMS2 SLC25A32 ZNF541,folic acid metabolic process|folic acid-containing compound metabolic process|pteridine-containing compound metabolic process|water-soluble vitamin metabolic process|dicarboxylic acid metabolic process,9.879e-06|1.777e-05|3.663e-05|0.0001669|0.000213,0.1558|0.1402|0.1926|0.6582|0.6719,433.6|316.8|216.8|99.25|87.64
2503,4,0.5708,3.425,3111.0,0.001097,0.9929309999999999,AKR1B15 C3orf18 CCNB1IP1 ITGA5,"cell-cell adhesion mediated by integrin|chiasma assembly|CD40 signaling pathway|wound healing, spreading of epidermal cells|estrogen biosynthetic process",0.001359|0.001359|0.001941|0.002134|0.002716,1|1|1|1|1,858.1|858.1|572.1|514.9|396.1
2504,4,0.5772,3.463,3223.0,0.0010710000000000001,0.9929309999999999,G0S2 GPR156 ITGA7 SLC5A2,alpha-glucoside transport|glucoside transport|glycoside transport|glucose import across plasma membrane|hexose import across plasma membrane,0.0005825|0.0007766|0.001165|0.001165|0.001359,1|1|1|1|1,2574|1716|1030|1030|858.1
2505,4,0.5582,3.3489999999999998,3208.0,0.0010400000000000001,0.9929309999999999,ITGAE PNPLA5 TTLL5 WNT1,midbrain-hindbrain boundary maturation|midbrain-hindbrain boundary maturation during brain development|cerebellum formation|hindbrain formation|central nervous system morphogenesis,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
2506,4,0.5579,3.3480000000000003,3074.0,0.001085,0.9929309999999999,IVNS1ABP RHBDD1 TMEM183A ZNF296,"membrane protein proteolysis involved in retrograde protein transport, ER to cytosol|retrograde protein transport, ER to cytosol|endoplasmic reticulum to cytosol transport|membrane protein intracellular domain proteolysis|spermatogenesis",0.0005825|0.003491|0.003491|0.004072|0.00412,1|1|1|1|1,2574|302.9|302.9|257.4|18.79
2507,5,0.5195,5.195,4200.0,0.001233,0.996692,IGFL4 IZUMO2 JOSD2 KCTD12 MS4A15,biological regulation|regulation of biological process|regulation of cellular process|UNCLASSIFIED|biological_process,0.008988|0.01377|0.01872|0.01923|0.01923,1|1|1|1|1,0|0|0|4.502|0.4615
2508,7,0.5123,10.76,5864.0,0.001827,0.9992989999999999,IGDCC3 IZUMO4 PLEKHO2 SCAMP2 SCAMP5 TBC1D21 TRH,macrophage apoptotic process|positive regulation of gamma-aminobutyric acid secretion|negative regulation of glutamate secretion|imidazole-containing compound metabolic process|histamine metabolic process,0.001358|0.001358|0.002037|0.002376|0.002376,1|1|1|1|1,980.7|980.7|588.4|490.4|490.4
2509,4,0.5146,3.088,3061.0,0.001005,0.9929309999999999,GIPC1 JAKMIP1 PPP1R16A SH3BP4,positive regulation of secondary metabolite biosynthetic process|positive regulation of melanin biosynthetic process|regulation of secondary metabolic process|regulation of secondary metabolite biosynthetic process|regulation of melanin biosynthetic process,0.001553|0.001553|0.002522|0.002522|0.002522,1|1|1|1|1,735.5|735.5|429.1|429.1|429.1
2510,4,0.5097,3.0580000000000003,3168.0,0.000962,0.9929309999999999,ATP2C2 JAML PKLR SLC5A10,monocyte extravasation|pyruvate biosynthetic process|neutrophil extravasation|positive regulation of epithelial cell proliferation involved in wound healing|manganese ion transmembrane transport,0.001165|0.001359|0.001359|0.001941|0.002134,1|1|1|1|1,1030|858.1|858.1|572.1|514.9
2511,4,0.5151,3.09,3325.0,0.0009263,0.9929309999999999,JCAD RETREG2 SZRD1 TSHR,cellular response to thyrotropin-releasing hormone|cellular response to glycoprotein|thyroid-stimulating hormone signaling pathway|response to thyrotropin-releasing hormone|positive regulation of vascular endothelial growth factor signaling pathway,0.0003883|0.0003883|0.0005825|0.0005825|0.001359,1|1|1|1|1,5149|5149|2574|2574|858.1
2512,4,0.572,3.432,3360.0,0.001018,0.9929309999999999,EZR JDP2 PRKAR1B SPATA25,protein localization to cell cortex|intestinal D-glucose absorption|cortical microtubule organization|terminal web assembly|membrane to membrane docking,0.0005825|0.0007766|0.0007766|0.0007766|0.001165,1|1|1|1|1,2574|1716|1716|1716|1030
2513,10,0.5372,24.17,7174.0,0.0033490000000000004,0.999933,ATP13A1 AUP1 JOSD1 MMD PCNX1 STUB1 TM2D1 TM2D2 TM2D3 ZDHHC6,cellular response to misfolded protein|response to misfolded protein|protein quality control for misfolded or incompletely synthesized proteins|ubiquitin-dependent ERAD pathway|ERAD pathway,5.818e-05|6.847e-05|9.155e-05|0.0006084|0.000867,0.9177|0.54|0.4814|1|1,187.2|171.6|147.1|54.92|45.77
2514,4,0.5238,3.1430000000000002,3080.0,0.001017,0.9929309999999999,JPH1 KCNMB2 SLC15A3 TMEM204,detection of calcium ion|neuronal action potential|regulation of cation transmembrane transport|transmission of nerve impulse|positive regulation of potassium ion transmembrane transport,5.648e-06|2.045e-05|5.824e-05|6.711e-05|9.15e-05,0.08909|0.1613|0.3062|0.2646|0.2887,588.4|294.2|33.22|158.4|135
2515,7,0.5111,10.73,5757.0,0.0018559999999999998,0.9992989999999999,GPR142 JPT1 LGALS3BP MCRIP1 MIF4GD SPHK1 SSTR2,regulation of endosomal vesicle fusion|sphingoid catabolic process|regulation of muscle contraction|somatostatin signaling pathway|somatostatin receptor signaling pathway,0.0006794|0.0006794|0.001242|0.002037|0.002037,1|1|1|1|1,2942|2942|37.01|588.4|588.4
2516,4,0.5398,3.239,3190.0,0.0010119999999999999,0.9929309999999999,BCL2A1 GPR87 JRKL TPCN1,G protein-coupled purinergic nucleotide receptor signaling pathway|negative regulation of adenylate cyclase activity|negative regulation of cyclase activity|negative regulation of lyase activity|signal transduction in absence of ligand,0.00291|0.004072|0.004653|0.00504|0.006007,1|1|1|1|1,367.8|257.4|223.9|205.9|171.6
2517,4,0.5573,3.344,3165.0,0.001053,0.9929309999999999,CRISP1 DCUN1D4 DEFB112 JSRP1,positive regulation of protein neddylation|regulation of protein neddylation|protein neddylation|fusion of sperm to egg plasma membrane involved in single fertilization|plasma membrane fusion,0.001165|0.002328|0.002716|0.004266|0.00504,1|1|1|1|1,1030|468.1|396.1|245.2|205.9
2518,46,0.5005,518.1,32360.0,0.01571,1.0,ACAD9 ATPAF2 C12orf65 CARS2 COA7 COQ7 DARS2 DDX28 ECSIT FOXRED1 GFM2 GRSF1 GTPBP10 GTPBP8 MCAT METTL17 MRM2 MRM3 MRPL58 MTFMT MTG1 MTIF2 MTIF3 MTO1 MTRF1L NDUFAF1 NDUFAF3 NDUFAF4 NDUFAF6 NDUFAF7 NDUFB3 NDUFB5 NDUFB9 NDUFC1 NDUFC2 NDUFS2 NDUFS8 NOA1 NSUN4 NUBPL RMND1 RTN4IP1 TBRG4 TFB1M TIMMDC1 YBEY,NADH dehydrogenase complex assembly|mitochondrial respiratory chain complex I assembly|mitochondrial respiratory chain complex assembly|mitochondrion organization|cellular protein-containing complex assembly,8.143e-30|8.143e-30|5.32e-27|5.877e-18|1.65e-14,1.285e-25|6.423e-26|2.797e-23|2.318e-14|5.205e-11,112.9|112.9|73.76|17.26|9.692
2519,4,0.5098,3.0589999999999997,3175.0,0.0009601000000000001,0.9929309999999999,ASB15 CDH20 KBTBD12 SLC5A7,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|homophilic cell adhesion via plasma membrane adhesion molecules|acetate ester biosynthetic process|acetylcholine biosynthetic process|acetate ester metabolic process,4.441e-05|0.0006583|0.0009706|0.0009706|0.001456,0.7005|1|1|1|1,196.1|49.33|1373|1373|823.8
2520,5,0.5193,5.193,4197.0,0.001233,0.996692,ANKRD62 AOX1 CALD1 KBTBD13 SLC28A1,cytidine transport|relaxation of skeletal muscle|regulation of skeletal muscle contraction by chemo-mechanical energy conversion|regulation of the force of skeletal muscle contraction|purine nucleobase transmembrane transport,0.0004854|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,4119|1373|1373|1373|1030
2521,5,0.5077,5.077,3819.0,0.001324,0.996692,BTN3A3 KBTBD4 KCNK13 NAT8L PPP2R5D,stabilization of membrane potential|negative regulation of peptidyl-threonine phosphorylation|T cell mediated immunity|positive regulation of protein dephosphorylation|regulation of peptidyl-threonine phosphorylation,0.004362|0.004845|0.007502|0.01112|0.01136,1|1|1|1|1,242.3|216.8|137.3|91.53|89.54
2522,9,0.5164,18.59,7436.0,0.0024879999999999998,0.9998530000000001,ATP12A C1QTNF9 GJB2 KBTBD7 KRTAP21-1 RNF6 SIAH3 VANGL1 ZAR1L,response to human chorionic gonadotropin|epididymis development|protein K27-linked ubiquitination|negative regulation of protein targeting to mitochondrion|gap junction-mediated intercellular transport,0.001746|0.002182|0.002618|0.003054|0.003054,1|1|1|1|1,762.8|572.1|457.7|381.4|381.4
2523,5,0.5182,5.182,3967.0,0.001301,0.996692,ADAT1 CDCA4 KCNA4 MGAT3 SULT1C3,negative regulation of lysosomal protein catabolic process|negative regulation of protein catabolic process in the vacuole|regulation of lysosomal protein catabolic process|positive regulation of protein localization to early endosome|regulation of protein localization to early endosome,0.0009706|0.0009706|0.002183|0.002425|0.002425,1|1|1|1|1,1373|1373|514.9|457.7|457.7
2524,5,0.5258,5.257999999999999,4137.0,0.001266,0.996692,ARHGAP31 KCNAB1 PLCXD2 SIDT1 SLC9C1,potassium ion transmembrane transport|potassium ion transport|diaphragm development|negative regulation of delayed rectifier potassium channel activity|negative regulation of voltage-gated potassium channel activity,0.0005904|0.0006661|0.002183|0.003152|0.003394,1|1|1|1|1,52.14|49.04|514.9|343.3|316.8
2525,5,0.5103,5.103,3928.0,0.001294,0.996692,EMC8 H3F3B H3F3C HIST3H2A KCNAB2,negative regulation of chromosome condensation|subtelomeric heterochromatin organization|subtelomeric heterochromatin assembly|pericentric heterochromatin organization|pericentric heterochromatin assembly,0.0002913|0.0002913|0.0002913|0.0005825|0.0005825,1|1|1|1|1,6865|6865|6865|2288|2288
2526,4,0.5352,3.2110000000000003,3373.0,0.0009488,0.9929309999999999,C1orf141 KCNAB3 SPINK6 TWSG1,"negative regulation of serine-type peptidase activity|negative regulation of serine-type endopeptidase activity|regulation of serine-type peptidase activity|negative regulation of CD4-positive, alpha-beta T cell proliferation|regulation of serine-type endopeptidase activity",0.001553|0.001553|0.001941|0.001941|0.001941,1|1|1|1|1,735.5|735.5|572.1|572.1|572.1
2527,12,0.5035,33.23,10130.0,0.0032619999999999997,0.999986,ATP6V0D2 C8orf44 CA1 CA8 CNGB3 CPA6 KCNB2 MCMDC2 PMP2 PRDM14 SGK3 TRIM55,one-carbon metabolic process|histone H3-R26 methylation|inactivation of paternal X chromosome|inner cell mass cell fate commitment|germ-line stem cell population maintenance,0.0002517|0.001164|0.001164|0.001746|0.002327,1|1|1|1|1,88.01|1716|1716|858.1|572.1
2528,4,0.5705,3.423,3389.0,0.001007,0.9929309999999999,GABBR1 INTU KCNC3 LIMCH1,cytoplasmic actin-based contraction involved in cell motility|neuron-glial cell signaling|tongue morphogenesis|negative regulation of keratinocyte proliferation|negative regulation of cell division,0.0007766|0.001165|0.002134|0.002716|0.003297,1|1|1|1|1,1716|1030|514.9|396.1|321.8
2529,4,0.5722,3.4330000000000003,3259.0,0.00105,0.9929309999999999,KCNE4 LURAP1 RWDD4 SLC2A12,negative regulation of delayed rectifier potassium channel activity|ventricular cardiac muscle cell membrane repolarization|membrane repolarization during ventricular cardiac muscle cell action potential|negative regulation of voltage-gated potassium channel activity|potassium ion export across plasma membrane,0.002522|0.002522|0.002522|0.002716|0.00291,1|1|1|1|1,429.1|429.1|429.1|396.1|367.8
2530,4,0.503,3.0180000000000002,2957.0,0.001017,0.9929309999999999,KCNF1 KLK14 LLPH OR52N2,seminal clot liquefaction|dendrite extension|insemination|copulation|positive regulation of G protein-coupled receptor signaling pathway,0.0003883|0.001941|0.002522|0.003104|0.005426,1|1|1|1|1,5149|572.1|429.1|343.2|190.7
2531,4,0.5928,3.557,3138.0,0.001129,0.9929309999999999,IL12A KCNG2 POGLUT1 ZC3H12A,cellular response to virus|regulation of muscle cell apoptotic process|regulation of protein transport|regulation of establishment of protein localization|regulation of peptide transport,2.792e-05|5.679e-05|8.258e-05|9.386e-05|9.767e-05,0.4404|0.4479|0.4342|0.3701|0.3081,239.5|166.1|27.24|26.09|25.74
2532,4,0.5846,3.5069999999999997,3137.0,0.001114,0.9929309999999999,ARHGAP21 ECHDC2 KCNH2 ZCWPW2,regulation of heart rate by hormone|maintenance of Golgi location|negative regulation of potassium ion export across plasma membrane|regulation of heart rate by chemical signal|regulation of potassium ion export across plasma membrane,0.0005825|0.0007766|0.0007766|0.001359|0.001553,1|1|1|1|1,2574|1716|1716|858.1|735.5
2533,5,0.5506,5.506,4107.0,0.001336,0.996692,C11orf71 KCNJ3 METTL24 OLIG3 TAAR6,spinal cord motor neuron migration|atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|motor neuron migration|spinal cord motor neuron cell fate specification,0.001213|0.001456|0.001456|0.001698|0.002667,1|1|1|1|1,1030|823.8|823.8|686.5|411.9
2534,13,0.5022,39.17,10420.0,0.003735,0.999993,A2M CLEC4D CLEC6A GYS2 IAPP KCNA6 KCNJ8 MANSC4 PKP2 SLCO1B1 SLCO1B3 SLCO1C1 TSPAN11,sodium-independent organic anion transport|bile acid and bile salt transport|pigment catabolic process|porphyrin-containing compound catabolic process|tetrapyrrole catabolic process,1.889e-07|1.505e-06|5.588e-05|5.588e-05|5.588e-05,0.00298|0.01187|0.2938|0.2204|0.1763,297|139.8|198|198|198
2535,13,0.5096,39.75,9442.0,0.004181,0.999993,ANKRD30A CDC123 HSD17B7 KIN MCM10 MTRNR2L7 PRPF18 RBM17 RPP38 UPF2 ZNF25 ZNF33A ZNF37A,mRNA metabolic process|eukaryotic translation initiation factor 2 complex assembly|nucleic acid metabolic process|organic cyclic compound metabolic process|nuclear retention of unspliced pre-mRNA at the site of transcription,0.0007306|0.001261|0.001421|0.00155|0.001891,1|1|1|1|1,9.131|1584|4.259|3.476|792.1
2536,4,0.5945,3.5669999999999997,3358.0,0.001058,0.9929309999999999,CALR3 KCNK18 RHBDD3 SLC10A1,response to 17alpha-ethynylestradiol|regulation of bile acid secretion|negative regulation of natural killer cell activation|bile acid signaling pathway|potassium ion export across plasma membrane,0.0007766|0.001165|0.001941|0.002716|0.00291,1|1|1|1|1,1716|1030|572.1|396.1|367.8
2537,5,0.5052,5.052,3893.0,0.0012929999999999999,0.996692,ADGRD1 CMC2 KCNK4 NID1 NUDT1,purine nucleoside triphosphate metabolic process|nucleoside triphosphate metabolic process|cellular response to alkaline pH|detection of mechanical stimulus involved in sensory perception of touch|dATP catabolic process,0.0001644|0.0002989|0.0008735|0.0008735|0.001165,1|1|1|1|1,102.5|75.44|1716|1716|1144
2538,5,0.5005,5.005,3959.0,0.00126,0.996692,KCNMA1 MRC2 PAQR9 PDE7B TLL2,smooth muscle contraction involved in micturition|negative regulation of skeletal muscle tissue growth|response to carbon monoxide|negative regulation of cell volume|relaxation of vascular associated smooth muscle,0.000728|0.000728|0.001213|0.001456|0.001698,1|1|1|1|1,2060|2060|1030|823.8|686.5
2539,4,0.5644,3.386,3158.0,0.001068,0.9929309999999999,KCNMB1 KCTD17 MPP5 RLBP1,protein localization to myelin sheath abaxonal region|cellular response to bile acid|response to bile acid|peripheral nervous system myelin maintenance|vitamin A metabolic process,0.0003883|0.001165|0.001165|0.001747|0.001941,1|1|1|1|1,5149|1030|1030|643.6|572.1
2540,4,0.5564,3.339,3106.0,0.0010710000000000001,0.9929309999999999,CNIH2 KCNN1 MAP3K11 TMEM179B,negative regulation of receptor localization to synapse|negative regulation of vesicle transport along microtubule|negative regulation of anterograde synaptic vesicle transport|negative regulation of synaptic vesicle transport|regulation of anterograde synaptic vesicle transport,0.0003883|0.0003883|0.0003883|0.0003883|0.0007766,1|1|1|1|1,5149|5149|5149|5149|1716
2541,12,0.5105,33.7,9997.0,0.003351,0.999986,CA1 CA13 CA2 CA3 CNGB3 CPA6 FABP4 KCNS2 MCMDC2 PMP2 SLC26A7 SLC7A13,bicarbonate transport|one-carbon metabolic process|organic anion transport|ion transport|organic substance transport,3.879e-11|8.035e-09|1.821e-08|3.053e-06|7.122e-05,6.118e-07|6.337e-05|9.575e-05|0.01204|0.2247,204.3|176|30.29|5.361|5.536
2542,4,0.5605,3.363,3100.0,0.0010810000000000001,0.9929309999999999,CA7 KCNT1 SMR3B VASH2,"positive regulation of cellular pH reduction|regulation of cellular pH reduction|regulation of chloride transport|positive regulation of synaptic transmission, GABAergic|labyrinthine layer blood vessel development",0.001165|0.001553|0.002134|0.002522|0.003685,1|1|1|1|1,1030|735.5|514.9|429.1|286
2543,4,0.5047,3.028,3145.0,0.0009595000000000001,0.9929309999999999,KCNV2 KCTD17 NAGS SHISA3,protein homooligomerization|protein complex oligomerization|arginine biosynthetic process|urea cycle|nitrogen cycle metabolic process,0.0004604|0.0007659|0.0009706|0.002522|0.002716,1|1|1|1|1,57.21|44.2|1287|429.1|396.1
2544,4,0.5643,3.386,3285.0,0.001027,0.9929309999999999,CHMP4A KCTD18 KLF13 MACF1,establishment of protein localization to membrane|negative regulation of erythrocyte differentiation|posttranslational protein targeting to endoplasmic reticulum membrane|plasma membrane tubulation|regulation of neuron projection arborization,0.001319|0.002328|0.002522|0.002716|0.003104,1|1|1|1|1,33.54|468.1|429.1|396.1|343.2
2545,4,0.5288,3.173,3225.0,0.0009803,0.9929309999999999,GFY GGT6 KCTD4 TNF,positive regulation of fractalkine production|regulation of fractalkine production|positive regulation of interleukin-33 production|regulation of interleukin-33 production|positive regulation of translational initiation by iron,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2546,7,0.5107,10.72,4604.0,0.002317,0.9992989999999999,FAM49B KCTD9 NF2 PICALM PPM1F PTPN14 TAOK1,regulation of actin cytoskeleton organization|regulation of supramolecular fiber organization|regulation of actin filament-based process|regulation of cytoskeleton organization|regulation of cellular protein localization,3.079e-06|3.777e-06|4.678e-06|1.352e-05|1.873e-05,0.04856|0.02979|0.0246|0.05333|0.05909,33.06|31.38|29.72|22.68|20.87
2547,4,0.5082,3.049,3151.0,0.0009644,0.9929309999999999,KERA NAV3 RAPGEF5 TMEM258,cornea development in camera-type eye|keratan sulfate catabolic process|carbohydrate derivative biosynthetic process|negative regulation of microtubule depolymerization|negative regulation of interleukin-2 production,0.002328|0.002522|0.004984|0.005426|0.00562,1|1|1|1|1,468.1|429.1|17.05|190.7|183.9
2548,5,0.5069,5.069,4024.0,0.001255,0.996692,CACFD1 ERC1 KHDRBS3 SLC6A12 WNT5B,positive regulation of convergent extension involved in gastrulation|regulation of convergent extension involved in gastrulation|gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|maintenance of presynaptic active zone structure,0.000728|0.000728|0.001213|0.001698|0.001698,1|1|1|1|1,2060|2060|1030|686.5|686.5
2549,4,0.545,3.27,3327.0,0.0009797,0.9929309999999999,DUXA KHNYN SPATC1L TRIM67,positive regulation of cAMP-dependent protein kinase activity|positive regulation of protein kinase A signaling|regulation of cAMP-dependent protein kinase activity|regulation of protein kinase A signaling|negative regulation of Ras protein signal transduction,0.001359|0.002716|0.004072|0.005233|0.009867,1|1|1|1|1,858.1|396.1|257.4|198|103
2550,4,0.505,3.03,3166.0,0.0009536,0.9929309999999999,DDX60 KIAA0232 PDE6A VPS13C,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization|regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization|positive regulation of MDA-5 signaling pathway|protein retention in Golgi apparatus|regulation of MDA-5 signaling pathway,0.0003883|0.0003883|0.0009706|0.001165|0.001553,1|1|1|1|1,5149|5149|1287|1030|735.5
2551,4,0.5741,3.444,3055.0,0.001123,0.9929309999999999,AVIL KIAA0895L NR2F6 OR56B1,regulation of diacylglycerol biosynthetic process|actin filament severing|detection of temperature stimulus involved in sensory perception of pain|detection of stimulus involved in sensory perception|detection of temperature stimulus involved in sensory perception,0.0003883|0.003104|0.003685|0.004209|0.004266,1|1|1|1|1,5149|343.2|286|18.59|245.2
2552,5,0.5192,5.192,4246.0,0.001218,0.996692,APBB3 DCTN3 EIF5A2 KCNU1 KIAA0930,polyamine homeostasis|positive regulation of translational termination|positive regulation of translational elongation|regulation of translational termination|regulation of translational elongation,0.0004854|0.001213|0.001456|0.00291|0.005329,1|1|1|1|1,4119|1030|823.8|374.5|196.1
2553,4,0.538,3.228,3311.0,0.0009716000000000001,0.9929309999999999,KIAA1191 MRPL35 SAMD12 TP53INP1,cellular response to methyl methanesulfonate|response to methyl methanesulfonate|negative regulation of myofibroblast differentiation|regulation of myofibroblast differentiation|autophagic cell death,0.0003883|0.0003883|0.0009706|0.001165|0.001359,1|1|1|1|1,5149|5149|1287|1030|858.1
2554,4,0.5081,3.048,3139.0,0.0009677999999999999,0.9929309999999999,CHRNB1 KIAA1211 OR5AS1 TM4SF18,negative regulation of barbed-end actin filament capping|regulation of barbed-end actin filament capping|behavioral response to nicotine|positive regulation of actin filament depolymerization|system process,0.0009706|0.001359|0.001359|0.002716|0.003608,1|1|1|1|1,1287|858.1|858.1|396.1|7.572
2555,5,0.5076,5.0760000000000005,4212.0,0.001201,0.996692,ANKRD53 FAM178B KIAA1324 SULT1C3 SULT1C4,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process,9.177e-06|9.911e-06|9.911e-06|0.0002536|0.0002536,0.1448|0.07817|0.05211|1|0.8001,429.1|411.9|411.9|77.42|77.42
2556,14,0.5084,46.26,11300.0,0.004068,0.9999969999999999,ABCA2 AK8 CERCAM DPP7 ENTPD2 FAM69B GLT6D1 LCN10 LCN15 LCN6 LCN8 NTMT1 PHPT1 TUBB4B,negative regulation of ATP citrate synthase activity|negative regulation of cholesterol esterification|N-terminal peptidyl-proline methylation|N-terminal peptidyl-serine methylation|N-terminal peptidyl-serine dimethylation,0.001358|0.001358|0.001358|0.001358|0.001358,1|1|1|1|1,1471|1471|1471|1471|1471
2557,6,0.5143,7.7139999999999995,5021.0,0.0015300000000000001,0.998474,CHIT1 FAM129A IGFN1 KIAA1614 METTL13 SEC16B,chitin catabolic process|chitin metabolic process|polysaccharide digestion|protein localization to endoplasmic reticulum exit site|glucosamine-containing compound catabolic process,0.001698|0.001698|0.001698|0.002183|0.002425,1|1|1|1|1,686.5|686.5|686.5|514.9|457.7
2558,4,0.5485,3.2910000000000004,3161.0,0.001038,0.9929309999999999,C2CD5 HHIPL2 KIF16B PRSS57,insulin receptor signaling pathway via phosphatidylinositol 3-kinase|positive regulation of vesicle fusion|Golgi to endosome transport|transmembrane receptor protein tyrosine kinase signaling pathway|regulation of receptor recycling,0.0009706|0.002134|0.003491|0.003704|0.004653,1|1|1|1|1,1287|514.9|302.9|19.84|223.9
2559,8,0.511,14.31,6272.0,0.00227,0.9996790000000001,EEF1A2 FAM209A KIF1A NPBWR2 OPRL1 RBM38 VAPB ZGPAT,opioid receptor signaling pathway|negative regulation by host of viral release from host cell|neuropeptide signaling pathway|positive regulation of gastric acid secretion|negative regulation by virus of viral protein levels in host cell,8.691e-06|0.0007765|0.0007886|0.001164|0.001164,0.1371|1|1|1|1,514.9|2574|47.24|1287|1287
2560,4,0.5527,3.3160000000000003,3298.0,0.0010019999999999999,0.9929309999999999,CYTH4 KIF21A PBLD ZMYND19,negative regulation of SMAD protein signal transduction|negative regulation of pathway-restricted SMAD protein phosphorylation|regulation of ARF protein signal transduction|maintenance of gastrointestinal epithelium|epithelial structure maintenance,0.001553|0.002716|0.003878|0.004072|0.005426,1|1|1|1|1,735.5|396.1|271|257.4|190.7
2561,4,0.5642,3.385,3122.0,0.00108,0.9929309999999999,IGSF11 KIF21B OR5M9 PITHD1,penetration of cumulus oophorus|positive regulation of mini excitatory postsynaptic potential|regulation of mini excitatory postsynaptic potential|penetration of zona pellucida|positive regulation of megakaryocyte differentiation,0.0003883|0.0005825|0.0005825|0.001941|0.002328,1|1|1|1|1,5149|2574|2574|572.1|468.1
2562,4,0.5037,3.022,3086.0,0.0009756999999999999,0.9929309999999999,EML3 IL4R KIF26A NKAIN1,negative regulation of T-helper 1 cell differentiation|response to odorant|regulation of cell growth by extracellular stimulus|interleukin-4-mediated signaling pathway|positive regulation of T-helper 2 cell differentiation,0.0007766|0.0007766|0.0007766|0.0009706|0.001553,1|1|1|1|1,1716|1716|1716|1287|735.5
2563,5,0.5107,5.107,4206.0,0.00121,0.996692,ACBD3 FAM177B HTR3D KIF3A SERP1,positive regulation of establishment or maintenance of cell polarity regulating cell shape|regulation of establishment or maintenance of cell polarity regulating cell shape|positive regulation of axo-dendritic protein transport|regulation of axo-dendritic protein transport|plus-end-directed vesicle transport along microtubule,0.0004854|0.0004854|0.0004854|0.0004854|0.001698,1|1|1|1|1,4119|4119|4119|4119|686.5
2564,5,0.5398,5.398,4139.0,0.001299,0.996692,APOB CIZ1 KIF3C PDGFD SLC37A2,positive regulation of DNA-dependent DNA replication initiation|positive regulation of monocyte extravasation|positive regulation of smooth muscle cell chemotaxis|triglyceride mobilization|regulation of monocyte extravasation,0.000728|0.0009706|0.001213|0.001213|0.001213,1|1|1|1|1,2060|1373|1030|1030|1030
2565,4,0.551,3.306,3390.0,0.0009721,0.9929309999999999,C5 CAMK1 KIF4B OSM,positive regulation of peptidyl-serine phosphorylation|positive regulation of protein phosphorylation|regulation of peptidyl-serine phosphorylation|positive regulation of phosphorylation|positive regulation of phosphorus metabolic process,0.0001714|0.0002538|0.0002966|0.000339|0.0004294,1|1|1|1|1,94.47|18.65|71.51|16.92|15.62
2566,4,0.5891,3.534,3111.0,0.001132,0.9929309999999999,DPYSL2 KIF5B MAP7D1 PPFIA1,synaptic vesicle transport|synaptic vesicle localization|regulation of protein localization to plasma membrane|regulation of protein localization to cell periphery|positive regulation of voltage-gated sodium channel activity,2.313e-05|3.048e-05|0.0001563|0.0002245|0.0003883,0.3649|0.2404|0.822|0.8851|1,264|228.8|99.01|82.38|5149
2567,4,0.5149,3.089,3123.0,0.0009857000000000002,0.9929309999999999,KIF6 NDUFS4 SRGAP3 ZFP30,"cAMP-mediated signaling|mitochondrial electron transport, NADH to ubiquinone|positive regulation of fibroblast proliferation|cyclic-nucleotide-mediated signaling|NADH dehydrogenase complex assembly",0.0062|0.009675|0.009675|0.01025|0.01295,1|1|1|1|1,166.1|105.1|105.1|99.01|78.01
2568,5,0.5254,5.254,3766.0,0.001389,0.996692,ADCY6 ANKMY2 KIF7 PTGES3 RIC8B,cellular response to vasopressin|response to vasopressin|telomerase holoenzyme complex assembly|negative regulation of urine volume|glucocorticoid receptor signaling pathway,0.0009706|0.0009706|0.001213|0.001456|0.001698,1|1|1|1|1,1373|1373|1030|823.8|686.5
2569,5,0.5028,5.0280000000000005,4091.0,0.001225,0.996692,GPR162 KIRREL3 METTL25 PITPNM2 PLEKHG7,principal sensory nucleus of trigeminal nerve development|trigeminal sensory nucleus development|inter-male aggressive behavior|aggressive behavior|glomerulus morphogenesis,0.000728|0.000728|0.000728|0.00194|0.002183,1|1|1|1|1,2060|2060|2060|588.4|514.9
2570,4,0.5404,3.242,3090.0,0.001045,0.9929309999999999,FXR1 FXR2 KISS1R OTUD4,"regulation of filopodium assembly|regulation of alternative mRNA splicing, via spliceosome|regulation of mRNA splicing, via spliceosome|positive regulation of response to DNA damage stimulus|positive regulation of translation",3.316e-05|4.987e-05|0.0001505|0.0001746|0.000265,0.523|0.3933|0.7912|0.6883|0.836,219.1|177.5|101|93.61|75.72
2571,5,0.5212,5.212000000000001,4072.0,0.001275,0.996692,DIABLO KITLG NOS1 RIMBP2 TMEM233,extrinsic apoptotic signaling pathway|negative regulation of mast cell apoptotic process|regulation of mast cell apoptotic process|positive regulation of mast cell proliferation|retrograde trans-synaptic signaling by nitric oxide,0.0002989|0.0005824|0.0008735|0.0008735|0.0008735,1|1|1|1|1,75.44|3432|1716|1716|1716
2572,8,0.5021,14.06,6689.0,0.002092,0.9996790000000001,AGO1 AGO4 BEST4 CLEC2L FAAH KL LURAP1 ZNF684,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",6.096e-06|7.619e-06|9.31e-06|1.776e-05|1.776e-05,0.09616|0.06009|0.04895|0.07002|0.05602,653.8|572.1|508.5|352.1|352.1
2573,5,0.5355,5.355,4252.0,0.001255,0.996692,ARL5B EBPL KIF5B KLC1 SLC2A8,stress granule disassembly|ribonucleoprotein complex disassembly|organelle disassembly|positive regulation of voltage-gated sodium channel activity|ribonucleoprotein complex subunit organization,9.893e-07|1.696e-06|0.0001299|0.0004854|0.0009109,0.01561|0.01337|0.6828|1|1,1648|1177|112.8|4119|41.82
2574,6,0.5001,7.502000000000001,5181.0,0.001442,0.998474,CPNE5 KLC4 MAP3K7CL RAB22A RAD21L1 WDYHV1,meiotic telomere tethering at nuclear periphery|meiotic attachment of telomere to nuclear envelope|telomere tethering at nuclear periphery|chromosome attachment to the nuclear envelope|replication-born double-strand break repair via sister chromatid exchange,0.001746|0.001746|0.001746|0.002328|0.002619,1|1|1|1|1,686.5|686.5|686.5|490.4|429.1
2575,4,0.6063,3.638,3235.0,0.001121,0.9929309999999999,KLF11 KLHDC9 SCAMP5 TMPRSS11E,positive regulation of calcium ion-dependent exocytosis|regulation of transcription involved in G1/S transition of mitotic cell cycle|regulation of calcium ion-dependent exocytosis|negative regulation of endocytosis|positive regulation of regulated secretory pathway,0.003878|0.00678|0.008131|0.009289|0.01045,1|1|1|1|1,271|151.4|125.6|109.5|97.15
2576,4,0.5334,3.201,3030.0,0.001052,0.9929309999999999,CALCA FOLR2 KLF14 RABL2A,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure|positive regulation of sphingolipid mediated signaling pathway|regulation of sphingolipid mediated signaling pathway|baroreceptor response to increased systemic arterial blood pressure|regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
2577,5,0.5014,5.013999999999999,4267.0,0.0011710000000000002,0.996692,KLF16 NIN NTPCR SLC23A2 SUMF1,transepithelial L-ascorbic acid transport|centrosome-templated microtubule nucleation|L-ascorbic acid transmembrane transport|corpus callosum morphogenesis|microtubule nucleation by microtubule organizing center,0.000728|0.000728|0.000728|0.001456|0.001456,1|1|1|1|1,2060|2060|2060|823.8|823.8
2578,5,0.5308,5.308,3630.0,0.001456,0.996692,AZIN1 METTL5 OAZ1 ODC1 RFX6,polyamine biosynthetic process|polyamine metabolic process|cellular biogenic amine biosynthetic process|amine biosynthetic process|regulation of cellular amino acid metabolic process,4.663e-09|1.056e-08|7.858e-08|8.447e-08|3.424e-07,7.356e-05|8.326e-05|0.0004132|0.0003331|0.00108,882.6|650.4|316.8|308.9|190.1
2579,4,0.507,3.042,3256.0,0.0009311,0.9929309999999999,APOBEC2 KLF9 LARGE1 RIPPLY2,cellular response to cortisol stimulus|response to cortisol|somite rostral/caudal axis specification|cytidine metabolic process|cytidine catabolic process,0.0003883|0.001165|0.002328|0.002522|0.002522,1|1|1|1|1,5149|1030|468.1|429.1|429.1
2580,4,0.5286,3.1719999999999997,3001.0,0.001053,0.9929309999999999,KCNK13 KLHDC3 KLHDC9 TSPYL1,stabilization of membrane potential|IRE1-mediated unfolded protein response|reciprocal meiotic recombination|reciprocal homologous recombination|homologous recombination,0.003491|0.01083|0.01102|0.01102|0.01141,1|1|1|1|1,302.9|93.61|91.94|91.94|88.77
2581,5,0.503,5.03,3611.0,0.001387,0.996692,KIF23 KLHDC8A LILRB3 PRC1 RACGAP1,mitotic spindle midzone assembly|spindle elongation|mitotic spindle elongation|spindle midzone assembly|mitotic spindle assembly,1.132e-09|1.132e-09|1.132e-09|3.121e-09|1.341e-07,1.786e-05|8.928e-06|5.952e-06|1.231e-05|0.000423,1545|1545|1545|1030|262.9
2582,4,0.5643,3.386,3259.0,0.001035,0.9929309999999999,KLHL14 PIK3AP1 SNRPN UCMA,toll-like receptor 7 signaling pathway|toll-like receptor 2 signaling pathway|negative regulation of SMAD protein signal transduction|toll-like receptor 9 signaling pathway|toll-like receptor 4 signaling pathway,0.001165|0.001165|0.001553|0.003297|0.004266,1|1|1|1|1,1030|1030|735.5|321.8|245.2
2583,5,0.5124,5.124,3645.0,0.0014,0.996692,APC AXIN1 CTNNBIP1 KLHL17 RTN4R,beta-catenin destruction complex assembly|negative regulation of Wnt signaling pathway|beta-catenin destruction complex disassembly|cell-cell signaling by wnt|Wnt signaling pathway,9.893e-07|1.135e-05|1.19e-05|4.823e-05|4.823e-05,0.01561|0.08952|0.06257|0.1902|0.1521,1648|57.74|392.3|35.41|35.41
2584,6,0.5399,8.099,5274.0,0.0015300000000000001,0.998474,CLDN24 FIGN KLHL2 PLAGL1 SMIM14 TSPAN5,microtubule severing|blastocyst hatching|organism emergence from protective structure|hatching|supramolecular fiber organization,0.003781|0.007839|0.007839|0.007839|0.01171,1|1|1|1|1,286|132|132|132|11.5
2585,5,0.5041,5.041,4064.0,0.001236,0.996692,ACTG2 ADORA2B KLHL21 REPIN1 ZNF843,chromosome passenger complex localization to spindle midzone|mesenchyme migration|G protein-coupled adenosine receptor signaling pathway|G protein-coupled purinergic receptor signaling pathway|cellular protein-containing complex localization,0.0004854|0.001456|0.002425|0.002425|0.005329,1|1|1|1|1,4119|823.8|457.7|457.7|196.1
2586,4,0.5388,3.233,3131.0,0.001029,0.9929309999999999,ATP13A4 KLHL24 LEP XKR6,negative regulation of glutamine transport|cellular response to L-ascorbic acid|positive regulation of fat cell apoptotic process|positive regulation of luteinizing hormone secretion|regulation of glutamine transport,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
2587,4,0.5326,3.195,3150.0,0.001011,0.9929309999999999,CLEC12A DMXL2 KLHL25 TRIM69,vacuolar acidification|protein ubiquitination|protein modification by small protein conjugation|intracellular pH reduction|pH reduction,0.004653|0.007427|0.009066|0.009482|0.01006,1|1|1|1|1,223.9|13.9|12.54|107.3|101
2588,4,0.5611,3.367,3257.0,0.00103,0.9929309999999999,ATP8A2 KLHL28 RNASE6 TOGARAM1,involuntary skeletal muscle contraction|positive regulation of phospholipid translocation|regulation of phospholipid translocation|aminophospholipid translocation|neurofilament cytoskeleton organization,0.0007766|0.001165|0.001359|0.001553|0.001747,1|1|1|1|1,1716|1030|858.1|735.5|643.6
2589,5,0.5483,5.483,3509.0,0.001556,0.996692,CASC1 KLHL29 KRAS LRMP SOX5,endocrine signaling|forebrain astrocyte development|forebrain astrocyte differentiation|positive regulation of mesenchymal stem cell differentiation|regulation of mesenchymal stem cell differentiation,0.0004854|0.000728|0.000728|0.001213|0.001698,1|1|1|1|1,4119|2060|2060|1030|686.5
2590,4,0.5026,3.016,3171.0,0.0009477999999999999,0.9929309999999999,B3GALT1 KLHL3 MTREX RILP,negative regulation of cardiac muscle cell myoblast differentiation|regulation of cardiac muscle cell myoblast differentiation|negative regulation of cardioblast differentiation|intralumenal vesicle formation|distal tubule morphogenesis,0.0004854|0.0004854|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|4119|2060|2060|1373
2591,4,0.5591,3.355,3246.0,0.00103,0.9929309999999999,FZD10 KLHL32 MYO3A PNPLA7,non-canonical Wnt signaling pathway via JNK cascade|non-canonical Wnt signaling pathway via MAPK cascade|phosphatidylcholine catabolic process|cochlea morphogenesis|glycerophospholipid catabolic process,0.001165|0.001359|0.002522|0.004846|0.005813,1|1|1|1|1,1030|858.1|429.1|214.5|177.5
2592,4,0.5271,3.1630000000000003,3245.0,0.0009712,0.9929309999999999,KLK13 LPCAT4 PSKH1 USP4,spliceosomal tri-snRNP complex assembly|phosphatidylglycerol acyl-chain remodeling|organonitrogen compound metabolic process|phosphatidylserine acyl-chain remodeling|phosphatidylethanolamine acyl-chain remodeling,0.002716|0.003685|0.004232|0.004459|0.005233,1|1|1|1|1,396.1|286|3.922|234|198
2593,4,0.5233,3.14,3197.0,0.0009787,0.9929309999999999,KIF19 KLK15 LXN TTYH2,axonemal microtubule depolymerization|plus-end specific microtubule depolymerization|cytoplasmic microtubule depolymerization|cilium disassembly|microtubule depolymerization,0.0003883|0.0003883|0.0003883|0.0003883|0.003491,1|1|1|1|1,5149|5149|5149|5149|302.9
2594,21,0.5015,105.3,17090.0,0.006111,1.0,GP6 KIR2DL1 KLK11 KLK3 KLK5 SIGLEC12 SIGLEC5 SIGLEC9 VN1R4 ZNF175 ZNF28 ZNF415 ZNF432 ZNF528 ZNF534 ZNF610 ZNF613 ZNF665 ZNF677 ZNF701 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of gene expression",5.499e-06|0.000111|0.0001114|0.000113|0.0001525,0.08674|0.8758|0.5856|0.4455|0.4811,4.155|3.102|3.101|3.097|2.573
2595,4,0.5542,3.325,3092.0,0.0010710000000000001,0.9929309999999999,DNAJC5 KLRF1 PPIC ZNF280A,protein folding|regulation of synaptic vesicle cycle|protein peptidyl-prolyl isomerization|synaptic vesicle exocytosis|chaperone-mediated protein folding,0.0007339|0.001747|0.009482|0.01122|0.01199,1|1|1|1|1,45.16|643.6|107.3|90.33|84.41
2596,4,0.5676,3.405,3057.0,0.0011099999999999999,0.9929309999999999,ANKRD61 IQCB1 KLRK1 SLC25A40,negative regulation of natural killer cell chemotaxis|negative regulation of lymphocyte chemotaxis|maintenance of animal organ identity|regulation of natural killer cell chemotaxis|negative regulation of lymphocyte migration,0.0005825|0.0007766|0.001165|0.001747|0.00291,1|1|1|1|1,2574|1716|1030|643.6|367.8
2597,4,0.5274,3.165,3199.0,0.000986,0.9929309999999999,IL23A KNDC1 LLPH OTOP3,positive regulation of T-helper 17 cell lineage commitment|positive regulation of NK T cell proliferation|regulation of NK T cell proliferation|regulation of T-helper 17 cell lineage commitment|positive regulation of T-helper 17 cell differentiation,0.0009706|0.0009706|0.001165|0.001553|0.001553,1|1|1|1|1,1287|1287|1030|735.5|735.5
2598,6,0.5035,7.553,4567.0,0.0016469999999999998,0.998474,CLEC12A CLEC4D CLEC9A KNG1 PRAP1 TAS2R20,regulated exocytosis|positive regulation of myeloid dendritic cell activation|exocytosis|vesicle-mediated transport|regulation of myeloid dendritic cell activation,0.0007114|0.0008735|0.001022|0.001051|0.001746,1|1|1|1|1,14.86|1716|13.12|7.012|686.5
2599,4,0.5065,3.0389999999999997,3115.0,0.0009720000000000001,0.9929309999999999,HSPH1 KPNA3 PSPC1 TSPAN15,viral penetration into host nucleus|positive regulation of MHC class I biosynthetic process|positive regulation of NK T cell activation|regulation of MHC class I biosynthetic process|regulation of NK T cell activation,0.0009706|0.001359|0.001553|0.001747|0.001941,1|1|1|1|1,1287|858.1|735.5|643.6|572.1
2600,4,0.5765,3.4589999999999996,3403.0,0.001013,0.9929309999999999,HOXB8 KRBA2 LMTK3 TEAD2,embryonic organ morphogenesis|lateral mesoderm development|embryonic organ development|grooming behavior|DNA integration,0.001179|0.002522|0.002525|0.002716|0.003685,1|1|1|1|1,35.51|429.1|24.12|396.1|286
2601,4,0.5121,3.073,3215.0,0.0009524,0.9929309999999999,CCDC112 KRCC1 LYSMD3 TCHP,negative regulation of cilium assembly|negative regulation of plasma membrane bounded cell projection assembly|negative regulation of organelle assembly|regulation of cilium assembly|Golgi organization,0.00291|0.006007|0.008324|0.0116|0.02615,1|1|1|1|1,367.8|171.6|122.6|87.27|38.14
2602,6,0.5288,7.933,4369.0,0.001807,0.998474,DDX49 EIF3G KRI1 PPAN SF3A2 XAB2,ribonucleoprotein complex biogenesis|ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|cellular component biogenesis|cellular protein-containing complex assembly,1.384e-10|1.127e-07|1.299e-07|5.123e-06|4.288e-05,2.184e-06|0.0008889|0.0006832|0.0202|0.1353,44.29|72.26|69.7|7.625|15.98
2603,4,0.5179,3.1069999999999998,3176.0,0.000975,0.9929309999999999,FGD5 FZD6 KRT18 RAB2B,cholangiocyte apoptotic process|embryonic nail plate morphogenesis|Golgi to plasma membrane CFTR protein transport|establishment of body hair planar orientation|establishment of body hair or bristle planar orientation,0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
2604,4,0.5056,3.034,3268.0,0.0009251,0.9929309999999999,CAP2 CATSPER3 KRT38 SRRM5,epithelial cell-cell adhesion|sperm capacitation|cAMP-mediated signaling|regulation of adenylate cyclase activity|activation of adenylate cyclase activity,0.004604|0.006537|0.007744|0.008226|0.01015,1|1|1|1|1,228.8|158.4|132.9|124.8|100.5
2605,5,0.5514,5.513999999999999,3973.0,0.001382,0.996692,CUEDC1 GJB6 KRT6C RASA3 ZFP90,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|maintenance of blood-brain barrier,0.001698|0.00194|0.002183|0.005087|0.008467,1|1|1|1|1,686.5|588.4|514.9|205.9|121.1
2606,5,0.5298,5.297999999999999,4280.0,0.001233,0.996692,FADS6 FCGRT KRTAP10-12 SGCA STOML3,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor|immunoglobulin transcytosis in epithelial cells|response to denervation involved in regulation of muscle adaptation|response to muscle inactivity involved in regulation of muscle adaptation|response to muscle inactivity,0.0004854|0.0009706|0.00291|0.00291|0.003152,1|1|1|1|1,4119|1373|374.5|374.5|343.3
2607,4,0.5438,3.263,3186.0,0.0010199999999999999,0.9929309999999999,KRTAP25-1 MGAT4C MNDA NOXO1,regulation of respiratory burst|negative regulation of B cell proliferation|regulation of hydrogen peroxide metabolic process|cellular response to interferon-beta|response to interferon-beta,0.003297|0.003685|0.003878|0.004459|0.006393,1|1|1|1|1,321.8|286|271|234|160.9
2608,27,0.5019,176.2,21710.0,0.008031,1.0,AEBP1 AGR3 CALM1 EGR3 FKBP9 GCK GHRHR GPCPD1 KIAA0895 LANCL2 MYL7 NIPSNAP2 NUPR2 PHKG1 PKD1L1 PSPH RNASET2 SEPT14 SLC29A4 SPATA48 SUMF2 VSTM2A VWC2 WIPF3 ZNF479 ZNF713 ZNF716,carbohydrate catabolic process|cellular carbohydrate metabolic process|negative regulation of ryanodine-sensitive calcium-release channel activity|negative regulation of release of sequestered calcium ion into cytosol|regulation of high voltage-gated calcium channel activity,2.313e-05|0.0001124|0.0001475|0.0001982|0.0002263,0.3649|0.8863|0.7755|0.7816|0.714,24.49|16.14|129.1|109.3|101.5
2609,4,0.5263,3.158,3107.0,0.001013,0.9929309999999999,CDA KRTAP5-5 TBX2 ZBTB46,negative regulation of cardiac chamber formation|regulation of cardiac chamber formation|negative regulation of heart looping|ureteric peristalsis|regulation of heart looping,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
2610,4,0.516,3.096,3228.0,0.0009557000000000001,0.9929309999999999,KRTAP5-6 STMN3 TEX101 TXNDC5,negative regulation of Rac protein signal transduction|regulation of microtubule-based process|microtubule depolymerization|regulation of flagellated sperm motility|regulation of Rac protein signal transduction,0.0007766|0.000779|0.003491|0.004072|0.004072,1|1|1|1|1,1716|43.82|302.9|257.4|257.4
2611,4,0.5337,3.202,3310.0,0.0009641,0.9929309999999999,DLGAP4 KRTAP5-8 RIMS4 SLPI,keratinization|GDP-mannose biosynthetic process|keratinocyte differentiation|GDP-mannose metabolic process|epidermal cell differentiation,0.001193|0.001456|0.001667|0.002183|0.002304,1|1|1|1|1,36.45|823.8|30.74|514.9|26.07
2612,9,0.5002,18.01,6233.0,0.002872,0.9998530000000001,FTSJ3 GNL2 NLE1 NOL12 NOP2 RPF2 RPL28 RRS1 SDAD1,ribosome biogenesis|ribosomal large subunit biogenesis|ribonucleoprotein complex biogenesis|ribosomal large subunit assembly|ribosome assembly,4.495e-14|2.014e-13|6.419e-13|6.003e-10|1.35e-08,7.091e-10|1.588e-09|3.375e-09|2.367e-06|4.259e-05,55.14|190.7|39.37|326.9|143
2613,24,0.5056,139.5,18160.0,0.007606999999999999,1.0,CLK2 CTSK FCRL3 FLG2 GBA HAPLN2 HIST2H2AB ITLN2 LCE3E LCE5A OR6K6 PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A6 S100A7A S100A8 S100A9 SLAMF7 THBS3 TRIM46 TTC24,neutrophil aggregation|sequestering of zinc ion|defense response to fungus|antimicrobial humoral response|peptidyl-cysteine S-nitrosylation,7.132e-06|1.781e-05|1.784e-05|2.757e-05|3.319e-05,0.1125|0.1404|0.0938|0.1087|0.1047,895.4|447.7|62.47|22.96|298.5
2614,5,0.5014,5.013999999999999,4029.0,0.00124,0.996692,ABHD12B JPH1 KRTCAP3 SLC15A3 TMEM204,peptidoglycan transport|phosphatidylserine catabolic process|dipeptide import across plasma membrane|oligopeptide import across plasma membrane|positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,0.0009706|0.001213|0.001456|0.001456|0.001456,1|1|1|1|1,1373|1030|823.8|823.8|823.8
2615,4,0.576,3.4560000000000004,3244.0,0.001062,0.9929309999999999,BMPR1B CASP10 CXCR2 KRTDAP,interleukin-8-mediated signaling pathway|ovarian cumulus expansion|cellular response to interleukin-8|response to interleukin-8|fused antrum stage,0.000728|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|1373|1373|1373|1373
2616,5,0.5087,5.087,4061.0,0.001248,0.996692,ARG2 KSR1 LPP RSPH4A SPO11,"negative regulation of chemokine (C-C motif) ligand 4 production|regulation of chemokine (C-C motif) ligand 4 production|negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process|radial spoke assembly|arginine catabolic process to ornithine",0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
2617,4,0.5096,3.057,3146.0,0.0009683999999999999,0.9929309999999999,KYNU SST TMEM252 VCAM1,amine metabolic process|response to nutrient|response to nutrient levels|response to extracellular stimulus|cellular biogenic amine metabolic process,5.585e-07|2.274e-06|5.518e-05|6.571e-05|0.0001419,0.00881|0.01794|0.2901|0.2591|0.4477,147.1|91.4|31.2|29.42|104
2618,4,0.5662,3.397,3370.0,0.001004,0.9929309999999999,IL36RN LACC1 PDIA5 RRP1B,response to other organism|response to external biotic stimulus|response to biotic stimulus|nucleotide-binding oligomerization domain containing 2 signaling pathway|cytokine production involved in immune response,0.001243|0.001248|0.001341|0.001747|0.002328,1|1|1|1|1,10.89|10.88|10.62|643.6|468.1
2619,4,0.5074,3.0439999999999996,3261.0,0.0009302999999999999,0.9929309999999999,B4GALNT3 LACTB TNC TNFAIP1,mesenchymal-epithelial cell signaling involved in prostate gland development|bud outgrowth involved in lung branching|cellular response to prostaglandin D stimulus|response to prostaglandin D|peripheral nervous system axon regeneration,0.0003883|0.0007766|0.0009706|0.0009706|0.001359,1|1|1|1|1,5149|1716|1287|1287|858.1
2620,5,0.5116,5.1160000000000005,4168.0,0.0012230000000000001,0.996692,CELF6 CMTM8 LAD1 SEMA7A SKOR1,positive regulation of macrophage cytokine production|regulation of macrophage cytokine production|positive regulation of myeloid leukocyte cytokine production involved in immune response|negative regulation of axon extension involved in axon guidance|chemotaxis,0.002667|0.003878|0.004604|0.006537|0.006697,1|1|1|1|1,411.9|274.6|228.8|158.4|15.09
2621,4,0.5027,3.016,3240.0,0.0009277,0.9929309999999999,LAMA1 MDH1 THAP2 TRIM54,retinal blood vessel morphogenesis|malate metabolic process|oxaloacetate metabolic process|retina vasculature morphogenesis in camera-type eye|branching involved in salivary gland morphogenesis,0.001359|0.001747|0.001941|0.002328|0.003104,1|1|1|1|1,858.1|643.6|572.1|468.1|343.2
2622,18,0.506,77.41,14410.0,0.0053289999999999995,1.0,ABHD3 B4GALT6 C18orf32 CHST9 CTIF DSC1 DSG1 DSG3 DSG4 HRH4 KIAA1328 LAMA3 MAPRE2 RMC1 SERPINB5 SERPINB7 ZNF396 ZNF397,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|epidermis development|keratinization|cell-cell adhesion,2.837e-06|1.278e-05|2.415e-05|4.086e-05|6.481e-05,0.04475|0.1008|0.127|0.1611|0.2045,40.5|27.41|13.72|20.25|11.13
2623,4,0.5366,3.22,3208.0,0.001,0.9929309999999999,APOE LAMA4 PLCB1 TCF7,regulation of embryonic development|fat cell differentiation|memory|regulation of developmental process|regulation of multicellular organismal process,5.679e-05|0.0001391|0.0001905|0.0001981|0.0002738,0.8958|1|1|0.781|0.8637,166.1|105.1|89.54|8.437|7.781
2624,4,0.5416,3.25,2942.0,0.001101,0.9929309999999999,LAMB3 RPL14 RPL21 VWDE,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,0.0001336|0.0001476|0.0001777|0.0001905|0.0001938,1|1|0.9343|0.7512|0.6113,107.3|102|92.77|89.54|88.77
2625,6,0.5063,7.593999999999999,4940.0,0.001531,0.998474,LAMC1 PEPD SIGLEC7 SIGLEC9 ZNF432 ZNF534,cell adhesion|biological adhesion|hemidesmosome assembly|maintenance of blood-brain barrier|collagen catabolic process,0.001782|0.001815|0.003781|0.01015|0.01275,1|1|1|1|1,10.83|10.76|286|101|79.83
2626,5,0.5309,5.309,4132.0,0.00128,0.996692,ABCA3 CCDC83 CUL4A LAMP1 SMIM18,positive regulation of protein homooligomerization|regulation of protein homooligomerization|positive regulation of protein oligomerization|drug export|regulation of nucleotide-excision repair,0.000728|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,2060|1373|1373|1373|1030
2627,5,0.5124,5.124,4028.0,0.001267,0.996692,B3GALT5 FAM107B LAMP5 SCGB2A2 ZNF841,poly-N-acetyllactosamine biosynthetic process|poly-N-acetyllactosamine metabolic process|androgen receptor signaling pathway|oligosaccharide biosynthetic process|cellular polysaccharide biosynthetic process,0.003152|0.003394|0.004604|0.007502|0.0116,1|1|1|1|1,343.3|316.8|228.8|137.3|87.64
2628,4,0.5692,3.415,3300.0,0.001031,0.9929309999999999,CLCA1 FAM25A LAMTOR5 PPP2R3A,regulation of cell migration involved in somitogenic axis elongation|somatic muscle development|Wnt signaling pathway involved in somitogenesis|positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding|regulation of RNA polymerase II regulatory region sequence-specific DNA binding,0.0005825|0.0007766|0.0009706|0.0009706|0.003104,1|1|1|1|1,2574|1716|1287|1287|343.2
2629,4,0.5971,3.582,3247.0,0.0011,0.9929309999999999,LANCL1 PDE8A TRPC4 ZNF865,regulation of oxidative stress-induced cell death|regulation of cellular response to oxidative stress|regulation of response to oxidative stress|gamma-aminobutyric acid secretion|cAMP catabolic process,5.859e-05|8.235e-05|0.0001028|0.0005825|0.001941,0.9241|0.6495|0.5406|1|1,163.5|137.3|122.6|2574|572.1
2630,4,0.5365,3.219,3222.0,0.0009956,0.9929309999999999,DDX25 FMNL3 LARP1B TTC39B,negative regulation of cholesterol storage|regulation of cholesterol storage|negative regulation of lipid storage|poly(A)+ mRNA export from nucleus|regulation of cholesterol efflux,0.001941|0.003297|0.004266|0.004459|0.0062,1|1|1|1|1,572.1|321.8|245.2|234|166.1
2631,4,0.5343,3.2060000000000004,2936.0,0.001088,0.9929309999999999,FAM102A KIAA0100 KIAA1109 LATS1,inner cell mass cellular morphogenesis|inner cell mass cell fate commitment|inner cell mass cell differentiation|mammary gland epithelial cell differentiation|cytoplasmic sequestering of protein,0.0005825|0.0005825|0.001359|0.003297|0.00504,1|1|1|1|1,2574|2574|858.1|321.8|205.9
2632,4,0.548,3.2880000000000003,3209.0,0.001021,0.9929309999999999,CD2AP LBX1 NKX2-4 SLC25A35,"negative regulation of transforming growth factor beta1 production|neuron fate determination|substrate-dependent cell migration, cell extension|regulation of transforming growth factor beta1 production|negative regulation of transforming growth factor beta production",0.001553|0.001747|0.001941|0.002716|0.00291,1|1|1|1|1,735.5|643.6|572.1|396.1|367.8
2633,5,0.5111,5.111000000000001,3959.0,0.001286,0.996692,BNIP2 CELF6 GOLGA6D LCE2D LINGO1,polyphosphate catabolic process|polyphosphate metabolic process|response to oxygen-glucose deprivation|mRNA splice site selection|spliceosomal complex assembly,0.001456|0.001698|0.002667|0.007985|0.014,1|1|1|1|1,823.8|686.5|411.9|128.7|72.26
2634,4,0.5007,3.0039999999999996,3020.0,0.0009912,0.9929309999999999,DISP1 LCK PSEN1 ZAP70,T cell receptor signaling pathway|T cell activation|mononuclear cell differentiation|antigen receptor-mediated signaling pathway|leukocyte differentiation,2.741e-06|6.59e-06|1.093e-05|1.235e-05|2.021e-05,0.04324|0.05198|0.05748|0.04869|0.06377,85.81|63.83|53.82|51.66|43.76
2635,4,0.5532,3.319,3243.0,0.0010199999999999999,0.9929309999999999,ACRV1 DPCD LCMT2 MC4R,third ventricle development|wybutosine biosynthetic process|wybutosine metabolic process|regulation of grooming behavior|negative regulation of feeding behavior,0.0009706|0.0009706|0.0009706|0.001165|0.001941,1|1|1|1|1,1287|1287|1287|1030|572.1
2636,4,0.5094,3.056,3311.0,0.0009199999999999999,0.9929309999999999,CD7 LCN9 PCDH10 RANBP3L,mesenchymal cell differentiation involved in bone development|positive regulation of myoblast differentiation|negative regulation of osteoblast differentiation|regulation of myoblast differentiation|regulation of osteoblast differentiation,0.0005825|0.004459|0.009096|0.01025|0.02329,1|1|1|1|1,2574|234|111.9|99.01|42.91
2637,14,0.5022,45.7,11210.0,0.004051,0.9999969999999999,ABCA2 AK8 DPP7 ENTPD2 FAM69B GLT6D1 LCN10 LCN15 LCN6 LCN8 LCNL1 PHPT1 STPG3 TUBB4B,negative regulation of ATP citrate synthase activity|regulation of ATP citrate synthase activity|peptidyl-histidine dephosphorylation|negative regulation of cholesterol esterification|nucleoside diphosphate metabolic process,0.001358|0.001358|0.001358|0.001358|0.001516,1|1|1|1|1,1471|1471|1471|1471|35.03
2638,8,0.5046,14.13,4900.0,0.002866,0.9996790000000001,CCNE2 CDK4 CDK6 CKS1B E2F3 SKP2 TCF19 UBE2Q1,G1 phase|mitotic G1 phase|mitotic interphase|interphase|mitotic cell cycle phase transition,1.188e-13|1.188e-13|5.538e-11|5.538e-11|2.062e-10,1.874e-09|9.372e-10|2.912e-07|2.184e-07|6.506e-07,612.9|612.9|162.9|162.9|54.2
2639,5,0.5174,5.1739999999999995,4491.0,0.0011480000000000001,0.996692,BDKRB2 CD2 CFAP65 LCP2 SUMF1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator|positive regulation of myeloid dendritic cell activation|membrane raft polarization|negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,0.0004854|0.0004854|0.000728|0.0009706|0.001213,1|1|1|1|1,4119|4119|2060|1373|1030
2640,4,0.5579,3.3480000000000003,3117.0,0.00107,0.9929309999999999,CSRNP3 LDB2 LRP12 TTN,striated muscle myosin thick filament assembly|sarcomerogenesis|skeletal muscle myosin thick filament assembly|myosin filament assembly|myosin filament organization,0.0007766|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1716|1287|1287
2641,4,0.5668,3.4010000000000002,3255.0,0.001041,0.9929309999999999,KIRREL3 LDLRAD2 PITPNM2 PLEKHG7,principal sensory nucleus of trigeminal nerve development|trigeminal sensory nucleus development|inter-male aggressive behavior|aggressive behavior|glomerulus morphogenesis,0.0005825|0.0005825|0.0005825|0.001553|0.001747,1|1|1|1|1,2574|2574|2574|735.5|643.6
2642,5,0.5313,5.313,4165.0,0.001271,0.996692,FZD2 LEAP2 MARK4 RFX2 TMX4,muscular septum morphogenesis|hard palate development|positive regulation of protein localization to centrosome|membranous septum morphogenesis|regulation of protein localization to centrosome,0.0009706|0.00194|0.00194|0.00194|0.002667,1|1|1|1|1,1373|588.4|588.4|588.4|411.9
2643,4,0.5423,3.2539999999999996,3194.0,0.001015,0.9929309999999999,GYPA HSD17B1 LECT2 NIPAL1,testosterone biosynthetic process|olefinic compound biosynthetic process|estrogen biosynthetic process|skeletal system development|magnesium ion transmembrane transport,0.001165|0.002522|0.002716|0.003062|0.003297,1|1|1|1|1,1030|429.1|396.1|21.86|321.8
2644,4,0.5549,3.3289999999999997,3224.0,0.001029,0.9929309999999999,LEKR1 LGI2 RPUSD1 SCN1B,corticospinal neuron axon guidance|membrane depolarization during Purkinje myocyte cell action potential|Purkinje myocyte action potential|response to pyrethroid|Purkinje myocyte to ventricular cardiac muscle cell signaling,0.0005825|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|1716|1716|1287|1030
2645,5,0.5019,5.019,3781.0,0.001322,0.996692,LENEP PCID2 TUBGCP3 ZBTB7B ZNF543,positive regulation of lymphocyte differentiation|negative regulation of NK T cell proliferation|positive regulation of leukocyte differentiation|positive regulation of hemopoiesis|positive regulation of SREBP signaling pathway,0.0002499|0.0004854|0.0005614|0.0005614|0.000728,1|1|1|1|1,80.76|4119|53.49|53.49|2060
2646,20,0.5006,95.11,15850.0,0.005947999999999999,1.0,LENG9 SMIM17 VN1R1 ZFP28 ZNF135 ZNF211 ZNF264 ZNF304 ZNF416 ZNF460 ZNF548 ZNF550 ZNF586 ZNF587 ZNF665 ZNF667 ZNF749 ZNF772 ZNF805 ZNF814,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",3.932e-13|4.846e-11|4.869e-11|4.986e-11|1.685e-10,6.202e-09|3.822e-07|2.56e-07|1.966e-07|5.314e-07,6.769|5.054|5.052|5.045|4.683
2647,4,0.5679,3.407,3250.0,0.001045,0.9929309999999999,CD79A DYRK4 EHD1 LEPR,negative regulation of growth hormone receptor signaling pathway|positive regulation of intracellular transport|endosomal transport|lymphocyte differentiation|regulation of growth hormone receptor signaling pathway,0.000728|0.001204|0.001267|0.001432|0.001698,1|1|1|1|1,2060|36.29|35.36|33.22|686.5
2648,5,0.5066,5.066,4212.0,0.001199,0.996692,CALCOCO2 LETMD1 PRAC1 PRR15L TBKBP1,xenophagy|positive regulation of autophagosome maturation|regulation of autophagosome maturation|positive regulation of protein-containing complex disassembly|selective autophagy,0.001213|0.001698|0.003636|0.008708|0.01448,1|1|1|1|1,1030|686.5|294.2|117.7|69.81
2649,8,0.5168,14.47,5062.0,0.002841,0.9996790000000001,KRAS MAP2K5 MAP3K2 MAPK7 NRAS RAF1 RCE1 SHOC2,MAPK cascade|intracellular signal transduction|cellular response to laminar fluid shear stress|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of heterotypic cell-cell adhesion,2.636e-14|1.195e-09|5.928e-06|7.696e-06|8.691e-06,4.158e-10|9.423e-06|0.03117|0.03035|0.02742,50.35|13.08|643.6|73.55|514.9
2650,5,0.5022,5.022,4258.0,0.001175,0.996692,CALHM1 H2AFY2 LGALS12 LMOD2 TMEM14A,lymphatic endothelial cell migration|sensory perception of umami taste|sensory perception of sweet taste|negative regulation of organelle organization|pointed-end actin filament capping,0.0005825|0.001359|0.001359|0.001539|0.001553,1|1|1|1|1,2574|858.1|858.1|31.02|735.5
2651,4,0.5156,3.094,3206.0,0.0009617000000000001,0.9929309999999999,LGALS3 MINDY4 SPATA3 VMO1,negative regulation of immunological synapse formation|negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell|regulation of immunological synapse formation|negative regulation of protein tyrosine phosphatase activity|regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,0.0005825|0.0007766|0.0007766|0.0007766|0.001359,1|1|1|1|1,2574|1716|1716|1716|858.1
2652,7,0.5031,10.56,5347.0,0.001967,0.9992989999999999,DVL1 FGFRL1 FZD5 LGR4 LRP5 RNF146 WLS,cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|canonical Wnt signaling pathway|cell-cell signaling,3.419e-12|3.419e-12|1.209e-11|7.441e-11|1.131e-08,5.393e-08|2.697e-08|6.359e-08|2.934e-07|3.569e-05,51.64|51.64|43.01|153.2|16.02
2653,4,0.5732,3.4389999999999996,3079.0,0.001113,0.9929309999999999,AADAC FGF12 LGR6 TFDP2,bone regeneration|regulation of neuronal action potential|regulation of voltage-gated sodium channel activity|positive regulation of triglyceride catabolic process|regulation of triglyceride catabolic process,0.0009706|0.001165|0.001553|0.001941|0.00291,1|1|1|1|1,1287|1030|735.5|572.1|367.8
2654,27,0.5012,175.9,20410.0,0.008522,1.0,CD1C CIART CTSK EFNA4 FCRL3 FLG2 GBA HAPLN2 HIST2H2AB HIST2H2BE HJV HRNR ITLN2 LCE3E LCE5A LYSMD1 PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A6 S100A8 S100A9 SELENBP1 SLAMF7 SPRR2G,skin development|regulation of water loss via skin|neutrophil aggregation|leukocyte activation|sequestering of zinc ion,5.67e-06|6.255e-06|8.455e-06|1.002e-05|2.111e-05,0.08944|0.04933|0.04446|0.03951|0.06658,12.91|91.53|823.8|7.049|411.9
2655,23,0.5039,127.5,18740.0,0.006742000000000001,1.0,ERVV-1 FPR2 KIR2DL1 KLK3 SIGLEC5 VN1R4 ZNF175 ZNF28 ZNF320 ZNF415 ZNF528 ZNF534 ZNF571 ZNF578 ZNF610 ZNF613 ZNF615 ZNF665 ZNF677 ZNF701 ZNF808 ZNF83 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.98e-10|1.934e-08|1.943e-08|1.987e-08|6.24e-08,3.123e-06|0.0001526|0.0001022|7.834e-05|0.0001968,5.416|4.043|4.042|4.036|3.747
2656,4,0.5424,3.255,3356.0,0.0009667,0.9929309999999999,CHDH EXD2 LHX9 MANEAL,dorsal spinal cord interneuron anterior axon guidance|glycine betaine biosynthetic process from choline|glycine betaine biosynthetic process|glycine betaine metabolic process|gonad morphogenesis,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
2657,9,0.5107,18.38,5981.0,0.003055,0.9998530000000001,CIP2A FEN1 H2AFX LIG1 LIG3 MAD2L2 NBN RHNO1 XRCC1,DNA recombination|DNA repair|DNA ligation involved in DNA repair|DNA ligation|DNA metabolic process,2.37e-12|8.82e-12|9.215e-12|3.808e-11|1.877e-10,3.739e-08|6.956e-08|4.845e-08|1.502e-07|5.921e-07,64.36|31.09|1177|748.9|21.1
2658,5,0.5474,5.474,4282.0,0.001274,0.996692,ADCK5 FAM76A LIN28A LRP3 PRR16,positive regulation of translation|positive regulation of cellular amide metabolic process|positive regulation of gene expression|RNA 3' uridylation|miRNA catabolic process,0.0004397|0.0006583|0.001309|0.001456|0.00194,1|1|1|1|1,60.57|49.33|11.53|823.8|588.4
2659,4,0.5147,3.088,3244.0,0.0009486000000000001,0.9929309999999999,ASIC3 EPHB4 LIN7B WSCD1,enterobactin transport|detection of chemical stimulus involved in sensory perception of pain|siderophore transport|sensory perception of sour taste|protein localization to basolateral plasma membrane,0.0003883|0.0007766|0.0007766|0.001165|0.001553,1|1|1|1|1,5149|1716|1716|1030|735.5
2660,4,0.5005,3.003,3336.0,0.0008972000000000001,0.9929309999999999,C15orf65 LIMS2 LMAN1L MYO16,negative regulation of hepatocyte proliferation|positive regulation of integrin-mediated signaling pathway|regulation of integrin-mediated signaling pathway|regulation of hepatocyte proliferation|negative regulation of neural precursor cell proliferation,0.0009706|0.001553|0.003104|0.003297|0.004459,1|1|1|1|1,1287|735.5|343.2|321.8|234
2661,5,0.5457,5.457000000000001,4204.0,0.0012929999999999999,0.996692,ANO7 DECR2 DGKH LIN28A LMF1,acylglycerol metabolic process|neutral lipid metabolic process|cellular lipid metabolic process|calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling,0.0002646|0.0002695|0.0009926|0.001213|0.001213,1|1|1|1|1,78.46|77.72|12.67|1030|1030
2662,5,0.5134,5.1339999999999995,4205.0,0.001217,0.996692,CLN5 CNR2 LMLN PTPRR USP45,vestibular receptor cell morphogenesis|positive regulation of GTP binding|vestibular receptor cell development|vestibular receptor cell differentiation|negative regulation of action potential,0.000728|0.000728|0.0009706|0.0009706|0.001698,1|1|1|1|1,2060|2060|1373|1373|686.5
2663,8,0.5374,15.05,5316.0,0.002814,0.9996790000000001,CNEP1R1 CTDNEP1 LMNA LMNB1 NDC1 SMPD4 TMEM209 TMPO,nuclear envelope organization|nucleus organization|endomembrane system organization|mitotic nuclear division|nuclear division,2.049e-08|1.798e-07|4.057e-07|7.526e-07|5.071e-06,0.0003233|0.001418|0.002133|0.002968|0.016,124.1|71.02|26.38|49.27|30.29
2664,5,0.5092,5.092,4370.0,0.001161,0.996692,CAPN13 LMNTD2 RNF183 TMEM236 WFIKKN1,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|positive regulation of response to endoplasmic reticulum stress|muscle fiber development|negative regulation of DNA binding,0.00291|0.008226|0.00919|0.01136|0.01352,1|1|1|1|1,374.5|124.8|111.3|89.54|74.89
2665,4,0.5484,3.2910000000000004,3181.0,0.001031,0.9929309999999999,DPYSL2 KIF5B LMTK2 MAP7D1,synaptic vesicle transport|axonogenesis|synaptic vesicle localization|axon development|cell morphogenesis involved in neuron differentiation,2.313e-05|2.596e-05|3.048e-05|3.363e-05|4.13e-05,0.3649|0.2047|0.1603|0.1326|0.1303,264|40.22|228.8|36.86|34.4
2666,4,0.5242,3.145,3308.0,0.0009476,0.9929309999999999,C2CD2L IRF5 LNX2 SNTN,response to peptidoglycan|response to muramyl dipeptide|positive regulation of interferon-alpha production|regulation of interferon-alpha production|positive regulation of interferon-beta production,0.002716|0.004072|0.004846|0.006007|0.006973,1|1|1|1|1,396.1|257.4|214.5|171.6|147.1
2667,4,0.5127,3.076,2870.0,0.001067,0.9929309999999999,DERL1 LOX SLC33A1 TWIST2,descending aorta development|acetyl-CoA transport|regulation of protein binding|thioester transport|fatty-acyl-CoA transport,0.0003883|0.0003883|0.0005612|0.0005825|0.0005825,1|1|1|1|1,5149|5149|51.75|2574|2574
2668,4,0.5135,3.0810000000000004,2907.0,0.001056,0.9929309999999999,FDX2 LPAR5 PUM1 PUM2,positive regulation of RIG-I signaling pathway|regulation of RIG-I signaling pathway|regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway|positive regulation of gene silencing by miRNA|positive regulation of posttranscriptional gene silencing,1.865e-06|6.525e-06|8.472e-06|1.313e-05|1.4e-05,0.02942|0.05146|0.04455|0.05176|0.04417,1030|514.9|447.7|355.1|343.2
2669,20,0.505,95.96,16040.0,0.0059310000000000005,1.0,BPIFB4 CNBD2 CPNE1 DEFB116 DUSP15 FAM209B FAM83C FOXS1 GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 NECAB3 NOL4L TM9SF4 WFDC11 WISP2 XKR7,"positive regulation of multicellular organism growth|regulation of multicellular organism growth|positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response|phagocytosis",0.0005219|0.001904|0.001939|0.002908|0.003754,1|1|1|1|1,62.41|31.68|1030|514.9|9.476
2670,5,0.5147,5.147,4157.0,0.001234,0.996692,CNIH2 FAXDC2 LPL MAP3K11 TMEM179B,negative regulation of receptor localization to synapse|negative regulation of vesicle transport along microtubule|negative regulation of anterograde synaptic vesicle transport|negative regulation of synaptic vesicle transport|low-density lipoprotein particle mediated signaling,0.0004854|0.0004854|0.0004854|0.0004854|0.0009706,1|1|1|1|1,4119|4119|4119|4119|1373
2671,4,0.5252,3.1510000000000002,3076.0,0.001021,0.9929309999999999,CDC16 FGF21 LRAT N4BP2L1,response to methionine|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway|positive regulation of low-density lipoprotein receptor activity|metaphase/anaphase transition of mitotic cell cycle|metaphase/anaphase transition of cell cycle,0.0007766|0.0009706|0.001165|0.001553|0.001553,1|1|1|1|1,1716|1287|1030|735.5|735.5
2672,4,0.5628,3.377,3194.0,0.001053,0.9929309999999999,C1orf162 ETFA GBP6 LRIG2,negative regulation of membrane protein ectodomain proteolysis|fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of axon regeneration|positive regulation of protein localization to cell surface|negative regulation of neuron projection regeneration,0.001747|0.002134|0.00291|0.003297|0.003297,1|1|1|1|1,643.6|514.9|367.8|321.8|321.8
2673,4,0.5026,3.016,3232.0,0.0009299,0.9929309999999999,C17orf97 GPN1 LRP1 PRSS54,positive regulation of sterol import|positive regulation of collateral sprouting of injured axon|regulation of collateral sprouting of injured axon|positive regulation of axon extension involved in regeneration|positive regulation of sprouting of injured axon,0.0002913|0.0002913|0.0002913|0.0002913|0.0002913,1|1|1|1|0.9189,6865|6865|6865|6865|6865
2674,4,0.5651,3.39,3200.0,0.001056,0.9929309999999999,C8A LRP11 MRPL20 PTPN22,phosphoanandamide dephosphorylation|positive regulation of granzyme B production|regulation of granzyme B production|negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway|negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,0.0003883|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|1716|1716|1716|1716
2675,4,0.5135,3.0810000000000004,3184.0,0.0009642999999999999,0.9929309999999999,GRIN3B LRP2BP SENP5 SERPINB1,protein desumoylation|type B pancreatic cell proliferation|ionotropic glutamate receptor signaling pathway|negative regulation of interleukin-1 beta production|negative regulation of interleukin-1 production,0.001747|0.001941|0.005426|0.00562|0.00678,1|1|1|1|1,643.6|572.1|190.7|183.9|151.4
2676,7,0.5056,10.62,5440.0,0.001943,0.9992989999999999,DVL1 FGFRL1 FZD5 LGR4 LRP5 LRP6 WLS,canonical Wnt signaling pathway|cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|morphogenesis of an epithelium,1.631e-13|3.419e-12|3.419e-12|1.209e-11|2.345e-09,2.572e-09|2.697e-08|1.798e-08|4.769e-08|7.398e-06,183.9|51.64|51.64|43.01|35.92
2677,4,0.5103,3.062,3225.0,0.0009460000000000001,0.9929309999999999,GNAL LRP8 LRPAP1 RIN3,negative regulation of receptor internalization|negative regulation of receptor-mediated endocytosis|negative regulation of endocytosis|regulation of receptor internalization|regulation of receptor-mediated endocytosis,2.967e-06|1.228e-05|3.316e-05|4.821e-05|0.0001653,0.0468|0.09686|0.1743|0.1901|0.5215,792.1|367.8|219.1|180.7|96.24
2678,18,0.5076,77.66,14280.0,0.005397,1.0,CRISP1 CRISP2 ENPP4 ENPP5 FBXO9 GLYATL3 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F KLHL31 LRRC1 MLIP MUT RAB23 TFAP2D,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of chemokine (C-X-C motif) ligand 1 production|regulation of chemokine (C-X-C motif) ligand 1 production|positive regulation of antimicrobial peptide production,1.06e-06|1.06e-06|9.585e-06|1.341e-05|1.787e-05,0.01672|0.008359|0.0504|0.05289|0.05639,165.2|165.2|605.7|484.6|403.8
2679,4,0.5392,3.235,3252.0,0.0009915,0.9929309999999999,DNAJC27 LRRC15 SLC25A29 ZNF813,regulation of MAPK export from nucleus|mitochondrial L-ornithine transmembrane transport|acyl carnitine transport|receptor-mediated virion attachment to host cell|L-lysine transport,0.0003883|0.0007766|0.001165|0.001165|0.001359,1|1|1|1|1,5149|1716|1030|1030|858.1
2680,8,0.5061,14.17,6677.0,0.002113,0.9996790000000001,CALHM3 CFAP70 CYP17A1 DUSP13 GSTO2 LRRC20 SH2D4B SORCS3,androgen biosynthetic process|glucocorticoid biosynthetic process|L-ascorbic acid metabolic process|regulation of long-term synaptic depression|progesterone metabolic process,0.004264|0.004651|0.004651|0.005811|0.005811,1|1|1|1|1,257.4|234|234|183.9|183.9
2681,4,0.5156,3.093,3128.0,0.0009854,0.9929309999999999,LRRC31 OTOP1 TM4SF1 TNFAIP2,exocyst localization|negative regulation of interferon-gamma-mediated signaling pathway|negative regulation of response to interferon-gamma|cellular protein-containing complex localization|regulation of interferon-gamma-mediated signaling pathway,0.001165|0.001747|0.001747|0.004266|0.005233,1|1|1|1|1,1030|643.6|643.6|245.2|198
2682,4,0.5439,3.264,3317.0,0.0009805,0.9929309999999999,ARMC2 LRRC34 SELP SNN,positive regulation of platelet activation|positive regulation of leukocyte tethering or rolling|regulation of leukocyte tethering or rolling|regulation of integrin activation|leukocyte tethering or rolling,0.0009706|0.001747|0.002716|0.003491|0.004072,1|1|1|1|1,1287|643.6|396.1|302.9|257.4
2683,4,0.5145,3.0869999999999997,3196.0,0.0009624000000000001,0.9929309999999999,LRRC39 MUC17 RPS6KC1 ZNF641,cellular protein modification process|protein modification process|O-glycan processing|macromolecule modification|cellular protein metabolic process,0.01123|0.01123|0.01199|0.01376|0.01923,1|1|1|1|1,5.116|5.116|84.41|4.767|4.24
2684,4,0.5784,3.471,3540.0,0.0009772000000000001,0.9929309999999999,BAG3 FAM178B FNDC9 LRRC4,positive regulation of aggrephagy|regulation of aggrephagy|negative regulation of protein targeting to mitochondrion|aggresome assembly|postsynaptic density protein 95 clustering,0.0007766|0.0007766|0.001359|0.001359|0.001359,1|1|1|1|1,1716|1716|858.1|858.1|858.1
2685,5,0.5022,5.022,4192.0,0.001194,0.996692,DPP7 LRRC4B LRRC61 TRIM36 ZNF576,regulation of postsynaptic density assembly|regulation of postsynaptic specialization assembly|regulation of excitatory synapse assembly|regulation of postsynaptic density organization|acrosome reaction,0.00349|0.003781|0.004361|0.004651|0.00697,1|1|1|1|1,312|286|245.2|228.8|149.2
2686,4,0.5221,3.133,3395.0,0.0009196,0.9929309999999999,FBLN7 LRRC55 MOCOS SLC38A9,Mo-molybdopterin cofactor biosynthetic process|molybdopterin cofactor biosynthetic process|prosthetic group metabolic process|molybdopterin cofactor metabolic process|Mo-molybdopterin cofactor metabolic process,0.001359|0.001359|0.001359|0.001359|0.001359,1|1|1|1|1,858.1|858.1|858.1|858.1|858.1
2687,4,0.5037,3.022,3147.0,0.0009570000000000001,0.9929309999999999,D2HGDH GPATCH3 LRRC56 SMAD9,negative regulation of RIG-I signaling pathway|response to cobalt ion|negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway|2-oxoglutarate metabolic process|response to manganese ion,0.001747|0.002134|0.002328|0.003491|0.003878,1|1|1|1|1,643.6|514.9|468.1|302.9|271
2688,5,0.5007,5.007,4102.0,0.001216,0.996692,BTRC GLRX2 LRRC71 RAB20 SMIM29,DNA protection|phagosome-lysosome fusion|mammary gland epithelial cell proliferation|positive regulation of ubiquitin protein ligase activity|phagolysosome assembly,0.001456|0.00291|0.003152|0.003394|0.003878,1|1|1|1|1,823.8|374.5|343.3|316.8|274.6
2689,5,0.5131,5.131,3903.0,0.001309,0.996692,CIB3 LRRC72 ZNF556 ZNF69 ZNF700,"cellular process|regulation of transcription by RNA polymerase II|negative regulation of transcription by RNA polymerase II|negative regulation of transcription, DNA-templated|negative regulation of nucleic acid-templated transcription",0.0009406|0.01628|0.01761|0.03451|0.03461,1|1|1|1|1,0|4.778|9.133|6.396|6.386
2690,5,0.5083,5.083,4272.0,0.001186,0.996692,LRRC8A LRRC8D SLC35B3 SLC4A3 TNFRSF21,sulfur compound transport|organic anion transport|anion transmembrane transport|alkanesulfonate transport|taurine transport,1.512e-07|3.771e-07|1.227e-06|1.319e-06|1.319e-06,0.002384|0.002974|0.00645|0.005201|0.004161,252.2|48.46|35.97|1373|1373
2691,24,0.5046,139.3,19250.0,0.007164,1.0,C1orf123 CASQ2 CD101 CLCA4 CYB561D1 FAM19A3 FAM69A GBP5 GBP6 GNAT2 GSTM2 GSTM3 GSTM4 GSTM5 HSD3B1 IFI44 IFI44L INKA2 KCNA10 MCOLN3 PPM1J RHOC SLC22A15 TMEM56,glutathione derivative biosynthetic process|glutathione derivative metabolic process|nitrobenzene metabolic process|xenobiotic catabolic process|glutathione metabolic process,1.431e-08|1.431e-08|3.681e-08|4.758e-07|8.029e-07,0.0002257|0.0001129|0.0001935|0.001876|0.002533,170.2|170.2|702.1|234|57.61
2692,4,0.5687,3.412,3103.0,0.0010960000000000002,0.9929309999999999,CPNE1 CRACR2B LRRFIP1 RALY,store-operated calcium entry|positive regulation of tumor necrosis factor-mediated signaling pathway|regulation of store-operated calcium entry|negative regulation of NIK/NF-kappaB signaling|positive regulation of cytokine-mediated signaling pathway,0.001747|0.002328|0.002716|0.005233|0.009675,1|1|1|1|1,643.6|468.1|396.1|198|105.1
2693,4,0.524,3.1439999999999997,3104.0,0.001009,0.9929309999999999,FAM193A GPX5 LRRIQ1 MTMR2,negative regulation of receptor catabolic process|regulation of phosphatidylinositol dephosphorylation|positive regulation of early endosome to late endosome transport|negative regulation of myelination|negative regulation of excitatory postsynaptic potential,0.0007766|0.001359|0.001747|0.001747|0.002134,1|1|1|1|1,1716|858.1|643.6|643.6|514.9
2694,4,0.5447,3.2680000000000002,3238.0,0.001006,0.9929309999999999,FAM102A LRRIQ3 MMP9 TBC1D10B,negative regulation of epithelial cell differentiation involved in kidney development|negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|positive regulation of receptor binding|cellular response to UV-A|positive regulation of keratinocyte migration,0.001165|0.001359|0.002134|0.002328|0.002522,1|1|1|1|1,1030|858.1|514.9|468.1|429.1
2695,5,0.5014,5.013999999999999,3456.0,0.0014449999999999999,0.996692,COPB1 EIF3F LRRN4CL NUP98 RPS13,viral gene expression|viral process|biological process involved in symbiotic interaction|viral transcription|translational initiation,5.952e-06|1.412e-05|2.085e-05|0.0003217|0.0004853,0.09388|0.1114|0.1096|1|1,71.84|19.41|17.58|71.02|57.61
2696,4,0.5554,3.333,3305.0,0.001005,0.9929309999999999,BPIFB3 CD300LF LRRTM1 TNFAIP1,interleukin-13-mediated signaling pathway|negative regulation of MyD88-dependent toll-like receptor signaling pathway|negative regulation of apoptotic cell clearance|positive regulation of interleukin-4-mediated signaling pathway|regulation of interleukin-4-mediated signaling pathway,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
2697,7,0.51,10.71,5497.0,0.0019399999999999999,0.9992989999999999,CNRIP1 FSHR LRRTM4 REG3G SIX3 TEX261 TEX37,regulation of acetylcholine metabolic process|neuroblast migration|primary ovarian follicle growth|optic vesicle morphogenesis|regulation of neural retina development,0.0006794|0.0006794|0.001019|0.001019|0.001358,1|1|1|1|1,2942|2942|1471|1471|980.7
2698,4,0.5509,3.305,3309.0,0.0009955,0.9929309999999999,BTG3 FHIT GLYCTK LSM14B,diadenosine triphosphate catabolic process|diadenosine triphosphate metabolic process|fructose catabolic process|fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate|diadenosine polyphosphate catabolic process,0.0003883|0.0003883|0.001165|0.001165|0.001359,1|1|1|1|1,5149|5149|1030|1030|858.1
2699,6,0.5106,7.659,4886.0,0.0015609999999999999,0.998474,APEH CCR2 FAM107A GLT8D1 LSMEM2 TOPAZ1,positive regulation of astrocyte chemotaxis|T-helper 17 cell chemotaxis|negative regulation of eosinophil degranulation|spermatocyte division|positive regulation of immune complex clearance by monocytes and macrophages,0.0005824|0.0005824|0.0005824|0.0005824|0.0008735,1|1|1|1|1,3432|3432|3432|3432|1716
2700,4,0.5266,3.16,3233.0,0.0009741,0.9929309999999999,ACSF3 CCDC39 LSP1 NUDT7,fatty-acyl-CoA metabolic process|fatty acid derivative metabolic process|acyl-CoA metabolic process|thioester metabolic process|purine nucleoside bisphosphate metabolic process,2.668e-05|9.807e-05|0.0001363|0.0001363|0.0002536,0.4209|0.7735|0.7169|0.5376|0.8001,245.2|125.6|106.2|106.2|77.42
2701,6,0.5205,7.807,4783.0,0.001626,0.998474,FPR1 FPR2 ITGA7 LTA SIGLEC5 ZNF615,complement receptor mediated signaling pathway|neutrophil degranulation|neutrophil activation involved in immune response|neutrophil mediated immunity|neutrophil activation,7.41e-06|0.000246|0.000252|0.0002628|0.000266,0.1169|1|1|1|0.8391,528.1|21.36|21.19|20.89|20.8
2702,7,0.5209,10.94,5551.0,0.001962,0.9992989999999999,CCDC71 EZR GNAT1 HYAL1 ITIH4 LTA4H PFKFB4,hyaluronan metabolic process|mucopolysaccharide metabolic process|cellular response to light stimulus|protein localization to cell cortex|glycosaminoglycan metabolic process,5.857e-05|0.0005936|0.0006932|0.001019|0.001137,0.9238|1|1|1|1,178.3|53.98|49.87|1471|38.71
2703,4,0.6038,3.623,3342.0,0.00108,0.9929309999999999,LUC7L RGS11 TPGS1 ZSCAN22,protein polyglutamylation|sperm axoneme assembly|peptidyl-glutamic acid modification|mRNA splice site selection|spliceosomal complex assembly,0.002716|0.004459|0.0062|0.006393|0.01122,1|1|1|1|1,396.1|234|166.1|160.9|90.33
2704,4,0.514,3.0839999999999996,3069.0,0.001001,0.9929309999999999,IL12RB1 LUZP6 TIRAP TMEM71,positive regulation of lymphocyte proliferation|positive regulation of mononuclear cell proliferation|positive regulation of leukocyte proliferation|positive regulation of interleukin-15 production|regulation of interleukin-15 production,0.0002727|0.0002766|0.0003214|0.0003883|0.0003883,1|1|1|1|1,74.62|74.08|68.65|5149|5149
2705,23,0.5044,127.6,17390.0,0.007267,1.0,C8orf33 FOXH1 GLI4 GML GSDMC KCNQ3 LRRC24 LY6D LY6K LYPD2 MAPK15 MROH6 NAPRT PSCA RHPN1 SLURP2 TSNARE1 WISP1 ZFP41 ZNF16 ZNF250 ZNF696 ZNF707,metabolic process|pyridine nucleotide salvage|positive regulation of metaphase/anaphase transition of meiotic cell cycle|positive regulation of metaphase/anaphase transition of meiosis I|regulation of metaphase/anaphase transition of meiosis I,0.001139|0.00223|0.00223|0.00223|0.00223,1|1|1|1|1,0.2149|895.4|895.4|895.4|895.4
2706,11,0.5068,27.87,8222.0,0.0033689999999999996,0.999969,HIST1H2AD HLA-F LY6G5B OR14J1 OR2B6 OR2J3 PSORS1C2 TRIM10 TRIM26 ZKSCAN3 ZKSCAN4,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway,5.818e-05|7.96e-05|0.0002075|0.0002775|0.000562,0.9177|0.6278|1|1|1,187.2|158.4|95.79|82.38|57.21
2707,10,0.5075,22.84,7687.0,0.002954,0.999933,AIF1 C6orf48 HLA-DMB LY6G5C MICB MSH5 NCR3 TAP1 TAP2 TNXB,antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of peptide antigen|antigen processing and presentation,9.343e-08|1.262e-07|2.988e-07|1.627e-06|2.86e-06,0.001474|0.000995|0.001571|0.006417|0.009023,363.4|325.2|237.6|42.68|36.94
2708,4,0.5403,3.242,3356.0,0.0009628,0.9929309999999999,DNALI1 LEMD1 LY75 TMC6,biological regulation|regulation of biological process|regulation of cellular process|vesicle-mediated transport|immune response,0.02306|0.03244|0.04148|0.04766|0.0483,1|1|1|1|1,0|0|0|5.259|5.222
2709,4,0.5126,3.076,3227.0,0.0009499,0.9929309999999999,ARL3 C5orf22 LY86 UBE2QL1,positive regulation of lipopolysaccharide-mediated signaling pathway|protein localization to ciliary membrane|positive regulation of multi-organism process|regulation of lipopolysaccharide-mediated signaling pathway|photoreceptor cell development,0.001747|0.002134|0.003878|0.00504|0.009482,1|1|1|1|1,643.6|514.9|271|205.9|107.3
2710,5,0.5413,5.412999999999999,4130.0,0.001306,0.996692,LYAR NOX4 PRSS12 SLC36A4 TYR,response to cAMP|response to organophosphorus|response to purine-containing compound|melanin biosynthetic process from tyrosine|proline import across plasma membrane,0.0002311|0.0004461|0.0005471|0.000728|0.000728,1|1|1|1|1,84.06|60.13|54.2|2060|2060
2711,11,0.5007,27.54,6934.0,0.003944,0.999969,ABL1 BCR EGFR FRS2 GAB1 GAB2 GRB2 LMO2 MYB PTPN11 SOS1,epidermal growth factor receptor signaling pathway|transmembrane receptor protein tyrosine kinase signaling pathway|ERBB signaling pathway|enzyme linked receptor protein signaling pathway|neuron projection morphogenesis,1.397e-13|2.34e-13|9.369e-13|4.596e-12|1.846e-11,2.204e-09|1.845e-09|4.926e-09|1.813e-08|5.824e-08,224.7|32.47|160.5|23.21|30.26
2712,5,0.5056,5.056,3954.0,0.001274,0.996692,CPA1 LYPD1 RELN RNF133 ZFHX3,regulation of behavior|positive regulation of lateral motor column neuron migration|regulation of lateral motor column neuron migration|positive regulation of motor neuron migration|regulation of motor neuron migration,0.0001131|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,121.1|4119|4119|4119|4119
2713,5,0.5373,5.372999999999999,4355.0,0.0012289999999999998,0.996692,ADAMDEC1 AZGP1 KLHL2 LYPLA1 MGARP,antigen processing and presentation of endogenous peptide antigen via MHC class Ib|negative regulation of Golgi to plasma membrane protein transport|cellular response to gonadotropin-releasing hormone|antigen processing and presentation of peptide antigen via MHC class Ib|response to gonadotropin-releasing hormone,0.001698|0.001698|0.001698|0.00194|0.00194,1|1|1|1|1,686.5|686.5|686.5|588.4|588.4
2714,4,0.5213,3.128,3117.0,0.0009999,0.9929309999999999,LYPLA2 SLC27A2 TGFBR3 TMEM222,cellular lipid catabolic process|prostaglandin catabolic process|prostanoid catabolic process|definitive erythrocyte differentiation|transforming growth factor beta receptor complex assembly,0.0005667|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,51.49|2574|2574|1716|1716
2715,5,0.5176,5.176,4001.0,0.001289,0.996692,LYRM2 PSTPIP2 TIFA TMPRSS11A ZNF397,actin filament polymerization|cytoplasmic pattern recognition receptor signaling pathway|actin polymerization or depolymerization|I-kappaB kinase/NF-kappaB signaling|protein polymerization,0.008467|0.009913|0.01472|0.01712|0.02333,1|1|1|1|1,121.1|103|68.65|58.84|42.91
2716,4,0.5077,3.0460000000000003,3231.0,0.0009397,0.9929309999999999,BCAR3 GBP6 KRTAP21-3 LYSMD2,endothelin receptor signaling pathway|lens morphogenesis in camera-type eye|defense response to protozoan|response to protozoan|positive regulation of epidermal growth factor receptor signaling pathway,0.001553|0.004266|0.004846|0.00504|0.007552,1|1|1|1|1,735.5|245.2|214.5|205.9|135.5
2717,4,0.5173,3.1039999999999996,3174.0,0.0009744999999999999,0.9929309999999999,IL2 KCNJ11 LYVE1 SRXN1,regulation of T cell homeostatic proliferation|positive regulation of plasma cell differentiation|regulation of heart contraction|regulation of plasma cell differentiation|regulation of blood circulation,0.0007766|0.0007766|0.0008053|0.0009706|0.001139,1|1|1|1|1,1716|1716|43.09|1287|36.13
2718,4,0.5272,3.1630000000000003,3115.0,0.0010119999999999999,0.9929309999999999,ARPC3 FAM149B1 LYZL4 UBOX5,actin polymerization-dependent cell motility|Arp2/3 complex-mediated actin nucleation|fusion of sperm to egg plasma membrane involved in single fertilization|plasma membrane fusion|actin nucleation,0.001553|0.004072|0.004266|0.00504|0.006393,1|1|1|1|1,735.5|257.4|245.2|205.9|160.9
2719,9,0.5093,18.33,5903.0,0.003087,0.9998530000000001,BUB1B DLGAP5 DSN1 KNTC1 MAD2L1 MAPRE1 TRIP13 ZWILCH ZWINT,mitotic spindle organization|microtubule cytoskeleton organization involved in mitosis|spindle organization|mitotic cell cycle process|anaphase,1.789e-16|4.575e-16|2.114e-15|5.307e-14|6.321e-14,2.822e-12|3.608e-12|1.111e-11|2.093e-10|1.994e-10,111.6|98.95|81.36|30.07|102
2720,6,0.5356,8.033999999999999,4770.0,0.0016769999999999999,0.998474,IGF1R LRRC28 LYSMD4 MAF1 PGPEP1L TTC23,inactivation of MAPKK activity|negative regulation of transcription by RNA polymerase III|negative regulation of transcription by RNA polymerase I|dendritic spine maintenance|insulin-like growth factor receptor signaling pathway,0.0008735|0.001165|0.002328|0.0032|0.004071,1|1|1|1|1,1716|1144|490.4|343.2|264
2721,24,0.5079,140.2,19290.0,0.007197,1.0,KIR2DL1 VN1R1 VN1R4 ZFP28 ZNF135 ZNF28 ZNF304 ZNF415 ZNF416 ZNF528 ZNF534 ZNF548 ZNF550 ZNF586 ZNF587 ZNF610 ZNF665 ZNF667 ZNF677 ZNF701 ZNF773 ZNF805 ZNF808 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",9.743e-16|3.653e-13|3.675e-13|3.783e-13|1.692e-12,1.537e-11|2.882e-09|1.932e-09|1.492e-09|5.338e-09,6.69|4.994|4.993|4.986|4.628
2722,4,0.5339,3.2030000000000003,3146.0,0.001015,0.9929309999999999,CD300LB GPR153 MAL SLC25A4,positive regulation of interleukin-15 production|regulation of interleukin-15 production|cytotoxic T cell differentiation|TIRAP-dependent toll-like receptor 4 signaling pathway|TIRAP-dependent toll-like receptor signaling pathway,0.0005824|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,3432|3432|3432|3432|3432
2723,4,0.5879,3.5269999999999997,3106.0,0.001131,0.9929309999999999,HBG1 MAMDC2 MS4A6A OR2B3,oxygen transport|long-chain fatty-acyl-CoA biosynthetic process|gas transport|long-chain fatty-acyl-CoA metabolic process|hydrogen peroxide catabolic process,0.003636|0.004845|0.004845|0.006295|0.007261,1|1|1|1|1,294.2|216.8|216.8|164.8|142
2724,4,0.5534,3.321,3177.0,0.001042,0.9929309999999999,MAN1B1 PRG2 PRG3 ZFPL1,reactive oxygen species metabolic process|histamine biosynthetic process|trimming of second mannose on A branch|trimming of first mannose on A branch|trimming of terminal mannose on B branch,0.0004889|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,58.68|1716|1716|1716|1716
2725,4,0.5898,3.5389999999999997,3356.0,0.001051,0.9929309999999999,C12orf40 DNAJC10 MANEA SYCE1,protein folding in endoplasmic reticulum|synaptonemal complex assembly|synaptonemal complex organization|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|homologous chromosome pairing at meiosis,0.002328|0.004459|0.00504|0.006586|0.01006,1|1|1|1|1,468.1|234|205.9|156|101
2726,4,0.52,3.12,3162.0,0.0009832,0.9929309999999999,CHCHD3 FBXL13 MAP10 PLXNC1,mitotic spindle midzone assembly|spindle elongation|mitotic spindle elongation|semaphorin-plexin signaling pathway involved in axon guidance|spindle midzone assembly,0.001747|0.001747|0.001747|0.002328|0.002522,1|1|1|1|1,643.6|643.6|643.6|468.1|429.1
2727,4,0.5936,3.562,3228.0,0.001099,0.9929309999999999,BLVRB CSKMT MAP1LC3B OXLD1,pexophagy|mitophagy|peptidyl-lysine monomethylation|autophagy of peroxisome|cellular response to nitrogen starvation,0.001553|0.001747|0.002134|0.002522|0.002716,1|1|1|1|1,735.5|643.6|514.9|429.1|396.1
2728,4,0.5035,3.0210000000000004,3128.0,0.0009622,0.9929309999999999,C1QTNF12 MAP1S PRKAG1 SCNN1D,regulation of chromatin disassembly|regulation of carbohydrate metabolic process|autophagy|process utilizing autophagic mechanism|regulation of small molecule metabolic process,0.0005825|0.0006476|0.001311|0.001311|0.002643,1|1|1|1|1,2574|48.12|33.65|33.65|23.56
2729,4,0.5694,3.4160000000000004,3285.0,0.001036,0.9929309999999999,ADAM11 MAP2K6 PYY SPATC1L,cellular response to sorbitol|response to sorbitol|positive regulation of cAMP-dependent protein kinase activity|positive regulation of protein serine/threonine kinase activity|DNA damage induced protein phosphorylation,0.0007766|0.001165|0.001359|0.001397|0.001747,1|1|1|1|1,1716|1030|858.1|32.59|643.6
2730,4,0.5468,3.281,3355.0,0.0009746,0.9929309999999999,CHRM1 MAP3K13 SLC43A3 TOB2,positive regulation of branching morphogenesis of a nerve|phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway|positive regulation of neuron maturation|regulation of branching morphogenesis of a nerve|saliva secretion,0.0003883|0.0007766|0.001165|0.001165|0.001165,1|1|1|1|1,5149|1716|1030|1030|1030
2731,4,0.5582,3.3489999999999998,3124.0,0.001068,0.9929309999999999,HCAR1 MAP3K21 NR5A2 SLC38A7,methionine transport|asparagine transport|pancreas morphogenesis|sulfur amino acid transport|L-histidine transmembrane transport,0.0003883|0.0007766|0.0009706|0.001359|0.001359,1|1|1|1|1,5149|1716|1287|858.1|858.1
2732,4,0.5054,3.032,3276.0,0.0009224999999999999,0.9929309999999999,DMAC2 MAP3K8 OPRK1 TRIM55,adenylate cyclase-inhibiting opioid receptor signaling pathway|response to acrylamide|negative regulation of luteinizing hormone secretion|conditioned place preference|positive regulation of eating behavior,0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
2733,6,0.5014,7.521,5074.0,0.001477,0.998474,MAP4K3 MCCC1 PNOC TNFRSF10C TNFRSF10D TSPYL4,leucine catabolic process|TRAIL-activated apoptotic signaling pathway|leucine metabolic process|biotin metabolic process|activation of MAPKKK activity,0.002037|0.002037|0.002619|0.002909|0.004071,1|1|1|1|1,572.1|572.1|429.1|381.4|264
2734,4,0.5147,3.088,3222.0,0.0009551999999999999,0.9929309999999999,MAP6 MRPL11 RNF144A SFRP4,negative regulation of sodium-dependent phosphate transport|positive regulation of keratinocyte apoptotic process|regulation of sodium-dependent phosphate transport|regulation of keratinocyte apoptotic process|negative regulation of non-canonical Wnt signaling pathway,0.0003883|0.0007766|0.001165|0.001359|0.001359,1|1|1|1|1,5149|1716|1030|858.1|858.1
2735,4,0.5403,3.242,3072.0,0.001052,0.9929309999999999,C1QTNF8 FAM173A MAP6D1 TMEM95,N-terminal protein palmitoylation|N-terminal peptidyl-L-cysteine N-palmitoylation|N-terminal protein lipidation|fusion of sperm to egg plasma membrane involved in single fertilization|plasma membrane fusion,0.0002913|0.0002913|0.0008737|0.003201|0.003782,1|1|1|1|1,6865|6865|1373|326.9|274.6
2736,5,0.5114,5.114,4122.0,0.001236,0.996692,CD8A COX6B2 GPR32 MAPK4 MYBPC2,cytotoxic T cell differentiation|complement receptor mediated signaling pathway|T cell mediated immunity|actin-myosin filament sliding|muscle filament sliding,0.0004854|0.003394|0.007502|0.009431|0.009431,1|1|1|1|1,4119|316.8|137.3|108.4|108.4
2737,4,0.5756,3.4530000000000003,3107.0,0.0011070000000000001,0.9929309999999999,FAM217B MAPKBP1 SEC14L4 ZNF318,negative regulation of defense response to bacterium|regulation of defense response to bacterium|negative regulation of interleukin-8 production|negative regulation of I-kappaB kinase/NF-kappaB signaling|regulation of interleukin-8 production,0.001165|0.003297|0.003878|0.008903|0.01564,1|1|1|1|1,1030|321.8|271|114.4|64.36
2738,7,0.5181,10.88,5414.0,0.002,0.9992989999999999,C11orf53 CASP1 CASP4 CRYAB KDELC2 OR6B3 TMEM136,positive regulation of tumor necrosis factor-mediated signaling pathway|pyroptosis|protein autoprocessing|positive regulation of cytokine-mediated signaling pathway|positive regulation of response to cytokine stimulus,5.506e-06|1.34e-05|2.29e-05|8.956e-05|0.000116,0.08685|0.1057|0.1204|0.3532|0.366,624.1|381.4|286|140.1|122.6
2739,4,0.5733,3.44,3302.0,0.001038,0.9929309999999999,MARCKSL1 MPZL2 TPTE ZNF19,phosphatidylinositol dephosphorylation|phosphatidylinositol 3-kinase signaling|phospholipid dephosphorylation|phosphatidylinositol-mediated signaling|inositol lipid-mediated signaling,0.0062|0.007552|0.008903|0.01583|0.0166,1|1|1|1|1,166.1|135.5|114.4|63.56|60.57
2740,5,0.5258,5.257999999999999,4280.0,0.001224,0.996692,MARCO MYPN SEC24C TNFRSF1B WNK4,negative regulation of secretion|distal tubule morphogenesis|negative regulation of pancreatic juice secretion|glial cell-neuron signaling|negative regulation of extracellular matrix constituent secretion,0.0006201|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,50.85|1373|1373|1373|1030
2741,13,0.5127,39.99,8504.0,0.004666,0.999993,AMOTL2 FRYL KIRREL1 LATS2 MAP4K4 MARK2 MARK3 NF2 PDCD10 PTPN14 RNF146 SAV1 TAOK1,hippo signaling|intracellular signal transduction|regulation of protein kinase activity|regulation of kinase activity|anatomical structure morphogenesis,8.725e-07|1.08e-06|4.661e-06|9.826e-06|1.074e-05,0.01376|0.008519|0.02451|0.03875|0.03389,169.7|8.047|11.93|10.47|5.936
2742,5,0.5475,5.475,3510.0,0.001553,0.996692,ANAPC5 CCDC59 DCTN2 MARS VEZT,methionyl-tRNA aminoacylation|biological phase|mitotic cell cycle phase|cell cycle phase|positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,0.0008735|0.002284|0.002284|0.002284|0.0032,1|1|1|1|1,1716|26.71|26.71|26.71|343.2
2743,4,0.5564,3.338,3368.0,0.0009877,0.9929309999999999,MARVELD2 S100A5 SIGLEC1 TEX35,clathrin-dependent endocytosis of virus by host cell|receptor-mediated endocytosis of virus by host cell|endocytosis involved in viral entry into host cell|multi-organism cellular process|clathrin-dependent endocytosis,0.0003883|0.001553|0.001553|0.003491|0.006007,1|1|1|1|1,5149|735.5|735.5|302.9|171.6
2744,5,0.5337,5.337000000000001,4431.0,0.0012,0.996692,MAS1 MYADML2 NYAP1 PPP1R27 TMEM220,angiotensin-activated signaling pathway|positive regulation of inositol phosphate biosynthetic process|protein kinase C signaling|regulation of inositol phosphate biosynthetic process|activation of NF-kappaB-inducing kinase activity,0.003152|0.003636|0.003878|0.00412|0.004604,1|1|1|1|1,343.3|294.2|274.6|257.4|228.8
2745,5,0.5074,5.074,4146.0,0.001219,0.996692,CORO2B HENMT1 MASP1 NMBR SYNE1,"bombesin receptor signaling pathway|nuclear matrix anchoring at nuclear membrane|nuclear matrix organization|complement activation, lectin pathway|production of siRNA involved in RNA interference",0.000728|0.0009706|0.0009706|0.002667|0.002667,1|1|1|1|1,2060|1373|1373|411.9|411.9
2746,4,0.5055,3.033,3081.0,0.0009807,0.9929309999999999,CPA5 CREB3L2 MAST3 PKP1,intermediate filament bundle assembly|intermediate filament organization|intermediate filament cytoskeleton organization|intermediate filament-based process|negative regulation of mRNA catabolic process,0.001553|0.004846|0.01006|0.01025|0.01141,1|1|1|1|1,735.5|214.5|101|99.01|88.77
2747,4,0.5936,3.5610000000000004,3151.0,0.001126,0.9929309999999999,DLGAP1 MAT2B TBC1D19 TCF7L2,regulation of molecular function|canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition|positive regulation of heparan sulfate proteoglycan biosynthetic process|regulation of heparan sulfate proteoglycan biosynthetic process|positive regulation of proteoglycan biosynthetic process,0.0005685|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,6.48|2574|1716|1716|1287
2748,4,0.5202,3.1210000000000004,3142.0,0.0009897,0.9929309999999999,FN3KRP MATK ROBO2 SEC11C,negative regulation of negative chemotaxis|apoptotic process involved in luteolysis|regulation of negative chemotaxis|positive regulation of Notch signaling pathway involved in heart induction|regulation of Notch signaling pathway involved in heart induction,0.0005825|0.0007766|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1287|1287|1287
2749,6,0.5335,8.003,3639.0,0.002187,0.998474,CDK4 CDK6 CDKN2C MAU2 PRR12 STAG1,mitotic cell cycle process|mitotic cell cycle|mitotic interphase|interphase|negative regulation of G1/S transition of mitotic cell cycle,8.249e-07|1.384e-06|2.103e-06|2.103e-06|5.103e-06,0.01301|0.01092|0.01106|0.008292|0.0161,21.48|19.33|111.7|111.7|82.49
2750,4,0.5142,3.085,3080.0,0.0009981,0.9929309999999999,ARFGAP1 ARHGAP28 CRYGS MB21D2,"positive regulation of GTPase activity|regulation of GTPase activity|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|positive regulation of hydrolase activity|endoplasmic reticulum to Golgi vesicle-mediated transport",7.933e-05|0.0001314|0.0001749|0.0005107|0.0009018,1|1|0.9195|1|1,29.92|25.22|96.92|15.9|42.03
2751,5,0.5413,5.412999999999999,4132.0,0.0013050000000000002,0.996692,ALLC FRMPD2 GPR3 MBL2 MYL5,"allantoin catabolic process|allantoin metabolic process|cellular amide catabolic process|complement activation, lectin pathway|regulation of meiotic nuclear division",0.0005824|0.001165|0.001456|0.0032|0.009285,1|1|1|1|1,3432|1144|858.1|343.2|110.7
2752,4,0.5507,3.304,3213.0,0.001025,0.9929309999999999,BMP5 DIRC2 GRXCR2 MC3R,epithelial cell development|allantois development|homoiothermy|neural fold elevation formation|negative regulation of cortisol biosynthetic process,0.0005283|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,53.35|2574|2574|1716|1287
2753,5,0.539,5.39,4152.0,0.0012929999999999999,0.996692,MCAM NR2F1 PQLC2 RANBP3 TMEM129,"vascular wound healing|glomerular filtration|renal filtration|angiogenesis involved in wound healing|retrograde protein transport, ER to cytosol",0.001747|0.00291|0.003104|0.003491|0.003491,1|1|1|1|1,643.6|367.8|343.2|302.9|302.9
2754,4,0.5346,3.208,3097.0,0.001032,0.9929309999999999,HSPA4L MCC SLC9A4 SPTLC2,sphinganine biosynthetic process|sphinganine metabolic process|positive regulation of lipophagy|regulation of lipophagy|sphingomyelin biosynthetic process,0.0003883|0.0005825|0.001165|0.001165|0.001553,1|1|1|1|1,5149|2574|1030|1030|735.5
2755,4,0.5102,3.0610000000000004,3224.0,0.0009463,0.9929309999999999,ATP6AP1L CD36 MCF2L2 SV2C,oxidised low-density lipoprotein particle clearance|positive regulation of blood microparticle formation|regulation of blood microparticle formation|response to linoleic acid|short-chain fatty acid transport,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
2756,5,0.5013,5.013,4289.0,0.001165,0.996692,ADRB3 EDNRB HSF5 MCIDAS TEX15,vasodilation|blood vessel diameter maintenance|regulation of tube diameter|regulation of tube size|enteric smooth muscle cell differentiation,3.128e-05|0.0003784|0.0003784|0.0003843|0.0004854,0.4935|1|1|1|1,235.4|65.38|65.38|64.87|4119
2757,9,0.5078,18.28,6270.0,0.0028989999999999997,0.9998530000000001,CDT1 MCM2 MCM3 MCM4 MCM5 MCM6 MCM7 ORC1 ORC6,DNA replication initiation|pre-replicative complex assembly|G1/S transition of mitotic cell cycle|cell cycle G1/S phase transition|DNA-dependent DNA replication,1.998e-24|6.004e-23|1.585e-20|1.818e-20|7.321e-19,3.152e-20|4.735e-19|8.332e-17|7.17e-17|2.309e-15,479|316.8|164.8|162.2|106.2
2758,4,0.5135,3.0810000000000004,3015.0,0.001018,0.9929309999999999,BAG5 GOLGA5 MCOLN2 ZNF446,"Golgi organization|positive regulation of macrophage inflammatory protein 1 alpha production|retrograde transport, vesicle recycling within Golgi|negative regulation of protein refolding|regulation of protein refolding",0.0002612|0.0003883|0.0005825|0.0009706|0.0009706,1|1|1|1|1,76.28|5149|2574|1287|1287
2759,5,0.5219,5.218999999999999,3738.0,0.00139,0.996692,KCNK13 MAFB MDGA2 ROR1 SLC5A12,rhombomere 6 development|abducens nerve formation|abducens nerve morphogenesis|abducens nerve development|inner ear development,0.0004854|0.000728|0.000728|0.000728|0.0008572,1|1|1|1|1,4119|2060|2060|2060|43.13
2760,4,0.5036,3.022,3043.0,0.0009894,0.9929309999999999,FKBP5 MDH1B MIOX NR1D2,inositol catabolic process|malate metabolic process|oxaloacetate metabolic process|inositol metabolic process|carbohydrate metabolic process,0.0003883|0.001747|0.001941|0.002328|0.0031,1|1|1|1|1,5149|643.6|572.1|468.1|21.72
2761,7,0.5217,10.96,5598.0,0.0019489999999999998,0.9992989999999999,CD244 MDP1 MFGE8 OR10Z1 SLC36A1 SPRR4 SWT1,fructosamine metabolic process|positive regulation of granzyme B production|regulation of granzyme B production|alkanesulfonate transport|taurine transport,0.001164|0.001552|0.001552|0.002715|0.002715,1|1|1|1|1,1287|858.1|858.1|429.1|429.1
2762,4,0.5706,3.424,3121.0,0.001093,0.9929309999999999,ARHGAP12 ASAP1 ME1 RAB40C,regulation of NADP metabolic process|positive regulation of membrane tubulation|regulation of membrane tubulation|malate metabolic process|positive regulation of podosome assembly,0.001165|0.001165|0.001553|0.001747|0.001941,1|1|1|1|1,1030|1030|735.5|643.6|572.1
2763,4,0.5352,3.2110000000000003,3030.0,0.001056,0.9929309999999999,ASCL2 ME3 QARS SLC1A5,tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|L-glutamine import across plasma membrane|glutamine secretion,5.293e-05|5.981e-05|6.219e-05|0.0004854|0.0004854,0.8349|0.4717|0.327|1|1,179.1|168.1|164.8|4119|4119
2764,5,0.5286,5.2860000000000005,4045.0,0.001302,0.996692,ARL15 C6orf48 MEA1 OARD1 SMIM29,peptidyl-glutamate ADP-deribosylation|protein de-ADP-ribosylation|purine nucleoside metabolic process|nucleoside metabolic process|biological regulation,0.0007766|0.001359|0.01218|0.02062|0.02306,1|1|1|1|1,1716|858.1|83.04|48.57|0
2765,4,0.5009,3.005,3115.0,0.0009613,0.9929309999999999,MEF2A SLITRK1 SLITRK5 SLITRK6,regulation of presynapse assembly|regulation of presynapse organization|positive regulation of synapse assembly|cell morphogenesis involved in neuron differentiation|neuron projection morphogenesis,1.958e-08|1.958e-08|1.036e-07|2.309e-07|3.403e-07,0.0003089|0.0001545|0.0005449|0.0009104|0.001074,468.1|468.1|261.8|45.87|41.61
2766,5,0.5113,5.113,3906.0,0.0013039999999999998,0.996692,HTR1B MEI4 NR2F1 PPFIBP2 WDR83OS,"negative regulation of gamma-aminobutyric acid secretion|cellular response to temperature stimulus|negative regulation of serotonin secretion|regulation of gamma-aminobutyric acid secretion|negative regulation of synaptic transmission, GABAergic",0.000728|0.001456|0.001456|0.001698|0.001698,1|1|1|1|1,2060|823.8|823.8|686.5|686.5
2767,4,0.5654,3.392,3317.0,0.001019,0.9929309999999999,MARK1 MEIG1 MYO9A ODF3L1,manchette assembly|regulation of neuron projection arborization|establishment of epithelial cell apical/basal polarity|microtubule cytoskeleton organization|sperm axoneme assembly,0.0009706|0.003104|0.003491|0.004389|0.004459,1|1|1|1|1,1287|343.2|302.9|18.19|234
2768,7,0.516,10.84,5294.0,0.002037,0.9992989999999999,HDDC2 INSM2 MEIS2 PBX1 PBX2 PBX3 TFAP2B,eye development|visual system development|sensory system development|sensory organ development|animal organ morphogenesis,3.759e-08|3.966e-08|4.293e-08|2.926e-07|4.009e-06,0.0005929|0.0003128|0.0002257|0.001154|0.01265,40.19|39.76|39.12|26.51|15.57
2769,5,0.5001,5.001,3595.0,0.001385,0.996692,ARHGAP11A ARHGAP11B CHRFAM7A MELK PHACTR4,negative regulation of acetylcholine-gated cation channel activity|regulation of acetylcholine-gated cation channel activity|closure of optic fissure|signal transduction|negative regulation of integrin-mediated signaling pathway,0.0004854|0.000728|0.000728|0.0009685|0.0009706,1|1|1|1|1,4119|2060|2060|4.008|1373
2770,4,0.5391,3.235,3254.0,0.0009908,0.9929309999999999,EVL MEOX1 QPCTL TULP2,"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase|peptidyl-glutamine modification|sclerotome development|somite specification|negative regulation of ruffle assembly",0.0005825|0.0009706|0.0009706|0.001165|0.001359,1|1|1|1|1,2574|1287|1287|1030|858.1
2771,5,0.5117,5.117,4115.0,0.001239,0.996692,ADPRHL1 EPHA5 MEPE NBEAL1 OVOL2,endocardium formation|negative regulation of stem cell proliferation|protein de-ADP-ribosylation|endocardium morphogenesis|negative regulation of keratinocyte differentiation,0.001213|0.001456|0.001698|0.001698|0.00194,1|1|1|1|1,1030|823.8|686.5|686.5|588.4
2772,4,0.5775,3.465,3218.0,0.001073,0.9929309999999999,B9D1 CLHC1 METTL18 SLC16A9,"peptidyl-histidine methylation, to form tele-methylhistidine|peptidyl-histidine methylation|peptidyl-histidine modification|urate metabolic process|neuroepithelial cell differentiation",0.0005825|0.0007766|0.002716|0.00291|0.003491,1|1|1|1|1,2574|1716|396.1|367.8|302.9
2773,4,0.5438,3.263,3218.0,0.001011,0.9929309999999999,BTBD8 IRAK3 KIF1B METTL21A,response to rotenone|positive regulation of macrophage tolerance induction|regulation of macrophage tolerance induction|clathrin-dependent synaptic vesicle endocytosis|retrograde neuronal dense core vesicle transport,0.0003883|0.0003883|0.0003883|0.0009706|0.001165,1|1|1|1|1,5149|5149|5149|1287|1030
2774,4,0.5549,3.3289999999999997,3263.0,0.001017,0.9929309999999999,EMILIN2 METTL4 MYOM1 RUBCN,DNA methylation on adenine|snRNA (adenine-N6)-methylation|regulation of mitochondrial transcription|extraocular skeletal muscle development|regulation of mitochondrial DNA replication,0.0005825|0.0005825|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2574|2574|1287|1287|1287
2775,4,0.5255,3.153,3015.0,0.001042,0.9929309999999999,FYTTD1 MFN1 SVIP TRIM14,positive regulation of autophagy|negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly|regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly|mitochondrial membrane fusion|negative regulation of ER-associated ubiquitin-dependent protein catabolic process,0.000214|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,84.41|5149|5149|2574|1716
2776,4,0.5106,3.0639999999999996,3349.0,0.0009117000000000001,0.9929309999999999,CHAC1 DEPP1 GMPR MFRP,glutathione catabolic process|glutathione biosynthetic process|purine-containing compound salvage|nonribosomal peptide biosynthetic process|purine nucleobase metabolic process,0.002328|0.003104|0.003104|0.003491|0.003878,1|1|1|1|1,468.1|343.2|343.2|302.9|271
2777,5,0.5548,5.547999999999999,4078.0,0.001355,0.996692,ARHGAP31 MFSD1 NPHP3 ROPN1 SCHIP1,determination of stomach left/right asymmetry|determination of intestine left/right asymmetry|regulation of planar cell polarity pathway involved in neural tube closure|cilium movement|stomach development,0.0004854|0.0004854|0.0004854|0.000492|0.0009706,1|1|1|1|1,4119|4119|4119|57.21|1373
2778,5,0.515,5.15,4194.0,0.001224,0.996692,C10orf71 DUSP23 KLHL31 MFSD12 SERGEF,negative regulation of secondary metabolite biosynthetic process|negative regulation of melanin biosynthetic process|regulation of secondary metabolic process|regulation of secondary metabolite biosynthetic process|regulation of melanin biosynthetic process,0.001456|0.001456|0.003152|0.003152|0.003152,1|1|1|1|1,823.8|823.8|343.3|343.3|343.3
2779,4,0.5867,3.52,3210.0,0.001093,0.9929309999999999,CDH20 KCTD3 MFSD4A REG1A,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration,4.441e-05|0.0004854|0.0004854|0.0004854|0.0004854,0.7005|1|1|1|1,196.1|4119|4119|4119|4119
2780,4,0.5082,3.049,3345.0,0.0009087,0.9929309999999999,MFSD5 PXDN SLC6A7 THPO,hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance,1.313e-05|2.547e-05|0.0001309|0.0001684|0.0001905,0.2071|0.2009|0.6881|0.664|0.601,355.1|251.2|108.4|95.35|89.54
2781,4,0.5784,3.47,3228.0,0.0010710000000000001,0.9929309999999999,MEDAG MFSD9 ZNF518B ZNF799,"positive regulation of fat cell differentiation|regulation of fat cell differentiation|cellular process|regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated",0.01276|0.02482|0.04971|0.07957|0.1341,1|1|1|1|1,79.21|40.22|0.3325|3.982|2.973
2782,6,0.5021,7.531000000000001,5221.0,0.001437,0.998474,CLDN22 FSD1 HMSD MGAT5B SLC4A3 SLC7A2,transport across blood-brain barrier|vascular transport|L-arginine import across plasma membrane|L-lysine transport|L-lysine transmembrane transport,0.0002676|0.0002737|0.001746|0.002037|0.002037,1|1|1|1|1,79.83|78.91|686.5|572.1|572.1
2783,4,0.5125,3.075,3179.0,0.0009641,0.9929309999999999,HIST1H1T MGP PRM2 ZNF75A,cartilage condensation|cell aggregation|chromosome condensation|regulation of bone mineralization|regulation of biomineral tissue development,0.003201|0.003346|0.007845|0.01103|0.01363,1|1|1|1|1,326.9|312|129.5|91.53|73.82
2784,5,0.5356,5.356,3687.0,0.0014470000000000002,0.996692,MAP2K5 MAP3K2 MAPK7 MIB2 TPH1,cellular response to laminar fluid shear stress|negative regulation of heterotypic cell-cell adhesion|regulation of cell-cell adhesion involved in gastrulation|response to laminar fluid shear stress|cellular response to fluid shear stress,2.119e-06|3.108e-06|3.108e-06|5.648e-06|8.939e-06,0.03343|0.02451|0.01634|0.02227|0.0282,1030|823.8|823.8|588.4|457.7
2785,5,0.52,5.2,4156.0,0.001247,0.996692,ADIPOQ CSRP1 MICAL1 MPZL3 SPAG1,negative regulation of metanephros development|negative regulation of metanephric mesenchymal cell migration|positive regulation of renal albumin absorption|positive regulation of metanephric glomerular visceral epithelial cell development|regulation of metanephric glomerular visceral epithelial cell development,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2786,4,0.5029,3.017,3139.0,0.000958,0.9929309999999999,CCDC122 DEFB131A MICALCL SH2D7,cellular response to lipoteichoic acid|response to lipoteichoic acid|positive regulation of monocyte chemotaxis|regulation of monocyte chemotaxis|positive regulation of cytokine production involved in immune response,0.002328|0.002328|0.004459|0.005813|0.01102,1|1|1|1|1,468.1|468.1|234|177.5|91.94
2787,4,0.5483,3.29,3108.0,0.0010550000000000002,0.9929309999999999,MICU2 PABPC1L PIP5K1B ZNF705G,negative regulation of mitochondrial calcium ion concentration|positive regulation of mitochondrial calcium ion concentration|calcium import into the mitochondrion|chromatin-mediated maintenance of transcription|oocyte maturation,0.0009706|0.002328|0.002328|0.002522|0.003685,1|1|1|1|1,1287|468.1|468.1|429.1|286
2788,4,0.5409,3.245,3150.0,0.001027,0.9929309999999999,KBTBD3 KDELC2 MICU3 MMP3,negative regulation of hydrogen peroxide metabolic process|cellular response to UV-A|calcium import into the mitochondrion|response to UV-A|cellular response to nitric oxide,0.001019|0.001747|0.001747|0.002183|0.002329,1|1|1|1|1,1144|624.1|624.1|490.4|457.7
2789,4,0.5093,3.056,3226.0,0.0009439,0.9929309999999999,LBHD1 MIGA1 RASSF2 THBD,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade|epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity|negative regulation of fibrinolysis|regulation of fibrinolysis|mitochondrial fusion,0.0003883|0.0003883|0.002134|0.00291|0.003491,1|1|1|1|1,5149|5149|514.9|367.8|302.9
2790,4,0.5098,3.0589999999999997,3317.0,0.0009191000000000001,0.9929309999999999,CDK18 DNAJA4 MINPP1 PUS7L,polyphosphate metabolic process|negative regulation of inclusion body assembly|pseudouridine synthesis|regulation of inclusion body assembly|protein refolding,0.001359|0.002328|0.003685|0.003685|0.003878,1|1|1|1|1,858.1|468.1|286|286|271
2791,4,0.5242,3.145,3027.0,0.001035,0.9929309999999999,FBXO4 MIP MLANA OR10G7,protein processing involved in protein targeting to mitochondrion|gap junction-mediated intercellular transport|common myeloid progenitor cell proliferation|intercellular transport|mitochondrial protein processing,0.002037|0.002376|0.002715|0.002715|0.004071,1|1|1|1|1,588.4|490.4|420.3|420.3|267.5
2792,13,0.5021,39.16,10810.0,0.0036,0.999993,C8orf44 CA1 CA2 CA3 CNGB3 CYP7A1 LYN MCMDC2 PMP2 SGK3 SLC26A7 SNX16 TMEM67,bicarbonate transport|organic anion transport|one-carbon metabolic process|ion transport|organic substance transport,1.53e-08|1.472e-06|2.219e-06|8.674e-06|0.0001402,0.0002414|0.01161|0.01167|0.03421|0.4422,150.9|23.3|121.9|4.949|5.11
2793,12,0.5224,34.48,7713.0,0.004436,0.999986,CKAP5 CLTC DLGAP5 DSN1 GAK GTSE1 KIF15 KNTC1 MAD2L1BP MAPRE1 TACC3 TRIP13,mitotic cell cycle|cell cycle|regulation of cell cycle process|mitotic spindle organization|regulation of mitotic sister chromatid separation,3.132e-13|1.557e-12|3.063e-11|2.559e-10|3.04e-10,4.94e-09|1.228e-08|1.61e-07|1.009e-06|9.592e-07,22.55|13.58|20.01|62.79|132
2794,5,0.5174,5.1739999999999995,4193.0,0.00123,0.996692,ANKRD29 B4GALNT3 CLDN5 MIXL1 MRPS9,establishment of blood-retinal barrier|positive regulation of mesoderm development|positive regulation of establishment of endothelial barrier|regulation of mesoderm development|positive regulation of endothelial cell development,0.0004854|0.000728|0.001698|0.001698|0.001698,1|1|1|1|1,4119|2060|686.5|686.5|686.5
2795,5,0.5039,5.039,3965.0,0.001266,0.996692,C12orf74 MKRN3 PLA2G4D RANGRF SNX22,regulation of microtubule nucleation by Ran protein signal transduction|regulation of bundle of His cell action potential|regulation of membrane depolarization during cardiac muscle cell action potential|Ran protein signal transduction|regulation of membrane depolarization during action potential,0.0004854|0.000728|0.001213|0.001213|0.001456,1|1|1|1|1,4119|2060|1030|1030|823.8
2796,5,0.5122,5.122000000000001,3618.0,0.00141,0.996692,ADAT2 DACT2 FDXR MKX TRMT61A,tRNA modification|tRNA processing|tRNA wobble adenosine to inosine editing|RNA modification|tRNA metabolic process,0.0001956|0.0004146|0.0004854|0.0006818|0.0007712,1|1|1|1|1,91.53|62.41|4119|48.46|45.51
2797,4,0.5302,3.181,3194.0,0.0009926,0.9929309999999999,DMTN FAM171A1 MLH1 STAP2,actin filament bundle assembly|actin filament bundle organization|regulation of cell shape|meiotic metaphase I plate congression|protein secretion by platelet,4.987e-05|5.502e-05|0.0003342|0.0003883|0.0005825,0.7867|0.4339|1|1|1,177.5|168.8|67.3|5149|2574
2798,4,0.5863,3.5180000000000002,3234.0,0.001084,0.9929309999999999,C1QTNF5 GUCA1A KCNQ2 MLKL,execution phase of necroptosis|positive regulation of cGMP-mediated signaling|necroptotic signaling pathway|positive regulation of guanylate cyclase activity|activation of JNKK activity,0.0005825|0.001553|0.001747|0.001941|0.002134,1|1|1|1|1,2574|735.5|643.6|572.1|514.9
2799,4,0.52,3.12,3319.0,0.0009368,0.9929309999999999,CCDC97 MLNR REC8 WDR19,ciliary receptor clustering involved in smoothened signaling pathway|gonad development|development of primary sexual characteristics|myotome development|sex differentiation,0.0005825|0.0006181|0.0006536|0.0007766|0.0009798,1|1|1|1|1,2574|49.27|47.9|1716|39.01
2800,4,0.5509,3.306,3216.0,0.001024,0.9929309999999999,CCL24 MLPH SLC6A11 TATDN2,gamma-aminobutyric acid reuptake|positive regulation of eosinophil migration|amino acid neurotransmitter reuptake|regulation of eosinophil migration|gamma-aminobutyric acid transport,0.0009706|0.0009706|0.001359|0.001359|0.001941,1|1|1|1|1,1287|1287|858.1|858.1|572.1
2801,5,0.5126,5.126,4117.0,0.001241,0.996692,CHCHD7 MMAA PNLIPRP1 SLURP1 TMEM177,urokinase plasminogen activator signaling pathway|short-chain fatty acid catabolic process|lipid catabolic process|negative regulation of keratinocyte proliferation|neuromuscular process controlling posture,0.0008735|0.002909|0.003171|0.004071|0.004942,1|1|1|1|1,1716|381.4|22.58|264|214.5
2802,4,0.572,3.432,3309.0,0.001034,0.9929309999999999,FGFBP1 MMAB PPP2R2C TIGD5,positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|peptidyl-serine dephosphorylation|regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|positive regulation of cell migration involved in sprouting angiogenesis,0.001747|0.001941|0.00291|0.003297|0.004072,1|1|1|1|1,643.6|572.1|367.8|321.8|257.4
2803,5,0.5118,5.118,3976.0,0.001282,0.996692,ADAM22 MMEL1 PLSCR2 TM4SF18 TM4SF4,neurotransmitter receptor localization to postsynaptic specialization membrane|protein localization to postsynaptic specialization membrane|plasma membrane phospholipid scrambling|myelination in peripheral nervous system|peripheral nervous system axon ensheathment,0.003152|0.003152|0.005087|0.00702|0.00702,1|1|1|1|1,343.3|343.3|205.9|147.1|147.1
2804,5,0.5464,5.4639999999999995,4299.0,0.001266,0.996692,C1orf123 CLEC10A IFI44L MMRN2 SLC16A8,lactate transmembrane transport|lactate transport|negative regulation of vascular endothelial growth factor receptor signaling pathway|negative regulation of cell migration involved in sprouting angiogenesis|cell migration involved in sprouting angiogenesis,0.001553|0.001553|0.00291|0.003104|0.004072,1|1|1|1|1,735.5|735.5|367.8|343.2|257.4
2805,8,0.5096,14.27,6519.0,0.002179,0.9996790000000001,C1QTNF9 DZIP1 MN1 POSTN RNF6 RXFP2 SOHLH2 ZAR1L,germ cell development|oocyte differentiation|cellular process involved in reproduction in multicellular organism|oogenesis|female gamete generation,0.0001062|0.0001182|0.0002686|0.0004106|0.001063,1|0.9322|1|1|1,30.05|125.6|21.88|66.01|40.54
2806,4,0.5973,3.5839999999999996,3180.0,0.001123,0.9929309999999999,GOLGA5 MND1 PLXNB2 TSPAN3,"retrograde transport, vesicle recycling within Golgi|semaphorin-plexin signaling pathway involved in axon guidance|semaphorin-plexin signaling pathway involved in neuron projection guidance|excitatory synapse assembly|neuroblast proliferation",0.0005825|0.002328|0.002716|0.003104|0.005426,1|1|1|1|1,2574|468.1|396.1|343.2|190.7
2807,4,0.5232,3.139,3040.0,0.001029,0.9929309999999999,CATSPERD CLEC4M CNN1 MNS1,cell-cell recognition|multi-organism process|peptide antigen transport|cell recognition|virion attachment to host cell,9.117e-05|0.0005374|0.0007766|0.000812|0.002134,1|1|1|1|1,130.3|14.48|1716|42.91|514.9
2808,4,0.5023,3.014,3133.0,0.0009586999999999999,0.9929309999999999,CCDC198 MOB3A RBM6 SERPINB1,type B pancreatic cell proliferation|negative regulation of interleukin-1 beta production|negative regulation of interleukin-1 production|regulation of interleukin-1 beta production|epithelial cell proliferation,0.001941|0.00562|0.00678|0.01698|0.01736,1|1|1|1|1,572.1|183.9|151.4|59.18|57.85
2809,4,0.5476,3.285,3240.0,0.001011,0.9929309999999999,ANKRD34C ARPIN MOCS2 SPTBN5,negative regulation of cytoskeleton organization|negative regulation of supramolecular fiber organization|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization|regulation of actin filament length,0.0003299|0.0003385|0.0004258|0.0005069|0.0005122,1|1|1|1|1,67.75|66.87|59.52|54.48|54.2
2810,4,0.5519,3.3110000000000004,3154.0,0.001046,0.9929309999999999,APOC4 CCDC171 MOG SYNPO2L,very-low-density lipoprotein particle clearance|positive regulation of sequestering of triglyceride|very-low-density lipoprotein particle assembly|regulation of sequestering of triglyceride|positive regulation of lipid storage,0.001359|0.001941|0.002716|0.00291|0.00504,1|1|1|1|1,858.1|572.1|396.1|367.8|205.9
2811,5,0.5326,5.3260000000000005,4344.0,0.001222,0.996692,ACADL COPS7B MOGAT1 RETREG2 WNT10A,"carnitine catabolic process|carnitine metabolic process, CoA-linked|amino-acid betaine catabolic process|long-chain fatty acid catabolic process|COP9 signalosome assembly",0.0004854|0.0009706|0.0009706|0.001456|0.001456,1|1|1|1|1,4119|1373|1373|823.8|823.8
2812,4,0.5193,3.116,3049.0,0.001018,0.9929309999999999,GTDC1 MOGAT2 RIN1 SPSB4,monoacylglycerol biosynthetic process|diacylglycerol biosynthetic process|monoacylglycerol metabolic process|positive regulation of protein polyubiquitination|glycerol metabolic process,0.001553|0.001747|0.00291|0.00291|0.004266,1|1|1|1|1,735.5|643.6|367.8|367.8|245.2
2813,4,0.5724,3.4339999999999997,3173.0,0.0010789999999999999,0.9929309999999999,MON1A REG1A SAMD7 ZSCAN31,cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration|positive regulation of acinar cell proliferation,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2814,5,0.5286,5.2860000000000005,3975.0,0.001325,0.996692,CALML6 FAAP20 HES3 MORN1 PRKCZ,activation of phospholipase D activity|positive regulation of T-helper 2 cell differentiation|positive regulation of T-helper 2 cell cytokine production|regulation of neurotransmitter receptor localization to postsynaptic specialization membrane|membrane hyperpolarization,0.001698|0.00194|0.00194|0.002425|0.002667,1|1|1|1|1,686.5|588.4|588.4|457.7|411.9
2815,4,0.5547,3.3280000000000003,3250.0,0.001021,0.9929309999999999,HK3 MOV10L1 NCF4 TCN2,cobalt ion transport|cobalamin transport|fructose 6-phosphate metabolic process|piRNA metabolic process|DNA methylation involved in gamete generation,0.001553|0.001747|0.002328|0.003685|0.004072,1|1|1|1|1,735.5|643.6|468.1|286|257.4
2816,4,0.5694,3.4160000000000004,3283.0,0.001037,0.9929309999999999,ACAA1 DIO2 MAP1A MPHOSPH9,phenylacetate catabolic process|retrograde axonal protein transport|thyroid hormone catabolic process|negative regulation of protein localization to microtubule|regulation of protein localization to microtubule,0.0005825|0.0005825|0.0005825|0.001165|0.001165,1|1|1|1|1,2574|2574|2574|1030|1030
2817,4,0.5272,3.1630000000000003,3202.0,0.0009843,0.9929309999999999,ATP8A2 GOT1L1 MPND MTUS2,involuntary skeletal muscle contraction|aspartate biosynthetic process|positive regulation of phospholipid translocation|regulation of phospholipid translocation|aminophospholipid translocation,0.0007766|0.0007766|0.001165|0.001359|0.001553,1|1|1|1|1,1716|1716|1030|858.1|735.5
2818,4,0.5578,3.347,3180.0,0.001049,0.9929309999999999,ATP10A MPP2 PAPLN PIK3C2B,maintenance of postsynaptic density structure|positive regulation of membrane tubulation|maintenance of postsynaptic specialization structure|regulation of membrane tubulation|phosphatidylinositol-3-phosphate biosynthetic process,0.001456|0.001456|0.00194|0.00194|0.003636,1|1|1|1|1,823.8|823.8|588.4|588.4|294.2
2819,4,0.5392,3.235,3375.0,0.0009555,0.9929309999999999,CDK18 LRTM2 MPP4 RSPH4A,radial spoke assembly|regulation of transcription involved in G1/S transition of mitotic cell cycle|negative chemotaxis|positive regulation of synapse assembly|protein localization to synapse,0.0005825|0.00678|0.009096|0.0116|0.01199,1|1|1|1|1,2574|151.4|111.9|87.27|84.41
2820,5,0.5076,5.0760000000000005,4260.0,0.001187,0.996692,DIRC1 MALL MPP7 SDC2 ZNF320,protein localization to adherens junction|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization|protein localization to cell-cell junction|bicellular tight junction assembly,0.001746|0.0032|0.0032|0.005522|0.01706,1|1|1|1|1,686.5|343.2|343.2|190.7|59.18
2821,12,0.5148,33.98,8094.0,0.004168,0.999986,LUZP1 MPRIP MYH9 MYL12A MYL12B MYL6 NUAK2 PPP1R12A ROCK1 ROCK2 SIAH1 SPECC1L,actin filament-based process|regulation of myosin-light-chain-phosphatase activity|muscle contraction|actin cytoskeleton organization|muscle system process,1.266e-08|1.806e-08|1.793e-07|2.28e-07|4.169e-07,0.0001997|0.0001425|0.0009426|0.0008989|0.001315,20.09|735.5|35.31|19.65|29.69
2822,4,0.5313,3.188,3149.0,0.001009,0.9929309999999999,LELP1 MR1 SLC38A8 TXLNB,positive regulation of T cell mediated cytotoxicity directed against tumor cell target|regulation of T cell mediated cytotoxicity directed against tumor cell target|methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione|methylglyoxal catabolic process|methylglyoxal catabolic process to lactate,0.000728|0.000728|0.0009706|0.001213|0.001213,1|1|1|1|1,2060|2060|1373|1030|1030
2823,4,0.5373,3.2239999999999998,3386.0,0.0009488999999999999,0.9929309999999999,ANK1 MRC1 PKD2L1 TMEM74,detection of chemical stimulus involved in sensory perception of sour taste|sensory perception of sour taste|modulation by symbiont of host defense response|maintenance of epithelial cell apical/basal polarity|response to host defenses,0.0005825|0.001165|0.001747|0.002328|0.002328,1|1|1|1|1,2574|1030|643.6|468.1|468.1
2824,4,0.5132,3.0789999999999997,3056.0,0.001004,0.9929309999999999,CLSPN DND1 MREG PTDSS2,phosphatidylserine biosynthetic process|minus-end-directed organelle transport along microtubule|mitotic DNA replication checkpoint|DNA replication checkpoint|3'-UTR-mediated mRNA destabilization,0.0009706|0.001165|0.002134|0.003491|0.003685,1|1|1|1|1,1287|1030|514.9|302.9|286
2825,22,0.4795,110.8,17250.0,0.006365,1.0,ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EPOP EVI2A GAS2L2 GSDMB KRTAP4-8 LYRM9 MRM1 MYO19 NME1 PIGS PIGW RDM1 SLFN12 SPAG5 UNC119,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|lymphocyte chemotaxis|regulation of natural killer cell chemotaxis,1.365e-06|1.592e-06|1.559e-05|2.586e-05|5.328e-05,0.02154|0.01255|0.08195|0.102|0.1681,158|149.2|65.52|54.82|223.9
2826,4,0.5488,3.293,3098.0,0.001059,0.9929309999999999,ACADSB C8G MRNIP TP53INP2,"isoleucine catabolic process|isoleucine metabolic process|positive regulation of double-strand break repair via homologous recombination|complement activation, alternative pathway|branched-chain amino acid catabolic process",0.0009706|0.001553|0.00291|0.003104|0.004266,1|1|1|1|1,1287|735.5|367.8|343.2|245.2
2827,4,0.5288,3.173,3155.0,0.0010019999999999999,0.9929309999999999,MRO PCDHGB6 ZNF501 ZNF502,positive regulation by host of viral release from host cell|modulation by host of viral release from host cell|positive regulation by host of viral process|positive regulation of viral release from host cell|modulation by host of viral process,0.001165|0.001165|0.003104|0.003104|0.006007,1|1|1|1|1,1030|1030|343.2|343.2|171.6
2828,4,0.536,3.216,3068.0,0.001045,0.9929309999999999,CABS1 INPP4A MROH2B ZNF543,phosphatidylinositol-3-phosphate biosynthetic process|protein kinase A signaling|spermatogenesis|male gamete generation|gamete generation,0.00291|0.003297|0.00412|0.004404|0.006537,1|1|1|1|1,367.8|321.8|18.79|18.16|14.84
2829,10,0.5172,23.28,7169.0,0.0032270000000000003,0.999933,DDX55 MAK16 MRTO4 PPAN PWP1 PWP2 RPF2 RRP1 URB1 WDR18,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,1.509e-17|4.158e-16|1.177e-13|1.582e-13|6.33e-12,2.38e-13|3.28e-12|6.188e-10|6.237e-10|1.997e-08,56.39|40.26|57.61|55.47|34.67
2830,4,0.5321,3.193,3328.0,0.0009561,0.9929309999999999,BPIFA3 DYM MS4A1 ZFP90,store-operated calcium entry|calcium ion import into cytosol|B cell proliferation|calcium ion import|negative regulation of DNA binding,0.001747|0.003491|0.008131|0.009675|0.01083,1|1|1|1|1,643.6|302.9|125.6|105.1|93.61
2831,6,0.5068,7.602,5259.0,0.00144,0.998474,C20orf194 CAMK2A LCA5L MS4A10 PLPP6 WASF1,transport along microtubule|peptidyl-threonine autophosphorylation|dendritic transport of mitochondrion|regulation of endocannabinoid signaling pathway|microtubule-based transport,0.0008592|0.0008735|0.0008735|0.001165|0.001278,1|1|1|1|1,44.01|1716|1716|1144|35.94
2832,4,0.5262,3.157,2840.0,0.001108,0.9929309999999999,FNTA FNTB MS4A13 ZNF395,protein farnesylation|protein prenylation|prenylation|regulation of rhodopsin mediated signaling pathway|positive regulation of tubulin deacetylation,4.712e-07|3.108e-06|3.108e-06|1.777e-05|0.0004854,0.007432|0.02451|0.01634|0.07008|1,2746|823.8|823.8|316.8|4119
2833,4,0.5289,3.173,3177.0,0.0009955,0.9929309999999999,CYP27A1 MS4A4A MS4A6E RWDD2A,cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process|vitamin D3 metabolic process,0.0009706|0.0009706|0.0009706|0.0009706|0.001359,1|1|1|1|1,1287|1287|1287|1287|858.1
2834,4,0.5064,3.0380000000000003,3174.0,0.0009541,0.9929309999999999,MN1 MS4A8 RNF175 S100Z,positive regulation of vitamin D receptor signaling pathway|intramembranous ossification|regulation of vitamin D receptor signaling pathway|direct ossification|negative regulation of osteoblast proliferation,0.0007766|0.001553|0.001553|0.001553|0.002134,1|1|1|1|1,1716|735.5|735.5|735.5|514.9
2835,4,0.5802,3.4810000000000003,3509.0,0.0009887000000000001,0.9929309999999999,DCHS1 MSANTD1 PLB1 SLC35D3,UDP-N-acetylgalactosamine transmembrane transport|UDP-glucuronic acid transmembrane transport|mitral valve formation|condensed mesenchymal cell proliferation|cell migration involved in endocardial cushion formation,0.0007766|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1716|1287|1287
2836,4,0.5388,3.233,3211.0,0.001003,0.9929309999999999,GRIN1 MSH2 MYDGF PWWP2A,ionotropic glutamate receptor signaling pathway|glutamate receptor signaling pathway|propylene metabolic process|response to glycine|cellular alkene metabolic process,1.909e-05|5.517e-05|0.0004854|0.000728|0.000728,0.3011|0.4352|1|1|1,305.1|175.3|4119|2060|2060
2837,4,0.5143,3.0860000000000003,3136.0,0.0009805,0.9929309999999999,LRP5 MSI1 SIGIRR TSPAN3,cell-cell signaling involved in mammary gland development|Norrin signaling pathway|apoptotic process involved in blood vessel morphogenesis|extracellular matrix-cell signaling|retinal blood vessel morphogenesis,0.0005825|0.0007766|0.001165|0.001165|0.001359,1|1|1|1|1,2574|1716|1030|1030|858.1
2838,4,0.514,3.0839999999999996,3267.0,0.0009408999999999999,0.9929309999999999,GPR176 MSS51 PLCL2 TCF25,B-1a B cell differentiation|B-1 B cell differentiation|B cell proliferation involved in immune response|negative regulation of B cell receptor signaling pathway|positive regulation of receptor binding,0.0005825|0.001165|0.001359|0.001553|0.002134,1|1|1|1|1,2574|1030|858.1|735.5|514.9
2839,4,0.549,3.2939999999999996,3130.0,0.001049,0.9929309999999999,FAM131C MMEL1 MST1R TMPPE,macrophage colony-stimulating factor signaling pathway|cellular response to macrophage colony-stimulating factor stimulus|response to macrophage colony-stimulating factor|hepatocyte growth factor receptor signaling pathway|peptidyl-tyrosine phosphorylation,0.0009706|0.001747|0.001747|0.002522|0.02843,1|1|1|1|1,1287|643.6|643.6|429.1|35.03
2840,4,0.5714,3.429,3194.0,0.00107,0.9929309999999999,C2orf54 ICAM2 MSTN SCN4A,regulation of skeletal muscle contraction by action potential|regulation of muscle system process|negative regulation of myoblast proliferation|negative regulation of skeletal muscle tissue growth|muscle system process,0.0002913|0.0003729|0.0004369|0.0004369|0.0005912,1|1|1|1|1,6865|59.96|3432|3432|47.51
2841,4,0.519,3.114,3238.0,0.0009585,0.9929309999999999,CYR61 MSX2 PTX3 SLC9A8,positive regulation of cell proliferation in midbrain|negative regulation of exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|modulation by host of viral glycoprotein metabolic process|negative regulation by host of viral exo-alpha-sialidase activity,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
2842,8,0.5393,15.1,5679.0,0.0026449999999999998,0.9996790000000001,CARS GGPS1 GUK1 NEDD8 RABGGTB RARS THG1L YARS,tRNA metabolic process|tRNA aminoacylation for protein translation|tRNA aminoacylation|amino acid activation|ncRNA metabolic process,4.283e-07|7.02e-07|8.416e-07|8.92e-07|2.61e-05,0.006756|0.005537|0.004425|0.003518|0.08234,56.89|167.9|157.6|154.5|19.92
2843,4,0.5384,3.23,3086.0,0.0010429999999999999,0.9929309999999999,MTERF2 MUSK SLC22A17 TNFRSF13B,positive regulation of protein geranylgeranylation|regulation of protein geranylgeranylation|termination of mitochondrial transcription|siderophore transport|regulation of synaptic growth at neuromuscular junction,0.0003883|0.0003883|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|5149|2574|1716|1030
2844,5,0.5179,5.178999999999999,3717.0,0.0013880000000000001,0.996692,EPS15L1 MEF2B MTFR2 SUGP2 TMEM221,mitochondrial fission|negative regulation of epidermal growth factor receptor signaling pathway|negative regulation of ERBB signaling pathway|aerobic respiration|regulation of epidermal growth factor receptor signaling pathway,0.005329|0.01184|0.01304|0.01879|0.02118,1|1|1|1|1,196.1|85.81|77.72|53.49|47.34
2845,4,0.5373,3.2239999999999998,3237.0,0.0009927,0.9929309999999999,GKN1 MTNR1A OAF ZNF749,"mating behavior|reproductive behavior|mating|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway",0.003878|0.005426|0.006393|0.01314|0.0164,1|1|1|1|1,271|190.7|160.9|76.85|61.29
2846,4,0.5327,3.196,3358.0,0.0009486000000000001,0.9929309999999999,C1orf141 LRRC7 MTTP OR10Q1,triglyceride transport|acylglycerol transport|ceramide 1-phosphate transport|chylomicron assembly|lipoprotein transport,0.001165|0.001165|0.001747|0.002328|0.002716,1|1|1|1|1,1030|1030|643.6|468.1|396.1
2847,6,0.5003,7.505,4833.0,0.001547,0.998474,ARHGEF28 LHCGR MTUS1 OXER1 POMK STON1,luteinizing hormone signaling pathway|cellular response to luteinizing hormone stimulus|response to luteinizing hormone|adenylate cyclase-modulating G protein-coupled receptor signaling pathway|positive regulation of inositol trisphosphate biosynthetic process,0.0008735|0.001165|0.001456|0.001685|0.001746,1|1|1|1|1,1716|1144|858.1|31.2|686.5
2848,5,0.5521,5.521,4108.0,0.0013390000000000001,0.996692,ANKDD1A CABCOCO1 MUC21 PRF1 TRIM36,negative regulation of cell-cell adhesion|negative regulation of cell adhesion|regulation of cell-cell adhesion|regulation of cell adhesion|defense response to tumor cell,2.508e-05|8.708e-05|0.0003113|0.001388|0.002037,0.3955|0.6868|1|1|1,47.97|31.41|20.34|12.16|588.4
2849,4,0.5184,3.11,3115.0,0.0009948000000000001,0.9929309999999999,DNAH10 HCAR3 MUC22 TMEM119,positive regulation of bone development|regulation of bone development|positive regulation of osteoblast proliferation|negative regulation of myotube differentiation|negative regulation of bone resorption,0.0007766|0.001553|0.002328|0.00291|0.003491,1|1|1|1|1,1716|735.5|468.1|367.8|302.9
2850,4,0.555,3.33,2960.0,0.001121,0.9929309999999999,CD5L CLDN4 MUC5B TEX29,positive regulation of complement-dependent cytotoxicity|positive regulation of metallopeptidase activity|regulation of complement-dependent cytotoxicity|regulation of metallopeptidase activity|renal absorption,0.0003883|0.001359|0.001747|0.00291|0.003297,1|1|1|1|1,5149|858.1|643.6|367.8|321.8
2851,4,0.5358,3.215,3048.0,0.001051,0.9929309999999999,FLOT1 MUC6 ZNF488 ZNF503,cyclic-GMP-AMP transmembrane import across plasma membrane|methotrexate transport|guanine nucleotide transport|cyclic nucleotide transport|guanine nucleotide transmembrane transport,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
2852,5,0.5139,5.138999999999999,3752.0,0.001364,0.996692,ARHGAP11B CHRFAM7A GOLGA8M MUCL3 MYO1E,negative regulation of acetylcholine-gated cation channel activity|regulation of acetylcholine-gated cation channel activity|post-embryonic hemopoiesis|glomerular visceral epithelial cell development|glomerular basement membrane development,0.0004854|0.000728|0.001213|0.00291|0.00291,1|1|1|1|1,4119|2060|1030|374.5|374.5
2853,5,0.5227,5.227,3920.0,0.001328,0.996692,ATP13A2 HLA-DMB MUL1 OR7G2 PKDREJ,peptidyl-aspartic acid autophosphorylation|polyamine transmembrane transport|peptidyl-aspartic acid phosphorylation|regulation of autophagosome size|spermine transmembrane transport,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2854,4,0.518,3.108,3081.0,0.001005,0.9929309999999999,GRIA4 MFSD14A MUTYH NPR3,osteoclast proliferation|pancreatic juice secretion|depurination|positive regulation of urine volume|secretion by tissue,0.0009706|0.001553|0.002522|0.00291|0.003491,1|1|1|1|1,1287|735.5|429.1|367.8|302.9
2855,4,0.5633,3.38,3278.0,0.0010279999999999998,0.9929309999999999,ATG16L1 MVP SERTAD2 SLN,negative regulation of calcium ion binding|regulation of calcium ion binding|negative stranded viral RNA replication|xenophagy|protein lipidation involved in autophagosome assembly,0.0007766|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1716|1287|1287
2856,4,0.5611,3.367,3342.0,0.001004,0.9929309999999999,FA2H FHL3 MXRA7 NSUN6,sebaceous gland cell differentiation|glucosylceramide biosynthetic process|tRNA C5-cytosine methylation|central nervous system myelin maintenance|glucosylceramide metabolic process,0.0005825|0.0005825|0.0005825|0.0009706|0.001165,1|1|1|1|1,2574|2574|2574|1287|1030
2857,4,0.5388,3.233,3373.0,0.0009552999999999999,0.9929309999999999,CFAP299 HADHA MYBPH TFPI,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|cardiolipin acyl-chain remodeling|negative regulation of protein activation cascade",0.0009706|0.0009706|0.0009706|0.001747|0.002134,1|1|1|1|1,1287|1287|1287|643.6|514.9
2858,4,0.5107,3.0639999999999996,3092.0,0.0009873,0.9929309999999999,ERCC6L2 MYH15 TMEM131L TRPC3,positive regulation of cardiac muscle hypertrophy in response to stress|positive regulation of cardiac muscle adaptation|extraocular skeletal muscle development|negative regulation of immature T cell proliferation in thymus|negative regulation of immature T cell proliferation,0.0005825|0.0005825|0.0009706|0.001165|0.001359,1|1|1|1|1,2574|2574|1287|1030|858.1
2859,4,0.5406,3.2439999999999998,3452.0,0.0009365,0.9929309999999999,ANKRD34B BTBD10 MYL4 PAFAH2,type B pancreatic cell proliferation|regulation of the force of heart contraction|actin-myosin filament sliding|muscle filament sliding|positive regulation of ATPase activity,0.001941|0.005233|0.007552|0.007552|0.01141,1|1|1|1|1,572.1|198|135.5|135.5|88.77
2860,5,0.5535,5.535,4113.0,0.00134,0.996692,C1QTNF12 MYLK OR1L6 SLC34A3 TRAF3IP1,aorta smooth muscle tissue morphogenesis|sodium-dependent phosphate transport|cellular hypotonic response|bleb assembly|cellular phosphate ion homeostasis,0.0009706|0.0009706|0.002183|0.002425|0.002425,1|1|1|1|1,1373|1373|514.9|457.7|457.7
2861,4,0.5299,3.179,3216.0,0.0009852,0.9929309999999999,MYO3B OR1E1 PCDHB12 RAD51AP2,cochlea morphogenesis|cochlea development|interstrand cross-link repair|sensory perception|inner ear morphogenesis,0.004846|0.009675|0.01102|0.0126|0.01909,1|1|1|1|1,214.5|105.1|91.94|10.58|52.54
2862,4,0.5421,3.252,3050.0,0.0010630000000000001,0.9929309999999999,MYO5B RNF130 SRM SUMO4,spermidine biosynthetic process|spermidine metabolic process|polyamine biosynthetic process|polyamine metabolic process|vesicle transport along actin filament,0.0007766|0.001747|0.00291|0.003878|0.003878,1|1|1|1|1,1716|643.6|367.8|271|271
2863,6,0.5098,7.647,4346.0,0.0017519999999999999,0.998474,ANAPC10 MYO7A NAF1 P2RY6 SPCS3 TMA16,cellular response to pyrimidine ribonucleotide|response to pyrimidine ribonucleotide|box H/ACA snoRNP assembly|snoRNA guided rRNA pseudouridine synthesis|telomerase RNA stabilization,0.0005824|0.0005824|0.0008735|0.001165|0.001456,1|1|1|1|1,3432|3432|1716|1144|858.1
2864,5,0.521,5.21,4193.0,0.0012380000000000002,0.996692,ANAPC16 GALNT16 MYOF TECTB TMEM63C,T-tubule organization|protein O-linked glycosylation via threonine|protein O-linked glycosylation via serine|plasma membrane repair|glomerular filtration,0.002425|0.002425|0.002667|0.003152|0.003636,1|1|1|1|1,457.7|457.7|411.9|343.3|294.2
2865,4,0.5443,3.266,3185.0,0.0010220000000000001,0.9929309999999999,DISC1 MYOT SESN3 TPH2,TOR signaling|serotonin biosynthetic process|pyramidal neuron migration|primary amino compound biosynthetic process|indole-containing compound biosynthetic process,1.4e-05|0.0007766|0.0007766|0.001165|0.001165,0.2208|1|1|1|1,343.2|1716|1716|1030|1030
2866,5,0.5032,5.032,4053.0,0.0012369999999999998,0.996692,C17orf78 CCL1 FAAP100 MYT1L NRG1,neuron fate commitment|ERBB4 signaling pathway|ERBB3 signaling pathway|chemorepulsion involved in interneuron migration from the subpallium to the cortex|directional guidance of interneurons involved in migration from the subpallium to the cortex,9.744e-05|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,130.8|4119|2060|1373|1373
2867,4,0.5433,3.26,3119.0,0.001041,0.9929309999999999,ANK2 BTC CBR4 MZB1,protein localization to T-tubule|protein localization to M-band|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|membrane depolarization during SA node cell action potential,0.0005825|0.0005825|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|2574|1716|1287|1030
2868,4,0.5101,3.06,3073.0,0.0009924,0.9929309999999999,DUXA MZT2B SLC25A40 ZNF286A,mitotic prometaphase|biological phase|mitotic cell cycle phase|cell cycle phase|cellular process,0.03223|0.04917|0.04917|0.04917|0.04971,1|1|1|1|1,30.83|20.03|20.03|20.03|0.3325
2869,4,0.5508,3.305,3266.0,0.001008,0.9929309999999999,LGI2 N4BP2 SEL1L3 SLC34A2,sodium-dependent phosphate transport|cellular phosphate ion homeostasis|cellular trivalent inorganic anion homeostasis|inhibitory synapse assembly|phosphate ion homeostasis,0.0007766|0.001941|0.001941|0.002522|0.002716,1|1|1|1|1,1716|572.1|572.1|429.1|396.1
2870,6,0.5007,7.511,4189.0,0.0017850000000000001,0.998474,HYPK NAA15 NAF1 RPL28 SPATA5 SPCS3,protein targeting to ER|establishment of protein localization to endoplasmic reticulum|protein localization to endoplasmic reticulum|box H/ACA snoRNP assembly|viral gene expression,0.0004409|0.0004726|0.0007146|0.0008735|0.001041,1|1|1|1|1,61.85|59.7|48.35|1716|39.91
2871,4,0.5341,3.205,3262.0,0.0009792,0.9929309999999999,NAA16 SLC12A4 SLC1A4 SLC31A2,cation transmembrane transport|inorganic ion transmembrane transport|chloride transmembrane transport|chloride transport|inorganic anion transmembrane transport,0.0001167|0.0001319|0.0001363|0.0001534|0.0001971,1|1|0.7169|0.6049|0.6217,24.25|23.26|106.2|99.98|88.01
2872,5,0.5426,5.426,3379.0,0.001598,0.996692,DCTN2 LEMD2 NAA20 NAA25 VEZT,N-terminal peptidyl-methionine acetylation|peptidyl-methionine modification|N-terminal protein amino acid acetylation|N-terminal protein amino acid modification|protein acetylation,1.696e-06|4.943e-06|7.2e-06|1.909e-05|0.0004461,0.02675|0.03898|0.03786|0.07526|1,1177|633.7|514.9|305.1|60.13
2873,9,0.5033,18.12,6015.0,0.002994,0.9998530000000001,CUL1 DCUN1D1 NAA35 NAE1 NEDD8 SENP8 UBA3 UBE2M UBE2R2,protein neddylation|post-translational protein modification|protein modification by small protein conjugation or removal|protein modification by small protein conjugation|cellular protein modification process,3.483e-14|1.913e-11|3.505e-10|5.539e-09|3.165e-08,5.494e-10|1.509e-07|1.843e-06|2.184e-05|9.986e-05,880.1|44.37|17.76|19.51|6.822
2874,18,0.504,77.11,14090.0,0.005431,1.0,BMF C15orf53 CHRNA7 DUOXA1 DUOXA2 EPB42 GABRA5 GOLGA8M MYO5A MYO5C NIPA2 PLA2G4D PLA2G4E PPP1R14D SNURF SPINT1 TGM5 TMCO5A,positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process|regulation of postsynaptic membrane potential,1.686e-05|2.246e-05|2.886e-05|3.606e-05|0.0001108,0.2659|0.1772|0.1518|0.1422|0.3494,433.6|361.3|309.7|271|32.52
2875,4,0.5238,3.1430000000000002,2957.0,0.001059,0.9929309999999999,NABP1 RARB RARG RXRA,"retinoic acid receptor signaling pathway|transcription by RNA polymerase II|transcription, DNA-templated|nucleic acid-templated transcription|RNA biosynthetic process",4.226e-09|1.547e-07|5.29e-07|5.328e-07|5.803e-07,6.667e-05|0.00122|0.002782|0.002101|0.001831,813|50.73|37.24|37.18|36.39
2876,5,0.5239,5.239,4136.0,0.0012619999999999999,0.996692,AIMP1 ERBB4 GPBAR1 NACAD NUDT17,cell surface bile acid receptor signaling pathway|central nervous system morphogenesis|positive regulation of cholangiocyte proliferation|NADP catabolic process|positive regulation of glucagon secretion,0.0004854|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|2060|2060|1373|1373
2877,4,0.564,3.384,3285.0,0.001027,0.9929309999999999,EPN3 NADSYN1 NARF ZNF160,'de novo' NAD biosynthetic process|NAD biosynthetic process|pyridine nucleotide biosynthetic process|nicotinamide nucleotide biosynthetic process|pyridine nucleotide metabolic process,0.001553|0.00562|0.0062|0.0062|0.00678,1|1|1|1|1,735.5|183.9|166.1|166.1|151.4
2878,10,0.503,22.64,7082.0,0.003177,0.999933,AK6 BMS1 IMP4 NAT10 NOC4L NOL10 NOL6 PDCD11 UTP25 UTP4,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,1.177e-13|1.582e-13|8.001e-13|6.33e-12|1.129e-11,1.856e-09|1.247e-09|4.207e-09|2.496e-08|3.562e-08,57.61|55.47|45.12|34.67|32.21
2879,4,0.5118,3.071,3172.0,0.0009647,0.9929309999999999,GRM3 NAXD PAIP2B TRDN,metabolite repair|positive regulation of cell communication by electrical coupling involved in cardiac conduction|positive regulation of cell communication by electrical coupling|endoplasmic reticulum membrane organization|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,0.0003883|0.0003883|0.0005825|0.001359|0.001553,1|1|1|1|1,5149|5149|2574|858.1|735.5
2880,5,0.5192,5.192,3582.0,0.001443,0.996692,NBEA POTEM SSBP3 TOMM40 USP10,midbrain-hindbrain boundary initiation|prechordal plate formation|positive regulation of anterior head development|regulation of anterior head development|neural plate anterior/posterior regionalization,0.0005824|0.0005824|0.0008735|0.0008735|0.001165,1|1|1|1|1,3432|3432|1716|1716|1144
2881,4,0.5289,3.173,3136.0,0.001008,0.9929309999999999,GRAP2 MRGPRD NCAM2 PVALB,neuron cell-cell adhesion|axonal fasciculation|neuron projection fasciculation|neuron recognition|cochlea development,0.003491|0.004072|0.004072|0.009289|0.009675,1|1|1|1|1,302.9|257.4|257.4|109.5|105.1
2882,4,0.5153,3.092,3193.0,0.0009648999999999999,0.9929309999999999,NCAN TMEM161A TRMO ZBTB26,dermatan sulfate biosynthetic process|dermatan sulfate metabolic process|chondroitin sulfate catabolic process|dermatan sulfate proteoglycan biosynthetic process|dermatan sulfate proteoglycan metabolic process,0.002522|0.002716|0.00291|0.003104|0.003297,1|1|1|1|1,429.1|396.1|367.8|343.2|321.8
2883,4,0.5304,3.1830000000000003,3264.0,0.0009718,0.9929309999999999,NCK1 RNF220 SLC30A3 UTS2R,positive regulation of cap-dependent translational initiation|regulation of cap-dependent translational initiation|zinc ion import into synaptic vesicle|zinc ion import into organelle|positive regulation of cap-independent translational initiation,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
2884,7,0.5501,11.55,5087.0,0.0022600000000000003,0.9992989999999999,DENND4A FLT3 IRF8 MEF2D NCKAP1L SIK3 ZFP64,dendritic cell differentiation|leukocyte homeostasis|plasmacytoid dendritic cell differentiation|hemopoiesis|hematopoietic or lymphoid organ development,6.916e-05|0.0002432|0.0006794|0.0006961|0.0008753,1|1|1|1|1,163.5|85.28|2942|15.43|14.26
2885,4,0.5456,3.2739999999999996,3210.0,0.001016,0.9929309999999999,ALKAL2 CD302 LRRC8E NCKAP5,positive regulation of ERK5 cascade|regulation of ERK5 cascade|aspartate transmembrane transport|microtubule depolymerization|C4-dicarboxylate transport,0.0005825|0.0005825|0.001941|0.003491|0.004846,1|1|1|1|1,2574|2574|572.1|302.9|214.5
2886,4,0.5946,3.5669999999999997,3276.0,0.001085,0.9929309999999999,CRYAB DAAM2 MYL3 NCR3LG1,muscle contraction|muscle organ development|muscle system process|tubulin complex assembly|negative regulation of oligodendrocyte differentiation,0.0008321|0.0011|0.001171|0.001941|0.002328,1|1|1|1|1,42.38|36.78|35.63|572.1|468.1
2887,4,0.5008,3.005,3171.0,0.0009442999999999999,0.9929309999999999,NCS1 SLC24A3 ZNF551 ZNF814,calcium ion transmembrane transport|calcium ion transport|metal ion transport|cellular calcium ion homeostasis|calcium ion homeostasis,0.0005122|0.0008389|0.001467|0.002525|0.002679,1|1|1|1|1,54.2|42.2|31.78|24.12|23.4
2888,4,0.5536,3.322,3352.0,0.0009877,0.9929309999999999,GAP43 NDN NUTM1 TWF2,neuron recognition|regulation of growth|regulation of plasma membrane bounded cell projection assembly|regulation of cell projection assembly|gliogenesis,3.316e-05|0.0001279|0.000486|0.0004964|0.0006963,0.523|1|1|1|1,219.1|23.51|55.66|55.07|46.39
2889,4,0.5451,3.2710000000000004,3299.0,0.0009880000000000002,0.9929309999999999,CDA HIC1 NDNF PCDH12,cytosine metabolic process|hypothalamic tangential migration using cell-axon interactions|gonadotrophin-releasing hormone neuronal migration to the hypothalamus|hypothalamus gonadotrophin-releasing hormone neuron development|hypothalamus gonadotrophin-releasing hormone neuron differentiation,0.0005825|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1716|1287|1287
2890,4,0.5968,3.5810000000000004,3315.0,0.001076,0.9929309999999999,NDRG2 RAB31 TAAR1 TTC30B,"regulation of platelet-derived growth factor production|positive regulation of phagocytosis, engulfment|positive regulation of membrane invagination|regulation of phagocytosis, engulfment|regulation of membrane invagination",0.0007766|0.002716|0.002716|0.003104|0.003297,1|1|1|1|1,1716|396.1|396.1|343.2|321.8
2891,16,0.5006,60.07,12520.0,0.004764,0.999999,ATXN7L3B C8orf44 CARNS1 CCNB1IP1 KIF26B LYRM1 MAP3K7CL NDRG3 NECAP2 NIPSNAP3B PCDH10 PCDHB12 PCDHGA9 RNF114 SDR39U1 ZNF286A,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|carnosine biosynthetic process|carnosine metabolic process|ureteric bud invasion,0.0002853|0.001006|0.001552|0.002327|0.003102,1|1|1|1|1,23.12|14.91|1287|643.6|429.1
2892,4,0.5601,3.36,3313.0,0.001011,0.9929309999999999,CBARP GLT8D2 NDST4 THAP9,"transposition, DNA-mediated|transposition|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|negative regulation of calcium ion-dependent exocytosis|heparin biosynthetic process",0.0007766|0.001553|0.001747|0.001941|0.002328,1|1|1|1|1,1716|735.5|643.6|572.1|468.1
2893,4,0.5199,3.12,3124.0,0.0009949,0.9929309999999999,C11orf54 FAT4 LRIT3 NDUFA7,condensed mesenchymal cell proliferation|regulation of metanephric nephron tubule epithelial cell differentiation|regulation of nephron tubule epithelial cell differentiation|ossification involved in bone maturation|mesenchymal cell proliferation,0.0009706|0.001553|0.002716|0.003104|0.003491,1|1|1|1|1,1287|735.5|396.1|343.2|302.9
2894,7,0.5192,10.9,4848.0,0.002238,0.9992989999999999,DCTN5 NDUFAB1 PALB2 PKD1 RBBP6 RRN3 SMG1,peptidyl-serine phosphorylation|peptidyl-serine modification|peptidyl-amino acid modification|in utero embryonic development|cellular macromolecule metabolic process,3.859e-05|5.55e-05|0.0002007|0.0002731|0.0002991,0.6087|0.4377|1|1|0.9436,42.43|37.49|11.77|21.76|3.631
2895,4,0.5215,3.1289999999999996,3067.0,0.001016,0.9929309999999999,DNAJB7 LPA NEB TCP10,cardiac muscle thin filament assembly|somatic muscle development|cardiac myofibril assembly|low-density lipoprotein particle remodeling|plasma lipoprotein particle remodeling,0.0007766|0.0007766|0.003297|0.003491|0.006393,1|1|1|1|1,1716|1716|321.8|302.9|160.9
2896,5,0.5742,5.742000000000001,4186.0,0.001367,0.996692,CAMKK1 KIAA0232 LDB2 MDGA1 NEBL,cardiac muscle thin filament assembly|regulation of synaptic membrane adhesion|spinal cord association neuron differentiation|cardiac myofibril assembly|dorsal spinal cord development,0.0009706|0.001213|0.003152|0.00412|0.005087,1|1|1|1|1,1373|1030|343.3|257.4|205.9
2897,4,0.5428,3.2569999999999997,3251.0,0.0009983,0.9929309999999999,AQP5 N4BP3 NECAB2 QRICH2,positive regulation of glutamate receptor signaling pathway|negative regulation of G protein-coupled receptor internalization|positive regulation of adenosine receptor signaling pathway|regulation of adenosine receptor signaling pathway|carbon dioxide transport,0.0005825|0.0005825|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|2574|1716|1287|1030
2898,5,0.5237,5.237,4169.0,0.001251,0.996692,ABR NEGR1 NEK10 NHLRC3 SERPINF2,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure|maintenance of blood vessel diameter homeostasis by renin-angiotensin|mucociliary clearance|negative regulation of plasminogen activation|regulation of ERK1 and ERK2 cascade,0.0009706|0.0009706|0.001456|0.001698|0.00196,1|1|1|1|1,1373|1373|823.8|686.5|28.31
2899,5,0.5801,5.801,3870.0,0.001493,0.996692,NEK11 PHLPP1 RNF219 USP46 WDR20,cellular protein modification process|protein modification process|macromolecule modification|cellular protein metabolic process|protein metabolic process,6.797e-05|6.797e-05|9.674e-05|0.0001738|0.0003614,1|0.5361|0.5087|0.6852|1,6.822|6.822|6.356|5.653|4.883
2900,8,0.5189,14.53,6677.0,0.002166,0.9996790000000001,AMER2 C1QTNF9 KBTBD7 KRTAP21-1 NEK3 RNF6 VANGL1 ZAR1L,protein K27-linked ubiquitination|protein K6-linked ubiquitination|cell-cell signaling by wnt|Wnt signaling pathway|ectoderm development,0.002328|0.003877|0.007572|0.007572|0.007741,1|1|1|1|1,514.9|286|14.75|14.75|135.5
2901,6,0.5014,7.521,4819.0,0.0015550000000000002,0.998474,CSNK1A1L LCP1 NEK5 PCDH17 RCBTB2 RNF6,presynaptic active zone assembly|protein K27-linked ubiquitination|regulation of synaptic vesicle clustering|presynaptic active zone organization|positive regulation of podosome assembly,0.001165|0.001746|0.002328|0.002619|0.002909,1|1|1|1|1,1144|686.5|490.4|429.1|381.4
2902,4,0.5878,3.5269999999999997,3342.0,0.001052,0.9929309999999999,ELOVL6 NELL1 RUNX1T1 SLC44A4,otolith formation|acetylcholine transport|acetylcholine secretion|neuromast hair cell differentiation|neuromast development,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
2903,4,0.5476,3.286,3319.0,0.0009866,0.9929309999999999,C2orf88 LST1 NEMP2 SMIM6,pigment catabolic process|porphyrin-containing compound catabolic process|tetrapyrrole catabolic process|sodium-independent organic anion transport|heme catabolic process,0.00412|0.00412|0.00412|0.00412|0.00412,1|1|1|1|1,257.4|257.4|257.4|257.4|257.4
2904,11,0.5198,28.59,8294.0,0.003426,0.999969,HLA-F LY6G6F MSH5 NUDT3 OR14J1 OR2J2 OR2J3 PPT2 PSORS1C2 TRIM10 TRIM26,negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral entry into host cell|modulation by symbiont of entry into host|interferon-gamma-mediated signaling pathway,7.105e-05|9.719e-05|0.0002533|0.0003386|0.0006852,1|0.7666|1|1|1,170.2|144|87.08|74.89|52.01
2905,4,0.5007,3.0039999999999996,3144.0,0.0009522,0.9929309999999999,FAM180A LSMEM1 NEU3 SHPK,"cellular response to interleukin-13|response to interleukin-13|negative regulation of clathrin-dependent endocytosis|pentose-phosphate shunt, non-oxidative branch|ganglioside catabolic process",0.0007766|0.0009706|0.001165|0.001359|0.001553,1|1|1|1|1,1716|1287|1030|858.1|735.5
2906,5,0.5244,5.244,4389.0,0.001191,0.996692,AREG GAPT KIAA1191 NEURL2 POU4F3,developmental growth involved in morphogenesis|dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis|epithelial cell proliferation involved in mammary gland duct elongation|thelarche|branch elongation involved in mammary gland duct branching,0.0003056|0.0004854|0.001213|0.001456|0.001456,1|1|1|1|1,72.9|4119|1030|823.8|823.8
2907,5,0.5075,5.075,4235.0,0.001194,0.996692,ABHD15 KLRD1 MATN2 NEUROD2 RAB11FIP4,positive regulation of G1 to G0 transition|regulation of G1 to G0 transition|negative regulation of synapse maturation|negative regulation of T cell mediated cytotoxicity|positive regulation of synaptic plasticity,0.0004854|0.0004854|0.0009706|0.002425|0.002425,1|1|1|1|1,4119|4119|1373|457.7|457.7
2908,4,0.577,3.4619999999999997,3329.0,0.001036,0.9929309999999999,NCR3 NFKBIL1 PALM3 PPM1M,Toll signaling pathway|response to lipopolysaccharide|response to molecule of bacterial origin|regulation of response to biotic stimulus|negative regulation of lipopolysaccharide-mediated signaling pathway,0.001359|0.001405|0.001558|0.002456|0.002716,1|1|1|1|1,858.1|32.48|30.83|24.46|396.1
2909,5,0.5045,5.045,4009.0,0.001254,0.996692,IL17C NFXL1 RHBDF2 SLC38A8 TREM2,positive regulation of C-C chemokine receptor CCR7 signaling pathway|regulation of C-C chemokine receptor CCR7 signaling pathway|positive regulation of CD40 signaling pathway|detection of lipoteichoic acid|positive regulation of CAMKK-AMPK signaling cascade,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
2910,6,0.5114,7.671,4117.0,0.001854,0.998474,GNL2 MRPL22 NGDN NOL12 RPF2 RRS1,ribosome biogenesis|ribonucleoprotein complex biogenesis|ribosome assembly|protein localization to nucleolus|ribosomal large subunit assembly,6.734e-09|3.564e-08|6.53e-07|2.543e-06|3.064e-05,0.0001062|0.0002811|0.003434|0.01003|0.09666,51.69|36.91|160.9|980.7|245.2
2911,5,0.5135,5.135,4053.0,0.0012619999999999999,0.996692,CCDC181 F2RL2 MDH1 NHEJ1 WASF1,dendritic transport of mitochondrion|modification of postsynaptic actin cytoskeleton|lamellipodium morphogenesis|positive regulation of neurotrophin TRK receptor signaling pathway|modification of postsynaptic structure,0.000728|0.001213|0.001456|0.001698|0.00194,1|1|1|1|1,2060|1030|823.8|686.5|588.4
2912,4,0.5373,3.2239999999999998,3051.0,0.001053,0.9929309999999999,NHLH1 PABPC3 REG3G TPRN,stereocilium maintenance|cell wall disruption in other organism|negative regulation of keratinocyte differentiation|cytolysis by host of symbiont cells|cytolysis in other organism involved in symbiotic interaction,0.0005825|0.0009706|0.001553|0.002522|0.002522,1|1|1|1|1,2574|1287|735.5|429.1|429.1
2913,4,0.5344,3.2060000000000004,3090.0,0.001034,0.9929309999999999,JPH3 NIF3L1 OVOL2 PCDHB7,endocardium formation|negative regulation of stem cell proliferation|endocardium morphogenesis|negative regulation of keratinocyte differentiation|neural fold formation,0.0009706|0.001165|0.001359|0.001553|0.001553,1|1|1|1|1,1287|1030|858.1|735.5|735.5
2914,4,0.5489,3.293,3294.0,0.0009962,0.9929309999999999,NIPAL4 NRXN2 SLC6A20 TMEM250,isoleucine transport|L-isoleucine import across plasma membrane|isoleucine transmembrane transport|proline import across plasma membrane|L-proline transmembrane transport,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
2915,4,0.518,3.108,3156.0,0.0009815,0.9929309999999999,NKX2-8 SGIP1 TMEM176A TMEM259,negative regulation of dendritic cell differentiation|positive regulation of feeding behavior|regulation of dendritic cell differentiation|positive regulation of ERAD pathway|clathrin coat assembly,0.001359|0.002134|0.002522|0.00291|0.003685,1|1|1|1|1,858.1|514.9|429.1|367.8|286
2916,5,0.5311,5.311,4183.0,0.001265,0.996692,NKX6-1 PCDH10 PRSS54 RNF150 TNIP3,type B pancreatic cell maturation|glandular epithelial cell maturation|detection of glucose|positive regulation of type B pancreatic cell development|detection of hexose stimulus,0.000728|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|1373|1373|1373|1373
2917,4,0.5361,3.217,3205.0,0.001,0.9929309999999999,NLGN2 TSPAN32 TTLL4 TUBAL3,cytoskeleton organization|positive regulation of synaptic vesicle clustering|negative regulation of myeloid dendritic cell activation|terminal button organization|organelle organization,0.0007676|0.0007766|0.0007766|0.0007766|0.000909,1|1|1|1|1,12.83|1716|1716|1716|5.762
2918,4,0.5622,3.373,3146.0,0.001068,0.9929309999999999,NLRP10 PTGR1 PXDNL ZNF133,lipoxin A4 metabolic process|response to antineoplastic agent|positive regulation of interleukin-1 alpha production|leukotriene B4 metabolic process|lipoxin metabolic process,0.0009706|0.0009706|0.001359|0.001359|0.001747,1|1|1|1|1,1287|1287|858.1|858.1|643.6
2919,21,0.5068,106.4,16710.0,0.006313,1.0,KIR2DL1 KIR2DL3 LAIR1 LAIR2 LILRA4 LILRB2 LILRB4 LILRB5 NLRP4 NLRP7 NLRP9 RFPL4A SHISA7 ZNF304 ZNF324 ZNF581 ZNF587 ZNF667 ZNF772 ZNF773 ZSCAN5B,immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|interleukin-10-mediated signaling pathway|negative regulation of T cell costimulation|regulation of gene expression,1.73e-07|2.995e-07|6.513e-06|1.085e-05|1.224e-05,0.002729|0.002362|0.03425|0.04278|0.03863,351.1|280.8|936.1|624.1|2.882
2920,6,0.5415,8.122,4633.0,0.001745,0.998474,NLRP8 PRB1 PRB2 PRB4 SPX TAS2R19,regulation of lipid kinase activity|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of cell cycle G1/S phase transition|regulation of G1/S transition of mitotic cell cycle|negative regulation of renal sodium excretion,0.0003327|0.0007606|0.0008027|0.001509|0.001552,1|1|1|1|1,73.55|48.12|46.81|33.87|858.1
2921,11,0.5003,27.52,8084.0,0.0033829999999999997,0.999969,CFAP53 ISL2 LHX3 LRP8 MAN1A2 MGAT1 NEUROD1 OTP OTX2 PRDX6 SCLY,forebrain development|ventral spinal cord development|central nervous system development|neuron differentiation|spinal cord motor neuron cell fate specification,1.577e-06|2.571e-06|9.079e-06|1.12e-05|2.045e-05,0.02487|0.02028|0.04774|0.04415|0.06452,22.58|114.4|10.39|10.02|343.2
2922,4,0.5762,3.457,3092.0,0.001114,0.9929309999999999,METTL23 MTRF1 NME5 VWDE,UTP biosynthetic process|regulation of translational termination|GTP biosynthetic process|UTP metabolic process|guanosine-containing compound biosynthetic process,0.002134|0.002328|0.002328|0.002522|0.002716,1|1|1|1|1,514.9|468.1|468.1|429.1|396.1
2923,6,0.5028,7.541,4904.0,0.001532,0.998474,LYG1 NMS SLC9A2 STRN SULT1C2 TMEM177,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process,3.204e-05|3.459e-05|3.459e-05|0.000876|0.000876,0.5053|0.2728|0.1819|1|1,245.2|235.4|235.4|44.24|44.24
2924,13,0.5198,40.54,9082.0,0.004432,0.999993,ARHGEF12 BTBD9 GNA13 GNAI2 GNAI3 LPAR1 LPAR2 MYO9A MYO9B PDCL RHOA RHOC RIC8A,positive regulation of catalytic activity|positive regulation of hydrolase activity|positive regulation of molecular function|regulation of hydrolase activity|regulation of small GTPase mediated signal transduction,1.151e-11|1.018e-10|1.261e-10|2.653e-10|4.355e-10,1.815e-07|8.026e-07|6.633e-07|1.046e-06|1.374e-06,12.32|18.35|9.868|12.11|33.91
2925,4,0.5349,3.2089999999999996,3222.0,0.0009927999999999998,0.9929309999999999,CLEC3B NNMT PCDHA12 VAX1,negative regulation of neuroblast proliferation|positive regulation of plasminogen activation|regulation of plasminogen activation|NAD biosynthesis via nicotinamide riboside salvage pathway|negative regulation of neural precursor cell proliferation,0.001359|0.001359|0.002716|0.00291|0.004459,1|1|1|1|1,858.1|858.1|396.1|367.8|234
2926,12,0.5068,33.45,8218.0,0.0040420000000000005,0.999986,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 NOP9 PARN PDCD2 POP4 WDR43 WDR75,ncRNA processing|rRNA processing|rRNA metabolic process|ncRNA metabolic process|ribosome biogenesis,5.753e-13|8.967e-13|1.204e-12|2.806e-12|6.058e-12,9.075e-09|7.073e-09|6.331e-09|1.106e-08|1.911e-08,33|48.75|46.94|27.58|38.17
2927,4,0.5025,3.015,3088.0,0.0009728,0.9929309999999999,EVI5L MTHFSD NOCT SHOX2,regulation of branching morphogenesis of a nerve|sinoatrial node cell development|cardiac pacemaker cell development|sinoatrial node cell differentiation|sinoatrial node development,0.001165|0.001165|0.001359|0.001359|0.001359,1|1|1|1|1,1030|1030|858.1|858.1|858.1
2928,4,0.5891,3.534,3260.0,0.00108,0.9929309999999999,HUS1B NOD1 POU5F2 SLC22A2,activation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of cysteine-type endopeptidase activity|positive regulation of endopeptidase activity|positive regulation of peptidase activity,0.0001203|0.0002727|0.0003385|0.0004604|0.0005501,1|1|1|1|1,113.2|74.62|66.87|57.21|52.27
2929,4,0.5096,3.057,3009.0,0.0010119999999999999,0.9929309999999999,ISY1 NOG PHYKPL SLU7,mRNA 3'-splice site recognition|mRNA splice site selection|spliceosomal complex assembly|fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation|ribonucleoprotein complex assembly,7.916e-07|1.583e-05|4.821e-05|0.0003883|0.0005122,0.01249|0.1249|0.2535|1|1,1716|321.8|180.7|5149|54.2
2930,21,0.5042,105.9,14470.0,0.007245999999999999,1.0,BET1 BUD31 COPS6 CUL1 EXOC4 LSM8 MCM7 MEPCE NOM1 NRF1 NUP205 ORC5 PMPCB POP7 PSMC2 RBM28 RINT1 SEM1 SRRT TNPO3 ZNHIT1,nucleic acid metabolic process|pre-replicative complex assembly|regulation of G2/M transition of mitotic cell cycle|regulation of mitotic cell cycle phase transition|regulation of cell cycle G2/M phase transition,2.577e-05|4.375e-05|5.168e-05|5.89e-05|6.902e-05,0.4065|0.345|0.2717|0.2323|0.2177,4.394|45.26|19.32|11.57|17.91
2931,4,0.5137,3.082,3070.0,0.001,0.9929309999999999,EIF2B1 FARSA NOSTRIN PRR23B,phenylalanyl-tRNA aminoacylation|translation|peptide biosynthetic process|protein heterotetramerization|amide biosynthetic process,0.0007766|0.00205|0.00232|0.00291|0.00383,1|1|1|1|1,1716|26.82|25.18|367.8|19.5
2932,5,0.5313,5.313,3951.0,0.00134,0.996692,KDR KIT LNX1 NOTCH4 PDGFRA,hematopoietic progenitor cell differentiation|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of phosphatidylinositol 3-kinase signaling|hemopoiesis|peptidyl-tyrosine phosphorylation,8.013e-07|9.141e-07|2.377e-06|2.958e-06|3.744e-06,0.01264|0.007209|0.0125|0.01167|0.01181,142|135.8|98.07|28.8|84.06
2933,16,0.5023,60.27,13710.0,0.004368,0.999999,AARD C8orf76 COL14A1 COLEC10 CSMD3 ENPP2 FBXO32 KLHL38 MTSS1 NOV RNF139 SLC22A4 SLC30A8 TRHR TRMT12 ZHX2,chemotaxis|taxis|nephron tubule epithelial cell differentiation|smooth muscle cell proliferation|epithelial cell proliferation,0.001139|0.001162|0.002618|0.002618|0.002817,1|1|1|1|1,8.382|8.336|572.1|572.1|25.71
2934,4,0.5888,3.533,3183.0,0.001106,0.9929309999999999,CKAP2 NPAS1 PPP1R1C STAT4,interleukin-21-mediated signaling pathway|cellular response to interleukin-21|response to interleukin-21|interleukin-23-mediated signaling pathway|interleukin-35-mediated signaling pathway,0.001747|0.001747|0.001747|0.001941|0.002328,1|1|1|1|1,643.6|643.6|643.6|572.1|468.1
2935,17,0.4757,64.69,12880.0,0.004983,1.0,ANO1 BBS1 CARNS1 CCDC36 CTTN FGF19 FGF4 FOLR2 GSTP1 MRGPRD MRGPRF MYEOV P2RY6 PITPNM1 POLD4 TBC1D10C TMEM134,regulation of ERK1 and ERK2 cascade|regulation of MAPK cascade|cellular response to endogenous stimulus|response to endogenous stimulus|positive regulation of ERK1 and ERK2 cascade,2.266e-06|0.0001415|0.0001483|0.0004677|0.0005149,0.03574|1|0.7798|1|1,22.12|9.274|6.739|5.454|18.84
2936,4,0.5375,3.225,3268.0,0.0009834,0.9929309999999999,NPBWR1 NPHP4 SERPINE2 STAP2,mating plug formation|seminal vesicle epithelium development|seminal vesicle development|negative regulation of plasminogen activation|regulation of timing of cell differentiation,0.0003883|0.0003883|0.0005825|0.001359|0.001553,1|1|1|1|1,5149|5149|2574|858.1|735.5
2937,4,0.5428,3.2569999999999997,3269.0,0.0009929000000000001,0.9929309999999999,MOCOS NDUFS4 NPPC VCAN,cyclic-nucleotide-mediated signaling|growth plate cartilage chondrocyte proliferation|second-messenger-mediated signaling|negative regulation of oocyte maturation|ossification,4.034e-05|0.0005825|0.0006717|0.0007766|0.0009653,0.6363|1|1|1|1,198|2574|47.24|1716|39.3
2938,4,0.5777,3.466,3237.0,0.001067,0.9929309999999999,FRZB NPR1 SMAD9 TAGLN3,negative regulation of hepatocyte differentiation|negative regulation of cell growth|regulation of hepatocyte differentiation|negative regulation of growth|convergent extension involved in organogenesis,0.0003883|0.0004964|0.0005825|0.0008525|0.001165,1|1|1|1|1,5149|55.07|2574|41.86|1030
2939,4,0.548,3.2880000000000003,3274.0,0.001001,0.9929309999999999,CXCL12 GABRA6 NPS WIPI1,"response to ultrasound|vesicle targeting, trans-Golgi to endosome|positive regulation of circadian sleep/wake cycle, wakefulness|negative regulation of leukocyte tethering or rolling|chemokine (C-X-C motif) ligand 12 signaling pathway",0.0005825|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|2574|1716|1287|1287
2940,4,0.5013,3.008,3125.0,0.0009591000000000001,0.9929309999999999,LRRC37A LRRC37A2 NPTX2 SPTBN2,cerebellar Purkinje cell layer morphogenesis|regulation of postsynaptic neurotransmitter receptor activity|behavior|cerebellar Purkinje cell layer development|cerebellar cortex morphogenesis,0.003491|0.003878|0.00412|0.005426|0.00678,1|1|1|1|1,302.9|271|18.79|190.7|151.4
2941,4,0.5214,3.1289999999999996,3209.0,0.0009716000000000001,0.9929309999999999,ATP13A5 CPT1B NPW TMEM41B,response to blue light|carnitine shuttle|carnitine metabolic process|amino-acid betaine metabolic process|intracellular lipid transport,0.001359|0.002328|0.00291|0.003685|0.007938,1|1|1|1|1,858.1|468.1|367.8|286|128.7
2942,4,0.5323,3.194,3226.0,0.0009865,0.9929309999999999,GALNTL6 LRRC40 NPY1R TMEM252,"protein O-linked glycosylation via threonine|regulation of multicellular organism growth|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|outflow tract morphogenesis|sensory perception of pain",0.001941|0.01276|0.01314|0.01352|0.01449,1|1|1|1|1,572.1|79.21|76.85|74.62|69.58
2943,18,0.505,77.27,14740.0,0.005203,1.0,ANKRD22 CALHM3 CYP2C9 IFIT1 IFIT1B IFIT2 IFIT5 LIPA LIPJ LIPK LRRTM3 MORN4 NUTM2A OPN4 PAPSS2 SEMA4G SFTPA2 SFXN2,cellular response to type I interferon|response to type I interferon|type I interferon signaling pathway|defense response to symbiont|defense response to virus,4.266e-07|5.869e-07|3.079e-05|3.198e-05|3.198e-05,0.006729|0.004629|0.1619|0.1261|0.1009,66.33|61.02|50.48|21.59|21.59
2944,4,0.5576,3.346,3559.0,0.0009372,0.9929309999999999,COL8A2 MITD1 NQO1 SNX15,response to flavonoid|response to hydrogen sulfide|response to L-glutamine|response to tetrachloromethane|NADH oxidation,0.0007766|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,1716|1716|1287|1287|1030
2945,27,0.5083,178.4,20430.0,0.008636,1.0,CD1C CIART CTSK EFNA4 FCRL3 FLG2 GABPB2 GBA HIST2H2AB HIST2H2BE HJV HRNR ITLN2 LCE3E LCE5A PGLYRP3 S100A12 S100A2 S100A4 S100A5 S100A6 S100A8 S100A9 SELENBP1 SLAMF7 SV2A YY1AP1,leukocyte activation|cell activation|regulation of water loss via skin|neutrophil aggregation|sequestering of zinc ion,1.313e-06|4.4e-06|7.063e-06|9.158e-06|2.286e-05,0.02071|0.0347|0.03714|0.03611|0.07212,7.625|6.577|88.01|792.1|396.1
2946,5,0.5122,5.122000000000001,4082.0,0.00125,0.996692,NR1I2 RIPPLY3 TLL1 TMEM178A TMPRSS11B,exogenous drug catabolic process|drug catabolic process|pharyngeal system development|negative regulation of osteoclast differentiation|xenobiotic transport,0.005812|0.006295|0.006537|0.007261|0.009913,1|1|1|1|1,179.1|164.8|158.4|142|103
2947,4,0.5728,3.437,3287.0,0.001042,0.9929309999999999,DQX1 NDN NR1I3 ZNF782,"positive regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|positive regulation of RNA metabolic process",0.0007714|0.001845|0.001845|0.001848|0.002183,1|1|1|1|1,12.81|9.523|9.523|9.517|8.991
2948,4,0.5071,3.042,3194.0,0.0009493,0.9929309999999999,GXYLT2 MEI4 NR2C1 SPATA45,positive regulation of retinoic acid receptor signaling pathway|meiotic DNA double-strand break formation|regulation of retinoic acid receptor signaling pathway|homologous chromosome pairing at meiosis|O-glycan processing,0.001165|0.001553|0.003297|0.01006|0.01199,1|1|1|1|1,1030|735.5|321.8|101|84.41
2949,4,0.5592,3.355,3192.0,0.001047,0.9929309999999999,AKAP13 BTBD11 NR3C1 USP43,glucocorticoid mediated signaling pathway|adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process|regulation of sarcomere organization|glucocorticoid receptor signaling pathway|corticosteroid receptor signaling pathway,0.0003883|0.0009706|0.001359|0.001359|0.001553,1|1|1|1|1,5149|1287|858.1|858.1|735.5
2950,4,0.5998,3.5989999999999998,3437.0,0.001044,0.9929309999999999,CLCN6 KLC4 NR3C2 RAD21L1,meiotic telomere tethering at nuclear periphery|meiotic attachment of telomere to nuclear envelope|telomere tethering at nuclear periphery|chromosome attachment to the nuclear envelope|replication-born double-strand break repair via sister chromatid exchange,0.001165|0.001165|0.001165|0.001553|0.001747,1|1|1|1|1,1030|1030|1030|735.5|643.6
2951,6,0.52,7.8,4379.0,0.001773,0.998474,NR4A2 NR5A2 PAX8 SOX17 VGLL2 WT1,"positive regulation of transcription by RNA polymerase II|positive regulation of nucleic acid-templated transcription|positive regulation of transcription, DNA-templated|positive regulation of RNA biosynthetic process|positive regulation of RNA metabolic process",4.098e-08|2.415e-07|2.415e-07|2.424e-07|3.407e-07,0.0006465|0.001905|0.00127|0.0009559|0.001075,17.08|12.7|12.7|12.69|11.99
2952,4,0.5359,3.216,3236.0,0.0009901,0.9929309999999999,FNBP1L MUCL1 NR5A1 SPATA24,primary sex determination|negative regulation of female gonad development|negative regulation of gonad development|regulation of female gonad development|response to gonadotropin-releasing hormone,0.0005825|0.0007766|0.0009706|0.001359|0.001553,1|1|1|1|1,2574|1716|1287|858.1|735.5
2953,5,0.5181,5.181,4177.0,0.001236,0.996692,CFAP43 COL2A1 CPLX3 NRAP PNLIP,cardiac muscle thin filament assembly|system process|anterior head development|visual perception|sensory perception of light stimulus,0.001165|0.00123|0.001456|0.001626|0.001685,1|1|1|1|1,1144|6.73|858.1|31.78|31.2
2954,5,0.5285,5.285,4064.0,0.001296,0.996692,ATP10B C11orf42 FAM205A NRCAM PTGES2,lysosomal membrane organization|clustering of voltage-gated sodium channels|cyclooxygenase pathway|neuronal ion channel clustering|axonal fasciculation,0.001456|0.001698|0.00291|0.00291|0.005087,1|1|1|1|1,823.8|686.5|374.5|374.5|205.9
2955,4,0.5146,3.088,3034.0,0.0010140000000000001,0.9929309999999999,BDNF LIN7C NRG3 OR10V1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway|regulation of brain-derived neurotrophic factor receptor signaling pathway|chemorepulsion involved in interneuron migration from the subpallium to the cortex|directional guidance of interneurons involved in migration from the subpallium to the cortex|mammary placode formation,0.0005825|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|1716|1716|1716|1716
2956,4,0.5563,3.338,3338.0,0.0009964,0.9929309999999999,NRIP2 PAPPA2 RASGRF2 TLCD2,phospholipid homeostasis|response to salt stress|membrane assembly|regulation of NMDA receptor activity|membrane biogenesis,0.003297|0.004459|0.00678|0.007938|0.007938,1|1|1|1|1,321.8|234|151.4|128.7|128.7
2957,4,0.5482,3.2889999999999997,3217.0,0.001019,0.9929309999999999,NRIP3 PKNOX2 TRIM65 UPK3B,cellular process|positive regulation of autophagy|regulation of autophagy|positive regulation of cellular catabolic process|positive regulation of catabolic process,0.00379|0.02367|0.06293|0.0738|0.08656,1|1|1|1|1,0|42.2|15.56|13.2|11.19
2958,4,0.5235,3.141,3244.0,0.0009651,0.9929309999999999,C10orf120 IL17RC NRN1 NTF3,positive regulation of neurotrophin TRK receptor signaling pathway|interleukin-17-mediated signaling pathway|cellular response to interleukin-17|response to interleukin-17|nerve growth factor signaling pathway,0.001359|0.001941|0.001941|0.001941|0.002522,1|1|1|1|1,858.1|572.1|572.1|572.1|429.1
2959,4,0.5335,3.201,3155.0,0.001011,0.9929309999999999,APOA5 ITPKB NRP2 PI16,alcohol biosynthetic process|vestibulocochlear nerve structural organization|negative regulation of neutrophil apoptotic process|dorsal root ganglion morphogenesis|ganglion morphogenesis,0.0002357|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,83.21|4119|4119|4119|4119
2960,4,0.5568,3.341,3280.0,0.001015,0.9929309999999999,GNA14 HLA-DOB NRROS ZNF286B,transforming growth factor beta1 production|transforming growth factor beta1 activation|negative regulation of antigen processing and presentation of peptide antigen via MHC class II|transforming growth factor beta activation|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
2961,4,0.557,3.342,3208.0,0.001038,0.9929309999999999,FAM181B NRSN1 PLCH2 TNFRSF9,inositol phosphate metabolic process|phosphatidylinositol-mediated signaling|inositol lipid-mediated signaling|polyol metabolic process|tumor necrosis factor-mediated signaling pathway,0.0116|0.01583|0.0166|0.02386|0.02425,1|1|1|1|1,87.27|63.56|60.57|41.86|41.19
2962,4,0.5538,3.323,3200.0,0.001035,0.9929309999999999,FZD1 NRTN PCDH20 PTGER3,stem cell differentiation|canonical Wnt signaling pathway involved in osteoblast differentiation|canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation|mesenchymal stem cell differentiation|intestine smooth muscle contraction,0.0003385|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,66.87|2574|1716|1287|1287
2963,4,0.5199,3.12,3208.0,0.0009691000000000001,0.9929309999999999,ALOX5AP GPR150 NRXN3 OXCT2,fatty acid derivative metabolic process|leukotriene production involved in inflammatory response|arachidonic acid metabolite production involved in inflammatory response|ketone body catabolic process|lipoxin biosynthetic process,9.807e-05|0.0005825|0.0005825|0.0009706|0.001553,1|1|1|1|1,125.6|2574|2574|1287|735.5
2964,12,0.5064,33.42,8766.0,0.003788,0.999986,ABCE1 LSM5 MAD2L1 NSA2 NUF2 PSMA4 RPF2 RPL18 RPL35A RPL5 RPL7 TTK,ribosome biogenesis|ribosomal large subunit biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process,2.262e-10|4.954e-10|2.27e-09|3.786e-09|4.722e-09,3.569e-06|3.907e-06|1.193e-05|1.493e-05|1.49e-05,36.19|119.2|25.84|39.61|38.14
2965,4,0.5413,3.248,3034.0,0.001067,0.9929309999999999,C19orf66 EPHX2 NSFL1C VAV1,negative regulation of translational frameshifting|regulation of translational frameshifting|viral translational frameshifting|stilbene metabolic process|olefinic compound catabolic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
2966,4,0.5274,3.1639999999999997,3256.0,0.0009686,0.9929309999999999,KCTD20 METTL7B NELL2 NSG1,"postsynaptic neurotransmitter receptor cycle|neurotransmitter receptor cycle|spontaneous synaptic transmission|neurotransmitter receptor transport, endosome to postsynaptic membrane|neurotransmitter receptor transport, endosome to plasma membrane",0.0003883|0.0003883|0.001553|0.001747|0.001941,1|1|1|1|1,5149|5149|735.5|643.6|572.1
2967,4,0.5126,3.076,3139.0,0.0009765,0.9929309999999999,BNIP3 DHRS2 NSMF SLC11A1,MHC class II biosynthetic process|nitrite transport|cellular cadmium ion homeostasis|intrinsic apoptotic signaling pathway in response to hypoxia|cadmium ion homeostasis,0.0003883|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|5149|2574|2574|1716
2968,4,0.5554,3.332,3175.0,0.001046,0.9929309999999999,FAM169B MT4 NT5C1B TBX5,cell migration involved in coronary vasculogenesis|cardiac left ventricle formation|bundle of His development|His-Purkinje system development|positive regulation of secondary heart field cardioblast proliferation,0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
2969,4,0.5512,3.307,3293.0,0.001001,0.9929309999999999,C1QTNF12 NT5C2 SCNN1D TNFRSF4,adenosine metabolic process|IMP metabolic process|negative regulation of gluconeogenesis|positive regulation of insulin receptor signaling pathway|positive regulation of cellular response to insulin stimulus,0.001941|0.00291|0.003685|0.004653|0.005233,1|1|1|1|1,572.1|367.8|286|223.9|198
2970,4,0.5165,3.0989999999999998,3065.0,0.001007,0.9929309999999999,CTSE NT5C3A OR2M4 ZFHX4,adenosine metabolic process|pyrimidine nucleoside catabolic process|protein autoprocessing|nucleoside catabolic process|pyrimidine nucleoside metabolic process,0.001941|0.004653|0.004846|0.00678|0.007166,1|1|1|1|1,572.1|223.9|214.5|151.4|143
2971,10,0.5197,23.39,6769.0,0.003433,0.999933,AURKA CSE1L DSN1 PPP6R3 PSMA7 RAE1 RBM39 RPS21 RTF2 TPX2,protein export from nucleus|mitotic spindle organization|nuclear export|cell division|microtubule cytoskeleton organization involved in mitosis,6.59e-05|8.224e-05|8.52e-05|9.568e-05|0.0001169,1|0.6486|0.448|0.3773|0.3686,36.95|34.25|33.84|15.22|30.36
2972,4,0.5546,3.327,3297.0,0.001006,0.9929309999999999,FZD10 INSM2 NTF4 STATH,formation of animal organ boundary|taste bud development|sensory organ boundary specification|neuron differentiation|ganglion mother cell fate determination,0.0003883|0.0003883|0.0003883|0.0004814|0.0005825,1|1|1|1|1,5149|5149|5149|15.03|2574
2973,4,0.5735,3.4410000000000003,3197.0,0.001072,0.9929309999999999,AKR1C3 CASC10 GRK5 NTHL1,negative regulation of retinoic acid biosynthetic process|negative regulation of isoprenoid metabolic process|farnesol catabolic process|farnesol metabolic process|regulation of retinoic acid biosynthetic process,0.0002913|0.0002913|0.0004369|0.0004369|0.0004369,1|1|1|1|1,6865|6865|3432|3432|3432
2974,4,0.5365,3.219,3281.0,0.0009776,0.9929309999999999,CAVIN4 CSN3 KNOP1 NTN4,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling|extracellular matrix-cell signaling|regulation of branching involved in salivary gland morphogenesis|basement membrane assembly|protein deneddylation,0.0004854|0.001456|0.00194|0.002667|0.002667,1|1|1|1|1,4119|823.8|588.4|411.9|411.9
2975,4,0.5053,3.032,3053.0,0.0009894,0.9929309999999999,KBTBD8 MRPS15 NTRK1 TMEM183A,behavioral response to formalin induced pain|behavioral response to chemical pain|olfactory nerve development|axonogenesis involved in innervation|response to hydrostatic pressure,0.0005825|0.0005825|0.0009706|0.001165|0.001359,1|1|1|1|1,2574|2574|1287|1030|858.1
2976,4,0.5584,3.3510000000000004,3163.0,0.0010550000000000002,0.9929309999999999,FNBP4 LIPC NTS ULBP1,cell killing|intermediate-density lipoprotein particle remodeling|triglyceride-rich lipoprotein particle clearance|chylomicron remnant clearance|very-low-density lipoprotein particle remodeling,0.0002071|0.0003883|0.001553|0.001553|0.001941,1|1|1|1|1,85.81|5149|735.5|735.5|572.1
2977,5,0.505,5.05,3913.0,0.001286,0.996692,CHDH DOK4 EPPIN NTSR1 SARS,negative regulation of calcium ion transport|glycine betaine biosynthetic process from choline|seryl-tRNA aminoacylation|glycine betaine biosynthetic process|glycine betaine metabolic process,8.576e-05|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,139.6|2060|2060|2060|2060
2978,4,0.5156,3.094,3117.0,0.0009891,0.9929309999999999,ABRACL BRSK2 KIF26B NUCB2,establishment of cell polarity|establishment or maintenance of cell polarity|microtubule cytoskeleton organization involved in establishment of planar polarity|ureteric bud invasion|metanephric renal vesicle formation,0.0002037|0.0005391|0.0005825|0.0007766|0.0009706,1|1|1|1|1,86.53|52.81|2574|1716|1287
2979,5,0.5534,5.534,4275.0,0.0012900000000000001,0.996692,AP3M1 CFAP70 ISM1 NUDT13 TMEM52,NADP catabolic process|pyridine nucleotide catabolic process|pyridine-containing compound catabolic process|microtubule-based movement|synaptic vesicle transport along microtubule,0.0009706|0.001213|0.00194|0.002814|0.00412,1|1|1|1|1,1373|1030|588.4|23.54|257.4
2980,20,0.5072,96.38,15810.0,0.006043,1.0,C17orf50 C17orf75 CCL13 CCL2 CCL7 CORO6 CRYBA1 EVI2A GAS2L2 LGALS9 LYRM9 PIPOX RDM1 SLC13A2 SLFN12 SLFN14 SPAG5 TIAF1 TMEM97 UNC119,eosinophil chemotaxis|eosinophil migration|regulation of ERK1 and ERK2 cascade|monocyte chemotaxis|cellular response to interferon-gamma,8.809e-07|1.027e-06|7.665e-06|1.008e-05|1.614e-05,0.01389|0.0081|0.0403|0.03976|0.05091,181.7|171.6|17.69|75.35|26.07
2981,4,0.5142,3.085,3162.0,0.0009722999999999999,0.9929309999999999,HSF2 NUDT2 TOX USP19,"NK T cell lineage commitment|CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment|CD8-positive, alpha-beta T cell lineage commitment|NK T cell differentiation|regulation of positive thymic T cell selection",0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
2982,5,0.5005,5.005,4442.0,0.001123,0.996692,AIDA APOBEC4 KCTD18 NUDT5 TMEM171,determination of ventral identity|D-ribose catabolic process|D-ribose metabolic process|ATP generation from poly-ADP-D-ribose|determination of dorsal/ventral asymmetry,0.0004854|0.000728|0.0009706|0.001213|0.001456,1|1|1|1|1,4119|2060|1373|1030|823.8
2983,5,0.5068,5.0680000000000005,4140.0,0.00122,0.996692,C1QL1 CDHR2 COL22A1 KLK1 NUDT6,negative regulation of cell growth involved in contact inhibition|intermicrovillar adhesion|brush border assembly|motor learning|regulation of microvillus length,0.0004854|0.000728|0.001456|0.001698|0.00194,1|1|1|1|1,4119|2060|823.8|686.5|588.4
2984,4,0.5134,3.08,3281.0,0.0009356,0.9929309999999999,LGALSL NUDT9 OTOA ZNF771,ADP catabolic process|IDP catabolic process|IDP metabolic process|purine ribonucleoside diphosphate catabolic process|purine nucleoside diphosphate catabolic process,0.0003883|0.0005825|0.0005825|0.001165|0.001165,1|1|1|1|1,5149|2574|2574|1030|1030
2985,6,0.5693,8.539,4250.0,0.002,0.998474,C12orf45 DDX51 NOP58 NUFIP1 ZNHIT3 ZNHIT6,snoRNA localization|box C/D snoRNP assembly|small nucleolar ribonucleoprotein complex assembly|ribonucleoprotein complex biogenesis|rRNA processing,7.683e-10|2.263e-09|3.922e-09|3.564e-08|3.876e-07,1.212e-05|1.785e-05|2.062e-05|0.0001405|0.001223,2060|1287|1030|36.91|52.81
2986,4,0.544,3.264,3279.0,0.0009920999999999999,0.9929309999999999,CEP295 KBTBD13 NUP210 SEMA6B,relaxation of skeletal muscle|positive regulation of centrosome duplication|regulation of skeletal muscle contraction by chemo-mechanical energy conversion|regulation of the force of skeletal muscle contraction|positive regulation of centriole elongation,0.0007766|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,1716|1716|1716|1716|1287
2987,7,0.5286,11.1,4863.0,0.002271,0.9992989999999999,HNRNPD NKTR NUP54 NUP58 NUP62 SFSWAP TMEM209,tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus|tRNA transport|ncRNA export from nucleus|intracellular transport of virus,1.857e-07|1.857e-07|2.36e-07|2.546e-07|6.973e-07,0.002929|0.001465|0.001241|0.001004|0.0022,259.6|259.6|238.6|232.3|163.5
2988,12,0.518,34.19,8049.0,0.004215999999999999,0.999986,DHX33 GEMIN4 MYBBP1A NDE1 NUP88 PAFAH1B1 PRPF8 PSMB6 RPA1 RPAIN TRAPPC1 TSR1,cellular component biogenesis|ribonucleoprotein complex biogenesis|DNA replication|regulation of microtubule motor activity|ribosome biogenesis,2.991e-07|6.683e-06|2.018e-05|2.854e-05|4.418e-05,0.004718|0.05271|0.1061|0.1126|0.1394,5.865|17.03|23.38|288|19.09
2989,4,0.5388,3.233,3382.0,0.0009527999999999998,0.9929309999999999,ABCC10 NUPR1 PRSS8 SPATS1,negative regulation of type B pancreatic cell proliferation|positive regulation of oxidative phosphorylation|regulation of female gonad development|leukotriene transport|regulation of type B pancreatic cell proliferation,0.0005825|0.0007766|0.001359|0.001553|0.002522,1|1|1|1|1,2574|1716|858.1|735.5|429.1
2990,4,0.5223,3.134,3108.0,0.001005,0.9929309999999999,CLCF1 NUTM2F SLC22A17 TRIM58,siderophore transport|positive regulation of isotype switching to IgE isotypes|regulation of isotype switching to IgE isotypes|positive regulation of astrocyte differentiation|iron coordination entity transport,0.0007766|0.0009706|0.001553|0.002328|0.00291,1|1|1|1|1,1716|1287|735.5|468.1|367.8
2991,4,0.5519,3.312,3029.0,0.0010890000000000001,0.9929309999999999,LRG1 NWD1 QTRT1 ZNF700,tRNA-guanine transglycosylation|brown fat cell differentiation|positive regulation of transforming growth factor beta receptor signaling pathway|positive regulation of cellular response to transforming growth factor beta stimulus|negative regulation of NF-kappaB transcription factor activity,0.0007766|0.005426|0.00562|0.00562|0.01698,1|1|1|1|1,1716|190.7|183.9|183.9|59.18
2992,4,0.5348,3.2089999999999996,2992.0,0.0010689999999999999,0.9929309999999999,DRC1 NXPH1 SLC5A7 TRMT1,axonemal dynein complex assembly|tRNA methylation|axoneme assembly|RNA methylation|tRNA modification,4.946e-05|6.35e-05|0.0002211|0.0002676|0.0002925,0.7803|0.5008|1|1|0.9227,190.7|167.4|88.01|79.83|76.28
2993,5,0.5156,5.156000000000001,4044.0,0.0012699999999999999,0.996692,APP CLUL1 DUSP14 OAZ2 SLC12A7,regulation of response to calcium ion|positive regulation of cellular response to tunicamycin|positive regulation of cellular response to thapsigargin|negative regulation of catalytic activity|cellular response to norepinephrine stimulus,0.0004854|0.0004854|0.0004854|0.0005854|0.000728,1|1|1|1|1,4119|4119|4119|15.18|2060
2994,4,0.5149,3.089,3033.0,0.001015,0.9929309999999999,ABHD17A OBSCN PABPC1 SF3A3,"protein localization to M-band|U2-type prespliceosome assembly|negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|negative regulation of protein localization to microtubule",0.0005825|0.0007766|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1716|1287|1287|1030
2995,4,0.5674,3.404,3199.0,0.00106,0.9929309999999999,GJA8 OCEL1 SCML4 SSTR4,somatostatin signaling pathway|somatostatin receptor signaling pathway|positive regulation of arachidonic acid secretion|gap junction-mediated intercellular transport|intercellular transport,0.001165|0.001165|0.001359|0.001359|0.001553,1|1|1|1|1,1030|1030|858.1|858.1|735.5
2996,16,0.5232,62.79,10440.0,0.005963,0.999999,CHMP1B CHMP3 CHMP5 CLTC HGS IST1 PTPN23 RNF11 STAMBP TFG UBAP1 USP8 VPS36 VPS37A VPS4A VTA1,multivesicular body assembly|multivesicular body organization|endosome organization|endosomal transport|vesicle organization,1.301e-21|1.678e-21|8.251e-21|2.117e-18|4.493e-17,2.052e-17|1.323e-17|4.338e-17|8.348e-15|1.417e-13,386.2|373.7|167.2|60.77|45.67
2997,5,0.5096,5.096,4125.0,0.001231,0.996692,ARL14EPL CCKAR ODF2 REN SLC35A5,cholecystokinin signaling pathway|renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of blood volume by renin-angiotensin,0.0008735|0.001456|0.002037|0.002037|0.002328,1|1|1|1|1,1716|858.1|572.1|572.1|490.4
2998,5,0.5062,5.062,4123.0,0.0012230000000000001,0.996692,FAR2 MANSC4 ODF3B RASSF8 RNF223,wax metabolic process|wax biosynthetic process|long-chain fatty-acyl-CoA metabolic process|fatty-acyl-CoA metabolic process|fatty acid derivative biosynthetic process,0.001213|0.001213|0.006295|0.01039|0.0152,1|1|1|1|1,1030|1030|164.8|98.07|66.44
2999,5,0.5395,5.395,3373.0,0.001593,0.996692,ILF2 ILF3 OGA ZC3H10 ZFR,negative regulation of production of miRNAs involved in gene silencing by miRNA|N-acetylglucosamine metabolic process|negative regulation of gene silencing by miRNA|negative regulation of posttranscriptional gene silencing|negative regulation of gene silencing by RNA,0.003878|0.004845|0.004845|0.005087|0.005087,1|1|1|1|1,274.6|216.8|216.8|205.9|205.9
3000,4,0.5659,3.395,3235.0,0.001046,0.9929309999999999,C6orf226 OGFRL1 RPL3L TMX4,opioid receptor signaling pathway|ribosomal large subunit assembly|ribosome assembly|ribosomal large subunit biogenesis|ribonucleoprotein complex assembly,0.002134|0.00562|0.01256|0.0141|0.03658,1|1|1|1|1,514.9|183.9|80.45|71.51|27.1
3001,4,0.5261,3.157,3078.0,0.0010220000000000001,0.9929309999999999,KIRREL3 OLAH OR2B2 UVSSA,principal sensory nucleus of trigeminal nerve development|trigeminal sensory nucleus development|inter-male aggressive behavior|medium-chain fatty acid biosynthetic process|aggressive behavior,0.0005825|0.0005825|0.0005825|0.001359|0.001553,1|1|1|1|1,2574|2574|2574|858.1|735.5
3002,5,0.501,5.01,4247.0,0.001176,0.996692,ATP2B2 C2orf91 CNPY1 GRIK1 OLFM4,regulation of cardiac conduction|negative regulation of citrulline biosynthetic process|regulation of citrulline biosynthetic process|negative regulation of cellular amine catabolic process|regulation of cellular amine catabolic process,0.000116|0.0005824|0.0005824|0.0005824|0.0005824,1|1|1|1|1,122.6|3432|3432|3432|3432
3003,4,0.5682,3.409,3271.0,0.001039,0.9929309999999999,C1orf105 GRM8 INTS4 OMG,adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|G protein-coupled glutamate receptor signaling pathway|neuron projection regeneration|snRNA processing|glutamate receptor signaling pathway,0.001553|0.003104|0.005813|0.007166|0.009289,1|1|1|1|1,735.5|343.2|177.5|143|109.5
3004,4,0.5853,3.512,3138.0,0.001115,0.9929309999999999,BET1L ONECUT2 RIT2 SCAF1,"regulation of retrograde vesicle-mediated transport, Golgi to ER|regulation of Cdc42 protein signal transduction|peripheral nervous system neuron development|peripheral nervous system neuron differentiation|regulation of vesicle-mediated transport",0.0005825|0.001553|0.002522|0.002522|0.003774,1|1|1|1|1,2574|735.5|429.1|429.1|19.65
3005,5,0.5335,5.335,3905.0,0.001361,0.996692,CYB5RL EPS15 ONECUT3 SMPD2 TMEM158,sphingomyelin catabolic process|receptor-mediated endocytosis of virus by host cell|endocytosis involved in viral entry into host cell|postsynaptic endocytosis|postsynaptic neurotransmitter receptor internalization,0.001698|0.00194|0.00194|0.002425|0.002425,1|1|1|1|1,686.5|588.4|588.4|457.7|457.7
3006,4,0.5524,3.315,3192.0,0.001035,0.9929309999999999,ARPIN CD276 OOSP2 XRCC1,positive regulation of DNA ligase activity|negative regulation of lamellipodium morphogenesis|regulation of DNA ligase activity|positive regulation of single strand break repair|directional locomotion,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
3007,4,0.5574,3.344,3144.0,0.00106,0.9929309999999999,GJA5 OPALIN RAB38 SEMA5A,regulation of Purkinje myocyte action potential|signal clustering|vasomotion|Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling|bundle of His cell to Purkinje myocyte communication by electrical coupling,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3008,4,0.5551,3.3310000000000004,3463.0,0.0009586999999999999,0.9929309999999999,ADD2 LRFN1 OPTC PRR14,regulation of postsynaptic density assembly|regulation of postsynaptic specialization assembly|regulation of excitatory synapse assembly|regulation of postsynaptic density organization|leukocyte tethering or rolling,0.002328|0.002522|0.00291|0.003104|0.004072,1|1|1|1|1,468.1|429.1|367.8|343.2|257.4
3009,4,0.5202,3.1210000000000004,2983.0,0.001042,0.9929309999999999,CHRNB2 OR10A2 OR2T29 TNN,lateral geniculate nucleus development|negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|regulation of canonical Wnt signaling pathway involved in osteoblast differentiation|sensory perception|synaptic transmission involved in micturition,0.0003883|0.0003883|0.0003883|0.0004092|0.0007766,1|1|1|1|1,5149|5149|5149|15.87|1716
3010,4,0.5038,3.023,3058.0,0.0009847999999999999,0.9929309999999999,CDON LRRC8E OR10A3 USP2,skeletal muscle satellite cell differentiation|muscle organ development|embryonic body morphogenesis|embryonic retina morphogenesis in camera-type eye|aspartate transmembrane transport,0.0009706|0.0011|0.001359|0.001553|0.001941,1|1|1|1|1,1287|36.78|858.1|735.5|572.1
3011,4,0.5564,3.338,3053.0,0.0010890000000000001,0.9929309999999999,LRRC30 OR10AG1 OR14C36 STK25,intrinsic apoptotic signaling pathway in response to hydrogen peroxide|hydrogen peroxide-mediated programmed cell death|programmed cell death in response to reactive oxygen species|Golgi reassembly|cell death in response to hydrogen peroxide,0.0005825|0.0005825|0.0007766|0.0009706|0.0009706,1|1|1|1|1,2574|2574|1716|1287|1287
3012,5,0.555,5.55,3617.0,0.0015279999999999998,0.996692,OR10G4 OR10G7 OR10G9 OR6X1 OR8D4,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,4.653e-09|6.251e-09|7.541e-09|1.076e-08|1.297e-08,7.34e-05|4.93e-05|3.965e-05|4.242e-05|4.091e-05,46.7|44.01|42.38|39.45|38
3013,4,0.53,3.18,3383.0,0.0009369,0.9929309999999999,COQ8B MDFI OR10K2 TMEM235,dorsal/ventral axis specification|trophoblast giant cell differentiation|ubiquinone biosynthetic process|quinone biosynthetic process|cytoplasmic sequestering of transcription factor,0.002328|0.00291|0.003297|0.003297|0.003297,1|1|1|1|1,468.1|367.8|321.8|321.8|321.8
3014,4,0.5088,3.053,3020.0,0.001007,0.9929309999999999,BTN1A1 DRC1 OR11A1 OR2H1,axonemal dynein complex assembly|axoneme assembly|microtubule bundle formation|cilium assembly|positive regulation of keratinocyte proliferation,3.302e-05|0.0001478|0.0002847|0.003271|0.003636,0.5208|1|1|1|1,228.8|105.6|75.58|21.79|294.2
3015,4,0.542,3.252,3030.0,0.0010689999999999999,0.9929309999999999,HIST1H1A OR12D3 OR2H2 TMEM14C,regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|regulation of tetrapyrrole metabolic process|detection of chemical stimulus involved in sensory perception of smell|negative regulation of chromatin silencing,0.0007766|0.0007766|0.0009706|0.00269|0.00291,1|1|1|1|1,1716|1716|1287|23.35|367.8
3016,4,0.5388,3.233,3437.0,0.0009375,0.9929309999999999,ASPG LYSMD4 OR13C2 TTLL12,cellular amino acid metabolic process|negative regulation of type I interferon-mediated signaling pathway|protein deglycosylation|regulation of type I interferon-mediated signaling pathway|aspartate family amino acid metabolic process,0.001804|0.003636|0.007985|0.008467|0.01424,1|1|1|1|1,29.53|294.2|128.7|121.1|71.02
3017,4,0.5038,3.023,3064.0,0.0009829,0.9929309999999999,GRIN2B OR13G1 RASIP1 SLC8A2,long-term synaptic potentiation|calcium ion transmembrane import into cytosol|calcium ion transport into cytosol|cytosolic calcium ion transport|positive regulation of synaptic transmission,3.181e-05|6.041e-05|7.811e-05|0.0001177|0.0002425,0.5017|0.4765|0.4107|0.4641|0.765,223.9|160.9|141.1|114.4|79.21
3018,4,0.5242,3.145,2961.0,0.001058,0.9929309999999999,DHRS7B LDAH OR14A16 OTOP1,negative regulation of interferon-gamma-mediated signaling pathway|negative regulation of response to interferon-gamma|ether lipid biosynthetic process|cellular lipid biosynthetic process|glycerol ether biosynthetic process,0.001747|0.001747|0.002328|0.002328|0.002328,1|1|1|1|1,643.6|643.6|468.1|468.1|468.1
3019,4,0.5618,3.3710000000000004,3155.0,0.001064,0.9929309999999999,ERBB4 GPR22 NAPEPLD OR14I1,central nervous system morphogenesis|host-mediated regulation of intestinal microbiota composition|negative regulation of eating behavior|cardiac muscle tissue regeneration|N-acylethanolamine metabolic process,0.0005825|0.0005825|0.0007766|0.0009706|0.001165,1|1|1|1|1,2574|2574|1716|1287|1030
3020,4,0.5384,3.23,3089.0,0.001042,0.9929309999999999,EVA1C OR1K1 PRSS50 TMEM247,cellular process|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.04971|0.08311|0.08802|0.09127|0.09776,1|1|1|1|1,0.3325|11.68|11|10.59|9.864
3021,4,0.5034,3.02,3294.0,0.0009138999999999999,0.9929309999999999,ANKRD34B CNTN2 IBSP OR1N1,establishment of protein localization to juxtaparanode region of axon|positive regulation of adenosine receptor signaling pathway|clustering of voltage-gated potassium channels|regulation of adenosine receptor signaling pathway|protein localization to juxtaparanode region of axon,0.0003883|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,5149|1716|1716|1287|1287
3022,14,0.503,45.78,10830.0,0.004197,0.9999969999999999,AKAP2 C9orf16 FAM129B KIF12 OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 OR1Q1 PALM2 TXNDC8 ZBTB6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.357e-09|5.035e-09|6.512e-09|1.06e-08|1.369e-08,5.295e-05|3.971e-05|3.424e-05|4.179e-05|4.319e-05,25.15|23.7|22.82|21.24|20.46
3023,4,0.5422,3.253,3140.0,0.001032,0.9929309999999999,OR1S2 RHCE SLC2A6 XPC,"UV-damage excision repair, DNA incision|pyrimidine dimer repair by nucleotide-excision repair|fructose transmembrane transport|dehydroascorbic acid transport|pyrimidine dimer repair",0.0003883|0.0009706|0.001165|0.001553|0.001941,1|1|1|1|1,5149|1287|1030|735.5|572.1
3024,4,0.5658,3.395,3280.0,0.001031,0.9929309999999999,F2 MTSS1L OR2A4 SLC47A2,acute-phase response|acute inflammatory response|neutrophil-mediated killing of gram-negative bacterium|positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway|neutrophil-mediated killing of bacterium,2.547e-05|7.603e-05|0.0007766|0.0009706|0.001165,0.4018|0.5997|1|1|1,251.2|143|1716|1287|1030
3025,5,0.5043,5.043,4096.0,0.001227,0.996692,DDC MORN1 OR2AE1 ROR2 RPH3A,neurotransmitter transport|phytoalexin metabolic process|embryonic genitalia morphogenesis|isoquinoline alkaloid metabolic process|serotonin biosynthetic process,0.0004786|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,58.01|2060|2060|1373|1373
3026,4,0.5256,3.154,3122.0,0.001007,0.9929309999999999,ETFA LRRC58 OR2AG1 SOX6,positive regulation of mesenchymal stem cell differentiation|spinal cord oligodendrocyte cell differentiation|regulation of mesenchymal stem cell differentiation|negative regulation of cardiac muscle cell differentiation|fatty acid beta-oxidation using acyl-CoA dehydrogenase,0.0009706|0.001165|0.001359|0.001553|0.002134,1|1|1|1|1,1287|1030|858.1|735.5|514.9
3027,4,0.5453,3.272,3081.0,0.001058,0.9929309999999999,ANTXRL OR2C3 PLK3 PRSS48,positive regulation of chaperone-mediated autophagy|positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia|endomitotic cell cycle|Golgi disassembly|regulation of chaperone-mediated autophagy,0.0003883|0.0005825|0.0007766|0.001553|0.001747,1|1|1|1|1,5149|2574|1716|735.5|643.6
3028,4,0.5206,3.1239999999999997,3408.0,0.0009136000000000001,0.9929309999999999,CCDC157 DPYS HSD17B8 OR2G6,uracil catabolic process|thymine catabolic process|pyrimidine nucleobase catabolic process|uracil metabolic process|thymine metabolic process,0.0005825|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|1716|1716|1716|1716
3029,12,0.5073,33.48,8850.0,0.003759,0.999986,CTTN FOLR1 FOLR2 KRTAP5-1 KRTAP5-10 KRTAP5-11 KRTAP5-3 KRTAP5-9 MRGPRD P2RY6 PLEKHB1 POLD4,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,3.066e-09|8.301e-09|2.174e-08|6.679e-08|1.097e-07,4.836e-05|6.547e-05|0.0001143|0.0002634|0.0003459,42.06|35.47|30.08|24.82|22.79
3030,5,0.5125,5.125,4061.0,0.001257,0.996692,ARPC1B OR2L2 SHISA4 UROC1 ZNF264,formamide metabolic process|histidine catabolic process to glutamate and formate|histidine catabolic process to glutamate and formamide|formate metabolic process|histidine catabolic process,0.001213|0.001213|0.001213|0.001698|0.002183,1|1|1|1|1,1030|1030|1030|686.5|514.9
3031,5,0.5047,5.047,3641.0,0.0013800000000000002,0.996692,OR10G8 OR10G9 OR10S1 OR2L3 OR8B2,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,4.653e-09|6.251e-09|7.541e-09|1.076e-08|1.297e-08,7.34e-05|4.93e-05|3.965e-05|4.242e-05|4.091e-05,46.7|44.01|42.38|39.45|38
3032,4,0.5037,3.022,3104.0,0.0009699999999999999,0.9929309999999999,IPP OR2M7 SH3PXD2A TMCO4,osteoclast fusion|multinuclear osteoclast differentiation|inositol phosphate dephosphorylation|inositol phosphate catabolic process|phosphorylated carbohydrate dephosphorylation,0.001698|0.002425|0.004362|0.004845|0.004845,1|1|1|1|1,686.5|457.7|242.3|216.8|216.8
3033,14,0.5169,47.04,10630.0,0.0043950000000000005,0.9999969999999999,CYBC1 DDC FDX1 KCNK13 MAFB MAPKAPK5 NAT8L PSKH1 RPH3A SLC5A12 TAL2 TNFRSF19 UCKL1 WNT8A,rhombomere 6 development|polarity specification of proximal/distal axis|abducens nerve formation|abducens nerve morphogenesis|abducens nerve development,0.001358|0.002037|0.002037|0.002037|0.002037,1|1|1|1|1,1471|735.5|735.5|735.5|735.5
3034,4,0.5107,3.0639999999999996,3022.0,0.00101,0.9929309999999999,ANKRD45 LY9 OR2T34 PAIP2B,"T-helper 17 cell lineage commitment|T-helper 17 cell differentiation|T-helper cell lineage commitment|T-helper 17 type immune response|CD4-positive, alpha-beta T cell lineage commitment",0.001553|0.002134|0.002328|0.002328|0.00291,1|1|1|1|1,735.5|514.9|468.1|468.1|367.8
3035,7,0.5222,10.97,5077.0,0.00215,0.9992989999999999,NBEAL1 OR2T4 POGZ PPIAL4G ST20 TSPYL5 ZNF728,cellular response to radiation|positive regulation of apoptotic DNA fragmentation|positive regulation of DNA catabolic process|cellular response to UV-C|protein-DNA complex assembly,0.001532|0.002037|0.002376|0.002715|0.0031,1|1|1|1|1,33.24|588.4|490.4|420.3|23.17
3036,4,0.5112,3.0669999999999997,2949.0,0.001036,0.9929309999999999,KLHL6 OR2T12 OR2T8 SYK,B cell receptor signaling pathway|positive regulation of immune response|positive regulation of interleukin-3 production|lysyl-tRNA aminoacylation|serotonin secretion by platelet,0.0003963|0.0004391|0.0004854|0.0004854|0.000728,1|1|1|1|1,63.86|16.74|4119|4119|2060
3037,5,0.5044,5.044,3867.0,0.001299,0.996692,BTNL9 MXD3 OR2V2 RAB24 TRIM41,cellular response to muramyl dipeptide|response to muramyl dipeptide|T cell receptor signaling pathway|cellular response to lipopolysaccharide|cellular response to molecule of bacterial origin,0.002425|0.005087|0.04317|0.04341|0.04575,1|1|1|1|1,457.7|205.9|22.88|22.76|21.57
3038,4,0.5057,3.034,3141.0,0.0009628,0.9929309999999999,EFHD1 GINM1 OR2W3 ST6GALNAC3,regulation of response to salt stress|regulation of cellular hyperosmotic salinity response|regulation of cellular response to osmotic stress|regulation of response to osmotic stress|glycosylceramide metabolic process,0.0009706|0.0009706|0.002134|0.002522|0.003104,1|1|1|1|1,1287|1287|514.9|429.1|343.2
3039,4,0.5394,3.236,3100.0,0.0010400000000000001,0.9929309999999999,EIF4E1B KCNE3 OR2Y1 OR52E8,negative regulation of membrane repolarization during cardiac muscle cell action potential|negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential|regulation of membrane repolarization during ventricular cardiac muscle cell action potential|negative regulation of potassium ion export across plasma membrane|regulation of membrane repolarization during cardiac muscle cell action potential,0.0003883|0.0003883|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|5149|1716|1716|1287
3040,5,0.5011,5.011,4002.0,0.001248,0.996692,GGT7 OR3A2 PKD2L2 WISP2 ZNF497,leukotriene D4 biosynthetic process|leukotriene D4 metabolic process|glutathione catabolic process|glutathione biosynthetic process|nonribosomal peptide biosynthetic process,0.002667|0.002667|0.00291|0.003878|0.004362,1|1|1|1|1,411.9|411.9|374.5|274.6|242.3
3041,4,0.5781,3.468,2863.0,0.001206,0.9929309999999999,OR4A15 OR4A16 OR4C15 OR4D6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.149e-07|2.723e-07|3.164e-07|4.205e-07|4.883e-07,0.00339|0.002147|0.001663|0.001658|0.001541,46.7|44.01|42.38|39.45|38
3042,6,0.5279,7.917999999999999,4393.0,0.001794,0.998474,DIS3L2 LCN10 OR4C11 OR4P4 OR4S2 TUT7,polyuridylation-dependent mRNA catabolic process|miRNA metabolic process|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception,7.066e-07|1.784e-05|0.0001895|0.0002256|0.000252,0.01115|0.1407|0.9963|0.8897|0.7951,2288|326.9|23.35|22|21.19
3043,5,0.503,5.03,3852.0,0.001301,0.996692,COA1 GXYLT1 OR4C6 RPRD1A SH2D2A,dephosphorylation of RNA polymerase II C-terminal domain|mitochondrial cytochrome c oxidase assembly|respiratory chain complex IV assembly|cytochrome complex assembly|O-glycan processing,0.00291|0.005571|0.006537|0.008949|0.01496,1|1|1|1|1,374.5|187.2|158.4|114.4|67.52
3044,4,0.5008,3.005,3177.0,0.0009426,0.9929309999999999,KCNC3 OR4D10 PCSK2 TIMP3,insulin processing|islet amyloid polypeptide processing|enkephalin processing|positive regulation of TRAIL-activated apoptotic signaling pathway|regulation of TRAIL-activated apoptotic signaling pathway,0.0003883|0.0003883|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|5149|2574|1716|1287
3045,4,0.5295,3.177,3045.0,0.0010400000000000001,0.9929309999999999,COL9A2 GBP6 OR4D9 PRKCI,negative regulation of glial cell apoptotic process|Golgi vesicle budding|regulation of glial cell apoptotic process|positive regulation of glial cell proliferation|positive regulation of endothelial cell apoptotic process,0.001747|0.002134|0.002134|0.003297|0.003685,1|1|1|1|1,643.6|514.9|514.9|321.8|286
3046,11,0.508,27.94,8095.0,0.00343,0.999969,ACR ANHX C8orf33 CHAMP1 MZF1 OR4F21 OR4F5 PARD6G PGBD2 RABL2B TUBB8,acrosome matrix dispersal|sister chromatid biorientation|spindle assembly involved in female meiosis|spindle assembly involved in meiosis|penetration of zona pellucida,0.001067|0.002134|0.003199|0.004263|0.005327,1|1|1|1|1,1872|624.1|374.5|267.5|208
3047,25,0.4902,147.1,18680.0,0.007790999999999999,1.0,CD1B CD1C CD1E CTSK EFNA4 FAM189B FCGR2B FCGR3A FCRL3 GBA HSPA6 ITLN2 KCNJ10 LCE3E OR10J5 OR6K6 PGLYRP3 S100A12 S100A2 S100A9 SLAMF7 TMCO1 TSACC XCL1 YY1AP1,"regulation of T cell mediated cytotoxicity|regulation of T cell mediated immunity|regulation of leukocyte mediated cytotoxicity|positive regulation of T cell mediated cytotoxicity|antigen processing and presentation, endogenous lipid antigen via MHC class Ib",1.597e-09|4.664e-08|4.955e-08|6.713e-08|8.781e-08,2.52e-05|0.0003679|0.0002606|0.0002647|0.000277,108.4|52.81|52.14|113.6|494.3
3048,4,0.557,3.342,3083.0,0.00108,0.9929309999999999,HDHD5 HECTD3 OR52A1 OR52A5,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.00269|0.003023|0.003256|0.003746|0.004032,1|1|1|1|1,23.35|22|21.19|19.73|19
3049,6,0.5253,7.879,4519.0,0.001736,0.998474,HBE1 OR51B4 OR52B6 OR52M1 OR52W1 OR56A1,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,2.742e-08|3.679e-08|4.434e-08|6.316e-08|7.608e-08,0.0004325|0.0002902|0.0002332|0.0002491|0.00024,38.92|36.67|35.31|32.88|31.67
3050,4,0.5687,3.412,3046.0,0.001116,0.9929309999999999,CALCB OR52E2 OR56A1 VAT1L,G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.001027|0.00269|0.003023|0.003256|0.003746,1|1|1|1|1,11.62|23.35|22|21.19|19.73
3051,4,0.5174,3.1039999999999996,3144.0,0.000984,0.9929309999999999,MEIOC OR52E4 PRMT9 SLC30A2,"positive regulation of sequestering of zinc ion|cell cycle switching|germline cell cycle switching, mitotic to meiotic cell cycle|cell cycle switching, mitotic to meiotic cell cycle|peptidyl-arginine methylation, to symmetrical-dimethyl arginine",0.0003883|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|1716|1716|1716|1287
3052,4,0.5723,3.4339999999999997,3090.0,0.0011070000000000001,0.9929309999999999,ATP8A2 FAM177A1 OR52E6 XCL2,involuntary skeletal muscle contraction|positive regulation of phospholipid translocation|regulation of phospholipid translocation|aminophospholipid translocation|neurofilament cytoskeleton organization,0.0007766|0.001165|0.001359|0.001553|0.001747,1|1|1|1|1,1716|1030|858.1|735.5|643.6
3053,4,0.5058,3.035,3049.0,0.0009918,0.9929309999999999,OR52H1 TLE4 ZKSCAN3 ZNF609,regulation of myoblast proliferation|positive regulation of neuron migration|negative regulation of cellular senescence|negative regulation of cell aging|beta-catenin-TCF complex assembly,0.002522|0.003297|0.004072|0.005233|0.005813,1|1|1|1|1,429.1|321.8|257.4|198|177.5
3054,4,0.5039,3.023,3104.0,0.0009704000000000001,0.9929309999999999,CASS4 CCDC33 OR52N1 OR52N5,actin filament reorganization|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.002134|0.00269|0.003023|0.003256|0.003746,1|1|1|1|1,514.9|23.35|22|21.19|19.73
3055,4,0.5127,3.076,3094.0,0.0009907,0.9929309999999999,CDK20 OR13C4 OR5AN1 TSPAN33,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.00269|0.003023|0.003256|0.003746|0.004032,1|1|1|1|1,23.35|22|21.19|19.73|19
3056,4,0.5112,3.0669999999999997,3088.0,0.0009897999999999999,0.9929309999999999,ANGPTL4 C10orf82 CDHR5 OR5AP2,intermicrovillar adhesion|protein unfolding|brush border assembly|negative regulation of lipoprotein lipase activity|regulation of microvillus length,0.0005825|0.0007766|0.001165|0.001359|0.001553,1|1|1|1|1,2574|1716|1030|858.1|735.5
3057,5,0.5284,5.284,4189.0,0.001257,0.996692,CLN8 CTNNAL1 LZTFL1 OR5B17 TTC23,negative regulation of protein localization to ciliary membrane|glutamate reuptake|age-dependent response to oxidative stress|regulation of protein localization to ciliary membrane|negative regulation of protein localization to cilium,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
3058,4,0.5792,3.475,3227.0,0.001073,0.9929309999999999,ACSL6 FAM131C OR5B21 PXYLP1,positive regulation of heparan sulfate proteoglycan biosynthetic process|regulation of heparan sulfate proteoglycan biosynthetic process|positive regulation of proteoglycan biosynthetic process|long-chain fatty-acyl-CoA biosynthetic process|positive regulation of glycoprotein biosynthetic process,0.0007766|0.0007766|0.0009706|0.003878|0.004653,1|1|1|1|1,1716|1716|1287|271|223.9
3059,4,0.5143,3.0860000000000003,3002.0,0.001024,0.9929309999999999,HACE1 OR5D16 RRP12 TIGD1,Rac protein signal transduction|protein K48-linked ubiquitination|Golgi organization|membrane fusion|Ras protein signal transduction,0.004266|0.01122|0.02615|0.02881|0.03393,1|1|1|1|1,245.2|90.33|38.14|34.56|29.25
3060,4,0.5369,3.222,3141.0,0.0010220000000000001,0.9929309999999999,CRIM1 HNF4G OR5L2 TACSTD2,negative regulation of branching involved in ureteric bud morphogenesis|negative regulation of ruffle assembly|negative regulation of morphogenesis of an epithelium|insulin-like growth factor receptor signaling pathway|negative regulation of substrate adhesion-dependent cell spreading,0.0005825|0.001359|0.001747|0.002716|0.00291,1|1|1|1|1,2574|858.1|643.6|396.1|367.8
3061,16,0.503,60.36,12520.0,0.004787,0.999999,A2M C3AR1 CLEC12B CLEC2B CLEC4D CLEC6A GALNT8 KCNA1 KCNA5 KCNA6 KLRC1 PKP2 SLCO1B1 SLCO1B3 SLCO1C1 TAS2R20,sodium-independent organic anion transport|bile acid and bile salt transport|regulation of innate immune response|natural killer cell inhibitory signaling pathway|regulation of immune response,3.691e-07|2.935e-06|3.169e-06|5.642e-06|1.118e-05,0.005822|0.02314|0.01666|0.02225|0.03526,241.3|113.6|20.63|858.1|7.981
3062,4,0.5774,3.464,3097.0,0.001115,0.9929309999999999,GRM5 OR6T1 SEC31B TYR,response to organonitrogen compound|response to nitrogen compound|phospholipase C-activating G protein-coupled glutamate receptor signaling pathway|melanin biosynthetic process from tyrosine|eye pigment biosynthetic process,0.0004398|0.0005646|0.0005825|0.0005825|0.0007766,1|1|1|1|1,15.49|14.24|2574|2574|1716
3063,4,0.5209,3.125,3072.0,0.0010140000000000001,0.9929309999999999,OR5T3 OR8A1 PDYN SLC25A29,sensory perception|mitochondrial L-ornithine transmembrane transport|G protein-coupled receptor signaling pathway|nervous system process|acyl carnitine transport,0.0004092|0.0007766|0.001027|0.001147|0.001165,1|1|1|1|1,15.87|1716|11.62|11.19|1030
3064,5,0.5035,5.035,3668.0,0.001367,0.996692,OR2M7 OR4D5 OR6M1 OR8B12 OR8B3,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,4.653e-09|6.251e-09|7.541e-09|1.076e-08|1.297e-08,7.34e-05|4.93e-05|3.965e-05|4.242e-05|4.091e-05,46.7|44.01|42.38|39.45|38
3065,11,0.5151,28.33,8350.0,0.003372,0.999969,ADAMTS8 CRYAB FXYD6 HTR3A HTR3B KCNJ1 NXPE1 NXPE2 NXPE4 OR8B8 TMEM136,ion transmembrane transport|serotonin receptor signaling pathway|transmembrane transport|cellular response to dopamine|response to dopamine,0.0001248|0.00021|0.0003288|0.0008611|0.0008818,1|1|1|1|1,8.907|96.01|7.246|46.23|45.67
3066,4,0.5267,3.16,2997.0,0.00105,0.9929309999999999,DDX24 OR8H2 SLURP2 SNAP25,exocytic insertion of neurotransmitter receptor to postsynaptic membrane|synaptic vesicle docking|vesicle fusion to plasma membrane|synaptic vesicle fusion to presynaptic active zone membrane|neurotransmitter receptor transport to postsynaptic membrane,0.0009706|0.002328|0.002716|0.002716|0.00291,1|1|1|1|1,1287|468.1|396.1|396.1|367.8
3067,4,0.5016,3.01,3099.0,0.0009676999999999999,0.9929309999999999,OLFM3 OR8H3 PDE6H SYNGR2,synaptic vesicle membrane organization|positive regulation of G protein-coupled receptor signaling pathway|eye photoreceptor cell development|positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of ERBB signaling pathway,0.0009706|0.005426|0.00678|0.007552|0.007938,1|1|1|1|1,1287|190.7|151.4|135.5|128.7
3068,13,0.5036,39.28,10300.0,0.0037890000000000003,0.999993,CDH10 CDH12 CDH18 CDH6 CEP72 DNAH5 FAM173B OTULIN OTULINL PRLR SLC6A18 SLC6A19 UGT3A1,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|adherens junction organization|cell-cell junction assembly|homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell junction organization,1.061e-08|4.659e-08|7.422e-07|2.151e-06|3.271e-06,0.0001674|0.0003674|0.003902|0.008484|0.01032,163.5|110.7|54.06|41.11|36.91
3069,4,0.5101,3.0610000000000004,3183.0,0.0009584,0.9929309999999999,C18orf63 OR9G4 SPAG1 ZNF670,axonemal dynein complex assembly|axoneme assembly|microtubule bundle formation|single fertilization|fertilization,0.007166|0.01525|0.02119|0.02919|0.03582,1|1|1|1|1,143|66.01|47.24|34.1|27.68
3070,4,0.5135,3.0810000000000004,3138.0,0.0009782999999999999,0.9929309999999999,DNAAF4 OR9I1 REXO1 YIF1A,inner dynein arm assembly|outer dynein arm assembly|epithelial cilium movement involved in extracellular fluid movement|axonemal dynein complex assembly|extracellular transport,0.003297|0.004266|0.00678|0.007166|0.007359,1|1|1|1|1,321.8|245.2|151.4|143|139.2
3071,4,0.5174,3.1039999999999996,3217.0,0.0009616,0.9929309999999999,CCDC148 OR9Q1 PRKAR2B SCUBE1,response to antipsychotic drug|response to clozapine|blood coagulation|coagulation|hemostasis,0.0005825|0.0007766|0.001244|0.001261|0.001277,1|1|1|1|1,2574|1716|34.56|34.33|34.1
3072,4,0.5112,3.0669999999999997,3289.0,0.0009294,0.9929309999999999,MSMP ORAI2 ZNF44 ZNF721,store-operated calcium entry|monocyte chemotaxis|lymphocyte chemotaxis|lymphocyte migration|mononuclear cell migration,0.001747|0.008131|0.009675|0.01449|0.02043,1|1|1|1|1,643.6|125.6|105.1|69.58|49.04
3073,4,0.5546,3.327,3250.0,0.0010199999999999999,0.9929309999999999,A3GALT2 NYAP1 ORM1 SLC4A9,cellular response to manganese ion|lipid glycosylation|response to manganese ion|glycosphingolipid biosynthetic process|phosphatidylinositol 3-kinase signaling,0.002522|0.002522|0.003878|0.00562|0.007552,1|1|1|1|1,429.1|429.1|271|183.9|135.5
3074,4,0.5659,3.395,3304.0,0.001024,0.9929309999999999,DPP7 ORM2 SLC6A20 WNT3,Spemann organizer formation at the anterior end of the primitive streak|canonical Wnt signaling pathway involved in stem cell proliferation|isoleucine transport|L-isoleucine import across plasma membrane|isoleucine transmembrane transport,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3075,5,0.5051,5.051,4033.0,0.001248,0.996692,DDX43 DPPA5 EXD3 OSBPL10 SELENOV,response to selenium ion|phosphatidylserine acyl-chain remodeling|phosphatidylserine metabolic process|sterol transport|regulation of cellular process,0.00291|0.005571|0.008949|0.01855|0.01872,1|1|1|1|1,374.5|187.2|114.4|54.2|0
3076,4,0.512,3.072,3098.0,0.0009883,0.9929309999999999,FER KRTAP5-5 OR5M1 OSBPL1A,Kit signaling pathway|cellular response to stem cell factor stimulus|response to stem cell factor|insulin receptor signaling pathway via phosphatidylinositol 3-kinase|extracellular matrix-cell signaling,0.0005825|0.0005825|0.0005825|0.0009706|0.001165,1|1|1|1|1,2574|2574|2574|1287|1030
3077,4,0.5847,3.508,3555.0,0.0009836,0.9929309999999999,CA9 CDK5RAP1 MYO1C OSBPL2,vesicle transport along actin filament|actin filament-based transport|vesicle cytoskeletal trafficking|actin filament-based movement|tRNA methylthiolation,9.879e-06|1.19e-05|0.0001131|0.0003382|0.000728,0.1558|0.09386|0.5945|1|1,433.6|392.3|121.1|69.23|2060
3078,5,0.5243,5.242999999999999,4057.0,0.001288,0.996692,EIF5AL1 GREB1 OSBPL6 PTGDS ZDBF2,monocarboxylic acid biosynthetic process|positive regulation of translational termination|positive regulation of translational elongation|carboxylic acid biosynthetic process|organic acid biosynthetic process,0.0007056|0.001213|0.001456|0.001792|0.001881,1|1|1|1|1,47.62|1030|823.8|29.63|28.91
3079,4,0.5724,3.4339999999999997,3162.0,0.001082,0.9929309999999999,KCNG1 OSCAR PCSK4 TOR1B,multinuclear osteoclast differentiation|collagen-activated signaling pathway|positive regulation of bone resorption|regulation of delayed rectifier potassium channel activity|acrosome reaction,0.001941|0.003104|0.004072|0.004266|0.004653,1|1|1|1|1,572.1|343.2|257.4|245.2|223.9
3080,5,0.5144,5.144,4026.0,0.001273,0.996692,CETN3 FGF9 OSCP1 ROR1 ZNF26,negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching|negative regulation of cell differentiation involved in phenotypic switching|negative regulation of phenotypic switching|regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching|regulation of cell differentiation involved in phenotypic switching,0.000728|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,2060|2060|2060|1373|1373
3081,4,0.5344,3.2060000000000004,3214.0,0.0009942,0.9929309999999999,CISD2 MMP15 OSGIN2 SLFN12L,cellular component disassembly|multicellular organism aging|endodermal cell differentiation|autophagy of mitochondrion|mitochondrion disassembly,0.002221|0.006973|0.007938|0.008131|0.008131,1|1|1|1|1,25.74|147.1|128.7|125.6|125.6
3082,4,0.509,3.054,3062.0,0.0009939,0.9929309999999999,FCHO1 KDR OSR1 PDGFRA,metanephric glomerulus vasculature development|metanephric glomerulus development|glomerulus vasculature development|kidney vasculature development|renal system vasculature development,7.916e-07|1.865e-06|5.367e-06|5.932e-06|5.932e-06,0.01249|0.01471|0.02822|0.02339|0.01871,1716|1030|572.1|542|542
3083,4,0.5595,3.3569999999999998,3222.0,0.001038,0.9929309999999999,OSR2 TCIRG1 TXNDC15 ZUP1,odontogenesis|response to silver ion|dentin mineralization|memory T cell activation|T-helper 1 cell activation,0.0002004|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,87.27|5149|5149|2574|1716
3084,4,0.5885,3.531,3260.0,0.0010789999999999999,0.9929309999999999,OTOF SHLD2 TTC32 ZNF512,synaptic vesicle priming|positive regulation of double-strand break repair via nonhomologous end joining|negative regulation of double-strand break repair via homologous recombination|positive regulation of isotype switching|regulation of double-strand break repair via nonhomologous end joining,0.00291|0.003491|0.003878|0.005426|0.006007,1|1|1|1|1,367.8|302.9|271|190.7|171.6
3085,5,0.555,5.55,4417.0,0.0012519999999999999,0.996692,GM2A OTOL1 SLC30A5 SULT1C2 TNFAIP6,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|purine nucleoside bisphosphate metabolic process|ribonucleoside bisphosphate metabolic process,2.29e-05|2.473e-05|2.473e-05|0.0006285|0.0006285,0.3613|0.1951|0.13|1|1,286|274.6|274.6|51.62|51.62
3086,9,0.5123,18.44,5544.0,0.0033049999999999998,0.9998530000000001,ICMT KRAS MAPK1 NF1 NRAS RAF1 RAP1GDS1 RCE1 SHOC2,MAPK cascade|intracellular signal transduction|Ras protein signal transduction|forebrain astrocyte development|forebrain astrocyte differentiation,2.329e-13|1.002e-08|6.86e-07|1.017e-06|1.017e-06,3.674e-09|7.902e-05|0.003607|0.004011|0.003209,44.76|11.62|52.01|2288|2288
3087,4,0.5471,3.282,3051.0,0.001072,0.9929309999999999,CTF1 MAP3K2 OTUD3 RNF125,protein K6-linked deubiquitination|protein K27-linked deubiquitination|negative regulation of RIG-I signaling pathway|leukemia inhibitory factor signaling pathway|protein K11-linked deubiquitination,0.0007766|0.0007766|0.001747|0.001941|0.002134,1|1|1|1|1,1716|1716|643.6|572.1|514.9
3088,6,0.5135,7.702000000000001,4038.0,0.001898,0.998474,ANKRD17 CNOT4 G3BP1 G3BP2 OTUD6B SRRD,positive regulation of stress granule assembly|regulation of stress granule assembly|stress granule assembly|positive regulation of organelle assembly|regulation of G1/S transition of mitotic cell cycle,4.24e-07|1.484e-06|1.629e-05|0.0001644|0.0008166,0.006689|0.0117|0.08564|0.6483|1,3432|1373|343.2|102.5|45.16
3089,4,0.5272,3.1630000000000003,3277.0,0.0009621,0.9929309999999999,ABR CDC42BPA LEMD1 OTUD7B,protein deubiquitination involved in ubiquitin-dependent protein catabolic process|protein K11-linked deubiquitination|negative regulation of interleukin-8 production|mucosal immune response|protein phosphorylation,0.001553|0.002134|0.003878|0.0062|0.006354,1|1|1|1|1,735.5|514.9|271|166.1|15.05
3090,4,0.554,3.324,3307.0,0.0010019999999999999,0.9929309999999999,EDEM3 MYBPC3 OVOL1 SPATA45,"cell cycle switching|germline cell cycle switching, mitotic to meiotic cell cycle|cell cycle switching, mitotic to meiotic cell cycle|regulation of muscle filament sliding|negative regulation of meiotic cell cycle phase transition",0.0007766|0.0007766|0.0007766|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1716|1287|1287
3091,5,0.5275,5.275,4235.0,0.001241,0.996692,ADRB3 B3GLCT DKK2 EDNRB OXGR1,vasodilation|blood vessel diameter maintenance|regulation of tube diameter|regulation of tube size|enteric smooth muscle cell differentiation,3.128e-05|0.0003784|0.0003784|0.0003843|0.0004854,0.4935|1|1|1|1,235.4|65.38|65.38|64.87|4119
3092,4,0.5011,3.0069999999999997,2736.0,0.0010949999999999998,0.9929309999999999,DCTD OXNAD1 PPIP5K1 TYMS,dTMP biosynthetic process|pyrimidine deoxyribonucleoside monophosphate biosynthetic process|dTMP metabolic process|pyrimidine deoxyribonucleotide biosynthetic process|deoxyribonucleoside monophosphate biosynthetic process,1.697e-07|4.241e-07|5.937e-07|1.018e-06|1.272e-06,0.002676|0.003345|0.003122|0.004013|0.004013,5149|2574|2060|1471|1287
3093,4,0.5082,3.049,3170.0,0.0009585,0.9929309999999999,ANP32A IRAK2 OXR1 PPP1R3D,negative regulation of cellular response to oxidative stress|negative regulation of peptidyl-cysteine S-nitrosylation|regulation of glycogen catabolic process|cellular response to hydroperoxide|regulation of peptidyl-cysteine S-nitrosylation,0.0005825|0.001165|0.001553|0.001747|0.001747,1|1|1|1|1,2574|1030|735.5|643.6|643.6
3094,8,0.5352,14.99,5333.0,0.002794,0.9996790000000001,C16orf72 DDX21 HSPA14 NCL NOLC1 PINX1 ZNF622 ZNHIT6,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA processing,2.677e-07|1.386e-06|5.206e-06|6.032e-06|3.753e-05,0.004222|0.01093|0.02738|0.02379|0.1184,31.02|22.15|31.68|30.51|19.07
3095,10,0.5092,22.91,7900.0,0.002885,0.999933,C8orf58 DEFA5 DEFB108B DEFB4A DEFB4B PABPC4 SOX7 TNFRSF10D ZNF705A ZNF705B,defense response to bacterium|killing of cells of other organism|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|antimicrobial humoral immune response mediated by antimicrobial peptide,0.0003721|0.0006082|0.0006807|0.0008541|0.0009047,1|1|1|1|1,19.9|54.48|51.42|45.77|44.43
3096,4,0.556,3.3360000000000003,3218.0,0.001033,0.9929309999999999,CTAGE15 MDH1 NT5E PABPN1L,NAD metabolic process|adenosine biosynthetic process|AMP catabolic process|purine ribonucleoside monophosphate catabolic process|purine nucleoside monophosphate catabolic process,3.316e-05|0.0003883|0.0005825|0.001165|0.001553,0.523|1|1|1|1,219.1|5149|2574|1030|735.5
3097,5,0.5043,5.043,4074.0,0.001233,0.996692,C11orf45 EPX MKS1 PACSIN1 TMEM102,defense response to nematode|negative regulation of interleukin-5 production|plasma membrane tubulation|positive regulation of T cell chemotaxis|positive regulation of dendrite development,0.000728|0.002183|0.003394|0.003878|0.00412,1|1|1|1|1,2060|514.9|316.8|274.6|257.4
3098,4,0.5726,3.4360000000000004,3302.0,0.001037,0.9929309999999999,CAMTA2 CDA PAH TMEM120B,"tyrosine biosynthetic process|aromatic amino acid family biosynthetic process, prephenate pathway|aromatic amino acid family biosynthetic process|cytosine metabolic process|small molecule catabolic process",0.0003883|0.0003883|0.0003883|0.0005825|0.00232,1|1|1|1|1,5149|5149|5149|2574|25.18
3099,5,0.501,5.01,4416.0,0.001131,0.996692,FABP6 FHOD3 PAIP2 SLC30A5 TRIM36,cortical actin cytoskeleton organization|cortical cytoskeleton organization|cobalt ion transport|cytoskeleton organization|actin filament network formation,5.487e-05|0.0001242|0.002328|0.003509|0.003781,0.8655|0.9795|1|1|1,180.7|118.4|490.4|8.553|286
3100,4,0.543,3.258,3124.0,0.001039,0.9929309999999999,PALM PLPP2 TPGS1 UQCR11,negative regulation of dopamine receptor signaling pathway|regulation of dopamine receptor signaling pathway|synapse maturation|cellular response to electrical stimulus|protein polyglutamylation,0.0007766|0.002328|0.002522|0.002716|0.002716,1|1|1|1|1,1716|468.1|429.1|396.1|396.1
3101,5,0.507,5.07,3371.0,0.001497,0.996692,PAN2 PAN3 SMG5 SMG6 SMG7,nuclear-transcribed mRNA catabolic process|mRNA catabolic process|RNA catabolic process|nucleobase-containing compound catabolic process|heterocycle catabolic process,1.739e-09|2.802e-09|5.311e-09|4.237e-08|7.236e-08,2.742e-05|2.21e-05|2.792e-05|0.0001671|0.0002283,75.05|68.11|59.8|39.23|35.19
3102,4,0.5505,3.303,3364.0,0.0009785,0.9929309999999999,PANK2 PI4K2B SCRT2 SLC30A7,sequestering of zinc ion|pantothenate metabolic process|coenzyme A biosynthetic process|sequestering of metal ion|regulation of bile acid metabolic process,0.0009706|0.001553|0.002328|0.002522|0.00291,1|1|1|1|1,1287|735.5|468.1|429.1|367.8
3103,4,0.5551,3.33,3329.0,0.0009969,0.9929309999999999,FAM24A LENEP NOTCH3 PAOX,positive regulation of spermidine biosynthetic process|regulation of spermidine biosynthetic process|regulation of polyamine biosynthetic process|spermine catabolic process|spermidine catabolic process,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
3104,4,0.5056,3.034,3322.0,0.0009102,0.9929309999999999,LOXL1 MESP2 PAPOLG STX12,protein deamination|peptidyl-lysine oxidation|somite rostral/caudal axis specification|protein oxidation|cholesterol efflux,0.0003883|0.001165|0.002328|0.002522|0.00504,1|1|1|1|1,5149|1030|468.1|429.1|205.9
3105,7,0.5112,10.74,5677.0,0.001883,0.9992989999999999,HTR1D NKD2 PAPPA SLC25A34 SLC6A18 SLC6A19 TPPP,amino acid transmembrane transport|sodium ion transmembrane transport|amino acid transport|carboxylic acid transmembrane transport|organic acid transmembrane transport,0.0004082|0.0007163|0.0008632|0.0009957|0.001009,1|1|1|1|1,65.38|49.04|44.58|41.44|41.15
3106,24,0.5018,138.5,17960.0,0.007631999999999999,1.0,APOA2 CD1B CD1E FCGR2B FCRL1 FCRL3 FMO2 GBA ITLN1 ITLN2 KCNJ10 LCE3E OR10J5 OR10T2 OR6K6 OR6N1 OR6N2 PAQR6 S100A12 S100A2 S100A9 SLAMF7 TTC24 YY1AP1,"regulation of T cell mediated cytotoxicity|negative regulation of production of molecular mediator of immune response|antigen processing and presentation, endogenous lipid antigen via MHC class Ib|negative regulation of B cell receptor signaling pathway|antigen processing and presentation, exogenous lipid antigen via MHC class Ib",1.628e-05|1.752e-05|2.953e-05|5.054e-05|5.054e-05,0.2568|0.1382|0.1552|0.1993|0.1594,65.04|63.37|329.5|235.4|235.4
3107,4,0.5823,3.4939999999999998,3379.0,0.00103,0.9929309999999999,C10orf88 MX2 PARD3B ZNF365,regulation of DNA strand resection involved in replication fork processing|cerebellar molecular layer morphogenesis|cerebellar molecular layer development|protein-containing complex localization|gamma-tubulin complex localization,0.0002913|0.0004369|0.0004369|0.0004686|0.0005825,1|1|1|1|1,6865|3432|3432|53.42|2288
3108,4,0.547,3.282,3212.0,0.001018,0.9929309999999999,PARK7 ROCK1 RUSC1 STK17B,negative regulation of protein binding|positive regulation of autophagy|negative regulation of protein catabolic process|negative regulation of binding|positive regulation of oxidative phosphorylation uncoupler activity,0.0001336|0.000214|0.0002174|0.0003786|0.0003883,1|1|1|1|0.2917,107.3|84.41|83.72|63.17|5149
3109,4,0.574,3.444,3339.0,0.0010279999999999998,0.9929309999999999,C5orf30 DGAT2 PARPBP PROKR1,cellular response to oleic acid|fat pad development|response to oleic acid|monoacylglycerol biosynthetic process|cellular triglyceride homeostasis,0.0007766|0.001165|0.001359|0.001553|0.001553,1|1|1|1|1,1716|1030|858.1|735.5|735.5
3110,9,0.5488,19.76,6228.0,0.003153,0.9998530000000001,CDC6 CDT1 MRE11 ORC1 ORC2 ORC3 ORC4 ORC5 ORC6,DNA replication initiation|pre-replicative complex assembly|DNA-dependent DNA replication|DNA replication|G1/S transition of mitotic cell cycle,7.111e-21|1.5e-19|7.321e-19|1.391e-17|2.18e-17,1.122e-16|1.183e-15|3.849e-15|5.484e-14|6.878e-14,425.7|281.6|106.2|76|146.5
3111,4,0.523,3.138,3021.0,0.001035,0.9929309999999999,DGUOK FDPS PATE3 SREBF2,regulation of cholesterol biosynthetic process|regulation of sterol biosynthetic process|regulation of cholesterol metabolic process|regulation of alcohol biosynthetic process|regulation of steroid biosynthetic process,2.919e-05|2.919e-05|4.987e-05|7.603e-05|0.0001126,0.4604|0.2302|0.2622|0.2998|0.3553,234|234|177.5|143|117
3112,4,0.5166,3.1,3307.0,0.0009341000000000001,0.9929309999999999,BCL2L10 CRABP1 DGKQ PBOV1,regulation of progesterone biosynthetic process|diterpenoid catabolic process|retinoic acid catabolic process|regulation of cortisol biosynthetic process|terpenoid catabolic process,0.0009706|0.001165|0.001165|0.001553|0.001553,1|1|1|1|1,1287|1030|1030|735.5|735.5
3113,4,0.5588,3.353,3278.0,0.001019,0.9929309999999999,PBX4 SLC25A2 SPIRE2 VIM,formin-nucleated actin cable organization|mitochondrial L-ornithine transmembrane transport|formin-nucleated actin cable assembly|polar body extrusion after meiotic divisions|establishment of meiotic spindle localization,0.0007766|0.0007766|0.0007766|0.0009706|0.001165,1|1|1|1|1,1716|1716|1716|1287|1030
3114,4,0.5572,3.343,3314.0,0.001006,0.9929309999999999,PCCA SERPINE2 SIGLEC12 SLC8A2,long-term synaptic potentiation|positive regulation of synaptic transmission|regulation of action potential firing pattern|mating plug formation|seminal vesicle epithelium development,3.181e-05|0.0002425|0.0003883|0.0003883|0.0003883,0.5017|1|1|1|1,223.9|79.21|5149|5149|5149
3115,4,0.5378,3.227,3172.0,0.0010140000000000001,0.9929309999999999,ERBB4 GPBAR1 PCDH18 SZRD1,cell surface bile acid receptor signaling pathway|central nervous system morphogenesis|positive regulation of cholangiocyte proliferation|positive regulation of ERK1 and ERK2 cascade|regulation of cholangiocyte proliferation,0.0003883|0.0005825|0.0005825|0.000595|0.0007766,1|1|1|1|1,5149|2574|2574|50.23|1716
3116,5,0.511,5.11,4278.0,0.00119,0.996692,FLRT1 GRK4 PCDH7 SH3BP2 UVSSA,G protein-coupled receptor internalization|desensitization of G protein-coupled receptor signaling pathway|negative adaptation of signaling pathway|adaptation of signaling pathway|regulation of rhodopsin mediated signaling pathway,0.004361|0.005522|0.005522|0.005812|0.007839,1|1|1|1|1,245.2|190.7|190.7|180.7|132
3117,4,0.5118,3.071,3017.0,0.0010140000000000001,0.9929309999999999,EIF2D EN1 KCNK13 PCDH8,anterior/posterior pattern specification|regulation of synaptic membrane adhesion|motor learning|regionalization|ribosome disassembly,0.0006065|0.0009706|0.001359|0.001414|0.001747,1|1|1|1|1,49.75|1287|858.1|32.38|643.6
3118,4,0.5394,3.237,3272.0,0.0009857000000000002,0.9929309999999999,MEPCE PCDH9 TREM2 TTC16,positive regulation of C-C chemokine receptor CCR7 signaling pathway|regulation of C-C chemokine receptor CCR7 signaling pathway|positive regulation of CD40 signaling pathway|detection of lipoteichoic acid|positive regulation of CAMKK-AMPK signaling cascade,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3119,4,0.5495,3.2969999999999997,3172.0,0.001036,0.9929309999999999,ITGB8 PCDHAC1 SPINK1 URGCP,Langerhans cell differentiation|negative regulation of nitric oxide mediated signal transduction|negative regulation of serine-type peptidase activity|hard palate development|negative regulation of serine-type endopeptidase activity,0.0005825|0.0007766|0.001553|0.001553|0.001553,1|1|1|1|1,2574|1716|735.5|735.5|735.5
3120,4,0.5454,3.273,3251.0,0.001003,0.9929309999999999,F5 NRCAM PCDHGA1 REPS1,membrane organization|clustering of voltage-gated sodium channels|neuronal ion channel clustering|cell-cell adhesion|axonal fasciculation,0.0003884|0.001359|0.002328|0.003634|0.004072,1|1|1|1|1,16.16|858.1|468.1|20.03|257.4
3121,5,0.5106,5.106,4227.0,0.001204,0.996692,KCTD6 PCED1A RNF24 TGM3 TMEM19,cell envelope organization|hair follicle morphogenesis|epidermis morphogenesis|negative regulation of smoothened signaling pathway|regulation of intracellular estrogen receptor signaling pathway,0.0009706|0.00702|0.007985|0.007985|0.01064,1|1|1|1|1,1373|147.1|128.7|128.7|95.79
3122,5,0.5109,5.109,4124.0,0.001234,0.996692,PCNX2 RDH10 SMCR8 ST5 WDR78,primary lung bud formation|positive regulation of retinoic acid biosynthetic process|positive regulation of isoprenoid metabolic process|regulation of retinoic acid biosynthetic process|regulation of isoprenoid metabolic process,0.0003883|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,5149|5149|5149|2574|1716
3123,4,0.556,3.3360000000000003,3202.0,0.001038,0.9929309999999999,ELOVL7 FAM186A PCNX3 VSIG10,"fatty acid elongation, unsaturated fatty acid|fatty acid elongation, saturated fatty acid|fatty acid elongation, polyunsaturated fatty acid|fatty acid elongation, monounsaturated fatty acid|very long-chain fatty acid biosynthetic process",0.001553|0.001553|0.001553|0.001553|0.002716,1|1|1|1|1,735.5|735.5|735.5|735.5|396.1
3124,32,0.5051,250.6,24780.0,0.009984,1.0,ARPC1B C7orf43 CASTOR3 CYP3A4 CYP3A43 CYP3A5 CYP3A7 DLX6 FBXO24 GJC3 IFT22 MOGAT3 MUC12 PILRA PILRB PON1 PON3 PVRIG RASA4 RASA4B RNF148 SEMA3E SLC26A5 SPDYE1 TECPR1 TRIM50 WNT2 ZKSCAN1 ZNF394 ZNF804B ZSCAN21 ZSCAN25,oxidative demethylation|lipid hydroxylation|demethylation|retinoic acid metabolic process|alkaloid catabolic process,3.623e-08|3.663e-07|3.571e-06|2.122e-05|2.18e-05,0.0005715|0.002889|0.01878|0.08369|0.06877,139.9|284.7|40.26|60.4|442.9
3125,26,0.5048,164.1,19530.0,0.008311,1.0,CTSK ECM1 FCRL3 FLG2 GBA HIST2H2AB HIST2H2BE HRNR ITLN2 LCE1B LCE2A LCE3A LCE3E LCE5A LIX1L PGLYRP3 PRR9 S100A12 S100A2 S100A4 S100A5 S100A6 S100A8 S100A9 SLAMF7 SPRR2G,skin development|keratinization|epidermis development|keratinocyte differentiation|epidermal cell differentiation,3.009e-10|6.319e-09|1.68e-08|1.983e-08|5.973e-08,4.746e-06|4.984e-05|8.836e-05|7.819e-05|0.0001884,20.16|26.58|16.46|22.41|19.01
3126,4,0.5628,3.377,3368.0,0.0009991,0.9929309999999999,AZGP1 CLIP3 PCSK5 SLC6A17,nitrogen compound transport|organic substance transport|anion transport|ion transport|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,5.878e-05|0.0001238|0.0001527|0.0003841|0.0005825,0.9271|0.9761|0.8026|1|1,11.44|9.491|9.005|7.149|2574
3127,5,0.5376,5.376,3694.0,0.00145,0.996692,MAT2A OSBPL5 PCTP SRRD TOM1L1,phospholipid transport|organophosphate ester transport|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|S-adenosylmethionine biosynthetic process,0.0002086|0.0004146|0.0009706|0.0009706|0.001213,1|1|1|1|1,88.58|62.41|1373|1373|1030
3128,4,0.5046,3.028,3135.0,0.0009624000000000001,0.9929309999999999,LTBP2 PCYOX1L SRXN1 XPA,nucleotide-excision repair involved in interstrand cross-link repair|prenylcysteine metabolic process|prenylcysteine catabolic process|prenylated protein catabolic process|UV-damage excision repair,0.0005825|0.0005825|0.0005825|0.0007766|0.002716,1|1|1|1|1,2574|2574|2574|1716|396.1
3129,5,0.5242,5.242000000000001,3856.0,0.001354,0.996692,BIVM COL4A2 KDELC1 PDCL2 PLA2G4A,phosphatidylglycerol catabolic process|platelet activating factor biosynthetic process|positive regulation of platelet activation|monoacylglycerol biosynthetic process|cardiolipin acyl-chain remodeling,0.0003883|0.0009706|0.0009706|0.001553|0.001747,1|1|1|1|1,5149|1287|1287|735.5|643.6
3130,10,0.5226,23.52,6916.0,0.0033799999999999998,0.999933,ESR1 FOXA1 GATA3 LMX1B QRICH1 QSER1 SEPHS1 SPDEF TRPS1 ZNF652,prostate glandular acinus development|negative regulation of transcription by RNA polymerase II|regulation of transcription by RNA polymerase II|uterus development|lung epithelial cell differentiation,1.396e-05|3.423e-05|4.203e-05|4.43e-05|4.872e-05,0.2201|0.27|0.221|0.1747|0.1537,411.9|11.42|5.575|216.8|205.9
3131,5,0.5061,5.061,4196.0,0.001202,0.996692,FAM43A IAPP PDE4C SCARA3 TPRG1,positive regulation of calcium ion import across plasma membrane|regulation of calcium ion import across plasma membrane|amylin receptor signaling pathway|calcitonin family receptor signaling pathway|cAMP catabolic process,0.0009706|0.001456|0.00194|0.002183|0.002425,1|1|1|1|1,1373|823.8|588.4|514.9|457.7
3132,4,0.5449,3.27,3036.0,0.001073,0.9929309999999999,EXOSC10 MRFAP1L1 PDE6B S100P,antisense RNA transcript catabolic process|nuclear polyadenylation-dependent antisense transcript catabolic process|nuclear polyadenylation-dependent CUT catabolic process|nuclear polyadenylation-dependent snRNA catabolic process|nuclear polyadenylation-dependent snoRNA catabolic process,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3133,5,0.5421,5.421,3083.0,0.00175,0.996692,CMIP DHX29 PDE7A PRKAR1A STK11,negative regulation of reproductive process|regulation of reproductive process|positive regulation of vesicle transport along microtubule|regulation of vesicle transport along microtubule|negative regulation of epithelial cell proliferation involved in prostate gland development,8.02e-05|0.0006277|0.001213|0.001456|0.001698,1|1|1|1|1,144.5|50.54|1030|823.8|686.5
3134,4,0.5902,3.5410000000000004,3138.0,0.001124,0.9929309999999999,C1orf210 FOXF1 PDGFRB RTP5,artery morphogenesis|vasculogenesis|artery development|right lung morphogenesis|metanephric glomerular mesangial cell proliferation involved in metanephros development,5.859e-05|7.398e-05|0.0001126|0.0003883|0.0003883,0.9241|0.5835|0.5922|1|1,163.5|145|117|5149|5149
3135,7,0.5006,10.51,5520.0,0.0018960000000000001,0.9992989999999999,CCNB1IP1 KIF26B PCDH10 PCDHB12 PCDHGA9 PDHA2 TXLNA,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|ureteric bud invasion|metanephric renal vesicle formation,1.886e-05|6.853e-05|0.00051|0.001358|0.001698,0.2974|0.5405|1|1|1,52.85|34.08|17.17|980.7|735.5
3136,6,0.5222,7.834,5322.0,0.001467,0.998474,B3GALT4 CD8B GPR3 IFI6 PDIK1L SPATC1,negative regulation of mitochondrial depolarization|negative regulation of membrane depolarization|ganglioside biosynthetic process|regulation of mitochondrial depolarization|release of cytochrome c from mitochondria,0.002037|0.002328|0.004942|0.006101|0.006681,1|1|1|1|1,572.1|490.4|214.5|171.6|156
3137,5,0.5165,5.165,4143.0,0.001242,0.996692,CCDC24 GPR22 NAPEPLD PDLIM2 SNRPN,host-mediated regulation of intestinal microbiota composition|negative regulation of eating behavior|N-acylethanolamine metabolic process|regulation of eating behavior|response to isolation stress,0.000728|0.0009706|0.001456|0.00194|0.002183,1|1|1|1|1,2060|1373|823.8|588.4|514.9
3138,4,0.507,3.042,3118.0,0.0009721,0.9929309999999999,CASTOR1 PCIF1 PDPN SYNE3,regulation of cell shape|regulation of myofibroblast contraction|positive regulation of platelet aggregation|lymphatic endothelial cell fate commitment|cellular response to L-arginine,0.0003342|0.0003883|0.0007766|0.0007766|0.0007766,1|1|1|1|1,67.3|5149|1716|1716|1716
3139,4,0.5027,3.016,3066.0,0.0009803,0.9929309999999999,EPN2 PDZK1IP1 SLFNL1 TIE1,negative regulation of angiogenesis|negative regulation of blood vessel morphogenesis|negative regulation of vasculature development|branching involved in lymph vessel morphogenesis|regulation of angiogenesis,0.0001505|0.0001534|0.0001563|0.0003883|0.001077,1|1|0.822|1|1,101|99.98|99.01|5149|37.18
3140,5,0.5514,5.513999999999999,3842.0,0.001429,0.996692,C4orf46 CNN2 PDZRN4 TBC1D3B UQCRH,"mitochondrial electron transport, ubiquinol to cytochrome c|negative regulation of phagocytosis|interleukin-12-mediated signaling pathway|cellular response to interleukin-12|response to interleukin-12",0.003636|0.005812|0.01136|0.01184|0.01208,1|1|1|1|1,294.2|179.1|89.54|85.81|84.06
3141,4,0.5379,3.227,3343.0,0.0009622999999999999,0.9929309999999999,CACNG1 CACNG4 CACNG5 PELI2,"cardiac conduction|neurotransmitter receptor transport, postsynaptic endosome to lysosome|multicellular organismal signaling|neurotransmitter receptor diffusion trapping|postsynaptic neurotransmitter receptor diffusion trapping",4.162e-07|1.018e-06|1.146e-06|1.555e-06|1.555e-06,0.006566|0.008027|0.006024|0.006131|0.004904,162.6|1471|115.3|1144|1144
3142,4,0.5731,3.4389999999999996,3230.0,0.0010609999999999999,0.9929309999999999,CAPN2 ITGA4 PEMT TG,blastocyst development|response to amino acid|response to acid chemical|clathrin-dependent extracellular exosome endocytosis|negative regulation of protein homodimerization activity,0.0001363|0.0001777|0.0002425|0.0003883|0.0003883,1|1|1|1|1,106.2|92.77|79.21|5149|5149
3143,4,0.5546,3.327,3213.0,0.001032,0.9929309999999999,CDKN2D PER3 TARBP1 TMEM178A,"autophagic cell death|response to light stimulus|response to radiation|regulation of circadian sleep/wake cycle, sleep|regulation of circadian sleep/wake cycle",0.001359|0.001371|0.002739|0.003491|0.004266,1|1|1|1|1,858.1|32.9|23.14|302.9|245.2
3144,8,0.5062,14.17,5602.0,0.002516,0.9996790000000001,LSM2 LSM3 LSM6 LSM7 LSM8 PDRG1 PFDN2 PFDN6,"exonucleolytic catabolism of deadenylated mRNA|nuclear-transcribed mRNA catabolic process, exonucleolytic|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",6.128e-10|7.629e-10|6.255e-09|3.839e-08|3.839e-08,9.666e-06|6.017e-06|3.289e-05|0.0001514|0.0001211,312|294.2|168.8|42.62|42.62
3145,13,0.5236,40.84,9874.0,0.004109000000000001,0.999993,CCDC137 DDX31 DNAJC21 EBNA1BP2 GNL1 GPATCH4 ODR4 PINX1 PUM3 RBM34 RPF1 WDR89 ZNF622,ribosomal large subunit biogenesis|ribosome biogenesis|ribonucleoprotein complex biogenesis|ganglion mother cell fate determination|positive regulation of telomeric DNA binding,1.637e-05|6.105e-05|0.0002211|0.002037|0.002037,0.2582|0.4815|1|1|1,61.29|17.72|12.65|735.5|735.5
3146,7,0.5235,10.99,4965.0,0.002203,0.9992989999999999,BRF2 DCTN6 FNTA GINS4 MAK16 PGGT1B TTI2,protein geranylgeranylation|protein prenylation|prenylation|positive regulation of tubulin deacetylation|cellular response to transforming growth factor beta stimulus,3.69e-06|8.691e-06|8.691e-06|0.0007765|0.001509,0.0582|0.06854|0.0457|1|1,858.1|514.9|514.9|2574|33.87
3147,5,0.5435,5.435,4288.0,0.001263,0.996692,CAMKMT ILDR2 NRN1L PGM1 STAG3,galactose catabolic process|galactose metabolic process|glycogen catabolic process|glucan catabolic process|cellular polysaccharide catabolic process,0.002183|0.003394|0.004604|0.004845|0.005087,1|1|1|1|1,514.9|316.8|228.8|216.8|205.9
3148,4,0.5138,3.083,3149.0,0.0009756,0.9929309999999999,GDPD3 PGPEP1 PTPRU SPN,T-helper 1 cell lineage commitment|N-acylethanolamine metabolic process|transmembrane receptor protein tyrosine phosphatase signaling pathway|interferon-gamma production|ethanolamine-containing compound metabolic process,0.0007766|0.001165|0.001359|0.001941|0.001941,1|1|1|1|1,1716|1030|858.1|572.1|572.1
3149,4,0.5509,3.305,3253.0,0.001013,0.9929309999999999,ARFGAP1 C1QTNF12 MGME1 PHGR1,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|endoplasmic reticulum to Golgi vesicle-mediated transport|COPI-coated vesicle budding|mitochondrial DNA repair|COPI coating of Golgi vesicle",0.0001749|0.0009018|0.001698|0.001698|0.001698,1|1|1|1|1,96.92|42.03|686.5|686.5|686.5
3150,4,0.528,3.168,3190.0,0.0009897999999999999,0.9929309999999999,ADAMTS15 EPB41L2 PHLDA1 ZNF587B,FasL biosynthetic process|positive regulation of protein localization to cell cortex|regulation of protein localization to cell cortex|cortical actin cytoskeleton organization|cortical cytoskeleton organization,0.0003883|0.001359|0.001941|0.007552|0.01141,1|1|1|1|1,5149|858.1|572.1|135.5|88.77
3151,5,0.5002,5.002,3902.0,0.001277,0.996692,GLT8D2 NADK2 PHLDB2 PROK1 SAA4,"NADP biosynthetic process|negative regulation of wound healing, spreading of epidermal cells|regulation of basement membrane organization|positive regulation of basement membrane assembly involved in embryonic body morphogenesis|regulation of basement membrane assembly involved in embryonic body morphogenesis",0.0009706|0.001213|0.001456|0.001456|0.001456,1|1|1|1|1,1373|1030|823.8|823.8|823.8
3152,5,0.5554,5.553999999999999,3968.0,0.001394,0.996692,LILRA1 OR4F6 PI3 SIGLEC12 TNNC2,copulation|skeletal muscle contraction|mating|actin-myosin filament sliding|muscle filament sliding,0.003878|0.007985|0.007985|0.009431|0.009431,1|1|1|1|1,274.6|128.7|128.7|108.4|108.4
3153,4,0.5265,3.159,2914.0,0.00108,0.9929309999999999,PIGG TRAPPC8 TXNL4A ZNF829,autophagy of peroxisome|protein localization to phagophore assembly site|preassembly of GPI anchor in ER membrane|GPI anchor biosynthetic process|GPI anchor metabolic process,0.002522|0.002716|0.003491|0.006393|0.006586,1|1|1|1|1,429.1|396.1|302.9|160.9|156
3154,4,0.5566,3.339,3128.0,0.001064,0.9929309999999999,FGFBP1 MANBAL PIGZ PROM2,negative regulation of caveolin-mediated endocytosis|negative regulation of pinocytosis|regulation of caveolin-mediated endocytosis|positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.0005825|0.001165|0.001553|0.001747|0.001941,1|1|1|1|1,2574|1030|735.5|643.6|572.1
3155,4,0.5605,3.363,3113.0,0.001076,0.9929309999999999,ANXA1 C14orf28 NPFFR1 PIKFYVE,"granulocyte chemotaxis|granulocyte migration|myeloid leukocyte migration|leukocyte chemotaxis|1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process",0.0001004|0.0001336|0.0002245|0.0002845|0.0003883,1|1|1|1|1,124.1|107.3|82.38|73.03|5149
3156,4,0.5059,3.035,3039.0,0.000995,0.9929309999999999,BEND5 DHRS4L2 ESYT2 PINK1,positive regulation of free ubiquitin chain polymerization|regulation of free ubiquitin chain polymerization|cellular response to hydrogen sulfide|negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway|regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
3157,4,0.5316,3.1889999999999996,3153.0,0.001008,0.9929309999999999,CDC27 CDK5RAP1 PIP4K2B TMEM150A,phosphatidylinositol phosphorylation|lipid phosphorylation|phosphatidylinositol metabolic process|tRNA methylthiolation|lipid modification,4.821e-05|7.603e-05|0.0004655|0.0005825|0.0007724,0.7605|0.5997|1|1|1,180.7|143|56.89|2574|44.01
3158,4,0.5535,3.321,3268.0,0.001013,0.9929309999999999,CYP39A1 FREM3 PIRT SPATA6,cholesterol catabolic process|sterol catabolic process|behavioral response to pain|motile cilium assembly|steroid catabolic process,0.002328|0.002328|0.002716|0.00504|0.005233,1|1|1|1|1,468.1|468.1|396.1|205.9|198
3159,5,0.52,5.2,4236.0,0.0012230000000000001,0.996692,LFNG LIM2 PITX2 ST3GAL4 TBC1D17,prolactin secreting cell differentiation|negative regulation of Notch signaling pathway involved in somitogenesis|regulation of Notch signaling pathway involved in somitogenesis|cell proliferation involved in outflow tract morphogenesis|cell proliferation involved in heart morphogenesis,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
3160,4,0.5244,3.1460000000000004,3205.0,0.0009782,0.9929309999999999,CLEC10A GP1BA PKDCC SLC25A12,negative regulation of NAD metabolic process|negative regulation of glucose catabolic process to lactate via pyruvate|regulation of NAD metabolic process|negative regulation of fermentation|malate-aspartate shuttle,0.0007766|0.0007766|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1287|1287|1287
3161,4,0.5188,3.113,3067.0,0.001011,0.9929309999999999,ELF1 PKN3 SGCD TTC7A,regulation of B cell receptor signaling pathway|phosphatidylinositol phosphorylation|regulation of antigen receptor-mediated signaling pathway|cellular iron ion homeostasis|phosphorylation,0.00504|0.01122|0.01256|0.01314|0.01385,1|1|1|1|1,205.9|90.33|80.45|76.85|10.08
3162,5,0.5153,5.153,3722.0,0.001379,0.996692,DNAAF5 PKNOX1 SP2 TRAF3IP1 WDCP,microtubule-based movement|cilium assembly|cilium organization|inner dynein arm assembly|plasma membrane bounded cell projection assembly,0.002814|0.003271|0.003689|0.00412|0.004983,1|1|1|1|1,23.54|21.79|20.49|257.4|17.57
3163,4,0.5383,3.23,3182.0,0.0010119999999999999,0.9929309999999999,FAM3B GABARAPL1 PLA2G3 SHC4,positive regulation of mast cell differentiation|regulation of mast cell differentiation|positive regulation of histamine secretion by mast cell|regulation of histamine secretion by mast cell|positive regulation of prostaglandin biosynthetic process,0.0003883|0.0007766|0.001165|0.001165|0.001553,1|1|1|1|1,5149|1716|1030|1030|735.5
3164,4,0.5463,3.278,3156.0,0.001035,0.9929309999999999,C1orf54 LGI3 PLA2G4B POLB,"immunoglobulin heavy chain V-D-J recombination|base-excision repair, base-free sugar-phosphate removal|DNA dephosphorylation|base-excision repair, DNA ligation|immunoglobulin V(D)J recombination",0.0005825|0.0005825|0.0005825|0.0007766|0.001359,1|1|1|1|1,2574|2574|2574|1716|858.1
3165,5,0.5687,5.687,3636.0,0.001558,0.996692,IPMK IPPK ITPK1 PLA2G4C SEC24B,inositol phosphate metabolic process|inositol phosphorylation|inositol trisphosphate metabolic process|polyol metabolic process|inositol metabolic process,2.585e-07|2.827e-07|1.319e-06|2.214e-06|3.672e-06,0.004078|0.00223|0.006935|0.008733|0.01159,209.4|4119|1373|100.5|748.9
3166,4,0.5266,3.159,3305.0,0.0009527999999999998,0.9929309999999999,CEACAM16 CPT1C PLBD2 TEX19,cellular lipid catabolic process|lipid catabolic process|carnitine metabolic process|amino-acid betaine metabolic process|negative regulation of transposition,0.0005667|0.001294|0.00291|0.003685|0.005233,1|1|1|1|1,51.49|33.87|367.8|286|198
3167,5,0.5368,5.367999999999999,4342.0,0.001232,0.996692,C19orf38 CPNE9 PLCD1 TMEM167B VANGL1,constitutive secretory pathway|positive regulation of dendrite extension|regulation of dendrite extension|inositol phosphate metabolic process|regulation of anatomical structure morphogenesis,0.001456|0.006054|0.006778|0.01448|0.01963,1|1|1|1|1,823.8|171.6|152.6|69.81|8.626
3168,5,0.5103,5.103,3919.0,0.001297,0.996692,CMPK2 EVI5 IL4I1 PLCD4 TMEM213,dUDP metabolic process|dTDP metabolic process|dTDP biosynthetic process|dUDP biosynthetic process|pyrimidine deoxyribonucleoside diphosphate biosynthetic process,0.000728|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,2060|2060|2060|2060|2060
3169,4,0.5439,3.264,2996.0,0.001085,0.9929309999999999,CTDSP2 LGR5 OR2T5 PLCE1,epithelial cell proliferation involved in renal tubule morphogenesis|G protein-coupled receptor signaling pathway|renal system development|urogenital system development|diacylglycerol biosynthetic process,0.0009706|0.001027|0.001163|0.001432|0.001747,1|1|1|1|1,1287|11.62|35.76|32.18|643.6
3170,7,0.5112,10.74,5162.0,0.00207,0.9992989999999999,DENND4A IRF8 MEF2D NCKAP1L PLCG2 SIK3 ZFP64,phagocytosis|positive regulation of endocytosis|plasmacytoid dendritic cell differentiation|hemopoiesis|regulation of type I interferon production,0.0001347|0.0005314|0.0006794|0.0006961|0.0008127,1|1|1|1|1,27.07|57.13|2942|15.43|45.97
3171,4,0.5583,3.35,3350.0,0.0009966,0.9929309999999999,CCDC88A PEBP1 PLCH1 TGOLN2,maintenance of protein location in plasma membrane|maintenance of protein location in membrane|positive regulation of protein localization to cilium|intracellular signal transduction|regulation of protein localization to cilium,0.0005825|0.0005825|0.001165|0.001692|0.001747,1|1|1|1|1,2574|2574|1030|9.807|643.6
3172,4,0.5253,3.1519999999999997,3090.0,0.001016,0.9929309999999999,ARF5 KCNK6 PLEKHA3 SLC30A1,ion transport|detoxification of cadmium ion|negative regulation of zinc ion transmembrane import|negative regulation of zinc ion transmembrane transport|negative regulation of zinc ion transport,0.0003841|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,7.149|5149|5149|5149|5149
3173,4,0.5413,3.248,3194.0,0.001013,0.9929309999999999,GDF3 PLEKHA5 SLC39A11 SLN,negative regulation of calcium ion binding|regulation of calcium ion binding|metal ion transport|negative regulation of calcium ion import|regulation of ATPase-coupled calcium transmembrane transporter activity,0.0007766|0.0007766|0.001467|0.001941|0.002328,1|1|1|1|1,1716|1716|31.78|572.1|468.1
3174,4,0.5156,3.094,3403.0,0.0009062999999999999,0.9929309999999999,IGFBP1 PLEKHA7 SQOR SYNJ2,"zonula adherens maintenance|sulfide oxidation|sulfide oxidation, using sulfide:quinone oxidoreductase|hydrogen sulfide metabolic process|adherens junction maintenance",0.0007766|0.001165|0.001165|0.001359|0.001359,1|1|1|1|1,1716|1030|1030|858.1|858.1
3175,4,0.5855,3.513,3360.0,0.001042,0.9929309999999999,ATP8A2 KRT31 PLEKHG1 PPP1R14C,involuntary skeletal muscle contraction|positive regulation of phospholipid translocation|regulation of phospholipid translocation|aminophospholipid translocation|neurofilament cytoskeleton organization,0.0007766|0.001165|0.001359|0.001553|0.001747,1|1|1|1|1,1716|1030|858.1|735.5|643.6
3176,5,0.5416,5.416,4219.0,0.001279,0.996692,ARL6IP5 CCDC80 PLEKHG3 RFTN1 TMC6,negative regulation of response to drug|negative regulation of L-glutamate import across plasma membrane|T cell antigen processing and presentation|dsRNA transport|positive regulation of growth rate,0.0004854|0.0004854|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|4119|1373|1373|1373
3177,4,0.5498,3.299,3317.0,0.000991,0.9929309999999999,ABHD15 ERGIC3 PLEKHH1 PLIN1,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|lipid metabolic process|endoplasmic reticulum to Golgi vesicle-mediated transport|intracellular receptor signaling pathway|lipid catabolic process",0.0166|0.01953|0.03771|0.03771|0.05793,1|1|1|1|1,60.57|8.427|26.27|26.27|16.94
3178,4,0.5638,3.383,3252.0,0.001037,0.9929309999999999,CDC20B DNM3 PLEKHH2 PRG4,positive regulation of anaphase-promoting complex-dependent catabolic process|regulation of anaphase-promoting complex-dependent catabolic process|negative regulation of dendritic spine morphogenesis|synaptic vesicle budding from presynaptic endocytic zone membrane|dynamin family protein polymerization involved in mitochondrial fission,0.0007766|0.0007766|0.001359|0.001553|0.001747,1|1|1|1|1,1716|1716|858.1|735.5|643.6
3179,5,0.5018,5.018,4268.0,0.001172,0.996692,MEIG1 PLEKHJ1 RHO SYNE2 UGT1A3,retinoid metabolic process|diterpenoid metabolic process|terpenoid metabolic process|isoprenoid metabolic process|absorption of visible light,0.0002796|0.0003109|0.0003667|0.0004853|0.0004854,1|1|1|1|1,76.28|72.26|66.44|57.61|4119
3180,4,0.5355,3.213,3183.0,0.001006,0.9929309999999999,ARL5C EPHB4 GRID1 PLEKHO1,protein localization to Golgi membrane|lamellipodium morphogenesis|myoblast migration|plasma membrane bounded cell projection morphogenesis|cell projection morphogenesis,0.0007766|0.001165|0.002716|0.003429|0.003483,1|1|1|1|1,1716|1030|396.1|20.64|20.47
3181,4,0.558,3.3480000000000003,3212.0,0.001039,0.9929309999999999,DAAM1 IL17B PLEKHS1 VRK3,positive regulation of phosphoprotein phosphatase activity|positive regulation of cytokine production involved in inflammatory response|positive regulation of phosphatase activity|positive regulation of protein dephosphorylation|regulation of cytokine production involved in inflammatory response,0.004266|0.004266|0.00678|0.008903|0.009482,1|1|1|1|1,245.2|245.2|151.4|114.4|107.3
3182,6,0.5206,7.809,4745.0,0.001639,0.998474,LPA PLG SLC22A2 TAAR6 TCP10 TCP10L2,histamine uptake|positive regulation of fibrinolysis|xenobiotic transport across blood-brain barrier|L-arginine import across plasma membrane|norepinephrine uptake,0.001165|0.001456|0.001746|0.001746|0.002037,1|1|1|1|1,1144|858.1|686.5|686.5|572.1
3183,4,0.5109,3.0660000000000003,3113.0,0.0009815,0.9929309999999999,CHCHD5 GPR45 PLK5 YIPF7,defense response to tumor cell|Golgi disassembly|Golgi inheritance|organelle inheritance|response to tumor cell,0.001165|0.001553|0.002328|0.002328|0.00291,1|1|1|1|1,1030|735.5|468.1|468.1|367.8
3184,5,0.5929,5.928999999999999,4217.0,0.001401,0.996692,BVES PLN PTGES RIOK3 ZDHHC14,regulation of heart rate|cardiac muscle tissue development|cellular response to dsDNA|response to dsDNA|negative regulation of calcium ion import into sarcoplasmic reticulum,0.0002265|0.0005192|0.000728|0.000728|0.000728,1|1|1|1|1,84.93|55.66|2060|2060|2060
3185,4,0.565,3.39,3152.0,0.0010710000000000001,0.9929309999999999,CRB1 DPYSL5 MNDA PLPBP,establishment of bipolar cell polarity|establishment of bipolar cell polarity involved in cell morphogenesis|post-embryonic retina morphogenesis in camera-type eye|photoreceptor cell outer segment organization|post-embryonic animal morphogenesis,0.0003883|0.0003883|0.0005825|0.002716|0.00291,1|1|1|1|1,5149|5149|2574|396.1|367.8
3186,5,0.527,5.27,4247.0,0.001236,0.996692,CCDC105 EFCAB12 PLPP3 SCARA3 SH3GLB1,canonical Wnt signaling pathway involved in positive regulation of wound healing|canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion|canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration|protein localization to vacuolar membrane|positive regulation of membrane tubulation,0.0004854|0.0004854|0.0004854|0.0004854|0.001456,1|1|1|1|1,4119|4119|4119|4119|823.8
3187,7,0.5019,10.54,5652.0,0.001857,0.9992989999999999,DNAJB4 EMID1 GUCD1 PLPPR2 PXK SEC14L4 SEC14L6,regulation of ATPase activity|negative regulation of ATPase activity|UNCLASSIFIED|biological_process|chaperone cofactor-dependent protein refolding,0.0003324|0.006439|0.00791|0.00791|0.01183,1|1|1|1|1,72.65|163.5|4.287|0.4945|86.53
3188,4,0.5554,3.332,3173.0,0.001046,0.9929309999999999,PI3 PLSCR4 TNNC2 TSC22D4,copulation|plasma membrane phospholipid scrambling|skeletal muscle contraction|mating|response to bacterium,0.003104|0.004072|0.006393|0.006393|0.006985,1|1|1|1|1,343.2|257.4|160.9|160.9|14.34
3189,5,0.5262,5.2620000000000005,4272.0,0.001227,0.996692,B2M PLXDC1 SLC16A6 TRAF3IP3 YPEL2,"antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular response to iron(III) ion|positive regulation of transferrin receptor binding|regulation of transferrin receptor binding|positive regulation of ferrous iron binding",0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
3190,4,0.5714,3.428,2997.0,0.00114,0.9929309999999999,LCE3A MROH7 PMCH SHE,feeding behavior|killing of cells of other organism|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|neuropeptide signaling pathway,0.01602|0.0164|0.01736|0.01947|0.02119,1|1|1|1|1,62.79|61.29|57.85|51.49|47.24
3191,11,0.525,28.88,6963.0,0.004117,0.999969,ATR ATRIP HUS1 RAD1 RAD17 RAD9A RFC5 RNASEH2A RNASEH2B RNASEH2C TIMELESS,DNA replication|DNA integrity checkpoint|DNA repair|cell cycle checkpoint|regulation of signal transduction by p53 class mediator,2.617e-14|3.725e-12|9.55e-12|2.05e-11|2.626e-11,4.129e-10|2.938e-08|5.021e-08|8.086e-08|8.284e-08,48.85|70.05|24.98|54.48|52.54
3192,5,0.5133,5.132999999999999,4308.0,0.001187,0.996692,CWC27 CYP19A1 DPEP2 PMFBP1 ZFP90,positive regulation of estradiol secretion|regulation of estradiol secretion|androgen catabolic process|hormone catabolic process|estrogen biosynthetic process,0.000728|0.0009706|0.001456|0.00291|0.003394,1|1|1|1|1,2060|1373|823.8|374.5|316.8
3193,4,0.5406,3.2439999999999998,3309.0,0.0009767999999999999,0.9929309999999999,CYTH2 ENOSF1 FAM78B PMS1,regulation of ARF protein signal transduction|mismatch repair|cellular carbohydrate catabolic process|cellular amino acid catabolic process|carbohydrate catabolic process,0.003878|0.00678|0.007745|0.02004|0.02253,1|1|1|1|1,271|151.4|132|49.99|44.39
3194,5,0.557,5.57,4131.0,0.001343,0.996692,DSCAM NPW PNLDC1 SLC25A39 SLC8B1,post-embryonic retina morphogenesis in camera-type eye|calcium export from the mitochondrion|regulation of chemotaxis|positive regulation of axon extension involved in axon guidance|regulation of cardiac muscle cell membrane potential,0.000728|0.000728|0.001152|0.00194|0.00194,1|1|1|1|1,2060|2060|37.11|588.4|588.4
3195,4,0.5237,3.142,3043.0,0.001029,0.9929309999999999,DMBT1 LPA PNLIPRP3 TCP10,induction of bacterial agglutination|detection of bacterial lipoprotein|response to bacterial lipoprotein|detection of molecule of bacterial origin|detection of bacterium,0.001165|0.001165|0.001747|0.002522|0.003491,1|1|1|1|1,1030|1030|643.6|429.1|302.9
3196,5,0.5109,5.109,3946.0,0.0012900000000000001,0.996692,KNCN NKAIN1 PNMT QDPR RBBP8NL,dihydrobiopterin metabolic process|epinephrine biosynthetic process|organic hydroxy compound biosynthetic process|epinephrine metabolic process|S-adenosylhomocysteine metabolic process,0.0008735|0.0008735|0.001064|0.001165|0.001165,1|1|1|1|1,1716|1716|39.45|1144|1144
3197,4,0.5412,3.247,3292.0,0.0009831,0.9929309999999999,APOM FFAR3 NUDT7 PNP,purine nucleotide catabolic process|purine-containing compound catabolic process|nucleotide catabolic process|nucleobase-containing small molecule metabolic process|nucleoside phosphate catabolic process,5.293e-05|6.463e-05|0.0001299|0.0001531|0.0001669,0.8349|0.5097|0.6828|0.6038|0.5266,179.1|161.5|112.8|23.95|99.25
3198,7,0.5217,10.95,4873.0,0.0022370000000000003,0.9992989999999999,ACTR1A DYNC1LI2 PPP2R5C PPP2R5D PPP2R5E SGO1 SNRK,regulation of protein autophosphorylation|regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|mitotic prometaphase|regulation of phosphatase activity,4.967e-07|7.497e-06|1.245e-05|1.886e-05|2.389e-05,0.007835|0.05913|0.06546|0.07436|0.07538,183.9|72.35|60.87|52.85|48.76
3199,4,0.516,3.096,3120.0,0.0009889,0.9929309999999999,EMX1 MYO1F PNPO TNFAIP8L1,pyridoxal phosphate biosynthetic process|pyridoxine biosynthetic process|pyridoxine metabolic process|pyridoxal phosphate metabolic process|vitamin B6 biosynthetic process,0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
3200,4,0.5849,3.509,3277.0,0.001067,0.9929309999999999,CAPN2 HSPG2 PODN WWP2,macromolecule catabolic process|organonitrogen compound catabolic process|positive regulation of phosphatidylcholine biosynthetic process|positive regulation of phosphatidylcholine metabolic process|regulation of phosphatidylcholine biosynthetic process,0.0005068|0.000557|0.0007766|0.0007766|0.001165,1|1|1|1|1,14.77|14.3|1716|1716|1030
3201,10,0.5172,23.27,7133.0,0.003243,0.999933,CLASRP GRWD1 LENG1 LENG8 NUP62 PNKP POLD1 SNRNP70 SYMPK TSEN34,"RNA splicing|mRNA processing|base-excision repair, gap-filling|DNA damage response, detection of DNA damage|nucleic acid metabolic process",2.979e-05|5.827e-05|0.0001399|0.0001721|0.0002324,0.4698|0.4596|0.7357|0.6786|0.7331,20.24|17.02|117.7|105.6|5.536
3202,4,0.51,3.06,3142.0,0.0009705,0.9929309999999999,ATF5 LRRC73 POLH YIPF3,olfactory bulb interneuron development|cellular response to UV-C|cerebellar granule cell precursor proliferation|cell proliferation in external granule layer|cell proliferation in hindbrain,0.001359|0.001553|0.001553|0.001553|0.001747,1|1|1|1|1,858.1|735.5|735.5|735.5|643.6
3203,4,0.5622,3.373,3384.0,0.0009934,0.9929309999999999,ALOX5AP GAS8 POLI ZNF219,leukotriene production involved in inflammatory response|arachidonic acid metabolite production involved in inflammatory response|positive regulation of protein localization to cilium|lipoxin biosynthetic process|lipoxin metabolic process,0.0005825|0.0005825|0.001165|0.001553|0.001747,1|1|1|1|1,2574|2574|1030|735.5|643.6
3204,4,0.5254,3.1519999999999997,3306.0,0.0009503000000000001,0.9929309999999999,PMP2 POLK POMT2 STAU2,positive regulation of protein O-linked glycosylation|regulation of protein O-linked glycosylation|positive regulation of protein glycosylation|ER-associated misfolded protein catabolic process|regulation of protein glycosylation,0.0007766|0.0007766|0.001941|0.002522|0.003104,1|1|1|1|1,1716|1716|572.1|429.1|343.2
3205,4,0.5739,3.443,3334.0,0.001029,0.9929309999999999,LHFPL6 LIN28A POLN ZYX,RNA 3' uridylation|miRNA catabolic process|positive regulation of cell proliferation involved in kidney development|positive regulation of cytoplasmic translation|positive regulation of production of miRNAs involved in gene silencing by miRNA,0.001165|0.001553|0.001747|0.002522|0.002522,1|1|1|1|1,1030|735.5|643.6|429.1|429.1
3206,12,0.5019,33.13,8664.0,0.0037990000000000003,0.999986,ARRDC4 CYS1 DNAL4 IER5 ITPKA POLR1E PTRH1 PWP1 SALL3 TCOF1 TMEM82 TSPAN17,transcription by RNA polymerase I|nucleolar large rRNA transcription by RNA polymerase I|rRNA transcription|transcription elongation from RNA polymerase I promoter|termination of RNA polymerase I transcription,2.931e-06|3.67e-06|9.225e-05|0.0001803|0.0001918,0.04623|0.02894|0.485|0.7109|0.6052,110.5|1056|150.9|105.6|102.2
3207,5,0.5348,5.348,4565.0,0.001168,0.996692,NQO1 POMGNT1 SMIM18 STPG1 TEX15,response to flavonoid|response to hydrogen sulfide|response to L-glutamine|response to tetrachloromethane|NADH oxidation,0.0009706|0.0009706|0.001213|0.001213|0.001456,1|1|1|1|1,1373|1373|1030|1030|823.8
3208,5,0.5292,5.292000000000001,3574.0,0.001474,0.996692,CXADR POTEC POTEF POTEM RNF145,AV node cell-bundle of His cell adhesion involved in cell communication|regulation of AV node cell action potential|tissue homeostasis|germ cell migration|cardiac muscle cell-cardiac muscle cell adhesion,0.0004854|0.0009706|0.001214|0.001698|0.00194,1|1|1|1|1,4119|1373|36.13|686.5|588.4
3209,5,0.5547,5.547000000000001,3691.0,0.0014960000000000002,0.996692,POTEC POTED POTEF POTEH POTEM,cellular process|UNCLASSIFIED|biological_process|regulation of biological process|regulation of cellular process,0.0009406|0.001414|0.001414|0.01377|0.01872,1|1|1|1|1,0|6.002|0.2308|0|0
3210,11,0.5095,28.02,8285.0,0.0033619999999999995,0.999969,CCDC74B CFC1 CFC1B FAHD2A IL1F10 LYG1 MRPL30 MZT2A POTEG POTEI TUBA3D,nodal signaling pathway|activin receptor signaling pathway|cell wall macromolecule catabolic process|determination of left/right symmetry|determination of bilateral symmetry,2.349e-05|0.0001044|0.001601|0.001907|0.002061,0.3706|0.8231|1|1|1,312|138.7|936.1|30.69|29.48
3211,5,0.5225,5.225,4237.0,0.0012289999999999998,0.996692,MATN2 POU3F1 SPARC ZBTB26 ZNF613,response to L-ascorbic acid|response to gravity|response to lead ion|myelination in peripheral nervous system|peripheral nervous system axon ensheathment,0.001698|0.002667|0.005812|0.00702|0.00702,1|1|1|1|1,686.5|411.9|179.1|147.1|147.1
3212,4,0.515,3.09,3186.0,0.0009667,0.9929309999999999,POU3F3 RAPGEF3 RELCH ZNF618,metanephric DCT cell differentiation|metanephric macula densa development|metanephric juxtaglomerular apparatus development|DCT cell differentiation|macula densa development,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3213,4,0.5494,3.2960000000000003,3264.0,0.001006,0.9929309999999999,ACVR1 PDE8A POU4F2 WDR53,endocardial cushion cell fate commitment|endocardial cell fate commitment|negative regulation of amacrine cell differentiation|positive regulation of determination of dorsal identity|endocardial cushion cell differentiation,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
3214,14,0.504,45.86,10130.0,0.004496,0.9999969999999999,C1orf131 COG2 EPRS GGPS1 GUK1 IARS2 INTS7 NUP133 NVL SDE2 SRP9 TBCE URB2 UTP25,gene expression|isoprenoid biosynthetic process|ncRNA metabolic process|tRNA aminoacylation for protein translation|tRNA aminoacylation,0.0001469|0.0001691|0.0002408|0.0004076|0.0004603,1|1|1|1|1,5.073|109.3|12.26|68.88|64.66
3215,4,0.5552,3.3310000000000004,3352.0,0.0009903,0.9929309999999999,DHRS7 LYPD5 PPFIBP1 WNT16,optic cup formation involved in camera-type eye development|oxidative stress-induced premature senescence|optic cup morphogenesis involved in camera-type eye development|stress-induced premature senescence|keratinocyte proliferation,0.0005825|0.0009706|0.001553|0.001747|0.002328,1|1|1|1|1,2574|1287|735.5|643.6|468.1
3216,5,0.5047,5.047,4207.0,0.0011949999999999999,0.996692,PLXDC1 PPM1E SLC16A6 YPEL2 ZACN,protein dephosphorylation|dephosphorylation|peptidyl-threonine dephosphorylation|positive regulation of stress fiber assembly|response to zinc ion,0.001626|0.003505|0.006681|0.01591|0.01735,1|1|1|1|1,31.78|21.45|156|63.56|58.18
3217,4,0.5022,3.013,3273.0,0.0009173,0.9929309999999999,BCL6B MSRA PPM1H SLC39A11,protein repair|type 2 immune response|methionine metabolic process|zinc ion transmembrane transport|zinc ion transport,0.001553|0.001941|0.003297|0.004846|0.00562,1|1|1|1|1,735.5|572.1|321.8|214.5|183.9
3218,4,0.5665,3.3989999999999996,3116.0,0.0010869999999999999,0.9929309999999999,APOBEC3D ARL6 LRRC14 PPM1K,positive regulation of cellular amino acid metabolic process|positive regulation of cellular amine metabolic process|DNA cytosine deamination|small molecule catabolic process|cytidine metabolic process,0.0007766|0.001747|0.002134|0.00232|0.002522,1|1|1|1|1,1716|643.6|514.9|25.18|429.1
3219,4,0.5497,3.298,3261.0,0.001008,0.9929309999999999,ARFGAP3 KCNMB4 PPM1N TOMM40,COPI-coated vesicle budding|COPI coating of Golgi vesicle|Golgi transport vesicle coating|Golgi vesicle budding|detection of calcium ion,0.001359|0.001359|0.001359|0.002134|0.00291,1|1|1|1|1,858.1|858.1|858.1|514.9|367.8
3220,4,0.5246,3.147,3047.0,0.001029,0.9929309999999999,ARPC5 PPP1R11 RHEX STARD9,orbitofrontal cortex development|erythropoietin-mediated signaling pathway|cellular response to erythropoietin|response to erythropoietin|smooth muscle cell migration,0.0007766|0.0009706|0.001553|0.001747|0.002134,1|1|1|1|1,1716|1287|735.5|643.6|514.9
3221,12,0.5066,33.43,8131.0,0.004083,0.999986,GNA13 LUZP1 MPRIP MYH9 MYL12B MYL6 PPP1R12A PPP1R12C ROCK1 ROCK2 SPECC1L SSH2,actin filament-based process|regulation of myosin-light-chain-phosphatase activity|actin cytoskeleton organization|cytoskeleton organization|regulation of angiotensin-activated signaling pathway,1.266e-08|1.806e-08|2.28e-07|1.451e-06|1.864e-06,0.0001997|0.0001425|0.001199|0.005723|0.00588,20.09|735.5|19.65|9.978|1716
3222,4,0.5476,3.285,3183.0,0.0010279999999999998,0.9929309999999999,PPP1R14B ROBO3 RWDD3 SPART,positive regulation of hypoxia-inducible factor-1alpha signaling pathway|regulation of hypoxia-inducible factor-1alpha signaling pathway|negative regulation of collateral sprouting in absence of injury|regulation of collateral sprouting in absence of injury|chemoattraction of axon,0.0003883|0.0003883|0.0003883|0.0007766|0.0009706,1|1|1|1|1,5149|5149|5149|1716|1287
3223,5,0.5239,5.239,3254.0,0.001602,0.996692,GIGYF2 PPP1R11 PPP1R2 PPP1R7 SUGT1,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|regulation of dephosphorylation|negative regulation of phosphoprotein phosphatase activity,2.162e-06|3.596e-06|6.919e-06|1.167e-05|9.744e-05,0.0341|0.02836|0.03638|0.04601|0.3074,101.3|85.22|68.27|57.21|130.8
3224,5,0.518,5.18,4013.0,0.001286,0.996692,NTN5 PPFIA3 PPP1R37 SIGLEC8 ZNF155,synaptic vesicle docking|regulation of short-term neuronal synaptic plasticity|glutamate secretion|motor neuron axon guidance|lipid export from cell,0.00291|0.003394|0.007261|0.007502|0.00919,1|1|1|1|1,374.5|316.8|142|137.3|111.3
3225,12,0.5047,33.31,9361.0,0.0035369999999999998,0.999986,ATXN7L3B C8orf44 CCNB1IP1 EPB41L5 HMHB1 KIF26B LRRN1 LYRM1 NDRG3 PCDH10 PCDHB12 PPP1R9A,"regulation of cell junction assembly|substrate-dependent cell migration, cell attachment to substrate|positive regulation of cell junction assembly|regulation of synapse assembly|unidimensional cell growth",0.0002362|0.001261|0.001722|0.001756|0.001891,1|1|1|1|1,24.25|1584|32.66|32.33|792.1
3226,4,0.5738,3.443,3237.0,0.00106,0.9929309999999999,HIVEP2 KLC4 PPP3CA PPP3R1,"calcineurin-NFAT signaling cascade|calcineurin-mediated signaling|inositol phosphate-mediated signaling|Wnt signaling pathway, calcium modulating pathway|non-canonical Wnt signaling pathway",2.572e-06|3.843e-06|9.177e-06|2.091e-05|0.0002612,0.04057|0.03031|0.04825|0.08245|0.824,858.1|686.5|429.1|278.3|76.28
3227,4,0.5316,3.1889999999999996,3373.0,0.0009425000000000001,0.9929309999999999,GPR88 NCR3 PPP3R2 TACC2,motor learning|positive regulation of natural killer cell mediated cytotoxicity|neuronal action potential|positive regulation of natural killer cell mediated immunity|regulation of natural killer cell mediated cytotoxicity,0.001359|0.00504|0.00562|0.006007|0.008517,1|1|1|1|1,858.1|205.9|183.9|171.6|119.7
3228,15,0.4935,51.82,11990.0,0.004292,0.999999,CEP170B FBLN5 GON7 GPR68 IFI27 PPP4R4 RIN3 SERPINA1 SERPINA11 SERPINA12 SERPINA3 SERPINA4 SERPINA6 SERPINA9 UBR7,negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of hydrolase activity|negative regulation of proteolysis|regulation of endopeptidase activity,2.225e-10|2.922e-10|3.424e-10|2.241e-09|9.278e-09,3.51e-06|2.304e-06|1.8e-06|8.836e-06|2.927e-05,39.23|37.69|24.14|27.94|22.67
3229,13,0.5122,39.96,8343.0,0.004751,0.999993,ANKRD52 CYB5R4 LCMT1 PPM1A PPME1 PPP4C PPP4R3A PPP4R3B PPP6C PPP6R1 PPP6R3 PTPA TIPRL,regulation of phosphoprotein phosphatase activity|regulation of protein dephosphorylation|regulation of phosphatase activity|protein dephosphorylation|regulation of dephosphorylation,1.572e-08|3.628e-08|1.063e-07|2.508e-07|2.508e-07,0.000248|0.0002861|0.0005592|0.000989|0.0007912,60.29|50.73|40.64|34.05|34.05
3230,4,0.5342,3.205,3349.0,0.0009538,0.9929309999999999,ABCC3 LTA4H PPY TPP2,glucuronoside transport|secretion|canalicular bile acid transport|glycoside transport|leukotriene transport,0.0003883|0.0005285|0.0009706|0.001165|0.001553,1|1|1|1|1,5149|14.56|1287|1030|735.5
3231,4,0.5966,3.58,3429.0,0.0010400000000000001,0.9929309999999999,DUOX1 ENAM PRADC1 SEMA3D,ameloblast differentiation|positive regulation of enamel mineralization|cuticle development|regulation of enamel mineralization|positive regulation of tooth mineralization,0.0003883|0.0007766|0.0007766|0.001165|0.001359,1|1|1|1|1,5149|1716|1716|1030|858.1
3232,4,0.5241,3.1439999999999997,3150.0,0.0009947,0.9929309999999999,CDHR3 EFCAB6 PITPNC1 PRAME,negative regulation of retinoic acid receptor signaling pathway|regulation of retinoic acid receptor signaling pathway|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|intermembrane lipid transfer|adherens junction organization,0.001941|0.003297|0.008324|0.009482|0.01218,1|1|1|1|1,572.1|321.8|122.6|107.3|83.04
3233,4,0.5104,3.063,3112.0,0.0009806,0.9929309999999999,COX8C NT5C OTOP2 PRCD,proton transmembrane transport|IMP catabolic process|dGMP catabolic process|dGMP metabolic process|dTMP catabolic process,0.0002574|0.0003883|0.0005825|0.0005825|0.0007766,1|1|1|1|1,76.85|5149|2574|2574|1716
3234,4,0.5023,3.014,3136.0,0.0009574999999999999,0.9929309999999999,KCTD16 NEUROD1 PRELID2 SEMA5B,pancreatic PP cell fate commitment|pancreatic A cell fate commitment|regulation of intestinal epithelial structure maintenance|pancreatic PP cell differentiation|amacrine cell differentiation,0.0005825|0.0005825|0.0005825|0.0005825|0.001165,1|1|1|1|1,2574|2574|2574|2574|1030
3235,4,0.5032,3.0189999999999997,3064.0,0.0009819,0.9929309999999999,CDC14A OR52N2 OVGP1 PREX1,negative regulation of binding of sperm to zona pellucida|regulation of binding of sperm to zona pellucida|chitin catabolic process|chitin metabolic process|glucosamine-containing compound catabolic process,0.0009706|0.001165|0.001359|0.001359|0.001941,1|1|1|1|1,1287|1030|858.1|858.1|572.1
3236,4,0.5623,3.3739999999999997,3435.0,0.0009789999999999998,0.9929309999999999,GPD1 KBTBD11 NRN1L PRICKLE1,negative regulation of cardiac muscle cell myoblast differentiation|regulation of cardiac muscle cell myoblast differentiation|glycerol-3-phosphate catabolic process|negative regulation of cardioblast differentiation|glycerophosphate shuttle,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
3237,10,0.5143,23.15,8283.0,0.00278,0.999933,FRS3 GUCA1A NCR2 PGC PRICKLE4 PRPH2 RSPH9 TJAP1 TMEM217 YIPF3,detection of light stimulus|radial spoke assembly|detection of external stimulus|detection of abiotic stimulus|positive regulation of antibacterial peptide production,0.0005291|0.001601|0.002287|0.002354|0.002667,1|1|1|1|1,59.44|936.1|27.94|27.53|468.1
3238,16,0.5079,60.95,11390.0,0.005306,0.999999,ANXA2R BRIX1 CCL28 CCT5 DROSHA EXOC3 FGF10 HCN1 ICE1 MRPS30 NUP155 TARS UGT3A1 WDR70 ZFR ZNF622,ribosomal large subunit biogenesis|lung proximal/distal axis specification|semicircular canal fusion|regulation of urothelial cell proliferation|positive regulation of urothelial cell proliferation,0.001477|0.001552|0.001552|0.001552|0.001552,1|1|1|1|1,35.76|1287|1287|1287|1287
3239,4,0.5388,3.233,3150.0,0.001023,0.9929309999999999,CRYAB KDELC2 PRIMA1 UPK2,tubulin complex assembly|neurotransmitter catabolic process|negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|apoptotic process involved in morphogenesis,0.001456|0.001747|0.001892|0.002329|0.002329,1|1|1|1|1,762.8|624.1|572.1|457.7|457.7
3240,9,0.5155,18.56,5883.0,0.003135,0.9998530000000001,CCNA2 CCNB1 CDC25B CDC7 DBF4 FBXO5 FOXM1 LIN54 PKMYT1,mitotic cell cycle phase transition|cell cycle phase transition|regulation of cell cycle|mitotic cell cycle process|cell cycle,1.352e-14|1.681e-14|7.782e-12|1.375e-11|2.995e-11,2.132e-10|1.326e-10|4.092e-08|5.424e-08|9.448e-08,64.23|62.48|17.22|26.73|14.82
3241,10,0.5035,22.66,6994.0,0.00322,0.999933,CCDC137 FTSJ3 GNL2 MRTO4 NOL12 NOP2 RPF2 RPL28 RRS1 TENT4B,ribosome biogenesis|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ribosomal large subunit biogenesis,2.215e-13|3.144e-12|6.584e-12|8.53e-12|1.586e-10,3.493e-09|2.48e-08|3.462e-08|3.364e-08|5.004e-07,49.63|35.43|55.45|53.39|143
3242,6,0.5059,7.587999999999999,4579.0,0.00165,0.998474,ADCY6 ANKMY2 GPR3 PRKACA PTGES3 RIC8B,activation of protein kinase A activity|cellular response to glucagon stimulus|renal water homeostasis|response to glucagon|multicellular organismal water homeostasis,2.072e-05|4.285e-05|7.671e-05|8.064e-05|0.0002714,0.3268|0.338|0.4034|0.318|0.8562,309.7|210.2|154.8|150.9|80.61
3243,4,0.5525,3.315,3120.0,0.001059,0.9929309999999999,LRP5 PLD3 PRKAG3 SPDYC,carbohydrate catabolic process|cell-cell signaling involved in mammary gland development|Norrin signaling pathway|response to muscle activity involved in regulation of muscle adaptation|lipid metabolic process,0.0001938|0.0005825|0.0007766|0.0007766|0.000802,1|1|1|1|1,88.77|2574|1716|1716|12.64
3244,13,0.5048,39.37,10360.0,0.0037770000000000004,0.999993,CCR2 CCR3 CCR5 CCR8 FAM198A GNAT1 IQCF5 PRKAR2A SCN10A SCN11A SLC22A14 VIPR1 XCR1,chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|calcium-mediated signaling|cell chemotaxis,7.725e-10|1.37e-09|1.37e-09|1.453e-08|7.289e-08,1.218e-05|1.08e-05|7.201e-06|5.729e-05|0.0002299,108.6|96.42|96.42|59.18|42.48
3245,4,0.5734,3.44,3438.0,0.0009974,0.9929309999999999,PATE3 PRKCG PTPRH PTRHD1,response to psychosocial stress|positive regulation of mismatch repair|regulation of mismatch repair|presynaptic modulation of chemical synaptic transmission|chemosensory behavior,0.0007766|0.0007766|0.0009706|0.002134|0.003297,1|1|1|1|1,1716|1716|1287|514.9|321.8
3246,4,0.5035,3.0210000000000004,3086.0,0.0009755000000000001,0.9929309999999999,BBS2 PHLDA2 PRKD3 ZNF507,regulation of growth hormone activity|regulation of cell proliferation involved in embryonic placenta development|regulation of spongiotrophoblast cell proliferation|protein kinase D signaling|negative regulation of appetite by leptin-mediated signaling pathway,0.0003883|0.0003883|0.0003883|0.0007766|0.0009706,1|1|1|1|1,5149|5149|5149|1716|1287
3247,4,0.5331,3.199,3266.0,0.000976,0.9929309999999999,ANKK1 JUND PRKN SMIM3,cellular response to metal ion|positive regulation of protein linear polyubiquitination|regulation of protein linear polyubiquitination|negative regulation of primary amine oxidase activity|negative regulation of endosome organization,0.0005283|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,53.35|2574|2574|2574|2574
3248,5,0.521,5.21,4168.0,0.001245,0.996692,CALCOCO2 CCL1 CRYGC PRL TBKBP1,positive regulation of lactation|response to interferon-gamma|regulation of lactation|innate immune response|viral process,0.0008735|0.00115|0.001165|0.001244|0.001283,1|1|1|1|1,1716|37.93|1144|12.26|12.13
3249,4,0.5546,3.3280000000000003,3138.0,0.001057,0.9929309999999999,ALPG C22orf42 CRYBA4 PRNP,regulation of intracellular calcium activated chloride channel activity|negative regulation of dendritic spine maintenance|regulation of calcium ion import across plasma membrane|regulation of glutamate receptor signaling pathway|regulation of inorganic anion transmembrane transport,0.0007766|0.0009706|0.001165|0.001359|0.001553,1|1|1|1|1,1716|1287|1030|858.1|735.5
3250,20,0.4841,91.98,15760.0,0.005788000000000001,1.0,ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 CRYBA1 DHRS11 EVI2A GAS2L2 LYRM9 PIGS PROCA1 RDM1 SEBOX SLC13A2 SLFN12 SPAG5 TLCD1 UNC119,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|lymphocyte chemotaxis|regulation of natural killer cell chemotaxis,8.809e-07|1.027e-06|1.008e-05|1.674e-05|4.005e-05,0.01389|0.0081|0.05301|0.06602|0.1264,181.7|171.6|75.35|63.05|257.4
3251,5,0.551,5.51,4039.0,0.001359,0.996692,FGF23 MYO9A PROCR SYTL2 TMEM239,positive regulation of vitamin D 24-hydroxylase activity|regulation of vitamin D 24-hydroxylase activity|response to sodium phosphate|vitamin D catabolic process|positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,0.0009706|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,1373|1373|1373|1373|1030
3252,5,0.5449,5.449,3959.0,0.001371,0.996692,ANKRD65 BMT2 FAM120B HES4 PROM1,positive regulation of nephron tubule epithelial cell differentiation|glomerular parietal epithelial cell differentiation|positive regulation of epithelial cell differentiation involved in kidney development|peroxisome proliferator activated receptor signaling pathway|regulation of nephron tubule epithelial cell differentiation,0.0009706|0.0009706|0.00194|0.00194|0.003394,1|1|1|1|1,1373|1373|588.4|588.4|316.8
3253,4,0.5316,3.1889999999999996,3357.0,0.000947,0.9929309999999999,ARRDC1 CCL14 MMP26 PROP1,extracellular vesicle biogenesis|extracellular transport|negative regulation of Notch signaling pathway|monocyte chemotaxis|collagen catabolic process,0.001747|0.007359|0.007745|0.008131|0.008517,1|1|1|1|1,643.6|139.2|132|125.6|119.7
3254,5,0.5161,5.1610000000000005,4309.0,0.001193,0.996692,CSF3 MALL MANSC4 MCCC2 PROSER1,leucine catabolic process|leucine metabolic process|biotin metabolic process|coenzyme A metabolic process|positive regulation of actin cytoskeleton reorganization,0.001698|0.002183|0.002425|0.00412|0.004845,1|1|1|1|1,686.5|514.9|457.7|257.4|216.8
3255,5,0.5275,5.275,3723.0,0.001411,0.996692,ANLN PRPH SEPT11 SEPT2 SNORC,cytoskeleton-dependent cytokinesis|cytokinesis|intermediate filament cytoskeleton organization|intermediate filament-based process|cell division,2.131e-06|3.009e-06|9.677e-05|0.0001005|0.0002613,0.03361|0.02373|0.5088|0.3962|0.8242,107.3|95.35|134.6|132|20.93
3256,4,0.5342,3.205,3324.0,0.0009609999999999999,0.9929309999999999,BICDL1 N4BP2L1 PRR18 URAD,allantoin biosynthetic process|Golgi to secretory granule transport|urate catabolic process|allantoin metabolic process|urate metabolic process,0.0003883|0.0005825|0.0005825|0.0007766|0.00291,1|1|1|1|1,5149|2574|2574|1716|367.8
3257,8,0.5001,14.0,5634.0,0.002472,0.9996790000000001,CCT8 CFAP298 DONSON MCM3AP PAXBP1 PWP2 URB1 WRB,positive regulation of chromosome organization|positive regulation of myoblast proliferation|rRNA processing|replication fork protection|rRNA metabolic process,0.001482|0.003054|0.003244|0.003393|0.003491,1|1|1|1|1,33.82|367.8|22.63|326.9|21.79
3258,4,0.5085,3.051,2978.0,0.001021,0.9929309999999999,FAM214B IGSF22 PRR5L SAA1,TORC2 signaling|macrophage chemotaxis|macrophage migration|regulation of protein transport|regulation of establishment of protein localization,0.001553|0.00291|0.004072|0.004404|0.004792,1|1|1|1|1,735.5|367.8|257.4|18.16|17.39
3259,5,0.5181,5.181,3594.0,0.001436,0.996692,ANKRD11 C6orf62 PRRC2A PRRC2B PRRC2C,stress granule assembly|face morphogenesis|head morphogenesis|biological regulation|body morphogenesis,0.005087|0.007502|0.008949|0.008988|0.01088,1|1|1|1|1,205.9|137.3|114.4|0|93.61
3260,4,0.5411,3.2460000000000004,2829.0,0.001143,0.9929309999999999,PRRG4 SLC3A2 SLC7A11 TMEM260,amino acid import across plasma membrane|amino acid import|L-alpha-amino acid transmembrane transport|L-amino acid transport|amino acid transmembrane transport,1.679e-05|2.547e-05|4.658e-05|5.327e-05|0.0001177,0.2649|0.2009|0.2449|0.2101|0.3713,312|251.2|183.9|171.6|114.4
3261,4,0.5726,3.4360000000000004,3320.0,0.001031,0.9929309999999999,HOPX PRRT2 SPATA18 ZXDC,negative regulation of short-term synaptic potentiation|regulation of short-term synaptic potentiation|mitophagy by induced vacuole formation|negative regulation of SNARE complex assembly|mitochondrial protein catabolic process,0.0003883|0.0003883|0.0003883|0.0007766|0.001165,1|1|1|1|1,5149|5149|5149|1716|1030
3262,4,0.5498,3.299,3217.0,0.0010220000000000001,0.9929309999999999,CA12 CCL17 PRRX2 PTMS,monovalent inorganic anion homeostasis|chloride ion homeostasis|negative regulation of myoblast differentiation|anion homeostasis|one-carbon metabolic process,0.003297|0.003297|0.005233|0.006973|0.007745,1|1|1|1|1,321.8|321.8|198|147.1|132
3263,4,0.5061,3.037,3223.0,0.0009390000000000001,0.9929309999999999,GRIN3B PALM PRSS36 TRAFD1,negative regulation of dopamine receptor signaling pathway|regulation of dopamine receptor signaling pathway|synapse maturation|cellular response to electrical stimulus|protein localization to membrane,0.0007766|0.002328|0.002522|0.002716|0.003959,1|1|1|1|1,1716|468.1|429.1|396.1|19.18
3264,9,0.5084,18.3,6687.0,0.002722,0.9998530000000001,ATP6V0A2 KCNK5 MSI2 NOTCH1 PRSS42 PSEN1 RHOH SUCLA2 SUCLG1,regulation of resting membrane potential|tricarboxylic acid cycle|astrocyte differentiation|heart looping|determination of heart left/right asymmetry,7.244e-06|8.257e-05|0.0001869|0.0002711|0.0003144,0.1143|0.6512|0.9827|1|0.992,572.1|151.4|99.01|81.73|75.72
3265,4,0.5094,3.056,3192.0,0.0009542,0.9929309999999999,MEIOC PRTG RRAD STRADA,"cell cycle switching|germline cell cycle switching, mitotic to meiotic cell cycle|cell cycle switching, mitotic to meiotic cell cycle|negative regulation of high voltage-gated calcium channel activity|female meiosis I",0.0007766|0.0007766|0.0007766|0.001165|0.001941,1|1|1|1|1,1716|1716|1716|1030|572.1
3266,4,0.5439,3.263,3162.0,0.001029,0.9929309999999999,C2orf73 MARCH3 MYOG PSAPL1,cellular response to magnetism|positive regulation of muscle atrophy|positive regulation of oxidative phosphorylation|response to muscle activity involved in regulation of muscle adaptation|response to magnetism,0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
3267,4,0.5946,3.5669999999999997,3215.0,0.001106,0.9929309999999999,ASCC1 C18orf54 IPP PSD,DNA dealkylation involved in DNA repair|inositol phosphate dephosphorylation|inositol phosphate catabolic process|regulation of ARF protein signal transduction|phosphorylated carbohydrate dephosphorylation,0.002667|0.004362|0.004845|0.004845|0.004845,1|1|1|1|1,411.9|242.3|216.8|216.8|216.8
3268,4,0.5409,3.245,3217.0,0.001005,0.9929309999999999,HERC4 NUDCD2 PLA2G2E PSD3,low-density lipoprotein particle remodeling|phosphatidylinositol acyl-chain remodeling|phosphatidylglycerol acyl-chain remodeling|regulation of ARF protein signal transduction|phosphatidylserine acyl-chain remodeling,0.003491|0.003685|0.003685|0.003878|0.004459,1|1|1|1|1,302.9|286|286|271|234
3269,4,0.7809,4.685,2231.0,0.002088,0.9929309999999999,PSMB5 PSMB6 PSMB7 THAP1,proteasomal ubiquitin-independent protein catabolic process|regulation of cellular amino acid metabolic process|S phase|pre-replicative complex assembly|mitotic S phase,6.311e-09|1.373e-07|1.373e-07|1.373e-07|1.373e-07,9.955e-05|0.001083|0.0007219|0.0005415|0.0004332,702.1|237.6|237.6|237.6|237.6
3270,4,0.586,3.516,3248.0,0.0010789999999999999,0.9929309999999999,PSMB9 SLC6A11 TATDN2 ZNF429,gamma-aminobutyric acid reuptake|amino acid neurotransmitter reuptake|gamma-aminobutyric acid transport|neurotransmitter reuptake|proteasomal ubiquitin-independent protein catabolic process,0.0009706|0.001359|0.001941|0.004459|0.004459,1|1|1|1|1,1287|858.1|572.1|234|234
3271,12,0.5032,33.21,8079.0,0.004082,0.999986,CDC27 CDC6 DHX8 PSMB3 PSMC5 PSMD1 PSMD11 PSMD12 PSMD3 PSMD6 PSMD7 ZNF830,negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|pre-replicative complex assembly|anaphase-promoting complex-dependent catabolic process|DNA-dependent DNA replication,6.056e-22|1.678e-21|1.308e-20|1.53e-19|4.697e-19,9.552e-18|1.323e-17|6.877e-17|6.033e-16|1.482e-15,176.9|158.9|237.6|177.5|88.47
3272,10,0.5118,23.03,6676.0,0.0034270000000000004,0.999933,CDC27 PSMC5 PSMD1 PSMD11 PSMD12 PSMD13 PSMD3 PSMD4 PSMD6 ZNF830,anaphase-promoting complex-dependent catabolic process|negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition|regulation of cellular amino acid metabolic process|S phase,7.013e-21|1.775e-20|4.463e-20|7.474e-19|7.474e-19,1.106e-16|1.4e-16|2.347e-16|2.947e-15|2.358e-15,213.1|191.1|171.6|253.5|253.5
3273,9,0.516,18.58,5937.0,0.0031100000000000004,0.9998530000000001,CCNA2 CCNB1 CDC25B FBXO5 FOXM1 LIN37 LIN54 PSME3 SKP2,regulation of cell cycle|mitotic cell cycle phase transition|cell cycle phase transition|G2/M transition of mitotic cell cycle|cell cycle G2/M phase transition,7.782e-12|6.112e-10|7.195e-10|1.984e-09|2.126e-09,1.227e-07|4.82e-06|3.783e-06|7.824e-06|6.707e-06,17.22|48.18|46.86|81.73|80.58
3274,11,0.5122,28.17,6933.0,0.004035,0.999969,EIF3B PSMA1 PSMA2 PSMA3 PSMA6 PSMB1 PSMB3 PSMG1 PSMG2 PSMG3 PSMG4,cellular protein-containing complex assembly|proteasomal ubiquitin-independent protein catabolic process|protein-containing complex assembly|protein-containing complex subunit organization|regulation of cellular amino acid metabolic process,7.151e-16|1.631e-15|9.038e-14|5.67e-13|6.144e-13,1.128e-11|1.286e-11|4.752e-10|2.236e-09|1.938e-09,23.98|510.6|15.4|13.03|172.8
3275,7,0.505,10.61,5797.0,0.0018219999999999998,0.9992989999999999,KCNK7 OR10Z1 PSORS1C1 SLC36A1 SPINK6 SPRR4 TNFRSF11B,negative regulation of animal organ morphogenesis|negative regulation of odontogenesis of dentin-containing tooth|negative regulation of odontogenesis|alkanesulfonate transport|taurine transport,0.001019|0.001019|0.001019|0.002376|0.002376,1|1|1|1|1,1471|1471|1471|490.4|490.4
3276,6,0.5047,7.571000000000001,4386.0,0.001719,0.998474,OR1M1 OR7G1 OR7G3 P2RY11 PSPN ZNF121,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.0001895|0.0002256|0.0002355|0.000252|0.0003108,1|1|1|0.9939|0.9804,23.35|22|10.33|21.19|19.73
3277,4,0.5646,3.388,3242.0,0.001041,0.9929309999999999,AQP9 CPB2 PTCHD3 TMEM44,positive regulation of extracellular matrix constituent secretion|negative regulation of hepatocyte proliferation|purine nucleobase transmembrane transport|canalicular bile acid transport|pyrimidine nucleobase transport,0.0007766|0.0009706|0.0009706|0.0009706|0.001165,1|1|1|1|1,1716|1287|1287|1287|1030
3278,4,0.5414,3.248,3215.0,0.001007,0.9929309999999999,AP4M1 CAPN11 LRFN4 PTCRA,protein localization to basolateral plasma membrane|negative regulation of thymocyte apoptotic process|Golgi to lysosome transport|regulation of postsynaptic density assembly|regulation of postsynaptic specialization assembly,0.001553|0.001747|0.002328|0.002328|0.002522,1|1|1|1|1,735.5|643.6|468.1|468.1|429.1
3279,4,0.591,3.5460000000000003,3257.0,0.001085,0.9929309999999999,ARL4A JPH3 PTER ZNF23,exploration behavior|regulation of ryanodine-sensitive calcium-release channel activity|brown fat cell differentiation|regulation of neuronal synaptic plasticity|neuromuscular process controlling balance,0.004653|0.005426|0.005426|0.009096|0.009867,1|1|1|1|1,223.9|190.7|190.7|111.9|103
3280,6,0.53,7.949,4815.0,0.001644,0.998474,BBOF1 GALNT16 PLBD1 PTGDR PTGER2 TSHR,negative regulation of inflammatory response to antigenic stimulus|regulation of inflammatory response to antigenic stimulus|negative regulation of inflammatory response|negative regulation of immune response|negative regulation of defense response,3.724e-07|4.81e-07|1.975e-06|2.6e-06|4.586e-06,0.005874|0.003793|0.01039|0.01025|0.01447,56.58|53.01|37.01|34.51|29.87
3281,4,0.5391,3.235,3119.0,0.001033,0.9929309999999999,CDON LRRC8E PTGDR2 USP2,negative regulation of male germ cell proliferation|negative regulation of germ cell proliferation|regulation of male germ cell proliferation|regulation of germ cell proliferation|skeletal muscle satellite cell differentiation,0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
3282,4,0.5645,3.387,3317.0,0.001018,0.9929309999999999,CYP27A1 PLA2G3 PTGER1 TEP1,alcohol catabolic process|organic hydroxy compound catabolic process|polyol metabolic process|positive regulation of mast cell differentiation|negative regulation of synaptic vesicle clustering,7.749e-05|0.0001515|0.0003609|0.0004854|0.0004854,1|1|1|1|1,147.1|104.3|66.98|4119|4119
3283,5,0.5755,5.755,3807.0,0.001505,0.996692,ERH IKZF2 IRAK2 NFKBIZ PTGER4,inflammatory response|JNK cascade|stress-activated MAPK cascade|stress-activated protein kinase signaling cascade|positive regulation of inflammatory response,0.0001362|0.0001789|0.0002847|0.0003667|0.0003843,1|1|1|1|1,24.91|95.79|75.58|66.44|64.87
3284,19,0.5101,87.23,14930.0,0.005795000000000001,1.0,ADAP2 ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 DHRS11 EVI2A GAS2L2 GSDMB LYRM9 NOS2 PTGES3L RDM1 SLC13A2 SLFN12 SPAG5 UNC119,eosinophil chemotaxis|eosinophil migration|monocyte chemotaxis|cellular response to interferon-gamma|lymphocyte chemotaxis,8.809e-07|1.027e-06|1.008e-05|1.614e-05|1.674e-05,0.01389|0.0081|0.05301|0.06364|0.05282,181.7|171.6|75.35|26.07|63.05
3285,16,0.5004,60.04,11970.0,0.004979,0.999999,BTN2A2 GPX6 HIST1H1T OR14J1 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 PSORS1C2 TRIM10 TRIM26 ZKSCAN4 ZNF165 ZSCAN16 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.016e-06|1.43e-06|1.775e-06|2.673e-06|3.313e-06,0.01603|0.01128|0.009335|0.01054|0.01045,16.48|15.53|14.96|13.92|13.41
3286,4,0.5495,3.2969999999999997,3131.0,0.001049,0.9929309999999999,FREM3 PTGR2 RPS5 RXRG,retinoic acid receptor signaling pathway|regulation of translational fidelity|ribosomal small subunit assembly|prostaglandin metabolic process|prostanoid metabolic process,0.003878|0.004072|0.004266|0.007359|0.007359,1|1|1|1|1,271|257.4|245.2|139.2|139.2
3287,4,0.5311,3.1860000000000004,3155.0,0.001006,0.9929309999999999,HYAL3 OR52N2 PTH1R RILPL1,hyaluronan catabolic process|hyaluronan metabolic process|glycosaminoglycan catabolic process|aminoglycan catabolic process|mucopolysaccharide metabolic process,8.939e-06|2.795e-05|9.445e-05|0.0001131|0.0002847,0.141|0.2205|0.4966|0.4459|0.8982,457.7|249.6|132.9|121.1|75.58
3288,13,0.503,39.23,9981.0,0.0039049999999999996,0.999993,CASS4 EEF1A2 FAM209A FAM209B MTRNR2L3 NPBWR2 OPRL1 PPDPF PTK6 RBM38 SLC2A4RG TFAP2C ZGPAT,opioid receptor signaling pathway|regulation of protein tyrosine kinase activity|negative regulation of protein tyrosine kinase activity|regulation of peptidyl-tyrosine phosphorylation|negative regulation of peptidyl-tyrosine phosphorylation,2.416e-05|2.794e-05|0.0001803|0.0005287|0.0005353,0.3811|0.2204|0.9478|1|1,316.8|50.56|105.6|18.35|59.78
3289,15,0.5034,52.86,9382.0,0.0055850000000000006,0.999999,CLPB CRLS1 DNAJC11 HTRA2 MFN2 MTX2 OPA1 PGS1 PTPMT1 ROMO1 TAMM41 TIMM13 TIMM44 TRIAP1 YME1L1,cardiolipin biosynthetic process|phosphatidylglycerol biosynthetic process|cardiolipin metabolic process|mitochondrion organization|phosphatidylglycerol metabolic process,3.98e-13|8.676e-13|4.032e-12|2.959e-11|1.292e-10,6.278e-09|6.843e-09|2.12e-08|1.167e-07|4.075e-07,673|550.7|378.6|23.86|173.1
3290,4,0.5028,3.017,2970.0,0.0010119999999999999,0.9929309999999999,NOP2 PTPN18 RNF182 USP5,macromolecule modification|rRNA base methylation|cellular macromolecule metabolic process|maturation of LSU-rRNA|ribosomal large subunit assembly,0.0006141|0.002328|0.003377|0.00562|0.00562,1|1|1|1|1,6.356|468.1|4.15|183.9|183.9
3291,12,0.5117,33.77,9705.0,0.00346,0.999986,FBLN5 GPR68 IFI27 PPP4R4 PTPN21 SERPINA1 SERPINA11 SERPINA12 SERPINA3 SERPINA4 SLC24A4 UBR7,negative regulation of hydrolase activity|negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|regulation of endopeptidase activity,1e-07|1.866e-07|2.267e-07|9.726e-07|2.682e-06,0.001578|0.001471|0.001192|0.003836|0.008461,22.63|35.03|33.65|24.95|20.24
3292,4,0.5159,3.096,2881.0,0.00107,0.9929309999999999,DDOST DHDDS GPN2 PTPN5,protein N-linked glycosylation|polyprenol biosynthetic process|protein glycosylation|macromolecule glycosylation|glycosylation,8.235e-05|0.0007766|0.0008254|0.0008254|0.0009151,1|1|1|1|1,137.3|1716|42.55|42.55|40.38
3293,4,0.5546,3.3280000000000003,3048.0,0.001088,0.9929309999999999,CLEC5A CLEC9A PTPN7 ST8SIA1,osteoblast development|N-glycan processing|sialylation|glycosphingolipid biosynthetic process|cellular defense response,0.003685|0.003878|0.004072|0.00562|0.01045,1|1|1|1|1,286|271|257.4|183.9|97.15
3294,4,0.5015,3.009,3154.0,0.0009507999999999999,0.9929309999999999,FAM131C ISLR NR2F2 PTPRCAP,radial pattern formation|lymphatic endothelial cell fate commitment|endothelial cell fate commitment|lymphatic endothelial cell differentiation|trophoblast giant cell differentiation,0.0003883|0.0007766|0.001747|0.001747|0.00291,1|1|1|1|1,5149|1716|643.6|643.6|367.8
3295,5,0.5107,5.107,4118.0,0.001236,0.996692,ARHGAP28 CLUL1 LRRC30 MC5R PTPRM,negative regulation of GTP binding|protein dephosphorylation|dephosphorylation|regulation of GTP binding|retinal ganglion cell axon guidance,0.0009706|0.001092|0.002361|0.003878|0.004362,1|1|1|1|1,1373|38.14|25.74|274.6|242.3
3296,4,0.5008,3.005,3208.0,0.0009333999999999999,0.9929309999999999,BCL11A CAMKV CHRNE PTPRT,negative regulation of branching morphogenesis of a nerve|negative regulation of protein homooligomerization|negative regulation of protein oligomerization|negative regulation of neuron remodeling|regulation of neuron remodeling,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3297,13,0.5028,39.22,9316.0,0.00418,0.999993,DDX41 GEMIN5 IK LARS NHP2 PTTG1 RACK1 RBM22 RPS14 SLU7 SPDL1 THOC3 TTC1,RNA processing|gene expression|nucleic acid metabolic process|RNA metabolic process|mRNA metabolic process,1.771e-08|3.911e-08|4.782e-08|5.622e-08|7.342e-08,0.0002794|0.0003085|0.0002514|0.0002217|0.0002316,13.73|7.247|7.098|8.917|15.98
3298,4,0.5186,3.112,3118.0,0.0009943,0.9929309999999999,ACKR2 PURB TUSC1 VIPR1,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|chemokine-mediated signaling pathway|cellular response to chemokine|response to chemokine|G protein-coupled receptor signaling pathway",0.01314|0.01545|0.01736|0.01736|0.02293,1|1|1|1|1,76.85|65.17|57.85|57.85|7.748
3299,4,0.5527,3.3160000000000003,3271.0,0.00101,0.9929309999999999,ALKAL2 CD300C PUSL1 TNK1,positive regulation of ERK5 cascade|regulation of ERK5 cascade|tRNA pseudouridine synthesis|pseudouridine synthesis|cellular defense response,0.0005825|0.0005825|0.001165|0.003685|0.01045,1|1|1|1|1,2574|2574|1030|286|97.15
3300,5,0.5551,5.551,4234.0,0.001306,0.996692,COL4A2 ESYT3 FMN2 PROZ PYGB,homologous chromosome movement towards spindle pole in meiosis I anaphase|formin-nucleated actin cable organization|formin-nucleated actin cable assembly|meiotic chromosome movement towards spindle pole|polar body extrusion after meiotic divisions,0.0004854|0.0009706|0.0009706|0.0009706|0.001213,1|1|1|1|1,4119|1373|1373|1373|1030
3301,4,0.5467,3.28,3396.0,0.0009627,0.9929309999999999,A4GALT BTBD1 C1QB PYGL,globoside biosynthetic process|globoside metabolic process|5-phosphoribose 1-diphosphate biosynthetic process|5-phosphoribose 1-diphosphate metabolic process|synapse pruning,0.0005825|0.0005825|0.001359|0.001359|0.002328,1|1|1|1|1,2574|2574|858.1|858.1|468.1
3302,4,0.5321,3.193,3078.0,0.001034,0.9929309999999999,GSTA5 NCR2 PYGM YIPF3,glycogen catabolic process|glucan catabolic process|cellular polysaccharide catabolic process|polysaccharide catabolic process|cellular carbohydrate catabolic process,0.003685|0.003878|0.004072|0.004459|0.007745,1|1|1|1|1,286|271|257.4|234|132
3303,4,0.533,3.198,3145.0,0.001013,0.9929309999999999,CIZ1 GPR35 MLYCD QSOX2,malonyl-CoA catabolic process|negative regulation of neuronal action potential|positive regulation of DNA-dependent DNA replication initiation|malonyl-CoA metabolic process|regulation of neuronal action potential,0.0003883|0.0003883|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|5149|2574|1716|1030
3304,4,0.5153,3.092,3161.0,0.0009746,0.9929309999999999,R3HDM4 THADA ZFAND2B ZNF655,"negative regulation of ATPase-coupled calcium transmembrane transporter activity|SRP-dependent cotranslational protein targeting to membrane, translocation|negative regulation of endoplasmic reticulum calcium ion concentration|regulation of ATPase-coupled calcium transmembrane transporter activity|adaptive thermogenesis",0.0009706|0.001747|0.001941|0.002328|0.003685,1|1|1|1|1,1287|643.6|572.1|468.1|286
3305,4,0.5299,3.179,3097.0,0.001023,0.9929309999999999,BAIAP2L1 DPEP2 EPS8 RAB13,actin crosslink formation|actin filament bundle assembly|actin filament bundle organization|actin cytoskeleton organization|actin filament-based process,3.391e-06|4.987e-05|5.502e-05|6.534e-05|9.671e-05,0.05349|0.3933|0.2893|0.2577|0.3051,735.5|177.5|168.8|29.48|25.83
3306,4,0.5333,3.2,3165.0,0.001007,0.9929309999999999,EEA1 ENTPD7 MKKS RAB29,viral RNA genome replication|viral genome replication|cellular pigmentation|pigmentation|UTP catabolic process,4.943e-06|1.909e-05|6.219e-05|0.0001872|0.0004854,0.07796|0.1505|0.327|0.7381|1,633.7|305.1|164.8|93.61|4119
3307,4,0.5392,3.235,3198.0,0.001008,0.9929309999999999,DERA FGF4 MAFK RAB33B,"negative regulation of constitutive secretory pathway|regulation of retrograde vesicle-mediated transport, Golgi to ER|regulation of constitutive secretory pathway|skeletal system morphogenesis|deoxyribonucleoside catabolic process",0.0003883|0.0005825|0.0005825|0.0007087|0.0007766,1|1|1|1|1,5149|2574|2574|45.97|1716
3308,4,0.5777,3.466,3257.0,0.0010609999999999999,0.9929309999999999,ARHGEF10 COMMD1 HADHB RAB5A,receptor internalization involved in canonical Wnt signaling pathway|regulation of endosome size|glycerophospholipid metabolic process|amyloid-beta clearance by transcytosis|cardiolipin acyl-chain remodeling,0.0007766|0.001165|0.00153|0.001553|0.001747,1|1|1|1|1,1716|1030|31.11|735.5|643.6
3309,4,0.5608,3.365,3492.0,0.0009606,0.9929309999999999,GAD2 MISP RAB6B TMEM8A,glutamate decarboxylation to succinate|gamma-aminobutyric acid biosynthetic process|gamma-aminobutyric acid metabolic process|glutamate catabolic process|establishment of centrosome localization,0.0005825|0.0007766|0.001165|0.001747|0.001941,1|1|1|1|1,2574|1716|1030|643.6|572.1
3310,4,0.5128,3.077,3213.0,0.0009542,0.9929309999999999,KITLG NOS1 PLEKHG7 RABGAP1,negative regulation of mast cell apoptotic process|regulation of mast cell apoptotic process|positive regulation of mast cell proliferation|retrograde trans-synaptic signaling by nitric oxide|retrograde trans-synaptic signaling by soluble gas,0.0004854|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,4119|2060|2060|2060|2060
3311,9,0.5295,19.06,6205.0,0.003054,0.9998530000000001,CARS EIF3CL GGPS1 GUK1 NEDD8 OSGEP RABGGTA RABGGTB YARS,protein geranylgeranylation|protein prenylation|prenylation|tRNA metabolic process|primary metabolic process,4.743e-06|1.117e-05|1.117e-05|5.657e-05|9.579e-05,0.07481|0.08809|0.05873|0.2231|0.3022,762.8|457.7|457.7|37.93|2.797
3312,11,0.5087,27.98,7191.0,0.003863,0.999969,ATM CDKN1A CHEK2 MDM2 MDM4 MRE11 NBN PPM1D RAD50 TP53 USP28,"signal transduction by p53 class mediator|DNA damage checkpoint|DNA integrity checkpoint|DNA damage response, signal transduction by p53 class mediator|cell cycle checkpoint",5.236e-19|2.16e-18|3.512e-18|1.185e-17|3.147e-17,8.259e-15|1.704e-14|1.847e-14|4.675e-14|9.927e-14,142.8|121.2|114.6|189.6|89.16
3313,5,0.5202,5.202000000000001,3987.0,0.0013,0.996692,ENO2 LCORL OXR1 RAD51AP1 TLR10,"toll-like receptor 10 signaling pathway|negative regulation of cellular response to oxidative stress|regulation of vacuole fusion, non-autophagic|positive regulation of reciprocal meiotic recombination|regulation of reciprocal meiotic recombination",0.0004854|0.000728|0.001213|0.001213|0.001213,1|1|1|1|1,4119|2060|1030|1030|1030
3314,4,0.5114,3.069,3188.0,0.0009591000000000001,0.9929309999999999,FAM213A MC3R RAD52 TM4SF18,homoiothermy|regulation of nucleotide-excision repair|DNA repair complex assembly|DNA recombinase assembly|double-strand break repair via single-strand annealing,0.0005825|0.0009706|0.0009706|0.0009706|0.001165,1|1|1|1|1,2574|1287|1287|1287|1030
3315,5,0.5058,5.058,4033.0,0.0012490000000000001,0.996692,EGFLAM EPHB3 HMX2 RAI14 TTC23L,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|corpus callosum development|retinal ganglion cell axon guidance|dendritic spine morphogenesis|axonal fasciculation,0.001698|0.003878|0.004362|0.004845|0.005087,1|1|1|1|1,686.5|274.6|242.3|216.8|205.9
3316,4,0.5166,3.1,3050.0,0.001013,0.9929309999999999,C11orf94 GFAP RALA SH2D4B,positive regulation of Schwann cell proliferation|D-aspartate import across plasma membrane|D-aspartate transport|membrane raft localization|regulation of Schwann cell proliferation,0.0003883|0.001165|0.001165|0.001553|0.001553,1|1|1|1|1,5149|1030|1030|735.5|735.5
3317,5,0.5052,5.052,3991.0,0.001261,0.996692,CCDC107 FZD1 RAC3 RALGAPA2 WDR41,canonical Wnt signaling pathway involved in osteoblast differentiation|central nervous system neuron differentiation|canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation|mesenchymal stem cell differentiation|receptor transactivation,0.0008735|0.00115|0.001165|0.001456|0.001746,1|1|1|1|1,1716|37.93|1144|858.1|686.5
3318,4,0.5768,3.4610000000000003,3281.0,0.001051,0.9929309999999999,CA3 NOXRED1 RALYL SERPINA1,proline biosynthetic process|L-proline biosynthetic process|proline metabolic process|glutamine family amino acid biosynthetic process|one-carbon metabolic process,0.001359|0.001359|0.002134|0.003491|0.007745,1|1|1|1|1,858.1|858.1|514.9|302.9|132
3319,4,0.5797,3.478,3473.0,0.0009981,0.9929309999999999,C2orf73 MGAT5B RAMP3 SH3BP2,cross-receptor inhibition within G protein-coupled receptor heterodimer|positive regulation of calcium ion import across plasma membrane|adrenomedullin receptor signaling pathway|regulation of calcium ion import across plasma membrane|G protein-coupled receptor signaling pathway involved in heart process,0.0005825|0.0007766|0.0009706|0.001165|0.001553,1|1|1|1|1,2574|1716|1287|1030|735.5
3320,4,0.5545,3.327,3097.0,0.00107,0.9929309999999999,CLTB RANBP17 TMEM179B TNFRSF9,clathrin coat assembly|establishment of localization in cell|clathrin-dependent endocytosis|cellular localization|intracellular protein transport,0.003685|0.005547|0.006007|0.01106|0.0126,1|1|1|1|1,286|6.531|171.6|5.144|10.58
3321,7,0.5337,11.21,5034.0,0.002215,0.9992989999999999,ATXN10 NOL12 RANGAP1 RPL3 RRP7A TOMM22 TUBGCP6,organelle assembly|organelle organization|ribosome assembly|cellular response to vasopressin|response to vasopressin,6.678e-05|0.0001635|0.0002101|0.001358|0.001358,1|1|1|1|1,15.07|4.939|91.94|980.7|980.7
3322,5,0.5106,5.106,3723.0,0.001366,0.996692,ANKRD66 RAP1GAP SHQ1 THOC7 UBA3,negative regulation of thyroid gland epithelial cell proliferation|regulation of thyroid gland epithelial cell proliferation|negative regulation of microvillus assembly|cellular response to glial cell derived neurotrophic factor|response to glial cell derived neurotrophic factor,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
3323,5,0.5006,5.006,4029.0,0.0012380000000000002,0.996692,GAPDHS ITLN1 RASAL1 S100A8 SPRR1A,antimicrobial humoral response|positive regulation of cell growth|neutrophil aggregation|response to nematode|sequestering of zinc ion,0.0005758|0.0006353|0.000728|0.0009706|0.001213,1|1|1|1|1,52.81|50.23|2060|1373|1030
3324,5,0.5324,5.324,3300.0,0.0016059999999999998,0.996692,DOCK5 KRAS PRAG1 RASAL2 RSU1,positive regulation of GTPase activity|positive regulation of catalytic activity|regulation of GTPase activity|positive regulation of Ras protein signal transduction|positive regulation of small GTPase mediated signal transduction,7.933e-05|0.000106|0.0001314|0.0001441|0.0001709,1|0.8358|0.6911|0.5684|0.5391,29.92|11.64|25.22|107|98.07
3325,4,0.5463,3.278,3104.0,0.001052,0.9929309999999999,CHRD MYOM2 RASEF ZCCHC14,BMP signaling pathway involved in spinal cord dorsal/ventral patterning|extraocular skeletal muscle development|floor plate development|spinal cord dorsal/ventral patterning|spinal cord patterning,0.0003883|0.0009706|0.001941|0.003491|0.003878,1|1|1|1|1,5149|1287|572.1|302.9|271
3326,6,0.5187,7.78,5040.0,0.001538,0.998474,C17orf107 DUPD1 FAM213A PALD1 RASGEF1A TBX1,peptidyl-tyrosine dephosphorylation|vagus nerve morphogenesis|positive regulation of tongue muscle cell differentiation|regulation of tongue muscle cell differentiation|mesenchymal cell apoptotic process,0.0004029|0.0008735|0.0008735|0.0008735|0.0008735,1|1|1|1|1,64.76|1716|1716|1716|1716
3327,6,0.5139,7.709,4971.0,0.001545,0.998474,CBY3 NSG2 RASGEF1C RUFY1 SCN1B ZNF454,corticospinal neuron axon guidance|membrane depolarization during Purkinje myocyte cell action potential|Purkinje myocyte action potential|response to pyrethroid|Purkinje myocyte to ventricular cardiac muscle cell signaling,0.0008735|0.001165|0.001165|0.001456|0.001746,1|1|1|1|1,1716|1144|1144|858.1|686.5
3328,4,0.5392,3.235,3175.0,0.001015,0.9929309999999999,CDC42EP5 HIVEP2 NFKBIZ RASL12,positive regulation of T-helper 17 cell differentiation|positive regulation of T-helper 17 type immune response|positive regulation of pseudopodium assembly|regulation of pseudopodium assembly|regulation of T-helper 17 cell differentiation,0.001553|0.001941|0.002716|0.00291|0.003685,1|1|1|1|1,735.5|572.1|396.1|367.8|286
3329,5,0.5026,5.026,4053.0,0.001235,0.996692,A1BG CASQ2 NPR3 RASSF6 ZNF324,osteoclast proliferation|sequestering of calcium ion|Purkinje myocyte to ventricular cardiac muscle cell signaling|Purkinje myocyte to ventricular cardiac muscle cell communication|pancreatic juice secretion,0.001213|0.001456|0.001456|0.001698|0.00194,1|1|1|1|1,1030|823.8|823.8|686.5|588.4
3330,4,0.5351,3.21,2973.0,0.001076,0.9929309999999999,BSPRY EFCC1 RAVER1 ZMAT3,"cellular response to leukemia inhibitory factor|response to leukemia inhibitory factor|calcium ion transport|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",0.01717|0.01736|0.04674|0.05756|0.05756,1|1|1|1|1,58.51|57.85|21.1|17.05|17.05
3331,5,0.5395,5.395,3985.0,0.001349,0.996692,CYP46A1 PSPC1 RAX2 ZMYM2 ZMYM5,protein localization to membrane raft|cholesterol catabolic process|sterol catabolic process|progesterone metabolic process|steroid catabolic process,0.002183|0.00291|0.00291|0.003636|0.006537,1|1|1|1|1,514.9|374.5|374.5|294.2|158.4
3332,15,0.499,52.4,9958.0,0.0052179999999999995,0.999999,ATP5F1A C18orf21 HAUS1 NARS PIK3C3 RBFA RPL17 RTTN SKA1 TRAPPC8 TXNL4A VPS4A WDR7 ZNF236 ZNF407,cell division|autophagy of peroxisome|protein localization to phagophore assembly site|vacuole organization|organelle assembly,1.965e-05|4.476e-05|5.163e-05|0.0001343|0.0001738,0.3099|0.3531|0.2715|0.5295|0.5484,13.95|228.8|211.2|29.85|8.79
3333,4,0.5657,3.3939999999999997,3101.0,0.001091,0.9929309999999999,GDPD3 RBFOX1 RSBN1L SOX6,positive regulation of mesenchymal stem cell differentiation|spinal cord oligodendrocyte cell differentiation|N-acylethanolamine metabolic process|regulation of mesenchymal stem cell differentiation|negative regulation of cardiac muscle cell differentiation,0.0009706|0.001165|0.001165|0.001359|0.001553,1|1|1|1|1,1287|1030|1030|858.1|735.5
3334,4,0.5417,3.25,3199.0,0.0010119999999999999,0.9929309999999999,GABRG3 RBFOX3 SAMD5 TCAIM,"synaptic transmission, GABAergic|gamma-aminobutyric acid signaling pathway|regulation of alternative mRNA splicing, via spliceosome|chloride transmembrane transport|regulation of postsynaptic membrane potential",0.003104|0.005426|0.01141|0.0189|0.01947,1|1|1|1|1,343.2|190.7|88.77|53.08|51.49
3335,4,0.5659,3.395,2638.0,0.001281,0.9929309999999999,EIF4ENIF1 RBM12 RPRD2 SCAF8,"mRNA 3'-end processing|RNA 3'-end processing|negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA|regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA|negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled",0.0001126|0.0002885|0.0003883|0.0003883|0.0005825,1|1|1|1|1,117|72.52|5149|5149|2574
3336,6,0.5129,7.694,4099.0,0.0018679999999999999,0.998474,CHERP ISY1 RBM17 RBM26 SLU7 U2SURP,"mRNA processing|mRNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions",1.757e-10|1.507e-09|4.218e-09|4.218e-09|4.429e-09,2.772e-06|1.189e-05|2.218e-05|1.663e-05|1.397e-05,42.55|29.68|56.83|56.83|56.27
3337,5,0.5358,5.358,4160.0,0.001283,0.996692,CCBE1 RBMS1 SCAMP2 SERTM1 TSSK3,positive regulation of lymphangiogenesis|regulation of lymphangiogenesis|positive regulation of vascular endothelial growth factor signaling pathway|venous blood vessel morphogenesis|lymphangiogenesis,0.000728|0.001456|0.001698|0.002183|0.003394,1|1|1|1|1,2060|823.8|686.5|514.9|316.8
3338,4,0.5507,3.304,3210.0,0.001026,0.9929309999999999,BTNL3 FKBP1B RBMS3 SFRP1,negative regulation of insulin secretion|negative regulation of peptide hormone secretion|negative regulation of protein secretion|negative regulation of hormone secretion|negative regulation of peptide secretion,2.201e-05|2.919e-05|6.227e-05|6.227e-05|7.603e-05,0.3471|0.2302|0.3274|0.2456|0.2399,271|234|158.4|158.4|143
3339,22,0.508,117.3,17320.0,0.006712,1.0,AGAP5 AGAP9 ANXA8L1 CALHM3 CYP26C1 DUSP13 GPRIN2 IFIT1 IFIT1B IFIT2 IFIT3 NUTM2A NUTM2B PTPN20 SFTPA1 SFTPA2 SYT15 WASHC2C ZNF239 ZNF32 ZNF33B ZNF485,cellular response to type I interferon|response to type I interferon|type I interferon signaling pathway|defense response to symbiont|defense response to virus,1.008e-06|1.386e-06|5.75e-05|7.391e-05|7.391e-05,0.0159|0.01093|0.3024|0.2915|0.2332,54.27|49.93|41.3|17.66|17.66
3340,4,0.5686,3.411,3223.0,0.0010550000000000002,0.9929309999999999,CRYL1 RBP4 RET TUB,retina development in camera-type eye|camera-type eye development|eye development|visual system development|sensory system development,1.599e-06|1.482e-05|2.251e-05|2.324e-05|2.438e-05,0.02522|0.1169|0.1183|0.09166|0.07692,103|48.57|42.2|41.75|41.08
3341,4,0.5413,3.248,3201.0,0.001011,0.9929309999999999,LRP6 RBP5 SLC36A2 ZNF346,canonical Wnt signaling pathway involved in neural crest cell differentiation|external genitalia morphogenesis|receptor-mediated endocytosis involved in cholesterol transport|axis elongation involved in somitogenesis|Wnt signaling pathway involved in somitogenesis,0.000728|0.000728|0.0009706|0.001213|0.001213,1|1|1|1|1,2060|2060|1373|1030|1030
3342,8,0.5032,14.09,5603.0,0.002501,0.9996790000000001,APPBP2 ID2 PRDM1 RC3H1 RC3H2 SMAD7 TCF12 TCF3,regulation of alpha-beta T cell differentiation|negative regulation of T-helper 17 cell differentiation|negative regulation of T-helper 17 type immune response|negative regulation of T-helper cell differentiation|regulation of T-helper 17 cell differentiation,1.519e-08|2.093e-08|2.615e-08|7.635e-08|7.635e-08,0.0002397|0.000165|0.0001375|0.0003011|0.0002409,138.7|624.1|572.1|381.4|381.4
3343,5,0.524,5.24,3827.0,0.001364,0.996692,HLA-F LY6G5B RCAN2 TRIM26 ZKSCAN3,interferon-gamma-mediated signaling pathway|negative regulation of natural killer cell degranulation|cellular response to interferon-gamma|negative regulation of natural killer cell cytokine production|response to interferon-gamma,0.0001264|0.0004854|0.0005904|0.000728|0.0007712,1|1|1|1|1,114.4|4119|52.14|2060|45.51
3344,4,0.5645,3.387,3152.0,0.0010710000000000001,0.9929309999999999,CTSC NOL11 RD3 TTC30A,negative regulation of guanylate cyclase activity|negative regulation of purine nucleotide biosynthetic process|negative regulation of nucleotide biosynthetic process|negative regulation of myelination|positive regulation of microglial cell activation,0.0007766|0.001359|0.001359|0.001747|0.001747,1|1|1|1|1,1716|858.1|858.1|643.6|643.6
3345,24,0.4912,135.6,19320.0,0.0069489999999999994,1.0,GP6 KIR2DL1 LAIR1 LAIR2 LILRB5 NLRP11 NLRP13 NLRP4 ZFP28 ZNF135 ZNF264 ZNF304 ZNF324 ZNF324B ZNF329 ZNF548 ZNF581 ZNF587 ZNF665 ZNF667 ZNF772 ZNF773 ZNF805 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",2.622e-09|1.832e-07|1.84e-07|1.878e-07|5.403e-07,4.135e-05|0.001445|0.0009675|0.0007407|0.001704,5.097|3.805|3.804|3.799|3.526
3346,4,0.5272,3.1630000000000003,3181.0,0.000991,0.9929309999999999,BBS10 PDE3B REEP5 SLC12A3,negative regulation of cell adhesion mediated by integrin|negative regulation of cAMP-mediated signaling|monovalent inorganic anion homeostasis|chloride ion homeostasis|chaperone-mediated protein complex assembly,0.002522|0.003297|0.003297|0.003297|0.004266,1|1|1|1|1,429.1|321.8|321.8|321.8|245.2
3347,4,0.5274,3.1639999999999997,3289.0,0.0009589,0.9929309999999999,CCDC166 FAM234A REEP6 TKTL2,detection of light stimulus involved in sensory perception|detection of light stimulus involved in visual perception|detection of visible light|detection of light stimulus|endoplasmic reticulum organization,0.004266|0.004266|0.009867|0.01237|0.01947,1|1|1|1|1,245.2|245.2|103|81.73|51.49
3348,4,0.5115,3.069,3139.0,0.000974,0.9929309999999999,DRD2 REG3A SLC15A1 WDR63,tripeptide import across plasma membrane|orbitofrontal cortex development|negative regulation of dopamine receptor signaling pathway|positive regulation of catecholamine uptake involved in synaptic transmission|positive regulation of dopamine uptake involved in synaptic transmission,0.0003883|0.0007766|0.0007766|0.0007766|0.0007766,1|1|1|1|1,5149|1716|1716|1716|1716
3349,18,0.503,76.96,14330.0,0.005328,1.0,CCM2L CPNE1 DEFB115 DEFB116 DUSP15 FAM83C FOXS1 GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 NOL4L PLAGL2 POFUT1 TM9SF4 XKR7,"positive regulation of multicellular organism growth|regulation of multicellular organism growth|positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response|phagocytosis",0.0004213|0.00154|0.001746|0.002618|0.002752,1|1|1|1|1,69.34|35.21|1144|572.1|10.53
3350,11,0.5269,28.98,7546.0,0.003814,0.999969,ATP13A1 BAX BCL2 BCL2L2 MARCH5 MCL1 PMAIP1 RER1 THAP3 UBE2J2 WSB2,signal transduction in absence of ligand|extrinsic apoptotic signaling pathway in absence of ligand|intrinsic apoptotic signaling pathway|regulation of intrinsic apoptotic signaling pathway|positive regulation of intrinsic apoptotic signaling pathway,2.021e-09|2.021e-09|9.114e-09|1.295e-08|2.576e-08,3.188e-05|1.594e-05|4.792e-05|5.106e-05|8.126e-05,249.6|249.6|63.68|59.25|126.9
3351,4,0.5213,3.128,3163.0,0.0009854,0.9929309999999999,DEFB135 GSTK1 PAFAH1B2 REX1BD,glutathione derivative biosynthetic process|glutathione derivative metabolic process|positive regulation of macroautophagy|glutathione metabolic process|protein targeting to peroxisome,0.004459|0.004459|0.01179|0.01276|0.01564,1|1|1|1|1,234|234|85.81|79.21|64.36
3352,4,0.5144,3.0860000000000003,3187.0,0.0009652000000000002,0.9929309999999999,DOK6 GSG1L REXO5 SLC30A2,positive regulation of sequestering of zinc ion|regulation of sequestering of zinc ion|regulation of postsynaptic neurotransmitter receptor internalization|zinc ion transmembrane transport|regulation of AMPA receptor activity,0.0003883|0.001165|0.002522|0.004846|0.005426,1|1|1|1|1,5149|1030|429.1|214.5|190.7
3353,8,0.5112,14.31,4997.0,0.0028469999999999997,0.9996790000000001,CCNE2 CCNF CDK4 CKS1B E2F3 SKP2 TCF19 UBE2Q1,G1 phase|mitotic G1 phase|mitotic cell cycle phase transition|cell cycle phase transition|mitotic interphase,1.176e-10|1.176e-10|2.062e-10|2.429e-10|1.693e-08,1.855e-06|9.275e-07|1.084e-06|9.577e-07|5.341e-05,490.4|490.4|54.2|52.72|130.3
3354,11,0.5067,27.87,7205.0,0.003841,0.999969,ATR ATRIP HUS1 RAD1 RAD17 RAD9A RFC2 RFC3 RFC5 TIMELESS TOPBP1,DNA replication|regulation of signal transduction by p53 class mediator|DNA repair|DNA integrity checkpoint|DNA metabolic process,9.095e-19|7.727e-18|1.251e-15|2.466e-14|8.265e-14,1.435e-14|6.095e-14|6.578e-12|9.725e-11|2.607e-10,59.71|75.05|30.53|80.06|20.72
3355,4,0.5766,3.46,3258.0,0.001058,0.9929309999999999,LCN10 RFESD TNFSF18 TTC21A,negative regulation of T-helper 17 cell lineage commitment|T cell proliferation involved in immune response|regulation of T-helper 17 cell lineage commitment|regulation of dendritic cell chemotaxis|negative regulation of T-helper 17 cell differentiation,0.0007766|0.001165|0.001553|0.002134|0.002328,1|1|1|1|1,1716|1030|735.5|514.9|468.1
3356,4,0.525,3.15,3047.0,0.00103,0.9929309999999999,C17orf47 CIART PCYT1A RFLNA,negative regulation of chondrocyte development|negative regulation of bone mineralization involved in bone maturation|regulation of chondrocyte development|regulation of bone mineralization involved in bone maturation|CDP-choline pathway,0.0007766|0.0009706|0.001165|0.001359|0.001553,1|1|1|1|1,1716|1287|1030|858.1|735.5
3357,4,0.5275,3.165,3354.0,0.0009404,0.9929309999999999,BDH2 C12orf43 RFPL4B RGMA,siderophore biosynthetic process|siderophore metabolic process|Spemann organizer formation|negative regulation of collateral sprouting|ketone body biosynthetic process,0.0003883|0.0003883|0.0009706|0.001941|0.001941,1|1|1|1|1,5149|5149|1287|572.1|572.1
3358,4,0.533,3.198,3234.0,0.0009854,0.9929309999999999,RFX3 ROBO1 TAOK3 ZNF621,negative regulation of negative chemotaxis|chemorepulsion involved in postnatal olfactory bulb interneuron migration|postnatal olfactory bulb interneuron migration|substrate-dependent cerebral cortex tangential migration|cerebral cortex tangential migration using cell-cell interactions,0.0005825|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,2574|2574|2574|2574|2574
3359,5,0.5293,5.292999999999999,4345.0,0.001214,0.996692,ACYP2 OSTN RFX8 SPTLC3 SULT1C4,negative regulation of dendrite extension|alcohol metabolic process|negative regulation of glucose import|ethanol catabolic process|sphingoid biosynthetic process,0.0009706|0.002538|0.00291|0.003152|0.003636,1|1|1|1|1,1373|24.81|374.5|343.3|294.2
3360,10,0.5045,22.7,7446.0,0.003031,0.999933,AES FUT5 FUT6 PLIN3 RFXANK SGTA UQCR11 ZNF555 ZNF556 ZNF77,fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|fucose metabolic process|fucosylation,1.163e-05|1.163e-05|1.163e-05|3.23e-05|3.609e-05,0.1835|0.09174|0.06116|0.1274|0.1139,457.7|457.7|457.7|257.4|242.3
3361,4,0.5113,3.068,3027.0,0.00101,0.9929309999999999,GLB1L3 RGCC THYN1 TMEFF1,negative regulation of exit from mitosis|negative regulation of fibroblast growth factor production|positive regulation of extracellular matrix constituent secretion|regulation of fibroblast growth factor production|fibroblast activation,0.0003883|0.0005825|0.0007766|0.001359|0.001359,1|1|1|1|1,5149|2574|1716|858.1|858.1
3362,4,0.5246,3.148,2972.0,0.0010550000000000002,0.9929309999999999,ACTR10 RGPD1 RGPD2 TRMT5,NLS-bearing protein import into nucleus|protein import into nucleus|import into nucleus|protein import|protein localization to nucleus,5.932e-06|0.0001336|0.0001905|0.0003472|0.0003832,0.09357|1|1|1|1,542|107.3|89.54|66.01|62.79
3363,4,0.5029,3.017,3215.0,0.0009354,0.9929309999999999,CHRNB4 GPR35 RGS1 TMEM154,negative regulation of neuronal action potential|synaptic transmission involved in micturition|regulation of neuronal action potential|leukotriene signaling pathway|negative regulation of action potential,0.0003883|0.0007766|0.001165|0.001165|0.001359,1|1|1|1|1,5149|1716|1030|1030|858.1
3364,5,0.5323,5.3229999999999995,4075.0,0.001301,0.996692,COL6A2 DZIP3 MTRF1 RGS10 SNORC,regulation of translational termination|G protein-coupled acetylcholine receptor signaling pathway|acetylcholine receptor signaling pathway|response to amphetamine|cellular response to acetylcholine,0.00291|0.004845|0.007261|0.007744|0.007744,1|1|1|1|1,374.5|216.8|142|132.9|132.9
3365,4,0.5391,3.235,3208.0,0.001005,0.9929309999999999,DHRS4 NRL RGS12 SALL2,eye development|visual system development|sensory system development|retinal rod cell development|retinal rod cell differentiation,0.001865|0.001905|0.001966|0.002134|0.002716,1|1|1|1|1,28.14|27.83|27.39|514.9|396.1
3366,4,0.5422,3.253,3129.0,0.001036,0.9929309999999999,ADRA1A ANKRD28 RGS14 TMEM249,neuron-glial cell signaling|positive regulation of heart rate by epinephrine-norepinephrine|positive regulation of blood pressure by epinephrine-norepinephrine|regulation of systemic arterial blood pressure by norepinephrine-epinephrine|adenylate cyclase-activating adrenergic receptor signaling pathway,9.893e-07|1.319e-06|1.696e-06|2.59e-06|1.19e-05,0.01561|0.0104|0.008915|0.01021|0.03754,1648|1373|1177|915.3|392.3
3367,6,0.5448,8.172,4739.0,0.0017170000000000002,0.998474,OR1J1 OR1J4 OR1Q1 PIP5KL1 RGS3 TOR1B,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.0001895|0.0002256|0.0002355|0.000252|0.0003108,1|1|1|0.9939|0.9804,23.35|22|10.33|21.19|19.73
3368,19,0.457,78.15,12830.0,0.006038,1.0,CNIH1 GOSR2 RAB18 RAB1A RAB1B SAR1A SCFD1 SEC23B SEC23IP SEC24A SEC31A TBC1D20 TRAPPC1 TRAPPC11 TRAPPC12 TRAPPC13 TRAPPC2L TRAPPC4 TRAPPC5,"COPII-coated vesicle budding|endoplasmic reticulum to Golgi vesicle-mediated transport|vesicle budding from membrane|COPII vesicle coating|vesicle targeting, rough ER to cis-Golgi",1.754e-33|1.531e-32|3.507e-31|2.098e-28|2.098e-28,2.767e-29|1.207e-28|1.844e-27|8.273e-25|6.619e-25,232.3|94.02|157.9|223.7|223.7
3369,4,0.5242,3.145,3254.0,0.0009632,0.9929309999999999,C11orf42 FADS6 RGS9 UNK,regulation of calcium ion export across plasma membrane|positive regulation of NMDA glutamate receptor activity|negative regulation of cytoplasmic translation|regulation of cytoplasmic translation|response to amphetamine,0.0005825|0.001553|0.001747|0.004266|0.0062,1|1|1|1|1,2574|735.5|643.6|245.2|166.1
3370,4,0.5092,3.055,3153.0,0.0009656,0.9929309999999999,ATP6V0E2 C11orf94 RGSL1 SHF,vacuolar acidification|phagosome acidification|transferrin transport|phagosome maturation|intracellular pH reduction,0.004653|0.00562|0.007166|0.008903|0.009482,1|1|1|1|1,223.9|183.9|143|114.4|107.3
3371,5,0.5135,5.135,3762.0,0.0013599999999999999,0.996692,HIST1H2AD OR11A1 RHAG SLC17A2 SLC17A4,sialic acid transport|organic anion transport|inorganic cation transmembrane transport|cation transmembrane transport|inorganic ion transmembrane transport,5.937e-07|1.808e-05|8.476e-05|0.0001167|0.0001319,0.009365|0.1426|0.4457|0.46|0.4162,2060|45.43|27|24.25|23.26
3372,4,0.5462,3.2769999999999997,3276.0,0.000997,0.9929309999999999,COLEC12 FSCN2 PROM1 RHBDD2,eye photoreceptor cell differentiation|photoreceptor cell differentiation|eye morphogenesis|positive regulation of nephron tubule epithelial cell differentiation|glomerular parietal epithelial cell differentiation,3.316e-05|5.327e-05|0.0003214|0.0007766|0.0007766,0.523|0.4202|1|1|1,219.1|171.6|68.65|1716|1716
3373,5,0.5091,5.091,4083.0,0.001242,0.996692,KIAA0930 PSG1 RHBDL1 RTN4R TPRX1,neuronal signal transduction|negative regulation of axon regeneration|corpus callosum development|negative regulation of neuron projection regeneration|regulation of axon regeneration,0.00194|0.003636|0.003878|0.00412|0.006778,1|1|1|1|1,588.4|294.2|274.6|257.4|152.6
3374,5,0.5587,5.587000000000001,3994.0,0.001393,0.996692,C1QB C1orf52 CELA3A GJB4 RHBDL2,gap junction-mediated intercellular transport|intercellular transport|olfactory behavior|synapse pruning|cell junction disassembly,0.001698|0.00194|0.002425|0.00291|0.003152,1|1|1|1|1,686.5|588.4|457.7|374.5|343.3
3375,4,0.5134,3.08,3155.0,0.000973,0.9929309999999999,FAM69C RHCG ST8SIA2 TMEM50A,transepithelial ammonium transport|amine transport|ammonium transmembrane transport|ammonium transport|ganglioside biosynthetic process,0.0007766|0.001747|0.002134|0.002134|0.003297,1|1|1|1|1,1716|643.6|514.9|514.9|321.8
3376,27,0.5037,176.8,22400.0,0.007812999999999999,1.0,ADAM2 ADAM32 ADRB3 AP3M2 BIN3 C8orf58 CHRNA2 CHRNA6 CHRNB3 DEFA5 DEFB4A DKK4 DMTN NAT1 PEBP4 PRSS55 RHOBTB2 RNF170 RNF5 SARAF SCARA3 SORBS3 STMN4 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D,"TRAIL-activated apoptotic signaling pathway|synaptic transmission, cholinergic|extrinsic apoptotic signaling pathway via death domain receptors|binding of sperm to zona pellucida|glutamine transport",2.319e-07|9.891e-06|1.761e-05|4.312e-05|9.137e-05,0.003658|0.07801|0.09261|0.1701|0.2883,343.2|79.21|64.36|46.81|171.6
3377,5,0.5125,5.125,3973.0,0.001285,0.996692,EML2 FLT3LG RHOBTB3 SPHK2 TMOD4,regulation of organelle organization|negative regulation of protein polymerization|regulation of cytoskeleton organization|negative regulation of cellular component organization|negative regulation of protein-containing complex assembly,5.321e-05|0.0001334|0.0001557|0.000405|0.0004525,0.8394|1|0.8189|1|1,13.87|111.3|23.81|17.21|59.7
3378,5,0.5779,5.779,4031.0,0.001428,0.996692,HSBP1L1 IFI27L2 ONECUT3 RHOV SLC16A10,thyroid-stimulating hormone secretion|heat acclimation|cellular heat acclimation|Cdc42 protein signal transduction|thyroid hormone transport,0.0004854|0.001456|0.001456|0.00194|0.002667,1|1|1|1|1,4119|823.8|823.8|588.4|411.9
3379,4,0.5546,3.327,3265.0,0.001016,0.9929309999999999,ADORA2B NPSR1 RIDA RXRB,negative regulation of inflammatory response to antigenic stimulus|regulation of inflammatory response to antigenic stimulus|threonine catabolic process|L-threonine catabolic process to glycine|threonine metabolic process,0.0006123|0.0006963|0.001165|0.001165|0.001359,1|1|1|1|1,49.51|46.39|1030|1030|858.1
3380,8,0.5059,14.16,5114.0,0.0027530000000000002,0.9996790000000001,CCNE2 CDK4 CKS1B E2F3 RIF1 SKP2 TCF19 UBE2Q1,G1 phase|mitotic G1 phase|mitotic interphase|interphase|mitotic cell cycle phase transition,2.115e-10|2.115e-10|3.037e-08|3.037e-08|6.421e-08,3.336e-06|1.668e-06|0.0001597|0.0001198|0.0002026,435.9|435.9|115.9|115.9|40.15
3381,4,0.5284,3.1710000000000003,3283.0,0.0009624000000000001,0.9929309999999999,FA2H MXRA7 NSUN6 RILPL2,sebaceous gland cell differentiation|glucosylceramide biosynthetic process|tRNA C5-cytosine methylation|protein transport from ciliary membrane to plasma membrane|central nervous system myelin maintenance,0.0005825|0.0005825|0.0005825|0.0005825|0.0009706,1|1|1|1|1,2574|2574|2574|2574|1287
3382,4,0.5073,3.0439999999999996,3141.0,0.0009658,0.9929309999999999,FBXO45 GYPC RIMKLA SAMD5,synapse assembly involved in innervation|anterior commissure morphogenesis|corticospinal tract morphogenesis|cerebral cortex tangential migration|innervation,0.0003883|0.001359|0.001359|0.001359|0.004653,1|1|1|1|1,5149|858.1|858.1|858.1|223.9
3383,4,0.5903,3.542,3321.0,0.0010630000000000001,0.9929309999999999,C17orf58 FLRT3 RIN2 SERPINE3,proepicardium cell migration involved in pericardium morphogenesis|positive regulation of endothelial cell-matrix adhesion via fibronectin|regulation of endothelial cell-matrix adhesion via fibronectin|pericardium morphogenesis|positive regulation of vasculogenesis,0.0003883|0.001165|0.001359|0.001941|0.002522,1|1|1|1|1,5149|1030|858.1|572.1|429.1
3384,4,0.5532,3.319,3278.0,0.001009,0.9929309999999999,DEPDC4 KCNN2 PBX4 RINL,atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell signaling|atrial cardiac muscle cell action potential|atrial cardiac muscle cell to AV node cell communication,0.001165|0.001165|0.00291|0.00291|0.003104,1|1|1|1|1,1030|1030|367.8|367.8|343.2
3385,19,0.5037,86.14,15460.0,0.005528,1.0,CNBD2 CPNE1 DUSP15 FAM209A FAM209B FAM83C GGT7 GHRH HCK LBP MAP1LC3A MYH7B MYLK2 PPP1R16B RIPOR3 TM9SF4 WFDC11 WFDC6 WISP2,"lipopolysaccharide-mediated signaling pathway|positive regulation of circadian sleep/wake cycle, REM sleep|positive regulation of cytolysis|response to lipopolysaccharide|leukocyte migration involved in immune response",0.0004458|0.001746|0.001746|0.002544|0.002618,1|1|1|1|1,67.3|1144|1144|10.83|572.1
3386,4,0.5272,3.1630000000000003,3221.0,0.0009786,0.9929309999999999,ENTPD5 KATNBL1 NEMP1 RITA1,nucleoside diphosphate catabolic process|positive regulation of glycolytic process|negative regulation of Notch signaling pathway|'de novo' posttranslational protein folding|positive regulation of ATP metabolic process,0.002522|0.004846|0.007745|0.007745|0.007938,1|1|1|1|1,429.1|214.5|132|132|128.7
3387,4,0.5199,3.12,3299.0,0.0009425000000000001,0.9929309999999999,RNF112 SLC25A45 TEX33 TLR5,toll-like receptor 5 signaling pathway|acyl carnitine transmembrane transport|cell death in response to hydrogen peroxide|acyl carnitine transport|embryonic brain development,0.0003883|0.0009706|0.0009706|0.001165|0.002522,1|1|1|1|1,5149|1287|1287|1030|429.1
3388,4,0.5367,3.22,2778.0,0.001155,0.9929309999999999,ARNT EPAS1 RNF123 TNFSF10,regulation of transcription from RNA polymerase II promoter in response to oxidative stress|reproductive structure development|reproductive system development|regulation of transcription from RNA polymerase II promoter in response to hypoxia|embryonic placenta development,2.204e-06|3.108e-05|3.176e-05|8.892e-05|9.574e-05,0.03477|0.2451|0.167|0.3507|0.302,936.1|37.86|37.58|132|127.1
3389,9,0.5051,18.18,7546.0,0.002398,0.9998530000000001,ADGRV1 ANKRD55 CDH12 DMGDH GZMK ITGA1 ITGA2 PLPP1 RNF138,detection of mechanical stimulus involved in sensory perception|positive regulation of phosphatase activity|detection of mechanical stimulus|positive regulation of dephosphorylation|cell adhesion,0.000106|0.000106|0.0002399|0.0003063|0.0004792,1|0.8363|1|1|1,134.6|134.6|88.01|77.57|9.625
3390,4,0.5579,3.347,3067.0,0.001088,0.9929309999999999,CGGBP1 CMTM8 RNF141 VGLL3,"dsDNA loop formation|protein autoubiquitination|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",0.001165|0.01352|0.01665|0.01667|0.01674,1|1|1|1|1,1030|74.62|4.459|4.458|4.451
3391,5,0.5027,5.027,4087.0,0.001225,0.996692,CFAP73 RNF167 SLC1A2 SOX18 TSPO2,amino acid import across plasma membrane|amino acid import|amino acid transmembrane transport|amino acid transport|import across plasma membrane,2.795e-05|4.239e-05|0.0001956|0.0004146|0.0004271,0.4409|0.3343|1|1|1,249.6|200.9|91.53|62.41|61.48
3392,4,0.572,3.432,3369.0,0.001015,0.9929309999999999,RNF186 SLC44A3 TNFRSF12A WFDC8,protein K29-linked ubiquitination|intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress|phosphatidylcholine biosynthetic process|protein K63-linked ubiquitination|positive regulation of extrinsic apoptotic signaling pathway,0.001359|0.006586|0.006973|0.008903|0.009482,1|1|1|1|1,858.1|156|147.1|114.4|107.3
3393,4,0.5112,3.0669999999999997,3177.0,0.0009619,0.9929309999999999,FAM166B GCNT2 RNF207 VAMP1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization|regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization|regulation of heart looping|positive regulation of membrane repolarization during cardiac muscle cell action potential|positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
3394,4,0.5328,3.197,3175.0,0.001003,0.9929309999999999,NPPB RNF212 SGK3 ST18,meiotic gene conversion|gene conversion|chiasma assembly|receptor guanylyl cyclase signaling pathway|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,0.0007766|0.0009706|0.001359|0.002134|0.002328,1|1|1|1|1,1716|1287|858.1|514.9|468.1
3395,4,0.5292,3.175,3381.0,0.0009361,0.9929309999999999,ADGRF3 RNF217 SMPD3 TRIM54,polysaccharide transport|polysaccharide localization|cellular response to redox state|negative regulation of hyaluronan biosynthetic process|sphingomyelin catabolic process,0.0003883|0.0005825|0.0009706|0.0009706|0.001359,1|1|1|1|1,5149|2574|1287|1287|858.1
3396,4,0.5547,3.3280000000000003,3338.0,0.0009938,0.9929309999999999,FAM219A GCHFR PI4K2A RNF38,negative regulation of GTP cyclohydrolase I activity|regulation of GTP cyclohydrolase I activity|tetrahydrobiopterin metabolic process|nitric oxide biosynthetic process|nitric oxide metabolic process,0.0003883|0.0003883|0.002716|0.003297|0.004072,1|1|1|1|1,5149|5149|396.1|321.8|257.4
3397,6,0.5268,7.902,4887.0,0.00161,0.998474,CYP2W1 DAGLB MICALL2 RNF43 RSPH10B TMEM184A,Wnt receptor catabolic process|endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|trans-synaptic signaling by endocannabinoid,0.0008735|0.001165|0.001165|0.001165|0.001746,1|1|1|1|1,1716|1144|1144|1144|686.5
3398,4,0.5006,3.0039999999999996,3190.0,0.0009382999999999999,0.9929309999999999,ERGIC2 FAM221A RNF44 SRR,D-serine biosynthetic process|D-amino acid biosynthetic process|D-serine metabolic process|D-amino acid metabolic process|pyruvate biosynthetic process,0.0003883|0.0003883|0.0005825|0.0007766|0.001359,1|1|1|1|1,5149|5149|2574|1716|858.1
3399,4,0.5716,3.43,3310.0,0.001033,0.9929309999999999,EXOC3L1 GRM5 HIBCH RNFT2,"phospholipase C-activating G protein-coupled glutamate receptor signaling pathway|trans-synaptic signaling by endocannabinoid, modulating synaptic transmission|trans-synaptic signaling by lipid, modulating synaptic transmission|regulation of intracellular calcium activated chloride channel activity|valine catabolic process",0.0005825|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|1716|1716|1716|1287
3400,4,0.5066,3.04,2992.0,0.0010119999999999999,0.9929309999999999,CCDC42 RNH1 SERPINB6 TSPYL1,"DNA replication, removal of RNA primer|RNA catabolic process|nucleobase-containing compound catabolic process|heterocycle catabolic process|cellular nitrogen compound catabolic process",0.001213|0.001409|0.003221|0.003981|0.004094,1|1|1|1|1,1030|33.49|21.97|19.71|19.43
3401,4,0.5118,3.071,2979.0,0.001027,0.9929309999999999,CHRM4 KIAA1549L PAMR1 RORB,amacrine cell differentiation|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway|retinal rod cell development|retinal cone cell differentiation|retinal cone cell development,0.001165|0.001747|0.002134|0.002328|0.002328,1|1|1|1|1,1030|643.6|514.9|468.1|468.1
3402,4,0.5281,3.1689999999999996,3183.0,0.0009920999999999999,0.9929309999999999,FTL PLCH1 ROS1 SLC1A1,cellular transition metal ion homeostasis|transition metal ion homeostasis|response to anesthetic|cysteine transport|cysteine transmembrane transport,0.000184|0.0002612|0.0003883|0.0003883|0.0003883,1|1|1|1|1,91.13|76.28|5149|5149|5149
3403,5,0.5225,5.225,4019.0,0.001295,0.996692,GSTO1 RP1 SLK SORCS1 TLX1,regulation of cell-substrate junction organization|cellular oxidant detoxification|regulation of calcium ion transport into cytosol|cellular detoxification|cellular response to toxic substance,0.0002432|0.0004537|0.0005114|0.000583|0.0006591,1|1|1|1|1,85.28|61.94|58.26|54.48|51.17
3404,4,0.5019,3.011,3058.0,0.0009814000000000001,0.9929309999999999,CNTN2 PEF1 RPGRIP1L TMEM81,regulation of G protein-coupled receptor signaling pathway|establishment of protein localization to juxtaparanode region of axon|positive regulation of adenosine receptor signaling pathway|clustering of voltage-gated potassium channels|telencephalon development,0.0003048|0.0003883|0.0007766|0.0007766|0.000894,1|1|1|1|1,70.53|5149|1716|1716|40.86
3405,5,0.5178,5.178,4097.0,0.001259,0.996692,AARD C5orf47 CFB RPL10L SNCAIP,"complement activation, alternative pathway|regulation of inclusion body assembly|ribosomal large subunit assembly|dopamine metabolic process|catecholamine metabolic process",0.003878|0.004604|0.00702|0.007502|0.01136,1|1|1|1|1,274.6|228.8|147.1|137.3|89.54
3406,12,0.5046,33.3,9020.0,0.003669,0.999986,ALDOC BPNT1 CCDC102A GML OR5AU1 PLEKHG4 PM20D1 PSD4 RAET1L RPL22L1 WFDC11 WRN,positive regulation of strand invasion|regulation of strand invasion|regulation of oxidative phosphorylation uncoupler activity|cellular amide catabolic process|protein localization to nucleolus,0.001164|0.001164|0.002909|0.002909|0.00465,1|1|1|1|1,1716|1716|429.1|429.1|245.2
3407,7,0.5082,10.67,5039.0,0.002107,0.9992989999999999,ISY1 MRPL3 NEPRO RPL24 TRMT10C U2SURP ZBTB11,mRNA metabolic process|RNA processing|gene expression|mitochondrial gene expression|generation of catalytic spliceosome for second transesterification step,4.214e-05|0.0001278|0.0002365|0.0009685|0.001019,0.6647|1|1|1|1,16.96|12.75|6.73|42.03|1471
3408,7,0.5464,11.47,4978.0,0.002293,0.9992989999999999,CHERP FAM32A HAUS8 RPL36 SUGP1 UBL5 YJU2,"mRNA metabolic process|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA processing",8.797e-07|1.613e-06|1.613e-06|1.677e-06|3.572e-06,0.01388|0.01272|0.008479|0.006611|0.01127,21.2|38.97|38.97|38.59|15.94
3409,4,0.5103,3.062,3053.0,0.0009993,0.9929309999999999,CNIH3 RP9 RPL36AL URGCP,"regulation of AMPA receptor activity|synaptic transmission, glutamatergic|COPII vesicle coating|vesicle targeting, rough ER to cis-Golgi|vesicle coating",0.005426|0.005426|0.01237|0.01237|0.01314,1|1|1|1|1,190.7|190.7|81.73|81.73|76.85
3410,11,0.5076,27.92,7643.0,0.003629,0.999969,BOP1 CYC1 EXOSC4 POP1 PUF60 RPL30 RPL37A RPL8 RRS1 UTP23 VPS28,ncRNA processing|ribonucleoprotein complex biogenesis|rRNA processing|rRNA metabolic process|ncRNA metabolic process,6.33e-12|1.129e-11|1.79e-11|2.318e-11|2.599e-11,9.986e-08|8.906e-08|9.412e-08|9.142e-08|8.198e-08,34.67|32.21|50.41|48.54|28.97
3411,6,0.5366,8.049,4322.0,0.001854,0.998474,EFL1 EIF2S1 PSMA4 RPLP1 RPS17 TIPIN,cellular macromolecule biosynthetic process|macromolecule biosynthetic process|translation|peptide biosynthetic process|cellular biosynthetic process,2.724e-07|3.154e-07|1.804e-06|2.313e-06|5.214e-06,0.004298|0.002488|0.009485|0.009123|0.01645,12.44|12.14|35.76|33.57|7.602
3412,11,0.5205,28.63,7238.0,0.003927,0.999969,ALG1 ALG2 DAD1 DOLK DPAGT1 HYOU1 RFT1 RPN1 RPN2 SLC39A7 TMEM258,protein N-linked glycosylation|protein glycosylation|macromolecule glycosylation|glycosylation|glycoprotein biosynthetic process,5.403e-23|4.041e-18|4.041e-18|6.735e-18|3.301e-17,8.523e-19|3.187e-14|2.125e-14|2.656e-14|1.041e-13,228.8|70.92|70.92|67.3|57.21
3413,16,0.4873,58.48,10880.0,0.005332,0.999999,AK6 C18orf21 C1D METAP1 NEPRO NOL6 POP1 POP4 POP5 POP7 RPP14 RPP21 RPP30 RPP38 RPP40 RRP12,"tRNA 5'-leader removal|tRNA 5'-end processing|ncRNA 5'-end processing|RNA 5'-end processing|RNA phosphodiester bond hydrolysis, endonucleolytic",6.516e-24|2.673e-23|1.869e-22|3.661e-22|2.007e-17,1.028e-19|2.108e-19|9.827e-19|1.444e-18|6.333e-14,838.7|681.5|519.2|474.1|122.5
3414,14,0.5101,46.42,9276.0,0.004965,0.9999969999999999,AK6 C18orf21 NEPRO POP1 POP4 POP5 POP7 RPP14 RPP21 RPP25L RPP30 RPP38 RPP40 SSB,tRNA 5'-leader removal|tRNA 5'-end processing|ncRNA 5'-end processing|RNA 5'-end processing|tRNA processing,4.774e-31|2.492e-30|2.464e-29|5.462e-29|1.617e-21,7.53e-27|1.965e-26|1.296e-25|2.154e-25|5.1e-18,1162|943.9|719.2|656.7|114.4
3415,4,0.5365,3.219,3104.0,0.001033,0.9929309999999999,RPRM SNAI1 SPAG4 WDR38,negative regulation of cell differentiation involved in embryonic placenta development|regulation of cell differentiation involved in embryonic placenta development|negative regulation of vitamin D biosynthetic process|negative regulation of vitamin metabolic process|regulation of vitamin D biosynthetic process,0.0003883|0.0009706|0.001165|0.001359|0.001553,1|1|1|1|1,5149|1287|1030|858.1|735.5
3416,4,0.5345,3.207,3185.0,0.001004,0.9929309999999999,BARHL1 MARCH10 PLA2G6 RPRML,phosphatidylethanolamine catabolic process|positive regulation of arachidonic acid secretion|urinary bladder smooth muscle contraction|regulation of arachidonic acid secretion|cardiolipin acyl-chain remodeling,0.0007766|0.001359|0.001553|0.001747|0.001747,1|1|1|1|1,1716|858.1|735.5|643.6|643.6
3417,4,0.5242,3.145,3169.0,0.0009889,0.9929309999999999,C22orf23 PRDX3 RPS10 SNRPC,ribonucleoprotein complex assembly|ribonucleoprotein complex subunit organization|peptidyl-cysteine oxidation|mRNA 5'-splice site recognition|protein oxidation,0.0005122|0.0005501|0.0007766|0.001359|0.002522,1|1|1|1|1,54.2|52.27|1716|858.1|429.1
3418,8,0.5367,15.03,5622.0,0.0026579999999999998,0.9996790000000001,MCM2 MCM3 MCM4 MCM5 MCM6 MCM7 ORC6 RPS19BP1,pre-replicative complex assembly involved in cell cycle DNA replication|pre-replicative complex assembly involved in nuclear cell cycle DNA replication|DNA replication initiation|double-strand break repair via break-induced replication|pre-replicative complex assembly,7.916e-19|7.916e-19|2.554e-18|4.892e-18|3.763e-17,1.249e-14|6.243e-15|1.343e-14|1.929e-14|1.187e-13,1931|1931|419.1|1287|277.2
3419,7,0.5037,10.58,5076.0,0.002074,0.9992989999999999,RPL29 RPL34 RPL6 RPS15A RPS2 RPS3A RPSA,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,6.346e-17|8.93e-17|1.689e-16|2.145e-16|2.275e-16,1.001e-12|7.043e-13|8.878e-13|8.46e-13|7.176e-13,214.5|203.9|185.5|179.1|177.5
3420,16,0.5033,60.39,11180.0,0.0053560000000000005,0.999999,MAD2L1 RPL14 RPL15 RPL17 RPL18 RPL18A RPL19 RPL23 RPL23A RPL27 RPL31 RPL35A RPL5 RPL7 RPS15A RPS24,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,5.531e-34|1.12e-33|4.184e-33|6.873e-33|7.761e-33,8.725e-30|8.831e-30|2.2e-29|2.71e-29|2.448e-29,201.1|191.2|173.9|167.9|166.4
3421,6,0.5527,8.29,4179.0,0.001974,0.998474,CCT2 COPA COPZ1 INTS3 PSMB4 RPS27,"intra-Golgi vesicle-mediated transport|toxin transport|retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|negative regulation of G2/M transition of mitotic cell cycle|negative regulation of cell cycle G2/M phase transition",4.687e-05|6.651e-05|0.0002616|0.0003386|0.0004179,0.7393|0.5246|1|1|1,196.1|163.5|80.76|70.77|63.56
3422,6,0.5121,7.682,4398.0,0.001739,0.998474,RPL13A RPL6 RPS2 RPS27A RPS3A RPSA,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,1.269e-14|1.703e-14|2.948e-14|3.623e-14|3.81e-14,2.002e-10|1.344e-10|1.55e-10|1.429e-10|1.202e-10,214.5|203.9|185.5|179.1|177.5
3423,12,0.5062,33.41,8105.0,0.004093,0.999986,EIF2B2 EIF2S1 ERH LRR1 NRDE2 POLE2 PSMA3 PSMA6 PSMC6 RBM25 RPS29 SNAPC1,posttranscriptional regulation of gene expression|cellular macromolecule biosynthetic process|macromolecule biosynthetic process|T cell receptor signaling pathway|DNA-dependent DNA replication,2.928e-07|6.522e-07|7.868e-07|2.88e-06|3.853e-06,0.004618|0.005144|0.004137|0.01136|0.01216,18.83|8.296|8.096|38.14|35.39
3424,5,0.5295,5.295,3577.0,0.001474,0.996692,MASTL NOL10 RPS27A RPS7 WDR43,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,2.019e-05|2.257e-05|4.16e-05|9.061e-05|0.0001126,0.3184|0.178|0.2188|0.3573|0.3553,47.53|45.77|37.22|28.6|26.57
3425,5,0.5202,5.202000000000001,4006.0,0.001294,0.996692,KIAA0355 RIPPLY3 RRAS TLL1 TMEM178A,Ras protein signal transduction|positive regulation of endothelial cell-matrix adhesion via fibronectin|small GTPase mediated signal transduction|regulation of endothelial cell-matrix adhesion via fibronectin|positive regulation of vasculogenesis,0.0007299|0.001456|0.001595|0.001698|0.003152,1|1|1|1|1,46.81|823.8|31.44|686.5|343.3
3426,4,0.5271,3.1630000000000003,3205.0,0.0009834,0.9929309999999999,MIDN RNF126 RRH ZNF283,cytoplasm protein quality control by the ubiquitin-proteasome system|cytoplasm protein quality control|negative regulation of glucokinase activity|negative regulation of hexokinase activity|regulation of glucokinase activity,0.0003883|0.0003883|0.001165|0.001165|0.002134,1|1|1|1|1,5149|5149|1030|1030|514.9
3427,4,0.5199,3.1189999999999998,3054.0,0.001018,0.9929309999999999,CMIP KCNV1 PDE7A RRM2B,mitochondrial DNA replication|cAMP catabolic process|nucleotide metabolic process|nucleoside phosphate metabolic process|cyclic nucleotide catabolic process,0.001941|0.001941|0.002572|0.00269|0.00291,1|1|1|1|1,572.1|572.1|23.89|23.35|367.8
3428,5,0.535,5.35,4210.0,0.001266,0.996692,ATP5MC2 FAM177A1 KLHL38 RRNAD1 VPS13B,"mitochondrial ATP synthesis coupled proton transport|ATP synthesis coupled proton transport|energy coupled proton transport, down electrochemical gradient|rRNA methylation|cristae formation",0.004845|0.006054|0.006054|0.00702|0.007744,1|1|1|1|1,216.8|171.6|171.6|147.1|132.9
3429,6,0.5475,8.213,4404.0,0.0018559999999999998,0.998474,ATRIP CCDC12 EXOSC7 GMPPB RRP9 SACM1L,U5 snRNA 3'-end processing|U1 snRNA 3'-end processing|polyadenylation-dependent mRNA catabolic process|nuclear polyadenylation-dependent mRNA catabolic process|GDP-mannose biosynthetic process,0.001165|0.001165|0.001456|0.001456|0.001746,1|1|1|1|1,1144|1144|858.1|858.1|686.5
3430,4,0.5115,3.069,3240.0,0.0009441000000000001,0.9929309999999999,DMC1 DTD1 RSPH3 VSX1,cell maturation|anatomical structure maturation|histidyl-tRNA aminoacylation|DNA repair complex assembly|retinal bipolar neuron differentiation,0.0005331|0.0008572|0.0009706|0.001213|0.001213,1|1|1|1|1,54.92|43.13|1373|1030|1030
3431,5,0.5274,5.274,4005.0,0.001312,0.996692,RNF19A RSPO2 ST8SIA2 VIP VIPR2,negative regulation of smooth muscle cell proliferation|regulation of smooth muscle cell proliferation|epinephrine secretion|negative regulation of animal organ morphogenesis|positive regulation of epinephrine secretion,5.073e-05|0.0004208|0.0004854|0.000728|0.000728,0.8002|1|1|1|1,183.1|61.94|4119|2060|2060
3432,4,0.5049,3.03,3024.0,0.0009982,0.9929309999999999,FCN2 RGS21 RSPRY1 TIAM2,"recognition of apoptotic cell|complement activation, lectin pathway|apoptotic cell clearance|opsonization|positive regulation of axonogenesis",0.001553|0.002134|0.00871|0.01391|0.01621,1|1|1|1|1,735.5|514.9|117|72.52|62.03
3433,12,0.5015,33.1,7634.0,0.004304,0.999986,CENPX CHTF18 CHTF8 DSCC1 FAAP24 FANCM FEN1 MMS22L POLE2 RTEL1 TRAIP USP37,DNA-dependent DNA replication|DNA replication|DNA metabolic process|telomere maintenance via semi-conservative replication|nuclear DNA replication,4.697e-19|1.221e-17|2.927e-15|7.013e-14|6.425e-13,7.41e-15|9.628e-14|1.539e-11|2.766e-10|2.027e-09,88.47|63.33|24.17|264|177.5
3434,4,0.5442,3.265,3267.0,0.0009962,0.9929309999999999,FA2H FHL3 RTKN SLC30A6,sebaceous gland cell differentiation|glucosylceramide biosynthetic process|septin ring organization|actomyosin contractile ring assembly|assembly of actomyosin apparatus involved in cytokinesis,0.0005825|0.0005825|0.0005825|0.0009706|0.0009706,1|1|1|1|1,2574|2574|2574|1287|1287
3435,5,0.5301,5.301,4235.0,0.001247,0.996692,BLOC1S2 CAMK1G PSD RTKN2 TMEM259,platelet dense granule organization|positive regulation of ERAD pathway|synaptic vesicle transport along microtubule|synaptic vesicle cytoskeletal transport|anterograde synaptic vesicle transport,0.002425|0.003636|0.00412|0.00412|0.00412,1|1|1|1|1,457.7|294.2|257.4|257.4|257.4
3436,4,0.5065,3.0389999999999997,3031.0,0.0009991,0.9929309999999999,DNAH2 RTL1 SPATA7 TRIQK,protein localization to photoreceptor connecting cilium|protein localization to photoreceptor outer segment|protein localization to ciliary transition zone|protein localization to non-motile cilium|microtubule-based process,0.0003883|0.001359|0.001747|0.002134|0.008684,1|1|1|1|1,5149|858.1|643.6|514.9|12.82
3437,9,0.5055,18.2,7466.0,0.002426,0.9998530000000001,AGR3 CYP2W1 GPER1 GPR146 PTCD1 RBAK RNF216 SCIN VSTM2A,"protein catabolic process at synapse|protein catabolic process, modulating synaptic transmission|nuclear fragmentation involved in apoptotic nuclear change|positive regulation of cardiac vascular smooth muscle cell differentiation|positive regulation of white fat cell proliferation",0.0008734|0.0008734|0.0008734|0.00131|0.00131,1|1|1|1|1,2288|2288|2288|1144|1144
3438,4,0.5718,3.431,3205.0,0.001067,0.9929309999999999,NKX3-2 NLRP6 RTL6 UMOD,citric acid secretion|metanephric thick ascending limb development|juxtaglomerular apparatus development|thick ascending limb development|creatinine homeostasis,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
3439,5,0.5221,5.221,4289.0,0.001213,0.996692,ANKIB1 CAPG GDF10 RHOBTB1 RTN2,actin filament organization|regulation of actin cytoskeleton organization|actin filament severing|engulfment of apoptotic cell|regulation of actin filament-based process,0.002516|0.004313|0.004651|0.004942|0.005305,1|1|1|1|1,25.43|19.28|228.8|214.5|17.34
3440,4,0.5587,3.352,3239.0,0.001031,0.9929309999999999,ADRA2B HNRNPA0 PLTP RTN4RL1,vitamin E biosynthetic process|negative regulation of epinephrine secretion|vitamin E metabolic process|receptor transactivation|regulation of epinephrine secretion,0.0003883|0.0009706|0.0009706|0.001165|0.001359,1|1|1|1|1,5149|1287|1287|1030|858.1
3441,5,0.5189,5.189,3681.0,0.0014039999999999999,0.996692,IRF2BP1 IRF2BP2 IRF2BPL RTP1 ZBTB43,"negative regulation of transcription by RNA polymerase II|regulation of transcription by RNA polymerase II|development of secondary female sexual characteristics|negative regulation of transcription, DNA-templated|negative regulation of nucleic acid-templated transcription",0.0007907|0.001122|0.00194|0.002231|0.002241,1|1|1|1|1,13.7|6.371|588.4|9.594|9.579
3442,4,0.5411,3.247,3219.0,0.001005,0.9929309999999999,COL1A1 GNAT1 PROB1 RUFY3,cellular response to fluoride|cellular response to vitamin E|visual perception|sensory perception of light stimulus|response to fluoride,0.0003883|0.0005825|0.0006596|0.0006839|0.0009706,1|1|1|1|1,5149|2574|47.67|46.81|1287
3443,4,0.521,3.1260000000000003,3210.0,0.0009704000000000001,0.9929309999999999,FAM166B GNG11 KIAA0355 RUNDC1,Rac protein signal transduction|activation of GTPase activity|Ras protein signal transduction|small GTPase mediated signal transduction|in utero embryonic development,0.004266|0.02253|0.03393|0.0501|0.06736,1|1|1|1|1,245.2|44.39|29.25|19.65|14.5
3444,4,0.5673,3.404,3326.0,0.0010199999999999999,0.9929309999999999,HOPX JPH4 RUNDC3B SELENOP,selenium compound metabolic process|regulation of store-operated calcium entry|trophectodermal cell differentiation|chaperone-mediated protein complex assembly|regulation of ryanodine-sensitive calcium-release channel activity,0.001165|0.002716|0.003685|0.004266|0.005426,1|1|1|1|1,1030|396.1|286|245.2|190.7
3445,4,0.5391,3.235,3209.0,0.001005,0.9929309999999999,ANGPTL8 RWDD2B SRSF12 ZNF442,"mRNA 5'-splice site recognition|spliceosomal tri-snRNP complex assembly|regulation of lipoprotein metabolic process|mRNA cis splicing, via spliceosome|negative regulation of mRNA splicing, via spliceosome",0.001359|0.002716|0.003104|0.004266|0.004266,1|1|1|1|1,858.1|396.1|343.2|245.2|245.2
3446,4,0.5723,3.4339999999999997,3307.0,0.001035,0.9929309999999999,ATP2C2 BIRC7 RANBP17 RXFP3,regulation of natural killer cell apoptotic process|manganese ion transmembrane transport|manganese ion transport|positive regulation of calcium ion import|positive regulation of cytokinesis,0.0003883|0.002134|0.003297|0.004459|0.007745,1|1|1|1|1,5149|514.9|321.8|234|132
3447,5,0.536,5.36,4180.0,0.0012779999999999998,0.996692,AP3B1 AP3M1 RYR2 SLC7A6 STXBP6,synaptic vesicle transport along microtubule|synaptic vesicle cytoskeletal transport|anterograde synaptic vesicle transport|protein targeting to lysosome|synaptic vesicle transport,7.2e-06|7.2e-06|7.2e-06|1.528e-05|3.85e-05,0.1136|0.05679|0.03786|0.06027|0.1215,514.9|514.9|514.9|343.3|211.2
3448,4,0.5675,3.405,3302.0,0.0010279999999999998,0.9929309999999999,APOF CHST3 PPP1R3C S1PR1,cardiac muscle tissue growth involved in heart morphogenesis|growth involved in heart morphogenesis|blood vessel maturation|sphingosine-1-phosphate receptor signaling pathway|carbohydrate metabolic process,0.0005825|0.0009706|0.001747|0.00291|0.0031,1|1|1|1|1,2574|1287|643.6|367.8|21.72
3449,4,0.5233,3.14,3247.0,0.0009639,0.9929309999999999,ACER1 FAM160A1 GOLGA4 S1PR3,negative regulation of establishment of endothelial barrier|negative regulation of endothelial cell development|response to alkaline pH|negative regulation of endothelial cell differentiation|sphingoid biosynthetic process,0.0005825|0.0005825|0.0007766|0.001941|0.00291,1|1|1|1|1,2574|2574|1716|572.1|367.8
3450,5,0.5404,5.404,4088.0,0.001317,0.996692,HLA-DPA1 REN S1PR5 TRPM5 ZNF76,regulation of neuron differentiation|renin-angiotensin regulation of aldosterone production|regulation of aldosterone secretion|regulation of mineralocorticoid secretion|regulation of blood volume by renin-angiotensin,0.001317|0.001456|0.002037|0.002037|0.002328,1|1|1|1|1,35.39|858.1|572.1|572.1|490.4
3451,5,0.5016,5.016,4327.0,0.001155,0.996692,CLDN20 PDZD3 PPIL6 SAC3D1 SUMO3,negative regulation of guanylate cyclase activity|negative regulation of purine nucleotide biosynthetic process|negative regulation of nucleotide biosynthetic process|negative regulation of cGMP-mediated signaling|receptor guanylyl cyclase signaling pathway,0.0009706|0.001698|0.001698|0.001698|0.002667,1|1|1|1|1,1373|686.5|686.5|686.5|411.9
3452,6,0.5191,7.787000000000001,4138.0,0.001873,0.998474,BRF2 FNTA GINS4 PGGT1B SAFB TTI2,protein geranylgeranylation|protein prenylation|prenylation|positive regulation of tubulin deacetylation|cellular response to steroid hormone stimulus,2.768e-06|6.521e-06|6.521e-06|0.0006794|0.0009957,0.04366|0.05143|0.03429|1|1,980.7|588.4|588.4|2942|41.44
3453,4,0.5068,3.0410000000000004,2988.0,0.0010140000000000001,0.9929309999999999,DNAJB6 MLF2 SAFB2 ZNF428,negative regulation of inclusion body assembly|Sertoli cell differentiation|regulation of inclusion body assembly|intermediate filament organization|regulation of androgen receptor signaling pathway,0.002328|0.003491|0.003685|0.004846|0.007166,1|1|1|1|1,468.1|302.9|286|214.5|143
3454,4,0.5028,3.017,3187.0,0.0009434,0.9929309999999999,GPR182 HBD KSR2 SAG,rhodopsin mediated signaling pathway|protein neddylation|G protein-coupled receptor internalization|oxygen transport|response to redox state,0.003781|0.004071|0.004361|0.004361|0.004651,1|1|1|1|1,286|264|245.2|245.2|228.8
3455,5,0.5142,5.142,3836.0,0.001335,0.996692,NUP153 RIOK1 RUNDC3B SAMD9 STEAP4,negative regulation of RNA export from nucleus|negative regulation of nucleobase-containing compound transport|viral penetration into host nucleus|copper ion import|endosomal vesicle fusion,0.000728|0.0009706|0.001213|0.001698|0.002183,1|1|1|1|1,2060|1373|1030|686.5|514.9
3456,5,0.5037,5.037,4158.0,0.001207,0.996692,ALPK1 BBOF1 FMNL2 OR6C65 SAMD9L,motile cilium assembly|cortical actin cytoskeleton organization|cytoplasmic pattern recognition receptor signaling pathway|cortical cytoskeleton organization|pattern recognition receptor signaling pathway,0.006295|0.009431|0.009913|0.01424|0.03069,1|1|1|1|1,164.8|108.4|103|71.02|32.43
3457,15,0.5022,52.73,11970.0,0.004374,0.999999,BCAS4 BPIFA3 CNBD2 FAM209A FAM209B GGT7 GHRH LBP MAP1LC3A MYLK2 NDFIP1 R3HDML SAMHD1 WFDC11 WISP2,"positive regulation of circadian sleep/wake cycle, REM sleep|positive regulation of cytolysis|negative regulation of immune response|positive regulation of respiratory burst involved in inflammatory response|DNA strand resection involved in replication fork processing",0.001455|0.001455|0.001807|0.002182|0.002182,1|1|1|1|1,1373|1373|12.08|686.5|686.5
3458,4,0.5718,3.431,3197.0,0.0010689999999999999,0.9929309999999999,ADAT1 CA9 SAPCD2 UCK1,symmetric cell division|negative regulation of protein localization to cell cortex|CTP salvage|pyrimidine ribonucleotide salvage|pyrimidine nucleotide salvage,0.0003883|0.0003883|0.0007766|0.001165|0.001165,1|1|1|1|1,5149|5149|1716|1030|1030
3459,7,0.5176,10.87,4948.0,0.002186,0.9992989999999999,CCDC86 INTS5 OSBP POLA2 SART1 TMEM258 WDR74,ncRNA processing|ncRNA metabolic process|maturation of 5S rRNA|positive regulation of cytotoxic T cell differentiation|RNA metabolic process,0.0003072|0.0005187|0.0006794|0.001019|0.001055,1|1|1|1|1,20.43|17.07|2942|1471|7.36
3460,5,0.5001,5.001,4161.0,0.0011970000000000001,0.996692,ARMS2 ASIC5 GGA3 HOXD8 SASH1,sodium ion transmembrane transport|sodium ion transport|regulation of protein autoubiquitination|positive regulation of lipopolysaccharide-mediated signaling pathway|regulation of protein K63-linked ubiquitination,0.0005137|0.001064|0.002037|0.002619|0.003781,1|1|1|1|1,57.21|39.45|572.1|429.1|286
3461,4,0.5445,3.267,3075.0,0.001059,0.9929309999999999,SBK2 SLC6A16 SMG9 SUSD4,"regulation of complement activation, alternative pathway|negative regulation of complement activation, alternative pathway|regulation of complement activation, classical pathway|negative regulation of complement activation, classical pathway|negative regulation of humoral immune response mediated by circulating immunoglobulin",0.0007766|0.0007766|0.0009706|0.0009706|0.001553,1|1|1|1|1,1716|1716|1287|1287|735.5
3462,5,0.5482,5.482,4072.0,0.001341,0.996692,HIST1H3H LYG2 RNF183 SBSPON SIVA1,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|activation-induced cell death of T cells|peptidoglycan metabolic process,0.0005825|0.0007766|0.0007766|0.001359|0.001359,1|1|1|1|1,2574|1716|1716|858.1|858.1
3463,4,0.5324,3.195,2620.0,0.001214,0.9929309999999999,PFDN1 SCAPER TTC5 TUBB4B,negative regulation of amyloid fibril formation|regulation of amyloid fibril formation|natural killer cell mediated cytotoxicity|natural killer cell mediated immunity|leukocyte mediated cytotoxicity,0.002522|0.003104|0.004846|0.005233|0.007745,1|1|1|1|1,429.1|343.2|214.5|198|132
3464,5,0.5397,5.397,4527.0,0.001188,0.996692,FRMD4B MAP1B SCARB1 SNPH TMEM171,establishment of cell polarity|induction of synaptic plasticity by chemical substance|positive regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity by chemical substance|lipopolysaccharide transport,0.0003382|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,69.23|4119|4119|4119|2060
3465,5,0.519,5.19,4322.0,0.0011970000000000001,0.996692,CXCL8 DCUN1D2 RASSF2 SCARB2 SPO11,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade|epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity|regulation of glucosylceramidase activity|meiotic DNA double-strand break processing|regulation of endosome organization,0.0004854|0.0004854|0.000728|0.001213|0.001213,1|1|1|1|1,4119|4119|2060|1030|1030
3466,4,0.505,3.03,3039.0,0.0009933,0.9929309999999999,FAM186A NYNRIN PYURF SCARF1,positive regulation of axon regeneration|positive regulation of neuron projection regeneration|cholesterol catabolic process|sterol catabolic process|neuron remodeling,0.001941|0.002134|0.002328|0.002328|0.002522,1|1|1|1|1,572.1|514.9|468.1|468.1|429.1
3467,5,0.5046,5.046,3655.0,0.001375,0.996692,CLNS1A POLD3 SCD5 THAP12 TSEN15,monounsaturated fatty acid biosynthetic process|DNA synthesis involved in UV-damage excision repair|monounsaturated fatty acid metabolic process|nucleobase-containing compound metabolic process|heterocycle metabolic process,0.000728|0.000728|0.0009706|0.001363|0.001758,1|1|1|1|1,2060|2060|1373|6.06|5.674
3468,4,0.5632,3.3789999999999996,3200.0,0.001052,0.9929309999999999,CASS4 NPPB SCN4B ST18,AV node cell to bundle of His cell signaling|AV node cell action potential|blood circulation|receptor guanylyl cyclase signaling pathway|actin filament reorganization,0.001553|0.001553|0.00206|0.002134|0.002134,1|1|1|1|1,735.5|735.5|26.75|514.9|514.9
3469,4,0.5376,3.225,3213.0,0.001,0.9929309999999999,GLDC PCDH15 SCN5A ZFAND2A,response to calcium ion|response to methylamine|response to lipoic acid|glycine decarboxylation via glycine cleavage system|membrane depolarization during atrial cardiac muscle cell action potential,0.0003257|0.0003883|0.0003883|0.0007766|0.0007766,1|1|1|1|1,68.2|5149|5149|1716|1716
3470,4,0.5423,3.2539999999999996,3396.0,0.0009548,0.9929309999999999,GGH LMX1A SCRN3 ZIC4,tetrahydrofolylpolyglutamate metabolic process|olfactory behavior|midbrain dopaminergic neuron differentiation|dentate gyrus development|chemosensory behavior,0.0005825|0.001941|0.002522|0.00291|0.003297,1|1|1|1|1,2574|572.1|429.1|367.8|321.8
3471,4,0.5427,3.2560000000000002,3192.0,0.001016,0.9929309999999999,GSTM3 SDC3 SLC6A5 SNTN,neurotransmitter uptake|sodium ion transmembrane transport|neurotransmitter transport|sodium ion transport|glycine import across plasma membrane,2.185e-05|0.0003438|0.0004786|0.0007136|0.000728,0.3447|1|1|1|1,284.1|68.65|58.01|47.34|2060
3472,4,0.5183,3.11,3147.0,0.0009847,0.9929309999999999,ACO1 HUS1B NUTM2G SDCCAG8,meiotic DNA integrity checkpoint|regulation of G2/M transition of mitotic cell cycle|regulation of cell cycle G2/M phase transition|response to iron(II) ion|citrate metabolic process,0.0005825|0.0005836|0.0006778|0.001165|0.001165,1|1|1|1|1,2574|50.73|47.02|1030|1030
3473,4,0.5214,3.1289999999999996,3181.0,0.00098,0.9929309999999999,HUS1B POU5F2 SDK1 SLC22A2,positive regulation of glucosylceramide catabolic process|regulation of glucosylceramide catabolic process|positive regulation of phospholipid scramblase activity|regulation of phospholipid scramblase activity|positive regulation of lipid transporter activity,0.0004854|0.0004854|0.0004854|0.0004854|0.000728,1|1|1|1|1,4119|4119|4119|4119|2060
3474,4,0.5591,3.355,3214.0,0.0010400000000000001,0.9929309999999999,CHRNB4 EHD4 SDR42E1 STX1B,regulation of neurotransmitter secretion|regulation of neurotransmitter transport|negative regulation of macropinocytosis|positive regulation of spontaneous neurotransmitter secretion|regulation of endocytosis,0.0001203|0.0001593|0.0003883|0.0003883|0.0006123,1|1|1|1|1,113.2|98.07|5149|5149|49.51
3475,10,0.5045,22.7,6676.0,0.003379,0.999933,APH1A HSPA13 NCSTN PSEN1 PSENEN SEC11A SPCS1 SPCS3 TGFBR1 TGFBR2,"protein processing|protein maturation|Notch receptor processing, ligand-dependent|amyloid-beta formation|Notch receptor processing",4.384e-13|4.025e-12|9.215e-12|2.793e-11|2.793e-11,6.915e-09|3.175e-08|4.845e-08|1.101e-07|8.812e-08,82.38|59.57|1177|823.8|823.8
3476,5,0.5455,5.455,4148.0,0.00131,0.996692,COL24A1 CRYZ SEC22A SLC35A3 ZNF264,UDP-galactose transmembrane transport|UDP-N-acetylglucosamine transmembrane transport|pyrimidine nucleotide-sugar transmembrane transport|nucleotide-sugar transmembrane transport|xenobiotic catabolic process,0.001213|0.001456|0.00291|0.003152|0.003152,1|1|1|1|1,1030|823.8|374.5|343.3|343.3
3477,4,0.5951,3.57,3413.0,0.0010429999999999999,0.9929309999999999,CARD10 HRH1 SELENON TMEM17,positive regulation of inositol trisphosphate biosynthetic process|regulation of inositol trisphosphate biosynthetic process|positive regulation of response to oxidative stress|cellular response to histamine|response to histamine,0.001165|0.001359|0.001553|0.001747|0.002522,1|1|1|1|1,1030|858.1|735.5|643.6|429.1
3478,4,0.5744,3.446,3263.0,0.001052,0.9929309999999999,IL36RN LGI2 SELENOO TTC3,protein nucleotidylation|protein adenylylation|antifungal humoral response|inhibitory synapse assembly|negative regulation of interleukin-17 production,0.0005825|0.0005825|0.002328|0.002522|0.003104,1|1|1|1|1,2574|2574|468.1|429.1|343.2
3479,4,0.53,3.18,3115.0,0.001017,0.9929309999999999,APRT LRRC49 SELENOW VWA2,adenine salvage|AMP salvage|adenine biosynthetic process|adenine metabolic process|purine nucleobase salvage,0.0005825|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|2574|1716|1716|1716
3480,5,0.5402,5.402,3557.0,0.0015119999999999999,0.996692,HEXIM1 LARP7 MEPCE OGA SELL,positive regulation of snRNA transcription by RNA polymerase II|regulation of snRNA transcription by RNA polymerase II|snRNA modification|positive regulation of protein localization to Cajal body|regulation of protein localization to Cajal body,7.067e-07|9.893e-07|1.696e-06|3.672e-06|3.672e-06,0.01115|0.007803|0.008915|0.01448|0.01159,2060|1648|1177|748.9|748.9
3481,4,0.5021,3.012,3154.0,0.0009517000000000001,0.9929309999999999,C4orf47 GSTZ1 GULP1 SELPLG,leukocyte adhesive activation|tyrosine catabolic process|regulation of acetyl-CoA biosynthetic process from pyruvate|regulation of acyl-CoA biosynthetic process|L-phenylalanine catabolic process,0.0005825|0.001165|0.001747|0.001941|0.002328,1|1|1|1|1,2574|1030|643.6|572.1|468.1
3482,4,0.5184,3.11,3254.0,0.0009526,0.9929309999999999,C1orf43 NDRG1 SEMA4A SMIM6,positive regulation of inhibitory synapse assembly|positive regulation of excitatory synapse assembly|regulation of inhibitory synapse assembly|peripheral nervous system myelin maintenance|T-helper 1 cell differentiation,0.0005825|0.0007766|0.0009706|0.001747|0.002134,1|1|1|1|1,2574|1716|1287|643.6|514.9
3483,4,0.55,3.3,3443.0,0.0009552999999999999,0.9929309999999999,B2M KCNJ15 SEMA4B ZNF576,"negative regulation of neuron projection development|negative regulation of neurogenesis|negative regulation of nervous system development|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular response to iron(III) ion",0.0004334|0.0004461|0.0004786|0.0004854|0.000728,1|1|1|1|1,61.02|60.13|58.01|4119|2060
3484,10,0.5023,22.6,7991.0,0.002813,0.999933,C6orf203 ENPP1 ENPP3 SEMA6D TAAR2 TAAR5 TAAR6 TAAR8 VNN2 WISP3,nucleoside triphosphate catabolic process|water-soluble vitamin metabolic process|nucleoside phosphate catabolic process|nucleoside triphosphate metabolic process|negative regulation of hh target transcription factor activity,2.029e-05|0.0005942|0.0005942|0.0007108|0.0008734,0.32|1|1|1|1,326.9|55.14|55.14|50.29|2288
3485,20,0.5026,95.5,16460.0,0.005754,1.0,ADA CNBD2 CPNE1 EPPIN FAM209A FAM209B FAM83C GGT7 GHRH HCK LBP MAP1LC3A MYH7B MYLK2 RBPJL SEMG2 WFDC11 WFDC6 WFDC8 WISP2,negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement|negative regulation of reproductive process|response to bacterium,1.205e-05|1.205e-05|1.205e-05|2.197e-05|3.371e-05,0.19|0.09501|0.06334|0.08666|0.1063,542|542|542|57.05|9.058
3486,4,0.5608,3.365,3055.0,0.001097,0.9929309999999999,RASSF9 SENP1 SOX1 TEAD2,positive regulation of transcription by RNA polymerase II|ventral spinal cord interneuron specification|cell fate specification involved in pattern specification|protein desumoylation|interneuron migration,0.0007714|0.001553|0.001553|0.001747|0.001747,1|1|1|1|1,12.81|735.5|735.5|643.6|643.6
3487,4,0.5457,3.2739999999999996,3147.0,0.001037,0.9929309999999999,AKR1A1 PRKACA SERAC1 USP47,peptidyl-threonine phosphorylation|peptidyl-threonine modification|regulation of mitotic cell cycle|phosphate-containing compound metabolic process|phosphorus metabolic process,0.0001334|0.0001669|0.000225|0.0003412|0.0003605,1|1|1|1|1,111.3|99.25|21.02|8.644|8.524
3488,4,0.5724,3.435,2896.0,0.001181,0.9929309999999999,DOHH METAP2 RCAN3 SERF2,peptidyl-lysine modification to peptidyl-hypusine|protein initiator methionine removal|protein maturation|peptidyl-methionine modification|regulation of rhodopsin mediated signaling pathway,0.0005825|0.0007766|0.0008254|0.002716|0.005233,1|1|1|1|1,2574|1716|42.55|396.1|198
3489,4,0.5014,3.009,3291.0,0.0009111000000000001,0.9929309999999999,ACAP3 CALML6 NEU2 SERINC2,sphingolipid metabolic process|cellular oligosaccharide catabolic process|cellular oligosaccharide metabolic process|maternal aggressive behavior|penile erection,0.0006201|0.000728|0.000728|0.0009706|0.0009706,1|1|1|1|1,50.85|2060|2060|1373|1373
3490,5,0.5012,5.012,3771.0,0.001324,0.996692,C1QTNF4 CD82 OR4B1 SERINC5 TP53I11,positive regulation of interleukin-6-mediated signaling pathway|positive regulation of serine C-palmitoyltransferase activity|positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity|regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity|regulation of interleukin-6-mediated signaling pathway,0.0009706|0.0009706|0.0009706|0.0009706|0.001456,1|1|1|1|1,1373|1373|1373|1373|823.8
3491,4,0.5092,3.055,3189.0,0.0009548,0.9929309999999999,NCEH1 SERPINA5 SLC22A3 TRAF3IP3,epinephrine uptake|seminal vesicle development|histamine uptake|epinephrine transport|imidazole-containing compound metabolic process,0.0005825|0.0005825|0.0007766|0.0009706|0.001359,1|1|1|1|1,2574|2574|1716|1287|858.1
3492,4,0.5263,3.158,3237.0,0.0009722999999999999,0.9929309999999999,LGI3 SERPINH1 SOGA3 TSPYL1,chondrocyte development involved in endochondral bone morphogenesis|collagen biosynthetic process|chondrocyte differentiation involved in endochondral bone morphogenesis|chondrocyte development|cartilage development involved in endochondral bone morphogenesis,0.001747|0.001941|0.003104|0.00504|0.006007,1|1|1|1|1,643.6|572.1|343.2|205.9|171.6
3493,4,0.5095,3.057,3128.0,0.000974,0.9929309999999999,CNN3 LIMA1 RFFL SERTAD4,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis|intestinal cholesterol absorption|intestinal lipid absorption|negative regulation of hydrolase activity,0.0007766|0.001165|0.002134|0.002522|0.002861,1|1|1|1|1,1716|1030|514.9|429.1|22.63
3494,4,0.5342,3.205,3183.0,0.001003,0.9929309999999999,CNTNAP3 SESTD1 SLC41A2 ZNF385B,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel|regulation of calcium ion transmembrane transport via high voltage-gated calcium channel|negative regulation of calcium ion transmembrane transport|intrinsic apoptotic signaling pathway by p53 class mediator|negative regulation of calcium ion transport,0.0005825|0.002522|0.007745|0.009867|0.0116,1|1|1|1|1,2574|429.1|132|103|87.27
3495,8,0.5045,14.13,5463.0,0.002571,0.9996790000000001,PSMD7 SF3A1 SF3B1 SF3B2 SF3B3 SMU1 SNRNP200 XAB2,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",1.26e-12|1.26e-12|1.349e-12|9.892e-12|3.28e-11,1.988e-08|9.938e-09|7.093e-09|3.901e-08|1.035e-07,59.67|59.67|59.08|44.28|37.23
3496,4,0.515,3.09,3115.0,0.0009886,0.9929309999999999,CYP26A1 CYP26C1 SFRP5 ZFP3,diterpenoid catabolic process|retinoic acid catabolic process|terpenoid catabolic process|negative regulation of retinoic acid receptor signaling pathway|isoprenoid catabolic process,5.937e-07|5.937e-07|1.018e-06|1.555e-06|1.865e-06,0.009365|0.004683|0.005351|0.006131|0.005885,2060|2060|1471|1144|1030
3497,4,0.5652,3.391,3220.0,0.00105,0.9929309999999999,CDK20 OR13C4 SFT2D1 TSPAN33,pore complex assembly|amyloid fibril formation|protein localization to plasma membrane|protein localization to cell periphery|protein maturation,0.004072|0.01256|0.03752|0.04486|0.04636,1|1|1|1|1,257.4|80.45|26.4|22|21.28
3498,4,0.5687,3.412,3177.0,0.00107,0.9929309999999999,CDRT1 FXYD3 MFN1 SFT2D2,mitochondrial membrane fusion|positive regulation of mitochondrial membrane potential|positive regulation of membrane potential|mitochondrial fusion|GTP metabolic process,0.0005825|0.002328|0.003297|0.003491|0.004846,1|1|1|1|1,2574|468.1|321.8|302.9|214.5
3499,4,0.522,3.1319999999999997,3150.0,0.0009906000000000001,0.9929309999999999,CYP3A7 GYS2 SFTA2 VAMP5,lipid hydroxylation|oxidative demethylation|glycogen biosynthetic process|glucan biosynthetic process|Golgi to plasma membrane protein transport,0.001553|0.003878|0.004459|0.004459|0.006007,1|1|1|1|1,735.5|271|234|234|171.6
3500,4,0.5031,3.0180000000000002,2916.0,0.001031,0.9929309999999999,PSMA6 SFTA3 SRP54 ZNF142,"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition|exocrine pancreas development|SRP-dependent cotranslational protein targeting to membrane, translocation|proteasomal ubiquitin-independent protein catabolic process|granulocyte differentiation",0.0005825|0.001165|0.001747|0.004459|0.005813,1|1|1|1|1,2574|1030|643.6|234|177.5
3501,16,0.5114,61.36,11840.0,0.00514,0.999999,CD19 CD79A CD79B CD81 DOCK2 EBF1 GNAI2 KLHL6 LDLRAP1 MEF2B ODC1 PAX5 RAC2 RHOH SFXN1 SYK,leukocyte differentiation|lymphocyte activation|lymphocyte differentiation|positive regulation of immune system process|cell activation,7.827e-09|1.563e-08|3.646e-08|4.135e-08|5.302e-08,0.0001235|0.0001233|0.0001917|0.0001631|0.0001673,24.02|21.69|29.31|10.35|10.06
3502,4,0.5591,3.355,3217.0,0.001039,0.9929309999999999,PNLIP SFXN3 SYNPO UBAC2,"spine apparatus assembly|modification of dendritic spine|serine import into mitochondrion|modification of postsynaptic structure|negative regulation of retrograde protein transport, ER to cytosol",0.0003883|0.0005825|0.0007766|0.001553|0.001941,1|1|1|1|1,5149|2574|1716|735.5|572.1
3503,4,0.5861,3.516,3247.0,0.0010789999999999999,0.9929309999999999,SGCG TMEM54 TSSK4 VIPR1,"peptidyl-threonine autophosphorylation|positive regulation of CREB transcription factor activity|G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger|peptidyl-threonine phosphorylation|peptidyl-threonine modification",0.0005825|0.004072|0.01314|0.01449|0.01621,1|1|1|1|1,2574|257.4|76.85|69.58|62.03
3504,4,0.5186,3.111,3065.0,0.001011,0.9929309999999999,GAMT RPS6KB1 SGK1 TRAPPC9,long-term memory|cellular response to corticosteroid stimulus|cellular response to ketone|regulation of growth|memory,1.778e-05|5.679e-05|0.0001255|0.0001279|0.0001905,0.2804|0.4479|0.66|0.5042|0.601,302.9|166.1|110.7|23.51|89.54
3505,4,0.5675,3.405,3197.0,0.0010609999999999999,0.9929309999999999,DAAM2 SGK2 WDR17 ZNF639,negative regulation of oligodendrocyte differentiation|regulation of cell growth|negative regulation by host of viral transcription|positive regulation by host of viral transcription|dorsal spinal cord development,0.002328|0.00241|0.003104|0.003297|0.004072,1|1|1|1|1,468.1|24.69|343.2|321.8|257.4
3506,6,0.5288,7.932,5640.0,0.001401,0.998474,ASB13 C19orf12 DNAI1 GJA9 HSD11B1 SGMS2,ceramide phosphoethanolamine biosynthetic process|ceramide phosphoethanolamine metabolic process|sphingomyelin biosynthetic process|glucocorticoid biosynthetic process|sphingomyelin metabolic process,0.001019|0.001019|0.002715|0.004071|0.005086,1|1|1|1|1,1471|1471|420.3|267.5|210.2
3507,4,0.5347,3.208,3282.0,0.0009741,0.9929309999999999,AK2 GPRC5C SGSH STC2,heparan sulfate proteoglycan catabolic process|proteoglycan catabolic process|ADP biosynthetic process|purine ribonucleoside diphosphate biosynthetic process|ribonucleoside diphosphate biosynthetic process,0.0007766|0.0009706|0.001165|0.001165|0.001359,1|1|1|1|1,1716|1287|1030|1030|858.1
3508,5,0.5337,5.337000000000001,4264.0,0.001247,0.996692,ABHD4 FUCA1 SH2B3 SUCLG2 ZNF362,negative regulation of Kit signaling pathway|regulation of Kit signaling pathway|monocyte homeostasis|thrombopoietin-mediated signaling pathway|succinyl-CoA metabolic process,0.0004854|0.0004854|0.000728|0.001456|0.001456,1|1|1|1|1,4119|4119|2060|823.8|823.8
3509,13,0.5053,39.41,10050.0,0.0038950000000000005,0.999993,AKAP2 C9orf84 FAM129B OR1J1 OR1J2 OR1J4 OR1L1 OR1L8 OR1N2 PALM2 SH2D3C TXNDC8 ZBTB6,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,4.246e-08|6.014e-08|7.502e-08|1.14e-07|1.42e-07,0.0006698|0.0004744|0.0003944|0.0004494|0.000448,25.47|24|23.11|21.52|20.73
3510,5,0.5144,5.144,4121.0,0.0012439999999999999,0.996692,FAM107B FAM76B FGFBP1 MDFI SH3BGR,positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis|dorsal/ventral axis specification|trophoblast giant cell differentiation|cytoplasmic sequestering of transcription factor,0.002183|0.002425|0.00291|0.003636|0.00412,1|1|1|1|1,514.9|457.7|374.5|294.2|257.4
3511,5,0.5125,5.125,4040.0,0.0012640000000000001,0.996692,BTN3A1 CD74 CEACAM21 FGF21 SH3BGRL2,macrophage migration inhibitory factor signaling pathway|positive regulation of lipid metabolic process|positive regulation of macrophage migration inhibitory factor signaling pathway|regulation of macrophage migration inhibitory factor signaling pathway|response to methionine,0.0004854|0.0005614|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|53.49|2060|1373|1373
3512,4,0.5031,3.0180000000000002,2947.0,0.0010199999999999999,0.9929309999999999,ARIH2 ASAP1 RAB40C SH3BP1,positive regulation of membrane tubulation|regulation of membrane tubulation|positive regulation of podosome assembly|positive regulation of GTPase activity|regulation of podosome assembly,0.001165|0.001553|0.001941|0.002365|0.002522,1|1|1|1|1,1030|735.5|572.1|24.93|429.1
3513,4,0.5301,3.181,3320.0,0.0009549,0.9929309999999999,FAIM KLK10 PTH SH3D21,positive regulation of osteoclast proliferation|regulation of osteoclast proliferation|negative regulation of bone mineralization involved in bone maturation|hormone-mediated apoptotic signaling pathway|negative regulation of apoptotic process in bone marrow cell,0.000728|0.001213|0.001213|0.001213|0.001456,1|1|1|1|1,2060|1030|1030|1030|823.8
3514,9,0.5127,18.46,6547.0,0.002803,0.9998530000000001,C7orf50 CHCHD1 CNIH4 FOXD4 HAMP NBEAL1 SH3RF2 ST20 TSPYL5,cellular response to radiation|regulation of protein ubiquitination|regulation of protein modification by small protein conjugation or removal|cellular response to abiotic stimulus|cellular response to environmental stimulus,5.299e-05|8.499e-05|0.0001291|0.0002855|0.0002855,0.8359|0.6703|0.6791|1|0.9008,38.79|33|28.6|21.79|21.79
3515,6,0.5017,7.526,5227.0,0.001434,0.998474,APBB2 SH3TC1 SMIM14 SORCS2 TLNRD1 ZKSCAN7,long-term synaptic depression|blastocyst hatching|organism emergence from protective structure|hatching|negative regulation of synaptic transmission,0.005522|0.007839|0.007839|0.007839|0.01792,1|1|1|1|1,190.7|132|132|132|56.27
3516,4,0.5292,3.175,3197.0,0.0009897,0.9929309999999999,DDX60 SH3YL1 USP53 WFIKKN2,positive regulation of MDA-5 signaling pathway|regulation of MDA-5 signaling pathway|positive regulation of RIG-I signaling pathway|regulation of RIG-I signaling pathway|regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,0.0009706|0.001553|0.002134|0.004072|0.004653,1|1|1|1|1,1287|735.5|514.9|257.4|223.9
3517,5,0.5247,5.247000000000001,4241.0,0.001233,0.996692,ACAD10 CTNNAL1 KBTBD4 SHANK1 TTC9C,determination of affect|sensory processing|habituation|synaptic growth at neuromuscular junction|nonassociative learning,0.0004854|0.001213|0.001213|0.001456|0.001698,1|1|1|1|1,4119|1030|1030|823.8|686.5
3518,4,0.5447,3.2680000000000002,3219.0,0.0010119999999999999,0.9929309999999999,SHC2 SNX27 TXNIP WFDC1,response to estradiol|establishment of natural killer cell polarity|cellular response to tumor cell|establishment of lymphocyte polarity|response to drug,0.0002727|0.0003883|0.0005825|0.001941|0.002039,1|1|1|1|1,74.62|5149|2574|572.1|26.89
3519,4,0.5355,3.213,3340.0,0.0009589,0.9929309999999999,CCNI2 HOGA1 LGALS3 SHCBP1L,oxalate metabolic process|male meiosis cytokinesis|negative regulation of immunological synapse formation|negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell|regulation of immunological synapse formation,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
3520,4,0.5254,3.1519999999999997,3249.0,0.0009668,0.9929309999999999,C18orf54 IGDCC4 RTP5 SHISA2,negative regulation of fibroblast growth factor receptor signaling pathway|regulation of fibroblast growth factor receptor signaling pathway|detection of chemical stimulus involved in sensory perception of bitter taste|sensory perception of bitter taste|detection of chemical stimulus involved in sensory perception of taste,0.003685|0.0062|0.007166|0.008131|0.008324,1|1|1|1|1,286|166.1|143|125.6|122.6
3521,4,0.5446,3.2680000000000002,3176.0,0.001025,0.9929309999999999,HBEGF LDLRAD3 LRRC75A SHISA6,negative regulation of elastin biosynthetic process|regulation of elastin biosynthetic process|regulation of signaling receptor activity|regulation of glutamate receptor clustering|regulation of AMPA glutamate receptor clustering,0.0003883|0.0003883|0.0005337|0.001359|0.001359,1|1|1|1|1,5149|5149|53.08|858.1|858.1
3522,5,0.5079,5.079,3982.0,0.001271,0.996692,ATG4C CYR61 HMGCS2 MS4A6A SHISAL2A,"isoprenoid biosynthetic process via mevalonate|farnesyl diphosphate biosynthetic process, mevalonate pathway|farnesyl diphosphate biosynthetic process|farnesyl diphosphate metabolic process|ketone body biosynthetic process",0.0005825|0.0005825|0.0009706|0.001165|0.001941,1|1|1|1|1,2574|2574|1287|1030|572.1
3523,5,0.5387,5.3870000000000005,4242.0,0.001265,0.996692,ATP2A1 CD8B INPP1 SHISAL2B TMEM163,positive regulation of actin filament-based movement|positive regulation of cardiac muscle cell contraction|positive regulation of calcium ion import into sarcoplasmic reticulum|maintenance of mitochondrion location|zinc ion import into synaptic vesicle,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
3524,4,0.5201,3.12,3262.0,0.0009533999999999999,0.9929309999999999,ANO4 OPN1SW SHKBP1 WNT9A,calcium activated galactosylceramide scrambling|calcium activated phosphatidylserine scrambling|calcium activated phosphatidylcholine scrambling|calcium activated phospholipid scrambling|iris morphogenesis,0.0009706|0.0009706|0.001165|0.001359|0.001941,1|1|1|1|1,1287|1287|1030|858.1|572.1
3525,5,0.5004,5.004,4086.0,0.00122,0.996692,AGO4 COL8A2 SHROOM1 SNX15 ZNF691,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",0.00194|0.002183|0.002425|0.003394|0.003394,1|1|1|1|1,588.4|514.9|457.7|316.8|316.8
3526,4,0.5582,3.3489999999999998,3333.0,0.0010019999999999999,0.9929309999999999,ACTA2 CERS3 F2RL3 SHTN1,actin filament bundle distribution|actin filament bundle retrograde transport|endoplasmic reticulum polarization|cytoplasmic actin-based contraction involved in cell motility|glomerular mesangial cell development,0.0003883|0.0003883|0.0003883|0.0007766|0.001165,1|1|1|1|1,5149|5149|5149|1716|1030
3527,4,0.5284,3.17,3240.0,0.000975,0.9929309999999999,MBNL2 SIDT2 TTC39A ZNF106,type B pancreatic cell proliferation|type B pancreatic cell development|glandular epithelial cell development|type B pancreatic cell differentiation|enteroendocrine cell differentiation,0.001941|0.003104|0.004266|0.004266|0.004653,1|1|1|1|1,572.1|343.2|245.2|245.2|223.9
3528,16,0.5086,61.03,13230.0,0.004582,0.999999,C5AR1 C5AR2 CABP5 CRX EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 KLK11 KLK3 LHB SPHK2 SULT2A1 SULT2B1,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,2.592e-07|3.838e-06|3.506e-05|3.506e-05|3.506e-05,0.004089|0.03027|0.1843|0.1383|0.1106,279.6|1211|269.2|269.2|269.2
3529,4,0.5374,3.225,3251.0,0.0009883,0.9929309999999999,CRYGA GUCA1C KCNN2 SIL1,visual perception|sensory perception of light stimulus|atrial cardiac muscle cell membrane repolarization|membrane repolarization during atrial cardiac muscle cell action potential|positive regulation of guanylate cyclase activity,0.0006596|0.0006839|0.001165|0.001165|0.001941,1|1|1|1|1,47.67|46.81|1030|1030|572.1
3530,5,0.5091,5.091,4166.0,0.001218,0.996692,ENTPD7 FAM149A MKKS PTGFR SIM1,UTP catabolic process|CTP catabolic process|pyrimidine ribonucleoside triphosphate catabolic process|pigment granule aggregation in cell center|UDP catabolic process,0.0005824|0.0005824|0.0005824|0.0008735|0.0008735,1|1|1|1|1,3432|3432|3432|1716|1716
3531,4,0.5201,3.1210000000000004,3135.0,0.0009919,0.9929309999999999,DNAJC22 PCNP SIPA1L2 ZNF398,activation of GTPase activity|cellular process|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of small GTPase mediated signal transduction|proteasomal protein catabolic process,0.02253|0.04971|0.06145|0.06219|0.06552,1|1|1|1|1,44.39|0.3325|15.94|15.75|14.92
3532,4,0.543,3.258,3009.0,0.0010789999999999999,0.9929309999999999,KCNG3 RPN1 SIX1 SIX2,kidney mesenchyme development|middle ear morphogenesis|regulation of branching involved in ureteric bud morphogenesis|regulation of kidney development|embryonic cranial skeleton morphogenesis,8.939e-06|9.879e-06|1.19e-05|2.481e-05|5.517e-05,0.141|0.07792|0.06257|0.09784|0.1741,457.7|433.6|392.3|265.7|175.3
3533,4,0.515,3.09,3076.0,0.001001,0.9929309999999999,CBR1 SKA2 SNX31 TRPT1,"vitamin K metabolic process|cyclooxygenase pathway|tRNA splicing, via endonucleolytic cleavage and ligation|RNA splicing, via endonucleolytic cleavage and ligation|prostaglandin biosynthetic process",0.001747|0.002328|0.003104|0.003297|0.004072,1|1|1|1|1,643.6|468.1|343.2|321.8|257.4
3534,5,0.5669,5.669,3617.0,0.0015609999999999999,0.996692,ETV6 FLI1 RNF216 TRIM11 TRIM8,negative regulation of viral release from host cell|negative regulation of viral transcription|negative regulation of viral entry into host cell|negative regulation of viral life cycle|regulation of viral release from host cell,6.401e-06|7.2e-06|1.298e-05|1.777e-05|2.331e-05,0.101|0.05679|0.06825|0.07008|0.07354,549.2|514.9|374.5|316.8|274.6
3535,4,0.5529,3.318,3244.0,0.001019,0.9929309999999999,DNAH14 ERO1A SLAIN2 TMEM135,response to temperature stimulus|animal organ senescence|protein maturation by protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline|protein folding in endoplasmic reticulum,0.0003925|0.0007766|0.001747|0.002134|0.002328,1|1|1|1|1,62.03|1716|643.6|514.9|468.1
3536,26,0.506,164.5,19550.0,0.008322,1.0,CD1B CD1C CD1E CLK2 CTSK EFNA4 FCGR2B FCGR3A FCRL3 GBA HAPLN2 ITLN2 KCNJ10 LCE3E OR10J5 OR6K6 PGLYRP3 S100A12 S100A2 S100A4 S100A8 S100A9 SLAMF7 THBS3 TTC24 YY1AP1,"antigen processing and presentation, endogenous lipid antigen via MHC class Ib|antigen processing and presentation, exogenous lipid antigen via MHC class Ib|antigen processing and presentation of lipid antigen via MHC class Ib|regulation of T cell mediated cytotoxicity|antigen processing and presentation via MHC class Ib",9.923e-08|2.123e-07|2.123e-07|2.151e-07|1.196e-06,0.001565|0.001674|0.001116|0.0008482|0.003773,475.3|339.5|339.5|83.38|169.7
3537,5,0.5371,5.371,4150.0,0.0012900000000000001,0.996692,FDCSP HECA OTUB2 SLAMF8 TNS1,B-1 B cell lineage commitment|negative regulation of dendritic cell chemotaxis|negative regulation of neutrophil migration|negative regulation of histone ubiquitination|negative regulation of histone H2A K63-linked ubiquitination,0.0004854|0.0004854|0.001213|0.001213|0.001213,1|1|1|1|1,4119|4119|1030|1030|1030
3538,4,0.5364,3.218,3195.0,0.001004,0.9929309999999999,CDH20 REG1A SLC14A1 USP50,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration,4.441e-05|0.0004854|0.0004854|0.0004854|0.0004854,0.7005|1|1|1|1,196.1|4119|4119|4119|4119
3539,19,0.5004,85.57,15640.0,0.0054280000000000005,1.0,B4GALT6 C18orf32 CABLES1 CHST9 CTIF DSC1 DSG1 DSG2 DSG3 DSG4 HRH4 MAPRE2 RIT2 SERPINB5 SERPINB7 SLC14A2 ZBTB7C ZNF396 ZNF397,cornification|homophilic cell adhesion via plasma membrane adhesion molecules|keratinization|cell-cell adhesion via plasma-membrane adhesion molecules|keratinocyte differentiation,6.155e-08|4.036e-07|1.731e-06|3.33e-06|3.923e-06,0.0009708|0.003183|0.009102|0.01313|0.01238,47.96|32.45|23.98|20.93|20.22
3540,4,0.5036,3.022,2989.0,0.001007,0.9929309999999999,RPL24 SLC15A4 TRMT10C UNG,"amino acid transmembrane export from vacuole|mast cell homeostasis|L-histidine transport|base-excision repair, AP site formation via deaminated base removal|L-histidine transmembrane export from vacuole",0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3541,4,0.55,3.3,3243.0,0.0010140000000000001,0.9929309999999999,FAM227B PRRG2 RTN3 SLC16A14,endoplasmic reticulum tubular network formation|endoplasmic reticulum tubular network organization|negative regulation of amyloid-beta formation|negative regulation of amyloid precursor protein catabolic process|regulation of amyloid-beta formation,0.0009706|0.003104|0.003685|0.004266|0.006973,1|1|1|1|1,1287|343.2|286|245.2|147.1
3542,4,0.5225,3.135,2976.0,0.001049,0.9929309999999999,CD300LD RPS6KB1 SLC16A3 USP24,plasma membrane lactate transport|response to electrical stimulus involved in regulation of muscle adaptation|organic acid transport|positive regulation of skeletal muscle tissue growth|lactate transmembrane transport,0.0007766|0.0009706|0.001108|0.001359|0.001553,1|1|1|1|1,1716|1287|36.65|858.1|735.5
3543,4,0.5706,3.424,3463.0,0.0009854,0.9929309999999999,ITGBL1 RSRC1 SLC16A5 SPATA4,"alternative mRNA splicing, via spliceosome|cell adhesion mediated by integrin|response to antibiotic|integrin-mediated signaling pathway|cell-matrix adhesion",0.004266|0.00504|0.009675|0.01909|0.02444,1|1|1|1|1,245.2|205.9|105.1|52.54|40.86
3544,4,0.5339,3.2039999999999997,3012.0,0.00106,0.9929309999999999,FBXL4 LRIG3 PPTC7 SLC16A7,regulation of ubiquinone biosynthetic process|otolith morphogenesis|pyruvate transport|pyruvate transmembrane transport|DNA ligation involved in DNA repair,0.0005825|0.0009706|0.001165|0.001165|0.001553,1|1|1|1|1,2574|1287|1030|1030|735.5
3545,4,0.5171,3.103,3156.0,0.0009798,0.9929309999999999,CHST13 KCNQ4 SLC17A1 ZSCAN23,sialic acid transport|urate transport|urate metabolic process|phosphate ion transmembrane transport|phosphate ion transport,0.001165|0.001359|0.00291|0.003104|0.004072,1|1|1|1|1,1030|858.1|367.8|343.2|257.4
3546,4,0.5297,3.178,2901.0,0.001092,0.9929309999999999,CD300LG PPP1R12A SLC18A1 SPECC1L,positive regulation of myosin-light-chain-phosphatase activity|aminergic neurotransmitter loading into synaptic vesicle|serotonin uptake|regulation of myosin-light-chain-phosphatase activity|neurotransmitter loading into synaptic vesicle,0.0003883|0.0009706|0.001553|0.001553|0.001747,1|1|1|1|1,5149|1287|735.5|735.5|643.6
3547,17,0.5006,68.09,13640.0,0.004953,1.0,ATXN7L3B CCNB1IP1 KIF26B LRRN1 LYRM1 MAP3K7CL PCDH10 PCDHA4 PCDHB12 PCDHB13 PCDHB16 PCDHGA9 PCDHGB1 RNF150 SDR39U1 TMEM100 ZNF286A,homophilic cell adhesion via plasma membrane adhesion molecules|cell-cell adhesion via plasma-membrane adhesion molecules|cell-cell adhesion|cell adhesion|biological adhesion,7.961e-11|1.552e-09|1.582e-07|9.289e-06|9.677e-06,1.256e-06|1.224e-05|0.0008319|0.03663|0.03053,47.96|30.92|15.58|8.422|8.369
3548,6,0.5067,7.6,5133.0,0.001475,0.998474,GP6 LAIR2 LILRA2 NLRP4 OR51V1 SLC22A1,granulocyte colony-stimulating factor production|granulocyte macrophage colony-stimulating factor production|acetate ester transport|epinephrine transport|xenobiotic transport across blood-brain barrier,0.0005824|0.0005824|0.001165|0.001456|0.001746,1|1|1|1|1,3432|3432|1144|858.1|686.5
3549,4,0.5294,3.176,3248.0,0.0009747,0.9929309999999999,CCDC184 IGSF6 SLC22A18 WNT2B,lung induction|regulation of branching involved in lung morphogenesis|mesenchymal-epithelial cell signaling|xenobiotic detoxification by transmembrane export across the plasma membrane|iris morphogenesis,0.0007766|0.001359|0.001553|0.001747|0.001941,1|1|1|1|1,1716|858.1|735.5|643.6|572.1
3550,4,0.5417,3.25,3293.0,0.0009835,0.9929309999999999,PATE3 SLC23A1 TRIM4 ZFP14,transepithelial L-ascorbic acid transport|L-ascorbic acid transmembrane transport|L-ascorbic acid metabolic process|vitamin transmembrane transport|transepithelial transport,2.827e-07|2.827e-07|3.672e-06|8.046e-06|1.777e-05,0.00446|0.00223|0.01931|0.03173|0.05606,4119|4119|748.9|484.6|316.8
3551,5,0.5008,5.008,4218.0,0.001183,0.996692,CDH24 GAA OSM SDCBP2 SLC23A3,vacuolar sequestering|diaphragm contraction|involuntary skeletal muscle contraction|sucrose metabolic process|maltose metabolic process,0.0004854|0.000728|0.0009706|0.0009706|0.0009706,1|1|1|1|1,4119|2060|1373|1373|1373
3552,4,0.5918,3.551,3301.0,0.001072,0.9929309999999999,GAREM2 NKAIN1 PRADC1 SLC25A21,mitochondrial alpha-ketoglutarate transmembrane transport|alpha-ketoglutarate transport|lysine catabolic process|lysine metabolic process|aspartate family amino acid catabolic process,0.0003883|0.0009706|0.002522|0.002716|0.004653,1|1|1|1|1,5149|1287|429.1|396.1|223.9
3553,4,0.5311,3.1860000000000004,3085.0,0.001029,0.9929309999999999,APOL3 ILKAP SLC25A22 TRPM6,malate-aspartate shuttle|lipid transport|aspartate transmembrane transport|lipid localization|L-aspartate transmembrane transport,0.0009706|0.001845|0.001941|0.002199|0.002328,1|1|1|1|1,1287|28.29|572.1|25.87|468.1
3554,8,0.5022,14.06,5971.0,0.002343,0.9996790000000001,FUT5 FUT6 PLIN3 SLC25A23 SLC25A41 UQCR11 ZNF556 ZNF77,fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process|fucose metabolic process|fucosylation,7.244e-06|7.244e-06|7.244e-06|2.012e-05|2.249e-05,0.1143|0.05713|0.03809|0.07935|0.07094,572.1|572.1|572.1|321.8|302.9
3555,5,0.5208,5.207999999999999,4353.0,0.001192,0.996692,C6orf203 CEP57L1 PPP3CB SLC25A42 TNFRSF17,"lymphocyte homeostasis|leukocyte homeostasis|adenosine 3',5'-bisphosphate transmembrane transport|coenzyme A transport|coenzyme A transmembrane transport",6.463e-05|0.0001163|0.000728|0.000728|0.000728,1|0.9176|1|1|1,161.5|119.4|2060|2060|2060
3556,26,0.5041,163.8,19840.0,0.008167,1.0,ACTR3B AGBL3 CPA1 EPHB6 FAM71F2 MGAM OR2A2 OR2A5 OR6V1 OR9A2 OR9A4 PRSS1 PRSS37 PRSS58 RNF148 TAS2R39 TAS2R40 TAS2R60 TRPV5 TRPV6 ZNF212 ZNF282 ZNF398 ZNF425 ZNF783 ZNF786,sensory perception of chemical stimulus|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|detection of stimulus involved in sensory perception|sensory perception,1.984e-08|1.524e-07|2.606e-07|4.069e-07|2.616e-06,0.000313|0.001202|0.00137|0.001604|0.008252,12.67|12.56|11.69|11.01|7.055
3557,8,0.5218,14.61,5370.0,0.002705,0.9996790000000001,CCNL1 CDK11A CTNNBL1 MMP23B PPP1R8 PRPF19 SAP30BP WBP11,RNA splicing|RNA processing|mRNA processing|nucleic acid metabolic process|mRNA metabolic process,1.816e-05|1.986e-05|3.564e-05|0.0001024|0.0001436,0.2865|0.1566|0.1874|0.4039|0.4531,22.49|12.4|18.91|6.151|13.19
3558,4,0.5329,3.197,3063.0,0.0010400000000000001,0.9929309999999999,GDNF NKX6-2 SLC28A3 ZDHHC4,postganglionic parasympathetic fiber development|regulation of semaphorin-plexin signaling pathway|positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis|positive regulation of ureteric bud formation|regulation of ureteric bud formation,0.0005825|0.0007766|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2574|1716|1287|1287|1287
3559,4,0.5294,3.176,3242.0,0.0009763,0.9929309999999999,DCK PAIP2 SLC29A1 TK1,deoxyribonucleoside monophosphate biosynthetic process|pyrimidine nucleoside salvage|pyrimidine-containing compound salvage|pyrimidine nucleoside biosynthetic process|nucleoside salvage,1.272e-06|2.204e-06|2.204e-06|4.323e-06|4.323e-06,0.02007|0.01739|0.01159|0.01705|0.01364,1287|936.1|936.1|643.6|643.6
3560,4,0.5728,3.437,3305.0,0.001036,0.9929309999999999,AMN SLC2A9 SMIM2 TMEM204,urate transport|cobalamin transport|high-density lipoprotein particle clearance|urate metabolic process|cobalamin metabolic process,0.001359|0.001747|0.002134|0.00291|0.004266,1|1|1|1|1,858.1|643.6|514.9|367.8|245.2
3561,5,0.5256,5.256,4016.0,0.0013039999999999998,0.996692,FUT8 GMDS RAB15 SLC30A10 SLC35C1,GDP-L-fucose metabolic process|fucosylation|nucleotide-sugar metabolic process|carbohydrate derivative biosynthetic process|protein glycosylation in Golgi,7.067e-07|8.046e-06|3.663e-05|0.0002435|0.0004854,0.01115|0.06346|0.1926|0.9604|1,2060|484.6|216.8|20.46|4119
3562,5,0.5249,5.249,3920.0,0.001334,0.996692,ARL6 C12orf71 LRRC14 RAB11FIP1 SLC32A1,negative regulation of adiponectin secretion|regulation of adiponectin secretion|neurotransmitter loading into synaptic vesicle|gamma-aminobutyric acid transport|glycine transport,0.001213|0.001698|0.002183|0.002425|0.00291,1|1|1|1|1,1030|686.5|514.9|457.7|374.5
3563,4,0.5207,3.1239999999999997,3194.0,0.0009747,0.9929309999999999,ANKS1B FAM160A2 IGIP SLC35A4,regulation of synaptic plasticity by receptor localization to synapse|positive regulation of translation in response to stress|pyrimidine nucleotide-sugar transmembrane transport|nucleotide-sugar transmembrane transport|regulation of translation in response to stress,0.0003883|0.001941|0.002328|0.002522|0.004072,1|1|1|1|1,5149|572.1|468.1|429.1|257.4
3564,4,0.5518,3.3110000000000004,3257.0,0.001013,0.9929309999999999,GRINA RASGRF1 RSPH9 SLC35D1,radial spoke assembly|UDP-glucuronate biosynthetic process|UDP-N-acetylgalactosamine transmembrane transport|UDP-glucuronic acid transmembrane transport|UDP-glucuronate metabolic process,0.0005825|0.0007766|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|1716|1716|1716|1287
3565,13,0.5194,40.51,8577.0,0.004686999999999999,0.999993,BUB3 C1orf109 DAD1 DHX33 DPAGT1 FARSB MYBBP1A OSGEP POP5 RPP21 SPATA5L1 THG1L WDR18,tRNA metabolic process|tRNA 5'-end processing|ncRNA metabolic process|ncRNA 5'-end processing|RNA 5'-end processing,6.888e-08|1.889e-07|3.829e-07|3.939e-07|5.056e-07,0.001087|0.00149|0.002013|0.001553|0.001595,43.76|297|18.39|226.3|206.6
3566,4,0.5504,3.303,3207.0,0.001026,0.9929309999999999,HAND1 PRRT2 SLC35G2 TREX1,detection of DNA damage stimulus involved in DNA damage checkpoint|detection of stimulus involved in cell cycle checkpoint|immune response in brain or nervous system|detection of endogenous biotic stimulus|negative regulation of short-term synaptic potentiation,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3567,9,0.5093,18.34,7072.0,0.0025800000000000003,0.9998530000000001,ABHD16A ATAT1 C6orf48 CFB CLIC1 MICB MSH5 NEU1 TNXB,lipid catabolic process|positive regulation of hindgut contraction|acylglycerol metabolic process|neutral lipid metabolic process|response to retinoic acid,0.0002575|0.0008734|0.0009392|0.0009567|0.0009922,1|1|1|1|1,22.58|2288|43.59|43.18|42.38
3568,5,0.5062,5.062,3434.0,0.001468,0.996692,BCAS2 CTNNBL1 POM121L12 PPP1R8 SLC39A5,RNA splicing|mRNA processing|mRNA metabolic process|response to zinc ion starvation|cellular response to zinc ion starvation,7.597e-05|0.0001267|0.0003665|0.000728|0.000728,1|0.9996|1|1|1,30.36|25.53|17.81|2060|2060
3569,4,0.5041,3.025,2990.0,0.001008,0.9929309999999999,IFITM2 IFITM3 KEL SLC3A1,negative regulation of viral entry into host cell|response to interferon-alpha|negative regulation of viral life cycle|response to interferon-beta|regulation of viral entry into host cell,7.795e-06|9.177e-06|1.067e-05|1.583e-05|2.792e-05,0.123|0.07238|0.05612|0.06244|0.08809,468.1|429.1|396.1|321.8|239.5
3570,4,0.5783,3.47,3358.0,0.00103,0.9929309999999999,DCUN1D2 MTTP PLCL1 SLC40A1,iron ion export across plasma membrane|triglyceride transport|acylglycerol transport|positive regulation of protein neddylation|multicellular organismal iron ion homeostasis,0.0003883|0.001165|0.001165|0.001165|0.001553,1|1|1|1|1,5149|1030|1030|1030|735.5
3571,4,0.5372,3.2230000000000003,3234.0,0.0009931,0.9929309999999999,DEFB123 MOBP NET1 SLC44A1,neurotransmitter uptake|sodium ion transmembrane transport|neurotransmitter transport|glycine import across plasma membrane|sodium ion transport,4.58e-05|0.0007163|0.0009957|0.001019|0.001482,0.7225|1|1|1|1,202.9|49.04|41.44|1471|33.82
3572,4,0.5529,3.3169999999999997,3362.0,0.0009835,0.9929309999999999,HOPX NR2E1 SGSM3 SLC45A1,regulation of timing of neuron differentiation|amygdala development|oligosaccharide transport|sucrose transport|disaccharide transport,0.0007766|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1716|1287|1287|1287|1287
3573,4,0.5733,3.44,3298.0,0.001039,0.9929309999999999,MLH3 RBCK1 SLC48A1 ZNF853,protein linear polyubiquitination|female meiosis I|heme transport|negative regulation of necroptotic process|iron coordination entity transport,0.0007766|0.001941|0.002134|0.002716|0.00291,1|1|1|1|1,1716|572.1|514.9|396.1|367.8
3574,4,0.5394,3.236,3195.0,0.001009,0.9929309999999999,GPR156 RHPN2 SLC49A3 ZCCHC4,gamma-aminobutyric acid signaling pathway|rRNA methylation|rRNA modification|RNA methylation|positive regulation of translation,0.005426|0.00562|0.007938|0.01679|0.02634,1|1|1|1|1,190.7|183.9|128.7|59.87|37.86
3575,5,0.5052,5.052,4036.0,0.001247,0.996692,ACSS2 SLC4A11 SYNJ2BP TRAF3IP3 ZFP82,borate transmembrane transport|borate transport|acetyl-CoA biosynthetic process from acetate|acetate biosynthetic process|acetate metabolic process,0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
3576,4,0.5343,3.2060000000000004,3064.0,0.001042,0.9929309999999999,HRASLS2 KIAA1549 SLC22A9 SLC6A2,short-chain fatty acid import|short-chain fatty acid transport|catecholamine uptake involved in synaptic transmission|dopamine uptake involved in synaptic transmission|norepinephrine uptake,0.0005825|0.0007766|0.001165|0.001165|0.001359,1|1|1|1|1,2574|1716|1030|1030|858.1
3577,4,0.5718,3.431,3365.0,0.001016,0.9929309999999999,EDEM2 FAM83C RAB3B SLC6A9,positive regulation of ion transport|positive regulation of transport|positive regulation of tetrapyrrole biosynthetic process|positive regulation of heme biosynthetic process|positive regulation of iron ion transmembrane transporter activity,0.0001603|0.0003649|0.0003883|0.0003883|0.0003883,1|1|1|1|1,21.79|16.5|5149|5149|5149
3578,5,0.5474,5.474,4105.0,0.001328,0.996692,DUOXA1 LRRIQ4 RTP1 SLC51A SLC7A14,organic substance transport|anion transport|positive regulation of hydrogen peroxide biosynthetic process|regulation of thyroid hormone generation|bile acid secretion,0.0005665|0.0006953|0.001456|0.001698|0.001698,1|1|1|1|1,7.593|7.204|823.8|686.5|686.5
3579,4,0.5448,3.2689999999999997,3199.0,0.001018,0.9929309999999999,ALDOB FAM135B SLC8A1 TPP1,cellular monovalent inorganic cation homeostasis|monovalent inorganic cation homeostasis|response to nutrient|vitamin E metabolic process|NADH oxidation,0.0003217|0.0005192|0.0006739|0.001213|0.001456,1|1|1|1|1,71.02|55.66|48.75|1030|823.8
3580,4,0.5499,3.299,3242.0,0.0010140000000000001,0.9929309999999999,CCDC140 CYTH3 SLC9A9 VWA3B,sodium ion import across plasma membrane|regulation of ARF protein signal transduction|establishment of epithelial cell polarity|inorganic ion import across plasma membrane|inorganic cation import across plasma membrane,0.003878|0.003878|0.0062|0.01621|0.01621,1|1|1|1|1,271|271|166.1|62.03|62.03
3581,7,0.5196,10.91,5791.0,0.001876,0.9992989999999999,RETSAT RNF103 SFTPB SLC9B1 TEX37 THNSL2 TRABD2A,2-oxobutyrate biosynthetic process|positive regulation of protein oxidation|regulation of protein oxidation|2-oxobutyrate metabolic process|short-chain fatty acid biosynthetic process,0.0006794|0.001019|0.001019|0.001019|0.001698,1|1|1|1|1,2942|1471|1471|1471|735.5
3582,4,0.6075,3.645,3265.0,0.001112,0.9929309999999999,FLVCR2 GAS6 SLCO3A1 ZNF782,negative regulation of renal albumin absorption|negative regulation of oligodendrocyte apoptotic process|regulation of renal albumin absorption|cellular response to vitamin K|regulation of oligodendrocyte apoptotic process,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
3583,4,0.5261,3.157,2925.0,0.001075,0.9929309999999999,SLCO5A1 SNAPC2 TIMM44 XAB2,"generation of catalytic spliceosome for first transesterification step|spliceosomal conformational changes to generate catalytic conformation|sodium-independent organic anion transport|protein import into mitochondrial matrix|transcription, DNA-templated",0.0007766|0.001359|0.003297|0.004072|0.004194,1|1|1|1|1,1716|858.1|321.8|257.4|18.62
3584,4,0.5621,3.372,3198.0,0.001051,0.9929309999999999,ARHGAP44 ILDR1 SLIT1 TMEM200A,"modification of dendritic spine|regulation of synapse organization|regulation of synapse structure or activity|dorsal/ventral axon guidance|regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane",0.0005825|0.0006123|0.0006778|0.0007766|0.0007766,1|1|1|1|1,2574|49.51|47.02|1716|1716
3585,4,0.5182,3.109,3052.0,0.001015,0.9929309999999999,MRI1 PRKAR2A SLIT2 UBALD2,induction of negative chemotaxis|positive regulation of negative chemotaxis|corticospinal neuron axon guidance through spinal cord|negative regulation of axon guidance|negative regulation of retinal ganglion cell axon guidance,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
3586,6,0.5191,7.7860000000000005,5224.0,0.001485,0.998474,F13B RSPO4 SLC49A3 SLIT3 SPO11 THPO,female gonad development|development of primary female sexual characteristics|female sex differentiation|apoptotic process involved in luteolysis|meiotic DNA double-strand break processing,0.0002862|0.0003184|0.0004179|0.001165|0.001456,1|1|1|1|1,77.13|73.03|63.56|1144|858.1
3587,5,0.5242,5.242000000000001,3315.0,0.001574,0.996692,CASC3 SMG6 SMG7 SMG8 SMG9,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|nuclear-transcribed mRNA catabolic process|mRNA catabolic process|RNA catabolic process|nucleobase-containing compound catabolic process",7.59e-12|8.416e-11|1.358e-10|2.581e-10|2.081e-09,1.197e-07|6.637e-07|7.143e-07|1.018e-06|6.566e-06,171.6|105.1|95.35|83.72|54.92
3588,4,0.514,3.0839999999999996,3161.0,0.0009722999999999999,0.9929309999999999,ACTL9 ALKAL2 CD302 SMIM24,positive regulation of ERK5 cascade|regulation of ERK5 cascade|positive regulation of protein tyrosine kinase activity|regulation of protein tyrosine kinase activity|positive regulation of neuron projection development,0.0005825|0.0005825|0.01199|0.01832|0.03033,1|1|1|1|1,2574|2574|84.41|54.77|32.79
3589,5,0.5012,5.012,4266.0,0.0011710000000000002,0.996692,CNTFR HHIPL1 MAST4 RGCC SMIM5,negative regulation of exit from mitosis|negative regulation of fibroblast growth factor production|positive regulation of extracellular matrix constituent secretion|ciliary neurotrophic factor-mediated signaling pathway|regulation of fibroblast growth factor production,0.0004854|0.000728|0.0009706|0.001456|0.001698,1|1|1|1|1,4119|2060|1373|823.8|686.5
3590,4,0.5531,3.318,3293.0,0.001004,0.9929309999999999,EVC2 SMLR1 TMEM45A ZNRF1,protein K48-linked ubiquitination|smoothened signaling pathway|protein polyubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|proteasomal protein catabolic process,0.01122|0.01372|0.06127|0.06145|0.06552,1|1|1|1|1,90.33|73.55|15.99|15.94|14.92
3591,5,0.5463,5.462999999999999,4347.0,0.0012519999999999999,0.996692,CPLX3 GRM7 SMOC1 TRIM60 ZNF106,negative regulation of glutamate secretion|adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway|regulation of synaptic vesicle fusion to presynaptic active zone membrane|negative regulation of amino acid transport|G protein-coupled glutamate receptor signaling pathway,0.001456|0.00194|0.002183|0.003394|0.003878,1|1|1|1|1,823.8|588.4|514.9|316.8|274.6
3592,5,0.5527,5.527,3889.0,0.001416,0.996692,MERTK OSBPL5 PCTP SRRD TOM1L1,phospholipid transport|organophosphate ester transport|regulation of tetrapyrrole biosynthetic process|regulation of heme biosynthetic process|organonitrogen compound metabolic process,0.0002086|0.0004146|0.0009706|0.0009706|0.00108,1|1|1|1|1,88.58|62.41|1373|1373|3.922
3593,7,0.5058,10.62,4847.0,0.0021809999999999998,0.9992989999999999,ANLN DIAPH3 ECT2 FLII KIF20A SEPT11 SMTN,cytoskeleton-dependent cytokinesis|cytokinesis|mitotic cytokinesis|cell division|cytoskeleton organization,1.809e-08|2.86e-08|1.359e-06|1.097e-05|1.312e-05,0.0002853|0.0002256|0.007147|0.04325|0.0414,122.6|109|129.8|23.92|12.22
3594,5,0.5044,5.044,4098.0,0.0012259999999999999,0.996692,C12orf10 ISM1 PRICKLE1 SNAI3 TNFSF14,negative regulation of cardiac muscle cell myoblast differentiation|regulation of cardiac muscle cell myoblast differentiation|negative regulation of cardioblast differentiation|regulation of cardioblast differentiation|negative regulation of cardiocyte differentiation,0.0004854|0.0004854|0.000728|0.002183|0.00291,1|1|1|1|1,4119|4119|2060|514.9|374.5
3595,4,0.5032,3.0189999999999997,3182.0,0.0009456,0.9929309999999999,DOPEY2 HEPACAM IFT80 SNAP91,articular cartilage development|osteoblast proliferation|receptor localization to non-motile cilium|negative regulation of non-canonical Wnt signaling pathway|protein localization,0.0005825|0.0008737|0.0008737|0.001019|0.001153,1|1|1|1|1,2288|1373|1373|1144|9.544
3596,6,0.5062,7.593,3998.0,0.0018899999999999998,0.998474,DDX39A DDX39B RBM33 SNRPA THOC6 XPO4,protein export from nucleus|nuclear export|nucleocytoplasmic transport|nuclear transport|mRNA 3'-end processing,4.69e-08|6.628e-08|3.817e-07|3.995e-07|1.652e-06,0.0007398|0.0005228|0.002007|0.001575|0.005211,90.33|82.71|53.01|52.4|117
3597,5,0.5341,5.341,4198.0,0.001268,0.996692,DCAKD ETNPPL SNTA1 ST8SIA4 UBQLN4,regulation of vasoconstriction by circulating norepinephrine|regulation of vasoconstriction by norepinephrine|negative regulation of peptidyl-cysteine S-nitrosylation|negative regulation of autophagosome maturation|regulation of peptidyl-cysteine S-nitrosylation,0.0004854|0.0004854|0.001456|0.001698|0.002183,1|1|1|1|1,4119|4119|823.8|686.5|514.9
3598,4,0.5068,3.0410000000000004,3099.0,0.0009777000000000002,0.9929309999999999,APAF1 CHST4 PRSS23 SNTB2,response to G1 DNA damage checkpoint signaling|response to mitotic cell cycle checkpoint signaling|cardiac muscle cell apoptotic process|striated muscle cell apoptotic process|muscle cell apoptotic process,0.0003883|0.0003883|0.001165|0.001165|0.001359,1|1|1|1|1,5149|5149|1030|1030|858.1
3599,4,0.5287,3.1719999999999997,3246.0,0.000974,0.9929309999999999,MTMR12 SNX13 SNX14 WDFY1,positive regulation of toll-like receptor 3 signaling pathway|regulation of toll-like receptor 3 signaling pathway|positive regulation of toll-like receptor 4 signaling pathway|regulation of toll-like receptor 4 signaling pathway|positive regulation of toll-like receptor signaling pathway,0.001553|0.001747|0.002328|0.004459|0.005426,1|1|1|1|1,735.5|643.6|468.1|234|190.7
3600,4,0.5092,3.055,3141.0,0.0009692,0.9929309999999999,CCDC110 MC1R OARD1 SNX19,peptidyl-glutamate ADP-deribosylation|dense core granule maturation|secretory granule maturation|protein de-ADP-ribosylation|positive regulation of protein kinase C signaling,0.0007766|0.0007766|0.0009706|0.001359|0.002134,1|1|1|1|1,1716|1716|1287|858.1|514.9
3601,4,0.5324,3.194,3310.0,0.0009618000000000001,0.9929309999999999,CNTNAP1 OR5AN1 RINL SNX2,protein localization to paranode region of axon|protein localization to juxtaparanode region of axon|lamellipodium morphogenesis|neuronal action potential propagation|action potential propagation,0.0007766|0.0009706|0.001165|0.001359|0.001359,1|1|1|1|1,1716|1287|1030|858.1|858.1
3602,16,0.5031,60.37,13810.0,0.004344,0.999999,AARD C8orf76 CA13 CA2 CA3 COL14A1 CSMD3 CYP7A1 KLHL38 MTSS1 NOV PKIA PMP2 PPDPFL SLC30A8 TRPA1,one-carbon metabolic process|bicarbonate transport|cellular response to fluid shear stress|organic anion transport|response to fluid shear stress,6.283e-06|7.754e-06|0.0001356|0.0001938|0.0003974,0.09911|0.06115|0.7128|0.7644|1,88.01|81.73|127.1|13.46|71.51
3603,8,0.5215,14.6,6563.0,0.002215,0.9996790000000001,FAM131A HRASLS HTR3D HTR3E SERP1 SERPINI1 SLC51A TCTEX1D2,serotonin receptor signaling pathway|cellular response to dopamine|response to dopamine|cellular response to catecholamine stimulus|cellular response to monoamine stimulus,0.0001074|0.000442|0.0004526|0.0006281|0.0006281,1|1|1|1|1,132|63.56|62.79|53.08|53.08
3604,4,0.5073,3.0439999999999996,3035.0,0.0009992,0.9929309999999999,SLC18B1 SOBP STRIP2 TRMT61A,mRNA methylation|mRNA modification|tRNA methylation|cochlea development|RNA methylation,0.003297|0.004846|0.008131|0.009675|0.01679,1|1|1|1|1,321.8|214.5|125.6|105.1|59.87
3605,20,0.502,95.38,16250.0,0.0058200000000000005,1.0,BPIFB4 CCM2L CDK5RAP1 CNBD2 CPNE1 DEFB116 DUSP15 FAM83C FOXS1 GGT7 GHRH HCK MAP1LC3A MYH7B MYLK2 NOL4L SOGA1 TM9SF4 WFDC11 XKR7,"positive regulation of multicellular organism growth|regulation of multicellular organism growth|positive regulation of circadian sleep/wake cycle, REM sleep|leukocyte migration involved in immune response|tRNA methylthiolation",0.0005219|0.001904|0.001939|0.002908|0.002908,1|1|1|1|1,62.41|31.68|1030|514.9|514.9
3606,4,0.5457,3.2739999999999996,3286.0,0.000993,0.9929309999999999,C12orf54 FAM3B SEC11C SOHLH1,signal peptide processing|insulin secretion|oocyte differentiation|peptide hormone secretion|hormone secretion,0.002522|0.007359|0.008131|0.01122|0.01391,1|1|1|1|1,429.1|139.2|125.6|90.33|72.52
3607,4,0.568,3.408,3476.0,0.0009771,0.9929309999999999,RAET1E SORBS1 ST6GAL2 ZDHHC14,positive regulation of glycogen biosynthetic process|stress fiber assembly|contractile actin filament bundle assembly|positive regulation of glycogen metabolic process|sialylation,0.003297|0.003297|0.003297|0.003685|0.004072,1|1|1|1|1,321.8|321.8|321.8|286|257.4
3608,4,0.5825,3.495,3272.0,0.001065,0.9929309999999999,ANHX CD28 SLC6A4 SORBS2,"positive regulation of serotonin secretion|negative regulation of synaptic transmission, dopaminergic|regulation of thalamus size|animal organ development|negative regulation of cerebellar granule cell precursor proliferation",0.0003883|0.0003883|0.0003883|0.000575|0.0005825,1|1|1|1|1,5149|5149|5149|6.462|2574
3609,4,0.5687,3.412,3334.0,0.0010199999999999999,0.9929309999999999,BACH2 SEPT9 SORL1 ZNF326,positive regulation of choline O-acetyltransferase activity|regulation of choline O-acetyltransferase activity|primary adaptive immune response involving T cells and B cells|primary adaptive immune response|insulin receptor recycling,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
3610,10,0.5172,23.28,6128.0,0.0037719999999999997,0.999933,LZTR1 MAPK1 NF1 NRAS PTPN11 RAF1 RASA2 SHOC2 SOS1 SOS2,MAPK cascade|regulation of intracellular signal transduction|regulation of small GTPase mediated signal transduction|intracellular signal transduction|small GTPase mediated signal transduction,1.481e-10|2.39e-09|3.388e-09|4.667e-08|8.41e-08,2.336e-06|1.885e-05|1.781e-05|0.0001841|0.0002653,35.25|10.48|37.79|10.46|39.3
3611,4,0.5591,3.355,3256.0,0.001027,0.9929309999999999,CDKL2 CYP2E1 SLC35F1 SOWAHA,4-nitrophenol metabolic process|benzene metabolic process|carbon tetrachloride metabolic process|halogenated hydrocarbon metabolic process|response to ozone,0.0003883|0.0003883|0.0003883|0.0005825|0.0009706,1|1|1|1|1,5149|5149|5149|2574|1287
3612,4,0.5822,3.4930000000000003,2997.0,0.001161,0.9929309999999999,CASC3 PYM1 SOWAHC TBX1,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|exon-exon junction complex disassembly|nuclear-transcribed mRNA catabolic process|vagus nerve morphogenesis|positive regulation of tongue muscle cell differentiation",0.0002071|0.0003883|0.0005446|0.0005825|0.0005825,1|1|1|1|1,85.81|5149|52.54|2574|2574
3613,7,0.5006,10.51,5184.0,0.002018,0.9992989999999999,CDKAL1 OR2B6 OR2J3 SOX12 SOX4 ZNF165 ZSCAN31,positive regulation of cell activation|positive regulation of T cell differentiation|positive regulation of lymphocyte differentiation|spinal cord development|positive regulation of N-terminal peptidyl-lysine acetylation,0.0004968|0.000531|0.0006928|0.0007195|0.0007765,1|1|1|1|1,17.71|57.85|50.48|49.51|2574
3614,4,0.5205,3.123,3191.0,0.0009750999999999999,0.9929309999999999,IL10RA JAGN1 SOX13 TRIM42,cellular response to tunicamycin|response to tunicamycin|granulocyte colony-stimulating factor signaling pathway|ubiquitin-dependent endocytosis|spinal cord oligodendrocyte cell differentiation,0.0003883|0.0003883|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|5149|2574|1716|1030
3615,4,0.5206,3.1239999999999997,2651.0,0.001174,0.9929309999999999,C15orf41 DNAJC9 SOX2 SOX21,endodermal cell fate specification|endodermal cell fate commitment|glial cell fate commitment|adenohypophysis development|neuronal stem cell population maintenance,0.001165|0.002522|0.002716|0.002716|0.003878,1|1|1|1|1,1030|429.1|396.1|396.1|271
3616,4,0.5408,3.245,3196.0,0.0010119999999999999,0.9929309999999999,PNLIPRP3 PREP SP7 XPNPEP1,bradykinin catabolic process|proteolysis|hematopoietic stem cell differentiation|positive regulation of stem cell differentiation|peptide catabolic process,0.001456|0.002236|0.003878|0.004604|0.007744,1|1|1|1|1,823.8|9.587|274.6|228.8|132.9
3617,4,0.5207,3.1239999999999997,3083.0,0.00101,0.9929309999999999,CDCA4 CLEC1A HIST4H4 SPACA1,"chromatin organization involved in regulation of transcription|regulation of gene expression, epigenetic|negative regulation of megakaryocyte differentiation|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization",0.0001151|0.0004161|0.001165|0.002134|0.002134,1|1|1|1|1,115.7|60.22|1030|514.9|514.9
3618,4,0.504,3.0239999999999996,3169.0,0.000951,0.9929309999999999,CCR1 SLC23A1 SPACA3 THUMPD3,transepithelial L-ascorbic acid transport|L-ascorbic acid transmembrane transport|L-ascorbic acid metabolic process|vitamin transmembrane transport|transepithelial transport,2.827e-07|2.827e-07|3.672e-06|8.046e-06|1.777e-05,0.00446|0.00223|0.01931|0.03173|0.05606,4119|4119|748.9|484.6|316.8
3619,4,0.5047,3.028,3198.0,0.0009437999999999998,0.9929309999999999,SPAG17 ZNF614 ZNF619 ZNF621,axonemal central apparatus assembly|epithelial cilium movement involved in extracellular fluid movement|regulation of transcription by RNA polymerase II|extracellular transport|negative regulation of transcription by RNA polymerase II,0.001165|0.00678|0.007187|0.007359|0.01088,1|1|1|1|1,1030|151.4|5.973|139.2|11.42
3620,4,0.5044,3.0260000000000002,3117.0,0.0009674,0.9929309999999999,CYB561D1 KRT13 SPATA21 ZPBP2,negative regulation of immunoglobulin production|acrosome assembly|secretory granule organization|membrane lipid catabolic process|negative regulation of production of molecular mediator of immune response,0.00291|0.003297|0.006973|0.007359|0.007745,1|1|1|1|1,367.8|321.8|147.1|139.2|132
3621,4,0.5223,3.134,3126.0,0.000999,0.9929309999999999,MATN1 SPATA2L THAP9 ZFP42,"chondrocyte morphogenesis|growth plate cartilage chondrocyte morphogenesis|chondrocyte morphogenesis involved in endochondral bone morphogenesis|growth plate cartilage morphogenesis|transposition, DNA-mediated",0.0003883|0.0003883|0.0003883|0.0005825|0.0007766,1|1|1|1|1,5149|5149|5149|2574|1716
3622,4,0.5745,3.447,3297.0,0.001042,0.9929309999999999,CAPN3 GNS LRRC27 SPATA31E1,calcium-dependent self proteolysis|positive regulation of satellite cell activation involved in skeletal muscle regeneration|regulation of satellite cell activation involved in skeletal muscle regeneration|G1 to G0 transition involved in cell differentiation|positive regulation of skeletal muscle tissue regeneration,0.0003883|0.0005825|0.0005825|0.0007766|0.001165,1|1|1|1|1,5149|2574|2574|1716|1030
3623,9,0.5058,18.21,5949.0,0.003043,0.9998530000000001,DHX9 HAUS1 HAUS4 HAUS6 RNPC3 SNRNP25 SPC24 SPC25 ZMAT5,mitotic prometaphase|spindle organization|biological phase|mitotic cell cycle phase|cell cycle phase,9.315e-09|3.995e-08|7.654e-08|7.654e-08|7.654e-08,0.0001469|0.0003151|0.0004025|0.0003018|0.0002415,61.66|45.77|40.07|40.07|40.07
3624,5,0.5668,5.667999999999999,4191.0,0.001347,0.996692,LPIN3 ORC2 SPDYA TMEM68 TNNT2,G1/S transition of mitotic cell cycle|cell cycle G1/S phase transition|regulation of muscle filament sliding speed|regulation of muscle filament sliding|mitotic cell cycle phase transition,0.0003725|0.0003843|0.000728|0.001213|0.001881,1|1|1|1|1,65.9|64.87|2060|1030|28.91
3625,14,0.505,45.96,10840.0,0.004211,0.9999969999999999,BCAS4 CASS4 FAM209A FAM209B GGT7 MTRNR2L3 R3HDML RBM38 RIPOR3 TFAP2C WFDC11 WFDC6 WISP2 ZGPAT,negative regulation of signaling receptor activity|regulation of protein tyrosine kinase activity|negative regulation of molecular function|cellular process|regulation of signaling receptor activity,0.0008174|0.00162|0.004964|0.00538|0.006552,1|1|1|1|1,48.01|33.71|5.412|0.5115|16.33
3626,5,0.5382,5.382000000000001,4086.0,0.001312,0.996692,ATXN10 DCLRE1C KRT27 SPEM2 TMIGD1,protection from non-homologous end joining at telomere|telomere maintenance in response to DNA damage|V(D)J recombination|telomere capping|hair follicle morphogenesis,0.00194|0.002667|0.00412|0.004845|0.00702,1|1|1|1|1,588.4|411.9|257.4|216.8|147.1
3627,6,0.5299,7.9479999999999995,4963.0,0.0015949999999999998,0.998474,CNMD COL4A1 F10 F7 SPERT ZIC5,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",1.483e-06|1.483e-06|1.483e-06|6.521e-06|7.705e-06,0.0234|0.0117|0.0078|0.02571|0.02431,1471|1471|1471|588.4|534.9
3628,5,0.5071,5.071000000000001,4104.0,0.001231,0.996692,NT5C1A RNASE12 SPG11 ST8SIA2 TMEM50A,phagosome-lysosome fusion involved in apoptotic cell clearance|phagolysosome assembly involved in apoptotic cell clearance|phagosome maturation involved in apoptotic cell clearance|purine nucleoside monophosphate catabolic process|adenosine metabolic process,0.0004854|0.000728|0.000728|0.00194|0.002425,1|1|1|1|1,4119|2060|2060|588.4|457.7
3629,13,0.4845,37.79,10830.0,0.003468,0.999993,C8orf44 CA8 CEBPD CYP7A1 EFCAB1 GGH MCMDC2 MOS NPBWR1 NSMAF PPDPFL SGK3 SPIDR,response to alcohol|establishment of meiotic spindle orientation|positive regulation of lipid biosynthetic process|cellular response to alcohol|double-strand break repair via homologous recombination,0.0004557|0.001261|0.001333|0.001364|0.001862,1|1|1|1|1,19.32|1584|37.28|36.84|31.37
3630,4,0.5392,3.235,3048.0,0.001057,0.9929309999999999,FEM1C PGM5 PIK3IP1 SPINK14,negative regulation of phosphatidylinositol 3-kinase activity|negative regulation of lipid kinase activity|negative regulation of phosphatidylinositol 3-kinase signaling|negative regulation of catalytic activity|myofibril assembly,0.0009706|0.001747|0.002716|0.008916|0.01064,1|1|1|1|1,1287|643.6|396.1|12.65|95.35
3631,4,0.5524,3.315,3301.0,0.001001,0.9929309999999999,CXCL11 IL36RN SPINK9 UGT1A8,antimicrobial humoral response|cellular response to lipopolysaccharide|cellular response to molecule of bacterial origin|cellular response to biotic stimulus|flavone metabolic process,0.0003472|0.0004655|0.0005176|0.0006536|0.001359,1|1|1|1|1,66.01|56.89|53.91|47.9|858.1
3632,5,0.5153,5.153,4121.0,0.0012460000000000001,0.996692,C22orf46 LRRC75B SHD SPON2 SULT4A1,sulfation|purine ribonucleoside bisphosphate metabolic process|3'-phosphoadenosine 5'-phosphosulfate metabolic process|biological regulation|regulation of biological process,0.006054|0.006295|0.006295|0.008988|0.01377,1|1|1|1|1,171.6|164.8|164.8|0|0
3633,4,0.5166,3.1,3200.0,0.0009652999999999999,0.9929309999999999,ACOT7 LMX1A RELN SPOP,hippocampus development|limbic system development|memory|positive regulation of lateral motor column neuron migration|regulation of lateral motor column neuron migration,8.892e-05|0.0001534|0.0001905|0.0003883|0.0003883,1|1|1|1|1,132|99.98|89.54|5149|5149
3634,4,0.5079,3.048,3144.0,0.0009658999999999999,0.9929309999999999,ADCY6 ANKMY2 SPOP SPOPL,cellular response to vasopressin|response to vasopressin|negative regulation of urine volume|proteasome-mediated ubiquitin-dependent protein catabolic process|proteasomal protein catabolic process,0.0007766|0.0007766|0.001165|0.001458|0.00166,1|1|1|1|1,1716|1716|1030|31.88|29.85
3635,5,0.5135,5.135,4294.0,0.001192,0.996692,CHCHD6 MTUS1 PDE6D SPP2 STON1,regulation of type B pancreatic cell proliferation|sphingosine metabolic process|sphingoid metabolic process|negative regulation of hydrolase activity|regulation of macrophage chemotaxis,0.003781|0.006101|0.006681|0.006943|0.008418,1|1|1|1|1,286|171.6|156|15.09|122.6
3636,18,0.505,77.26,13280.0,0.00577,1.0,ACCS ACCSL CAT CHRM4 CRY2 EHF ELF5 F2 FBXO3 MAPK8IP1 OR4B1 OR4C13 OR4C3 OR4X1 PAMR1 SLC1A2 TCP11L1 TP53I11,hydrogen peroxide catabolic process|acute-phase response|hydrogen peroxide metabolic process|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell,0.0004514|0.0008702|0.0008702|0.0009576|0.001191,1|1|1|1|1,67.64|47.84|47.84|8.895|8.382
3637,5,0.5029,5.029,4017.0,0.001247,0.996692,CD1B LIPE SPRR1B SPRR4 UNC5C,triglyceride catabolic process|acylglycerol catabolic process|neutral lipid catabolic process|glycerolipid catabolic process|triglyceride metabolic process,2.86e-05|5.213e-05|5.213e-05|0.0001326|0.0002211,0.4511|0.4112|0.2741|0.5231|0.6976,254.3|185.5|185.5|114.4|88.01
3638,5,0.5202,5.202000000000001,4176.0,0.001241,0.996692,CTRL FAM69C SFI1 SPRY1 ZNF70,epithelial to mesenchymal transition involved in cardiac fibroblast development|epicardium-derived cardiac fibroblast cell development|epicardium-derived cardiac fibroblast cell differentiation|cardiac fibroblast cell development|cardiac fibroblast cell differentiation,0.000728|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,2060|1373|1373|1373|1373
3639,5,0.5087,5.087,3992.0,0.001269,0.996692,CCDC70 DHRS12 MAN1A2 NLK SPRY4,Golgi apparatus mannose trimming|serine phosphorylation of STAT protein|negative regulation of substrate adhesion-dependent cell spreading|negative regulation of cell morphogenesis involved in differentiation|negative regulation of fibroblast growth factor receptor signaling pathway,0.001165|0.001456|0.004361|0.004361|0.005522,1|1|1|1|1,1144|858.1|245.2|245.2|190.7
3640,9,0.5007,18.02,6805.0,0.002635,0.9998530000000001,DNAJC14 KRT82 KRT85 OR10AD1 OR8S1 PPP1R1A PUS7L SLC38A4 SPRYD4,cornification|keratinization|keratinocyte differentiation|epidermal cell differentiation|pseudouridine synthesis,0.001084|0.00417|0.005796|0.007958|0.00827,1|1|1|1|1,40.5|20.25|17.08|14.48|127.1
3641,17,0.5043,68.59,12830.0,0.005305,1.0,BTN2A2 GPX6 HIST1H1T HIST1H2AD OR14J1 OR2B6 OR2J3 SLC17A2 SLC17A4 TMEM14B TRIM10 ZKSCAN4 ZNF165 ZNF184 ZNF322 ZSCAN16 ZSCAN31,sialic acid transport|cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance|detoxification,1.341e-05|6.752e-05|9.782e-05|0.0001173|0.0001785,0.2116|0.5326|0.5144|0.4626|0.5633,484.6|38.26|33.65|31.6|27.33
3642,4,0.5309,3.185,3124.0,0.001016,0.9929309999999999,CLEC4C CLSTN3 SLC2A3 SPTBN4,glucose import across plasma membrane|clustering of voltage-gated sodium channels|hexose import across plasma membrane|carbohydrate import across plasma membrane|positive regulation of protein localization to synapse,0.001165|0.001359|0.001359|0.001359|0.002328,1|1|1|1|1,1030|858.1|858.1|858.1|468.1
3643,4,0.542,3.252,3333.0,0.0009722999999999999,0.9929309999999999,AKNAD1 COX8C FZD2 SREK1IP1,muscular septum morphogenesis|hard palate development|membranous septum morphogenesis|planar cell polarity pathway involved in neural tube closure|regulation of establishment of planar polarity involved in neural tube closure,0.0007766|0.001553|0.001553|0.002328|0.002716,1|1|1|1|1,1716|735.5|735.5|468.1|396.1
3644,9,0.5126,18.45,6187.0,0.0029649999999999998,0.9998530000000001,DIAPH1 DIAPH3 FLII LRRFIP2 MYL6 PFN1 SRF TMOD3 XPO6,actin filament-based process|actin cytoskeleton organization|actin filament organization|myofibril assembly|negative regulation of actin filament polymerization,6.222e-10|2.216e-08|4.926e-08|1.666e-06|2.259e-06,9.814e-06|0.0001747|0.000259|0.006572|0.007126,26.79|26.2|42.38|127.1|114.4
3645,12,0.5069,33.46,8655.0,0.0038399999999999997,0.999986,CAMLG DDX41 DDX46 GEMIN5 IK LARS PHAX RPS14 SLU7 SRFBP1 SRP19 TTC1,"RNA metabolic process|RNA processing|gene expression|nucleic acid metabolic process|mRNA splicing, via spliceosome",1.86e-08|2.42e-07|2.833e-07|3.392e-07|5.164e-07,0.0002934|0.001909|0.001489|0.001338|0.001629,9.66|13.02|7.066|6.92|28.41
3646,7,0.5321,11.17,5333.0,0.002085,0.9992989999999999,CENPE EXOC1 EXOSC9 GAR1 SPATA5 SRP72 YTHDC1,ribonucleoprotein complex biogenesis|cellular component biogenesis|lateral attachment of mitotic spindle microtubules to kinetochore|microtubule plus-end directed mitotic chromosome migration|snoRNA guided rRNA pseudouridine synthesis,0.0003808|0.0006495|0.0006794|0.0006794|0.001358,1|1|1|1|1,18.98|5.446|2942|2942|980.7
3647,5,0.519,5.19,4043.0,0.001279,0.996692,C6orf203 HOXD12 MAP2K6 SSBP2 TMC7,cellular response to sorbitol|regulation of mitochondrial transcription|response to sorbitol|DNA damage induced protein phosphorylation|positive regulation of prostaglandin secretion,0.0009706|0.001213|0.001456|0.002183|0.00291,1|1|1|1|1,1373|1030|823.8|514.9|374.5
3648,5,0.534,5.34,4190.0,0.0012699999999999999,0.996692,HOPX SCRN3 SSTR3 TIMM21 TRIM56,interferon-beta production|hormone-mediated apoptotic signaling pathway|somatostatin signaling pathway|somatostatin receptor signaling pathway|type I interferon production,0.0009706|0.001213|0.001456|0.001456|0.001456,1|1|1|1|1,1373|1030|823.8|823.8|823.8
3649,4,0.5269,3.161,3022.0,0.001042,0.9929309999999999,CCS CYB5R4 PI3 ST3GAL5,superoxide metabolic process|reactive oxygen species metabolic process|protein maturation by copper ion transfer|detection of oxygen|removal of superoxide radicals,2.313e-05|0.0001971|0.0003883|0.0009706|0.002716,0.3649|1|1|1|1,264|88.01|5149|1287|396.1
3650,4,0.5039,3.023,3148.0,0.0009568999999999999,0.9929309999999999,LUZP6 ST6GAL1 TIRAP TMEM71,positive regulation of interleukin-15 production|regulation of interleukin-15 production|TIRAP-dependent toll-like receptor 4 signaling pathway|TIRAP-dependent toll-like receptor signaling pathway|positive regulation of chemokine (C-X-C motif) ligand 1 production,0.0003883|0.0003883|0.0003883|0.0003883|0.0009706,1|1|1|1|1,5149|5149|5149|5149|1287
3651,4,0.5165,3.0989999999999998,3200.0,0.0009652000000000002,0.9929309999999999,AAED1 GALNT4 RAB11FIP2 ST6GALNAC1,protein glycosylation|macromolecule glycosylation|glycosylation|TRAM-dependent toll-like receptor 4 signaling pathway|TRAM-dependent toll-like receptor signaling pathway,0.000416|0.000416|0.0004614|0.0005825|0.0005825,1|1|1|1|1,56.74|56.74|53.84|2288|2288
3652,5,0.5083,5.083,4131.0,0.0012259999999999999,0.996692,BIN1 DDX58 MAP1B PHETA1 ST6GALNAC2,positive regulation of protein polymerization|induction of synaptic plasticity by chemical substance|positive regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity by chemical substance|negative regulation of cardiac muscle cell contraction,0.0003725|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,65.9|4119|4119|4119|4119
3653,4,0.5072,3.043,3042.0,0.0009968,0.9929309999999999,MIGA2 MRI1 OR1J1 ST6GALNAC4,L-methionine salvage from S-adenosylmethionine|L-methionine salvage from methylthioadenosine|S-adenosylmethionine cycle|L-methionine salvage|L-methionine biosynthetic process,0.0007766|0.001165|0.001553|0.001553|0.001553,1|1|1|1|1,1716|1030|735.5|735.5|735.5
3654,4,0.5091,3.055,3228.0,0.0009431000000000001,0.9929309999999999,CCDC43 CEP131 S100A6 ST6GALNAC5,intramanchette transport|manchette assembly|ganglioside biosynthetic process|sialylation|sperm axoneme assembly,0.0003883|0.0009706|0.003297|0.004072|0.004459,1|1|1|1|1,5149|1287|321.8|257.4|234
3655,4,0.5013,3.008,2909.0,0.00103,0.9929309999999999,COG3 DDIT4L ST6GALNAC6 YKT6,endoplasmic reticulum to Golgi vesicle-mediated transport|protein glycosylation|macromolecule glycosylation|glycosylation|glycoprotein biosynthetic process,0.0005446|0.0008254|0.0008254|0.0009151|0.001261,1|1|1|1|1,52.54|42.55|42.55|40.38|34.33
3656,5,0.5182,5.182,3815.0,0.001353,0.996692,IVNS1ABP LAX1 ST7L TFAP2B WFDC12,cellular urea homeostasis|cellular creatinine homeostasis|cellular ammonium homeostasis|urea homeostasis|creatinine homeostasis,0.0004854|0.0004854|0.0004854|0.000728|0.000728,1|1|1|1|1,4119|4119|4119|2060|2060
3657,4,0.5927,3.556,3280.0,0.00108,0.9929309999999999,C10orf105 DHRS9 PAIP2B ST8SIA5,9-cis-retinoic acid metabolic process|9-cis-retinoic acid biosynthetic process|retinoic acid biosynthetic process|diterpenoid biosynthetic process|progesterone metabolic process,0.0009706|0.0009706|0.001747|0.001941|0.00291,1|1|1|1|1,1287|1287|643.6|572.1|367.8
3658,4,0.5124,3.074,3137.0,0.0009767,0.9929309999999999,ADAM23 ATP7B STAB2 TMTC1,copper ion export|sequestering of calcium ion|copper ion transmembrane transport|copper ion import|cellular copper ion homeostasis,0.0009706|0.001456|0.001698|0.001698|0.003636,1|1|1|1|1,1373|823.8|686.5|686.5|294.2
3659,4,0.5702,3.4210000000000003,3178.0,0.001073,0.9929309999999999,CSF3R FAT1 POM121L12 STAMBPL1,establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis|establishment of epithelial cell apical/basal polarity|amelogenesis|polarized epithelial cell differentiation|establishment of apical/basal cell polarity,0.0003883|0.003491|0.004266|0.004459|0.004459,1|1|1|1|1,5149|302.9|245.2|234|234
3660,4,0.5219,3.1319999999999997,3268.0,0.0009549,0.9929309999999999,CLEC11A SERINC4 STARD13 WDR76,endothelial tube lumen extension|endothelial tube morphogenesis|morphogenesis of an endothelium|negative regulation of cell migration involved in sprouting angiogenesis|regulation of DNA damage checkpoint,0.0005825|0.002716|0.002716|0.003104|0.003491,1|1|1|1|1,2574|396.1|396.1|343.2|302.9
3661,4,0.5124,3.074,3106.0,0.0009864,0.9929309999999999,NCS1 STARD3 VTN WWC2,vesicle tethering to endoplasmic reticulum|smooth muscle cell-matrix adhesion|progesterone biosynthetic process|vesicle tethering|olefinic compound biosynthetic process,0.0005825|0.0005825|0.0009706|0.001941|0.002522,1|1|1|1|1,2574|2574|1287|572.1|429.1
3662,4,0.5625,3.375,3361.0,0.001001,0.9929309999999999,GNAS SPRYD3 STARD3NL ZBED6,regulation of hormone levels|regulation of parathyroid hormone secretion|post-embryonic body morphogenesis|regulation of insulin secretion|vesicle tethering to endoplasmic reticulum,6.835e-05|0.0003883|0.0003883|0.0005069|0.0005825,1|1|1|1|1,29.03|5149|5149|54.48|2574
3663,4,0.5167,3.1,3052.0,0.0010119999999999999,0.9929309999999999,HLX PSMD5 STAU1 THBD,negative regulation of cell activation|proteasome regulatory particle assembly|negative regulation of T-helper 2 cell differentiation|positive regulation by virus of viral protein levels in host cell|positive regulation of T-helper 1 cell differentiation,0.0005667|0.0007766|0.0009706|0.0009706|0.001359,1|1|1|1|1,51.49|1716|1287|1287|858.1
3664,5,0.5048,5.048,3919.0,0.001283,0.996692,CALB2 CES4A DYNLRB2 PPP1R3E STBD1,glycogen metabolic process|cellular glucan metabolic process|glucan metabolic process|energy reserve metabolic process|cellular polysaccharide metabolic process,7.22e-05|7.482e-05|7.482e-05|0.0001131|0.000163,1|0.5901|0.3934|0.4459|0.5142,152.6|149.8|149.8|121.1|100.5
3665,4,0.5861,3.517,3278.0,0.0010689999999999999,0.9929309999999999,MRFAP1L1 PPP2R2C S100P STIM2,activation of store-operated calcium channel activity|positive regulation of store-operated calcium channel activity|store-operated calcium entry|regulation of store-operated calcium channel activity|peptidyl-serine dephosphorylation,0.001359|0.001553|0.001747|0.001941|0.00291,1|1|1|1|1,858.1|735.5|643.6|572.1|367.8
3666,4,0.5166,3.1,3276.0,0.0009429999999999999,0.9929309999999999,MAP1B SOCS1 STIMATE TEKT5,"induction of synaptic plasticity by chemical substance|positive regulation of synaptic plasticity by chemical substance|regulation of synaptic plasticity by chemical substance|negative regulation of CD8-positive, alpha-beta T cell differentiation|negative regulation of CD8-positive, alpha-beta T cell activation",0.0003883|0.0003883|0.0003883|0.0005825|0.001359,1|1|1|1|1,5149|5149|5149|2574|858.1
3667,4,0.5421,3.252,3265.0,0.0009927,0.9929309999999999,OCLM SEMG2 SLC2A10 STK11IP,negative regulation of proteoglycan biosynthetic process|negative regulation of connective tissue growth factor production|galactose transmembrane transport|positive regulation of serine-type peptidase activity|negative regulation of integrin-mediated signaling pathway,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
3668,4,0.5128,3.077,3372.0,0.0009094,0.9929309999999999,CPT1B ELMOD2 STK32A TPP2,response to blue light|carnitine shuttle|carnitine metabolic process|amino-acid betaine metabolic process|intracellular lipid transport,0.001359|0.002328|0.00291|0.003685|0.007938,1|1|1|1|1,858.1|468.1|367.8|286|128.7
3669,5,0.5068,5.0680000000000005,3945.0,0.00128,0.996692,C10orf88 CCDC190 DAOA ESM1 STK32B,positive regulation of hepatocyte growth factor receptor signaling pathway|negative regulation of D-amino-acid oxidase activity|regulation of D-amino-acid oxidase activity|regulation of hepatocyte growth factor receptor signaling pathway|negative regulation of oxidoreductase activity,0.0003883|0.0003883|0.0003883|0.0009706|0.005426,1|1|1|1|1,5149|5149|5149|1287|190.7
3670,4,0.5508,3.305,3170.0,0.001039,0.9929309999999999,GFY PLEKHG4 STK38L TMCC1,endosome membrane tubulation|endosome fission|membrane tubulation|membrane fission|endosome organization,0.0005825|0.0007766|0.0009706|0.003104|0.01506,1|1|1|1|1,2574|1716|1287|343.2|66.87
3671,10,0.5164,23.24,7353.0,0.0031420000000000003,0.999933,CFAP53 ISL2 LHX3 MAN1A2 MGAT1 NEUROD1 OTP OTX2 SCLY STMN1,central nervous system development|neuron differentiation|spinal cord motor neuron cell fate specification|generation of neurons|brain development,4.735e-06|5.849e-06|1.705e-05|1.787e-05|2.426e-05,0.07469|0.04613|0.08964|0.07046|0.07652,11.34|10.93|374.5|8.994|12.57
3672,4,0.5223,3.134,3113.0,0.001003,0.9929309999999999,ARMS2 CACNG7 MMP3 STOX1,regulation of response to oxidative stress|positive regulation of otic vesicle morphogenesis|regulation of otic vesicle morphogenesis|regulation of mitochondrial DNA metabolic process|cellular response to nitrosative stress,0.0001028|0.0003883|0.0003883|0.0007766|0.0009706,1|1|1|1|1,122.6|5149|5149|1716|1287
3673,4,0.5504,3.302,2969.0,0.001108,0.9929309999999999,CWC22 SF3B1 STPG2 WDR75,"RNA processing|mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA metabolic process",0.0003501|0.001277|0.001277|0.001302|0.001769,1|1|1|1|1,16.73|34.1|34.1|33.76|9.66
3674,4,0.5086,3.052,3142.0,0.0009676999999999999,0.9929309999999999,ASB17 LNX1 PTGES STRADB,regulation of fever generation|cyclooxygenase pathway|positive regulation of prostaglandin secretion|regulation of prostaglandin secretion|chronic inflammatory response,0.001941|0.002328|0.002328|0.002716|0.00291,1|1|1|1|1,572.1|468.1|468.1|396.1|367.8
3675,9,0.5016,18.06,6712.0,0.002676,0.9998530000000001,ARHGAP11B CHRFAM7A CHRNA7 DEXI GOLGA8M MPHOSPH10 PPIP5K1 STRC WHAMM,"synaptic transmission, cholinergic|excitatory postsynaptic potential|chemical synaptic transmission, postsynaptic|regulation of postsynaptic membrane potential|modulation of excitatory postsynaptic potential",2.988e-07|3.879e-06|4.624e-06|1.419e-05|0.0002265,0.004713|0.0306|0.02431|0.05596|0.7146,237.6|96.54|90.86|61.79|91.53
3676,4,0.5214,3.128,3243.0,0.0009612,0.9929309999999999,DNAJC12 NME4 STX1A STYXL1,negative regulation of stress granule assembly|positive regulation of norepinephrine secretion|regulation of stress granule assembly|regulation of synaptic vesicle priming|lipid transport,0.0003883|0.0009706|0.001165|0.001747|0.001845,1|1|1|1|1,5149|1287|1030|643.6|28.29
3677,5,0.5316,5.316,4299.0,0.001232,0.996692,ETV7 MSH3 OLR1 STX6 ZNF573,removal of nonhomologous ends|synaptic vesicle to endosome fusion|replication fork arrest|meiotic mismatch repair|maintenance of DNA repeat elements,0.0004854|0.0009706|0.001213|0.001456|0.001698,1|1|1|1|1,4119|1373|1030|823.8|686.5
3678,4,0.5121,3.073,3075.0,0.0009958,0.9929309999999999,DOCK10 FLT3 SPN STXBP5L,lymphocyte differentiation|mononuclear cell differentiation|leukocyte differentiation|lymphocyte activation|leukocyte homeostasis,7.087e-06|1.093e-05|2.021e-05|2.739e-05|6.997e-05,0.1118|0.08622|0.1063|0.108|0.2207,62.28|53.82|43.76|39.5|149.2
3679,9,0.5133,18.48,7326.0,0.00251,0.9998530000000001,ANKRD23 CFC1 IL1F10 IL1RN IL36G LYG1 RNF149 SCTR SUCNR1,inflammatory response to antigenic stimulus|response to stimulus|protein secretion|establishment of protein localization to extracellular region|inflammatory response,4.825e-07|0.0003471|0.0009392|0.0009567|0.001064,0.00761|1|1|1|1,196.1|2.424|43.59|43.18|13.84
3680,16,0.5068,60.82,13440.0,0.004493,0.999999,C8orf44 CA1 CA13 CA2 CA3 CNGB3 CYP7A1 FABP12 FABP4 MCMDC2 PMP2 SGK3 SNX16 SULF1 TMEM69 TRIM55,one-carbon metabolic process|bicarbonate transport|organic anion transport|ion transport|triglyceride catabolic process,2.934e-08|3.874e-08|4.791e-06|9.289e-05|0.0002266,0.0004628|0.0003056|0.02519|0.3663|0.7149,132|122.6|18.93|4.021|95.35
3681,5,0.5286,5.2860000000000005,4175.0,0.001261,0.996692,EFCAB13 RARS REG1A RTL10 SULT6B1,cellular response to gastrin|response to gastrin|response to growth hormone-releasing hormone|pancreas regeneration|positive regulation of acinar cell proliferation,0.0004854|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,4119|4119|4119|4119|4119
3682,4,0.5161,3.096,3232.0,0.0009545999999999999,0.9929309999999999,CHRNG SFT2D3 SUMO1 ZBTB43,protein localization to nuclear pore|positive regulation of ATPase-coupled calcium transmembrane transporter activity|negative regulation of action potential|PML body organization|protein localization to nuclear envelope,0.0007766|0.001165|0.001359|0.001553|0.002134,1|1|1|1|1,1716|1030|858.1|735.5|514.9
3683,4,0.5281,3.1689999999999996,3105.0,0.001017,0.9929309999999999,DRC1 NXPH1 SLC5A7 SUN1,axonemal dynein complex assembly|axoneme assembly|microtubule cytoskeleton organization|microtubule bundle formation|microtubule-based process,3.302e-05|0.0001478|0.0002011|0.0002847|0.0005625,0.5208|1|1|1|1,228.8|105.6|21.83|75.58|15.39
3684,4,0.5112,3.0669999999999997,3329.0,0.0009183999999999999,0.9929309999999999,PROM1 SIGLEC1 SUN3 TEX35,clathrin-dependent endocytosis of virus by host cell|positive regulation of nephron tubule epithelial cell differentiation|glomerular parietal epithelial cell differentiation|positive regulation of epithelial cell differentiation involved in kidney development|receptor-mediated endocytosis of virus by host cell,0.0003883|0.0007766|0.0007766|0.001553|0.001553,1|1|1|1|1,5149|1716|1716|735.5|735.5
3685,4,0.5227,3.136,3129.0,0.0009988,0.9929309999999999,FN3K HEXDC SUOX WNT1,midbrain-hindbrain boundary maturation|midbrain-hindbrain boundary maturation during brain development|cerebellum formation|hindbrain formation|fructoselysine metabolic process,0.0002913|0.0002913|0.0002913|0.0002913|0.0002913,1|1|1|1|0.9189,6865|6865|6865|6865|6865
3686,11,0.5082,27.95,7220.0,0.0038450000000000003,0.999969,ATM CDKN1A CHEK2 HEATR3 MDM2 MDM4 PPM1D SURF2 TP53 USP28 XPO7,"signal transduction by p53 class mediator|DNA damage response, signal transduction by p53 class mediator|signal transduction in response to DNA damage|DNA damage checkpoint|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",2.535e-16|5.595e-15|3.091e-14|2.499e-13|3.221e-13,3.998e-12|4.413e-11|1.625e-10|9.855e-10|1.016e-09,126.9|165.9|128.5|94.29|193.7
3687,4,0.5628,3.377,2998.0,0.0011220000000000002,0.9929309999999999,FAM20C FBXO45 MVB12B SUSD1,synapse assembly involved in innervation|virus maturation|odontoblast differentiation|anterior commissure morphogenesis|corticospinal tract morphogenesis,0.0003883|0.0005825|0.0007766|0.001359|0.001359,1|1|1|1|1,5149|2574|1716|858.1|858.1
3688,4,0.5503,3.302,3321.0,0.0009908,0.9929309999999999,DACT1 RFX2 SUSD3 ZSCAN30,embryonic hindgut morphogenesis|negative regulation of beta-catenin-TCF complex assembly|regulation of beta-catenin-TCF complex assembly|hindgut morphogenesis|hindgut development,0.0005825|0.0005825|0.0005825|0.001359|0.001553,1|1|1|1|1,2574|2574|2574|858.1|735.5
3689,4,0.5755,3.4530000000000003,3315.0,0.001038,0.9929309999999999,DIP2B MPHOSPH9 SVIL TENM3,regulation of homophilic cell adhesion|regulation of cellular component size|regulation of neuron projection development|actin filament severing|regulation of anatomical structure size,0.0007766|0.00205|0.002655|0.003104|0.003524,1|1|1|1|1,1716|26.82|23.51|343.2|20.35
3690,5,0.5667,5.667000000000001,4095.0,0.001379,0.996692,ADPRHL1 CCDC113 GSG1L H1FNT SVOPL,spermatid nucleus elongation|protein de-ADP-ribosylation|regulation of postsynaptic neurotransmitter receptor internalization|sperm chromatin condensation|spermatid nucleus differentiation,0.0009706|0.001698|0.003152|0.003394|0.005087,1|1|1|1|1,1373|686.5|343.3|316.8|205.9
3691,4,0.5039,3.0239999999999996,3101.0,0.0009716000000000001,0.9929309999999999,CHRNA10 DAB1 SLC9A3R1 SWAP70,Golgi localization|negative regulation of ERK1 and ERK2 cascade|cellular ion homeostasis|inner ear morphogenesis|inorganic ion homeostasis,3.391e-06|7.603e-05|0.0001239|0.0001391|0.000165,0.05349|0.5997|0.6512|0.5486|0.5205,735.5|143|23.76|105.1|21.57
3692,6,0.5153,7.73,5108.0,0.001507,0.998474,CYP4V2 LMOD3 NHLRC1 NLRP11 SECTM1 SYCE3,fatty acid omega-oxidation|skeletal muscle thin filament assembly|pointed-end actin filament capping|skeletal myofibril assembly|positive regulation of skeletal muscle fiber development,0.001746|0.002037|0.002328|0.002619|0.002909,1|1|1|1|1,686.5|572.1|490.4|429.1|381.4
3693,32,0.5013,248.7,24970.0,0.009834,1.0,ACAP1 AIPL1 ALDH3A1 ALOX12B ALOX15 ALOX15B ALOXE3 ASGR1 ASGR2 CCDC144A CLEC10A KCTD11 MFSD6L MYH10 MYH2 MYH4 MYH8 OR1A1 OR1D5 OR1E2 OR3A1 OVCA2 P2RX1 SHBG SLC16A13 SLC2A4 SPNS3 TBC1D28 TMEM256 TNFSF12 TNFSF13 VAMP2,hepoxilin biosynthetic process|hepoxilin metabolic process|lipoxygenase pathway|linoleic acid metabolic process|long-chain fatty acid biosynthetic process,3.377e-09|3.377e-09|2.271e-08|5.896e-08|3.039e-07,5.326e-05|2.663e-05|0.0001194|0.0002325|0.0009586,286|286|160.9|122.6|78.01
3694,5,0.5336,5.336,4191.0,0.001269,0.996692,BBS9 OTULINL SEPT3 SYDE2 WBP2NL,male pronucleus assembly|female pronucleus assembly|egg activation|organelle assembly|protein localization to cilium,0.000728|0.000728|0.001456|0.01337|0.01352,1|1|1|1|1,2060|2060|823.8|10.55|74.89
3695,9,0.5039,18.14,6843.0,0.002637,0.9998530000000001,AIF1 C6orf48 HLA-DMB MICB MSH5 SYNGAP1 TAP1 TAP2 TNXB,,,,
3696,4,0.5363,3.218,2938.0,0.001091,0.9929309999999999,OR2M7 OR8B12 OR8B3 SYT13,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.915e-05|4.671e-05|5.225e-05|6.46e-05|7.223e-05,0.6176|0.3684|0.2747|0.2548|0.2279,35.03|33|31.78|29.59|28.5
3697,4,0.5194,3.117,3252.0,0.0009551000000000001,0.9929309999999999,CYB561D2 HCN2 SYT2 THAP10,cellular response to cGMP|response to cGMP|calcium ion-regulated exocytosis of neurotransmitter|membrane depolarization during cardiac muscle cell action potential|sodium ion import across plasma membrane,0.001359|0.001553|0.003104|0.003491|0.003878,1|1|1|1|1,858.1|735.5|343.2|302.9|271
3698,4,0.5117,3.07,3238.0,0.0009451,0.9929309999999999,CD5 CELA3B IDUA SYT8,heparin catabolic process|dermatan sulfate catabolic process|disaccharide metabolic process|heparin metabolic process|dermatan sulfate metabolic process,0.0003883|0.0003883|0.002328|0.002522|0.002716,1|1|1|1|1,5149|5149|468.1|429.1|396.1
3699,4,0.5321,3.193,3183.0,0.0009996,0.9929309999999999,AKAP8 DMRT3 SYTL3 TBC1D4,negative regulation of vesicle fusion|protein transport|peptide transport|amide transport|ventral spinal cord interneuron specification,0.001359|0.001362|0.001443|0.001542|0.001553,1|1|1|1|1,858.1|10.56|10.35|10.12|735.5
3700,4,0.5546,3.3280000000000003,3334.0,0.0009949,0.9929309999999999,FAM180A POU4F2 TAC1 WASF1,cellular response to nerve growth factor stimulus|response to nerve growth factor|neuron projection extension|developmental cell growth|cell growth,4.185e-05|4.498e-05|5.502e-05|0.0001028|0.0001077,0.6602|0.3547|0.2893|0.4054|0.3397,194.3|187.2|168.8|122.6|119.7
3701,36,0.5006,315.4,25760.0,0.01206,1.0,ACAD9 ATPAF2 CARS2 COA7 COQ7 COX14 DARS2 FOXRED1 GRSF1 GTPBP10 GTPBP8 MCAT METTL17 MRM2 MRM3 MRPL58 MTFMT MTG1 MTIF2 MTIF3 MTO1 NDUFAF1 NDUFAF3 NDUFAF7 NDUFB9 NOA1 NSUN3 NSUN4 NUBPL PET117 PREPL SURF1 TACO1 TBRG4 TFB1M YBEY,mitochondrial respiratory chain complex assembly|mitochondrion organization|NADH dehydrogenase complex assembly|mitochondrial respiratory chain complex I assembly|mitochondrial gene expression,5.54e-17|1.832e-11|4.889e-11|4.889e-11|1.876e-10,8.738e-13|1.445e-07|2.571e-07|1.928e-07|5.919e-07,60.62|14.62|59.04|59.04|31.81
3702,4,0.5284,3.17,3144.0,0.001005,0.9929309999999999,IL31 INTS11 NOL9 TAGAP,"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|ncRNA processing|endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|endonucleolytic cleavage involved in rRNA processing|maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",0.0005825|0.002584|0.003104|0.003104|0.003104,1|1|1|1|1,2574|23.84|343.2|343.2|343.2
3703,5,0.508,5.08,4140.0,0.001222,0.996692,AMIGO3 LOR RETREG2 TANK ZC3H14,positive regulation of ubiquitin-specific protease activity|lysine biosynthetic process|lysine biosynthetic process via aminoadipic acid|L-lysine catabolic process to acetyl-CoA via saccharopine|L-lysine catabolic process,0.0008735|0.0008735|0.0008735|0.001165|0.001456,1|1|1|1|1,1716|1716|1716|1144|858.1
3704,12,0.5046,33.3,8942.0,0.003701,0.999986,BTN2A1 BTN2A2 HLA-A HLA-C HLA-F MICB OR14J1 OR2J2 OR2J3 TAPBP TRIM10 TRIM26,"antigen processing and presentation of endogenous peptide antigen via MHC class I|antigen processing and presentation of endogenous peptide antigen|antigen processing and presentation of endogenous antigen|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway",3.923e-10|5.801e-10|1.791e-09|2.483e-08|2.483e-08,6.189e-06|4.575e-06|9.419e-06|9.791e-05|7.833e-05,403.8|361.3|264|643.6|643.6
3705,4,0.5599,3.359,3082.0,0.001086,0.9929309999999999,FEM1C GUCD1 PIK3IP1 TATDN1,negative regulation of phosphatidylinositol 3-kinase activity|negative regulation of lipid kinase activity|negative regulation of phosphatidylinositol 3-kinase signaling|regulation of phosphatidylinositol 3-kinase activity|regulation of lipid kinase activity,0.0009706|0.001747|0.002716|0.01141|0.01372,1|1|1|1|1,1287|643.6|396.1|88.77|73.55
3706,4,0.6028,3.617,3170.0,0.001137,0.9929309999999999,BTBD7 CDK18 KLHL20 TATDN3,protein K33-linked ubiquitination|regulation of branching involved in salivary gland morphogenesis|Golgi to endosome transport|response to interferon-alpha|regulation of transcription involved in G1/S transition of mitotic cell cycle,0.0003883|0.001553|0.003491|0.004846|0.00678,1|1|1|1|1,5149|735.5|302.9|214.5|151.4
3707,12,0.5131,33.87,8132.0,0.004135,0.999986,CIAO1 CIAO2B CIAPIN1 FXN GLRX3 HSCB LYRM4 NDOR1 NUBP2 SOD1 TIMM10 TIMM9,metallo-sulfur cluster assembly|iron-sulfur cluster assembly|sulfur compound metabolic process|protein maturation by iron-sulfur cluster transfer|protein maturation,3.337e-24|3.337e-24|2.515e-16|2.542e-10|1.757e-07,5.265e-20|2.632e-20|1.322e-12|1.003e-06|0.0005543,671.6|671.6|46.51|457.7|35.46
3708,4,0.5686,3.412,3139.0,0.001083,0.9929309999999999,NIPSNAP3A NIPSNAP3B TBC1D13 TMEM220,UNCLASSIFIED|biological_process|activation of GTPase activity|regulation of biological process|regulation of cellular process,0.008539|0.008539|0.02253|0.03244|0.04148,1|1|1|1|1,5.627|0.2884|44.39|0|0
3709,5,0.505,5.05,4085.0,0.001232,0.996692,MAN1C1 PRR5 SBF1 TBC1D22A WDR76,Golgi apparatus mannose trimming|TORC2 signaling|regulation of DNA damage checkpoint|N-glycan processing|regulation of GTPase activity,0.0009706|0.00194|0.004362|0.004845|0.005427,1|1|1|1|1,1373|588.4|242.3|216.8|16.81
3710,4,0.5057,3.034,3175.0,0.0009523,0.9929309999999999,ADGRG1 LUC7L3 PDE5A TBC1D22B,cGMP catabolic process|cerebral cortex regionalization|vascular endothelial growth factor production|negative regulation of neuron migration|telencephalon regionalization,0.001165|0.001359|0.001553|0.002328|0.002522,1|1|1|1|1,1030|858.1|735.5|468.1|429.1
3711,5,0.501,5.01,4517.0,0.001105,0.996692,ABHD6 CAPN13 MEGF11 RYR2 TBC1D32,retina development in camera-type eye|lysobisphosphatidic acid metabolic process|left ventricular cardiac muscle tissue morphogenesis|type B pancreatic cell apoptotic process|regulation of endocannabinoid signaling pathway,0.0005331|0.000728|0.000728|0.000728|0.0009706,1|1|1|1|1,54.92|2060|2060|2060|1373
3712,5,0.5124,5.124,3333.0,0.0015300000000000001,0.996692,NOL6 PDCD2 PWP2 TBL3 WDR3,rRNA processing|rRNA metabolic process|maturation of SSU-rRNA|ribosome biogenesis|ribosomal small subunit biogenesis,1.305e-07|1.515e-07|1.602e-07|3.432e-07|5.194e-07,0.002059|0.001195|0.0008425|0.001353|0.001639,63.37|61.02|247.1|49.63|164.8
3713,4,0.5566,3.34,3119.0,0.001067,0.9929309999999999,FAM110B PLCXD3 RNF11 TBPL2,"protein autoubiquitination|organic substance catabolic process|DNA-templated transcription, initiation|catabolic process|lipid catabolic process",0.01352|0.03908|0.04298|0.05352|0.05793,1|1|1|1|1,74.62|5.848|22.99|4.941|16.94
3714,13,0.503,39.23,9835.0,0.003961999999999999,0.999993,BTN2A2 CDKAL1 GPX6 HIST1H1T HLA-DMB HLA-DRB1 OR14J1 OR2B6 OR2J3 SLC17A2 SLC17A4 ZNF165 ZSCAN31,peptide antigen assembly with MHC class II protein complex|MHC class II protein complex assembly|sialic acid transport|peptide antigen assembly with MHC protein complex|MHC protein complex assembly,6.418e-06|6.418e-06|8.982e-06|1.197e-05|1.539e-05,0.1012|0.05062|0.04723|0.04721|0.04854,735.5|735.5|588.4|490.4|420.3
3715,9,0.5083,18.3,5731.0,0.003173,0.9998530000000001,BRAF DUSP4 MAFF MAPK1 MITF SOX10 SOX9 TFAP2A ZEB2,regulation of cell differentiation|regulation of multicellular organismal development|regulation of developmental process|negative regulation of apoptotic process|negative regulation of programmed cell death,1.007e-08|1.438e-07|3.176e-07|4.927e-07|5.578e-07,0.0001588|0.001134|0.00167|0.001943|0.00176,11.62|12.15|7.5|15.46|15.14
3716,5,0.5219,5.218999999999999,4221.0,0.001232,0.996692,ADCY1 KIAA0895 STEAP1 STK17A TBX4,embryonic lung development|neuroinflammatory response|positive regulation of fibroblast apoptotic process|cAMP biosynthetic process|cellular response to forskolin,0.000728|0.001698|0.002183|0.002667|0.002667,1|1|1|1|1,2060|686.5|514.9|411.9|411.9
3717,6,0.5023,7.535,5063.0,0.001483,0.998474,DDX25 HTR6 NCMAP PLA2G2E TC2N ZNF683,regulation of extrathymic T cell differentiation|regulation of natural killer cell differentiation involved in immune response|peripheral nervous system myelin formation|cellular response to ionomycin|response to ionomycin,0.0008735|0.001165|0.001165|0.001746|0.001746,1|1|1|1|1,1716|1144|1144|686.5|686.5
3718,4,0.5121,3.072,3139.0,0.0009753,0.9929309999999999,KIAA1522 NGF SLFN13 TCEANC2,tRNA catabolic process|nerve growth factor processing|positive regulation of collateral sprouting|nerve growth factor signaling pathway|regulation of collateral sprouting,0.0005825|0.0009706|0.002328|0.002522|0.003878,1|1|1|1|1,2574|1287|468.1|429.1|271
3719,4,0.5624,3.3739999999999997,3094.0,0.0010869999999999999,0.9929309999999999,ASB6 C9orf84 ECPAS TCF23,proteasome assembly|decidualization|maternal placenta development|negative regulation of muscle cell differentiation|maternal process involved in female pregnancy,0.002183|0.003637|0.004944|0.008134|0.009293,1|1|1|1|1,490.4|286|208|124.8|109
3720,23,0.5077,128.5,18620.0,0.006836,1.0,ERVV-2 KIR2DL1 KIR2DL3 KLK3 NLRP11 SIGLEC5 VN1R4 ZFP28 ZNF175 ZNF28 ZNF320 ZNF415 ZNF528 ZNF534 ZNF571 ZNF578 ZNF610 ZNF665 ZNF677 ZNF701 ZNF808 ZNF813 ZNF880,"regulation of transcription by RNA polymerase II|cellular process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",2.622e-09|1.102e-08|1.832e-07|1.84e-07|1.878e-07,4.135e-05|8.695e-05|0.0009635|0.0007256|0.0005926,5.097|0.266|3.805|3.804|3.799
3721,5,0.5398,5.398,4071.0,0.0013210000000000001,0.996692,GALNT16 SERPINA11 SYNDIG1L TCL1B TMEM63C,protein O-linked glycosylation via threonine|protein O-linked glycosylation via serine|glomerular filtration|renal filtration|peptidyl-threonine modification,0.002425|0.002667|0.003636|0.003878|0.02022,1|1|1|1|1,457.7|411.9|294.2|274.6|49.63
3722,4,0.5304,3.182,3369.0,0.0009414,0.9929309999999999,ENOPH1 GPR171 IL36RN TCTA,negative regulation of myeloid cell differentiation|L-methionine salvage from S-adenosylmethionine|regulation of myeloid cell differentiation|L-methionine salvage from methylthioadenosine|osteoclast fusion,0.0001028|0.0007766|0.0007855|0.001165|0.001359,1|1|1|1|1,122.6|1716|43.63|1030|858.1
3723,15,0.5024,52.75,12460.0,0.004207,0.999999,C8orf44 CA1 CA2 CA3 CNGB3 CPA6 CYP7A1 FABP12 FABP4 HEY1 MCMDC2 PMP2 SGK3 TMEM69 TRIM55,one-carbon metabolic process|bicarbonate transport|organic anion transport|triglyceride catabolic process|acylglycerol catabolic process,3.52e-06|4.345e-06|9.001e-05|0.0001985|0.0003607,0.05552|0.03427|0.4732|0.7826|1,105.6|98.07|16.15|101.7|74.22
3724,5,0.5547,5.547000000000001,4053.0,0.001363,0.996692,EVA1B HPCAL4 TCTEX1D1 TMEM39A TMEM39B,negative regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|positive regulation of viral genome replication|negative regulation of macroautophagy,1.319e-06|5.648e-06|7.2e-06|2.481e-05|3.302e-05,0.0208|0.04455|0.03786|0.09784|0.1042,1373|588.4|514.9|265.7|228.8
3725,6,0.5028,7.542999999999999,4908.0,0.001531,0.998474,AGO1 AGO3 CFH EVA1B GJB4 TCTEX1D4,"miRNA loading onto RISC involved in gene silencing by miRNA|RNA secondary structure unwinding|small RNA loading onto RISC|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",2.543e-06|3.178e-06|3.883e-06|7.41e-06|7.41e-06,0.04011|0.02506|0.02042|0.02922|0.02338,980.7|858.1|762.8|528.1|528.1
3726,12,0.5062,33.41,7970.0,0.004162,0.999986,AMOTL2 DLG5 KIRREL1 LATS2 NF2 PKN2 PTPN14 RNF146 SAV1 TAOK1 TEAD1 TP53BP2,hippo signaling|intracellular signal transduction|regulation of hippo signaling|cell-cell junction organization|regulation of cellular protein localization,2.349e-09|4.458e-07|7.135e-05|0.0001572|0.000237,3.706e-05|0.003516|0.3751|0.6198|0.7477,245.2|8.717|171.6|27.68|12.17
3727,4,0.5283,3.17,3137.0,0.001007,0.9929309999999999,CHSY1 FAM20B GRAMD1C TECPR2,proteoglycan biosynthetic process|proteoglycan metabolic process|glycoprotein biosynthetic process|glycoprotein metabolic process|cellular response to cholesterol,5.327e-05|0.0001052|0.001261|0.001926|0.003491,0.8403|0.8299|1|1|1,171.6|121.1|34.33|27.68|302.9
3728,5,0.5433,5.433,4199.0,0.001289,0.996692,GPR142 LGALS3BP SSTR2 TECTA TMEM235,somatostatin signaling pathway|somatostatin receptor signaling pathway|peristalsis|phasic smooth muscle contraction|cellular response to estradiol stimulus,0.001456|0.001456|0.00291|0.004845|0.008949,1|1|1|1|1,823.8|823.8|374.5|216.8|114.4
3729,4,0.505,3.03,3103.0,0.0009729,0.9929309999999999,CDX2 TENT5A UNC119B VPREB3,regulation of somitogenesis|lipoprotein transport|lipoprotein localization|trophectodermal cell differentiation|intestinal epithelial cell differentiation,0.001359|0.002716|0.00291|0.003685|0.004459,1|1|1|1|1,858.1|396.1|367.8|286|234
3730,5,0.5357,5.357,3954.0,0.00135,0.996692,ARMC1 EVA1B TENT5B TMEM39A TMEM39B,negative regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|negative regulation of cellular catabolic process|positive regulation of viral genome replication,1.319e-06|5.648e-06|7.2e-06|1.862e-05|2.481e-05,0.0208|0.04455|0.03786|0.07344|0.07827,1373|588.4|514.9|48.84|265.7
3731,4,0.5586,3.352,3336.0,0.001001,0.9929309999999999,GUCY1B1 LCT NRG2 TESC,"nitric oxide-cGMP-mediated signaling pathway|trans-synaptic signaling by nitric oxide, modulating synaptic transmission|trans-synaptic signaling by soluble gas, modulating synaptic transmission|trans-synaptic signaling by nitric oxide|trans-synaptic signaling by soluble gas",0.0005825|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,2574|2574|2574|1716|1716
3732,5,0.5363,5.3629999999999995,4131.0,0.001294,0.996692,ARHGAP25 C2orf78 COCH NCF2 TESK2,phagocytosis|superoxide anion generation|respiratory burst|actin cytoskeleton organization|focal adhesion assembly,0.002449|0.00412|0.005329|0.006183|0.00702,1|1|1|1|1,25.27|257.4|196.1|15.72|147.1
3733,17,0.5059,68.8,12690.0,0.005378,1.0,BTN2A1 BTN2A2 GPX6 HIST1H1T OR14J1 OR2B3 OR2B6 OR2J2 OR2J3 OR2W1 SLC17A4 TRIM10 ZKSCAN4 ZKSCAN8 ZNF165 ZSCAN16 ZSCAN31,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,1.496e-06|2.103e-06|2.609e-06|3.921e-06|4.857e-06,0.0236|0.01658|0.01372|0.01546|0.01532,15.57|14.67|14.13|13.15|12.67
3734,4,0.561,3.366,3340.0,0.001004,0.9929309999999999,GULP1 MEX3D SCD5 TEX22,monounsaturated fatty acid biosynthetic process|mRNA localization resulting in posttranscriptional regulation of gene expression|monounsaturated fatty acid metabolic process|intracellular mRNA localization|fatty-acyl-CoA biosynthetic process,0.0005825|0.0005825|0.0007766|0.001941|0.0062,1|1|1|1|1,2574|2574|1716|572.1|166.1
3735,8,0.5237,14.66,5418.0,0.002691,0.9996790000000001,CIP2A FEN1 HELQ LIG1 POLQ RHNO1 TEX30 TOPBP1,DNA recombination|DNA repair|DNA replication|recombinational repair|DNA metabolic process,1.973e-08|2.369e-08|5.017e-08|8.49e-08|2.32e-07,0.0003112|0.0001869|0.0002638|0.0003348|0.0007318,51.08|25.91|42.22|88.87|17.58
3736,5,0.5125,5.125,4124.0,0.0012380000000000002,0.996692,ADAM7 C3orf80 PLXND1 RPL35A TEX38,dichotomous subdivision of terminal units involved in salivary gland branching|dichotomous subdivision of an epithelial terminal unit|semaphorin-plexin signaling pathway involved in axon guidance|semaphorin-plexin signaling pathway involved in neuron projection guidance|branching involved in salivary gland morphogenesis,0.001213|0.002183|0.00291|0.003394|0.003878,1|1|1|1|1,1030|514.9|374.5|316.8|274.6
3737,5,0.5033,5.033,3943.0,0.001271,0.996692,EVI5 IL4I1 PLCD4 TEX45 TMEM213,L-phenylalanine catabolic process|L-phenylalanine metabolic process|erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process|erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process|aromatic amino acid family catabolic process,0.00291|0.00291|0.00291|0.00291|0.005087,1|1|1|1|1,374.5|374.5|374.5|374.5|205.9
3738,4,0.535,3.21,3203.0,0.0009988,0.9929309999999999,RNF220 TFEB TNFRSF11A TREM2,osteoclast differentiation|myeloid leukocyte differentiation|positive regulation of inflammatory response|positive regulation of C-C chemokine receptor CCR7 signaling pathway|regulation of C-C chemokine receptor CCR7 signaling pathway,2.429e-05|0.0002105|0.0002316|0.0003883|0.0003883,0.3831|1|1|1|1,257.4|85.1|81.08|5149|5149
3739,4,0.5581,3.3480000000000003,3121.0,0.0010689999999999999,0.9929309999999999,ABCB1 GALNTL5 QPCT TFPI2,"ceramide translocation|peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase|terpenoid transport|isoprenoid transport|positive regulation of anion channel activity",0.0005825|0.0005825|0.0007766|0.0007766|0.0009706,1|1|1|1|1,2574|2574|1716|1716|1287
3740,5,0.5084,5.084,4243.0,0.001194,0.996692,ELOVL7 NOX5 PDE1A RELT TGFA,epithelial cell proliferation|reductive iron assimilation|regulation of fusion of sperm to egg plasma membrane|anatomical structure formation involved in morphogenesis|cGMP catabolic process,0.0001913|0.0004854|0.0004854|0.0007113|0.001456,1|1|1|1|1,92.56|4119|4119|14.2|823.8
3741,4,0.5064,3.0380000000000003,3067.0,0.0009871,0.9929309999999999,FAM186B FCN1 TGFB2 ZNF519,substantia propria of cornea development|positive regulation of timing of catagen|uterine wall breakdown|negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation|negative regulation of cardiac epithelial to mesenchymal transition,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
3742,4,0.5413,3.248,3079.0,0.001051,0.9929309999999999,DNAH14 INPPL1 STYXL1 THAP4,negative regulation of stress granule assembly|nitrate metabolic process|regulation of stress granule assembly|dephosphorylation|tyrosine metabolic process,0.0003883|0.0009706|0.001165|0.001432|0.002522,1|1|1|1|1,5149|1287|1030|32.18|429.1
3743,4,0.5899,3.5389999999999997,3459.0,0.0010199999999999999,0.9929309999999999,ENAH FAM229B FOXP2 THBS4,putamen development|caudate nucleus development|innate vocalization behavior|endothelial cell-cell adhesion|actin polymerization-dependent cell motility,0.0003883|0.0003883|0.0003883|0.0009706|0.001553,1|1|1|1|1,5149|5149|5149|1287|735.5
3744,4,0.5827,3.4960000000000004,3158.0,0.001103,0.9929309999999999,CD300LF CYB561D2 THEG TMEM233,interleukin-13-mediated signaling pathway|negative regulation of MyD88-dependent toll-like receptor signaling pathway|negative regulation of apoptotic cell clearance|positive regulation of interleukin-4-mediated signaling pathway|regulation of interleukin-4-mediated signaling pathway,0.0003883|0.0005825|0.0005825|0.0005825|0.0007766,1|1|1|1|1,5149|2574|2574|2574|1716
3745,4,0.5325,3.195,3089.0,0.001031,0.9929309999999999,CSF3 MARCH9 THRA TIMM21,negative regulation of RNA polymerase II transcription preinitiation complex assembly|female courtship behavior|myeloid cell differentiation|thyroid hormone mediated signaling pathway|positive regulation of female receptivity,0.0005825|0.0005825|0.0007149|0.0007766|0.0007766,1|1|1|1|1,2574|2574|45.77|1716|1716
3746,4,0.5588,3.353,3139.0,0.001064,0.9929309999999999,ADGRF4 CALD1 SERPINE1 THSD1,positive regulation of odontoblast differentiation|positive regulation of leukotriene production involved in inflammatory response|regulation of leukotriene production involved in inflammatory response|positive regulation of neuroepithelial cell differentiation|negative regulation of smooth muscle cell-matrix adhesion,0.0003883|0.0003883|0.0003883|0.0003883|0.0005825,1|1|1|1|1,5149|5149|5149|5149|2574
3747,4,0.5873,3.5239999999999996,3313.0,0.00106,0.9929309999999999,DAPP1 GCNT4 THY1 TMPRSS11A,inter-male aggressive behavior|regulation of Rho-dependent protein serine/threonine kinase activity|aggressive behavior|protein metabolic process|retinal cone cell differentiation,0.0005825|0.001165|0.001553|0.001763|0.002328,1|1|1|1|1,2574|1030|735.5|4.883|468.1
3748,4,0.5429,3.2569999999999997,3267.0,0.0009936,0.9929309999999999,GPCPD1 RIMBP2 SLC32A1 TICAM1,positive regulation of myeloid dendritic cell cytokine production|regulation of myeloid dendritic cell cytokine production|negative regulation of MyD88-independent toll-like receptor signaling pathway|regulation of MyD88-independent toll-like receptor signaling pathway|neurotransmitter loading into synaptic vesicle,0.001359|0.001359|0.001553|0.001747|0.001747,1|1|1|1|1,858.1|858.1|735.5|643.6|643.6
3749,4,0.5285,3.1710000000000003,3273.0,0.0009652999999999999,0.9929309999999999,IPCEF1 RAB11FIP5 TICAM2 TSPYL4,positive regulation of interleukin-18-mediated signaling pathway|regulation of interleukin-18-mediated signaling pathway|TRAM-dependent toll-like receptor 4 signaling pathway|TRAM-dependent toll-like receptor signaling pathway|negative regulation of adiponectin secretion,0.0003883|0.0003883|0.0007766|0.0007766|0.0009706,1|1|1|1|1,5149|5149|1716|1716|1287
3750,6,0.528,7.92,3518.0,0.002239,0.998474,CMIP CSDE1 DHX29 EIF4G2 STK11 STRAP,regulation of translational initiation|regulation of translation|regulation of cellular amide metabolic process|positive regulation of axonogenesis|regulation of cellular protein metabolic process,2.344e-06|0.0001921|0.0003072|0.0003486|0.0003979,0.03698|1|1|1|1,107.6|23.98|20.43|70.9|6.036
3751,14,0.5021,45.69,10650.0,0.004261,0.9999969999999999,CHRM1 HRASLS2 HRASLS5 OCM2 PLA2G16 RARRES3 RASGRP2 SCGB1D1 SCGB1D2 SCGB1D4 SCGB2A1 SLC22A10 SLC22A9 TIGD3,N-acylphosphatidylethanolamine metabolic process|phosphatidylethanolamine metabolic process|phosphatidylethanolamine acyl-chain remodeling|glycerophospholipid metabolic process|phosphatidylcholine metabolic process,4.3e-08|1.16e-06|0.0001376|0.00107|0.001273,0.0006783|0.009151|0.7234|1|1,528.1|153.3|121.9|14.36|38.17
3752,6,0.5076,7.615,4744.0,0.001599,0.998474,EDN1 GATA3 ISL1 PHOX2B SOX11 TIGD4,neural crest cell development|stem cell development|mesenchymal cell development|neural crest cell differentiation|sympathetic nervous system development,3.651e-09|4.219e-09|4.422e-09|5.797e-09|2.772e-08,5.76e-05|3.327e-05|2.325e-05|2.286e-05|8.745e-05,173.8|167.4|165.4|154.3|490.4
3753,10,0.5246,23.61,6696.0,0.003503,0.999933,FDX2 FXN HSCB LYRM4 SLC25A37 TIMM10 TIMM10B TIMM22 TIMM29 TIMM9,protein insertion into mitochondrial inner membrane|protein insertion into mitochondrial membrane|establishment of protein localization to mitochondrial membrane|inner mitochondrial membrane organization|protein targeting to mitochondrion,3.55e-14|9.627e-13|2.253e-12|3.375e-11|4.791e-11,5.6e-10|7.592e-09|1.185e-08|1.331e-07|1.512e-07,936.1|429.1|355.1|198|183.9
3754,5,0.5088,5.088,4254.0,0.001192,0.996692,C10orf71 DEDD2 LMOD3 SLC24A5 TK2,deoxycytidine metabolic process|pyrimidine deoxyribonucleoside metabolic process|thymidine metabolic process|negative regulation of secondary metabolite biosynthetic process|negative regulation of melanin biosynthetic process,0.0004854|0.001456|0.001456|0.001456|0.001456,1|1|1|1|1,4119|823.8|823.8|823.8|823.8
3755,4,0.5448,3.2689999999999997,3182.0,0.001024,0.9929309999999999,ADARB1 SRMS TKFC TMEM179,innate immune response|hypoglossal nerve morphogenesis|hypoglossal nerve development|defense response to other organism|spinal cord ventral commissure morphogenesis,0.0002649|0.0003883|0.0003883|0.000487|0.0007766,1|1|1|1|1,18.39|5149|5149|14.97|1716
3756,7,0.5063,10.63,5543.0,0.0019100000000000002,0.9992989999999999,FAM69A GBP4 GBP5 GBP7 SAMD13 ST6GALNAC3 TLE6,cellular response to interferon-gamma|response to interferon-gamma|defense response to protozoan|response to protozoan|defense response to Gram-positive bacterium,1.602e-05|2.389e-05|3.204e-05|3.459e-05|0.0005015,0.2527|0.1884|0.1684|0.1364|1,55.86|48.76|245.2|235.4|58.84
3757,5,0.5273,5.273,4169.0,0.00126,0.996692,GNPAT SQOR TEX9 TLN2 ZNF280D,"cell-cell junction assembly|cell-cell junction organization|sulfide oxidation|sulfide oxidation, using sulfide:quinone oxidoreductase|hydrogen sulfide metabolic process",0.0003843|0.0008136|0.001456|0.001456|0.001698,1|1|1|1|1,64.87|44.29|823.8|823.8|686.5
3758,4,0.5544,3.326,3445.0,0.0009622,0.9929309999999999,GFAP IL1RL1 RRH TLR2,positive regulation of chemokine production|positive regulation of gliogenesis|regulation of chemokine production|regulation of gliogenesis|glial cell development,5.502e-05|5.502e-05|0.0001101|0.0001203|0.0001808,0.8678|0.4339|0.5791|0.4743|0.5705,168.8|168.8|118.4|113.2|91.94
3759,4,0.5008,3.005,2931.0,0.001021,0.9929309999999999,N4BP2L1 OR4A15 OR4C15 TLR3,positive regulation of type III interferon production|regulation of type III interferon production|detection of virus|negative regulation of MyD88-independent toll-like receptor signaling pathway|regulation of MyD88-independent toll-like receptor signaling pathway,0.0005825|0.0009706|0.001359|0.001553|0.001747,1|1|1|1|1,2574|1287|858.1|735.5|643.6
3760,4,0.5301,3.18,3149.0,0.001006,0.9929309999999999,C1orf21 EVPLL LYSMD1 TLR4,nitric oxide production involved in inflammatory response|negative regulation of interleukin-23 production|positive regulation of cellular response to macrophage colony-stimulating factor stimulus|positive regulation of response to macrophage colony-stimulating factor|detection of fungus,0.0003883|0.0005825|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|2574|2574|2574|2574
3761,4,0.5828,3.497,3234.0,0.001077,0.9929309999999999,MYL5 NICN1 TLX3 ZNF662,regulation of respiratory gaseous exchange by nervous system process|regulation of respiratory system process|regulation of respiratory gaseous exchange|neuron fate specification|regulation of system process,0.003394|0.00412|0.005571|0.007261|0.007605,1|1|1|1|1,316.8|257.4|187.2|142|14.13
3762,5,0.5238,5.2379999999999995,4410.0,0.001184,0.996692,LMNTD2 MOAP1 MPP4 TMBIM1 WFIKKN1,negative regulation of Fas signaling pathway|positive regulation of blood vessel remodeling|regulation of Fas signaling pathway|regulation of blood vessel remodeling|protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,0.0004854|0.000728|0.0009706|0.001698|0.00194,1|1|1|1|1,4119|2060|1373|686.5|588.4
3763,4,0.5356,3.214,3170.0,0.00101,0.9929309999999999,CABYR COX8C RNF149 TMC4,sperm capacitation|epithelial cilium movement involved in extracellular fluid movement|extracellular transport|cellular response to drug|ion transmembrane transport,0.005233|0.00678|0.007359|0.01314|0.01462,1|1|1|1|1,198|151.4|139.2|76.85|9.798
3764,16,0.488,58.56,10690.0,0.0054340000000000005,0.999999,CNIH1 GORASP2 GOSR2 RAB1A RAB1B SAR1A SEC23IP SEC31A SURF4 SYVN1 TM9SF3 TMED10 TMED2 TRAPPC12 TRAPPC13 TRAPPC2L,"COPII-coated vesicle budding|vesicle budding from membrane|endoplasmic reticulum to Golgi vesicle-mediated transport|COPII vesicle coating|vesicle targeting, rough ER to cis-Golgi",3.402e-21|1.272e-19|3.354e-19|5.172e-19|5.172e-19,5.366e-17|1.003e-15|1.764e-15|2.04e-15|1.632e-15,183.9|125|72.24|183.9|183.9
3765,4,0.5636,3.3819999999999997,3422.0,0.0009847999999999999,0.9929309999999999,ATP10D POTED SELENOP TMED4,selenium compound metabolic process|phospholipid translocation|lipid translocation|regulation of membrane lipid distribution|phospholipid transport,0.001165|0.009096|0.009675|0.01122|0.01813,1|1|1|1|1,1030|111.9|105.1|90.33|55.36
3766,4,0.5143,3.0860000000000003,3451.0,0.0008912000000000001,0.9929309999999999,AMTN CLN5 PROSER1 TMED8,positive regulation of GTP binding|positive regulation of enamel mineralization|regulation of enamel mineralization|positive regulation of tooth mineralization|lysosomal lumen acidification,0.0005825|0.0007766|0.001165|0.001359|0.002134,1|1|1|1|1,2574|1716|1030|858.1|514.9
3767,5,0.5008,5.008,3632.0,0.001373,0.996692,IRF2BP1 IRF2BP2 IRF2BPL TMEM106A ZIC4,regulation of macromolecule biosynthetic process|regulation of biosynthetic process|CD80 biosynthetic process|CD86 biosynthetic process|negative regulation of transcription by RNA polymerase II,0.0002584|0.0003491|0.0004854|0.000728|0.0007907,1|1|1|1|1,5.222|4.916|4119|2060|13.7
3768,4,0.5214,3.1289999999999996,2602.0,0.0011970000000000001,0.9929309999999999,CCND3 CDK6 MSI2 TMEM117,regulation of G1/S transition of mitotic cell cycle|regulation of cell cycle G1/S phase transition|mitotic cell cycle phase transition|cell cycle phase transition|cell dedifferentiation,0.0003299|0.0004209|0.001139|0.001203|0.001359,1|1|1|1|1,67.75|59.87|36.13|35.15|858.1
3769,5,0.5281,5.281000000000001,4190.0,0.001256,0.996692,IGFBP5 TECRL TMEM125 TRIM9 ZDHHC2,negative regulation of skeletal muscle hypertrophy|positive regulation of postsynaptic membrane organization|positive regulation of endosome to plasma membrane protein transport|positive regulation of AMPA glutamate receptor clustering|negative regulation of SNARE complex assembly,0.0004854|0.000728|0.000728|0.000728|0.0009706,1|1|1|1|1,4119|2060|2060|2060|1373
3770,4,0.5426,3.2560000000000002,2988.0,0.001086,0.9929309999999999,OR4A15 OR4A16 OR4C15 TMEM130,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.915e-05|4.671e-05|5.225e-05|6.46e-05|7.223e-05,0.6176|0.3684|0.2747|0.2548|0.2279,35.03|33|31.78|29.59|28.5
3771,6,0.5179,7.769,4644.0,0.001666,0.998474,HCAR2 HCAR3 P2RX4 PITPNM2 TMEM132B TMEM233,neutrophil apoptotic process|positive regulation of adiponectin secretion|microglial cell migration|sensory perception of touch|positive regulation of neutrophil apoptotic process,0.0008735|0.0008735|0.0008735|0.001456|0.001746,1|1|1|1|1,1716|1716|1716|858.1|686.5
3772,4,0.5838,3.503,3186.0,0.0010960000000000002,0.9929309999999999,ARF5 CD28 LSM14B TMEM139,regulatory T cell differentiation|regulation of translation|positive regulation of isotype switching to IgG isotypes|negative thymic T cell selection|negative T cell selection,0.001359|0.001885|0.001941|0.002328|0.002522,1|1|1|1|1,858.1|27.98|572.1|468.1|429.1
3773,4,0.5003,3.002,3167.0,0.0009447000000000001,0.9929309999999999,HID1 RAB3IP RCN3 TMEM140,collagen biosynthetic process|surfactant homeostasis|chemical homeostasis within a tissue|phospholipid homeostasis|lung epithelium development,0.001941|0.002522|0.00291|0.003297|0.006007,1|1|1|1|1,572.1|429.1|367.8|321.8|171.6
3774,4,0.5002,3.0010000000000003,3209.0,0.0009318999999999999,0.9929309999999999,MGST2 NEDD4 TMEM155 VPS9D1,development involved in symbiotic interaction|negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage|regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage|glucocorticoid receptor signaling pathway|corticosteroid receptor signaling pathway,0.0003883|0.0003883|0.0005825|0.001359|0.001553,1|1|1|1|1,5149|5149|2574|858.1|735.5
3775,4,0.5324,3.194,3228.0,0.000986,0.9929309999999999,AGBL5 CHRND PBK TMEM156,protein branching point deglutamylation|skeletal muscle tissue growth|protein deglutamylation|peptidyl-glutamic acid modification|skeletal muscle contraction,0.0003883|0.0007766|0.001747|0.0062|0.006393,1|1|1|1|1,5149|1716|643.6|166.1|160.9
3776,5,0.5243,5.242999999999999,4125.0,0.001266,0.996692,FAM209A PI3 SMCR8 TMEM159 WFDC3,antibacterial humoral response|antimicrobial humoral response|negative regulation of catalytic activity|negative regulation of cellular protein metabolic process|negative regulation of protein metabolic process,8.295e-05|0.0005758|0.0005854|0.00102|0.001253,1|1|1|1|1,142|52.81|15.18|12.56|11.7
3777,4,0.5114,3.068,3369.0,0.0009077,0.9929309999999999,ASIC4 FOXF2 FRRS1L TMEM169,establishment of planar polarity of embryonic epithelium|regulation of glutamate receptor signaling pathway|establishment of tissue polarity|establishment of planar polarity|embryonic camera-type eye morphogenesis,0.0007766|0.001359|0.004846|0.004846|0.005233,1|1|1|1|1,1716|858.1|214.5|214.5|198
3778,5,0.52,5.2,4144.0,0.00125,0.996692,EPB41L2 H1FNT PRELID2 SPTSSB TMEM174,spermatid nucleus elongation|regulation of serine C-palmitoyltransferase activity|positive regulation of protein localization to cell cortex|regulation of protein localization to cell cortex|sperm chromatin condensation,0.0009706|0.001456|0.001698|0.002425|0.003394,1|1|1|1|1,1373|823.8|686.5|457.7|316.8
3779,5,0.508,5.08,4009.0,0.0012619999999999999,0.996692,DERL3 DHRS7B SLC2A2 TMEM175 TMEM41A,"fructose transmembrane transport|intestinal hexose absorption|dehydroascorbic acid transport|negative regulation of retrograde protein transport, ER to cytosol|negative regulation of protein exit from endoplasmic reticulum",0.001456|0.001698|0.00194|0.002425|0.002667,1|1|1|1|1,823.8|686.5|588.4|457.7|411.9
3780,5,0.5081,5.081,4155.0,0.001218,0.996692,CAMKK1 FBLN2 FBXO41 RBP7 TMEM184B,positive regulation of cell-substrate adhesion|regulation of cell-substrate adhesion|protein polyubiquitination|post-translational protein modification|extracellular matrix organization,0.03045|0.05181|0.07598|0.08484|0.08958,1|1|1|1|1,32.69|18.98|12.79|11.41|10.78
3781,4,0.5096,3.057,3382.0,0.000901,0.9929309999999999,EIF5A2 KIAA0930 ORMDL1 TMEM192,polyamine homeostasis|positive regulation of translational termination|cellular sphingolipid homeostasis|negative regulation of ceramide biosynthetic process|positive regulation of translational elongation,0.0003883|0.0009706|0.001165|0.001165|0.001165,1|1|1|1|1,5149|1287|1030|1030|1030
3782,4,0.562,3.372,3220.0,0.001044,0.9929309999999999,MICALL2 OAS1 PCDHB1 TMEM196,regulation of ribonuclease activity|cellular response to interferon-alpha|regulation of nuclease activity|response to interferon-alpha|positive regulation of protein targeting to mitochondrion,0.001941|0.002716|0.004459|0.004846|0.006393,1|1|1|1|1,572.1|396.1|234|214.5|160.9
3783,4,0.5403,3.242,3317.0,0.000974,0.9929309999999999,CNNM2 LGI3 SOGA3 TMEM198,magnesium ion homeostasis|magnesium ion transmembrane transport|magnesium ion transport|positive regulation of canonical Wnt signaling pathway|positive regulation of Wnt signaling pathway,0.002328|0.003297|0.003491|0.02843|0.03469,1|1|1|1|1,468.1|321.8|302.9|35.03|28.6
3784,4,0.5119,3.071,3145.0,0.0009731,0.9929309999999999,FAM110C NUDT15 TMEM200B WDR86,dGTP catabolic process|dGTP metabolic process|purine deoxyribonucleoside triphosphate catabolic process|DNA protection|purine nucleoside triphosphate catabolic process,0.0007766|0.0009706|0.001165|0.001165|0.001359,1|1|1|1|1,1716|1287|1030|1030|858.1
3785,7,0.5404,11.35,5184.0,0.0021780000000000002,0.9992989999999999,CCDC107 JKAMP MICALL2 PTP4A2 TMEM203 TMEM60 TRPM7,calcium-dependent cell-matrix adhesion|cell-substrate adhesion|cellular magnesium ion homeostasis|magnesium ion homeostasis|necroptotic process,0.001019|0.00167|0.001698|0.004071|0.008465,1|1|1|1|1,1471|31.81|735.5|267.5|122.6
3786,4,0.5795,3.477,2808.0,0.001233,0.9929309999999999,CD46 CR1 CR1L TMEM206,regulation of complement activation|regulation of humoral immune response|positive regulation of regulatory T cell differentiation|regulation of regulatory T cell differentiation|regulation of immune effector process,1.928e-07|3.277e-07|2.417e-06|7.926e-06|1.226e-05,0.003042|0.002584|0.01271|0.03125|0.03869,176|147.1|807.6|429.1|43.54
3787,4,0.5302,3.181,3131.0,0.0010119999999999999,0.9929309999999999,CNNM4 GNB1L TCHHL1 TMEM214,magnesium ion homeostasis|enamel mineralization|magnesium ion transmembrane transport|tooth mineralization|magnesium ion transport,0.002328|0.002522|0.003297|0.003297|0.003491,1|1|1|1|1,468.1|429.1|321.8|321.8|302.9
3788,4,0.5392,3.235,3097.0,0.001041,0.9929309999999999,CD5 RAVER1 SECISBP2L TMEM219,translational readthrough|selenocysteine incorporation|T cell costimulation|lymphocyte costimulation|apoptotic process,0.001747|0.001747|0.01045|0.01083|0.01112,1|1|1|1|1,643.6|643.6|97.15|93.61|11.29
3789,4,0.5456,3.2739999999999996,3311.0,0.0009853,0.9929309999999999,LHX9 MANEAL MGST3 TMEM223,dorsal spinal cord interneuron anterior axon guidance|gonad morphogenesis|dorsal spinal cord interneuron axon guidance|spinal cord interneuron axon guidance|interneuron axon guidance,0.0003883|0.0005825|0.0005825|0.0007766|0.0009706,1|1|1|1|1,5149|2574|2574|1716|1287
3790,4,0.5003,3.002,3060.0,0.0009773,0.9929309999999999,HIST1H2AH KLHL42 OR5B2 TMEM231,neuroepithelial cell differentiation|embryonic digit morphogenesis|smoothened signaling pathway|columnar/cuboidal epithelial cell differentiation|embryonic limb morphogenesis,0.002619|0.008424|0.01031|0.01117|0.01723,1|1|1|1|1,403.8|120.4|98.07|90.33|58.18
3791,4,0.5678,3.407,3156.0,0.001076,0.9929309999999999,BAIAP2L1 DPEP2 EPS8 TMEM234,actin crosslink formation|actin filament bundle assembly|actin filament bundle organization|regulation of actin filament polymerization|regulation of actin polymerization or depolymerization,3.391e-06|4.987e-05|5.502e-05|0.0004258|0.0005069,0.05349|0.3933|0.2893|1|1,735.5|177.5|168.8|59.52|54.48
3792,4,0.5308,3.185,3059.0,0.001037,0.9929309999999999,ORAI3 PDPK1 TEPSIN TMEM241,store-operated calcium entry|cellular response to brain-derived neurotrophic factor stimulus|positive regulation of vascular endothelial cell proliferation|type B pancreatic cell development|regulation of vascular endothelial cell proliferation,0.001747|0.002134|0.003104|0.003104|0.004072,1|1|1|1|1,643.6|514.9|343.2|343.2|257.4
3793,5,0.5009,5.0089999999999995,3993.0,0.00125,0.996692,DNAJB9 GNAT3 PLSCR1 TMEM243 ZNF277,platelet activation|phosphatidylserine biosynthetic process|cell activation|negative regulation of IRE1-mediated unfolded protein response|positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,0.000472|0.001213|0.001352|0.001456|0.001698,1|1|1|1|1,58.43|1030|11.4|823.8|686.5
3794,8,0.505,14.14,5533.0,0.002542,0.9996790000000001,BCL9L BMPR1A FOXA2 HNF1A HNF4A TCF7L2 TMEM245 UBAC1,pancreas development|endocrine system development|endocrine pancreas development|positive regulation of transcription by RNA polymerase II|regulation of hormone secretion,1.121e-08|9.456e-08|5.411e-07|1.035e-06|2.239e-06,0.0001768|0.0007458|0.002845|0.00408|0.007064,145|83.72|183.9|12.81|37.31
3795,4,0.531,3.1860000000000004,3394.0,0.0009356,0.9929309999999999,CYTH1 TMEM25 UGT1A4 ZNF35,bilirubin conjugation|vitamin D3 metabolic process|negative regulation of cellular glucuronidation|negative regulation of glucuronosyltransferase activity|regulation of glucuronosyltransferase activity,0.0005825|0.001359|0.001747|0.001747|0.001747,1|1|1|1|1,2574|858.1|643.6|643.6|643.6
3796,5,0.513,5.13,3571.0,0.00143,0.996692,ATXN2 ATXN2L LSM12 NPEPPS TMEM254,regulation of cytoplasmic mRNA processing body assembly|stress granule assembly|regulation of organelle assembly|negative regulation of receptor internalization|P-body assembly,3.108e-06|1.087e-05|0.0008572|0.003394|0.003636,0.04902|0.0857|1|1|1,823.8|411.9|43.13|316.8|294.2
3797,4,0.5374,3.2239999999999998,3291.0,0.0009763,0.9929309999999999,GAP43 MTMR14 TEX33 TMEM262,axon choice point recognition|regulation of postsynaptic specialization assembly|axon regeneration|protein kinase C-activating G protein-coupled receptor signaling pathway|neuron projection regeneration,0.001553|0.002522|0.004653|0.00562|0.005813,1|1|1|1|1,735.5|429.1|223.9|183.9|177.5
3798,4,0.5465,3.279,3255.0,0.001004,0.9929309999999999,C12orf75 CNPPD1 QSOX1 TMEM266,extracellular matrix assembly|negative regulation of macroautophagy|negative regulation of autophagy|regulation of cyclin-dependent protein serine/threonine kinase activity|regulation of cyclin-dependent protein kinase activity,0.006586|0.007166|0.0164|0.01928|0.02004,1|1|1|1|1,156|143|61.29|52.01|49.99
3799,4,0.5297,3.178,3205.0,0.0009880000000000002,0.9929309999999999,ADAM18 FBXO22 RABL6 TMEM268,regulation of skeletal muscle fiber development|regulation of myotube differentiation|binding of sperm to zona pellucida|sperm-egg recognition|cell-cell recognition,0.002716|0.007938|0.00871|0.01199|0.01545,1|1|1|1|1,396.1|128.7|117|84.41|65.17
3800,4,0.561,3.366,3240.0,0.001035,0.9929309999999999,CREB3L3 EPHB3 MEGF9 TMEM35B,substrate adhesion-dependent cell spreading|cell-substrate adhesion|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|corpus callosum development|retinal ganglion cell axon guidance,4.658e-05|0.000486|0.002522|0.003104|0.003491,0.7348|1|1|1|1,183.9|55.66|429.1|343.2|302.9
3801,4,0.5303,3.182,3149.0,0.001007,0.9929309999999999,CCBE1 HIST1H2AL TMEM38B UBE2QL1,lung development|respiratory tube development|respiratory system development|positive regulation of lymphangiogenesis|secretion by lung epithelial cell involved in lung growth,0.0003925|0.0004114|0.0005229|0.0005825|0.0007766,1|1|1|1|1,62.03|60.57|53.63|2574|1716
3802,4,0.5324,3.195,3291.0,0.0009674,0.9929309999999999,GPR15 KLF13 LRRC30 TMEM40,negative regulation of erythrocyte differentiation|T cell migration|regulation of erythrocyte differentiation|lymphocyte migration|negative regulation of myeloid cell differentiation,0.002328|0.006007|0.009096|0.01449|0.0164,1|1|1|1|1,468.1|171.6|111.9|69.58|61.29
3803,4,0.5717,3.43,3372.0,0.0010140000000000001,0.9929309999999999,DAGLA FLRT1 RETREG1 TMEM43,endocannabinoid signaling pathway|retrograde trans-synaptic signaling by endocannabinoid|retrograde trans-synaptic signaling by lipid|diacylglycerol catabolic process|trans-synaptic signaling by endocannabinoid,0.0009706|0.0009706|0.0009706|0.0009706|0.001456,1|1|1|1|1,1373|1373|1373|1373|823.8
3804,4,0.5528,3.3169999999999997,3308.0,0.0009993,0.9929309999999999,CTGF DCAF10 HEG1 TMEM59,lymph circulation|negative regulation of protein glycosylation in Golgi|negative regulation of protein glycosylation|negative regulation of Rho-dependent protein serine/threonine kinase activity|regulation of protein glycosylation in Golgi,0.0004369|0.0004369|0.0005825|0.0005825|0.0005825,1|1|1|1|1,3432|3432|2288|2288|2288
3805,4,0.5396,3.238,3391.0,0.0009515000000000001,0.9929309999999999,MANEAL NRN1L TMEM223 TMEM65,regulation of cardiac conduction|neuron projection extension|developmental cell growth|cell growth|developmental growth involved in morphogenesis,0.01102|0.01199|0.0164|0.01679|0.02196,1|1|1|1|1,91.94|84.41|61.29|59.87|45.56
3806,4,0.5334,3.201,3001.0,0.001062,0.9929309999999999,OR51I1 OR52B2 OR5P2 TMEM86A,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.915e-05|4.671e-05|5.225e-05|6.46e-05|7.223e-05,0.6176|0.3684|0.2747|0.2548|0.2279,35.03|33|31.78|29.59|28.5
3807,4,0.5681,3.408,3229.0,0.001052,0.9929309999999999,C1orf61 IL22 MATN3 TMEM92,acute-phase response|acute inflammatory response|response to glucocorticoid|cartilage development|response to corticosteroid,0.006105|0.01059|0.02083|0.02241|0.02341,1|1|1|1|1,167.4|95.35|48.01|44.58|42.64
3808,18,0.5048,77.24,14480.0,0.005291,1.0,CRISP1 CRISP2 ENPP4 FBXO9 GLYATL3 GSTA1 GSTA3 GSTA4 GUCA1A IL17A IL17F MLIP MUT PGC PKHD1 RAB23 TFAP2D TMEM217,positive regulation of antimicrobial peptide production|regulation of antimicrobial peptide production|positive regulation of antimicrobial humoral response|regulation of antimicrobial humoral response|positive regulation of humoral immune response,4.681e-08|6.683e-08|6.683e-08|1.59e-07|9.794e-07,0.0007384|0.0005271|0.0003514|0.0006271|0.00309,572.1|490.4|490.4|343.2|171.6
3809,6,0.506,7.59,4779.0,0.001582,0.998474,CKS2 GNA14 TMOD1 TRPM3 TRPM6 ZNF510,protein tetramerization|calcium ion transmembrane transport|protein complex oligomerization|calcium ion transport|pointed-end actin filament capping,0.0002616|0.001265|0.001886|0.002064|0.002328,1|1|1|1|1,80.76|36.13|29.46|28.14|490.4
3810,4,0.5628,3.377,3324.0,0.001013,0.9929309999999999,ACAT1 ORMDL1 TMPRSS13 WNT7A,cholesterol esterification|sterol esterification|steroid esterification|metanephric proximal convoluted tubule development|proximal convoluted tubule development,7.067e-07|7.067e-07|7.067e-07|0.0004854|0.0004854,0.01115|0.005574|0.003716|1|1,2060|2060|2060|4119|4119
3811,4,0.5208,3.125,3395.0,0.0009172000000000001,0.9929309999999999,ASB16 FAM124A TMPRSS15 ZYX,stress fiber assembly|contractile actin filament bundle assembly|actin filament bundle assembly|actin filament bundle organization|integrin-mediated signaling pathway,0.003297|0.003297|0.01141|0.01199|0.01909,1|1|1|1|1,321.8|321.8|88.77|84.41|52.54
3812,4,0.5582,3.3489999999999998,3267.0,0.001021,0.9929309999999999,CCDC34 DEPDC4 SCN1A TMTC4,outer hair cell apoptotic process|sensory perception of mechanical stimulus|positive regulation of endoplasmic reticulum calcium ion concentration|detection of mechanical stimulus involved in sensory perception of pain|protein O-linked mannosylation,0.0003883|0.0004258|0.0007766|0.00291|0.003685,1|1|1|1|1,5149|59.52|1716|367.8|286
3813,4,0.5263,3.158,3193.0,0.0009857000000000002,0.9929309999999999,DGAT1 SEMG1 TM4SF18 TNFRSF18,positive regulation of serine-type peptidase activity|positive regulation of serine-type endopeptidase activity|negative regulation of cilium-dependent cell motility|negative regulation of flagellated sperm motility|negative regulation of cilium movement,0.0007766|0.0007766|0.0009706|0.0009706|0.0009706,1|1|1|1|1,1716|1716|1287|1287|1287
3814,4,0.5544,3.327,3342.0,0.000992,0.9929309999999999,BATF2 LRFN5 SDC2 TNIP2,regulation of macrophage activation|toll-like receptor 2 signaling pathway|CD40 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 9 signaling pathway,4.658e-05|0.001165|0.001941|0.002328|0.003297,0.7348|1|1|1|1,183.9|1030|572.1|468.1|321.8
3815,8,0.5131,14.37,6424.0,0.002226,0.9996790000000001,HRASLS HTR3D IQCG MUC4 OR52N2 SLC51A TCTEX1D2 TNK2,regulation of intraciliary retrograde transport|bile acid secretion|N-acylphosphatidylethanolamine metabolic process|intraciliary retrograde transport|microtubule-based movement,0.001164|0.002715|0.003877|0.005811|0.007614,1|1|1|1|1,1287|429.1|286|183.9|14.71
3816,4,0.5312,3.187,3055.0,0.001039,0.9929309999999999,NUP37 RHBDL3 TNNI3K WDR78,bundle of His cell to Purkinje myocyte communication|microtubule cytoskeleton organization|tRNA-containing ribonucleoprotein complex export from nucleus|tRNA export from nucleus|axonemal dynein complex assembly,0.002716|0.004389|0.00678|0.00678|0.007166,1|1|1|1|1,396.1|18.19|151.4|151.4|143
3817,5,0.5158,5.1579999999999995,4179.0,0.00123,0.996692,CATIP CLEC11A SLC2A13 SPDYA TOGARAM2,myo-inositol transport|nuclear division|organelle fission|polyol transport|positive regulation of amyloid-beta formation,0.001213|0.002659|0.003137|0.003152|0.004845,1|1|1|1|1,1030|24.23|22.26|343.3|216.8
3818,13,0.5028,39.22,11020.0,0.0035380000000000003,0.999993,AK8 CERCAM DBH DPP7 ENTPD2 ENTR1 LCN10 LCN6 LCN8 MYMK NTMT1 SARDH USP20,amine catabolic process|cellular biogenic amine catabolic process|peptidyl-alanine modification|N-terminal peptidyl-proline dimethylation|N-terminal peptidyl-glycine methylation,0.0002037|0.0002037|0.001261|0.001261|0.001261,1|1|1|1|1,99.01|99.01|1584|1584|1584
3819,4,0.5658,3.395,3214.0,0.001052,0.9929309999999999,GALK1 MORN2 TOM1 UBE2O,galactitol metabolic process|glycolytic process from galactose|glycolytic process through glucose-1-phosphate|endosomal transport|hexitol metabolic process,0.0003883|0.0003883|0.0005825|0.0007659|0.0007766,1|1|1|1|1,5149|5149|2574|44.2|1716
3820,8,0.5128,14.36,6409.0,0.00223,0.9996790000000001,CERCAM CIZ1 LCN6 NTMT1 OR1J4 PIP5KL1 TOR1A TOR1B,protein localization to nucleus|chaperone cofactor-dependent protein refolding|'de novo' posttranslational protein folding|'de novo' protein folding|nuclear membrane organization,2.843e-05|8.257e-05|0.0001074|0.0001295|0.0002309,0.4485|0.6512|0.5645|0.5108|0.7285,47.09|151.4|132|119.7|88.77
3821,5,0.509,5.09,4217.0,0.0012029999999999999,0.996692,C9orf43 FBXL13 HIGD1B SPATA31E1 TOR4A,mitochondrial respirasome assembly|biological regulation|regulation of biological process|regulation of cellular process|SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,0.002667|0.008988|0.01377|0.01872|0.02261,1|1|1|1|1,411.9|0|0|0|44.29
3822,4,0.5203,3.122,3122.0,0.0009964,0.9929309999999999,CWC25 SHKBP1 TP53AIP1 UBE2QL1,positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of ERBB signaling pathway|regulation of epidermal growth factor receptor signaling pathway|regulation of ERBB signaling pathway|protein homooligomerization,0.007552|0.007938|0.01698|0.01832|0.03469,1|1|1|1|1,135.5|128.7|59.18|54.77|28.6
3823,4,0.5129,3.077,3033.0,0.001011,0.9929309999999999,BMP4 PUM3 TP53TG5 ZNF322,BMP signaling pathway involved in nephric duct formation|bud dilation involved in lung branching|BMP signaling pathway involved in ureter morphogenesis|renal system segmentation|pulmonary artery endothelial tube morphogenesis,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|0.245|0.2552|0.2663|0.2917,5149|5149|5149|5149|5149
3824,5,0.5033,5.033,4272.0,0.001174,0.996692,ITPRIPL1 SMAP1 TMEM247 TNFRSF11A TPBG,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling|positive regulation of fever generation by positive regulation of prostaglandin secretion|mesenchymal cell migration|olfactory learning|circadian temperature homeostasis,0.0008735|0.0008735|0.0008735|0.0008735|0.001165,1|1|1|1|1,1716|1716|1716|1716|1144
3825,4,0.5426,3.2560000000000002,3186.0,0.001018,0.9929309999999999,ATP6AP1L CD36 SLC31A2 TPD52L2,cellular cation homeostasis|cellular ion homeostasis|cation homeostasis|inorganic ion homeostasis|cellular chemical homeostasis,0.0001161|0.0001239|0.0001576|0.000165|0.0001886,1|0.9769|0.8286|0.6507|0.5949,24.29|23.76|21.91|21.57|20.62
3826,4,0.543,3.258,3124.0,0.001039,0.9929309999999999,BTN3A2 HIST1H4B NHLRC1 TPM4,negative regulation of megakaryocyte differentiation|interferon-gamma production|DNA replication-dependent nucleosome assembly|DNA replication-dependent nucleosome organization|positive regulation of histone exchange,0.001165|0.001941|0.002134|0.002134|0.002328,1|1|1|1|1,1030|572.1|514.9|514.9|468.1
3827,4,0.5042,3.025,3172.0,0.0009505000000000001,0.9929309999999999,ADCY9 CCDC153 CYSRT1 TPPP2,cAMP biosynthetic process|activation of protein kinase A activity|regulation of flagellated sperm motility|adenylate cyclase-activating adrenergic receptor signaling pathway|cAMP metabolic process,0.002134|0.003878|0.004072|0.004266|0.004459,1|1|1|1|1,514.9|271|257.4|245.2|234
3828,6,0.5095,7.643,3884.0,0.0019579999999999997,0.998474,OSGEP TIMM9 TP53RK TPRKB TRMT5 YRDC,tRNA threonylcarbamoyladenosine metabolic process|tRNA processing|tRNA metabolic process|tRNA threonylcarbamoyladenosine modification|tRNA modification,9.675e-12|2.698e-08|9.312e-08|7.066e-07|1.764e-06,1.526e-07|0.0002128|0.0004896|0.002787|0.005565,858.1|104|75.86|2288|114.4
3829,17,0.5048,68.66,13090.0,0.005204,1.0,BICDL2 CLDN6 CLUAP1 CORO7 GLIS2 HS3ST6 NOXO1 OR1F1 PAQR4 PRSS21 PRSS27 PRSS33 SEPT12 TPSG1 ZNF213 ZNF500 ZSCAN10,regulation of transcription from RNA polymerase II promoter involved in kidney development|Golgi to secretory granule transport|transport along microtubule|cellular metabolic process|microtubule-based transport,0.001649|0.002472|0.007363|0.009292|0.01081,1|1|1|1|1,1211|605.7|15.53|0.16|12.69
3830,4,0.5155,3.093,3248.0,0.0009490999999999999,0.9929309999999999,CXCL14 GATM HKDC1 TPTE2,creatine biosynthetic process|positive regulation of natural killer cell chemotaxis|creatine metabolic process|regulation of natural killer cell chemotaxis|muscle atrophy,0.0005825|0.001359|0.001553|0.001747|0.002134,1|1|1|1|1,2574|858.1|735.5|643.6|514.9
3831,5,0.5374,5.374,4234.0,0.001265,0.996692,ARHGEF37 HTR1E MDGA1 NCF1 TRAP1,negative regulation of cellular respiration|translational attenuation|negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide|regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide|regulation of synaptic membrane adhesion,0.0006794|0.001019|0.001358|0.001358|0.001698,1|1|1|1|1,2942|1471|980.7|980.7|735.5
3832,4,0.5006,3.0039999999999996,3121.0,0.0009589,0.9929309999999999,CIB2 SDHAF1 SDHAF3 TRAPPC6A,mitochondrial respiratory chain complex II assembly|respiratory chain complex II assembly|mitochondrial respiratory chain complex assembly|protein-containing complex assembly|melanosome assembly,4.241e-07|4.241e-07|0.0001476|0.001045|0.001165,0.00669|0.003345|0.7761|1|1,2574|2574|102|11.55|1030
3833,5,0.5018,5.018,4040.0,0.0012369999999999998,0.996692,ATG16L1 SNX13 SNX14 TREML4 WDFY1,positive regulation of toll-like receptor signaling pathway|positive regulation of pattern recognition receptor signaling pathway|regulation of toll-like receptor signaling pathway|regulation of pattern recognition receptor signaling pathway|macroautophagy,1.909e-05|4.647e-05|0.0001264|0.0002452|0.000866,0.3011|0.3665|0.6647|0.9668|1,305.1|191.6|114.4|81.56|42.91
3834,4,0.5457,3.2739999999999996,3273.0,0.0009968,0.9929309999999999,RCBTB2 SDF2 SIAH3 TRIM13,negative regulation of protein targeting to mitochondrion|proteasome-mediated ubiquitin-dependent protein catabolic process|proteasomal protein catabolic process|negative regulation of establishment of protein localization to mitochondrion|negative regulation of viral release from host cell,0.001359|0.001458|0.00166|0.001747|0.003104,1|1|1|1|1,858.1|31.88|29.85|643.6|343.2
3835,4,0.5519,3.3110000000000004,3166.0,0.001042,0.9929309999999999,HIST3H3 MRM1 THBS3 TRIM17,rRNA 2'-O-methylation|bone trabecula formation|bone trabecula morphogenesis|ossification involved in bone maturation|growth plate cartilage development,0.0007281|0.001165|0.001601|0.002329|0.002619,1|1|1|1|1,1716|980.7|686.5|457.7|403.8
3836,5,0.5054,5.053999999999999,3865.0,0.001303,0.996692,GNAI2 KLHL6 OSTF1 SYK TRIM2,positive regulation of superoxide anion generation|regulation of superoxide anion generation|regulation of superoxide metabolic process|cell activation|granulocyte activation,1.629e-05|1.946e-05|3.493e-05|0.0001065|0.0002723,0.2569|0.1534|0.1836|0.4201|0.8591,343.2|312|228.8|12.67|20.64
3837,4,0.5252,3.1510000000000002,2866.0,0.0010949999999999998,0.9929309999999999,CYP4F22 OR52K2 TRIM21 WIZ,negative regulation of protein deubiquitination|regulation of protein stability|positive regulation of nuclear cell cycle DNA replication|positive regulation of cell cycle|positive regulation of DNA-dependent DNA replication,0.0009706|0.001286|0.001359|0.002124|0.002522,1|1|1|1|1,1287|33.99|858.1|26.34|429.1
3838,4,0.5468,3.281,3093.0,0.001057,0.9929309999999999,HTR2A KCNRG LRRC63 TRIM35,negative regulation of potassium ion transport|regulation of potassium ion transport|phospholipase C-activating serotonin receptor signaling pathway|positive regulation of phosphatidylinositol biosynthetic process|regulation of phosphatidylinositol biosynthetic process,1.679e-05|0.0002071|0.0007766|0.0007766|0.001165,0.2649|1|1|1|1,312|85.81|1716|1716|1030
3839,16,0.5068,60.82,12120.0,0.00498,0.999999,BTN2A1 BTN2A2 GPX6 HIST1H1T OR14J1 OR2B6 OR2J2 OR2J3 SLC17A4 TMEM14B TRIM10 TRIM26 TRIM39 ZKSCAN4 ZNF184 ZSCAN16,cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance|negative regulation of viral entry into host cell|detoxification,6.752e-05|9.782e-05|0.0001173|0.0001748|0.0001785,1|0.7715|0.6167|0.6895|0.5633,38.26|33.65|31.6|110.1|27.33
3840,4,0.5024,3.014,3109.0,0.0009662000000000001,0.9929309999999999,CACNA1I FAM219A OR5D16 TRIM44,negative regulation of protein K48-linked ubiquitination|regulation of protein K48-linked ubiquitination|negative regulation of protein polyubiquitination|sleep|positive regulation of calcium ion-dependent exocytosis,0.0005825|0.0009706|0.002134|0.00291|0.003878,1|1|1|1|1,2574|1287|514.9|367.8|271
3841,11,0.5105,28.08,8040.0,0.003471,0.999969,FOLR1 FOLR2 KRTAP5-1 KRTAP5-10 KRTAP5-11 KRTAP5-9 P2RY6 PLEKHB1 POLD4 TRIM48 TRIM49D1,keratinization|keratinocyte differentiation|epidermal cell differentiation|skin development|epidermis development,1.667e-09|4.521e-09|1.186e-08|3.655e-08|6.01e-08,2.629e-05|3.566e-05|6.238e-05|0.0001442|0.0001896,45.56|38.42|32.59|26.89|24.69
3842,4,0.54,3.24,3265.0,0.000989,0.9929309999999999,ACAA1 MOBP OLR1 TRIM52,immune effector process|phenylacetate catabolic process|central nervous system myelin formation|xenobiotic catabolic process|alpha-linolenic acid metabolic process,0.0005801|0.0005825|0.001165|0.002522|0.002716,1|1|1|1|1,14.11|2574|1030|429.1|396.1
3843,4,0.5214,3.1289999999999996,3303.0,0.0009441000000000001,0.9929309999999999,C19orf73 IQCK RUNDC3B TRIM61,UNCLASSIFIED|biological_process|regulation of cellular process|cellular process|protein ubiquitination,0.008539|0.008539|0.04148|0.04971|0.1365,1|1|1|1|1,5.627|0.2884|0|0.3325|6.948
3844,4,0.5293,3.176,2984.0,0.00106,0.9929309999999999,CALCB OR52E2 OR56A1 TRIM68,G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,0.001027|0.00269|0.003023|0.003256|0.003746,1|1|1|1|1,11.62|23.35|22|21.19|19.73
3845,4,0.55,3.3,3269.0,0.001006,0.9929309999999999,DYRK4 GPN1 LEPR TRIM7,negative regulation of growth hormone receptor signaling pathway|regulation of growth hormone receptor signaling pathway|leptin-mediated signaling pathway|negative regulation of protein localization to cell surface|late endosome to vacuole transport via multivesicular body sorting pathway,0.000728|0.001698|0.00291|0.003394|0.004362,1|1|1|1|1,2060|686.5|374.5|316.8|242.3
3846,4,0.5592,3.355,3051.0,0.0010960000000000002,0.9929309999999999,C20orf202 OR1L3 PITPNM1 TRIM77,detection of stimulus|phototransduction|intermembrane lipid transfer|detection of light stimulus|phospholipid transport,0.006985|0.00871|0.009482|0.01237|0.01813,1|1|1|1|1,14.34|117|107.3|81.73|55.36
3847,5,0.5043,5.043,4147.0,0.001212,0.996692,ADAM2 RNF170 THSD4 TRMT10B UNC5D,netrin-activated signaling pathway|elastic fiber assembly|mitochondrial tRNA processing|mitochondrial RNA processing|fusion of sperm to egg plasma membrane involved in single fertilization,0.002667|0.00291|0.003394|0.004362|0.005329,1|1|1|1|1,411.9|374.5|316.8|242.3|196.1
3848,23,0.5001,126.5,19020.0,0.006592,1.0,ADAM28 ADAM32 BIN3 C8orf58 CHRNA2 CHRNA6 CHRNB3 DEFA5 DEFB4A DMTN NAT1 PEBP4 PRSS55 RHOBTB2 SARAF SCARA3 SORBS3 STMN4 TNFRSF10A TNFRSF10B TNFRSF10C TNFRSF10D TRMT9B,"TRAIL-activated apoptotic signaling pathway|synaptic transmission, cholinergic|extrinsic apoptotic signaling pathway via death domain receptors|glutamine transport|excitatory postsynaptic potential",1.487e-07|6.362e-06|1.134e-05|6.836e-05|8.08e-05,0.002346|0.05018|0.05962|0.2696|0.2549,396.1|91.4|74.26|198|37.13
3849,5,0.5064,5.064,4012.0,0.001257,0.996692,ADPRHL1 GSG1L H1FNT SVOPL TROAP,spermatid nucleus elongation|protein de-ADP-ribosylation|regulation of postsynaptic neurotransmitter receptor internalization|sperm chromatin condensation|spermatid nucleus differentiation,0.0009706|0.001698|0.003152|0.003394|0.005087,1|1|1|1|1,1373|686.5|343.3|316.8|205.9
3850,4,0.5115,3.069,3039.0,0.001006,0.9929309999999999,ADH1B HTR3E TFDP2 TRPC1,regulation of biological quality|ethanol oxidation|melanin biosynthetic process|melanin metabolic process|secondary metabolite biosynthetic process,0.001436|0.002522|0.002522|0.002716|0.00291,1|1|1|1|1,5.14|429.1|429.1|396.1|367.8
3851,4,0.5718,3.431,3408.0,0.001003,0.9929309999999999,CXXC4 GUCA2B MKI67 TRPV3,negative regulation of hair cycle|zygotic specification of dorsal/ventral axis|positive regulation of guanylate cyclase activity|dorsal/ventral axis specification|regulation of guanylate cyclase activity,0.0003883|0.0007766|0.001941|0.002328|0.002522,1|1|1|1|1,5149|1716|572.1|468.1|429.1
3852,4,0.555,3.33,3150.0,0.001053,0.9929309999999999,C14orf119 GLTPD2 NXPH4 TSPAN12,ceramide 1-phosphate transport|ceramide transport|regulation of vascular endothelial growth factor signaling pathway|regulation of cellular response to vascular endothelial growth factor stimulus|retina layer formation,0.001747|0.00291|0.004072|0.004459|0.005233,1|1|1|1|1,643.6|367.8|257.4|234|198
3853,6,0.5103,7.654,5105.0,0.0014939999999999999,0.998474,ANKRD29 CCDC182 CTIF HRH4 NUDT16L1 TSPAN16,negative regulation of double-strand break repair via nonhomologous end joining|adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway|G protein-coupled acetylcholine receptor signaling pathway|acetylcholine receptor signaling pathway|regulation of double-strand break repair via nonhomologous end joining,0.002328|0.002619|0.005812|0.008707|0.008996,1|1|1|1|1,490.4|429.1|180.7|118.4|114.4
3854,5,0.5104,5.104,3788.0,0.001342,0.996692,BICDL2 IL32 MMP25 THOC6 TSPAN8,collagen catabolic process|collagen metabolic process|Golgi to secretory granule transport|positive regulation of type III interferon production|positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,6.96e-05|0.000137|0.0008735|0.0008735|0.001456,1|1|1|1|1,159.7|112.5|1716|1716|858.1
3855,6,0.51,7.65,4853.0,0.00157,0.998474,C22orf46 DESI1 MEI1 MPPED2 PMM1 TSPO,response to vitamin B1|GDP-mannose biosynthetic process|maintenance of protein location in mitochondrion|peripheral nervous system axon regeneration|negative regulation of autophagy of mitochondrion,0.001165|0.001746|0.001746|0.002037|0.002328,1|1|1|1|1,1144|686.5|686.5|572.1|490.4
3856,4,0.6021,3.613,3291.0,0.001094,0.9929309999999999,DCAF13 DNAJB2 SLC39A11 TSPYL6,negative regulation of protein deubiquitination|regulation of chaperone-mediated protein folding|negative regulation of inclusion body assembly|regulation of protein folding|regulation of protein deubiquitination,0.0009706|0.001165|0.002328|0.002522|0.002716,1|1|1|1|1,1287|1030|468.1|429.1|396.1
3857,4,0.5107,3.0639999999999996,3149.0,0.0009697000000000001,0.9929309999999999,FXYD6 SKIDA1 TCAIM TTC19,respiratory chain complex III assembly|mitochondrial respiratory chain complex III assembly|cytochrome complex assembly|regulation of sodium ion transmembrane transporter activity|regulation of cardiac conduction,0.001941|0.001941|0.007166|0.01083|0.01102,1|1|1|1|1,572.1|572.1|143|93.61|91.94
3858,5,0.5304,5.303999999999999,3910.0,0.001351,0.996692,C4orf46 CNN2 TBC1D3B TTC21B UQCRH,"regulation of intraciliary retrograde transport|mitochondrial electron transport, ubiquinol to cytochrome c|intraciliary retrograde transport|negative regulation of phagocytosis|intraciliary transport involved in cilium assembly",0.000728|0.003636|0.003636|0.005812|0.009913,1|1|1|1|1,2060|294.2|294.2|179.1|103
3859,5,0.5008,5.008,4053.0,0.001231,0.996692,FAAP100 FAM124A LECT2 LRRIQ1 TTC29,biological regulation|interstrand cross-link repair|regulation of biological process|regulation of cellular process|cilium movement,0.008988|0.01376|0.01377|0.01872|0.03471,1|1|1|1|1,0|73.55|0|0|28.6
3860,4,0.5393,3.236,3314.0,0.0009731,0.9929309999999999,AMIGO3 ITPR1 TTC31 ZNRF4,voluntary musculoskeletal movement|epithelial fluid transport|regulation of postsynaptic cytosolic calcium ion concentration|negative regulation of calcium-mediated signaling|inositol phosphate-mediated signaling,0.001359|0.002134|0.002328|0.003878|0.004846,1|1|1|1|1,858.1|514.9|468.1|271|214.5
3861,5,0.5005,5.005,4147.0,0.001202,0.996692,IL9 MIA PRF1 TTC34 ZNF575,defense response to tumor cell|immune response to tumor cell|interleukin-9-mediated signaling pathway|cellular response to interleukin-9|positive regulation of interleukin-5 production,0.001456|0.001698|0.002425|0.002425|0.002667,1|1|1|1|1,823.8|686.5|457.7|457.7|411.9
3862,5,0.5245,5.245,4113.0,0.0012699999999999999,0.996692,IGDCC3 IGF2BP2 IZUMO4 TRH TTC7B,positive regulation of gamma-aminobutyric acid secretion|negative regulation of glutamate secretion|imidazole-containing compound metabolic process|histamine metabolic process|regulation of gamma-aminobutyric acid secretion,0.0009706|0.001456|0.001698|0.001698|0.001698,1|1|1|1|1,1373|823.8|686.5|686.5|686.5
3863,4,0.521,3.1260000000000003,3105.0,0.001003,0.9929309999999999,NAAA NPFFR2 TTLL2 UGT2B11,N-acylethanolamine metabolic process|N-acylphosphatidylethanolamine metabolic process|ethanolamine-containing compound metabolic process|xenobiotic glucuronidation|protein polyglutamylation,0.001165|0.001941|0.001941|0.002328|0.002716,1|1|1|1|1,1030|572.1|572.1|468.1|396.1
3864,4,0.5789,3.4739999999999998,3422.0,0.0010119999999999999,0.9929309999999999,ALPK1 PARM1 SAMD9L TTLL6,microtubule severing|protein polyglutamylation|positive regulation of cilium movement|peptidyl-glutamic acid modification|positive regulation of telomerase activity,0.002522|0.002716|0.00291|0.0062|0.00678,1|1|1|1|1,429.1|396.1|367.8|166.1|151.4
3865,4,0.5502,3.301,3216.0,0.001023,0.9929309999999999,DAZL IGFBP6 MTMR11 TTLL9,protein polyglutamylation|3'-UTR-mediated mRNA stabilization|regulation of insulin-like growth factor receptor signaling pathway|positive regulation of translational initiation|peptidyl-glutamic acid modification,0.002716|0.004072|0.004459|0.006007|0.0062,1|1|1|1|1,396.1|257.4|234|171.6|166.1
3866,4,0.5138,3.083,3171.0,0.0009686,0.9929309999999999,C6orf120 RFTN1 TNFRSF8 TTPAL,positive regulation of TRAIL production|regulation of TRAIL production|T cell antigen processing and presentation|dsRNA transport|positive regulation of growth rate,0.0005825|0.0005825|0.0007766|0.0007766|0.0007766,1|1|1|1|1,2574|2574|1716|1716|1716
3867,4,0.5291,3.175,3255.0,0.0009718999999999999,0.9929309999999999,FBXO25 MFGE8 SYNJ2BP TTR,amyloid fibril formation|thyroid hormone transport|negative regulation of sprouting angiogenesis|purine nucleobase metabolic process|supramolecular fiber organization,6.041e-05|0.002134|0.002328|0.003878|0.004872,0.953|1|1|1|1,160.9|514.9|468.1|271|17.25
3868,11,0.5064,27.85,8520.0,0.00325,0.999969,CFC1 CFC1B FAHD2A IL1F10 LYG1 LYG2 MGAT4A MRPL30 POTEI TUBA3D TUBA3E,cell wall macromolecule catabolic process|cell wall organization or biogenesis|cell wall macromolecule metabolic process|peptidoglycan metabolic process|peptidoglycan catabolic process,1.554e-06|2.588e-06|2.588e-06|7.241e-06|7.241e-06,0.02451|0.02042|0.01361|0.02856|0.02285,1872|1248|1248|624.1|624.1
3869,9,0.506,18.22,6955.0,0.002606,0.9998530000000001,BTN2A2 HIST1H1T OR2B6 SERPINB9 SLC17A2 SLC17A4 TUBB2A TUBB2B ZNF184,sialic acid transport|neuron migration|sodium ion transmembrane transport|positive regulation of axon guidance|sodium ion transport,2.768e-06|0.0008904|0.0009513|0.001552|0.001964,0.04366|1|1|1|1,1030|44.39|42.91|858.1|29.59
3870,4,0.5025,3.015,3091.0,0.0009718999999999999,0.9929309999999999,DCAF13 DNAJB2 GDF11 TUBB6,spinal cord anterior/posterior patterning|negative regulation of protein deubiquitination|regulation of chaperone-mediated protein folding|negative regulation of inclusion body assembly|regulation of protein folding,0.0003883|0.0009706|0.001165|0.002328|0.002522,1|1|1|1|1,5149|1287|1030|468.1|429.1
3871,15,0.5064,53.17,10160.0,0.0051920000000000004,0.999999,CNIH4 DUX4 HSPE1 NEDD1 OR2A25 PAFAH1B1 RPL11 RPL12 RPL13 RPL17 RPL23 RPL37 RPL4 RPLP2 RPS13,SRP-dependent cotranslational protein targeting to membrane|cotranslational protein targeting to membrane|protein targeting to ER|establishment of protein localization to endoplasmic reticulum|viral transcription,1.808e-17|2.789e-17|6.261e-17|8.486e-17|9.142e-17,2.851e-13|2.2e-13|3.292e-13|3.346e-13|2.884e-13,120.7|114.7|104.4|100.7|99.87
3872,5,0.5262,5.2620000000000005,4206.0,0.001247,0.996692,CD300LG CNTNAP1 MPP3 TUFM WASF1,dendritic transport of mitochondrion|protein localization to paranode region of axon|protein localization to juxtaparanode region of axon|modification of postsynaptic actin cytoskeleton|lamellipodium morphogenesis,0.000728|0.0009706|0.001213|0.001213|0.001456,1|1|1|1|1,2060|1373|1030|1030|823.8
3873,4,0.5015,3.009,3220.0,0.0009312000000000001,0.9929309999999999,CBLN1 NCKIPSD OR11L1 TULP3,negative regulation of inhibitory synapse assembly|central nervous system neuron differentiation|bronchus morphogenesis|negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning|regulation of inhibitory synapse assembly,0.0003883|0.0004655|0.0005825|0.0005825|0.0009706,1|1|1|1|1,5149|56.89|2574|2574|1287
3874,21,0.5008,105.2,16710.0,0.006239,1.0,ALDOC C17orf50 C17orf75 CCL13 CCL2 CCL7 CRYBA1 EVI2A GAS2L2 LGALS9 LYRM9 PIPOX RDM1 SLC13A2 SLFN12 SLFN14 SPAG5 TIAF1 TWF1 UNC119 VTN,eosinophil chemotaxis|eosinophil migration|regulation of ERK1 and ERK2 cascade|monocyte chemotaxis|lymphocyte chemotaxis,1.027e-06|1.197e-06|9.94e-06|1.174e-05|1.949e-05,0.0162|0.009443|0.05227|0.04631|0.0615,173.1|163.5|16.85|71.76|60.04
3875,4,0.5247,3.148,3166.0,0.000991,0.9929309999999999,NAGLU PROSER1 UACA ZSWIM8,retinal rod cell development|retinal rod cell differentiation|locomotor rhythm|regulation of axon guidance|middle ear morphogenesis,0.002134|0.002716|0.002716|0.00291|0.003878,1|1|1|1|1,514.9|396.1|396.1|367.8|271
3876,5,0.5689,5.689,4294.0,0.00132,0.996692,C10orf67 FOXI2 GPR4 PDE4B UBAP1L,negative regulation of relaxation of cardiac muscle|negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process|negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway|glomerular mesangial cell development,0.000728|0.0009706|0.0009706|0.001213|0.001456,1|1|1|1|1,2060|1373|1373|1030|823.8
3877,7,0.5022,10.55,4609.0,0.0022760000000000002,0.9992989999999999,BRAP DDI2 NGLY1 PLAA UBB UBC USP14,proteolysis involved in cellular protein catabolic process|cellular protein catabolic process|protein catabolic process|cellular macromolecule catabolic process|protein deglycosylation,1.617e-08|2.224e-08|3.62e-08|1.996e-07|2.5e-07,0.0002551|0.0001754|0.0001903|0.0007873|0.0007888,25.92|24.56|22.62|16.94|241.3
3878,4,0.5469,3.281,3260.0,0.001003,0.9929309999999999,HOXD8 SSFA2 UBE2E3 ZC3H14,"negative regulation of mRNA polyadenylation|negative regulation of mRNA 3'-end processing|tripartite regional subdivision|regulation of mRNA polyadenylation|anterior/posterior axis specification, embryo",0.00131|0.001456|0.002619|0.002619|0.002619,1|1|1|1|1,858.1|762.8|403.8|403.8|403.8
3879,4,0.5445,3.267,3327.0,0.0009785,0.9929309999999999,ACVR1 ANGPTL3 POU4F2 UBE2U,circulatory system development|endocardial cushion cell fate commitment|endocardial cell fate commitment|negative regulation of amacrine cell differentiation|regulation of locomotion,0.0002772|0.0003883|0.0003883|0.0003883|0.0004307,1|1|1|1|1,18.11|5149|5149|5149|15.6
3880,8,0.5037,14.1,6826.0,0.0020570000000000002,0.9996790000000001,ARNTL2 DCLRE1C ETFBKMT ITPR2 KLHL42 MANSC4 TM7SF3 UBE3B,negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of electron transfer activity|regulation of insulin secretion|negative regulation of fatty acid beta-oxidation,0.0007765|0.0007765|0.0007765|0.002308|0.002715,1|1|1|1|1,2574|2574|2574|27.24|429.1
3881,4,0.5187,3.112,3125.0,0.0009924,0.9929309999999999,OR52N2 PTH1R PTK2B UBE3C,regulation of inositol phosphate biosynthetic process|bone resorption|bone remodeling|regulation of alcohol biosynthetic process|regulation of carbohydrate biosynthetic process,4.323e-06|9.177e-06|3.048e-05|7.603e-05|0.0001363,0.06819|0.07238|0.1603|0.2998|0.4301,643.6|429.1|228.8|143|106.2
3882,5,0.5324,5.324,4347.0,0.001221,0.996692,CACNB1 GRN OSBPL7 UBE4A UBXN4,ubiquitin-dependent ERAD pathway|ERAD pathway|positive regulation of lysosome organization|positive regulation of inflammatory response to wounding|negative regulation of neutrophil activation,0.0001369|0.0001956|0.0004854|0.000728|0.0009706,1|1|1|1|1,109.8|91.53|4119|2060|1373
3883,4,0.5204,3.123,3194.0,0.0009742,0.9929309999999999,SI SNX14 TREML4 UBL3,positive regulation of toll-like receptor 7 signaling pathway|polysaccharide digestion|regulation of toll-like receptor 7 signaling pathway|positive regulation of toll-like receptor signaling pathway|autophagosome maturation,0.001359|0.001359|0.001553|0.005426|0.005813,1|1|1|1|1,858.1|858.1|735.5|190.7|177.5
3884,5,0.511,5.11,3417.0,0.001489,0.996692,C16orf72 DDA1 UBE4B UBL7 VCPIP1,protein ubiquitination|granzyme-mediated apoptotic signaling pathway|protein modification by small protein conjugation|endoplasmic reticulum membrane fusion|protein modification by small protein conjugation or removal,0.0004443|0.0004854|0.0006002|0.000728|0.001168,1|1|1|1|1,16.68|4119|15.05|2060|11.99
3885,5,0.5186,5.186,4156.0,0.001243,0.996692,AGBL3 CAVIN4 KIF13B UBN2 ZNF783,protein side chain deglutamylation|protein deglutamylation|peptidyl-glutamic acid modification|regulation of Rho protein signal transduction|regulation of axonogenesis,0.001456|0.002183|0.007744|0.02094|0.038,1|1|1|1|1,823.8|514.9|132.9|47.9|26.07
3886,5,0.5194,5.194,3876.0,0.001335,0.996692,PSPC1 RNF6 UBQLN1 ZMYM2 ZMYM5,negative regulation of store-operated calcium channel activity|protein K27-linked ubiquitination|positive regulation of ER-associated ubiquitin-dependent protein catabolic process|regulation of store-operated calcium channel activity|protein K6-linked ubiquitination,0.0004854|0.001456|0.002183|0.002425|0.002425,1|1|1|1|1,4119|823.8|514.9|457.7|457.7
3887,4,0.5186,3.112,3295.0,0.0009413000000000001,0.9929309999999999,ANGPTL2 CYP27A1 PLPPR1 UBQLN3,cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process|vitamin D3 metabolic process,0.0009706|0.0009706|0.0009706|0.0009706|0.001359,1|1|1|1|1,1287|1287|1287|1287|858.1
3888,5,0.529,5.29,4203.0,0.001254,0.996692,LCA5L PPP1R3B SLC28A2 THAP6 UBR1,inosine transport|ubiquitin-dependent protein catabolic process via the N-end rule pathway|adenosine transport|purine nucleobase transmembrane transport|purine nucleoside transmembrane transport,0.0004854|0.0009706|0.0009706|0.001213|0.001213,1|1|1|1|1,4119|1373|1373|1030|1030
3889,4,0.5344,3.2060000000000004,3232.0,0.0009885,0.9929309999999999,AIMP1 ISM1 TMEM52 UBTD1,positive regulation of glucagon secretion|regulation of glucagon secretion|negative regulation of endothelial cell proliferation|tRNA aminoacylation for protein translation|tRNA aminoacylation,0.0007766|0.002134|0.008517|0.009096|0.009675,1|1|1|1|1,1716|514.9|119.7|111.9|105.1
3890,4,0.556,3.3360000000000003,3207.0,0.001037,0.9929309999999999,CSF3R S100A14 SPINK2 UBXN10,negative regulation of serine-type peptidase activity|negative regulation of serine-type endopeptidase activity|regulation of serine-type peptidase activity|regulation of serine-type endopeptidase activity|acrosome assembly,0.001553|0.001553|0.001941|0.001941|0.003297,1|1|1|1|1,735.5|735.5|572.1|572.1|321.8
3891,8,0.5177,14.5,6405.0,0.0022530000000000002,0.9996790000000001,ARL11 C1QTNF9 COMMD6 KRTAP21-1 RCBTB2 RNF6 SIAH3 UCHL3,ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process|proteolysis involved in cellular protein catabolic process|cellular protein catabolic process,0.0008894|0.0009235|0.0009789|0.001228|0.001433,1|1|1|1|1,14.49|14.3|14.02|12.96|12.28
3892,5,0.5029,5.029,4038.0,0.001241,0.996692,ARHGEF10 PATE2 PAX4 UCN ZNF646,gastric emptying|gastric motility|positive regulation of corticotropin secretion|positive regulation of behavioral fear response|negative regulation of gastric acid secretion,0.0009706|0.0009706|0.001698|0.00194|0.00194,1|1|1|1|1,1373|1373|686.5|588.4|588.4
3893,4,0.564,3.384,3022.0,0.001116,0.9929309999999999,OR4A15 OR4A16 OR4C15 UCN2,G protein-coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus,1.746e-05|3.915e-05|4.671e-05|5.225e-05|6.46e-05,0.2755|0.3088|0.2456|0.206|0.2038,15.5|35.03|33|31.78|29.59
3894,4,0.523,3.138,3197.0,0.0009782,0.9929309999999999,ASNSD1 DUS1L UCN3 ZFP36,"negative regulation of polynucleotide adenylyltransferase activity|regulation of polynucleotide adenylyltransferase activity|p38MAPK cascade|negative regulation of translation, ncRNA-mediated|miRNA mediated inhibition of translation",2.827e-07|4.712e-07|2.119e-06|4.943e-06|4.943e-06,0.00446|0.003716|0.01114|0.01949|0.01559,4119|2746|1030|633.7|633.7
3895,5,0.5366,5.3660000000000005,4223.0,0.001266,0.996692,CABLES1 LMO3 UCP1 ZADH2 ZNF776,regulation of fat cell differentiation|positive regulation of glucocorticoid receptor signaling pathway|regulation of glucocorticoid receptor signaling pathway|positive regulation of peroxisome proliferator activated receptor signaling pathway|cellular response to cold,0.0003903|0.000728|0.002183|0.002183|0.002667,1|1|1|1|1,64.36|2060|514.9|514.9|411.9
3896,13,0.5003,39.03,9734.0,0.0039829999999999996,0.999993,CTTN FOLR1 FOLR2 KRTAP5-11 KRTAP5-9 MRGPRD MRGPRF P2RY2 P2RY6 PLEKHB1 POLD4 UCP2 UCP3,cellular response to folic acid|folate import across plasma membrane|folate transmembrane transport|keratinization|folic acid transport,2.964e-06|1.036e-05|1.381e-05|1.873e-05|2.217e-05,0.04675|0.08172|0.07261|0.07385|0.06995,1373|549.2|457.7|24.3|343.2
3897,4,0.5481,3.2889999999999997,3170.0,0.001034,0.9929309999999999,LAMA3 TMPRSS6 UGT1A1 ZNF396,biphenyl catabolic process|bilirubin conjugation|biphenyl metabolic process|flavone metabolic process|negative regulation of cellular glucuronidation,0.0003883|0.0005825|0.0007766|0.001359|0.001747,1|1|1|1|1,5149|2574|1716|858.1|643.6
3898,4,0.5273,3.1639999999999997,3307.0,0.0009533999999999999,0.9929309999999999,C16orf90 CLUAP1 IL27 UGT1A7,flavone metabolic process|negative regulation of cellular glucuronidation|coumarin metabolic process|phenylpropanoid metabolic process|negative regulation of glucuronosyltransferase activity,0.001359|0.001747|0.001747|0.001747|0.001747,1|1|1|1|1,858.1|643.6|643.6|643.6|643.6
3899,4,0.5882,3.529,3234.0,0.0010869999999999999,0.9929309999999999,PLEKHA7 SLC25A47 TNFRSF18 UMODL1,zonula adherens maintenance|acyl carnitine transmembrane transport|acyl carnitine transport|adherens junction maintenance|cell-cell adhesion mediated by cadherin,0.0007766|0.0009706|0.001165|0.001359|0.001747,1|1|1|1|1,1716|1287|1030|858.1|643.6
3900,5,0.5027,5.027,3925.0,0.001276,0.996692,C19orf44 EVA1B TMEM39A TMEM39B UNC13A,negative regulation of autophagosome maturation|regulation of autophagosome maturation|negative regulation of autophagosome assembly|positive regulation of viral genome replication|negative regulation of macroautophagy,1.319e-06|5.648e-06|7.2e-06|2.481e-05|3.302e-05,0.0208|0.04455|0.03786|0.09784|0.1042,1373|588.4|514.9|265.7|228.8
3901,5,0.5065,5.065,4100.0,0.001231,0.996692,FBXL15 PLEKHA6 SERPINA1 SERPINA3 UNC13D,acute-phase response|neutrophil degranulation|acute inflammatory response|neutrophil activation involved in immune response|neutrophil mediated immunity,4.239e-05|0.0001252|0.0001264|0.0001283|0.0001338,0.6687|0.9875|0.6647|0.5059|0.4222,200.9|25.64|114.4|25.43|25.06
3902,6,0.5115,7.672999999999999,4559.0,0.0016760000000000002,0.998474,ADAMTS8 OR10G9 OR10S1 OR8B2 OR8D4 UNC45B,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.113e-06|3.935e-06|4.566e-06|6.051e-06|7.017e-06,0.04911|0.03104|0.02401|0.02386|0.02214,31.13|29.34|28.25|26.3|25.33
3903,4,0.5696,3.418,3276.0,0.0010400000000000001,0.9929309999999999,CETN1 KCTD19 TTC38 UNC5CL,netrin-activated signaling pathway|centriole replication|aggrephagy|centriole assembly|centrosome duplication,0.002134|0.004653|0.00562|0.005813|0.006973,1|1|1|1|1,514.9|223.9|183.9|177.5|147.1
3904,4,0.5047,3.028,3319.0,0.0009095,0.9929309999999999,CMSS1 LCLAT1 PACRG UNC79,cardiolipin acyl-chain remodeling|CDP-diacylglycerol biosynthetic process|CDP-diacylglycerol metabolic process|cardiolipin metabolic process|phosphatidylinositol acyl-chain remodeling,0.001747|0.002716|0.00291|0.003297|0.003685,1|1|1|1|1,643.6|396.1|367.8|321.8|286
3905,5,0.5225,5.225,4105.0,0.001268,0.996692,ATRNL1 DTNBP1 FAM135A TSTA3 UNC93A,'de novo' GDP-L-fucose biosynthetic process|GDP-L-fucose biosynthetic process|GDP-L-fucose metabolic process|positive regulation of endothelial cell-matrix adhesion via fibronectin|regulation of endothelial cell-matrix adhesion via fibronectin,0.000728|0.0009706|0.001213|0.001456|0.001698,1|1|1|1|1,2060|1373|1030|823.8|686.5
3906,5,0.5124,5.124,3822.0,0.001336,0.996692,HAGHL HBM HBQ1 HBZ UNKL,oxygen transport|gas transport|hydrogen peroxide catabolic process|hydrogen peroxide metabolic process|cellular oxidant detoxification,4.663e-09|1.056e-08|3.398e-08|9.064e-08|1.037e-06,7.356e-05|8.326e-05|0.0001786|0.0003575|0.003271,882.6|650.4|426.1|301.4|130.1
3907,4,0.5328,3.197,3074.0,0.001036,0.9929309999999999,GNG4 PRSS38 USF1 USF2,positive regulation of transcription from RNA polymerase II promoter by glucose|regulation of transcription from RNA polymerase II promoter by glucose|positive regulation of transcription by glucose|late viral transcription|carbon catabolite activation of transcription from RNA polymerase II promoter,2.828e-07|2.828e-07|4.241e-07|4.241e-07|4.241e-07,0.00446|0.00223|0.00223|0.001673|0.001338,3432|3432|2574|2574|2574
3908,5,0.5436,5.436,4374.0,0.0012380000000000002,0.996692,CBS KRTAP20-3 MCIDAS SLC36A4 USF3,cysteine biosynthetic process from serine|proline import across plasma membrane|L-tryptophan transmembrane transport|L-proline transmembrane transport|L-proline import across plasma membrane,0.000728|0.000728|0.000728|0.000728|0.000728,1|1|1|1|1,2060|2060|2060|2060|2060
3909,4,0.5587,3.352,3350.0,0.0009972000000000002,0.9929309999999999,RFESD TNFSF18 TTC21A USP12,negative regulation of T-helper 17 cell lineage commitment|T cell proliferation involved in immune response|regulation of T-helper 17 cell lineage commitment|regulation of dendritic cell chemotaxis|negative regulation of T-helper 17 cell differentiation,0.0007766|0.001165|0.001553|0.002134|0.002328,1|1|1|1|1,1716|1030|735.5|514.9|468.1
3910,6,0.5132,7.6979999999999995,4126.0,0.001857,0.998474,CNEP1R1 CTDNEP1 LMNB1 SMPD4 TMEM209 USP34,mitotic nuclear envelope disassembly|positive regulation of triglyceride biosynthetic process|nuclear envelope disassembly|membrane disassembly|regulation of triglyceride biosynthetic process,8.988e-06|1.037e-05|1.343e-05|1.343e-05|1.875e-05,0.1418|0.08178|0.07059|0.05294|0.05914,490.4|452.6|392.3|392.3|326.9
3911,11,0.5016,27.59,8023.0,0.0034170000000000003,0.999969,ABCE1 LSM5 MAD2L1 PES1 PSMA4 RPL18 RPL35A RPL5 RPL7 TTK USP39,ribonucleoprotein complex biogenesis|translational initiation|ribosome biogenesis|nuclear-transcribed mRNA catabolic process|ribosomal large subunit biogenesis,9.65e-10|7.97e-09|8.034e-09|3.701e-08|5.528e-08,1.522e-05|6.286e-05|4.224e-05|0.000146|0.0001744,28.18|65.46|33.84|47.76|104
3912,4,0.5392,3.235,3239.0,0.0009954,0.9929309999999999,BTNL9 CRYGB FBXL14 USP44,lens fiber cell morphogenesis|proteasome-mediated ubiquitin-dependent protein catabolic process|proteasomal protein catabolic process|negative regulation of ubiquitin protein ligase activity|lens fiber cell development,0.001165|0.001458|0.00166|0.002134|0.002716,1|1|1|1|1,1030|31.88|29.85|514.9|396.1
3913,20,0.5008,95.16,16360.0,0.005767,1.0,C5AR1 C5AR2 CABP5 FFAR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 LAIR2 LILRA4 LILRB2 LILRB4 LILRB5 PSG2 SIGLEC11 SULT2B1 VN1R4 ZNF665 ZNF880,immune response-inhibiting cell surface receptor signaling pathway|immune response-inhibiting signal transduction|immune response-regulating cell surface receptor signaling pathway|complement receptor mediated signaling pathway|immune response-regulating signaling pathway,1.73e-07|2.995e-07|5.728e-07|5.853e-07|5.963e-07,0.002729|0.002362|0.003012|0.002308|0.001881,351.1|280.8|13.35|216|13.27
3914,13,0.5168,40.31,8865.0,0.0045130000000000005,0.999993,AATF CDC6 DHX8 NLE1 NSRP1 PSMB3 PSMD11 PSMD3 RPL19 RPL23 UTP6 ZNF207 ZNF830,negative regulation of mitotic cell cycle|negative regulation of cell cycle|negative regulation of cell cycle process|regulation of mitotic cell cycle|negative regulation of mitotic cell cycle phase transition,2.106e-10|4.094e-10|5.137e-10|5.292e-10|2.987e-09,3.322e-06|3.229e-06|2.701e-06|2.087e-06|9.424e-06,37.72|22.27|33.1|21.55|42.25
3915,4,0.5406,3.2439999999999998,3353.0,0.0009642999999999999,0.9929309999999999,FFAR1 INSL6 SPSB3 VASN,cellular response to redox state|response to redox state|negative regulation of interleukin-1 beta production|negative regulation of interleukin-1 production|negative regulation of epithelial to mesenchymal transition,0.0009706|0.003104|0.00562|0.00678|0.006973,1|1|1|1|1,1287|343.2|183.9|151.4|147.1
3916,4,0.5535,3.321,3328.0,0.0009945,0.9929309999999999,FKBP15 LEMD1 LY75 VAX2,dorsal/ventral axis specification|ectoderm development|endocytosis|embryonic eye morphogenesis|protein peptidyl-prolyl isomerization,0.002328|0.003878|0.004329|0.00678|0.009482,1|1|1|1|1,468.1|271|18.32|151.4|107.3
3917,5,0.5462,5.462000000000001,4045.0,0.0013449999999999998,0.996692,ADAMDEC1 CEP85 KRT39 LBX1 VIT,spinal cord development|neuron fate determination|regulation of mitotic centrosome separation|spinal cord motor neuron differentiation|cell fate determination,0.0002597|0.002183|0.002425|0.007502|0.01064,1|1|1|1|1,79.21|514.9|457.7|137.3|95.79
3918,4,0.5105,3.063,3079.0,0.0009911,0.9929309999999999,BCL2L14 KIRREL2 RMDN2 VMAC,positive regulation of extrinsic apoptotic signaling pathway|positive regulation of apoptotic signaling pathway|regulation of extrinsic apoptotic signaling pathway|regulation of apoptotic signaling pathway|negative regulation of protein phosphorylation,0.009482|0.02367|0.03014|0.06589|0.06663,1|1|1|1|1,107.3|42.2|33|14.84|14.67
3919,5,0.5047,5.047,3652.0,0.001376,0.996692,ASCL1 NKX2-1 SOX1 TOX3 VN1R2,forebrain neuron differentiation|forebrain generation of neurons|neuron fate commitment|dorsal/ventral pattern formation|neuron migration,1.512e-07|2.46e-07|3.127e-07|4.994e-07|1.864e-06,0.002384|0.00194|0.001644|0.00197|0.00588,252.2|213.1|196.1|167|106.5
3920,10,0.5034,22.65,7063.0,0.003188,0.999933,C1D DIMT1 EXOSC1 EXOSC10 EXOSC8 HEATR1 MTREX PPWD1 TENT4B ZCCHC7,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,3.247e-14|4.366e-14|2.215e-13|1.76e-12|3.144e-12,5.122e-10|3.443e-10|1.164e-09|6.94e-09|9.918e-09,63.37|61.02|49.63|38.14|35.43
3921,4,0.5645,3.387,3455.0,0.0009771,0.9929309999999999,IRX3 STMN4 VRTN ZAR1L,"transposition, DNA-mediated|specification of loop of Henle identity|specification of nephron tubule identity|proximal/distal pattern formation involved in nephron development|transposition",0.0007766|0.0009706|0.001165|0.001165|0.001553,1|1|1|1|1,1716|1287|1030|1030|735.5
3922,4,0.5094,3.057,2873.0,0.00106,0.9929309999999999,DAZAP1 HNRNPL S1PR4 VSIR,"regulation of mRNA splicing, via spliceosome|regulation of mRNA processing|regulation of RNA splicing|negative regulation of CD8-positive, alpha-beta T cell proliferation|positive regulation of collagen catabolic process",0.0001505|0.0002845|0.0003172|0.0003883|0.0003883,1|1|1|1|1,101|73.03|69.11|5149|5149
3923,4,0.5391,3.235,3113.0,0.001035,0.9929309999999999,ADAMTS18 BTG3 MYO6 VSTM5,positive regulation of excitatory synapse assembly|negative regulation of platelet aggregation|negative regulation of homotypic cell-cell adhesion|regulation of excitatory synapse assembly|negative regulation of platelet activation,0.0007766|0.002522|0.00291|0.00291|0.003878,1|1|1|1|1,1716|429.1|367.8|367.8|271
3924,4,0.5002,3.0010000000000003,3119.0,0.0009589,0.9929309999999999,BHMT2 C11orf52 NEB VTCN1,S-methylmethionine metabolic process|cardiac muscle thin filament assembly|somatic muscle development|L-methionine salvage|L-methionine biosynthetic process,0.0003883|0.0007766|0.0007766|0.001553|0.001553,1|1|1|1|1,5149|1716|1716|735.5|735.5
3925,4,0.5209,3.125,3146.0,0.0009899,0.9929309999999999,FIGN SYNPO VCAN VWC2L,spine apparatus assembly|modification of dendritic spine|modification of postsynaptic structure|modification of synaptic structure|microtubule severing,0.0003883|0.0005825|0.001553|0.002522|0.002522,1|1|1|1|1,5149|2574|735.5|429.1|429.1
3926,5,0.5142,5.142,4082.0,0.001255,0.996692,C14orf119 DNAH14 IGIP VXN ZIK1,cilium-dependent cell motility|cilium or flagellum-dependent cell motility|biological regulation|response to stimulus|microtubule-based movement,0.02689|0.02689|0.07935|0.08193|0.08235,1|1|1|1|1,37.11|37.11|0.3277|0|11.77
3927,10,0.5236,23.56,7955.0,0.0029460000000000003,0.999933,ATP12A C1QTNF9 C1QTNF9B GJB2 GJB6 RNF6 SIAH3 SOHLH2 SPATA13 WASF3,gap junction-mediated intercellular transport|intercellular transport|gap junction assembly|cell communication by electrical coupling|lamellipodium assembly,5.927e-06|7.618e-06|9.52e-06|4.872e-05|0.0001476,0.09349|0.06008|0.05006|0.1921|0.4658,686.5|588.4|514.9|205.9|114.4
3928,4,0.5385,3.2310000000000003,3229.0,0.0009972999999999998,0.9929309999999999,MASP1 NMBR SYNE1 WDR35,response to paclitaxel|cellular response to paclitaxel|bombesin receptor signaling pathway|nuclear matrix anchoring at nuclear membrane|nuclear matrix organization,0.0003883|0.0003883|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|5149|2574|1716|1716
3929,4,0.549,3.2939999999999996,3216.0,0.001021,0.9929309999999999,CDK3 CHST5 HEXDC WDR36,G0 to G1 transition|protein sulfation|N-acetylglucosamine metabolic process|sulfation|glucosamine-containing compound metabolic process,0.0002913|0.00131|0.00291|0.003637|0.003927,1|1|1|1|1,6865|858.1|361.3|286|264
3930,8,0.5236,14.66,5622.0,0.002593,0.9996790000000001,ANAPC10 HSPA13 NAF1 NOP10 SPCS3 TMA16 TRAPPC11 WDR55,snoRNA guided rRNA pseudouridine synthesis|rRNA pseudouridine synthesis|positive regulation of telomerase RNA localization to Cajal body|pseudouridine synthesis|regulation of telomerase RNA localization to Cajal body,1.319e-06|8.691e-06|1.789e-05|2.498e-05|2.498e-05,0.0208|0.06854|0.09407|0.09851|0.07881,1716|514.9|343.2|286|286
3931,4,0.5773,3.464,3213.0,0.001074,0.9929309999999999,CARF KCNRG MX1 WDR93,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion|positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus|cellular response to calcium ion|response to calcium ion|cellular response to metal ion,2.827e-07|1.411e-05|0.0001749|0.0005401|0.0008749,0.00446|0.1113|0.9195|1|1,4119|358.2|96.92|54.56|42.68
3932,4,0.5303,3.182,2923.0,0.001084,0.9929309999999999,OR10G8 OR10G9 OR10S1 WFDC10A,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,3.915e-05|4.671e-05|5.225e-05|6.46e-05|7.223e-05,0.6176|0.3684|0.2747|0.2548|0.2279,35.03|33|31.78|29.59|28.5
3933,17,0.5004,68.05,13620.0,0.004958,1.0,BCAS4 CNBD2 EPPIN FAM209A FAM209B GGT7 LBP MAP1LC3A MYH7B R3HDML RBPJL SLC13A3 TFAP2C WFDC11 WFDC6 WFDC9 WISP2,negative regulation of peptidase activity|negative regulation of proteolysis|defense response to bacterium|response to bacterium|antimicrobial humoral response,3.937e-05|0.0001238|0.0001252|0.0001658|0.0002343,0.621|0.9765|0.6582|0.6537|0.7393,20.19|14.97|14.92|8.964|24.75
3934,4,0.5352,3.2110000000000003,3106.0,0.00103,0.9929309999999999,CRYL1 CYP4A11 ERG WHRN,monocarboxylic acid catabolic process|paranodal junction maintenance|oxylipin biosynthetic process|oxylipin metabolic process|lauric acid metabolic process,0.0001905|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,89.54|5149|2574|2574|2574
3935,4,0.5375,3.225,3159.0,0.001017,0.9929309999999999,KLRC2 SFT2D1 SPSB2 WIF1,positive regulation of natural killer cell degranulation|regulation of natural killer cell degranulation|positive regulation of natural killer cell activation|positive regulation of leukocyte degranulation|positive regulation of natural killer cell mediated cytotoxicity,0.001165|0.001165|0.004653|0.00504|0.00504,1|1|1|1|1,1030|1030|223.9|205.9|205.9
3936,4,0.5681,3.409,3512.0,0.0009675,0.9929309999999999,FDXACB1 KRTCAP3 POFUT2 WNT7B,outer medullary collecting duct development|fibroblast proliferation|establishment or maintenance of polarity of embryonic epithelium|renal outer medulla development|renal inner medulla development,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
3937,5,0.5187,5.187,4216.0,0.0012259999999999999,0.996692,CHST9 RIT2 SLC14A2 SYT4 WRNIP1,negative regulation of dense core granule exocytosis|vesicle fusion with vesicle|regulation of endocytosis|secretory granule maturation|negative regulation of vesicle fusion,0.0004854|0.0004854|0.001014|0.001213|0.001698,1|1|1|1|1,4119|4119|39.61|1030|686.5
3938,4,0.5603,3.362,3133.0,0.0010689999999999999,0.9929309999999999,GNLY STON1 TLX2 WTIP,negative regulation of dendrite morphogenesis|negative regulation of hippo signaling|enteric nervous system development|regulation of hippo signaling|positive regulation of gene silencing by miRNA,0.001941|0.002716|0.003104|0.004072|0.005813,1|1|1|1|1,572.1|396.1|343.2|257.4|177.5
3939,5,0.5023,5.023,4218.0,0.001187,0.996692,AMBN FAM229B KCNJ8 MANSC4 WWOX,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand|ventricular cardiac muscle cell membrane repolarization|membrane repolarization during ventricular cardiac muscle cell action potential|cardiac muscle cell membrane repolarization|membrane repolarization during cardiac muscle cell action potential,0.002425|0.003152|0.003152|0.004845|0.004845,1|1|1|1|1,457.7|343.3|343.3|216.8|216.8
3940,4,0.5064,3.0380000000000003,3072.0,0.0009857000000000002,0.9929309999999999,KRTAP4-12 PARPBP TCF23 WWP1,negative regulation of nucleobase-containing compound metabolic process|negative regulation of double-strand break repair via homologous recombination|decidualization|negative regulation of nitrogen compound metabolic process|negative regulation of double-strand break repair,0.001507|0.003878|0.004846|0.005719|0.006586,1|1|1|1|1,10.2|271|214.5|6.463|156
3941,4,0.5334,3.2,3292.0,0.0009689,0.9929309999999999,FOXA3 LAMB1 LDLRAD4 XKR3,neuronal-glial interaction involved in cerebral cortex radial glia guided migration|negative regulation of SMAD protein complex assembly|regulation of SMAD protein complex assembly|basement membrane assembly|negative regulation of pathway-restricted SMAD protein phosphorylation,0.0005825|0.001165|0.001359|0.002134|0.002716,1|1|1|1|1,2574|1030|858.1|514.9|396.1
3942,5,0.5114,5.114,4288.0,0.001188,0.996692,ADAM18 COLEC10 FBXO22 RABL6 XKR9,"phosphatidylserine exposure on apoptotic cell surface|complement activation, lectin pathway|regulation of skeletal muscle fiber development|engulfment of apoptotic cell|plasma membrane phospholipid scrambling",0.002183|0.002667|0.003394|0.00412|0.005087,1|1|1|1|1,514.9|411.9|316.8|257.4|205.9
3943,4,0.5435,3.261,3110.0,0.001045,0.9929309999999999,IAH1 LRRC24 SPRY2 XPNPEP3,negative regulation of neurotrophin TRK receptor signaling pathway|lung growth|negative regulation of lens fiber cell differentiation|bud elongation involved in lung branching|regulation of lens fiber cell differentiation,0.0009706|0.001359|0.001359|0.001553|0.001747,1|1|1|1|1,1287|858.1|858.1|735.5|643.6
3944,4,0.5539,3.324,3204.0,0.001034,0.9929309999999999,EVPLL GRHL3 LYSMD1 XYLB,xylulose catabolic process|D-xylose metabolic process|xylulose metabolic process|glucuronate catabolic process|xylulose 5-phosphate biosynthetic process,0.0003883|0.0007766|0.0009706|0.001165|0.001165,1|1|1|1|1,5149|1716|1287|1030|1030
3945,4,0.5014,3.008,3170.0,0.0009459,0.9929309999999999,BTG4 LGALS16 TMEM225 YIPF4,positive regulation of T cell apoptotic process|positive regulation of lymphocyte apoptotic process|positive regulation of leukocyte apoptotic process|regulation of T cell apoptotic process|regulation of lymphocyte apoptotic process,0.00291|0.003491|0.00562|0.007166|0.01083,1|1|1|1|1,367.8|302.9|183.9|143|93.61
3946,4,0.5002,3.0010000000000003,3065.0,0.0009756999999999999,0.9929309999999999,HIVEP2 PPP3CA PPP3R1 YJEFN3,"calcineurin-NFAT signaling cascade|calcineurin-mediated signaling|inositol phosphate-mediated signaling|Wnt signaling pathway, calcium modulating pathway|non-canonical Wnt signaling pathway",2.572e-06|3.843e-06|9.177e-06|2.091e-05|0.0002612,0.04057|0.03031|0.04825|0.08245|0.824,858.1|686.5|429.1|278.3|76.28
3947,7,0.5114,10.74,5427.0,0.00197,0.9992989999999999,CDK18 CHIT1 RGS18 RGS2 RGS21 TROVE2 YOD1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway|negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process|regulation of G protein-coupled receptor signaling pathway|negative regulation of glycine import across plasma membrane,0.0005824|0.0005824|0.0005824|0.0007546|0.0008735,1|1|1|1|1,3432|3432|3432|47.02|1716
3948,4,0.5502,3.301,3292.0,0.0009994,0.9929309999999999,SNN ZBED2 ZDHHC1 ZNF205,positive regulation of protein oligomerization|regulation of protein oligomerization|positive regulation of hydrogen peroxide biosynthetic process|positive regulation of hydrogen peroxide metabolic process|regulation of hydrogen peroxide biosynthetic process,0.0007766|0.0009706|0.001165|0.001553|0.001747,1|1|1|1|1,1716|1287|1030|735.5|643.6
3949,6,0.5024,7.5360000000000005,5049.0,0.0014869999999999998,0.998474,KCNA6 MPPED2 PIANP PRB4 TAS2R19 ZBED4,sensory perception of taste|cellular process|potassium ion transmembrane transport|potassium ion transport|protein homooligomerization,0.01993|0.0366|0.04543|0.04823|0.05158,1|1|1|1|1,50.48|0.4433|21.72|20.43|19.07
3950,4,0.5872,3.523,3203.0,0.0010960000000000002,0.9929309999999999,FAM19A5 SCUBE1 UTP18 ZBED9,adult heart development|DNA integration|positive regulation of smoothened signaling pathway|extracellular matrix disassembly|regulation of smoothened signaling pathway,0.002038|0.002765|0.005525|0.009727|0.0119,1|1|1|1|1,528.1|381.4|185.5|104|84.75
3951,5,0.5064,5.064,4237.0,0.001191,0.996692,C1RL IBTK NT5DC3 RRAS ZBP1,pallium cell proliferation in forebrain|regulation of mRNA stability involved in response to stress|positive regulation of necroptotic process|positive regulation of programmed necrotic cell death|CRD-mediated mRNA stabilization,0.0005824|0.001165|0.001165|0.001456|0.001746,1|1|1|1|1,3432|1144|1144|858.1|686.5
3952,5,0.529,5.29,3950.0,0.001334,0.996692,CARNS1 EPB41L5 FAIM TEX12 ZBTB12,"substrate-dependent cell migration, cell attachment to substrate|carnosine biosynthetic process|unidimensional cell growth|carnosine metabolic process|apical constriction",0.0004854|0.0004854|0.000728|0.000728|0.000728,1|1|1|1|1,4119|4119|2060|2060|2060
3953,4,0.5125,3.075,3195.0,0.0009592,0.9929309999999999,PLD4 RNASEK SH3TC1 ZBTB22,"nucleic acid phosphodiester bond hydrolysis|regulation of cytokine production involved in inflammatory response|inositol phosphate metabolic process|hematopoietic progenitor cell differentiation|RNA phosphodiester bond hydrolysis, endonucleolytic",0.001286|0.009482|0.0116|0.01698|0.01736,1|1|1|1|1,33.99|107.3|87.27|59.18|57.85
3954,5,0.5377,5.377000000000001,3731.0,0.0014349999999999999,0.996692,SIK2 SIK3 STK11 STRADA ZBTB3,protein phosphorylation|phosphorylation|regulation of TORC1 signaling|regulation of TOR signaling|phosphate-containing compound metabolic process,6.005e-06|2.938e-05|3.85e-05|0.0002357|0.0003412,0.09472|0.2317|0.2024|0.9296|1,24.09|16.12|211.2|83.21|8.644
3955,4,0.5158,3.095,3143.0,0.0009811,0.9929309999999999,FAM189B GOLGA7B WFDC13 ZBTB34,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine|peptidyl-L-cysteine S-palmitoylation|protein palmitoylation|peptidyl-cysteine modification|antibacterial humoral response,0.004846|0.004846|0.006393|0.007552|0.01141,1|1|1|1|1,214.5|214.5|160.9|135.5|88.77
3956,4,0.5034,3.02,3277.0,0.0009186,0.9929309999999999,DOK5 KCNQ2 TKTL2 ZBTB4,regulation of neurotrophin TRK receptor signaling pathway|potassium ion transmembrane transport|potassium ion transport|axon guidance|neuron projection guidance,0.002522|0.03052|0.03242|0.05309|0.05328,1|1|1|1|1,429.1|32.59|30.65|18.52|18.45
3957,4,0.5182,3.109,3073.0,0.001008,0.9929309999999999,CCDC14 COL20A1 HRCT1 ZBTB40,protein localization to centrosome|protein localization to microtubule organizing center|protein localization to microtubule cytoskeleton|protein localization to cytoskeleton|substantia nigra development,0.004653|0.004846|0.007552|0.008324|0.009096,1|1|1|1|1,223.9|214.5|135.5|122.6|111.9
3958,12,0.5027,33.18,9485.0,0.0034770000000000005,0.999986,ADSSL1 APOPT1 CDC42BPB CRIP1 GPR68 PPP4R4 SERPINA11 SERPINA12 SERPINA3 SERPINA4 UBR7 ZBTB42,negative regulation of hydrolase activity|negative regulation of endopeptidase activity|negative regulation of peptidase activity|negative regulation of proteolysis|negative regulation of catalytic activity,1.247e-06|4.129e-06|4.827e-06|1.55e-05|2.091e-05,0.01967|0.03257|0.02538|0.06111|0.06596,22.63|33.62|32.31|23.95|12.65
3959,10,0.5145,23.15,7700.0,0.00299,0.999933,C6orf48 HLA-DMB LY6G6F MSH5 NCR3 NUDT3 PPT2 STK19 TNXB ZBTB9,diphosphoinositol polyphosphate catabolic process|positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell|peptide antigen assembly with MHC class II protein complex|MHC class II protein complex assembly|diphosphoinositol polyphosphate metabolic process,0.0008734|0.001746|0.002182|0.002182|0.002618,1|1|1|1|1,2288|762.8|572.1|572.1|457.7
3960,4,0.5609,3.365,3165.0,0.00106,0.9929309999999999,CLIC4 MACO1 STK10 ZC2HC1A,lymphocyte aggregation|neuronal signal transduction|leukocyte aggregation|retina vasculature morphogenesis in camera-type eye|endothelial cell morphogenesis,0.001165|0.001553|0.002328|0.002328|0.002716,1|1|1|1|1,1030|735.5|468.1|468.1|396.1
3961,5,0.5302,5.3020000000000005,4075.0,0.001296,0.996692,ADORA2B LAT REPIN1 ZC2HC1B ZNF843,G protein-coupled adenosine receptor signaling pathway|G protein-coupled purinergic receptor signaling pathway|MAPK cascade|mast cell activation involved in immune response|mast cell degranulation,0.002425|0.002425|0.003816|0.005087|0.005087,1|1|1|1|1,457.7|457.7|20.14|205.9|205.9
3962,5,0.514,5.14,3844.0,0.001332,0.996692,AP1G2 C17orf50 MRM1 ZC3H3 ZFC3H1,RNA processing|rRNA 2'-O-methylation|positive regulation of activin receptor signaling pathway|RNA metabolic process|regulation of mRNA polyadenylation,0.0008457|0.001213|0.00194|0.004165|0.004362,1|1|1|1|1,13.39|1030|588.4|7.728|242.3
3963,4,0.5217,3.13,3390.0,0.0009204,0.9929309999999999,AGBL1 MMAA UBTD1 ZC3H6,protein side chain deglutamylation|C-terminal protein deglutamylation|protein deglutamylation|short-chain fatty acid catabolic process|C-terminal protein amino acid modification,0.001456|0.001456|0.002183|0.002425|0.003878,1|1|1|1|1,823.8|823.8|514.9|457.7|274.6
3964,4,0.5209,3.1260000000000003,3195.0,0.000975,0.9929309999999999,ADIRF DDX50 ITPRIP ZC3H7A,regulation of response to drug|cellular response to cisplatin|response to cisplatin|production of miRNAs involved in gene silencing by miRNA|production of small RNA involved in gene silencing by RNA,0.0009706|0.001359|0.001941|0.006007|0.00678,1|1|1|1|1,1287|858.1|572.1|171.6|151.4
3965,4,0.53,3.18,3076.0,0.00103,0.9929309999999999,B4GALT2 CEACAM3 VWCE ZC3H7B,cerebellar Purkinje cell layer development|keratan sulfate biosynthetic process|production of miRNAs involved in gene silencing by miRNA|keratan sulfate metabolic process|production of small RNA involved in gene silencing by RNA,0.005426|0.00562|0.006007|0.006586|0.00678,1|1|1|1|1,190.7|183.9|171.6|156|151.4
3966,4,0.5199,3.12,3105.0,0.001001,0.9929309999999999,FKBP4 RXYLT1 TRMT112 ZC3HAV1,rRNA (guanine-N7)-methylation|peptidyl-glutamine methylation|RNA (guanine-N7)-methylation|positive regulation of rRNA processing|positive regulation of RIG-I signaling pathway,0.0005825|0.001359|0.001553|0.002134|0.002134,1|1|1|1|1,2574|858.1|735.5|514.9|514.9
3967,4,0.5898,3.5389999999999997,3343.0,0.0010550000000000002,0.9929309999999999,ABHD12 PSKH1 UBL4B ZC3HAV1L,phosphatidylserine catabolic process|monoacylglycerol catabolic process|protein depalmitoylation|macromolecule depalmitoylation|monoacylglycerol metabolic process,0.0009706|0.001553|0.002134|0.00291|0.00291,1|1|1|1|1,1287|735.5|514.9|367.8|367.8
3968,5,0.5188,5.188,3782.0,0.001366,0.996692,ADIPOR2 BEND4 IRF8 MEF2D ZCCHC2,plasmacytoid dendritic cell differentiation|negative regulation of hepatic stellate cell migration|regulation of hepatic stellate cell migration|plasmacytoid dendritic cell activation|adiponectin-activated signaling pathway,0.0004854|0.0004854|0.000728|0.0009706|0.00194,1|1|1|1|1,4119|4119|2060|1373|588.4
3969,10,0.5321,23.95,6601.0,0.003604,0.999933,ARMC7 CCDC84 DDX59 DHX9 PPIH RBM48 SCNM1 TXNL4B ZCRB1 ZMAT5,"mRNA splicing, via spliceosome|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|RNA splicing, via transesterification reactions|RNA splicing|mRNA processing",2.122e-09|2.122e-09|2.249e-09|1.227e-08|3.398e-08,3.347e-05|1.674e-05|1.183e-05|4.839e-05|0.0001072,40.92|40.92|40.51|30.36|25.53
3970,4,0.5762,3.457,3297.0,0.001045,0.9929309999999999,ALB CNOT6L KLRB1 ZDHHC13,maintenance of mitochondrion location|positive regulation of cytoplasmic mRNA processing body assembly|maintenance of organelle location|regulation of cytoplasmic mRNA processing body assembly|heterocycle catabolic process,0.000728|0.001698|0.002667|0.002667|0.003981,1|1|1|1|1,2060|686.5|411.9|411.9|19.71
3971,4,0.5066,3.04,3128.0,0.0009683999999999999,0.9929309999999999,ERAP1 SYNC TNIK ZDHHC16,asparaginyl-tRNA aminoacylation|activation of JNKK activity|microvillus assembly|microvillus organization|antigen processing and presentation of endogenous peptide antigen via MHC class I,0.0009706|0.002667|0.00291|0.003394|0.004362,1|1|1|1|1,1373|411.9|374.5|316.8|242.3
3972,6,0.5208,7.812,4363.0,0.001782,0.998474,PHLPP1 RNF219 USP1 USP46 WDR20 WDR48,protein deubiquitination|protein modification by small protein removal|protein modification by small protein conjugation or removal|cellular protein modification process|protein modification process,5.046e-07|6.377e-07|1.832e-06|9.981e-06|9.981e-06,0.00796|0.005029|0.009635|0.03936|0.03149,49.39|46.54|16.65|6.822|6.822
3973,4,0.536,3.216,3234.0,0.000991,0.9929309999999999,F2RL1 GPHA2 MAPK1IP1L ZDHHC7,positive regulation of neutrophil mediated killing of gram-negative bacterium|positive regulation of neutrophil mediated killing of bacterium|negative regulation of toll-like receptor 3 signaling pathway|positive regulation of eosinophil activation|regulation of neutrophil mediated killing of gram-negative bacterium,0.0003883|0.0003883|0.0005825|0.0005825|0.0005825,1|1|1|1|1,5149|5149|2574|2574|2574
3974,4,0.523,3.138,2990.0,0.001046,0.9929309999999999,HCAR2 HCAR3 P2RX4 ZFP62,neutrophil apoptotic process|positive regulation of adiponectin secretion|microglial cell migration|sensory perception of touch|positive regulation of secretion by cell,0.0005825|0.0005825|0.0005825|0.0009706|0.001132,1|1|1|1|1,2574|2574|2574|1287|36.26
3975,4,0.5099,3.0589999999999997,3089.0,0.0009869,0.9929309999999999,GBA POLK PRKAB2 ZFYVE16,regulation of macroautophagy|positive regulation of neuronal action potential|macroautophagy|beta-glucoside catabolic process|beta-glucoside metabolic process,0.0003695|0.0003883|0.0005229|0.0005825|0.0005825,1|1|1|1|1,63.96|5149|53.63|2574|2574
3976,4,0.5161,3.096,3055.0,0.00101,0.9929309999999999,IRF8 LYST SLC17A9 ZFYVE26,defense response to protozoan|response to protozoan|plasmacytoid dendritic cell differentiation|mast cell secretory granule organization|guanine nucleotide transport,9.177e-06|9.911e-06|0.0003883|0.0005825|0.0005825,0.1448|0.07817|1|1|1,429.1|411.9|5149|2574|2574
3977,5,0.5109,5.109,4205.0,0.0012109999999999998,0.996692,APOD KIF3C RITA1 TIMP3 ZFYVE28,negative regulation of signal transduction|negative regulation of cell communication|negative regulation of signaling|negative regulation of response to stimulus|negative regulation of lipoprotein oxidation,7.053e-05|9.412e-05|9.493e-05|0.0002751|0.0004854,1|0.7423|0.4991|1|1,12.91|12|11.97|9.133|4119
3978,4,0.5787,3.472,3323.0,0.001041,0.9929309999999999,C20orf173 CAVIN4 CSN3 ZIM2,"protein deneddylation|positive regulation of calcium ion import|nucleotide-excision repair, DNA damage recognition|regulation of calcium ion import|lactation",0.002667|0.005571|0.005812|0.01039|0.01112,1|1|1|1|1,411.9|187.2|179.1|98.07|91.53
3979,23,0.5056,127.9,18280.0,0.006933,1.0,NLRP4 VN1R1 ZFP28 ZIM3 ZNF135 ZNF211 ZNF264 ZNF304 ZNF324B ZNF416 ZNF460 ZNF548 ZNF550 ZNF586 ZNF587 ZNF665 ZNF667 ZNF71 ZNF772 ZNF773 ZNF805 ZNF814 ZSCAN5B,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",2.52e-17|1.039e-14|1.045e-14|1.076e-14|4.959e-14,3.975e-13|8.191e-11|5.493e-11|4.244e-11|1.564e-10,7.272|5.428|5.427|5.419|5.031
3980,4,0.5153,3.092,2877.0,0.0010710000000000001,0.9929309999999999,BCL9L SSBP3 TCF7L2 ZMIZ1,positive regulation of transcription by RNA polymerase II|beta-catenin-TCF complex assembly|positive regulation of developmental process|positive regulation of epithelial to mesenchymal transition|positive regulation of nucleic acid-templated transcription,1.185e-05|1.313e-05|1.407e-05|3.454e-05|3.869e-05,0.1869|0.1035|0.07398|0.1362|0.1221,17.08|355.1|16.36|214.5|12.7
3981,5,0.5237,5.237,3686.0,0.001415,0.996692,AGO4 CHAMP1 POGZ RLF ZMYM4,nuclear chromosome segregation|chromosome segregation|nuclear division|chromosome organization|organelle fission,2.68e-05|5.296e-05|8.816e-05|9.797e-05|0.0001131,0.4227|0.4177|0.4636|0.3863|0.3568,45.36|36.01|30.29|12.94|27.83
3982,5,0.5092,5.092,3921.0,0.001294,0.996692,FAM183A FAM221A ONECUT1 SLC35F6 ZNF114,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|spleen development|endocrine pancreas development|regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway|negative regulation of mitochondrion organization,0.002425|0.008226|0.01039|0.01136|0.01208,1|1|1|1|1,457.7|124.8|98.07|89.54|84.06
3983,4,0.512,3.072,3108.0,0.0009847999999999999,0.9929309999999999,HSF2 TOX USP19 ZNF134,"NK T cell lineage commitment|CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment|CD8-positive, alpha-beta T cell lineage commitment|NK T cell differentiation|regulation of positive thymic T cell selection",0.0003883|0.0005825|0.0005825|0.0007766|0.0007766,1|1|1|1|1,5149|2574|2574|1716|1716
3984,11,0.5103,28.07,7353.0,0.0037909999999999997,0.999969,AK6 C18orf21 C1D EXOSC1 EXOSC10 HEATR1 MDM2 NOP9 PDCD2 WDR43 WDR75,rRNA processing|rRNA metabolic process|ribosome biogenesis|ncRNA processing|ribonucleoprotein complex biogenesis,4.247e-11|5.498e-11|2.262e-10|1.372e-09|2.27e-09,6.699e-07|4.336e-07|1.19e-06|5.409e-06|7.16e-06,46.21|44.5|36.19|27.81|25.84
3985,4,0.5461,3.2769999999999997,3104.0,0.001052,0.9929309999999999,C12orf56 IFNL2 MORN2 ZNF146,mucosal immune response|organ or tissue specific immune response|receptor signaling pathway via JAK-STAT|receptor signaling pathway via STAT|defense response to symbiont,0.0062|0.006973|0.007745|0.007938|0.04073,1|1|1|1|1,166.1|147.1|132|128.7|24.29
3986,23,0.5041,127.5,18530.0,0.0068189999999999995,1.0,NLRP4 VN1R1 ZFP28 ZNF135 ZNF154 ZNF211 ZNF256 ZNF264 ZNF304 ZNF324B ZNF416 ZNF460 ZNF548 ZNF550 ZNF586 ZNF587 ZNF610 ZNF665 ZNF667 ZNF772 ZNF773 ZNF805 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",2.52e-17|1.039e-14|1.045e-14|1.076e-14|4.959e-14,3.975e-13|8.191e-11|5.493e-11|4.244e-11|1.564e-10,7.272|5.428|5.427|5.419|5.031
3987,4,0.5578,3.347,3193.0,0.001044,0.9929309999999999,FAM69C PLA2G7 TUBB3 ZNF169,plasma lipoprotein particle oxidation|ether catabolic process|glycerol ether catabolic process|platelet activating factor catabolic process|dorsal root ganglion development,0.0003883|0.0005825|0.0005825|0.0005825|0.001359,1|1|1|1|1,5149|2574|2574|2574|858.1
3988,4,0.548,3.2880000000000003,3014.0,0.0010869999999999999,0.9929309999999999,CHCHD2 KLK14 MRPS18A ZNF17,seminal clot liquefaction|positive regulation of mitochondrial ATP synthesis coupled electron transport|regulation of mitochondrial ATP synthesis coupled electron transport|insemination|regulation of cellular response to hypoxia,0.0003883|0.0009706|0.001359|0.002522|0.002522,1|1|1|1|1,5149|1287|858.1|429.1|429.1
3989,6,0.5323,7.984,4451.0,0.001786,0.998474,FBN3 OR1M1 OR7G1 OR7G3 ZNF177 ZNF266,detection of chemical stimulus involved in sensory perception of smell|sensory perception of smell|detection of chemical stimulus involved in sensory perception|detection of chemical stimulus|sensory perception of chemical stimulus,0.0001895|0.0002256|0.000252|0.0003108|0.000347,1|1|1|1|1,23.35|22|21.19|19.73|19
3990,4,0.562,3.372,3287.0,0.0010220000000000001,0.9929309999999999,CYP2R1 DMRT3 PCDHGB7 ZNF18,response to cesium ion|cellular alcohol biosynthetic process|cellular alcohol metabolic process|calcitriol biosynthetic process from calciol|vitamin D biosynthetic process,0.0003883|0.0009706|0.0009706|0.0009706|0.0009706,1|1|1|1|1,5149|1287|1287|1287|1287
3991,4,0.5437,3.262,3139.0,0.001036,0.9929309999999999,C4orf17 PURA SCG3 ZNF215,protein localization to secretory granule|dendritic transport of messenger ribonucleoprotein complex|dendritic transport of ribonucleoprotein complex|dendritic transport|axo-dendritic protein transport,0.0007766|0.0007766|0.0007766|0.002134|0.002716,1|1|1|1|1,1716|1716|1716|514.9|396.1
3992,17,0.5071,68.97,14040.0,0.004877,1.0,C5AR1 C5AR2 CABP5 CRX EML2 FFAR3 FLT3LG FUT1 FUT2 GPR32 IGFL1 KLK11 KLK3 SULT2A1 SULT2B1 ZNF221 ZNF880,complement receptor mediated signaling pathway|complement component C5a signaling pathway|fucose catabolic process|L-fucose catabolic process|L-fucose metabolic process,3.109e-07|4.317e-06|3.943e-05|3.943e-05|3.943e-05,0.004904|0.03405|0.2073|0.1555|0.1244,264|1144|254.3|254.3|254.3
3993,4,0.5047,3.028,3190.0,0.0009460000000000001,0.9929309999999999,CC2D2A FEZ2 SPINT2 ZNF223,neural tube closure|tube closure|primary neural tube formation|neural tube formation|embryonic epithelial tube formation,0.0001177|0.0001203|0.0001336|0.0001563|0.0002174,1|0.9486|0.7024|0.6165|0.686,114.4|113.2|107.3|99.01|83.72
3994,5,0.5211,5.211,4172.0,0.001245,0.996692,A4GNT FBLN5 GPR22 NAPEPLD ZNF267,host-mediated regulation of intestinal microbiota composition|negative regulation of eating behavior|N-acylethanolamine metabolic process|regulation of removal of superoxide radicals|regulation of eating behavior,0.000728|0.0009706|0.001456|0.001698|0.00194,1|1|1|1|1,2060|1373|823.8|686.5|588.4
3995,19,0.5146,87.99,14890.0,0.0058590000000000005,1.0,ABHD14A ABHD14B APEH CCR2 CCR3 CCR5 FAM107A GNAT1 IQCF1 IQCF2 IQCF3 IQCF5 ITIH3 ITIH4 MUSTN1 SEMA3G TLR9 TOPAZ1 ZNF502,cellular defense response|chemokine-mediated signaling pathway|inflammatory response|cellular response to chemokine|response to chemokine,1.784e-05|5.614e-05|7.289e-05|7.915e-05|7.915e-05,0.2814|0.4428|0.3833|0.3121|0.2497,61.36|41.16|10.93|36.54|36.54
3996,5,0.554,5.54,3490.0,0.0015810000000000002,0.996692,WIZ ZBTB2 ZNF292 ZNF592 ZNF644,"cellular process|regulation of transcription by RNA polymerase II|positive regulation of nuclear cell cycle DNA replication|positive regulation of DNA-dependent DNA replication|regulation of transcription, DNA-templated",0.0009406|0.001122|0.001698|0.003152|0.003471,1|1|1|1|1,0|6.371|686.5|343.3|4.756
3997,4,0.5445,3.267,3057.0,0.001065,0.9929309999999999,FAM83A HNF4G RBM47 ZNF3,cytidine to uridine editing|base conversion or substitution editing|epidermal growth factor receptor signaling pathway|ERBB signaling pathway|hematopoietic progenitor cell differentiation,0.002522|0.004072|0.009867|0.01372|0.01698,1|1|1|1|1,429.1|257.4|103|73.55|59.18
3998,4,0.5623,3.3739999999999997,2897.0,0.00116,0.9929309999999999,ARL15 PTP4A1 RWDD4 ZNF330,peptidyl-tyrosine dephosphorylation|protein dephosphorylation|cellular process|dephosphorylation|positive regulation of cell migration,0.02062|0.04148|0.04971|0.0609|0.09704,1|1|1|1|1,48.57|23.84|0.3325|16.09|9.94
3999,4,0.527,3.162,3284.0,0.0009596,0.9929309999999999,MAJIN NT5DC3 SLC9A3R2 ZNF384,meiotic telomere tethering at nuclear periphery|meiotic attachment of telomere to nuclear envelope|telomere tethering at nuclear periphery|chromosome attachment to the nuclear envelope|meiotic telomere clustering,0.001165|0.001165|0.001165|0.001553|0.001941,1|1|1|1|1,1030|1030|1030|735.5|572.1
4000,5,0.5011,5.011,3950.0,0.0012640000000000001,0.996692,CCL16 RARS SPATA45 TMEM126A ZNF385D,arginyl-tRNA aminoacylation|optic nerve development|monocyte chemotaxis|tRNA aminoacylation for protein translation|positive chemotaxis,0.0009706|0.003394|0.01015|0.01136|0.01184,1|1|1|1|1,1373|316.8|100.5|89.54|85.81
4001,16,0.5041,60.49,12000.0,0.0050030000000000005,0.999999,BTN2A2 GPX6 HIST1H1T OR14J1 OR2B6 OR2J2 OR2J3 SLC17A4 TRIM10 TRIM26 ZKSCAN4 ZNF165 ZNF184 ZNF391 ZSCAN16 ZSCAN31,cellular oxidant detoxification|cellular detoxification|cellular response to toxic substance|negative regulation of viral entry into host cell|detoxification,6.752e-05|9.782e-05|0.0001173|0.0001748|0.0001785,1|0.7715|0.6167|0.6895|0.5633,38.26|33.65|31.6|110.1|27.33
4002,4,0.5225,3.135,3103.0,0.001007,0.9929309999999999,ESPN MST1 VN1R4 ZNF408,positive regulation of mammary gland epithelial cell proliferation|regulation of mammary gland epithelial cell proliferation|regulation of macrophage chemotaxis|regulation of macrophage migration|regulation of leukocyte chemotaxis,3.108e-06|9.879e-06|2.045e-05|4.239e-05|0.0003495,0.04902|0.07792|0.1075|0.1672|1,823.8|433.6|294.2|200.9|68.08
4003,4,0.5038,3.023,3136.0,0.0009605000000000001,0.9929309999999999,SIGLECL1 SLC34A1 SPHK2 ZNF419,polyol metabolic process|sphinganine-1-phosphate biosynthetic process|arsenate ion transmembrane transport|positive regulation of phosphate transmembrane transport|regulation of phosphate transmembrane transport,0.0003609|0.0004854|0.0004854|0.0004854|0.0004854,1|1|1|1|1,66.98|4119|4119|4119|4119
4004,7,0.5064,10.63,5879.0,0.001801,0.9992989999999999,BPI DLGAP4 GHRH HCK NNAT SLC32A1 ZNF469,lipopolysaccharide-mediated signaling pathway|secretion by cell|export from cell|secretion|positive regulation of peptide hormone secretion,6.2e-05|0.0001418|0.0001716|0.0002192|0.0005415,0.978|1|0.9025|0.8643|1,173.1|12.41|11.82|11.09|56.58
4005,4,0.5271,3.162,3087.0,0.001021,0.9929309999999999,ATP9B LRRC8C WRAP53 ZNF474,telomerase RNA localization|telomerase RNA localization to Cajal body|telomere formation via telomerase|protein localization to Cajal body|protein localization to nuclear body,0.0003883|0.0003883|0.0003883|0.0003883|0.0003883,1|1|1|1|1,5149|5149|5149|5149|5149
4006,5,0.5047,5.047,3673.0,0.001368,0.996692,STX10 TMEM205 ZNF121 ZNF491 ZNF562,cellular process|vesicle docking|regulation of transcription by RNA polymerase II|vesicle fusion|organelle membrane fusion,0.01519|0.01568|0.01628|0.01975|0.02118,1|1|1|1|1,0.266|64.36|4.778|50.85|47.34
4007,4,0.563,3.378,3155.0,0.001067,0.9929309999999999,GJC2 KRTAP19-7 TNNI1 ZNF496,positive regulation of oligodendrocyte progenitor proliferation|transition between fast and slow fiber|regulation of oligodendrocyte progenitor proliferation|regulation of skeletal muscle adaptation|cell communication by electrical coupling,0.0007766|0.001553|0.001747|0.002716|0.004072,1|1|1|1|1,1716|735.5|643.6|396.1|257.4
4008,12,0.5116,33.76,9556.0,0.003512,0.999986,A1BG SLC27A5 ZBTB45 ZNF132 ZNF135 ZNF324 ZNF324B ZNF497 ZNF544 ZNF587 ZNF837 ZSCAN22,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",5.136e-08|8.69e-07|8.714e-07|8.836e-07|1.806e-06,0.0008102|0.006854|0.004582|0.003484|0.005697,6.637|4.955|4.953|4.946|4.591
4009,4,0.5615,3.3689999999999998,3253.0,0.001032,0.9929309999999999,ADPRM MYT1 SPINT4 ZNF547,negative regulation of hydrolase activity|nucleobase-containing small molecule catabolic process|negative regulation of catalytic activity|regulation of nitrogen compound metabolic process|regulation of cyclin-dependent protein serine/threonine kinase activity,0.004698|0.01208|0.01447|0.02269|0.02404,1|1|1|1|1,18.11|84.06|10.12|2.897|41.61
4010,4,0.5014,3.009,2938.0,0.0010199999999999999,0.9929309999999999,AKT3 MYCN PDK1 ZNF558,positive regulation of vascular endothelial cell proliferation|regulation of vascular endothelial cell proliferation|positive regulation of blood vessel endothelial cell migration|regulation of blood vessel endothelial cell migration|positive regulation of endothelial cell proliferation,6.401e-06|1.087e-05|7.22e-05|0.0001999|0.0002042,0.101|0.0857|0.3796|0.7881|0.6441,549.2|411.9|152.6|90.53|89.54
4011,4,0.547,3.282,3080.0,0.001062,0.9929309999999999,ATP5S CRYGA RSPH10B ZNF561,"mitochondrial ATP synthesis coupled proton transport|ATP synthesis coupled proton transport|energy coupled proton transport, down electrochemical gradient|cristae formation|ATP biosynthetic process",0.003878|0.004846|0.004846|0.0062|0.007166,1|1|1|1|1,271|214.5|214.5|166.1|143
4012,4,0.5228,3.137,3161.0,0.0009888,0.9929309999999999,C6orf163 SMCO3 ZNF572 ZNF729,"cellular process|regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",0.00379|0.07957|0.1341|0.1342|0.1346,1|1|1|1|1,0|3.982|2.973|2.972|2.968
4013,4,0.5263,3.158,3261.0,0.000965,0.9929309999999999,CDH23 SDC4 TDGF1 ZNF579,inner ear receptor cell stereocilium organization|inner ear receptor cell development|inner ear receptor cell differentiation|mechanoreceptor differentiation|inner ear development,1.879e-05|3.181e-05|4.987e-05|5.859e-05|0.0005176,0.2964|0.2509|0.2622|0.231|1,294.2|223.9|177.5|163.5|53.91
4014,21,0.5052,106.1,16990.0,0.00619,1.0,C5AR1 FFAR3 GPR32 KIR2DL1 KIR2DL3 KLK11 KLK3 LAIR1 LAIR2 LILRA1 LILRA4 LILRB2 LILRB4 LILRB5 NLRP11 NLRP9 SULT2B1 VN1R4 ZNF28 ZNF665 ZNF880,regulation of immune response|immune response-inhibiting cell surface receptor signaling pathway|immune response|immune response-inhibiting signal transduction|regulation of immune system process,1.504e-07|1.989e-07|2.999e-07|3.443e-07|6.626e-07,0.002372|0.001569|0.001577|0.001358|0.00209,7.931|335.8|5.449|268.6|5.791
4015,22,0.5059,116.9,17760.0,0.006522,1.0,ERVV-2 KIR2DL1 KIR2DL3 SIGLEC5 VN1R4 ZFP28 ZNF28 ZNF320 ZNF415 ZNF480 ZNF528 ZNF534 ZNF571 ZNF578 ZNF600 ZNF610 ZNF665 ZNF677 ZNF701 ZNF808 ZNF83 ZNF880,"regulation of transcription by RNA polymerase II|cellular process|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",2.38e-11|6.301e-10|2.552e-09|2.563e-09|2.622e-09,3.754e-07|4.969e-06|1.342e-05|1.011e-05|8.273e-06,5.886|0.1735|4.394|4.393|4.387
4016,6,0.5347,8.021,4901.0,0.0016300000000000002,0.998474,CYP2F1 HIST1H4I MGST1 SEC11C ZNF404 ZNF611,xenobiotic metabolic process|trichloroethylene metabolic process|cellular response to lipid hydroperoxide|chlorinated hydrocarbon metabolic process|cellular response to xenobiotic stimulus,0.0005478|0.0005824|0.0005824|0.0005824|0.000592,1|1|1|1|1,55.36|3432|3432|3432|53.22
4017,13,0.5036,39.28,8948.0,0.004358,0.999993,AK6 C18orf21 C1D DIMT1 EXOSC1 EXOSC10 HEATR1 NOL6 NOP9 PARN POP4 SRFBP1 WDR43,rRNA processing|ncRNA processing|rRNA metabolic process|ncRNA metabolic process|ribosome biogenesis,1.205e-16|1.375e-16|1.742e-16|9.566e-16|1.311e-15,1.902e-12|1.085e-12|9.158e-13|3.772e-12|4.137e-12,56.58|37.46|54.48|31.3|44.31
4018,22,0.5062,116.9,17860.0,0.006488,1.0,KIR2DL1 SIGLEC12 SIGLEC5 VN1R4 ZNF175 ZNF28 ZNF415 ZNF432 ZNF528 ZNF534 ZNF571 ZNF577 ZNF578 ZNF610 ZNF613 ZNF614 ZNF649 ZNF665 ZNF677 ZNF701 ZNF841 ZNF880,"regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process|regulation of RNA metabolic process",1.135e-12|1.703e-10|1.711e-10|1.754e-10|6.194e-10,1.79e-08|1.343e-06|8.997e-07|6.915e-07|1.954e-06,6.233|4.653|4.652|4.645|4.312
4019,8,0.5337,14.94,6179.0,0.0024059999999999997,0.9996790000000001,AGPAT5 CFAP53 ISL2 LHX3 NEUROD1 OTP OTX2 ZNF669,forebrain development|spinal cord motor neuron cell fate specification|pattern specification process|endocrine system development|central nervous system development,7.838e-06|8.691e-06|1.192e-05|1.223e-05|1.295e-05,0.1236|0.06854|0.06269|0.04823|0.04087,27.1|514.9|24.34|62.79|12.99
4020,28,0.5009,189.3,22040.0,0.008497,1.0,APOC2 C5AR1 CBLC CCDC61 CEACAM19 CYP2A13 EML2 IGFL1 IGFL2 IGFL3 IGFL4 PGLYRP1 PSG11 PSG2 PSG3 PSG4 PSG6 PSG8 PSG9 PVR ZNF155 ZNF222 ZNF230 ZNF233 ZNF284 ZNF285 ZNF45 ZNF780B,female pregnancy|multi-multicellular organism process|cellular process|multi-organism reproductive process|positive regulation of phospholipase activity,2.384e-07|5.61e-07|9.193e-06|0.002862|0.00378,0.00376|0.004425|0.04833|1|1,23.01|19.8|0.4876|4.123|22.51
4021,4,0.545,3.27,3125.0,0.0010429999999999999,0.9929309999999999,C4orf47 RIPK4 ZBTB45 ZNF750,"negative regulation of epithelial to mesenchymal transition|negative regulation of transcription by RNA polymerase II|regulation of transcription, DNA-templated|regulation of nucleic acid-templated transcription|regulation of RNA biosynthetic process",0.006973|0.01088|0.01665|0.01667|0.01674,1|1|1|1|1,147.1|11.42|4.459|4.458|4.451
4022,7,0.5023,10.55,5379.0,0.001952,0.9992989999999999,LILRB2 PRB1 PRB2 PRB4 PRH2 TAS2R19 ZNF777,regulation of lipid kinase activity|negative regulation of postsynaptic density organization|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of cell cycle G1/S phase transition|interleukin-10-mediated signaling pathway,0.0004267|0.0008734|0.0009744|0.001028|0.00131,1|1|1|1|1,65.38|2288|42.77|41.61|1144
4023,5,0.5162,5.162000000000001,4112.0,0.001251,0.996692,COL9A2 ISCU OXT PPAN ZNF784,positive regulation of hindgut contraction|negative regulation of iron ion import across plasma membrane|regulation of hindgut contraction|maternal aggressive behavior|regulation of iron ion import across plasma membrane,0.0004854|0.0004854|0.000728|0.0009706|0.0009706,1|1|1|1|1,4119|4119|2060|1373|1373
4024,4,0.5657,3.3939999999999997,3092.0,0.001094,0.9929309999999999,CCDC85C IZUMO2 PRKG1 ZNF816,relaxation of vascular associated smooth muscle|negative regulation of vascular associated smooth muscle cell migration|relaxation of smooth muscle|forebrain development|negative regulation of platelet aggregation,0.001359|0.001359|0.001553|0.002008|0.002522,1|1|1|1|1,858.1|858.1|735.5|27.1|429.1
4025,6,0.507,7.606,5046.0,0.001501,0.998474,C1QA CEP126 ITGA10 SLC25A32 SLC36A4 ZNF821,mitochondrial FAD transmembrane transport|folate import into mitochondrion|carboxylic acid transmembrane transport|organic acid transmembrane transport|proline import across plasma membrane,0.0005824|0.0005824|0.0007146|0.0007245|0.0008735,1|1|1|1|1,3432|3432|48.35|48.01|1716
4026,7,0.5233,10.99,5722.0,0.001912,0.9992989999999999,HRASLS HTR3D MUC4 SLC51A TCTEX1D2 TMEM259 ZNF827,regulation of intraciliary retrograde transport|bile acid secretion|N-acylphosphatidylethanolamine metabolic process|intraciliary retrograde transport|positive regulation of ERAD pathway,0.001019|0.002376|0.003393|0.005086|0.005086,1|1|1|1|1,1471|490.4|326.9|210.2|210.2
4027,4,0.5783,3.47,3154.0,0.0010960000000000002,0.9929309999999999,APTX REPIN1 WDR38 ZNF835,polynucleotide 3' dephosphorylation|DNA ligation|single strand break repair|hematopoietic progenitor cell differentiation|response to hydrogen peroxide,0.0005825|0.002328|0.002328|0.01698|0.0231,1|1|1|1|1,2574|468.1|468.1|59.18|43.27
4028,16,0.5015,60.18,9987.0,0.005971,0.999999,BNIP1 C19orf25 IER3IP1 INPP5K NBAS RAB18 RAB3GAP1 RAB3GAP2 RINT1 SCFD1 SCYL1 TBC1D20 TMEM167A UNC50 USE1 YIPF5,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum|Golgi vesicle transport|regulation of ER to Golgi vesicle-mediated transport|protein localization|vesicle-mediated transport",7.455e-11|4.235e-10|1.218e-09|6.718e-09|4.225e-08,1.176e-06|3.34e-06|6.403e-06|2.649e-05|0.0001333,85.52|24.47|323.1|6.737|6.806
4029,4,0.5103,3.062,3148.0,0.0009691000000000001,0.9929309999999999,GJC1 PPP2R2B TM6SF1 ZNF845,gap junction assembly|cell communication by electrical coupling involved in cardiac conduction|cell communication by electrical coupling|cell communication involved in cardiac conduction|cardiac conduction,2.119e-06|6.401e-06|1.087e-05|4.647e-05|0.0002174,0.03343|0.05048|0.05714|0.1832|0.6859,1030|549.2|411.9|191.6|86.72
4030,4,0.5136,3.082,3174.0,0.0009675,0.9929309999999999,ASCL2 CASP7 ETFDH ZNF846,spongiotrophoblast layer development|cellular response to staurosporine|response to staurosporine|negative regulation of Schwann cell proliferation|regulation of Schwann cell proliferation,0.0003883|0.001165|0.001165|0.001359|0.001553,1|1|1|1|1,5149|1030|1030|858.1|735.5
4031,4,0.5911,3.5460000000000003,3186.0,0.001109,0.9929309999999999,AKR1E2 GCSAM PABPN1L ZP3,positive regulation of type IV hypersensitivity|positive regulation of antral ovarian follicle growth|regulation of antral ovarian follicle growth|positive regulation of ovarian follicle development|positive regulation of acrosomal vesicle exocytosis,0.0003883|0.0003883|0.0003883|0.0005825|0.0005825,1|1|1|1|1,5149|5149|5149|2574|2574
4032,11,0.526,28.93,7314.0,0.003928,0.999969,BIRC6 HECTD1 KCMF1 PLAA PPP1R15B UBA6 UBR4 USP15 USP19 VCPIP1 ZRANB1,protein modification by small protein conjugation or removal|ubiquitin-dependent protein catabolic process|modification-dependent protein catabolic process|modification-dependent macromolecule catabolic process|proteolysis involved in cellular protein catabolic process,1.031e-10|2.461e-09|2.691e-09|3.09e-09|5.291e-09,1.627e-06|1.941e-05|1.415e-05|1.218e-05|1.669e-05,16.34|24.59|24.27|23.79|21.99
4033,4,0.5407,3.2439999999999998,2878.0,0.001123,0.9929309999999999,ATAD3B ROMO1 ST3GAL3 ZRANB2,ganglioside biosynthetic process via lactosylceramide|protein insertion into mitochondrial inner membrane|cytolysis by host of symbiont cells|cytolysis in other organism involved in symbiotic interaction|cytolysis in other organism,0.001165|0.002328|0.002522|0.002522|0.002716,1|1|1|1|1,1030|468.1|429.1|429.1|396.1
4034,5,0.5262,5.2620000000000005,4160.0,0.00126,0.996692,DNAJB9 INTU MYOM3 RBM43 ZSCAN2,negative regulation of IRE1-mediated unfolded protein response|tongue morphogenesis|negative regulation of keratinocyte proliferation|regulation of IRE1-mediated unfolded protein response|negative regulation of cell division,0.001456|0.002667|0.003394|0.003878|0.00412,1|1|1|1|1,823.8|411.9|316.8|274.6|257.4
4035,4,0.5306,3.1839999999999997,3171.0,0.001,0.9929309999999999,CCDC177 CPA3 LRRC25 ZSCAN32,angiotensin maturation|regulation of angiotensin levels in blood|regulation of systemic arterial blood pressure by circulatory renin-angiotensin|regulation of systemic arterial blood pressure by renin-angiotensin|peptide hormone processing,0.003152|0.003152|0.003878|0.005087|0.007985,1|1|1|1|1,343.3|343.3|274.6|205.9|128.7
4036,4,0.5315,3.1889999999999996,3324.0,0.0009562000000000001,0.9929309999999999,TEX38 TMEM79 VPS37D ZSCAN4,cuticle development|negative regulation of mitotic recombination|regulation of mitotic recombination|epithelial cell maturation|viral budding via host ESCRT complex,0.0007766|0.0007766|0.001359|0.003104|0.004072,1|1|1|1|1,1716|1716|858.1|343.2|257.4
4037,4,0.5041,3.025,3089.0,0.0009756999999999999,0.9929309999999999,FAM45A PTPRS RSPH6A ZSCAN9,manchette disassembly|negative regulation of toll-like receptor 9 signaling pathway|negative regulation of interferon-alpha production|negative regulation of collateral sprouting|regulation of toll-like receptor 9 signaling pathway,0.0002913|0.0007281|0.001019|0.001456|0.001747,1|1|1|1|1,6865|1716|1144|762.8|624.1
4038,4,0.553,3.318,3104.0,0.001065,0.9929309999999999,ICK MRAS NDRG3 ZSWIM1,intraciliary anterograde transport|MAPK cascade|intraciliary retrograde transport|intraciliary transport|protein transport along microtubule,0.0007766|0.00232|0.00291|0.01045|0.01333,1|1|1|1|1,1716|25.18|367.8|97.15|75.72
4039,4,0.5111,3.0669999999999997,3390.0,0.0009016,0.9929309999999999,HCST RSPH1 TFPI ZSWIM2,"negative regulation of blood coagulation, extrinsic pathway|regulation of blood coagulation, extrinsic pathway|blood coagulation, extrinsic pathway|negative regulation of protein activation cascade|regulation of protein activation cascade",0.0009706|0.0009706|0.0009706|0.002134|0.002328,1|1|1|1|1,1287|1287|1287|514.9|468.1
4040,4,0.573,3.438,3072.0,0.001115,0.9929309999999999,BAG5 CES4A GLCCI1 ZSWIM3,negative regulation of protein refolding|regulation of protein refolding|negative regulation of protein folding|regulation of protein folding|negative regulation of ubiquitin-protein transferase activity,0.0009706|0.0009706|0.001359|0.002522|0.003491,1|1|1|1|1,1287|1287|858.1|429.1|302.9
4041,6,0.5029,7.544,4642.0,0.0016179999999999999,0.998474,DVL1 FGFRL1 FZD5 LGR4 WLS ZSWIM5,canonical Wnt signaling pathway|cell-cell signaling by wnt|Wnt signaling pathway|cell surface receptor signaling pathway involved in cell-cell signaling|regulation of animal organ morphogenesis,1.077e-08|2.973e-08|2.973e-08|7.321e-08|2.157e-07,0.0001699|0.0002345|0.0001563|0.0002887|0.0006805,140.1|42.15|42.15|35.11|65.02
4042,4,0.5364,3.218,2891.0,0.001109,0.9929309999999999,TGIF1 UBE4B UBL7 ZSWIM6,granzyme-mediated apoptotic signaling pathway|striatal medium spiny neuron differentiation|granzyme-mediated programmed cell death signaling pathway|regulation of axon guidance|striatum development,0.0003883|0.0009706|0.001747|0.00291|0.003685,1|1|1|1|1,5149|1287|643.6|367.8|286
